<!-- some code adapted from www.degeneratestate.org/static/metal_lyrics/metal_line.html -->
<!-- <!DOCTYPE html>
<meta content="utf-8"> -->
<style> /* set the CSS */

body {
  font: 12px Arial;
}


svg {
  font: 12px Helvetica;
}

path {
  stroke: steelblue;
  stroke-width: 2;
  fill: none;
}

.axis path,
.axis lineper {
  fill: none;
  stroke: grey;
  stroke-width: 1;
  shape-rendering: crispEdges;
}

div.tooltip {
  position: absolute;
  text-align: center;
  width: 150px;
  height: 28px;
  padding: 2px;
  font: 12px sans-serif;
  background: lightsteelblue;
  border: 0px;
  border-radius: 8px;
  pointer-events: none;
}

div.tooltipscore {
  position: absolute;
  text-align: center;
  width: 150px;
  height: 42px;
  padding: 2px;
  font: 10px sans-serif;
  background: lightsteelblue;
  border: 0px;
  border-radius: 8px;
  pointer-events: none;
}


.category_header {
  font: 12px sans-serif;
  font-weight: bolder;
  text-decoration: underline;
}

div.label {
  color: rgb(252, 251, 253);
  color: rgb(63, 0, 125);
  color: rgb(158, 155, 201);

  position: absolute;
  text-align: left;
  padding: 1px;
  border-spacing: 1px;
  font: 10px sans-serif;
  font-family: Sans-Serif;
  border: 0;
  pointer-events: none;
}

input {
  border: 1px dotted #ccc;
  background: white;
  font-family: monospace;
  padding: 10px 20px;
  font-size: 14px;
  margin: 20px 10px 30px 0;
  color: darkred;
}

.alert {
  font-family: monospace;
  padding: 10px 20px;
  font-size: 14px;
  margin: 20px 10px 30px 0;
  color: darkred;
}

ul.top_terms li {
  padding-right: 20px;
  font-size: 30pt;
  color: red;
}

input:focus {
  background-color: lightyellow;
  outline: none;
}

.snippet {
  padding-bottom: 10px;
  padding-left: 5px;
  padding-right: 5px;
  white-space: pre-wrap;
}

.snippet_header {
  font-size: 20px;
  font-family: Helvetica, Arial, Sans-Serif;
  font-weight: bolder;
  #text-decoration: underline;
  text-align: center;
  border-bottom-width: 10px;
  border-bottom-color: #888888;
  padding-bottom: 10px;
}


#title-div {
  font-size: 20px;
  font-family: Helvetica, Arial, Sans-Serif;
  text-align: center;
}


.text_header {
  font: 18px sans-serif;
  font-size: 18px;
  font-family: Helvetica, Arial, Sans-Serif;

  font-weight: bolder;
  text-decoration: underline;
  text-align: center;
  color: darkblue;
  padding-bottom: 10px;
}

.text_subheader {
  font-size: 14px;
  font-family: Helvetica, Arial, Sans-Serif;

  text-align: center;
}


.snippet_meta {
  border-top: 3px solid #4588ba;
  font-size: 12px;
  font-family: Helvetica, Arial, Sans-Serif;
color: darkblue;
}

.left_contexts {
  width: 45%;
  float: left;
}

.right_contexts {
  width: 45%;
  float: left;
}

.scattertext {
  font-size: 10px;
  font-family: Helvetica, Arial, Sans-Serif;
}

.label {
  font-size: 10px;
  font-family: Helvetica, Arial, Sans-Serif;
}


.small_label {
  font-size: 10px;
}

#corpus-stats {
  text-align: center;
}

#cat {
}

#notcat {
}

</style>
<script src="https://cdnjs.cloudflare.com/ajax/libs/d3/4.6.0/d3.min.js" charset="utf-8"></script>
<script src="https://d3js.org/d3-scale-chromatic.v1.min.js" charset="utf-8"></script>


<span id="title-div"></span>
<div class="scattertext" id="d3-div-1"> </div>
<div id="corpus-stats"> </div>
<form name="termForm" onSubmit="handleSearch(); return false;">
  <input name="Submit" type="submit" value="Search for term">
  <input type="text" id="searchTerm" placeholder="Type a word or two&hellip;">
  <span id="alertMessage" class="alert"></span>
</form>
<a name="snippets"></a>
<a name="snippetsalt"></a>
<div id="termstats"></div>
<div id="d3-div-2">
 <div class="snippet_header left_contexts" id="cathead"></div>
 <div class="snippet_header right_contexts" id="notcathead"></div>
 <div class="snippet left_contexts" id="cat"></div>
 <div class="snippet right_contexts" id="notcat"></div>
</div>
<script charset="utf-8">
  // Created using Cozy: github.com/uwplse/cozy
function Rectangle(ax1, ay1, ax2, ay2) {
    this.ax1 = ax1;
    this.ay1 = ay1;
    this.ax2 = ax2;
    this.ay2 = ay2;
    this._left7 = undefined;
    this._right8 = undefined;
    this._parent9 = undefined;
    this._min_ax12 = undefined;
    this._min_ay13 = undefined;
    this._max_ay24 = undefined;
    this._height10 = undefined;
}
function RectangleHolder() {
    this.my_size = 0;
    (this)._root1 = null;
}
RectangleHolder.prototype.size = function () {
    return this.my_size;
};
RectangleHolder.prototype.add = function (x) {
    ++this.my_size;
    var _idx69 = (x).ax2;
    (x)._left7 = null;
    (x)._right8 = null;
    (x)._min_ax12 = (x).ax1;
    (x)._min_ay13 = (x).ay1;
    (x)._max_ay24 = (x).ay2;
    (x)._height10 = 0;
    var _previous70 = null;
    var _current71 = (this)._root1;
    var _is_left72 = false;
    while (!((_current71) == null)) {
        _previous70 = _current71;
        if ((_idx69) < ((_current71).ax2)) {
            _current71 = (_current71)._left7;
            _is_left72 = true;
        } else {
            _current71 = (_current71)._right8;
            _is_left72 = false;
        }
    }
    if ((_previous70) == null) {
        (this)._root1 = x;
    } else {
        (x)._parent9 = _previous70;
        if (_is_left72) {
            (_previous70)._left7 = x;
        } else {
            (_previous70)._right8 = x;
        }
    }
    var _cursor73 = (x)._parent9;
    var _changed74 = true;
    while ((_changed74) && (!((_cursor73) == (null)))) {
        var _old__min_ax1275 = (_cursor73)._min_ax12;
        var _old__min_ay1376 = (_cursor73)._min_ay13;
        var _old__max_ay2477 = (_cursor73)._max_ay24;
        var _old_height78 = (_cursor73)._height10;
        /* _min_ax12 is min of ax1 */
        var _augval79 = (_cursor73).ax1;
        var _child80 = (_cursor73)._left7;
        if (!((_child80) == null)) {
            var _val81 = (_child80)._min_ax12;
            _augval79 = ((_augval79) < (_val81)) ? (_augval79) : (_val81);
        }
        var _child82 = (_cursor73)._right8;
        if (!((_child82) == null)) {
            var _val83 = (_child82)._min_ax12;
            _augval79 = ((_augval79) < (_val83)) ? (_augval79) : (_val83);
        }
        (_cursor73)._min_ax12 = _augval79;
        /* _min_ay13 is min of ay1 */
        var _augval84 = (_cursor73).ay1;
        var _child85 = (_cursor73)._left7;
        if (!((_child85) == null)) {
            var _val86 = (_child85)._min_ay13;
            _augval84 = ((_augval84) < (_val86)) ? (_augval84) : (_val86);
        }
        var _child87 = (_cursor73)._right8;
        if (!((_child87) == null)) {
            var _val88 = (_child87)._min_ay13;
            _augval84 = ((_augval84) < (_val88)) ? (_augval84) : (_val88);
        }
        (_cursor73)._min_ay13 = _augval84;
        /* _max_ay24 is max of ay2 */
        var _augval89 = (_cursor73).ay2;
        var _child90 = (_cursor73)._left7;
        if (!((_child90) == null)) {
            var _val91 = (_child90)._max_ay24;
            _augval89 = ((_augval89) < (_val91)) ? (_val91) : (_augval89);
        }
        var _child92 = (_cursor73)._right8;
        if (!((_child92) == null)) {
            var _val93 = (_child92)._max_ay24;
            _augval89 = ((_augval89) < (_val93)) ? (_val93) : (_augval89);
        }
        (_cursor73)._max_ay24 = _augval89;
        (_cursor73)._height10 = 1 + ((((((_cursor73)._left7) == null) ? (-1) : (((_cursor73)._left7)._height10)) > ((((_cursor73)._right8) == null) ? (-1) : (((_cursor73)._right8)._height10))) ? ((((_cursor73)._left7) == null) ? (-1) : (((_cursor73)._left7)._height10)) : ((((_cursor73)._right8) == null) ? (-1) : (((_cursor73)._right8)._height10)));
        _changed74 = false;
        _changed74 = (_changed74) || (!((_old__min_ax1275) == ((_cursor73)._min_ax12)));
        _changed74 = (_changed74) || (!((_old__min_ay1376) == ((_cursor73)._min_ay13)));
        _changed74 = (_changed74) || (!((_old__max_ay2477) == ((_cursor73)._max_ay24)));
        _changed74 = (_changed74) || (!((_old_height78) == ((_cursor73)._height10)));
        _cursor73 = (_cursor73)._parent9;
    }
    /* rebalance AVL tree */
    var _cursor94 = x;
    var _imbalance95;
    while (!(((_cursor94)._parent9) == null)) {
        _cursor94 = (_cursor94)._parent9;
        (_cursor94)._height10 = 1 + ((((((_cursor94)._left7) == null) ? (-1) : (((_cursor94)._left7)._height10)) > ((((_cursor94)._right8) == null) ? (-1) : (((_cursor94)._right8)._height10))) ? ((((_cursor94)._left7) == null) ? (-1) : (((_cursor94)._left7)._height10)) : ((((_cursor94)._right8) == null) ? (-1) : (((_cursor94)._right8)._height10)));
        _imbalance95 = ((((_cursor94)._left7) == null) ? (-1) : (((_cursor94)._left7)._height10)) - ((((_cursor94)._right8) == null) ? (-1) : (((_cursor94)._right8)._height10));
        if ((_imbalance95) > (1)) {
            if ((((((_cursor94)._left7)._left7) == null) ? (-1) : ((((_cursor94)._left7)._left7)._height10)) < (((((_cursor94)._left7)._right8) == null) ? (-1) : ((((_cursor94)._left7)._right8)._height10))) {
                /* rotate ((_cursor94)._left7)._right8 */
                var _a96 = (_cursor94)._left7;
                var _b97 = (_a96)._right8;
                var _c98 = (_b97)._left7;
                /* replace _a96 with _b97 in (_a96)._parent9 */
                if (!(((_a96)._parent9) == null)) {
                    if ((((_a96)._parent9)._left7) == (_a96)) {
                        ((_a96)._parent9)._left7 = _b97;
                    } else {
                        ((_a96)._parent9)._right8 = _b97;
                    }
                }
                if (!((_b97) == null)) {
                    (_b97)._parent9 = (_a96)._parent9;
                }
                /* replace _c98 with _a96 in _b97 */
                (_b97)._left7 = _a96;
                if (!((_a96) == null)) {
                    (_a96)._parent9 = _b97;
                }
                /* replace _b97 with _c98 in _a96 */
                (_a96)._right8 = _c98;
                if (!((_c98) == null)) {
                    (_c98)._parent9 = _a96;
                }
                /* _min_ax12 is min of ax1 */
                var _augval99 = (_a96).ax1;
                var _child100 = (_a96)._left7;
                if (!((_child100) == null)) {
                    var _val101 = (_child100)._min_ax12;
                    _augval99 = ((_augval99) < (_val101)) ? (_augval99) : (_val101);
                }
                var _child102 = (_a96)._right8;
                if (!((_child102) == null)) {
                    var _val103 = (_child102)._min_ax12;
                    _augval99 = ((_augval99) < (_val103)) ? (_augval99) : (_val103);
                }
                (_a96)._min_ax12 = _augval99;
                /* _min_ay13 is min of ay1 */
                var _augval104 = (_a96).ay1;
                var _child105 = (_a96)._left7;
                if (!((_child105) == null)) {
                    var _val106 = (_child105)._min_ay13;
                    _augval104 = ((_augval104) < (_val106)) ? (_augval104) : (_val106);
                }
                var _child107 = (_a96)._right8;
                if (!((_child107) == null)) {
                    var _val108 = (_child107)._min_ay13;
                    _augval104 = ((_augval104) < (_val108)) ? (_augval104) : (_val108);
                }
                (_a96)._min_ay13 = _augval104;
                /* _max_ay24 is max of ay2 */
                var _augval109 = (_a96).ay2;
                var _child110 = (_a96)._left7;
                if (!((_child110) == null)) {
                    var _val111 = (_child110)._max_ay24;
                    _augval109 = ((_augval109) < (_val111)) ? (_val111) : (_augval109);
                }
                var _child112 = (_a96)._right8;
                if (!((_child112) == null)) {
                    var _val113 = (_child112)._max_ay24;
                    _augval109 = ((_augval109) < (_val113)) ? (_val113) : (_augval109);
                }
                (_a96)._max_ay24 = _augval109;
                (_a96)._height10 = 1 + ((((((_a96)._left7) == null) ? (-1) : (((_a96)._left7)._height10)) > ((((_a96)._right8) == null) ? (-1) : (((_a96)._right8)._height10))) ? ((((_a96)._left7) == null) ? (-1) : (((_a96)._left7)._height10)) : ((((_a96)._right8) == null) ? (-1) : (((_a96)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval114 = (_b97).ax1;
                var _child115 = (_b97)._left7;
                if (!((_child115) == null)) {
                    var _val116 = (_child115)._min_ax12;
                    _augval114 = ((_augval114) < (_val116)) ? (_augval114) : (_val116);
                }
                var _child117 = (_b97)._right8;
                if (!((_child117) == null)) {
                    var _val118 = (_child117)._min_ax12;
                    _augval114 = ((_augval114) < (_val118)) ? (_augval114) : (_val118);
                }
                (_b97)._min_ax12 = _augval114;
                /* _min_ay13 is min of ay1 */
                var _augval119 = (_b97).ay1;
                var _child120 = (_b97)._left7;
                if (!((_child120) == null)) {
                    var _val121 = (_child120)._min_ay13;
                    _augval119 = ((_augval119) < (_val121)) ? (_augval119) : (_val121);
                }
                var _child122 = (_b97)._right8;
                if (!((_child122) == null)) {
                    var _val123 = (_child122)._min_ay13;
                    _augval119 = ((_augval119) < (_val123)) ? (_augval119) : (_val123);
                }
                (_b97)._min_ay13 = _augval119;
                /* _max_ay24 is max of ay2 */
                var _augval124 = (_b97).ay2;
                var _child125 = (_b97)._left7;
                if (!((_child125) == null)) {
                    var _val126 = (_child125)._max_ay24;
                    _augval124 = ((_augval124) < (_val126)) ? (_val126) : (_augval124);
                }
                var _child127 = (_b97)._right8;
                if (!((_child127) == null)) {
                    var _val128 = (_child127)._max_ay24;
                    _augval124 = ((_augval124) < (_val128)) ? (_val128) : (_augval124);
                }
                (_b97)._max_ay24 = _augval124;
                (_b97)._height10 = 1 + ((((((_b97)._left7) == null) ? (-1) : (((_b97)._left7)._height10)) > ((((_b97)._right8) == null) ? (-1) : (((_b97)._right8)._height10))) ? ((((_b97)._left7) == null) ? (-1) : (((_b97)._left7)._height10)) : ((((_b97)._right8) == null) ? (-1) : (((_b97)._right8)._height10)));
                if (!(((_b97)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval129 = ((_b97)._parent9).ax1;
                    var _child130 = ((_b97)._parent9)._left7;
                    if (!((_child130) == null)) {
                        var _val131 = (_child130)._min_ax12;
                        _augval129 = ((_augval129) < (_val131)) ? (_augval129) : (_val131);
                    }
                    var _child132 = ((_b97)._parent9)._right8;
                    if (!((_child132) == null)) {
                        var _val133 = (_child132)._min_ax12;
                        _augval129 = ((_augval129) < (_val133)) ? (_augval129) : (_val133);
                    }
                    ((_b97)._parent9)._min_ax12 = _augval129;
                    /* _min_ay13 is min of ay1 */
                    var _augval134 = ((_b97)._parent9).ay1;
                    var _child135 = ((_b97)._parent9)._left7;
                    if (!((_child135) == null)) {
                        var _val136 = (_child135)._min_ay13;
                        _augval134 = ((_augval134) < (_val136)) ? (_augval134) : (_val136);
                    }
                    var _child137 = ((_b97)._parent9)._right8;
                    if (!((_child137) == null)) {
                        var _val138 = (_child137)._min_ay13;
                        _augval134 = ((_augval134) < (_val138)) ? (_augval134) : (_val138);
                    }
                    ((_b97)._parent9)._min_ay13 = _augval134;
                    /* _max_ay24 is max of ay2 */
                    var _augval139 = ((_b97)._parent9).ay2;
                    var _child140 = ((_b97)._parent9)._left7;
                    if (!((_child140) == null)) {
                        var _val141 = (_child140)._max_ay24;
                        _augval139 = ((_augval139) < (_val141)) ? (_val141) : (_augval139);
                    }
                    var _child142 = ((_b97)._parent9)._right8;
                    if (!((_child142) == null)) {
                        var _val143 = (_child142)._max_ay24;
                        _augval139 = ((_augval139) < (_val143)) ? (_val143) : (_augval139);
                    }
                    ((_b97)._parent9)._max_ay24 = _augval139;
                    ((_b97)._parent9)._height10 = 1 + (((((((_b97)._parent9)._left7) == null) ? (-1) : ((((_b97)._parent9)._left7)._height10)) > (((((_b97)._parent9)._right8) == null) ? (-1) : ((((_b97)._parent9)._right8)._height10))) ? (((((_b97)._parent9)._left7) == null) ? (-1) : ((((_b97)._parent9)._left7)._height10)) : (((((_b97)._parent9)._right8) == null) ? (-1) : ((((_b97)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b97;
                }
            }
            /* rotate (_cursor94)._left7 */
            var _a144 = _cursor94;
            var _b145 = (_a144)._left7;
            var _c146 = (_b145)._right8;
            /* replace _a144 with _b145 in (_a144)._parent9 */
            if (!(((_a144)._parent9) == null)) {
                if ((((_a144)._parent9)._left7) == (_a144)) {
                    ((_a144)._parent9)._left7 = _b145;
                } else {
                    ((_a144)._parent9)._right8 = _b145;
                }
            }
            if (!((_b145) == null)) {
                (_b145)._parent9 = (_a144)._parent9;
            }
            /* replace _c146 with _a144 in _b145 */
            (_b145)._right8 = _a144;
            if (!((_a144) == null)) {
                (_a144)._parent9 = _b145;
            }
            /* replace _b145 with _c146 in _a144 */
            (_a144)._left7 = _c146;
            if (!((_c146) == null)) {
                (_c146)._parent9 = _a144;
            }
            /* _min_ax12 is min of ax1 */
            var _augval147 = (_a144).ax1;
            var _child148 = (_a144)._left7;
            if (!((_child148) == null)) {
                var _val149 = (_child148)._min_ax12;
                _augval147 = ((_augval147) < (_val149)) ? (_augval147) : (_val149);
            }
            var _child150 = (_a144)._right8;
            if (!((_child150) == null)) {
                var _val151 = (_child150)._min_ax12;
                _augval147 = ((_augval147) < (_val151)) ? (_augval147) : (_val151);
            }
            (_a144)._min_ax12 = _augval147;
            /* _min_ay13 is min of ay1 */
            var _augval152 = (_a144).ay1;
            var _child153 = (_a144)._left7;
            if (!((_child153) == null)) {
                var _val154 = (_child153)._min_ay13;
                _augval152 = ((_augval152) < (_val154)) ? (_augval152) : (_val154);
            }
            var _child155 = (_a144)._right8;
            if (!((_child155) == null)) {
                var _val156 = (_child155)._min_ay13;
                _augval152 = ((_augval152) < (_val156)) ? (_augval152) : (_val156);
            }
            (_a144)._min_ay13 = _augval152;
            /* _max_ay24 is max of ay2 */
            var _augval157 = (_a144).ay2;
            var _child158 = (_a144)._left7;
            if (!((_child158) == null)) {
                var _val159 = (_child158)._max_ay24;
                _augval157 = ((_augval157) < (_val159)) ? (_val159) : (_augval157);
            }
            var _child160 = (_a144)._right8;
            if (!((_child160) == null)) {
                var _val161 = (_child160)._max_ay24;
                _augval157 = ((_augval157) < (_val161)) ? (_val161) : (_augval157);
            }
            (_a144)._max_ay24 = _augval157;
            (_a144)._height10 = 1 + ((((((_a144)._left7) == null) ? (-1) : (((_a144)._left7)._height10)) > ((((_a144)._right8) == null) ? (-1) : (((_a144)._right8)._height10))) ? ((((_a144)._left7) == null) ? (-1) : (((_a144)._left7)._height10)) : ((((_a144)._right8) == null) ? (-1) : (((_a144)._right8)._height10)));
            /* _min_ax12 is min of ax1 */
            var _augval162 = (_b145).ax1;
            var _child163 = (_b145)._left7;
            if (!((_child163) == null)) {
                var _val164 = (_child163)._min_ax12;
                _augval162 = ((_augval162) < (_val164)) ? (_augval162) : (_val164);
            }
            var _child165 = (_b145)._right8;
            if (!((_child165) == null)) {
                var _val166 = (_child165)._min_ax12;
                _augval162 = ((_augval162) < (_val166)) ? (_augval162) : (_val166);
            }
            (_b145)._min_ax12 = _augval162;
            /* _min_ay13 is min of ay1 */
            var _augval167 = (_b145).ay1;
            var _child168 = (_b145)._left7;
            if (!((_child168) == null)) {
                var _val169 = (_child168)._min_ay13;
                _augval167 = ((_augval167) < (_val169)) ? (_augval167) : (_val169);
            }
            var _child170 = (_b145)._right8;
            if (!((_child170) == null)) {
                var _val171 = (_child170)._min_ay13;
                _augval167 = ((_augval167) < (_val171)) ? (_augval167) : (_val171);
            }
            (_b145)._min_ay13 = _augval167;
            /* _max_ay24 is max of ay2 */
            var _augval172 = (_b145).ay2;
            var _child173 = (_b145)._left7;
            if (!((_child173) == null)) {
                var _val174 = (_child173)._max_ay24;
                _augval172 = ((_augval172) < (_val174)) ? (_val174) : (_augval172);
            }
            var _child175 = (_b145)._right8;
            if (!((_child175) == null)) {
                var _val176 = (_child175)._max_ay24;
                _augval172 = ((_augval172) < (_val176)) ? (_val176) : (_augval172);
            }
            (_b145)._max_ay24 = _augval172;
            (_b145)._height10 = 1 + ((((((_b145)._left7) == null) ? (-1) : (((_b145)._left7)._height10)) > ((((_b145)._right8) == null) ? (-1) : (((_b145)._right8)._height10))) ? ((((_b145)._left7) == null) ? (-1) : (((_b145)._left7)._height10)) : ((((_b145)._right8) == null) ? (-1) : (((_b145)._right8)._height10)));
            if (!(((_b145)._parent9) == null)) {
                /* _min_ax12 is min of ax1 */
                var _augval177 = ((_b145)._parent9).ax1;
                var _child178 = ((_b145)._parent9)._left7;
                if (!((_child178) == null)) {
                    var _val179 = (_child178)._min_ax12;
                    _augval177 = ((_augval177) < (_val179)) ? (_augval177) : (_val179);
                }
                var _child180 = ((_b145)._parent9)._right8;
                if (!((_child180) == null)) {
                    var _val181 = (_child180)._min_ax12;
                    _augval177 = ((_augval177) < (_val181)) ? (_augval177) : (_val181);
                }
                ((_b145)._parent9)._min_ax12 = _augval177;
                /* _min_ay13 is min of ay1 */
                var _augval182 = ((_b145)._parent9).ay1;
                var _child183 = ((_b145)._parent9)._left7;
                if (!((_child183) == null)) {
                    var _val184 = (_child183)._min_ay13;
                    _augval182 = ((_augval182) < (_val184)) ? (_augval182) : (_val184);
                }
                var _child185 = ((_b145)._parent9)._right8;
                if (!((_child185) == null)) {
                    var _val186 = (_child185)._min_ay13;
                    _augval182 = ((_augval182) < (_val186)) ? (_augval182) : (_val186);
                }
                ((_b145)._parent9)._min_ay13 = _augval182;
                /* _max_ay24 is max of ay2 */
                var _augval187 = ((_b145)._parent9).ay2;
                var _child188 = ((_b145)._parent9)._left7;
                if (!((_child188) == null)) {
                    var _val189 = (_child188)._max_ay24;
                    _augval187 = ((_augval187) < (_val189)) ? (_val189) : (_augval187);
                }
                var _child190 = ((_b145)._parent9)._right8;
                if (!((_child190) == null)) {
                    var _val191 = (_child190)._max_ay24;
                    _augval187 = ((_augval187) < (_val191)) ? (_val191) : (_augval187);
                }
                ((_b145)._parent9)._max_ay24 = _augval187;
                ((_b145)._parent9)._height10 = 1 + (((((((_b145)._parent9)._left7) == null) ? (-1) : ((((_b145)._parent9)._left7)._height10)) > (((((_b145)._parent9)._right8) == null) ? (-1) : ((((_b145)._parent9)._right8)._height10))) ? (((((_b145)._parent9)._left7) == null) ? (-1) : ((((_b145)._parent9)._left7)._height10)) : (((((_b145)._parent9)._right8) == null) ? (-1) : ((((_b145)._parent9)._right8)._height10)));
            } else {
                (this)._root1 = _b145;
            }
            _cursor94 = (_cursor94)._parent9;
        } else if ((_imbalance95) < (-1)) {
            if ((((((_cursor94)._right8)._left7) == null) ? (-1) : ((((_cursor94)._right8)._left7)._height10)) > (((((_cursor94)._right8)._right8) == null) ? (-1) : ((((_cursor94)._right8)._right8)._height10))) {
                /* rotate ((_cursor94)._right8)._left7 */
                var _a192 = (_cursor94)._right8;
                var _b193 = (_a192)._left7;
                var _c194 = (_b193)._right8;
                /* replace _a192 with _b193 in (_a192)._parent9 */
                if (!(((_a192)._parent9) == null)) {
                    if ((((_a192)._parent9)._left7) == (_a192)) {
                        ((_a192)._parent9)._left7 = _b193;
                    } else {
                        ((_a192)._parent9)._right8 = _b193;
                    }
                }
                if (!((_b193) == null)) {
                    (_b193)._parent9 = (_a192)._parent9;
                }
                /* replace _c194 with _a192 in _b193 */
                (_b193)._right8 = _a192;
                if (!((_a192) == null)) {
                    (_a192)._parent9 = _b193;
                }
                /* replace _b193 with _c194 in _a192 */
                (_a192)._left7 = _c194;
                if (!((_c194) == null)) {
                    (_c194)._parent9 = _a192;
                }
                /* _min_ax12 is min of ax1 */
                var _augval195 = (_a192).ax1;
                var _child196 = (_a192)._left7;
                if (!((_child196) == null)) {
                    var _val197 = (_child196)._min_ax12;
                    _augval195 = ((_augval195) < (_val197)) ? (_augval195) : (_val197);
                }
                var _child198 = (_a192)._right8;
                if (!((_child198) == null)) {
                    var _val199 = (_child198)._min_ax12;
                    _augval195 = ((_augval195) < (_val199)) ? (_augval195) : (_val199);
                }
                (_a192)._min_ax12 = _augval195;
                /* _min_ay13 is min of ay1 */
                var _augval200 = (_a192).ay1;
                var _child201 = (_a192)._left7;
                if (!((_child201) == null)) {
                    var _val202 = (_child201)._min_ay13;
                    _augval200 = ((_augval200) < (_val202)) ? (_augval200) : (_val202);
                }
                var _child203 = (_a192)._right8;
                if (!((_child203) == null)) {
                    var _val204 = (_child203)._min_ay13;
                    _augval200 = ((_augval200) < (_val204)) ? (_augval200) : (_val204);
                }
                (_a192)._min_ay13 = _augval200;
                /* _max_ay24 is max of ay2 */
                var _augval205 = (_a192).ay2;
                var _child206 = (_a192)._left7;
                if (!((_child206) == null)) {
                    var _val207 = (_child206)._max_ay24;
                    _augval205 = ((_augval205) < (_val207)) ? (_val207) : (_augval205);
                }
                var _child208 = (_a192)._right8;
                if (!((_child208) == null)) {
                    var _val209 = (_child208)._max_ay24;
                    _augval205 = ((_augval205) < (_val209)) ? (_val209) : (_augval205);
                }
                (_a192)._max_ay24 = _augval205;
                (_a192)._height10 = 1 + ((((((_a192)._left7) == null) ? (-1) : (((_a192)._left7)._height10)) > ((((_a192)._right8) == null) ? (-1) : (((_a192)._right8)._height10))) ? ((((_a192)._left7) == null) ? (-1) : (((_a192)._left7)._height10)) : ((((_a192)._right8) == null) ? (-1) : (((_a192)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval210 = (_b193).ax1;
                var _child211 = (_b193)._left7;
                if (!((_child211) == null)) {
                    var _val212 = (_child211)._min_ax12;
                    _augval210 = ((_augval210) < (_val212)) ? (_augval210) : (_val212);
                }
                var _child213 = (_b193)._right8;
                if (!((_child213) == null)) {
                    var _val214 = (_child213)._min_ax12;
                    _augval210 = ((_augval210) < (_val214)) ? (_augval210) : (_val214);
                }
                (_b193)._min_ax12 = _augval210;
                /* _min_ay13 is min of ay1 */
                var _augval215 = (_b193).ay1;
                var _child216 = (_b193)._left7;
                if (!((_child216) == null)) {
                    var _val217 = (_child216)._min_ay13;
                    _augval215 = ((_augval215) < (_val217)) ? (_augval215) : (_val217);
                }
                var _child218 = (_b193)._right8;
                if (!((_child218) == null)) {
                    var _val219 = (_child218)._min_ay13;
                    _augval215 = ((_augval215) < (_val219)) ? (_augval215) : (_val219);
                }
                (_b193)._min_ay13 = _augval215;
                /* _max_ay24 is max of ay2 */
                var _augval220 = (_b193).ay2;
                var _child221 = (_b193)._left7;
                if (!((_child221) == null)) {
                    var _val222 = (_child221)._max_ay24;
                    _augval220 = ((_augval220) < (_val222)) ? (_val222) : (_augval220);
                }
                var _child223 = (_b193)._right8;
                if (!((_child223) == null)) {
                    var _val224 = (_child223)._max_ay24;
                    _augval220 = ((_augval220) < (_val224)) ? (_val224) : (_augval220);
                }
                (_b193)._max_ay24 = _augval220;
                (_b193)._height10 = 1 + ((((((_b193)._left7) == null) ? (-1) : (((_b193)._left7)._height10)) > ((((_b193)._right8) == null) ? (-1) : (((_b193)._right8)._height10))) ? ((((_b193)._left7) == null) ? (-1) : (((_b193)._left7)._height10)) : ((((_b193)._right8) == null) ? (-1) : (((_b193)._right8)._height10)));
                if (!(((_b193)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval225 = ((_b193)._parent9).ax1;
                    var _child226 = ((_b193)._parent9)._left7;
                    if (!((_child226) == null)) {
                        var _val227 = (_child226)._min_ax12;
                        _augval225 = ((_augval225) < (_val227)) ? (_augval225) : (_val227);
                    }
                    var _child228 = ((_b193)._parent9)._right8;
                    if (!((_child228) == null)) {
                        var _val229 = (_child228)._min_ax12;
                        _augval225 = ((_augval225) < (_val229)) ? (_augval225) : (_val229);
                    }
                    ((_b193)._parent9)._min_ax12 = _augval225;
                    /* _min_ay13 is min of ay1 */
                    var _augval230 = ((_b193)._parent9).ay1;
                    var _child231 = ((_b193)._parent9)._left7;
                    if (!((_child231) == null)) {
                        var _val232 = (_child231)._min_ay13;
                        _augval230 = ((_augval230) < (_val232)) ? (_augval230) : (_val232);
                    }
                    var _child233 = ((_b193)._parent9)._right8;
                    if (!((_child233) == null)) {
                        var _val234 = (_child233)._min_ay13;
                        _augval230 = ((_augval230) < (_val234)) ? (_augval230) : (_val234);
                    }
                    ((_b193)._parent9)._min_ay13 = _augval230;
                    /* _max_ay24 is max of ay2 */
                    var _augval235 = ((_b193)._parent9).ay2;
                    var _child236 = ((_b193)._parent9)._left7;
                    if (!((_child236) == null)) {
                        var _val237 = (_child236)._max_ay24;
                        _augval235 = ((_augval235) < (_val237)) ? (_val237) : (_augval235);
                    }
                    var _child238 = ((_b193)._parent9)._right8;
                    if (!((_child238) == null)) {
                        var _val239 = (_child238)._max_ay24;
                        _augval235 = ((_augval235) < (_val239)) ? (_val239) : (_augval235);
                    }
                    ((_b193)._parent9)._max_ay24 = _augval235;
                    ((_b193)._parent9)._height10 = 1 + (((((((_b193)._parent9)._left7) == null) ? (-1) : ((((_b193)._parent9)._left7)._height10)) > (((((_b193)._parent9)._right8) == null) ? (-1) : ((((_b193)._parent9)._right8)._height10))) ? (((((_b193)._parent9)._left7) == null) ? (-1) : ((((_b193)._parent9)._left7)._height10)) : (((((_b193)._parent9)._right8) == null) ? (-1) : ((((_b193)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b193;
                }
            }
            /* rotate (_cursor94)._right8 */
            var _a240 = _cursor94;
            var _b241 = (_a240)._right8;
            var _c242 = (_b241)._left7;
            /* replace _a240 with _b241 in (_a240)._parent9 */
            if (!(((_a240)._parent9) == null)) {
                if ((((_a240)._parent9)._left7) == (_a240)) {
                    ((_a240)._parent9)._left7 = _b241;
                } else {
                    ((_a240)._parent9)._right8 = _b241;
                }
            }
            if (!((_b241) == null)) {
                (_b241)._parent9 = (_a240)._parent9;
            }
            /* replace _c242 with _a240 in _b241 */
            (_b241)._left7 = _a240;
            if (!((_a240) == null)) {
                (_a240)._parent9 = _b241;
            }
            /* replace _b241 with _c242 in _a240 */
            (_a240)._right8 = _c242;
            if (!((_c242) == null)) {
                (_c242)._parent9 = _a240;
            }
            /* _min_ax12 is min of ax1 */
            var _augval243 = (_a240).ax1;
            var _child244 = (_a240)._left7;
            if (!((_child244) == null)) {
                var _val245 = (_child244)._min_ax12;
                _augval243 = ((_augval243) < (_val245)) ? (_augval243) : (_val245);
            }
            var _child246 = (_a240)._right8;
            if (!((_child246) == null)) {
                var _val247 = (_child246)._min_ax12;
                _augval243 = ((_augval243) < (_val247)) ? (_augval243) : (_val247);
            }
            (_a240)._min_ax12 = _augval243;
            /* _min_ay13 is min of ay1 */
            var _augval248 = (_a240).ay1;
            var _child249 = (_a240)._left7;
            if (!((_child249) == null)) {
                var _val250 = (_child249)._min_ay13;
                _augval248 = ((_augval248) < (_val250)) ? (_augval248) : (_val250);
            }
            var _child251 = (_a240)._right8;
            if (!((_child251) == null)) {
                var _val252 = (_child251)._min_ay13;
                _augval248 = ((_augval248) < (_val252)) ? (_augval248) : (_val252);
            }
            (_a240)._min_ay13 = _augval248;
            /* _max_ay24 is max of ay2 */
            var _augval253 = (_a240).ay2;
            var _child254 = (_a240)._left7;
            if (!((_child254) == null)) {
                var _val255 = (_child254)._max_ay24;
                _augval253 = ((_augval253) < (_val255)) ? (_val255) : (_augval253);
            }
            var _child256 = (_a240)._right8;
            if (!((_child256) == null)) {
                var _val257 = (_child256)._max_ay24;
                _augval253 = ((_augval253) < (_val257)) ? (_val257) : (_augval253);
            }
            (_a240)._max_ay24 = _augval253;
            (_a240)._height10 = 1 + ((((((_a240)._left7) == null) ? (-1) : (((_a240)._left7)._height10)) > ((((_a240)._right8) == null) ? (-1) : (((_a240)._right8)._height10))) ? ((((_a240)._left7) == null) ? (-1) : (((_a240)._left7)._height10)) : ((((_a240)._right8) == null) ? (-1) : (((_a240)._right8)._height10)));
            /* _min_ax12 is min of ax1 */
            var _augval258 = (_b241).ax1;
            var _child259 = (_b241)._left7;
            if (!((_child259) == null)) {
                var _val260 = (_child259)._min_ax12;
                _augval258 = ((_augval258) < (_val260)) ? (_augval258) : (_val260);
            }
            var _child261 = (_b241)._right8;
            if (!((_child261) == null)) {
                var _val262 = (_child261)._min_ax12;
                _augval258 = ((_augval258) < (_val262)) ? (_augval258) : (_val262);
            }
            (_b241)._min_ax12 = _augval258;
            /* _min_ay13 is min of ay1 */
            var _augval263 = (_b241).ay1;
            var _child264 = (_b241)._left7;
            if (!((_child264) == null)) {
                var _val265 = (_child264)._min_ay13;
                _augval263 = ((_augval263) < (_val265)) ? (_augval263) : (_val265);
            }
            var _child266 = (_b241)._right8;
            if (!((_child266) == null)) {
                var _val267 = (_child266)._min_ay13;
                _augval263 = ((_augval263) < (_val267)) ? (_augval263) : (_val267);
            }
            (_b241)._min_ay13 = _augval263;
            /* _max_ay24 is max of ay2 */
            var _augval268 = (_b241).ay2;
            var _child269 = (_b241)._left7;
            if (!((_child269) == null)) {
                var _val270 = (_child269)._max_ay24;
                _augval268 = ((_augval268) < (_val270)) ? (_val270) : (_augval268);
            }
            var _child271 = (_b241)._right8;
            if (!((_child271) == null)) {
                var _val272 = (_child271)._max_ay24;
                _augval268 = ((_augval268) < (_val272)) ? (_val272) : (_augval268);
            }
            (_b241)._max_ay24 = _augval268;
            (_b241)._height10 = 1 + ((((((_b241)._left7) == null) ? (-1) : (((_b241)._left7)._height10)) > ((((_b241)._right8) == null) ? (-1) : (((_b241)._right8)._height10))) ? ((((_b241)._left7) == null) ? (-1) : (((_b241)._left7)._height10)) : ((((_b241)._right8) == null) ? (-1) : (((_b241)._right8)._height10)));
            if (!(((_b241)._parent9) == null)) {
                /* _min_ax12 is min of ax1 */
                var _augval273 = ((_b241)._parent9).ax1;
                var _child274 = ((_b241)._parent9)._left7;
                if (!((_child274) == null)) {
                    var _val275 = (_child274)._min_ax12;
                    _augval273 = ((_augval273) < (_val275)) ? (_augval273) : (_val275);
                }
                var _child276 = ((_b241)._parent9)._right8;
                if (!((_child276) == null)) {
                    var _val277 = (_child276)._min_ax12;
                    _augval273 = ((_augval273) < (_val277)) ? (_augval273) : (_val277);
                }
                ((_b241)._parent9)._min_ax12 = _augval273;
                /* _min_ay13 is min of ay1 */
                var _augval278 = ((_b241)._parent9).ay1;
                var _child279 = ((_b241)._parent9)._left7;
                if (!((_child279) == null)) {
                    var _val280 = (_child279)._min_ay13;
                    _augval278 = ((_augval278) < (_val280)) ? (_augval278) : (_val280);
                }
                var _child281 = ((_b241)._parent9)._right8;
                if (!((_child281) == null)) {
                    var _val282 = (_child281)._min_ay13;
                    _augval278 = ((_augval278) < (_val282)) ? (_augval278) : (_val282);
                }
                ((_b241)._parent9)._min_ay13 = _augval278;
                /* _max_ay24 is max of ay2 */
                var _augval283 = ((_b241)._parent9).ay2;
                var _child284 = ((_b241)._parent9)._left7;
                if (!((_child284) == null)) {
                    var _val285 = (_child284)._max_ay24;
                    _augval283 = ((_augval283) < (_val285)) ? (_val285) : (_augval283);
                }
                var _child286 = ((_b241)._parent9)._right8;
                if (!((_child286) == null)) {
                    var _val287 = (_child286)._max_ay24;
                    _augval283 = ((_augval283) < (_val287)) ? (_val287) : (_augval283);
                }
                ((_b241)._parent9)._max_ay24 = _augval283;
                ((_b241)._parent9)._height10 = 1 + (((((((_b241)._parent9)._left7) == null) ? (-1) : ((((_b241)._parent9)._left7)._height10)) > (((((_b241)._parent9)._right8) == null) ? (-1) : ((((_b241)._parent9)._right8)._height10))) ? (((((_b241)._parent9)._left7) == null) ? (-1) : ((((_b241)._parent9)._left7)._height10)) : (((((_b241)._parent9)._right8) == null) ? (-1) : ((((_b241)._parent9)._right8)._height10)));
            } else {
                (this)._root1 = _b241;
            }
            _cursor94 = (_cursor94)._parent9;
        }
    }
};
RectangleHolder.prototype.remove = function (x) {
    --this.my_size;
    var _parent288 = (x)._parent9;
    var _left289 = (x)._left7;
    var _right290 = (x)._right8;
    var _new_x291;
    if (((_left289) == null) && ((_right290) == null)) {
        _new_x291 = null;
        /* replace x with _new_x291 in _parent288 */
        if (!((_parent288) == null)) {
            if (((_parent288)._left7) == (x)) {
                (_parent288)._left7 = _new_x291;
            } else {
                (_parent288)._right8 = _new_x291;
            }
        }
        if (!((_new_x291) == null)) {
            (_new_x291)._parent9 = _parent288;
        }
    } else if ((!((_left289) == null)) && ((_right290) == null)) {
        _new_x291 = _left289;
        /* replace x with _new_x291 in _parent288 */
        if (!((_parent288) == null)) {
            if (((_parent288)._left7) == (x)) {
                (_parent288)._left7 = _new_x291;
            } else {
                (_parent288)._right8 = _new_x291;
            }
        }
        if (!((_new_x291) == null)) {
            (_new_x291)._parent9 = _parent288;
        }
    } else if (((_left289) == null) && (!((_right290) == null))) {
        _new_x291 = _right290;
        /* replace x with _new_x291 in _parent288 */
        if (!((_parent288) == null)) {
            if (((_parent288)._left7) == (x)) {
                (_parent288)._left7 = _new_x291;
            } else {
                (_parent288)._right8 = _new_x291;
            }
        }
        if (!((_new_x291) == null)) {
            (_new_x291)._parent9 = _parent288;
        }
    } else {
        var _root292 = (x)._right8;
        var _x293 = _root292;
        var _descend294 = true;
        var _from_left295 = true;
        while (true) {
            if ((_x293) == null) {
                _x293 = null;
                break;
            }
            if (_descend294) {
                /* too small? */
                if (false) {
                    if ((!(((_x293)._right8) == null)) && (true)) {
                        if ((_x293) == (_root292)) {
                            _root292 = (_x293)._right8;
                        }
                        _x293 = (_x293)._right8;
                    } else if ((_x293) == (_root292)) {
                        _x293 = null;
                        break;
                    } else {
                        _descend294 = false;
                        _from_left295 = (!(((_x293)._parent9) == null)) && ((_x293) == (((_x293)._parent9)._left7));
                        _x293 = (_x293)._parent9;
                    }
                } else if ((!(((_x293)._left7) == null)) && (true)) {
                    _x293 = (_x293)._left7;
                    /* too large? */
                } else if (false) {
                    if ((_x293) == (_root292)) {
                        _x293 = null;
                        break;
                    } else {
                        _descend294 = false;
                        _from_left295 = (!(((_x293)._parent9) == null)) && ((_x293) == (((_x293)._parent9)._left7));
                        _x293 = (_x293)._parent9;
                    }
                    /* node ok? */
                } else if (true) {
                    break;
                } else if ((_x293) == (_root292)) {
                    _root292 = (_x293)._right8;
                    _x293 = (_x293)._right8;
                } else {
                    if ((!(((_x293)._right8) == null)) && (true)) {
                        if ((_x293) == (_root292)) {
                            _root292 = (_x293)._right8;
                        }
                        _x293 = (_x293)._right8;
                    } else {
                        _descend294 = false;
                        _from_left295 = (!(((_x293)._parent9) == null)) && ((_x293) == (((_x293)._parent9)._left7));
                        _x293 = (_x293)._parent9;
                    }
                }
            } else if (_from_left295) {
                if (false) {
                    _x293 = null;
                    break;
                } else if (true) {
                    break;
                } else if ((!(((_x293)._right8) == null)) && (true)) {
                    _descend294 = true;
                    if ((_x293) == (_root292)) {
                        _root292 = (_x293)._right8;
                    }
                    _x293 = (_x293)._right8;
                } else if ((_x293) == (_root292)) {
                    _x293 = null;
                    break;
                } else {
                    _descend294 = false;
                    _from_left295 = (!(((_x293)._parent9) == null)) && ((_x293) == (((_x293)._parent9)._left7));
                    _x293 = (_x293)._parent9;
                }
            } else {
                if ((_x293) == (_root292)) {
                    _x293 = null;
                    break;
                } else {
                    _descend294 = false;
                    _from_left295 = (!(((_x293)._parent9) == null)) && ((_x293) == (((_x293)._parent9)._left7));
                    _x293 = (_x293)._parent9;
                }
            }
        }
        _new_x291 = _x293;
        var _mp296 = (_x293)._parent9;
        var _mr297 = (_x293)._right8;
        /* replace _x293 with _mr297 in _mp296 */
        if (!((_mp296) == null)) {
            if (((_mp296)._left7) == (_x293)) {
                (_mp296)._left7 = _mr297;
            } else {
                (_mp296)._right8 = _mr297;
            }
        }
        if (!((_mr297) == null)) {
            (_mr297)._parent9 = _mp296;
        }
        /* replace x with _x293 in _parent288 */
        if (!((_parent288) == null)) {
            if (((_parent288)._left7) == (x)) {
                (_parent288)._left7 = _x293;
            } else {
                (_parent288)._right8 = _x293;
            }
        }
        if (!((_x293) == null)) {
            (_x293)._parent9 = _parent288;
        }
        /* replace null with _left289 in _x293 */
        (_x293)._left7 = _left289;
        if (!((_left289) == null)) {
            (_left289)._parent9 = _x293;
        }
        /* replace _mr297 with (x)._right8 in _x293 */
        (_x293)._right8 = (x)._right8;
        if (!(((x)._right8) == null)) {
            ((x)._right8)._parent9 = _x293;
        }
        /* _min_ax12 is min of ax1 */
        var _augval298 = (_x293).ax1;
        var _child299 = (_x293)._left7;
        if (!((_child299) == null)) {
            var _val300 = (_child299)._min_ax12;
            _augval298 = ((_augval298) < (_val300)) ? (_augval298) : (_val300);
        }
        var _child301 = (_x293)._right8;
        if (!((_child301) == null)) {
            var _val302 = (_child301)._min_ax12;
            _augval298 = ((_augval298) < (_val302)) ? (_augval298) : (_val302);
        }
        (_x293)._min_ax12 = _augval298;
        /* _min_ay13 is min of ay1 */
        var _augval303 = (_x293).ay1;
        var _child304 = (_x293)._left7;
        if (!((_child304) == null)) {
            var _val305 = (_child304)._min_ay13;
            _augval303 = ((_augval303) < (_val305)) ? (_augval303) : (_val305);
        }
        var _child306 = (_x293)._right8;
        if (!((_child306) == null)) {
            var _val307 = (_child306)._min_ay13;
            _augval303 = ((_augval303) < (_val307)) ? (_augval303) : (_val307);
        }
        (_x293)._min_ay13 = _augval303;
        /* _max_ay24 is max of ay2 */
        var _augval308 = (_x293).ay2;
        var _child309 = (_x293)._left7;
        if (!((_child309) == null)) {
            var _val310 = (_child309)._max_ay24;
            _augval308 = ((_augval308) < (_val310)) ? (_val310) : (_augval308);
        }
        var _child311 = (_x293)._right8;
        if (!((_child311) == null)) {
            var _val312 = (_child311)._max_ay24;
            _augval308 = ((_augval308) < (_val312)) ? (_val312) : (_augval308);
        }
        (_x293)._max_ay24 = _augval308;
        (_x293)._height10 = 1 + ((((((_x293)._left7) == null) ? (-1) : (((_x293)._left7)._height10)) > ((((_x293)._right8) == null) ? (-1) : (((_x293)._right8)._height10))) ? ((((_x293)._left7) == null) ? (-1) : (((_x293)._left7)._height10)) : ((((_x293)._right8) == null) ? (-1) : (((_x293)._right8)._height10)));
        var _cursor313 = _mp296;
        var _changed314 = true;
        while ((_changed314) && (!((_cursor313) == (_parent288)))) {
            var _old__min_ax12315 = (_cursor313)._min_ax12;
            var _old__min_ay13316 = (_cursor313)._min_ay13;
            var _old__max_ay24317 = (_cursor313)._max_ay24;
            var _old_height318 = (_cursor313)._height10;
            /* _min_ax12 is min of ax1 */
            var _augval319 = (_cursor313).ax1;
            var _child320 = (_cursor313)._left7;
            if (!((_child320) == null)) {
                var _val321 = (_child320)._min_ax12;
                _augval319 = ((_augval319) < (_val321)) ? (_augval319) : (_val321);
            }
            var _child322 = (_cursor313)._right8;
            if (!((_child322) == null)) {
                var _val323 = (_child322)._min_ax12;
                _augval319 = ((_augval319) < (_val323)) ? (_augval319) : (_val323);
            }
            (_cursor313)._min_ax12 = _augval319;
            /* _min_ay13 is min of ay1 */
            var _augval324 = (_cursor313).ay1;
            var _child325 = (_cursor313)._left7;
            if (!((_child325) == null)) {
                var _val326 = (_child325)._min_ay13;
                _augval324 = ((_augval324) < (_val326)) ? (_augval324) : (_val326);
            }
            var _child327 = (_cursor313)._right8;
            if (!((_child327) == null)) {
                var _val328 = (_child327)._min_ay13;
                _augval324 = ((_augval324) < (_val328)) ? (_augval324) : (_val328);
            }
            (_cursor313)._min_ay13 = _augval324;
            /* _max_ay24 is max of ay2 */
            var _augval329 = (_cursor313).ay2;
            var _child330 = (_cursor313)._left7;
            if (!((_child330) == null)) {
                var _val331 = (_child330)._max_ay24;
                _augval329 = ((_augval329) < (_val331)) ? (_val331) : (_augval329);
            }
            var _child332 = (_cursor313)._right8;
            if (!((_child332) == null)) {
                var _val333 = (_child332)._max_ay24;
                _augval329 = ((_augval329) < (_val333)) ? (_val333) : (_augval329);
            }
            (_cursor313)._max_ay24 = _augval329;
            (_cursor313)._height10 = 1 + ((((((_cursor313)._left7) == null) ? (-1) : (((_cursor313)._left7)._height10)) > ((((_cursor313)._right8) == null) ? (-1) : (((_cursor313)._right8)._height10))) ? ((((_cursor313)._left7) == null) ? (-1) : (((_cursor313)._left7)._height10)) : ((((_cursor313)._right8) == null) ? (-1) : (((_cursor313)._right8)._height10)));
            _changed314 = false;
            _changed314 = (_changed314) || (!((_old__min_ax12315) == ((_cursor313)._min_ax12)));
            _changed314 = (_changed314) || (!((_old__min_ay13316) == ((_cursor313)._min_ay13)));
            _changed314 = (_changed314) || (!((_old__max_ay24317) == ((_cursor313)._max_ay24)));
            _changed314 = (_changed314) || (!((_old_height318) == ((_cursor313)._height10)));
            _cursor313 = (_cursor313)._parent9;
        }
    }
    var _cursor334 = _parent288;
    var _changed335 = true;
    while ((_changed335) && (!((_cursor334) == (null)))) {
        var _old__min_ax12336 = (_cursor334)._min_ax12;
        var _old__min_ay13337 = (_cursor334)._min_ay13;
        var _old__max_ay24338 = (_cursor334)._max_ay24;
        var _old_height339 = (_cursor334)._height10;
        /* _min_ax12 is min of ax1 */
        var _augval340 = (_cursor334).ax1;
        var _child341 = (_cursor334)._left7;
        if (!((_child341) == null)) {
            var _val342 = (_child341)._min_ax12;
            _augval340 = ((_augval340) < (_val342)) ? (_augval340) : (_val342);
        }
        var _child343 = (_cursor334)._right8;
        if (!((_child343) == null)) {
            var _val344 = (_child343)._min_ax12;
            _augval340 = ((_augval340) < (_val344)) ? (_augval340) : (_val344);
        }
        (_cursor334)._min_ax12 = _augval340;
        /* _min_ay13 is min of ay1 */
        var _augval345 = (_cursor334).ay1;
        var _child346 = (_cursor334)._left7;
        if (!((_child346) == null)) {
            var _val347 = (_child346)._min_ay13;
            _augval345 = ((_augval345) < (_val347)) ? (_augval345) : (_val347);
        }
        var _child348 = (_cursor334)._right8;
        if (!((_child348) == null)) {
            var _val349 = (_child348)._min_ay13;
            _augval345 = ((_augval345) < (_val349)) ? (_augval345) : (_val349);
        }
        (_cursor334)._min_ay13 = _augval345;
        /* _max_ay24 is max of ay2 */
        var _augval350 = (_cursor334).ay2;
        var _child351 = (_cursor334)._left7;
        if (!((_child351) == null)) {
            var _val352 = (_child351)._max_ay24;
            _augval350 = ((_augval350) < (_val352)) ? (_val352) : (_augval350);
        }
        var _child353 = (_cursor334)._right8;
        if (!((_child353) == null)) {
            var _val354 = (_child353)._max_ay24;
            _augval350 = ((_augval350) < (_val354)) ? (_val354) : (_augval350);
        }
        (_cursor334)._max_ay24 = _augval350;
        (_cursor334)._height10 = 1 + ((((((_cursor334)._left7) == null) ? (-1) : (((_cursor334)._left7)._height10)) > ((((_cursor334)._right8) == null) ? (-1) : (((_cursor334)._right8)._height10))) ? ((((_cursor334)._left7) == null) ? (-1) : (((_cursor334)._left7)._height10)) : ((((_cursor334)._right8) == null) ? (-1) : (((_cursor334)._right8)._height10)));
        _changed335 = false;
        _changed335 = (_changed335) || (!((_old__min_ax12336) == ((_cursor334)._min_ax12)));
        _changed335 = (_changed335) || (!((_old__min_ay13337) == ((_cursor334)._min_ay13)));
        _changed335 = (_changed335) || (!((_old__max_ay24338) == ((_cursor334)._max_ay24)));
        _changed335 = (_changed335) || (!((_old_height339) == ((_cursor334)._height10)));
        _cursor334 = (_cursor334)._parent9;
    }
    if (((this)._root1) == (x)) {
        (this)._root1 = _new_x291;
    }
};
RectangleHolder.prototype.updateAx1 = function (__x, new_val) {
    if ((__x).ax1 != new_val) {
        /* _min_ax12 is min of ax1 */
        var _augval355 = new_val;
        var _child356 = (__x)._left7;
        if (!((_child356) == null)) {
            var _val357 = (_child356)._min_ax12;
            _augval355 = ((_augval355) < (_val357)) ? (_augval355) : (_val357);
        }
        var _child358 = (__x)._right8;
        if (!((_child358) == null)) {
            var _val359 = (_child358)._min_ax12;
            _augval355 = ((_augval355) < (_val359)) ? (_augval355) : (_val359);
        }
        (__x)._min_ax12 = _augval355;
        var _cursor360 = (__x)._parent9;
        var _changed361 = true;
        while ((_changed361) && (!((_cursor360) == (null)))) {
            var _old__min_ax12362 = (_cursor360)._min_ax12;
            var _old_height363 = (_cursor360)._height10;
            /* _min_ax12 is min of ax1 */
            var _augval364 = (_cursor360).ax1;
            var _child365 = (_cursor360)._left7;
            if (!((_child365) == null)) {
                var _val366 = (_child365)._min_ax12;
                _augval364 = ((_augval364) < (_val366)) ? (_augval364) : (_val366);
            }
            var _child367 = (_cursor360)._right8;
            if (!((_child367) == null)) {
                var _val368 = (_child367)._min_ax12;
                _augval364 = ((_augval364) < (_val368)) ? (_augval364) : (_val368);
            }
            (_cursor360)._min_ax12 = _augval364;
            (_cursor360)._height10 = 1 + ((((((_cursor360)._left7) == null) ? (-1) : (((_cursor360)._left7)._height10)) > ((((_cursor360)._right8) == null) ? (-1) : (((_cursor360)._right8)._height10))) ? ((((_cursor360)._left7) == null) ? (-1) : (((_cursor360)._left7)._height10)) : ((((_cursor360)._right8) == null) ? (-1) : (((_cursor360)._right8)._height10)));
            _changed361 = false;
            _changed361 = (_changed361) || (!((_old__min_ax12362) == ((_cursor360)._min_ax12)));
            _changed361 = (_changed361) || (!((_old_height363) == ((_cursor360)._height10)));
            _cursor360 = (_cursor360)._parent9;
        }
        (__x).ax1 = new_val;
    }
}
RectangleHolder.prototype.updateAy1 = function (__x, new_val) {
    if ((__x).ay1 != new_val) {
        /* _min_ay13 is min of ay1 */
        var _augval369 = new_val;
        var _child370 = (__x)._left7;
        if (!((_child370) == null)) {
            var _val371 = (_child370)._min_ay13;
            _augval369 = ((_augval369) < (_val371)) ? (_augval369) : (_val371);
        }
        var _child372 = (__x)._right8;
        if (!((_child372) == null)) {
            var _val373 = (_child372)._min_ay13;
            _augval369 = ((_augval369) < (_val373)) ? (_augval369) : (_val373);
        }
        (__x)._min_ay13 = _augval369;
        var _cursor374 = (__x)._parent9;
        var _changed375 = true;
        while ((_changed375) && (!((_cursor374) == (null)))) {
            var _old__min_ay13376 = (_cursor374)._min_ay13;
            var _old_height377 = (_cursor374)._height10;
            /* _min_ay13 is min of ay1 */
            var _augval378 = (_cursor374).ay1;
            var _child379 = (_cursor374)._left7;
            if (!((_child379) == null)) {
                var _val380 = (_child379)._min_ay13;
                _augval378 = ((_augval378) < (_val380)) ? (_augval378) : (_val380);
            }
            var _child381 = (_cursor374)._right8;
            if (!((_child381) == null)) {
                var _val382 = (_child381)._min_ay13;
                _augval378 = ((_augval378) < (_val382)) ? (_augval378) : (_val382);
            }
            (_cursor374)._min_ay13 = _augval378;
            (_cursor374)._height10 = 1 + ((((((_cursor374)._left7) == null) ? (-1) : (((_cursor374)._left7)._height10)) > ((((_cursor374)._right8) == null) ? (-1) : (((_cursor374)._right8)._height10))) ? ((((_cursor374)._left7) == null) ? (-1) : (((_cursor374)._left7)._height10)) : ((((_cursor374)._right8) == null) ? (-1) : (((_cursor374)._right8)._height10)));
            _changed375 = false;
            _changed375 = (_changed375) || (!((_old__min_ay13376) == ((_cursor374)._min_ay13)));
            _changed375 = (_changed375) || (!((_old_height377) == ((_cursor374)._height10)));
            _cursor374 = (_cursor374)._parent9;
        }
        (__x).ay1 = new_val;
    }
}
RectangleHolder.prototype.updateAx2 = function (__x, new_val) {
    if ((__x).ax2 != new_val) {
        var _parent383 = (__x)._parent9;
        var _left384 = (__x)._left7;
        var _right385 = (__x)._right8;
        var _new_x386;
        if (((_left384) == null) && ((_right385) == null)) {
            _new_x386 = null;
            /* replace __x with _new_x386 in _parent383 */
            if (!((_parent383) == null)) {
                if (((_parent383)._left7) == (__x)) {
                    (_parent383)._left7 = _new_x386;
                } else {
                    (_parent383)._right8 = _new_x386;
                }
            }
            if (!((_new_x386) == null)) {
                (_new_x386)._parent9 = _parent383;
            }
        } else if ((!((_left384) == null)) && ((_right385) == null)) {
            _new_x386 = _left384;
            /* replace __x with _new_x386 in _parent383 */
            if (!((_parent383) == null)) {
                if (((_parent383)._left7) == (__x)) {
                    (_parent383)._left7 = _new_x386;
                } else {
                    (_parent383)._right8 = _new_x386;
                }
            }
            if (!((_new_x386) == null)) {
                (_new_x386)._parent9 = _parent383;
            }
        } else if (((_left384) == null) && (!((_right385) == null))) {
            _new_x386 = _right385;
            /* replace __x with _new_x386 in _parent383 */
            if (!((_parent383) == null)) {
                if (((_parent383)._left7) == (__x)) {
                    (_parent383)._left7 = _new_x386;
                } else {
                    (_parent383)._right8 = _new_x386;
                }
            }
            if (!((_new_x386) == null)) {
                (_new_x386)._parent9 = _parent383;
            }
        } else {
            var _root387 = (__x)._right8;
            var _x388 = _root387;
            var _descend389 = true;
            var _from_left390 = true;
            while (true) {
                if ((_x388) == null) {
                    _x388 = null;
                    break;
                }
                if (_descend389) {
                    /* too small? */
                    if (false) {
                        if ((!(((_x388)._right8) == null)) && (true)) {
                            if ((_x388) == (_root387)) {
                                _root387 = (_x388)._right8;
                            }
                            _x388 = (_x388)._right8;
                        } else if ((_x388) == (_root387)) {
                            _x388 = null;
                            break;
                        } else {
                            _descend389 = false;
                            _from_left390 = (!(((_x388)._parent9) == null)) && ((_x388) == (((_x388)._parent9)._left7));
                            _x388 = (_x388)._parent9;
                        }
                    } else if ((!(((_x388)._left7) == null)) && (true)) {
                        _x388 = (_x388)._left7;
                        /* too large? */
                    } else if (false) {
                        if ((_x388) == (_root387)) {
                            _x388 = null;
                            break;
                        } else {
                            _descend389 = false;
                            _from_left390 = (!(((_x388)._parent9) == null)) && ((_x388) == (((_x388)._parent9)._left7));
                            _x388 = (_x388)._parent9;
                        }
                        /* node ok? */
                    } else if (true) {
                        break;
                    } else if ((_x388) == (_root387)) {
                        _root387 = (_x388)._right8;
                        _x388 = (_x388)._right8;
                    } else {
                        if ((!(((_x388)._right8) == null)) && (true)) {
                            if ((_x388) == (_root387)) {
                                _root387 = (_x388)._right8;
                            }
                            _x388 = (_x388)._right8;
                        } else {
                            _descend389 = false;
                            _from_left390 = (!(((_x388)._parent9) == null)) && ((_x388) == (((_x388)._parent9)._left7));
                            _x388 = (_x388)._parent9;
                        }
                    }
                } else if (_from_left390) {
                    if (false) {
                        _x388 = null;
                        break;
                    } else if (true) {
                        break;
                    } else if ((!(((_x388)._right8) == null)) && (true)) {
                        _descend389 = true;
                        if ((_x388) == (_root387)) {
                            _root387 = (_x388)._right8;
                        }
                        _x388 = (_x388)._right8;
                    } else if ((_x388) == (_root387)) {
                        _x388 = null;
                        break;
                    } else {
                        _descend389 = false;
                        _from_left390 = (!(((_x388)._parent9) == null)) && ((_x388) == (((_x388)._parent9)._left7));
                        _x388 = (_x388)._parent9;
                    }
                } else {
                    if ((_x388) == (_root387)) {
                        _x388 = null;
                        break;
                    } else {
                        _descend389 = false;
                        _from_left390 = (!(((_x388)._parent9) == null)) && ((_x388) == (((_x388)._parent9)._left7));
                        _x388 = (_x388)._parent9;
                    }
                }
            }
            _new_x386 = _x388;
            var _mp391 = (_x388)._parent9;
            var _mr392 = (_x388)._right8;
            /* replace _x388 with _mr392 in _mp391 */
            if (!((_mp391) == null)) {
                if (((_mp391)._left7) == (_x388)) {
                    (_mp391)._left7 = _mr392;
                } else {
                    (_mp391)._right8 = _mr392;
                }
            }
            if (!((_mr392) == null)) {
                (_mr392)._parent9 = _mp391;
            }
            /* replace __x with _x388 in _parent383 */
            if (!((_parent383) == null)) {
                if (((_parent383)._left7) == (__x)) {
                    (_parent383)._left7 = _x388;
                } else {
                    (_parent383)._right8 = _x388;
                }
            }
            if (!((_x388) == null)) {
                (_x388)._parent9 = _parent383;
            }
            /* replace null with _left384 in _x388 */
            (_x388)._left7 = _left384;
            if (!((_left384) == null)) {
                (_left384)._parent9 = _x388;
            }
            /* replace _mr392 with (__x)._right8 in _x388 */
            (_x388)._right8 = (__x)._right8;
            if (!(((__x)._right8) == null)) {
                ((__x)._right8)._parent9 = _x388;
            }
            /* _min_ax12 is min of ax1 */
            var _augval393 = (_x388).ax1;
            var _child394 = (_x388)._left7;
            if (!((_child394) == null)) {
                var _val395 = (_child394)._min_ax12;
                _augval393 = ((_augval393) < (_val395)) ? (_augval393) : (_val395);
            }
            var _child396 = (_x388)._right8;
            if (!((_child396) == null)) {
                var _val397 = (_child396)._min_ax12;
                _augval393 = ((_augval393) < (_val397)) ? (_augval393) : (_val397);
            }
            (_x388)._min_ax12 = _augval393;
            /* _min_ay13 is min of ay1 */
            var _augval398 = (_x388).ay1;
            var _child399 = (_x388)._left7;
            if (!((_child399) == null)) {
                var _val400 = (_child399)._min_ay13;
                _augval398 = ((_augval398) < (_val400)) ? (_augval398) : (_val400);
            }
            var _child401 = (_x388)._right8;
            if (!((_child401) == null)) {
                var _val402 = (_child401)._min_ay13;
                _augval398 = ((_augval398) < (_val402)) ? (_augval398) : (_val402);
            }
            (_x388)._min_ay13 = _augval398;
            /* _max_ay24 is max of ay2 */
            var _augval403 = (_x388).ay2;
            var _child404 = (_x388)._left7;
            if (!((_child404) == null)) {
                var _val405 = (_child404)._max_ay24;
                _augval403 = ((_augval403) < (_val405)) ? (_val405) : (_augval403);
            }
            var _child406 = (_x388)._right8;
            if (!((_child406) == null)) {
                var _val407 = (_child406)._max_ay24;
                _augval403 = ((_augval403) < (_val407)) ? (_val407) : (_augval403);
            }
            (_x388)._max_ay24 = _augval403;
            (_x388)._height10 = 1 + ((((((_x388)._left7) == null) ? (-1) : (((_x388)._left7)._height10)) > ((((_x388)._right8) == null) ? (-1) : (((_x388)._right8)._height10))) ? ((((_x388)._left7) == null) ? (-1) : (((_x388)._left7)._height10)) : ((((_x388)._right8) == null) ? (-1) : (((_x388)._right8)._height10)));
            var _cursor408 = _mp391;
            var _changed409 = true;
            while ((_changed409) && (!((_cursor408) == (_parent383)))) {
                var _old__min_ax12410 = (_cursor408)._min_ax12;
                var _old__min_ay13411 = (_cursor408)._min_ay13;
                var _old__max_ay24412 = (_cursor408)._max_ay24;
                var _old_height413 = (_cursor408)._height10;
                /* _min_ax12 is min of ax1 */
                var _augval414 = (_cursor408).ax1;
                var _child415 = (_cursor408)._left7;
                if (!((_child415) == null)) {
                    var _val416 = (_child415)._min_ax12;
                    _augval414 = ((_augval414) < (_val416)) ? (_augval414) : (_val416);
                }
                var _child417 = (_cursor408)._right8;
                if (!((_child417) == null)) {
                    var _val418 = (_child417)._min_ax12;
                    _augval414 = ((_augval414) < (_val418)) ? (_augval414) : (_val418);
                }
                (_cursor408)._min_ax12 = _augval414;
                /* _min_ay13 is min of ay1 */
                var _augval419 = (_cursor408).ay1;
                var _child420 = (_cursor408)._left7;
                if (!((_child420) == null)) {
                    var _val421 = (_child420)._min_ay13;
                    _augval419 = ((_augval419) < (_val421)) ? (_augval419) : (_val421);
                }
                var _child422 = (_cursor408)._right8;
                if (!((_child422) == null)) {
                    var _val423 = (_child422)._min_ay13;
                    _augval419 = ((_augval419) < (_val423)) ? (_augval419) : (_val423);
                }
                (_cursor408)._min_ay13 = _augval419;
                /* _max_ay24 is max of ay2 */
                var _augval424 = (_cursor408).ay2;
                var _child425 = (_cursor408)._left7;
                if (!((_child425) == null)) {
                    var _val426 = (_child425)._max_ay24;
                    _augval424 = ((_augval424) < (_val426)) ? (_val426) : (_augval424);
                }
                var _child427 = (_cursor408)._right8;
                if (!((_child427) == null)) {
                    var _val428 = (_child427)._max_ay24;
                    _augval424 = ((_augval424) < (_val428)) ? (_val428) : (_augval424);
                }
                (_cursor408)._max_ay24 = _augval424;
                (_cursor408)._height10 = 1 + ((((((_cursor408)._left7) == null) ? (-1) : (((_cursor408)._left7)._height10)) > ((((_cursor408)._right8) == null) ? (-1) : (((_cursor408)._right8)._height10))) ? ((((_cursor408)._left7) == null) ? (-1) : (((_cursor408)._left7)._height10)) : ((((_cursor408)._right8) == null) ? (-1) : (((_cursor408)._right8)._height10)));
                _changed409 = false;
                _changed409 = (_changed409) || (!((_old__min_ax12410) == ((_cursor408)._min_ax12)));
                _changed409 = (_changed409) || (!((_old__min_ay13411) == ((_cursor408)._min_ay13)));
                _changed409 = (_changed409) || (!((_old__max_ay24412) == ((_cursor408)._max_ay24)));
                _changed409 = (_changed409) || (!((_old_height413) == ((_cursor408)._height10)));
                _cursor408 = (_cursor408)._parent9;
            }
        }
        var _cursor429 = _parent383;
        var _changed430 = true;
        while ((_changed430) && (!((_cursor429) == (null)))) {
            var _old__min_ax12431 = (_cursor429)._min_ax12;
            var _old__min_ay13432 = (_cursor429)._min_ay13;
            var _old__max_ay24433 = (_cursor429)._max_ay24;
            var _old_height434 = (_cursor429)._height10;
            /* _min_ax12 is min of ax1 */
            var _augval435 = (_cursor429).ax1;
            var _child436 = (_cursor429)._left7;
            if (!((_child436) == null)) {
                var _val437 = (_child436)._min_ax12;
                _augval435 = ((_augval435) < (_val437)) ? (_augval435) : (_val437);
            }
            var _child438 = (_cursor429)._right8;
            if (!((_child438) == null)) {
                var _val439 = (_child438)._min_ax12;
                _augval435 = ((_augval435) < (_val439)) ? (_augval435) : (_val439);
            }
            (_cursor429)._min_ax12 = _augval435;
            /* _min_ay13 is min of ay1 */
            var _augval440 = (_cursor429).ay1;
            var _child441 = (_cursor429)._left7;
            if (!((_child441) == null)) {
                var _val442 = (_child441)._min_ay13;
                _augval440 = ((_augval440) < (_val442)) ? (_augval440) : (_val442);
            }
            var _child443 = (_cursor429)._right8;
            if (!((_child443) == null)) {
                var _val444 = (_child443)._min_ay13;
                _augval440 = ((_augval440) < (_val444)) ? (_augval440) : (_val444);
            }
            (_cursor429)._min_ay13 = _augval440;
            /* _max_ay24 is max of ay2 */
            var _augval445 = (_cursor429).ay2;
            var _child446 = (_cursor429)._left7;
            if (!((_child446) == null)) {
                var _val447 = (_child446)._max_ay24;
                _augval445 = ((_augval445) < (_val447)) ? (_val447) : (_augval445);
            }
            var _child448 = (_cursor429)._right8;
            if (!((_child448) == null)) {
                var _val449 = (_child448)._max_ay24;
                _augval445 = ((_augval445) < (_val449)) ? (_val449) : (_augval445);
            }
            (_cursor429)._max_ay24 = _augval445;
            (_cursor429)._height10 = 1 + ((((((_cursor429)._left7) == null) ? (-1) : (((_cursor429)._left7)._height10)) > ((((_cursor429)._right8) == null) ? (-1) : (((_cursor429)._right8)._height10))) ? ((((_cursor429)._left7) == null) ? (-1) : (((_cursor429)._left7)._height10)) : ((((_cursor429)._right8) == null) ? (-1) : (((_cursor429)._right8)._height10)));
            _changed430 = false;
            _changed430 = (_changed430) || (!((_old__min_ax12431) == ((_cursor429)._min_ax12)));
            _changed430 = (_changed430) || (!((_old__min_ay13432) == ((_cursor429)._min_ay13)));
            _changed430 = (_changed430) || (!((_old__max_ay24433) == ((_cursor429)._max_ay24)));
            _changed430 = (_changed430) || (!((_old_height434) == ((_cursor429)._height10)));
            _cursor429 = (_cursor429)._parent9;
        }
        if (((this)._root1) == (__x)) {
            (this)._root1 = _new_x386;
        }
        (__x)._left7 = null;
        (__x)._right8 = null;
        (__x)._min_ax12 = (__x).ax1;
        (__x)._min_ay13 = (__x).ay1;
        (__x)._max_ay24 = (__x).ay2;
        (__x)._height10 = 0;
        var _previous450 = null;
        var _current451 = (this)._root1;
        var _is_left452 = false;
        while (!((_current451) == null)) {
            _previous450 = _current451;
            if ((new_val) < ((_current451).ax2)) {
                _current451 = (_current451)._left7;
                _is_left452 = true;
            } else {
                _current451 = (_current451)._right8;
                _is_left452 = false;
            }
        }
        if ((_previous450) == null) {
            (this)._root1 = __x;
        } else {
            (__x)._parent9 = _previous450;
            if (_is_left452) {
                (_previous450)._left7 = __x;
            } else {
                (_previous450)._right8 = __x;
            }
        }
        var _cursor453 = (__x)._parent9;
        var _changed454 = true;
        while ((_changed454) && (!((_cursor453) == (null)))) {
            var _old__min_ax12455 = (_cursor453)._min_ax12;
            var _old__min_ay13456 = (_cursor453)._min_ay13;
            var _old__max_ay24457 = (_cursor453)._max_ay24;
            var _old_height458 = (_cursor453)._height10;
            /* _min_ax12 is min of ax1 */
            var _augval459 = (_cursor453).ax1;
            var _child460 = (_cursor453)._left7;
            if (!((_child460) == null)) {
                var _val461 = (_child460)._min_ax12;
                _augval459 = ((_augval459) < (_val461)) ? (_augval459) : (_val461);
            }
            var _child462 = (_cursor453)._right8;
            if (!((_child462) == null)) {
                var _val463 = (_child462)._min_ax12;
                _augval459 = ((_augval459) < (_val463)) ? (_augval459) : (_val463);
            }
            (_cursor453)._min_ax12 = _augval459;
            /* _min_ay13 is min of ay1 */
            var _augval464 = (_cursor453).ay1;
            var _child465 = (_cursor453)._left7;
            if (!((_child465) == null)) {
                var _val466 = (_child465)._min_ay13;
                _augval464 = ((_augval464) < (_val466)) ? (_augval464) : (_val466);
            }
            var _child467 = (_cursor453)._right8;
            if (!((_child467) == null)) {
                var _val468 = (_child467)._min_ay13;
                _augval464 = ((_augval464) < (_val468)) ? (_augval464) : (_val468);
            }
            (_cursor453)._min_ay13 = _augval464;
            /* _max_ay24 is max of ay2 */
            var _augval469 = (_cursor453).ay2;
            var _child470 = (_cursor453)._left7;
            if (!((_child470) == null)) {
                var _val471 = (_child470)._max_ay24;
                _augval469 = ((_augval469) < (_val471)) ? (_val471) : (_augval469);
            }
            var _child472 = (_cursor453)._right8;
            if (!((_child472) == null)) {
                var _val473 = (_child472)._max_ay24;
                _augval469 = ((_augval469) < (_val473)) ? (_val473) : (_augval469);
            }
            (_cursor453)._max_ay24 = _augval469;
            (_cursor453)._height10 = 1 + ((((((_cursor453)._left7) == null) ? (-1) : (((_cursor453)._left7)._height10)) > ((((_cursor453)._right8) == null) ? (-1) : (((_cursor453)._right8)._height10))) ? ((((_cursor453)._left7) == null) ? (-1) : (((_cursor453)._left7)._height10)) : ((((_cursor453)._right8) == null) ? (-1) : (((_cursor453)._right8)._height10)));
            _changed454 = false;
            _changed454 = (_changed454) || (!((_old__min_ax12455) == ((_cursor453)._min_ax12)));
            _changed454 = (_changed454) || (!((_old__min_ay13456) == ((_cursor453)._min_ay13)));
            _changed454 = (_changed454) || (!((_old__max_ay24457) == ((_cursor453)._max_ay24)));
            _changed454 = (_changed454) || (!((_old_height458) == ((_cursor453)._height10)));
            _cursor453 = (_cursor453)._parent9;
        }
        /* rebalance AVL tree */
        var _cursor474 = __x;
        var _imbalance475;
        while (!(((_cursor474)._parent9) == null)) {
            _cursor474 = (_cursor474)._parent9;
            (_cursor474)._height10 = 1 + ((((((_cursor474)._left7) == null) ? (-1) : (((_cursor474)._left7)._height10)) > ((((_cursor474)._right8) == null) ? (-1) : (((_cursor474)._right8)._height10))) ? ((((_cursor474)._left7) == null) ? (-1) : (((_cursor474)._left7)._height10)) : ((((_cursor474)._right8) == null) ? (-1) : (((_cursor474)._right8)._height10)));
            _imbalance475 = ((((_cursor474)._left7) == null) ? (-1) : (((_cursor474)._left7)._height10)) - ((((_cursor474)._right8) == null) ? (-1) : (((_cursor474)._right8)._height10));
            if ((_imbalance475) > (1)) {
                if ((((((_cursor474)._left7)._left7) == null) ? (-1) : ((((_cursor474)._left7)._left7)._height10)) < (((((_cursor474)._left7)._right8) == null) ? (-1) : ((((_cursor474)._left7)._right8)._height10))) {
                    /* rotate ((_cursor474)._left7)._right8 */
                    var _a476 = (_cursor474)._left7;
                    var _b477 = (_a476)._right8;
                    var _c478 = (_b477)._left7;
                    /* replace _a476 with _b477 in (_a476)._parent9 */
                    if (!(((_a476)._parent9) == null)) {
                        if ((((_a476)._parent9)._left7) == (_a476)) {
                            ((_a476)._parent9)._left7 = _b477;
                        } else {
                            ((_a476)._parent9)._right8 = _b477;
                        }
                    }
                    if (!((_b477) == null)) {
                        (_b477)._parent9 = (_a476)._parent9;
                    }
                    /* replace _c478 with _a476 in _b477 */
                    (_b477)._left7 = _a476;
                    if (!((_a476) == null)) {
                        (_a476)._parent9 = _b477;
                    }
                    /* replace _b477 with _c478 in _a476 */
                    (_a476)._right8 = _c478;
                    if (!((_c478) == null)) {
                        (_c478)._parent9 = _a476;
                    }
                    /* _min_ax12 is min of ax1 */
                    var _augval479 = (_a476).ax1;
                    var _child480 = (_a476)._left7;
                    if (!((_child480) == null)) {
                        var _val481 = (_child480)._min_ax12;
                        _augval479 = ((_augval479) < (_val481)) ? (_augval479) : (_val481);
                    }
                    var _child482 = (_a476)._right8;
                    if (!((_child482) == null)) {
                        var _val483 = (_child482)._min_ax12;
                        _augval479 = ((_augval479) < (_val483)) ? (_augval479) : (_val483);
                    }
                    (_a476)._min_ax12 = _augval479;
                    /* _min_ay13 is min of ay1 */
                    var _augval484 = (_a476).ay1;
                    var _child485 = (_a476)._left7;
                    if (!((_child485) == null)) {
                        var _val486 = (_child485)._min_ay13;
                        _augval484 = ((_augval484) < (_val486)) ? (_augval484) : (_val486);
                    }
                    var _child487 = (_a476)._right8;
                    if (!((_child487) == null)) {
                        var _val488 = (_child487)._min_ay13;
                        _augval484 = ((_augval484) < (_val488)) ? (_augval484) : (_val488);
                    }
                    (_a476)._min_ay13 = _augval484;
                    /* _max_ay24 is max of ay2 */
                    var _augval489 = (_a476).ay2;
                    var _child490 = (_a476)._left7;
                    if (!((_child490) == null)) {
                        var _val491 = (_child490)._max_ay24;
                        _augval489 = ((_augval489) < (_val491)) ? (_val491) : (_augval489);
                    }
                    var _child492 = (_a476)._right8;
                    if (!((_child492) == null)) {
                        var _val493 = (_child492)._max_ay24;
                        _augval489 = ((_augval489) < (_val493)) ? (_val493) : (_augval489);
                    }
                    (_a476)._max_ay24 = _augval489;
                    (_a476)._height10 = 1 + ((((((_a476)._left7) == null) ? (-1) : (((_a476)._left7)._height10)) > ((((_a476)._right8) == null) ? (-1) : (((_a476)._right8)._height10))) ? ((((_a476)._left7) == null) ? (-1) : (((_a476)._left7)._height10)) : ((((_a476)._right8) == null) ? (-1) : (((_a476)._right8)._height10)));
                    /* _min_ax12 is min of ax1 */
                    var _augval494 = (_b477).ax1;
                    var _child495 = (_b477)._left7;
                    if (!((_child495) == null)) {
                        var _val496 = (_child495)._min_ax12;
                        _augval494 = ((_augval494) < (_val496)) ? (_augval494) : (_val496);
                    }
                    var _child497 = (_b477)._right8;
                    if (!((_child497) == null)) {
                        var _val498 = (_child497)._min_ax12;
                        _augval494 = ((_augval494) < (_val498)) ? (_augval494) : (_val498);
                    }
                    (_b477)._min_ax12 = _augval494;
                    /* _min_ay13 is min of ay1 */
                    var _augval499 = (_b477).ay1;
                    var _child500 = (_b477)._left7;
                    if (!((_child500) == null)) {
                        var _val501 = (_child500)._min_ay13;
                        _augval499 = ((_augval499) < (_val501)) ? (_augval499) : (_val501);
                    }
                    var _child502 = (_b477)._right8;
                    if (!((_child502) == null)) {
                        var _val503 = (_child502)._min_ay13;
                        _augval499 = ((_augval499) < (_val503)) ? (_augval499) : (_val503);
                    }
                    (_b477)._min_ay13 = _augval499;
                    /* _max_ay24 is max of ay2 */
                    var _augval504 = (_b477).ay2;
                    var _child505 = (_b477)._left7;
                    if (!((_child505) == null)) {
                        var _val506 = (_child505)._max_ay24;
                        _augval504 = ((_augval504) < (_val506)) ? (_val506) : (_augval504);
                    }
                    var _child507 = (_b477)._right8;
                    if (!((_child507) == null)) {
                        var _val508 = (_child507)._max_ay24;
                        _augval504 = ((_augval504) < (_val508)) ? (_val508) : (_augval504);
                    }
                    (_b477)._max_ay24 = _augval504;
                    (_b477)._height10 = 1 + ((((((_b477)._left7) == null) ? (-1) : (((_b477)._left7)._height10)) > ((((_b477)._right8) == null) ? (-1) : (((_b477)._right8)._height10))) ? ((((_b477)._left7) == null) ? (-1) : (((_b477)._left7)._height10)) : ((((_b477)._right8) == null) ? (-1) : (((_b477)._right8)._height10)));
                    if (!(((_b477)._parent9) == null)) {
                        /* _min_ax12 is min of ax1 */
                        var _augval509 = ((_b477)._parent9).ax1;
                        var _child510 = ((_b477)._parent9)._left7;
                        if (!((_child510) == null)) {
                            var _val511 = (_child510)._min_ax12;
                            _augval509 = ((_augval509) < (_val511)) ? (_augval509) : (_val511);
                        }
                        var _child512 = ((_b477)._parent9)._right8;
                        if (!((_child512) == null)) {
                            var _val513 = (_child512)._min_ax12;
                            _augval509 = ((_augval509) < (_val513)) ? (_augval509) : (_val513);
                        }
                        ((_b477)._parent9)._min_ax12 = _augval509;
                        /* _min_ay13 is min of ay1 */
                        var _augval514 = ((_b477)._parent9).ay1;
                        var _child515 = ((_b477)._parent9)._left7;
                        if (!((_child515) == null)) {
                            var _val516 = (_child515)._min_ay13;
                            _augval514 = ((_augval514) < (_val516)) ? (_augval514) : (_val516);
                        }
                        var _child517 = ((_b477)._parent9)._right8;
                        if (!((_child517) == null)) {
                            var _val518 = (_child517)._min_ay13;
                            _augval514 = ((_augval514) < (_val518)) ? (_augval514) : (_val518);
                        }
                        ((_b477)._parent9)._min_ay13 = _augval514;
                        /* _max_ay24 is max of ay2 */
                        var _augval519 = ((_b477)._parent9).ay2;
                        var _child520 = ((_b477)._parent9)._left7;
                        if (!((_child520) == null)) {
                            var _val521 = (_child520)._max_ay24;
                            _augval519 = ((_augval519) < (_val521)) ? (_val521) : (_augval519);
                        }
                        var _child522 = ((_b477)._parent9)._right8;
                        if (!((_child522) == null)) {
                            var _val523 = (_child522)._max_ay24;
                            _augval519 = ((_augval519) < (_val523)) ? (_val523) : (_augval519);
                        }
                        ((_b477)._parent9)._max_ay24 = _augval519;
                        ((_b477)._parent9)._height10 = 1 + (((((((_b477)._parent9)._left7) == null) ? (-1) : ((((_b477)._parent9)._left7)._height10)) > (((((_b477)._parent9)._right8) == null) ? (-1) : ((((_b477)._parent9)._right8)._height10))) ? (((((_b477)._parent9)._left7) == null) ? (-1) : ((((_b477)._parent9)._left7)._height10)) : (((((_b477)._parent9)._right8) == null) ? (-1) : ((((_b477)._parent9)._right8)._height10)));
                    } else {
                        (this)._root1 = _b477;
                    }
                }
                /* rotate (_cursor474)._left7 */
                var _a524 = _cursor474;
                var _b525 = (_a524)._left7;
                var _c526 = (_b525)._right8;
                /* replace _a524 with _b525 in (_a524)._parent9 */
                if (!(((_a524)._parent9) == null)) {
                    if ((((_a524)._parent9)._left7) == (_a524)) {
                        ((_a524)._parent9)._left7 = _b525;
                    } else {
                        ((_a524)._parent9)._right8 = _b525;
                    }
                }
                if (!((_b525) == null)) {
                    (_b525)._parent9 = (_a524)._parent9;
                }
                /* replace _c526 with _a524 in _b525 */
                (_b525)._right8 = _a524;
                if (!((_a524) == null)) {
                    (_a524)._parent9 = _b525;
                }
                /* replace _b525 with _c526 in _a524 */
                (_a524)._left7 = _c526;
                if (!((_c526) == null)) {
                    (_c526)._parent9 = _a524;
                }
                /* _min_ax12 is min of ax1 */
                var _augval527 = (_a524).ax1;
                var _child528 = (_a524)._left7;
                if (!((_child528) == null)) {
                    var _val529 = (_child528)._min_ax12;
                    _augval527 = ((_augval527) < (_val529)) ? (_augval527) : (_val529);
                }
                var _child530 = (_a524)._right8;
                if (!((_child530) == null)) {
                    var _val531 = (_child530)._min_ax12;
                    _augval527 = ((_augval527) < (_val531)) ? (_augval527) : (_val531);
                }
                (_a524)._min_ax12 = _augval527;
                /* _min_ay13 is min of ay1 */
                var _augval532 = (_a524).ay1;
                var _child533 = (_a524)._left7;
                if (!((_child533) == null)) {
                    var _val534 = (_child533)._min_ay13;
                    _augval532 = ((_augval532) < (_val534)) ? (_augval532) : (_val534);
                }
                var _child535 = (_a524)._right8;
                if (!((_child535) == null)) {
                    var _val536 = (_child535)._min_ay13;
                    _augval532 = ((_augval532) < (_val536)) ? (_augval532) : (_val536);
                }
                (_a524)._min_ay13 = _augval532;
                /* _max_ay24 is max of ay2 */
                var _augval537 = (_a524).ay2;
                var _child538 = (_a524)._left7;
                if (!((_child538) == null)) {
                    var _val539 = (_child538)._max_ay24;
                    _augval537 = ((_augval537) < (_val539)) ? (_val539) : (_augval537);
                }
                var _child540 = (_a524)._right8;
                if (!((_child540) == null)) {
                    var _val541 = (_child540)._max_ay24;
                    _augval537 = ((_augval537) < (_val541)) ? (_val541) : (_augval537);
                }
                (_a524)._max_ay24 = _augval537;
                (_a524)._height10 = 1 + ((((((_a524)._left7) == null) ? (-1) : (((_a524)._left7)._height10)) > ((((_a524)._right8) == null) ? (-1) : (((_a524)._right8)._height10))) ? ((((_a524)._left7) == null) ? (-1) : (((_a524)._left7)._height10)) : ((((_a524)._right8) == null) ? (-1) : (((_a524)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval542 = (_b525).ax1;
                var _child543 = (_b525)._left7;
                if (!((_child543) == null)) {
                    var _val544 = (_child543)._min_ax12;
                    _augval542 = ((_augval542) < (_val544)) ? (_augval542) : (_val544);
                }
                var _child545 = (_b525)._right8;
                if (!((_child545) == null)) {
                    var _val546 = (_child545)._min_ax12;
                    _augval542 = ((_augval542) < (_val546)) ? (_augval542) : (_val546);
                }
                (_b525)._min_ax12 = _augval542;
                /* _min_ay13 is min of ay1 */
                var _augval547 = (_b525).ay1;
                var _child548 = (_b525)._left7;
                if (!((_child548) == null)) {
                    var _val549 = (_child548)._min_ay13;
                    _augval547 = ((_augval547) < (_val549)) ? (_augval547) : (_val549);
                }
                var _child550 = (_b525)._right8;
                if (!((_child550) == null)) {
                    var _val551 = (_child550)._min_ay13;
                    _augval547 = ((_augval547) < (_val551)) ? (_augval547) : (_val551);
                }
                (_b525)._min_ay13 = _augval547;
                /* _max_ay24 is max of ay2 */
                var _augval552 = (_b525).ay2;
                var _child553 = (_b525)._left7;
                if (!((_child553) == null)) {
                    var _val554 = (_child553)._max_ay24;
                    _augval552 = ((_augval552) < (_val554)) ? (_val554) : (_augval552);
                }
                var _child555 = (_b525)._right8;
                if (!((_child555) == null)) {
                    var _val556 = (_child555)._max_ay24;
                    _augval552 = ((_augval552) < (_val556)) ? (_val556) : (_augval552);
                }
                (_b525)._max_ay24 = _augval552;
                (_b525)._height10 = 1 + ((((((_b525)._left7) == null) ? (-1) : (((_b525)._left7)._height10)) > ((((_b525)._right8) == null) ? (-1) : (((_b525)._right8)._height10))) ? ((((_b525)._left7) == null) ? (-1) : (((_b525)._left7)._height10)) : ((((_b525)._right8) == null) ? (-1) : (((_b525)._right8)._height10)));
                if (!(((_b525)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval557 = ((_b525)._parent9).ax1;
                    var _child558 = ((_b525)._parent9)._left7;
                    if (!((_child558) == null)) {
                        var _val559 = (_child558)._min_ax12;
                        _augval557 = ((_augval557) < (_val559)) ? (_augval557) : (_val559);
                    }
                    var _child560 = ((_b525)._parent9)._right8;
                    if (!((_child560) == null)) {
                        var _val561 = (_child560)._min_ax12;
                        _augval557 = ((_augval557) < (_val561)) ? (_augval557) : (_val561);
                    }
                    ((_b525)._parent9)._min_ax12 = _augval557;
                    /* _min_ay13 is min of ay1 */
                    var _augval562 = ((_b525)._parent9).ay1;
                    var _child563 = ((_b525)._parent9)._left7;
                    if (!((_child563) == null)) {
                        var _val564 = (_child563)._min_ay13;
                        _augval562 = ((_augval562) < (_val564)) ? (_augval562) : (_val564);
                    }
                    var _child565 = ((_b525)._parent9)._right8;
                    if (!((_child565) == null)) {
                        var _val566 = (_child565)._min_ay13;
                        _augval562 = ((_augval562) < (_val566)) ? (_augval562) : (_val566);
                    }
                    ((_b525)._parent9)._min_ay13 = _augval562;
                    /* _max_ay24 is max of ay2 */
                    var _augval567 = ((_b525)._parent9).ay2;
                    var _child568 = ((_b525)._parent9)._left7;
                    if (!((_child568) == null)) {
                        var _val569 = (_child568)._max_ay24;
                        _augval567 = ((_augval567) < (_val569)) ? (_val569) : (_augval567);
                    }
                    var _child570 = ((_b525)._parent9)._right8;
                    if (!((_child570) == null)) {
                        var _val571 = (_child570)._max_ay24;
                        _augval567 = ((_augval567) < (_val571)) ? (_val571) : (_augval567);
                    }
                    ((_b525)._parent9)._max_ay24 = _augval567;
                    ((_b525)._parent9)._height10 = 1 + (((((((_b525)._parent9)._left7) == null) ? (-1) : ((((_b525)._parent9)._left7)._height10)) > (((((_b525)._parent9)._right8) == null) ? (-1) : ((((_b525)._parent9)._right8)._height10))) ? (((((_b525)._parent9)._left7) == null) ? (-1) : ((((_b525)._parent9)._left7)._height10)) : (((((_b525)._parent9)._right8) == null) ? (-1) : ((((_b525)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b525;
                }
                _cursor474 = (_cursor474)._parent9;
            } else if ((_imbalance475) < (-1)) {
                if ((((((_cursor474)._right8)._left7) == null) ? (-1) : ((((_cursor474)._right8)._left7)._height10)) > (((((_cursor474)._right8)._right8) == null) ? (-1) : ((((_cursor474)._right8)._right8)._height10))) {
                    /* rotate ((_cursor474)._right8)._left7 */
                    var _a572 = (_cursor474)._right8;
                    var _b573 = (_a572)._left7;
                    var _c574 = (_b573)._right8;
                    /* replace _a572 with _b573 in (_a572)._parent9 */
                    if (!(((_a572)._parent9) == null)) {
                        if ((((_a572)._parent9)._left7) == (_a572)) {
                            ((_a572)._parent9)._left7 = _b573;
                        } else {
                            ((_a572)._parent9)._right8 = _b573;
                        }
                    }
                    if (!((_b573) == null)) {
                        (_b573)._parent9 = (_a572)._parent9;
                    }
                    /* replace _c574 with _a572 in _b573 */
                    (_b573)._right8 = _a572;
                    if (!((_a572) == null)) {
                        (_a572)._parent9 = _b573;
                    }
                    /* replace _b573 with _c574 in _a572 */
                    (_a572)._left7 = _c574;
                    if (!((_c574) == null)) {
                        (_c574)._parent9 = _a572;
                    }
                    /* _min_ax12 is min of ax1 */
                    var _augval575 = (_a572).ax1;
                    var _child576 = (_a572)._left7;
                    if (!((_child576) == null)) {
                        var _val577 = (_child576)._min_ax12;
                        _augval575 = ((_augval575) < (_val577)) ? (_augval575) : (_val577);
                    }
                    var _child578 = (_a572)._right8;
                    if (!((_child578) == null)) {
                        var _val579 = (_child578)._min_ax12;
                        _augval575 = ((_augval575) < (_val579)) ? (_augval575) : (_val579);
                    }
                    (_a572)._min_ax12 = _augval575;
                    /* _min_ay13 is min of ay1 */
                    var _augval580 = (_a572).ay1;
                    var _child581 = (_a572)._left7;
                    if (!((_child581) == null)) {
                        var _val582 = (_child581)._min_ay13;
                        _augval580 = ((_augval580) < (_val582)) ? (_augval580) : (_val582);
                    }
                    var _child583 = (_a572)._right8;
                    if (!((_child583) == null)) {
                        var _val584 = (_child583)._min_ay13;
                        _augval580 = ((_augval580) < (_val584)) ? (_augval580) : (_val584);
                    }
                    (_a572)._min_ay13 = _augval580;
                    /* _max_ay24 is max of ay2 */
                    var _augval585 = (_a572).ay2;
                    var _child586 = (_a572)._left7;
                    if (!((_child586) == null)) {
                        var _val587 = (_child586)._max_ay24;
                        _augval585 = ((_augval585) < (_val587)) ? (_val587) : (_augval585);
                    }
                    var _child588 = (_a572)._right8;
                    if (!((_child588) == null)) {
                        var _val589 = (_child588)._max_ay24;
                        _augval585 = ((_augval585) < (_val589)) ? (_val589) : (_augval585);
                    }
                    (_a572)._max_ay24 = _augval585;
                    (_a572)._height10 = 1 + ((((((_a572)._left7) == null) ? (-1) : (((_a572)._left7)._height10)) > ((((_a572)._right8) == null) ? (-1) : (((_a572)._right8)._height10))) ? ((((_a572)._left7) == null) ? (-1) : (((_a572)._left7)._height10)) : ((((_a572)._right8) == null) ? (-1) : (((_a572)._right8)._height10)));
                    /* _min_ax12 is min of ax1 */
                    var _augval590 = (_b573).ax1;
                    var _child591 = (_b573)._left7;
                    if (!((_child591) == null)) {
                        var _val592 = (_child591)._min_ax12;
                        _augval590 = ((_augval590) < (_val592)) ? (_augval590) : (_val592);
                    }
                    var _child593 = (_b573)._right8;
                    if (!((_child593) == null)) {
                        var _val594 = (_child593)._min_ax12;
                        _augval590 = ((_augval590) < (_val594)) ? (_augval590) : (_val594);
                    }
                    (_b573)._min_ax12 = _augval590;
                    /* _min_ay13 is min of ay1 */
                    var _augval595 = (_b573).ay1;
                    var _child596 = (_b573)._left7;
                    if (!((_child596) == null)) {
                        var _val597 = (_child596)._min_ay13;
                        _augval595 = ((_augval595) < (_val597)) ? (_augval595) : (_val597);
                    }
                    var _child598 = (_b573)._right8;
                    if (!((_child598) == null)) {
                        var _val599 = (_child598)._min_ay13;
                        _augval595 = ((_augval595) < (_val599)) ? (_augval595) : (_val599);
                    }
                    (_b573)._min_ay13 = _augval595;
                    /* _max_ay24 is max of ay2 */
                    var _augval600 = (_b573).ay2;
                    var _child601 = (_b573)._left7;
                    if (!((_child601) == null)) {
                        var _val602 = (_child601)._max_ay24;
                        _augval600 = ((_augval600) < (_val602)) ? (_val602) : (_augval600);
                    }
                    var _child603 = (_b573)._right8;
                    if (!((_child603) == null)) {
                        var _val604 = (_child603)._max_ay24;
                        _augval600 = ((_augval600) < (_val604)) ? (_val604) : (_augval600);
                    }
                    (_b573)._max_ay24 = _augval600;
                    (_b573)._height10 = 1 + ((((((_b573)._left7) == null) ? (-1) : (((_b573)._left7)._height10)) > ((((_b573)._right8) == null) ? (-1) : (((_b573)._right8)._height10))) ? ((((_b573)._left7) == null) ? (-1) : (((_b573)._left7)._height10)) : ((((_b573)._right8) == null) ? (-1) : (((_b573)._right8)._height10)));
                    if (!(((_b573)._parent9) == null)) {
                        /* _min_ax12 is min of ax1 */
                        var _augval605 = ((_b573)._parent9).ax1;
                        var _child606 = ((_b573)._parent9)._left7;
                        if (!((_child606) == null)) {
                            var _val607 = (_child606)._min_ax12;
                            _augval605 = ((_augval605) < (_val607)) ? (_augval605) : (_val607);
                        }
                        var _child608 = ((_b573)._parent9)._right8;
                        if (!((_child608) == null)) {
                            var _val609 = (_child608)._min_ax12;
                            _augval605 = ((_augval605) < (_val609)) ? (_augval605) : (_val609);
                        }
                        ((_b573)._parent9)._min_ax12 = _augval605;
                        /* _min_ay13 is min of ay1 */
                        var _augval610 = ((_b573)._parent9).ay1;
                        var _child611 = ((_b573)._parent9)._left7;
                        if (!((_child611) == null)) {
                            var _val612 = (_child611)._min_ay13;
                            _augval610 = ((_augval610) < (_val612)) ? (_augval610) : (_val612);
                        }
                        var _child613 = ((_b573)._parent9)._right8;
                        if (!((_child613) == null)) {
                            var _val614 = (_child613)._min_ay13;
                            _augval610 = ((_augval610) < (_val614)) ? (_augval610) : (_val614);
                        }
                        ((_b573)._parent9)._min_ay13 = _augval610;
                        /* _max_ay24 is max of ay2 */
                        var _augval615 = ((_b573)._parent9).ay2;
                        var _child616 = ((_b573)._parent9)._left7;
                        if (!((_child616) == null)) {
                            var _val617 = (_child616)._max_ay24;
                            _augval615 = ((_augval615) < (_val617)) ? (_val617) : (_augval615);
                        }
                        var _child618 = ((_b573)._parent9)._right8;
                        if (!((_child618) == null)) {
                            var _val619 = (_child618)._max_ay24;
                            _augval615 = ((_augval615) < (_val619)) ? (_val619) : (_augval615);
                        }
                        ((_b573)._parent9)._max_ay24 = _augval615;
                        ((_b573)._parent9)._height10 = 1 + (((((((_b573)._parent9)._left7) == null) ? (-1) : ((((_b573)._parent9)._left7)._height10)) > (((((_b573)._parent9)._right8) == null) ? (-1) : ((((_b573)._parent9)._right8)._height10))) ? (((((_b573)._parent9)._left7) == null) ? (-1) : ((((_b573)._parent9)._left7)._height10)) : (((((_b573)._parent9)._right8) == null) ? (-1) : ((((_b573)._parent9)._right8)._height10)));
                    } else {
                        (this)._root1 = _b573;
                    }
                }
                /* rotate (_cursor474)._right8 */
                var _a620 = _cursor474;
                var _b621 = (_a620)._right8;
                var _c622 = (_b621)._left7;
                /* replace _a620 with _b621 in (_a620)._parent9 */
                if (!(((_a620)._parent9) == null)) {
                    if ((((_a620)._parent9)._left7) == (_a620)) {
                        ((_a620)._parent9)._left7 = _b621;
                    } else {
                        ((_a620)._parent9)._right8 = _b621;
                    }
                }
                if (!((_b621) == null)) {
                    (_b621)._parent9 = (_a620)._parent9;
                }
                /* replace _c622 with _a620 in _b621 */
                (_b621)._left7 = _a620;
                if (!((_a620) == null)) {
                    (_a620)._parent9 = _b621;
                }
                /* replace _b621 with _c622 in _a620 */
                (_a620)._right8 = _c622;
                if (!((_c622) == null)) {
                    (_c622)._parent9 = _a620;
                }
                /* _min_ax12 is min of ax1 */
                var _augval623 = (_a620).ax1;
                var _child624 = (_a620)._left7;
                if (!((_child624) == null)) {
                    var _val625 = (_child624)._min_ax12;
                    _augval623 = ((_augval623) < (_val625)) ? (_augval623) : (_val625);
                }
                var _child626 = (_a620)._right8;
                if (!((_child626) == null)) {
                    var _val627 = (_child626)._min_ax12;
                    _augval623 = ((_augval623) < (_val627)) ? (_augval623) : (_val627);
                }
                (_a620)._min_ax12 = _augval623;
                /* _min_ay13 is min of ay1 */
                var _augval628 = (_a620).ay1;
                var _child629 = (_a620)._left7;
                if (!((_child629) == null)) {
                    var _val630 = (_child629)._min_ay13;
                    _augval628 = ((_augval628) < (_val630)) ? (_augval628) : (_val630);
                }
                var _child631 = (_a620)._right8;
                if (!((_child631) == null)) {
                    var _val632 = (_child631)._min_ay13;
                    _augval628 = ((_augval628) < (_val632)) ? (_augval628) : (_val632);
                }
                (_a620)._min_ay13 = _augval628;
                /* _max_ay24 is max of ay2 */
                var _augval633 = (_a620).ay2;
                var _child634 = (_a620)._left7;
                if (!((_child634) == null)) {
                    var _val635 = (_child634)._max_ay24;
                    _augval633 = ((_augval633) < (_val635)) ? (_val635) : (_augval633);
                }
                var _child636 = (_a620)._right8;
                if (!((_child636) == null)) {
                    var _val637 = (_child636)._max_ay24;
                    _augval633 = ((_augval633) < (_val637)) ? (_val637) : (_augval633);
                }
                (_a620)._max_ay24 = _augval633;
                (_a620)._height10 = 1 + ((((((_a620)._left7) == null) ? (-1) : (((_a620)._left7)._height10)) > ((((_a620)._right8) == null) ? (-1) : (((_a620)._right8)._height10))) ? ((((_a620)._left7) == null) ? (-1) : (((_a620)._left7)._height10)) : ((((_a620)._right8) == null) ? (-1) : (((_a620)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval638 = (_b621).ax1;
                var _child639 = (_b621)._left7;
                if (!((_child639) == null)) {
                    var _val640 = (_child639)._min_ax12;
                    _augval638 = ((_augval638) < (_val640)) ? (_augval638) : (_val640);
                }
                var _child641 = (_b621)._right8;
                if (!((_child641) == null)) {
                    var _val642 = (_child641)._min_ax12;
                    _augval638 = ((_augval638) < (_val642)) ? (_augval638) : (_val642);
                }
                (_b621)._min_ax12 = _augval638;
                /* _min_ay13 is min of ay1 */
                var _augval643 = (_b621).ay1;
                var _child644 = (_b621)._left7;
                if (!((_child644) == null)) {
                    var _val645 = (_child644)._min_ay13;
                    _augval643 = ((_augval643) < (_val645)) ? (_augval643) : (_val645);
                }
                var _child646 = (_b621)._right8;
                if (!((_child646) == null)) {
                    var _val647 = (_child646)._min_ay13;
                    _augval643 = ((_augval643) < (_val647)) ? (_augval643) : (_val647);
                }
                (_b621)._min_ay13 = _augval643;
                /* _max_ay24 is max of ay2 */
                var _augval648 = (_b621).ay2;
                var _child649 = (_b621)._left7;
                if (!((_child649) == null)) {
                    var _val650 = (_child649)._max_ay24;
                    _augval648 = ((_augval648) < (_val650)) ? (_val650) : (_augval648);
                }
                var _child651 = (_b621)._right8;
                if (!((_child651) == null)) {
                    var _val652 = (_child651)._max_ay24;
                    _augval648 = ((_augval648) < (_val652)) ? (_val652) : (_augval648);
                }
                (_b621)._max_ay24 = _augval648;
                (_b621)._height10 = 1 + ((((((_b621)._left7) == null) ? (-1) : (((_b621)._left7)._height10)) > ((((_b621)._right8) == null) ? (-1) : (((_b621)._right8)._height10))) ? ((((_b621)._left7) == null) ? (-1) : (((_b621)._left7)._height10)) : ((((_b621)._right8) == null) ? (-1) : (((_b621)._right8)._height10)));
                if (!(((_b621)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval653 = ((_b621)._parent9).ax1;
                    var _child654 = ((_b621)._parent9)._left7;
                    if (!((_child654) == null)) {
                        var _val655 = (_child654)._min_ax12;
                        _augval653 = ((_augval653) < (_val655)) ? (_augval653) : (_val655);
                    }
                    var _child656 = ((_b621)._parent9)._right8;
                    if (!((_child656) == null)) {
                        var _val657 = (_child656)._min_ax12;
                        _augval653 = ((_augval653) < (_val657)) ? (_augval653) : (_val657);
                    }
                    ((_b621)._parent9)._min_ax12 = _augval653;
                    /* _min_ay13 is min of ay1 */
                    var _augval658 = ((_b621)._parent9).ay1;
                    var _child659 = ((_b621)._parent9)._left7;
                    if (!((_child659) == null)) {
                        var _val660 = (_child659)._min_ay13;
                        _augval658 = ((_augval658) < (_val660)) ? (_augval658) : (_val660);
                    }
                    var _child661 = ((_b621)._parent9)._right8;
                    if (!((_child661) == null)) {
                        var _val662 = (_child661)._min_ay13;
                        _augval658 = ((_augval658) < (_val662)) ? (_augval658) : (_val662);
                    }
                    ((_b621)._parent9)._min_ay13 = _augval658;
                    /* _max_ay24 is max of ay2 */
                    var _augval663 = ((_b621)._parent9).ay2;
                    var _child664 = ((_b621)._parent9)._left7;
                    if (!((_child664) == null)) {
                        var _val665 = (_child664)._max_ay24;
                        _augval663 = ((_augval663) < (_val665)) ? (_val665) : (_augval663);
                    }
                    var _child666 = ((_b621)._parent9)._right8;
                    if (!((_child666) == null)) {
                        var _val667 = (_child666)._max_ay24;
                        _augval663 = ((_augval663) < (_val667)) ? (_val667) : (_augval663);
                    }
                    ((_b621)._parent9)._max_ay24 = _augval663;
                    ((_b621)._parent9)._height10 = 1 + (((((((_b621)._parent9)._left7) == null) ? (-1) : ((((_b621)._parent9)._left7)._height10)) > (((((_b621)._parent9)._right8) == null) ? (-1) : ((((_b621)._parent9)._right8)._height10))) ? (((((_b621)._parent9)._left7) == null) ? (-1) : ((((_b621)._parent9)._left7)._height10)) : (((((_b621)._parent9)._right8) == null) ? (-1) : ((((_b621)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b621;
                }
                _cursor474 = (_cursor474)._parent9;
            }
        }
        (__x).ax2 = new_val;
    }
}
RectangleHolder.prototype.updateAy2 = function (__x, new_val) {
    if ((__x).ay2 != new_val) {
        /* _max_ay24 is max of ay2 */
        var _augval668 = new_val;
        var _child669 = (__x)._left7;
        if (!((_child669) == null)) {
            var _val670 = (_child669)._max_ay24;
            _augval668 = ((_augval668) < (_val670)) ? (_val670) : (_augval668);
        }
        var _child671 = (__x)._right8;
        if (!((_child671) == null)) {
            var _val672 = (_child671)._max_ay24;
            _augval668 = ((_augval668) < (_val672)) ? (_val672) : (_augval668);
        }
        (__x)._max_ay24 = _augval668;
        var _cursor673 = (__x)._parent9;
        var _changed674 = true;
        while ((_changed674) && (!((_cursor673) == (null)))) {
            var _old__max_ay24675 = (_cursor673)._max_ay24;
            var _old_height676 = (_cursor673)._height10;
            /* _max_ay24 is max of ay2 */
            var _augval677 = (_cursor673).ay2;
            var _child678 = (_cursor673)._left7;
            if (!((_child678) == null)) {
                var _val679 = (_child678)._max_ay24;
                _augval677 = ((_augval677) < (_val679)) ? (_val679) : (_augval677);
            }
            var _child680 = (_cursor673)._right8;
            if (!((_child680) == null)) {
                var _val681 = (_child680)._max_ay24;
                _augval677 = ((_augval677) < (_val681)) ? (_val681) : (_augval677);
            }
            (_cursor673)._max_ay24 = _augval677;
            (_cursor673)._height10 = 1 + ((((((_cursor673)._left7) == null) ? (-1) : (((_cursor673)._left7)._height10)) > ((((_cursor673)._right8) == null) ? (-1) : (((_cursor673)._right8)._height10))) ? ((((_cursor673)._left7) == null) ? (-1) : (((_cursor673)._left7)._height10)) : ((((_cursor673)._right8) == null) ? (-1) : (((_cursor673)._right8)._height10)));
            _changed674 = false;
            _changed674 = (_changed674) || (!((_old__max_ay24675) == ((_cursor673)._max_ay24)));
            _changed674 = (_changed674) || (!((_old_height676) == ((_cursor673)._height10)));
            _cursor673 = (_cursor673)._parent9;
        }
        (__x).ay2 = new_val;
    }
}
RectangleHolder.prototype.update = function (__x, ax1, ay1, ax2, ay2) {
    var _parent682 = (__x)._parent9;
    var _left683 = (__x)._left7;
    var _right684 = (__x)._right8;
    var _new_x685;
    if (((_left683) == null) && ((_right684) == null)) {
        _new_x685 = null;
        /* replace __x with _new_x685 in _parent682 */
        if (!((_parent682) == null)) {
            if (((_parent682)._left7) == (__x)) {
                (_parent682)._left7 = _new_x685;
            } else {
                (_parent682)._right8 = _new_x685;
            }
        }
        if (!((_new_x685) == null)) {
            (_new_x685)._parent9 = _parent682;
        }
    } else if ((!((_left683) == null)) && ((_right684) == null)) {
        _new_x685 = _left683;
        /* replace __x with _new_x685 in _parent682 */
        if (!((_parent682) == null)) {
            if (((_parent682)._left7) == (__x)) {
                (_parent682)._left7 = _new_x685;
            } else {
                (_parent682)._right8 = _new_x685;
            }
        }
        if (!((_new_x685) == null)) {
            (_new_x685)._parent9 = _parent682;
        }
    } else if (((_left683) == null) && (!((_right684) == null))) {
        _new_x685 = _right684;
        /* replace __x with _new_x685 in _parent682 */
        if (!((_parent682) == null)) {
            if (((_parent682)._left7) == (__x)) {
                (_parent682)._left7 = _new_x685;
            } else {
                (_parent682)._right8 = _new_x685;
            }
        }
        if (!((_new_x685) == null)) {
            (_new_x685)._parent9 = _parent682;
        }
    } else {
        var _root686 = (__x)._right8;
        var _x687 = _root686;
        var _descend688 = true;
        var _from_left689 = true;
        while (true) {
            if ((_x687) == null) {
                _x687 = null;
                break;
            }
            if (_descend688) {
                /* too small? */
                if (false) {
                    if ((!(((_x687)._right8) == null)) && (true)) {
                        if ((_x687) == (_root686)) {
                            _root686 = (_x687)._right8;
                        }
                        _x687 = (_x687)._right8;
                    } else if ((_x687) == (_root686)) {
                        _x687 = null;
                        break;
                    } else {
                        _descend688 = false;
                        _from_left689 = (!(((_x687)._parent9) == null)) && ((_x687) == (((_x687)._parent9)._left7));
                        _x687 = (_x687)._parent9;
                    }
                } else if ((!(((_x687)._left7) == null)) && (true)) {
                    _x687 = (_x687)._left7;
                    /* too large? */
                } else if (false) {
                    if ((_x687) == (_root686)) {
                        _x687 = null;
                        break;
                    } else {
                        _descend688 = false;
                        _from_left689 = (!(((_x687)._parent9) == null)) && ((_x687) == (((_x687)._parent9)._left7));
                        _x687 = (_x687)._parent9;
                    }
                    /* node ok? */
                } else if (true) {
                    break;
                } else if ((_x687) == (_root686)) {
                    _root686 = (_x687)._right8;
                    _x687 = (_x687)._right8;
                } else {
                    if ((!(((_x687)._right8) == null)) && (true)) {
                        if ((_x687) == (_root686)) {
                            _root686 = (_x687)._right8;
                        }
                        _x687 = (_x687)._right8;
                    } else {
                        _descend688 = false;
                        _from_left689 = (!(((_x687)._parent9) == null)) && ((_x687) == (((_x687)._parent9)._left7));
                        _x687 = (_x687)._parent9;
                    }
                }
            } else if (_from_left689) {
                if (false) {
                    _x687 = null;
                    break;
                } else if (true) {
                    break;
                } else if ((!(((_x687)._right8) == null)) && (true)) {
                    _descend688 = true;
                    if ((_x687) == (_root686)) {
                        _root686 = (_x687)._right8;
                    }
                    _x687 = (_x687)._right8;
                } else if ((_x687) == (_root686)) {
                    _x687 = null;
                    break;
                } else {
                    _descend688 = false;
                    _from_left689 = (!(((_x687)._parent9) == null)) && ((_x687) == (((_x687)._parent9)._left7));
                    _x687 = (_x687)._parent9;
                }
            } else {
                if ((_x687) == (_root686)) {
                    _x687 = null;
                    break;
                } else {
                    _descend688 = false;
                    _from_left689 = (!(((_x687)._parent9) == null)) && ((_x687) == (((_x687)._parent9)._left7));
                    _x687 = (_x687)._parent9;
                }
            }
        }
        _new_x685 = _x687;
        var _mp690 = (_x687)._parent9;
        var _mr691 = (_x687)._right8;
        /* replace _x687 with _mr691 in _mp690 */
        if (!((_mp690) == null)) {
            if (((_mp690)._left7) == (_x687)) {
                (_mp690)._left7 = _mr691;
            } else {
                (_mp690)._right8 = _mr691;
            }
        }
        if (!((_mr691) == null)) {
            (_mr691)._parent9 = _mp690;
        }
        /* replace __x with _x687 in _parent682 */
        if (!((_parent682) == null)) {
            if (((_parent682)._left7) == (__x)) {
                (_parent682)._left7 = _x687;
            } else {
                (_parent682)._right8 = _x687;
            }
        }
        if (!((_x687) == null)) {
            (_x687)._parent9 = _parent682;
        }
        /* replace null with _left683 in _x687 */
        (_x687)._left7 = _left683;
        if (!((_left683) == null)) {
            (_left683)._parent9 = _x687;
        }
        /* replace _mr691 with (__x)._right8 in _x687 */
        (_x687)._right8 = (__x)._right8;
        if (!(((__x)._right8) == null)) {
            ((__x)._right8)._parent9 = _x687;
        }
        /* _min_ax12 is min of ax1 */
        var _augval692 = (_x687).ax1;
        var _child693 = (_x687)._left7;
        if (!((_child693) == null)) {
            var _val694 = (_child693)._min_ax12;
            _augval692 = ((_augval692) < (_val694)) ? (_augval692) : (_val694);
        }
        var _child695 = (_x687)._right8;
        if (!((_child695) == null)) {
            var _val696 = (_child695)._min_ax12;
            _augval692 = ((_augval692) < (_val696)) ? (_augval692) : (_val696);
        }
        (_x687)._min_ax12 = _augval692;
        /* _min_ay13 is min of ay1 */
        var _augval697 = (_x687).ay1;
        var _child698 = (_x687)._left7;
        if (!((_child698) == null)) {
            var _val699 = (_child698)._min_ay13;
            _augval697 = ((_augval697) < (_val699)) ? (_augval697) : (_val699);
        }
        var _child700 = (_x687)._right8;
        if (!((_child700) == null)) {
            var _val701 = (_child700)._min_ay13;
            _augval697 = ((_augval697) < (_val701)) ? (_augval697) : (_val701);
        }
        (_x687)._min_ay13 = _augval697;
        /* _max_ay24 is max of ay2 */
        var _augval702 = (_x687).ay2;
        var _child703 = (_x687)._left7;
        if (!((_child703) == null)) {
            var _val704 = (_child703)._max_ay24;
            _augval702 = ((_augval702) < (_val704)) ? (_val704) : (_augval702);
        }
        var _child705 = (_x687)._right8;
        if (!((_child705) == null)) {
            var _val706 = (_child705)._max_ay24;
            _augval702 = ((_augval702) < (_val706)) ? (_val706) : (_augval702);
        }
        (_x687)._max_ay24 = _augval702;
        (_x687)._height10 = 1 + ((((((_x687)._left7) == null) ? (-1) : (((_x687)._left7)._height10)) > ((((_x687)._right8) == null) ? (-1) : (((_x687)._right8)._height10))) ? ((((_x687)._left7) == null) ? (-1) : (((_x687)._left7)._height10)) : ((((_x687)._right8) == null) ? (-1) : (((_x687)._right8)._height10)));
        var _cursor707 = _mp690;
        var _changed708 = true;
        while ((_changed708) && (!((_cursor707) == (_parent682)))) {
            var _old__min_ax12709 = (_cursor707)._min_ax12;
            var _old__min_ay13710 = (_cursor707)._min_ay13;
            var _old__max_ay24711 = (_cursor707)._max_ay24;
            var _old_height712 = (_cursor707)._height10;
            /* _min_ax12 is min of ax1 */
            var _augval713 = (_cursor707).ax1;
            var _child714 = (_cursor707)._left7;
            if (!((_child714) == null)) {
                var _val715 = (_child714)._min_ax12;
                _augval713 = ((_augval713) < (_val715)) ? (_augval713) : (_val715);
            }
            var _child716 = (_cursor707)._right8;
            if (!((_child716) == null)) {
                var _val717 = (_child716)._min_ax12;
                _augval713 = ((_augval713) < (_val717)) ? (_augval713) : (_val717);
            }
            (_cursor707)._min_ax12 = _augval713;
            /* _min_ay13 is min of ay1 */
            var _augval718 = (_cursor707).ay1;
            var _child719 = (_cursor707)._left7;
            if (!((_child719) == null)) {
                var _val720 = (_child719)._min_ay13;
                _augval718 = ((_augval718) < (_val720)) ? (_augval718) : (_val720);
            }
            var _child721 = (_cursor707)._right8;
            if (!((_child721) == null)) {
                var _val722 = (_child721)._min_ay13;
                _augval718 = ((_augval718) < (_val722)) ? (_augval718) : (_val722);
            }
            (_cursor707)._min_ay13 = _augval718;
            /* _max_ay24 is max of ay2 */
            var _augval723 = (_cursor707).ay2;
            var _child724 = (_cursor707)._left7;
            if (!((_child724) == null)) {
                var _val725 = (_child724)._max_ay24;
                _augval723 = ((_augval723) < (_val725)) ? (_val725) : (_augval723);
            }
            var _child726 = (_cursor707)._right8;
            if (!((_child726) == null)) {
                var _val727 = (_child726)._max_ay24;
                _augval723 = ((_augval723) < (_val727)) ? (_val727) : (_augval723);
            }
            (_cursor707)._max_ay24 = _augval723;
            (_cursor707)._height10 = 1 + ((((((_cursor707)._left7) == null) ? (-1) : (((_cursor707)._left7)._height10)) > ((((_cursor707)._right8) == null) ? (-1) : (((_cursor707)._right8)._height10))) ? ((((_cursor707)._left7) == null) ? (-1) : (((_cursor707)._left7)._height10)) : ((((_cursor707)._right8) == null) ? (-1) : (((_cursor707)._right8)._height10)));
            _changed708 = false;
            _changed708 = (_changed708) || (!((_old__min_ax12709) == ((_cursor707)._min_ax12)));
            _changed708 = (_changed708) || (!((_old__min_ay13710) == ((_cursor707)._min_ay13)));
            _changed708 = (_changed708) || (!((_old__max_ay24711) == ((_cursor707)._max_ay24)));
            _changed708 = (_changed708) || (!((_old_height712) == ((_cursor707)._height10)));
            _cursor707 = (_cursor707)._parent9;
        }
    }
    var _cursor728 = _parent682;
    var _changed729 = true;
    while ((_changed729) && (!((_cursor728) == (null)))) {
        var _old__min_ax12730 = (_cursor728)._min_ax12;
        var _old__min_ay13731 = (_cursor728)._min_ay13;
        var _old__max_ay24732 = (_cursor728)._max_ay24;
        var _old_height733 = (_cursor728)._height10;
        /* _min_ax12 is min of ax1 */
        var _augval734 = (_cursor728).ax1;
        var _child735 = (_cursor728)._left7;
        if (!((_child735) == null)) {
            var _val736 = (_child735)._min_ax12;
            _augval734 = ((_augval734) < (_val736)) ? (_augval734) : (_val736);
        }
        var _child737 = (_cursor728)._right8;
        if (!((_child737) == null)) {
            var _val738 = (_child737)._min_ax12;
            _augval734 = ((_augval734) < (_val738)) ? (_augval734) : (_val738);
        }
        (_cursor728)._min_ax12 = _augval734;
        /* _min_ay13 is min of ay1 */
        var _augval739 = (_cursor728).ay1;
        var _child740 = (_cursor728)._left7;
        if (!((_child740) == null)) {
            var _val741 = (_child740)._min_ay13;
            _augval739 = ((_augval739) < (_val741)) ? (_augval739) : (_val741);
        }
        var _child742 = (_cursor728)._right8;
        if (!((_child742) == null)) {
            var _val743 = (_child742)._min_ay13;
            _augval739 = ((_augval739) < (_val743)) ? (_augval739) : (_val743);
        }
        (_cursor728)._min_ay13 = _augval739;
        /* _max_ay24 is max of ay2 */
        var _augval744 = (_cursor728).ay2;
        var _child745 = (_cursor728)._left7;
        if (!((_child745) == null)) {
            var _val746 = (_child745)._max_ay24;
            _augval744 = ((_augval744) < (_val746)) ? (_val746) : (_augval744);
        }
        var _child747 = (_cursor728)._right8;
        if (!((_child747) == null)) {
            var _val748 = (_child747)._max_ay24;
            _augval744 = ((_augval744) < (_val748)) ? (_val748) : (_augval744);
        }
        (_cursor728)._max_ay24 = _augval744;
        (_cursor728)._height10 = 1 + ((((((_cursor728)._left7) == null) ? (-1) : (((_cursor728)._left7)._height10)) > ((((_cursor728)._right8) == null) ? (-1) : (((_cursor728)._right8)._height10))) ? ((((_cursor728)._left7) == null) ? (-1) : (((_cursor728)._left7)._height10)) : ((((_cursor728)._right8) == null) ? (-1) : (((_cursor728)._right8)._height10)));
        _changed729 = false;
        _changed729 = (_changed729) || (!((_old__min_ax12730) == ((_cursor728)._min_ax12)));
        _changed729 = (_changed729) || (!((_old__min_ay13731) == ((_cursor728)._min_ay13)));
        _changed729 = (_changed729) || (!((_old__max_ay24732) == ((_cursor728)._max_ay24)));
        _changed729 = (_changed729) || (!((_old_height733) == ((_cursor728)._height10)));
        _cursor728 = (_cursor728)._parent9;
    }
    if (((this)._root1) == (__x)) {
        (this)._root1 = _new_x685;
    }
    (__x)._left7 = null;
    (__x)._right8 = null;
    (__x)._min_ax12 = (__x).ax1;
    (__x)._min_ay13 = (__x).ay1;
    (__x)._max_ay24 = (__x).ay2;
    (__x)._height10 = 0;
    var _previous749 = null;
    var _current750 = (this)._root1;
    var _is_left751 = false;
    while (!((_current750) == null)) {
        _previous749 = _current750;
        if ((ax2) < ((_current750).ax2)) {
            _current750 = (_current750)._left7;
            _is_left751 = true;
        } else {
            _current750 = (_current750)._right8;
            _is_left751 = false;
        }
    }
    if ((_previous749) == null) {
        (this)._root1 = __x;
    } else {
        (__x)._parent9 = _previous749;
        if (_is_left751) {
            (_previous749)._left7 = __x;
        } else {
            (_previous749)._right8 = __x;
        }
    }
    var _cursor752 = (__x)._parent9;
    var _changed753 = true;
    while ((_changed753) && (!((_cursor752) == (null)))) {
        var _old__min_ax12754 = (_cursor752)._min_ax12;
        var _old__min_ay13755 = (_cursor752)._min_ay13;
        var _old__max_ay24756 = (_cursor752)._max_ay24;
        var _old_height757 = (_cursor752)._height10;
        /* _min_ax12 is min of ax1 */
        var _augval758 = (_cursor752).ax1;
        var _child759 = (_cursor752)._left7;
        if (!((_child759) == null)) {
            var _val760 = (_child759)._min_ax12;
            _augval758 = ((_augval758) < (_val760)) ? (_augval758) : (_val760);
        }
        var _child761 = (_cursor752)._right8;
        if (!((_child761) == null)) {
            var _val762 = (_child761)._min_ax12;
            _augval758 = ((_augval758) < (_val762)) ? (_augval758) : (_val762);
        }
        (_cursor752)._min_ax12 = _augval758;
        /* _min_ay13 is min of ay1 */
        var _augval763 = (_cursor752).ay1;
        var _child764 = (_cursor752)._left7;
        if (!((_child764) == null)) {
            var _val765 = (_child764)._min_ay13;
            _augval763 = ((_augval763) < (_val765)) ? (_augval763) : (_val765);
        }
        var _child766 = (_cursor752)._right8;
        if (!((_child766) == null)) {
            var _val767 = (_child766)._min_ay13;
            _augval763 = ((_augval763) < (_val767)) ? (_augval763) : (_val767);
        }
        (_cursor752)._min_ay13 = _augval763;
        /* _max_ay24 is max of ay2 */
        var _augval768 = (_cursor752).ay2;
        var _child769 = (_cursor752)._left7;
        if (!((_child769) == null)) {
            var _val770 = (_child769)._max_ay24;
            _augval768 = ((_augval768) < (_val770)) ? (_val770) : (_augval768);
        }
        var _child771 = (_cursor752)._right8;
        if (!((_child771) == null)) {
            var _val772 = (_child771)._max_ay24;
            _augval768 = ((_augval768) < (_val772)) ? (_val772) : (_augval768);
        }
        (_cursor752)._max_ay24 = _augval768;
        (_cursor752)._height10 = 1 + ((((((_cursor752)._left7) == null) ? (-1) : (((_cursor752)._left7)._height10)) > ((((_cursor752)._right8) == null) ? (-1) : (((_cursor752)._right8)._height10))) ? ((((_cursor752)._left7) == null) ? (-1) : (((_cursor752)._left7)._height10)) : ((((_cursor752)._right8) == null) ? (-1) : (((_cursor752)._right8)._height10)));
        _changed753 = false;
        _changed753 = (_changed753) || (!((_old__min_ax12754) == ((_cursor752)._min_ax12)));
        _changed753 = (_changed753) || (!((_old__min_ay13755) == ((_cursor752)._min_ay13)));
        _changed753 = (_changed753) || (!((_old__max_ay24756) == ((_cursor752)._max_ay24)));
        _changed753 = (_changed753) || (!((_old_height757) == ((_cursor752)._height10)));
        _cursor752 = (_cursor752)._parent9;
    }
    /* rebalance AVL tree */
    var _cursor773 = __x;
    var _imbalance774;
    while (!(((_cursor773)._parent9) == null)) {
        _cursor773 = (_cursor773)._parent9;
        (_cursor773)._height10 = 1 + ((((((_cursor773)._left7) == null) ? (-1) : (((_cursor773)._left7)._height10)) > ((((_cursor773)._right8) == null) ? (-1) : (((_cursor773)._right8)._height10))) ? ((((_cursor773)._left7) == null) ? (-1) : (((_cursor773)._left7)._height10)) : ((((_cursor773)._right8) == null) ? (-1) : (((_cursor773)._right8)._height10)));
        _imbalance774 = ((((_cursor773)._left7) == null) ? (-1) : (((_cursor773)._left7)._height10)) - ((((_cursor773)._right8) == null) ? (-1) : (((_cursor773)._right8)._height10));
        if ((_imbalance774) > (1)) {
            if ((((((_cursor773)._left7)._left7) == null) ? (-1) : ((((_cursor773)._left7)._left7)._height10)) < (((((_cursor773)._left7)._right8) == null) ? (-1) : ((((_cursor773)._left7)._right8)._height10))) {
                /* rotate ((_cursor773)._left7)._right8 */
                var _a775 = (_cursor773)._left7;
                var _b776 = (_a775)._right8;
                var _c777 = (_b776)._left7;
                /* replace _a775 with _b776 in (_a775)._parent9 */
                if (!(((_a775)._parent9) == null)) {
                    if ((((_a775)._parent9)._left7) == (_a775)) {
                        ((_a775)._parent9)._left7 = _b776;
                    } else {
                        ((_a775)._parent9)._right8 = _b776;
                    }
                }
                if (!((_b776) == null)) {
                    (_b776)._parent9 = (_a775)._parent9;
                }
                /* replace _c777 with _a775 in _b776 */
                (_b776)._left7 = _a775;
                if (!((_a775) == null)) {
                    (_a775)._parent9 = _b776;
                }
                /* replace _b776 with _c777 in _a775 */
                (_a775)._right8 = _c777;
                if (!((_c777) == null)) {
                    (_c777)._parent9 = _a775;
                }
                /* _min_ax12 is min of ax1 */
                var _augval778 = (_a775).ax1;
                var _child779 = (_a775)._left7;
                if (!((_child779) == null)) {
                    var _val780 = (_child779)._min_ax12;
                    _augval778 = ((_augval778) < (_val780)) ? (_augval778) : (_val780);
                }
                var _child781 = (_a775)._right8;
                if (!((_child781) == null)) {
                    var _val782 = (_child781)._min_ax12;
                    _augval778 = ((_augval778) < (_val782)) ? (_augval778) : (_val782);
                }
                (_a775)._min_ax12 = _augval778;
                /* _min_ay13 is min of ay1 */
                var _augval783 = (_a775).ay1;
                var _child784 = (_a775)._left7;
                if (!((_child784) == null)) {
                    var _val785 = (_child784)._min_ay13;
                    _augval783 = ((_augval783) < (_val785)) ? (_augval783) : (_val785);
                }
                var _child786 = (_a775)._right8;
                if (!((_child786) == null)) {
                    var _val787 = (_child786)._min_ay13;
                    _augval783 = ((_augval783) < (_val787)) ? (_augval783) : (_val787);
                }
                (_a775)._min_ay13 = _augval783;
                /* _max_ay24 is max of ay2 */
                var _augval788 = (_a775).ay2;
                var _child789 = (_a775)._left7;
                if (!((_child789) == null)) {
                    var _val790 = (_child789)._max_ay24;
                    _augval788 = ((_augval788) < (_val790)) ? (_val790) : (_augval788);
                }
                var _child791 = (_a775)._right8;
                if (!((_child791) == null)) {
                    var _val792 = (_child791)._max_ay24;
                    _augval788 = ((_augval788) < (_val792)) ? (_val792) : (_augval788);
                }
                (_a775)._max_ay24 = _augval788;
                (_a775)._height10 = 1 + ((((((_a775)._left7) == null) ? (-1) : (((_a775)._left7)._height10)) > ((((_a775)._right8) == null) ? (-1) : (((_a775)._right8)._height10))) ? ((((_a775)._left7) == null) ? (-1) : (((_a775)._left7)._height10)) : ((((_a775)._right8) == null) ? (-1) : (((_a775)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval793 = (_b776).ax1;
                var _child794 = (_b776)._left7;
                if (!((_child794) == null)) {
                    var _val795 = (_child794)._min_ax12;
                    _augval793 = ((_augval793) < (_val795)) ? (_augval793) : (_val795);
                }
                var _child796 = (_b776)._right8;
                if (!((_child796) == null)) {
                    var _val797 = (_child796)._min_ax12;
                    _augval793 = ((_augval793) < (_val797)) ? (_augval793) : (_val797);
                }
                (_b776)._min_ax12 = _augval793;
                /* _min_ay13 is min of ay1 */
                var _augval798 = (_b776).ay1;
                var _child799 = (_b776)._left7;
                if (!((_child799) == null)) {
                    var _val800 = (_child799)._min_ay13;
                    _augval798 = ((_augval798) < (_val800)) ? (_augval798) : (_val800);
                }
                var _child801 = (_b776)._right8;
                if (!((_child801) == null)) {
                    var _val802 = (_child801)._min_ay13;
                    _augval798 = ((_augval798) < (_val802)) ? (_augval798) : (_val802);
                }
                (_b776)._min_ay13 = _augval798;
                /* _max_ay24 is max of ay2 */
                var _augval803 = (_b776).ay2;
                var _child804 = (_b776)._left7;
                if (!((_child804) == null)) {
                    var _val805 = (_child804)._max_ay24;
                    _augval803 = ((_augval803) < (_val805)) ? (_val805) : (_augval803);
                }
                var _child806 = (_b776)._right8;
                if (!((_child806) == null)) {
                    var _val807 = (_child806)._max_ay24;
                    _augval803 = ((_augval803) < (_val807)) ? (_val807) : (_augval803);
                }
                (_b776)._max_ay24 = _augval803;
                (_b776)._height10 = 1 + ((((((_b776)._left7) == null) ? (-1) : (((_b776)._left7)._height10)) > ((((_b776)._right8) == null) ? (-1) : (((_b776)._right8)._height10))) ? ((((_b776)._left7) == null) ? (-1) : (((_b776)._left7)._height10)) : ((((_b776)._right8) == null) ? (-1) : (((_b776)._right8)._height10)));
                if (!(((_b776)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval808 = ((_b776)._parent9).ax1;
                    var _child809 = ((_b776)._parent9)._left7;
                    if (!((_child809) == null)) {
                        var _val810 = (_child809)._min_ax12;
                        _augval808 = ((_augval808) < (_val810)) ? (_augval808) : (_val810);
                    }
                    var _child811 = ((_b776)._parent9)._right8;
                    if (!((_child811) == null)) {
                        var _val812 = (_child811)._min_ax12;
                        _augval808 = ((_augval808) < (_val812)) ? (_augval808) : (_val812);
                    }
                    ((_b776)._parent9)._min_ax12 = _augval808;
                    /* _min_ay13 is min of ay1 */
                    var _augval813 = ((_b776)._parent9).ay1;
                    var _child814 = ((_b776)._parent9)._left7;
                    if (!((_child814) == null)) {
                        var _val815 = (_child814)._min_ay13;
                        _augval813 = ((_augval813) < (_val815)) ? (_augval813) : (_val815);
                    }
                    var _child816 = ((_b776)._parent9)._right8;
                    if (!((_child816) == null)) {
                        var _val817 = (_child816)._min_ay13;
                        _augval813 = ((_augval813) < (_val817)) ? (_augval813) : (_val817);
                    }
                    ((_b776)._parent9)._min_ay13 = _augval813;
                    /* _max_ay24 is max of ay2 */
                    var _augval818 = ((_b776)._parent9).ay2;
                    var _child819 = ((_b776)._parent9)._left7;
                    if (!((_child819) == null)) {
                        var _val820 = (_child819)._max_ay24;
                        _augval818 = ((_augval818) < (_val820)) ? (_val820) : (_augval818);
                    }
                    var _child821 = ((_b776)._parent9)._right8;
                    if (!((_child821) == null)) {
                        var _val822 = (_child821)._max_ay24;
                        _augval818 = ((_augval818) < (_val822)) ? (_val822) : (_augval818);
                    }
                    ((_b776)._parent9)._max_ay24 = _augval818;
                    ((_b776)._parent9)._height10 = 1 + (((((((_b776)._parent9)._left7) == null) ? (-1) : ((((_b776)._parent9)._left7)._height10)) > (((((_b776)._parent9)._right8) == null) ? (-1) : ((((_b776)._parent9)._right8)._height10))) ? (((((_b776)._parent9)._left7) == null) ? (-1) : ((((_b776)._parent9)._left7)._height10)) : (((((_b776)._parent9)._right8) == null) ? (-1) : ((((_b776)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b776;
                }
            }
            /* rotate (_cursor773)._left7 */
            var _a823 = _cursor773;
            var _b824 = (_a823)._left7;
            var _c825 = (_b824)._right8;
            /* replace _a823 with _b824 in (_a823)._parent9 */
            if (!(((_a823)._parent9) == null)) {
                if ((((_a823)._parent9)._left7) == (_a823)) {
                    ((_a823)._parent9)._left7 = _b824;
                } else {
                    ((_a823)._parent9)._right8 = _b824;
                }
            }
            if (!((_b824) == null)) {
                (_b824)._parent9 = (_a823)._parent9;
            }
            /* replace _c825 with _a823 in _b824 */
            (_b824)._right8 = _a823;
            if (!((_a823) == null)) {
                (_a823)._parent9 = _b824;
            }
            /* replace _b824 with _c825 in _a823 */
            (_a823)._left7 = _c825;
            if (!((_c825) == null)) {
                (_c825)._parent9 = _a823;
            }
            /* _min_ax12 is min of ax1 */
            var _augval826 = (_a823).ax1;
            var _child827 = (_a823)._left7;
            if (!((_child827) == null)) {
                var _val828 = (_child827)._min_ax12;
                _augval826 = ((_augval826) < (_val828)) ? (_augval826) : (_val828);
            }
            var _child829 = (_a823)._right8;
            if (!((_child829) == null)) {
                var _val830 = (_child829)._min_ax12;
                _augval826 = ((_augval826) < (_val830)) ? (_augval826) : (_val830);
            }
            (_a823)._min_ax12 = _augval826;
            /* _min_ay13 is min of ay1 */
            var _augval831 = (_a823).ay1;
            var _child832 = (_a823)._left7;
            if (!((_child832) == null)) {
                var _val833 = (_child832)._min_ay13;
                _augval831 = ((_augval831) < (_val833)) ? (_augval831) : (_val833);
            }
            var _child834 = (_a823)._right8;
            if (!((_child834) == null)) {
                var _val835 = (_child834)._min_ay13;
                _augval831 = ((_augval831) < (_val835)) ? (_augval831) : (_val835);
            }
            (_a823)._min_ay13 = _augval831;
            /* _max_ay24 is max of ay2 */
            var _augval836 = (_a823).ay2;
            var _child837 = (_a823)._left7;
            if (!((_child837) == null)) {
                var _val838 = (_child837)._max_ay24;
                _augval836 = ((_augval836) < (_val838)) ? (_val838) : (_augval836);
            }
            var _child839 = (_a823)._right8;
            if (!((_child839) == null)) {
                var _val840 = (_child839)._max_ay24;
                _augval836 = ((_augval836) < (_val840)) ? (_val840) : (_augval836);
            }
            (_a823)._max_ay24 = _augval836;
            (_a823)._height10 = 1 + ((((((_a823)._left7) == null) ? (-1) : (((_a823)._left7)._height10)) > ((((_a823)._right8) == null) ? (-1) : (((_a823)._right8)._height10))) ? ((((_a823)._left7) == null) ? (-1) : (((_a823)._left7)._height10)) : ((((_a823)._right8) == null) ? (-1) : (((_a823)._right8)._height10)));
            /* _min_ax12 is min of ax1 */
            var _augval841 = (_b824).ax1;
            var _child842 = (_b824)._left7;
            if (!((_child842) == null)) {
                var _val843 = (_child842)._min_ax12;
                _augval841 = ((_augval841) < (_val843)) ? (_augval841) : (_val843);
            }
            var _child844 = (_b824)._right8;
            if (!((_child844) == null)) {
                var _val845 = (_child844)._min_ax12;
                _augval841 = ((_augval841) < (_val845)) ? (_augval841) : (_val845);
            }
            (_b824)._min_ax12 = _augval841;
            /* _min_ay13 is min of ay1 */
            var _augval846 = (_b824).ay1;
            var _child847 = (_b824)._left7;
            if (!((_child847) == null)) {
                var _val848 = (_child847)._min_ay13;
                _augval846 = ((_augval846) < (_val848)) ? (_augval846) : (_val848);
            }
            var _child849 = (_b824)._right8;
            if (!((_child849) == null)) {
                var _val850 = (_child849)._min_ay13;
                _augval846 = ((_augval846) < (_val850)) ? (_augval846) : (_val850);
            }
            (_b824)._min_ay13 = _augval846;
            /* _max_ay24 is max of ay2 */
            var _augval851 = (_b824).ay2;
            var _child852 = (_b824)._left7;
            if (!((_child852) == null)) {
                var _val853 = (_child852)._max_ay24;
                _augval851 = ((_augval851) < (_val853)) ? (_val853) : (_augval851);
            }
            var _child854 = (_b824)._right8;
            if (!((_child854) == null)) {
                var _val855 = (_child854)._max_ay24;
                _augval851 = ((_augval851) < (_val855)) ? (_val855) : (_augval851);
            }
            (_b824)._max_ay24 = _augval851;
            (_b824)._height10 = 1 + ((((((_b824)._left7) == null) ? (-1) : (((_b824)._left7)._height10)) > ((((_b824)._right8) == null) ? (-1) : (((_b824)._right8)._height10))) ? ((((_b824)._left7) == null) ? (-1) : (((_b824)._left7)._height10)) : ((((_b824)._right8) == null) ? (-1) : (((_b824)._right8)._height10)));
            if (!(((_b824)._parent9) == null)) {
                /* _min_ax12 is min of ax1 */
                var _augval856 = ((_b824)._parent9).ax1;
                var _child857 = ((_b824)._parent9)._left7;
                if (!((_child857) == null)) {
                    var _val858 = (_child857)._min_ax12;
                    _augval856 = ((_augval856) < (_val858)) ? (_augval856) : (_val858);
                }
                var _child859 = ((_b824)._parent9)._right8;
                if (!((_child859) == null)) {
                    var _val860 = (_child859)._min_ax12;
                    _augval856 = ((_augval856) < (_val860)) ? (_augval856) : (_val860);
                }
                ((_b824)._parent9)._min_ax12 = _augval856;
                /* _min_ay13 is min of ay1 */
                var _augval861 = ((_b824)._parent9).ay1;
                var _child862 = ((_b824)._parent9)._left7;
                if (!((_child862) == null)) {
                    var _val863 = (_child862)._min_ay13;
                    _augval861 = ((_augval861) < (_val863)) ? (_augval861) : (_val863);
                }
                var _child864 = ((_b824)._parent9)._right8;
                if (!((_child864) == null)) {
                    var _val865 = (_child864)._min_ay13;
                    _augval861 = ((_augval861) < (_val865)) ? (_augval861) : (_val865);
                }
                ((_b824)._parent9)._min_ay13 = _augval861;
                /* _max_ay24 is max of ay2 */
                var _augval866 = ((_b824)._parent9).ay2;
                var _child867 = ((_b824)._parent9)._left7;
                if (!((_child867) == null)) {
                    var _val868 = (_child867)._max_ay24;
                    _augval866 = ((_augval866) < (_val868)) ? (_val868) : (_augval866);
                }
                var _child869 = ((_b824)._parent9)._right8;
                if (!((_child869) == null)) {
                    var _val870 = (_child869)._max_ay24;
                    _augval866 = ((_augval866) < (_val870)) ? (_val870) : (_augval866);
                }
                ((_b824)._parent9)._max_ay24 = _augval866;
                ((_b824)._parent9)._height10 = 1 + (((((((_b824)._parent9)._left7) == null) ? (-1) : ((((_b824)._parent9)._left7)._height10)) > (((((_b824)._parent9)._right8) == null) ? (-1) : ((((_b824)._parent9)._right8)._height10))) ? (((((_b824)._parent9)._left7) == null) ? (-1) : ((((_b824)._parent9)._left7)._height10)) : (((((_b824)._parent9)._right8) == null) ? (-1) : ((((_b824)._parent9)._right8)._height10)));
            } else {
                (this)._root1 = _b824;
            }
            _cursor773 = (_cursor773)._parent9;
        } else if ((_imbalance774) < (-1)) {
            if ((((((_cursor773)._right8)._left7) == null) ? (-1) : ((((_cursor773)._right8)._left7)._height10)) > (((((_cursor773)._right8)._right8) == null) ? (-1) : ((((_cursor773)._right8)._right8)._height10))) {
                /* rotate ((_cursor773)._right8)._left7 */
                var _a871 = (_cursor773)._right8;
                var _b872 = (_a871)._left7;
                var _c873 = (_b872)._right8;
                /* replace _a871 with _b872 in (_a871)._parent9 */
                if (!(((_a871)._parent9) == null)) {
                    if ((((_a871)._parent9)._left7) == (_a871)) {
                        ((_a871)._parent9)._left7 = _b872;
                    } else {
                        ((_a871)._parent9)._right8 = _b872;
                    }
                }
                if (!((_b872) == null)) {
                    (_b872)._parent9 = (_a871)._parent9;
                }
                /* replace _c873 with _a871 in _b872 */
                (_b872)._right8 = _a871;
                if (!((_a871) == null)) {
                    (_a871)._parent9 = _b872;
                }
                /* replace _b872 with _c873 in _a871 */
                (_a871)._left7 = _c873;
                if (!((_c873) == null)) {
                    (_c873)._parent9 = _a871;
                }
                /* _min_ax12 is min of ax1 */
                var _augval874 = (_a871).ax1;
                var _child875 = (_a871)._left7;
                if (!((_child875) == null)) {
                    var _val876 = (_child875)._min_ax12;
                    _augval874 = ((_augval874) < (_val876)) ? (_augval874) : (_val876);
                }
                var _child877 = (_a871)._right8;
                if (!((_child877) == null)) {
                    var _val878 = (_child877)._min_ax12;
                    _augval874 = ((_augval874) < (_val878)) ? (_augval874) : (_val878);
                }
                (_a871)._min_ax12 = _augval874;
                /* _min_ay13 is min of ay1 */
                var _augval879 = (_a871).ay1;
                var _child880 = (_a871)._left7;
                if (!((_child880) == null)) {
                    var _val881 = (_child880)._min_ay13;
                    _augval879 = ((_augval879) < (_val881)) ? (_augval879) : (_val881);
                }
                var _child882 = (_a871)._right8;
                if (!((_child882) == null)) {
                    var _val883 = (_child882)._min_ay13;
                    _augval879 = ((_augval879) < (_val883)) ? (_augval879) : (_val883);
                }
                (_a871)._min_ay13 = _augval879;
                /* _max_ay24 is max of ay2 */
                var _augval884 = (_a871).ay2;
                var _child885 = (_a871)._left7;
                if (!((_child885) == null)) {
                    var _val886 = (_child885)._max_ay24;
                    _augval884 = ((_augval884) < (_val886)) ? (_val886) : (_augval884);
                }
                var _child887 = (_a871)._right8;
                if (!((_child887) == null)) {
                    var _val888 = (_child887)._max_ay24;
                    _augval884 = ((_augval884) < (_val888)) ? (_val888) : (_augval884);
                }
                (_a871)._max_ay24 = _augval884;
                (_a871)._height10 = 1 + ((((((_a871)._left7) == null) ? (-1) : (((_a871)._left7)._height10)) > ((((_a871)._right8) == null) ? (-1) : (((_a871)._right8)._height10))) ? ((((_a871)._left7) == null) ? (-1) : (((_a871)._left7)._height10)) : ((((_a871)._right8) == null) ? (-1) : (((_a871)._right8)._height10)));
                /* _min_ax12 is min of ax1 */
                var _augval889 = (_b872).ax1;
                var _child890 = (_b872)._left7;
                if (!((_child890) == null)) {
                    var _val891 = (_child890)._min_ax12;
                    _augval889 = ((_augval889) < (_val891)) ? (_augval889) : (_val891);
                }
                var _child892 = (_b872)._right8;
                if (!((_child892) == null)) {
                    var _val893 = (_child892)._min_ax12;
                    _augval889 = ((_augval889) < (_val893)) ? (_augval889) : (_val893);
                }
                (_b872)._min_ax12 = _augval889;
                /* _min_ay13 is min of ay1 */
                var _augval894 = (_b872).ay1;
                var _child895 = (_b872)._left7;
                if (!((_child895) == null)) {
                    var _val896 = (_child895)._min_ay13;
                    _augval894 = ((_augval894) < (_val896)) ? (_augval894) : (_val896);
                }
                var _child897 = (_b872)._right8;
                if (!((_child897) == null)) {
                    var _val898 = (_child897)._min_ay13;
                    _augval894 = ((_augval894) < (_val898)) ? (_augval894) : (_val898);
                }
                (_b872)._min_ay13 = _augval894;
                /* _max_ay24 is max of ay2 */
                var _augval899 = (_b872).ay2;
                var _child900 = (_b872)._left7;
                if (!((_child900) == null)) {
                    var _val901 = (_child900)._max_ay24;
                    _augval899 = ((_augval899) < (_val901)) ? (_val901) : (_augval899);
                }
                var _child902 = (_b872)._right8;
                if (!((_child902) == null)) {
                    var _val903 = (_child902)._max_ay24;
                    _augval899 = ((_augval899) < (_val903)) ? (_val903) : (_augval899);
                }
                (_b872)._max_ay24 = _augval899;
                (_b872)._height10 = 1 + ((((((_b872)._left7) == null) ? (-1) : (((_b872)._left7)._height10)) > ((((_b872)._right8) == null) ? (-1) : (((_b872)._right8)._height10))) ? ((((_b872)._left7) == null) ? (-1) : (((_b872)._left7)._height10)) : ((((_b872)._right8) == null) ? (-1) : (((_b872)._right8)._height10)));
                if (!(((_b872)._parent9) == null)) {
                    /* _min_ax12 is min of ax1 */
                    var _augval904 = ((_b872)._parent9).ax1;
                    var _child905 = ((_b872)._parent9)._left7;
                    if (!((_child905) == null)) {
                        var _val906 = (_child905)._min_ax12;
                        _augval904 = ((_augval904) < (_val906)) ? (_augval904) : (_val906);
                    }
                    var _child907 = ((_b872)._parent9)._right8;
                    if (!((_child907) == null)) {
                        var _val908 = (_child907)._min_ax12;
                        _augval904 = ((_augval904) < (_val908)) ? (_augval904) : (_val908);
                    }
                    ((_b872)._parent9)._min_ax12 = _augval904;
                    /* _min_ay13 is min of ay1 */
                    var _augval909 = ((_b872)._parent9).ay1;
                    var _child910 = ((_b872)._parent9)._left7;
                    if (!((_child910) == null)) {
                        var _val911 = (_child910)._min_ay13;
                        _augval909 = ((_augval909) < (_val911)) ? (_augval909) : (_val911);
                    }
                    var _child912 = ((_b872)._parent9)._right8;
                    if (!((_child912) == null)) {
                        var _val913 = (_child912)._min_ay13;
                        _augval909 = ((_augval909) < (_val913)) ? (_augval909) : (_val913);
                    }
                    ((_b872)._parent9)._min_ay13 = _augval909;
                    /* _max_ay24 is max of ay2 */
                    var _augval914 = ((_b872)._parent9).ay2;
                    var _child915 = ((_b872)._parent9)._left7;
                    if (!((_child915) == null)) {
                        var _val916 = (_child915)._max_ay24;
                        _augval914 = ((_augval914) < (_val916)) ? (_val916) : (_augval914);
                    }
                    var _child917 = ((_b872)._parent9)._right8;
                    if (!((_child917) == null)) {
                        var _val918 = (_child917)._max_ay24;
                        _augval914 = ((_augval914) < (_val918)) ? (_val918) : (_augval914);
                    }
                    ((_b872)._parent9)._max_ay24 = _augval914;
                    ((_b872)._parent9)._height10 = 1 + (((((((_b872)._parent9)._left7) == null) ? (-1) : ((((_b872)._parent9)._left7)._height10)) > (((((_b872)._parent9)._right8) == null) ? (-1) : ((((_b872)._parent9)._right8)._height10))) ? (((((_b872)._parent9)._left7) == null) ? (-1) : ((((_b872)._parent9)._left7)._height10)) : (((((_b872)._parent9)._right8) == null) ? (-1) : ((((_b872)._parent9)._right8)._height10)));
                } else {
                    (this)._root1 = _b872;
                }
            }
            /* rotate (_cursor773)._right8 */
            var _a919 = _cursor773;
            var _b920 = (_a919)._right8;
            var _c921 = (_b920)._left7;
            /* replace _a919 with _b920 in (_a919)._parent9 */
            if (!(((_a919)._parent9) == null)) {
                if ((((_a919)._parent9)._left7) == (_a919)) {
                    ((_a919)._parent9)._left7 = _b920;
                } else {
                    ((_a919)._parent9)._right8 = _b920;
                }
            }
            if (!((_b920) == null)) {
                (_b920)._parent9 = (_a919)._parent9;
            }
            /* replace _c921 with _a919 in _b920 */
            (_b920)._left7 = _a919;
            if (!((_a919) == null)) {
                (_a919)._parent9 = _b920;
            }
            /* replace _b920 with _c921 in _a919 */
            (_a919)._right8 = _c921;
            if (!((_c921) == null)) {
                (_c921)._parent9 = _a919;
            }
            /* _min_ax12 is min of ax1 */
            var _augval922 = (_a919).ax1;
            var _child923 = (_a919)._left7;
            if (!((_child923) == null)) {
                var _val924 = (_child923)._min_ax12;
                _augval922 = ((_augval922) < (_val924)) ? (_augval922) : (_val924);
            }
            var _child925 = (_a919)._right8;
            if (!((_child925) == null)) {
                var _val926 = (_child925)._min_ax12;
                _augval922 = ((_augval922) < (_val926)) ? (_augval922) : (_val926);
            }
            (_a919)._min_ax12 = _augval922;
            /* _min_ay13 is min of ay1 */
            var _augval927 = (_a919).ay1;
            var _child928 = (_a919)._left7;
            if (!((_child928) == null)) {
                var _val929 = (_child928)._min_ay13;
                _augval927 = ((_augval927) < (_val929)) ? (_augval927) : (_val929);
            }
            var _child930 = (_a919)._right8;
            if (!((_child930) == null)) {
                var _val931 = (_child930)._min_ay13;
                _augval927 = ((_augval927) < (_val931)) ? (_augval927) : (_val931);
            }
            (_a919)._min_ay13 = _augval927;
            /* _max_ay24 is max of ay2 */
            var _augval932 = (_a919).ay2;
            var _child933 = (_a919)._left7;
            if (!((_child933) == null)) {
                var _val934 = (_child933)._max_ay24;
                _augval932 = ((_augval932) < (_val934)) ? (_val934) : (_augval932);
            }
            var _child935 = (_a919)._right8;
            if (!((_child935) == null)) {
                var _val936 = (_child935)._max_ay24;
                _augval932 = ((_augval932) < (_val936)) ? (_val936) : (_augval932);
            }
            (_a919)._max_ay24 = _augval932;
            (_a919)._height10 = 1 + ((((((_a919)._left7) == null) ? (-1) : (((_a919)._left7)._height10)) > ((((_a919)._right8) == null) ? (-1) : (((_a919)._right8)._height10))) ? ((((_a919)._left7) == null) ? (-1) : (((_a919)._left7)._height10)) : ((((_a919)._right8) == null) ? (-1) : (((_a919)._right8)._height10)));
            /* _min_ax12 is min of ax1 */
            var _augval937 = (_b920).ax1;
            var _child938 = (_b920)._left7;
            if (!((_child938) == null)) {
                var _val939 = (_child938)._min_ax12;
                _augval937 = ((_augval937) < (_val939)) ? (_augval937) : (_val939);
            }
            var _child940 = (_b920)._right8;
            if (!((_child940) == null)) {
                var _val941 = (_child940)._min_ax12;
                _augval937 = ((_augval937) < (_val941)) ? (_augval937) : (_val941);
            }
            (_b920)._min_ax12 = _augval937;
            /* _min_ay13 is min of ay1 */
            var _augval942 = (_b920).ay1;
            var _child943 = (_b920)._left7;
            if (!((_child943) == null)) {
                var _val944 = (_child943)._min_ay13;
                _augval942 = ((_augval942) < (_val944)) ? (_augval942) : (_val944);
            }
            var _child945 = (_b920)._right8;
            if (!((_child945) == null)) {
                var _val946 = (_child945)._min_ay13;
                _augval942 = ((_augval942) < (_val946)) ? (_augval942) : (_val946);
            }
            (_b920)._min_ay13 = _augval942;
            /* _max_ay24 is max of ay2 */
            var _augval947 = (_b920).ay2;
            var _child948 = (_b920)._left7;
            if (!((_child948) == null)) {
                var _val949 = (_child948)._max_ay24;
                _augval947 = ((_augval947) < (_val949)) ? (_val949) : (_augval947);
            }
            var _child950 = (_b920)._right8;
            if (!((_child950) == null)) {
                var _val951 = (_child950)._max_ay24;
                _augval947 = ((_augval947) < (_val951)) ? (_val951) : (_augval947);
            }
            (_b920)._max_ay24 = _augval947;
            (_b920)._height10 = 1 + ((((((_b920)._left7) == null) ? (-1) : (((_b920)._left7)._height10)) > ((((_b920)._right8) == null) ? (-1) : (((_b920)._right8)._height10))) ? ((((_b920)._left7) == null) ? (-1) : (((_b920)._left7)._height10)) : ((((_b920)._right8) == null) ? (-1) : (((_b920)._right8)._height10)));
            if (!(((_b920)._parent9) == null)) {
                /* _min_ax12 is min of ax1 */
                var _augval952 = ((_b920)._parent9).ax1;
                var _child953 = ((_b920)._parent9)._left7;
                if (!((_child953) == null)) {
                    var _val954 = (_child953)._min_ax12;
                    _augval952 = ((_augval952) < (_val954)) ? (_augval952) : (_val954);
                }
                var _child955 = ((_b920)._parent9)._right8;
                if (!((_child955) == null)) {
                    var _val956 = (_child955)._min_ax12;
                    _augval952 = ((_augval952) < (_val956)) ? (_augval952) : (_val956);
                }
                ((_b920)._parent9)._min_ax12 = _augval952;
                /* _min_ay13 is min of ay1 */
                var _augval957 = ((_b920)._parent9).ay1;
                var _child958 = ((_b920)._parent9)._left7;
                if (!((_child958) == null)) {
                    var _val959 = (_child958)._min_ay13;
                    _augval957 = ((_augval957) < (_val959)) ? (_augval957) : (_val959);
                }
                var _child960 = ((_b920)._parent9)._right8;
                if (!((_child960) == null)) {
                    var _val961 = (_child960)._min_ay13;
                    _augval957 = ((_augval957) < (_val961)) ? (_augval957) : (_val961);
                }
                ((_b920)._parent9)._min_ay13 = _augval957;
                /* _max_ay24 is max of ay2 */
                var _augval962 = ((_b920)._parent9).ay2;
                var _child963 = ((_b920)._parent9)._left7;
                if (!((_child963) == null)) {
                    var _val964 = (_child963)._max_ay24;
                    _augval962 = ((_augval962) < (_val964)) ? (_val964) : (_augval962);
                }
                var _child965 = ((_b920)._parent9)._right8;
                if (!((_child965) == null)) {
                    var _val966 = (_child965)._max_ay24;
                    _augval962 = ((_augval962) < (_val966)) ? (_val966) : (_augval962);
                }
                ((_b920)._parent9)._max_ay24 = _augval962;
                ((_b920)._parent9)._height10 = 1 + (((((((_b920)._parent9)._left7) == null) ? (-1) : ((((_b920)._parent9)._left7)._height10)) > (((((_b920)._parent9)._right8) == null) ? (-1) : ((((_b920)._parent9)._right8)._height10))) ? (((((_b920)._parent9)._left7) == null) ? (-1) : ((((_b920)._parent9)._left7)._height10)) : (((((_b920)._parent9)._right8) == null) ? (-1) : ((((_b920)._parent9)._right8)._height10)));
            } else {
                (this)._root1 = _b920;
            }
            _cursor773 = (_cursor773)._parent9;
        }
    }
    (__x).ax1 = ax1;
    (__x).ay1 = ay1;
    (__x).ax2 = ax2;
    (__x).ay2 = ay2;
}
RectangleHolder.prototype.findMatchingRectangles = function (bx1, by1, bx2, by2, __callback) {
    var _root967 = (this)._root1;
    var _x968 = _root967;
    var _descend969 = true;
    var _from_left970 = true;
    while (true) {
        if ((_x968) == null) {
            _x968 = null;
            break;
        }
        if (_descend969) {
            /* too small? */
            if ((false) || (((_x968).ax2) <= (bx1))) {
                if ((!(((_x968)._right8) == null)) && ((((true) && ((((_x968)._right8)._min_ax12) < (bx2))) && ((((_x968)._right8)._min_ay13) < (by2))) && ((((_x968)._right8)._max_ay24) > (by1)))) {
                    if ((_x968) == (_root967)) {
                        _root967 = (_x968)._right8;
                    }
                    _x968 = (_x968)._right8;
                } else if ((_x968) == (_root967)) {
                    _x968 = null;
                    break;
                } else {
                    _descend969 = false;
                    _from_left970 = (!(((_x968)._parent9) == null)) && ((_x968) == (((_x968)._parent9)._left7));
                    _x968 = (_x968)._parent9;
                }
            } else if ((!(((_x968)._left7) == null)) && ((((true) && ((((_x968)._left7)._min_ax12) < (bx2))) && ((((_x968)._left7)._min_ay13) < (by2))) && ((((_x968)._left7)._max_ay24) > (by1)))) {
                _x968 = (_x968)._left7;
                /* too large? */
            } else if (false) {
                if ((_x968) == (_root967)) {
                    _x968 = null;
                    break;
                } else {
                    _descend969 = false;
                    _from_left970 = (!(((_x968)._parent9) == null)) && ((_x968) == (((_x968)._parent9)._left7));
                    _x968 = (_x968)._parent9;
                }
                /* node ok? */
            } else if ((((true) && (((_x968).ax1) < (bx2))) && (((_x968).ay1) < (by2))) && (((_x968).ay2) > (by1))) {
                break;
            } else if ((_x968) == (_root967)) {
                _root967 = (_x968)._right8;
                _x968 = (_x968)._right8;
            } else {
                if ((!(((_x968)._right8) == null)) && ((((true) && ((((_x968)._right8)._min_ax12) < (bx2))) && ((((_x968)._right8)._min_ay13) < (by2))) && ((((_x968)._right8)._max_ay24) > (by1)))) {
                    if ((_x968) == (_root967)) {
                        _root967 = (_x968)._right8;
                    }
                    _x968 = (_x968)._right8;
                } else {
                    _descend969 = false;
                    _from_left970 = (!(((_x968)._parent9) == null)) && ((_x968) == (((_x968)._parent9)._left7));
                    _x968 = (_x968)._parent9;
                }
            }
        } else if (_from_left970) {
            if (false) {
                _x968 = null;
                break;
            } else if ((((true) && (((_x968).ax1) < (bx2))) && (((_x968).ay1) < (by2))) && (((_x968).ay2) > (by1))) {
                break;
            } else if ((!(((_x968)._right8) == null)) && ((((true) && ((((_x968)._right8)._min_ax12) < (bx2))) && ((((_x968)._right8)._min_ay13) < (by2))) && ((((_x968)._right8)._max_ay24) > (by1)))) {
                _descend969 = true;
                if ((_x968) == (_root967)) {
                    _root967 = (_x968)._right8;
                }
                _x968 = (_x968)._right8;
            } else if ((_x968) == (_root967)) {
                _x968 = null;
                break;
            } else {
                _descend969 = false;
                _from_left970 = (!(((_x968)._parent9) == null)) && ((_x968) == (((_x968)._parent9)._left7));
                _x968 = (_x968)._parent9;
            }
        } else {
            if ((_x968) == (_root967)) {
                _x968 = null;
                break;
            } else {
                _descend969 = false;
                _from_left970 = (!(((_x968)._parent9) == null)) && ((_x968) == (((_x968)._parent9)._left7));
                _x968 = (_x968)._parent9;
            }
        }
    }
    var _prev_cursor5 = null;
    var _cursor6 = _x968;
    for (; ;) {
        if (!(!((_cursor6) == null))) break;
        var _name971 = _cursor6;
        /* ADVANCE */
        _prev_cursor5 = _cursor6;
        do {
            var _right_min972 = null;
            if ((!(((_cursor6)._right8) == null)) && ((((true) && ((((_cursor6)._right8)._min_ax12) < (bx2))) && ((((_cursor6)._right8)._min_ay13) < (by2))) && ((((_cursor6)._right8)._max_ay24) > (by1)))) {
                var _root973 = (_cursor6)._right8;
                var _x974 = _root973;
                var _descend975 = true;
                var _from_left976 = true;
                while (true) {
                    if ((_x974) == null) {
                        _x974 = null;
                        break;
                    }
                    if (_descend975) {
                        /* too small? */
                        if ((false) || (((_x974).ax2) <= (bx1))) {
                            if ((!(((_x974)._right8) == null)) && ((((true) && ((((_x974)._right8)._min_ax12) < (bx2))) && ((((_x974)._right8)._min_ay13) < (by2))) && ((((_x974)._right8)._max_ay24) > (by1)))) {
                                if ((_x974) == (_root973)) {
                                    _root973 = (_x974)._right8;
                                }
                                _x974 = (_x974)._right8;
                            } else if ((_x974) == (_root973)) {
                                _x974 = null;
                                break;
                            } else {
                                _descend975 = false;
                                _from_left976 = (!(((_x974)._parent9) == null)) && ((_x974) == (((_x974)._parent9)._left7));
                                _x974 = (_x974)._parent9;
                            }
                        } else if ((!(((_x974)._left7) == null)) && ((((true) && ((((_x974)._left7)._min_ax12) < (bx2))) && ((((_x974)._left7)._min_ay13) < (by2))) && ((((_x974)._left7)._max_ay24) > (by1)))) {
                            _x974 = (_x974)._left7;
                            /* too large? */
                        } else if (false) {
                            if ((_x974) == (_root973)) {
                                _x974 = null;
                                break;
                            } else {
                                _descend975 = false;
                                _from_left976 = (!(((_x974)._parent9) == null)) && ((_x974) == (((_x974)._parent9)._left7));
                                _x974 = (_x974)._parent9;
                            }
                            /* node ok? */
                        } else if ((((true) && (((_x974).ax1) < (bx2))) && (((_x974).ay1) < (by2))) && (((_x974).ay2) > (by1))) {
                            break;
                        } else if ((_x974) == (_root973)) {
                            _root973 = (_x974)._right8;
                            _x974 = (_x974)._right8;
                        } else {
                            if ((!(((_x974)._right8) == null)) && ((((true) && ((((_x974)._right8)._min_ax12) < (bx2))) && ((((_x974)._right8)._min_ay13) < (by2))) && ((((_x974)._right8)._max_ay24) > (by1)))) {
                                if ((_x974) == (_root973)) {
                                    _root973 = (_x974)._right8;
                                }
                                _x974 = (_x974)._right8;
                            } else {
                                _descend975 = false;
                                _from_left976 = (!(((_x974)._parent9) == null)) && ((_x974) == (((_x974)._parent9)._left7));
                                _x974 = (_x974)._parent9;
                            }
                        }
                    } else if (_from_left976) {
                        if (false) {
                            _x974 = null;
                            break;
                        } else if ((((true) && (((_x974).ax1) < (bx2))) && (((_x974).ay1) < (by2))) && (((_x974).ay2) > (by1))) {
                            break;
                        } else if ((!(((_x974)._right8) == null)) && ((((true) && ((((_x974)._right8)._min_ax12) < (bx2))) && ((((_x974)._right8)._min_ay13) < (by2))) && ((((_x974)._right8)._max_ay24) > (by1)))) {
                            _descend975 = true;
                            if ((_x974) == (_root973)) {
                                _root973 = (_x974)._right8;
                            }
                            _x974 = (_x974)._right8;
                        } else if ((_x974) == (_root973)) {
                            _x974 = null;
                            break;
                        } else {
                            _descend975 = false;
                            _from_left976 = (!(((_x974)._parent9) == null)) && ((_x974) == (((_x974)._parent9)._left7));
                            _x974 = (_x974)._parent9;
                        }
                    } else {
                        if ((_x974) == (_root973)) {
                            _x974 = null;
                            break;
                        } else {
                            _descend975 = false;
                            _from_left976 = (!(((_x974)._parent9) == null)) && ((_x974) == (((_x974)._parent9)._left7));
                            _x974 = (_x974)._parent9;
                        }
                    }
                }
                _right_min972 = _x974;
            }
            if (!((_right_min972) == null)) {
                _cursor6 = _right_min972;
                break;
            } else {
                while ((!(((_cursor6)._parent9) == null)) && ((_cursor6) == (((_cursor6)._parent9)._right8))) {
                    _cursor6 = (_cursor6)._parent9;
                }
                _cursor6 = (_cursor6)._parent9;
                if ((!((_cursor6) == null)) && (false)) {
                    _cursor6 = null;
                }
            }
        } while ((!((_cursor6) == null)) && (!((((true) && (((_cursor6).ax1) < (bx2))) && (((_cursor6).ay1) < (by2))) && (((_cursor6).ay2) > (by1)))));
        if (__callback(_name971)) {
            var _to_remove977 = _prev_cursor5;
            var _parent978 = (_to_remove977)._parent9;
            var _left979 = (_to_remove977)._left7;
            var _right980 = (_to_remove977)._right8;
            var _new_x981;
            if (((_left979) == null) && ((_right980) == null)) {
                _new_x981 = null;
                /* replace _to_remove977 with _new_x981 in _parent978 */
                if (!((_parent978) == null)) {
                    if (((_parent978)._left7) == (_to_remove977)) {
                        (_parent978)._left7 = _new_x981;
                    } else {
                        (_parent978)._right8 = _new_x981;
                    }
                }
                if (!((_new_x981) == null)) {
                    (_new_x981)._parent9 = _parent978;
                }
            } else if ((!((_left979) == null)) && ((_right980) == null)) {
                _new_x981 = _left979;
                /* replace _to_remove977 with _new_x981 in _parent978 */
                if (!((_parent978) == null)) {
                    if (((_parent978)._left7) == (_to_remove977)) {
                        (_parent978)._left7 = _new_x981;
                    } else {
                        (_parent978)._right8 = _new_x981;
                    }
                }
                if (!((_new_x981) == null)) {
                    (_new_x981)._parent9 = _parent978;
                }
            } else if (((_left979) == null) && (!((_right980) == null))) {
                _new_x981 = _right980;
                /* replace _to_remove977 with _new_x981 in _parent978 */
                if (!((_parent978) == null)) {
                    if (((_parent978)._left7) == (_to_remove977)) {
                        (_parent978)._left7 = _new_x981;
                    } else {
                        (_parent978)._right8 = _new_x981;
                    }
                }
                if (!((_new_x981) == null)) {
                    (_new_x981)._parent9 = _parent978;
                }
            } else {
                var _root982 = (_to_remove977)._right8;
                var _x983 = _root982;
                var _descend984 = true;
                var _from_left985 = true;
                while (true) {
                    if ((_x983) == null) {
                        _x983 = null;
                        break;
                    }
                    if (_descend984) {
                        /* too small? */
                        if (false) {
                            if ((!(((_x983)._right8) == null)) && (true)) {
                                if ((_x983) == (_root982)) {
                                    _root982 = (_x983)._right8;
                                }
                                _x983 = (_x983)._right8;
                            } else if ((_x983) == (_root982)) {
                                _x983 = null;
                                break;
                            } else {
                                _descend984 = false;
                                _from_left985 = (!(((_x983)._parent9) == null)) && ((_x983) == (((_x983)._parent9)._left7));
                                _x983 = (_x983)._parent9;
                            }
                        } else if ((!(((_x983)._left7) == null)) && (true)) {
                            _x983 = (_x983)._left7;
                            /* too large? */
                        } else if (false) {
                            if ((_x983) == (_root982)) {
                                _x983 = null;
                                break;
                            } else {
                                _descend984 = false;
                                _from_left985 = (!(((_x983)._parent9) == null)) && ((_x983) == (((_x983)._parent9)._left7));
                                _x983 = (_x983)._parent9;
                            }
                            /* node ok? */
                        } else if (true) {
                            break;
                        } else if ((_x983) == (_root982)) {
                            _root982 = (_x983)._right8;
                            _x983 = (_x983)._right8;
                        } else {
                            if ((!(((_x983)._right8) == null)) && (true)) {
                                if ((_x983) == (_root982)) {
                                    _root982 = (_x983)._right8;
                                }
                                _x983 = (_x983)._right8;
                            } else {
                                _descend984 = false;
                                _from_left985 = (!(((_x983)._parent9) == null)) && ((_x983) == (((_x983)._parent9)._left7));
                                _x983 = (_x983)._parent9;
                            }
                        }
                    } else if (_from_left985) {
                        if (false) {
                            _x983 = null;
                            break;
                        } else if (true) {
                            break;
                        } else if ((!(((_x983)._right8) == null)) && (true)) {
                            _descend984 = true;
                            if ((_x983) == (_root982)) {
                                _root982 = (_x983)._right8;
                            }
                            _x983 = (_x983)._right8;
                        } else if ((_x983) == (_root982)) {
                            _x983 = null;
                            break;
                        } else {
                            _descend984 = false;
                            _from_left985 = (!(((_x983)._parent9) == null)) && ((_x983) == (((_x983)._parent9)._left7));
                            _x983 = (_x983)._parent9;
                        }
                    } else {
                        if ((_x983) == (_root982)) {
                            _x983 = null;
                            break;
                        } else {
                            _descend984 = false;
                            _from_left985 = (!(((_x983)._parent9) == null)) && ((_x983) == (((_x983)._parent9)._left7));
                            _x983 = (_x983)._parent9;
                        }
                    }
                }
                _new_x981 = _x983;
                var _mp986 = (_x983)._parent9;
                var _mr987 = (_x983)._right8;
                /* replace _x983 with _mr987 in _mp986 */
                if (!((_mp986) == null)) {
                    if (((_mp986)._left7) == (_x983)) {
                        (_mp986)._left7 = _mr987;
                    } else {
                        (_mp986)._right8 = _mr987;
                    }
                }
                if (!((_mr987) == null)) {
                    (_mr987)._parent9 = _mp986;
                }
                /* replace _to_remove977 with _x983 in _parent978 */
                if (!((_parent978) == null)) {
                    if (((_parent978)._left7) == (_to_remove977)) {
                        (_parent978)._left7 = _x983;
                    } else {
                        (_parent978)._right8 = _x983;
                    }
                }
                if (!((_x983) == null)) {
                    (_x983)._parent9 = _parent978;
                }
                /* replace null with _left979 in _x983 */
                (_x983)._left7 = _left979;
                if (!((_left979) == null)) {
                    (_left979)._parent9 = _x983;
                }
                /* replace _mr987 with (_to_remove977)._right8 in _x983 */
                (_x983)._right8 = (_to_remove977)._right8;
                if (!(((_to_remove977)._right8) == null)) {
                    ((_to_remove977)._right8)._parent9 = _x983;
                }
                /* _min_ax12 is min of ax1 */
                var _augval988 = (_x983).ax1;
                var _child989 = (_x983)._left7;
                if (!((_child989) == null)) {
                    var _val990 = (_child989)._min_ax12;
                    _augval988 = ((_augval988) < (_val990)) ? (_augval988) : (_val990);
                }
                var _child991 = (_x983)._right8;
                if (!((_child991) == null)) {
                    var _val992 = (_child991)._min_ax12;
                    _augval988 = ((_augval988) < (_val992)) ? (_augval988) : (_val992);
                }
                (_x983)._min_ax12 = _augval988;
                /* _min_ay13 is min of ay1 */
                var _augval993 = (_x983).ay1;
                var _child994 = (_x983)._left7;
                if (!((_child994) == null)) {
                    var _val995 = (_child994)._min_ay13;
                    _augval993 = ((_augval993) < (_val995)) ? (_augval993) : (_val995);
                }
                var _child996 = (_x983)._right8;
                if (!((_child996) == null)) {
                    var _val997 = (_child996)._min_ay13;
                    _augval993 = ((_augval993) < (_val997)) ? (_augval993) : (_val997);
                }
                (_x983)._min_ay13 = _augval993;
                /* _max_ay24 is max of ay2 */
                var _augval998 = (_x983).ay2;
                var _child999 = (_x983)._left7;
                if (!((_child999) == null)) {
                    var _val1000 = (_child999)._max_ay24;
                    _augval998 = ((_augval998) < (_val1000)) ? (_val1000) : (_augval998);
                }
                var _child1001 = (_x983)._right8;
                if (!((_child1001) == null)) {
                    var _val1002 = (_child1001)._max_ay24;
                    _augval998 = ((_augval998) < (_val1002)) ? (_val1002) : (_augval998);
                }
                (_x983)._max_ay24 = _augval998;
                (_x983)._height10 = 1 + ((((((_x983)._left7) == null) ? (-1) : (((_x983)._left7)._height10)) > ((((_x983)._right8) == null) ? (-1) : (((_x983)._right8)._height10))) ? ((((_x983)._left7) == null) ? (-1) : (((_x983)._left7)._height10)) : ((((_x983)._right8) == null) ? (-1) : (((_x983)._right8)._height10)));
                var _cursor1003 = _mp986;
                var _changed1004 = true;
                while ((_changed1004) && (!((_cursor1003) == (_parent978)))) {
                    var _old__min_ax121005 = (_cursor1003)._min_ax12;
                    var _old__min_ay131006 = (_cursor1003)._min_ay13;
                    var _old__max_ay241007 = (_cursor1003)._max_ay24;
                    var _old_height1008 = (_cursor1003)._height10;
                    /* _min_ax12 is min of ax1 */
                    var _augval1009 = (_cursor1003).ax1;
                    var _child1010 = (_cursor1003)._left7;
                    if (!((_child1010) == null)) {
                        var _val1011 = (_child1010)._min_ax12;
                        _augval1009 = ((_augval1009) < (_val1011)) ? (_augval1009) : (_val1011);
                    }
                    var _child1012 = (_cursor1003)._right8;
                    if (!((_child1012) == null)) {
                        var _val1013 = (_child1012)._min_ax12;
                        _augval1009 = ((_augval1009) < (_val1013)) ? (_augval1009) : (_val1013);
                    }
                    (_cursor1003)._min_ax12 = _augval1009;
                    /* _min_ay13 is min of ay1 */
                    var _augval1014 = (_cursor1003).ay1;
                    var _child1015 = (_cursor1003)._left7;
                    if (!((_child1015) == null)) {
                        var _val1016 = (_child1015)._min_ay13;
                        _augval1014 = ((_augval1014) < (_val1016)) ? (_augval1014) : (_val1016);
                    }
                    var _child1017 = (_cursor1003)._right8;
                    if (!((_child1017) == null)) {
                        var _val1018 = (_child1017)._min_ay13;
                        _augval1014 = ((_augval1014) < (_val1018)) ? (_augval1014) : (_val1018);
                    }
                    (_cursor1003)._min_ay13 = _augval1014;
                    /* _max_ay24 is max of ay2 */
                    var _augval1019 = (_cursor1003).ay2;
                    var _child1020 = (_cursor1003)._left7;
                    if (!((_child1020) == null)) {
                        var _val1021 = (_child1020)._max_ay24;
                        _augval1019 = ((_augval1019) < (_val1021)) ? (_val1021) : (_augval1019);
                    }
                    var _child1022 = (_cursor1003)._right8;
                    if (!((_child1022) == null)) {
                        var _val1023 = (_child1022)._max_ay24;
                        _augval1019 = ((_augval1019) < (_val1023)) ? (_val1023) : (_augval1019);
                    }
                    (_cursor1003)._max_ay24 = _augval1019;
                    (_cursor1003)._height10 = 1 + ((((((_cursor1003)._left7) == null) ? (-1) : (((_cursor1003)._left7)._height10)) > ((((_cursor1003)._right8) == null) ? (-1) : (((_cursor1003)._right8)._height10))) ? ((((_cursor1003)._left7) == null) ? (-1) : (((_cursor1003)._left7)._height10)) : ((((_cursor1003)._right8) == null) ? (-1) : (((_cursor1003)._right8)._height10)));
                    _changed1004 = false;
                    _changed1004 = (_changed1004) || (!((_old__min_ax121005) == ((_cursor1003)._min_ax12)));
                    _changed1004 = (_changed1004) || (!((_old__min_ay131006) == ((_cursor1003)._min_ay13)));
                    _changed1004 = (_changed1004) || (!((_old__max_ay241007) == ((_cursor1003)._max_ay24)));
                    _changed1004 = (_changed1004) || (!((_old_height1008) == ((_cursor1003)._height10)));
                    _cursor1003 = (_cursor1003)._parent9;
                }
            }
            var _cursor1024 = _parent978;
            var _changed1025 = true;
            while ((_changed1025) && (!((_cursor1024) == (null)))) {
                var _old__min_ax121026 = (_cursor1024)._min_ax12;
                var _old__min_ay131027 = (_cursor1024)._min_ay13;
                var _old__max_ay241028 = (_cursor1024)._max_ay24;
                var _old_height1029 = (_cursor1024)._height10;
                /* _min_ax12 is min of ax1 */
                var _augval1030 = (_cursor1024).ax1;
                var _child1031 = (_cursor1024)._left7;
                if (!((_child1031) == null)) {
                    var _val1032 = (_child1031)._min_ax12;
                    _augval1030 = ((_augval1030) < (_val1032)) ? (_augval1030) : (_val1032);
                }
                var _child1033 = (_cursor1024)._right8;
                if (!((_child1033) == null)) {
                    var _val1034 = (_child1033)._min_ax12;
                    _augval1030 = ((_augval1030) < (_val1034)) ? (_augval1030) : (_val1034);
                }
                (_cursor1024)._min_ax12 = _augval1030;
                /* _min_ay13 is min of ay1 */
                var _augval1035 = (_cursor1024).ay1;
                var _child1036 = (_cursor1024)._left7;
                if (!((_child1036) == null)) {
                    var _val1037 = (_child1036)._min_ay13;
                    _augval1035 = ((_augval1035) < (_val1037)) ? (_augval1035) : (_val1037);
                }
                var _child1038 = (_cursor1024)._right8;
                if (!((_child1038) == null)) {
                    var _val1039 = (_child1038)._min_ay13;
                    _augval1035 = ((_augval1035) < (_val1039)) ? (_augval1035) : (_val1039);
                }
                (_cursor1024)._min_ay13 = _augval1035;
                /* _max_ay24 is max of ay2 */
                var _augval1040 = (_cursor1024).ay2;
                var _child1041 = (_cursor1024)._left7;
                if (!((_child1041) == null)) {
                    var _val1042 = (_child1041)._max_ay24;
                    _augval1040 = ((_augval1040) < (_val1042)) ? (_val1042) : (_augval1040);
                }
                var _child1043 = (_cursor1024)._right8;
                if (!((_child1043) == null)) {
                    var _val1044 = (_child1043)._max_ay24;
                    _augval1040 = ((_augval1040) < (_val1044)) ? (_val1044) : (_augval1040);
                }
                (_cursor1024)._max_ay24 = _augval1040;
                (_cursor1024)._height10 = 1 + ((((((_cursor1024)._left7) == null) ? (-1) : (((_cursor1024)._left7)._height10)) > ((((_cursor1024)._right8) == null) ? (-1) : (((_cursor1024)._right8)._height10))) ? ((((_cursor1024)._left7) == null) ? (-1) : (((_cursor1024)._left7)._height10)) : ((((_cursor1024)._right8) == null) ? (-1) : (((_cursor1024)._right8)._height10)));
                _changed1025 = false;
                _changed1025 = (_changed1025) || (!((_old__min_ax121026) == ((_cursor1024)._min_ax12)));
                _changed1025 = (_changed1025) || (!((_old__min_ay131027) == ((_cursor1024)._min_ay13)));
                _changed1025 = (_changed1025) || (!((_old__max_ay241028) == ((_cursor1024)._max_ay24)));
                _changed1025 = (_changed1025) || (!((_old_height1029) == ((_cursor1024)._height10)));
                _cursor1024 = (_cursor1024)._parent9;
            }
            if (((this)._root1) == (_to_remove977)) {
                (this)._root1 = _new_x981;
            }
            _prev_cursor5 = null;
        }
    };
}
; 
 
 buildViz = function (d3) {
    return function (widthInPixels = 800,
                     heightInPixels = 600,
                     max_snippets = null,
                     color = null,
                     sortByDist = true,
                     useFullDoc = false,
                     greyZeroScores = false,
                     asianMode = false,
                     nonTextFeaturesMode = false,
                     showCharacteristic = true,
                     wordVecMaxPValue = false,
                     saveSvgButton = false,
                     reverseSortScoresForNotCategory = false,
                     minPVal = 0.1,
                     pValueColors = false,
                     xLabelText = null,
                     yLabelText = null) {
        var divName = 'd3-div-1';

        // Account for both categories
        minPVal /= 2.;

        // Set the dimensions of the canvas / graph
        var margin = {top: 30, right: 20, bottom: 30, left: 50},
            width = widthInPixels - margin.left - margin.right,
            height = heightInPixels - margin.top - margin.bottom;

        // Set the ranges
        var x = d3.scaleLinear().range([0, width]);
        var y = d3.scaleLinear().range([height, 0]);

        console.log('X Label');
        console.log(xLabelText);
        console.log('Y Label');
        console.log(yLabelText);
        console.log(yLabelText == null);
        console.log(yLabelText != null);
        console.log(yLabelText === undefined);
        console.log(yLabelText !== undefined);

        function axisLabelerFactory(axis) {
            if ((axis == "x" && xLabelText == null)
                || (axis == "y" && yLabelText == null))
                return function (d, i) {
                    return ["Infrequent", "Average", "Frequent"][i];
                };

            return function (d, i) {
                return ["Low", "Medium", "High"][i];
            }
        }

        var xAxis = d3.axisBottom(x).ticks(3).tickFormat(axisLabelerFactory('x'));
        var yAxis = d3.axisLeft(y).ticks(3).tickFormat(axisLabelerFactory('y'));

        // var label = d3.select("body").append("div")
        var label = d3.select('#' + divName).append("div")
            .attr("class", "label");

        var interpolateLightGreys = d3.interpolate(d3.rgb(230, 230, 230), d3.rgb(130, 130, 130));
        // setup fill color
        //var color = d3.interpolateRdYlBu;
        if (color == null) {
            color = d3.interpolateRdYlBu;
        }
        ;

        // Adds the svg canvas
        // var svg = d3.select("body")
        svg = d3.select('#' + divName)
            .append("svg")
            .attr("width", width + margin.left + margin.right + 200)
            .attr("height", height + margin.top + margin.bottom)
            .append("g")
            .attr("transform",
                "translate(" + margin.left + "," + margin.top + ")");

        var lastCircleSelected = null;

        function deselectLastCircle() {
            if (lastCircleSelected) {
                lastCircleSelected.style["stroke"] = null;
                lastCircleSelected = null;
            }
        }

        function getSentenceBoundaries(text) {
            // !!! need to use spacy's sentence splitter
            if (asianMode) {
                var sentenceRe = /\n/gmi;
            } else {
                var sentenceRe = /\(?[^\.\?\!\n\b]+[\n\.!\?]\)?/g;
            }
            var offsets = [];
            var match;
            while ((match = sentenceRe.exec(text)) != null) {
                offsets.push(match.index);
            }
            offsets.push(text.length);
            return offsets;
        }

        function getMatchingSnippet(text, boundaries, start, end) {
            var sentenceStart = null;
            var sentenceEnd = null;
            for (var i in boundaries) {
                var position = boundaries[i];
                if (position <= start && (sentenceStart == null || position > sentenceStart)) {
                    sentenceStart = position;
                }
                if (position >= end) {
                    sentenceEnd = position;
                    break;
                }
            }
            var snippet = (text.slice(sentenceStart, start) + "<b>" + text.slice(start, end)
            + "</b>" + text.slice(end, sentenceEnd)).trim();
            if (sentenceStart == null) {
                sentenceStart = 0;
            }
            return {'snippet': snippet, 'sentenceStart': sentenceStart};
        }

        function gatherTermContexts(d) {
            var category_name = fullData['info']['category_name'];
            var not_category_name = fullData['info']['not_category_name'];
            var matches = [[], []];
            if (fullData.docs === undefined) return matches;
            if (!nonTextFeaturesMode) {
                return searchInText(d);
            } else {
                return searchInExtraFeatures(d);
            }
        }

        function searchInExtraFeatures(d) {
            var matches = [[], []];
            var term = d.term;
            for (var i in fullData.docs.extra) {

                if (term in fullData.docs.extra[i]) {
                    var strength = fullData.docs.extra[i][term] /
                        Object.values(fullData.docs.extra[i]).reduce(
                            function (a, b) {
                                return a + b
                            });
                    var text = fullData.docs.texts[i];
                    if (!useFullDoc)
                        text = text.slice(0, 300);
                    var curMatch = {'id': i, 'snippets': [text], 'strength': strength};

                    curMatch['meta'] = fullData.docs.meta[i];
                    matches[fullData.docs.labels[i]].push(curMatch);
                }
            }
            for (var i in [0, 1]) {
                matches[i] = matches[i].sort(function (a, b) {
                    return a.strength < b.strength ? 1 : -1
                })
            }
            return {'contexts': matches, 'info': d};
        }

        // from https://mathiasbynens.be/notes/es-unicode-property-escapes#emoji
        var emojiRE = (/(?:[\u261D\u26F9\u270A-\u270D]|\uD83C[\uDF85\uDFC2-\uDFC4\uDFC7\uDFCA-\uDFCC]|\uD83D[\uDC42\uDC43\uDC46-\uDC50\uDC66-\uDC69\uDC6E\uDC70-\uDC78\uDC7C\uDC81-\uDC83\uDC85-\uDC87\uDCAA\uDD74\uDD75\uDD7A\uDD90\uDD95\uDD96\uDE45-\uDE47\uDE4B-\uDE4F\uDEA3\uDEB4-\uDEB6\uDEC0\uDECC]|\uD83E[\uDD18-\uDD1C\uDD1E\uDD1F\uDD26\uDD30-\uDD39\uDD3D\uDD3E\uDDD1-\uDDDD])(?:\uD83C[\uDFFB-\uDFFF])?|(?:[\u231A\u231B\u23E9-\u23EC\u23F0\u23F3\u25FD\u25FE\u2614\u2615\u2648-\u2653\u267F\u2693\u26A1\u26AA\u26AB\u26BD\u26BE\u26C4\u26C5\u26CE\u26D4\u26EA\u26F2\u26F3\u26F5\u26FA\u26FD\u2705\u270A\u270B\u2728\u274C\u274E\u2753-\u2755\u2757\u2795-\u2797\u27B0\u27BF\u2B1B\u2B1C\u2B50\u2B55]|\uD83C[\uDC04\uDCCF\uDD8E\uDD91-\uDD9A\uDDE6-\uDDFF\uDE01\uDE1A\uDE2F\uDE32-\uDE36\uDE38-\uDE3A\uDE50\uDE51\uDF00-\uDF20\uDF2D-\uDF35\uDF37-\uDF7C\uDF7E-\uDF93\uDFA0-\uDFCA\uDFCF-\uDFD3\uDFE0-\uDFF0\uDFF4\uDFF8-\uDFFF]|\uD83D[\uDC00-\uDC3E\uDC40\uDC42-\uDCFC\uDCFF-\uDD3D\uDD4B-\uDD4E\uDD50-\uDD67\uDD7A\uDD95\uDD96\uDDA4\uDDFB-\uDE4F\uDE80-\uDEC5\uDECC\uDED0-\uDED2\uDEEB\uDEEC\uDEF4-\uDEF8]|\uD83E[\uDD10-\uDD3A\uDD3C-\uDD3E\uDD40-\uDD45\uDD47-\uDD4C\uDD50-\uDD6B\uDD80-\uDD97\uDDC0\uDDD0-\uDDE6])|(?:[#\*0-9\xA9\xAE\u203C\u2049\u2122\u2139\u2194-\u2199\u21A9\u21AA\u231A\u231B\u2328\u23CF\u23E9-\u23F3\u23F8-\u23FA\u24C2\u25AA\u25AB\u25B6\u25C0\u25FB-\u25FE\u2600-\u2604\u260E\u2611\u2614\u2615\u2618\u261D\u2620\u2622\u2623\u2626\u262A\u262E\u262F\u2638-\u263A\u2640\u2642\u2648-\u2653\u2660\u2663\u2665\u2666\u2668\u267B\u267F\u2692-\u2697\u2699\u269B\u269C\u26A0\u26A1\u26AA\u26AB\u26B0\u26B1\u26BD\u26BE\u26C4\u26C5\u26C8\u26CE\u26CF\u26D1\u26D3\u26D4\u26E9\u26EA\u26F0-\u26F5\u26F7-\u26FA\u26FD\u2702\u2705\u2708-\u270D\u270F\u2712\u2714\u2716\u271D\u2721\u2728\u2733\u2734\u2744\u2747\u274C\u274E\u2753-\u2755\u2757\u2763\u2764\u2795-\u2797\u27A1\u27B0\u27BF\u2934\u2935\u2B05-\u2B07\u2B1B\u2B1C\u2B50\u2B55\u3030\u303D\u3297\u3299]|\uD83C[\uDC04\uDCCF\uDD70\uDD71\uDD7E\uDD7F\uDD8E\uDD91-\uDD9A\uDDE6-\uDDFF\uDE01\uDE02\uDE1A\uDE2F\uDE32-\uDE3A\uDE50\uDE51\uDF00-\uDF21\uDF24-\uDF93\uDF96\uDF97\uDF99-\uDF9B\uDF9E-\uDFF0\uDFF3-\uDFF5\uDFF7-\uDFFF]|\uD83D[\uDC00-\uDCFD\uDCFF-\uDD3D\uDD49-\uDD4E\uDD50-\uDD67\uDD6F\uDD70\uDD73-\uDD7A\uDD87\uDD8A-\uDD8D\uDD90\uDD95\uDD96\uDDA4\uDDA5\uDDA8\uDDB1\uDDB2\uDDBC\uDDC2-\uDDC4\uDDD1-\uDDD3\uDDDC-\uDDDE\uDDE1\uDDE3\uDDE8\uDDEF\uDDF3\uDDFA-\uDE4F\uDE80-\uDEC5\uDECB-\uDED2\uDEE0-\uDEE5\uDEE9\uDEEB\uDEEC\uDEF0\uDEF3-\uDEF8]|\uD83E[\uDD10-\uDD3A\uDD3C-\uDD3E\uDD40-\uDD45\uDD47-\uDD4C\uDD50-\uDD6B\uDD80-\uDD97\uDDC0\uDDD0-\uDDE6])\uFE0F/g);

        function isEmoji(str) {
            console.log(str);
            if (str.match(emojiRE)) return true;
            return false;
        }

        function searchInText(d) {
            function stripNonWordChars(term) {
                //d.term.replace(" ", "[^\\w]+")
            }

            function removeUnderScoreJoin(term) {
                /*
                '_ _asjdklf_jaksdlf_jaksdfl skld_Jjskld asdfjkl_sjkdlf'
                  ->
                "_ _asjdklf jaksdlf jaksdfl skld Jjskld asdfjkl_sjkdlf"
                 */
                return term.replace(/(\w+)(_)(\w+)/, "$1 $3")
                    .replace(/(\w+)(_)(\w+)/, "$1 $3")
                    .replace(/(\w+)(_)(\w+)/, "$1 $3");
            }

            function buildMatcher(term) {

                var boundary = '\\b';
                var wordSep = "[^\\w]+";
                if (asianMode) {
                    boundary = '( |$|^)';
                    wordSep = ' ';
                }
                if (isEmoji(term)) {
                    boundary = '';
                    wordSep = '';
                }
                var regexp = new RegExp(boundary + '('
                    + removeUnderScoreJoin(
                        term.replace('$', '\\$')
                        .replace(' ', wordSep, 'gim')
                    )
                    + ')' + boundary, 'gim');
                try {
                    regexp.exec('X');
                } catch (err) {
                    console.log("Can't search " + term);
                    console.log(err);
                    return null;
                }
                return regexp;
            }

            var matches = [[], []];
            var pattern = buildMatcher(d.term);
            if (pattern !== null) {
                for (var i in fullData.docs.texts) {
                    if (fullData.docs.labels[i] > 1) continue;
                    var text = removeUnderScoreJoin(fullData.docs.texts[i]);
                    //var pattern = new RegExp("\\b(" + stripNonWordChars(d.term) + ")\\b", "gim");
                    var match;
                    var sentenceOffsets = null;
                    var lastSentenceStart = null;
                    var matchFound = false;
                    var curMatch = {'id': i, 'snippets': []};
                    if (fullData.docs.meta) {
                        curMatch['meta'] = fullData.docs.meta[i];
                    }
                    while ((match = pattern.exec(text)) != null) {
                        if (sentenceOffsets == null) {
                            sentenceOffsets = getSentenceBoundaries(text);
                        }
                        var foundSnippet = getMatchingSnippet(text, sentenceOffsets,
                            match.index, pattern.lastIndex);
                        if (foundSnippet.sentenceStart == lastSentenceStart) continue; // ensure we don't duplicate sentences
                        lastSentenceStart = foundSnippet.sentenceStart;
                        curMatch.snippets.push(foundSnippet.snippet);
                        matchFound = true;
                    }
                    if (matchFound) {
                        if (useFullDoc) {
                            curMatch.snippets = [
                                text
                                    .replace(/\n$/g, '\n\n')
                                    .replace(
                                        //new RegExp("\\b(" + d.term.replace(" ", "[^\\w]+") + ")\\b",
                                        //    'gim'),
                                        pattern,
                                        '<b>$&</b>')
                            ];
                        }
                        matches[fullData.docs.labels[i]].push(curMatch);

                    }
                }
            }
            return {'contexts': matches, 'info': d};
        }

        function displayTermContexts(termInfo, jump=true) {
            var contexts = termInfo.contexts;
            var info = termInfo.info;
            if (contexts[0].length == 0 && contexts[1].length == 0) {
                return null;
            }
            //var categoryNames = [fullData.info.category_name,
            //    fullData.info.not_category_name];
            var catInternalName = fullData.info.category_internal_name;
            fullData.docs.categories
                .map(
                    function (catName, catIndex) {
                        if (max_snippets != null) {
                            var contextsToDisplay = contexts[catIndex].slice(0, max_snippets);
                        }
                        var divId = catName == catInternalName ? '#cat' : '#notcat';
                        var temp = d3.select(divId)
                            .selectAll("div").remove();
                        contexts[catIndex].forEach(function (context) {
                            var meta = context.meta ? context.meta : '&nbsp;';
                            d3.select(divId)
                                .append("div")
                                .attr('class', 'snippet_meta')
                                .html(meta);
                            context.snippets.forEach(function (snippet) {
                                d3.select(divId)
                                    .append("div")
                                    .attr('class', 'snippet')
                                    .html(snippet);
                            })

                        });
                    });
            d3.select('#termstats')
                .selectAll("div")
                .remove();
            d3.select('#termstats')
                .append('div')
                .attr("class", "snippet_header")
                .html('Term: <b>' + info.term + '</b>');
            var message = '';
            var cat_name = fullData.info.category_name;
            var ncat_name = fullData.info.not_category_name;

            function getFrequencyDescription(name, count25k, count) {
                var desc = name + ' frequency: <div class=text_subhead>' + count25k
                    + ' per 25,000 terms</div>';
                if (count == 0) {
                    desc += '<u>Not found in any ' + name + ' documents.</u>';
                } else {
                    desc += '<u>Some of the ' + count + ' mentions:</u>';
                }
                return desc;
            }

            d3.select('#cathead')
                .style('fill', color(1))
                .html(getFrequencyDescription(cat_name, info.cat25k, info.cat));
            d3.select('#notcathead')
                .style('fill', color(0))
                .html(getFrequencyDescription(ncat_name, info.ncat25k, info.ncat));
            console.log(info);
            if (jump) {
                if (window.location.hash == '#snippets') {
                    window.location.hash = '#snippetsalt';
                } else {
                    window.location.hash = '#snippets';
                }
            }
        }

        function showTooltip(d, pageX, pageY) {
            deselectLastCircle();
            var message = d.term + "<br/>" + d.cat25k + ":" + d.ncat25k + " per 25k words";
            if (!sortByDist) {
                message += '<br/>score: ' + d.os.toFixed(5);
            }
            /*
             if (d.p) {
             message += ';  (p:' + d.p.toFixed(5) +')';
             }*/

            tooltip.transition()
                .duration(0)
                .style("opacity", 1)
                .style("z-index", 10000000);
            tooltip.html(message)
                .style("left", (pageX) + "px")
                .style("top", (pageY - 28) + "px");

            tooltip.on('click', function () {
                tooltip.transition()
                    .style('opacity', 0)
            });
        }

        handleSearch = function (event) {
            deselectLastCircle();
            var searchTerm = document
                .getElementById("searchTerm")
                .value
                .toLowerCase()
                .replace("'", " '")
                .trim();
            showToolTipForTerm(searchTerm);
            var termInfo = termDict[searchTerm];
            if (termInfo != null) {
                displayTermContexts(gatherTermContexts(termInfo), false);
            }
            return false;
        };

        function showToolTipForTerm(searchTerm) {
            var searchTermInfo = termDict[searchTerm];
            if (searchTermInfo === undefined) {
                d3.select("#alertMessage")
                    .text(searchTerm + " didn't make it into the visualization.");
            } else {
                d3.select("#alertMessage").text("");
                var circle = mysvg._groups[0][searchTermInfo.i];
                var mySVGMatrix = circle.getScreenCTM()
                    .translate(circle.cx.baseVal.value, circle.cy.baseVal.value);
                var pageX = mySVGMatrix.e;
                var pageY = mySVGMatrix.f;
                circle.style["stroke"] = "black";
                showTooltip(searchTermInfo, pageX, pageY);
                lastCircleSelected = circle;

            }
        };

        function makeWordInteractive(domObj, term) {
            return domObj
                .on("mouseover", function (d) {
                    showToolTipForTerm(term);
                    d3.select(this).style("stroke", "black");
                })
                .on("mouseout", function (d) {
                    tooltip.transition()
                        .duration(0)
                        .style("opacity", 0);
                    d3.select(this).style("stroke", null);
                })
                .on("click", function (d) {
                    displayTermContexts(gatherTermContexts(termDict[term]));
                });
        }

        function processData(fullData) {
            var modelInfo = fullData['info'];
            /*
             categoryTermList.data(modelInfo['category_terms'])
             .enter()
             .append("li")
             .text(function(d) {return d;});
             */
            data = fullData['data'];
            termDict = Object();
            data.forEach(function (x, i) {
                termDict[x.term] = x;
                termDict[x.term].i = i;
            });

            console.log(data);
            // Scale the range of the data.  Add some space on either end.
            x.domain([-0.1, d3.max(data, function (d) {
                return d.x;
            }) + 0.1]);
            y.domain([-0.1, d3.max(data, function (d) {
                return d.y;
            }) + 0.1]);

            /*
             data.sort(function (a, b) {
             return Math.abs(b.os) - Math.abs(a.os)
             });
             */


            //var rangeTree = null; // keep boxes of all points and labels here
            var rectHolder = new RectangleHolder();
            // Add the scatterplot
            mysvg = svg
                .selectAll("dot")
                .data(data)
                .enter()
                .append("circle")
                .attr("r", function (d) {
                    if (pValueColors && d.p) {
                        return (d.p >= 1 - minPVal || d.p <= minPVal) ? 2 : 1.75;
                    }
                    return 2;
                })
                .attr("cx", function (d) {
                    return x(d.x);
                })
                .attr("cy", function (d) {
                    return y(d.y);
                })
                .style("fill", function (d) {
                    //.attr("fill", function (d) {
                    if (greyZeroScores && d.os == 0) {
                        return d3.rgb(230, 230, 230);
                    } else if (pValueColors && d.p) {
                        if (d.p >= 1 - minPVal) {
                            return d3.interpolateYlGnBu(d.s);
                        } else if (d.p <= minPVal) {
                            return d3.interpolateYlOrBr(d.s);
                        } else {
                            return interpolateLightGreys(d.s);
                        }
                    } else {
                        return color(d.s);
                    }
                })
                .on("mouseover", function (d) {
                    showTooltip(d, d3.event.pageX, d3.event.pageY);
                    d3.select(this).style("stroke", "black");
                })
                .on("click", function (d) {
                    displayTermContexts(gatherTermContexts(d));
                })
                .on("mouseout", function (d) {
                    tooltip.transition()
                        .duration(0)
                        .style("opacity", 0);
                    d3.select(this).style("stroke", null);
                });

            coords = Object();

            function censorPoints(datum) {
                var term = datum.term;
                var curLabel = svg.append("text")
                    .attr("x", x(datum.x))
                    .attr("y", y(datum.y) + 3)
                    .attr("text-anchor", "middle")
                    .text("x");
                var bbox = curLabel.node().getBBox();
                var borderToRemove = .5;
                var x1 = bbox.x + borderToRemove,
                    y1 = bbox.y + borderToRemove,
                    x2 = bbox.x + bbox.width - borderToRemove,
                    y2 = bbox.y + bbox.height - borderToRemove;
                //rangeTree = insertRangeTree(rangeTree, x1, y1, x2, y2, '~~' + term);
                rectHolder.add(new Rectangle(x1, y1, x2, y2));

                curLabel.remove();
            }

            function labelPointsIfPossible(i, useOffset) {
                var term = data[i].term;

                var configs = [
                    {'anchor': 'end', 'xoff': -5, 'yoff': -3, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'end', 'xoff': -5, 'yoff': 10, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 3, 'yoff': 10, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 3, 'yoff': -3, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 5, 'yoff': 10, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 5, 'yoff': -3, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 10, 'yoff': 15, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': -10, 'yoff': -15, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': 10, 'yoff': -15, 'alignment-baseline': 'ideographic'},
                    {'anchor': 'start', 'xoff': -10, 'yoff': 15, 'alignment-baseline': 'ideographic'},
                ];
                /*if(!useOffset) {
                 configs = [{'anchor': 'middle', 'xoff': 0, 'yoff': 0,
                 'alignment-baseline': 'middle'}];
                 }*/
                var matchedElement = null;
                for (var configI in configs) {
                    var config = configs[configI];
                    var curLabel = makeWordInteractive(
                        svg.append("text")
                            .attr("x", x(data[i].x) + config['xoff'])
                            .attr("y", y(data[i].y) + config['yoff'])
                            .attr('class', 'label')
                            .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                            .attr('font-size', '10px')
                            .attr("text-anchor", config['anchor'])
                            .attr("alignment-baseline", config['alignment'])
                            .text(term),
                        term
                    );
                    var bbox = curLabel.node().getBBox();
                    var borderToRemove = .5;
                    var x1 = bbox.x + borderToRemove,
                        y1 = bbox.y + borderToRemove,
                        x2 = bbox.x + bbox.width - borderToRemove,
                        y2 = bbox.y + bbox.height - borderToRemove;
                    //matchedElement = searchRangeTree(rangeTree, x1, y1, x2, y2);
                    var matchedElement = false;
                    rectHolder.findMatchingRectangles(x1, y1, x2, y2, function (elem) {
                        matchedElement = true;
                        return false;
                    });
                    if (matchedElement) {
                        curLabel.remove();
                    } else {
                        break;
                    }
                }

                if (!matchedElement) {
                    coords[term] = [x1, y1, x2, y2];
                    //rangeTree = insertRangeTree(rangeTree, x1, y1, x2, y2, term);
                    rectHolder.add(new Rectangle(x1, y1, x2, y2));
                    return true;

                } else {
                    //curLabel.remove();
                    return false;
                }

            }

            var radius = 2;

            function euclideanDistanceSort(a, b) {
                var aCatDist = a.x * a.x + (1 - a.y) * (1 - a.y);
                var aNotCatDist = a.y * a.y + (1 - a.x) * (1 - a.x);
                var bCatDist = b.x * b.x + (1 - b.y) * (1 - b.y);
                var bNotCatDist = b.y * b.y + (1 - b.x) * (1 - b.x);
                return (Math.min(aCatDist, aNotCatDist) > Math.min(bCatDist, bNotCatDist)) * 2 - 1;
            }

            function euclideanDistanceSortForCategory(a, b) {
                var aCatDist = a.x * a.x + (1 - a.y) * (1 - a.y);
                var bCatDist = b.x * b.x + (1 - b.y) * (1 - b.y);
                return (aCatDist > bCatDist) * 2 - 1;
            }

            function euclideanDistanceSortForNotCategory(a, b) {
                var aNotCatDist = a.y * a.y + (1 - a.x) * (1 - a.x);
                var bNotCatDist = b.y * b.y + (1 - b.x) * (1 - b.x);
                return (aNotCatDist > bNotCatDist) * 2 - 1;
            }

            function scoreSort(a, b) {
                return a.s - b.s;
            }

            function scoreSortReverse(a, b) {
                return b.s - a.s;
            }

            function backgroundScoreSort(a, b) {
                if (b.bg === a.bg)
                    return (b.cat + b.ncat) - (a.cat + a.ncat);
                return b.bg - a.bg;
            }

            function arePointsPredictiveOfDifferentCategories(a, b) {
                var aCatDist = a.x * a.x + (1 - a.y) * (1 - a.y);
                var bCatDist = b.x * b.x + (1 - b.y) * (1 - b.y);
                var aNotCatDist = a.y * a.y + (1 - a.x) * (1 - a.x);
                var bNotCatDist = b.y * b.y + (1 - b.x) * (1 - b.x);
                var aGood = aCatDist < aNotCatDist;
                var bGood = bCatDist < bNotCatDist;
                return {aGood: aGood, bGood: bGood};
            }

            function scoreSortForCategory(a, b) {
                var __ret = arePointsPredictiveOfDifferentCategories(a, b);
                if (sortByDist) {
                    var aGood = __ret.aGood;
                    var bGood = __ret.bGood;
                    if (aGood && !bGood) return -1;
                    if (!aGood && bGood) return 1;
                }
                return b.s - a.s;
            }

            function scoreSortForNotCategory(a, b) {
                var __ret = arePointsPredictiveOfDifferentCategories(a, b);
                if (sortByDist) {
                    var aGood = __ret.aGood;
                    var bGood = __ret.bGood;
                    if (aGood && !bGood) return 1;
                    if (!aGood && bGood) return -1;
                }
                if (reverseSortScoresForNotCategory)
                    return a.s - b.s;
                else
                    return b.s - a.s;
            }

            data = data.sort(sortByDist ? euclideanDistanceSort : scoreSort);
            console.log("Sorted Data:");
            console.log(data);
            data.forEach(censorPoints);

            var myXAxis = svg.append("g")
                .attr("class", "x axis")
                .attr("transform", "translate(0," + height + ")")
                .call(xAxis);

            function registerFigureBBox(curLabel) {
                var bbox = curLabel.node().getBBox();
                var borderToRemove = 1.5;
                var x1 = bbox.x + borderToRemove,
                    y1 = bbox.y + borderToRemove,
                    x2 = bbox.x + bbox.width - borderToRemove,
                    y2 = bbox.y + bbox.height - borderToRemove;
                rectHolder.add(new Rectangle(x1, y1, x2, y2));
                //return insertRangeTree(rangeTree, x1, y1, x2, y2, '~~_other_');
            }

            //rangeTree = registerFigureBBox(myXAxis);
            var xLabel = svg.append("text")
                .attr("class", "x label")
                .attr("text-anchor", "end")
                .attr("x", width)
                .attr("y", height - 6)
                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                .attr('font-size', '10px')
                .text(getLabelText('x'));

            //console.log('xLabel');
            //console.log(xLabel);

            //rangeTree = registerFigureBBox(xLabel);
            // Add the Y Axis
            var myYAxis = svg.append("g")
                .attr("class", "y axis")
                .call(yAxis)
                .selectAll("text")
                .style("text-anchor", "end")
                .attr("dx", "30px")
                .attr("dy", "-13px")
                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                .attr('font-size', '10px')
                .attr("transform", "rotate(-90)");
            registerFigureBBox(myYAxis);

            function getLabelText(axis) {
                if (axis == 'y') {
                    if (yLabelText == null)
                        return modelInfo['category_name'] + " Frequency";
                    else
                        return yLabelText;
                } else {
                    if (xLabelText == null)
                        return modelInfo['not_category_name'] + " Frequency";
                    else
                        return xLabelText;
                }
            }

            var yLabel = svg.append("text")
                .attr("class", "y label")
                .attr("text-anchor", "end")
                .attr("y", 6)
                .attr("dy", ".75em")
                .attr("transform", "rotate(-90)")
                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                .attr('font-size', '10px')
                .text(getLabelText('y'));
            registerFigureBBox(yLabel);

            var catHeader = svg.append("text")
                .attr("text-anchor", "start")
                .attr("x", width)
                .attr("dy", "6px")
                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                .attr('font-size', '12px')
                .attr('font-weight', 'bolder')
                .attr('font-decoration', 'underline')
                .text("Top " + fullData['info']['category_name']);
            registerFigureBBox(catHeader);
            console.log(catHeader);

            function showWordList(word, termDataList) {
                var maxWidth = word.node().getBBox().width;
                for (var i in termDataList) {
                    var curTerm = termDataList[i].term;
                    word = (function (word, curTerm) {
                        return makeWordInteractive(
                            svg.append("text")
                                .attr("text-anchor", "start")
                                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                                .attr('font-size', '12px')
                                .attr("x", word.node().getBBox().x)
                                .attr("y", word.node().getBBox().y
                                    + 2 * word.node().getBBox().height)
                                .text(curTerm)
                            ,
                            curTerm);
                    })(word, curTerm);
                    if (word.node().getBBox().width > maxWidth)
                        maxWidth = word.node().getBBox().width;
                    registerFigureBBox(word);
                }
                return {
                    'word': word,
                    'maxWidth': maxWidth
                };
            }

            function pickEuclideanDistanceSortAlgo(category) {
                if (category == true) return euclideanDistanceSortForCategory;
                return euclideanDistanceSortForNotCategory;
            }

            function pickScoreSortAlgo(category) {
                console.log("PICK SCORE ALGO")
                console.log(category)
                if (category == true) {
                    return scoreSortForCategory;
                } else {
                    return scoreSortForNotCategory;
                }
            }

            function pickTermSortingAlgorithm(category) {
                if (sortByDist) return pickEuclideanDistanceSortAlgo(category);
                return pickScoreSortAlgo(category);
            }

            function showAssociatedWordList(header, isAssociatedToCategory, length=14) {
                var sortedData = null;
                var sortingAlgo = pickTermSortingAlgorithm(isAssociatedToCategory);
                sortedData = data.sort(sortingAlgo);
                if (wordVecMaxPValue) {
                    function signifTest(x) {
                        if (isAssociatedToCategory)
                            return x.p >= 1 - minPVal;
                        return x.p <= minPVal;
                    }

                    sortedData = sortedData.filter(signifTest)
                }
                return showWordList(header, sortedData.slice(0, length));

            }

            var wordListData = showAssociatedWordList(catHeader, true);
            var word = wordListData.word;
            var maxWidth = wordListData.maxWidth;

            catHeader = svg.append("text")
                .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                .attr('font-size', '12px')
                .attr('font-weight', 'bolder')
                .attr('font-decoration', 'underline')
                .attr("text-anchor", "start")
                .attr("x", width)
                .attr("y", word.node().getBBox().y + 4 * word.node().getBBox().height)
                .text("Top " + fullData['info']['not_category_name']);


            wordListData = showAssociatedWordList(catHeader, false);
            word = wordListData.word;
            if (wordListData.maxWidth > maxWidth) {
                maxWidth = wordListData.maxWidth;
            }


            if (!nonTextFeaturesMode && !asianMode && showCharacteristic) {
                var sortMethod = backgroundScoreSort;
                var title = 'Characteristic';
                if (wordVecMaxPValue) {
                    title = 'Most similar';
                    sortMethod = scoreSortReverse;
                } else if (data.reduce(function (a, b) {
                        return a + b.bg
                    }, 0) === 0) {
                    title = 'Most frequent';
                }
                word = svg.append("text")
                    .attr('font-family', 'Helvetica, Arial, Sans-Serif')
                    .attr("text-anchor", "start")
                    .attr('font-size', '12px')
                    .attr('font-weight', 'bolder')
                    .attr('font-decoration', 'underline')
                    .attr("x", catHeader.node().getBBox().x + maxWidth + 10)
                    .attr("dy", "6px")
                    .text(title);

                var wordListData = showWordList(word, data.sort(sortMethod).slice(0, 30));

                word = wordListData.word;
                maxWidth = wordListData.maxWidth;
                console.log(maxWidth);
                console.log(word.node().getBBox().x + maxWidth);

                svg.attr('width', word.node().getBBox().x + 3 * maxWidth + 10);
            }

            var numPointsLabeled = 0;
            for (var i = 0; i < data.length; i++) {
                if (labelPointsIfPossible(i), true) numPointsLabeled++;
            }
            console.log('numPointsLabeled');
            console.log(numPointsLabeled);


            function populateCorpusStats() {
                var wordCounts = {};
                var docCounts = {}
                fullData.docs.labels.forEach(function (x, i) {
                    var cnt = (
                        fullData.docs.texts[i]
                            .trim()
                            .replace(/['";:,.?¿\-!¡]+/g, '')
                            .match(/\S+/g) || []
                    ).length;
                    wordCounts[x] = wordCounts[x] ? wordCounts[x] + cnt : cnt
                });
                fullData.docs.labels.forEach(function (x) {
                    docCounts[x] = docCounts[x] ? docCounts[x] + 1 : 1
                });
                var messages = [];
                fullData.docs.categories.forEach(function (x, i) {
                    var name = fullData.info.not_category_name;
                    if (x == fullData.info.category_internal_name) {
                        name = fullData.info.category_name;
                    }

                    messages.push('<b>' + name + '</b> document count: '
                        + Number(docCounts[i]).toLocaleString('en')
                        + '; word count: '
                        + Number(wordCounts[i]).toLocaleString('en'));
                });

                d3.select('#corpus-stats')
                    .style('width', width + margin.left + margin.right + 200)
                    .append('div')
                    .html(messages.join('<br />'));
            };

            if (fullData.docs) {
                populateCorpusStats();
            }

            if (saveSvgButton) {
                // from https://stackoverflow.com/questions/23218174/how-do-i-save-export-an-svg-file-after-creating-an-svg-with-d3-js-ie-safari-an
                var svgElement = document.getElementById("d3-div-1");

                var serializer = new XMLSerializer();
                var source = serializer.serializeToString(svgElement);

                if (!source.match(/^<svg[^>]+xmlns="http\:\/\/www\.w3\.org\/2000\/svg"/)) {
                    source = source.replace(/^<svg/, '<svg xmlns="https://www.w3.org/2000/svg"');
                }
                if (!source.match(/^<svg[^>]+"http\:\/\/www\.w3\.org\/1999\/xlink"/)) {
                    source = source.replace(/^<svg/, '<svg xmlns:xlink="https://www.w3.org/1999/xlink"');
                }

                source = '<?xml version="1.0" standalone="no"?>\r\n' + source;

                var url = "data:image/svg+xml;charset=utf-8," + encodeURIComponent(source);

                var downloadLink = document.createElement("a");
                downloadLink.href = url;
                downloadLink.download = fullData['info']['category_name'] + ".svg";
                downloadLink.innerText = 'Download SVG';
                document.body.appendChild(downloadLink);

            }

        };

        fullData = getDataAndInfo();
        processData(fullData);

        // The tool tip is down here in order to make sure it has the highest z-index
        var tooltip = d3.select('#' + divName)
            .append("div")
            .attr("class", sortByDist ? "tooltip" : "tooltipscore")
            .style("opacity", 0);
    };
}(d3);

function getDataAndInfo() { return{"info": {"category_name": "Geriatric", "not_category_name": "Mnchn", "category_terms": ["breastfeeding", "hepatitis", "nfp", "supplementation", "milk", "feeding", "iron", "measles", "newborn", "micronutrient"], "not_category_terms": ["breastfeeding", "hepatitis", "nfp", "supplementation", "milk", "feeding", "iron", "measles", "newborn", "micronutrient"], "category_internal_name": "geriatric"}, "data": [{"x": 0.0, "y": 0.5388739946380697, "term": "squamous", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.1402692745891941e-05}, {"x": 0.0001675603217158177, "y": 0.5390415549597856, "term": "carcinoma", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.3602329313468013e-06}, {"x": 0.0003351206434316354, "y": 0.7893766756032171, "term": "cancers", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 0, "s": 0.9741957104557641, "os": 0.883545208862591, "bg": 1.1183334988905474e-05}, {"x": 0.0005026809651474531, "y": 0.3788538873994638, "term": "utilizes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.240544395255681e-06}, {"x": 0.0006702412868632708, "y": 0.7414544235924933, "term": "pap", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 1.1540624551968544e-05}, {"x": 0.0008378016085790885, "y": 0.7238605898123325, "term": "pap smear", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.0010053619302949062, "y": 0.37918900804289546, "term": "cytology", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.943123188808769e-06}, {"x": 0.0011729222520107238, "y": 0.724195710455764, "term": "smears", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 3.2126449706042984e-05}, {"x": 0.0013404825737265416, "y": 0.37952412868632707, "term": "intraepithelial", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.8757415040633253e-05}, {"x": 0.0015080428954423592, "y": 0.471514745308311, "term": "abnormal cells", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.001675603217158177, "y": 0.3796916890080429, "term": "today", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.3391327808863366e-08}, {"x": 0.0018431635388739946, "y": 0.5871313672922251, "term": "vascular", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.7691209781484713e-06}, {"x": 0.0020107238605898124, "y": 0.587298927613941, "term": "accidents", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.5146908786397208e-06}, {"x": 0.00217828418230563, "y": 0.5402144772117963, "term": "obstructive", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0678607723125058e-05}, {"x": 0.0023458445040214475, "y": 0.5405495978552279, "term": "obstructive pulmonary", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.0025134048257372654, "y": 0.8450067024128687, "term": "drugstores", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 0, "s": 0.9812332439678284, "os": 0.9054172249875654, "bg": 8.218671451759823e-05}, {"x": 0.002680965147453083, "y": 0.5408847184986595, "term": "bought", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.772002562447074e-07}, {"x": 0.002848525469168901, "y": 0.38103217158176944, "term": "macapagal arroyo", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0030160857908847183, "y": 0.9170576407506702, "term": "botika", "cat25k": 8, "ncat25k": 0, "cat": 48, "ncat": 0, "s": 0.9941353887399464, "os": 0.9563793888261423, "bg": 0.00030768737680485886}, {"x": 0.003183646112600536, "y": 0.9663203753351206, "term": "bnb", "cat25k": 17, "ncat25k": 0, "cat": 105, "ncat": 0, "s": 0.9989946380697051, "os": 0.9959021013841388, "bg": 0.00037573200646259043}, {"x": 0.003351206434316354, "y": 0.3811997319034853, "term": "metformin", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.938507537396482e-06}, {"x": 0.0035187667560321718, "y": 0.3815348525469169, "term": "salbutamol", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.9096041151968682e-05}, {"x": 0.003686327077747989, "y": 0.7248659517426274, "term": "bnbs", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 7.693072068058044e-05}, {"x": 0.003853887399463807, "y": 0.8989611260053619, "term": "ng", "cat25k": 6, "ncat25k": 0, "cat": 39, "ncat": 0, "s": 0.9914544235924934, "os": 0.940989319862942, "bg": 6.522916091381707e-06}, {"x": 0.004021447721179625, "y": 0.3817024128686327, "term": "existence", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.933517460427486e-07}, {"x": 0.0041890080428954425, "y": 0.8991286863270778, "term": "botika ng", "cat25k": 6, "ncat25k": 0, "cat": 39, "ncat": 0, "s": 0.9914544235924934, "os": 0.940989319862942, "bg": 0.0}, {"x": 0.00435656836461126, "y": 0.6801273458445041, "term": "144", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 0.0}, {"x": 0.004524128686327078, "y": 0.6802949061662198, "term": "144 s.", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 0.0}, {"x": 0.004691689008042895, "y": 0.3820375335120643, "term": "hereon", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.0319421302881297e-05}, {"x": 0.004859249329758713, "y": 0.38220509383378015, "term": "fdros", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.005026809651474531, "y": 0.3825402144772118, "term": "operators", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.2913518960050947e-07}, {"x": 0.0051943699731903485, "y": 0.8322721179624665, "term": "pharma", "cat25k": 4, "ncat25k": 0, "cat": 22, "ncat": 0, "s": 0.978887399463807, "os": 0.8995507024296459, "bg": 1.4232623826253306e-05}, {"x": 0.005361930294906166, "y": 0.7250335120643432, "term": "pharma 50", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.005529490616621984, "y": 0.38304289544235925, "term": "forward", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.36299080937001e-07}, {"x": 0.005697050938337802, "y": 0.8012734584450402, "term": "sell", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 0, "s": 0.9750335120643432, "os": 0.8869054488035317, "bg": 2.6085333182308915e-07}, {"x": 0.005864611260053619, "y": 0.9291219839142091, "term": "pharmacist", "cat25k": 9, "ncat25k": 0, "cat": 55, "ncat": 0, "s": 0.995475871313673, "os": 0.9659002167422814, "bg": 2.6641936490951794e-05}, {"x": 0.006032171581769437, "y": 0.6239946380697051, "term": "dispense", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.3500400793148547e-05}, {"x": 0.0061997319034852545, "y": 0.7572050938337802, "term": "supervising pharmacist", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 0.0}, {"x": 0.006367292225201072, "y": 0.8101541554959786, "term": "dispensed", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 3.4389856078452314e-05}, {"x": 0.00653485254691689, "y": 0.3835455764075067, "term": "spent", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.663877409427169e-07}, {"x": 0.006702412868632708, "y": 0.542225201072386, "term": "stating", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.0707370685058495e-06}, {"x": 0.006869973190348526, "y": 0.4723525469168901, "term": "unenforceable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.0344310370688363e-05}, {"x": 0.0070375335120643435, "y": 0.5425603217158177, "term": "construed", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.2190844494614475e-06}, {"x": 0.0072050938337801605, "y": 0.38421581769436997, "term": "177", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.007372654155495978, "y": 0.8181970509383378, "term": "9257", "cat25k": 3, "ncat25k": 0, "cat": 20, "ncat": 0, "s": 0.9772117962466488, "os": 0.8933841364376087, "bg": 0.0}, {"x": 0.007540214477211796, "y": 0.7670911528150134, "term": "9165", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 0.0}, {"x": 0.007707774798927614, "y": 0.657171581769437, "term": "preservation", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.8480906451499634e-06}, {"x": 0.007875335120643432, "y": 0.5432305630026809, "term": "competence", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.3052390014165694e-06}, {"x": 0.00804289544235925, "y": 0.47285522788203754, "term": "uphold", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.160450156413829e-06}, {"x": 0.008210455764075067, "y": 0.6248324396782842, "term": "irrational", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 9.748227650360318e-06}, {"x": 0.008378016085790885, "y": 0.3852211796246649, "term": "distributing", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.1203528161068363e-06}, {"x": 0.008545576407506703, "y": 0.3853887399463807, "term": "illegal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.745569634891704e-07}, {"x": 0.00871313672922252, "y": 0.6576742627345844, "term": "narcotic", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.2768375288086467e-05}, {"x": 0.008880697050938339, "y": 0.47319034852546915, "term": "enumerated", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.111225526833475e-06}, {"x": 0.009048257372654156, "y": 0.473357908847185, "term": "perception", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.1574801518197265e-06}, {"x": 0.009215817694369972, "y": 0.6578418230563002, "term": "misuse", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.565647586286862e-06}, {"x": 0.00938337801608579, "y": 0.7066018766756033, "term": "offender", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 4.783227395717489e-06}, {"x": 0.009550938337801608, "y": 0.88421581769437, "term": "employee", "cat25k": 5, "ncat25k": 0, "cat": 33, "ncat": 0, "s": 0.9887734584450403, "os": 0.9284120787017222, "bg": 1.43379104867738e-06}, {"x": 0.009718498659517426, "y": 0.3863941018766756, "term": "probable cause", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.009886058981233244, "y": 0.9076742627345844, "term": "residential", "cat25k": 7, "ncat25k": 0, "cat": 43, "ncat": 0, "s": 0.9927949061662199, "os": 0.9483071406793615, "bg": 2.7173029542233348e-06}, {"x": 0.010053619302949061, "y": 0.7072721179624665, "term": "psychiatric", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 4.155988609568673e-06}, {"x": 0.01022117962466488, "y": 0.3867292225201072, "term": "dedicated", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.3372315433937713e-07}, {"x": 0.010388739946380697, "y": 0.6260053619302949, "term": "psychologists", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 6.882638115189552e-06}, {"x": 0.010556300268096515, "y": 0.3870643431635389, "term": "enjoy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5856210806419928e-07}, {"x": 0.010723860589812333, "y": 0.5440683646112601, "term": "precursor", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.760789941391223e-06}, {"x": 0.01089142091152815, "y": 0.5444034852546917, "term": "chewing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 6.596984188678146e-06}, {"x": 0.011058981233243968, "y": 0.6826407506702413, "term": "property", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.041149562384016e-07}, {"x": 0.011226541554959786, "y": 0.5896447721179625, "term": "premises", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.386189532308563e-06}, {"x": 0.011394101876675604, "y": 0.8503686327077749, "term": "addiction", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 0, "s": 0.9824061662198392, "os": 0.9082416640679376, "bg": 5.185115896673499e-06}, {"x": 0.011561662198391422, "y": 0.9004691689008043, "term": "specialty", "cat25k": 6, "ncat25k": 0, "cat": 39, "ncat": 0, "s": 0.9914544235924934, "os": 0.940989319862942, "bg": 3.3556895393477186e-06}, {"x": 0.011729222520107238, "y": 0.6829758713136729, "term": "ddb", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 3.0223807293004705e-05}, {"x": 0.011896782841823056, "y": 0.7277144772117963, "term": "conspicuous", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.8172415333581185e-05}, {"x": 0.012064343163538873, "y": 0.6833109919571045, "term": "conspicuous places", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 0.0}, {"x": 0.012231903485254691, "y": 0.5904825737265416, "term": "stressful", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 7.411497456003499e-06}, {"x": 0.012399463806970509, "y": 0.5457439678284183, "term": "queries", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.997876297247204e-07}, {"x": 0.012567024128686327, "y": 0.5906501340482574, "term": "productivity", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 8.24405803628422e-07}, {"x": 0.012734584450402145, "y": 0.38873994638069703, "term": "mood", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.56796007862505e-07}, {"x": 0.012902144772117962, "y": 0.47637399463806973, "term": "explanation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.365619543470499e-07}, {"x": 0.01306970509383378, "y": 0.3890750670241287, "term": "validly", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.320413091235593e-05}, {"x": 0.013237265415549598, "y": 0.3892426273458445, "term": "wit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.464898290280583e-06}, {"x": 0.013404825737265416, "y": 0.38974530831099197, "term": "sick leave", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.013572386058981234, "y": 0.7694369973190348, "term": "ddo", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 4.9911324213979825e-05}, {"x": 0.013739946380697051, "y": 0.7923927613941019, "term": "aftercare", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 0, "s": 0.9741957104557641, "os": 0.883545208862591, "bg": 4.65087012308391e-05}, {"x": 0.01390750670241287, "y": 0.590985254691689, "term": "con\ufb01nement", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.014075067024128687, "y": 0.7590482573726541, "term": "deducted", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 1.3734801583622623e-05}, {"x": 0.014242627345844505, "y": 0.6849865951742627, "term": "dependency", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 4.3582508334609936e-06}, {"x": 0.014410187667560321, "y": 0.6853217158176944, "term": "osc", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.56865451796031e-05}, {"x": 0.014577747989276139, "y": 0.7459785522788204, "term": "7277", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 0.0}, {"x": 0.014745308310991957, "y": 0.7461461126005362, "term": "magna", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 1.0070146315352829e-05}, {"x": 0.014912868632707774, "y": 0.7595509383378016, "term": "carta", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 2.388318393548811e-05}, {"x": 0.015080428954423592, "y": 0.746313672922252, "term": "magna carta", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 0.0}, {"x": 0.01524798927613941, "y": 0.9726876675603218, "term": "pwd", "cat25k": 20, "ncat25k": 0, "cat": 123, "ncat": 0, "s": 0.9998324396782842, "os": 0.9984150977256832, "bg": 0.00018132900895588398}, {"x": 0.015415549597855228, "y": 0.685656836461126, "term": "orthopedic", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 9.63070577182643e-06}, {"x": 0.015583109919571046, "y": 0.47955764075067026, "term": "22%", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.015750670241286863, "y": 0.4802278820375335, "term": "prerequisite", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.5055819450613149e-06}, {"x": 0.01591823056300268, "y": 0.5923257372654156, "term": "charity", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 9.686153408467442e-07}, {"x": 0.0160857908847185, "y": 0.6293565683646113, "term": "affordability", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 9.788435208512024e-06}, {"x": 0.016253351206434317, "y": 0.3919235924932976, "term": "caliber", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.8034762822350557e-06}, {"x": 0.016420911528150135, "y": 0.6295241286863271, "term": "stakeholder", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 5.461302575277229e-06}, {"x": 0.016588471849865952, "y": 0.6864946380697051, "term": "govemment", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 6.024967465175689e-05}, {"x": 0.01675603217158177, "y": 0.7096179624664879, "term": "stroke", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 1.8719638023464896e-06}, {"x": 0.016923592493297588, "y": 0.8473525469168901, "term": "impairments", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 0, "s": 0.9812332439678284, "os": 0.9054172249875654, "bg": 3.056612280194553e-05}, {"x": 0.017091152815013406, "y": 0.660857908847185, "term": "worse", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.125724333250676e-06}, {"x": 0.017258713136729224, "y": 0.3929289544235925, "term": "unaided", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5106339186410338e-05}, {"x": 0.01742627345844504, "y": 0.3930965147453083, "term": "decibels", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.4179117704400843e-05}, {"x": 0.01759383378016086, "y": 0.39326407506702415, "term": "better ear", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.017761394101876677, "y": 0.6871648793565683, "term": "dementia", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 7.3187475573680015e-06}, {"x": 0.017928954423592495, "y": 0.48156836461126007, "term": "psychotic", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 7.992423182822685e-06}, {"x": 0.018096514745308313, "y": 0.5494302949061662, "term": "ofthe", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.608941012952954e-06}, {"x": 0.018264075067024127, "y": 0.8125, "term": "functioning", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 6.406472830401614e-06}, {"x": 0.018431635388739945, "y": 0.48173592493297585, "term": "interpersonal", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.619170601911501e-06}, {"x": 0.018599195710455763, "y": 0.39359919571045576, "term": "cognitive emotional", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.01876675603217158, "y": 0.48223860589812334, "term": "3/60", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.018934316353887398, "y": 0.5497654155495979, "term": "meters", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0156699248793596e-06}, {"x": 0.019101876675603216, "y": 0.3937667560321716, "term": "devoted", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 9.492633004840769e-07}, {"x": 0.019269436997319034, "y": 0.48257372654155495, "term": "cater", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.158367258679552e-06}, {"x": 0.01943699731903485, "y": 0.5502680965147453, "term": "intersectoral", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.95688127875259e-05}, {"x": 0.01960455764075067, "y": 0.3941018766756032, "term": "coalitions", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.805799902677062e-06}, {"x": 0.019772117962466487, "y": 0.48341152815013405, "term": "impacts", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 7.753385884232179e-07}, {"x": 0.019939678284182305, "y": 0.8726541554959786, "term": "assistive", "cat25k": 5, "ncat25k": 0, "cat": 30, "ncat": 0, "s": 0.986260053619303, "os": 0.9213327989384801, "bg": 3.202476581889995e-05}, {"x": 0.020107238605898123, "y": 0.8413203753351206, "term": "assistive devices", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 0, "s": 0.9803954423592494, "os": 0.9025207255958541, "bg": 0.0}, {"x": 0.02027479892761394, "y": 0.4839142091152815, "term": "pdmc", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.02044235924932976, "y": 0.5516085790884718, "term": "nominated", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.07409245923933e-06}, {"x": 0.020609919571045576, "y": 0.6620308310991957, "term": "retain", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.9965032354998683e-06}, {"x": 0.020777479892761394, "y": 0.39510723860589814, "term": "unserved", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.963807036320611e-05}, {"x": 0.020945040214477212, "y": 0.594671581769437, "term": "continually", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.504165410857525e-06}, {"x": 0.02111260053619303, "y": 0.5519436997319035, "term": "scene", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 4.0425306565312337e-07}, {"x": 0.021280160857908847, "y": 0.5521112600536193, "term": "global scene", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.021447721179624665, "y": 0.39527479892761397, "term": "accredit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.8449205876994535e-05}, {"x": 0.021615281501340483, "y": 0.3956099195710456, "term": "legislation ordinances", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0217828418230563, "y": 0.48458445040214476, "term": "ordinances resolutions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.02195040214477212, "y": 0.3959450402144772, "term": "indigents", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.3631862840668073e-05}, {"x": 0.022117962466487937, "y": 0.4850871313672922, "term": "imperative", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.4128330029142186e-06}, {"x": 0.022285522788203754, "y": 0.5955093833780161, "term": "admitting", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 8.714548128893147e-06}, {"x": 0.022453083109919572, "y": 0.8059651474530831, "term": "lung", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 0, "s": 0.9750335120643432, "os": 0.8869054488035317, "bg": 3.386444701521586e-06}, {"x": 0.02262064343163539, "y": 0.8882372654155496, "term": "morphine", "cat25k": 5, "ncat25k": 0, "cat": 34, "ncat": 0, "s": 0.9892761394101877, "os": 0.9306505378807958, "bg": 4.261348503734007e-05}, {"x": 0.022788203753351208, "y": 0.8274128686327078, "term": "prescribing", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 1.853244236410425e-05}, {"x": 0.022955764075067026, "y": 0.3964477211796247, "term": "legitimate", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.104855938524711e-06}, {"x": 0.023123324396782843, "y": 0.4859249329758713, "term": "opioid", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 9.747586253953864e-06}, {"x": 0.02329088471849866, "y": 0.48609249329758714, "term": "analgesic", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.147533835035126e-05}, {"x": 0.023458445040214475, "y": 0.7605563002680965, "term": "capita", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 5.827617411921807e-06}, {"x": 0.023626005361930293, "y": 0.39661528150134046, "term": "1980", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.02379356568364611, "y": 0.9421916890080428, "term": "hospice", "cat25k": 10, "ncat25k": 0, "cat": 64, "ncat": 0, "s": 0.9968163538873994, "os": 0.9755445584889838, "bg": 4.025433190074037e-05}, {"x": 0.02396112600536193, "y": 0.8138404825737265, "term": "morphine sulfate", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 0.0}, {"x": 0.024128686327077747, "y": 0.6335455764075067, "term": "sulfate tablets", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.024296246648793565, "y": 0.5527815013404825, "term": "cosmetic", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0945819107569126e-06}, {"x": 0.024463806970509382, "y": 0.6340482573726541, "term": "hospices", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 2.9106944371171756e-05}, {"x": 0.0246313672922252, "y": 0.6635388739946381, "term": "palliation", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 4.779873545789861e-05}, {"x": 0.024798927613941018, "y": 0.3972855227882037, "term": "permission", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.9829090098081126e-07}, {"x": 0.024966487935656836, "y": 0.7850201072386059, "term": "mmd", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 5.3894918382882976e-05}, {"x": 0.025134048257372654, "y": 0.8527144772117963, "term": "pdea", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 0, "s": 0.9824061662198392, "os": 0.9082416640679376, "bg": 0.00016026565635196904}, {"x": 0.02530160857908847, "y": 0.55328418230563, "term": "controlled chemical", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.02546916890080429, "y": 0.7851876675603218, "term": "retailer", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 3.061429008092218e-06}, {"x": 0.025636729222520107, "y": 0.39745308310991956, "term": "s2", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.025804289544235925, "y": 0.5966823056300268, "term": "authorize", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.9663323398238805e-06}, {"x": 0.025971849865951743, "y": 0.5968498659517426, "term": "medicinal", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 5.178095030619186e-06}, {"x": 0.02613941018766756, "y": 0.3976206434316354, "term": "active medicinal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.026306970509383378, "y": 0.3977882037533512, "term": "medicinal ingredient", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.026474530831099196, "y": 0.4879356568364611, "term": "s3", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.026642091152815014, "y": 0.397955764075067, "term": "s3 license", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.02680965147453083, "y": 0.39812332439678283, "term": "controlled chemicals", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.02697721179624665, "y": 0.3984584450402145, "term": "s4", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.027144772117962467, "y": 0.5537868632707775, "term": "purchases", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.957055770009261e-07}, {"x": 0.027312332439678285, "y": 0.5539544235924933, "term": "ddaptp", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.846610014649173e-05}, {"x": 0.027479892761394103, "y": 0.39912868632707776, "term": "permits", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.799789546513535e-07}, {"x": 0.02764745308310992, "y": 0.4882707774798928, "term": "division mmd", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.02781501340482574, "y": 0.39946380697050937, "term": "forwarder", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.2835590525408854e-05}, {"x": 0.027982573726541556, "y": 0.6653820375335121, "term": "eligibility", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.1612632014658753e-06}, {"x": 0.028150134048257374, "y": 0.4008042895442359, "term": "transaction", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.59150637474424e-07}, {"x": 0.028317694369973192, "y": 0.7607238605898123, "term": "ims", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 1.141638618372635e-05}, {"x": 0.02848525469168901, "y": 0.7496648793565683, "term": "centered", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 4.237639660786724e-06}, {"x": 0.028652815013404824, "y": 0.4896112600536193, "term": "nscb", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.0314053595246762e-05}, {"x": 0.028820375335120642, "y": 0.4019772117962466, "term": "poverty threshold", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.02898793565683646, "y": 0.6658847184986595, "term": "pcpt", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.769859535975074e-05}, {"x": 0.029155495978552277, "y": 0.48994638069705093, "term": "excess", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 5.726770401003925e-07}, {"x": 0.029323056300268095, "y": 0.4023123324396783, "term": "c-2", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.029490616621983913, "y": 0.4024798927613941, "term": "modifying", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.2687575914755973e-06}, {"x": 0.02965817694369973, "y": 0.5554624664879356, "term": "modi\ufb01ers", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.02982573726541555, "y": 0.4026474530831099, "term": "latest pcpt", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.029993297587131366, "y": 0.40298257372654156, "term": "mss", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 5.220378268609343e-06}, {"x": 0.030160857908847184, "y": 0.7335790884718498, "term": "resides", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 8.474315937328196e-06}, {"x": 0.030328418230563002, "y": 0.8962801608579088, "term": "discounts", "cat25k": 6, "ncat25k": 0, "cat": 37, "ncat": 0, "s": 0.9909517426273459, "os": 0.9370196544566375, "bg": 3.3881952347689635e-06}, {"x": 0.03049597855227882, "y": 0.599195710455764, "term": "exchange", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.8089862710992567e-07}, {"x": 0.030663538873994638, "y": 0.4921246648793566, "term": "pangkalahatan", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.030831099195710455, "y": 0.4922922252010724, "term": "2040", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.030998659517426273, "y": 0.9492292225201072, "term": "wellness", "cat25k": 12, "ncat25k": 0, "cat": 72, "ncat": 0, "s": 0.9971514745308311, "os": 0.982095490754396, "bg": 1.4853023147198822e-05}, {"x": 0.03116621983914209, "y": 0.40482573726541554, "term": "obesity", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.3440891830054708e-06}, {"x": 0.03133378016085791, "y": 0.4049932975871314, "term": "globalization", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.6327723535719548e-06}, {"x": 0.03150134048257373, "y": 0.750837801608579, "term": "radiology", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 6.506955935895472e-06}, {"x": 0.031668900804289545, "y": 0.49363270777479895, "term": "subsidies", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.520007600342923e-06}, {"x": 0.03183646112600536, "y": 0.6003686327077749, "term": "universities", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 7.293138589168387e-07}, {"x": 0.03200402144772118, "y": 0.5571380697050938, "term": "housing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.0653325616562442e-07}, {"x": 0.032171581769437, "y": 0.4054959785522788, "term": "accountabilities", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.764520348228091e-05}, {"x": 0.032339142091152816, "y": 0.40566353887399464, "term": "compendium", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.644183015642189e-06}, {"x": 0.032506702412868634, "y": 0.952245308310992, "term": "smoke", "cat25k": 12, "ncat25k": 0, "cat": 76, "ncat": 0, "s": 0.9978217158176943, "os": 0.98477420283559, "bg": 9.004864166955868e-06}, {"x": 0.03267426273458445, "y": 0.49396782841823056, "term": "taxes", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.942333153674471e-07}, {"x": 0.03284182305630027, "y": 0.6017091152815014, "term": "hrh", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.2257197818794613e-05}, {"x": 0.03300938337801609, "y": 0.4943029490616622, "term": "streamline", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.104008713631301e-06}, {"x": 0.033176943699731905, "y": 0.407171581769437, "term": "gida", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.03334450402144772, "y": 0.6025469168900804, "term": "tumor", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.8082145637734028e-06}, {"x": 0.03351206434316354, "y": 0.40884718498659517, "term": "tumor boards", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.03367962466487936, "y": 0.49547587131367293, "term": "thousands", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.569168503258181e-07}, {"x": 0.033847184986595176, "y": 0.8486930294906166, "term": "cigarette", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 0, "s": 0.9812332439678284, "os": 0.9054172249875654, "bg": 6.664178706616197e-06}, {"x": 0.034014745308310994, "y": 0.40918230563002683, "term": "tar", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.1223898823286447e-06}, {"x": 0.03418230563002681, "y": 0.8488605898123325, "term": "nicotine", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 0, "s": 0.9812332439678284, "os": 0.9054172249875654, "bg": 2.2169835721517306e-05}, {"x": 0.03434986595174263, "y": 0.8656166219839142, "term": "cigarettes", "cat25k": 4, "ncat25k": 0, "cat": 28, "ncat": 0, "s": 0.9854222520107239, "os": 0.9162969607966494, "bg": 8.034135895687076e-06}, {"x": 0.03451742627345845, "y": 0.4093498659517426, "term": "oncology", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.7535414962443525e-06}, {"x": 0.034684986595174265, "y": 0.4098525469168901, "term": "prohibitive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.0360842232865111e-05}, {"x": 0.03485254691689008, "y": 0.6689008042895442, "term": "deceptive", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.2585168379065272e-05}, {"x": 0.0350201072386059, "y": 0.41069034852546915, "term": "injurious", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.0535021043704534e-05}, {"x": 0.03518766756032172, "y": 0.6692359249329759, "term": "ban", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.4691380615963882e-06}, {"x": 0.035355227882037536, "y": 0.6389075067024129, "term": "9711", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.035522788203753354, "y": 0.41152815013404825, "term": "cosmetics", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.683445326260378e-07}, {"x": 0.03569034852546917, "y": 0.4964812332439678, "term": "biologicals", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.030353789147759e-05}, {"x": 0.03585790884718499, "y": 0.5596514745308311, "term": "vitro", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.2588732777738354e-06}, {"x": 0.03602546916890081, "y": 0.5598190348525469, "term": "health-", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.036193029490616625, "y": 0.4116957104557641, "term": "adversely", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.9005348586279314e-06}, {"x": 0.03636058981233244, "y": 0.4968163538873995, "term": "market authorization", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.036528150134048254, "y": 0.6933646112600537, "term": "electronic cigarettes", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 0.0}, {"x": 0.03669571045576407, "y": 0.41270107238605896, "term": "battery", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5455496670113243e-07}, {"x": 0.03686327077747989, "y": 0.4969839142091153, "term": "cartridge", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.361052041675069e-07}, {"x": 0.03703083109919571, "y": 0.4128686327077748, "term": "quit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.521084420036018e-07}, {"x": 0.037198391420911525, "y": 0.49748659517426275, "term": "clauses", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.620021892902937e-06}, {"x": 0.03736595174262734, "y": 0.6392426273458445, "term": "cure mitigation", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.03753351206434316, "y": 0.7163203753351206, "term": "enroll", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 4.5915234633110145e-06}, {"x": 0.03770107238605898, "y": 0.693867292225201, "term": "emissions", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.4254885042192324e-06}, {"x": 0.037868632707774796, "y": 0.6699061662198391, "term": "unhealthy", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.2026345714678955e-05}, {"x": 0.038036193029490614, "y": 0.5603217158176944, "term": "inactivity", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.026835489830478e-05}, {"x": 0.03820375335120643, "y": 0.41387399463806973, "term": "unhealthy diet", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.03837131367292225, "y": 0.5604892761394102, "term": "physical inactivity", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.03853887399463807, "y": 0.49832439678284185, "term": "evident", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.4760842613844106e-06}, {"x": 0.038706434316353885, "y": 0.41437667560321717, "term": "0010", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0388739946380697, "y": 0.670073726541555, "term": "reportable", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.8664531997229353e-05}, {"x": 0.03904155495978552, "y": 0.5608243967828418, "term": "injuries violence", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.03920911528150134, "y": 0.6940348525469169, "term": "endeavor", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 7.723269089893833e-06}, {"x": 0.03937667560321716, "y": 0.4147117962466488, "term": "privileged", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.9035694544679277e-06}, {"x": 0.039544235924932974, "y": 0.4991621983914209, "term": "reyes", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 5.028615335567044e-06}, {"x": 0.03971179624664879, "y": 0.49949731903485256, "term": "reyes memorial", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.03987935656836461, "y": 0.5611595174262735, "term": "copd", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0304542156311317e-05}, {"x": 0.04004691689008043, "y": 0.6402479892761395, "term": "urs", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.5668547545228243e-05}, {"x": 0.040214477211796246, "y": 0.6404155495978552, "term": "upload", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 8.326327942625773e-07}, {"x": 0.040382037533512063, "y": 0.6942024128686327, "term": "uploading", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 6.401192158027511e-06}, {"x": 0.04054959785522788, "y": 0.4155495978552279, "term": "carrying", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.807602742977744e-07}, {"x": 0.0407171581769437, "y": 0.5619973190348525, "term": "erroneous", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 5.78231603922916e-06}, {"x": 0.04088471849865952, "y": 0.5011729222520107, "term": "\ufb01gure", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.041052278820375335, "y": 0.7984249329758714, "term": "aging", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 0, "s": 0.9741957104557641, "os": 0.883545208862591, "bg": 2.7584011365910753e-06}, {"x": 0.04121983914209115, "y": 0.4165549597855228, "term": "5.4%", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.04138739946380697, "y": 0.7357573726541555, "term": "cy", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 6.828208810039515e-06}, {"x": 0.04155495978552279, "y": 0.5016756032171582, "term": "census", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.8914875810567674e-07}, {"x": 0.041722520107238606, "y": 0.4167225201072386, "term": "4.8", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.041890080428954424, "y": 0.8540549597855228, "term": "9994", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 0, "s": 0.9824061662198392, "os": 0.9082416640679376, "bg": 0.0}, {"x": 0.04205764075067024, "y": 0.9234249329758714, "term": "privileges", "cat25k": 8, "ncat25k": 0, "cat": 51, "ncat": 0, "s": 0.9948056300268098, "os": 0.9606987630878521, "bg": 1.6784028713194847e-05}, {"x": 0.04222520107238606, "y": 0.7863605898123325, "term": "pharmacies", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 3.925227844143431e-06}, {"x": 0.04239276139410188, "y": 0.41722520107238603, "term": "pertinent de\ufb01nitions", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.042560321715817695, "y": 0.7528485254691689, "term": "sixty 60", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 0.0}, {"x": 0.04272788203753351, "y": 0.6412533512064343, "term": "citizenship", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 2.3870468098387503e-06}, {"x": 0.04289544235924933, "y": 0.41739276139410186, "term": "prove", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.89034950044163e-07}, {"x": 0.04306300268096515, "y": 0.4175603217158177, "term": "dual citizenship", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.043230563002680966, "y": 0.5628351206434317, "term": "accessories", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.533228127617404e-08}, {"x": 0.043398123324396784, "y": 0.671916890080429, "term": "apparatus", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 2.9471516761433967e-06}, {"x": 0.0435656836461126, "y": 0.5021782841823056, "term": "implants", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.90039689031047e-06}, {"x": 0.04373324396782842, "y": 0.41806300268096513, "term": "metabolized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5959558478814685e-05}, {"x": 0.04390080428954424, "y": 0.7629021447721179, "term": "\ufb01lling", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 0, "s": 0.9673257372654156, "os": 0.8729620419385988, "bg": 0.0}, {"x": 0.044068364611260055, "y": 0.5025134048257373, "term": "extractions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.7794290879714154e-05}, {"x": 0.04423592493297587, "y": 0.5026809651474531, "term": "gum", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.0768462176372843e-06}, {"x": 0.04440348525469169, "y": 0.6948726541554959, "term": "treatments", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.5806234532117676e-06}, {"x": 0.04457104557640751, "y": 0.5028485254691689, "term": "repositioning", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.6120348070555537e-05}, {"x": 0.044738605898123326, "y": 0.5630026809651475, "term": "alteration", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.7991298726215076e-06}, {"x": 0.044906166219839144, "y": 0.5031836461126006, "term": "alveolar", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.189465145102853e-05}, {"x": 0.04507372654155496, "y": 0.5033512064343163, "term": "periodontium", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.994065761660389e-05}, {"x": 0.04524128686327078, "y": 0.5035187667560321, "term": "maxilla", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.4612113097582105e-05}, {"x": 0.0454088471849866, "y": 0.503686327077748, "term": "mandible", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.7853157777281857e-05}, {"x": 0.045576407506702415, "y": 0.5038538873994638, "term": "cleaning permanent", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04574396782841823, "y": 0.5040214477211796, "term": "temporary \ufb01lling", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04591152815013405, "y": 0.5041890080428955, "term": "\ufb01lling extractions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04607908847184987, "y": 0.5043565683646113, "term": "gum treatments", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04624664879356569, "y": 0.5045241286863271, "term": "treatments restoration", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.046414209115281505, "y": 0.5046916890080428, "term": "restoration replacement", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04658176943699732, "y": 0.5048592493297587, "term": "periodontium process", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04674932975871314, "y": 0.7362600536193029, "term": "scans", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 5.728475967611198e-06}, {"x": 0.04691689008042895, "y": 0.5053619302949062, "term": "histopathology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.8094962362478285e-05}, {"x": 0.04708445040214477, "y": 0.563337801608579, "term": "hematology", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 8.461692507735396e-06}, {"x": 0.04725201072386059, "y": 0.505529490616622, "term": "parasitology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.1317350970293084e-05}, {"x": 0.047419571045576404, "y": 0.5056970509383378, "term": "bacteriology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.6049148913633108e-05}, {"x": 0.04758713136729222, "y": 0.4185656836461126, "term": "ray ct", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.04775469168900804, "y": 0.5635053619302949, "term": "ct scans", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.04792225201072386, "y": 0.5060321715817694, "term": "chemistry exams", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.048089812332439676, "y": 0.5061997319034852, "term": "exams histopathology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04825737265415549, "y": 0.506367292225201, "term": "hematology urine", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04842493297587131, "y": 0.5065348525469169, "term": "analysis parasitology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.04859249329758713, "y": 0.8434986595174263, "term": "dentist", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 0, "s": 0.9803954423592494, "os": 0.9025207255958541, "bg": 9.292347347943866e-06}, {"x": 0.04876005361930295, "y": 0.776642091152815, "term": "educators", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 3.852028189142288e-06}, {"x": 0.048927613941018765, "y": 0.6720844504021448, "term": "optical", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 6.672237490731614e-07}, {"x": 0.04909517426273458, "y": 0.7530160857908847, "term": "operated", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 1.7225298557487248e-06}, {"x": 0.0492627345844504, "y": 0.6952077747989276, "term": "corporations", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.7765989057039039e-06}, {"x": 0.04943029490616622, "y": 0.641588471849866, "term": "goccs", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 5.128780472168353e-05}, {"x": 0.049597855227882036, "y": 0.6722520107238605, "term": "gocc", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.486266047328189e-05}, {"x": 0.049765415549597854, "y": 0.6055630026809652, "term": "defense", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 3.671497290618574e-07}, {"x": 0.04993297587131367, "y": 0.6057305630026809, "term": "controlled corporations", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.05010053619302949, "y": 0.5638404825737265, "term": "corporations goccs", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.05026809651474531, "y": 0.4187332439678284, "term": "donation principal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.050435656836461125, "y": 0.7768096514745308, "term": "osca", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 8.030494464312483e-05}, {"x": 0.05060321715817694, "y": 0.5640080428954424, "term": "passport", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.2654846547858046e-06}, {"x": 0.05077077747989276, "y": 0.6062332439678284, "term": "affairs osca", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.05093833780160858, "y": 0.5641756032171582, "term": "elderly resides", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.051105898123324396, "y": 0.9147117962466488, "term": "vat", "cat25k": 7, "ncat25k": 0, "cat": 46, "ncat": 0, "s": 0.9934651474530831, "os": 0.9532864653659051, "bg": 4.409716119252336e-06}, {"x": 0.051273458445040214, "y": 0.8438337801608579, "term": "pay sections", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 0, "s": 0.9803954423592494, "os": 0.9025207255958541, "bg": 0.0}, {"x": 0.05144101876675603, "y": 0.8698056300268097, "term": "vat exemption", "cat25k": 5, "ncat25k": 0, "cat": 29, "ncat": 0, "s": 0.9859249329758714, "os": 0.9188474000474952, "bg": 0.0}, {"x": 0.05160857908847185, "y": 0.5072050938337802, "term": "privilege", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.5943877551020409e-06}, {"x": 0.05177613941018767, "y": 0.564343163538874, "term": "rays", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.8354441706063714e-06}, {"x": 0.051943699731903485, "y": 0.41906836461126007, "term": "computerized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.8905274164718876e-06}, {"x": 0.0521112600536193, "y": 0.41923592493297585, "term": "tomography", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.718002067664406e-06}, {"x": 0.05227882037533512, "y": 0.4194034852546917, "term": "rays computerized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.05244638069705094, "y": 0.4195710455764075, "term": "computerized tomography", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.052613941018766756, "y": 0.41973860589812334, "term": "tomography scans", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.052781501340482574, "y": 0.4199061662198391, "term": "radiotherapy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 5.316600220240165e-06}, {"x": 0.05294906166219839, "y": 0.6419235924932976, "term": "surgeries", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.1617294375704752e-05}, {"x": 0.05311662198391421, "y": 0.7364276139410187, "term": "dyes", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.2202060012781658e-05}, {"x": 0.05328418230563003, "y": 0.7365951742627346, "term": "radioactive", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 5.949761699648592e-06}, {"x": 0.053451742627345845, "y": 0.7367627345844504, "term": "isotopes", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.781700157680464e-05}, {"x": 0.05361930294906166, "y": 0.7369302949061662, "term": "reagents dyes", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.05378686327077748, "y": 0.7370978552278821, "term": "dyes contrast", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.0539544235924933, "y": 0.7372654155495979, "term": "contrast media", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.05412198391420912, "y": 0.7374329758713136, "term": "radioactive isotopes", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.054289544235924934, "y": 0.8587466487935657, "term": "geriatric", "cat25k": 4, "ncat25k": 0, "cat": 26, "ncat": 0, "s": 0.9837466487935658, "os": 0.9109954868852783, "bg": 3.2684195871357525e-05}, {"x": 0.05445710455764075, "y": 0.5077077747989276, "term": "radiation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.563858267396095e-07}, {"x": 0.05462466487935657, "y": 0.42007372654155495, "term": "wheelchair", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.6852617748713566e-06}, {"x": 0.05479222520107239, "y": 0.4204088471849866, "term": "eyeglasses", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.187696756314786e-06}, {"x": 0.054959785522788206, "y": 0.9044906166219839, "term": "pen", "cat25k": 7, "ncat25k": 0, "cat": 41, "ncat": 0, "s": 0.9922922252010724, "os": 0.9447488061187903, "bg": 4.915110349921691e-06}, {"x": 0.055127345844504023, "y": 0.6065683646112601, "term": "pack", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.648096248614171e-07}, {"x": 0.05529490616621984, "y": 0.4205764075067024, "term": "glucometer", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.243397401024111e-05}, {"x": 0.05546246648793566, "y": 0.6953753351206434, "term": "cotton", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 8.477669183545353e-07}, {"x": 0.05563002680965148, "y": 0.5078753351206434, "term": "wheelchairs", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.300681103627303e-06}, {"x": 0.055797587131367295, "y": 0.5648458445040214, "term": "run residential", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.05596514745308311, "y": 0.6425938337801609, "term": "deduction", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 3.618213362423769e-06}, {"x": 0.05613270777479893, "y": 0.42091152815013405, "term": "taxable", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.6612171821354365e-06}, {"x": 0.05630026809651475, "y": 0.4210790884718499, "term": "gross income", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.056467828418230566, "y": 0.753686327077748, "term": "diagnose", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 8.431011465202783e-06}, {"x": 0.056635388739946384, "y": 0.8543900804289544, "term": "cpgs", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 0, "s": 0.9824061662198392, "os": 0.9082416640679376, "bg": 0.0001467644313465343}, {"x": 0.0568029490616622, "y": 0.6429289544235925, "term": "extensively tested", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.05697050938337802, "y": 0.7379356568364611, "term": "reimbursement", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 4.600771856158401e-06}, {"x": 0.05713806970509384, "y": 0.5651809651474531, "term": "enumerates", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.7007136635856022e-05}, {"x": 0.05730563002680965, "y": 0.5653485254691689, "term": "mosc", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.438139279022193e-05}, {"x": 0.057473190348525466, "y": 0.738103217158177, "term": "shoulder", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.9335972102703986e-06}, {"x": 0.057640750670241284, "y": 0.7382707774798928, "term": "billing", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.7825780624356878e-06}, {"x": 0.0578083109919571, "y": 0.7384383378016086, "term": "of\ufb01cial receipts", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.05797587131367292, "y": 0.8545576407506702, "term": "discounted", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 0, "s": 0.9824061662198392, "os": 0.9082416640679376, "bg": 5.1608311084990426e-06}, {"x": 0.05814343163538874, "y": 0.4214142091152815, "term": "precondition", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 9.63979693767751e-06}, {"x": 0.058310991957104555, "y": 0.4215817694369973, "term": "herein described", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.05847855227882037, "y": 0.5087131367292225, "term": "grievance", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.6055980515348133e-06}, {"x": 0.05864611260053619, "y": 0.42191689008042893, "term": "pacu", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.0303589420814733e-05}, {"x": 0.05881367292225201, "y": 0.5088806970509383, "term": "entertain", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.0813308021227903e-06}, {"x": 0.058981233243967826, "y": 0.50921581769437, "term": "grievance mechanism", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.059148793565683644, "y": 0.5093833780160858, "term": "entertain questions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.05931635388739946, "y": 0.7769772117962467, "term": "board accommodation", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 0.0}, {"x": 0.05948391420911528, "y": 0.42208445040214476, "term": "accrue", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.454783034571011e-06}, {"x": 0.0596514745308311, "y": 0.5095509383378016, "term": "billing statement", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.059819034852546915, "y": 0.5097184986595175, "term": "statement showing", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.05998659517426273, "y": 0.4222520107238606, "term": "p100.00", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06015415549597855, "y": 0.5660187667560321, "term": "un\ufb01lled", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06032171581769437, "y": 0.566186327077748, "term": "partial \ufb01lling", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.060489276139410186, "y": 0.7386058981233244, "term": "partially \ufb01lled", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.060656836461126004, "y": 0.5663538873994638, "term": "un\ufb01lled balance", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06082439678284182, "y": 0.8364611260053619, "term": "citizens\u2019", "cat25k": 4, "ncat25k": 0, "cat": 22, "ncat": 0, "s": 0.978887399463807, "os": 0.8995507024296459, "bg": 0.0}, {"x": 0.06099195710455764, "y": 0.42275469168900803, "term": "lane", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.1754988669026165e-07}, {"x": 0.06115951742627346, "y": 0.9207439678284183, "term": "generic", "cat25k": 8, "ncat25k": 0, "cat": 49, "ncat": 0, "s": 0.9944705093833781, "os": 0.9578608787300045, "bg": 3.8018721815227927e-06}, {"x": 0.061327077747989275, "y": 0.5665214477211796, "term": "menu", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.607047352614473e-07}, {"x": 0.06149463806970509, "y": 0.5666890080428955, "term": "generic menu", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06166219839142091, "y": 0.5668565683646113, "term": "menu card", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06182975871313673, "y": 0.42292225201072386, "term": "booklets", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.3878653583514796e-06}, {"x": 0.06199731903485255, "y": 0.7868632707774799, "term": "convenience stores", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 0.0}, {"x": 0.062164879356568364, "y": 0.5670241286863271, "term": "curb", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.1403583148837283e-06}, {"x": 0.06233243967828418, "y": 0.510053619302949, "term": "availing discounts", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.0625, "y": 0.42392761394101874, "term": "counter otc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06266756032171582, "y": 0.6441018766756033, "term": "strength", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 5.62184590288479e-07}, {"x": 0.06283512064343164, "y": 0.5673592493297587, "term": "dosage strength", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06300268096514745, "y": 0.5675268096514745, "term": "strength quantity", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06317024128686327, "y": 0.5676943699731903, "term": "narcotic license", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06333780160857909, "y": 0.4240951742627346, "term": "double discounts", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0635053619302949, "y": 0.568029490616622, "term": "pesos php", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06367292225201072, "y": 0.4242627345844504, "term": "abuses", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.7991063852864972e-06}, {"x": 0.06384048257372654, "y": 0.424597855227882, "term": "alien", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.405682843300843e-07}, {"x": 0.06400804289544236, "y": 0.42476541554959785, "term": "deported", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.144342176392198e-06}, {"x": 0.06417560321715818, "y": 0.5107238605898123, "term": "sentence", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.815780494790223e-07}, {"x": 0.064343163538874, "y": 0.4249329758713137, "term": "deportation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.2897630960729866e-06}, {"x": 0.06451072386058981, "y": 0.4251005361930295, "term": "proceedings", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.261805472934476e-07}, {"x": 0.06467828418230563, "y": 0.4252680965147453, "term": "further deportation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06484584450402145, "y": 0.4254356568364611, "term": "deportation proceedings", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06501340482573727, "y": 0.42560321715817695, "term": "of\ufb01cials thereof", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06518096514745308, "y": 0.5681970509383378, "term": "\ufb01ling", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.0653485254691689, "y": 0.42593833780160856, "term": "franchise", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 5.835800417960025e-07}, {"x": 0.06551608579088472, "y": 0.4261058981233244, "term": "business permit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06568364611260054, "y": 0.4262734584450402, "term": "permit permit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06585120643431636, "y": 0.42644101876675605, "term": "business entity", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.06601876675603217, "y": 0.4271112600536193, "term": "habit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5406486670115154e-06}, {"x": 0.06618632707774799, "y": 0.511058981233244, "term": "compounds", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.1269213163252357e-06}, {"x": 0.06635388739946381, "y": 0.42761394101876676, "term": "literacy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.489238976121384e-07}, {"x": 0.06652144772117963, "y": 0.6451072386058981, "term": "antimicrobial resistance", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.06668900804289545, "y": 0.9313002680965148, "term": "rum", "cat25k": 9, "ncat25k": 0, "cat": 56, "ncat": 0, "s": 0.9959785522788204, "os": 0.9671070010164441, "bg": 4.3657500670454476e-05}, {"x": 0.06685656836461126, "y": 0.6454423592493298, "term": "amr", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 9.241631702493391e-06}, {"x": 0.06702412868632708, "y": 0.5113941018766756, "term": "attack", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.7846252486148234e-07}, {"x": 0.0671916890080429, "y": 0.6729222520107239, "term": "pharmacopoeia", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 4.183419713203337e-05}, {"x": 0.06735924932975872, "y": 0.5700402144772118, "term": "latest edition", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.06752680965147453, "y": 0.5117292225201072, "term": "fec", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 7.009162377059292e-06}, {"x": 0.06769436997319035, "y": 0.7193364611260054, "term": "therapeutics", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 1.2213259047110426e-05}, {"x": 0.06786193029490617, "y": 0.7546916890080428, "term": "pnf", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 6.564048705241392e-05}, {"x": 0.06802949061662199, "y": 0.920911528150134, "term": "ncpam", "cat25k": 8, "ncat25k": 0, "cat": 49, "ncat": 0, "s": 0.9944705093833781, "os": 0.9578608787300045, "bg": 0.00031409652378479904}, {"x": 0.0681970509383378, "y": 0.7774798927613941, "term": "ncpgs", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 9.616247611965175e-05}, {"x": 0.06836461126005362, "y": 0.5127345844504021, "term": "nmis", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.9187194993812316e-05}, {"x": 0.06853217158176944, "y": 0.4296246648793566, "term": "ched", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.1247775623489414e-05}, {"x": 0.06869973190348526, "y": 0.6734249329758714, "term": "raised", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 7.284525555208328e-07}, {"x": 0.06886729222520108, "y": 0.4299597855227882, "term": "ptcs", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.2766143329946868e-05}, {"x": 0.0690348525469169, "y": 0.43029490616621985, "term": "truthful", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.655540820927682e-06}, {"x": 0.06920241286863271, "y": 0.4304624664879357, "term": "balanced", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.076959695062463e-07}, {"x": 0.06936997319034853, "y": 0.6100871313672922, "term": "amending", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 4.924867626593722e-06}, {"x": 0.06953753351206435, "y": 0.5715482573726541, "term": "crafting", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.889312939459384e-06}, {"x": 0.06970509383378017, "y": 0.5720509383378016, "term": "bwc", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.3713071830846753e-05}, {"x": 0.06987265415549598, "y": 0.5152479892761395, "term": "dole bwc", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.0700402144772118, "y": 0.5722184986595175, "term": "assuring", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.705357406582174e-06}, {"x": 0.07020777479892762, "y": 0.6105898123324397, "term": "remainder", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.30282928896198e-06}, {"x": 0.07037533512064344, "y": 0.572553619302949, "term": "cvd", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.2470745709024247e-05}, {"x": 0.07054289544235925, "y": 0.8823726541554959, "term": "ncds", "cat25k": 5, "ncat25k": 0, "cat": 32, "ncat": 0, "s": 0.9879356568364611, "os": 0.9261138264364877, "bg": 0.00017599388421252361}, {"x": 0.07071045576407507, "y": 0.6977211796246648, "term": "cholesterol", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 2.23897297414087e-06}, {"x": 0.07087801608579089, "y": 0.43146782841823056, "term": "waist", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.502217366721867e-06}, {"x": 0.07104557640750671, "y": 0.4316353887399464, "term": "fats", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.686783510403561e-06}, {"x": 0.07121313672922253, "y": 0.8699731903485255, "term": "smokers", "cat25k": 5, "ncat25k": 0, "cat": 29, "ncat": 0, "s": 0.9859249329758714, "os": 0.9188474000474952, "bg": 1.7383120989519174e-05}, {"x": 0.07138069705093834, "y": 0.7200067024128687, "term": "diabetic", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 4.64547037076766e-06}, {"x": 0.07154825737265416, "y": 0.6469504021447721, "term": "creating", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 4.084157016335428e-07}, {"x": 0.07171581769436998, "y": 0.7878686327077749, "term": "ncd", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 4.637734930260061e-05}, {"x": 0.0718833780160858, "y": 0.43230563002680966, "term": "built", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.2941872952706916e-07}, {"x": 0.07205093833780161, "y": 0.43264075067024127, "term": "perspective", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.658694645436359e-07}, {"x": 0.07221849865951743, "y": 0.6472855227882037, "term": "fasting", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 8.889002470587124e-06}, {"x": 0.07238605898123325, "y": 0.43314343163538876, "term": "causation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.808915829648502e-06}, {"x": 0.07255361930294907, "y": 0.6114276139410187, "term": "workforce", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.2144456927211242e-06}, {"x": 0.07272117962466489, "y": 0.4343163538873995, "term": "programmes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.4205909357551095e-07}, {"x": 0.0728887399463807, "y": 0.6115951742627346, "term": "grassroots", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 4.468260984740889e-06}, {"x": 0.07305630026809651, "y": 0.8664544235924933, "term": "fctc", "cat25k": 4, "ncat25k": 0, "cat": 28, "ncat": 0, "s": 0.9854222520107239, "os": 0.9162969607966494, "bg": 0.00015140864110744606}, {"x": 0.07322386058981233, "y": 0.5740616621983914, "term": "9211", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.07339142091152814, "y": 0.4346514745308311, "term": "disseminating", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.358175761065318e-06}, {"x": 0.07355898123324396, "y": 0.7404490616621984, "term": "interaction", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 1.2104495079901017e-06}, {"x": 0.07372654155495978, "y": 0.6120978552278821, "term": "dependents", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 8.148246875583836e-06}, {"x": 0.0738941018766756, "y": 0.435656836461126, "term": "clinically significant", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07406166219839141, "y": 0.5182640750670241, "term": "recurrent", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.958303233735826e-06}, {"x": 0.07422922252010723, "y": 0.6990616621983914, "term": "distance", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 3.3353857073385824e-07}, {"x": 0.07439678284182305, "y": 0.5191018766756033, "term": "visibility", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.290953898745322e-06}, {"x": 0.07456434316353887, "y": 0.4363270777479893, "term": "detoxification", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.516117208658291e-06}, {"x": 0.07473190348525469, "y": 0.4364946380697051, "term": "coordinative", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.4336747576212044e-05}, {"x": 0.0748994638069705, "y": 0.4366621983914209, "term": "npmc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.07506702412868632, "y": 0.6127680965147453, "term": "6675", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.07523458445040214, "y": 0.7206769436997319, "term": "generics", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 2.1558440031279334e-05}, {"x": 0.07540214477211796, "y": 0.9262734584450402, "term": "pitc", "cat25k": 8, "ncat25k": 0, "cat": 52, "ncat": 0, "s": 0.9951407506702413, "os": 0.9620570447390064, "bg": 0.0003333237182260768}, {"x": 0.07556970509383377, "y": 0.7558646112600537, "term": "bayan", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 5.145845125895081e-05}, {"x": 0.07573726541554959, "y": 0.4371648793565684, "term": "qualified botika", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07590482573726541, "y": 0.7560321715817694, "term": "ng bayan", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 0, "s": 0.9646447721179625, "os": 0.8692615152577313, "bg": 0.0}, {"x": 0.07607238605898123, "y": 0.9296246648793566, "term": "bnb express", "cat25k": 9, "ncat25k": 0, "cat": 55, "ncat": 0, "s": 0.995475871313673, "os": 0.9659002167422814, "bg": 0.0}, {"x": 0.07623994638069705, "y": 0.43733243967828417, "term": "pltc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.07640750670241286, "y": 0.4375, "term": "ll", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.213036317061184e-07}, {"x": 0.07657506702412868, "y": 0.8614276139410187, "term": "express outlet", "cat25k": 4, "ncat25k": 0, "cat": 27, "ncat": 0, "s": 0.9849195710455764, "os": 0.9136801177204308, "bg": 0.0}, {"x": 0.0767426273458445, "y": 0.5196045576407506, "term": "outlet operator", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.07691018766756032, "y": 0.4378351206434316, "term": "slto", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.07707774798927614, "y": 0.6134383378016086, "term": "a0 144", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.07724530831099195, "y": 0.5197721179624665, "term": "owners", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.6422337591333446e-07}, {"x": 0.07741286863270777, "y": 0.5754021447721179, "term": "margins", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.531147884002555e-06}, {"x": 0.07758042895442359, "y": 0.5199396782841823, "term": "prevailing market", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.0777479892761394, "y": 0.43817024128686327, "term": "supervising bnbs", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07791554959785522, "y": 0.8165214477211796, "term": "pmu", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 8.140008140008139e-05}, {"x": 0.07808310991957104, "y": 0.6489611260053619, "term": "50 pmu", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.07825067024128686, "y": 0.4385053619302949, "term": "circumstance", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.1409069761507005e-06}, {"x": 0.07841823056300268, "y": 0.6491286863270778, "term": "agree", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 3.3463789126594273e-07}, {"x": 0.0785857908847185, "y": 0.4390080428954424, "term": "hereto", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 6.273914397143488e-06}, {"x": 0.07875335120643431, "y": 0.6997319034852547, "term": "pccp", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 5.962638109605214e-05}, {"x": 0.07892091152815013, "y": 0.5209450402144772, "term": "oncologists", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.59857279420933e-05}, {"x": 0.07908847184986595, "y": 0.5214477211796247, "term": "immunopathology", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.7600216385696464e-05}, {"x": 0.07925603217158177, "y": 0.4395107238605898, "term": "immunopathology hematology", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07942359249329758, "y": 0.43967828418230565, "term": "iealth", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.0795911528150134, "y": 0.4398458445040214, "term": "enroll themselves", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07975871313672922, "y": 0.4401809651474531, "term": "starting cy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.07992627345844504, "y": 0.4403485254691689, "term": "tax deduction", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08009383378016086, "y": 0.5764075067024129, "term": "value added", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.08026139410187667, "y": 0.5216152815013405, "term": "added tax", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.08042895442359249, "y": 0.5765750670241286, "term": "generic alternatives", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.08059651474530831, "y": 0.4405160857908847, "term": "honored", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.6421611744244072e-06}, {"x": 0.08076407506702413, "y": 0.7210120643431636, "term": "picture", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 1.7680829823065766e-07}, {"x": 0.08093163538873994, "y": 0.5769101876675603, "term": "authorization letter", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.08109919571045576, "y": 0.5217828418230563, "term": "bir", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.0126448968266747e-05}, {"x": 0.08126675603217158, "y": 0.5770777479892761, "term": "deduct", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 7.413782344942287e-06}, {"x": 0.0814343163538874, "y": 0.7409517426273459, "term": "discounted prices", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 0.0}, {"x": 0.08160187667560322, "y": 0.6142761394101877, "term": "entrance", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.0834088624083125e-06}, {"x": 0.08176943699731903, "y": 0.5221179624664879, "term": "main entrance", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.08193699731903485, "y": 0.4406836461126005, "term": "aggrieved", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 9.510585281418219e-06}, {"x": 0.08210455764075067, "y": 0.44085120643431636, "term": "writing copy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08227211796246649, "y": 0.4410187667560322, "term": "aggrieved party", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0824396782841823, "y": 0.44118632707774796, "term": "inscribe", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.990232931886766e-05}, {"x": 0.08260723860589812, "y": 0.4413538873994638, "term": "inscribe his", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08277479892761394, "y": 0.5222855227882037, "term": "obliged", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.5313377978860005e-06}, {"x": 0.08294235924932976, "y": 0.8592493297587132, "term": "p100", "cat25k": 4, "ncat25k": 0, "cat": 26, "ncat": 0, "s": 0.9837466487935658, "os": 0.9109954868852783, "bg": 0.0}, {"x": 0.08310991957104558, "y": 0.5227882037533512, "term": "lost", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.3322565502991196e-07}, {"x": 0.0832774798927614, "y": 0.6147788203753352, "term": "interdisciplinary", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 3.35364604805152e-06}, {"x": 0.08344504021447721, "y": 0.4421916890080429, "term": "acquiring", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.231928631850068e-06}, {"x": 0.08361260053619303, "y": 0.6154490616621984, "term": "navigation", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.239465323175161e-07}, {"x": 0.08378016085790885, "y": 0.5232908847184986, "term": "expectancy", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.600463542706564e-06}, {"x": 0.08394772117962467, "y": 0.5779155495978552, "term": "nccc", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.961917150240779e-05}, {"x": 0.08411528150134048, "y": 0.5234584450402144, "term": "pcpcp", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.0842828418230563, "y": 0.5241286863270778, "term": "csc", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.202353401952161e-06}, {"x": 0.08445040214477212, "y": 0.675603217158177, "term": "botica", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.769859535975074e-05}, {"x": 0.08461796246648794, "y": 0.5785857908847185, "term": "revolving", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 5.206026322536758e-06}, {"x": 0.08478552278820375, "y": 0.443029490616622, "term": "rf", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 5.77935213751506e-07}, {"x": 0.08495308310991957, "y": 0.4431970509383378, "term": "revolving fund", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08512064343163539, "y": 0.5244638069705094, "term": "profit", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.8518065567139337e-07}, {"x": 0.08528820375335121, "y": 0.9029825737265416, "term": "mns", "cat25k": 6, "ncat25k": 0, "cat": 40, "ncat": 0, "s": 0.9921246648793566, "os": 0.9428947637796876, "bg": 0.00014253135689851768}, {"x": 0.08545576407506703, "y": 0.4436997319034853, "term": "schizophrenia", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.9682067949674057e-06}, {"x": 0.08562332439678284, "y": 0.6506367292225201, "term": "suicide", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.4149035862588457e-06}, {"x": 0.08579088471849866, "y": 0.6166219839142091, "term": "epilepsy", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 4.590275305040188e-06}, {"x": 0.08595844504021448, "y": 0.6762734584450402, "term": "nmhp", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.769859535975074e-05}, {"x": 0.0861260053619303, "y": 0.4442024128686327, "term": "dimensions", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.5445422688880907e-07}, {"x": 0.08629356568364611, "y": 0.5795911528150134, "term": "pharmacologic", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.0495583201820007e-05}, {"x": 0.08646112600536193, "y": 0.7888739946380697, "term": "smoker", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 1.4347575394266889e-05}, {"x": 0.08662868632707775, "y": 0.6766085790884718, "term": "treaty", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.915269539606444e-06}, {"x": 0.08679624664879357, "y": 0.651642091152815, "term": "packet", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.034070824027773e-06}, {"x": 0.08696380697050939, "y": 0.5251340482573726, "term": "impression", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.213843987788244e-06}, {"x": 0.0871313672922252, "y": 0.6174597855227882, "term": "principal display", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.08729892761394102, "y": 0.4450402144772118, "term": "false misleading", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08746648793565684, "y": 0.4452077747989276, "term": "misleading deceptive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08763404825737266, "y": 0.4453753351206434, "term": "erroneous impression", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08780160857908847, "y": 0.44587801608579086, "term": "posed", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.042458108545926e-06}, {"x": 0.08796916890080429, "y": 0.5253016085790885, "term": "exporters", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.1261057078496887e-06}, {"x": 0.08813672922252011, "y": 0.8166890080428955, "term": "wholesalers", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 9.666188359925102e-06}, {"x": 0.08830428954423593, "y": 0.8305965147453083, "term": "retailers", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 4.1998164680203475e-06}, {"x": 0.08847184986595175, "y": 0.4460455764075067, "term": "concessionaires", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.037557274461512e-05}, {"x": 0.08863941018766756, "y": 0.4462131367292225, "term": "sellers", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.1333124822725138e-07}, {"x": 0.08880697050938338, "y": 0.6519772117962467, "term": "manufacturers importers", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.0889745308310992, "y": 0.44638069705093836, "term": "importers exporters", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08914209115281502, "y": 0.44654825737265413, "term": "exporters wholesalers", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08930965147453084, "y": 0.44671581769436997, "term": "wholesalers distributors", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08947721179624665, "y": 0.4468833780160858, "term": "retailers concessionaires", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.08964477211796247, "y": 0.5807640750670241, "term": "carton", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 5.128056107771227e-06}, {"x": 0.08981233243967829, "y": 0.44738605898123324, "term": "carton purchased", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0899798927613941, "y": 0.525804289544236, "term": "inserts", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.5518432474144724e-06}, {"x": 0.09014745308310992, "y": 0.5259718498659517, "term": "onserts", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.09031501340482574, "y": 0.5261394101876675, "term": "occupy", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.7463454400232575e-06}, {"x": 0.09048257372654156, "y": 0.4478887399463807, "term": "descriptor", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.182811544534894e-06}, {"x": 0.09065013404825738, "y": 0.6182975871313673, "term": "trademark", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 5.15707549468602e-07}, {"x": 0.0908176943699732, "y": 0.4480563002680965, "term": "ultra", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.618757394704564e-07}, {"x": 0.09098525469168901, "y": 0.44855898123324395, "term": "ninety", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.7593942715664773e-06}, {"x": 0.09115281501340483, "y": 0.526642091152815, "term": "patent", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.5610177746967585e-07}, {"x": 0.09132037533512065, "y": 0.5269772117962467, "term": "branded", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.559482370285433e-06}, {"x": 0.09148793565683647, "y": 0.5271447721179625, "term": "7432", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.09165549597855228, "y": 0.4492292225201072, "term": "killed", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.39666745313671e-07}, {"x": 0.0918230563002681, "y": 0.44939678284182305, "term": "smokes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.1973772757207265e-06}, {"x": 0.09199061662198392, "y": 0.4495643431635389, "term": "clothing", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.099385795143969e-07}, {"x": 0.09215817694369974, "y": 0.5274798927613941, "term": "smoked", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.915753671298341e-06}, {"x": 0.09232573726541556, "y": 0.4497319034852547, "term": "border", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.39755274275939e-07}, {"x": 0.09249329758713137, "y": 0.4500670241286863, "term": "subprogram", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.569904922633123e-05}, {"x": 0.09266085790884719, "y": 0.45023458445040215, "term": "indoor", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 5.640206437195808e-07}, {"x": 0.09282841823056301, "y": 0.4507372654155496, "term": "bilateral agreements", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09299597855227883, "y": 0.8793565683646113, "term": "acetic", "cat25k": 5, "ncat25k": 0, "cat": 31, "ncat": 0, "s": 0.9872654155495979, "os": 0.9237545003383993, "bg": 6.779216235129462e-05}, {"x": 0.09316353887399464, "y": 0.5283176943699732, "term": "hcs", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.2995417815678192e-05}, {"x": 0.09333109919571046, "y": 0.8746648793565683, "term": "acetic acid", "cat25k": 5, "ncat25k": 0, "cat": 30, "ncat": 0, "s": 0.986260053619303, "os": 0.9213327989384801, "bg": 0.0}, {"x": 0.09349865951742628, "y": 0.8307640750670241, "term": "acid wash", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 0.0}, {"x": 0.0936662198391421, "y": 0.4509048257372654, "term": "smear pap", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0938337801608579, "y": 0.8168565683646113, "term": "colposcopy", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 0, "s": 0.9757037533512065, "os": 0.8901845737546732, "bg": 8.448668778833862e-05}, {"x": 0.09400134048257372, "y": 0.528485254691689, "term": "suspicious", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.0417233187634784e-06}, {"x": 0.09416890080428954, "y": 0.45107238605898126, "term": "cin", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.388190282901143e-06}, {"x": 0.09433646112600536, "y": 0.45123994638069703, "term": "aaw", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.095019614621142e-05}, {"x": 0.09450402144772117, "y": 0.5810991957104558, "term": "gently", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.0770387520043425e-06}, {"x": 0.09467158176943699, "y": 0.7012399463806971, "term": "speculum", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 3.210963513821593e-05}, {"x": 0.09483914209115281, "y": 0.45140750670241286, "term": "visualized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 9.435230679596078e-06}, {"x": 0.09500670241286863, "y": 0.5289879356568364, "term": "pink", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.380018450379031e-07}, {"x": 0.09517426273458444, "y": 0.4517426273458445, "term": "os", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.783004556579582e-07}, {"x": 0.09534182305630026, "y": 0.45207774798927614, "term": "shaped", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.252972812231412e-07}, {"x": 0.09550938337801608, "y": 0.6523123324396782, "term": "canal", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.8625960561158284e-06}, {"x": 0.0956769436997319, "y": 0.5293230563002681, "term": "atypical", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 7.995950850489312e-06}, {"x": 0.09584450402144772, "y": 0.45224530831099197, "term": "contour", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.2179323713606156e-06}, {"x": 0.09601206434316353, "y": 0.4524128686327078, "term": "magni\ufb01cation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09617962466487935, "y": 0.5294906166219839, "term": "optic", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.0530377670668516e-06}, {"x": 0.09634718498659517, "y": 0.45291554959785524, "term": "lens", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.470817023385671e-07}, {"x": 0.09651474530831099, "y": 0.6524798927613941, "term": "colposcopic", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 5.128780472168353e-05}, {"x": 0.0966823056300268, "y": 0.7017426273458445, "term": "endocervical", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 5.621941312554638e-05}, {"x": 0.09684986595174262, "y": 0.5816018766756033, "term": "transformation", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0247956130549396e-06}, {"x": 0.09701742627345844, "y": 0.6528150134048257, "term": "junction", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.5596262667576969e-06}, {"x": 0.09718498659517426, "y": 0.5299932975871313, "term": "transformation zone", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.09735254691689008, "y": 0.4534182305630027, "term": "endocervical canal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.0975201072386059, "y": 0.5301608579088471, "term": "capillary", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.819775165652338e-06}, {"x": 0.09768766756032171, "y": 0.4535857908847185, "term": "atypical vessels", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09785522788203753, "y": 0.4539209115281501, "term": "frame", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.7244370316644577e-07}, {"x": 0.09802278820375335, "y": 0.5817694369973191, "term": "hazard", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.443525146147899e-06}, {"x": 0.09819034852546916, "y": 0.4544235924932976, "term": "frail", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.935445153674855e-06}, {"x": 0.09835790884718498, "y": 0.7226876675603218, "term": "surrogate decision", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 0.0}, {"x": 0.0985254691689008, "y": 0.7228552278820375, "term": "decision maker", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 0.0}, {"x": 0.09869302949061662, "y": 0.4550938337801609, "term": "persons\u2019", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09886058981233244, "y": 0.45526139410187666, "term": "older persons\u2019", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09902815013404825, "y": 0.4555965147453083, "term": "culturally sensitive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.09919571045576407, "y": 0.45576407506702415, "term": "tailored", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.6433526283473808e-06}, {"x": 0.09936327077747989, "y": 0.45593163538873993, "term": "carer", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.252269280384515e-06}, {"x": 0.09953083109919571, "y": 0.45609919571045576, "term": "lighting", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.3110145466521762e-07}, {"x": 0.09969839142091153, "y": 0.7788203753351206, "term": "views", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 3.8637235345080157e-07}, {"x": 0.09986595174262734, "y": 0.4564343163538874, "term": "contrasting", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.513111434926856e-06}, {"x": 0.10003351206434316, "y": 0.6531501340482574, "term": "paths", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 1.7547634699482498e-06}, {"x": 0.10020107238605898, "y": 0.4566018766756032, "term": "branches", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.401438284494635e-07}, {"x": 0.1003686327077748, "y": 0.5318364611260054, "term": "external paths", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.10053619302949061, "y": 0.7020777479892761, "term": "\ufb02oor", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 0.0}, {"x": 0.10070375335120643, "y": 0.619470509383378, "term": "surfaces", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 1.569107764976349e-06}, {"x": 0.10087131367292225, "y": 0.6533176943699732, "term": "wheels", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 8.28202746724057e-07}, {"x": 0.10103887399463807, "y": 0.45693699731903487, "term": "brakes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.3292713017803097e-06}, {"x": 0.10120643431635389, "y": 0.4571045576407507, "term": "tread", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 4.031175092578456e-06}, {"x": 0.1013739946380697, "y": 0.4572721179624665, "term": "tires", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 9.616393643227228e-07}, {"x": 0.10154155495978552, "y": 0.45760723860589814, "term": "good tread", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10170911528150134, "y": 0.45777479892761397, "term": "moving freely", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10187667560321716, "y": 0.6776139410187667, "term": "shower", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 8.591759948518174e-07}, {"x": 0.10204423592493297, "y": 0.8309316353887399, "term": "overseas", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 2.784204281045535e-06}, {"x": 0.10221179624664879, "y": 0.5328418230563002, "term": "mentally", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 2.409111452241293e-06}, {"x": 0.10237935656836461, "y": 0.4582774798927614, "term": "pdmt", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.10254691689008043, "y": 0.5330093833780161, "term": "rmht", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.10271447721179625, "y": 0.5831099195710456, "term": "pharmacological", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.0545065656215041e-05}, {"x": 0.10288203753351206, "y": 0.6198056300268097, "term": "ets", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 8.469065226925577e-06}, {"x": 0.10304959785522788, "y": 0.458612600536193, "term": "shs", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.878645227559895e-06}, {"x": 0.1032171581769437, "y": 0.45878016085790885, "term": "\ufb01'om", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10338471849865952, "y": 0.45911528150134046, "term": "adaptation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.421921154116524e-06}, {"x": 0.10355227882037533, "y": 0.5333445040214477, "term": "consistently", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.31295314936759e-06}, {"x": 0.10371983914209115, "y": 0.9113605898123325, "term": "nscp", "cat25k": 7, "ncat25k": 0, "cat": 44, "ncat": 0, "s": 0.9929624664879356, "os": 0.950013611716575, "bg": 0.0002651688643540727}, {"x": 0.10388739946380697, "y": 0.5335120643431636, "term": "schools industrial", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.10405495978552279, "y": 0.5336796246648794, "term": "industrial establishments", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.1042225201072386, "y": 0.6199731903485255, "term": "scc", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 8.157495602235852e-06}, {"x": 0.10439008042895442, "y": 0.45961796246648795, "term": "converting", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.508385207643365e-06}, {"x": 0.10455764075067024, "y": 0.5834450402144772, "term": "seafarers", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 2.019379310112715e-05}, {"x": 0.10472520107238606, "y": 0.534014745308311, "term": "peme", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.2055186208576686e-05}, {"x": 0.10489276139410188, "y": 0.5341823056300268, "term": "10029", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.1050603217158177, "y": 0.45995308310991956, "term": "psychology", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.2992396778440923e-07}, {"x": 0.10522788203753351, "y": 0.5343498659517426, "term": "acronym", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.102390750257528e-06}, {"x": 0.10539544235924933, "y": 0.7791554959785523, "term": "wholesaler", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 1.4083323514127217e-05}, {"x": 0.10556300268096515, "y": 0.6201407506702413, "term": "wholesalers retailers", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.10573056300268097, "y": 0.583612600536193, "term": "wholesaler retailer", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.10589812332439678, "y": 0.5345174262734584, "term": "textual", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 3.9922948708991646e-06}, {"x": 0.1060656836461126, "y": 0.8827077747989276, "term": "phil pen", "cat25k": 5, "ncat25k": 0, "cat": 32, "ncat": 0, "s": 0.9879356568364611, "os": 0.9261138264364877, "bg": 0.0}, {"x": 0.10623324396782842, "y": 0.4609584450402145, "term": "126", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10640080428954424, "y": 0.46112600536193027, "term": "glucose concentration", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10656836461126006, "y": 0.4612935656836461, "term": "126 mg", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10673592493297587, "y": 0.5839477211796247, "term": "prediction", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.6100006802252874e-06}, {"x": 0.10690348525469169, "y": 0.46162868632707776, "term": "heart attack", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10707104557640751, "y": 0.8748324396782842, "term": "compack", "cat25k": 5, "ncat25k": 0, "cat": 30, "ncat": 0, "s": 0.986260053619303, "os": 0.9213327989384801, "bg": 0.00019231570546208657}, {"x": 0.10723860589812333, "y": 0.5350201072386059, "term": "mmhg", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.3896165075324163e-05}, {"x": 0.10740616621983914, "y": 0.46229892761394104, "term": "2140/90", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10757372654155496, "y": 0.4624664879356568, "term": "tc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 7.176887122098766e-07}, {"x": 0.10774128686327078, "y": 0.5841152815013405, "term": "visually impaired", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.1079088471849866, "y": 0.46263404825737264, "term": "monocular", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.1009623787393154e-05}, {"x": 0.10807640750670242, "y": 0.4629691689008043, "term": "count fingers", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10824396782841823, "y": 0.8310991957104558, "term": "cataract", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 3.07610728876298e-05}, {"x": 0.10841152815013405, "y": 0.7890415549597856, "term": "acuity", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 0, "s": 0.9716823056300269, "os": 0.8801022855002765, "bg": 3.0727217208778e-05}, {"x": 0.10857908847184987, "y": 0.5842828418230563, "term": "refraction", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 1.4191492909575356e-05}, {"x": 0.10874664879356569, "y": 0.7793230563002681, "term": "visual acuity", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 0.0}, {"x": 0.1089142091152815, "y": 0.7230227882037533, "term": "sight", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 1.6090731833545475e-06}, {"x": 0.10908176943699732, "y": 0.5353552278820375, "term": "cataract surgeries", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.10924932975871314, "y": 0.4633042895442359, "term": "sight preservation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.10941689008042896, "y": 0.6781166219839142, "term": "refractive", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.4769642804394132e-05}, {"x": 0.10958445040214478, "y": 0.5355227882037533, "term": "refractive errors", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.1097520107238606, "y": 0.4639745308310992, "term": "ophthalmology", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.857955852446692e-06}, {"x": 0.10991957104557641, "y": 0.5356903485254692, "term": "optometric", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 1.90425772985819e-05}, {"x": 0.11008713136729223, "y": 0.7027479892761395, "term": "pmc", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 2.2488895545601973e-06}, {"x": 0.11025469168900805, "y": 0.6208109919571045, "term": "10754", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 0.0}, {"x": 0.11042225201072386, "y": 0.535857908847185, "term": "9442", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.11058981233243968, "y": 0.6209785522788204, "term": "ncda", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 3.929515715256064e-05}, {"x": 0.1107573726541555, "y": 0.7231903485254692, "term": "9502", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 0.0}, {"x": 0.11092493297587132, "y": 0.4644772117962466, "term": "cheaper", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.79311912049464e-07}, {"x": 0.11109249329758714, "y": 0.5847855227882037, "term": "intellectual property", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.11126005361930295, "y": 0.5360254691689008, "term": "te", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 6.506448410891066e-07}, {"x": 0.11142761394101877, "y": 0.5852882037533512, "term": "pharma inc.", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 0.0}, {"x": 0.11159517426273459, "y": 0.4648123324396783, "term": "spatula", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.014166640256077e-05}, {"x": 0.11176273458445041, "y": 0.4649798927613941, "term": "degrees", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.816581369433832e-07}, {"x": 0.11193029490616623, "y": 0.46531501340482573, "term": "dirfo", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.11209785522788204, "y": 0.46548257372654156, "term": "dirfos", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.11226541554959786, "y": 0.5361930294906166, "term": "checks", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.385873732274163e-07}, {"x": 0.11243297587131368, "y": 0.46581769436997317, "term": "ageing", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.095140358811884e-06}, {"x": 0.1126005361930295, "y": 0.703083109919571, "term": "aquino", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 3.274195898414798e-05}, {"x": 0.11276809651474531, "y": 0.7032506702412868, "term": "organ", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 2.130057929055439e-06}, {"x": 0.11293565683646113, "y": 0.6543230563002681, "term": "hwpsc", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 5.128780472168353e-05}, {"x": 0.11310321715817695, "y": 0.6784517426273459, "term": "unbranded", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.2771564254094527e-05}, {"x": 0.11327077747989277, "y": 0.6786193029490617, "term": "unbranded generic", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 0.0}, {"x": 0.11343833780160859, "y": 0.5363605898123325, "term": "balance billing", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.1136058981233244, "y": 0.46615281501340483, "term": "suc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 8.575888033205839e-06}, {"x": 0.11377345844504022, "y": 0.536695710455764, "term": "catastrophic", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 4.849672283395451e-06}, {"x": 0.11394101876675604, "y": 0.7035857908847185, "term": "nhts", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 6.410934489865916e-05}, {"x": 0.11410857908847186, "y": 0.4668230563002681, "term": "ewebpais", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.5644231169921883e-05}, {"x": 0.11427613941018767, "y": 0.46699061662198393, "term": "authorize release", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11444369973190349, "y": 0.5859584450402144, "term": "hcwp", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 0, "s": 0.9138739946380697, "os": 0.8407713837304778, "bg": 3.846610014649173e-05}, {"x": 0.1146112600536193, "y": 0.4671581769436997, "term": "ppp", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.5427554422144556e-06}, {"x": 0.11477882037533511, "y": 0.8887399463806971, "term": "clubs", "cat25k": 5, "ncat25k": 0, "cat": 34, "ncat": 0, "s": 0.9892761394101877, "os": 0.9306505378807958, "bg": 1.9321601522087574e-06}, {"x": 0.11494638069705093, "y": 0.6787868632707775, "term": "pr", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 5.82313470599284e-07}, {"x": 0.11511394101876675, "y": 0.5368632707774799, "term": "nhts pr", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.11528150134048257, "y": 0.6211461126005362, "term": "hwop", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 4.4876972984062266e-05}, {"x": 0.11544906166219839, "y": 0.46732573726541554, "term": "polyvalent", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 2.1527250808617357e-05}, {"x": 0.1156166219839142, "y": 0.4674932975871314, "term": "\ufb01lled syringe", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11578418230563002, "y": 0.537701072386059, "term": "x\u2019", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 0.0}, {"x": 0.11595174262734584, "y": 0.621313672922252, "term": "hsra", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 4.4876972984062266e-05}, {"x": 0.11611930294906166, "y": 0.8312667560321716, "term": "ppi", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 0, "s": 0.9773793565683646, "os": 0.8965056730307135, "bg": 3.385554162820973e-05}, {"x": 0.11628686327077747, "y": 0.4683310991957105, "term": "inc. ppi", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11645442359249329, "y": 0.46849865951742625, "term": "23 july", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11662198391420911, "y": 0.6789544235924933, "term": "ndp", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 1.0227429625340844e-05}, {"x": 0.11678954423592493, "y": 0.6791219839142091, "term": "ndp pmu", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 0.0}, {"x": 0.11695710455764075, "y": 0.6792895442359249, "term": "pmu 50", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 0, "s": 0.9443699731903485, "os": 0.8535521208182848, "bg": 0.0}, {"x": 0.11712466487935656, "y": 0.5380361930294906, "term": "receptor", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 0, "s": 0.8910857908847185, "os": 0.836312098399492, "bg": 9.86623652506414e-07}, {"x": 0.11729222520107238, "y": 0.723357908847185, "term": "aha", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 1.2110109519426816e-05}, {"x": 0.1174597855227882, "y": 0.7235254691689008, "term": "pcsi", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 6.723942430827441e-05}, {"x": 0.11762734584450402, "y": 0.46933646112600536, "term": "navigator", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.3279286636721875e-06}, {"x": 0.11779490616621983, "y": 0.4695040214477212, "term": "quintile", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 1.209001621573425e-05}, {"x": 0.11796246648793565, "y": 0.7412868632707775, "term": "uhc", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 0, "s": 0.9594504021447722, "os": 0.8654718946127837, "bg": 5.311038772795974e-05}, {"x": 0.11813002680965147, "y": 0.469671581769437, "term": "sdn", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 3.7725652453369913e-06}, {"x": 0.11829758713136729, "y": 0.7796581769436998, "term": "compacks", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 0, "s": 0.9691689008042895, "os": 0.8765750955079443, "bg": 8.778603616784689e-05}, {"x": 0.1184651474530831, "y": 0.6216487935656837, "term": "habilitation", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 0, "s": 0.9284517426273459, "os": 0.8451300469074743, "bg": 2.824163543276272e-05}, {"x": 0.11863270777479892, "y": 0.4700067024128686, "term": "habilitation assistive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11880026809651474, "y": 0.47017426273458446, "term": "internationally comparable", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11896782841823056, "y": 0.7236930294906166, "term": "philpen", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 0, "s": 0.9562667560321716, "os": 0.8615915492278902, "bg": 7.052005333880398e-05}, {"x": 0.11913538873994638, "y": 0.8969504021447721, "term": "club", "cat25k": 6, "ncat25k": 0, "cat": 37, "ncat": 0, "s": 0.9909517426273459, "os": 0.9370196544566375, "bg": 5.574787358211405e-07}, {"x": 0.1193029490616622, "y": 0.6548257372654156, "term": "fbs", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 2.8805265602552148e-05}, {"x": 0.11947050938337801, "y": 0.7037533512064343, "term": "bp", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 0, "s": 0.9507372654155497, "os": 0.857618839930711, "bg": 1.9065522481110832e-06}, {"x": 0.11963806970509383, "y": 0.6549932975871313, "term": "organ damage", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 0, "s": 0.9371648793565683, "os": 0.8493897410689546, "bg": 0.0}, {"x": 0.11980563002680965, "y": 0.47050938337801607, "term": "inputs processes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 0, "s": 0.8498659517426274, "os": 0.8317505417086504, "bg": 0.0}, {"x": 0.11997319034852547, "y": 0.5387064343163539, "term": "rizal", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.5850480818943232e-05}, {"x": 0.12014075067024128, "y": 0.6556635388739946, "term": "lesions", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 6.192912954273388e-06}, {"x": 0.1203083109919571, "y": 0.5393766756032171, "term": "malignant", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 5.102390397009708e-06}, {"x": 0.12047587131367292, "y": 0.47084450402144773, "term": "interpretation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 7.309461525370106e-07}, {"x": 0.12064343163538874, "y": 0.3084785522788204, "term": "interpret", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.4961823038289922e-06}, {"x": 0.12081099195710455, "y": 0.47117962466487934, "term": "anatomical", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 6.894958750909273e-06}, {"x": 0.12097855227882037, "y": 0.3086461126005362, "term": "counterparts", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.6078526354632752e-06}, {"x": 0.12114611260053619, "y": 0.765583109919571, "term": "mellitus", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 1, "s": 0.9435321715817695, "os": 0.8522771154489783, "bg": 2.0132104352246394e-05}, {"x": 0.12131367292225201, "y": 0.9884383378016086, "term": "citizens", "cat25k": 43, "ncat25k": 0, "cat": 268, "ncat": 1, "s": 0.9996648793565684, "os": 0.9983271455584679, "bg": 2.1624738990807195e-05}, {"x": 0.12148123324396783, "y": 0.9874329758713136, "term": "discount", "cat25k": 40, "ncat25k": 0, "cat": 247, "ncat": 1, "s": 0.9994973190348526, "os": 0.9981846308363987, "bg": 5.978844990090125e-06}, {"x": 0.12164879356568364, "y": 0.38019436997319034, "term": "gloria", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.2322255690724254e-06}, {"x": 0.12181635388739946, "y": 0.38036193029490617, "term": "macapagal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.1856155895588775e-05}, {"x": 0.12198391420911528, "y": 0.380529490616622, "term": "arroyo", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.699359904889082e-06}, {"x": 0.1221514745308311, "y": 0.8987935656836461, "term": "prices", "cat25k": 6, "ncat25k": 0, "cat": 39, "ncat": 1, "s": 0.988941018766756, "os": 0.9305666408320525, "bg": 3.2820819148158207e-07}, {"x": 0.12231903485254692, "y": 0.3806970509383378, "term": "president gloria", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.12248659517426273, "y": 0.3808646112600536, "term": "gloria macapagal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.12265415549597855, "y": 0.6806300268096515, "term": "instrument", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 1.0829318035510514e-06}, {"x": 0.12282171581769437, "y": 0.7052613941018767, "term": "operator", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 9.308424403337752e-07}, {"x": 0.12298927613941019, "y": 0.7441353887399463, "term": "counter", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 7.852438985777859e-07}, {"x": 0.123156836461126, "y": 0.3843833780160858, "term": "limitation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.1355733805247348e-06}, {"x": 0.12332439678284182, "y": 0.5888069705093834, "term": "chapter", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 1.8141651123145653e-07}, {"x": 0.12349195710455764, "y": 0.681132707774799, "term": "safeguard", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 7.867983814842023e-06}, {"x": 0.12365951742627346, "y": 0.38455093833780163, "term": "stands", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.153955611969608e-07}, {"x": 0.12382707774798928, "y": 0.38488605898123324, "term": "costly", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.8632685120850664e-06}, {"x": 0.1239946380697051, "y": 0.8386394101876675, "term": "ethical", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 1, "s": 0.9746983914209116, "os": 0.8859768261822922, "bg": 4.3809382819803704e-06}, {"x": 0.12416219839142091, "y": 0.4725201072386059, "term": "accountable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 3.1467007629176e-06}, {"x": 0.12432975871313673, "y": 0.767426273458445, "term": "selling", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 1, "s": 0.9435321715817695, "os": 0.8522771154489783, "bg": 7.160800222110121e-07}, {"x": 0.12449731903485255, "y": 0.3855563002680965, "term": "xiv", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 3.889367713269589e-06}, {"x": 0.12466487935656836, "y": 0.38572386058981234, "term": "salary", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 4.658047384732309e-07}, {"x": 0.12483243967828418, "y": 0.6253351206434317, "term": "principle", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.0622291610702927e-06}, {"x": 0.125, "y": 0.4730227882037534, "term": "accurately", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.7391821061350373e-06}, {"x": 0.1251675603217158, "y": 0.9582774798927614, "term": "substance", "cat25k": 14, "ncat25k": 0, "cat": 87, "ncat": 1, "s": 0.9979892761394102, "os": 0.9853860818486522, "bg": 1.0667368126934407e-05}, {"x": 0.12533512064343164, "y": 0.7067694369973191, "term": "cognitive", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 2.815608277559848e-06}, {"x": 0.12550268096514744, "y": 0.3113270777479893, "term": "controlling", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 9.041617889021826e-07}, {"x": 0.12567024128686327, "y": 0.38605898123324395, "term": "performs", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.5533324261871965e-06}, {"x": 0.12583780160857908, "y": 0.6580093833780161, "term": "mandatory", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 1.961483524911429e-06}, {"x": 0.1260053619302949, "y": 0.4745308310991957, "term": "psychologist", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.013139017142124e-06}, {"x": 0.1261729222520107, "y": 0.4746983914209115, "term": "dynamic", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.059059175704529e-07}, {"x": 0.12634048257372654, "y": 0.6823056300268097, "term": "spiritual", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 1.0911310143327498e-06}, {"x": 0.12650804289544235, "y": 0.3873994638069705, "term": "money", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.248874491716053e-08}, {"x": 0.12667560321715818, "y": 0.31182975871313673, "term": "presumptive", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.1833216726843503e-05}, {"x": 0.12684316353887398, "y": 0.9691689008042895, "term": "smoking", "cat25k": 18, "ncat25k": 0, "cat": 112, "ncat": 1, "s": 0.9986595174262736, "os": 0.9931402544659718, "bg": 8.11819604919009e-06}, {"x": 0.1270107238605898, "y": 0.31233243967828417, "term": "unexpected", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.1106353889528429e-06}, {"x": 0.12717828418230562, "y": 0.3125, "term": "well-", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.12734584450402145, "y": 0.5449061662198391, "term": "vice chairperson", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 0.0}, {"x": 0.12751340482573725, "y": 0.31300268096514744, "term": "salient", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.669200963032619e-06}, {"x": 0.12768096514745308, "y": 0.545073726541555, "term": "features", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 8.680929533100173e-08}, {"x": 0.1278485254691689, "y": 0.3133378016085791, "term": "cooperating", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.594234350745672e-06}, {"x": 0.12801608579088472, "y": 0.6276809651474531, "term": "paragraph", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 7.152092139926232e-07}, {"x": 0.12818364611260052, "y": 0.545911528150134, "term": "police", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.170202267191707e-07}, {"x": 0.12835120643431636, "y": 0.6588471849865952, "term": "complaints", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 1.4598335556173227e-06}, {"x": 0.12851876675603216, "y": 0.6844839142091153, "term": "heavy", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 5.79250392593536e-07}, {"x": 0.128686327077748, "y": 0.47670911528150134, "term": "satisfactory", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.6908102630492156e-06}, {"x": 0.1288538873994638, "y": 0.5465817694369973, "term": "prejudice", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.7858251643985077e-06}, {"x": 0.12902144772117963, "y": 0.4773793565683646, "term": "without prejudice", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.12918900804289543, "y": 0.5908176943699732, "term": "helshe", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 5.128780472168353e-05}, {"x": 0.12935656836461126, "y": 0.728887399463807, "term": "determination", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 1, "s": 0.8902479892761395, "os": 0.8356225954175445, "bg": 1.4815068063841547e-06}, {"x": 0.12952412868632707, "y": 0.708612600536193, "term": "neurological", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 8.956614161004097e-06}, {"x": 0.1296916890080429, "y": 0.39041554959785524, "term": "administratively", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.262363270278288e-05}, {"x": 0.1298592493297587, "y": 0.7697721179624665, "term": "disciplinary", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 1, "s": 0.9435321715817695, "os": 0.8522771154489783, "bg": 5.459315221031466e-06}, {"x": 0.13002680965147453, "y": 0.31467828418230565, "term": "uniform", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.458075464852349e-07}, {"x": 0.13019436997319034, "y": 0.39075067024128685, "term": "format", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 8.961248942886269e-08}, {"x": 0.13036193029490617, "y": 0.3909182305630027, "term": "reliance", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.5703053992752726e-06}, {"x": 0.13052949061662197, "y": 0.3910857908847185, "term": "self reliance", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1306970509383378, "y": 0.9762064343163539, "term": "pwds", "cat25k": 23, "ncat25k": 0, "cat": 142, "ncat": 1, "s": 0.999162198391421, "os": 0.9963278250540295, "bg": 0.0008491182233834096}, {"x": 0.1308646112600536, "y": 0.7598860589812333, "term": "intellectual", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 1, "s": 0.9359919571045576, "os": 0.8470778420720038, "bg": 1.5072582775986902e-06}, {"x": 0.13103217158176944, "y": 0.7464812332439679, "term": "moving", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 5.376566251355087e-07}, {"x": 0.13119973190348524, "y": 0.3148458445040214, "term": "piloted", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.031349146494122e-05}, {"x": 0.13136729222520108, "y": 0.47989276139410186, "term": "revealed", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 8.985783591779446e-07}, {"x": 0.13153485254691688, "y": 0.770274798927614, "term": "thrusts", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 1, "s": 0.9435321715817695, "os": 0.8522771154489783, "bg": 4.869853173926806e-05}, {"x": 0.1317024128686327, "y": 0.48073056300268097, "term": "advanced", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 6.907105940799518e-08}, {"x": 0.13186997319034852, "y": 0.8982908847184986, "term": "availment", "cat25k": 6, "ncat25k": 0, "cat": 38, "ncat": 1, "s": 0.9886058981233244, "os": 0.9283703665740268, "bg": 0.000250003205169297}, {"x": 0.13203753351206435, "y": 0.4808981233243968, "term": "regulate", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 2.8483712301213355e-06}, {"x": 0.13220509383378015, "y": 0.954926273458445, "term": "palliative", "cat25k": 13, "ncat25k": 0, "cat": 81, "ncat": 1, "s": 0.9973190348525469, "os": 0.9822087929995769, "bg": 9.587363387379172e-05}, {"x": 0.13237265415549598, "y": 0.3922587131367292, "term": "preventive curative", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1325402144772118, "y": 0.39242627345844505, "term": "curative rehabilitative", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.13270777479892762, "y": 0.3153485254691689, "term": "traumatic", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.895573319897873e-06}, {"x": 0.13287533512064342, "y": 0.39276139410187666, "term": "ear", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.585527697017256e-07}, {"x": 0.13304289544235925, "y": 0.39343163538873993, "term": "muscles", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.6214577229220614e-06}, {"x": 0.13321045576407506, "y": 0.3165214477211796, "term": "socially", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.1617549342731923e-06}, {"x": 0.1333780160857909, "y": 0.7473190348525469, "term": "mission", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 5.280200436408567e-07}, {"x": 0.1335455764075067, "y": 0.6310321715817694, "term": "dignity", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 4.109551510945106e-06}, {"x": 0.13371313672922253, "y": 0.5504356568364611, "term": "standardization", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 6.026230459409678e-06}, {"x": 0.13388069705093833, "y": 0.5511058981233244, "term": "compensation", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 5.577315940606366e-07}, {"x": 0.13404825737265416, "y": 0.48374664879356566, "term": "modi\ufb01cation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.13421581769436997, "y": 0.31786193029490617, "term": "a1", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1343833780160858, "y": 0.784014745308311, "term": "assistant", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 1, "s": 0.950402144772118, "os": 0.8571928828044061, "bg": 9.705679826636005e-07}, {"x": 0.1345509383378016, "y": 0.3181970509383378, "term": "title", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.061161539512832e-08}, {"x": 0.13471849865951743, "y": 0.6881702412868632, "term": "multi disciplinary", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 0.0}, {"x": 0.13488605898123324, "y": 0.3183646112600536, "term": "prepares", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.1753962144298925e-06}, {"x": 0.13505361930294907, "y": 0.5945040214477212, "term": "plantilla", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 5.128780472168353e-05}, {"x": 0.13522117962466487, "y": 0.3949396782841823, "term": "attract", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.2624754669454888e-06}, {"x": 0.1353887399463807, "y": 0.48441689008042893, "term": "plantilla positions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.1355563002680965, "y": 0.31853217158176944, "term": "situational", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.844334174616076e-06}, {"x": 0.13572386058981234, "y": 0.3186997319034853, "term": "situational analysis", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.13589142091152814, "y": 0.8195375335120644, "term": "transparency", "cat25k": 3, "ncat25k": 0, "cat": 20, "ncat": 1, "s": 0.9684986595174263, "os": 0.8746498767192079, "bg": 7.3615244665523885e-06}, {"x": 0.13605898123324398, "y": 0.48542225201072386, "term": "-provide", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.13622654155495978, "y": 0.3969504021447721, "term": "p1", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1363941018766756, "y": 0.3200402144772118, "term": "expense", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.159365047262364e-07}, {"x": 0.13656166219839141, "y": 0.6337131367292225, "term": "household targeting", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 0.0}, {"x": 0.13672922252010725, "y": 0.48693029490616624, "term": "enter", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.0024546019846311e-07}, {"x": 0.13689678284182305, "y": 0.8063002680965148, "term": "authorization", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 1, "s": 0.9634718498659518, "os": 0.8663130854586677, "bg": 3.619257880695926e-06}, {"x": 0.13706434316353888, "y": 0.5534517426273459, "term": "ingredient", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.7222529988047365e-06}, {"x": 0.13723190348525469, "y": 0.7121313672922251, "term": "wholesale", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 6.874955080046104e-07}, {"x": 0.13739946380697052, "y": 0.48810321715817695, "term": "manufacture", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.2857994699291686e-06}, {"x": 0.13756702412868632, "y": 0.39862600536193027, "term": "holder", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.617369084966527e-07}, {"x": 0.13773458445040215, "y": 0.8738270777479893, "term": "packaging", "cat25k": 5, "ncat25k": 0, "cat": 30, "ncat": 1, "s": 0.9822386058981234, "os": 0.9082341946755605, "bg": 2.9894135223902732e-06}, {"x": 0.13790214477211796, "y": 0.3212131367292225, "term": "replenishment", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.0424308444862574e-05}, {"x": 0.1380697050938338, "y": 0.6650469168900804, "term": "moa", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 2.2266458252617425e-05}, {"x": 0.1382372654155496, "y": 0.3222184986595174, "term": "agreement moa", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.13840482573726542, "y": 0.5544571045576407, "term": "supplier", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 5.919811668802944e-07}, {"x": 0.13857238605898123, "y": 0.6352211796246648, "term": "warehouse", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.2127606677460236e-06}, {"x": 0.13873994638069706, "y": 0.5546246648793566, "term": "invoice", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.7461719545326757e-06}, {"x": 0.13890750670241286, "y": 0.40097184986595175, "term": "invoice receipt", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1390750670241287, "y": 0.48910857908847183, "term": "veri\ufb01cation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.1392426273458445, "y": 0.3230563002680965, "term": "capacitate", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.5644231169921883e-05}, {"x": 0.13941018766756033, "y": 0.4894436997319035, "term": "\ufb01nd", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.13957774798927614, "y": 0.4014745308310992, "term": ":", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.13974530831099197, "y": 0.5549597855227882, "term": "magnitude", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.05302795226886e-06}, {"x": 0.13991286863270777, "y": 0.7129691689008043, "term": "paying", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 1.2040054854489918e-06}, {"x": 0.1400804289544236, "y": 0.8426608579088471, "term": "con\ufb01ned", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 1, "s": 0.9746983914209116, "os": 0.8859768261822922, "bg": 0.0}, {"x": 0.1402479892761394, "y": 0.9011394101876675, "term": "phil", "cat25k": 6, "ncat25k": 0, "cat": 39, "ncat": 1, "s": 0.988941018766756, "os": 0.9305666408320525, "bg": 5.351342742197926e-06}, {"x": 0.14041554959785524, "y": 0.3242292225201072, "term": "ethnic", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.817059229897945e-07}, {"x": 0.14058310991957104, "y": 0.5557975871313673, "term": "kidney", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.7887681967236153e-06}, {"x": 0.14075067024128687, "y": 0.835455764075067, "term": "tax", "cat25k": 4, "ncat25k": 0, "cat": 22, "ncat": 1, "s": 0.973357908847185, "os": 0.8823416833828224, "bg": 3.124604521013377e-07}, {"x": 0.14091823056300268, "y": 0.9026474530831099, "term": "exemption", "cat25k": 6, "ncat25k": 0, "cat": 40, "ncat": 1, "s": 0.989946380697051, "os": 0.9326992793057585, "bg": 1.1461784244771155e-05}, {"x": 0.1410857908847185, "y": 0.4912868632707775, "term": "relationships", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 3.9784784209816994e-07}, {"x": 0.1412533512064343, "y": 0.40365281501340483, "term": "describe", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 4.0114700766194795e-07}, {"x": 0.14142091152815014, "y": 0.5995308310991957, "term": "served", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 4.870066474276719e-07}, {"x": 0.14158847184986595, "y": 0.40415549597855227, "term": "league", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.414235957572411e-07}, {"x": 0.14175603217158178, "y": 0.3257372654155496, "term": "real", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.6846857944757447e-08}, {"x": 0.14192359249329758, "y": 0.3259048257372654, "term": "2022", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.14209115281501342, "y": 0.7342493297587132, "term": "empower", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 1, "s": 0.8902479892761395, "os": 0.8356225954175445, "bg": 1.150386994609552e-05}, {"x": 0.14225871313672922, "y": 0.7617292225201072, "term": "socio economic", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 1, "s": 0.9359919571045576, "os": 0.8470778420720038, "bg": 0.0}, {"x": 0.14242627345844505, "y": 0.49279490616621985, "term": "neglected", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 3.942106227936524e-06}, {"x": 0.14259383378016086, "y": 0.49313002680965146, "term": "noncommunicable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 3.4981343283582085e-05}, {"x": 0.1427613941018767, "y": 0.4932975871313673, "term": "lifestyles", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 3.1652673107809794e-06}, {"x": 0.1429289544235925, "y": 0.3269101876675603, "term": "freedom", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.039688358055461e-07}, {"x": 0.14309651474530832, "y": 0.714142091152815, "term": "revenue", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 7.407365112267106e-07}, {"x": 0.14326407506702413, "y": 0.32707774798927614, "term": "harness", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.581910536631511e-06}, {"x": 0.14343163538873996, "y": 0.6005361930294906, "term": "colleges", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 7.106566382947368e-07}, {"x": 0.14359919571045576, "y": 0.4063337801608579, "term": "collectively", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.8279047459876982e-06}, {"x": 0.1437667560321716, "y": 0.40650134048257375, "term": "generating", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.0914396099369464e-06}, {"x": 0.1439343163538874, "y": 0.9909517426273459, "term": "tobacco", "cat25k": 51, "ncat25k": 0, "cat": 315, "ncat": 1, "s": 1.0, "os": 0.9985770456876052, "bg": 4.551209022915913e-05}, {"x": 0.14410187667560323, "y": 0.3277479892761394, "term": "premium", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.0457598634905356e-07}, {"x": 0.14426943699731903, "y": 0.869470509383378, "term": "diagnostics", "cat25k": 5, "ncat25k": 0, "cat": 29, "ncat": 1, "s": 0.9810656836461126, "os": 0.9053548894536977, "bg": 1.3990458973328822e-05}, {"x": 0.14443699731903487, "y": 0.32825067024128685, "term": "geographically isolated", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.14460455764075067, "y": 0.5574731903485255, "term": "online", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.327015397327333e-08}, {"x": 0.1447721179624665, "y": 0.5576407506702413, "term": "warehousing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 4.007215277336507e-06}, {"x": 0.1449396782841823, "y": 0.4078418230563003, "term": "investments", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.174000873267867e-07}, {"x": 0.14510723860589814, "y": 0.5579758713136729, "term": "csos", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.4714067070447446e-05}, {"x": 0.14527479892761394, "y": 0.4081769436997319, "term": "leverage", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.2960530847473194e-06}, {"x": 0.14544235924932977, "y": 0.5583109919571045, "term": "harmonize", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.000120007200432e-05}, {"x": 0.14560991957104558, "y": 0.40834450402144773, "term": "unauthorized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.60490716414509e-06}, {"x": 0.1457774798927614, "y": 0.40851206434316356, "term": "declared unauthorized", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1459450402144772, "y": 0.40867962466487934, "term": "rendered invalid", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.14611260053619302, "y": 0.3289209115281501, "term": "smaller", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.162741763439646e-07}, {"x": 0.14628016085790885, "y": 0.558813672922252, "term": "prevalent", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 6.1282207630247665e-06}, {"x": 0.14644772117962465, "y": 0.3295911528150134, "term": "compounded", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.812044299401651e-06}, {"x": 0.14661528150134048, "y": 0.4100201072386059, "term": "chemotherapeutic", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.0866676543560228e-05}, {"x": 0.1467828418230563, "y": 0.3297587131367292, "term": "rizal avenue", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.14695040214477212, "y": 0.41035522788203754, "term": "fundamental", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.267012981804042e-07}, {"x": 0.14711796246648792, "y": 0.6687332439678284, "term": "instill", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 2.595181526459822e-05}, {"x": 0.14728552278820375, "y": 0.3300938337801609, "term": "find", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.5924993313344135e-08}, {"x": 0.14745308310991956, "y": 0.3304289544235925, "term": "3720", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1476206434316354, "y": 0.49631367292225204, "term": "entered", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.991850595908405e-07}, {"x": 0.1477882037533512, "y": 0.5594839142091153, "term": "obligations", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.1539333011715636e-06}, {"x": 0.14795576407506703, "y": 0.7972520107238605, "term": "parties", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 1, "s": 0.958780160857909, "os": 0.8618619100649988, "bg": 6.778189600912812e-07}, {"x": 0.14812332439678283, "y": 0.9460455764075067, "term": "establishments", "cat25k": 11, "ncat25k": 0, "cat": 69, "ncat": 1, "s": 0.9966487935656837, "os": 0.9735418729331728, "bg": 3.0089803017104546e-05}, {"x": 0.14829088471849866, "y": 0.41236595174262736, "term": "preserve", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.0843069234840388e-06}, {"x": 0.14845844504021447, "y": 0.6697386058981233, "term": "registration cpr", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 0.0}, {"x": 0.1486260053619303, "y": 0.4973190348525469, "term": "inhalation", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 5.504483631271155e-06}, {"x": 0.1487935656836461, "y": 0.6935321715817694, "term": "articles", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 1.4488631044527625e-07}, {"x": 0.14896112600536193, "y": 0.6394101876675603, "term": "cgmp", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 2.6638646756744756e-05}, {"x": 0.14912868632707774, "y": 0.41337131367292224, "term": "ingestion", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.665209207586608e-06}, {"x": 0.14929624664879357, "y": 0.639745308310992, "term": "exempted", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.1684055353861352e-05}, {"x": 0.14946380697050937, "y": 0.498156836461126, "term": "dual", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.0204599868577864e-07}, {"x": 0.1496313672922252, "y": 0.8533847184986595, "term": "cardiovascular", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 1, "s": 0.977044235924933, "os": 0.8928722359608778, "bg": 8.666153919226446e-06}, {"x": 0.149798927613941, "y": 0.4988270777479893, "term": "0003", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.14996648793565684, "y": 0.8083109919571045, "term": "uni\ufb01ed", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 1, "s": 0.9634718498659518, "os": 0.8663130854586677, "bg": 0.0}, {"x": 0.15013404825737264, "y": 0.4148793565683646, "term": "extending", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.417088758362418e-06}, {"x": 0.15030160857908847, "y": 0.640583109919571, "term": "\ufb01ll", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 0.0}, {"x": 0.15046916890080428, "y": 0.41538203753351205, "term": "7.0", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1506367292225201, "y": 0.3334450402144772, "term": "disclose", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.3653708500833046e-06}, {"x": 0.15080428954423591, "y": 0.4157171581769437, "term": "nbc", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.6258964990058455e-06}, {"x": 0.15097184986595175, "y": 0.33411528150134046, "term": "harmonized", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 9.456186532735546e-06}, {"x": 0.15113941018766755, "y": 0.5005026809651475, "term": "licensure", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 5.132433902805389e-06}, {"x": 0.15130697050938338, "y": 0.33461796246648795, "term": "penalized", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 9.332351880993849e-06}, {"x": 0.15147453083109919, "y": 0.3352882037533512, "term": "translate", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 7.228027834412388e-07}, {"x": 0.15164209115281502, "y": 0.335455764075067, "term": "favorable", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.8409561189699481e-06}, {"x": 0.15180965147453082, "y": 0.5015080428954424, "term": "3.7", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.15197721179624665, "y": 0.7359249329758714, "term": "expenditure", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 1, "s": 0.8902479892761395, "os": 0.8356225954175445, "bg": 2.4920334005319723e-06}, {"x": 0.15214477211796246, "y": 0.5625, "term": "viability", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 5.231653897694261e-06}, {"x": 0.1523123324396783, "y": 0.7764745308310992, "term": "sixty", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 1, "s": 0.9435321715817695, "os": 0.8522771154489783, "bg": 6.197338359374743e-06}, {"x": 0.1524798927613941, "y": 0.6053954423592494, "term": "restoration", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 1.2785033328584225e-06}, {"x": 0.15264745308310992, "y": 0.5050268096514745, "term": "chemistry", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.925769474973725e-07}, {"x": 0.15281501340482573, "y": 0.5051943699731903, "term": "exams", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.5631213814554145e-06}, {"x": 0.15298257372654156, "y": 0.5068699731903485, "term": "privately", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 2.2721669770068067e-06}, {"x": 0.15315013404825736, "y": 0.5070375335120644, "term": "privately owned", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.1533176943699732, "y": 0.7531836461126006, "term": "rooms", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 4.2575596087996096e-07}, {"x": 0.153485254691689, "y": 0.3359584450402145, "term": "hemodialysis", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.131834689884369e-05}, {"x": 0.15365281501340483, "y": 0.6422587131367292, "term": "ef\ufb01ciency", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 0.0}, {"x": 0.15382037533512063, "y": 0.7634048257372654, "term": "contrast", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 1, "s": 0.9359919571045576, "os": 0.8470778420720038, "bg": 1.6422376517140198e-06}, {"x": 0.15398793565683647, "y": 0.7376005361930295, "term": "necessity", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 1, "s": 0.8902479892761395, "os": 0.8356225954175445, "bg": 4.3644196396197984e-06}, {"x": 0.15415549597855227, "y": 0.5646782841823056, "term": "strips", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.2937076227276933e-06}, {"x": 0.1543230563002681, "y": 0.33662868632707776, "term": "6.5", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1544906166219839, "y": 0.7987600536193029, "term": "booklet", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 1, "s": 0.958780160857909, "os": 0.8618619100649988, "bg": 6.894653713144485e-06}, {"x": 0.15465817694369974, "y": 0.9046581769436998, "term": "pneumococcal", "cat25k": 7, "ncat25k": 0, "cat": 41, "ncat": 1, "s": 0.9904490616621985, "os": 0.9347702224418114, "bg": 0.00012448981406557058}, {"x": 0.15482573726541554, "y": 0.6070710455764075, "term": "internal revenue", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 0.0}, {"x": 0.15499329758713137, "y": 0.6427613941018767, "term": "extensively", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 4.705874971176517e-06}, {"x": 0.15516085790884718, "y": 0.5650134048257373, "term": "deductions", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 4.4055566656859066e-06}, {"x": 0.155328418230563, "y": 0.6430965147453083, "term": "availing", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 4.189339527349406e-05}, {"x": 0.1554959785522788, "y": 0.5656836461126006, "term": "meant", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 7.715669212506836e-07}, {"x": 0.15566353887399464, "y": 0.42174932975871315, "term": "1.7", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.15583109919571045, "y": 0.6432640750670241, "term": "complaint", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.284337017739477e-06}, {"x": 0.15599865951742628, "y": 0.786695710455764, "term": "inclusive", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 1, "s": 0.950402144772118, "os": 0.8571928828044061, "bg": 3.137524721849206e-06}, {"x": 0.15616621983914208, "y": 0.5658512064343163, "term": "transferable", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 7.2842913217034406e-06}, {"x": 0.15633378016085792, "y": 0.6437667560321716, "term": "displayed", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 5.987241388176509e-07}, {"x": 0.15650134048257372, "y": 0.8089812332439679, "term": "convenience", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 1, "s": 0.9634718498659518, "os": 0.8663130854586677, "bg": 3.0366963173424365e-06}, {"x": 0.15666890080428955, "y": 0.6955428954423593, "term": "prc", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 9.374087890595872e-06}, {"x": 0.15683646112600536, "y": 0.42359249329758714, "term": "appropriation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.4057458834680753e-06}, {"x": 0.1570040214477212, "y": 0.42376005361930297, "term": "gaa", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 7.221269816969695e-06}, {"x": 0.157171581769437, "y": 0.7391085790884718, "term": "imprisonment", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 1, "s": 0.8902479892761395, "os": 0.8356225954175445, "bg": 7.935979840169367e-06}, {"x": 0.15733914209115282, "y": 0.42443029490616624, "term": "punished", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 4.04120901658391e-06}, {"x": 0.15750670241286863, "y": 0.4257707774798928, "term": "cancellation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.1770972194020932e-06}, {"x": 0.15767426273458446, "y": 0.42660857908847183, "term": "memoranda", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 9.364961931429749e-06}, {"x": 0.15784182305630026, "y": 0.42677613941018766, "term": "thirty 30", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1580093833780161, "y": 0.3378016085790885, "term": "print", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.480215656076648e-08}, {"x": 0.1581769436997319, "y": 0.7543565683646113, "term": "antimicrobial", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 1.9938532353117105e-05}, {"x": 0.15834450402144773, "y": 0.33847184986595175, "term": "extend", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.19211372442454e-07}, {"x": 0.15851206434316353, "y": 0.33880697050938335, "term": "ade", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.792722616624678e-06}, {"x": 0.15867962466487937, "y": 0.339142091152815, "term": "viruses", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 8.792625273478123e-07}, {"x": 0.15884718498659517, "y": 0.816186327077748, "term": "edition", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 1, "s": 0.9671581769436998, "os": 0.8705694954512225, "bg": 3.6243886562434075e-07}, {"x": 0.159014745308311, "y": 0.511896782841823, "term": "proprietary", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.4258519554549593e-06}, {"x": 0.1591823056300268, "y": 0.5702077747989276, "term": "instrumentalities", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 3.054680971301272e-05}, {"x": 0.15934986595174264, "y": 0.4289544235924933, "term": "informal", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.1826810551643836e-06}, {"x": 0.15951742627345844, "y": 0.4292895442359249, "term": "pillars", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 4.666906545663113e-06}, {"x": 0.15968498659517427, "y": 0.3399798927613941, "term": "multimedia", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.1718772036918115e-07}, {"x": 0.15985254691689008, "y": 0.5708780160857909, "term": "veterinary", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.6523582279591052e-06}, {"x": 0.1600201072386059, "y": 0.6735924932975871, "term": "multidisciplinary", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 1.0391667129961826e-05}, {"x": 0.1601876675603217, "y": 0.5140750670241286, "term": "sourced", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 7.137809691717999e-06}, {"x": 0.16035522788203754, "y": 0.5712131367292225, "term": "osec", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 4.035873146741465e-05}, {"x": 0.16052278820375335, "y": 0.34132037533512066, "term": "commission prc", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.16069034852546918, "y": 0.515583109919571, "term": "pharmacists", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 5.027557298442086e-06}, {"x": 0.16085790884718498, "y": 0.6466152815013405, "term": "held invalid", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 0.0}, {"x": 0.16102546916890081, "y": 0.5157506702412868, "term": "dm", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.3903875786481423e-06}, {"x": 0.16119302949061662, "y": 0.3418230563002681, "term": "occupation", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.239892770834337e-07}, {"x": 0.16136058981233245, "y": 0.3424932975871314, "term": "talking", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.1662716966665059e-07}, {"x": 0.16152815013404825, "y": 0.4318029490616622, "term": "ranked", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.0067099229786373e-06}, {"x": 0.16169571045576409, "y": 0.4324731903485255, "term": "n gos", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.1618632707774799, "y": 0.5167560321715817, "term": "feature", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.8575599213614393e-07}, {"x": 0.16203083109919572, "y": 0.3438337801608579, "term": "viewed", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.2235281126357072e-07}, {"x": 0.16219839142091153, "y": 0.4328083109919571, "term": "\ufb01ght", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.16236595174262736, "y": 0.3441689008042895, "term": "7.2", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.16253351206434316, "y": 0.344671581769437, "term": "span", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 8.547793921236353e-07}, {"x": 0.162701072386059, "y": 0.4334785522788204, "term": "duplication", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.1031502667215165e-06}, {"x": 0.1628686327077748, "y": 0.43381367292225204, "term": "complementation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.9252428212508304e-05}, {"x": 0.16303619302949063, "y": 0.5177613941018767, "term": "investing", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 7.193010839088091e-07}, {"x": 0.16320375335120643, "y": 0.3453418230563003, "term": "chp", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.074794387193727e-06}, {"x": 0.16337131367292226, "y": 0.3456769436997319, "term": "n chp", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.16353887399463807, "y": 0.43498659517426275, "term": "gather", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.2492420224029071e-06}, {"x": 0.1637064343163539, "y": 0.34617962466487934, "term": "afflicted", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.82413354829354e-06}, {"x": 0.1638739946380697, "y": 0.4351541554959786, "term": "impoverishment", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.2510810816894816e-05}, {"x": 0.16404155495978553, "y": 0.3468498659517426, "term": "gradual", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.2279410577962845e-06}, {"x": 0.16420911528150134, "y": 0.43582439678284185, "term": "neglect", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.192031614356755e-06}, {"x": 0.16437667560321717, "y": 0.3473525469168901, "term": "liability", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.9466008160316295e-07}, {"x": 0.16454423592493297, "y": 0.34785522788203754, "term": "recover", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 8.072774447085586e-07}, {"x": 0.1647117962466488, "y": 0.6122654155495979, "term": "depression", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 1.010113700292068e-06}, {"x": 0.1648793565683646, "y": 0.3480227882037534, "term": "ulcer", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.852702287927812e-06}, {"x": 0.16504691689008044, "y": 0.43682975871313673, "term": "priced", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.394389307046425e-07}, {"x": 0.16521447721179625, "y": 0.3488605898123324, "term": "accrediting", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 9.913234415775922e-06}, {"x": 0.16538203753351208, "y": 0.3496983914209115, "term": "re\ufb02ected", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.16554959785522788, "y": 0.5757372654155496, "term": "sourcing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 3.177811250722952e-06}, {"x": 0.1657171581769437, "y": 0.5204423592493298, "term": "practicable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 5.221343634464174e-06}, {"x": 0.16588471849865952, "y": 0.43884048257372654, "term": "7.4", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.16605227882037535, "y": 0.613941018766756, "term": "pain relief", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 0.0}, {"x": 0.16621983914209115, "y": 0.43917560321715815, "term": "metro", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 5.249171064028497e-07}, {"x": 0.16638739946380698, "y": 0.3503686327077748, "term": "metro manila", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1665549597855228, "y": 0.7208445040214477, "term": "disciplines", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 3.886283459686124e-06}, {"x": 0.1667225201072386, "y": 0.6494638069705094, "term": "smallest", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 3.341301098935369e-06}, {"x": 0.16689008042895442, "y": 0.6496313672922251, "term": "alternatives", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.40352792338297e-06}, {"x": 0.16705764075067023, "y": 0.4415214477211796, "term": "$", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.16722520107238606, "y": 0.35170911528150134, "term": "organs", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.568945239300431e-06}, {"x": 0.16739276139410186, "y": 0.5777479892761395, "term": "comfort", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 4.958818781030251e-07}, {"x": 0.1675603217158177, "y": 0.3522117962466488, "term": "surgeon", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.4129040883616088e-06}, {"x": 0.1677278820375335, "y": 0.6754356568364611, "term": "kmits", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 6.410934489865916e-05}, {"x": 0.16789544235924933, "y": 0.35288203753351205, "term": "lmd", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.7071328277374942e-05}, {"x": 0.16806300268096513, "y": 0.44286193029490617, "term": "revenues", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 7.235536614528596e-07}, {"x": 0.16823056300268097, "y": 0.35338471849865954, "term": "satisfaction", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.000699122171599e-07}, {"x": 0.16839812332439677, "y": 0.5784182305630027, "term": "formulary pndf", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 0.0}, {"x": 0.1685656836461126, "y": 0.6757707774798928, "term": "pndf volume", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 0.0}, {"x": 0.1687332439678284, "y": 0.6759383378016086, "term": "2020", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 0.0}, {"x": 0.16890080428954424, "y": 0.5794235924932976, "term": "neurologic", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.578371796750809e-05}, {"x": 0.16906836461126004, "y": 0.4440348525469169, "term": "peripheral", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.7271720959457918e-06}, {"x": 0.16923592493297587, "y": 0.4445375335120643, "term": "stigma", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.661031434073442e-06}, {"x": 0.16940348525469168, "y": 0.35640080428954424, "term": "advocated", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.266005695185159e-06}, {"x": 0.1695710455764075, "y": 0.35656836461126007, "term": "enjoyment", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.9378122148539604e-06}, {"x": 0.1697386058981233, "y": 0.3570710455764075, "term": "senate", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.3111544170089872e-07}, {"x": 0.16990616621983914, "y": 0.5804289544235925, "term": "observance", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.0128714253777829e-05}, {"x": 0.17007372654155495, "y": 0.8825402144772118, "term": "warnings", "cat25k": 5, "ncat25k": 0, "cat": 32, "ncat": 1, "s": 0.9850871313672922, "os": 0.9137324418570476, "bg": 7.509322653407781e-06}, {"x": 0.17024128686327078, "y": 0.35723860589812334, "term": "delegated", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.434764800186851e-06}, {"x": 0.17040884718498658, "y": 0.8967828418230563, "term": "graphic", "cat25k": 6, "ncat25k": 0, "cat": 37, "ncat": 1, "s": 0.9877680965147454, "os": 0.9261084088827729, "bg": 2.2965797672108178e-06}, {"x": 0.17057640750670242, "y": 0.6518096514745308, "term": "importers", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 5.892356467925121e-06}, {"x": 0.17074396782841822, "y": 0.6177949061662198, "term": "inside", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 1, "s": 0.825402144772118, "os": 0.7954045823239977, "bg": 2.1523106002655706e-07}, {"x": 0.17091152815013405, "y": 0.4472184986595174, "term": "brochure", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 8.040927678609911e-07}, {"x": 0.17107908847184986, "y": 0.4477211796246649, "term": "variations", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.036703986282333e-06}, {"x": 0.1712466487935657, "y": 0.8227211796246648, "term": "templates", "cat25k": 3, "ncat25k": 0, "cat": 20, "ncat": 1, "s": 0.9684986595174263, "os": 0.8746498767192079, "bg": 2.176579127590809e-06}, {"x": 0.1714142091152815, "y": 0.5263069705093834, "term": "colors", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 4.2518543399740217e-07}, {"x": 0.17158176943699732, "y": 0.35874664879356566, "term": "verify", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.377888421856626e-07}, {"x": 0.17174932975871313, "y": 0.44906166219839144, "term": "billion", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 3.134899915969008e-07}, {"x": 0.17191689008042896, "y": 0.6767761394101877, "term": "youth", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 3.865614090874634e-07}, {"x": 0.17208445040214476, "y": 0.4498994638069705, "term": "advertisements", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.3065222767927543e-06}, {"x": 0.1722520107238606, "y": 0.450402144772118, "term": "ex", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.3489721872532039e-07}, {"x": 0.1724195710455764, "y": 0.45056970509383376, "term": "dedication", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.141683958979899e-06}, {"x": 0.17258713136729223, "y": 0.36042225201072386, "term": "56%", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.17275469168900803, "y": 0.3609249329758713, "term": "inef\ufb01cient", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.17292225201072386, "y": 0.6772788203753352, "term": "vessels", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 2.4824450793159826e-06}, {"x": 0.17308981233243967, "y": 0.3626005361930295, "term": "estrogen", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.958966166810978e-06}, {"x": 0.1732573726541555, "y": 0.45325067024128685, "term": "columnar", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.8004393071909547e-05}, {"x": 0.1734249329758713, "y": 0.36343833780160856, "term": "corresponds", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.6705318597571799e-06}, {"x": 0.17359249329758714, "y": 0.3637734584450402, "term": "forces", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.3113061237131227e-07}, {"x": 0.17376005361930294, "y": 0.5308310991957105, "term": "mobility", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.0953727348034147e-06}, {"x": 0.17392761394101877, "y": 0.7223525469168901, "term": "surrogate", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 1.7659836234451986e-05}, {"x": 0.17409517426273458, "y": 0.7225201072386059, "term": "maker", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 1, "s": 0.8475201072386059, "os": 0.8292178369061765, "bg": 1.4161033132333204e-06}, {"x": 0.1742627345844504, "y": 0.5316689008042895, "term": "chairs", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 7.432626492618504e-07}, {"x": 0.1744302949061662, "y": 0.36595174262734587, "term": "8%", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.17459785522788204, "y": 0.4574396782841823, "term": "freely", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.400809191437526e-06}, {"x": 0.17476541554959785, "y": 0.3674597855227882, "term": "enhances", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.372584079189739e-06}, {"x": 0.17493297587131368, "y": 0.5829423592493298, "term": "formation", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 7.838686988574666e-07}, {"x": 0.17510053619302948, "y": 0.36779490616621985, "term": "psycho", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.010300495721234e-06}, {"x": 0.17526809651474531, "y": 0.4584450402144772, "term": "sub-", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 0.0}, {"x": 0.17543565683646112, "y": 0.36813002680965146, "term": "occupying", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 4.608719697667988e-06}, {"x": 0.17560321715817695, "y": 0.3682975871313673, "term": "equally", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 7.329025515361041e-07}, {"x": 0.17577077747989275, "y": 0.4594504021447721, "term": "asthma", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.2298395477535625e-06}, {"x": 0.17593833780160859, "y": 0.5832774798927614, "term": "industrial", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 2.1137304122867405e-07}, {"x": 0.1761058981233244, "y": 0.6779490616621984, "term": "applicants", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 1.5723002209789345e-06}, {"x": 0.17627345844504022, "y": 0.4597855227882037, "term": "personality", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 8.566193158918217e-07}, {"x": 0.17644101876675602, "y": 0.7024128686327078, "term": "rebates", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 1, "s": 0.8433310991957105, "os": 0.8222137460639005, "bg": 3.6909141270241525e-06}, {"x": 0.17660857908847186, "y": 0.37014075067024127, "term": "alleviation", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 8.788398435225659e-06}, {"x": 0.17677613941018766, "y": 0.3703083109919571, "term": "sixteen", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 2.197221503547689e-06}, {"x": 0.1769436997319035, "y": 0.4602882037533512, "term": "claiming", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.888935860427285e-06}, {"x": 0.1771112600536193, "y": 0.37064343163538876, "term": "fostering", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.4752842130870515e-06}, {"x": 0.17727882037533513, "y": 0.6536528150134048, "term": "mmol", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.589493799208079e-05}, {"x": 0.17744638069705093, "y": 0.6538203753351206, "term": "dl", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 1, "s": 0.8326072386058981, "os": 0.805635863714776, "bg": 1.7922258618789276e-06}, {"x": 0.17761394101876676, "y": 0.8094839142091153, "term": "blind", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 1, "s": 0.9634718498659518, "os": 0.8663130854586677, "bg": 2.2622473307862813e-06}, {"x": 0.17778150134048257, "y": 0.37131367292225204, "term": "concentrating", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 3.9746338865361265e-06}, {"x": 0.1779490616621984, "y": 0.46380697050938335, "term": "academy", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 3.3824776899382143e-07}, {"x": 0.1781166219839142, "y": 0.46464477211796246, "term": "fer", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 6.699817362978685e-06}, {"x": 0.17828418230563003, "y": 0.5851206434316354, "term": "corporate", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 1, "s": 0.8121648793565683, "os": 0.7830818946176672, "bg": 1.6468720682368735e-07}, {"x": 0.17845174262734584, "y": 0.67828418230563, "term": "inc.", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 1, "s": 0.839142091152815, "os": 0.8144385959760871, "bg": 0.0}, {"x": 0.17861930294906167, "y": 0.37164879356568364, "term": "nss", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 6.1412282917175555e-06}, {"x": 0.17878686327077747, "y": 0.3726541554959786, "term": "san", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.274875127551426e-08}, {"x": 0.1789544235924933, "y": 0.5365281501340483, "term": "2017", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 0.0}, {"x": 0.1791219839142091, "y": 0.756367292225201, "term": "bene\ufb01ciaries", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 1, "s": 0.9272788203753352, "os": 0.8415473836538294, "bg": 0.0}, {"x": 0.17928954423592494, "y": 0.37365951742627346, "term": "polysaccharide", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 1.3365700604965022e-05}, {"x": 0.17945710455764075, "y": 0.3746648793565684, "term": "1a", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.17962466487935658, "y": 0.46816353887399464, "term": "mhos", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 2.969588444737444e-05}, {"x": 0.17979222520107238, "y": 0.3758378016085791, "term": "\ufb01rm", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1799597855227882, "y": 0.5382037533512064, "term": "anticancer", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 1, "s": 0.7974195710455765, "os": 0.7674911903824064, "bg": 1.902741374635506e-05}, {"x": 0.18012734584450402, "y": 0.376843163538874, "term": "diverse", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 5.820598107199702e-07}, {"x": 0.18029490616621985, "y": 0.3773458445040214, "term": "conditional cash", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.18046246648793565, "y": 0.37751340482573725, "term": "cash transfer", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.18063002680965148, "y": 0.3776809651474531, "term": "65", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 1, "s": 0.7258713136729222, "os": 0.714543258843584, "bg": 0.0}, {"x": 0.1807975871313673, "y": 0.4698391420911528, "term": "comparable", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 1, "s": 0.7680965147453083, "os": 0.7463391423438774, "bg": 1.2370623381690512e-06}, {"x": 0.18096514745308312, "y": 0.225201072386059, "term": "sexes", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.16651259250309e-06}, {"x": 0.18113270777479892, "y": 0.6219839142091153, "term": "invasive", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 4.901302472118941e-06}, {"x": 0.18130026809651476, "y": 0.2263739946380697, "term": "staining", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.7672161779331544e-06}, {"x": 0.18146782841823056, "y": 0.22654155495978553, "term": "describing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.0085343436830388e-06}, {"x": 0.1816353887399464, "y": 0.5398793565683646, "term": "female", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 2.434588243872461e-07}, {"x": 0.1818029490616622, "y": 0.47168230563002683, "term": "genital tract", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.18197050938337803, "y": 0.3089812332439678, "term": "8)", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 0.0}, {"x": 0.18213806970509383, "y": 0.22687667560321717, "term": "reveals", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.1084426892870262e-06}, {"x": 0.18230563002680966, "y": 0.9948056300268097, "term": "senior", "cat25k": 71, "ncat25k": 0, "cat": 440, "ncat": 2, "s": 0.9993297587131368, "os": 0.9979615636573774, "bg": 1.544177575390365e-05}, {"x": 0.18247319034852547, "y": 0.9793900804289544, "term": "citizen", "cat25k": 25, "ncat25k": 0, "cat": 156, "ncat": 2, "s": 0.9988270777479893, "os": 0.9940297815639774, "bg": 1.9084393604264083e-05}, {"x": 0.1826407506702413, "y": 0.9710120643431636, "term": "granted", "cat25k": 19, "ncat25k": 0, "cat": 118, "ncat": 2, "s": 0.9984919571045577, "os": 0.9903073652059045, "bg": 1.2067389734603407e-05}, {"x": 0.1828083109919571, "y": 0.3800268096514745, "term": "numerous", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.994878575233179e-07}, {"x": 0.18297587131367293, "y": 0.7426273458445041, "term": "sold", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 6.929822358854706e-07}, {"x": 0.18314343163538874, "y": 0.8914209115281502, "term": "formulary", "cat25k": 6, "ncat25k": 0, "cat": 36, "ncat": 2, "s": 0.984416890080429, "os": 0.9124179358375633, "bg": 7.91942196555885e-05}, {"x": 0.18331099195710457, "y": 0.7429624664879356, "term": "institutional", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 2.035807685662607e-06}, {"x": 0.18347855227882037, "y": 0.38186997319034854, "term": "reflected", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.4937730204426575e-06}, {"x": 0.1836461126005362, "y": 0.3827077747989276, "term": "aforementioned", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 6.043464597384389e-06}, {"x": 0.183813672922252, "y": 0.3828753351206434, "term": "forwarded", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.374766679173771e-06}, {"x": 0.18398123324396784, "y": 0.8761729222520107, "term": "consumers", "cat25k": 5, "ncat25k": 0, "cat": 31, "ncat": 2, "s": 0.9787198391420913, "os": 0.8980587933712887, "bg": 2.958977807666442e-06}, {"x": 0.18414879356568364, "y": 0.22754691689008044, "term": "consequence", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.1694265132379082e-06}, {"x": 0.18431635388739948, "y": 0.22788203753351208, "term": "pending", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.239491818349363e-07}, {"x": 0.18448391420911528, "y": 0.5884718498659517, "term": "maximize", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 3.0968637028992836e-06}, {"x": 0.1846514745308311, "y": 0.30998659517426275, "term": "twelve", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.70015431463708e-07}, {"x": 0.18481903485254692, "y": 0.22804959785522788, "term": "twelve 12", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.18498659517426275, "y": 0.38404825737265413, "term": "did", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.352849590808198e-08}, {"x": 0.18515415549597855, "y": 0.3101541554959786, "term": "accorded", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.484534814167477e-06}, {"x": 0.18532171581769438, "y": 0.8671246648793566, "term": "poverty", "cat25k": 5, "ncat25k": 0, "cat": 29, "ncat": 2, "s": 0.9767091152815014, "os": 0.8915979152834471, "bg": 3.1403815381224083e-06}, {"x": 0.1854892761394102, "y": 0.8384718498659517, "term": "affect", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 2, "s": 0.9643096514745308, "os": 0.8690553927943385, "bg": 2.0228073142932415e-06}, {"x": 0.18565683646112602, "y": 0.5430630026809652, "term": "job", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 8.987810024255066e-08}, {"x": 0.18582439678284182, "y": 0.9120308310991957, "term": "employees", "cat25k": 7, "ncat25k": 0, "cat": 45, "ncat": 2, "s": 0.9902815013404827, "os": 0.9331445945507495, "bg": 1.6835028292339622e-06}, {"x": 0.18599195710455765, "y": 0.22871983914209115, "term": "considers", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.1601890412023736e-06}, {"x": 0.18615951742627346, "y": 0.31082439678284185, "term": "analytical", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.1657715484127437e-06}, {"x": 0.1863270777479893, "y": 0.47369302949061665, "term": "dependence", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.2978073173674022e-06}, {"x": 0.1864946380697051, "y": 0.22939008042895442, "term": "variable", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.2839040633536714e-07}, {"x": 0.18666219839142092, "y": 0.3862265415549598, "term": "illicit", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.62807697520879e-06}, {"x": 0.18682975871313673, "y": 0.4741957104557641, "term": "probable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.7886185323221797e-06}, {"x": 0.18699731903485256, "y": 0.3114946380697051, "term": "believe", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.3118192355071684e-07}, {"x": 0.18716487935656836, "y": 0.22955764075067023, "term": "arising", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 7.13245649290695e-07}, {"x": 0.1873324396782842, "y": 0.38689678284182305, "term": "therapists", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.163635069422017e-06}, {"x": 0.1875, "y": 0.4743632707774799, "term": "compulsory", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 3.2202829984699053e-06}, {"x": 0.1876675603217158, "y": 0.5439008042895442, "term": "pattern", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 4.646186643764064e-07}, {"x": 0.18783512064343164, "y": 0.7680965147453083, "term": "equal", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 2, "s": 0.8466823056300269, "os": 0.8273118371934367, "bg": 9.674391839274888e-07}, {"x": 0.18800268096514744, "y": 0.22989276139410186, "term": "introducing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 9.819017104114108e-07}, {"x": 0.18817024128686327, "y": 0.2300603217158177, "term": "drinking", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.330833684401539e-07}, {"x": 0.18833780160857908, "y": 0.3121648793565684, "term": "unintended", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 7.479353245366168e-06}, {"x": 0.1885053619302949, "y": 0.31266756032171583, "term": "emphasize", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.6907101349095157e-06}, {"x": 0.1886729222520107, "y": 0.5447386058981233, "term": "workplaces", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.0934697983641693e-05}, {"x": 0.18884048257372654, "y": 0.6585120643431636, "term": "heads", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 2, "s": 0.8084785522788205, "os": 0.7743900665142975, "bg": 1.1756852053697606e-06}, {"x": 0.18900804289544235, "y": 0.6834785522788204, "term": "website", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 9.868900254289074e-08}, {"x": 0.18917560321715818, "y": 0.8259048257372654, "term": "degenerative", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 2, "s": 0.9555965147453084, "os": 0.8602026835946577, "bg": 4.827419744146754e-05}, {"x": 0.18934316353887398, "y": 0.7283847184986595, "term": "speech", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 2, "s": 0.8319369973190348, "os": 0.8049417444951836, "bg": 8.9082231266826e-07}, {"x": 0.1895107238605898, "y": 0.31384048257372654, "term": "confirmation", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.019447480919128e-07}, {"x": 0.18967828418230562, "y": 0.7287198391420912, "term": "donor", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 2, "s": 0.8319369973190348, "os": 0.8049417444951836, "bg": 3.779368051868047e-06}, {"x": 0.18984584450402145, "y": 0.2320710455764075, "term": "wait", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.0349328269945643e-07}, {"x": 0.19001340482573725, "y": 0.3899128686327078, "term": "interview", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.664937376146114e-07}, {"x": 0.19018096514745308, "y": 0.4782171581769437, "term": "arrival", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 8.927035386385685e-07}, {"x": 0.1903485254691689, "y": 0.5475871313672922, "term": "discretion", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.7347439837723376e-06}, {"x": 0.19051608579088472, "y": 0.47871983914209115, "term": "sanction", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 7.152034370633748e-06}, {"x": 0.19068364611260052, "y": 0.5918230563002681, "term": "unconstitutional", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 9.856208864017172e-06}, {"x": 0.19085120643431636, "y": 0.7466487935656837, "term": "devolved", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 3.6709551580590925e-05}, {"x": 0.19101876675603216, "y": 0.6603552278820375, "term": "prescribes", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 2, "s": 0.8084785522788205, "os": 0.7743900665142975, "bg": 2.758005109831285e-05}, {"x": 0.191186327077748, "y": 0.5482573726541555, "term": "aligned", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 4.058621717431146e-06}, {"x": 0.1913538873994638, "y": 0.39158847184986595, "term": "remove", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.3834037400729e-07}, {"x": 0.19152144772117963, "y": 0.5926608579088471, "term": "acting", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 9.61558391274349e-07}, {"x": 0.19168900804289543, "y": 0.3920911528150134, "term": "individually", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.6126049805842358e-06}, {"x": 0.19185656836461126, "y": 0.3151809651474531, "term": "conception", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.5155612619665244e-06}, {"x": 0.19202412868632707, "y": 0.23307640750670242, "term": "lasts", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.675023439892892e-06}, {"x": 0.1921916890080429, "y": 0.3156836461126005, "term": "abilities", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.2673264114499394e-06}, {"x": 0.1923592493297587, "y": 0.5489276139410187, "term": "sensory", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 4.316299506943712e-06}, {"x": 0.19252680965147453, "y": 0.23341152815013405, "term": "substantially", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 9.65589061227761e-07}, {"x": 0.19269436997319034, "y": 0.6303619302949062, "term": "limits", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 8.972989328064872e-07}, {"x": 0.19286193029490617, "y": 0.6868297587131368, "term": "threshold", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 2.155942365552066e-06}, {"x": 0.19302949061662197, "y": 0.2337466487935657, "term": "41", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.1931970509383378, "y": 0.5490951742627346, "term": "organic", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 6.544502350110342e-07}, {"x": 0.1933646112600536, "y": 0.5492627345844504, "term": "nervous", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.946338001543933e-06}, {"x": 0.19353217158176944, "y": 0.2339142091152815, "term": "slums", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.0310062234113162e-05}, {"x": 0.19369973190348524, "y": 0.23408176943699732, "term": "urban slums", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.19386729222520108, "y": 0.23424932975871313, "term": "\ufb01ngers", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.19403485254691688, "y": 0.5933310991957105, "term": "urgency", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 6.907179783145253e-06}, {"x": 0.1942024128686327, "y": 0.3939343163538874, "term": "cooperate", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.4796688747098834e-06}, {"x": 0.19436997319034852, "y": 0.3171916890080429, "term": "compare", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.449150389450506e-08}, {"x": 0.19453753351206435, "y": 0.4835790884718499, "term": "trends", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.345172534151644e-07}, {"x": 0.19470509383378015, "y": 0.6880026809651475, "term": "occupational", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 1.8926956694413319e-06}, {"x": 0.19487265415549598, "y": 0.9420241286863271, "term": "dental", "cat25k": 10, "ncat25k": 0, "cat": 64, "ncat": 2, "s": 0.9949731903485255, "os": 0.9620004182278353, "bg": 5.604445854047492e-06}, {"x": 0.1950402144772118, "y": 0.8522117962466488, "term": "affairs", "cat25k": 4, "ncat25k": 0, "cat": 25, "ncat": 2, "s": 0.9708445040214477, "os": 0.8771697018155629, "bg": 1.4538078012780426e-06}, {"x": 0.19520777479892762, "y": 0.6618632707774799, "term": "quali\ufb01ed", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 2, "s": 0.8084785522788205, "os": 0.7743900665142975, "bg": 0.0}, {"x": 0.19537533512064342, "y": 0.4840817694369973, "term": "methodologies", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 4.129704581582757e-06}, {"x": 0.19554289544235925, "y": 0.5517761394101877, "term": "underserved", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.584426670258034e-05}, {"x": 0.19571045576407506, "y": 0.7486595174262735, "term": "zone", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 6.354674731737406e-07}, {"x": 0.1958780160857909, "y": 0.23542225201072386, "term": "chosen", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.693850869544038e-07}, {"x": 0.1960455764075067, "y": 0.23558981233243967, "term": "specialties", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3481047416719565e-06}, {"x": 0.19621313672922253, "y": 0.7114611260053619, "term": "appropriations", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 4.167476118758964e-06}, {"x": 0.19638069705093833, "y": 0.8197050938337802, "term": "nhip", "cat25k": 3, "ncat25k": 0, "cat": 20, "ncat": 2, "s": 0.9495643431635389, "os": 0.8554539285186291, "bg": 0.0001410351337750297}, {"x": 0.19654825737265416, "y": 0.3957774798927614, "term": "emphasizes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.704996706502305e-06}, {"x": 0.19671581769436997, "y": 0.3192024128686327, "term": "afford", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 9.380711680824663e-07}, {"x": 0.1968833780160858, "y": 0.7489946380697051, "term": "sponsored", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 3.887667103109135e-07}, {"x": 0.1970509383378016, "y": 0.5958445040214477, "term": "and/", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 0.0}, {"x": 0.19721849865951743, "y": 0.23609249329758714, "term": "19%", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.19738605898123324, "y": 0.4857573726541555, "term": "6%", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.19755361930294907, "y": 0.689343163538874, "term": "subsidy", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 7.636264364926891e-06}, {"x": 0.19772117962466487, "y": 0.2369302949061662, "term": "stopped", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.239433601509375e-07}, {"x": 0.1978887399463807, "y": 0.8815348525469169, "term": "quantity", "cat25k": 5, "ncat25k": 0, "cat": 32, "ncat": 2, "s": 0.9795576407506703, "os": 0.9011252117797461, "bg": 1.769210451329749e-06}, {"x": 0.1980563002680965, "y": 0.8925938337801609, "term": "dswd", "cat25k": 6, "ncat25k": 0, "cat": 36, "ncat": 2, "s": 0.984416890080429, "os": 0.9124179358375633, "bg": 0.00023231004832660344}, {"x": 0.19822386058981234, "y": 0.23760053619302948, "term": "agent", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3933490815452153e-07}, {"x": 0.19839142091152814, "y": 0.3203753351206434, "term": "face", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.2030807529456828e-07}, {"x": 0.19855898123324398, "y": 0.63421581769437, "term": "deal", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 3.118168725700014e-07}, {"x": 0.19872654155495978, "y": 0.7119638069705094, "term": "chemicals", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 1.730868000344842e-06}, {"x": 0.1988941018766756, "y": 0.3987935656836461, "term": "q.", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 0.0}, {"x": 0.19906166219839141, "y": 0.6898458445040214, "term": "1988", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 0.0}, {"x": 0.19922922252010725, "y": 0.32087801608579086, "term": "un", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.0423371591482245e-07}, {"x": 0.19939678284182305, "y": 0.7494973190348525, "term": "permit", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 1.1256395321001626e-06}, {"x": 0.19956434316353888, "y": 0.8929289544235925, "term": "outlet", "cat25k": 6, "ncat25k": 0, "cat": 36, "ncat": 2, "s": 0.984416890080429, "os": 0.9124179358375633, "bg": 3.4229631736453453e-06}, {"x": 0.19973190348525469, "y": 0.23843833780160859, "term": "accompany", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.1325042156942715e-06}, {"x": 0.19989946380697052, "y": 0.2386058981233244, "term": "island", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 7.795070785040312e-08}, {"x": 0.20006702412868632, "y": 0.3999664879356568, "term": "behalf", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.565918729330439e-07}, {"x": 0.20023458445040215, "y": 0.23894101876675602, "term": "\ufb01led", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.20040214477211796, "y": 0.23927613941018766, "term": "veri\ufb01ed", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2005697050938338, "y": 0.2396112600536193, "term": "gathered", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 8.957190451814122e-07}, {"x": 0.2007372654155496, "y": 0.401642091152815, "term": "falls", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.579367523372375e-07}, {"x": 0.20090482573726542, "y": 0.32339142091152817, "term": "bills", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.387705192099167e-07}, {"x": 0.20107238605898123, "y": 0.691186327077748, "term": "herein", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 1.8921004490900414e-06}, {"x": 0.20123994638069706, "y": 0.2404490616621984, "term": "concrete", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.1536646147390405e-07}, {"x": 0.20140750670241286, "y": 0.24078418230563003, "term": "intentions", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.942503357495647e-06}, {"x": 0.2015750670241287, "y": 0.24095174262734584, "term": "climate", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.148602589166753e-07}, {"x": 0.2017426273458445, "y": 0.3238941018766756, "term": "belonging", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.1568704844568363e-06}, {"x": 0.20191018766756033, "y": 0.24178954423592494, "term": "indigency", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.3647510212768474e-05}, {"x": 0.20207774798927614, "y": 0.3248994638069705, "term": "true", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.0353948486538501e-07}, {"x": 0.20224530831099197, "y": 0.24229222520107238, "term": "totally", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.253511413196031e-07}, {"x": 0.20241286863270777, "y": 0.7964142091152815, "term": "accommodation", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 2, "s": 0.9128686327077747, "os": 0.8396049574119416, "bg": 6.239555005445736e-07}, {"x": 0.2025804289544236, "y": 0.6675603217158177, "term": "cash", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 2, "s": 0.8084785522788205, "os": 0.7743900665142975, "bg": 2.7678206130169093e-07}, {"x": 0.2027479892761394, "y": 0.24279490616621985, "term": "pro\ufb01le", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.20291554959785524, "y": 0.8289209115281502, "term": "pha", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 2, "s": 0.9555965147453084, "os": 0.8602026835946577, "bg": 3.0127544303863793e-05}, {"x": 0.20308310991957104, "y": 0.4924597855227882, "term": "seeks", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.3350933678474043e-06}, {"x": 0.20325067024128687, "y": 0.492627345844504, "term": "realize", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 9.71516725666646e-07}, {"x": 0.20341823056300268, "y": 0.5998659517426274, "term": "guarantees", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 2.576551123140106e-06}, {"x": 0.2035857908847185, "y": 0.6380697050938338, "term": "compliant", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 2.7256363543196433e-06}, {"x": 0.2037533512064343, "y": 0.24396782841823056, "term": "e.g", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.20392091152815014, "y": 0.32724530831099197, "term": "invest", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 9.716409110571572e-07}, {"x": 0.20408847184986595, "y": 0.3275804289544236, "term": "transform", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.2819056707148393e-06}, {"x": 0.20425603217158178, "y": 0.2443029490616622, "term": "luzon", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3649734171427013e-05}, {"x": 0.20442359249329758, "y": 0.24447050938337803, "term": "visayas", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.767768280933735e-05}, {"x": 0.20459115281501342, "y": 0.32791554959785524, "term": "retention", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.048435189510951e-06}, {"x": 0.20475871313672922, "y": 0.24463806970509383, "term": "revise", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.1123885781037194e-06}, {"x": 0.20492627345844505, "y": 0.3285857908847185, "term": "ease", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 6.999534670935076e-07}, {"x": 0.20509383378016086, "y": 0.7349195710455764, "term": "poorest", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 2, "s": 0.8319369973190348, "os": 0.8049417444951836, "bg": 1.293030794913771e-05}, {"x": 0.2052613941018767, "y": 0.2451407506702413, "term": "convergence", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.338780384457563e-06}, {"x": 0.2054289544235925, "y": 0.5581434316353887, "term": "advocating", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 9.658149788245067e-06}, {"x": 0.20559651474530832, "y": 0.24564343163538874, "term": "eleven", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.2606837034411779e-06}, {"x": 0.20576407506702413, "y": 0.49564343163538876, "term": "raw", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.527886291063114e-07}, {"x": 0.20593163538873996, "y": 0.49581099195710454, "term": "avenue", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 3.871713858664247e-07}, {"x": 0.20609919571045576, "y": 0.7151474530831099, "term": "consciousness", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 3.3575043515193416e-06}, {"x": 0.2062667560321716, "y": 0.4110254691689008, "term": "prohibition", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.2240540222491967e-06}, {"x": 0.2064343163538874, "y": 0.4961461126005362, "term": "declare", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.3632556953196226e-06}, {"x": 0.20660187667560323, "y": 0.6032171581769437, "term": "interests", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 4.5511585492413487e-07}, {"x": 0.20676943699731903, "y": 0.4120308310991957, "term": "advertisement", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.429234740548386e-07}, {"x": 0.20693699731903487, "y": 0.8151809651474531, "term": "ends", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 2, "s": 0.9433646112600537, "os": 0.8504589009145043, "bg": 1.2312853783835245e-06}, {"x": 0.20710455764075067, "y": 0.9259383378016086, "term": "cessation", "cat25k": 8, "ncat25k": 0, "cat": 52, "ncat": 2, "s": 0.9924597855227882, "os": 0.9457483957392359, "bg": 4.4096049361444287e-05}, {"x": 0.2072721179624665, "y": 0.4121983914209115, "term": "pose", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.1604618203187113e-06}, {"x": 0.2074396782841823, "y": 0.33076407506702415, "term": "restore", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.768297134441582e-07}, {"x": 0.20760723860589814, "y": 0.33093163538873993, "term": "draw", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.344551994794532e-07}, {"x": 0.20777479892761394, "y": 0.6037198391420912, "term": "air", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.1168860531813856e-07}, {"x": 0.20794235924932977, "y": 0.33109919571045576, "term": "brands", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.922732199378946e-07}, {"x": 0.20810991957104558, "y": 0.7161528150134048, "term": "mitigation", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 5.658570558022111e-06}, {"x": 0.2082774798927614, "y": 0.24698391420911528, "term": "trial", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.4069735306421425e-07}, {"x": 0.2084450402144772, "y": 0.3316018766756032, "term": "subjects", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.0045717867826795e-07}, {"x": 0.20861260053619302, "y": 0.3321045576407507, "term": "behind", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.847169107131098e-07}, {"x": 0.20878016085790885, "y": 0.6042225201072386, "term": "toxic", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.9195219110760144e-06}, {"x": 0.20894772117962465, "y": 0.24731903485254692, "term": "drive", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 7.399779331180564e-08}, {"x": 0.20911528150134048, "y": 0.41420911528150134, "term": "lessen", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 8.575796101871883e-06}, {"x": 0.2092828418230563, "y": 0.3324396782841823, "term": "asia", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.7764787849084078e-07}, {"x": 0.20945040214477212, "y": 0.24782171581769438, "term": "6.0", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.20961796246648792, "y": 0.7169906166219839, "term": "signature", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 9.470744560432329e-07}, {"x": 0.20978552278820375, "y": 0.24849195710455765, "term": "restricted", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.56764895305233e-07}, {"x": 0.20995308310991956, "y": 0.6943699731903485, "term": "contents", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 3.050415746246082e-07}, {"x": 0.2101206434316354, "y": 0.333612600536193, "term": "legally", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.4086693455801168e-06}, {"x": 0.2102882037533512, "y": 0.5618297587131368, "term": "disclosure", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.0399854922023838e-06}, {"x": 0.21045576407506703, "y": 0.6945375335120644, "term": "assessed", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 2.5464888057413135e-06}, {"x": 0.21062332439678283, "y": 0.2489946380697051, "term": "streamlining", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.096027675965648e-06}, {"x": 0.21079088471849866, "y": 0.5006702412868632, "term": "develops", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.232547221563089e-06}, {"x": 0.21095844504021447, "y": 0.3351206434316354, "term": "software", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.6966607250242027e-08}, {"x": 0.2111260053619303, "y": 0.416387399463807, "term": "segments", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.5869136750699037e-06}, {"x": 0.2112935656836461, "y": 0.5010053619302949, "term": "directive", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.391927516368819e-06}, {"x": 0.21146112600536193, "y": 0.4168900804289544, "term": "alongside", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.3736280429911513e-06}, {"x": 0.21162868632707774, "y": 0.5626675603217158, "term": "residents", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 5.319587872908928e-07}, {"x": 0.21179624664879357, "y": 0.717828418230563, "term": "humans", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 1.9937115271186173e-06}, {"x": 0.21196380697050937, "y": 0.5631702412868632, "term": "ct", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 4.6463238605050447e-07}, {"x": 0.2121313672922252, "y": 0.5067024128686327, "term": "counselors", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 4.0378578010691675e-06}, {"x": 0.212298927613941, "y": 0.5636729222520107, "term": "wholly", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.3321629111108058e-06}, {"x": 0.21246648793565684, "y": 0.6417560321715817, "term": "interior", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 7.401894366825302e-07}, {"x": 0.21263404825737264, "y": 0.8884048257372654, "term": "subsidized", "cat25k": 5, "ncat25k": 0, "cat": 34, "ncat": 2, "s": 0.9820710455764076, "os": 0.9069570315335915, "bg": 4.513515156948086e-05}, {"x": 0.21280160857908847, "y": 0.6724195710455764, "term": "captain", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 2, "s": 0.8084785522788205, "os": 0.7743900665142975, "bg": 1.2440574345126752e-06}, {"x": 0.21296916890080428, "y": 0.24949731903485256, "term": "\ufb02uid", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2131367292225201, "y": 0.25, "term": "gloves", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.861405946677612e-07}, {"x": 0.21330428954423591, "y": 0.2503351206434316, "term": "reside", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.5718254592074725e-06}, {"x": 0.21347184986595175, "y": 0.25050268096514744, "term": "explore", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.49593155356982e-07}, {"x": 0.21363941018766755, "y": 0.4207439678284182, "term": "sum", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.718564017108228e-07}, {"x": 0.21380697050938338, "y": 0.25067024128686327, "term": "mooe", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.5644231169921883e-05}, {"x": 0.21397453083109919, "y": 0.6069034852546917, "term": "gross", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.0744629058395626e-06}, {"x": 0.21414209115281502, "y": 0.8223860589812333, "term": "receipts", "cat25k": 3, "ncat25k": 0, "cat": 20, "ncat": 2, "s": 0.9495643431635389, "os": 0.8554539285186291, "bg": 8.593533483238409e-06}, {"x": 0.21430965147453082, "y": 0.5085455764075067, "term": "1.6", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.21447721179624665, "y": 0.6435991957104558, "term": "showing", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 4.1617026224594517e-07}, {"x": 0.21464477211796246, "y": 0.25134048257372654, "term": "5.5", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2148123324396783, "y": 0.3371313672922252, "term": "5.6", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 0.0}, {"x": 0.2149798927613941, "y": 0.6444369973190348, "term": "double", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 2.5773346995784577e-07}, {"x": 0.21514745308310992, "y": 0.8440013404825737, "term": "penalties", "cat25k": 4, "ncat25k": 0, "cat": 23, "ncat": 2, "s": 0.9643096514745308, "os": 0.8690553927943385, "bg": 6.815975610803431e-06}, {"x": 0.21531501340482573, "y": 0.5103887399463807, "term": "violates", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.621848752993634e-06}, {"x": 0.21548257372654156, "y": 0.6447721179624665, "term": "exceeding", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 4.090567621480144e-06}, {"x": 0.21565013404825736, "y": 0.5105563002680965, "term": "fifty thousand", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.2158176943699732, "y": 0.5683646112600537, "term": "abide", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.965525702306995e-06}, {"x": 0.215985254691689, "y": 0.5685321715817694, "term": "r.a.", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 0.0}, {"x": 0.21615281501340483, "y": 0.33763404825737264, "term": "belong", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.0476075837989162e-06}, {"x": 0.21632037533512063, "y": 0.6082439678284183, "term": "circulars", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.7264067337535537e-05}, {"x": 0.21648793565683647, "y": 0.25167560321715815, "term": "indeed", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.9352437171383413e-07}, {"x": 0.21665549597855227, "y": 0.251843163538874, "term": "windows", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.7380983559331745e-08}, {"x": 0.2168230563002681, "y": 0.3379691689008043, "term": "ample", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.857302866103359e-06}, {"x": 0.2169906166219839, "y": 0.6085790884718498, "term": "visitors", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 4.0737941557982744e-07}, {"x": 0.21715817694369974, "y": 0.5690348525469169, "term": "granting", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.848760085856216e-06}, {"x": 0.21732573726541554, "y": 0.2526809651474531, "term": "buy", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.9460357618078206e-08}, {"x": 0.21749329758713137, "y": 0.3381367292225201, "term": "antimicrobials", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.22087489145474e-05}, {"x": 0.21766085790884718, "y": 0.7545241286863271, "term": "resistance", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 1.4601926656079945e-06}, {"x": 0.217828418230563, "y": 0.8091487935656837, "term": "barriers", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 2, "s": 0.9353217158176944, "os": 0.8451879813755002, "bg": 4.6107931520961184e-06}, {"x": 0.2179959785522788, "y": 0.25418900804289546, "term": "causal", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.4375675428310174e-06}, {"x": 0.21816353887399464, "y": 0.3394772117962466, "term": "resistant", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.777824056416829e-07}, {"x": 0.21833109919571045, "y": 0.25519436997319034, "term": "pharmacovigilance", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.1025961806340378e-05}, {"x": 0.21849865951742628, "y": 0.6963806970509383, "term": "embodied", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 1.4454757512408507e-05}, {"x": 0.21866621983914208, "y": 0.6457774798927614, "term": "broad", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 9.224201741040406e-07}, {"x": 0.21883378016085792, "y": 0.5122319034852547, "term": "teaching", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.456599735027643e-07}, {"x": 0.21900134048257372, "y": 0.5125670241286864, "term": "bases", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.5598317476343757e-06}, {"x": 0.21916890080428955, "y": 0.255529490616622, "term": "combat", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.234322973692161e-07}, {"x": 0.21933646112600536, "y": 0.2561997319034853, "term": "internationally accepted", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2195040214477212, "y": 0.34031501340482573, "term": "continues", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.1125832834099997e-07}, {"x": 0.219671581769437, "y": 0.2565348525469169, "term": "operate lto", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.21983914209115282, "y": 0.2567024128686327, "term": "norms", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.3202138773152107e-06}, {"x": 0.22000670241286863, "y": 0.25686997319034854, "term": "enforced", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.4748945153553285e-06}, {"x": 0.22017426273458446, "y": 0.5137399463806971, "term": "donated", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.5771364553255233e-06}, {"x": 0.22034182305630026, "y": 0.3406501340482574, "term": "shelf", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 8.621444031525173e-07}, {"x": 0.2205093833780161, "y": 0.6972184986595175, "term": "misleading", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 6.062499826334641e-06}, {"x": 0.2206769436997319, "y": 0.25720509383378015, "term": "planners", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.41489545337495e-06}, {"x": 0.22084450402144773, "y": 0.514745308310992, "term": "progressive", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 8.79136446874601e-07}, {"x": 0.22101206434316353, "y": 0.43063002680965146, "term": "databases", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.472014612467821e-07}, {"x": 0.22117962466487937, "y": 0.25804289544235925, "term": "nationally", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3461357574546053e-06}, {"x": 0.22134718498659517, "y": 0.57171581769437, "term": "designing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.6350011230413964e-06}, {"x": 0.221514745308311, "y": 0.2585455764075067, "term": "da", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.3695143262761398e-07}, {"x": 0.2216823056300268, "y": 0.5154155495978552, "term": "commit", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 7.949760240909533e-07}, {"x": 0.22184986595174264, "y": 0.43113270777479895, "term": "overweight", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.381988129924487e-06}, {"x": 0.22201742627345844, "y": 0.25888069705093836, "term": "inactive", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.603220870729295e-06}, {"x": 0.22218498659517427, "y": 0.5159182305630027, "term": "spending", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 7.0586311075688e-07}, {"x": 0.22235254691689008, "y": 0.6982238605898123, "term": "hypertensive", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 2.96848214086932e-05}, {"x": 0.2225201072386059, "y": 0.25955093833780163, "term": "came", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.08697638564183e-07}, {"x": 0.2226876675603217, "y": 0.5162533512064343, "term": "fall", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.1272369073658526e-07}, {"x": 0.22285522788203754, "y": 0.26005361930294907, "term": "realized", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.957690026038286e-07}, {"x": 0.22302278820375335, "y": 0.7551943699731903, "term": "environments", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 2.1988429834810455e-06}, {"x": 0.22319034852546918, "y": 0.7203418230563002, "term": "equity", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 8.261680204594791e-07}, {"x": 0.22335790884718498, "y": 0.3433310991957105, "term": "encompasses", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.38786824635774e-06}, {"x": 0.22352546916890081, "y": 0.34349865951742625, "term": "fruits", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.2092788936936228e-06}, {"x": 0.22369302949061662, "y": 0.3436662198391421, "term": "vegetables", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.066153320950318e-06}, {"x": 0.22386058981233245, "y": 0.573558981233244, "term": "pathway", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.1069258231168876e-06}, {"x": 0.22402815013404825, "y": 0.2613941018766756, "term": "healthier", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.8824133870807355e-06}, {"x": 0.22419571045576409, "y": 0.6112600536193029, "term": "regimens", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.741315912435027e-05}, {"x": 0.2243632707774799, "y": 0.26156166219839144, "term": "attacks", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.890383012097924e-07}, {"x": 0.22453083109919572, "y": 0.3448391420911528, "term": "modify", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.5394863589342815e-07}, {"x": 0.22469839142091153, "y": 0.26189678284182305, "term": "innovative approaches", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.22486595174262736, "y": 0.2620643431635389, "term": "acceptability", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 7.970000916550107e-06}, {"x": 0.22503351206434316, "y": 0.4344839142091153, "term": "incorporating", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.522456166017975e-06}, {"x": 0.225201072386059, "y": 0.6476206434316354, "term": "pricing", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 4.5107372461723575e-07}, {"x": 0.2253686327077748, "y": 0.755529490616622, "term": "chaired", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 2, "s": 0.8369638069705094, "os": 0.8130579573381993, "bg": 1.4573244397680522e-05}, {"x": 0.22553619302949063, "y": 0.34517426273458446, "term": "cdpc", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 3.2055186208576686e-05}, {"x": 0.22570375335120643, "y": 0.34550938337801607, "term": "n cdpc", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 0.0}, {"x": 0.22587131367292226, "y": 0.6477882037533512, "term": "hpdpb", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 6.410934489865916e-05}, {"x": 0.22603887399463807, "y": 0.4348190348525469, "term": "forum", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.7097583178099694e-08}, {"x": 0.2262064343163539, "y": 0.5745643431635389, "term": "xiii", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 6.264523416592765e-06}, {"x": 0.2263739946380697, "y": 0.43532171581769435, "term": "distress", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.1831530563441967e-06}, {"x": 0.22654155495978553, "y": 0.34701742627345844, "term": "manifested", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 6.781486271220119e-06}, {"x": 0.22670911528150134, "y": 0.4359919571045576, "term": "accounted", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.883094136627428e-06}, {"x": 0.22687667560321717, "y": 0.34819034852546915, "term": "effected", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.108721251309749e-06}, {"x": 0.22704423592493297, "y": 0.26306970509383376, "term": "legislations", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.7957351290684626e-05}, {"x": 0.2272117962466488, "y": 0.34902815013404825, "term": "intends", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.653209587638166e-06}, {"x": 0.2273793565683646, "y": 0.699396782841823, "term": "suppliers", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 9.361678989041647e-07}, {"x": 0.22754691689008044, "y": 0.43766756032171583, "term": "signatory", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.1816327012911307e-05}, {"x": 0.22771447721179625, "y": 0.5755697050938338, "term": "assets", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 5.226272957588044e-07}, {"x": 0.22788203753351208, "y": 0.26390750670241286, "term": "properties", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3102045114599496e-07}, {"x": 0.22804959785522788, "y": 0.2642426273458445, "term": "bulk", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.361702464067478e-07}, {"x": 0.2282171581769437, "y": 0.7882037533512064, "term": "trade", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 2, "s": 0.8890750670241286, "os": 0.8336649980143047, "bg": 3.260912098853463e-07}, {"x": 0.22838471849865952, "y": 0.34986595174262736, "term": "foregoing", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 3.280823749226956e-06}, {"x": 0.22855227882037535, "y": 0.5206099195710456, "term": "7.1", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.22871983914209115, "y": 0.4386729222520107, "term": "7.3", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 0.0}, {"x": 0.22888739946380698, "y": 0.35020107238605896, "term": "signing", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.0879098618811399e-06}, {"x": 0.2290549597855228, "y": 0.6137734584450402, "term": "emerging", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 1.3028358756124684e-06}, {"x": 0.2292225201072386, "y": 0.26457774798927614, "term": "119", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.22939008042895442, "y": 0.35070375335120646, "term": "experienced", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.0459333191348047e-07}, {"x": 0.22955764075067023, "y": 0.2652479892761394, "term": "timetable", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.0558507842942252e-06}, {"x": 0.22972520107238606, "y": 0.5212801608579088, "term": "discussed", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.499208526412836e-07}, {"x": 0.22989276139410186, "y": 0.35087131367292224, "term": "si", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.192942749260213e-07}, {"x": 0.2300603217158177, "y": 0.35103887399463807, "term": "servicing", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.230754113120203e-06}, {"x": 0.2302278820375335, "y": 0.5224530831099196, "term": "portions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.054591453907235e-06}, {"x": 0.23039544235924933, "y": 0.5226206434316354, "term": "newspapers", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 7.595390509407651e-07}, {"x": 0.23056300268096513, "y": 0.2659182305630027, "term": "8.2", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23073056300268097, "y": 0.2670911528150134, "term": "typically", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.216099333408344e-07}, {"x": 0.23089812332439677, "y": 0.44202412868632707, "term": "likelihood", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.0671357457037167e-06}, {"x": 0.2310656836461126, "y": 0.26742627345844505, "term": "peace", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.6608480929789266e-07}, {"x": 0.2312332439678284, "y": 0.61578418230563, "term": "blhsd", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 5.769859535975074e-05}, {"x": 0.23140080428954424, "y": 0.2680965147453083, "term": "regulating", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.7612800880296092e-06}, {"x": 0.23156836461126004, "y": 0.7004021447721179, "term": "pndf", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 2, "s": 0.818867292225201, "os": 0.7858839785222409, "bg": 7.693072068058044e-05}, {"x": 0.23173592493297587, "y": 0.2689343163538874, "term": "proceeds", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.0031778165283076e-06}, {"x": 0.23190348525469168, "y": 0.44353217158176944, "term": "deposited", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 2.88336638792523e-06}, {"x": 0.2320710455764075, "y": 0.26926943699731903, "term": "9.1", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2322386058981233, "y": 0.353887399463807, "term": "pls", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.121879016255867e-06}, {"x": 0.23240616621983914, "y": 0.6167895442359249, "term": "16%", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 0.0}, {"x": 0.23257372654155495, "y": 0.2697721179624665, "term": "spite", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.6648963269057236e-06}, {"x": 0.23274128686327078, "y": 0.44386729222520105, "term": "contributes", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 3.1690698779908098e-06}, {"x": 0.23290884718498658, "y": 0.2699396782841823, "term": "backed", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 9.99991750068062e-07}, {"x": 0.23307640750670242, "y": 0.6172922252010724, "term": "empowerment", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 5.729861843481184e-06}, {"x": 0.23324396782841822, "y": 0.5249664879356568, "term": "concerning", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.744163099438807e-07}, {"x": 0.23341152815013405, "y": 0.3558981233243968, "term": "adopts", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.476319300082584e-06}, {"x": 0.23357908847184986, "y": 0.27027479892761397, "term": "anchored", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.459129882935783e-06}, {"x": 0.2337466487935657, "y": 0.3560656836461126, "term": "trauma", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.7401294203855117e-06}, {"x": 0.2339142091152815, "y": 0.2707774798927614, "term": "mn", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.073646333497236e-07}, {"x": 0.23408176943699732, "y": 0.2714477211796247, "term": "binding", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.430457767606312e-07}, {"x": 0.23424932975871313, "y": 0.27161528150134046, "term": "faith", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.206986657662161e-07}, {"x": 0.23441689008042896, "y": 0.2719504021447721, "term": "supreme court", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23458445040214476, "y": 0.27211796246648795, "term": "motivation", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.0488503354813351e-06}, {"x": 0.2347520107238606, "y": 0.2722855227882037, "term": "exhibition", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.902151523665289e-07}, {"x": 0.2349195710455764, "y": 0.721514745308311, "term": "slide", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 2, "s": 0.827245308310992, "os": 0.7959598436986017, "bg": 1.1478494554822923e-06}, {"x": 0.23508713136729223, "y": 0.5254691689008043, "term": "transparent", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.707875256791244e-06}, {"x": 0.23525469168900803, "y": 0.3577412868632708, "term": "partly", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 7.090926238057995e-07}, {"x": 0.23542225201072386, "y": 0.5256367292225201, "term": "insert", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 6.845049972776258e-07}, {"x": 0.23558981233243967, "y": 0.2726206434316354, "term": "lea\ufb02et", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2357573726541555, "y": 0.27329088471849866, "term": "withdrawn", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.6542077254809194e-06}, {"x": 0.2359249329758713, "y": 0.2734584450402145, "term": "parts thereof", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23609249329758714, "y": 0.35941689008042893, "term": "bigger", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 7.42710850039995e-07}, {"x": 0.23626005361930294, "y": 0.5273123324396782, "term": "35", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.23642761394101877, "y": 0.27396112600536193, "term": "concerted", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.0524581680570925e-06}, {"x": 0.23659517426273458, "y": 0.27446380697050937, "term": "variety", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.595005972499864e-07}, {"x": 0.2367627345844504, "y": 0.5276474530831099, "term": "33", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 0.0}, {"x": 0.2369302949061662, "y": 0.27479892761394104, "term": "commitments", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.3146156170748191e-06}, {"x": 0.23709785522788204, "y": 0.27513404825737264, "term": "managerial", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.561316311678898e-06}, {"x": 0.23726541554959785, "y": 0.5809316353887399, "term": "limiting", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 2.5328731313926353e-06}, {"x": 0.23743297587131368, "y": 0.2756367292225201, "term": "changing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.470006479753249e-07}, {"x": 0.23760053619302948, "y": 0.27630697050938335, "term": "instruct", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.007843349434844e-06}, {"x": 0.23776809651474531, "y": 0.36142761394101874, "term": "inspect", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.7801285309022407e-06}, {"x": 0.23793565683646112, "y": 0.27680965147453085, "term": "\ufb01nger", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23810321715817695, "y": 0.3615951742627346, "term": "saline", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.315590502248422e-06}, {"x": 0.23827077747989275, "y": 0.3617627345844504, "term": "opening", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.7893857290060994e-07}, {"x": 0.23843833780160859, "y": 0.5288203753351206, "term": "walls", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 9.241036936754674e-07}, {"x": 0.2386058981233244, "y": 0.2773123324396783, "term": "6-", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23877345844504022, "y": 0.2776474530831099, "term": "closer", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.141554713597406e-07}, {"x": 0.23894101876675602, "y": 0.778485254691689, "term": "printed", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 2, "s": 0.8466823056300269, "os": 0.8273118371934367, "bg": 1.2500218294253302e-06}, {"x": 0.23910857908847186, "y": 0.2781501340482574, "term": "quick", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 9.313527697575692e-08}, {"x": 0.23927613941018766, "y": 0.7786528150134048, "term": "epithelium", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 2, "s": 0.8466823056300269, "os": 0.8273118371934367, "bg": 3.055803465101376e-05}, {"x": 0.2394436997319035, "y": 0.278485254691689, "term": "packed", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 8.05953741479054e-07}, {"x": 0.2396112600536193, "y": 0.27882037533512066, "term": "\ufb01lter", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.23977882037533513, "y": 0.27949061662198393, "term": "consultative", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.196349281034232e-06}, {"x": 0.23994638069705093, "y": 0.530328418230563, "term": "workshops", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 8.200609398999594e-07}, {"x": 0.24011394101876676, "y": 0.36410857908847183, "term": "ranging", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 9.501170496699342e-07}, {"x": 0.24028150134048257, "y": 0.280328418230563, "term": "largely", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.723085681188925e-07}, {"x": 0.2404490616621984, "y": 0.2804959785522788, "term": "deterioration", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.6807365890061916e-06}, {"x": 0.2406166219839142, "y": 0.28066353887399464, "term": "discussions", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.4769600145892947e-07}, {"x": 0.24078418230563003, "y": 0.5311662198391421, "term": "understood", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 1.1405681854472624e-06}, {"x": 0.24095174262734584, "y": 0.2811662198391421, "term": "meals", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.763728995979385e-07}, {"x": 0.24111930294906167, "y": 0.3652815013404826, "term": "spaces", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 6.260942954357413e-07}, {"x": 0.24128686327077747, "y": 0.2813337801608579, "term": "encourages", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.472023729022512e-06}, {"x": 0.2414544235924933, "y": 0.36578418230563003, "term": "speakers", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 3.380783188852747e-07}, {"x": 0.2416219839142091, "y": 0.5315013404825737, "term": "comfortable", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 7.059137572052995e-07}, {"x": 0.24178954423592494, "y": 0.4562667560321716, "term": "stress", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.5780823999895007e-07}, {"x": 0.24195710455764075, "y": 0.28150134048257375, "term": "bottom", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.742525632334236e-07}, {"x": 0.24212466487935658, "y": 0.28183646112600536, "term": "suf\ufb01ciently", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24229222520107238, "y": 0.36611930294906164, "term": "glass", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.565638223967554e-07}, {"x": 0.2424597855227882, "y": 0.2825067024128686, "term": "reception", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.869757563604509e-07}, {"x": 0.24262734584450402, "y": 0.3664544235924933, "term": "consulting", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 3.2284531583408404e-07}, {"x": 0.24279490616621985, "y": 0.28300938337801607, "term": "flooring", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.054410897336624e-06}, {"x": 0.24296246648793565, "y": 0.3671246648793566, "term": "objects", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.9276466958125606e-07}, {"x": 0.24313002680965148, "y": 0.5826072386058981, "term": "undertaking", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.5336321166522636e-06}, {"x": 0.2432975871313673, "y": 0.2848525469168901, "term": "stability", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.416067739842435e-07}, {"x": 0.24346514745308312, "y": 0.2850201072386059, "term": "necessitates", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.1715809606378087e-05}, {"x": 0.24363270777479892, "y": 0.28535522788203754, "term": "decision makers", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24380026809651476, "y": 0.5326742627345844, "term": "pool", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 2.6237393916125573e-07}, {"x": 0.24396782841823056, "y": 0.285857908847185, "term": "ventilation", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.6458812439076678e-06}, {"x": 0.2441353887399464, "y": 0.4589477211796247, "term": "recruitment", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 6.574060794065465e-07}, {"x": 0.2443029490616622, "y": 0.3691353887399464, "term": "ordinance", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.160245846812973e-06}, {"x": 0.24447050938337803, "y": 0.28770107238605896, "term": "seminar", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.1378029052755545e-07}, {"x": 0.24463806970509383, "y": 0.36963806970509383, "term": "abstract", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.777340409849722e-07}, {"x": 0.24480563002680966, "y": 0.36980563002680966, "term": "english", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 5.790940962352931e-08}, {"x": 0.24497319034852547, "y": 0.28837131367292224, "term": "nf", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.7538924903366004e-06}, {"x": 0.2451407506702413, "y": 0.2887064343163539, "term": "scheduling", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 8.60347251206664e-07}, {"x": 0.2453083109919571, "y": 0.4601206434316354, "term": "reimbursed", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 7.242663634404824e-06}, {"x": 0.24547587131367293, "y": 0.46062332439678283, "term": "logo", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.718165356205245e-07}, {"x": 0.24564343163538874, "y": 0.5346849865951743, "term": "appendix", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 2, "s": 0.7112935656836461, "os": 0.699736052194767, "bg": 5.905254909186037e-07}, {"x": 0.24581099195710457, "y": 0.46079088471849866, "term": "of-", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 0.0}, {"x": 0.24597855227882037, "y": 0.28920911528150134, "term": "plasma", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.072442231388837e-07}, {"x": 0.2461461126005362, "y": 0.28937667560321717, "term": "strati\ufb01cation", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.246313672922252, "y": 0.289544235924933, "term": "\ufb02ow", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24648123324396784, "y": 0.29004691689008044, "term": "non\u2014", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24664879356568364, "y": 0.37081099195710454, "term": "considerable", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 9.233063007714592e-07}, {"x": 0.24681635388739948, "y": 0.6206434316353887, "term": "visually", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 4.5616229646291764e-06}, {"x": 0.24698391420911528, "y": 0.3709785522788204, "term": "error", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.1147223532609314e-07}, {"x": 0.2471514745308311, "y": 0.2905495978552279, "term": "depletion", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.04792131650545e-06}, {"x": 0.24731903485254692, "y": 0.29088471849865954, "term": "too little", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24748659517426275, "y": 0.2910522788203753, "term": "evolving", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.9456435824162464e-06}, {"x": 0.24765415549597855, "y": 0.4636394101876676, "term": "practical", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 4.074581548114849e-07}, {"x": 0.24782171581769438, "y": 0.29121983914209115, "term": "enacted", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.5981844624506562e-06}, {"x": 0.2479892761394102, "y": 0.2917225201072386, "term": "difference", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.7833733693224027e-07}, {"x": 0.24815683646112602, "y": 0.5846179624664879, "term": "claim", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 3.9606600509286423e-07}, {"x": 0.24832439678284182, "y": 0.2925603217158177, "term": "favor", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.568261519930199e-07}, {"x": 0.24849195710455765, "y": 0.3714812332439678, "term": "adapt", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.0050008731778803e-06}, {"x": 0.24865951742627346, "y": 0.2927278820375335, "term": "cutting", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.9816198473795343e-07}, {"x": 0.2488270777479893, "y": 0.2928954423592493, "term": "0005", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2489946380697051, "y": 0.29306300268096513, "term": "official gazette", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.24916219839142092, "y": 0.29323056300268097, "term": "minimize", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.061622684965857e-06}, {"x": 0.24932975871313673, "y": 0.2933981233243968, "term": "curettage", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.0172881595271478e-05}, {"x": 0.24949731903485256, "y": 0.4656501340482574, "term": "cruz", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.345855773609114e-06}, {"x": 0.24966487935656836, "y": 0.29423592493297585, "term": "declines", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.4879954097980406e-06}, {"x": 0.2498324396782842, "y": 0.29507372654155495, "term": "po", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.952714720144493e-07}, {"x": 0.25, "y": 0.2952412868632708, "term": "manned", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.730219818395008e-06}, {"x": 0.25016756032171583, "y": 0.2954088471849866, "term": "audiology", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 7.366835244413177e-06}, {"x": 0.2503351206434316, "y": 0.29591152815013405, "term": "p100,000.00", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.25050268096514744, "y": 0.2960790884718499, "term": "pesos p50,000.00", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.25067024128686327, "y": 0.29624664879356566, "term": "pesos p100,000.00", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2508378016085791, "y": 0.3723190348525469, "term": "sta", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.198259725705548e-06}, {"x": 0.2510053619302949, "y": 0.29674932975871315, "term": "advances", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 8.529028334711483e-07}, {"x": 0.2511729222520107, "y": 0.37282171581769435, "term": "dif\ufb01culties", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 0.0}, {"x": 0.25134048257372654, "y": 0.46632037533512066, "term": "dnd", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 1.4316614311603498e-05}, {"x": 0.2515080428954424, "y": 0.5857908847184986, "term": "allotment", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 2, "s": 0.7489946380697051, "os": 0.7252243621633205, "bg": 1.0650407045244261e-05}, {"x": 0.25167560321715815, "y": 0.37332439678284185, "term": "inpatients", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.8818605578963808e-05}, {"x": 0.251843163538874, "y": 0.46665549597855227, "term": "liquidation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 5.242830429387812e-06}, {"x": 0.2520107238605898, "y": 0.2975871313672922, "term": "transfers", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 6.828419986409737e-07}, {"x": 0.25217828418230565, "y": 0.2980898123324397, "term": "85", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2523458445040214, "y": 0.29876005361930297, "term": "deltoid", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.891083070551582e-05}, {"x": 0.25251340482573725, "y": 0.29976541554959785, "term": "redness", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 8.241449753426124e-06}, {"x": 0.2526809651474531, "y": 0.3001005361930295, "term": "rare", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.663566275521959e-07}, {"x": 0.2528485254691689, "y": 0.30093833780160856, "term": "shock", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 5.276227318075846e-07}, {"x": 0.2530160857908847, "y": 0.375, "term": "reproduce", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.8361399344277706e-06}, {"x": 0.2531836461126005, "y": 0.3019436997319035, "term": "college", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.3749941586992055e-08}, {"x": 0.25335120643431636, "y": 0.6214812332439679, "term": "virtue", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 2, "s": 0.7645777479892762, "os": 0.7449988962972793, "bg": 3.2968445900428697e-06}, {"x": 0.2535187667560322, "y": 0.3022788203753351, "term": "lazaro", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 1.732422945075696e-05}, {"x": 0.25368632707774796, "y": 0.30244638069705093, "term": "lazaro compound", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2538538873994638, "y": 0.30294906166219837, "term": "alliance", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 3.481487451587741e-07}, {"x": 0.2540214477211796, "y": 0.37550268096514744, "term": "requisition", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 9.684761028521621e-06}, {"x": 0.25418900804289546, "y": 0.4688337801608579, "term": "acquisition", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 2, "s": 0.6744302949061662, "os": 0.6650301137706325, "bg": 6.158276007053895e-07}, {"x": 0.25435656836461124, "y": 0.30345174262734587, "term": "mostly", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.953515323778932e-07}, {"x": 0.25452412868632707, "y": 0.3042895442359249, "term": "\ufb01nance", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2546916890080429, "y": 0.3765080428954424, "term": "deliberate", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 3.6573421509414364e-06}, {"x": 0.25485924932975873, "y": 0.3047922252010724, "term": "in\ufb02uence", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2550268096514745, "y": 0.30563002680965146, "term": "piph", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.5644231169921883e-05}, {"x": 0.25519436997319034, "y": 0.3059651474530831, "term": "~\u2014", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.25536193029490617, "y": 0.3063002680965147, "term": "links", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 2.351291800596982e-08}, {"x": 0.255529490616622, "y": 0.3770107238605898, "term": "helping", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 4.059878663218368e-07}, {"x": 0.2556970509383378, "y": 0.37717828418230565, "term": "conditional", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 1.8434158347945475e-06}, {"x": 0.2558646112600536, "y": 0.6546581769436998, "term": "cct", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 2, "s": 0.7907171581769437, "os": 0.7610029397943634, "bg": 2.1697292394882045e-05}, {"x": 0.25603217158176944, "y": 0.306970509383378, "term": "accelerating", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 4.253717217133123e-06}, {"x": 0.2561997319034853, "y": 0.37835120643431636, "term": "symptom", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 2, "s": 0.6142761394101877, "os": 0.6142357970396949, "bg": 2.4412268532024382e-06}, {"x": 0.25636729222520105, "y": 0.3078083109919571, "term": "follow-", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 2, "s": 0.49178954423592497, "os": 0.5324595556096989, "bg": 0.0}, {"x": 0.2565348525469169, "y": 0.8617627345844504, "term": "cervix", "cat25k": 4, "ncat25k": 0, "cat": 28, "ncat": 3, "s": 0.9683310991957105, "os": 0.8738216418813771, "bg": 5.1369366458289314e-05}, {"x": 0.2567024128686327, "y": 0.6223190348525469, "term": "competencies", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 6.958931234688374e-06}, {"x": 0.25686997319034854, "y": 0.22670911528150134, "term": "organisms", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.8101172521551256e-06}, {"x": 0.2570375335120643, "y": 0.8096514745308311, "term": "heart", "cat25k": 3, "ncat25k": 0, "cat": 19, "ncat": 3, "s": 0.84936327077748, "os": 0.830138461158626, "bg": 4.85859050257746e-07}, {"x": 0.25720509383378015, "y": 0.9013069705093834, "term": "medications", "cat25k": 6, "ncat25k": 0, "cat": 40, "ncat": 3, "s": 0.9840817694369973, "os": 0.9118795961663125, "bg": 9.109533561163473e-06}, {"x": 0.257372654155496, "y": 0.8002680965147453, "term": "assure", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 4.981939874865532e-06}, {"x": 0.2575402144772118, "y": 0.8004356568364611, "term": "accountability", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 4.504938377806013e-06}, {"x": 0.2577077747989276, "y": 0.6566689008042895, "term": "names", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 3.322678840592752e-07}, {"x": 0.2578753351206434, "y": 0.6568364611260054, "term": "validity", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 3.7240127913632693e-06}, {"x": 0.25804289544235925, "y": 0.5427278820375335, "term": "declared invalid", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 0.0}, {"x": 0.2582104557640751, "y": 0.7258713136729222, "term": "integrity", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 3, "s": 0.8079758713136729, "os": 0.7743320336063835, "bg": 2.212550916327962e-06}, {"x": 0.25837801608579086, "y": 0.7672587131367292, "term": "officials", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 1.1849575953049872e-06}, {"x": 0.2585455764075067, "y": 0.6246648793565683, "term": "duties", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 1.2399503433704308e-06}, {"x": 0.2587131367292225, "y": 0.15398793565683647, "term": "justice", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.759895131368912e-07}, {"x": 0.25888069705093836, "y": 0.22855227882037535, "term": "influence", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 3.7351569066580925e-07}, {"x": 0.25904825737265413, "y": 0.22888739946380698, "term": "employer", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 4.001123675573048e-07}, {"x": 0.25921581769436997, "y": 0.5433981233243967, "term": "instituting", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 2.6986506746626685e-05}, {"x": 0.2593833780160858, "y": 0.8456769436997319, "term": "device", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 3, "s": 0.9500670241286864, "os": 0.8567109040480005, "bg": 1.0560923296933286e-06}, {"x": 0.25955093833780163, "y": 0.47402815013404825, "term": "desire", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 8.84215026504898e-07}, {"x": 0.2597184986595174, "y": 0.7267091152815014, "term": "random", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 3, "s": 0.8079758713136729, "os": 0.7743320336063835, "bg": 6.764303983221278e-07}, {"x": 0.25988605898123324, "y": 0.3872319034852547, "term": "render", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.525464347208054e-06}, {"x": 0.26005361930294907, "y": 0.31199731903485256, "term": "intramuscularly", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 3.262944372236694e-05}, {"x": 0.2602211796246649, "y": 0.7275469168900804, "term": "consist", "cat25k": 2, "ncat25k": 0, "cat": 12, "ncat": 3, "s": 0.8079758713136729, "os": 0.7743320336063835, "bg": 4.181953449003378e-06}, {"x": 0.2603887399463807, "y": 0.23039544235924933, "term": "invited", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.635903502814751e-07}, {"x": 0.2605563002680965, "y": 0.1543230563002681, "term": "forums", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.040239825699435e-08}, {"x": 0.26072386058981234, "y": 0.2310656836461126, "term": "dealing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 5.676751036432821e-07}, {"x": 0.26089142091152817, "y": 0.2312332439678284, "term": "attitude", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.90953266368066e-07}, {"x": 0.26105898123324395, "y": 0.6836461126005362, "term": "court", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 3, "s": 0.7833445040214477, "os": 0.7500166525303732, "bg": 2.0307430916209346e-07}, {"x": 0.2612265415549598, "y": 0.6839812332439679, "term": "yearly", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 3, "s": 0.7833445040214477, "os": 0.7500166525303732, "bg": 4.238665563744151e-06}, {"x": 0.2613941018766756, "y": 0.15482573726541554, "term": "filing", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.06581859797518e-07}, {"x": 0.26156166219839144, "y": 0.3136729222520107, "term": "relations", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.162451502069448e-07}, {"x": 0.2617292225201072, "y": 0.5460790884718498, "term": "con\ufb01dentiality", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 0.0}, {"x": 0.26189678284182305, "y": 0.659014745308311, "term": "writing", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 2.874985358538106e-07}, {"x": 0.2620643431635389, "y": 0.47754691689008044, "term": "endorse", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 3.955638503097389e-06}, {"x": 0.2622319034852547, "y": 0.7696045576407506, "term": "slip", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 2.7276880797757837e-06}, {"x": 0.2623994638069705, "y": 0.15583109919571045, "term": "re\ufb02ect", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.2625670241286863, "y": 0.314343163538874, "term": "recommending", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.088156552400805e-06}, {"x": 0.26273458445040215, "y": 0.3902479892761394, "term": "fora", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.3025049030005992e-05}, {"x": 0.262902144772118, "y": 0.23290884718498658, "term": "penalty", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.978142086417033e-07}, {"x": 0.26306970509383376, "y": 0.6854892761394102, "term": "xii", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 3, "s": 0.7833445040214477, "os": 0.7500166525303732, "bg": 7.603319609341438e-06}, {"x": 0.2632372654155496, "y": 0.15616621983914208, "term": "112", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.2634048257372654, "y": 0.3917560321715818, "term": "surrounding", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 8.689152579843539e-07}, {"x": 0.26357238605898126, "y": 0.8470174262734584, "term": "marginalized", "cat25k": 4, "ncat25k": 0, "cat": 24, "ncat": 3, "s": 0.9500670241286864, "os": 0.8567109040480005, "bg": 5.882775885848002e-05}, {"x": 0.26373994638069703, "y": 0.31501340482573725, "term": "output", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.137830987678451e-07}, {"x": 0.26390750670241286, "y": 0.7935656836461126, "term": "promotive", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 3, "s": 0.8419906166219839, "os": 0.8171543614404275, "bg": 0.00012175596452031196}, {"x": 0.2640750670241287, "y": 0.7471514745308311, "term": "rehabilitative", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 3, "s": 0.8181970509383378, "os": 0.7845365358473202, "bg": 4.366633462058048e-05}, {"x": 0.2642426273458445, "y": 0.15666890080428955, "term": "sphere", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.37119852349343e-06}, {"x": 0.2644101876675603, "y": 0.7097855227882037, "term": "determinants", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.361845845859478e-05}, {"x": 0.26457774798927614, "y": 0.23357908847184986, "term": "regarded", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.3880051922498231e-06}, {"x": 0.26474530831099197, "y": 0.31618632707774796, "term": "4.0", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.2649128686327078, "y": 0.3163538873994638, "term": "structural", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 7.25591904619493e-07}, {"x": 0.2650804289544236, "y": 0.4819034852546917, "term": "transactions", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 6.832859168494846e-07}, {"x": 0.2652479892761394, "y": 0.8684651474530831, "term": "equitable", "cat25k": 5, "ncat25k": 0, "cat": 29, "ncat": 3, "s": 0.9710120643431636, "os": 0.8776704473629504, "bg": 1.932241134032322e-05}, {"x": 0.26541554959785524, "y": 0.8046246648793566, "term": "enrollment", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 3.3424292505215186e-06}, {"x": 0.26558310991957107, "y": 0.4827412868632708, "term": "fast", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 1.6975508277751188e-07}, {"x": 0.26575067024128685, "y": 0.7707774798927614, "term": "evaluated", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 3.3961008234412462e-06}, {"x": 0.2659182305630027, "y": 0.31702412868632707, "term": "caregiver", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 6.483591650430673e-06}, {"x": 0.2660857908847185, "y": 0.7102882037533512, "term": "forth", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.368418274639593e-06}, {"x": 0.26625335120643434, "y": 0.710455764075067, "term": "set forth", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 0.0}, {"x": 0.2664209115281501, "y": 0.39426943699731903, "term": "muslim", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.190117232497987e-06}, {"x": 0.26658847184986595, "y": 0.39443699731903487, "term": "muslim mindanao", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 0.0}, {"x": 0.2667560321715818, "y": 0.4832439678284182, "term": "parameters", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 5.29198808879321e-07}, {"x": 0.2669235924932976, "y": 0.6315348525469169, "term": "fair", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 4.415640286206549e-07}, {"x": 0.2670911528150134, "y": 0.551441018766756, "term": "lodged", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 8.912532406958114e-06}, {"x": 0.2672587131367292, "y": 0.661695710455764, "term": "positions", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 8.684904918746562e-07}, {"x": 0.26742627345844505, "y": 0.6318699731903485, "term": "assisting", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 4.297109158877993e-06}, {"x": 0.2675938337801609, "y": 0.23525469168900803, "term": "collate", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.582576466138403e-05}, {"x": 0.26776139410187666, "y": 0.7722855227882037, "term": "legislation", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 1.1903098462496608e-06}, {"x": 0.2679289544235925, "y": 0.5950067024128687, "term": "gos", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 2.9708058905139197e-05}, {"x": 0.2680965147453083, "y": 0.6623659517426274, "term": "culturally", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 1.0118679461736846e-05}, {"x": 0.26826407506702415, "y": 0.2357573726541555, "term": "accelerate", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.848001585767283e-06}, {"x": 0.26843163538873993, "y": 0.2359249329758713, "term": "none", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.1650237094557623e-07}, {"x": 0.26859919571045576, "y": 0.8612600536193029, "term": "owned", "cat25k": 4, "ncat25k": 0, "cat": 27, "ncat": 3, "s": 0.9666554959785524, "os": 0.8698141404553501, "bg": 1.6967260059824862e-06}, {"x": 0.2687667560321716, "y": 0.39628016085790885, "term": "herewith", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.682722645239998e-05}, {"x": 0.2689343163538874, "y": 0.7116286863270778, "term": "relief", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.0449604301475114e-06}, {"x": 0.2691018766756032, "y": 0.319872654155496, "term": "gradually", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.931547253050074e-06}, {"x": 0.26926943699731903, "y": 0.8344504021447721, "term": "cognizant", "cat25k": 4, "ncat25k": 0, "cat": 22, "ncat": 3, "s": 0.9358243967828418, "os": 0.8469098069349894, "bg": 6.077763771908819e-05}, {"x": 0.26943699731903487, "y": 0.5526139410187667, "term": "indicating", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 2.0410815282802054e-06}, {"x": 0.2696045576407507, "y": 0.8277479892761395, "term": "non-", "cat25k": 3, "ncat25k": 0, "cat": 21, "ncat": 3, "s": 0.92828418230563, "os": 0.8416251130589525, "bg": 0.0}, {"x": 0.2697721179624665, "y": 0.23726541554959785, "term": "analgesics", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.1931764624465606e-05}, {"x": 0.2699396782841823, "y": 0.23743297587131368, "term": "yellow", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.2145293514761833e-07}, {"x": 0.27010723860589814, "y": 0.5961796246648794, "term": "kind", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 2.827563193457222e-07}, {"x": 0.27027479892761397, "y": 0.3202077747989276, "term": "paper", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 8.872367292287106e-08}, {"x": 0.27044235924932974, "y": 0.5963471849865952, "term": "focuses", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 2.1260372271244504e-06}, {"x": 0.2706099195710456, "y": 0.23793565683646112, "term": "walk", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.535411650830105e-07}, {"x": 0.2707774798927614, "y": 0.15750670241286863, "term": "ultimate", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.654529538227664e-07}, {"x": 0.2709450402144772, "y": 0.23810321715817695, "term": "veterinarians", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 5.330797295366685e-06}, {"x": 0.271112600536193, "y": 0.5971849865951743, "term": "secured", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.5655427791609347e-06}, {"x": 0.27128016085790885, "y": 0.39929624664879354, "term": "shipment", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.8883700816895411e-06}, {"x": 0.2714477211796247, "y": 0.3210455764075067, "term": "reaches", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.7399779805786559e-06}, {"x": 0.27161528150134046, "y": 0.5975201072386059, "term": "thirty", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.6284724732783951e-06}, {"x": 0.2717828418230563, "y": 0.1581769436997319, "term": "anticipated", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 9.855775509087764e-07}, {"x": 0.2719504021447721, "y": 0.7128016085790885, "term": "medication", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.8864713459151092e-06}, {"x": 0.27211796246648795, "y": 0.32138069705093836, "term": "presidential", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.1170419834644275e-06}, {"x": 0.2722855227882037, "y": 0.32154825737265413, "term": "unused", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.246799714656436e-06}, {"x": 0.27245308310991956, "y": 0.3218833780160858, "term": "register", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 7.266279880570214e-08}, {"x": 0.2726206434316354, "y": 0.8818699731903485, "term": "inspection", "cat25k": 5, "ncat25k": 0, "cat": 32, "ncat": 3, "s": 0.9755361930294907, "os": 0.8883643252014314, "bg": 3.137402685051966e-06}, {"x": 0.2727882037533512, "y": 0.5542895442359249, "term": "discussion", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.6030574651928132e-07}, {"x": 0.272955764075067, "y": 0.15867962466487937, "term": "posting", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.765784835353866e-07}, {"x": 0.27312332439678283, "y": 0.15884718498659517, "term": "specification", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.206187964971077e-07}, {"x": 0.27329088471849866, "y": 0.4006367292225201, "term": "sending", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 6.687497265291296e-07}, {"x": 0.2734584450402145, "y": 0.7736260053619303, "term": "bill", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 3.6434982315522275e-07}, {"x": 0.27362600536193027, "y": 0.159014745308311, "term": "to-", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.2737935656836461, "y": 0.2394436997319035, "term": "demands", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 8.226558770412459e-07}, {"x": 0.27396112600536193, "y": 0.8071380697050938, "term": "socio", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 1.041738234496765e-05}, {"x": 0.27412868632707776, "y": 0.598357908847185, "term": "statistical", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.074173737504808e-06}, {"x": 0.27429624664879354, "y": 0.9167225201072386, "term": "income", "cat25k": 8, "ncat25k": 0, "cat": 47, "ncat": 3, "s": 0.9884383378016086, "os": 0.9279537472871945, "bg": 1.2570313146487276e-06}, {"x": 0.27446380697050937, "y": 0.7739611260053619, "term": "avail", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 8.541561577778275e-06}, {"x": 0.2746313672922252, "y": 0.8074731903485255, "term": "charges", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 1.1344396929428289e-06}, {"x": 0.27479892761394104, "y": 0.15934986595174264, "term": "3.3.1", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.2749664879356568, "y": 0.1600201072386059, "term": "crises", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.357555296837267e-06}, {"x": 0.27513404825737264, "y": 0.24028150134048257, "term": "differently", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.5798923935290768e-06}, {"x": 0.2753016085790885, "y": 0.16035522788203754, "term": "armed", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.642247911063502e-07}, {"x": 0.2754691689008043, "y": 0.5556300268096515, "term": "disadvantaged", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 5.622691182433213e-06}, {"x": 0.2756367292225201, "y": 0.3245643431635389, "term": "ways", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.053865076263091e-07}, {"x": 0.2758042895442359, "y": 0.6670576407506702, "term": "discrimination", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 1.7712469933082287e-06}, {"x": 0.27597184986595175, "y": 0.24195710455764075, "term": "certify", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.9346107106834797e-06}, {"x": 0.2761394101876676, "y": 0.16102546916890081, "term": "warranted", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.6530147417409904e-06}, {"x": 0.27630697050938335, "y": 0.16119302949061662, "term": "reserves", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.810322037098905e-07}, {"x": 0.2764745308310992, "y": 0.2424597855227882, "term": "compromised", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 4.050516420591044e-06}, {"x": 0.276642091152815, "y": 0.4043230563002681, "term": "gains", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.3397731764012352e-06}, {"x": 0.27680965147453085, "y": 0.2432975871313673, "term": "2030", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.2769772117962466, "y": 0.16152815013404825, "term": "popcom", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.5644231169921883e-05}, {"x": 0.27714477211796246, "y": 0.7749664879356568, "term": "academic", "cat25k": 2, "ncat25k": 0, "cat": 15, "ncat": 3, "s": 0.8295911528150135, "os": 0.8022007142036142, "bg": 6.52197118027895e-07}, {"x": 0.2773123324396783, "y": 0.1618632707774799, "term": "staffed", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.682445336840485e-06}, {"x": 0.2774798927613941, "y": 0.556970509383378, "term": "align", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 3.1084813359009395e-06}, {"x": 0.2776474530831099, "y": 0.5573056300268097, "term": "dole", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.1716049816643821e-05}, {"x": 0.27781501340482573, "y": 0.6010388739946381, "term": "limit", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 5.181043938387129e-07}, {"x": 0.27798257372654156, "y": 0.6015415549597856, "term": "trust", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 3.605610466899693e-07}, {"x": 0.2781501340482574, "y": 0.4070040214477212, "term": "geographically", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 6.496754870941965e-06}, {"x": 0.27831769436997317, "y": 0.8853887399463807, "term": "electronic", "cat25k": 5, "ncat25k": 0, "cat": 33, "ncat": 3, "s": 0.9768766756032171, "os": 0.8916726785124813, "bg": 9.348282535480141e-07}, {"x": 0.278485254691689, "y": 0.4073391420911528, "term": "unavailable", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.428844658662279e-06}, {"x": 0.27865281501340483, "y": 0.16236595174262736, "term": "incomplete", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.10376281020219e-06}, {"x": 0.27882037533512066, "y": 0.49463806970509383, "term": "researchers", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 8.518627229610919e-07}, {"x": 0.27898793565683644, "y": 0.4075067024128686, "term": "expenditures", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.3708424551475036e-06}, {"x": 0.27915549597855227, "y": 0.2453083109919571, "term": "raising", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.406162074969616e-07}, {"x": 0.2793230563002681, "y": 0.162701072386059, "term": "consolidating", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.29708713178623e-06}, {"x": 0.27949061662198393, "y": 0.7149798927613941, "term": "boards", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 5.264202621264573e-07}, {"x": 0.2796581769436997, "y": 0.32908847184986595, "term": "fields", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.9261230021163674e-07}, {"x": 0.27982573726541554, "y": 0.3294235924932976, "term": "emphasizing", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 6.765526036563158e-06}, {"x": 0.2799932975871314, "y": 0.24581099195710457, "term": "chances", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.2058805973208952e-06}, {"x": 0.2801608579088472, "y": 0.16320375335120643, "term": "excellent", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.319516064844186e-07}, {"x": 0.280328418230563, "y": 0.40968498659517427, "term": "extensive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 6.373472950024781e-07}, {"x": 0.2804959785522788, "y": 0.953083109919571, "term": "price", "cat25k": 12, "ncat25k": 0, "cat": 77, "ncat": 3, "s": 0.9961461126005362, "os": 0.9681667735474845, "bg": 3.187484260177821e-07}, {"x": 0.28066353887399464, "y": 0.4105227882037534, "term": "7394", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 0.0}, {"x": 0.2808310991957105, "y": 0.7974195710455764, "term": "reagents", "cat25k": 3, "ncat25k": 0, "cat": 17, "ncat": 3, "s": 0.8419906166219839, "os": 0.8171543614404275, "bg": 2.1758228009910876e-05}, {"x": 0.28099865951742625, "y": 0.4125335120643432, "term": "conventional", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.0990467182779005e-06}, {"x": 0.2811662198391421, "y": 0.1637064343163539, "term": "lungs", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.547722018050611e-06}, {"x": 0.2813337801608579, "y": 0.603887399463807, "term": "claimed", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.79898307084971e-06}, {"x": 0.28150134048257375, "y": 0.24664879356568364, "term": "concentrations", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.08701784372401e-06}, {"x": 0.2816689008042895, "y": 0.3314343163538874, "term": "man", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 6.60220370335872e-08}, {"x": 0.28183646112600536, "y": 0.2471514745308311, "term": "applying", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.778530036446122e-07}, {"x": 0.2820040214477212, "y": 0.8081434316353887, "term": "worldwide", "cat25k": 3, "ncat25k": 0, "cat": 18, "ncat": 3, "s": 0.8450067024128687, "os": 0.8238584615974118, "bg": 6.814658551208785e-07}, {"x": 0.282171581769437, "y": 0.4140415549597855, "term": "took", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.101813686557336e-07}, {"x": 0.2823391420911528, "y": 0.16437667560321717, "term": "complements", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.95009989920359e-06}, {"x": 0.2825067024128686, "y": 0.24765415549597855, "term": "amendment", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 3.513276073023022e-07}, {"x": 0.28267426273458446, "y": 0.1647117962466488, "term": "transferring", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.184989395973338e-06}, {"x": 0.2828418230563003, "y": 0.33260723860589814, "term": "american", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.266693486132868e-08}, {"x": 0.28300938337801607, "y": 0.1648793565683646, "term": "warmth", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.339598583373058e-06}, {"x": 0.2831769436997319, "y": 0.41504691689008044, "term": "protected", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.588549366826073e-07}, {"x": 0.28334450402144773, "y": 0.16504691689008044, "term": "3.0", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.28351206434316356, "y": 0.16521447721179625, "term": "internet", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.0292794321930746e-08}, {"x": 0.28367962466487934, "y": 0.2479892761394102, "term": "email", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.2509259904357973e-08}, {"x": 0.28384718498659517, "y": 0.16538203753351208, "term": "noti\ufb01ed", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.284014745308311, "y": 0.7166554959785523, "term": "addressed", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.69771988337392e-06}, {"x": 0.28418230563002683, "y": 0.33294235924932974, "term": "standardize", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.3539387771450623e-05}, {"x": 0.2843498659517426, "y": 0.16588471849865952, "term": "identity", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.9755846214794135e-07}, {"x": 0.28451742627345844, "y": 0.41588471849865954, "term": "selecting", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.2975804203270792e-06}, {"x": 0.28468498659517427, "y": 0.6409182305630027, "term": "irregular", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 6.4518948188645204e-06}, {"x": 0.2848525469168901, "y": 0.6048927613941019, "term": "posted", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 7.571076155679632e-08}, {"x": 0.2850201072386059, "y": 0.6710790884718498, "term": "encountered", "cat25k": 1, "ncat25k": 0, "cat": 9, "ncat": 3, "s": 0.7583780160857909, "os": 0.7351673430650947, "bg": 3.7378455774511967e-06}, {"x": 0.2851876675603217, "y": 0.41621983914209115, "term": "failed", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.529435784037408e-07}, {"x": 0.28535522788203754, "y": 0.6410857908847185, "term": "pocket", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 5.606067926380707e-07}, {"x": 0.2855227882037534, "y": 0.1665549597855228, "term": "hierarchy", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.1960551112293877e-06}, {"x": 0.28569034852546915, "y": 0.1667225201072386, "term": "whole hierarchy", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.285857908847185, "y": 0.8934316353887399, "term": "stores", "cat25k": 6, "ncat25k": 0, "cat": 36, "ncat": 3, "s": 0.9793900804289545, "os": 0.9009236511210256, "bg": 5.511493870699464e-07}, {"x": 0.2860254691689008, "y": 0.4178954423592493, "term": "actually", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.0069780044815532e-07}, {"x": 0.28619302949061665, "y": 0.6052278820375335, "term": "cleaning", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 6.776346349904098e-07}, {"x": 0.2863605898123324, "y": 0.5030160857908847, "term": "teeth", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 1.5870808445095233e-06}, {"x": 0.28652815013404825, "y": 0.6058981233243967, "term": "donation", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.7305267074349916e-06}, {"x": 0.2866957104557641, "y": 0.16705764075067023, "term": "oxygen", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.759962600506914e-07}, {"x": 0.2868632707774799, "y": 0.4202412868632708, "term": "stand", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 3.0039906084095903e-07}, {"x": 0.2870308310991957, "y": 0.25016756032171583, "term": "steel", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.0094619131210748e-07}, {"x": 0.2871983914209115, "y": 0.16839812332439677, "term": "2.6", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.28736595174262736, "y": 0.5098860589812333, "term": "inc", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 2.438096984237078e-07}, {"x": 0.2875335120643432, "y": 0.4224195710455764, "term": "formulations", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 7.3294668650509036e-06}, {"x": 0.28770107238605896, "y": 0.1685656836461126, "term": "3.5", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.2878686327077748, "y": 0.9261058981233244, "term": "outlets", "cat25k": 8, "ncat25k": 0, "cat": 52, "ncat": 3, "s": 0.9912868632707775, "os": 0.9374643012230232, "bg": 2.047211298075268e-05}, {"x": 0.28803619302949063, "y": 0.3374664879356568, "term": "convenient", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 9.151027877767586e-07}, {"x": 0.28820375335120646, "y": 0.6446045576407506, "term": "suffer", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 2.4321114773772727e-06}, {"x": 0.28837131367292224, "y": 0.6077412868632708, "term": "fifty", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 2.368235800502184e-06}, {"x": 0.28853887399463807, "y": 0.7541890080428955, "term": "hundred thousand", "cat25k": 2, "ncat25k": 0, "cat": 13, "ncat": 3, "s": 0.8181970509383378, "os": 0.7845365358473202, "bg": 0.0}, {"x": 0.2887064343163539, "y": 0.2515080428954424, "term": "\ufb01fty thousand", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.28887399463806973, "y": 0.6079088471849866, "term": "of\ufb01cials", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 0.0}, {"x": 0.2890415549597855, "y": 0.6080764075067024, "term": "revocation", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 8.338270284197435e-06}, {"x": 0.28920911528150134, "y": 0.16890080428954424, "term": "repeal", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.1840935423000858e-06}, {"x": 0.28937667560321717, "y": 0.2520107238605898, "term": "henceforth", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.052678118401024e-05}, {"x": 0.289544235924933, "y": 0.25217828418230565, "term": "papers", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.9479263194532154e-07}, {"x": 0.2897117962466488, "y": 0.2523458445040214, "term": "everyone", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.550149282476201e-07}, {"x": 0.2898793565683646, "y": 0.2530160857908847, "term": "perceived", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.4621687237431053e-06}, {"x": 0.29004691689008044, "y": 0.645274798927614, "term": "sets", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 4.2744850469575493e-07}, {"x": 0.2902144772117963, "y": 0.2540214477211796, "term": "definitions", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 5.397040575976488e-07}, {"x": 0.29038203753351205, "y": 0.16940348525469168, "term": "untoward", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.7399209640902064e-05}, {"x": 0.2905495978552279, "y": 0.42828418230563003, "term": "modification", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.1376015167153478e-06}, {"x": 0.2907171581769437, "y": 0.33930965147453085, "term": "antibiotic", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 4.380425339300446e-06}, {"x": 0.29088471849865954, "y": 0.5697050938337802, "term": "allowing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 9.16889470808073e-07}, {"x": 0.2910522788203753, "y": 0.25536193029490617, "term": "science", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 5.7291891030067006e-08}, {"x": 0.29121983914209115, "y": 0.17024128686327078, "term": "t.", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.291387399463807, "y": 0.42945710455764075, "term": "foundation", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.1516786520802936e-07}, {"x": 0.2915549597855228, "y": 0.1714142091152815, "term": "jurisdictions", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.038236293752653e-06}, {"x": 0.2917225201072386, "y": 0.7875335120643432, "term": "updates", "cat25k": 3, "ncat25k": 0, "cat": 16, "ncat": 3, "s": 0.8361260053619303, "os": 0.8099618812018978, "bg": 7.728187759494242e-07}, {"x": 0.2918900804289544, "y": 0.5134048257372654, "term": "curricula", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 6.7977383924368366e-06}, {"x": 0.29205764075067026, "y": 0.2570375335120643, "term": "qualification", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.4599394796688097e-06}, {"x": 0.29222520107238603, "y": 0.6464477211796247, "term": "false", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 6.511104926219118e-07}, {"x": 0.29239276139410186, "y": 0.5149128686327078, "term": "deveiopment", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 5.128780472168353e-05}, {"x": 0.2925603217158177, "y": 0.1724195710455764, "term": "computer", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.563648871395967e-08}, {"x": 0.2927278820375335, "y": 0.25921581769436997, "term": "remained", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 8.543983100684945e-07}, {"x": 0.2928954423592493, "y": 0.2597184986595174, "term": "employing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.8401498349446923e-06}, {"x": 0.29306300268096513, "y": 0.17292225201072386, "term": "orientations", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.303481097436058e-06}, {"x": 0.29323056300268097, "y": 0.25988605898123324, "term": "preferences", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 4.917078390030525e-07}, {"x": 0.2933981233243968, "y": 0.17308981233243967, "term": "responding", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.1525285034705513e-06}, {"x": 0.2935656836461126, "y": 0.43213806970509383, "term": "entails", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 8.332187657530422e-06}, {"x": 0.2937332439678284, "y": 0.516588471849866, "term": "attained", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 5.7437161053440614e-06}, {"x": 0.29390080428954424, "y": 0.34316353887399464, "term": "collect analyze", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.29406836461126007, "y": 0.1732573726541555, "term": "acids", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.785511724759581e-07}, {"x": 0.29423592493297585, "y": 0.6107573726541555, "term": "intermediate", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.4843376770248946e-06}, {"x": 0.2944034852546917, "y": 0.2612265415549598, "term": "2%", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.2945710455764075, "y": 0.6987265415549598, "term": "figure", "cat25k": 2, "ncat25k": 0, "cat": 10, "ncat": 3, "s": 0.7833445040214477, "os": 0.7500166525303732, "bg": 3.085624025447189e-07}, {"x": 0.29473860589812334, "y": 0.6109249329758714, "term": "coalition", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.5890237864148639e-06}, {"x": 0.2949061662198391, "y": 0.3445040214477212, "term": "encompass", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 6.384058580121531e-06}, {"x": 0.29507372654155495, "y": 0.6110924932975871, "term": "choices", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 1.006844731856104e-06}, {"x": 0.2952412868632708, "y": 0.43331099195710454, "term": "definitive", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.803967614174056e-06}, {"x": 0.2954088471849866, "y": 0.3450067024128686, "term": "conducive", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 8.281110579739849e-06}, {"x": 0.2955764075067024, "y": 0.5738941018766756, "term": "base", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 2.1896039889524263e-07}, {"x": 0.2957439678284182, "y": 0.7645777479892761, "term": "oversight", "cat25k": 2, "ncat25k": 0, "cat": 14, "ncat": 3, "s": 0.8247319034852547, "os": 0.7937691672966498, "bg": 6.436400038164067e-06}, {"x": 0.29591152815013405, "y": 0.34584450402144773, "term": "flaming", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.308412107957177e-06}, {"x": 0.2960790884718499, "y": 0.2623994638069705, "term": "blhd", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 3.2055186208576686e-05}, {"x": 0.29624664879356566, "y": 0.647955764075067, "term": "bihc", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 7.052005333880398e-05}, {"x": 0.2964142091152815, "y": 0.5179289544235925, "term": "cooperation bihc", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 0.0}, {"x": 0.2965817694369973, "y": 0.5747319034852547, "term": "ever", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.7896807010775867e-07}, {"x": 0.29674932975871315, "y": 0.17376005361930294, "term": "turned", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.3170212814639544e-07}, {"x": 0.29691689008042893, "y": 0.3475201072386059, "term": "relieve", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 3.602767285552033e-06}, {"x": 0.29708445040214476, "y": 0.17409517426273458, "term": "intra", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.357283431214617e-06}, {"x": 0.2972520107238606, "y": 0.1742627345844504, "term": "phased", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.595934092007154e-06}, {"x": 0.2974195710455764, "y": 0.2632372654155496, "term": "beneficial", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.335809924934161e-06}, {"x": 0.2975871313672922, "y": 0.34869302949061665, "term": "ancillary", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.499834088338335e-06}, {"x": 0.29775469168900803, "y": 0.9343163538873994, "term": "express", "cat25k": 9, "ncat25k": 0, "cat": 58, "ncat": 3, "s": 0.9926273458445041, "os": 0.9471091239974337, "bg": 2.0296227432071563e-06}, {"x": 0.29792225201072386, "y": 0.3493632707774799, "term": "offers", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 8.426973866942802e-08}, {"x": 0.2980898123324397, "y": 0.3495308310991957, "term": "latter", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 8.358892970505367e-07}, {"x": 0.2982573726541555, "y": 0.26373994638069703, "term": "chains", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 9.770448204655715e-07}, {"x": 0.2984249329758713, "y": 0.6487935656836461, "term": "owner", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 3.7606179337989024e-07}, {"x": 0.29859249329758714, "y": 0.2640750670241287, "term": "assured", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.574645189136145e-06}, {"x": 0.29876005361930297, "y": 0.5201072386058981, "term": "asked", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 2.109574267212679e-07}, {"x": 0.29892761394101874, "y": 0.2650804289544236, "term": "cebu", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 9.220839096357768e-06}, {"x": 0.2990951742627346, "y": 0.439343163538874, "term": "1989", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 0.0}, {"x": 0.2992627345844504, "y": 0.26558310991957107, "term": "1994", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.29943029490616624, "y": 0.521112600536193, "term": "al", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 1.268839209110951e-07}, {"x": 0.299597855227882, "y": 0.5767426273458445, "term": "residing", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 7.336954528001487e-06}, {"x": 0.29976541554959785, "y": 0.577245308310992, "term": "cited", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.5641415339536024e-06}, {"x": 0.2999329758713137, "y": 0.3512064343163539, "term": "instructed", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 3.838432691163544e-06}, {"x": 0.3001005361930295, "y": 0.6144436997319035, "term": "copy furnished", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 0.0}, {"x": 0.3002680965147453, "y": 0.35137399463806973, "term": "000", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.3004356568364611, "y": 0.2660857908847185, "term": "asian", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.506243794746267e-07}, {"x": 0.30060321715817695, "y": 0.44185656836461124, "term": "urgent", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.0039549482299706e-06}, {"x": 0.3007707774798928, "y": 0.7211796246648794, "term": "epidemic", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 8.130895806926073e-06}, {"x": 0.30093833780160856, "y": 0.2667560321715818, "term": "boundaries", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 9.807793724051644e-07}, {"x": 0.3011058981233244, "y": 0.352044235924933, "term": "distinct", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.1282520808494157e-06}, {"x": 0.3012734584450402, "y": 0.6151139410187667, "term": "chemotherapy", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 5.110571037320711e-06}, {"x": 0.30144101876675605, "y": 0.35254691689008044, "term": "overcome", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.5136922928464798e-06}, {"x": 0.30160857908847183, "y": 0.6156166219839142, "term": "hfdb", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 6.410934489865916e-05}, {"x": 0.30177613941018766, "y": 0.44269436997319034, "term": "hfsrb", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.4876972984062266e-05}, {"x": 0.3019436997319035, "y": 0.3532171581769437, "term": "minimizing", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.39701329284374e-06}, {"x": 0.3021112600536193, "y": 0.17593833780160859, "term": "efficacious", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.335925027887435e-05}, {"x": 0.3022788203753351, "y": 0.5242962466487936, "term": "floor", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 2.959027675341993e-07}, {"x": 0.30244638069705093, "y": 0.3540549597855228, "term": "batch", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.472932472306108e-06}, {"x": 0.30261394101876676, "y": 0.2696045576407507, "term": "60%", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.3027815013404826, "y": 0.3550603217158177, "term": "39", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.30294906166219837, "y": 0.17644101876675602, "term": "13%", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3031166219839142, "y": 0.27010723860589814, "term": "we", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.189207638561296e-09}, {"x": 0.30328418230563003, "y": 0.650804289544236, "term": "attain", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 7.381948384745807e-06}, {"x": 0.30345174262734587, "y": 0.17660857908847186, "term": "10th", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.30361930294906164, "y": 0.44436997319034854, "term": "scienti\ufb01c", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 0.0}, {"x": 0.3037868632707775, "y": 0.6513069705093834, "term": "extreme", "cat25k": 1, "ncat25k": 0, "cat": 8, "ncat": 3, "s": 0.7443029490616623, "os": 0.7177667884480506, "bg": 7.331653407149308e-07}, {"x": 0.3039544235924933, "y": 0.1769436997319035, "term": "domestic violence", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.30412198391420914, "y": 0.17744638069705093, "term": "epidemics", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.506611231916805e-06}, {"x": 0.3042895442359249, "y": 0.35673592493297585, "term": "leads", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 3.893668709728717e-07}, {"x": 0.30445710455764075, "y": 0.7213471849865952, "term": "labelling", "cat25k": 2, "ncat25k": 0, "cat": 11, "ncat": 3, "s": 0.7933981233243969, "os": 0.7629283556392243, "bg": 1.2495699025023083e-05}, {"x": 0.3046246648793566, "y": 0.44705093833780163, "term": "accompanied", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.660371486772532e-06}, {"x": 0.3047922252010724, "y": 0.44755361930294907, "term": "bear", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.3352611000799357e-07}, {"x": 0.3049597855227882, "y": 0.3580764075067024, "term": "front", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.1857906000916654e-07}, {"x": 0.305127345844504, "y": 0.3582439678284182, "term": "transitions", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.69480461880529e-06}, {"x": 0.30529490616621985, "y": 0.6181300268096515, "term": "printing", "cat25k": 1, "ncat25k": 0, "cat": 7, "ncat": 3, "s": 0.704926273458445, "os": 0.6969112840054432, "bg": 5.650905800643503e-07}, {"x": 0.3054624664879357, "y": 0.27362600536193027, "term": "300", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.30563002680965146, "y": 0.2746313672922252, "term": "sponsorship", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.3299152737577394e-06}, {"x": 0.3057975871313673, "y": 0.1789544235924933, "term": "wpr", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.157421665367719e-05}, {"x": 0.3059651474530831, "y": 0.17928954423592494, "term": "valuable", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.5089202505584443e-07}, {"x": 0.30613270777479895, "y": 0.2753016085790885, "term": "triage", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.1449350363860356e-05}, {"x": 0.3063002680965147, "y": 0.1799597855227882, "term": "intervals", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.3248459286987793e-06}, {"x": 0.30646782841823056, "y": 0.36109249329758714, "term": "et", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.1476332097316427e-07}, {"x": 0.3066353887399464, "y": 0.36126005361930297, "term": "et al", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.3068029490616622, "y": 0.2764745308310992, "term": "refrain", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 4.332031124777226e-06}, {"x": 0.306970509383378, "y": 0.2769772117962466, "term": "thumb", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.316422049121499e-06}, {"x": 0.30713806970509383, "y": 0.4519101876675603, "term": "appears", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.19404039442074e-07}, {"x": 0.30730563002680966, "y": 0.36193029490616624, "term": "removed", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 4.010408212433729e-07}, {"x": 0.3074731903485255, "y": 0.27781501340482573, "term": "slowly", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.511729189543012e-07}, {"x": 0.30764075067024127, "y": 0.18113270777479892, "term": "adjust", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.486283566831658e-07}, {"x": 0.3078083109919571, "y": 0.27798257372654156, "term": "remember", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.211621788962964e-07}, {"x": 0.30797587131367293, "y": 0.5298257372654156, "term": "becoming", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 7.019043410546174e-07}, {"x": 0.30814343163538876, "y": 0.36226541554959785, "term": "makes", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.3614462761783854e-07}, {"x": 0.30831099195710454, "y": 0.1818029490616622, "term": "densely", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 7.526153383005947e-06}, {"x": 0.3084785522788204, "y": 0.18197050938337803, "term": "bright", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.048925392425645e-07}, {"x": 0.3086461126005362, "y": 0.1826407506702413, "term": "locating", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.3717364905889493e-06}, {"x": 0.30881367292225204, "y": 0.3632707774798928, "term": "density", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 6.431499253758501e-07}, {"x": 0.3089812332439678, "y": 0.18297587131367293, "term": "exact", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.5371782637919666e-07}, {"x": 0.30914879356568364, "y": 0.18314343163538874, "term": "borders", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.615037893244173e-07}, {"x": 0.3093163538873995, "y": 0.18331099195710457, "term": "consistency", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.2097643711690168e-06}, {"x": 0.3094839142091153, "y": 0.18347855227882037, "term": "unusually", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.94006180971964e-06}, {"x": 0.3096514745308311, "y": 0.1836461126005362, "term": "in-", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3098190348525469, "y": 0.45375335120643434, "term": "accomplish", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 2.1862565665777586e-06}, {"x": 0.30998659517426275, "y": 0.18414879356568364, "term": "gynecological", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.330171957979868e-05}, {"x": 0.3101541554959786, "y": 0.5304959785522788, "term": "reimbursements", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 1.725664623551655e-05}, {"x": 0.31032171581769435, "y": 0.18498659517426275, "term": "6th", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3104892761394102, "y": 0.4547587131367292, "term": "independence", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 9.508130164400323e-07}, {"x": 0.310656836461126, "y": 0.18532171581769438, "term": "beliefs", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.83001135429085e-07}, {"x": 0.31082439678284185, "y": 0.3646112600536193, "term": "sought", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 9.44085587022977e-07}, {"x": 0.3109919571045576, "y": 0.18615951742627346, "term": "preference", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 7.185410813737894e-07}, {"x": 0.31115951742627346, "y": 0.36544906166219837, "term": "heights", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 7.722648294314759e-07}, {"x": 0.3113270777479893, "y": 0.5821045576407506, "term": "furniture", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 2.658397239603012e-07}, {"x": 0.3114946380697051, "y": 0.2823391420911528, "term": "xv", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.921074324399325e-06}, {"x": 0.3116621983914209, "y": 0.45676943699731903, "term": "\ufb01nding", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 0.0}, {"x": 0.31182975871313673, "y": 0.28351206434316356, "term": "soap", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.814123872617279e-07}, {"x": 0.31199731903485256, "y": 0.18817024128686327, "term": "drainage", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.2493659467820083e-06}, {"x": 0.3121648793565684, "y": 0.28384718498659517, "term": "firm", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.244350218642354e-07}, {"x": 0.31233243967828417, "y": 0.28451742627345844, "term": "nso", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.8564586195373706e-05}, {"x": 0.3125, "y": 0.18967828418230562, "term": "indirect", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.003473145992423e-06}, {"x": 0.31266756032171583, "y": 0.2851876675603217, "term": "misconceptions", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 8.45259951245406e-06}, {"x": 0.3128351206434316, "y": 0.18984584450402145, "term": "researcher", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.270949820518055e-06}, {"x": 0.31300268096514744, "y": 0.19001340482573725, "term": "clearing", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.2520721794570012e-06}, {"x": 0.31317024128686327, "y": 0.5331769436997319, "term": "suggested", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 6.18074021858265e-07}, {"x": 0.3133378016085791, "y": 0.2860254691689008, "term": "serves", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.6805760714191e-07}, {"x": 0.3135053619302949, "y": 0.2863605898123324, "term": "motor", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.443337954418406e-07}, {"x": 0.3136729222520107, "y": 0.19101876675603216, "term": "quarters", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.0452221913736507e-06}, {"x": 0.31384048257372654, "y": 0.191186327077748, "term": "posters", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.2830035777234444e-07}, {"x": 0.3140080428954424, "y": 0.1913538873994638, "term": "things", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.395130816208975e-08}, {"x": 0.31417560321715815, "y": 0.36896782841823056, "term": "attend", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 5.727481559060572e-07}, {"x": 0.314343163538874, "y": 0.1923592493297587, "term": "d.1", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3145107238605898, "y": 0.19252680965147453, "term": "ci", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.830888593814558e-07}, {"x": 0.31467828418230565, "y": 0.1933646112600536, "term": "write", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.301340566096052e-08}, {"x": 0.3148458445040214, "y": 0.28820375335120646, "term": "revoked", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 4.78266837503581e-06}, {"x": 0.31501340482573725, "y": 0.1942024128686327, "term": "visibly", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 7.672241829062452e-06}, {"x": 0.3151809651474531, "y": 0.2890415549597855, "term": "repository", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.0864102463261407e-06}, {"x": 0.3153485254691689, "y": 0.19470509383378015, "term": "alternately", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.461612770085317e-06}, {"x": 0.3155160857908847, "y": 0.1950402144772118, "term": ".of", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3156836461126005, "y": 0.19520777479892762, "term": "25%", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.31585120643431636, "y": 0.19537533512064342, "term": "2025", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3160187667560322, "y": 0.5837801608579088, "term": "concentration", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.0944322340937044e-06}, {"x": 0.31618632707774796, "y": 0.19554289544235925, "term": "meal", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.038053017728327e-07}, {"x": 0.3163538873994638, "y": 0.19571045576407506, "term": "load", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.093792207088612e-07}, {"x": 0.3165214477211796, "y": 0.1968833780160858, "term": "-any", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.31668900804289546, "y": 0.4628016085790885, "term": "fingers", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 1.426989654223079e-06}, {"x": 0.31685656836461124, "y": 0.29222520107238603, "term": "inconsistent herewith", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.31702412868632707, "y": 0.19738605898123324, "term": "void", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.438794860983663e-07}, {"x": 0.3171916890080429, "y": 0.29239276139410186, "term": "affects", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.1434523915020906e-06}, {"x": 0.31735924932975873, "y": 0.19755361930294907, "term": "councils", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.2710982447722113e-06}, {"x": 0.3175268096514745, "y": 0.5849530831099196, "term": "cf", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 1.2450218148572326e-06}, {"x": 0.31769436997319034, "y": 0.19855898123324398, "term": "venue", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.511146811095454e-07}, {"x": 0.31786193029490617, "y": 0.19989946380697052, "term": "menstruation", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 9.081476738932518e-06}, {"x": 0.318029490616622, "y": 0.20090482573726542, "term": "indication", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.1461543013093524e-06}, {"x": 0.3181970509383378, "y": 0.20123994638069706, "term": "trend", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 4.981636752872022e-07}, {"x": 0.3183646112600536, "y": 0.2944034852546917, "term": "restrictions", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.117738695351847e-07}, {"x": 0.31853217158176944, "y": 0.2945710455764075, "term": "0036", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.3186997319034853, "y": 0.2949061662198391, "term": "engagement", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 8.421402252741946e-07}, {"x": 0.31886729222520105, "y": 0.20224530831099197, "term": "words", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 8.769804300940044e-08}, {"x": 0.3190348525469169, "y": 0.2957439678284182, "term": "p50,000.00", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.3192024128686327, "y": 0.20408847184986595, "term": "rich", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.1325989799832393e-07}, {"x": 0.31936997319034854, "y": 0.2972520107238606, "term": "prioritizing", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 1.4643989960080486e-05}, {"x": 0.3195375335120643, "y": 0.20425603217158178, "term": "prone", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.414700697848502e-06}, {"x": 0.31970509383378015, "y": 0.2974195710455764, "term": "dif\ufb01culty", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.319872654155496, "y": 0.20492627345844505, "term": "allotted", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.230905234305323e-06}, {"x": 0.3200402144772118, "y": 0.3734919571045576, "term": "doh\u2014", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 0.0}, {"x": 0.3202077747989276, "y": 0.29775469168900803, "term": "hepo", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 3.2055186208576686e-05}, {"x": 0.3203753351206434, "y": 0.20609919571045576, "term": "acceleration", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.8057443436187027e-06}, {"x": 0.32054289544235925, "y": 0.20710455764075067, "term": "catch", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.8623198831262e-07}, {"x": 0.3207104557640751, "y": 0.2992627345844504, "term": "waste disposal", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 0.0}, {"x": 0.32087801608579086, "y": 0.4679959785522788, "term": "seizures", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 5.7487382546091545e-06}, {"x": 0.3210455764075067, "y": 0.5861260053619303, "term": "lasting", "cat25k": 1, "ncat25k": 0, "cat": 6, "ncat": 3, "s": 0.6858243967828418, "os": 0.6712224987731548, "bg": 2.647451269246971e-06}, {"x": 0.3212131367292225, "y": 0.3004356568364611, "term": "encephalitis", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 9.862895884312176e-06}, {"x": 0.32138069705093836, "y": 0.37483243967828417, "term": "coordinates", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 1.7273422004525925e-06}, {"x": 0.32154825737265413, "y": 0.21196380697050937, "term": "70", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.32171581769436997, "y": 0.3753351206434316, "term": "ordering", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 4.260018311688712e-07}, {"x": 0.3218833780160858, "y": 0.3027815013404826, "term": "books", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.8733803624094658e-08}, {"x": 0.32205093833780163, "y": 0.21330428954423591, "term": "eventual", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.6703308803288614e-06}, {"x": 0.3222184986595174, "y": 0.5378686327077749, "term": "eg", "cat25k": 1, "ncat25k": 0, "cat": 5, "ncat": 3, "s": 0.6496313672922253, "os": 0.6385121649248989, "bg": 2.465028714657304e-07}, {"x": 0.32238605898123324, "y": 0.37567024128686327, "term": "improves", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.2834756097212885e-06}, {"x": 0.32255361930294907, "y": 0.3039544235924933, "term": "formerly", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 9.528404937390756e-07}, {"x": 0.3227211796246649, "y": 0.4691689008042895, "term": "launched", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 9.226299646224132e-07}, {"x": 0.3228887399463807, "y": 0.21414209115281502, "term": "nearby", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.901172185983559e-07}, {"x": 0.3230563002680965, "y": 0.2148123324396783, "term": "nine", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.9498928617349445e-07}, {"x": 0.32322386058981234, "y": 0.2158176943699732, "term": "cooperative", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.799790124477808e-07}, {"x": 0.32339142091152817, "y": 0.21632037533512063, "term": "variables", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 3.2877478869438845e-07}, {"x": 0.32355898123324395, "y": 0.21665549597855227, "term": "clustering", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.677607370382048e-06}, {"x": 0.3237265415549598, "y": 0.30613270777479895, "term": "prematurity", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.0089680333006538e-05}, {"x": 0.3238941018766756, "y": 0.21883378016085792, "term": "presenting", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.1707141180512997e-06}, {"x": 0.32406166219839144, "y": 0.21983914209115282, "term": "discipline", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 6.640697113820221e-07}, {"x": 0.3242292225201072, "y": 0.30646782841823056, "term": "collective", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 7.943529764644335e-07}, {"x": 0.32439678284182305, "y": 0.22034182305630026, "term": "juridical", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.3598064995351162e-05}, {"x": 0.3245643431635389, "y": 0.3066353887399464, "term": "randomly", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 2.40596120195085e-06}, {"x": 0.3247319034852547, "y": 0.2205093833780161, "term": "sole", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.833571841348721e-07}, {"x": 0.3248994638069705, "y": 0.22084450402144773, "term": "specifications", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.519855754637109e-07}, {"x": 0.3250670241286863, "y": 0.22201742627345844, "term": "ensuing", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 5.8262368554634445e-06}, {"x": 0.32523458445040215, "y": 0.22218498659517427, "term": "barrier", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 9.231928903069131e-07}, {"x": 0.325402144772118, "y": 0.30713806970509383, "term": "venous", "cat25k": 0, "ncat25k": 0, "cat": 2, "ncat": 3, "s": 0.4401809651474531, "os": 0.46221562814754114, "bg": 6.723620212278137e-06}, {"x": 0.32556970509383376, "y": 0.4703418230563003, "term": "bhw", "cat25k": 1, "ncat25k": 0, "cat": 4, "ncat": 3, "s": 0.590985254691689, "os": 0.5951459484884531, "bg": 4.0579710144927535e-05}, {"x": 0.3257372654155496, "y": 0.3785187667560322, "term": "contraindicated", "cat25k": 0, "ncat25k": 0, "cat": 3, "ncat": 3, "s": 0.5204423592493298, "os": 0.5347946725474838, "bg": 2.1818776875732974e-05}, {"x": 0.3259048257372654, "y": 0.22319034852546918, "term": "reminders", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 2.8556446635675783e-06}, {"x": 0.32607238605898126, "y": 0.22335790884718498, "term": "phones", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.1830127706376467e-07}, {"x": 0.32623994638069703, "y": 0.22369302949061662, "term": "mobile phones", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.32640750670241286, "y": 0.22469839142091153, "term": "attitudes", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 1.0171081403360043e-06}, {"x": 0.3265750670241287, "y": 0.22503351206434316, "term": "i-", "cat25k": 0, "ncat25k": 0, "cat": 1, "ncat": 3, "s": 0.31384048257372654, "os": 0.3330183227792405, "bg": 0.0}, {"x": 0.3267426273458445, "y": 0.6794571045576407, "term": "internationally", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 4.365683358856989e-06}, {"x": 0.3269101876675603, "y": 0.5392091152815014, "term": "80", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 0.0}, {"x": 0.32707774798927614, "y": 0.8855563002680965, "term": "screen", "cat25k": 5, "ncat25k": 1, "cat": 34, "ncat": 4, "s": 0.9736930294906166, "os": 0.882684249723245, "bg": 9.806975748303863e-07}, {"x": 0.32724530831099197, "y": 0.22603887399463807, "term": "abnormalities", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 5.08727646719173e-06}, {"x": 0.3274128686327078, "y": 0.2262064343163539, "term": "sensitivity", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.2315944622176068e-06}, {"x": 0.3275804289544236, "y": 0.5397117962466488, "term": "vagina", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 3.2488787307280575e-06}, {"x": 0.3277479892761394, "y": 0.5869638069705094, "term": "accompanying", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 3.6709598542161725e-06}, {"x": 0.32791554959785524, "y": 0.7424597855227882, "term": "statistics", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 4.891634470599982e-07}, {"x": 0.32808310991957107, "y": 0.4718498659517426, "term": "pneumonia", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 7.681973140407691e-06}, {"x": 0.32825067024128685, "y": 0.5874664879356568, "term": "majority", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 7.647238186025048e-07}, {"x": 0.3284182305630027, "y": 0.6561662198391421, "term": "lifetime", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 1.78798992041313e-06}, {"x": 0.3285857908847185, "y": 0.47201742627345844, "term": "passage", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 1.586355649303299e-06}, {"x": 0.32875335120643434, "y": 0.9725201072386059, "term": "lifestyle", "cat25k": 20, "ncat25k": 1, "cat": 123, "ncat": 4, "s": 0.9974865951742627, "os": 0.9837368312372821, "bg": 1.1082232829072835e-05}, {"x": 0.3289209115281501, "y": 0.3096514745308311, "term": "pharmaceuticals", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.8787739872468822e-06}, {"x": 0.32908847184986595, "y": 0.9214142091152815, "term": "rational", "cat25k": 8, "ncat25k": 1, "cat": 50, "ncat": 4, "s": 0.9876005361930296, "os": 0.925189354163224, "bg": 1.4880050261503108e-05}, {"x": 0.3292560321715818, "y": 0.6565013404825737, "term": "reasonable", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 9.687703826028216e-07}, {"x": 0.3294235924932976, "y": 0.15365281501340483, "term": "nets", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.9831224381776452e-06}, {"x": 0.3295911528150134, "y": 0.7055965147453083, "term": "parts", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 4, "s": 0.756534852546917, "os": 0.7308528358327331, "bg": 2.9717835982448927e-07}, {"x": 0.3297587131367292, "y": 0.22838471849865952, "term": "affecting", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.368306018904516e-06}, {"x": 0.32992627345844505, "y": 0.9269436997319035, "term": "dangerous", "cat25k": 9, "ncat25k": 1, "cat": 53, "ncat": 4, "s": 0.9896112600536193, "os": 0.9309928823438682, "bg": 6.619503670776081e-06}, {"x": 0.3300938337801609, "y": 0.625, "term": "duty", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 7.424982616259449e-07}, {"x": 0.33026139410187666, "y": 0.38589142091152817, "term": "schedules", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.209434435198654e-06}, {"x": 0.3304289544235925, "y": 0.2292225201072386, "term": "annexes", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.2554770184931763e-05}, {"x": 0.3305965147453083, "y": 0.31115951742627346, "term": "intensity", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.440668634894435e-06}, {"x": 0.33076407506702415, "y": 0.7069369973190348, "term": "strong", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 4, "s": 0.756534852546917, "os": 0.7308528358327331, "bg": 4.895467171086901e-07}, {"x": 0.33093163538873993, "y": 0.5437332439678284, "term": "hired", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 2.9246637331314533e-06}, {"x": 0.33109919571045576, "y": 0.3116621983914209, "term": "chance", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.198274613087587e-07}, {"x": 0.3312667560321716, "y": 0.791387399463807, "term": "directed", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 4, "s": 0.8250670241286864, "os": 0.7948081144442001, "bg": 1.7032293227960211e-06}, {"x": 0.3314343163538874, "y": 0.7074396782841823, "term": "emotional", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 4, "s": 0.756534852546917, "os": 0.7308528358327331, "bg": 2.2267089583024995e-06}, {"x": 0.3316018766756032, "y": 0.8676273458445041, "term": "controlled", "cat25k": 5, "ncat25k": 1, "cat": 29, "ncat": 4, "s": 0.9592828418230563, "os": 0.8636551059920985, "bg": 2.79929167741319e-06}, {"x": 0.33176943699731903, "y": 0.7453083109919572, "term": "employment", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 4.2811922314493113e-07}, {"x": 0.33193699731903487, "y": 0.8394772117962467, "term": "chairperson", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 4, "s": 0.8897453083109921, "os": 0.834747595571899, "bg": 1.2392654368869652e-05}, {"x": 0.3321045576407507, "y": 0.7687667560321716, "term": "display", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 4, "s": 0.8094839142091154, "os": 0.7773363886846305, "bg": 3.56290589291977e-07}, {"x": 0.3322721179624665, "y": 0.31317024128686327, "term": "channels", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 5.897681958232617e-07}, {"x": 0.3324396782841823, "y": 0.5452412868632708, "term": "orient", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 6.52490654702598e-06}, {"x": 0.33260723860589814, "y": 0.23140080428954424, "term": "experiencing", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.1203398904844447e-06}, {"x": 0.33277479892761397, "y": 0.6270107238605898, "term": "turn", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 2.976190550004726e-07}, {"x": 0.33294235924932974, "y": 0.1544906166219839, "term": "participants", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.239419852298652e-07}, {"x": 0.3331099195710456, "y": 0.3135053619302949, "term": "paraphernalia", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.644190195224097e-05}, {"x": 0.3332774798927614, "y": 0.38806970509383376, "term": "36", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 0.0}, {"x": 0.3334450402144772, "y": 0.15465817694369974, "term": "returning", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.994251813176254e-07}, {"x": 0.333612600536193, "y": 0.47603887399463807, "term": "wastage", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 3.258107256890897e-05}, {"x": 0.33378016085790885, "y": 0.38890750670241286, "term": "confirmatory", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 2.9328577215728185e-05}, {"x": 0.3339477211796247, "y": 0.3140080428954424, "term": "challenge", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.7603794867538616e-07}, {"x": 0.33411528150134046, "y": 0.38957774798927614, "term": "whatever", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 4.971764726646782e-07}, {"x": 0.3342828418230563, "y": 0.7084450402144772, "term": "funded", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 4, "s": 0.756534852546917, "os": 0.7308528358327331, "bg": 1.9461928283961987e-06}, {"x": 0.3344504021447721, "y": 0.546916890080429, "term": "noted", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 6.65191449416248e-07}, {"x": 0.33461796246648795, "y": 0.8039544235924933, "term": "xi", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 4, "s": 0.8309316353887399, "os": 0.8025862425484014, "bg": 5.5685283986722104e-06}, {"x": 0.3347855227882037, "y": 0.9792225201072386, "term": "disability", "cat25k": 25, "ncat25k": 1, "cat": 153, "ncat": 4, "s": 0.9983243967828419, "os": 0.9879431555928151, "bg": 1.4198822402124217e-05}, {"x": 0.33495308310991956, "y": 0.47972520107238603, "term": "12%", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 0.0}, {"x": 0.3351206434316354, "y": 0.48056300268096513, "term": "medium term", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 0.0}, {"x": 0.3352882037533512, "y": 0.4810656836461126, "term": "classifying", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 1.6510535097269984e-05}, {"x": 0.335455764075067, "y": 0.729725201072386, "term": "holistic", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 4, "s": 0.7634048257372654, "os": 0.7444133258404695, "bg": 7.038642808893589e-06}, {"x": 0.33562332439678283, "y": 0.5484249329758714, "term": "specially", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 3.136179008079895e-06}, {"x": 0.33579088471849866, "y": 0.6861595174262735, "term": "curative", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 3.875234071057953e-05}, {"x": 0.3359584450402145, "y": 0.6301943699731903, "term": "brain", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 7.074480394890421e-07}, {"x": 0.33612600536193027, "y": 0.23324396782841822, "term": "restriction", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.5801994685789185e-06}, {"x": 0.3362935656836461, "y": 0.9023123324396782, "term": "impairment", "cat25k": 6, "ncat25k": 1, "cat": 40, "ncat": 4, "s": 0.9797252010723861, "os": 0.901330990866013, "bg": 1.8835826083680724e-05}, {"x": 0.33646112600536193, "y": 0.6308646112600537, "term": "physically", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 3.4591413431096355e-06}, {"x": 0.33662868632707776, "y": 0.9369973190348525, "term": "elderly", "cat25k": 10, "ncat25k": 1, "cat": 60, "ncat": 4, "s": 0.9919571045576407, "os": 0.9426181780043126, "bg": 1.4486042019481012e-05}, {"x": 0.33679624664879354, "y": 0.7300603217158177, "term": "models", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 4, "s": 0.7634048257372654, "os": 0.7444133258404695, "bg": 3.6830225516419904e-07}, {"x": 0.33696380697050937, "y": 0.23441689008042896, "term": "epidemiologic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.4204024236800024e-05}, {"x": 0.3371313672922252, "y": 0.8051273458445041, "term": "aimed", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 4, "s": 0.8309316353887399, "os": 0.8025862425484014, "bg": 4.254352662049985e-06}, {"x": 0.33729892761394104, "y": 0.4830764075067024, "term": "useful", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 3.0792101141788215e-07}, {"x": 0.3374664879356568, "y": 0.5509383378016086, "term": "formulating", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.5136584974517558e-05}, {"x": 0.33763404825737264, "y": 0.23458445040214476, "term": "necessarily", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 7.416664961863817e-07}, {"x": 0.3378016085790885, "y": 0.2347520107238606, "term": "handled", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.4664112992856255e-06}, {"x": 0.3379691689008043, "y": 0.7484919571045576, "term": "curriculum", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 1.3989200830695204e-06}, {"x": 0.3381367292225201, "y": 0.6886729222520107, "term": "ordinances", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 1.0517174546033673e-05}, {"x": 0.3383042895442359, "y": 0.3190348525469169, "term": "prioritize", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.1120969939223899e-05}, {"x": 0.33847184986595175, "y": 0.7845174262734584, "term": "moreover", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 4, "s": 0.8215482573726542, "os": 0.7864246394684007, "bg": 3.3031243344720575e-06}, {"x": 0.3386394101876676, "y": 0.7726206434316354, "term": "enrolled", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 4, "s": 0.8094839142091154, "os": 0.7773363886846305, "bg": 4.473703511892575e-06}, {"x": 0.33880697050938335, "y": 0.749162198391421, "term": "targeting", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 6.501958045542008e-06}, {"x": 0.3389745308310992, "y": 0.6338806970509383, "term": "surgery", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 5.949711845539134e-07}, {"x": 0.339142091152815, "y": 0.9066689008042895, "term": "license", "cat25k": 7, "ncat25k": 1, "cat": 42, "ncat": 4, "s": 0.9819034852546917, "os": 0.9067409694499722, "bg": 1.0742781735201896e-06}, {"x": 0.33930965147453085, "y": 0.8347855227882037, "term": "principal", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 4, "s": 0.8471849865951743, "os": 0.8290453887464253, "bg": 1.8390085254313306e-06}, {"x": 0.3394772117962466, "y": 0.5536193029490617, "term": "o.", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 0.0}, {"x": 0.33964477211796246, "y": 0.6640415549597856, "term": "awards", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 5.069645621631757e-07}, {"x": 0.3398123324396783, "y": 0.1580093833780161, "term": "expiration", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.7267002947304733e-06}, {"x": 0.3399798927613941, "y": 0.8212131367292225, "term": "pharmacy", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 4, "s": 0.8418230563002681, "os": 0.816632330506634, "bg": 1.6159328827663585e-06}, {"x": 0.3401474530831099, "y": 0.39979892761394104, "term": "returned", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 4.6443720167529464e-07}, {"x": 0.34031501340482573, "y": 0.6648793565683646, "term": "distribute", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 2.8918694423274474e-06}, {"x": 0.34048257372654156, "y": 0.4011394101876676, "term": "sampling", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.3479188259694422e-06}, {"x": 0.3406501340482574, "y": 0.8284182305630027, "term": "latest", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 4, "s": 0.8448391420911529, "os": 0.8230194779558386, "bg": 3.7803137214311766e-07}, {"x": 0.34081769436997317, "y": 0.40180965147453085, "term": "ncr", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 7.986096206504476e-06}, {"x": 0.340985254691689, "y": 0.5552949061662198, "term": "limitations", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.5201756958262206e-06}, {"x": 0.34115281501340483, "y": 0.5985254691689008, "term": "maybe", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 4.2139477187382215e-07}, {"x": 0.34132037533512066, "y": 0.9085120643431636, "term": "ward", "cat25k": 7, "ncat25k": 1, "cat": 43, "ncat": 4, "s": 0.9835790884718499, "os": 0.9093147623728122, "bg": 6.208647681899011e-06}, {"x": 0.34148793565683644, "y": 0.49044906166219837, "term": "categorized", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 6.632032718028075e-06}, {"x": 0.34165549597855227, "y": 0.15951742627345844, "term": "expenses incurred", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3418230563002681, "y": 0.15968498659517427, "term": "3.3.2", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.34199061662198393, "y": 0.15985254691689008, "term": "3.3.3", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3421581769436997, "y": 0.5986930294906166, "term": "coming", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 3.133854652903803e-07}, {"x": 0.34232573726541554, "y": 0.32355898123324395, "term": "examples", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.7495834279768363e-07}, {"x": 0.3424932975871314, "y": 0.24111930294906167, "term": "typhoons", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.5768934261301285e-05}, {"x": 0.3426608579088472, "y": 0.3237265415549598, "term": "con\ufb02ict", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.342828418230563, "y": 0.32439678284182305, "term": "expensive", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 7.712654267546577e-07}, {"x": 0.3429959785522788, "y": 0.2414544235924933, "term": "conducts", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 4.337875691665242e-06}, {"x": 0.34316353887399464, "y": 0.4914544235924933, "term": "complex", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 3.8153421052994153e-07}, {"x": 0.3433310991957105, "y": 0.3247319034852547, "term": "sheet", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.1385102357243124e-07}, {"x": 0.34349865951742625, "y": 0.556132707774799, "term": "adjusted", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.8107644332185094e-06}, {"x": 0.3436662198391421, "y": 0.325402144772118, "term": "stay", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.728266252551029e-07}, {"x": 0.3438337801608579, "y": 0.32556970509383376, "term": "encouraging", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.8669168335223587e-06}, {"x": 0.34400134048257375, "y": 0.6373994638069705, "term": "unique", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 3.7837660921207043e-07}, {"x": 0.3441689008042895, "y": 0.24262734584450402, "term": "of\ufb01cially", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 0.0}, {"x": 0.34433646112600536, "y": 0.24346514745308312, "term": "define", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.2967966757519973e-07}, {"x": 0.3445040214477212, "y": 0.8078083109919572, "term": "value", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 4, "s": 0.8309316353887399, "os": 0.8025862425484014, "bg": 2.4126348458627366e-07}, {"x": 0.344671581769437, "y": 0.32623994638069703, "term": "efficiency", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 6.003970940609105e-07}, {"x": 0.3448391420911528, "y": 0.4929624664879357, "term": "challenges", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 8.008459068365279e-07}, {"x": 0.3450067024128686, "y": 0.6000335120643432, "term": "accessing", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 2.8471228335498226e-06}, {"x": 0.34517426273458446, "y": 0.405328418230563, "term": "advance", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 3.551540105389289e-07}, {"x": 0.3453418230563003, "y": 0.7345844504021448, "term": "decision making", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 4, "s": 0.7634048257372654, "os": 0.7444133258404695, "bg": 0.0}, {"x": 0.34550938337801607, "y": 0.3274128686327078, "term": "elicit", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.2351517119202727e-05}, {"x": 0.3456769436997319, "y": 0.600201072386059, "term": "multisectoral", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 5.912214366143435e-05}, {"x": 0.34584450402144773, "y": 0.6007037533512064, "term": "deped", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 6.725525202377166e-05}, {"x": 0.34601206434316356, "y": 0.4938002680965147, "term": "contracting", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 2.028735917191508e-06}, {"x": 0.34617962466487934, "y": 0.4066689008042895, "term": "costing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 5.619725799528926e-06}, {"x": 0.34634718498659517, "y": 0.6018766756032171, "term": "oriented", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 1.2867173570919063e-06}, {"x": 0.346514745308311, "y": 0.7347520107238605, "term": "party", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 4, "s": 0.7634048257372654, "os": 0.7444133258404695, "bg": 2.2066002129245085e-07}, {"x": 0.34668230563002683, "y": 0.5578083109919572, "term": "dilg", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 6.148624552687565e-05}, {"x": 0.3468498659517426, "y": 0.32875335120643434, "term": "dr.", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.34701742627345844, "y": 0.5584785522788204, "term": "assume", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 8.698919185387973e-07}, {"x": 0.34718498659517427, "y": 0.7154825737265416, "term": "exercise", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 4, "s": 0.756534852546917, "os": 0.7308528358327331, "bg": 7.497875851771193e-07}, {"x": 0.3473525469168901, "y": 0.410857908847185, "term": "unsafe", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 6.518798585420707e-06}, {"x": 0.3475201072386059, "y": 0.7761394101876675, "term": "cpr", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 4, "s": 0.8094839142091154, "os": 0.7773363886846305, "bg": 1.5081340016748225e-05}, {"x": 0.3476876675603217, "y": 0.41320375335120646, "term": "ingredients", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.1653307969908536e-06}, {"x": 0.34785522788203754, "y": 0.7623994638069705, "term": "manufacturing", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 4, "s": 0.796916890080429, "os": 0.7674185629193313, "bg": 8.76052406623034e-07}, {"x": 0.3480227882037534, "y": 0.6395777479892761, "term": "proof", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 9.016784293122432e-07}, {"x": 0.34819034852546915, "y": 0.5599865951742627, "term": "harm", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.9345066954727614e-06}, {"x": 0.348357908847185, "y": 0.41353887399463807, "term": "expose", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 4.091201053893392e-06}, {"x": 0.3485254691689008, "y": 0.4137064343163539, "term": "prolonged", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 4.961129549975938e-06}, {"x": 0.34869302949061665, "y": 0.5601541554959786, "term": "causing", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.793147683374231e-06}, {"x": 0.3488605898123324, "y": 0.5609919571045576, "term": "jose", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 9.645634344901553e-07}, {"x": 0.34902815013404825, "y": 0.16454423592493297, "term": "dr. jose", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3491957104557641, "y": 0.7625670241286864, "term": "renal", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 4, "s": 0.796916890080429, "os": 0.7674185629193313, "bg": 7.490510459561543e-06}, {"x": 0.3493632707774799, "y": 0.7354222520107239, "term": "lesion", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 4, "s": 0.7634048257372654, "os": 0.7444133258404695, "bg": 1.936732985649414e-05}, {"x": 0.3495308310991957, "y": 0.16554959785522788, "term": "mail", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.2190656554418285e-08}, {"x": 0.3496983914209115, "y": 0.5001675603217158, "term": "fails", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 1.4601702071738163e-06}, {"x": 0.34986595174262736, "y": 0.33378016085790885, "term": "whom", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 4.829162845304116e-07}, {"x": 0.3500335120643432, "y": 0.24865951742627346, "term": "suspend", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.31114589653828e-06}, {"x": 0.35020107238605896, "y": 0.3344504021447721, "term": "constitute", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.4477037195748262e-06}, {"x": 0.3503686327077748, "y": 0.4160522788203753, "term": "correction", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.201058102161552e-06}, {"x": 0.35053619302949063, "y": 0.33495308310991956, "term": "generated", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.6129281200466594e-07}, {"x": 0.35070375335120646, "y": 0.6712466487935657, "term": "rise", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 8.71101590045185e-07}, {"x": 0.35087131367292224, "y": 0.5621648793565683, "term": "relatively", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 9.997058865281834e-07}, {"x": 0.35103887399463807, "y": 0.5623324396782842, "term": "growing", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 5.1227815474335e-07}, {"x": 0.3512064343163539, "y": 0.6717493297587132, "term": "parallel", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 1.3990287081767093e-06}, {"x": 0.35137399463806973, "y": 0.6050603217158177, "term": "de\ufb01nitions", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 0.0}, {"x": 0.3515415549597855, "y": 0.8436662198391421, "term": "partially", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 4, "s": 0.8897453083109921, "os": 0.834747595571899, "bg": 7.158178105810864e-06}, {"x": 0.35170911528150134, "y": 0.1677278820375335, "term": "replacements", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.1864923315468798e-06}, {"x": 0.35187667560321717, "y": 0.33646112600536193, "term": "6.3", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.352044235924933, "y": 0.8885723860589813, "term": "in\ufb02uenza", "cat25k": 5, "ncat25k": 1, "cat": 34, "ncat": 4, "s": 0.9736930294906166, "os": 0.882684249723245, "bg": 0.0}, {"x": 0.3522117962466488, "y": 0.2508378016085791, "term": "procedural", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.1751407645738957e-06}, {"x": 0.3523793565683646, "y": 0.5082104557640751, "term": "requesting", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 2.7006840832782946e-06}, {"x": 0.35254691689008044, "y": 0.5655160857908847, "term": "er", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.1412554723199898e-06}, {"x": 0.3527144772117963, "y": 0.808813672922252, "term": "purchased", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 4, "s": 0.8309316353887399, "os": 0.8025862425484014, "bg": 2.0683426478480705e-06}, {"x": 0.35288203753351205, "y": 0.7540214477211796, "term": "prescriptions", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 7.440865363887862e-06}, {"x": 0.3530495978552279, "y": 0.5678619302949062, "term": "php", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 3.8487907118827224e-07}, {"x": 0.3532171581769437, "y": 0.4269436997319035, "term": "fact", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.6999588014984457e-07}, {"x": 0.35338471849865954, "y": 0.568867292225201, "term": "beneficiaries", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 4.920079459283267e-06}, {"x": 0.3535522788203753, "y": 0.2535187667560322, "term": "feeds", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.761083560651657e-07}, {"x": 0.35371983914209115, "y": 0.16923592493297587, "term": "ef\ufb01cacious", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.353887399463807, "y": 0.2538538873994638, "term": "optimum", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.181745985860104e-06}, {"x": 0.3540549597855228, "y": 0.672754691689008, "term": "patients\u2019", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 0.0}, {"x": 0.3542225201072386, "y": 0.42794906166219837, "term": "relationship", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 3.3145700357358293e-07}, {"x": 0.3543900804289544, "y": 0.1697386058981233, "term": "bacteria", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.2750335301942602e-06}, {"x": 0.35455764075067026, "y": 0.16990616621983914, "term": "parasitic", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.577123754131426e-06}, {"x": 0.35472520107238603, "y": 0.25452412868632707, "term": "persist", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 5.625897506461578e-06}, {"x": 0.35489276139410186, "y": 0.42861930294906164, "term": "biological", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 7.86029697675784e-07}, {"x": 0.3550603217158177, "y": 0.4287868632707775, "term": "specified", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 3.29240937077324e-07}, {"x": 0.3552278820375335, "y": 0.33964477211796246, "term": "origin", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 4.386678572112311e-07}, {"x": 0.3553954423592493, "y": 0.6730898123324397, "term": "relating", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 1.1300049876681686e-06}, {"x": 0.35556300268096513, "y": 0.2556970509383378, "term": "independent", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.8609963802534824e-07}, {"x": 0.35573056300268097, "y": 0.7548592493297587, "term": "adapted", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 4.802755764754807e-06}, {"x": 0.3558981233243968, "y": 0.17107908847184986, "term": "instructional", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.0038177195509962e-06}, {"x": 0.3560656836461126, "y": 0.2558646112600536, "term": "advisories", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.18234604141346e-06}, {"x": 0.3562332439678284, "y": 0.6095844504021448, "term": "technologies", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 3.7584745486183114e-07}, {"x": 0.35640080428954424, "y": 0.5710455764075067, "term": "prevailing", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 6.5000276251174066e-06}, {"x": 0.35656836461126007, "y": 0.6097520107238605, "term": "foreign", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 3.246973481259148e-07}, {"x": 0.35673592493297585, "y": 0.34081769436997317, "term": "pia", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.0849155664460413e-05}, {"x": 0.3569034852546917, "y": 0.2582104557640751, "term": "peer reviewed", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 0.0}, {"x": 0.3570710455764075, "y": 0.34115281501340483, "term": "professions", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.3326906001461624e-06}, {"x": 0.35723860589812334, "y": 0.610254691689008, "term": "concepts", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 9.502289101444539e-07}, {"x": 0.3574061662198391, "y": 0.34165549597855227, "term": "circumference", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.1701400323292975e-05}, {"x": 0.35757372654155495, "y": 0.3426608579088472, "term": "intensified", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.1456122233551055e-05}, {"x": 0.3577412868632708, "y": 0.5730563002680965, "term": "evidenced", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 1.0227286092476145e-05}, {"x": 0.3579088471849866, "y": 0.5732238605898123, "term": "scientific", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 4.6808351489902794e-07}, {"x": 0.3580764075067024, "y": 0.6474530831099196, "term": "model", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 1.4859051771220953e-07}, {"x": 0.3582439678284182, "y": 0.6988941018766756, "term": "operationalization", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 7.816862088218872e-05}, {"x": 0.35841152815013405, "y": 0.4336461126005362, "term": "facilitating", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 5.326143040229024e-06}, {"x": 0.3585790884718499, "y": 0.2625670241286863, "term": "exist", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 4.6763405343911527e-07}, {"x": 0.35874664879356566, "y": 0.34634718498659517, "term": "proposed", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 2.6010344425450905e-07}, {"x": 0.3589142091152815, "y": 0.34668230563002683, "term": "drawing", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 6.869740109880511e-07}, {"x": 0.3590817694369973, "y": 0.5192694369973191, "term": "wider", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 2.1179787093720207e-06}, {"x": 0.35924932975871315, "y": 0.2634048257372654, "term": "consisting", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.6163499182059594e-06}, {"x": 0.35941689008042893, "y": 0.7556970509383378, "term": "f1", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 4, "s": 0.787701072386059, "os": 0.7565124560313529, "bg": 0.0}, {"x": 0.35958445040214476, "y": 0.613103217158177, "term": "pursuit", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 3.848500624156828e-06}, {"x": 0.3597520107238606, "y": 0.43699731903485256, "term": "qualified", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 6.936333690713477e-07}, {"x": 0.3599195710455764, "y": 0.3500335120643432, "term": "assign", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.9126333669000486e-06}, {"x": 0.3600871313672922, "y": 0.2644101876675603, "term": "hereof", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 8.209866069718182e-06}, {"x": 0.36025469168900803, "y": 0.5207774798927614, "term": "chairman", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 6.076031201230357e-07}, {"x": 0.36042225201072386, "y": 0.44001340482573725, "term": "proposals", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 8.988269690110864e-07}, {"x": 0.3605898123324397, "y": 0.6751005361930295, "term": "furnished", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 3.467552973206618e-06}, {"x": 0.3607573726541555, "y": 0.5231233243967829, "term": "gaps", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 3.040221625400444e-06}, {"x": 0.3609249329758713, "y": 0.6499664879356568, "term": "avoidable", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 4, "s": 0.6910187667560321, "os": 0.6771203885078122, "bg": 3.681919016191238e-05}, {"x": 0.36109249329758714, "y": 0.6752680965147453, "term": "involves", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 4, "s": 0.7087801608579088, "os": 0.697787585594738, "bg": 1.9711825245268172e-06}, {"x": 0.36126005361930297, "y": 0.7783176943699732, "term": "biopsy", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 4, "s": 0.8094839142091154, "os": 0.7773363886846305, "bg": 1.6709679433594637e-05}, {"x": 0.36142761394101874, "y": 0.17526809651474531, "term": "genetic counselor", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3615951742627346, "y": 0.3527144772117963, "term": "governor", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 6.728817873585891e-07}, {"x": 0.3617627345844504, "y": 0.3530495978552279, "term": "1987 constitution", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.36193029490616624, "y": 0.26859919571045576, "term": "hygienic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.3133557333450076e-05}, {"x": 0.362097855227882, "y": 0.17627345844504022, "term": "lot", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 9.370563331092831e-08}, {"x": 0.36226541554959785, "y": 0.35489276139410186, "term": "4th", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.3624329758713137, "y": 0.6171246648793566, "term": "developmental", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 2.707829615483271e-06}, {"x": 0.3626005361930295, "y": 0.27044235924932974, "term": "incidents", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.8340934122115774e-06}, {"x": 0.3627680965147453, "y": 0.271112600536193, "term": "facilitates", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 4.843074302849544e-06}, {"x": 0.3629356568364611, "y": 0.1771112600536193, "term": "hemb", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.2055186208576686e-05}, {"x": 0.36310321715817695, "y": 0.3569034852546917, "term": "concurrence", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.1070484191348574e-05}, {"x": 0.3632707774798928, "y": 0.17778150134048257, "term": "thirds", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 2.520207655029944e-06}, {"x": 0.36343833780160856, "y": 0.2717828418230563, "term": "supreme", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 5.352785832853107e-07}, {"x": 0.3636058981233244, "y": 0.7994302949061662, "term": "color", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 4, "s": 0.8250670241286864, "os": 0.7948081144442001, "bg": 3.7077044934094497e-07}, {"x": 0.3637734584450402, "y": 0.5805965147453083, "term": "manufactured", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 4, "s": 0.6322050938337802, "os": 0.6225553914328668, "bg": 2.0708825832355014e-06}, {"x": 0.36394101876675605, "y": 0.7009048257372654, "term": "brand", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 3.368641832910745e-07}, {"x": 0.36410857908847183, "y": 0.35841152815013405, "term": "replaced", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 9.150565429778203e-07}, {"x": 0.36427613941018766, "y": 0.27312332439678283, "term": "safer", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.223456240435664e-06}, {"x": 0.3644436997319035, "y": 0.17861930294906167, "term": "imported", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.0966557264291399e-06}, {"x": 0.3646112600536193, "y": 0.3597520107238606, "term": "globally", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.8410475743921756e-06}, {"x": 0.3647788203753351, "y": 0.7010723860589813, "term": "advocates", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 4, "s": 0.7417895442359249, "os": 0.7154731154209545, "bg": 5.330735995680581e-06}, {"x": 0.36494638069705093, "y": 0.1791219839142091, "term": "play", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 6.619873210230391e-08}, {"x": 0.36511394101876676, "y": 0.5278150134048257, "term": "makers", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 1.3258146873456438e-06}, {"x": 0.3652815013404826, "y": 0.2749664879356568, "term": "holding", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 4.831709348846234e-07}, {"x": 0.36544906166219837, "y": 0.5281501340482574, "term": "addresses", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 4, "s": 0.579088471849866, "os": 0.5851535991398453, "bg": 6.064603185432824e-07}, {"x": 0.3656166219839142, "y": 0.36025469168900803, "term": "civic", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.3212991919689168e-06}, {"x": 0.36578418230563003, "y": 0.6188002680965148, "term": "55", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 4, "s": 0.6623659517426274, "os": 0.6525104030665676, "bg": 0.0}, {"x": 0.36595174262734587, "y": 0.17945710455764075, "term": "peak", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.8923239945582196e-07}, {"x": 0.36611930294906164, "y": 0.18096514745308312, "term": "poorly", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.9564004423030118e-06}, {"x": 0.3662868632707775, "y": 0.2774798927613941, "term": "fold", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.2259176146585422e-06}, {"x": 0.3664544235924933, "y": 0.36310321715817695, "term": "temporarily", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 2.46475575326809e-06}, {"x": 0.36662198391420914, "y": 0.2796581769436997, "term": "representation", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 6.328401311350224e-07}, {"x": 0.3667895442359249, "y": 0.27982573726541554, "term": "exploitation", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.767958572886693e-06}, {"x": 0.36695710455764075, "y": 0.18565683646112602, "term": "communicated", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.8679497429554e-06}, {"x": 0.3671246648793566, "y": 0.18599195710455765, "term": "discontinue", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 6.2949776150596e-06}, {"x": 0.3672922252010724, "y": 0.1863270777479893, "term": "criterion", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.5485269637257556e-06}, {"x": 0.3674597855227882, "y": 0.3647788203753351, "term": "versa", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.936572814084383e-06}, {"x": 0.367627345844504, "y": 0.36494638069705093, "term": "vice versa", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.36779490616621985, "y": 0.1864946380697051, "term": "admissions", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.564497935194644e-07}, {"x": 0.3679624664879357, "y": 0.18666219839142092, "term": "enables", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 6.984389818910838e-07}, {"x": 0.36813002680965146, "y": 0.18716487935656836, "term": "fresh", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 2.5579467668256304e-07}, {"x": 0.3682975871313673, "y": 0.2816689008042895, "term": "drop", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.1792293738751486e-07}, {"x": 0.3684651474530831, "y": 0.3667895442359249, "term": "ef\ufb01ciently", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 0.0}, {"x": 0.36863270777479895, "y": 0.2831769436997319, "term": "arms", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 4.325121705320519e-07}, {"x": 0.3688002680965147, "y": 0.28334450402144773, "term": "positioned", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.084822595708549e-06}, {"x": 0.36896782841823056, "y": 0.18800268096514744, "term": "move", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.419948245158381e-07}, {"x": 0.3691353887399464, "y": 0.45794235924932974, "term": "bathroom", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 8.626637666067493e-07}, {"x": 0.3693029490616622, "y": 0.18833780160857908, "term": "bedside", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.118253408397688e-06}, {"x": 0.369470509383378, "y": 0.18900804289544235, "term": "150", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.36963806970509383, "y": 0.18917560321715818, "term": "nearly", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.1260056946445737e-07}, {"x": 0.36980563002680966, "y": 0.7789879356568364, "term": ">", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 4, "s": 0.8094839142091154, "os": 0.7773363886846305, "bg": 0.0}, {"x": 0.3699731903485255, "y": 0.19051608579088472, "term": "trainees", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 4.506640083499027e-06}, {"x": 0.37014075067024127, "y": 0.36863270777479895, "term": "want", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 5.40535721633277e-08}, {"x": 0.3703083109919571, "y": 0.2868632707774799, "term": "40%", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 0.0}, {"x": 0.37047587131367293, "y": 0.28736595174262736, "term": "43", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 0.0}, {"x": 0.37064343163538876, "y": 0.1921916890080429, "term": "lectures", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.0800877506492138e-06}, {"x": 0.37081099195710454, "y": 0.19286193029490617, "term": "d.2", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3709785522788204, "y": 0.46196380697050937, "term": "fatal", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 2.256155744687212e-06}, {"x": 0.3711461126005362, "y": 0.1958780160857909, "term": "logistical", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.753891484288678e-06}, {"x": 0.37131367292225204, "y": 0.29038203753351205, "term": "cagayan", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.621237704756891e-05}, {"x": 0.3714812332439678, "y": 0.3711461126005362, "term": "tissues", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 2.9867864567154908e-06}, {"x": 0.37164879356568364, "y": 0.46430965147453085, "term": "preceding", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 2.365700302735711e-06}, {"x": 0.3718163538873995, "y": 0.1978887399463807, "term": "enactment", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 4.066979905458985e-06}, {"x": 0.3719839142091153, "y": 0.3718163538873995, "term": "slides", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 1.9147029905882776e-06}, {"x": 0.3721514745308311, "y": 0.4651474530831099, "term": "disbursement", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 1.2151452668193193e-05}, {"x": 0.3723190348525469, "y": 0.20023458445040215, "term": "allowances", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.278770225094133e-06}, {"x": 0.37248659517426275, "y": 0.20040214477211796, "term": "allowance", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.544229353885173e-06}, {"x": 0.3726541554959786, "y": 0.29390080428954424, "term": "defines", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.3396859753745623e-06}, {"x": 0.37282171581769435, "y": 0.29406836461126007, "term": "absolute", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 7.268090671369283e-07}, {"x": 0.3729892761394102, "y": 0.2007372654155496, "term": "decade", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 8.702775584920074e-07}, {"x": 0.373156836461126, "y": 0.20140750670241286, "term": "looking", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 6.625933168267202e-08}, {"x": 0.37332439678284185, "y": 0.2015750670241287, "term": "intensi\ufb01ed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3734919571045576, "y": 0.20241286863270777, "term": "rhythm", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.368776430217382e-06}, {"x": 0.37365951742627346, "y": 0.20308310991957104, "term": "corrected", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.5542512969449947e-06}, {"x": 0.3738270777479893, "y": 0.2964142091152815, "term": "impose", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 2.1714992175364487e-06}, {"x": 0.3739946380697051, "y": 0.20442359249329758, "term": "insuf\ufb01cient", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3741621983914209, "y": 0.20593163538873996, "term": "prevents", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.8645897622834513e-06}, {"x": 0.37432975871313673, "y": 0.20660187667560323, "term": "calculate", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 5.241144535986274e-07}, {"x": 0.37449731903485256, "y": 0.29859249329758714, "term": "inactivated", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.71803840102166e-05}, {"x": 0.3746648793565684, "y": 0.2072721179624665, "term": "diluent", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 2.054653790836244e-05}, {"x": 0.37483243967828417, "y": 0.2990951742627346, "term": "wastes", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.1222038388016562e-06}, {"x": 0.375, "y": 0.2082774798927614, "term": "disposed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.063454246851305e-06}, {"x": 0.37516756032171583, "y": 0.2084450402144772, "term": "eggs", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 8.930583999465595e-07}, {"x": 0.3753351206434316, "y": 0.3002680965147453, "term": "encephalopathy", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.7036355582813723e-05}, {"x": 0.37550268096514744, "y": 0.2092828418230563, "term": "neck", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 5.660304842509659e-07}, {"x": 0.37567024128686327, "y": 0.2101206434316354, "term": "sudden", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.3709174933870368e-06}, {"x": 0.3758378016085791, "y": 0.21045576407506703, "term": "bacterial", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.6868805563736928e-06}, {"x": 0.3760053619302949, "y": 0.21079088471849866, "term": "readily", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.405905223711154e-06}, {"x": 0.3761729222520107, "y": 0.2111260053619303, "term": "immunize", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 2.3794737080052632e-05}, {"x": 0.37634048257372654, "y": 0.21146112600536193, "term": "1st", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3765080428954424, "y": 0.37516756032171583, "term": "counsel", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 9.284188410401712e-07}, {"x": 0.37667560321715815, "y": 0.30261394101876676, "term": "congress", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.0380848237333567e-07}, {"x": 0.376843163538874, "y": 0.21296916890080428, "term": "pp", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 2.2140085947370845e-07}, {"x": 0.3770107238605898, "y": 0.46900134048257375, "term": "universally", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 4, "s": 0.5304959785522789, "os": 0.5370714647674827, "bg": 8.789962741545427e-06}, {"x": 0.37717828418230565, "y": 0.30412198391420914, "term": "hiring", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 1.3464818784858452e-06}, {"x": 0.3773458445040214, "y": 0.21363941018766755, "term": "app", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 8.020041120354833e-07}, {"x": 0.37751340482573725, "y": 0.21397453083109919, "term": "transfusions", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.66310761636764e-05}, {"x": 0.3776809651474531, "y": 0.21430965147453082, "term": "\ufb01xed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3778485254691689, "y": 0.21464477211796246, "term": "42", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3780160857908847, "y": 0.215985254691689, "term": "ilhz", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.2055186208576686e-05}, {"x": 0.3781836461126005, "y": 0.21766085790884718, "term": "payments", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.0239702867098803e-07}, {"x": 0.37835120643431636, "y": 0.21933646112600536, "term": "contributing", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.164825213899766e-06}, {"x": 0.3785187667560322, "y": 0.22134718498659517, "term": "dialogues", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 6.922048732607487e-06}, {"x": 0.37868632707774796, "y": 0.221514745308311, "term": "architectural", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 9.489751258435915e-07}, {"x": 0.3788538873994638, "y": 0.2216823056300268, "term": "bene\ufb01cial", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 0.0}, {"x": 0.3790214477211796, "y": 0.22184986595174264, "term": "informs", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 4.919565110444237e-06}, {"x": 0.37918900804289546, "y": 0.3781836461126005, "term": "accelerated", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 4, "s": 0.4636394101876676, "os": 0.48684898040067537, "bg": 3.012061153447304e-06}, {"x": 0.37935656836461124, "y": 0.2226876675603217, "term": "apart", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 5.945606146520068e-07}, {"x": 0.37952412868632707, "y": 0.22285522788203754, "term": "technologist", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 7.71812779830371e-06}, {"x": 0.3796916890080429, "y": 0.30814343163538876, "term": "lce", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 4, "s": 0.3838806970509383, "os": 0.3989566107889031, "bg": 3.0215740386358597e-05}, {"x": 0.37985924932975873, "y": 0.22419571045576409, "term": "tapped", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 5.100344171224674e-06}, {"x": 0.3800268096514745, "y": 0.2243632707774799, "term": "implementors", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 1.5877476687894853e-05}, {"x": 0.38019436997319034, "y": 0.22486595174262736, "term": "credible", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 4, "s": 0.2702747989276139, "os": 0.2916726300430427, "bg": 3.1491143430821513e-06}, {"x": 0.38036193029490617, "y": 0.004524128686327078, "term": "distinguish", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.550890734707345e-06}, {"x": 0.380529490616622, "y": 0.004691689008042895, "term": "37", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3806970509383378, "y": 0.006032171581769437, "term": "lactational", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.4331862269493625e-05}, {"x": 0.3808646112600536, "y": 0.006702412868632708, "term": "contraceptives", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.3985001915551e-06}, {"x": 0.38103217158176944, "y": 0.00938337801608579, "term": "officially", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.0196608455078715e-06}, {"x": 0.3811997319034853, "y": 0.009550938337801608, "term": "beginning", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6174423364116293e-07}, {"x": 0.38136729222520105, "y": 0.009886058981233244, "term": "character", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.5284622210374944e-07}, {"x": 0.3815348525469169, "y": 0.01089142091152815, "term": "bbt", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6516606415462847e-05}, {"x": 0.3817024128686327, "y": 0.011058981233243968, "term": "thermal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.517651968722362e-07}, {"x": 0.38186997319034854, "y": 0.011394101876675604, "term": "thermometers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.811934516933798e-06}, {"x": 0.3820375335120643, "y": 0.011896782841823056, "term": "advantage", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.4041762946414214e-07}, {"x": 0.38220509383378015, "y": 0.012064343163538873, "term": "suckling", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4447187403497306e-05}, {"x": 0.382372654155496, "y": 0.012567024128686327, "term": "juices", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.956648975499936e-06}, {"x": 0.3825402144772118, "y": 0.012902144772117962, "term": "minerals", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.260622628701817e-07}, {"x": 0.3827077747989276, "y": 0.013404825737265416, "term": "variation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.044818430372185e-07}, {"x": 0.3828753351206434, "y": 0.013739946380697051, "term": "window", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.765205349496556e-08}, {"x": 0.38304289544235925, "y": 0.01390750670241287, "term": "fertile window", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3832104557640751, "y": 0.014577747989276139, "term": "adjunct", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.3166120807595043e-06}, {"x": 0.38337801608579086, "y": 0.014745308310991957, "term": "virtually", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.611527429946832e-07}, {"x": 0.3835455764075067, "y": 0.014912868632707774, "term": "teachers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.595397469747475e-07}, {"x": 0.3837131367292225, "y": 0.015080428954423592, "term": "menstrual cycles", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38388069705093836, "y": 0.015415549597855228, "term": "injectable", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.724528421149877e-06}, {"x": 0.38404825737265413, "y": 0.015583109919571046, "term": "teacher", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6558037317883582e-07}, {"x": 0.38421581769436997, "y": 0.016588471849865952, "term": "know", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.6108572092363224e-08}, {"x": 0.3843833780160858, "y": 0.016923592493297588, "term": "proficiency", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.1132786011786286e-06}, {"x": 0.38455093833780163, "y": 0.01742627345844504, "term": "fhsis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.3847184986595174, "y": 0.018264075067024127, "term": "asin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.734648945554646e-07}, {"x": 0.38488605898123324, "y": 0.018599195710455763, "term": "asin law", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38505361930294907, "y": 0.021447721179624665, "term": "fortify", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3949287365781702e-05}, {"x": 0.3852211796246649, "y": 0.024463806970509382, "term": "archives", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.875228826973985e-08}, {"x": 0.3853887399463807, "y": 0.0246313672922252, "term": "destruction", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.266783719741913e-07}, {"x": 0.3855563002680965, "y": 0.024966487935656836, "term": "upm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6438209796762083e-05}, {"x": 0.38572386058981234, "y": 0.026642091152815014, "term": "3.3.4", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38589142091152817, "y": 0.02680965147453083, "term": "3.4.2", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38605898123324395, "y": 0.027479892761394103, "term": "3.4.5", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3862265415549598, "y": 0.02764745308310992, "term": "3.4.6", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3863941018766756, "y": 0.030328418230563002, "term": "sponsor", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.3323551921564761e-07}, {"x": 0.38656166219839144, "y": 0.030663538873994638, "term": "soup", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.369697755798063e-07}, {"x": 0.3867292225201072, "y": 0.03267426273458445, "term": "54", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38689678284182305, "y": 0.03518766756032172, "term": "iodization", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.447613423935824e-05}, {"x": 0.3870643431635389, "y": 0.035522788203753354, "term": "salt iodization", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3872319034852547, "y": 0.036193029490616625, "term": "hands", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6194434264443125e-07}, {"x": 0.3873994638069705, "y": 0.03703083109919571, "term": "spoon", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.8551296770427934e-06}, {"x": 0.3875670241286863, "y": 0.038706434316353885, "term": "educated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3420263087482502e-06}, {"x": 0.38773458445040215, "y": 0.0407171581769437, "term": "tolerated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.006972131508825e-06}, {"x": 0.387902144772118, "y": 0.041052278820375335, "term": "applicable codex", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38806970509383376, "y": 0.041722520107238606, "term": "recurrence", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.7839192890015656e-06}, {"x": 0.3882372654155496, "y": 0.04205764075067024, "term": "expressing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.7101486204658617e-06}, {"x": 0.3884048257372654, "y": 0.04222520107238606, "term": "fathers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3071775813816083e-06}, {"x": 0.38857238605898126, "y": 0.04239276139410188, "term": "knowledgeable", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.2755762683564338e-06}, {"x": 0.38873994638069703, "y": 0.04373324396782842, "term": "fabella", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.38890750670241286, "y": 0.04390080428954424, "term": "jose fabella", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3890750670241287, "y": 0.044068364611260055, "term": "fabella memorial", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3892426273458445, "y": 0.04423592493297587, "term": "interagency", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.853008440594931e-06}, {"x": 0.3894101876675603, "y": 0.04457104557640751, "term": "imr", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4722634762717138e-05}, {"x": 0.38957774798927614, "y": 0.044906166219839144, "term": "rate imr", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.38974530831099197, "y": 0.04591152815013405, "term": "normal spontaneous", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3899128686327078, "y": 0.04708445040214477, "term": "delivers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.1563939603534e-07}, {"x": 0.3900804289544236, "y": 0.04775469168900804, "term": "morning", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4882061614971936e-07}, {"x": 0.3902479892761394, "y": 0.04909517426273458, "term": "superiority", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.865354358962196e-06}, {"x": 0.39041554959785524, "y": 0.049765415549597854, "term": "spearhead", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.927270335703055e-06}, {"x": 0.39058310991957107, "y": 0.05010053619302949, "term": "mbfhi assessor", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39075067024128685, "y": 0.05177613941018767, "term": "susceptibility", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.5340887153454997e-06}, {"x": 0.3909182305630027, "y": 0.0521112600536193, "term": "db8", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3910857908847185, "y": 0.052613941018766756, "term": "con\ufb01rming", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39125335120643434, "y": 0.05529490616621984, "term": "38\u00b0c", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3914209115281501, "y": 0.055797587131367295, "term": "fever 38\u00b0c", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39158847184986595, "y": 0.05730563002680965, "term": "path", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.7309351716961117e-07}, {"x": 0.3917560321715818, "y": 0.057473190348525466, "term": "courier", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.177663036595013e-07}, {"x": 0.3919235924932976, "y": 0.057640750670241284, "term": "oropharyngeal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.041373538185168e-05}, {"x": 0.3920911528150134, "y": 0.05814343163538874, "term": "cifs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3724999056406315e-05}, {"x": 0.3922587131367292, "y": 0.05998659517426273, "term": "abusive", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.2884905516806963e-06}, {"x": 0.39242627345844505, "y": 0.060489276139410186, "term": "warts", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.5755073537457305e-06}, {"x": 0.3925938337801609, "y": 0.06082439678284182, "term": "trachomatis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.5764199109716853e-05}, {"x": 0.39276139410187666, "y": 0.06099195710455764, "term": "chlamydia trachomatis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3929289544235925, "y": 0.062164879356568364, "term": "50,000", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3930965147453083, "y": 0.0625, "term": "penicillin 50,000", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39326407506702415, "y": 0.06266756032171582, "term": "50,000 iu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39343163538873993, "y": 0.06317024128686327, "term": "worsen", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.724262063746002e-06}, {"x": 0.39359919571045576, "y": 0.06400804289544236, "term": "illnesses imci", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3937667560321716, "y": 0.0653485254691689, "term": "11.50", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3939343163538874, "y": 0.06551608579088472, "term": "mid upper", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3941018766756032, "y": 0.06568364611260054, "term": "arm circumference", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39426943699731903, "y": 0.06585120643431636, "term": "circumference muac", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39443699731903487, "y": 0.06668900804289545, "term": "125 mm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3946045576407507, "y": 0.06702412868632708, "term": "mineral", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.178092604931601e-07}, {"x": 0.3947721179624665, "y": 0.06752680965147453, "term": "electrolyte", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.467620263377666e-06}, {"x": 0.3949396782841823, "y": 0.0681970509383378, "term": "targeted supplementary", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39510723860589814, "y": 0.06869973190348526, "term": "lt -3", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39527479892761397, "y": 0.07054289544235925, "term": "buffer stocks", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39544235924932974, "y": 0.07071045576407507, "term": "assessments", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.184490697047497e-07}, {"x": 0.3956099195710456, "y": 0.07104557640750671, "term": "defaulted", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.0946158582472464e-05}, {"x": 0.3957774798927614, "y": 0.07138069705093834, "term": "responder", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.916127787367641e-06}, {"x": 0.3959450402144772, "y": 0.07154825737265416, "term": "discharged mam", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.396112600536193, "y": 0.07221849865951743, "term": "suggestions", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.552519443577563e-07}, {"x": 0.39628016085790885, "y": 0.07305630026809651, "term": "thiamin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.514959276000962e-05}, {"x": 0.3964477211796247, "y": 0.07372654155495978, "term": "mg/100", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39661528150134046, "y": 0.07406166219839141, "term": "mg/100 g", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3967828418230563, "y": 0.07439678284182305, "term": "% rda", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3969504021447721, "y": 0.0748994638069705, "term": "asphyxia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.8453163564228545e-05}, {"x": 0.39711796246648795, "y": 0.07540214477211796, "term": "enc", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.0289443140672885e-06}, {"x": 0.3972855227882037, "y": 0.07623994638069705, "term": "practicum", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.789931563852781e-06}, {"x": 0.39745308310991956, "y": 0.07741286863270777, "term": "dtp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.205941298600697e-06}, {"x": 0.3976206434316354, "y": 0.07791554959785522, "term": "1000 livebirths", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3977882037533512, "y": 0.07975871313672922, "term": "ambulatory clinic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.397955764075067, "y": 0.08059651474530831, "term": "earmarked amount", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39812332439678283, "y": 0.08076407506702413, "term": "outlay", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.459708376465345e-06}, {"x": 0.39829088471849866, "y": 0.08093163538873994, "term": "capital outlay", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.3984584450402145, "y": 0.08193699731903485, "term": "presenter", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.650993111725773e-06}, {"x": 0.39862600536193027, "y": 0.0824396782841823, "term": "iob", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.836197418765479e-05}, {"x": 0.3987935656836461, "y": 0.08260723860589812, "term": "fur", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.12100522780788e-06}, {"x": 0.39896112600536193, "y": 0.0842828418230563, "term": "a.1", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39912868632707776, "y": 0.08461796246648794, "term": "logbooks", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.7315792435596074e-05}, {"x": 0.39929624664879354, "y": 0.08595844504021448, "term": "height measurements", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.39946380697050937, "y": 0.08629356568364611, "term": "curve", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.027939044576285e-07}, {"x": 0.3996313672922252, "y": 0.08679624664879357, "term": "chronically", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.2747635227737e-06}, {"x": 0.39979892761394104, "y": 0.08696380697050939, "term": "hbv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.413846827298274e-06}, {"x": 0.3999664879356568, "y": 0.0871313672922252, "term": "chronically infected", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40013404825737264, "y": 0.08729892761394102, "term": "suggest", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.1599265214596665e-07}, {"x": 0.4003016085790885, "y": 0.08830428954423593, "term": "seroprevalence", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.9994601457606446e-05}, {"x": 0.4004691689008043, "y": 0.08847184986595175, "term": "inborn", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.535838798359724e-05}, {"x": 0.4006367292225201, "y": 0.0889745308310992, "term": "obtaining", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.893447274697576e-07}, {"x": 0.4008042895442359, "y": 0.08964477211796247, "term": "121 s.", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40097184986595175, "y": 0.09014745308310992, "term": "lying ins", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4011394101876676, "y": 0.0918230563002681, "term": "pie", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.00545972353145e-07}, {"x": 0.40130697050938335, "y": 0.09215817694369974, "term": "mainstreamed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.986713851120631e-05}, {"x": 0.4014745308310992, "y": 0.09249329758713137, "term": "designs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.4047393324185105e-07}, {"x": 0.401642091152815, "y": 0.09266085790884719, "term": "bottle fed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40180965147453085, "y": 0.09282841823056301, "term": "sponsorships", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.113981048864729e-06}, {"x": 0.4019772117962466, "y": 0.09299597855227883, "term": "advancement", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4499840683000495e-06}, {"x": 0.40214477211796246, "y": 0.0936662198391421, "term": "informational", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.300695573770791e-07}, {"x": 0.4023123324396783, "y": 0.0938337801608579, "term": "microorganisms", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.516564173501461e-06}, {"x": 0.4024798927613941, "y": 0.09433646112600536, "term": "c.3", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4026474530831099, "y": 0.09450402144772117, "term": "audio", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.283051600252403e-08}, {"x": 0.40281501340482573, "y": 0.09467158176943699, "term": "audio visual", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40298257372654156, "y": 0.09534182305630026, "term": "imposition", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.2093919954201815e-06}, {"x": 0.4031501340482574, "y": 0.09550938337801608, "term": "cdo", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.2251823990296556e-05}, {"x": 0.40331769436997317, "y": 0.0956769436997319, "term": "gravity", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.0530300676940379e-06}, {"x": 0.403485254691689, "y": 0.09584450402144772, "term": "equipments", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.3528697381966484e-06}, {"x": 0.40365281501340483, "y": 0.09601206434316353, "term": "unprotected", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.100462415051062e-06}, {"x": 0.40382037533512066, "y": 0.09651474530831099, "term": "attach", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 8.201194155377981e-07}, {"x": 0.40398793565683644, "y": 0.09684986595174262, "term": "diarrheal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.9690078169610334e-05}, {"x": 0.40415549597855227, "y": 0.09886058981233244, "term": "bloody", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3624982904904264e-06}, {"x": 0.4043230563002681, "y": 0.09902815013404825, "term": "24-hour", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40449061662198393, "y": 0.09919571045576407, "term": "watery stools", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4046581769436997, "y": 0.09936327077747989, "term": "absorption", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4268681047713577e-06}, {"x": 0.40482573726541554, "y": 0.09986595174262734, "term": "extra fluid", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4049932975871314, "y": 0.10304959785522788, "term": "indonesia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.3663241139855105e-07}, {"x": 0.4051608579088472, "y": 0.10371983914209115, "term": "poliovirus cvdpv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.405328418230563, "y": 0.10388739946380697, "term": "\ufb02oppy", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4054959785522788, "y": 0.10455764075067024, "term": "differentiation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.0392317602189727e-06}, {"x": 0.40566353887399464, "y": 0.10472520107238606, "term": "isolate", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.279810918900525e-06}, {"x": 0.4058310991957105, "y": 0.10573056300268097, "term": "indicative", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.802450041949174e-06}, {"x": 0.40599865951742625, "y": 0.10589812332439678, "term": "bearing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.329488161685578e-07}, {"x": 0.4061662198391421, "y": 0.10757372654155496, "term": "ice packs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4063337801608579, "y": 0.10774128686327078, "term": "fastest", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.16385231398153e-07}, {"x": 0.40650134048257375, "y": 0.1079088471849866, "term": "igm antibody", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4066689008042895, "y": 0.10824396782841823, "term": "sentinel sites", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40683646112600536, "y": 0.10841152815013405, "term": "sera", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.424768971750063e-06}, {"x": 0.4070040214477212, "y": 0.10991957104557641, "term": "complicated pregnancies", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.407171581769437, "y": 0.11042225201072386, "term": "-in", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4073391420911528, "y": 0.11209785522788204, "term": "amv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6124383494274836e-05}, {"x": 0.4075067024128686, "y": 0.1126005361930295, "term": "roads", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 5.192922928844882e-07}, {"x": 0.40767426273458446, "y": 0.11293565683646113, "term": "listing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.226158363990282e-08}, {"x": 0.4078418230563003, "y": 0.11343833780160859, "term": "tally", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.7654749252317882e-06}, {"x": 0.40800938337801607, "y": 0.11494638069705093, "term": "road", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.05544145716145e-08}, {"x": 0.4081769436997319, "y": 0.11511394101876675, "term": "main road", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40834450402144773, "y": 0.11595174262734584, "term": "obstetricians", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.0432519205615827e-05}, {"x": 0.40851206434316356, "y": 0.11611930294906166, "term": "accuracy", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.680248288820607e-07}, {"x": 0.40867962466487934, "y": 0.11628686327077747, "term": "deve10p", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40884718498659517, "y": 0.11645442359249329, "term": "creative", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.664951939601371e-07}, {"x": 0.409014745308311, "y": 0.11729222520107238, "term": "prophylaxis pep", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40918230563002683, "y": 0.1174597855227882, "term": "threats", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.872775940796724e-07}, {"x": 0.4093498659517426, "y": 0.11779490616621983, "term": "handlers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.6344968266299585e-06}, {"x": 0.40951742627345844, "y": 0.11863270777479892, "term": "potentially rabid", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.40968498659517427, "y": 0.11880026809651474, "term": "rabid animals", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4098525469168901, "y": 0.1193029490616622, "term": "abdominal pain", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4100201072386059, "y": 0.11947050938337801, "term": "spinal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.5962742957936175e-06}, {"x": 0.4101876675603217, "y": 0.12097855227882037, "term": "1.0 ml", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41035522788203754, "y": 0.12114611260053619, "term": "ntv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6259237279179233e-05}, {"x": 0.4105227882037534, "y": 0.12198391420911528, "term": "equine", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.134471982522184e-06}, {"x": 0.41069034852546915, "y": 0.12231903485254692, "term": "200 iu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.410857908847185, "y": 0.12332439678284182, "term": "anaphylaxis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4229457110637586e-05}, {"x": 0.4110254691689008, "y": 0.1239946380697051, "term": "-adults 500", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41119302949061665, "y": 0.12466487935656836, "term": "booster", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.6611923457240287e-06}, {"x": 0.4113605898123324, "y": 0.125, "term": "disable ad", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41152815013404825, "y": 0.1251675603217158, "term": "disposable syringes", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4116957104557641, "y": 0.12533512064343164, "term": "sharp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.172568701975241e-07}, {"x": 0.4118632707774799, "y": 0.12583780160857908, "term": "gop", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.8844222585130542e-06}, {"x": 0.4120308310991957, "y": 0.1261729222520107, "term": "de\ufb01cient", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4121983914209115, "y": 0.12650804289544235, "term": "qa", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.5647077047772093e-06}, {"x": 0.41236595174262736, "y": 0.12684316353887398, "term": "cd4", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4125335120643432, "y": 0.1270107238605898, "term": "cd4 cell", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41270107238605896, "y": 0.12717828418230562, "term": "cell count", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4128686327077748, "y": 0.12768096514745308, "term": "diphtheria pertussis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41303619302949063, "y": 0.1278485254691689, "term": "execom", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.41320375335120646, "y": 0.12801608579088472, "term": "reorganize", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.1955519489738429e-05}, {"x": 0.41337131367292224, "y": 0.12818364611260052, "term": "prioritization", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.515257120088492e-06}, {"x": 0.41353887399463807, "y": 0.128686327077748, "term": "fetal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.325629395257867e-06}, {"x": 0.4137064343163539, "y": 0.12918900804289543, "term": "cloth", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 7.939581373662701e-07}, {"x": 0.41387399463806973, "y": 0.12952412868632707, "term": "hypoglycemia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.219840174070584e-06}, {"x": 0.4140415549597855, "y": 0.1296916890080429, "term": "malformations", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.1557820888449693e-05}, {"x": 0.41420911528150134, "y": 0.1298592493297587, "term": "malformation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.449130974268868e-05}, {"x": 0.41437667560321717, "y": 0.13019436997319034, "term": "cord stump", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.414544235924933, "y": 0.13036193029490617, "term": "kmc", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.218223403898924e-05}, {"x": 0.4147117962466488, "y": 0.13052949061662197, "term": "suctioning", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.186503261989554e-05}, {"x": 0.4148793565683646, "y": 0.1306970509383378, "term": "nipple confusion", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41504691689008044, "y": 0.13103217158176944, "term": "sore nipples", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4152144772117963, "y": 0.13136729222520108, "term": "incl", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.2998109912342372e-06}, {"x": 0.41538203753351205, "y": 0.13153485254691688, "term": "recombinant", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.7085131955377246e-06}, {"x": 0.4155495978552279, "y": 0.13186997319034852, "term": "3-a", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4157171581769437, "y": 0.13203753351206435, "term": "lu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.451768617117804e-06}, {"x": 0.41588471849865954, "y": 0.13237265415549598, "term": "10,000 i.u.", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4160522788203753, "y": 0.1325402144772118, "term": "9709", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41621983914209115, "y": 0.13371313672922253, "term": "nhscs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.416387399463807, "y": 0.13404825737265416, "term": "appointed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.538571904311019e-07}, {"x": 0.4165549597855228, "y": 0.13488605898123324, "term": "hib", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.291787300761993e-05}, {"x": 0.4167225201072386, "y": 0.13572386058981234, "term": "compute", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4778973068277378e-06}, {"x": 0.4168900804289544, "y": 0.13589142091152814, "term": "b3", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41705764075067026, "y": 0.1363941018766756, "term": "consultants", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.096413390376572e-07}, {"x": 0.41722520107238603, "y": 0.13656166219839141, "term": "imprest", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.1822268533925445e-05}, {"x": 0.41739276139410186, "y": 0.13672922252010725, "term": "imprest fund", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4175603217158177, "y": 0.13739946380697052, "term": "adsorbed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.2012354706815961e-05}, {"x": 0.4177278820375335, "y": 0.13790214477211796, "term": "111", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4178954423592493, "y": 0.1382372654155496, "term": "isoniazid", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.5717617287807257e-05}, {"x": 0.41806300268096513, "y": 0.13857238605898123, "term": "pyrazinamide", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.1888842983120965e-05}, {"x": 0.41823056300268097, "y": 0.13890750670241286, "term": "childbearing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.0934712929614621e-05}, {"x": 0.4183981233243968, "y": 0.1392426273458445, "term": "masterlisting", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.4185656836461126, "y": 0.13957774798927614, "term": "nightblindness", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.4187332439678284, "y": 0.13991286863270777, "term": "dark colored", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41890080428954424, "y": 0.1400804289544236, "term": "cool dry", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.41906836461126007, "y": 0.14075067024128687, "term": "discomfort", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 3.3986800376403815e-06}, {"x": 0.41923592493297585, "y": 0.1410857908847185, "term": "abortions", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 4.841305046394831e-06}, {"x": 0.4194034852546917, "y": 0.14142091152815014, "term": "cpc v", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4195710455764075, "y": 0.14175603217158178, "term": "xeropthalmia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.41973860589812334, "y": 0.1427613941018767, "term": "mru", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.7646877164499778e-05}, {"x": 0.4199061662198391, "y": 0.14359919571045576, "term": "publicly", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.426926530894571e-07}, {"x": 0.42007372654155495, "y": 0.1437667560321716, "term": "net arrangement", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4202412868632708, "y": 0.14410187667560323, "term": "0\u20145", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4204088471849866, "y": 0.14460455764075067, "term": "pill", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 6.12505181411019e-07}, {"x": 0.4205764075067024, "y": 0.1447721179624665, "term": "presently compromise", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4207439678284182, "y": 0.1449396782841823, "term": "poorly maintained", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42091152815013405, "y": 0.14510723860589814, "term": "undergoing internal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4210790884718499, "y": 0.14527479892761394, "term": "guttering", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.655588023476238e-05}, {"x": 0.42124664879356566, "y": 0.14544235924932977, "term": "paintwork", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.947732595791924e-05}, {"x": 0.4214142091152815, "y": 0.14560991957104558, "term": "ceiling guttering", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4215817694369973, "y": 0.1457774798927614, "term": "guttering paintwork", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42174932975871315, "y": 0.1459450402144772, "term": "piped", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.16428586156888e-06}, {"x": 0.42191689008042893, "y": 0.14611260053619302, "term": "piped water", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42208445040214476, "y": 0.14628016085790885, "term": "bedside tables", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4222520107238606, "y": 0.14644772117962465, "term": "tiles", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4379468419811456e-06}, {"x": 0.4224195710455764, "y": 0.14695040214477212, "term": "-all", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.4225871313672922, "y": 0.14711796246648792, "term": "manual expression", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42275469168900803, "y": 0.14728552278820375, "term": "34 weeks", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42292225201072386, "y": 0.1477882037533512, "term": "mastitis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4432461492388683e-05}, {"x": 0.4230898123324397, "y": 0.14829088471849866, "term": "tetracyclines", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.0713690195692587e-05}, {"x": 0.4232573726541555, "y": 0.14845844504021447, "term": "intracranial", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 9.643364280496536e-06}, {"x": 0.4234249329758713, "y": 0.14946380697050937, "term": "irrigation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.3023302758416918e-06}, {"x": 0.42359249329758714, "y": 0.1506367292225201, "term": "ascites", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.4803821606547733e-05}, {"x": 0.42376005361930297, "y": 0.15080428954423591, "term": "portal hypertension", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42392761394101874, "y": 0.15113941018766755, "term": "imprint", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.561039574304508e-06}, {"x": 0.4240951742627346, "y": 0.15130697050938338, "term": "selective", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 1.336309294131364e-06}, {"x": 0.4242627345844504, "y": 0.15197721179624665, "term": "mg/24", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 0.0}, {"x": 0.42443029490616624, "y": 0.15264745308310992, "term": "parasitologic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 4, "s": 0.1417560321715818, "os": 0.1712896210598095, "bg": 2.5644231169921883e-05}, {"x": 0.424597855227882, "y": 0.2253686327077748, "term": "fourth", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 5.369051330815248e-07}, {"x": 0.42476541554959785, "y": 0.15298257372654156, "term": "technologists", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 9.8026962315985e-06}, {"x": 0.4249329758713137, "y": 0.6226541554959786, "term": "grade", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 4.763030093190516e-07}, {"x": 0.4251005361930295, "y": 0.30914879356568364, "term": "menstrual cycle", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.4252680965147453, "y": 0.9777144772117963, "term": "diabetes", "cat25k": 24, "ncat25k": 1, "cat": 147, "ncat": 5, "s": 0.9976541554959786, "os": 0.9842346837692374, "bg": 1.5096178298181006e-05}, {"x": 0.4254356568364611, "y": 0.909014745308311, "term": "retail", "cat25k": 7, "ncat25k": 1, "cat": 44, "ncat": 5, "s": 0.9800603217158177, "os": 0.9020656514752314, "bg": 1.6752860704818152e-06}, {"x": 0.42560321715817695, "y": 0.7042560321715817, "term": "mandate", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 5, "s": 0.7184986595174263, "os": 0.7001748310268806, "bg": 5.866800527498703e-06}, {"x": 0.4257707774798928, "y": 0.9571045576407506, "term": "dispensing", "cat25k": 14, "ncat25k": 1, "cat": 85, "ncat": 5, "s": 0.9953083109919572, "os": 0.96326263192213, "bg": 8.200959967925135e-05}, {"x": 0.42593833780160856, "y": 0.9532506702412868, "term": "prescription", "cat25k": 13, "ncat25k": 1, "cat": 78, "ncat": 5, "s": 0.9943029490616623, "os": 0.9574317963775714, "bg": 6.2533201928222575e-06}, {"x": 0.4261058981233244, "y": 0.382372654155496, "term": "handle", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 5.516289280461662e-07}, {"x": 0.4262734584450402, "y": 0.704926273458445, "term": "jointly", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 5, "s": 0.7184986595174263, "os": 0.7001748310268806, "bg": 6.710543837151877e-06}, {"x": 0.42644101876675605, "y": 0.725201072386059, "term": "pass", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 5, "s": 0.7427949061662198, "os": 0.7155838851720784, "bg": 6.125943341222106e-07}, {"x": 0.42660857908847183, "y": 0.8326072386058981, "term": "supervising", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 5, "s": 0.8364611260053619, "os": 0.8112702567084342, "bg": 2.775340788721015e-05}, {"x": 0.42677613941018766, "y": 0.7811662198391421, "term": "procured", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 5, "s": 0.7955764075067024, "os": 0.7633062374560202, "bg": 4.137857653755895e-05}, {"x": 0.4269436997319035, "y": 0.9095174262734584, "term": "sale", "cat25k": 7, "ncat25k": 1, "cat": 44, "ncat": 5, "s": 0.9800603217158177, "os": 0.9020656514752314, "bg": 5.458497771507016e-07}, {"x": 0.4271112600536193, "y": 0.7575402144772118, "term": "thereafter", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 5, "s": 0.7623994638069705, "os": 0.7417400106398584, "bg": 6.856836825688742e-06}, {"x": 0.4272788203753351, "y": 0.8104892761394102, "term": "separability clause", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 5, "s": 0.822721179624665, "os": 0.7897429372877913, "bg": 0.0}, {"x": 0.42744638069705093, "y": 0.4726876675603217, "term": "utmost", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.720577860371339e-06}, {"x": 0.42761394101876676, "y": 0.802446380697051, "term": "chemical", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 5, "s": 0.8111595174262735, "os": 0.7815738192186401, "bg": 1.1441856774567937e-06}, {"x": 0.4277815013404826, "y": 0.7064343163538874, "term": "substances", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 5, "s": 0.7184986595174263, "os": 0.7001748310268806, "bg": 1.955980177118895e-06}, {"x": 0.42794906166219837, "y": 0.15415549597855227, "term": "difficulties", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.1144062452811863e-06}, {"x": 0.4281166219839142, "y": 0.47486595174262736, "term": "him", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 9.098022503867684e-08}, {"x": 0.42828418230563003, "y": 0.22972520107238606, "term": "compatible", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.498189960489827e-07}, {"x": 0.42845174262734587, "y": 0.4750335120643432, "term": "productive", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 2.721792398278793e-06}, {"x": 0.42861930294906164, "y": 0.5445710455764075, "term": "confidentiality", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 3.8026921331806494e-06}, {"x": 0.4287868632707775, "y": 0.2302278820375335, "term": "submits", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 6.8762515391752335e-06}, {"x": 0.4289544235924933, "y": 0.7454758713136729, "term": "vice", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 1.1065884091442195e-06}, {"x": 0.42912198391420914, "y": 0.38773458445040215, "term": "educate", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 3.5797130502018957e-06}, {"x": 0.4292895442359249, "y": 0.23056300268096513, "term": "poster", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 3.3171031425500665e-07}, {"x": 0.42945710455764075, "y": 0.23156836461126004, "term": "assignment", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 9.311808157596233e-07}, {"x": 0.4296246648793566, "y": 0.683813672922252, "term": "conform", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 6.681591858079426e-06}, {"x": 0.4297922252010724, "y": 0.23173592493297587, "term": "anytime", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 8.482560763915186e-07}, {"x": 0.4299597855227882, "y": 0.7692694369973191, "term": "factor", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 5, "s": 0.7856903485254693, "os": 0.753002391988301, "bg": 1.024271364719449e-06}, {"x": 0.430127345844504, "y": 0.15499329758713137, "term": "hot", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 7.518837413298877e-08}, {"x": 0.43029490616621985, "y": 0.5462466487935657, "term": "fifteen", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 3.351498965529376e-06}, {"x": 0.4304624664879357, "y": 0.4765415549597855, "term": "decide", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 9.406168810066029e-07}, {"x": 0.43063002680965146, "y": 0.23257372654155495, "term": "shouldered", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.3867894613016188e-05}, {"x": 0.4307975871313673, "y": 0.47838471849865954, "term": "clearance", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.732277624254636e-07}, {"x": 0.4309651474530831, "y": 0.7925603217158177, "term": "twg", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 5, "s": 0.806970509383378, "os": 0.7727922914807652, "bg": 9.606693245184645e-05}, {"x": 0.43113270777479895, "y": 0.4785522788203753, "term": "prescribe", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.657476466814595e-06}, {"x": 0.4313002680965147, "y": 0.628686327077748, "term": "enforcement", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 1.0855686095644773e-06}, {"x": 0.43146782841823056, "y": 0.8510388739946381, "term": "disabled", "cat25k": 4, "ncat25k": 1, "cat": 25, "ncat": 5, "s": 0.8490281501340483, "os": 0.8293596850063149, "bg": 2.5676020740576032e-06}, {"x": 0.4316353887399464, "y": 0.4790549597855228, "term": "mainstream", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 2.493905518389436e-06}, {"x": 0.4318029490616622, "y": 0.760053619302949, "term": "allied", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 5, "s": 0.7623994638069705, "os": 0.7417400106398584, "bg": 4.858845425806198e-06}, {"x": 0.431970509383378, "y": 0.5479222520107239, "term": "station", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 3.536735322255024e-07}, {"x": 0.43213806970509383, "y": 0.4803954423592493, "term": "medium", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 3.872777403366265e-07}, {"x": 0.43230563002680966, "y": 0.8044571045576407, "term": "language", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 5, "s": 0.8111595174262735, "os": 0.7815738192186401, "bg": 3.31340555193658e-07}, {"x": 0.4324731903485255, "y": 0.9512399463806971, "term": "injury", "cat25k": 12, "ncat25k": 1, "cat": 74, "ncat": 5, "s": 0.993632707774799, "os": 0.9534945002547146, "bg": 5.162756047784771e-06}, {"x": 0.43264075067024127, "y": 0.3160187667560322, "term": "2.0", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.4328083109919571, "y": 0.7940683646112601, "term": "disorder", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 5, "s": 0.806970509383378, "os": 0.7727922914807652, "bg": 3.450997444144234e-06}, {"x": 0.43297587131367293, "y": 0.8047922252010724, "term": "speci\ufb01ed", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 5, "s": 0.8111595174262735, "os": 0.7815738192186401, "bg": 0.0}, {"x": 0.43314343163538876, "y": 0.7836796246648794, "term": "partnerships", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 5, "s": 0.7955764075067024, "os": 0.7633062374560202, "bg": 3.290041865782742e-06}, {"x": 0.43331099195710454, "y": 0.8128351206434317, "term": "networks", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 5, "s": 0.822721179624665, "os": 0.7897429372877913, "bg": 7.819463063862094e-07}, {"x": 0.4334785522788204, "y": 0.6613605898123325, "term": "entity", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 1.570387692826783e-06}, {"x": 0.4336461126005362, "y": 0.8339477211796247, "term": "researches", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 5, "s": 0.8364611260053619, "os": 0.8112702567084342, "bg": 4.6921065733806365e-05}, {"x": 0.43381367292225204, "y": 0.6317024128686327, "term": "innovative", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 1.4443396495787582e-06}, {"x": 0.4339812332439678, "y": 0.8265750670241286, "term": "structure", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 5, "s": 0.831769436997319, "os": 0.8045336029660177, "bg": 7.703304273111764e-07}, {"x": 0.43414879356568364, "y": 0.318029490616622, "term": "choose", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.7714372331239852e-07}, {"x": 0.4343163538873995, "y": 0.3947721179624665, "term": "represent", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 6.830873529450494e-07}, {"x": 0.4344839142091153, "y": 0.7721179624664879, "term": "institutionalization", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 5, "s": 0.7856903485254693, "os": 0.753002391988301, "bg": 6.988144612664614e-05}, {"x": 0.4346514745308311, "y": 0.6621983914209115, "term": "zones", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 2.7913231719200867e-06}, {"x": 0.4348190348525469, "y": 0.8610924932975871, "term": "competent", "cat25k": 4, "ncat25k": 1, "cat": 27, "ncat": 5, "s": 0.9132037533512064, "os": 0.8399645258346586, "bg": 1.0273390986319375e-05}, {"x": 0.43498659517426275, "y": 0.5953418230563002, "term": "auditing", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 5.217375425379139e-06}, {"x": 0.4351541554959786, "y": 0.5522788203753352, "term": "enrolment", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 8.353356074712417e-06}, {"x": 0.43532171581769435, "y": 0.4855898123324397, "term": "estimate", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.950330721432907e-07}, {"x": 0.4354892761394102, "y": 0.48626005361930297, "term": "amounts", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 6.689767996504462e-07}, {"x": 0.435656836461126, "y": 0.552446380697051, "term": "eight", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 6.691060244724919e-07}, {"x": 0.43582439678284185, "y": 0.4865951742627346, "term": "decreased", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 2.5188158693963744e-06}, {"x": 0.4359919571045576, "y": 0.8136729222520107, "term": "sulfate", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 5, "s": 0.822721179624665, "os": 0.7897429372877913, "bg": 1.6486409531342897e-05}, {"x": 0.43615951742627346, "y": 0.39711796246648795, "term": "presentation", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 4.77464067380578e-07}, {"x": 0.4363270777479893, "y": 0.4874329758713137, "term": "m.", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 0.0}, {"x": 0.4364946380697051, "y": 0.8419906166219839, "term": "sales", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 5, "s": 0.8424932975871314, "os": 0.817629412060617, "bg": 3.226620448401715e-07}, {"x": 0.4366621983914209, "y": 0.39829088471849866, "term": "p.", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 0.0}, {"x": 0.43682975871313673, "y": 0.6900134048257373, "term": "r.", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 0.0}, {"x": 0.43699731903485256, "y": 0.5973525469168901, "term": "whichever", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 6.756638819930507e-06}, {"x": 0.4371648793565684, "y": 0.15834450402144773, "term": "freight", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.369067360510005e-06}, {"x": 0.43733243967828417, "y": 0.5541219839142091, "term": "smooth", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 1.1612234756104803e-06}, {"x": 0.4375, "y": 0.40013404825737264, "term": "movement", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 5.082254740056646e-07}, {"x": 0.43766756032171583, "y": 0.32238605898123324, "term": "logistic", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 9.742914921822244e-06}, {"x": 0.4378351206434316, "y": 0.4003016085790885, "term": "interested", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 3.488768568583065e-07}, {"x": 0.43800268096514744, "y": 0.3228887399463807, "term": "promotions", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.1687119734906907e-06}, {"x": 0.43817024128686327, "y": 0.6355563002680965, "term": "nchp", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 8.334134692438375e-05}, {"x": 0.4383378016085791, "y": 0.23977882037533513, "term": "satisfy", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 1.498650625681284e-06}, {"x": 0.4385053619302949, "y": 0.7737935656836461, "term": "rendered", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 5, "s": 0.7856903485254693, "os": 0.753002391988301, "bg": 6.346660633107958e-06}, {"x": 0.4386729222520107, "y": 0.5551273458445041, "term": "evaluating", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 2.7447657317495533e-06}, {"x": 0.43884048257372654, "y": 0.40214477211796246, "term": "classified", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 7.822803079837573e-07}, {"x": 0.4390080428954424, "y": 0.1601876675603217, "term": "guardians", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.173437330920212e-06}, {"x": 0.43917560321715815, "y": 0.16052278820375335, "term": "assessor", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.487573161925937e-06}, {"x": 0.439343163538874, "y": 0.7501675603217158, "term": "engage", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 3.518398831422468e-06}, {"x": 0.4395107238605898, "y": 0.6918565683646113, "term": "schemes", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 2.740788802671794e-06}, {"x": 0.43967828418230565, "y": 0.49195710455764075, "term": "consolidate", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 5.286388791164118e-06}, {"x": 0.4398458445040214, "y": 0.40398793565683644, "term": "2.4", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 0.0}, {"x": 0.44001340482573725, "y": 0.24296246648793565, "term": "consult", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 1.1688119235513514e-06}, {"x": 0.4401809651474531, "y": 0.7503351206434317, "term": "1990", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 0.0}, {"x": 0.4403485254691689, "y": 0.5996983914209115, "term": "fourmula", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 7.693072068058044e-05}, {"x": 0.4405160857908847, "y": 0.4046581769436997, "term": "explicit", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.8217052537574695e-06}, {"x": 0.4406836461126005, "y": 0.16136058981233245, "term": "adopting", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.968150263596478e-06}, {"x": 0.44085120643431636, "y": 0.32607238605898126, "term": "geographic", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.1897457892479848e-06}, {"x": 0.4410187667560322, "y": 0.7505026809651475, "term": "injuries", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 2.0698860217262137e-06}, {"x": 0.44118632707774796, "y": 0.4051608579088472, "term": "mobile", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.2345510087156213e-07}, {"x": 0.4413538873994638, "y": 0.6678954423592494, "term": "expand", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 1.1292493198188539e-06}, {"x": 0.4415214477211796, "y": 0.16203083109919572, "term": "zero", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.865061055886368e-07}, {"x": 0.44168900804289546, "y": 0.2441353887399464, "term": "fixed", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.8267200803693054e-07}, {"x": 0.44185656836461124, "y": 0.4941353887399464, "term": "supporting", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.066690882872697e-07}, {"x": 0.44202412868632707, "y": 0.40683646112600536, "term": "link", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 7.477734453676867e-08}, {"x": 0.4421916890080429, "y": 0.7513404825737265, "term": "incentives", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 4.028015293926514e-06}, {"x": 0.44235924932975873, "y": 0.24480563002680966, "term": "competency", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.084985199223269e-06}, {"x": 0.4425268096514745, "y": 0.6384048257372654, "term": "published", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 3.0503685537411943e-07}, {"x": 0.44269436997319034, "y": 0.40767426273458446, "term": "eliminate", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.6146194099857752e-06}, {"x": 0.44286193029490617, "y": 0.6926943699731903, "term": "agreements", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 1.66474397985571e-06}, {"x": 0.443029490616622, "y": 0.24547587131367293, "term": "satellite", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 3.2793638277783995e-07}, {"x": 0.4431970509383378, "y": 0.7515080428954424, "term": "cure", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 5, "s": 0.7545241286863271, "os": 0.7293422010993859, "bg": 3.4752647548398614e-06}, {"x": 0.4433646112600536, "y": 0.2461461126005362, "term": "promptly", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.4878336051587716e-06}, {"x": 0.44353217158176944, "y": 0.6690683646112601, "term": "sound", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 2.790990570797842e-07}, {"x": 0.4436997319034853, "y": 0.32992627345844505, "term": "departments", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 5.31908174032376e-07}, {"x": 0.44386729222520105, "y": 0.6033847184986595, "term": "hazardous", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 2.1039498502513694e-06}, {"x": 0.4440348525469169, "y": 0.41303619302949063, "term": "lto", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.862079881157924e-05}, {"x": 0.4442024128686327, "y": 0.4976541554959786, "term": "claims", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 5.368464277245533e-07}, {"x": 0.44436997319034854, "y": 0.4979892761394102, "term": "applicant", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 1.0251004560005615e-06}, {"x": 0.4445375335120643, "y": 0.3322721179624665, "term": "3%", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.44470509383378015, "y": 0.16420911528150134, "term": "leader", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.0072239533808115e-07}, {"x": 0.444872654155496, "y": 0.4989946380697051, "term": "supports", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 6.843254335603663e-07}, {"x": 0.4450402144772118, "y": 0.414544235924933, "term": "thereto", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 6.374407180132248e-06}, {"x": 0.4452077747989276, "y": 0.49932975871313673, "term": "memorial", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 9.768662920612373e-07}, {"x": 0.4453753351206434, "y": 0.7979222520107239, "term": "associations", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 5, "s": 0.806970509383378, "os": 0.7727922914807652, "bg": 2.886155277121742e-06}, {"x": 0.44554289544235925, "y": 0.7980898123324397, "term": "bhfs", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 5, "s": 0.806970509383378, "os": 0.7727922914807652, "bg": 0.0001410351337750297}, {"x": 0.4457104557640751, "y": 0.6045576407506702, "term": "exceed", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 1.784699503451981e-06}, {"x": 0.44587801608579086, "y": 0.670911528150134, "term": "view", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 4.6465987424096665e-08}, {"x": 0.4460455764075067, "y": 0.3347855227882037, "term": "stop", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.049667648952807e-07}, {"x": 0.4462131367292225, "y": 0.6947050938337802, "term": "train", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 9.337375337869036e-07}, {"x": 0.44638069705093836, "y": 0.24916219839142092, "term": "desk", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.2913971464906426e-07}, {"x": 0.44654825737265413, "y": 0.500837801608579, "term": "directives", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 5.80908500230766e-06}, {"x": 0.44671581769436997, "y": 0.33562332439678283, "term": "caring", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.1148277446366646e-06}, {"x": 0.4468833780160858, "y": 0.5020107238605898, "term": "pursuing", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 4.532990880982244e-06}, {"x": 0.44705093833780163, "y": 0.7861930294906166, "term": "applies", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 5, "s": 0.7955764075067024, "os": 0.7633062374560202, "bg": 2.4856199488281872e-06}, {"x": 0.4472184986595174, "y": 0.5058646112600537, "term": "serology", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 3.868142749940044e-05}, {"x": 0.44738605898123324, "y": 0.4183981233243968, "term": "banking", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 5.919629778460816e-07}, {"x": 0.44755361930294907, "y": 0.6060656836461126, "term": "mayor", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 1.5642500046927496e-06}, {"x": 0.4477211796246649, "y": 0.5075402144772118, "term": "6.1", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 0.0}, {"x": 0.4478887399463807, "y": 0.5645107238605898, "term": "6.2", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 0.0}, {"x": 0.4480563002680965, "y": 0.7179959785522788, "term": "endorsed", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 5, "s": 0.7184986595174263, "os": 0.7001748310268806, "bg": 5.491501386775711e-06}, {"x": 0.44822386058981234, "y": 0.7639075067024129, "term": "\ufb01ne", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 5, "s": 0.7623994638069705, "os": 0.7417400106398584, "bg": 0.0}, {"x": 0.44839142091152817, "y": 0.6725871313672922, "term": "\ufb01fty", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 5, "s": 0.6715817694369974, "os": 0.6627610259861301, "bg": 0.0}, {"x": 0.44855898123324395, "y": 0.6958780160857909, "term": "enjoined", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 5.065428450823132e-05}, {"x": 0.4487265415549598, "y": 0.3386394101876676, "term": "integrating", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.532595292855074e-06}, {"x": 0.4488941018766756, "y": 0.6090817694369973, "term": "guiding", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 5.912680062664554e-06}, {"x": 0.44906166219839144, "y": 0.5695375335120644, "term": "guiding principles", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 0.0}, {"x": 0.4492292225201072, "y": 0.25435656836461124, "term": "normally", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 6.932133374444185e-07}, {"x": 0.44939678284182305, "y": 0.7394436997319035, "term": "compound", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 5, "s": 0.7427949061662198, "os": 0.7155838851720784, "bg": 3.4984383588537553e-06}, {"x": 0.4495643431635389, "y": 0.7990951742627346, "term": "lowest", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 5, "s": 0.806970509383378, "os": 0.7727922914807652, "bg": 1.0190387944363448e-06}, {"x": 0.4497319034852547, "y": 0.17074396782841822, "term": "requisite", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 4.7025168261930195e-06}, {"x": 0.4498994638069705, "y": 0.17091152815013405, "term": "solutions", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.127653336585736e-07}, {"x": 0.4500670241286863, "y": 0.5705428954423593, "term": "courses", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 3.2332170609692445e-07}, {"x": 0.45023458445040215, "y": 0.34048257372654156, "term": "modules", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 6.387353550957388e-07}, {"x": 0.450402144772118, "y": 0.2578753351206434, "term": "completeness", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.1054646960827125e-06}, {"x": 0.45056970509383376, "y": 0.340985254691689, "term": "thru", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.4918544282015684e-06}, {"x": 0.4507372654155496, "y": 0.34148793565683644, "term": "27", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.4509048257372654, "y": 0.2587131367292225, "term": "onwards", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 6.317529881916341e-06}, {"x": 0.45107238605898126, "y": 0.34232573726541554, "term": "similarly", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.5364847916814715e-06}, {"x": 0.45123994638069703, "y": 0.5728887399463807, "term": "ensured", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 1.157874016991275e-05}, {"x": 0.45140750670241286, "y": 0.26105898123324395, "term": "adult males", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 0.0}, {"x": 0.4515750670241287, "y": 0.5733914209115282, "term": "females", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 2.469868169663777e-06}, {"x": 0.4517426273458445, "y": 0.5175938337801609, "term": "sustaining", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 7.641734108154228e-06}, {"x": 0.4519101876675603, "y": 0.262902144772118, "term": "grounds", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 1.0561895081604596e-06}, {"x": 0.45207774798927614, "y": 0.3476876675603217, "term": "larger", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.598342303081624e-07}, {"x": 0.45224530831099197, "y": 0.5184316353887399, "term": "4.5", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 0.0}, {"x": 0.4524128686327078, "y": 0.17392761394101877, "term": "induced", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 9.317997875962384e-07}, {"x": 0.4525804289544236, "y": 0.3485254691689008, "term": "itself", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 3.1135261089888644e-07}, {"x": 0.4527479892761394, "y": 0.6484584450402144, "term": "specialists", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 1.9469931125118643e-06}, {"x": 0.45291554959785524, "y": 0.26474530831099197, "term": "significantly", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 6.675309603243438e-07}, {"x": 0.45308310991957107, "y": 0.1744302949061662, "term": "element", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.2770448985463764e-07}, {"x": 0.45325067024128685, "y": 0.26541554959785524, "term": "calls", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 3.183728636072233e-07}, {"x": 0.4534182305630027, "y": 0.74078418230563, "term": "grant", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 5, "s": 0.7427949061662198, "os": 0.7155838851720784, "bg": 7.094922001557628e-07}, {"x": 0.4535857908847185, "y": 0.3515415549597855, "term": "operationalize", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 4.306319254360821e-05}, {"x": 0.45375335120643434, "y": 0.17493297587131368, "term": "starts", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.111668226151448e-07}, {"x": 0.4539209115281501, "y": 0.26776139410187666, "term": "allocations", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.8758232305115085e-06}, {"x": 0.45408847184986595, "y": 0.26843163538873993, "term": "56", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 0.0}, {"x": 0.4542560321715818, "y": 0.6162868632707775, "term": "coa", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 8.590284245347109e-06}, {"x": 0.4544235924932976, "y": 0.35371983914209115, "term": "5th", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.4545911528150134, "y": 0.26943699731903487, "term": "separated", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 1.3910944912856872e-06}, {"x": 0.4547587131367292, "y": 0.35556300268096513, "term": "highest attainable", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 0.0}, {"x": 0.45492627345844505, "y": 0.17761394101876676, "term": "humanitarian", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.0224399828294844e-06}, {"x": 0.4550938337801609, "y": 0.7007372654155496, "term": "70%", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 5, "s": 0.69671581769437, "os": 0.6827353621769425, "bg": 0.0}, {"x": 0.45526139410187666, "y": 0.27128016085790885, "term": "eventually", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 7.75893821369069e-07}, {"x": 0.4554289544235925, "y": 0.1781166219839142, "term": "obligation", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 8.313358756969972e-07}, {"x": 0.4555965147453083, "y": 0.44554289544235925, "term": "implications", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.3333211852958672e-06}, {"x": 0.45576407506702415, "y": 0.17828418230563003, "term": "complying", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.6540059338792285e-06}, {"x": 0.45593163538873993, "y": 0.6176273458445041, "term": "packs", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 2.000792647353793e-06}, {"x": 0.45609919571045576, "y": 0.6521447721179625, "term": "expertise", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 5, "s": 0.6528150134048257, "os": 0.6395704007933991, "bg": 1.4370179357524758e-06}, {"x": 0.4562667560321716, "y": 0.4487265415549598, "term": "90", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 0.0}, {"x": 0.4564343163538874, "y": 0.5264745308310992, "term": "govern", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 5.488856797372813e-06}, {"x": 0.4566018766756032, "y": 0.4488941018766756, "term": "solely", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.7301593495984972e-06}, {"x": 0.45676943699731903, "y": 0.17979222520107238, "term": "fewer", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.0806187514909162e-06}, {"x": 0.45693699731903487, "y": 0.18046246648793565, "term": "abdomen", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 6.656877358684203e-06}, {"x": 0.4571045576407507, "y": 0.18063002680965148, "term": "warm", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.226996478528914e-07}, {"x": 0.4572721179624665, "y": 0.5286528150134048, "term": "little", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 1.0669256536223943e-07}, {"x": 0.4574396782841823, "y": 0.4527479892761394, "term": "rubber", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.0002154352912569e-06}, {"x": 0.45760723860589814, "y": 0.18130026809651476, "term": "marking", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.975208499717216e-06}, {"x": 0.45777479892761397, "y": 0.5814343163538874, "term": "characterized", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 5, "s": 0.5747319034852547, "os": 0.5794208392094585, "bg": 3.5043755314305847e-06}, {"x": 0.45794235924932974, "y": 0.3627680965147453, "term": "thoroughly", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.333337708341536e-06}, {"x": 0.4581099195710456, "y": 0.2793230563002681, "term": "carefully", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 8.241260790459352e-07}, {"x": 0.4582774798927614, "y": 0.3629356568364611, "term": "deep", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 2.976225077021449e-07}, {"x": 0.4584450402144772, "y": 0.6193029490616622, "term": "score", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 3.4469400242345735e-07}, {"x": 0.458612600536193, "y": 0.18448391420911528, "term": "ambulatory", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 6.757114396820553e-06}, {"x": 0.45878016085790885, "y": 0.1846514745308311, "term": "recalled", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.927889191627311e-06}, {"x": 0.4589477211796247, "y": 0.2801608579088472, "term": "communicate", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 1.0522527679509062e-06}, {"x": 0.45911528150134046, "y": 0.4554289544235925, "term": "appropriateness", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 5, "s": 0.4731903485254692, "os": 0.5, "bg": 1.1373494828535088e-05}, {"x": 0.4592828418230563, "y": 0.5309986595174263, "term": "regard", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 1.0550056748755253e-06}, {"x": 0.4594504021447721, "y": 0.36511394101876676, "term": "incidental", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 4.7101381012491285e-06}, {"x": 0.45961796246648795, "y": 0.5313337801608579, "term": "toilets", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 6.747092003346557e-06}, {"x": 0.4597855227882037, "y": 0.2820040214477212, "term": "min", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.761240140794846e-07}, {"x": 0.45995308310991956, "y": 0.1875, "term": "detail", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.6197271523607333e-07}, {"x": 0.4601206434316354, "y": 0.18783512064343164, "term": "legs", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.277861600482502e-07}, {"x": 0.4602882037533512, "y": 0.6196380697050938, "term": "frequently", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 7.401597838437368e-07}, {"x": 0.460455764075067, "y": 0.367627345844504, "term": "reading", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 1.6736154132615654e-07}, {"x": 0.46062332439678283, "y": 0.19018096514745308, "term": "shifting", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.832111041409712e-06}, {"x": 0.46079088471849866, "y": 0.1903485254691689, "term": "august", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 8.585417896647022e-08}, {"x": 0.4609584450402145, "y": 0.19068364611260052, "term": "educating", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 4.539656166441954e-06}, {"x": 0.46112600536193027, "y": 0.3684651474530831, "term": "assembly", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 4.703638578996684e-07}, {"x": 0.4612935656836461, "y": 0.2866957104557641, "term": "attributed", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.6290270121258237e-06}, {"x": 0.46146112600536193, "y": 0.2870308310991957, "term": "enclosed", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.464420804781258e-06}, {"x": 0.46162868632707776, "y": 0.3693029490616622, "term": "june", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 9.74043197671316e-08}, {"x": 0.46179624664879354, "y": 0.19269436997319034, "term": "taught", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 7.319539052028198e-07}, {"x": 0.46196380697050937, "y": 0.1931970509383378, "term": "acronyms", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.806942340051317e-06}, {"x": 0.4621313672922252, "y": 0.37047587131367293, "term": "formed", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 8.104572898885677e-07}, {"x": 0.46229892761394104, "y": 0.19403485254691688, "term": "shipping", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 4.672291490436106e-08}, {"x": 0.4624664879356568, "y": 0.19487265415549598, "term": "proposal", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.9342627963618696e-07}, {"x": 0.46263404825737264, "y": 0.6203083109919572, "term": "instituted", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 5, "s": 0.611260053619303, "os": 0.6122269323621026, "bg": 1.2749308748416296e-05}, {"x": 0.4628016085790885, "y": 0.19621313672922253, "term": "-a", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.4629691689008043, "y": 0.2898793565683646, "term": "servings", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 5.169765879766755e-06}, {"x": 0.4631367292225201, "y": 0.5351876675603218, "term": "specialist", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 8.086916561823162e-07}, {"x": 0.4633042895442359, "y": 0.19721849865951743, "term": "legal guardian", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.46347184986595175, "y": 0.29205764075067026, "term": "endorsement", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 2.4756042463685983e-06}, {"x": 0.4636394101876676, "y": 0.2937332439678284, "term": "copies", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 5.246991637344728e-07}, {"x": 0.46380697050938335, "y": 0.2025804289544236, "term": "unable", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.823106260334194e-07}, {"x": 0.4639745308310992, "y": 0.2027479892761394, "term": "pet", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.622521643288671e-07}, {"x": 0.464142091152815, "y": 0.2955764075067024, "term": "34", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 0.0}, {"x": 0.46430965147453085, "y": 0.29691689008042893, "term": "cerebral", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 3.7203725474772684e-06}, {"x": 0.4644772117962466, "y": 0.373156836461126, "term": "extremely", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 6.55357624354826e-07}, {"x": 0.46464477211796246, "y": 0.20509383378016086, "term": "b.1", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.4648123324396783, "y": 0.20576407506702413, "term": "immunizing", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.149391380115792e-05}, {"x": 0.4649798927613941, "y": 0.2062667560321716, "term": "cohort", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.5971320066510974e-06}, {"x": 0.4651474530831099, "y": 0.20693699731903487, "term": "b1", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.46531501340482573, "y": 0.3741621983914209, "term": "swelling", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 5, "s": 0.41705764075067026, "os": 0.4337636671337912, "bg": 5.646361996031313e-06}, {"x": 0.46548257372654156, "y": 0.2999329758713137, "term": "allergic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 5, "s": 0.34517426273458446, "os": 0.3551061324117912, "bg": 4.3405240314663186e-06}, {"x": 0.4656501340482574, "y": 0.20894772117962465, "term": "cns", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 4.963095250896873e-06}, {"x": 0.46581769436997317, "y": 0.20911528150134048, "term": "meningitis", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 8.306889734345666e-06}, {"x": 0.465985254691689, "y": 0.20978552278820375, "term": "upper arm", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.46615281501340483, "y": 0.21095844504021447, "term": "calculation", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.2150671977725387e-06}, {"x": 0.46632037533512066, "y": 0.21280160857908847, "term": "solid", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.1797844567207084e-07}, {"x": 0.46648793565683644, "y": 0.2131367292225201, "term": "financed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.717556190087322e-06}, {"x": 0.46665549597855227, "y": 0.21531501340482573, "term": "100,000 live", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.4668230563002681, "y": 0.2179959785522788, "term": "\ufb01om", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 0.0}, {"x": 0.46699061662198393, "y": 0.21900134048257372, "term": "xerophthalmia", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.846610014649173e-05}, {"x": 0.4671581769436997, "y": 0.21916890080428955, "term": "combined", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 3.9797767643718447e-07}, {"x": 0.46732573726541554, "y": 0.2195040214477212, "term": "look", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 6.922213044200955e-08}, {"x": 0.4674932975871314, "y": 0.22000670241286863, "term": "permitted", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 7.650728435417747e-07}, {"x": 0.4676608579088472, "y": 0.22101206434316353, "term": "unmet", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 1.3295014148110887e-05}, {"x": 0.467828418230563, "y": 0.22117962466487937, "term": "clarify", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 2.2518760942710394e-06}, {"x": 0.4679959785522788, "y": 0.5385388739946381, "term": "manuals", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 5, "s": 0.535857908847185, "os": 0.5392912007866004, "bg": 1.8885211623432278e-06}, {"x": 0.46816353887399464, "y": 0.22453083109919572, "term": "adequacy", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 5, "s": 0.24631367292225204, "os": 0.26422245741412986, "bg": 5.246431442912923e-06}, {"x": 0.4683310991957105, "y": 0.002848525469168901, "term": "oil capsule", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.46849865951742625, "y": 0.003686327077747989, "term": "placenta", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.581105606808595e-06}, {"x": 0.4686662198391421, "y": 0.006869973190348526, "term": "condoms", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.9041342383777277e-06}, {"x": 0.4688337801608579, "y": 0.00804289544235925, "term": "infertile phases", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.46900134048257375, "y": 0.008545576407506703, "term": "really", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 6.159708224969693e-08}, {"x": 0.4691689008042895, "y": 0.010388739946380697, "term": "ovulatory", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.8077032145394107e-05}, {"x": 0.46933646112600536, "y": 0.017258713136729224, "term": "continuation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.0968061867524628e-06}, {"x": 0.4695040214477212, "y": 0.01759383378016086, "term": "conflict", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.996632437508156e-07}, {"x": 0.469671581769437, "y": 0.01943699731903485, "term": "cooking oil", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4698391420911528, "y": 0.0217828418230563, "term": "nfa", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.3371129058137669e-05}, {"x": 0.4700067024128686, "y": 0.024296246648793565, "term": "promulgating", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.166701695010736e-05}, {"x": 0.47017426273458446, "y": 0.025134048257372654, "term": "investigators", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.6599306680158582e-06}, {"x": 0.4703418230563003, "y": 0.027312332439678285, "term": "tap", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.1009728636612454e-06}, {"x": 0.47050938337801607, "y": 0.02965817694369973, "term": "pediatrician", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.082799513173339e-05}, {"x": 0.4706769436997319, "y": 0.03150134048257373, "term": "stable", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 5.394385986981944e-07}, {"x": 0.47084450402144773, "y": 0.03183646112600536, "term": "pmec", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.2055186208576686e-05}, {"x": 0.47101206434316356, "y": 0.032339142091152816, "term": "precautions", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.5586650727889046e-06}, {"x": 0.47117962466487934, "y": 0.03736595174262734, "term": "industrially", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.2318937618569356e-05}, {"x": 0.47134718498659517, "y": 0.04004691689008043, "term": "maple", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 9.983514222963622e-07}, {"x": 0.471514745308311, "y": 0.040214477211796246, "term": "maple syrup", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47168230563002683, "y": 0.040382037533512063, "term": "syrup urine", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4718498659517426, "y": 0.04054959785522788, "term": "eliminated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.9967421155642454e-06}, {"x": 0.47201742627345844, "y": 0.04088471849865952, "term": "amino", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.1647405546238279e-06}, {"x": 0.47218498659517427, "y": 0.04121983914209115, "term": "wherever", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.413395198583439e-06}, {"x": 0.4723525469168901, "y": 0.04155495978552279, "term": "malnourished", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.7856058739290833e-05}, {"x": 0.4725201072386059, "y": 0.042560321715817695, "term": "insufficient", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.9298812389683165e-06}, {"x": 0.4726876675603217, "y": 0.043230563002680966, "term": "breaks", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 6.114347843047626e-07}, {"x": 0.47285522788203754, "y": 0.04440348525469169, "term": "coaching", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 9.089622496161224e-07}, {"x": 0.4730227882037534, "y": 0.04574396782841823, "term": "spontaneous", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.947424142881691e-06}, {"x": 0.47319034852546915, "y": 0.04825737265415549, "term": "latching", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.7877830060498575e-05}, {"x": 0.473357908847185, "y": 0.04876005361930295, "term": "roomed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.5616000778726425e-05}, {"x": 0.4735254691689008, "y": 0.048927613941018765, "term": "nicu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.6146819803105678e-05}, {"x": 0.47369302949061665, "y": 0.04993297587131367, "term": "kangaroo", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.725346332446071e-06}, {"x": 0.4738605898123324, "y": 0.05077077747989276, "term": "plays", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.531881149422829e-07}, {"x": 0.47402815013404825, "y": 0.05160857908847185, "term": "pathways", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.0609645685154276e-06}, {"x": 0.4741957104557641, "y": 0.052781501340482574, "term": "nasopharyngeal swab", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4743632707774799, "y": 0.05294906166219839, "term": "allows", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.8634140600330147e-07}, {"x": 0.4745308310991957, "y": 0.055127345844504023, "term": "virology", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 7.329938106002633e-06}, {"x": 0.4746983914209115, "y": 0.05546246648793566, "term": "coryza", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.0494219820633e-05}, {"x": 0.47486595174262736, "y": 0.05596514745308311, "term": "cough coryza", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4750335120643432, "y": 0.05630026809651475, "term": "molecular", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 5.341560761321971e-07}, {"x": 0.47520107238605896, "y": 0.056635388739946384, "term": "gold", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 9.275599774194798e-08}, {"x": 0.4753686327077748, "y": 0.05864611260053619, "term": "completely filled", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47553619302949063, "y": 0.05881367292225201, "term": "separate plastic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47570375335120646, "y": 0.059148793565683644, "term": "shipping box", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47587131367292224, "y": 0.05931635388739946, "term": "completely investigated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47603887399463807, "y": 0.06032171581769437, "term": "chlamydia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.675427112965339e-06}, {"x": 0.4762064343163539, "y": 0.06115951742627346, "term": "serological", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.738462260592016e-05}, {"x": 0.47637399463806973, "y": 0.061327077747989275, "term": "examine", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 7.494810218664087e-07}, {"x": 0.4765415549597855, "y": 0.06300268096514745, "term": "weigh", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.564132150242759e-06}, {"x": 0.47670911528150134, "y": 0.064343163538874, "term": "timbang opt", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47687667560321717, "y": 0.06601876675603217, "term": "lt 115", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.477044235924933, "y": 0.06769436997319035, "term": "mobilizing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.161742427762856e-05}, {"x": 0.4772117962466488, "y": 0.06802949061662199, "term": "tsfp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.2055186208576686e-05}, {"x": 0.4773793565683646, "y": 0.06836461126005362, "term": "cut off", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47754691689008044, "y": 0.0690348525469169, "term": "-2", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4777144772117963, "y": 0.06936997319034853, "term": "-2 sd", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.47788203753351205, "y": 0.0700402144772118, "term": "stabilization", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.7490547695662233e-06}, {"x": 0.4780495978552279, "y": 0.07020777479892762, "term": "forti\ufb01ed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4782171581769437, "y": 0.07037533512064344, "term": "buffer", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 6.166735199650518e-07}, {"x": 0.47838471849865954, "y": 0.07087801608579089, "term": "analyzed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.5499992560003568e-06}, {"x": 0.4785522788203753, "y": 0.0728887399463807, "term": "biochemical", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.5639773131460148e-06}, {"x": 0.47871983914209115, "y": 0.0738941018766756, "term": "male adult", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.478887399463807, "y": 0.07556970509383377, "term": "magnesium", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.7005036169195193e-06}, {"x": 0.4790549597855228, "y": 0.07607238605898123, "term": "mcp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 6.994371629150023e-06}, {"x": 0.4792225201072386, "y": 0.07657506702412868, "term": "psnbm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.2055186208576686e-05}, {"x": 0.4793900804289544, "y": 0.0767426273458445, "term": "pediatrics", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.630499750234049e-06}, {"x": 0.47955764075067026, "y": 0.0777479892761394, "term": "abortion", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.0299428062460264e-06}, {"x": 0.47972520107238603, "y": 0.07808310991957104, "term": "gmc", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.5138965866325053e-06}, {"x": 0.47989276139410186, "y": 0.07825067024128686, "term": "congenital metabolic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4800603217158177, "y": 0.07908847184986595, "term": "0015", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4802278820375335, "y": 0.08109919571045576, "term": "salaries", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.555392343052358e-06}, {"x": 0.4803954423592493, "y": 0.08126675603217158, "term": "wages", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.1050456383848653e-06}, {"x": 0.48056300268096513, "y": 0.08294235924932976, "term": "executed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.0879187385625743e-06}, {"x": 0.48073056300268097, "y": 0.08445040214477212, "term": "raso", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.9305059811627075e-05}, {"x": 0.4808981233243968, "y": 0.08528820375335121, "term": "b.3", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4810656836461126, "y": 0.08545576407506703, "term": "filling", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.0620938287675336e-06}, {"x": 0.4812332439678284, "y": 0.08662868632707775, "term": "scholars", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.3206067342755686e-06}, {"x": 0.48140080428954424, "y": 0.08780160857908847, "term": "cirrhosis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 9.36665489590368e-06}, {"x": 0.48156836461126007, "y": 0.08796916890080429, "term": "steering", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.977641453289825e-07}, {"x": 0.48173592493297585, "y": 0.08813672922252011, "term": "sti", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.36793550268795e-06}, {"x": 0.4819034852546917, "y": 0.08880697050938338, "term": "hypothyroidism", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.2201803182474306e-05}, {"x": 0.4820710455764075, "y": 0.08947721179624665, "term": "121", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48223860589812334, "y": 0.08981233243967829, "term": "kit", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.6590540694182397e-07}, {"x": 0.4824061662198391, "y": 0.0899798927613941, "term": "ins", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.929894966575403e-07}, {"x": 0.48257372654155495, "y": 0.09065013404825738, "term": "esp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.030563225444094e-06}, {"x": 0.4827412868632708, "y": 0.09199061662198392, "term": "contamination", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.7239319508893164e-06}, {"x": 0.4829088471849866, "y": 0.09232573726541556, "term": "ambulance", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.1387428127547778e-06}, {"x": 0.4830764075067024, "y": 0.09483914209115281, "term": "induce", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.121965839449785e-06}, {"x": 0.4832439678284182, "y": 0.09617962466487935, "term": "beads", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.978848168216207e-07}, {"x": 0.48341152815013405, "y": 0.0966823056300268, "term": "episodes", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.204117117247292e-06}, {"x": 0.4835790884718499, "y": 0.09718498659517426, "term": "salts", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.070443088082353e-06}, {"x": 0.48374664879356566, "y": 0.0975201072386059, "term": "oral rehydration", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4839142091152815, "y": 0.09869302949061662, "term": "reformulated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.590186640205961e-05}, {"x": 0.4840817694369973, "y": 0.09953083109919571, "term": "helps", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.342251016086087e-07}, {"x": 0.48424932975871315, "y": 0.09969839142091153, "term": "cpc", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.5035166548422977e-06}, {"x": 0.48441689008042893, "y": 0.10003351206434316, "term": "wants", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.0441237209809773e-07}, {"x": 0.48458445040214476, "y": 0.10070375335120643, "term": "exerted", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.0034095857724548e-05}, {"x": 0.4847520107238606, "y": 0.10170911528150134, "term": "disable", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.2628601787730124e-06}, {"x": 0.4849195710455764, "y": 0.10237935656836461, "term": "auto disabled", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4850871313672922, "y": 0.10355227882037533, "term": "derived poliovirus", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48525469168900803, "y": 0.1042225201072386, "term": "nausea vomiting", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48542225201072386, "y": 0.10439008042895442, "term": "poliomyelitis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.051669238092112e-05}, {"x": 0.4855898123324397, "y": 0.1050603217158177, "term": "attenuated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.1956816760587464e-05}, {"x": 0.4857573726541555, "y": 0.10640080428954424, "term": "six signal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4859249329758713, "y": 0.10656836461126006, "term": "signal obstetric", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48609249329758714, "y": 0.10690348525469169, "term": "transfusion", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 6.649625892047314e-06}, {"x": 0.48626005361930297, "y": 0.10723860589812333, "term": "dies", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.2748201101342591e-06}, {"x": 0.48642761394101874, "y": 0.10874664879356569, "term": "neonate", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.954369383630984e-05}, {"x": 0.4865951742627346, "y": 0.1089142091152815, "term": "suck", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.3800925145620556e-07}, {"x": 0.4867627345844504, "y": 0.10958445040214478, "term": "bemonc signal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48693029490616624, "y": 0.11008713136729223, "term": "suturing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.5471347281443102e-05}, {"x": 0.487097855227882, "y": 0.1136058981233244, "term": "eccd cards", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48726541554959785, "y": 0.11377345844504022, "term": "cool", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.7610860631840345e-07}, {"x": 0.4874329758713137, "y": 0.11427613941018767, "term": "learned", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.2674341220191705e-07}, {"x": 0.4876005361930295, "y": 0.11444369973190349, "term": "town", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.1014326753352502e-07}, {"x": 0.4877680965147453, "y": 0.11477882037533511, "term": "remote", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.9609615692712615e-07}, {"x": 0.4879356568364611, "y": 0.11544906166219839, "term": "puncture", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 9.68054211035818e-06}, {"x": 0.48810321715817695, "y": 0.11578418230563002, "term": "insertion", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.8529457761359853e-06}, {"x": 0.4882707774798928, "y": 0.11662198391420911, "term": "economically deprived", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48843833780160856, "y": 0.12131367292225201, "term": "immunogenicity", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.2151436077600915e-05}, {"x": 0.4886058981233244, "y": 0.12148123324396783, "term": "journals", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.5965943740350886e-07}, {"x": 0.4887734584450402, "y": 0.12164879356568364, "term": "reviewed journals", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.48894101876675605, "y": 0.12265415549597855, "term": "anterolateral", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.9748624126134167e-05}, {"x": 0.48910857908847183, "y": 0.12282171581769437, "term": "thigh", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.027274312554343e-06}, {"x": 0.48927613941018766, "y": 0.123156836461126, "term": "antihistamines", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.4070199037035577e-05}, {"x": 0.4894436997319035, "y": 0.12365951742627346, "term": "-adults", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4896112600536193, "y": 0.12432975871313673, "term": "-children", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4897788203753351, "y": 0.12449731903485255, "term": "restarted", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.909908352682684e-06}, {"x": 0.48994638069705093, "y": 0.12483243967828418, "term": "-health", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.49011394101876676, "y": 0.13304289544235925, "term": "signi\ufb01cance", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4902815013404826, "y": 0.1333780160857909, "term": "audiologic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.8771182783324225e-05}, {"x": 0.49044906166219837, "y": 0.13421581769436997, "term": "adb", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 5.785781442106024e-06}, {"x": 0.4906166219839142, "y": 0.1345509383378016, "term": "hep", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.082328057723374e-06}, {"x": 0.49078418230563003, "y": 0.13505361930294907, "term": "ep", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 8.773223490235709e-07}, {"x": 0.49095174262734587, "y": 0.1355563002680965, "term": "stock multiplier", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.49111930294906164, "y": 0.13622654155495978, "term": "subcomponents", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.6113683308917036e-05}, {"x": 0.4912868632707775, "y": 0.13840482573726542, "term": "rifampicin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.430517578718388e-05}, {"x": 0.4914544235924933, "y": 0.13974530831099197, "term": "sunlight", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.7403927311630886e-06}, {"x": 0.49162198391420914, "y": 0.14041554959785524, "term": "gastrointestinal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.901152595534351e-06}, {"x": 0.4917895442359249, "y": 0.14058310991957104, "term": "epigastric", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.8379018823803187e-05}, {"x": 0.49195710455764075, "y": 0.14209115281501342, "term": "final causality", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4921246648793566, "y": 0.14259383378016086, "term": "naefic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.2055186208576686e-05}, {"x": 0.4922922252010724, "y": 0.14343163538873996, "term": "aspirations", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 4.262369289117788e-06}, {"x": 0.4924597855227882, "y": 0.14812332439678283, "term": "diet diversi\ufb01cation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.492627345844504, "y": 0.14929624664879357, "term": "schistosoma japonicum", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.49279490616621985, "y": 0.15097184986595175, "term": "epg", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 1.518453000083515e-05}, {"x": 0.4929624664879357, "y": 0.15214477211796246, "term": "convulsant", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.0356936863642714e-05}, {"x": 0.49313002680965146, "y": 0.1523123324396783, "term": "anti convulsant", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 0.0}, {"x": 0.4932975871313673, "y": 0.1524798927613941, "term": "rebleeding", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 3.057430779767147e-05}, {"x": 0.4934651474530831, "y": 0.15281501340482573, "term": "loperamide", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 5, "s": 0.11494638069705095, "os": 0.16650444570551476, "bg": 2.740566968494442e-05}, {"x": 0.49363270777479895, "y": 0.4706769436997319, "term": "standardized", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 5.012781453437754e-06}, {"x": 0.4938002680965147, "y": 0.655328418230563, "term": "accounts", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 7.035275056741839e-07}, {"x": 0.49396782841823056, "y": 0.22570375335120643, "term": "85%", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 0.0}, {"x": 0.4941353887399464, "y": 0.22587131367292226, "term": "prevented", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 3.5933649414696996e-06}, {"x": 0.4943029490616622, "y": 0.7240281501340483, "term": "cultural", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 6, "s": 0.6998994638069705, "os": 0.6880787549902654, "bg": 8.50371912518084e-07}, {"x": 0.494470509383378, "y": 0.8857238605898123, "term": "authorized", "cat25k": 5, "ncat25k": 1, "cat": 34, "ncat": 6, "s": 0.9554289544235925, "os": 0.8582489541110996, "bg": 3.4250720324758485e-06}, {"x": 0.49463806970509383, "y": 0.6796246648793566, "term": "systematic", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 6, "s": 0.661695710455764, "os": 0.6520305574425849, "bg": 4.6786943226237535e-06}, {"x": 0.49480563002680966, "y": 0.5867962466487936, "term": "recognizing", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 6.242092349355504e-06}, {"x": 0.4949731903485255, "y": 0.5407171581769437, "term": "commonly", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 2.008282491709559e-06}, {"x": 0.49514075067024127, "y": 0.8098190348525469, "term": "places", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 6, "s": 0.8057975871313673, "os": 0.7699890985229259, "bg": 9.613852684935627e-07}, {"x": 0.4953083109919571, "y": 0.38136729222520105, "term": "500", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 0.0}, {"x": 0.49547587131367293, "y": 0.3098190348525469, "term": "500 mg", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 0.0}, {"x": 0.49564343163538876, "y": 0.6238270777479893, "term": "joint", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 7.153984508761945e-07}, {"x": 0.49581099195710454, "y": 0.47218498659517427, "term": "incident", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 1.5866804236667522e-06}, {"x": 0.4959785522788204, "y": 0.5423927613941019, "term": "undergone", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 1.2963394075836937e-05}, {"x": 0.4961461126005362, "y": 0.8247319034852547, "term": "separability", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 6, "s": 0.8210455764075067, "os": 0.786284649866179, "bg": 0.00012808014971146388}, {"x": 0.49631367292225204, "y": 0.832774798927614, "term": "invalid", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 6, "s": 0.8245643431635389, "os": 0.793691957673369, "bg": 6.201522230076253e-06}, {"x": 0.4964812332439678, "y": 0.2282171581769437, "term": "criminal", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.7115801777107924e-07}, {"x": 0.49664879356568364, "y": 0.9155495978552279, "term": "workplace", "cat25k": 8, "ncat25k": 1, "cat": 47, "ncat": 6, "s": 0.9792225201072386, "os": 0.9004164161543009, "bg": 6.767610903744846e-06}, {"x": 0.4968163538873995, "y": 0.6244973190348525, "term": "harmful", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 4.977107969647462e-06}, {"x": 0.4969839142091153, "y": 0.6251675603217158, "term": "chiefs", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 6.042830720888123e-06}, {"x": 0.4971514745308311, "y": 0.8254021447721179, "term": "behavioral", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 6, "s": 0.8210455764075067, "os": 0.786284649866179, "bg": 6.837626750923112e-06}, {"x": 0.4973190348525469, "y": 0.6821380697050938, "term": "ground", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 6, "s": 0.661695710455764, "os": 0.6520305574425849, "bg": 5.246662663463055e-07}, {"x": 0.49748659517426275, "y": 0.6261729222520107, "term": "subjected", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 7.150264598095119e-06}, {"x": 0.4976541554959786, "y": 0.8564008042895442, "term": "dependent", "cat25k": 4, "ncat25k": 1, "cat": 26, "ncat": 6, "s": 0.842828418230563, "os": 0.8194643227629814, "bg": 3.269772531632112e-06}, {"x": 0.49782171581769435, "y": 0.8565683646112601, "term": "consumption", "cat25k": 4, "ncat25k": 1, "cat": 26, "ncat": 6, "s": 0.842828418230563, "os": 0.8194643227629814, "bg": 3.380414764215014e-06}, {"x": 0.4979892761394102, "y": 0.7076072386058981, "term": "occurrence", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 6, "s": 0.6849865951742627, "os": 0.6711324141418226, "bg": 5.78869919926967e-06}, {"x": 0.498156836461126, "y": 0.7684316353887399, "term": "employed", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 6, "s": 0.755529490616622, "os": 0.7293945006077671, "bg": 2.1252783798415927e-06}, {"x": 0.49832439678284185, "y": 0.5898123324396782, "term": "concept", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 8.1266956858467e-07}, {"x": 0.4984919571045576, "y": 0.23073056300268097, "term": "message", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.285027070671909e-08}, {"x": 0.49865951742627346, "y": 0.4753686327077748, "term": "detect", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 2.516146224694145e-06}, {"x": 0.4988270777479893, "y": 0.3882372654155496, "term": "appearance", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 1.1843729334542894e-06}, {"x": 0.4989946380697051, "y": 0.15516085790884718, "term": "difficulty", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.111607540923236e-06}, {"x": 0.4991621983914209, "y": 0.47687667560321717, "term": "examined", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 1.9997354895329756e-06}, {"x": 0.49932975871313673, "y": 0.7587131367292225, "term": "urine", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 6, "s": 0.7434651474530831, "os": 0.7169444149410544, "bg": 7.668845449565932e-06}, {"x": 0.49949731903485256, "y": 0.4772117962466488, "term": "sec", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 5.302543487906574e-07}, {"x": 0.4996648793565684, "y": 0.8118297587131368, "term": "entitled", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 6, "s": 0.8057975871313673, "os": 0.7699890985229259, "bg": 2.7096486306492582e-06}, {"x": 0.49983243967828417, "y": 0.92828418230563, "term": "pay", "cat25k": 9, "ncat25k": 1, "cat": 54, "ncat": 6, "s": 0.9857573726541555, "os": 0.9165577194063306, "bg": 9.265654634290132e-07}, {"x": 0.5, "y": 0.7087801608579088, "term": "seeking", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 6, "s": 0.6849865951742627, "os": 0.6711324141418226, "bg": 1.1999276373050726e-06}, {"x": 0.5001675603217158, "y": 0.6598525469168901, "term": "passed", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 8.940796903957006e-07}, {"x": 0.5003351206434317, "y": 0.4792225201072386, "term": "categories", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 1.2632717028241058e-07}, {"x": 0.5005026809651475, "y": 0.9688337801608579, "term": "disabilities", "cat25k": 18, "ncat25k": 1, "cat": 111, "ncat": 6, "s": 0.9964812332439679, "os": 0.9724973643941937, "bg": 1.417272187123537e-05}, {"x": 0.5006702412868632, "y": 0.9251005361930295, "term": "visual", "cat25k": 8, "ncat25k": 1, "cat": 52, "ncat": 6, "s": 0.9842493297587132, "os": 0.9123050288162895, "bg": 2.307026895657648e-06}, {"x": 0.500837801608579, "y": 0.4800603217158177, "term": "frontline", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 7.675111149564194e-06}, {"x": 0.5010053619302949, "y": 0.3925938337801609, "term": "performing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 9.425337191438024e-07}, {"x": 0.5011729222520107, "y": 0.31585120643431636, "term": "1.0", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 0.0}, {"x": 0.5013404825737265, "y": 0.6610254691689008, "term": "syndrome", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 2.0926733413645486e-06}, {"x": 0.5015080428954424, "y": 0.9537533512064343, "term": "indigent", "cat25k": 13, "ncat25k": 1, "cat": 78, "ncat": 6, "s": 0.9931300268096515, "os": 0.9516249210052077, "bg": 0.00018430591270920913}, {"x": 0.5016756032171582, "y": 0.5929959785522788, "term": "count", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 6.394841153744452e-07}, {"x": 0.501843163538874, "y": 0.4824061662198391, "term": "pursue", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 2.775061581139269e-06}, {"x": 0.5020107238605898, "y": 0.31685656836461124, "term": "upgrade", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 4.6048093754737515e-07}, {"x": 0.5021782841823056, "y": 0.8049597855227882, "term": "linkages", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 6, "s": 0.7903820375335121, "os": 0.7609733226979014, "bg": 2.116286411148597e-05}, {"x": 0.5023458445040214, "y": 0.7476541554959786, "term": "identifying", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 6, "s": 0.7193364611260054, "os": 0.7032504886008583, "bg": 3.1586956980725803e-06}, {"x": 0.5025134048257373, "y": 0.3175268096514745, "term": "protecting", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 1.7554226223848956e-06}, {"x": 0.5026809651474531, "y": 0.7603887399463807, "term": "membership", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 6, "s": 0.7434651474530831, "os": 0.7169444149410544, "bg": 7.54004716978109e-07}, {"x": 0.5028485254691689, "y": 0.7314008042895442, "term": "manpower", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 6, "s": 0.6998994638069705, "os": 0.6880787549902654, "bg": 1.3413796238473449e-05}, {"x": 0.5030160857908847, "y": 0.4847520107238606, "term": "gender sensitive", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 0.0}, {"x": 0.5031836461126006, "y": 0.662701072386059, "term": "entire", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 5.300728996890575e-07}, {"x": 0.5033512064343163, "y": 0.6322050938337802, "term": "voluntary", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 2.3365911255100753e-06}, {"x": 0.5035187667560321, "y": 0.7846849865951743, "term": "top", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 6, "s": 0.7615616621983915, "os": 0.7407872275786457, "bg": 9.081044712277933e-08}, {"x": 0.503686327077748, "y": 0.8135053619302949, "term": "50%", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 6, "s": 0.8057975871313673, "os": 0.7699890985229259, "bg": 0.0}, {"x": 0.5038538873994638, "y": 0.6330428954423593, "term": "power", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 1.2339784480111153e-07}, {"x": 0.5040214477211796, "y": 0.7322386058981233, "term": "pursued", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 6, "s": 0.6998994638069705, "os": 0.6880787549902654, "bg": 1.1113879290304715e-05}, {"x": 0.5041890080428955, "y": 0.6632037533512064, "term": "resident", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 1.5787894063862349e-06}, {"x": 0.5043565683646113, "y": 0.6633713136729222, "term": "covers", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 9.013192158703086e-07}, {"x": 0.5045241286863271, "y": 0.15733914209115282, "term": "potent", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 5.124649785094151e-06}, {"x": 0.5046916890080428, "y": 0.5970174262734584, "term": "securing", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 5.04759689735867e-06}, {"x": 0.5048592493297587, "y": 0.15784182305630026, "term": "connection", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.272195409324561e-07}, {"x": 0.5050268096514745, "y": 0.828083109919571, "term": "\ufb01lled", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 6, "s": 0.8210455764075067, "os": 0.786284649866179, "bg": 0.0}, {"x": 0.5051943699731903, "y": 0.7126340482573726, "term": "30%", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 6, "s": 0.6849865951742627, "os": 0.6711324141418226, "bg": 0.0}, {"x": 0.5053619302949062, "y": 0.8421581769436998, "term": "security", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 6, "s": 0.829088471849866, "os": 0.8006743832323652, "bg": 2.5181698436526957e-07}, {"x": 0.505529490616622, "y": 0.4887734584450402, "term": "guardian", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 1.3349644981361774e-06}, {"x": 0.5056970509383378, "y": 0.48927613941018766, "term": "discuss", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 5.055114883574845e-07}, {"x": 0.5058646112600537, "y": 0.8068029490616622, "term": "easy", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 6, "s": 0.7903820375335121, "os": 0.7609733226979014, "bg": 3.813745928945401e-07}, {"x": 0.5060321715817694, "y": 0.5981903485254692, "term": "arrangement", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 2.203623451943931e-06}, {"x": 0.5061997319034852, "y": 0.6357238605898123, "term": "\ufb01fteen", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 0.0}, {"x": 0.506367292225201, "y": 0.5547922252010724, "term": "of\ufb01cial gazette", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 0.0}, {"x": 0.5065348525469169, "y": 0.636058981233244, "term": "relatives", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 3.94205905288934e-06}, {"x": 0.5067024128686327, "y": 0.761058981233244, "term": "example", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 6, "s": 0.7434651474530831, "os": 0.7169444149410544, "bg": 3.0147444594442214e-07}, {"x": 0.5068699731903485, "y": 0.40281501340482573, "term": "capital", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 2.885837731133597e-07}, {"x": 0.5070375335120644, "y": 0.32406166219839144, "term": "economically", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 4.243443526131833e-06}, {"x": 0.5072050938337802, "y": 0.5559651474530831, "term": "validated", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 7.4102525784591365e-06}, {"x": 0.5073726541554959, "y": 0.403485254691689, "term": "organizing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 2.8428203222422116e-06}, {"x": 0.5075402144772118, "y": 0.2416219839142091, "term": "potentially", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 1.474145559896607e-06}, {"x": 0.5077077747989276, "y": 0.16085790884718498, "term": "getting", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.492612373694741e-07}, {"x": 0.5078753351206434, "y": 0.6920241286863271, "term": "hospitalization", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 6, "s": 0.661695710455764, "os": 0.6520305574425849, "bg": 2.071346226169e-05}, {"x": 0.5080428954423593, "y": 0.7138069705093834, "term": "classi\ufb01ed", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 6, "s": 0.6849865951742627, "os": 0.6711324141418226, "bg": 0.0}, {"x": 0.5082104557640751, "y": 0.7340817694369973, "term": "relation", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 6, "s": 0.6998994638069705, "os": 0.6880787549902654, "bg": 1.5881483196420244e-06}, {"x": 0.5083780160857909, "y": 0.7965817694369973, "term": "constitution", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 6, "s": 0.7850201072386059, "os": 0.7512727853554764, "bg": 2.2173516539924935e-06}, {"x": 0.5085455764075067, "y": 0.858411528150134, "term": "alcohol", "cat25k": 4, "ncat25k": 1, "cat": 26, "ncat": 6, "s": 0.842828418230563, "os": 0.8194643227629814, "bg": 2.5223062518040404e-06}, {"x": 0.5087131367292225, "y": 0.874162198391421, "term": "technology", "cat25k": 5, "ncat25k": 1, "cat": 30, "ncat": 6, "s": 0.9135388739946382, "os": 0.8405516019894652, "bg": 3.0127251358758915e-07}, {"x": 0.5088806970509383, "y": 0.6023793565683646, "term": "simple", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 3.0257224110091986e-07}, {"x": 0.5090482573726541, "y": 0.40800938337801607, "term": "expanding", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 2.1142869345313163e-06}, {"x": 0.50921581769437, "y": 0.4949731903485255, "term": "pro", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 2.1381470825158e-07}, {"x": 0.5093833780160858, "y": 0.7350871313672922, "term": "governance", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 6, "s": 0.6998994638069705, "os": 0.6880787549902654, "bg": 2.5758478063185686e-06}, {"x": 0.5095509383378016, "y": 0.1628686327077748, "term": "strategically", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 7.843286650838167e-06}, {"x": 0.5097184986595175, "y": 0.33026139410187666, "term": "seizure", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 6.7533141889382216e-06}, {"x": 0.5098860589812333, "y": 0.751843163538874, "term": "distributor", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 6, "s": 0.7193364611260054, "os": 0.7032504886008583, "bg": 3.3586261451368413e-06}, {"x": 0.510053619302949, "y": 0.3305965147453083, "term": "k", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 9.185551867879676e-08}, {"x": 0.5102211796246648, "y": 0.6694034852546917, "term": "withdrawal", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 3.5289974188912876e-06}, {"x": 0.5103887399463807, "y": 0.715985254691689, "term": "documentary", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 6, "s": 0.6849865951742627, "os": 0.6711324141418226, "bg": 3.1654461389098316e-06}, {"x": 0.5105563002680965, "y": 0.6705764075067024, "term": "inputs", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 3.7208817745629364e-06}, {"x": 0.5107238605898123, "y": 0.5, "term": "consolidated", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 2.229025478166493e-06}, {"x": 0.5108914209115282, "y": 0.5003351206434317, "term": "liable", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 1.7686565124344592e-06}, {"x": 0.511058981233244, "y": 0.16621983914209115, "term": "confirm", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 6.096640903278316e-07}, {"x": 0.5112265415549598, "y": 0.16638739946380698, "term": "opinion", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.484445684143405e-07}, {"x": 0.5113941018766756, "y": 0.41705764075067026, "term": "constraints", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 1.8448160990459625e-06}, {"x": 0.5115616621983914, "y": 0.8935991957104558, "term": "sections", "cat25k": 6, "ncat25k": 1, "cat": 36, "ncat": 6, "s": 0.963304289544236, "os": 0.8660898975618541, "bg": 2.0446424307410236e-06}, {"x": 0.5117292225201072, "y": 0.1675603217158177, "term": "arti\ufb01cial", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 0.0}, {"x": 0.511896782841823, "y": 0.6072386058981233, "term": "lists", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 4.43979791132781e-07}, {"x": 0.5120643431635389, "y": 0.4225871313672922, "term": "3.4", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 0.0}, {"x": 0.5122319034852547, "y": 0.5671916890080428, "term": "5.2", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 0.0}, {"x": 0.5123994638069705, "y": 0.5102211796246648, "term": "5.4", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 0.0}, {"x": 0.5125670241286864, "y": 0.4277815013404826, "term": "arises", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 5.1155853725974975e-06}, {"x": 0.5127345844504021, "y": 0.25485924932975873, "term": "plant", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 2.9873278300282164e-07}, {"x": 0.5129021447721179, "y": 0.17040884718498658, "term": "instruction", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 5.518833413225016e-07}, {"x": 0.5130697050938338, "y": 0.6459450402144772, "term": "adherence", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 1.2717561135133172e-05}, {"x": 0.5132372654155496, "y": 0.6965482573726541, "term": "collaborative", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 6, "s": 0.661695710455764, "os": 0.6520305574425849, "bg": 3.084021961705892e-06}, {"x": 0.5134048257372654, "y": 0.5129021447721179, "term": "revision", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 8.210702755541702e-07}, {"x": 0.5135723860589813, "y": 0.4297922252010724, "term": "promoted", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 3.5155575727043673e-06}, {"x": 0.5137399463806971, "y": 0.6462801608579088, "term": "stipulated", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 1.62835382732936e-05}, {"x": 0.5139075067024129, "y": 0.2577077747989276, "term": "ones", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.339565582362921e-07}, {"x": 0.5140750670241286, "y": 0.7640750670241286, "term": "communications", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 6, "s": 0.7434651474530831, "os": 0.7169444149410544, "bg": 6.095933565784489e-07}, {"x": 0.5142426273458445, "y": 0.6104222520107239, "term": "students", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 1.2675928974468788e-07}, {"x": 0.5144101876675603, "y": 0.17208445040214476, "term": "fines", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 3.90787682818852e-06}, {"x": 0.5145777479892761, "y": 0.4313002680965147, "term": "index", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 8.225774037419613e-08}, {"x": 0.514745308310992, "y": 0.2593833780160858, "term": "compromise", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 2.7598545349670982e-06}, {"x": 0.5149128686327078, "y": 0.17275469168900803, "term": "mid", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 3.506799684588417e-07}, {"x": 0.5150804289544236, "y": 0.2602211796246649, "term": "toward", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 5.274170153827106e-07}, {"x": 0.5152479892761395, "y": 0.5169235924932976, "term": "uses", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 3.917776415420496e-07}, {"x": 0.5154155495978552, "y": 0.5737265415549598, "term": "recognizes", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 5.166080890494584e-06}, {"x": 0.515583109919571, "y": 0.6117627345844504, "term": "pacific", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 4.7645564208051105e-07}, {"x": 0.5157506702412868, "y": 0.6119302949061662, "term": "western pacific", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 0.0}, {"x": 0.5159182305630027, "y": 0.6744302949061662, "term": "hhrdb", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 9.616247611965175e-05}, {"x": 0.5160857908847185, "y": 0.26357238605898126, "term": "intensify", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 1.5454830842046798e-05}, {"x": 0.5162533512064343, "y": 0.7781501340482574, "term": "pilot", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 6, "s": 0.755529490616622, "os": 0.7293945006077671, "bg": 1.890035230256692e-06}, {"x": 0.5164209115281502, "y": 0.43800268096514744, "term": "imposed", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 2.125285359408601e-06}, {"x": 0.516588471849866, "y": 0.4383378016085791, "term": "suspension", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 1.4995731090251884e-06}, {"x": 0.5167560321715817, "y": 0.520274798927614, "term": "quarter", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 6.036185118932464e-07}, {"x": 0.5169235924932976, "y": 0.6492962466487936, "term": "characteristics", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 1.1437509959313917e-06}, {"x": 0.5170911528150134, "y": 0.6146112600536193, "term": "2014", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 0.0}, {"x": 0.5172587131367292, "y": 0.26625335120643434, "term": "75%", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 0.0}, {"x": 0.517426273458445, "y": 0.2669235924932976, "term": "systemic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.261093156817549e-06}, {"x": 0.5175938337801609, "y": 0.17510053619302948, "term": "survivors", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.458289845015361e-06}, {"x": 0.5177613941018767, "y": 0.4425268096514745, "term": "hold", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 3.1206339405577276e-07}, {"x": 0.5179289544235925, "y": 0.822553619302949, "term": "dpcb", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 6, "s": 0.8104892761394102, "os": 0.7784031160006154, "bg": 0.00016667574835808364}, {"x": 0.5180965147453083, "y": 0.5237935656836461, "term": "eb", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 6, "s": 0.4731903485254692, "os": 0.5, "bg": 4.406679645005901e-06}, {"x": 0.5182640750670241, "y": 0.6504691689008043, "term": "visible", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 1.7441665260432405e-06}, {"x": 0.5184316353887399, "y": 0.5787533512064343, "term": "ceiling", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 2.2422718698585408e-06}, {"x": 0.5185991957104558, "y": 0.3542225201072386, "term": "expiry", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 7.395146072622799e-06}, {"x": 0.5187667560321716, "y": 0.3543900804289544, "term": "expiry date", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 0.0}, {"x": 0.5189343163538874, "y": 0.3552278820375335, "term": "recently", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 2.90569245815254e-07}, {"x": 0.5191018766756033, "y": 0.6169571045576407, "term": "appear", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 6, "s": 0.5715482573726542, "os": 0.5760054663937487, "bg": 6.030653253813448e-07}, {"x": 0.5192694369973191, "y": 0.5797587131367292, "term": "attaining", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 1.6352004142507716e-05}, {"x": 0.5194369973190348, "y": 0.5800938337801609, "term": "treating", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 3.3384964107685983e-06}, {"x": 0.5196045576407506, "y": 0.5802613941018767, "term": "protective", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 6, "s": 0.5418900804289544, "os": 0.5414551309586919, "bg": 2.1479108702905264e-06}, {"x": 0.5197721179624665, "y": 0.3562332439678284, "term": "reduces", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 2.183745171496788e-06}, {"x": 0.5199396782841823, "y": 0.17727882037533513, "term": "mhpss", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 4.4876972984062266e-05}, {"x": 0.5201072386058981, "y": 0.444872654155496, "term": "pictures", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 9.288937198587052e-08}, {"x": 0.520274798927614, "y": 0.3574061662198391, "term": "tasked", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 1.9766578668786818e-05}, {"x": 0.5204423592493298, "y": 0.3585790884718499, "term": "numbers", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 2.7527521174551616e-07}, {"x": 0.5206099195710456, "y": 0.17878686327077747, "term": "investigate", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.3552438838811553e-06}, {"x": 0.5207774798927614, "y": 0.35924932975871315, "term": "comprise", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 5.512306070182069e-06}, {"x": 0.5209450402144772, "y": 0.35958445040214476, "term": "cross", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 2.414715469246828e-07}, {"x": 0.521112600536193, "y": 0.2761394101876676, "term": "signi\ufb01cantly", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 0.0}, {"x": 0.5212801608579088, "y": 0.4515750670241287, "term": "vaginal", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 4.778859472619405e-06}, {"x": 0.5214477211796247, "y": 0.27714477211796246, "term": "cm", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.62102537664967e-07}, {"x": 0.5216152815013405, "y": 0.4525804289544236, "term": "focusing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 2.1979009825826237e-06}, {"x": 0.5217828418230563, "y": 0.362097855227882, "term": "comes", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 2.787725440452489e-07}, {"x": 0.5219504021447721, "y": 0.677446380697051, "term": "white", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 6, "s": 0.6417560321715817, "os": 0.6302783931880885, "bg": 1.4273771828647308e-07}, {"x": 0.5221179624664879, "y": 0.27831769436997317, "term": "washing", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 1.8768297623910062e-06}, {"x": 0.5222855227882037, "y": 0.45492627345844505, "term": "gives", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 4.351504716606841e-07}, {"x": 0.5224530831099196, "y": 0.3662868632707775, "term": "drinks", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 1.5721492021997858e-06}, {"x": 0.5226206434316354, "y": 0.1876675603217158, "term": "loose", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.0879131758252636e-06}, {"x": 0.5227882037533512, "y": 0.1885053619302949, "term": "undue", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 8.286323245918542e-06}, {"x": 0.522955764075067, "y": 0.284014745308311, "term": "mix", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 4.886957644677006e-07}, {"x": 0.5231233243967829, "y": 0.28418230563002683, "term": "positioning", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 2.809548602117873e-06}, {"x": 0.5232908847184986, "y": 0.1886729222520107, "term": "eat", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 4.7378346281835364e-07}, {"x": 0.5234584450402144, "y": 0.18934316353887398, "term": "38", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 0.0}, {"x": 0.5236260053619303, "y": 0.2843498659517426, "term": "15%", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 0.0}, {"x": 0.5237935656836461, "y": 0.19152144772117963, "term": "awarded", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 8.876074092140876e-07}, {"x": 0.5239611260053619, "y": 0.19168900804289543, "term": "posts", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 6.447628684674723e-08}, {"x": 0.5241286863270778, "y": 0.369470509383378, "term": "begin", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 3.934695594898431e-07}, {"x": 0.5242962466487936, "y": 0.19386729222520108, "term": "governed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.6927727134416674e-06}, {"x": 0.5244638069705094, "y": 0.1960455764075067, "term": "algorithm", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 8.349611098971041e-07}, {"x": 0.5246313672922251, "y": 0.19638069705093833, "term": "preliminary", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.0433126009730975e-06}, {"x": 0.524798927613941, "y": 0.2897117962466488, "term": "excessive", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 2.2191871755392314e-06}, {"x": 0.5249664879356568, "y": 0.2902144772117963, "term": "linking", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 1.2434651051439121e-06}, {"x": 0.5251340482573726, "y": 0.2907171581769437, "term": "replace", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 6.985519236919343e-07}, {"x": 0.5253016085790885, "y": 0.6541554959785523, "term": "errors", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 6, "s": 0.6053954423592494, "os": 0.6052252805925691, "bg": 7.262291642583308e-07}, {"x": 0.5254691689008043, "y": 0.2915549597855228, "term": "computation", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 2.665367744119366e-06}, {"x": 0.5256367292225201, "y": 0.2918900804289544, "term": "#", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 0.0}, {"x": 0.525804289544236, "y": 0.19772117962466487, "term": "thorough", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.5439420562683637e-06}, {"x": 0.5259718498659517, "y": 0.1980563002680965, "term": "rho", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 8.917140655155062e-06}, {"x": 0.5261394101876675, "y": 0.19872654155495978, "term": "represented", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 8.219019492109213e-07}, {"x": 0.5263069705093834, "y": 0.20325067024128687, "term": "measurements", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 9.406313154574414e-07}, {"x": 0.5264745308310992, "y": 0.37248659517426275, "term": "1,000", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 6, "s": 0.37751340482573725, "os": 0.3932022580980996, "bg": 0.0}, {"x": 0.526642091152815, "y": 0.20392091152815014, "term": "severely", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 3.257968758872147e-06}, {"x": 0.5268096514745308, "y": 0.2982573726541555, "term": "immunizations", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 1.5021400801955036e-05}, {"x": 0.5269772117962467, "y": 0.20777479892761394, "term": "8\u00b0c", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 0.0}, {"x": 0.5271447721179625, "y": 0.20794235924932977, "term": "freeze", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.397796082857556e-06}, {"x": 0.5273123324396782, "y": 0.20810991957104558, "term": "sanitary", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 4.058679224606729e-06}, {"x": 0.5274798927613941, "y": 0.20995308310991956, "term": "sometimes", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.9340916870538885e-07}, {"x": 0.5276474530831099, "y": 0.3021112600536193, "term": "packaged", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 3.001681879878319e-06}, {"x": 0.5278150134048257, "y": 0.4686662198391421, "term": "execution", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 6, "s": 0.43414879356568364, "os": 0.45473418619836237, "bg": 9.040927964462644e-07}, {"x": 0.5279825737265416, "y": 0.21263404825737264, "term": "savings", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 4.225822139734174e-07}, {"x": 0.5281501340482574, "y": 0.217828418230563, "term": "caesarean", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 2.658130271167261e-05}, {"x": 0.5283176943699732, "y": 0.21849865951742628, "term": "corneal", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.3894085387094181e-05}, {"x": 0.528485254691689, "y": 0.22017426273458446, "term": "us", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 1.1387441051223616e-08}, {"x": 0.5286528150134048, "y": 0.30730563002680966, "term": "elevated", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 6, "s": 0.30328418230563, "os": 0.3227093236648778, "bg": 3.335324800182776e-06}, {"x": 0.5288203753351206, "y": 0.22402815013404825, "term": "chos", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 6, "s": 0.22838471849865954, "os": 0.24416679908948957, "bg": 3.874531596805172e-05}, {"x": 0.5289879356568364, "y": 0.0030160857908847183, "term": "behaviors", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.251590044744723e-06}, {"x": 0.5291554959785523, "y": 0.0051943699731903485, "term": "attendant", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 4.591615938876408e-06}, {"x": 0.5293230563002681, "y": 0.0061997319034852545, "term": "programming", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.355603655237304e-07}, {"x": 0.5294906166219839, "y": 0.009048257372654156, "term": "contraception", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.712014508516852e-06}, {"x": 0.5296581769436998, "y": 0.010053619302949061, "term": "thick", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 8.366731116061273e-07}, {"x": 0.5298257372654156, "y": 0.011561662198391422, "term": "breasts", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 6.450080835638072e-07}, {"x": 0.5299932975871313, "y": 0.01306970509383378, "term": "receives", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 9.828351123740907e-07}, {"x": 0.5301608579088471, "y": 0.013237265415549598, "term": "supplemented", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.6677213351451145e-06}, {"x": 0.530328418230563, "y": 0.017091152815013406, "term": "spacing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.5178597341377505e-06}, {"x": 0.5304959785522788, "y": 0.018934316353887398, "term": "flour", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.1918588881247824e-06}, {"x": 0.5306635388739946, "y": 0.019101876675603216, "term": "cooking", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 4.970380467299432e-07}, {"x": 0.5308310991957105, "y": 0.02027479892761394, "term": "staples", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.9475512726543882e-06}, {"x": 0.5309986595174263, "y": 0.020945040214477212, "term": "staple", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.440395480482128e-06}, {"x": 0.5311662198391421, "y": 0.022285522788203754, "term": "corrective actions", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5313337801608579, "y": 0.022788203753351208, "term": "spots", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.1514519088913676e-06}, {"x": 0.5315013404825737, "y": 0.02697721179624665, "term": "1594", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5316689008042895, "y": 0.027144772117962467, "term": "pd 1594", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5318364611260054, "y": 0.029323056300268095, "term": "refusal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.175994562697309e-06}, {"x": 0.5320040214477212, "y": 0.030160857908847184, "term": "vaccinating", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.0321253682768934e-05}, {"x": 0.532171581769437, "y": 0.03049597855227882, "term": "preschoolers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.2412556128027241e-05}, {"x": 0.5323391420911529, "y": 0.030831099195710455, "term": "mobilized", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.3173509389967713e-05}, {"x": 0.5325067024128687, "y": 0.03284182305630027, "term": "1998 ndhs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5326742627345844, "y": 0.034684986595174265, "term": "1986", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5328418230563002, "y": 0.03485254691689008, "term": "7600", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5330093833780161, "y": 0.03753351206434316, "term": "safely", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.5330496765584566e-06}, {"x": 0.5331769436997319, "y": 0.03937667560321716, "term": "depends", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 6.223439849753714e-07}, {"x": 0.5333445040214477, "y": 0.03971179624664879, "term": "galactosemia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.4627237785241874e-05}, {"x": 0.5335120643431636, "y": 0.04306300268096515, "term": "refrigerators", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.019780024873011e-06}, {"x": 0.5336796246648794, "y": 0.043398123324396784, "term": "maternity leave", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5338471849865952, "y": 0.04658176943699732, "term": "clamping", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.2516297262059974e-05}, {"x": 0.534014745308311, "y": 0.04674932975871314, "term": "cord clamping", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5341823056300268, "y": 0.04691689008042895, "term": "pre natal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5343498659517426, "y": 0.0492627345844504, "term": "gifts", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.253599148446813e-07}, {"x": 0.5345174262734584, "y": 0.049597855227882036, "term": "ntwg", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5346849865951743, "y": 0.05563002680965148, "term": "conjunctivitis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.02377258192906e-05}, {"x": 0.5348525469168901, "y": 0.06182975871313673, "term": "erythromycin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.567695031059958e-05}, {"x": 0.5350201072386059, "y": 0.06886729222520108, "term": "-3 sd", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5351876675603218, "y": 0.06970509383378017, "term": "stomach", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.5902450130247693e-06}, {"x": 0.5353552278820375, "y": 0.07255361930294907, "term": "drying", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.891832453011337e-06}, {"x": 0.5355227882037533, "y": 0.07691018766756032, "term": "pps", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.350376064557638e-06}, {"x": 0.5356903485254692, "y": 0.07841823056300268, "term": "aspect", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 7.661277553784723e-07}, {"x": 0.535857908847185, "y": 0.0785857908847185, "term": "lessons", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.196830383857813e-07}, {"x": 0.5360254691689008, "y": 0.07892091152815013, "term": "acnbs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5361930294906166, "y": 0.07942359249329758, "term": "ncnbss", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5363605898123325, "y": 0.08009383378016086, "term": "complies", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.597255106095971e-06}, {"x": 0.5365281501340483, "y": 0.08176943699731903, "term": "orientation seminars", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.536695710455764, "y": 0.08227211796246649, "term": "contaminated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.535299288911932e-06}, {"x": 0.5368632707774799, "y": 0.08478552278820375, "term": "b.2", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5370308310991957, "y": 0.08512064343163539, "term": "afpso", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5371983914209115, "y": 0.08746648793565684, "term": "inject", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 8.002080540940645e-06}, {"x": 0.5373659517426274, "y": 0.08863941018766756, "term": "untreated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 7.033527654072354e-06}, {"x": 0.5375335120643432, "y": 0.08930965147453084, "term": "maximum allowable", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.537701072386059, "y": 0.0908176943699732, "term": "description", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 6.103353951683651e-08}, {"x": 0.5378686327077749, "y": 0.09115281501340483, "term": "watery", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.2805108384571551e-05}, {"x": 0.5380361930294906, "y": 0.09165549597855228, "term": "vector", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 7.390809565259647e-07}, {"x": 0.5382037533512064, "y": 0.09400134048257372, "term": "c.1", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5383713136729222, "y": 0.09416890080428954, "term": "c.2", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5385388739946381, "y": 0.09634718498659517, "term": "prototype iec", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5387064343163539, "y": 0.09768766756032171, "term": "ors solution", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5388739946380697, "y": 0.09785522788203753, "term": "newly formulated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5390415549597856, "y": 0.09802278820375335, "term": "fluids", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.204755001821369e-06}, {"x": 0.5392091152815014, "y": 0.10103887399463807, "term": "sia", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 8.29318624906788e-06}, {"x": 0.5393766756032171, "y": 0.10288203753351206, "term": "wpv importation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.539544235924933, "y": 0.1032171581769437, "term": "circulating", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.740050340241484e-06}, {"x": 0.5397117962466488, "y": 0.10522788203753351, "term": "vaccinators", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5398793565683646, "y": 0.10857908847184987, "term": "carriers", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.0952729570809077e-06}, {"x": 0.5400469168900804, "y": 0.10908176943699732, "term": "af p", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5402144772117963, "y": 0.10941689008042896, "term": "fic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 6.951009286548408e-06}, {"x": 0.5403820375335121, "y": 0.11025469168900805, "term": "parenthood", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 6.2850226339377606e-06}, {"x": 0.5405495978552279, "y": 0.11142761394101877, "term": "markets", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.7791069886249757e-07}, {"x": 0.5407171581769437, "y": 0.11159517426273459, "term": "unimmunized", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5408847184986595, "y": 0.11276809651474531, "term": "recorder", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 8.755292209336703e-07}, {"x": 0.5410522788203753, "y": 0.11410857908847186, "term": "discard", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.249125692501843e-06}, {"x": 0.5412198391420912, "y": 0.11528150134048257, "term": "grab sample", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.541387399463807, "y": 0.11813002680965147, "term": "globulins", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.080430028031913e-05}, {"x": 0.5415549597855228, "y": 0.11829758713136729, "term": "immune globulins", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5417225201072386, "y": 0.12181635388739946, "term": "hrig", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5418900804289544, "y": 0.12248659517426273, "term": "in\ufb01ltrated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5420576407506702, "y": 0.12416219839142091, "term": "tid", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.0267406033983403e-05}, {"x": 0.542225201072386, "y": 0.12550268096514744, "term": "\ufb01nal disposal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5423927613941019, "y": 0.12567024128686327, "term": "septic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.092371373064581e-06}, {"x": 0.5425603217158177, "y": 0.12667560321715818, "term": "plhiv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5427278820375335, "y": 0.12734584450402145, "term": "diphtheria", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.609353562907619e-05}, {"x": 0.5428954423592494, "y": 0.12751340482573725, "term": "pertussis", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.368816088151756e-05}, {"x": 0.5430630026809652, "y": 0.12902144772117963, "term": "bathing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.934221134045798e-06}, {"x": 0.5432305630026809, "y": 0.1308646112600536, "term": "sore", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.2946233394411985e-06}, {"x": 0.5433981233243967, "y": 0.13119973190348524, "term": "jaundice", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.592652562843416e-05}, {"x": 0.5435656836461126, "y": 0.13287533512064342, "term": "deaf", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.971671030631881e-06}, {"x": 0.5437332439678284, "y": 0.13873994638069706, "term": "tuberculous", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.793796839750141e-05}, {"x": 0.5439008042895442, "y": 0.1390750670241287, "term": "assess accomplishments", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5440683646112601, "y": 0.13941018766756033, "term": "diversi\ufb01cation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5442359249329759, "y": 0.1402479892761394, "term": "200,000 i.u.", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5444034852546917, "y": 0.1429289544235925, "term": "releases", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 1.7878043140909967e-07}, {"x": 0.5445710455764075, "y": 0.14309651474530832, "term": "press releases", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5447386058981233, "y": 0.14326407506702413, "term": "enterprises", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 4.2270135969289624e-07}, {"x": 0.5449061662198391, "y": 0.14426943699731903, "term": "engineer", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 5.235706488563056e-07}, {"x": 0.545073726541555, "y": 0.1476206434316354, "term": "engorgement", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.457027705196201e-05}, {"x": 0.5452412868632708, "y": 0.1486260053619303, "term": "telegenetics", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 3.846610014649173e-05}, {"x": 0.5454088471849866, "y": 0.14896112600536193, "term": "schistosoma", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 2.7468188404304265e-05}, {"x": 0.5455764075067024, "y": 0.15013404825737264, "term": "stool exam", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 6, "s": 0.09567694369973191, "os": 0.1618308741828312, "bg": 0.0}, {"x": 0.5457439678284183, "y": 0.6551608579088471, "term": "average", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 3.102291017679908e-07}, {"x": 0.545911528150134, "y": 0.47101206434316356, "term": "enough", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 2.8603919559342316e-07}, {"x": 0.5460790884718498, "y": 0.780328418230563, "term": "abnormal", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 7, "s": 0.7473190348525469, "os": 0.7189906106798993, "bg": 1.0759451183785226e-05}, {"x": 0.5462466487935657, "y": 0.5400469168900804, "term": "tract", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 4.187459011218525e-06}, {"x": 0.5464142091152815, "y": 0.9381702412868632, "term": "hypertension", "cat25k": 10, "ncat25k": 1, "cat": 62, "ncat": 7, "s": 0.9874329758713137, "os": 0.9239622388401774, "bg": 3.076972473136693e-05}, {"x": 0.5465817694369973, "y": 0.704088471849866, "term": "listed", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 7, "s": 0.6556635388739946, "os": 0.6438261840580721, "bg": 3.0440531052990306e-07}, {"x": 0.5467493297587132, "y": 0.7902144772117963, "term": "president", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 7, "s": 0.7561997319034853, "os": 0.7303666977893609, "bg": 4.208003101158019e-07}, {"x": 0.546916890080429, "y": 0.6229892761394102, "term": "31", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 0.0}, {"x": 0.5470844504021448, "y": 0.6233243967828418, "term": "strict", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 3.501219533117044e-06}, {"x": 0.5472520107238605, "y": 0.6236595174262735, "term": "jurisdiction", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 2.3130562852177278e-06}, {"x": 0.5474195710455764, "y": 0.3837131367292225, "term": "note", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 1.3176074725400723e-07}, {"x": 0.5475871313672922, "y": 0.766588471849866, "term": "remaining", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 7, "s": 0.7210120643431636, "os": 0.7066403195924121, "bg": 2.0538171989732964e-06}, {"x": 0.547754691689008, "y": 0.6809651474530831, "term": "modified", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 6.430888358756715e-07}, {"x": 0.5479222520107239, "y": 0.6813002680965148, "term": "ill", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 2.0661231101885938e-06}, {"x": 0.5480898123324397, "y": 0.681970509383378, "term": "physiological", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 9.592621130117982e-06}, {"x": 0.5482573726541555, "y": 0.5893096514745308, "term": "seen", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 3.558842706041296e-07}, {"x": 0.5484249329758714, "y": 0.3875670241286863, "term": "arise", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 2.543628724551717e-06}, {"x": 0.5485924932975871, "y": 0.6266756032171582, "term": "institutionalize", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 6.798065723699417e-05}, {"x": 0.5487600536193029, "y": 0.5899798927613941, "term": "raise", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 1.3076831898353412e-06}, {"x": 0.5489276139410187, "y": 0.8029490616621984, "term": "governmental", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 7, "s": 0.7617292225201072, "os": 0.740895335176513, "bg": 5.176894484536616e-06}, {"x": 0.5490951742627346, "y": 0.8114946380697051, "term": "light", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 7, "s": 0.7841823056300268, "os": 0.7506815458112462, "bg": 4.094113754871946e-07}, {"x": 0.5492627345844504, "y": 0.47587131367292224, "term": "eyes", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 4.970254682476937e-07}, {"x": 0.5494302949061662, "y": 0.6846514745308311, "term": "respect", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 6.989894175469204e-07}, {"x": 0.5495978552278821, "y": 0.23190348525469168, "term": "calendar", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 1.7713785263299773e-07}, {"x": 0.5497654155495979, "y": 0.31417560321715815, "term": "going", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 1.2853796903633438e-07}, {"x": 0.5499329758713136, "y": 0.5470844504021448, "term": "guarantee", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 6.513710056927822e-07}, {"x": 0.5501005361930295, "y": 0.547754691689008, "term": "refuse", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 3.1635138803430075e-06}, {"x": 0.5502680965147453, "y": 0.5919906166219839, "term": "july", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 1.7836724357937803e-07}, {"x": 0.5504356568364611, "y": 0.9103552278820375, "term": "economic", "cat25k": 7, "ncat25k": 1, "cat": 44, "ncat": 7, "s": 0.9735254691689008, "os": 0.8825316649856492, "bg": 1.0925881242483503e-06}, {"x": 0.550603217158177, "y": 0.8186997319034852, "term": "sharing", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 7, "s": 0.7897117962466488, "os": 0.7598130025762758, "bg": 1.7708976001090873e-06}, {"x": 0.5507707774798928, "y": 0.5487600536193029, "term": "de\ufb01nes", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 0.0}, {"x": 0.5509383378016086, "y": 0.958612600536193, "term": "blindness", "cat25k": 14, "ncat25k": 1, "cat": 87, "ncat": 7, "s": 0.9938002680965148, "os": 0.9542239602974041, "bg": 8.850936575035934e-05}, {"x": 0.5511058981233244, "y": 0.7706099195710456, "term": "ability", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 7, "s": 0.7210120643431636, "os": 0.7066403195924121, "bg": 8.410385847859026e-07}, {"x": 0.5512734584450402, "y": 0.4829088471849866, "term": "promulgated", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 1.390573188474234e-05}, {"x": 0.551441018766756, "y": 0.6875, "term": "institutionalized", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 3.312474486639524e-05}, {"x": 0.5516085790884718, "y": 0.6611930294906166, "term": "organizational", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 2.7825099770373365e-06}, {"x": 0.5517761394101877, "y": 0.31735924932975873, "term": "outputs", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 3.1470807049964307e-06}, {"x": 0.5519436997319035, "y": 0.9286193029490617, "term": "agenda", "cat25k": 9, "ncat25k": 1, "cat": 54, "ncat": 7, "s": 0.9832439678284183, "os": 0.9083991582823283, "bg": 5.016878712721558e-06}, {"x": 0.5521112600536193, "y": 0.6615281501340483, "term": "stages", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 2.472037203541904e-06}, {"x": 0.5522788203753352, "y": 0.5512734584450402, "term": "periodically", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 3.3222994656847995e-06}, {"x": 0.552446380697051, "y": 0.9594504021447721, "term": "communicable", "cat25k": 14, "ncat25k": 1, "cat": 89, "ncat": 7, "s": 0.9939678284182306, "os": 0.9558121647283966, "bg": 0.00016038773735505582}, {"x": 0.5526139410187667, "y": 0.7478217158176944, "term": "master", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 7, "s": 0.6933646112600537, "os": 0.6783654032843591, "bg": 6.449919903282162e-07}, {"x": 0.5527815013404825, "y": 0.7479892761394102, "term": "matters", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 7, "s": 0.6933646112600537, "os": 0.6783654032843591, "bg": 1.3241114268896176e-06}, {"x": 0.5529490616621984, "y": 0.5940013404825737, "term": "5%", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 0.0}, {"x": 0.5531166219839142, "y": 0.9081769436997319, "term": "burden", "cat25k": 7, "ncat25k": 1, "cat": 43, "ncat": 7, "s": 0.9715147453083111, "os": 0.8794444055687329, "bg": 9.965936429284704e-06}, {"x": 0.55328418230563, "y": 0.9450402144772118, "term": "filipinos", "cat25k": 11, "ncat25k": 1, "cat": 67, "ncat": 7, "s": 0.9897788203753352, "os": 0.9319347492844334, "bg": 0.0001965500160028898}, {"x": 0.5534517426273459, "y": 0.7483243967828418, "term": "generation", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 7, "s": 0.6933646112600537, "os": 0.6783654032843591, "bg": 9.944260925871352e-07}, {"x": 0.5536193029490617, "y": 0.48424932975871315, "term": "incentive", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 2.8386916990385943e-06}, {"x": 0.5537868632707775, "y": 0.39544235924932974, "term": "convene", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 1.875254651057729e-05}, {"x": 0.5539544235924933, "y": 0.5948391420911529, "term": "resolutions", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 3.6233131212849717e-06}, {"x": 0.5541219839142091, "y": 0.7724530831099196, "term": "counterpart", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 7, "s": 0.7210120643431636, "os": 0.7066403195924121, "bg": 1.9899012511504118e-05}, {"x": 0.5542895442359249, "y": 0.7957439678284183, "term": "clearly", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 7, "s": 0.7561997319034853, "os": 0.7303666977893609, "bg": 1.4701082431511258e-06}, {"x": 0.5544571045576407, "y": 0.3195375335120643, "term": "resolved", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 1.8476931735497547e-06}, {"x": 0.5546246648793566, "y": 0.6332104557640751, "term": "5.3", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 0.0}, {"x": 0.5547922252010724, "y": 0.7117962466487936, "term": "procure", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 7, "s": 0.6556635388739946, "os": 0.6438261840580721, "bg": 2.5672915644504287e-05}, {"x": 0.5549597855227882, "y": 0.2367627345844504, "term": "late", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 2.731967903869699e-07}, {"x": 0.5551273458445041, "y": 0.8207104557640751, "term": "direction", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 7, "s": 0.7897117962466488, "os": 0.7598130025762758, "bg": 1.5798456169011884e-06}, {"x": 0.5552949061662198, "y": 0.8783512064343163, "term": "consumer", "cat25k": 5, "ncat25k": 1, "cat": 31, "ncat": 7, "s": 0.8887399463806971, "os": 0.8321086190707532, "bg": 1.1180119910905037e-06}, {"x": 0.5554624664879356, "y": 0.4876005361930295, "term": "n.", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 0.0}, {"x": 0.5556300268096515, "y": 0.39896112600536193, "term": "bids", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 7.522551841067627e-07}, {"x": 0.5557975871313673, "y": 0.6642091152815014, "term": "location", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 1.512606826320868e-07}, {"x": 0.5559651474530831, "y": 0.848357908847185, "term": "determined", "cat25k": 4, "ncat25k": 1, "cat": 24, "ncat": 7, "s": 0.8237265415549597, "os": 0.791107793797847, "bg": 1.7758472345174978e-06}, {"x": 0.556132707774799, "y": 0.15851206434316353, "term": "transported", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 4.85077206100816e-06}, {"x": 0.5563002680965148, "y": 0.9068364611260054, "term": "licensed", "cat25k": 7, "ncat25k": 1, "cat": 42, "ncat": 7, "s": 0.9690013404825737, "os": 0.8762493080464575, "bg": 3.703197628018786e-06}, {"x": 0.5564678284182306, "y": 0.32205093833780163, "term": "transition", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 9.8307764548775e-07}, {"x": 0.5566353887399463, "y": 0.1591823056300268, "term": "incurred", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 2.3327015599941685e-06}, {"x": 0.5568029490616622, "y": 0.6915214477211796, "term": "1.4", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 0.0}, {"x": 0.556970509383378, "y": 0.4917895442359249, "term": "baseline", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 2.504672257373442e-06}, {"x": 0.5571380697050938, "y": 0.5990281501340483, "term": "contribution", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 1.3474037574759857e-06}, {"x": 0.5573056300268097, "y": 0.32523458445040215, "term": "instead", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 3.5203947911534586e-07}, {"x": 0.5574731903485255, "y": 0.40382037533512066, "term": "matter", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 3.2862909252078575e-07}, {"x": 0.5576407506702413, "y": 0.5993632707774799, "term": "nchfd", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 8.975193207060913e-05}, {"x": 0.5578083109919572, "y": 0.6377345844504021, "term": "values", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 4.269960814284943e-07}, {"x": 0.5579758713136729, "y": 0.6680630026809652, "term": "enforce", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 6.1202506854680766e-06}, {"x": 0.5581434316353887, "y": 0.6012064343163539, "term": "expert", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 7.397783439137047e-07}, {"x": 0.5583109919571045, "y": 0.4061662198391421, "term": "bodies", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 1.0943401275771774e-06}, {"x": 0.5584785522788204, "y": 0.32808310991957107, "term": "isolated", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.0547234496341048e-06}, {"x": 0.5586461126005362, "y": 0.8294235924932976, "term": "throughout", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 7, "s": 0.8052949061662199, "os": 0.7683634175405367, "bg": 1.0879574552682892e-06}, {"x": 0.558813672922252, "y": 0.409014745308311, "term": "doing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 2.711566460358365e-07}, {"x": 0.5589812332439679, "y": 0.6928619302949062, "term": "utilizing", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 6.86880759318396e-06}, {"x": 0.5591487935656837, "y": 0.16353887399463807, "term": "streets", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 9.847115530605975e-07}, {"x": 0.5593163538873994, "y": 0.8297587131367292, "term": "2009", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 7, "s": 0.8052949061662199, "os": 0.7683634175405367, "bg": 0.0}, {"x": 0.5594839142091153, "y": 0.4118632707774799, "term": "labels", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 1.1739975968269194e-06}, {"x": 0.5596514745308311, "y": 0.6035522788203753, "term": "labeling", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 6.369928115361218e-06}, {"x": 0.5598190348525469, "y": 0.49865951742627346, "term": "april", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 1.5969260663686732e-07}, {"x": 0.5599865951742627, "y": 0.560656836461126, "term": "paci\ufb01c", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 0.0}, {"x": 0.5601541554959786, "y": 0.7168230563002681, "term": "coordinated", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 7, "s": 0.6556635388739946, "os": 0.6438261840580721, "bg": 6.561411899193384e-06}, {"x": 0.5603217158176944, "y": 0.5013404825737265, "term": "governments", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 1.3590594991152238e-06}, {"x": 0.5604892761394102, "y": 0.8086461126005362, "term": "pertinent", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 7, "s": 0.7617292225201072, "os": 0.740895335176513, "bg": 1.3400647465682953e-05}, {"x": 0.560656836461126, "y": 0.41823056300268097, "term": "ray", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 6.784686912295771e-07}, {"x": 0.5608243967828418, "y": 0.24932975871313673, "term": "x ray", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 0.0}, {"x": 0.5609919571045576, "y": 0.5073726541554959, "term": "prioritized", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 2.905762490238454e-05}, {"x": 0.5611595174262735, "y": 0.16722520107238606, "term": "gauge", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.5587809981868454e-06}, {"x": 0.5613270777479893, "y": 0.7181635388739946, "term": "run", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 7, "s": 0.6556635388739946, "os": 0.6438261840580721, "bg": 3.0631639726990404e-07}, {"x": 0.5614946380697051, "y": 0.6434316353887399, "term": "questions", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 1.910637156476674e-07}, {"x": 0.561662198391421, "y": 0.4232573726541555, "term": "4.4", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 0.0}, {"x": 0.5618297587131368, "y": 0.6442694369973191, "term": "substantial", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 7, "s": 0.5685321715817695, "os": 0.5739789301301984, "bg": 1.8832923717242483e-06}, {"x": 0.5619973190348525, "y": 0.7771447721179625, "term": "hundred", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 7, "s": 0.7210120643431636, "os": 0.7066403195924121, "bg": 2.3590633874970714e-06}, {"x": 0.5621648793565683, "y": 0.25251340482573725, "term": "crucial", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 1.7659278351628018e-06}, {"x": 0.5623324396782842, "y": 0.25335120643431636, "term": "geographical", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 2.4294799576676617e-06}, {"x": 0.5625, "y": 0.4281166219839142, "term": "occurs", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 7, "s": 0.4038203753351206, "os": 0.41807370367103724, "bg": 1.3323304518659287e-06}, {"x": 0.5626675603217158, "y": 0.2546916890080429, "term": "certified", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 4.890593749870094e-07}, {"x": 0.5628351206434317, "y": 0.609416890080429, "term": "decisions", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 8.851475808142113e-07}, {"x": 0.5630026809651475, "y": 0.17057640750670242, "term": "unknown", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 3.289616049378782e-07}, {"x": 0.5631702412868632, "y": 0.5135723860589813, "term": "emphasized", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 7.147256108819358e-06}, {"x": 0.563337801608579, "y": 0.7396112600536193, "term": "held", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 7, "s": 0.6710790884718498, "os": 0.6620176306353456, "bg": 4.972984653474054e-07}, {"x": 0.5635053619302949, "y": 0.6983914209115282, "term": "statements", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 9.790123930299384e-07}, {"x": 0.5636729222520107, "y": 0.3429959785522788, "term": "evidences", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.184192995293064e-05}, {"x": 0.5638404825737265, "y": 0.1734249329758713, "term": "sodium", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.8992876602924594e-06}, {"x": 0.5640080428954424, "y": 0.517426273458445, "term": "western paci\ufb01c", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 0.0}, {"x": 0.5641756032171582, "y": 0.5748994638069705, "term": "task force", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 0.0}, {"x": 0.564343163538874, "y": 0.348357908847185, "term": "involve", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 1.627574497339892e-06}, {"x": 0.5645107238605898, "y": 0.6124329758713136, "term": "legislative", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 1.4902729088876417e-06}, {"x": 0.5646782841823056, "y": 0.6126005361930295, "term": "kept", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 9.946594248829471e-07}, {"x": 0.5648458445040214, "y": 0.614946380697051, "term": "decrease", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 2.0237247028991448e-06}, {"x": 0.5650134048257373, "y": 0.2672587131367292, "term": "dying", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 1.9076843965088103e-06}, {"x": 0.5651809651474531, "y": 0.6159517426273459, "term": "pd", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 3.357607234780206e-06}, {"x": 0.5653485254691689, "y": 0.2679289544235925, "term": "aware", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 6.919804919935167e-07}, {"x": 0.5655160857908847, "y": 0.2687667560321716, "term": "disposition", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 2.985544986357718e-06}, {"x": 0.5656836461126006, "y": 0.5789209115281502, "term": "covering", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 7, "s": 0.4802278820375335, "os": 0.508094392168233, "bg": 1.6417765967650811e-06}, {"x": 0.5658512064343163, "y": 0.35472520107238603, "term": "conference", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 1.9550407490120836e-07}, {"x": 0.5660187667560321, "y": 0.3553954423592493, "term": "attainable", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.2563507813178668e-05}, {"x": 0.566186327077748, "y": 0.35573056300268097, "term": "considerations", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.0334376452954743e-06}, {"x": 0.5663538873994638, "y": 0.2706099195710456, "term": "domestic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 4.994921413652669e-07}, {"x": 0.5665214477211796, "y": 0.1779490616621984, "term": "bound", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 7.074760050669431e-07}, {"x": 0.5666890080428955, "y": 0.3590817694369973, "term": "male", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.987267861094853e-07}, {"x": 0.5668565683646113, "y": 0.2737935656836461, "term": "twice", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 8.885582574582741e-07}, {"x": 0.5670241286863271, "y": 0.3599195710455764, "term": "shared", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 6.38960753337284e-07}, {"x": 0.5671916890080428, "y": 0.6769436997319035, "term": "experiences", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 7, "s": 0.6005361930294907, "os": 0.6003404980908781, "bg": 1.3093042721248179e-06}, {"x": 0.5673592493297587, "y": 0.27597184986595175, "term": "portion", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 7.605019617148102e-07}, {"x": 0.5675268096514745, "y": 0.3607573726541555, "term": "45", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 0.0}, {"x": 0.5676943699731903, "y": 0.6189678284182306, "term": "ratio", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 7, "s": 0.5439008042895442, "os": 0.5435644868809641, "bg": 1.045950354788228e-06}, {"x": 0.5678619302949062, "y": 0.5296581769436998, "term": "protein", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 4.4804735083882955e-07}, {"x": 0.568029490616622, "y": 0.18247319034852547, "term": "ideally", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 3.6695631751996244e-06}, {"x": 0.5681970509383378, "y": 0.7019101876675603, "term": "night", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 2.598525025225181e-07}, {"x": 0.5683646112600537, "y": 0.2799932975871314, "term": "expression", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 5.715796680601886e-07}, {"x": 0.5685321715817694, "y": 0.1854892761394102, "term": "timeliness", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 7.7702266283724e-06}, {"x": 0.5686997319034852, "y": 0.2828418230563003, "term": "meaning", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 6.178518615722126e-07}, {"x": 0.568867292225201, "y": 0.3672922252010724, "term": "placing", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 2.1207259287268554e-06}, {"x": 0.5690348525469169, "y": 0.1895107238605898, "term": "big", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 7.373186571099171e-08}, {"x": 0.5692024128686327, "y": 0.28569034852546915, "term": "toxicity", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 3.561997758316077e-06}, {"x": 0.5693699731903485, "y": 0.3688002680965147, "term": "fail", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 6.566563563957722e-07}, {"x": 0.5695375335120644, "y": 0.19436997319034852, "term": "unreadable", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 2.0060432051555307e-05}, {"x": 0.5697050938337802, "y": 0.5348525469168901, "term": "measurement", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 7, "s": 0.4562667560321716, "os": 0.46845824993329155, "bg": 1.1552310982050403e-06}, {"x": 0.5698726541554959, "y": 0.19671581769436997, "term": "weekly", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 3.534714095754963e-07}, {"x": 0.5700402144772118, "y": 0.7029155495978552, "term": "finance", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 3.5099985094894567e-07}, {"x": 0.5702077747989276, "y": 0.19939678284182305, "term": "bleeding", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 2.7547588027887106e-06}, {"x": 0.5703753351206434, "y": 0.2935656836461126, "term": "augmentation", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 5.665884669658463e-06}, {"x": 0.5705428954423593, "y": 0.3721514745308311, "term": "chief executives", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 0.0}, {"x": 0.5707104557640751, "y": 0.7034182305630027, "term": "-to", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 7, "s": 0.636896782841823, "os": 0.6234230603619043, "bg": 0.0}, {"x": 0.5708780160857909, "y": 0.20341823056300268, "term": "introduction", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 2.6094271426740174e-07}, {"x": 0.5710455764075067, "y": 0.2965817694369973, "term": "crisis", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 9.09875055957316e-07}, {"x": 0.5712131367292225, "y": 0.29708445040214476, "term": "programme", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 3.129106191329477e-07}, {"x": 0.5713806970509383, "y": 0.2054289544235925, "term": "designation", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 2.4733993627904888e-06}, {"x": 0.5715482573726541, "y": 0.2064343163538874, "term": "protects", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 3.0840507927745316e-06}, {"x": 0.57171581769437, "y": 0.3739946380697051, "term": "muscle", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 7, "s": 0.35573056300268097, "os": 0.361113871594011, "bg": 9.494526144578182e-07}, {"x": 0.5718833780160858, "y": 0.20945040214477212, "term": "hypersensitivity", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.704392325547456e-05}, {"x": 0.5720509383378016, "y": 0.30060321715817695, "term": "manifestations", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 1.042657432583508e-05}, {"x": 0.5722184986595175, "y": 0.2102882037533512, "term": "sepsis", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.880295676495129e-05}, {"x": 0.5723860589812333, "y": 0.3012734584450402, "term": "vaccinator", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 5.769859535975074e-05}, {"x": 0.572553619302949, "y": 0.2112935656836461, "term": "carrier", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 6.887300772987592e-07}, {"x": 0.5727211796246648, "y": 0.30177613941018766, "term": "phos", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 2.9847825834619833e-05}, {"x": 0.5728887399463807, "y": 0.21866621983914208, "term": "envisioned", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.2016188810374778e-05}, {"x": 0.5730563002680965, "y": 0.2206769436997319, "term": "renewal", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 1.5315982112464494e-06}, {"x": 0.5732238605898123, "y": 0.22352546916890081, "term": "bonding", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 7, "s": 0.21732573726541557, "os": 0.22850563672012947, "bg": 4.842978528654694e-06}, {"x": 0.5733914209115282, "y": 0.30797587131367293, "term": "bhws", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 7, "s": 0.2863605898123324, "os": 0.2975585609642455, "bg": 5.769859535975074e-05}, {"x": 0.573558981233244, "y": 0.003853887399463807, "term": "preterm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.843514581541942e-05}, {"x": 0.5737265415549598, "y": 0.005529490616621984, "term": "gave", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.795253038466028e-07}, {"x": 0.5738941018766756, "y": 0.005864611260053619, "term": "pfpp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5740616621983914, "y": 0.006367292225201072, "term": "married", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.587963817744317e-07}, {"x": 0.5742292225201072, "y": 0.00653485254691689, "term": "contraceptive", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 8.878009803859398e-06}, {"x": 0.574396782841823, "y": 0.008210455764075067, "term": "cycles", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.6007001004896656e-06}, {"x": 0.5745643431635389, "y": 0.014410187667560321, "term": "condom", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.581291510855612e-06}, {"x": 0.5747319034852547, "y": 0.02379356568364611, "term": "registries assists", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5748994638069705, "y": 0.02396112600536193, "term": "oversees content", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5750670241286864, "y": 0.025636729222520107, "term": "unreadable text", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5752345844504021, "y": 0.02781501340482574, "term": "delays", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.456265133455257e-06}, {"x": 0.5754021447721179, "y": 0.029993297587131366, "term": "arrange", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.7413316510411174e-06}, {"x": 0.5755697050938338, "y": 0.03133378016085791, "term": "remind", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 2.384952449158776e-06}, {"x": 0.5757372654155496, "y": 0.03200402144772118, "term": "evacuation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.16345849925554e-06}, {"x": 0.5759048257372654, "y": 0.037868632707774796, "term": "alimentarius", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.389321699890089e-05}, {"x": 0.5760723860589813, "y": 0.038036193029490614, "term": "codex alimentarius", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5762399463806971, "y": 0.03853887399463807, "term": "goiter", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.0292408289733905e-05}, {"x": 0.5764075067024129, "y": 0.039544235924932974, "term": "interfere", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.5525375902883775e-06}, {"x": 0.5765750670241286, "y": 0.045576407506702415, "term": "minimal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.1570373199908198e-06}, {"x": 0.5767426273458445, "y": 0.04607908847184987, "term": "marketed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.549290582655693e-06}, {"x": 0.5769101876675603, "y": 0.04758713136729222, "term": "refrigerator", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 2.318316438602287e-06}, {"x": 0.5770777479892761, "y": 0.04943029490616622, "term": "assessors", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.183278916589824e-05}, {"x": 0.577245308310992, "y": 0.05227882037533512, "term": "nasopharyngeal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.0256728339964596e-05}, {"x": 0.5774128686327078, "y": 0.05311662198391421, "term": "cif", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.36666432381354e-05}, {"x": 0.5775804289544236, "y": 0.05378686327077748, "term": "drus", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.1792292307233054e-05}, {"x": 0.5777479892761395, "y": 0.05462466487935657, "term": "pesu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5779155495978552, "y": 0.0578083109919571, "term": "-3", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.578083109919571, "y": 0.05847855227882037, "term": "sealed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 9.967362583175863e-07}, {"x": 0.5782506702412868, "y": 0.058981233243967826, "term": "plastic bag", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5784182305630027, "y": 0.0596514745308311, "term": "fine", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.9367944024538963e-07}, {"x": 0.5785857908847185, "y": 0.06283512064343164, "term": "orally", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 8.138650042117514e-06}, {"x": 0.5787533512064343, "y": 0.06685656836461126, "term": "115 mm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5789209115281502, "y": 0.06953753351206435, "term": "attachment", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 8.168360648525826e-07}, {"x": 0.579088471849866, "y": 0.07121313672922253, "term": "default", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 2.601087213581049e-07}, {"x": 0.5792560321715817, "y": 0.07171581769436998, "term": "neighboring", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.346396635392273e-06}, {"x": 0.5794235924932976, "y": 0.07238605898123325, "term": "nutrient(s", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5795911528150134, "y": 0.07707774798927614, "term": "nic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.3482986337984922e-06}, {"x": 0.5797587131367292, "y": 0.07875335120643431, "term": "rh", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.7864657862452854e-06}, {"x": 0.579926273458445, "y": 0.07925603217158177, "term": "presently", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 2.51492292389969e-06}, {"x": 0.5800938337801609, "y": 0.08042895442359249, "term": "earmarked", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.3663108728091449e-05}, {"x": 0.5802613941018767, "y": 0.08160187667560322, "term": "traveling expenses", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5804289544235925, "y": 0.08210455764075067, "term": "overhead", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.8865460831328093e-06}, {"x": 0.5805965147453083, "y": 0.08562332439678284, "term": "dhl", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 9.862189983818963e-06}, {"x": 0.5807640750670241, "y": 0.09349865951742628, "term": "metabolism", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 9.521312608156159e-07}, {"x": 0.5809316353887399, "y": 0.09517426273458444, "term": "monitors", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 7.621650801656119e-07}, {"x": 0.5810991957104558, "y": 0.09701742627345844, "term": "rehydration", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.069960002806821e-05}, {"x": 0.5812667560321716, "y": 0.0985254691689008, "term": "usaid", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.3786140925067836e-06}, {"x": 0.5814343163538874, "y": 0.10053619302949061, "term": "deprived", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.67269444477085e-06}, {"x": 0.5816018766756033, "y": 0.10338471849865952, "term": "cvdpv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5817694369973191, "y": 0.10405495978552279, "term": "headache", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.090523417668567e-06}, {"x": 0.5819369973190348, "y": 0.10539544235924933, "term": "af", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.242955328718181e-06}, {"x": 0.5821045576407506, "y": 0.10740616621983914, "term": "ice", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 3.331896730526355e-07}, {"x": 0.5822721179624665, "y": 0.10924932975871314, "term": "episo", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5824396782841823, "y": 0.11796246648793565, "term": "host", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 2.787149346252222e-07}, {"x": 0.5826072386058981, "y": 0.11913538873994638, "term": "immune globulin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.582774798927614, "y": 0.1203083109919571, "term": "puri\ufb01ed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5829423592493298, "y": 0.12047587131367292, "term": "pvrv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5831099195710456, "y": 0.12064343163538874, "term": "pcecv", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5832774798927614, "y": 0.12851876675603216, "term": "breathing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.9745516956674246e-06}, {"x": 0.5834450402144772, "y": 0.13605898123324398, "term": "ifpmhp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.583612600536193, "y": 0.14225871313672922, "term": "investigations", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 1.4811747450818914e-06}, {"x": 0.5837801608579088, "y": 0.14661528150134048, "term": "nfpmc", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.4876972984062266e-05}, {"x": 0.5839477211796247, "y": 0.149798927613941, "term": "kato", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 8.962334508892879e-06}, {"x": 0.5841152815013405, "y": 0.14996648793565684, "term": "katz", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 5.167189967679226e-06}, {"x": 0.5842828418230563, "y": 0.15030160857908847, "term": "kato katz", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 0.0}, {"x": 0.5844504021447721, "y": 0.15046916890080428, "term": "portal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 7, "s": 0.08294235924932976, "os": 0.15726697108112597, "bg": 4.5926298001838634e-07}, {"x": 0.5846179624664879, "y": 0.3790214477211796, "term": "inappropriate", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 2.938672476748672e-06}, {"x": 0.5847855227882037, "y": 0.8314343163538874, "term": "secondary", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 8, "s": 0.7892091152815014, "os": 0.759445147995417, "bg": 2.0606422279993475e-06}, {"x": 0.5849530831099196, "y": 0.7801608579088471, "term": "manner", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 8, "s": 0.710455764075067, "os": 0.6979947529849143, "bg": 1.679446496420942e-06}, {"x": 0.5851206434316354, "y": 0.7999329758713136, "term": "illnesses", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 8, "s": 0.7474865951742627, "os": 0.7214169209993817, "bg": 1.5885817630813597e-05}, {"x": 0.5852882037533512, "y": 0.5410522788203753, "term": "wherein", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 5.9474247650767225e-06}, {"x": 0.585455764075067, "y": 0.5415549597855228, "term": "released", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 5.297184238205597e-07}, {"x": 0.5856233243967829, "y": 0.8016085790884718, "term": "volume", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 8, "s": 0.7474865951742627, "os": 0.7214169209993817, "bg": 6.9709341805199e-07}, {"x": 0.5857908847184986, "y": 0.22771447721179625, "term": "allowable", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 6.586977413913145e-06}, {"x": 0.5859584450402144, "y": 0.7907171581769437, "term": "thereby", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 8, "s": 0.723357908847185, "os": 0.7101524875611589, "bg": 5.783067871241151e-06}, {"x": 0.5861260053619303, "y": 0.8708109919571045, "term": "personal", "cat25k": 5, "ncat25k": 1, "cat": 30, "ncat": 8, "s": 0.8384718498659518, "os": 0.8136600169956084, "bg": 3.5351484131123456e-07}, {"x": 0.5862935656836461, "y": 0.3109919571045576, "term": "validate", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 5.461848984840887e-06}, {"x": 0.5864611260053619, "y": 0.7910522788203753, "term": "convention", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 8, "s": 0.723357908847185, "os": 0.7101524875611589, "bg": 1.7677674059328538e-06}, {"x": 0.5866286863270778, "y": 0.4738605898123324, "term": "involving", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 1.5579807323324386e-06}, {"x": 0.5867962466487936, "y": 0.625837801608579, "term": "mean", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 3.969034338286626e-07}, {"x": 0.5869638069705094, "y": 0.7449731903485255, "term": "notice", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 8, "s": 0.666387399463807, "os": 0.6547462474662054, "bg": 3.684088886749388e-07}, {"x": 0.5871313672922251, "y": 0.8185321715817694, "term": "consideration", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 8, "s": 0.7620643431635389, "os": 0.7416767714402845, "bg": 2.5634313066097754e-06}, {"x": 0.587298927613941, "y": 0.707774798927614, "term": "damage", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 8, "s": 0.6300268096514745, "os": 0.6182673404298341, "bg": 1.0602120954296905e-06}, {"x": 0.5874664879356568, "y": 0.7583780160857909, "term": "of\ufb01cers", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 8, "s": 0.6836461126005363, "os": 0.670461856946621, "bg": 0.0}, {"x": 0.5876340482573726, "y": 0.7273793565683646, "term": "creation", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 1.3467101151262076e-06}, {"x": 0.5878016085790885, "y": 0.387902144772118, "term": "extended", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 6.673421466800798e-07}, {"x": 0.5879691689008043, "y": 0.8845509383378016, "term": "division", "cat25k": 5, "ncat25k": 1, "cat": 33, "ncat": 8, "s": 0.8473525469168901, "os": 0.8292136710214568, "bg": 1.1675378183653158e-06}, {"x": 0.5881367292225201, "y": 0.6271782841823056, "term": "involvement", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 2.070822518408803e-06}, {"x": 0.588304289544236, "y": 0.7081099195710456, "term": "irr", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 8, "s": 0.6300268096514745, "os": 0.6182673404298341, "bg": 3.350485467710137e-05}, {"x": 0.5884718498659517, "y": 0.477044235924933, "term": "original", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 2.2854098389864603e-07}, {"x": 0.5886394101876675, "y": 0.8037868632707775, "term": "certificate", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 8, "s": 0.7474865951742627, "os": 0.7214169209993817, "bg": 1.1742149266743423e-06}, {"x": 0.5888069705093834, "y": 0.3914209115281501, "term": "representing", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 1.9152240441056948e-06}, {"x": 0.5889745308310992, "y": 0.7468163538873994, "term": "paramedical", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 8, "s": 0.666387399463807, "os": 0.6547462474662054, "bg": 0.00010037881051109543}, {"x": 0.589142091152815, "y": 0.8406501340482574, "term": "classi\ufb01cation", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 8, "s": 0.8047922252010724, "os": 0.7675524452437785, "bg": 0.0}, {"x": 0.5893096514745308, "y": 0.8512064343163539, "term": "business", "cat25k": 4, "ncat25k": 1, "cat": 25, "ncat": 8, "s": 0.8118297587131367, "os": 0.7824545139897876, "bg": 1.0353815493254035e-07}, {"x": 0.5894772117962467, "y": 0.8719839142091153, "term": "tertiary", "cat25k": 5, "ncat25k": 1, "cat": 30, "ncat": 8, "s": 0.8384718498659518, "os": 0.8136600169956084, "bg": 2.548781497992667e-05}, {"x": 0.5896447721179625, "y": 0.8513739946380697, "term": "processes", "cat25k": 4, "ncat25k": 1, "cat": 25, "ncat": 8, "s": 0.8118297587131367, "os": 0.7824545139897876, "bg": 1.659858313488386e-06}, {"x": 0.5898123324396782, "y": 0.8411528150134048, "term": "capabilities", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 8, "s": 0.8047922252010724, "os": 0.7675524452437785, "bg": 3.3905868558978706e-06}, {"x": 0.5899798927613941, "y": 0.631367292225201, "term": "allocated", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 1.9325527028259356e-06}, {"x": 0.5901474530831099, "y": 0.8267426273458445, "term": "chair", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 8, "s": 0.7843498659517427, "os": 0.7508384893287885, "bg": 1.412017058821539e-06}, {"x": 0.5903150134048257, "y": 0.3946045576407507, "term": "details", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 8.536677889908228e-08}, {"x": 0.5904825737265416, "y": 0.7310656836461126, "term": "priorities", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 3.4482015473804445e-06}, {"x": 0.5906501340482574, "y": 0.6885053619302949, "term": "1999", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 8, "s": 0.5981903485254692, "os": 0.5968779690592753, "bg": 0.0}, {"x": 0.5908176943699732, "y": 0.8574061662198391, "term": "addressing", "cat25k": 4, "ncat25k": 1, "cat": 26, "ncat": 8, "s": 0.8222184986595175, "os": 0.7893270499387341, "bg": 7.017279534878201e-06}, {"x": 0.590985254691689, "y": 0.7955764075067024, "term": "accounting", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 8, "s": 0.723357908847185, "os": 0.7101524875611589, "bg": 1.2156187166188062e-06}, {"x": 0.5911528150134048, "y": 0.31936997319034854, "term": "mop", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 1.0231948981642023e-05}, {"x": 0.5913203753351206, "y": 0.7319034852546917, "term": "requiring", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 3.364156859869073e-06}, {"x": 0.5914879356568364, "y": 0.8736595174262735, "term": "reform", "cat25k": 5, "ncat25k": 1, "cat": 30, "ncat": 8, "s": 0.8384718498659518, "os": 0.8136600169956084, "bg": 3.295259643262995e-06}, {"x": 0.5916554959785523, "y": 0.914544235924933, "term": "article", "cat25k": 7, "ncat25k": 1, "cat": 46, "ncat": 8, "s": 0.9713471849865952, "os": 0.879013442237008, "bg": 5.924906224369637e-07}, {"x": 0.5918230563002681, "y": 0.4877680965147453, "term": "quantities", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 3.411704113399796e-06}, {"x": 0.5919906166219839, "y": 0.15767426273458446, "term": "contracts", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 7.374755450036463e-07}, {"x": 0.5921581769436998, "y": 0.23827077747989275, "term": "lines", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 2.593417895008796e-07}, {"x": 0.5923257372654156, "y": 0.6343833780160858, "term": "starting", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 4.678897568097663e-07}, {"x": 0.5924932975871313, "y": 0.32171581769436997, "term": "instances", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 2.4585340297987736e-06}, {"x": 0.5926608579088471, "y": 0.795911528150134, "term": "inventory", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 8, "s": 0.723357908847185, "os": 0.7101524875611589, "bg": 2.1861206262011366e-06}, {"x": 0.592828418230563, "y": 0.6358914209115282, "term": "gazette", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 4.8034048935588e-06}, {"x": 0.5929959785522788, "y": 0.23994638069705093, "term": "qualify", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 2.0446920611968157e-06}, {"x": 0.5931635388739946, "y": 0.7746313672922251, "term": "1.3", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 8, "s": 0.6988941018766756, "os": 0.6848158465208438, "bg": 0.0}, {"x": 0.5933310991957105, "y": 0.49095174262734587, "term": "opd", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 5.028449419600895e-05}, {"x": 0.5934986595174263, "y": 0.7337466487935657, "term": "association", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 3.645365601599288e-07}, {"x": 0.5936662198391421, "y": 0.6367292225201072, "term": "sign", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 1.319029823392088e-07}, {"x": 0.5938337801608579, "y": 0.24212466487935658, "term": "depend", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 1.8982186546678997e-06}, {"x": 0.5940013404825737, "y": 0.5563002680965148, "term": "analyze", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 3.091637231703856e-06}, {"x": 0.5941689008042895, "y": 0.5564678284182306, "term": "5.1", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 0.0}, {"x": 0.5943364611260054, "y": 0.40449061662198393, "term": "earlier", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 6.978433007406588e-07}, {"x": 0.5945040214477212, "y": 0.82171581769437, "term": "bureaus", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 8, "s": 0.7620643431635389, "os": 0.7416767714402845, "bg": 3.577152471652664e-05}, {"x": 0.594671581769437, "y": 0.16169571045576409, "term": "nnc", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 4.242061453330254e-05}, {"x": 0.5948391420911529, "y": 0.5568029490616622, "term": "becomes", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 1.0081208454619873e-06}, {"x": 0.5950067024128687, "y": 0.8582439678284183, "term": "2016", "cat25k": 4, "ncat25k": 1, "cat": 26, "ncat": 8, "s": 0.8222184986595175, "os": 0.7893270499387341, "bg": 0.0}, {"x": 0.5951742627345844, "y": 0.6008713136729222, "term": "grants", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 8, "s": 0.4832439678284183, "os": 0.5145364113355444, "bg": 1.2366164097513634e-06}, {"x": 0.5953418230563002, "y": 0.7148123324396782, "term": "official", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 8, "s": 0.6300268096514745, "os": 0.6182673404298341, "bg": 3.6597223659492577e-07}, {"x": 0.5955093833780161, "y": 0.775804289544236, "term": "warning", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 8, "s": 0.6988941018766756, "os": 0.6848158465208438, "bg": 7.821709638005837e-07}, {"x": 0.5956769436997319, "y": 0.5586461126005362, "term": "reliable", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 1.3550283043635543e-06}, {"x": 0.5958445040214477, "y": 0.16337131367292226, "term": "possibility", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 1.0442064208136794e-06}, {"x": 0.5960120643431636, "y": 0.86578418230563, "term": "industry", "cat25k": 4, "ncat25k": 1, "cat": 28, "ncat": 8, "s": 0.8294235924932977, "os": 0.8020740979714034, "bg": 4.4685909445394736e-07}, {"x": 0.5961796246648794, "y": 0.829926273458445, "term": "designed", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 8, "s": 0.7843498659517427, "os": 0.7508384893287885, "bg": 6.915343038214472e-07}, {"x": 0.5963471849865952, "y": 0.24681635388739948, "term": "trials", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 1.2685405928866966e-06}, {"x": 0.596514745308311, "y": 0.7622319034852547, "term": "ef\ufb01cacy", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 8, "s": 0.6836461126005363, "os": 0.670461856946621, "bg": 0.0}, {"x": 0.5966823056300268, "y": 0.24748659517426275, "term": "slow", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 7.35775428389608e-07}, {"x": 0.5968498659517426, "y": 0.4152144772117963, "term": "frequency", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 7.968007123398368e-07}, {"x": 0.5970174262734584, "y": 0.1657171581769437, "term": "offense", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 2.102629092373285e-06}, {"x": 0.5971849865951743, "y": 0.3339477211796247, "term": "audit", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 1.0427424391575192e-06}, {"x": 0.5973525469168901, "y": 0.16605227882037535, "term": "delayed", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 1.8196905070385628e-06}, {"x": 0.5975201072386059, "y": 0.3342828418230563, "term": "verbal", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 3.948675120780101e-06}, {"x": 0.5976876675603218, "y": 0.8790214477211796, "term": "60", "cat25k": 5, "ncat25k": 1, "cat": 31, "ncat": 8, "s": 0.8426608579088473, "os": 0.8190705875991862, "bg": 0.0}, {"x": 0.5978552278820375, "y": 0.41890080428954424, "term": "exam", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 1.2848099171907887e-06}, {"x": 0.5980227882037533, "y": 0.642426273458445, "term": "recovery", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 8.430636490397689e-07}, {"x": 0.5981903485254692, "y": 0.16739276139410186, "term": "bag", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 4.391980662987537e-07}, {"x": 0.598357908847185, "y": 0.7377680965147453, "term": "pressure", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 7.734065996873349e-07}, {"x": 0.5985254691689008, "y": 0.33696380697050937, "term": "nor", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 5.49106548734554e-07}, {"x": 0.5986930294906166, "y": 0.5090482573726541, "term": "regards", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 1.9619842905427076e-06}, {"x": 0.5988605898123325, "y": 0.2510053619302949, "term": "-the", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 0.0}, {"x": 0.5990281501340483, "y": 0.16823056300268097, "term": "2.5", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 0.0}, {"x": 0.599195710455764, "y": 0.6074061662198391, "term": "indicate", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 8, "s": 0.4832439678284183, "os": 0.5145364113355444, "bg": 1.222276029529211e-06}, {"x": 0.5993632707774799, "y": 0.6439343163538874, "term": "4.3", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 0.0}, {"x": 0.5995308310991957, "y": 0.8366286863270778, "term": "thousand pesos", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 8, "s": 0.7892091152815014, "os": 0.759445147995417, "bg": 0.0}, {"x": 0.5996983914209115, "y": 0.5108914209115282, "term": "managing", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 1.0249782872147638e-06}, {"x": 0.5998659517426274, "y": 0.2528485254691689, "term": "mainly", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 1.20416083326003e-06}, {"x": 0.6000335120643432, "y": 0.25368632707774796, "term": "indications", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 5.701959706531538e-06}, {"x": 0.600201072386059, "y": 0.2550268096514745, "term": "49", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 0.0}, {"x": 0.6003686327077749, "y": 0.42912198391420914, "term": "outreach", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 2.4207772893971673e-06}, {"x": 0.6005361930294906, "y": 0.69671581769437, "term": "attainment", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 8, "s": 0.5981903485254692, "os": 0.5968779690592753, "bg": 1.043453157503747e-05}, {"x": 0.6007037533512064, "y": 0.25603217158176944, "term": "disseminated", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 1.295746323967679e-05}, {"x": 0.6008713136729222, "y": 0.6099195710455764, "term": "certification", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 8, "s": 0.4832439678284183, "os": 0.5145364113355444, "bg": 1.0706456617883885e-06}, {"x": 0.6010388739946381, "y": 0.2575402144772118, "term": "promotes", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 3.6665137119363177e-06}, {"x": 0.6012064343163539, "y": 0.5150804289544236, "term": "engaged", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 2.0574236434693735e-06}, {"x": 0.6013739946380697, "y": 0.5718833780160858, "term": "executives", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 3.2834452910000295e-06}, {"x": 0.6015415549597856, "y": 0.17174932975871313, "term": "supervised", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 5.211973872954083e-06}, {"x": 0.6017091152815014, "y": 0.6973860589812333, "term": "defined", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 8, "s": 0.5981903485254692, "os": 0.5968779690592753, "bg": 7.011373304445436e-07}, {"x": 0.6018766756032171, "y": 0.5160857908847185, "term": "degree", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 3.8609089149812413e-07}, {"x": 0.602044235924933, "y": 0.17258713136729223, "term": "undermine", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 7.97501516360522e-06}, {"x": 0.6022117962466488, "y": 0.6467828418230563, "term": "underlying", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 2.8287722916096493e-06}, {"x": 0.6023793565683646, "y": 0.5172587131367292, "term": "mdg", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 3.6123754425159916e-05}, {"x": 0.6025469168900804, "y": 0.7401139410187667, "term": "impaired", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 8, "s": 0.6482908847184987, "os": 0.6374413491197679, "bg": 6.75730578785202e-06}, {"x": 0.6027144772117963, "y": 0.3491957104557641, "term": "enhancing", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 3.366707607871607e-06}, {"x": 0.6028820375335121, "y": 0.5760723860589813, "term": "store", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 9.601507239119822e-08}, {"x": 0.6030495978552279, "y": 0.17459785522788204, "term": "reproduction", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 1.3085807053700736e-06}, {"x": 0.6032171581769437, "y": 0.3523793565683646, "term": "rather", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 2.97390131243672e-07}, {"x": 0.6033847184986595, "y": 0.578083109919571, "term": "hpcs", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 7.653974736416245e-05}, {"x": 0.6035522788203753, "y": 0.6164544235924933, "term": "die", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 8, "s": 0.4832439678284183, "os": 0.5145364113355444, "bg": 6.375190410999601e-07}, {"x": 0.6037198391420912, "y": 0.6514745308310992, "term": "preventing", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 4.354346958175681e-06}, {"x": 0.603887399463807, "y": 0.6179624664879356, "term": "ensures", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 8, "s": 0.4832439678284183, "os": 0.5145364113355444, "bg": 4.221670340458012e-06}, {"x": 0.6040549597855228, "y": 0.27412868632707776, "term": "boys", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 3.7190928968784434e-07}, {"x": 0.6042225201072386, "y": 0.5279825737265416, "term": "thrust", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 6.819419924404108e-06}, {"x": 0.6043900804289544, "y": 0.8093163538873994, "term": "surface", "cat25k": 3, "ncat25k": 1, "cat": 18, "ncat": 8, "s": 0.7474865951742627, "os": 0.7214169209993817, "bg": 1.0330939323572212e-06}, {"x": 0.6045576407506702, "y": 0.18146782841823056, "term": "you", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 6.007022227004435e-09}, {"x": 0.604725201072386, "y": 0.183813672922252, "term": "indicates", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 8.170484234642144e-07}, {"x": 0.6048927613941019, "y": 0.4545911528150134, "term": "consists", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 1.453707062036222e-06}, {"x": 0.6050603217158177, "y": 0.5819369973190348, "term": "documented", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 8, "s": 0.4607908847184987, "os": 0.4779427818020229, "bg": 3.473948857517476e-06}, {"x": 0.6052278820375335, "y": 0.3644436997319035, "term": "consent", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 8, "s": 0.3334450402144772, "os": 0.3349731834040748, "bg": 1.0350221381826066e-06}, {"x": 0.6053954423592494, "y": 0.18699731903485256, "term": "dark", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 3.5306735997588786e-07}, {"x": 0.6055630026809652, "y": 0.1873324396782842, "term": "telephone", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 2.847729979509001e-07}, {"x": 0.6057305630026809, "y": 0.532171581769437, "term": "too", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 8, "s": 0.42292225201072386, "os": 0.43532233265848563, "bg": 1.4738792459236964e-07}, {"x": 0.6058981233243967, "y": 0.702245308310992, "term": "toilet", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 8, "s": 0.5981903485254692, "os": 0.5968779690592753, "bg": 3.623724889222227e-06}, {"x": 0.6060656836461126, "y": 0.28367962466487934, "term": "grab", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 2.5244642676598584e-06}, {"x": 0.6062332439678284, "y": 0.2855227882037534, "term": "2nd", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 0.0}, {"x": 0.6064008042895442, "y": 0.653485254691689, "term": "january", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 8, "s": 0.5470844504021448, "os": 0.5456204808880888, "bg": 1.0300721848835362e-07}, {"x": 0.6065683646112601, "y": 0.19185656836461126, "term": "dc", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 2.471144310599337e-07}, {"x": 0.6067359249329759, "y": 0.2871983914209115, "term": "vehicles", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 5.323919082712168e-07}, {"x": 0.6069034852546917, "y": 0.19654825737265416, "term": "drink", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 6.087888203915034e-07}, {"x": 0.6070710455764075, "y": 0.4621313672922252, "term": "200", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 0.0}, {"x": 0.6072386058981233, "y": 0.19973190348525469, "term": "quickly", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 4.4473518046019415e-07}, {"x": 0.6074061662198391, "y": 0.29473860589812334, "term": "continuously", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 3.377029848216016e-06}, {"x": 0.607573726541555, "y": 0.20459115281501342, "term": "abused", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 4.956134083251487e-06}, {"x": 0.6077412868632708, "y": 0.46648793565683644, "term": "threatening", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 4.412614783142047e-06}, {"x": 0.6079088471849866, "y": 0.2052613941018767, "term": "usage", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 6.989647400247247e-07}, {"x": 0.6080764075067024, "y": 0.2984249329758713, "term": "strains", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 4.0474023670423265e-06}, {"x": 0.6082439678284183, "y": 0.467828418230563, "term": "vvm", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 8, "s": 0.3733243967828418, "os": 0.3877361052749111, "bg": 7.309028782346258e-05}, {"x": 0.608411528150134, "y": 0.299597855227882, "term": "egg", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 1.529227942511734e-06}, {"x": 0.6085790884718498, "y": 0.3007707774798928, "term": "generalized", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 5.6449400450917805e-06}, {"x": 0.6087466487935657, "y": 0.21347184986595175, "term": "10,000", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 0.0}, {"x": 0.6089142091152815, "y": 0.3054624664879357, "term": "preparedness", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 5.325200686844385e-06}, {"x": 0.6090817694369973, "y": 0.21715817694369974, "term": "garantisadong", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 5.769859535975074e-05}, {"x": 0.6092493297587132, "y": 0.21732573726541554, "term": "pambata", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 5.769859535975074e-05}, {"x": 0.609416890080429, "y": 0.21749329758713137, "term": "garantisadong pambata", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 0.0}, {"x": 0.6095844504021448, "y": 0.2225201072386059, "term": "manifestation", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 8, "s": 0.20727211796246653, "os": 0.21567545105480757, "bg": 9.824748322697133e-06}, {"x": 0.6097520107238605, "y": 0.3074731903485255, "term": "session", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 8, "s": 0.2605563002680965, "os": 0.2772596876081219, "bg": 3.60649757422465e-07}, {"x": 0.6099195710455764, "y": 0.004859249329758713, "term": "dif\ufb01cult", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6100871313672922, "y": 0.00871313672922252, "term": "classification", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 7.904123769093275e-07}, {"x": 0.610254691689008, "y": 0.009215817694369972, "term": "timing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.3798884705143705e-06}, {"x": 0.6104222520107239, "y": 0.011226541554959786, "term": "occurred", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 8.253476222328222e-07}, {"x": 0.6105898123324397, "y": 0.011729222520107238, "term": "abdominal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.702959601870956e-06}, {"x": 0.6107573726541555, "y": 0.014242627345844505, "term": "colored", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.523560675565848e-06}, {"x": 0.6109249329758714, "y": 0.015750670241286863, "term": "explain", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 6.325140694848331e-07}, {"x": 0.6110924932975871, "y": 0.016420911528150135, "term": "venues", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.6492453104998069e-06}, {"x": 0.6112600536193029, "y": 0.018096514745308313, "term": "8172", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6114276139410187, "y": 0.023626005361930293, "term": "protocols maintains", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6115951742627346, "y": 0.029155495978552277, "term": "rounds", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.648886019262368e-06}, {"x": 0.6117627345844504, "y": 0.031668900804289545, "term": "discarded", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 6.1556099728576075e-06}, {"x": 0.6119302949061662, "y": 0.032171581769437, "term": "died", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.4302630493605786e-07}, {"x": 0.6120978552278821, "y": 0.033847184986595176, "term": "exclusively breastfed", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6122654155495979, "y": 0.03987935656836461, "term": "phenylketonuria", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.015026235687059e-05}, {"x": 0.6124329758713136, "y": 0.047419571045576404, "term": "touch", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.307675739708694e-07}, {"x": 0.6126005361930295, "y": 0.05412198391420912, "term": "globulin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.4017208329768283e-05}, {"x": 0.6127680965147453, "y": 0.05697050938337802, "term": "ops", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 3.4730422460858813e-06}, {"x": 0.6129356568364611, "y": 0.05797587131367292, "term": "resus", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.772258859251173e-05}, {"x": 0.613103217158177, "y": 0.05948391420911528, "term": "esu", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.0169931674356454e-05}, {"x": 0.6132707774798928, "y": 0.06015415549597855, "term": "rectal", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 8.045974699432558e-06}, {"x": 0.6134383378016086, "y": 0.06166219839142091, "term": "125", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6136058981233244, "y": 0.06199731903485255, "term": "penicillin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.3125372740077426e-05}, {"x": 0.6137734584450402, "y": 0.06518096514745308, "term": "115", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.613941018766756, "y": 0.07640750670241286, "term": "pogs", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.5945061193078384e-05}, {"x": 0.6141085790884718, "y": 0.08277479892761394, "term": "fho", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 5.128780472168353e-05}, {"x": 0.6142761394101877, "y": 0.08495308310991957, "term": "stools", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 5.313757450884276e-06}, {"x": 0.6144436997319035, "y": 0.0861260053619303, "term": "represents", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 8.002178993339886e-07}, {"x": 0.6146112600536193, "y": 0.08646112600536193, "term": "falling", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.2661929258592602e-06}, {"x": 0.6147788203753352, "y": 0.09835790884718498, "term": "nausea", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 6.098853263115203e-06}, {"x": 0.614946380697051, "y": 0.1097520107238606, "term": "complicated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.8316263720312482e-06}, {"x": 0.6151139410187667, "y": 0.11243297587131368, "term": "unvaccinated", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.334445841099215e-05}, {"x": 0.6152815013404825, "y": 0.11310321715817695, "term": "tt", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.3442435500463975e-06}, {"x": 0.6154490616621984, "y": 0.11394101876675604, "term": "revisit", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.1783906718594416e-05}, {"x": 0.6156166219839142, "y": 0.11997319034852547, "term": "nrpcp", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 5.128780472168353e-05}, {"x": 0.61578418230563, "y": 0.12382707774798928, "term": "p.o", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6159517426273459, "y": 0.1317024128686327, "term": "vad", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.259172239291524e-05}, {"x": 0.6161193029490617, "y": 0.1343833780160858, "term": "hbsag", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 3.394519548189448e-05}, {"x": 0.6162868632707775, "y": 0.13471849865951743, "term": "hepb", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 4.7474645572099155e-05}, {"x": 0.6164544235924933, "y": 0.13522117962466487, "term": "multiplier", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 9.67281696612096e-06}, {"x": 0.6166219839142091, "y": 0.1353887399463807, "term": "reserve stock", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6167895442359249, "y": 0.13773458445040215, "term": "sputum", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.5532512463057645e-05}, {"x": 0.6169571045576407, "y": 0.14091823056300268, "term": "gestational", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.58648159036847e-05}, {"x": 0.6171246648793566, "y": 0.14242627345844505, "term": "raefic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 5.128780472168353e-05}, {"x": 0.6172922252010724, "y": 0.14745308310991956, "term": "ebm", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 2.3535849511778218e-05}, {"x": 0.6174597855227882, "y": 0.14912868632707774, "term": "japonicum", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 3.850448577259251e-05}, {"x": 0.6176273458445041, "y": 0.15164209115281502, "term": "eeg", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 1.3464737955160741e-05}, {"x": 0.6177949061662198, "y": 0.15180965147453082, "term": "kg/24", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 8, "s": 0.07355898123324396, "os": 0.15281080205967357, "bg": 0.0}, {"x": 0.6179624664879356, "y": 0.8230563002680965, "term": "1987", "cat25k": 3, "ncat25k": 1, "cat": 21, "ncat": 9, "s": 0.7580428954423593, "os": 0.7337600197796413, "bg": 0.0}, {"x": 0.6181300268096515, "y": 0.22553619302949063, "term": "demonstrated", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.8283057971089167e-06}, {"x": 0.6182975871313673, "y": 0.8490281501340483, "term": "smear", "cat25k": 4, "ncat25k": 1, "cat": 25, "ncat": 9, "s": 0.7965817694369974, "os": 0.7673137008161133, "bg": 4.245968983196578e-05}, {"x": 0.6184651474530831, "y": 0.7654155495978552, "term": "accurate", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 9, "s": 0.6739276139410187, "os": 0.663958845219141, "bg": 1.8855726118692551e-06}, {"x": 0.618632707774799, "y": 0.9425268096514745, "term": "pharmaceutical", "cat25k": 10, "ncat25k": 1, "cat": 65, "ncat": 9, "s": 0.985254691689008, "os": 0.9150560258186468, "bg": 1.2823027662389781e-05}, {"x": 0.6188002680965148, "y": 0.7808310991957105, "term": "mandated", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 9, "s": 0.6928619302949062, "os": 0.6778440879843974, "bg": 1.716445296716749e-05}, {"x": 0.6189678284182306, "y": 0.7570375335120644, "term": "tablet", "cat25k": 2, "ncat25k": 1, "cat": 14, "ncat": 9, "s": 0.6596849865951743, "os": 0.6488724343341541, "bg": 4.227932238746186e-06}, {"x": 0.6191353887399463, "y": 0.6797922252010724, "term": "letter", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 9, "s": 0.5650134048257373, "os": 0.5723032880724448, "bg": 5.616995135238766e-07}, {"x": 0.6193029490616622, "y": 0.623156836461126, "term": "february", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 2.6559008942769827e-07}, {"x": 0.619470509383378, "y": 0.6563337801608579, "term": "march", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 9, "s": 0.549597855227882, "os": 0.5476243056279355, "bg": 2.269957981312243e-07}, {"x": 0.6196380697050938, "y": 0.7434651474530831, "term": "requests", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 1.2037704937138832e-06}, {"x": 0.6198056300268097, "y": 0.7439678284182306, "term": "what", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 5.4140015562129116e-08}, {"x": 0.6199731903485255, "y": 0.5886394101876675, "term": "presented", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 9, "s": 0.4629691689008043, "os": 0.4847459646913398, "bg": 6.802486674513193e-07}, {"x": 0.6201407506702413, "y": 0.15382037533512063, "term": "reaching", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 1.9715641305451474e-06}, {"x": 0.6203083109919572, "y": 0.38505361930294907, "term": "ethics", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 9, "s": 0.3590817694369973, "os": 0.3621482642836723, "bg": 1.4694014941213485e-06}, {"x": 0.6204758713136729, "y": 0.31032171581769435, "term": "lives", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 5.573357400948376e-07}, {"x": 0.6206434316353887, "y": 0.8498659517426274, "term": "prohibited", "cat25k": 4, "ncat25k": 1, "cat": 25, "ncat": 9, "s": 0.7965817694369974, "os": 0.7673137008161133, "bg": 4.121815654946809e-06}, {"x": 0.6208109919571045, "y": 0.2290549597855228, "term": "counselor", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 4.389529217005754e-06}, {"x": 0.6209785522788204, "y": 0.4735254691689008, "term": "undergoing", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 1.0083720086014132e-05}, {"x": 0.6211461126005362, "y": 0.6828083109919572, "term": "adhere", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 9, "s": 0.5650134048257373, "os": 0.5723032880724448, "bg": 1.2806462005923325e-05}, {"x": 0.621313672922252, "y": 0.3128351206434316, "term": "updating", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 2.6693944912373232e-06}, {"x": 0.6214812332439679, "y": 0.5901474530831099, "term": "regulated", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 9, "s": 0.4629691689008043, "os": 0.4847459646913398, "bg": 3.939363349640656e-06}, {"x": 0.6216487935656837, "y": 0.9018096514745308, "term": "psychosocial", "cat25k": 6, "ncat25k": 1, "cat": 40, "ncat": 9, "s": 0.936662198391421, "os": 0.8484186737409825, "bg": 7.130586505292278e-05}, {"x": 0.6218163538873994, "y": 0.6273458445040214, "term": "near", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 4.1481251066235906e-07}, {"x": 0.6219839142091153, "y": 0.6280160857908847, "term": "tasks", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 1.6516602804898065e-06}, {"x": 0.6221514745308311, "y": 0.6281836461126006, "term": "subsequently", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 4.472384276727988e-06}, {"x": 0.6223190348525469, "y": 0.7920576407506702, "term": "institution", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 9, "s": 0.7014075067024129, "os": 0.6906785757843883, "bg": 2.106507959116245e-06}, {"x": 0.6224865951742627, "y": 0.7828418230563002, "term": "extent", "cat25k": 3, "ncat25k": 1, "cat": 16, "ncat": 9, "s": 0.6928619302949062, "os": 0.6778440879843974, "bg": 1.9818198155583715e-06}, {"x": 0.6226541554959786, "y": 0.8121648793565683, "term": "accessibility", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 9, "s": 0.7248659517426274, "os": 0.7136807062395826, "bg": 2.8994116938347587e-06}, {"x": 0.6228217158176944, "y": 0.846514745308311, "term": "x.", "cat25k": 4, "ncat25k": 1, "cat": 24, "ncat": 9, "s": 0.7895442359249331, "os": 0.7596212403102869, "bg": 0.0}, {"x": 0.6229892761394102, "y": 0.921916890080429, "term": "participating", "cat25k": 8, "ncat25k": 1, "cat": 50, "ncat": 9, "s": 0.9730227882037533, "os": 0.8815873073403442, "bg": 7.225098178675208e-06}, {"x": 0.623156836461126, "y": 0.6290214477211796, "term": "1991", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 0.0}, {"x": 0.6233243967828418, "y": 0.5921581769436998, "term": "seven", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 9, "s": 0.4629691689008043, "os": 0.4847459646913398, "bg": 7.18505668077909e-07}, {"x": 0.6234919571045576, "y": 0.7293900804289544, "term": "guided", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 9, "s": 0.6276809651474531, "os": 0.6143385581413292, "bg": 4.502747640935465e-06}, {"x": 0.6236595174262735, "y": 0.7704423592493298, "term": "specialized", "cat25k": 2, "ncat25k": 1, "cat": 15, "ncat": 9, "s": 0.6739276139410187, "os": 0.663958845219141, "bg": 4.259878502940248e-06}, {"x": 0.6238270777479893, "y": 0.5485924932975871, "term": "referrals", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 4.7375447579541e-06}, {"x": 0.6239946380697051, "y": 0.6296916890080428, "term": "open", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 1.4167711240209982e-07}, {"x": 0.624162198391421, "y": 0.6873324396782842, "term": "caregivers", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 9, "s": 0.5650134048257373, "os": 0.5723032880724448, "bg": 1.4623191149736861e-05}, {"x": 0.6243297587131368, "y": 0.7302278820375335, "term": "track", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 9, "s": 0.6276809651474531, "os": 0.6143385581413292, "bg": 3.7267999714030213e-07}, {"x": 0.6244973190348525, "y": 0.5501005361930295, "term": "incorporated", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 1.7808939992895418e-06}, {"x": 0.6246648793565683, "y": 0.7111260053619303, "term": "initially", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 9, "s": 0.5898123324396782, "os": 0.5944113055070378, "bg": 3.5836529877138937e-06}, {"x": 0.6248324396782842, "y": 0.873156836461126, "term": "usual", "cat25k": 5, "ncat25k": 1, "cat": 30, "ncat": 9, "s": 0.8289209115281502, "os": 0.8004351300618222, "bg": 4.493870101919245e-06}, {"x": 0.625, "y": 0.864946380697051, "term": "responsive", "cat25k": 4, "ncat25k": 1, "cat": 28, "ncat": 9, "s": 0.8220509383378016, "os": 0.7881405796457772, "bg": 1.59383281469152e-05}, {"x": 0.6251675603217158, "y": 0.48525469168900803, "term": "governing", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 2.7995442341986726e-06}, {"x": 0.6253351206434317, "y": 0.6323726541554959, "term": "circular", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 4.094707205552615e-06}, {"x": 0.6255026809651475, "y": 0.6327077747989276, "term": "step", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 3.9324883811450093e-07}, {"x": 0.6256702412868632, "y": 0.4867627345844504, "term": "effort", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 6.8225951290277e-07}, {"x": 0.625837801608579, "y": 0.6638739946380697, "term": "obtain", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 9, "s": 0.549597855227882, "os": 0.5476243056279355, "bg": 1.161888995255523e-06}, {"x": 0.6260053619302949, "y": 0.8141756032171582, "term": "2011", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 9, "s": 0.7248659517426274, "os": 0.7136807062395826, "bg": 0.0}, {"x": 0.6261729222520107, "y": 0.6345509383378016, "term": "material", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 3.4398927109604247e-07}, {"x": 0.6263404825737265, "y": 0.23877345844504022, "term": "applications", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 2.2080339314596156e-07}, {"x": 0.6265080428954424, "y": 0.814343163538874, "term": "pertaining", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 9, "s": 0.7248659517426274, "os": 0.7136807062395826, "bg": 1.154338333267371e-05}, {"x": 0.6266756032171582, "y": 0.8424932975871313, "term": "payment", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 9, "s": 0.7851876675603218, "os": 0.7514946028443537, "bg": 4.415067291868709e-07}, {"x": 0.626843163538874, "y": 0.8215482573726541, "term": "class", "cat25k": 3, "ncat25k": 1, "cat": 20, "ncat": 9, "s": 0.7484919571045577, "os": 0.724045442189418, "bg": 3.0303068775578435e-07}, {"x": 0.6270107238605898, "y": 0.49011394101876676, "term": "suf\ufb01cient", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 0.0}, {"x": 0.6271782841823056, "y": 0.4902815013404826, "term": "3.3", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 0.0}, {"x": 0.6273458445040214, "y": 0.6363941018766756, "term": "1s", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 0.0}, {"x": 0.6275134048257373, "y": 0.7131367292225201, "term": "4.2", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 9, "s": 0.5898123324396782, "os": 0.5944113055070378, "bg": 0.0}, {"x": 0.6276809651474531, "y": 0.713304289544236, "term": "instruments", "cat25k": 2, "ncat25k": 1, "cat": 11, "ncat": 9, "s": 0.5898123324396782, "os": 0.5944113055070378, "bg": 8.19592623945046e-07}, {"x": 0.6278485254691689, "y": 0.2406166219839142, "term": "calamities", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 3.7119900653647706e-05}, {"x": 0.6280160857908847, "y": 0.7510053619302949, "term": "paid", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 7.259898611885937e-07}, {"x": 0.6281836461126006, "y": 0.6382372654155496, "term": "strongly", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 2.0304543063875522e-06}, {"x": 0.6283512064343163, "y": 0.24497319034852547, "term": "widely", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.6285101796690867e-06}, {"x": 0.6285187667560321, "y": 0.796916890080429, "term": "leadership", "cat25k": 3, "ncat25k": 1, "cat": 17, "ncat": 9, "s": 0.7014075067024129, "os": 0.6906785757843883, "bg": 1.4277637614392362e-06}, {"x": 0.628686327077748, "y": 0.7520107238605898, "term": "efficacy", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 9.458726524354393e-06}, {"x": 0.6288538873994638, "y": 0.24648123324396784, "term": "mouth", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 9.48589918929625e-07}, {"x": 0.6290214477211796, "y": 0.7521782841823056, "term": "respiratory", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 5.483016356834705e-06}, {"x": 0.6291890080428955, "y": 0.33176943699731903, "term": "compared", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 6.866918602465326e-07}, {"x": 0.6293565683646113, "y": 0.33193699731903487, "term": "complied", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 1.1634378035845518e-05}, {"x": 0.6295241286863271, "y": 0.4984919571045576, "term": "generally", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 6.871539321009458e-07}, {"x": 0.6296916890080428, "y": 0.24832439678284182, "term": "fill", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 6.204175116565169e-07}, {"x": 0.6298592493297587, "y": 0.3332774798927614, "term": "via", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 2.462066303301927e-07}, {"x": 0.6300268096514745, "y": 0.604725201072386, "term": "approve", "cat25k": 1, "ncat25k": 1, "cat": 7, "ncat": 9, "s": 0.4629691689008043, "os": 0.4847459646913398, "bg": 3.291176787001004e-06}, {"x": 0.6301943699731903, "y": 0.501843163538874, "term": "enabling", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 2.9723953642521895e-06}, {"x": 0.6303619302949062, "y": 0.16789544235924933, "term": "disposable", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 4.921293749071107e-06}, {"x": 0.630529490616622, "y": 0.16806300268096513, "term": "weighing", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 5.523506940838821e-06}, {"x": 0.6306970509383378, "y": 0.7535187667560321, "term": "rest", "cat25k": 2, "ncat25k": 1, "cat": 13, "ncat": 9, "s": 0.6442694369973191, "os": 0.6324046788903058, "bg": 8.205283206562019e-07}, {"x": 0.6308646112600537, "y": 0.5083780160857909, "term": "1.5", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 0.0}, {"x": 0.6310321715817694, "y": 0.2511729222520107, "term": "potency", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.3999025158793488e-05}, {"x": 0.6311997319034852, "y": 0.8158512064343163, "term": "balance", "cat25k": 3, "ncat25k": 1, "cat": 19, "ncat": 9, "s": 0.7248659517426274, "os": 0.7136807062395826, "bg": 1.3344866157307425e-06}, {"x": 0.631367292225201, "y": 0.4234249329758713, "term": "make sure", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 9, "s": 0.3590817694369973, "os": 0.3621482642836723, "bg": 0.0}, {"x": 0.6315348525469169, "y": 0.738941018766756, "term": "offer", "cat25k": 2, "ncat25k": 1, "cat": 12, "ncat": 9, "s": 0.6276809651474531, "os": 0.6143385581413292, "bg": 3.319083769138252e-07}, {"x": 0.6317024128686327, "y": 0.5686997319034852, "term": "university", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 9.625074226968261e-08}, {"x": 0.6318699731903485, "y": 0.2531836461126005, "term": "supplied", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 6.557104015668854e-07}, {"x": 0.6320375335120644, "y": 0.5698726541554959, "term": "spread", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 1.2080920421165048e-06}, {"x": 0.6322050938337802, "y": 0.5130697050938338, "term": "achievement", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 2.1280433014250975e-06}, {"x": 0.6323726541554959, "y": 0.25636729222520105, "term": "recognize", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.5056151231647921e-06}, {"x": 0.6325402144772118, "y": 0.5142426273458445, "term": "donors", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 4.730544789811758e-06}, {"x": 0.6327077747989276, "y": 0.6737600536193029, "term": "undersecretary", "cat25k": 1, "ncat25k": 1, "cat": 9, "ncat": 9, "s": 0.549597855227882, "os": 0.5476243056279355, "bg": 5.873168917232367e-05}, {"x": 0.6328753351206434, "y": 0.4309651474530831, "term": "fnri", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 9, "s": 0.3590817694369973, "os": 0.3621482642836723, "bg": 8.334134692438375e-05}, {"x": 0.6330428954423593, "y": 0.5727211796246648, "term": "shows", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 3.5245764604581877e-07}, {"x": 0.6332104557640751, "y": 0.6980563002680965, "term": "1993", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 9, "s": 0.5650134048257373, "os": 0.5723032880724448, "bg": 0.0}, {"x": 0.6333780160857909, "y": 0.8441689008042895, "term": "across", "cat25k": 4, "ncat25k": 1, "cat": 23, "ncat": 9, "s": 0.7851876675603218, "os": 0.7514946028443537, "bg": 8.321507690763413e-07}, {"x": 0.6335455764075067, "y": 0.5164209115281502, "term": "desired", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 1.7953702402891468e-06}, {"x": 0.6337131367292225, "y": 0.698558981233244, "term": "continuum", "cat25k": 2, "ncat25k": 1, "cat": 10, "ncat": 9, "s": 0.5650134048257373, "os": 0.5723032880724448, "bg": 1.1420033021927065e-05}, {"x": 0.6338806970509383, "y": 0.26089142091152817, "term": "produced", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 5.591902213897631e-07}, {"x": 0.6340482573726541, "y": 0.5180965147453083, "term": "off", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 9.847100414371613e-08}, {"x": 0.63421581769437, "y": 0.34718498659517427, "term": "repeated", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 2.3239114217922466e-06}, {"x": 0.6343833780160858, "y": 0.5750670241286864, "term": "persistent", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 5.31492150038108e-06}, {"x": 0.6345509383378016, "y": 0.5219504021447721, "term": "offering", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 7.974510729590265e-07}, {"x": 0.6347184986595175, "y": 0.2675938337801609, "term": "genetic", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.345671345341656e-06}, {"x": 0.6348860589812333, "y": 0.17543565683646112, "term": "j", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 1.1046564256436513e-07}, {"x": 0.635053619302949, "y": 0.6503016085790885, "term": "consultations", "cat25k": 1, "ncat25k": 1, "cat": 8, "ncat": 9, "s": 0.48458445040214476, "os": 0.5198971747644501, "bg": 7.434701996370553e-06}, {"x": 0.6352211796246648, "y": 0.26826407506702415, "term": "a.o.", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 0.0}, {"x": 0.6353887399463807, "y": 0.5792560321715817, "term": "estimates", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 9.78842514810866e-07}, {"x": 0.6355563002680965, "y": 0.524798927613941, "term": "3rd", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 0.0}, {"x": 0.6357238605898123, "y": 0.5268096514745308, "term": "labeled", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 4.607088565189727e-06}, {"x": 0.6358914209115282, "y": 0.8369638069705094, "term": "wash", "cat25k": 4, "ncat25k": 1, "cat": 22, "ncat": 9, "s": 0.7630697050938338, "os": 0.742890696428352, "bg": 4.796999121143338e-06}, {"x": 0.636058981233244, "y": 0.5291554959785523, "term": "swab", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 3.820866845519624e-05}, {"x": 0.6362265415549598, "y": 0.45408847184986595, "term": "residence", "cat25k": 1, "ncat25k": 1, "cat": 4, "ncat": 9, "s": 0.3590817694369973, "os": 0.3621482642836723, "bg": 1.392224202928886e-06}, {"x": 0.6363941018766756, "y": 0.18481903485254692, "term": "advantages", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 1.5526538697452272e-06}, {"x": 0.6365616621983914, "y": 0.18515415549597855, "term": "reserve", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 5.582217778280673e-07}, {"x": 0.6367292225201072, "y": 0.28099865951742625, "term": "confusion", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 2.7276137917080044e-06}, {"x": 0.636896782841823, "y": 0.3656166219839142, "term": "outlined", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 3.337163655618059e-06}, {"x": 0.6370643431635389, "y": 0.5822721179624665, "term": "avoided", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 6.300174325823595e-06}, {"x": 0.6372319034852547, "y": 0.28468498659517427, "term": "29", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 0.0}, {"x": 0.6373994638069705, "y": 0.3679624664879357, "term": "flow", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 5.10679369532273e-07}, {"x": 0.6375670241286864, "y": 0.19453753351206435, "term": "heat", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 4.964810786468477e-07}, {"x": 0.6377345844504021, "y": 0.291387399463807, "term": "december", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.198588670557427e-07}, {"x": 0.6379021447721179, "y": 0.585455764075067, "term": "q", "cat25k": 1, "ncat25k": 1, "cat": 6, "ncat": 9, "s": 0.430127345844504, "os": 0.4478184146236402, "bg": 2.14476026523907e-07}, {"x": 0.6380697050938338, "y": 0.20006702412868632, "term": "suggestive", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 1.6919328641039524e-05}, {"x": 0.6382372654155496, "y": 0.20107238605898123, "term": "demographic", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 3.40991955829266e-06}, {"x": 0.6384048257372654, "y": 0.3729892761394102, "term": "collaborating", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 1.3640168933492242e-05}, {"x": 0.6385723860589813, "y": 0.29792225201072386, "term": "volunteer", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 9.71351789223373e-07}, {"x": 0.6387399463806971, "y": 0.20878016085790885, "term": "cough", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 5.314051121703196e-06}, {"x": 0.6389075067024129, "y": 0.3031166219839142, "term": "liquid", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 1.0216297120754913e-06}, {"x": 0.6390750670241286, "y": 0.30328418230563003, "term": "repair", "cat25k": 0, "ncat25k": 1, "cat": 2, "ncat": 9, "s": 0.24011394101876676, "os": 0.26036399232479746, "bg": 4.415431580138056e-07}, {"x": 0.6392426273458445, "y": 0.5383713136729222, "term": "mdgs", "cat25k": 1, "ncat25k": 1, "cat": 5, "ncat": 9, "s": 0.396112600536193, "os": 0.4070276070268575, "bg": 3.26095944414617e-05}, {"x": 0.6394101876675603, "y": 0.21565013404825736, "term": "maintains", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 2.8289723545749086e-06}, {"x": 0.6395777479892761, "y": 0.3778485254691689, "term": "removal", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 8.831318829781076e-07}, {"x": 0.639745308310992, "y": 0.3780160857908847, "term": "0029", "cat25k": 0, "ncat25k": 1, "cat": 3, "ncat": 9, "s": 0.29591152815013405, "os": 0.3131479553554762, "bg": 0.0}, {"x": 0.6399128686327078, "y": 0.22386058981233245, "term": "church", "cat25k": 0, "ncat25k": 1, "cat": 1, "ncat": 9, "s": 0.202245308310992, "os": 0.20478511439102715, "bg": 2.3565755704886508e-07}, {"x": 0.6400804289544236, "y": 0.009718498659517426, "term": "ovulation", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.431792962737588e-05}, {"x": 0.6402479892761395, "y": 0.01876675603217158, "term": "8976", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6404155495978552, "y": 0.02613941018766756, "term": "schematic", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 7.508559758124262e-06}, {"x": 0.640583109919571, "y": 0.027982573726541556, "term": "classes", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 3.6623373769607243e-07}, {"x": 0.6407506702412868, "y": 0.02848525469168901, "term": "street", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.2044748650185168e-07}, {"x": 0.6409182305630027, "y": 0.029490616621983913, "term": "pediatricians", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 2.1492639964847595e-05}, {"x": 0.6410857908847185, "y": 0.03300938337801609, "term": "underweight", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 3.073445092903416e-05}, {"x": 0.6412533512064343, "y": 0.034014745308310994, "term": "median", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.41771477138286e-06}, {"x": 0.6414209115281502, "y": 0.03669571045576407, "term": "nipples", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.3722709628302874e-06}, {"x": 0.641588471849866, "y": 0.03770107238605898, "term": "codex", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.1711918047805447e-05}, {"x": 0.6417560321715817, "y": 0.03820375335120643, "term": "71", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6419235924932976, "y": 0.04859249329758713, "term": "practicing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 3.84687307990276e-06}, {"x": 0.6420911528150134, "y": 0.05026809651474531, "term": "immunity", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 4.577185071866892e-06}, {"x": 0.6422587131367292, "y": 0.060656836461126004, "term": "reviewing", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 2.680457720916997e-06}, {"x": 0.642426273458445, "y": 0.06467828418230563, "term": "bilateral pitting", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6425938337801609, "y": 0.07272117962466489, "term": "frozen", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.8992316236415085e-06}, {"x": 0.6427613941018767, "y": 0.07573726541554959, "term": "oxytocin", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 3.189628744934249e-05}, {"x": 0.6429289544235925, "y": 0.0814343163538874, "term": "diem", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.1029993002082217e-05}, {"x": 0.6430965147453083, "y": 0.10120643431635389, "term": "intramuscular", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 3.065306351825645e-05}, {"x": 0.6432640750670241, "y": 0.10623324396782842, "term": "loading", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.0372901785274364e-06}, {"x": 0.6434316353887399, "y": 0.11092493297587132, "term": "kontra", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 5.18527267332494e-05}, {"x": 0.6435991957104558, "y": 0.11109249329758714, "term": "patak kontra", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6437667560321716, "y": 0.11126005361930295, "term": "kontra polio", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6439343163538874, "y": 0.12081099195710455, "term": "tissue culture", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6441018766756033, "y": 0.12935656836461126, "term": "page", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 1.6629194071208957e-08}, {"x": 0.6442694369973191, "y": 0.13689678284182305, "term": "tritanrix", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 5.769859535975074e-05}, {"x": 0.6444369973190348, "y": 0.13706434316353888, "term": "hb10", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6446045576407506, "y": 0.13723190348525469, "term": "tritanrix hb10", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 0.0}, {"x": 0.6447721179624665, "y": 0.14158847184986595, "term": "motorcycles", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 2.9696104910399426e-06}, {"x": 0.6449396782841823, "y": 0.1467828418230563, "term": "nmrl", "cat25k": 0, "ncat25k": 1, "cat": 0, "ncat": 9, "s": 0.06668900804289543, "os": 0.14846043654035368, "bg": 5.769859535975074e-05}, {"x": 0.6451072386058981, "y": 0.9921246648793566, "term": "cancer", "cat25k": 56, "ncat25k": 2, "cat": 348, "ncat": 10, "s": 0.9981568364611261, "os": 0.9870089964523876, "bg": 1.094961968346454e-05}, {"x": 0.645274798927614, "y": 0.9550938337801609, "term": "registry", "cat25k": 13, "ncat25k": 2, "cat": 82, "ncat": 10, "s": 0.9901139410187668, "os": 0.9330738780853618, "bg": 9.286605489807117e-06}, {"x": 0.6454423592493298, "y": 0.5866286863270778, "term": "reasons", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 9.189727409170152e-07}, {"x": 0.6456099195710456, "y": 0.789544235924933, "term": "undertaken", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 10, "s": 0.6890080428954424, "os": 0.6719704167648872, "bg": 6.494498318045205e-06}, {"x": 0.6457774798927614, "y": 0.7417895442359249, "term": "task", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 10, "s": 0.610254691689008, "os": 0.6113203119619368, "bg": 1.1458548414646307e-06}, {"x": 0.6459450402144772, "y": 0.37935656836461124, "term": "obtained", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 8.284457744812605e-07}, {"x": 0.646112600536193, "y": 0.7243632707774799, "term": "cells", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 10, "s": 0.5884718498659518, "os": 0.5926646817997547, "bg": 9.90097695414851e-07}, {"x": 0.6462801608579088, "y": 0.5403820375335121, "term": "pulmonary", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 6.534222069212522e-06}, {"x": 0.6464477211796247, "y": 0.8376340482573726, "term": "2001", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 10, "s": 0.7598860589812332, "os": 0.7358229833251795, "bg": 0.0}, {"x": 0.6466152815013405, "y": 0.9805630026809652, "term": "20%", "cat25k": 26, "ncat25k": 2, "cat": 161, "ncat": 10, "s": 0.996313672922252, "os": 0.971529114402693, "bg": 0.0}, {"x": 0.6467828418230563, "y": 0.3094839142091153, "term": "cut", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 4.217397976722786e-07}, {"x": 0.6469504021447721, "y": 0.6228217158176944, "term": "half", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 4.1569289163423253e-07}, {"x": 0.6471179624664879, "y": 0.8595844504021448, "term": "inclusion", "cat25k": 4, "ncat25k": 2, "cat": 27, "ncat": 10, "s": 0.7972520107238606, "os": 0.7674801034704117, "bg": 6.969382748140635e-06}, {"x": 0.6472855227882037, "y": 0.7660857908847185, "term": "secure", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 7.987252600441778e-07}, {"x": 0.6474530831099196, "y": 0.9505697050938338, "term": "purchase", "cat25k": 12, "ncat25k": 2, "cat": 74, "ncat": 10, "s": 0.9867627345844505, "os": 0.9228408486094632, "bg": 1.9847546271482484e-06}, {"x": 0.6476206434316354, "y": 0.8800268096514745, "term": "doctor", "cat25k": 5, "ncat25k": 2, "cat": 32, "ncat": 10, "s": 0.8287533512064343, "os": 0.799239416529668, "bg": 2.0917527939654124e-06}, {"x": 0.6477882037533512, "y": 0.7675938337801609, "term": "position", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 5.717476458204921e-07}, {"x": 0.647955764075067, "y": 0.6816353887399463, "term": "down", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 1.7759791371468408e-07}, {"x": 0.6481233243967829, "y": 0.8393096514745308, "term": "change", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 10, "s": 0.7598860589812332, "os": 0.7358229833251795, "bg": 3.129248873970611e-07}, {"x": 0.6482908847184986, "y": 0.850201072386059, "term": "thereof", "cat25k": 4, "ncat25k": 2, "cat": 25, "ncat": 10, "s": 0.7855227882037534, "os": 0.7524847432617445, "bg": 6.622804150151838e-06}, {"x": 0.6484584450402144, "y": 0.23089812332439677, "term": "supervisor", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.9251501617126132e-06}, {"x": 0.6486260053619303, "y": 0.7691018766756033, "term": "co", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 4.356739445476295e-07}, {"x": 0.6487935656836461, "y": 0.7082774798927614, "term": "requested", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 1.6877714448842562e-06}, {"x": 0.6489611260053619, "y": 0.3894101876675603, "term": "doh-", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 0.0}, {"x": 0.6491286863270778, "y": 0.47788203753351205, "term": "leave", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 10, "s": 0.36930294906166217, "os": 0.3825456909334583, "bg": 4.209361164619108e-07}, {"x": 0.6492962466487936, "y": 0.6848190348525469, "term": "except", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 7.619689995198453e-07}, {"x": 0.6494638069705094, "y": 0.15599865951742628, "term": "visited", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 1.4547425300789508e-06}, {"x": 0.6496313672922251, "y": 0.6285187667560321, "term": "entry", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 4.4428114095790444e-07}, {"x": 0.649798927613941, "y": 0.6851541554959786, "term": "reason", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 6.118204693592967e-07}, {"x": 0.6499664879356568, "y": 0.478887399463807, "term": "advised", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 10, "s": 0.36930294906166217, "os": 0.3825456909334583, "bg": 3.077251948362071e-06}, {"x": 0.6501340482573726, "y": 0.7089477211796247, "term": "1995", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 0.0}, {"x": 0.6503016085790885, "y": 0.5480898123324397, "term": "households", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 3.0294346497457595e-06}, {"x": 0.6504691689008043, "y": 0.7092828418230563, "term": "integral", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 4.575431544898819e-06}, {"x": 0.6506367292225201, "y": 0.6291890080428955, "term": "incorporate", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 4.741438805410298e-06}, {"x": 0.650804289544236, "y": 0.15633378016085792, "term": "51", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 0.0}, {"x": 0.6509718498659517, "y": 0.6605227882037533, "term": "opportunities", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 10, "s": 0.48693029490616624, "os": 0.5245056511520116, "bg": 5.401901546108094e-07}, {"x": 0.6511394101876675, "y": 0.15650134048257372, "term": "contacts", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 6.236276294479462e-07}, {"x": 0.6513069705093834, "y": 0.6300268096514745, "term": "delivering", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 4.309073052553335e-06}, {"x": 0.6514745308310992, "y": 0.7939008042895442, "term": "suffering", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 10, "s": 0.6890080428954424, "os": 0.6719704167648872, "bg": 4.934286271938385e-06}, {"x": 0.651642091152815, "y": 0.6869973190348525, "term": "partial", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 2.6748454524450933e-06}, {"x": 0.6518096514745308, "y": 0.7942359249329759, "term": "living", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 10, "s": 0.6890080428954424, "os": 0.6719704167648872, "bg": 5.021950340444059e-07}, {"x": 0.6519772117962467, "y": 0.4820710455764075, "term": "urban", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 10, "s": 0.36930294906166217, "os": 0.3825456909334583, "bg": 7.81250590006956e-07}, {"x": 0.6521447721179625, "y": 0.9574396782841823, "term": "eye", "cat25k": 14, "ncat25k": 2, "cat": 85, "ncat": 10, "s": 0.9907841823056301, "os": 0.9363532344301604, "bg": 3.5848550665737776e-06}, {"x": 0.6523123324396782, "y": 0.8902479892761395, "term": "capability", "cat25k": 6, "ncat25k": 2, "cat": 35, "ncat": 10, "s": 0.8414879356568365, "os": 0.8152159151488276, "bg": 6.520289074842705e-06}, {"x": 0.6524798927613941, "y": 0.6311997319034852, "term": "implementers", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 5.9717635115296513e-05}, {"x": 0.6526474530831099, "y": 0.5934986595174263, "term": "techniques", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 8.37640096845977e-07}, {"x": 0.6528150134048257, "y": 0.5507707774798928, "term": "mindanao", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 4.24527613531287e-05}, {"x": 0.6529825737265416, "y": 0.7307305630026809, "term": "utilize", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 10, "s": 0.5884718498659518, "os": 0.5926646817997547, "bg": 6.936855069548278e-06}, {"x": 0.6531501340482574, "y": 0.9202412868632708, "term": "devices", "cat25k": 8, "ncat25k": 2, "cat": 49, "ncat": 10, "s": 0.9668230563002681, "os": 0.8699045181918031, "bg": 2.4621564467560338e-06}, {"x": 0.6533176943699732, "y": 0.8054624664879356, "term": "l.", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 10, "s": 0.6987265415549597, "os": 0.6844400850206973, "bg": 0.0}, {"x": 0.653485254691689, "y": 0.5938337801608579, "term": "assisted", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 3.495899874959887e-06}, {"x": 0.6536528150134048, "y": 0.5951742627345844, "term": "items", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 1.0277576203776454e-07}, {"x": 0.6538203753351206, "y": 0.396112600536193, "term": "left", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 1.6272957758040207e-07}, {"x": 0.6539879356568364, "y": 0.6890080428954424, "term": "10%", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 0.0}, {"x": 0.6541554959785523, "y": 0.7731233243967829, "term": "stocks", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 2.2974455943057537e-06}, {"x": 0.6543230563002681, "y": 0.32054289544235925, "term": "parenteral", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 3.39394129264781e-05}, {"x": 0.6544906166219839, "y": 0.32255361930294907, "term": "awarding", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 1.3601548902538101e-05}, {"x": 0.6546581769436998, "y": 0.635053619302949, "term": "processing", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 6.451746678690094e-07}, {"x": 0.6548257372654156, "y": 0.4004691689008043, "term": "notify", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 1.1813968143972442e-06}, {"x": 0.6549932975871313, "y": 0.23910857908847186, "term": "sufficient", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.1473921282876192e-06}, {"x": 0.6551608579088471, "y": 0.8145107238605898, "term": "recipient", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 10, "s": 0.7039209115281502, "os": 0.6960712165315166, "bg": 4.507508810236832e-06}, {"x": 0.655328418230563, "y": 0.7744638069705094, "term": "beds", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 2.6862546926183226e-06}, {"x": 0.6554959785522788, "y": 0.6667225201072386, "term": "2.2", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 10, "s": 0.48693029490616624, "os": 0.5245056511520116, "bg": 0.0}, {"x": 0.6556635388739946, "y": 0.5988605898123325, "term": "2.3", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 0.0}, {"x": 0.6558310991957105, "y": 0.16069034852546918, "term": "severity", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 4.105050480925323e-06}, {"x": 0.6559986595174263, "y": 0.6370643431635389, "term": "vital", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 2.4864253263968512e-06}, {"x": 0.6561662198391421, "y": 0.8580764075067024, "term": "sustainability", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 10, "s": 0.7902144772117963, "os": 0.7601731394442688, "bg": 1.0065385864954956e-05}, {"x": 0.6563337801608579, "y": 0.5566353887399463, "term": "adolescents", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 8.092282365020098e-06}, {"x": 0.6565013404825737, "y": 0.7511729222520107, "term": "expansion", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 10, "s": 0.610254691689008, "os": 0.6113203119619368, "bg": 2.1547430602401053e-06}, {"x": 0.6566689008042895, "y": 0.3284182305630027, "term": "complement", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 3.896592819238857e-06}, {"x": 0.6568364611260054, "y": 0.49480563002680966, "term": "reforms", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 10, "s": 0.36930294906166217, "os": 0.3825456909334583, "bg": 4.4767566793209655e-06}, {"x": 0.6570040214477212, "y": 0.8218833780160858, "term": "carry", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 10, "s": 0.7216823056300268, "os": 0.7069532467952884, "bg": 1.7981049412403278e-06}, {"x": 0.657171581769437, "y": 0.6028820375335121, "term": "structures", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 1.3190019887834398e-06}, {"x": 0.6573391420911529, "y": 0.41119302949061665, "term": "read", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 8.678302656778366e-08}, {"x": 0.6575067024128687, "y": 0.8220509383378016, "term": "market", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 10, "s": 0.7216823056300268, "os": 0.7069532467952884, "bg": 3.687720463069271e-07}, {"x": 0.6576742627345844, "y": 0.6931970509383378, "term": "promotional", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 2.985786982162834e-06}, {"x": 0.6578418230563002, "y": 0.1638739946380697, "term": "plastic", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 6.156744559746589e-07}, {"x": 0.6580093833780161, "y": 0.6400804289544236, "term": "de\ufb01ne", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 0.0}, {"x": 0.6581769436997319, "y": 0.8964477211796247, "term": "settings", "cat25k": 6, "ncat25k": 2, "cat": 37, "ncat": 10, "s": 0.8463471849865952, "os": 0.8248418546912202, "bg": 2.2182965191293383e-06}, {"x": 0.6583445040214477, "y": 0.4177278820375335, "term": "recipients", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 3.5732949799672153e-06}, {"x": 0.6585120643431636, "y": 0.42124664879356566, "term": "borne", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 7.585214466521031e-06}, {"x": 0.6586796246648794, "y": 0.4230898123324397, "term": "sure", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 2.5261476354116856e-07}, {"x": 0.6588471849865952, "y": 0.7190013404825737, "term": "sex", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 1.3107878775478317e-07}, {"x": 0.659014745308311, "y": 0.33729892761394104, "term": "opt", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 2.3474712497973047e-06}, {"x": 0.6591823056300268, "y": 0.7773123324396782, "term": "2012", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 10, "s": 0.6565013404825738, "os": 0.644079328346067, "bg": 0.0}, {"x": 0.6593498659517426, "y": 0.6449396782841823, "term": "optimal", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 3.3823431727262127e-06}, {"x": 0.6595174262734584, "y": 0.42744638069705093, "term": "periods", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 1.3589377920988251e-06}, {"x": 0.6596849865951743, "y": 0.6962131367292225, "term": "directions", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 10, "s": 0.5504356568364612, "os": 0.5495771337131191, "bg": 9.05254379309506e-07}, {"x": 0.6598525469168901, "y": 0.6732573726541555, "term": "efficient", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 10, "s": 0.48693029490616624, "os": 0.5245056511520116, "bg": 1.6326066958957683e-06}, {"x": 0.6600201072386059, "y": 0.5139075067024129, "term": "donations", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 10, "s": 0.36930294906166217, "os": 0.3825456909334583, "bg": 1.967552307869993e-06}, {"x": 0.6601876675603218, "y": 0.6471179624664879, "term": "males", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 3.991134802684393e-06}, {"x": 0.6603552278820375, "y": 0.7644101876675603, "term": "collaborate", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 10, "s": 0.6402479892761395, "os": 0.6283906245237229, "bg": 1.6687734932018337e-05}, {"x": 0.6605227882037533, "y": 0.43414879356568364, "term": "feasible", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 10, "s": 0.3374664879356568, "os": 0.3402045031552115, "bg": 6.187042697444553e-06}, {"x": 0.6606903485254692, "y": 0.6749329758713136, "term": "recognition", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 10, "s": 0.48693029490616624, "os": 0.5245056511520116, "bg": 1.6960831459235845e-06}, {"x": 0.660857908847185, "y": 0.6136058981233244, "term": "mark", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 10, "s": 0.43800268096514744, "os": 0.4571683370728506, "bg": 3.544667597023755e-07}, {"x": 0.6610254691689008, "y": 0.2649128686327078, "term": "prompt", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 2.438271598666997e-06}, {"x": 0.6611930294906166, "y": 0.17476541554959785, "term": "200,000", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 0.0}, {"x": 0.6613605898123325, "y": 0.6509718498659517, "term": "nation", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 8.046199669260963e-07}, {"x": 0.6615281501340483, "y": 0.2709450402144772, "term": "increases", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.085416586956386e-06}, {"x": 0.661695710455764, "y": 0.27245308310991956, "term": "boxes", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 9.195503414156317e-07}, {"x": 0.6618632707774799, "y": 0.3579088471849866, "term": "sucking", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 2.449671499051977e-06}, {"x": 0.6620308310991957, "y": 0.7216823056300268, "term": "size", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 1.952070796439447e-07}, {"x": 0.6621983914209115, "y": 0.7218498659517426, "term": "back", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 10, "s": 0.5640080428954424, "os": 0.5721806066291762, "bg": 8.60063409567354e-08}, {"x": 0.6623659517426274, "y": 0.7561997319034852, "term": "bilateral", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 10, "s": 0.610254691689008, "os": 0.6113203119619368, "bg": 1.1311869470862715e-05}, {"x": 0.6625335120643432, "y": 0.276642091152815, "term": "ask", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 2.249040320438767e-07}, {"x": 0.662701072386059, "y": 0.5812667560321716, "term": "red", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 2.26771020548608e-07}, {"x": 0.6628686327077749, "y": 0.27898793565683644, "term": "tube", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.365134909457427e-06}, {"x": 0.6630361930294906, "y": 0.6526474530831099, "term": "get", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 5.9376890695240925e-08}, {"x": 0.6632037533512064, "y": 0.6529825737265416, "term": "signi\ufb01cant", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 10, "s": 0.47101206434316356, "os": 0.4897533419793072, "bg": 0.0}, {"x": 0.6633713136729222, "y": 0.28619302949061665, "term": "passive", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 3.5982980050436144e-06}, {"x": 0.6635388739946381, "y": 0.19202412868632707, "term": "abstinence", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 1.4945337428355788e-05}, {"x": 0.6637064343163539, "y": 0.28887399463806973, "term": "box", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.41556787044553e-07}, {"x": 0.6638739946380697, "y": 0.5844504021447721, "term": "although", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 10, "s": 0.40834450402144773, "os": 0.42149859313101995, "bg": 4.0054383839658295e-07}, {"x": 0.6640415549597856, "y": 0.20475871313672922, "term": "1%", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 0.0}, {"x": 0.6642091152815014, "y": 0.20676943699731903, "term": "injections", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 1.0257275788772851e-05}, {"x": 0.6643766756032171, "y": 0.20861260053619302, "term": "steroids", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 4.600589377322775e-06}, {"x": 0.664544235924933, "y": 0.7565348525469169, "term": "mho", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 10, "s": 0.610254691689008, "os": 0.6113203119619368, "bg": 0.00011909138451501328}, {"x": 0.6647117962466488, "y": 0.21179624664879357, "term": "traveling", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 10, "s": 0.19755361930294907, "os": 0.19529073987103535, "bg": 2.208933146537914e-06}, {"x": 0.6648793565683646, "y": 0.37634048257372654, "term": "budgets", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 10, "s": 0.28300938337801607, "os": 0.29454628830910873, "bg": 4.68553821245636e-06}, {"x": 0.6650469168900804, "y": 0.3068029490616622, "term": "iac", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 10, "s": 0.23508713136729223, "os": 0.24594892464600837, "bg": 1.841899059326801e-05}, {"x": 0.6652144772117963, "y": 0.0035187667560321718, "term": "asymptomatic", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 2.1403193356448784e-05}, {"x": 0.6653820375335121, "y": 0.004021447721179625, "term": "hemorrhage", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.5497376681562228e-05}, {"x": 0.6655495978552279, "y": 0.014075067024128687, "term": "necklace", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 2.0399091914024357e-06}, {"x": 0.6657171581769437, "y": 0.03602546916890081, "term": "drops", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 2.353045264119919e-06}, {"x": 0.6658847184986595, "y": 0.04725201072386059, "term": "nursery", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 2.1620265972511995e-06}, {"x": 0.6660522788203753, "y": 0.05244638069705094, "term": "nps", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.1049913009559834e-05}, {"x": 0.6662198391420912, "y": 0.06384048257372654, "term": "timbang", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 6.410934489865916e-05}, {"x": 0.666387399463807, "y": 0.06417560321715818, "term": "operation timbang", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 0.0}, {"x": 0.6665549597855228, "y": 0.06652144772117963, "term": "gt=", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 0.0}, {"x": 0.6667225201072386, "y": 0.0718833780160858, "term": "npmt", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 6.410934489865916e-05}, {"x": 0.6668900804289544, "y": 0.07322386058981233, "term": "deficient", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 8.365397203698677e-06}, {"x": 0.6670576407506702, "y": 0.07339142091152814, "term": "folate", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 2.20466816437124e-05}, {"x": 0.667225201072386, "y": 0.07758042895442359, "term": "livebirths", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 6.410934489865916e-05}, {"x": 0.6673927613941019, "y": 0.08914209115281502, "term": "confirmed", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.2781656584495952e-06}, {"x": 0.6675603217158177, "y": 0.10187667560321716, "term": "empty", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 7.542051462132265e-07}, {"x": 0.6677278820375335, "y": 0.10221179624664879, "term": "bites", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 5.8856471725203845e-06}, {"x": 0.6678954423592494, "y": 0.1060656836461126, "term": "signal", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 5.889250465964859e-07}, {"x": 0.6680630026809652, "y": 0.10807640750670242, "term": "sentinel", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 4.958271189667757e-06}, {"x": 0.6682305630026809, "y": 0.11176273458445041, "term": "antigens", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 7.4937661233061755e-06}, {"x": 0.6683981233243967, "y": 0.11226541554959786, "term": "press", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.1113290736126988e-07}, {"x": 0.6685656836461126, "y": 0.11327077747989277, "term": "capsules", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 4.528433809467959e-06}, {"x": 0.6687332439678284, "y": 0.12349195710455764, "term": "cat", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 4.2416176409895674e-07}, {"x": 0.6689008042895442, "y": 0.12634048257372654, "term": "g6pd con\ufb01rmatory", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 0.0}, {"x": 0.6690683646112601, "y": 0.13002680965147453, "term": "stump", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.1982893221636792e-05}, {"x": 0.6692359249329759, "y": 0.1412533512064343, "term": "iodized oil", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 0.0}, {"x": 0.6694034852546917, "y": 0.14443699731903487, "term": "electricity", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 10, "s": 0.061829758713136736, "os": 0.1442139501908164, "bg": 1.2747365820590005e-06}, {"x": 0.6695710455764075, "y": 0.6218163538873994, "term": "manila", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 7.920095407970367e-06}, {"x": 0.6697386058981233, "y": 0.539544235924933, "term": "success", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 5.733695768112613e-07}, {"x": 0.6699061662198391, "y": 0.30881367292225204, "term": "menstrual", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 1.6993879775583678e-05}, {"x": 0.670073726541555, "y": 0.3093163538873995, "term": "referring", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 3.5857124215097155e-06}, {"x": 0.6702412868632708, "y": 0.2272117962466488, "term": "syrup", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 7.602103560532918e-06}, {"x": 0.6704088471849866, "y": 0.7246983914209115, "term": "17", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 11, "s": 0.5658512064343163, "os": 0.5723551377448648, "bg": 0.0}, {"x": 0.6705764075067024, "y": 0.7903820375335121, "term": "operate", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 11, "s": 0.6657171581769437, "os": 0.6540361841611486, "bg": 3.016921644133943e-06}, {"x": 0.6707439678284183, "y": 0.5417225201072386, "term": "alone", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 8.577542917925201e-07}, {"x": 0.670911528150134, "y": 0.7573726541554959, "term": "signed", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 11, "s": 0.6087466487935657, "os": 0.6089931718014261, "bg": 1.292592707010984e-06}, {"x": 0.6710790884718498, "y": 0.8173592493297587, "term": "containing", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 11, "s": 0.7012399463806971, "os": 0.6904210273482005, "bg": 2.1704006776691046e-06}, {"x": 0.6712466487935657, "y": 0.5428954423592494, "term": "acts", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 1.4166891566070278e-06}, {"x": 0.6714142091152815, "y": 0.7059316353887399, "term": "aids", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 11, "s": 0.5522788203753352, "os": 0.5514801174428143, "bg": 1.3146991854721438e-06}, {"x": 0.6715817694369973, "y": 0.8599195710455764, "term": "document", "cat25k": 4, "ncat25k": 2, "cat": 27, "ncat": 11, "s": 0.7865281501340483, "os": 0.7536960232961611, "bg": 7.675545249273279e-07}, {"x": 0.6717493297587132, "y": 0.310656836461126, "term": "november", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 1.7112785368988996e-07}, {"x": 0.671916890080429, "y": 0.7062667560321716, "term": "22", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 11, "s": 0.5522788203753352, "os": 0.5514801174428143, "bg": 0.0}, {"x": 0.6720844504021448, "y": 0.5435656836461126, "term": "con\ufb01rm", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 0.0}, {"x": 0.6722520107238605, "y": 0.9307975871313673, "term": "psychological", "cat25k": 9, "ncat25k": 2, "cat": 56, "ncat": 11, "s": 0.9728552278820375, "os": 0.8810920525498722, "bg": 1.2797023450545474e-05}, {"x": 0.6724195710455764, "y": 0.7912198391420912, "term": "submission", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 11, "s": 0.6657171581769437, "os": 0.6540361841611486, "bg": 2.502428249126027e-06}, {"x": 0.6725871313672922, "y": 0.8108243967828418, "term": "internal", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 11, "s": 0.6945375335120644, "os": 0.6790844578095484, "bg": 1.1357778503329495e-06}, {"x": 0.672754691689008, "y": 0.6824731903485255, "term": "19", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 0.0}, {"x": 0.6729222520107239, "y": 0.626843163538874, "term": "initiative", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 1.7162873957569945e-06}, {"x": 0.6730898123324397, "y": 0.47520107238605896, "term": "newly", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 11, "s": 0.3550603217158177, "os": 0.3611100967766122, "bg": 1.4943283468063378e-06}, {"x": 0.6732573726541555, "y": 0.5903150134048257, "term": "supervisors", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 6.415946907326459e-06}, {"x": 0.6734249329758714, "y": 0.7826742627345844, "term": "undergo", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 11, "s": 0.6544906166219839, "os": 0.6401361725438127, "bg": 1.841704791092697e-05}, {"x": 0.6735924932975871, "y": 0.38857238605898126, "term": "peer", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 1.6605396443876862e-06}, {"x": 0.6737600536193029, "y": 0.5911528150134048, "term": "counselling", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 8.036087389771669e-06}, {"x": 0.6739276139410187, "y": 0.39058310991957107, "term": "again", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 1.985526990764149e-07}, {"x": 0.6740951742627346, "y": 0.6288538873994638, "term": "declaration", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 2.940906508117753e-06}, {"x": 0.6742627345844504, "y": 0.7699396782841823, "term": "force", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 11, "s": 0.6394101876675604, "os": 0.6251676074594859, "bg": 6.539909964053385e-07}, {"x": 0.6744302949061662, "y": 0.9199061662198391, "term": "affordable", "cat25k": 8, "ncat25k": 2, "cat": 49, "ncat": 11, "s": 0.9560991957104558, "os": 0.8611011653792628, "bg": 5.463977521560741e-06}, {"x": 0.6745978552278821, "y": 0.7701072386058981, "term": "learning", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 11, "s": 0.6394101876675604, "os": 0.6251676074594859, "bg": 4.407346341175325e-07}, {"x": 0.6747654155495979, "y": 0.8607573726541555, "term": "\ufb01nancing", "cat25k": 4, "ncat25k": 2, "cat": 27, "ncat": 11, "s": 0.7865281501340483, "os": 0.7536960232961611, "bg": 0.0}, {"x": 0.6749329758713136, "y": 0.6859919571045576, "term": "focal", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 6.821793160307754e-06}, {"x": 0.6751005361930295, "y": 0.8475201072386059, "term": "registration", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 11, "s": 0.7558646112600536, "os": 0.7295125901189188, "bg": 1.0243261810440627e-06}, {"x": 0.6752680965147453, "y": 0.1570040214477212, "term": "accomplishments", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 6.2605924659508545e-06}, {"x": 0.6754356568364611, "y": 0.7305630026809652, "term": "agreed", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 11, "s": 0.5658512064343163, "os": 0.5723551377448648, "bg": 1.5845938892547996e-06}, {"x": 0.675603217158177, "y": 0.7107908847184986, "term": "sanctions", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 11, "s": 0.5522788203753352, "os": 0.5514801174428143, "bg": 8.598099429203445e-06}, {"x": 0.6757707774798928, "y": 0.6878351206434317, "term": "acquire", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 4.607451697451026e-06}, {"x": 0.6759383378016086, "y": 0.31769436997319034, "term": "aside", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 2.317761836726923e-06}, {"x": 0.6761058981233244, "y": 0.7308981233243967, "term": "designate", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 11, "s": 0.5658512064343163, "os": 0.5723551377448648, "bg": 1.2815872960151828e-05}, {"x": 0.6762734584450402, "y": 0.5943364611260054, "term": "offered", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 7.106292869081851e-07}, {"x": 0.676441018766756, "y": 0.688337801608579, "term": "upgrading", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 7.291614764547685e-06}, {"x": 0.6766085790884718, "y": 0.7843498659517426, "term": "k.", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 11, "s": 0.6544906166219839, "os": 0.6401361725438127, "bg": 0.0}, {"x": 0.6767761394101877, "y": 0.6896782841823056, "term": "practitioner", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 7.337722339538426e-06}, {"x": 0.6769436997319035, "y": 0.3996313672922252, "term": "receiving", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 1.1739181678862633e-06}, {"x": 0.6771112600536193, "y": 0.5978552278820375, "term": "transportation", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 6.737180619040227e-07}, {"x": 0.6772788203753352, "y": 0.5980227882037533, "term": "space", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 2.9552466315852626e-07}, {"x": 0.677446380697051, "y": 0.7329088471849866, "term": "newspaper", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 11, "s": 0.5658512064343163, "os": 0.5723551377448648, "bg": 1.688338200274054e-06}, {"x": 0.6776139410187667, "y": 0.32322386058981234, "term": "mode", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 4.1403376312255974e-07}, {"x": 0.6777815013404825, "y": 0.666387399463807, "term": "3.2", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 11, "s": 0.47989276139410186, "os": 0.5033008466102684, "bg": 0.0}, {"x": 0.6779490616621984, "y": 0.6362265415549598, "term": "marked", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 2.106929908707282e-06}, {"x": 0.6781166219839142, "y": 0.6665549597855228, "term": "4.1", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 11, "s": 0.47989276139410186, "os": 0.5033008466102684, "bg": 0.0}, {"x": 0.67828418230563, "y": 0.6365616621983914, "term": "needing", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 9.928452436442229e-06}, {"x": 0.6784517426273459, "y": 0.7612265415549598, "term": "transferred", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 11, "s": 0.6087466487935657, "os": 0.6089931718014261, "bg": 4.410734669609509e-06}, {"x": 0.6786193029490617, "y": 0.7967493297587132, "term": "vulnerable", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 11, "s": 0.6657171581769437, "os": 0.6540361841611486, "bg": 6.962439380153915e-06}, {"x": 0.6787868632707775, "y": 0.954088471849866, "term": "older", "cat25k": 13, "ncat25k": 2, "cat": 79, "ncat": 11, "s": 0.9870978552278821, "os": 0.9237150481117857, "bg": 4.041843317674335e-06}, {"x": 0.6789544235924933, "y": 0.4934651474530831, "term": "formal", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 11, "s": 0.3550603217158177, "os": 0.3611100967766122, "bg": 1.4167674158016233e-06}, {"x": 0.6791219839142091, "y": 0.6923592493297587, "term": "licensing", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 2.16420001969422e-06}, {"x": 0.6792895442359249, "y": 0.6925268096514745, "term": "benefit", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 8.747175755627901e-07}, {"x": 0.6794571045576407, "y": 0.4953083109919571, "term": "started", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 11, "s": 0.3550603217158177, "os": 0.3611100967766122, "bg": 4.1116669642271484e-07}, {"x": 0.6796246648793566, "y": 0.5589812332439679, "term": "finding", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 9.087389792680289e-07}, {"x": 0.6797922252010724, "y": 0.693029490616622, "term": "hazards", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 5.868614301393865e-06}, {"x": 0.6799597855227882, "y": 0.16404155495978553, "term": "deficiencies", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 7.060775626202539e-06}, {"x": 0.6801273458445041, "y": 0.735254691689008, "term": "contrary", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 11, "s": 0.5658512064343163, "os": 0.5723551377448648, "bg": 5.048413739016546e-06}, {"x": 0.6802949061662198, "y": 0.785857908847185, "term": "registries", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 11, "s": 0.6544906166219839, "os": 0.6401361725438127, "bg": 3.468433083970123e-05}, {"x": 0.6804624664879356, "y": 0.9462131367292225, "term": "twenty", "cat25k": 11, "ncat25k": 2, "cat": 69, "ncat": 11, "s": 0.9834115281501341, "os": 0.9085970077865047, "bg": 7.470892701638227e-06}, {"x": 0.6806300268096515, "y": 0.8153485254691689, "term": "account", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 11, "s": 0.6945375335120644, "os": 0.6790844578095484, "bg": 2.9422821917742657e-07}, {"x": 0.6807975871313673, "y": 0.7171581769436998, "term": "consider", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 11, "s": 0.5522788203753352, "os": 0.5514801174428143, "bg": 8.09208528219253e-07}, {"x": 0.6809651474530831, "y": 0.6064008042895442, "term": "wards", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 1.7376689460699965e-05}, {"x": 0.681132707774799, "y": 0.9088471849865952, "term": "bed", "cat25k": 7, "ncat25k": 2, "cat": 43, "ncat": 11, "s": 0.9130361930294906, "os": 0.8399441891386148, "bg": 1.672476664769335e-06}, {"x": 0.6813002680965148, "y": 0.4272788203753351, "term": "correctly", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 2.206881291266841e-06}, {"x": 0.6814678284182306, "y": 0.5692024128686327, "term": "led", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 7.154339406701154e-07}, {"x": 0.6816353887399463, "y": 0.17191689008042896, "term": "patterns", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 9.187733533523839e-07}, {"x": 0.6818029490616622, "y": 0.3421581769436997, "term": "men", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 1.6057773299086383e-07}, {"x": 0.681970509383378, "y": 0.25904825737265413, "term": "complication", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 1.8984199304886244e-05}, {"x": 0.6821380697050938, "y": 0.7778150134048257, "term": "supportive", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 11, "s": 0.6394101876675604, "os": 0.6251676074594859, "bg": 9.933743838929693e-06}, {"x": 0.6823056300268097, "y": 0.7642426273458445, "term": "actively", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 11, "s": 0.6087466487935657, "os": 0.6089931718014261, "bg": 5.71930432212403e-06}, {"x": 0.6824731903485255, "y": 0.43297587131367293, "term": "adolescent", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 5.0936916666185594e-06}, {"x": 0.6826407506702413, "y": 0.2617292225201072, "term": "unnecessary", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 4.467813783583568e-06}, {"x": 0.6828083109919572, "y": 0.2622319034852547, "term": "exposures", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 7.785246957016454e-06}, {"x": 0.6829758713136729, "y": 0.5759048257372654, "term": "whereas", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 2.2703982933015373e-06}, {"x": 0.6831434316353887, "y": 0.649798927613941, "term": "approximately", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 11, "s": 0.4547587131367293, "os": 0.4643365072391288, "bg": 1.0523602099392156e-06}, {"x": 0.6833109919571045, "y": 0.44168900804289546, "term": "nations", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 9.445342714027924e-07}, {"x": 0.6834785522788204, "y": 0.6161193029490617, "term": "respectively", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 11, "s": 0.4155495978552279, "os": 0.432650612880096, "bg": 2.0983328920034108e-06}, {"x": 0.6836461126005362, "y": 0.35455764075067026, "term": "united nations", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 0.0}, {"x": 0.683813672922252, "y": 0.44470509383378015, "term": "augment", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 2.250788901509979e-05}, {"x": 0.6839812332439679, "y": 0.35757372654155495, "term": "containers", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 3.559763987647619e-06}, {"x": 0.6841487935656837, "y": 0.2727882037533512, "term": "upper", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 6.726431876250212e-07}, {"x": 0.6843163538873994, "y": 0.18029490616621985, "term": "intercourse", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 7.673968874382246e-06}, {"x": 0.6844839142091153, "y": 0.36394101876675605, "term": "please", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 11, "s": 0.26457774798927614, "os": 0.2784146779989761, "bg": 7.361479584202285e-08}, {"x": 0.6846514745308311, "y": 0.5325067024128687, "term": "ages", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 11, "s": 0.3550603217158177, "os": 0.3611100967766122, "bg": 1.2930426104817023e-06}, {"x": 0.6848190348525469, "y": 0.19353217158176944, "term": "derived", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 1.4021557326465263e-06}, {"x": 0.6849865951742627, "y": 0.7025804289544236, "term": "glucose", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 11, "s": 0.4887734584450402, "os": 0.5285648532981324, "bg": 7.481380713748659e-06}, {"x": 0.6851541554959786, "y": 0.1970509383378016, "term": "parent", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 5.125113195599048e-07}, {"x": 0.6853217158176944, "y": 0.19822386058981234, "term": "teach", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 1.237639590275288e-06}, {"x": 0.6854892761394102, "y": 0.5856233243967829, "term": "our", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 11, "s": 0.3822050938337802, "os": 0.3982809476697333, "bg": 3.403165093276012e-08}, {"x": 0.685656836461126, "y": 0.20207774798927614, "term": "midwifery", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 11, "s": 0.1920241286863271, "os": 0.1868419228664529, "bg": 1.8109735944958477e-05}, {"x": 0.6858243967828418, "y": 0.4676608579088472, "term": "0.5 ml", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 11, "s": 0.30144101876675605, "os": 0.3211115244602879, "bg": 0.0}, {"x": 0.6859919571045576, "y": 0.29943029490616624, "term": "contraindications", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 2.487919238313956e-05}, {"x": 0.6861595174262735, "y": 0.3037868632707775, "term": "t", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 6.687931063522926e-08}, {"x": 0.6863270777479893, "y": 0.3046246648793566, "term": "live births", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 11, "s": 0.223357908847185, "os": 0.23340143279788106, "bg": 0.0}, {"x": 0.6864946380697051, "y": 0.0011729222520107238, "term": "tracking", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 8.591628941605042e-07}, {"x": 0.686662198391421, "y": 0.010723860589812333, "term": "consecutive", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 3.1733219401459554e-06}, {"x": 0.6868297587131368, "y": 0.012734584450402145, "term": "vitamins", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 2.104978129755636e-06}, {"x": 0.6869973190348525, "y": 0.01591823056300268, "term": "artificial", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 2.0155004812923534e-06}, {"x": 0.6871648793565683, "y": 0.019269436997319034, "term": "rice", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 1.023416895012685e-06}, {"x": 0.6873324396782842, "y": 0.028317694369973192, "term": "difficult", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 5.146406010871221e-07}, {"x": 0.6875, "y": 0.044738605898123326, "term": "1000", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 0.0}, {"x": 0.6876675603217158, "y": 0.04624664879356569, "term": "grams", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 3.961969415757184e-06}, {"x": 0.6878351206434317, "y": 0.05479222520107239, "term": "pidsr", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 7.052005333880398e-05}, {"x": 0.6880026809651475, "y": 0.0568029490616622, "term": "igm antibodies", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 0.0}, {"x": 0.6881702412868632, "y": 0.06451072386058981, "term": "pitting", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 3.526370034830918e-05}, {"x": 0.688337801608579, "y": 0.06484584450402145, "term": "pitting edema", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 0.0}, {"x": 0.6885053619302949, "y": 0.06786193029490617, "term": "itc", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 8.887158137283971e-06}, {"x": 0.6886729222520107, "y": 0.07590482573726541, "term": "gestation", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 2.0642933548520277e-05}, {"x": 0.6888404825737265, "y": 0.1013739946380697, "term": "intradermal", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 5.751212983101891e-05}, {"x": 0.6890080428954424, "y": 0.10154155495978552, "term": "auto", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 2.3154887282587577e-07}, {"x": 0.6891756032171582, "y": 0.10556300268096515, "term": "round", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 3.539898762113493e-07}, {"x": 0.689343163538874, "y": 0.1146112600536193, "term": "populated", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 7.181335578262358e-06}, {"x": 0.6895107238605898, "y": 0.11980563002680965, "term": "biting animal", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 0.0}, {"x": 0.6896782841823056, "y": 0.1221514745308311, "term": "erig", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 7.052005333880398e-05}, {"x": 0.6898458445040214, "y": 0.12298927613941019, "term": "dog", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 2.835650869973175e-07}, {"x": 0.6900134048257373, "y": 0.12835120643431636, "term": "symptomatic", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 1.8862569887964906e-05}, {"x": 0.6901809651474531, "y": 0.13220509383378015, "term": "i.u.", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 0.0}, {"x": 0.6903485254691689, "y": 0.13270777479892762, "term": "unhsp", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 7.052005333880398e-05}, {"x": 0.6905160857908847, "y": 0.1335455764075067, "term": "nhsc", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 11, "s": 0.05596514745308311, "os": 0.1400694272077308, "bg": 6.28174781066812e-05}, {"x": 0.6906836461126006, "y": 0.8232238605898123, "term": "physicians", "cat25k": 3, "ncat25k": 2, "cat": 21, "ncat": 12, "s": 0.6992292225201072, "os": 0.6854953597891624, "bg": 4.7042709933795226e-06}, {"x": 0.6908512064343163, "y": 0.7799932975871313, "term": "understanding", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 12, "s": 0.6362265415549598, "os": 0.6225666696098732, "bg": 1.1266845971813852e-06}, {"x": 0.6910187667560321, "y": 0.6224865951742627, "term": "mild", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 12, "s": 0.42744638069705093, "os": 0.4414302217892607, "bg": 5.6045360873276396e-06}, {"x": 0.691186327077748, "y": 0.9354892761394102, "term": "attending", "cat25k": 10, "ncat25k": 2, "cat": 60, "ncat": 12, "s": 0.9740281501340483, "os": 0.8833208314749752, "bg": 1.4422952686905944e-05}, {"x": 0.6913538873994638, "y": 0.7427949061662198, "term": "series", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 12, "s": 0.5666890080428955, "os": 0.5727459003192917, "bg": 3.0896517004123674e-07}, {"x": 0.6915214477211796, "y": 0.6234919571045576, "term": "directors", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 12, "s": 0.42744638069705093, "os": 0.4414302217892607, "bg": 1.3936729616783838e-06}, {"x": 0.6916890080428955, "y": 0.8099865951742627, "term": "requirement", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 12, "s": 0.6714142091152816, "os": 0.6627270170877783, "bg": 2.6304633450872613e-06}, {"x": 0.6918565683646113, "y": 0.8840482573726541, "term": "states", "cat25k": 5, "ncat25k": 2, "cat": 33, "ncat": 12, "s": 0.8109919571045576, "os": 0.7809985466787933, "bg": 3.444989038944403e-07}, {"x": 0.6920241286863271, "y": 0.744470509383378, "term": "interest", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 12, "s": 0.5666890080428955, "os": 0.5727459003192917, "bg": 4.1464551167380533e-07}, {"x": 0.6921916890080428, "y": 0.6256702412868632, "term": "de\ufb01nition", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 12, "s": 0.42744638069705093, "os": 0.4414302217892607, "bg": 0.0}, {"x": 0.6923592493297587, "y": 0.7265415549597856, "term": "permanent", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 12, "s": 0.55328418230563, "os": 0.5533343885895665, "bg": 1.6254667841111571e-06}, {"x": 0.6925268096514745, "y": 0.860254691689008, "term": "created", "cat25k": 4, "ncat25k": 2, "cat": 27, "ncat": 12, "s": 0.7613941018766757, "os": 0.7402087914349402, "bg": 9.43683291950603e-07}, {"x": 0.6926943699731903, "y": 0.7079423592493298, "term": "disseminate", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 12, "s": 0.4911193029490617, "os": 0.5322070008300925, "bg": 2.4248072541798932e-05}, {"x": 0.6928619302949062, "y": 0.8569034852546917, "term": "cooperation", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 12, "s": 0.7575402144772119, "os": 0.7322366927528812, "bg": 3.898467091962069e-06}, {"x": 0.693029490616622, "y": 0.6831434316353887, "term": "seek", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 12, "s": 0.48156836461126007, "os": 0.5091294994487032, "bg": 1.799788058594391e-06}, {"x": 0.6931970509383378, "y": 0.7917225201072386, "term": "context", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 12, "s": 0.647955764075067, "os": 0.6368712725070999, "bg": 1.4187729839694555e-06}, {"x": 0.6933646112600537, "y": 0.3884048257372654, "term": "frequent", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 12, "s": 0.2915549597855228, "os": 0.30428868768717954, "bg": 2.9872805329009744e-06}, {"x": 0.6935321715817694, "y": 0.6591823056300268, "term": "bring", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 7.251374705257516e-07}, {"x": 0.6936997319034852, "y": 0.5472520107238605, "term": "privacy", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 1.0791871497636752e-07}, {"x": 0.693867292225201, "y": 0.8403150134048257, "term": "copy", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 12, "s": 0.7205093833780162, "os": 0.7057297612893603, "bg": 8.757917814548188e-07}, {"x": 0.6940348525469169, "y": 0.6595174262734584, "term": "outcome", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 2.9466388952966594e-06}, {"x": 0.6942024128686327, "y": 0.5916554959785523, "term": "resolution", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 12, "s": 0.40097184986595175, "os": 0.4106948437732975, "bg": 6.817198176399488e-07}, {"x": 0.6943699731903485, "y": 0.6601876675603218, "term": "\ufb01nal", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 0.0}, {"x": 0.6945375335120644, "y": 0.4812332439678284, "term": "retardation", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 12, "s": 0.34014745308310995, "os": 0.34214210335193007, "bg": 1.747393685227585e-05}, {"x": 0.6947050938337802, "y": 0.3155160857908847, "term": "might", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 2.4289929849306167e-07}, {"x": 0.6948726541554959, "y": 0.818867292225201, "term": "range", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 12, "s": 0.6898458445040214, "os": 0.674459069991219, "bg": 4.975630566520709e-07}, {"x": 0.6950402144772118, "y": 0.686662198391421, "term": "moderate", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 12, "s": 0.48156836461126007, "os": 0.5091294994487032, "bg": 3.580852433315372e-06}, {"x": 0.6952077747989276, "y": 0.48140080428954424, "term": "26", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 12, "s": 0.34014745308310995, "os": 0.34214210335193007, "bg": 0.0}, {"x": 0.6953753351206434, "y": 0.9294571045576407, "term": "factors", "cat25k": 9, "ncat25k": 2, "cat": 55, "ncat": 12, "s": 0.9669906166219839, "os": 0.8705389613517158, "bg": 3.1589963406563582e-06}, {"x": 0.6955428954423593, "y": 0.8957774798927614, "term": "outcomes", "cat25k": 6, "ncat25k": 2, "cat": 37, "ncat": 12, "s": 0.8316018766756033, "os": 0.8029610660122846, "bg": 6.722694148491555e-06}, {"x": 0.6957104557640751, "y": 0.8192024128686327, "term": "commission", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 12, "s": 0.6898458445040214, "os": 0.674459069991219, "bg": 8.088009983940624e-07}, {"x": 0.6958780160857909, "y": 0.6320375335120644, "term": "scheme", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 12, "s": 0.42744638069705093, "os": 0.4414302217892607, "bg": 1.3975719842161014e-06}, {"x": 0.6960455764075067, "y": 0.8478552278820375, "term": "coordinating", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 12, "s": 0.7416219839142092, "os": 0.7150339583129176, "bg": 1.5836803499581644e-05}, {"x": 0.6962131367292225, "y": 0.31970509383378015, "term": "produce", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 8.404528326244068e-07}, {"x": 0.6963806970509383, "y": 0.6637064343163539, "term": "preparations", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 9.668721960706314e-06}, {"x": 0.6965482573726541, "y": 0.49162198391420914, "term": "religious", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 12, "s": 0.34014745308310995, "os": 0.34214210335193007, "bg": 9.351404721260204e-07}, {"x": 0.69671581769437, "y": 0.8356233243967829, "term": "sustainable", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 12, "s": 0.7037533512064343, "os": 0.6959001231918481, "bg": 3.6509661342287358e-06}, {"x": 0.6968833780160858, "y": 0.7615616621983914, "term": "deliver", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 12, "s": 0.5871313672922253, "os": 0.5906433303969223, "bg": 2.249227466060563e-06}, {"x": 0.6970509383378016, "y": 0.16219839142091153, "term": "select", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 1.538597963849043e-07}, {"x": 0.6972184986595175, "y": 0.40599865951742625, "term": "premature", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 12, "s": 0.2915549597855228, "os": 0.30428868768717954, "bg": 8.109042291696442e-06}, {"x": 0.6973860589812333, "y": 0.7144772117962467, "term": "surveys", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 12, "s": 0.4911193029490617, "os": 0.5322070008300925, "bg": 2.4419619954269486e-06}, {"x": 0.697553619302949, "y": 0.7146447721179625, "term": "multi sectoral", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 12, "s": 0.4911193029490617, "os": 0.5322070008300925, "bg": 0.0}, {"x": 0.6977211796246648, "y": 0.6387399463806971, "term": "scale", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 12, "s": 0.42744638069705093, "os": 0.4414302217892607, "bg": 8.580100049543643e-07}, {"x": 0.6978887399463807, "y": 0.8743297587131368, "term": "media", "cat25k": 5, "ncat25k": 2, "cat": 30, "ncat": 12, "s": 0.7928954423592494, "os": 0.7619704134206433, "bg": 3.875530706062778e-07}, {"x": 0.6980563002680965, "y": 0.7153150134048257, "term": "choice", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 12, "s": 0.4911193029490617, "os": 0.5322070008300925, "bg": 6.711966115076806e-07}, {"x": 0.6982238605898123, "y": 0.5614946380697051, "term": "nec", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 2.5150248281853803e-06}, {"x": 0.6983914209115282, "y": 0.6707439678284183, "term": "equivalent", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 1.723950674323306e-06}, {"x": 0.698558981233244, "y": 0.8433310991957105, "term": "summary", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 12, "s": 0.7205093833780162, "os": 0.7057297612893603, "bg": 8.659228125806313e-07}, {"x": 0.6987265415549598, "y": 0.7525134048257373, "term": "continuous", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 12, "s": 0.5666890080428955, "os": 0.5727459003192917, "bg": 2.25378055912329e-06}, {"x": 0.6988941018766756, "y": 0.6067359249329759, "term": "syringe", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 12, "s": 0.40097184986595175, "os": 0.4106948437732975, "bg": 2.7166064723864103e-05}, {"x": 0.6990616621983914, "y": 0.3398123324396783, "term": "ready", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 4.763455682586686e-07}, {"x": 0.6992292225201072, "y": 0.6739276139410187, "term": "significant", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 7.161051084074014e-07}, {"x": 0.699396782841823, "y": 0.5170911528150134, "term": "shift", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 12, "s": 0.34014745308310995, "os": 0.34214210335193007, "bg": 1.6895644894093875e-06}, {"x": 0.6995643431635389, "y": 0.34400134048257375, "term": "millennium", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 3.293014396839409e-06}, {"x": 0.6997319034852547, "y": 0.7553619302949062, "term": "strengthened", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 12, "s": 0.5666890080428955, "os": 0.5727459003192917, "bg": 1.8118206804836112e-05}, {"x": 0.6998994638069705, "y": 0.4339812332439678, "term": "emphasis", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 12, "s": 0.2915549597855228, "os": 0.30428868768717954, "bg": 2.041745138269852e-06}, {"x": 0.7000670241286864, "y": 0.574396782841823, "term": "clusters", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 5.778374305752403e-06}, {"x": 0.7002345844504021, "y": 0.4354892761394102, "term": "occurring", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 12, "s": 0.2915549597855228, "os": 0.30428868768717954, "bg": 4.859243655687965e-06}, {"x": 0.7004021447721179, "y": 0.43615951742627346, "term": "closely", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 12, "s": 0.2915549597855228, "os": 0.30428868768717954, "bg": 2.0998543750990865e-06}, {"x": 0.7005697050938338, "y": 0.5752345844504021, "term": "considering", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 1.998750225900416e-06}, {"x": 0.7007372654155496, "y": 0.579926273458445, "term": "assessing", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 5.293929245459206e-06}, {"x": 0.7009048257372654, "y": 0.17845174262734584, "term": "indirectly", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 6.06817218018457e-06}, {"x": 0.7010723860589813, "y": 0.272955764075067, "term": "extra", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 12, "s": 0.21447721179624668, "os": 0.2222992488245219, "bg": 4.6909597398715394e-07}, {"x": 0.7012399463806971, "y": 0.27429624664879354, "term": "girls", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 12, "s": 0.21447721179624668, "os": 0.2222992488245219, "bg": 2.1110189860750175e-07}, {"x": 0.7014075067024129, "y": 0.18398123324396784, "term": "o", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 1.0537331695205151e-07}, {"x": 0.7015750670241286, "y": 0.36695710455764075, "term": "text", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 1.4347747660920175e-07}, {"x": 0.7017426273458445, "y": 0.582774798927614, "term": "32", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 12, "s": 0.3664544235924933, "os": 0.3776189206159662, "bg": 0.0}, {"x": 0.7019101876675603, "y": 0.6777815013404825, "term": "measure", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 12, "s": 0.4587801608579089, "os": 0.46993518362269454, "bg": 1.2964659172538038e-06}, {"x": 0.7020777479892761, "y": 0.19302949061662197, "term": "spot", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 9.607248654329309e-07}, {"x": 0.702245308310992, "y": 0.7411193029490617, "term": "release", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 12, "s": 0.55328418230563, "os": 0.5533343885895665, "bg": 3.820049349148349e-07}, {"x": 0.7024128686327078, "y": 0.3011058981233244, "term": "vomiting", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 12, "s": 0.21447721179624668, "os": 0.2222992488245219, "bg": 1.1674177053904678e-05}, {"x": 0.7025804289544236, "y": 0.21380697050938338, "term": "send", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 9.474681495553839e-08}, {"x": 0.7027479892761395, "y": 0.37667560321715815, "term": "measured", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 12, "s": 0.24530831099195713, "os": 0.26421856277612193, "bg": 1.6636033259866762e-06}, {"x": 0.7029155495978552, "y": 0.21833109919571045, "term": "_", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 12, "s": 0.189343163538874, "os": 0.1792027845521179, "bg": 0.0}, {"x": 0.703083109919571, "y": 0.00435656836461126, "term": "trimester", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 1.57019662132942e-05}, {"x": 0.7032506702412868, "y": 0.007875335120643432, "term": "infertile", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 4.057844574408189e-05}, {"x": 0.7034182305630027, "y": 0.02195040214477212, "term": "award", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 4.002392763807296e-07}, {"x": 0.7035857908847185, "y": 0.03904155495978552, "term": "substitute", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 2.259496168129863e-06}, {"x": 0.7037533512064343, "y": 0.03920911528150134, "term": "bottle", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 1.331236561790926e-06}, {"x": 0.7039209115281502, "y": 0.04272788203753351, "term": "nipple", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 3.0352759774094527e-06}, {"x": 0.704088471849866, "y": 0.05713806970509384, "term": "epidemiological linkage", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 0.0}, {"x": 0.7042560321715817, "y": 0.058310991957104555, "term": "filled", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 1.0100885540426628e-06}, {"x": 0.7044235924932976, "y": 0.09333109919571046, "term": "r", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 7.41092485192509e-08}, {"x": 0.7045911528150134, "y": 0.10489276139410188, "term": "monovalent", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 6.115475465476867e-05}, {"x": 0.7047587131367292, "y": 0.10673592493297587, "term": "resuscitation", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 2.4091064222762037e-05}, {"x": 0.704926273458445, "y": 0.1156166219839142, "term": "conformation", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 1.650161612702944e-05}, {"x": 0.7050938337801609, "y": 0.1184651474530831, "term": "rabid", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 2.5955907402300344e-05}, {"x": 0.7052613941018767, "y": 0.12014075067024128, "term": "tcv", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 6.184244092114315e-05}, {"x": 0.7054289544235925, "y": 0.1288538873994638, "term": "colostrum", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 12, "s": 0.05177613941018767, "os": 0.13602496240968603, "bg": 3.53215957708276e-05}, {"x": 0.7055965147453083, "y": 0.5864611260053619, "term": "90%", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 13, "s": 0.37617292225201077, "os": 0.3909006008156076, "bg": 0.0}, {"x": 0.7057640750670241, "y": 0.6221514745308311, "term": "inadequate", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 13, "s": 0.407171581769437, "os": 0.4206701909930792, "bg": 8.070286817993512e-06}, {"x": 0.7059316353887399, "y": 0.7900469168900804, "term": "furthermore", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 13, "s": 0.631534852546917, "os": 0.6204618180010547, "bg": 5.095950808447116e-06}, {"x": 0.7060991957104558, "y": 0.7047587131367292, "term": "entities", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 4.10771911450926e-06}, {"x": 0.7062667560321716, "y": 0.7659182305630027, "term": "mentioned", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 13, "s": 0.5857908847184986, "os": 0.5901452838755467, "bg": 1.9391774902493134e-06}, {"x": 0.7064343163538874, "y": 0.2273793565683646, "term": "preferred", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 13, "s": 0.20643431635388743, "os": 0.21234248671491002, "bg": 1.5035921568423042e-06}, {"x": 0.7066018766756033, "y": 0.5420576407506702, "term": "computed", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 6.311241882995554e-06}, {"x": 0.7067694369973191, "y": 0.7263739946380697, "term": "tool", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 13, "s": 0.5291554959785523, "os": 0.5355220310713622, "bg": 7.654422657287018e-07}, {"x": 0.7069369973190348, "y": 0.8458445040214477, "term": "behavior", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 13, "s": 0.7191689008042895, "os": 0.7009562695421316, "bg": 2.2811192835805803e-06}, {"x": 0.7071045576407506, "y": 0.7071045576407506, "term": "temporary", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 2.2895895796199054e-06}, {"x": 0.7072721179624665, "y": 0.6583445040214477, "term": "aim", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 13, "s": 0.4316353887399464, "os": 0.4484611835301789, "bg": 1.5035939826032127e-06}, {"x": 0.7074396782841823, "y": 0.5454088471849866, "term": "brought", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 9.47471671843685e-07}, {"x": 0.7076072386058981, "y": 0.5455764075067024, "term": "trainers", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 5.7366534869568886e-06}, {"x": 0.707774798927614, "y": 0.6586796246648794, "term": "just", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 13, "s": 0.4316353887399464, "os": 0.4484611835301789, "bg": 9.500199923070835e-08}, {"x": 0.7079423592493298, "y": 0.880529490616622, "term": "receipt", "cat25k": 5, "ncat25k": 2, "cat": 32, "ncat": 13, "s": 0.7949061662198391, "os": 0.7630724909349231, "bg": 6.070756283350796e-06}, {"x": 0.7081099195710456, "y": 0.8034517426273459, "term": "users", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 13, "s": 0.6464477211796247, "os": 0.6341544435333908, "bg": 4.143492569401262e-07}, {"x": 0.7082774798927614, "y": 0.8404825737265416, "term": "self", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 13, "s": 0.7020777479892761, "os": 0.6913345412554124, "bg": 6.359628007338905e-07}, {"x": 0.7084450402144772, "y": 0.39125335120643434, "term": "1992", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 0.0}, {"x": 0.708612600536193, "y": 0.8716487935656837, "term": "registered", "cat25k": 5, "ncat25k": 2, "cat": 30, "ncat": 13, "s": 0.7823391420911529, "os": 0.7496140640720383, "bg": 9.682620040422688e-07}, {"x": 0.7087801608579088, "y": 0.7091152815013405, "term": "concern", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 1.92586549298004e-06}, {"x": 0.7089477211796247, "y": 0.7469839142091153, "term": "acceptance", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 13, "s": 0.5539544235924933, "os": 0.5551410582460871, "bg": 1.3987179458901662e-06}, {"x": 0.7091152815013405, "y": 0.8718163538873994, "term": "academe", "cat25k": 5, "ncat25k": 2, "cat": 30, "ncat": 13, "s": 0.7823391420911529, "os": 0.7496140640720383, "bg": 0.00012293424018777491}, {"x": 0.7092828418230563, "y": 0.8808646112600537, "term": "function", "cat25k": 5, "ncat25k": 2, "cat": 32, "ncat": 13, "s": 0.7949061662198391, "os": 0.7630724909349231, "bg": 9.555064290772328e-07}, {"x": 0.7094504021447721, "y": 0.6306970509383378, "term": "resulting", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 13, "s": 0.407171581769437, "os": 0.4206701909930792, "bg": 1.8956948093845017e-06}, {"x": 0.7096179624664879, "y": 0.592828418230563, "term": "acquired", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 13, "s": 0.37617292225201077, "os": 0.3909006008156076, "bg": 3.093193273541907e-06}, {"x": 0.7097855227882037, "y": 0.5495978552278821, "term": "victims", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 2.3773085151499923e-06}, {"x": 0.7099530831099196, "y": 0.9143766756032171, "term": "partnership", "cat25k": 7, "ncat25k": 2, "cat": 46, "ncat": 13, "s": 0.8889075067024128, "os": 0.8327131510277793, "bg": 3.7404260941253505e-06}, {"x": 0.7101206434316354, "y": 0.7106233243967829, "term": "m", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 1.4039364429899624e-07}, {"x": 0.7102882037533512, "y": 0.7712801608579088, "term": "utilized", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 13, "s": 0.5857908847184986, "os": 0.5901452838755467, "bg": 1.16637191476404e-05}, {"x": 0.710455764075067, "y": 0.7716152815013405, "term": "composition", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 13, "s": 0.5857908847184986, "os": 0.5901452838755467, "bg": 3.445550609754785e-06}, {"x": 0.7106233243967829, "y": 0.7952412868632708, "term": "secretariat", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 13, "s": 0.631534852546917, "os": 0.6204618180010547, "bg": 1.0174021551629853e-05}, {"x": 0.7107908847184986, "y": 0.8689678284182306, "term": "organized", "cat25k": 5, "ncat25k": 2, "cat": 29, "ncat": 13, "s": 0.7629021447721179, "os": 0.7424285666366391, "bg": 4.611660066411199e-06}, {"x": 0.7109584450402144, "y": 0.8733243967828418, "term": "bene\ufb01t", "cat25k": 5, "ncat25k": 2, "cat": 30, "ncat": 13, "s": 0.7823391420911529, "os": 0.7496140640720383, "bg": 0.0}, {"x": 0.7111260053619303, "y": 0.7488270777479893, "term": "actual", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 13, "s": 0.5539544235924933, "os": 0.5551410582460871, "bg": 1.2131131937257787e-06}, {"x": 0.7112935656836461, "y": 0.7315683646112601, "term": "organize", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 13, "s": 0.5291554959785523, "os": 0.5355220310713622, "bg": 6.1384324555129395e-06}, {"x": 0.7114611260053619, "y": 0.6630361930294906, "term": "p", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 13, "s": 0.4316353887399464, "os": 0.4484611835301789, "bg": 1.4494573704325859e-07}, {"x": 0.7116286863270778, "y": 0.9468833780160858, "term": "medically", "cat25k": 11, "ncat25k": 2, "cat": 70, "ncat": 13, "s": 0.9785522788203754, "os": 0.8974033711026836, "bg": 8.226634870227313e-05}, {"x": 0.7117962466487936, "y": 0.487097855227882, "term": "supervise", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 1.7048820718863526e-05}, {"x": 0.7119638069705094, "y": 0.7732908847184986, "term": "manufacturer", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 13, "s": 0.5857908847184986, "os": 0.5901452838755467, "bg": 9.582946079637295e-07}, {"x": 0.7121313672922251, "y": 0.6905160857908847, "term": "succeeding", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 13, "s": 0.4601206434316354, "os": 0.4743710048386596, "bg": 2.4029106561252023e-05}, {"x": 0.712298927613941, "y": 0.4886058981233244, "term": "accomplished", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 4.368600152464146e-06}, {"x": 0.7124664879356568, "y": 0.636896782841823, "term": "whenever", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 13, "s": 0.407171581769437, "os": 0.4206701909930792, "bg": 2.8873210582774133e-06}, {"x": 0.7126340482573726, "y": 0.7756367292225201, "term": "remain valid", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 13, "s": 0.5857908847184986, "os": 0.5901452838755467, "bg": 0.0}, {"x": 0.7128016085790885, "y": 0.16303619302949063, "term": "cured", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 13, "s": 0.18599195710455768, "os": 0.1722086559193094, "bg": 1.2347704297177491e-05}, {"x": 0.7129691689008043, "y": 0.7516756032171582, "term": "experts", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 13, "s": 0.5539544235924933, "os": 0.5551410582460871, "bg": 1.6131129705202365e-06}, {"x": 0.7131367292225201, "y": 0.4113605898123324, "term": "commercial", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 3.7417362928589205e-07}, {"x": 0.713304289544236, "y": 0.6695710455764075, "term": "put", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 13, "s": 0.4316353887399464, "os": 0.4484611835301789, "bg": 3.8089609077598735e-07}, {"x": 0.7134718498659517, "y": 0.7523458445040214, "term": "animals", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 13, "s": 0.5539544235924933, "os": 0.5551410582460871, "bg": 8.890326994262338e-07}, {"x": 0.7136394101876675, "y": 0.561662198391421, "term": "namely", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 5.550298189770246e-06}, {"x": 0.7138069705093834, "y": 0.24815683646112602, "term": "sent", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 13, "s": 0.20643431635388743, "os": 0.21234248671491002, "bg": 4.3373603507316806e-07}, {"x": 0.7139745308310992, "y": 0.8155160857908847, "term": "managed", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 13, "s": 0.6581769436997319, "os": 0.6469968265251553, "bg": 2.070253268315304e-06}, {"x": 0.714142091152815, "y": 0.7176608579088471, "term": "aged", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 2.6130173556612763e-06}, {"x": 0.7143096514745308, "y": 0.7632372654155496, "term": "political", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 13, "s": 0.5675268096514746, "os": 0.5732959667865816, "bg": 6.558670544849045e-07}, {"x": 0.7144772117962467, "y": 0.7387734584450402, "term": "later", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 13, "s": 0.5291554959785523, "os": 0.5355220310713622, "bg": 5.870614750581766e-07}, {"x": 0.7146447721179625, "y": 0.719671581769437, "term": "companies", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 13, "s": 0.48223860589812334, "os": 0.5142570404588606, "bg": 4.0534357339291343e-07}, {"x": 0.7148123324396782, "y": 0.430127345844504, "term": "reviews", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 1.1039101644142045e-07}, {"x": 0.7149798927613941, "y": 0.5145777479892761, "term": "build", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 4.644259405109072e-07}, {"x": 0.7151474530831099, "y": 0.34199061662198393, "term": "exposed", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 13, "s": 0.23877345844504025, "os": 0.2515693048457792, "bg": 2.274593149920567e-06}, {"x": 0.7153150134048257, "y": 0.34433646112600536, "term": "contained", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 13, "s": 0.23877345844504025, "os": 0.2515693048457792, "bg": 1.0572565197705649e-06}, {"x": 0.7154825737265416, "y": 0.739946380697051, "term": "western", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 13, "s": 0.5291554959785523, "os": 0.5355220310713622, "bg": 6.283986864406307e-07}, {"x": 0.7156501340482574, "y": 0.6481233243967829, "term": "budgetary", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 13, "s": 0.407171581769437, "os": 0.4206701909930792, "bg": 1.821589215150938e-05}, {"x": 0.7158176943699732, "y": 0.6482908847184986, "term": "despite", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 13, "s": 0.407171581769437, "os": 0.4206701909930792, "bg": 1.4757053054451734e-06}, {"x": 0.715985254691689, "y": 0.7406166219839142, "term": "experience", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 13, "s": 0.5291554959785523, "os": 0.5355220310713622, "bg": 3.637775251900658e-07}, {"x": 0.7161528150134048, "y": 0.5189343163538874, "term": "ngo", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 8.482647566257725e-06}, {"x": 0.7163203753351206, "y": 0.5236260053619303, "term": "h", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 1.630172854880559e-07}, {"x": 0.7164879356568364, "y": 0.579088471849866, "term": "united", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 13, "s": 0.3530495978552279, "os": 0.3590836231161315, "bg": 1.2683910908623676e-07}, {"x": 0.7166554959785523, "y": 0.6761058981233244, "term": "improved", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 13, "s": 0.4316353887399464, "os": 0.4484611835301789, "bg": 1.5879055298701812e-06}, {"x": 0.7168230563002681, "y": 0.44839142091152817, "term": "contains", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 6.130776015957039e-07}, {"x": 0.7169906166219839, "y": 0.8744973190348525, "term": "acid", "cat25k": 5, "ncat25k": 2, "cat": 30, "ncat": 13, "s": 0.7823391420911529, "os": 0.7496140640720383, "bg": 2.7581883154355238e-06}, {"x": 0.7171581769436998, "y": 0.2758042895442359, "term": "attendance", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 13, "s": 0.20643431635388743, "os": 0.21234248671491002, "bg": 2.092805750025654e-06}, {"x": 0.7173257372654156, "y": 0.4542560321715818, "term": "solution", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 4.575269460158439e-07}, {"x": 0.7174932975871313, "y": 0.5306635388739946, "term": "decline", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 13, "s": 0.30831099195710454, "os": 0.32519890252993944, "bg": 3.086453359017198e-06}, {"x": 0.7176608579088471, "y": 0.18582439678284182, "term": "conferences", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 13, "s": 0.18599195710455768, "os": 0.1722086559193094, "bg": 1.4786042271816251e-06}, {"x": 0.717828418230563, "y": 0.46179624664879354, "term": "rapidly", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 13, "s": 0.26926943699731903, "os": 0.2893029882713123, "bg": 2.7707357175296873e-06}, {"x": 0.7179959785522788, "y": 0.20760723860589814, "term": "route", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 13, "s": 0.18599195710455768, "os": 0.1722086559193094, "bg": 8.818563782246733e-07}, {"x": 0.7181635388739946, "y": 0.20961796246648792, "term": "wasting", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 13, "s": 0.18599195710455768, "os": 0.1722086559193094, "bg": 9.023545976416963e-06}, {"x": 0.7183310991957105, "y": 0.2168230563002681, "term": "natal", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 13, "s": 0.18599195710455768, "os": 0.1722086559193094, "bg": 8.428659972504508e-06}, {"x": 0.7184986595174263, "y": 0.0018431635388739946, "term": "sexually transmitted", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 0.0}, {"x": 0.7186662198391421, "y": 0.01675603217158177, "term": "seminars", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 1.913889263692203e-06}, {"x": 0.7188337801608579, "y": 0.022117962466487937, "term": "corrective", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 7.586336890547249e-06}, {"x": 0.7190013404825737, "y": 0.025971849865951743, "term": "waiting homes", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 0.0}, {"x": 0.7191689008042895, "y": 0.0388739946380697, "term": "iodized", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 6.710196918471108e-05}, {"x": 0.7193364611260054, "y": 0.05093833780160858, "term": "outbreaks", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 1.4975655919329596e-05}, {"x": 0.7195040214477212, "y": 0.059819034852546915, "term": "stds", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 2.113135657620008e-05}, {"x": 0.719671581769437, "y": 0.06735924932975872, "term": "supplementary", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 5.612881303535554e-06}, {"x": 0.7198391420911529, "y": 0.08310991957104558, "term": "flaccid", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 5.696694821485303e-05}, {"x": 0.7200067024128687, "y": 0.08378016085790885, "term": "acute flaccid", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 0.0}, {"x": 0.7201742627345844, "y": 0.08394772117962467, "term": "flaccid paralysis", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 0.0}, {"x": 0.7203418230563002, "y": 0.08763404825737266, "term": "naspcp", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 8.334134692438375e-05}, {"x": 0.7205093833780161, "y": 0.09500670241286863, "term": "leaders", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 7.417123628046085e-07}, {"x": 0.7206769436997319, "y": 0.1496313672922252, "term": "snail", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 13, "s": 0.04808981233243968, "os": 0.13207866314919486, "bg": 1.3737642726182363e-05}, {"x": 0.7208445040214477, "y": 0.6554959785522788, "term": "identification", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 1.9014676808985044e-06}, {"x": 0.7210120643431636, "y": 0.7567024128686327, "term": "gender", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 14, "s": 0.5549597855227882, "os": 0.5569012167272867, "bg": 1.8943905674504862e-06}, {"x": 0.7211796246648794, "y": 0.47134718498659517, "term": "genital", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 14, "s": 0.29507372654155495, "os": 0.3099372325176686, "bg": 1.4751495529908656e-05}, {"x": 0.7213471849865952, "y": 0.8317694369973191, "term": "certain", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 14, "s": 0.6823056300268097, "os": 0.6669392560929321, "bg": 9.806564694193312e-07}, {"x": 0.721514745308311, "y": 0.7245308310991957, "term": "ten", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 14, "s": 0.4840817694369973, "os": 0.518836806644528, "bg": 1.1012409799892655e-06}, {"x": 0.7216823056300268, "y": 0.859416890080429, "term": "memorandum", "cat25k": 4, "ncat25k": 2, "cat": 27, "ncat": 14, "s": 0.7257037533512064, "os": 0.7141755492882187, "bg": 1.5452630150719678e-05}, {"x": 0.7218498659517426, "y": 0.800603217158177, "term": "statement", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 14, "s": 0.6306970509383377, "os": 0.6187572998475165, "bg": 6.325300791031245e-07}, {"x": 0.7220174262734584, "y": 0.8007707774798928, "term": "themselves", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 14, "s": 0.6306970509383377, "os": 0.6187572998475165, "bg": 1.3477078448199492e-06}, {"x": 0.7221849865951743, "y": 0.5878016085790885, "term": "f", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 1.4113011871338028e-07}, {"x": 0.7223525469168901, "y": 0.5879691689008043, "term": "officers", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 1.43505828250038e-06}, {"x": 0.7225201072386059, "y": 0.7050938337801609, "term": "along", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 14, "s": 0.4602882037533512, "os": 0.4779242376681658, "bg": 5.969668971587695e-07}, {"x": 0.7226876675603218, "y": 0.8558981233243967, "term": "stated", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 14, "s": 0.7201742627345845, "os": 0.705646944261021, "bg": 2.3942938709608484e-06}, {"x": 0.7228552278820375, "y": 0.5418900804289544, "term": "keep", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 14, "s": 0.34081769436997317, "os": 0.3423354075053314, "bg": 3.3357102770840267e-07}, {"x": 0.7230227882037533, "y": 0.38388069705093836, "term": "successfully", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 14, "s": 0.25921581769436997, "os": 0.275825905095839, "bg": 1.9631196348553857e-06}, {"x": 0.7231903485254692, "y": 0.7667560321715817, "term": "1.2", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 14, "s": 0.5681970509383378, "os": 0.5739642428480926, "bg": 0.0}, {"x": 0.723357908847185, "y": 0.6570040214477212, "term": "specifically", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 1.7407070744568152e-06}, {"x": 0.7235254691689008, "y": 0.782171581769437, "term": "officer", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 14, "s": 0.5847855227882037, "os": 0.589889138032513, "bg": 1.2296303534416696e-06}, {"x": 0.7236930294906166, "y": 0.7585455764075067, "term": "situation", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 14, "s": 0.5549597855227882, "os": 0.5569012167272867, "bg": 1.2965293414429699e-06}, {"x": 0.7238605898123325, "y": 0.15566353887399464, "term": "72", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 0.0}, {"x": 0.7240281501340483, "y": 0.5913203753351206, "term": "sessions", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 1.9250281294735415e-06}, {"x": 0.724195710455764, "y": 0.7292225201072386, "term": "certi\ufb01cate", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 14, "s": 0.4840817694369973, "os": 0.518836806644528, "bg": 0.0}, {"x": 0.7243632707774799, "y": 0.5474195710455764, "term": "completion", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 14, "s": 0.34081769436997317, "os": 0.3423354075053314, "bg": 2.0813445652399014e-06}, {"x": 0.7245308310991957, "y": 0.7928954423592494, "term": "consequences", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 14, "s": 0.6045576407506703, "os": 0.6047874247835774, "bg": 4.565847548706915e-06}, {"x": 0.7246983914209115, "y": 0.7830093833780161, "term": "violations", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 14, "s": 0.5847855227882037, "os": 0.589889138032513, "bg": 6.499862148756929e-06}, {"x": 0.7248659517426274, "y": 0.8041219839142091, "term": "modi\ufb01ed", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 14, "s": 0.6306970509383377, "os": 0.6187572998475165, "bg": 0.0}, {"x": 0.7250335120643432, "y": 0.6858243967828418, "term": "absence", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 14, "s": 0.4334785522788204, "os": 0.45417015642647746, "bg": 3.2013067734249124e-06}, {"x": 0.725201072386059, "y": 0.9019772117962467, "term": "formulation", "cat25k": 6, "ncat25k": 2, "cat": 40, "ncat": 14, "s": 0.8285857908847185, "os": 0.7971678393042148, "bg": 2.0858182896908043e-05}, {"x": 0.7253686327077749, "y": 0.7932305630026809, "term": "situations", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 14, "s": 0.6045576407506703, "os": 0.6047874247835774, "bg": 3.73879229169575e-06}, {"x": 0.7255361930294906, "y": 0.7298927613941019, "term": "greater", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 14, "s": 0.4840817694369973, "os": 0.518836806644528, "bg": 9.288062506945953e-07}, {"x": 0.7257037533512064, "y": 0.8642761394101877, "term": "functional", "cat25k": 4, "ncat25k": 2, "cat": 28, "ncat": 14, "s": 0.7481568364611261, "os": 0.7223112736151206, "bg": 1.991704267197939e-06}, {"x": 0.7258713136729222, "y": 0.8190348525469169, "term": "populations", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 14, "s": 0.6575067024128687, "os": 0.6442478793171375, "bg": 6.081224772978042e-06}, {"x": 0.7260388739946381, "y": 0.8954423592493298, "term": "vision", "cat25k": 6, "ncat25k": 2, "cat": 37, "ncat": 14, "s": 0.811662198391421, "os": 0.7816424272066183, "bg": 2.3320907252797583e-06}, {"x": 0.7262064343163539, "y": 0.7949061662198391, "term": "enhancement", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 14, "s": 0.6045576407506703, "os": 0.6047874247835774, "bg": 6.459531711039308e-06}, {"x": 0.7263739946380697, "y": 0.8688002680965148, "term": "promoting", "cat25k": 5, "ncat25k": 2, "cat": 29, "ncat": 14, "s": 0.7560321715817694, "os": 0.7300816211411162, "bg": 6.481612118624957e-06}, {"x": 0.7265415549597856, "y": 0.8781836461126006, "term": "environmental", "cat25k": 5, "ncat25k": 2, "cat": 31, "ncat": 14, "s": 0.7642426273458446, "os": 0.7446232569102897, "bg": 1.0987895965770799e-06}, {"x": 0.7267091152815014, "y": 0.852044235924933, "term": "stage", "cat25k": 4, "ncat25k": 2, "cat": 25, "ncat": 14, "s": 0.7044235924932977, "os": 0.6966949471133119, "bg": 1.4764247337788527e-06}, {"x": 0.7268766756032171, "y": 0.6625335120643432, "term": "achieving", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 5.062995774599831e-06}, {"x": 0.727044235924933, "y": 0.9190683646112601, "term": "intended", "cat25k": 8, "ncat25k": 2, "cat": 48, "ncat": 14, "s": 0.8496983914209116, "os": 0.8313617942946865, "bg": 3.3384992121411093e-06}, {"x": 0.7272117962466488, "y": 0.6333780160857909, "term": "distributed", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 14, "s": 0.39242627345844505, "os": 0.4017558064222921, "bg": 1.548920325087398e-06}, {"x": 0.7273793565683646, "y": 0.5531166219839142, "term": "exclusively", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 14, "s": 0.34081769436997317, "os": 0.3423354075053314, "bg": 4.539596402642227e-06}, {"x": 0.7275469168900804, "y": 0.6901809651474531, "term": "importation", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 14, "s": 0.4334785522788204, "os": 0.45417015642647746, "bg": 3.131027635884969e-05}, {"x": 0.7277144772117963, "y": 0.6353887399463807, "term": "carried", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 14, "s": 0.39242627345844505, "os": 0.4017558064222921, "bg": 1.5979968093088254e-06}, {"x": 0.7278820375335121, "y": 0.3227211796246649, "term": "assists", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 14, "s": 0.22654155495978556, "os": 0.24017815344664806, "bg": 6.024988818329575e-06}, {"x": 0.7280495978552279, "y": 0.806970509383378, "term": "circulation", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 14, "s": 0.6306970509383377, "os": 0.6187572998475165, "bg": 7.4726870369780076e-06}, {"x": 0.7282171581769437, "y": 0.8285857908847185, "term": "described", "cat25k": 3, "ncat25k": 2, "cat": 21, "ncat": 14, "s": 0.6670576407506702, "os": 0.655912563195001, "bg": 1.5480884027478478e-06}, {"x": 0.7283847184986595, "y": 0.7498324396782842, "term": "located", "cat25k": 2, "ncat25k": 2, "cat": 13, "ncat": 14, "s": 0.5355227882037534, "os": 0.5385733579742635, "bg": 8.112784409620134e-07}, {"x": 0.7285522788203753, "y": 0.6916890080428955, "term": "2.1", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 14, "s": 0.4334785522788204, "os": 0.45417015642647746, "bg": 0.0}, {"x": 0.7287198391420912, "y": 0.6668900804289544, "term": "caused", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 1.681970218962174e-06}, {"x": 0.728887399463807, "y": 0.8485254691689008, "term": "increasing", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 14, "s": 0.6995643431635389, "os": 0.6872856267065935, "bg": 2.641738297168863e-06}, {"x": 0.7290549597855228, "y": 0.6379021447721179, "term": "equipped", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 14, "s": 0.39242627345844505, "os": 0.4017558064222921, "bg": 3.3982515223587573e-06}, {"x": 0.7292225201072386, "y": 0.8357908847184986, "term": "100%", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 14, "s": 0.6823056300268097, "os": 0.6669392560929321, "bg": 0.0}, {"x": 0.7293900804289544, "y": 0.7143096514745308, "term": "arrangements", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 14, "s": 0.4602882037533512, "os": 0.4779242376681658, "bg": 2.6390074756220366e-06}, {"x": 0.7295576407506702, "y": 0.6013739946380697, "term": "sugar", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 1.8451553535139733e-06}, {"x": 0.729725201072386, "y": 0.8079758713136729, "term": "sectoral", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 14, "s": 0.6306970509383377, "os": 0.6187572998475165, "bg": 3.602281144534777e-05}, {"x": 0.7298927613941019, "y": 0.40951742627345844, "term": "production", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 14, "s": 0.25921581769436997, "os": 0.275825905095839, "bg": 3.9593195750937415e-07}, {"x": 0.7300603217158177, "y": 0.49664879356568364, "term": "conducting", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 14, "s": 0.29507372654155495, "os": 0.3099372325176686, "bg": 4.601685379379897e-06}, {"x": 0.7302278820375335, "y": 0.6043900804289544, "term": "energy", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 3.566484956239527e-07}, {"x": 0.7303954423592494, "y": 0.8585790884718498, "term": "a0", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 14, "s": 0.7201742627345845, "os": 0.705646944261021, "bg": 0.0}, {"x": 0.7305630026809652, "y": 0.16689008042895442, "term": "kits", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 1.2322121954834001e-06}, {"x": 0.7307305630026809, "y": 0.33612600536193027, "term": "consumed", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 14, "s": 0.22654155495978556, "os": 0.24017815344664806, "bg": 8.226728641355765e-06}, {"x": 0.7308981233243967, "y": 0.6087466487935657, "term": "antibiotics", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 14, "s": 0.3632707774798927, "os": 0.3729440857779587, "bg": 1.2017157066817969e-05}, {"x": 0.7310656836461126, "y": 0.6968833780160858, "term": "accepted", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 14, "s": 0.4334785522788204, "os": 0.45417015642647746, "bg": 1.0162175405033082e-06}, {"x": 0.7312332439678284, "y": 0.25837801608579086, "term": "tropical medicine", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 14, "s": 0.20090482573726542, "os": 0.20331248983305267, "bg": 0.0}, {"x": 0.7314008042895442, "y": 0.7779825737265416, "term": "enhanced", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 14, "s": 0.5681970509383378, "os": 0.5739642428480926, "bg": 3.1428945169820886e-06}, {"x": 0.7315683646112601, "y": 0.6747654155495979, "term": "clinically", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 2.1719884318007436e-05}, {"x": 0.7317359249329759, "y": 0.6501340482573726, "term": "2015", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 14, "s": 0.39242627345844505, "os": 0.4017558064222921, "bg": 0.0}, {"x": 0.7319034852546917, "y": 0.35187667560321717, "term": "tissue", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 14, "s": 0.22654155495978556, "os": 0.24017815344664806, "bg": 2.157349591965878e-06}, {"x": 0.7320710455764075, "y": 0.1761058981233244, "term": "bid", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 4.240936898732336e-07}, {"x": 0.7322386058981233, "y": 0.6511394101876675, "term": "maintaining", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 14, "s": 0.39242627345844505, "os": 0.4017558064222921, "bg": 3.2176074499897878e-06}, {"x": 0.7324061662198391, "y": 0.676441018766756, "term": "points", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 14, "s": 0.4137064343163539, "os": 0.4288087772299797, "bg": 5.105879626845445e-07}, {"x": 0.732573726541555, "y": 0.7221849865951743, "term": "easily", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 14, "s": 0.4602882037533512, "os": 0.4779242376681658, "bg": 1.1831163896190623e-06}, {"x": 0.7327412868632708, "y": 0.1828083109919571, "term": "technique", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 1.5671804824596457e-06}, {"x": 0.7329088471849866, "y": 0.3636058981233244, "term": "prototype", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 14, "s": 0.22654155495978556, "os": 0.24017815344664806, "bg": 5.5650734679721015e-06}, {"x": 0.7330764075067024, "y": 0.28853887399463807, "term": "metabolic", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 14, "s": 0.20090482573726542, "os": 0.20331248983305267, "bg": 8.809920190382376e-06}, {"x": 0.7332439678284183, "y": 0.19956434316353888, "term": "95%", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 0.0}, {"x": 0.733411528150134, "y": 0.20291554959785524, "term": "obstetrical", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 5.781895343839679e-05}, {"x": 0.7335790884718498, "y": 0.465985254691689, "term": "your", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 14, "s": 0.25921581769436997, "os": 0.275825905095839, "bg": 1.7455573560322403e-08}, {"x": 0.7337466487935657, "y": 0.2121313672922252, "term": "couple", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 6.835243362346436e-07}, {"x": 0.7339142091152815, "y": 0.21548257372654156, "term": "expressed", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 1.187825266152048e-06}, {"x": 0.7340817694369973, "y": 0.22235254691689008, "term": "screened", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 14, "s": 0.11343833780160859, "os": 0.16574099081198662, "bg": 8.191564654381503e-06}, {"x": 0.7342493297587132, "y": 0.007540214477211796, "term": "fertility awareness", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 0.0}, {"x": 0.734416890080429, "y": 0.01022117962466488, "term": "wet", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 1.15557960261681e-06}, {"x": 0.7345844504021448, "y": 0.020777479892761394, "term": "diamond sangkap", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 0.0}, {"x": 0.7347520107238605, "y": 0.02982573726541555, "term": "mchs", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 8.133647447051407e-05}, {"x": 0.7349195710455764, "y": 0.03116621983914209, "term": "antigen", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 7.403163318806389e-06}, {"x": 0.7350871313672922, "y": 0.036528150134048254, "term": "teats", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 6.66097312059454e-05}, {"x": 0.735254691689008, "y": 0.05613270777479893, "term": "mmr", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 3.1556158127908385e-05}, {"x": 0.7354222520107239, "y": 0.0795911528150134, "term": "nscs", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 7.834052387427465e-05}, {"x": 0.7355898123324397, "y": 0.08579088471849866, "term": "eccd card", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 0.0}, {"x": 0.7357573726541555, "y": 0.1107573726541555, "term": "patak", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 14, "s": 0.04524128686327079, "os": 0.1282286510531101, "bg": 8.275454411112753e-05}, {"x": 0.7359249329758714, "y": 0.5862935656836461, "term": "100,000", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 15, "s": 0.352044235924933, "os": 0.3565617759225108, "bg": 0.0}, {"x": 0.7360924932975871, "y": 0.7897117962466488, "term": "undertake", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 15, "s": 0.5841152815013405, "os": 0.5898232571843925, "bg": 1.0800900255036257e-05}, {"x": 0.7362600536193029, "y": 0.7568699731903485, "term": "hand", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 15, "s": 0.5410522788203753, "os": 0.5414070702492477, "bg": 4.769397689294249e-07}, {"x": 0.7364276139410187, "y": 0.6559986595174263, "term": "preventable", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 15, "s": 0.40130697050938335, "os": 0.4107473867191723, "bg": 4.780562233956731e-05}, {"x": 0.7365951742627346, "y": 0.8858914209115282, "term": "amended", "cat25k": 5, "ncat25k": 2, "cat": 34, "ncat": 15, "s": 0.7863605898123325, "os": 0.7532484411359646, "bg": 5.279501951180015e-06}, {"x": 0.7367627345844504, "y": 0.8242292225201072, "term": "25", "cat25k": 3, "ncat25k": 2, "cat": 21, "ncat": 15, "s": 0.6551608579088471, "os": 0.6418986863904278, "bg": 0.0}, {"x": 0.7369302949061662, "y": 0.7045911528150134, "term": "formulated", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 15, "s": 0.4395107238605898, "os": 0.4588583038357306, "bg": 1.5546798854320513e-05}, {"x": 0.7370978552278821, "y": 0.8552278820375335, "term": "applicable", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 15, "s": 0.7029155495978552, "os": 0.6928765560060498, "bg": 2.377824271652852e-06}, {"x": 0.7372654155495979, "y": 0.8942694369973191, "term": "deemed", "cat25k": 6, "ncat25k": 2, "cat": 37, "ncat": 15, "s": 0.8066353887399464, "os": 0.7712198046483818, "bg": 9.964883367747315e-06}, {"x": 0.7374329758713136, "y": 0.6814678284182306, "term": "book", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 15, "s": 0.4247654155495979, "os": 0.43553352501108644, "bg": 1.5093340340990134e-07}, {"x": 0.7376005361930295, "y": 0.8627680965147453, "term": "welfare", "cat25k": 4, "ncat25k": 2, "cat": 28, "ncat": 15, "s": 0.7228552278820375, "os": 0.710015645176003, "bg": 4.759931472484248e-06}, {"x": 0.7377680965147453, "y": 0.7816689008042895, "term": "reducing", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 15, "s": 0.5700402144772118, "os": 0.5747203994091339, "bg": 4.058865862535509e-06}, {"x": 0.7379356568364611, "y": 0.7580428954423593, "term": "monitored", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 15, "s": 0.5410522788203753, "os": 0.5414070702492477, "bg": 1.0120482600447534e-05}, {"x": 0.738103217158177, "y": 0.7682640750670241, "term": "18", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 15, "s": 0.5563002680965148, "os": 0.5586159335230511, "bg": 0.0}, {"x": 0.7382707774798928, "y": 0.6263404825737265, "term": "enable", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 15, "s": 0.3709785522788204, "os": 0.38443809018811015, "bg": 1.1487080767437883e-06}, {"x": 0.7384383378016086, "y": 0.7272117962466488, "term": "23", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 15, "s": 0.4624664879356568, "os": 0.48079410565702607, "bg": 0.0}, {"x": 0.7386058981233244, "y": 0.8637734584450402, "term": "design", "cat25k": 4, "ncat25k": 2, "cat": 28, "ncat": 15, "s": 0.7228552278820375, "os": 0.710015645176003, "bg": 3.248220648335097e-07}, {"x": 0.7387734584450402, "y": 0.7825067024128687, "term": "focused", "cat25k": 3, "ncat25k": 2, "cat": 16, "ncat": 15, "s": 0.5700402144772118, "os": 0.5747203994091339, "bg": 3.0630375600040412e-06}, {"x": 0.738941018766756, "y": 0.7588806970509383, "term": "\ufb01ndings", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 15, "s": 0.5410522788203753, "os": 0.5414070702492477, "bg": 0.0}, {"x": 0.7391085790884718, "y": 0.792225201072386, "term": "strictly", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 15, "s": 0.5841152815013405, "os": 0.5898232571843925, "bg": 6.106206586898619e-06}, {"x": 0.7392761394101877, "y": 0.3900804289544236, "term": "length", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 15, "s": 0.2448056300268097, "os": 0.2636042188149176, "bg": 5.445563609671516e-07}, {"x": 0.7394436997319035, "y": 0.5914879356568364, "term": "admission", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 15, "s": 0.352044235924933, "os": 0.3565617759225108, "bg": 2.639677009121164e-06}, {"x": 0.7396112600536193, "y": 0.7597184986595175, "term": "speci\ufb01cally", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 15, "s": 0.5410522788203753, "os": 0.5414070702492477, "bg": 0.0}, {"x": 0.7397788203753352, "y": 0.9529155495978552, "term": "illness", "cat25k": 12, "ncat25k": 2, "cat": 77, "ncat": 15, "s": 0.9783847184986596, "os": 0.8973694373107661, "bg": 1.4317252257846244e-05}, {"x": 0.739946380697051, "y": 0.630529490616622, "term": "0.5", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 15, "s": 0.3709785522788204, "os": 0.38443809018811015, "bg": 0.0}, {"x": 0.7401139410187667, "y": 0.7101206434316354, "term": "future", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 15, "s": 0.4395107238605898, "os": 0.4588583038357306, "bg": 4.2568395582599004e-07}, {"x": 0.7402815013404825, "y": 0.8646112600536193, "term": "investment", "cat25k": 4, "ncat25k": 2, "cat": 28, "ncat": 15, "s": 0.7228552278820375, "os": 0.710015645176003, "bg": 1.2427183747717535e-06}, {"x": 0.7404490616621984, "y": 0.8056300268096515, "term": "sensitive", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 15, "s": 0.6043900804289545, "os": 0.6040157990043871, "bg": 3.420273932848622e-06}, {"x": 0.7406166219839142, "y": 0.813337801608579, "term": "j.", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 15, "s": 0.6295241286863271, "os": 0.6173791280515017, "bg": 0.0}, {"x": 0.74078418230563, "y": 0.7954088471849866, "term": "allocate", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 15, "s": 0.5841152815013405, "os": 0.5898232571843925, "bg": 1.9213057193668818e-05}, {"x": 0.7409517426273459, "y": 0.5960120643431636, "term": "administer", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 15, "s": 0.352044235924933, "os": 0.3565617759225108, "bg": 1.0819777668323158e-05}, {"x": 0.7411193029490617, "y": 0.8418230563002681, "term": "pesos", "cat25k": 4, "ncat25k": 2, "cat": 23, "ncat": 15, "s": 0.6735924932975872, "os": 0.6638695220644256, "bg": 3.822170499985164e-05}, {"x": 0.7412868632707775, "y": 0.6895107238605898, "term": "tablets", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 15, "s": 0.4247654155495979, "os": 0.43553352501108644, "bg": 6.411974490600686e-06}, {"x": 0.7414544235924933, "y": 0.23776809651474531, "term": "oversees", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 15, "s": 0.19705093833780163, "os": 0.19504613050006875, "bg": 2.2773626800539867e-05}, {"x": 0.7416219839142091, "y": 0.48726541554959785, "term": "arm", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 15, "s": 0.28468498659517427, "os": 0.2960876620604941, "bg": 1.6641680570097379e-06}, {"x": 0.7417895442359249, "y": 0.6906836461126006, "term": "recorded", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 15, "s": 0.4247654155495979, "os": 0.43553352501108644, "bg": 1.8989363298042238e-06}, {"x": 0.7419571045576407, "y": 0.6657171581769437, "term": "%", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 15, "s": 0.40130697050938335, "os": 0.4107473867191723, "bg": 0.0}, {"x": 0.7421246648793566, "y": 0.8146782841823056, "term": "costs", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 15, "s": 0.6295241286863271, "os": 0.6173791280515017, "bg": 6.705918577663625e-07}, {"x": 0.7422922252010724, "y": 0.6662198391420912, "term": "3.1", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 15, "s": 0.40130697050938335, "os": 0.4107473867191723, "bg": 0.0}, {"x": 0.7424597855227882, "y": 0.8352882037533512, "term": "share", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 15, "s": 0.6650469168900804, "os": 0.6531763623682498, "bg": 6.186968430199312e-07}, {"x": 0.7426273458445041, "y": 0.24128686327077747, "term": "indigenous", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 15, "s": 0.19705093833780163, "os": 0.19504613050006875, "bg": 3.7995521669013637e-06}, {"x": 0.7427949061662198, "y": 0.3250670241286863, "term": "category", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 15, "s": 0.2213471849865952, "os": 0.22982638492340035, "bg": 2.154090171758354e-07}, {"x": 0.7429624664879356, "y": 0.8788538873994638, "term": "map", "cat25k": 5, "ncat25k": 2, "cat": 31, "ncat": 15, "s": 0.7578753351206434, "os": 0.7330014457536682, "bg": 2.967851228998807e-07}, {"x": 0.7431300268096515, "y": 0.5591487935656837, "term": "locally", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 15, "s": 0.310656836461126, "os": 0.3271027734978297, "bg": 4.3439286925488286e-06}, {"x": 0.7432975871313673, "y": 0.5593163538873994, "term": "agents", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 15, "s": 0.310656836461126, "os": 0.3271027734978297, "bg": 8.423031769610186e-07}, {"x": 0.7434651474530831, "y": 0.7620643431635389, "term": "aid", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 15, "s": 0.5410522788203753, "os": 0.5414070702492477, "bg": 1.1522925456208514e-06}, {"x": 0.743632707774799, "y": 0.797754691689008, "term": "diagnosed", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 15, "s": 0.5841152815013405, "os": 0.5898232571843925, "bg": 1.2788326815283009e-05}, {"x": 0.7438002680965148, "y": 0.6414209115281502, "term": "replacement", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 15, "s": 0.3709785522788204, "os": 0.38443809018811015, "bg": 1.4699450403527075e-06}, {"x": 0.7439678284182306, "y": 0.3362935656836461, "term": "needle", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 15, "s": 0.2213471849865952, "os": 0.22982638492340035, "bg": 5.9800843258335324e-06}, {"x": 0.7441353887399463, "y": 0.5080428954423593, "term": "vaccinations", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 15, "s": 0.28468498659517427, "os": 0.2960876620604941, "bg": 3.3211337022005834e-05}, {"x": 0.7443029490616622, "y": 0.7184986595174263, "term": "otc", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 15, "s": 0.4395107238605898, "os": 0.4588583038357306, "bg": 1.9213971217471115e-05}, {"x": 0.744470509383378, "y": 0.8589142091152815, "term": "thousand", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 15, "s": 0.7029155495978552, "os": 0.6928765560060498, "bg": 4.564090912683487e-06}, {"x": 0.7446380697050938, "y": 0.7392761394101877, "term": "reaction", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 15, "s": 0.4624664879356568, "os": 0.48079410565702607, "bg": 2.9243699444954585e-06}, {"x": 0.7448056300268097, "y": 0.6978887399463807, "term": "40", "cat25k": 2, "ncat25k": 2, "cat": 10, "ncat": 15, "s": 0.4247654155495979, "os": 0.43553352501108644, "bg": 0.0}, {"x": 0.7449731903485255, "y": 0.7402815013404825, "term": "establishing", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 15, "s": 0.4624664879356568, "os": 0.48079410565702607, "bg": 4.899693741920609e-06}, {"x": 0.7451407506702413, "y": 0.26273458445040215, "term": "ad", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 15, "s": 0.19705093833780163, "os": 0.19504613050006875, "bg": 4.299109643012936e-07}, {"x": 0.7453083109919572, "y": 0.5187667560321716, "term": "go", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 15, "s": 0.28468498659517427, "os": 0.2960876620604941, "bg": 9.49220646540998e-08}, {"x": 0.7454758713136729, "y": 0.522955764075067, "term": "reached", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 15, "s": 0.28468498659517427, "os": 0.2960876620604941, "bg": 1.7545960547030411e-06}, {"x": 0.7456434316353887, "y": 0.44822386058981234, "term": "introduced", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 15, "s": 0.2448056300268097, "os": 0.2636042188149176, "bg": 1.2626311292268404e-06}, {"x": 0.7458109919571045, "y": 0.3589142091152815, "term": "label", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 15, "s": 0.2213471849865952, "os": 0.22982638492340035, "bg": 8.638929049243623e-07}, {"x": 0.7459785522788204, "y": 0.19369973190348524, "term": "option", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 15, "s": 0.09483914209115281, "os": 0.15971216413702055, "bg": 5.158843366681816e-07}, {"x": 0.7461461126005362, "y": 0.19839142091152814, "term": "feed", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 15, "s": 0.09483914209115281, "os": 0.15971216413702055, "bg": 5.081320339169241e-07}, {"x": 0.746313672922252, "y": 0.2035857908847185, "term": "hygiene", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 15, "s": 0.09483914209115281, "os": 0.15971216413702055, "bg": 5.857122095736856e-06}, {"x": 0.7464812332439679, "y": 0.019772117962466487, "term": "pinoy", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 2.6074848722419328e-05}, {"x": 0.7466487935656837, "y": 0.020107238605898123, "term": "diamond", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 7.521617316207213e-07}, {"x": 0.7468163538873994, "y": 0.02044235924932976, "term": "sangkap pinoy", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 0.0}, {"x": 0.7469839142091153, "y": 0.020609919571045576, "term": "pinoy seal", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 0.0}, {"x": 0.7471514745308311, "y": 0.02546916890080429, "term": "civil works", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 0.0}, {"x": 0.7473190348525469, "y": 0.033176943699731905, "term": "initiation", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 7.197890154437932e-06}, {"x": 0.7474865951742627, "y": 0.035355227882037536, "term": "forti\ufb01cation", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 0.0}, {"x": 0.7476541554959786, "y": 0.04524128686327078, "term": "partum", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 5.591058778800942e-05}, {"x": 0.7478217158176944, "y": 0.0454088471849866, "term": "post partum", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 0.0}, {"x": 0.7479892761394102, "y": 0.06367292225201072, "term": "imci", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 7.936276986648536e-05}, {"x": 0.748156836461126, "y": 0.06987265415549598, "term": "discharged", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 8.717005046274221e-06}, {"x": 0.7483243967828418, "y": 0.07205093833780161, "term": "weights", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 4.40804444601828e-06}, {"x": 0.7484919571045576, "y": 0.07473190348525469, "term": "neonates", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 5.024873121953671e-05}, {"x": 0.7486595174262735, "y": 0.07523458445040214, "term": "emonc", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 9.616247611965175e-05}, {"x": 0.7488270777479893, "y": 0.08361260053619303, "term": "eradication", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 1.9269741046796563e-05}, {"x": 0.7489946380697051, "y": 0.11058981233243968, "term": "cemonc", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 15, "s": 0.04138739946380697, "os": 0.12447306360058547, "bg": 9.616247611965175e-05}, {"x": 0.749162198391421, "y": 0.30831099195710454, "term": "cell", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 3.351574631060208e-07}, {"x": 0.7493297587131368, "y": 0.37868632707774796, "term": "detected", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 16, "s": 0.23910857908847186, "os": 0.2524399087862266, "bg": 3.5638537911162926e-06}, {"x": 0.7494973190348525, "y": 0.8445040214477212, "term": "provider", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 16, "s": 0.6705764075067024, "os": 0.6611697235208827, "bg": 1.9375794256191113e-06}, {"x": 0.7496648793565683, "y": 0.1533176943699732, "term": "perinatal", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 16, "s": 0.08160187667560322, "os": 0.15405590021743393, "bg": 2.966913676773953e-05}, {"x": 0.7498324396782842, "y": 0.8550603217158177, "term": "leading", "cat25k": 4, "ncat25k": 2, "cat": 26, "ncat": 16, "s": 0.6953753351206434, "os": 0.6804591481288462, "bg": 1.4863705132401992e-06}, {"x": 0.75, "y": 0.8178619302949062, "term": "declared", "cat25k": 3, "ncat25k": 2, "cat": 20, "ncat": 16, "s": 0.6290214477211796, "os": 0.6162692943192618, "bg": 5.990052519449368e-06}, {"x": 0.7501675603217158, "y": 0.624162198391421, "term": "far", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 16, "s": 0.36142761394101874, "os": 0.36850987660562046, "bg": 5.140629139110083e-07}, {"x": 0.7503351206434317, "y": 0.979725201072386, "term": "rehabilitation", "cat25k": 25, "ncat25k": 2, "cat": 157, "ncat": 16, "s": 0.9932975871313673, "os": 0.9529780876476213, "bg": 2.5287534246885707e-05}, {"x": 0.7505026809651475, "y": 0.3104892761394102, "term": "committed", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 1.7292733393196531e-06}, {"x": 0.7506702412868632, "y": 0.8674597855227882, "term": "create", "cat25k": 5, "ncat25k": 2, "cat": 29, "ncat": 16, "s": 0.7208445040214477, "os": 0.7062362731061431, "bg": 6.551022962616572e-07}, {"x": 0.750837801608579, "y": 0.7578753351206434, "term": "effectively", "cat25k": 2, "ncat25k": 2, "cat": 14, "ncat": 16, "s": 0.48776809651474534, "os": 0.526761168459056, "bg": 3.027276060028462e-06}, {"x": 0.7510053619302949, "y": 0.8329423592493298, "term": "head", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 16, "s": 0.6539879356568364, "os": 0.6398849410255416, "bg": 6.688479382045053e-07}, {"x": 0.7511729222520107, "y": 0.8843833780160858, "term": "inpatient", "cat25k": 5, "ncat25k": 2, "cat": 33, "ncat": 16, "s": 0.7597184986595173, "os": 0.7357905894061058, "bg": 3.786681545491569e-05}, {"x": 0.7513404825737265, "y": 0.7278820375335121, "term": "messages", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 16, "s": 0.45408847184986595, "os": 0.4627439732690397, "bg": 5.090465526253916e-07}, {"x": 0.7515080428954424, "y": 0.8461796246648794, "term": "partner", "cat25k": 4, "ncat25k": 2, "cat": 24, "ncat": 16, "s": 0.6705764075067024, "os": 0.6611697235208827, "bg": 1.5011688382043416e-06}, {"x": 0.7516756032171582, "y": 0.9180630026809652, "term": "concerns", "cat25k": 8, "ncat25k": 2, "cat": 48, "ncat": 16, "s": 0.8389745308310992, "os": 0.8140770679668428, "bg": 4.357056712879834e-06}, {"x": 0.751843163538874, "y": 0.8507037533512064, "term": "user", "cat25k": 4, "ncat25k": 2, "cat": 25, "ncat": 16, "s": 0.6846514745308312, "os": 0.6710454851400096, "bg": 2.588725185660293e-07}, {"x": 0.7520107238605898, "y": 0.897955764075067, "term": "rights", "cat25k": 6, "ncat25k": 2, "cat": 38, "ncat": 16, "s": 0.7964142091152816, "os": 0.7666849312189741, "bg": 3.065017944700963e-07}, {"x": 0.7521782841823056, "y": 0.8337801608579088, "term": "approaches", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 16, "s": 0.6539879356568364, "os": 0.6398849410255416, "bg": 4.372555288516444e-06}, {"x": 0.7523458445040214, "y": 0.8810321715817694, "term": "types", "cat25k": 5, "ncat25k": 2, "cat": 32, "ncat": 16, "s": 0.7543565683646113, "os": 0.7288542492107621, "bg": 1.240586644994307e-06}, {"x": 0.7525134048257373, "y": 0.15683646112600536, "term": "collecting", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 16, "s": 0.08160187667560322, "os": 0.15405590021743393, "bg": 3.575740493788728e-06}, {"x": 0.7526809651474531, "y": 0.795073726541555, "term": "delivered", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 16, "s": 0.5708780160857909, "os": 0.5755416314940346, "bg": 2.2416646248271968e-06}, {"x": 0.7528485254691689, "y": 0.23508713136729223, "term": "search", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 16, "s": 0.19369973190348527, "os": 0.1874192297744664, "bg": 3.51423477352821e-08}, {"x": 0.7530160857908847, "y": 0.5941689008042895, "term": "recommends", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 16, "s": 0.3393096514745308, "os": 0.34153773269151577, "bg": 5.198704663622335e-06}, {"x": 0.7531836461126006, "y": 0.8341152815013405, "term": "ngos", "cat25k": 4, "ncat25k": 2, "cat": 22, "ncat": 16, "s": 0.6539879356568364, "os": 0.6398849410255416, "bg": 1.5098450839344734e-05}, {"x": 0.7533512064343163, "y": 0.7317359249329759, "term": "attention", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 16, "s": 0.45408847184986595, "os": 0.4627439732690397, "bg": 1.2426636522013442e-06}, {"x": 0.7535187667560321, "y": 0.31886729222520105, "term": "gain", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 1.1767557055774565e-06}, {"x": 0.753686327077748, "y": 0.7727882037533512, "term": "2013", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 16, "s": 0.5464142091152816, "os": 0.5440575480180225, "bg": 0.0}, {"x": 0.7538538873994638, "y": 0.8057975871313673, "term": "annually", "cat25k": 3, "ncat25k": 2, "cat": 18, "ncat": 16, "s": 0.5851206434316354, "os": 0.5899081583856729, "bg": 6.909899884696127e-06}, {"x": 0.7540214477211796, "y": 0.9132037533512064, "term": "pain", "cat25k": 7, "ncat25k": 2, "cat": 45, "ncat": 16, "s": 0.8292560321715818, "os": 0.8015019913086157, "bg": 2.8709384222301373e-06}, {"x": 0.7541890080428955, "y": 0.8525469168900804, "term": "outside", "cat25k": 4, "ncat25k": 2, "cat": 25, "ncat": 16, "s": 0.6846514745308312, "os": 0.6710454851400096, "bg": 1.2107280426644027e-06}, {"x": 0.7543565683646113, "y": 0.596514745308311, "term": "almost", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 16, "s": 0.3393096514745308, "os": 0.34153773269151577, "bg": 6.895817583198527e-07}, {"x": 0.7545241286863271, "y": 0.5976876675603218, "term": "determining", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 16, "s": 0.3393096514745308, "os": 0.34153773269151577, "bg": 3.5882070610766665e-06}, {"x": 0.7546916890080428, "y": 0.6652144772117963, "term": "advertising", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 16, "s": 0.3808646112600536, "os": 0.39408226841507515, "bg": 5.523501388182939e-07}, {"x": 0.7548592493297587, "y": 0.7741286863270778, "term": "1.1", "cat25k": 2, "ncat25k": 2, "cat": 15, "ncat": 16, "s": 0.5464142091152816, "os": 0.5440575480180225, "bg": 0.0}, {"x": 0.7550268096514745, "y": 0.8148458445040214, "term": "applied", "cat25k": 3, "ncat25k": 2, "cat": 19, "ncat": 16, "s": 0.6037198391420912, "os": 0.6034614718746787, "bg": 1.5462027469396229e-06}, {"x": 0.7551943699731903, "y": 0.4031501340482574, "term": "short", "cat25k": 1, "ncat25k": 2, "cat": 4, "ncat": 16, "s": 0.23910857908847186, "os": 0.2524399087862266, "bg": 3.7359707643102234e-07}, {"x": 0.7553619302949062, "y": 0.7960790884718498, "term": "relative", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 16, "s": 0.5708780160857909, "os": 0.5755416314940346, "bg": 2.4482243214468088e-06}, {"x": 0.755529490616622, "y": 0.7339142091152815, "term": "requires", "cat25k": 2, "ncat25k": 2, "cat": 12, "ncat": 16, "s": 0.45408847184986595, "os": 0.4627439732690397, "bg": 1.1433024241522966e-06}, {"x": 0.7556970509383378, "y": 0.24313002680965148, "term": "october", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 16, "s": 0.19369973190348527, "os": 0.1874192297744664, "bg": 2.1994802884684382e-07}, {"x": 0.7558646112600537, "y": 0.3265750670241287, "term": "tropical", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 2.337502227547353e-06}, {"x": 0.7560321715817694, "y": 0.246313672922252, "term": "48", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 16, "s": 0.19369973190348527, "os": 0.1874192297744664, "bg": 0.0}, {"x": 0.7561997319034852, "y": 0.6030495978552279, "term": "september", "cat25k": 1, "ncat25k": 2, "cat": 7, "ncat": 16, "s": 0.3393096514745308, "os": 0.34153773269151577, "bg": 2.9207418290580605e-07}, {"x": 0.756367292225201, "y": 0.7975871313672922, "term": "distributors", "cat25k": 3, "ncat25k": 2, "cat": 17, "ncat": 16, "s": 0.5708780160857909, "os": 0.5755416314940346, "bg": 7.4628300182160885e-06}, {"x": 0.7565348525469169, "y": 0.6704088471849866, "term": "elements", "cat25k": 1, "ncat25k": 2, "cat": 9, "ncat": 16, "s": 0.3808646112600536, "os": 0.39408226841507515, "bg": 1.1237933184958152e-06}, {"x": 0.7567024128686327, "y": 0.6456099195710456, "term": "surgical", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 16, "s": 0.36142761394101874, "os": 0.36850987660562046, "bg": 4.741264269970749e-06}, {"x": 0.7568699731903485, "y": 0.7201742627345844, "term": "\ufb01eld", "cat25k": 2, "ncat25k": 2, "cat": 11, "ncat": 16, "s": 0.42727882037533516, "os": 0.44114964532442225, "bg": 0.0}, {"x": 0.7570375335120644, "y": 0.5742292225201072, "term": "commodities", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 16, "s": 0.29775469168900803, "os": 0.3131666854273387, "bg": 7.244993915028406e-06}, {"x": 0.7572050938337802, "y": 0.6486260053619303, "term": "periodic", "cat25k": 1, "ncat25k": 2, "cat": 8, "ncat": 16, "s": 0.36142761394101874, "os": 0.36850987660562046, "bg": 6.46790437203386e-06}, {"x": 0.7573726541554959, "y": 0.5194369973190348, "term": "hard", "cat25k": 1, "ncat25k": 2, "cat": 5, "ncat": 16, "s": 0.2670911528150134, "os": 0.2834362090935776, "bg": 3.221681956385698e-07}, {"x": 0.7575402144772118, "y": 0.5775804289544236, "term": "volunteers", "cat25k": 1, "ncat25k": 2, "cat": 6, "ncat": 16, "s": 0.29775469168900803, "os": 0.3131666854273387, "bg": 2.5653347021337407e-06}, {"x": 0.7577077747989276, "y": 0.3605898123324397, "term": "interval", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 3.675752578903173e-06}, {"x": 0.7578753351206434, "y": 0.2808310991957105, "term": "options", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 16, "s": 0.19369973190348527, "os": 0.1874192297744664, "bg": 2.6088625815695307e-07}, {"x": 0.7580428954423593, "y": 0.28652815013404825, "term": "trainings", "cat25k": 0, "ncat25k": 2, "cat": 2, "ncat": 16, "s": 0.19369973190348527, "os": 0.1874192297744664, "bg": 2.7435490397959414e-05}, {"x": 0.7582104557640751, "y": 0.20191018766756033, "term": "childbirth", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 16, "s": 0.08160187667560322, "os": 0.15405590021743393, "bg": 1.5799418023790204e-05}, {"x": 0.7583780160857909, "y": 0.3760053619302949, "term": "scheduled", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 1.8085335943205954e-06}, {"x": 0.7585455764075067, "y": 0.3761729222520107, "term": "improvements", "cat25k": 0, "ncat25k": 2, "cat": 3, "ncat": 16, "s": 0.2128016085790885, "os": 0.22034543060861633, "bg": 1.9958415066544507e-06}, {"x": 0.7587131367292225, "y": 0.219671581769437, "term": "opportunity", "cat25k": 0, "ncat25k": 2, "cat": 1, "ncat": 16, "s": 0.08160187667560322, "os": 0.15405590021743393, "bg": 5.634248515367231e-07}, {"x": 0.7588806970509383, "y": 0.0015080428954423592, "term": "syphilis", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 2.8732948790702016e-05}, {"x": 0.7590482573726541, "y": 0.0072050938337801605, "term": "routinely", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 1.0235607696025482e-05}, {"x": 0.75921581769437, "y": 0.008378016085790885, "term": "instructions", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 6.309466101851148e-07}, {"x": 0.7593833780160858, "y": 0.012231903485254691, "term": "fed", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 2.5979662632972235e-06}, {"x": 0.7595509383378016, "y": 0.01960455764075067, "term": "sangkap", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 0.00010257297907190687}, {"x": 0.7597184986595175, "y": 0.03418230563002681, "term": "attendants", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 2.1568603662079292e-05}, {"x": 0.7598860589812333, "y": 0.048089812332439676, "term": "chest", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 2.3140804491514454e-06}, {"x": 0.760053619302949, "y": 0.04842493297587131, "term": "sterile", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 1.3816788520666677e-05}, {"x": 0.7602211796246648, "y": 0.09316353887399464, "term": "fluid", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 2.414127049018623e-06}, {"x": 0.7603887399463807, "y": 0.10087131367292225, "term": "knock", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 5.80974606689269e-06}, {"x": 0.7605563002680965, "y": 0.10254691689008043, "term": "wpv", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 0.00010257297907190687}, {"x": 0.7607238605898123, "y": 0.10707104557640751, "term": "nt", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 1.0155253838027447e-06}, {"x": 0.7608914209115282, "y": 0.11963806970509383, "term": "biting", "cat25k": 0, "ncat25k": 2, "cat": 0, "ncat": 16, "s": 0.03837131367292226, "os": 0.12081005554750268, "bg": 1.4728014985755247e-05}, {"x": 0.761058981233244, "y": 0.957774798927614, "term": "cervical", "cat25k": 14, "ncat25k": 3, "cat": 87, "ncat": 17, "s": 0.9798927613941019, "os": 0.9014136282899631, "bg": 6.312947369443391e-05}, {"x": 0.7612265415549598, "y": 0.8796916890080428, "term": "setting", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 17, "s": 0.7464812332439679, "os": 0.7179165565219815, "bg": 2.100331057181706e-06}, {"x": 0.7613941018766756, "y": 0.9093498659517426, "term": "regulatory", "cat25k": 7, "ncat25k": 3, "cat": 44, "ncat": 17, "s": 0.8218833780160858, "os": 0.7879934823999208, "bg": 5.465184645966906e-06}, {"x": 0.7615616621983914, "y": 0.541387399463807, "term": "reviewed", "cat25k": 1, "ncat25k": 3, "cat": 6, "ncat": 17, "s": 0.29038203753351205, "os": 0.3003488502910439, "bg": 1.5344612134739438e-06}, {"x": 0.7617292225201072, "y": 0.5881367292225201, "term": "return", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 17, "s": 0.3114946380697051, "os": 0.327693776199943, "bg": 2.3307562161850977e-07}, {"x": 0.761896782841823, "y": 0.9376675603217158, "term": "name", "cat25k": 10, "ncat25k": 3, "cat": 61, "ncat": 17, "s": 0.943029490616622, "os": 0.8496972669601051, "bg": 3.355959260866064e-07}, {"x": 0.7620643431635389, "y": 0.7577077747989276, "term": "written", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 17, "s": 0.4819034852546917, "os": 0.5129120251924931, "bg": 6.30280902576078e-07}, {"x": 0.7622319034852547, "y": 0.6807975871313673, "term": "continued", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 17, "s": 0.39359919571045576, "os": 0.4022574992941706, "bg": 1.325926250950646e-06}, {"x": 0.7623994638069705, "y": 0.8560656836461126, "term": "contain", "cat25k": 4, "ncat25k": 3, "cat": 26, "ncat": 17, "s": 0.6831434316353887, "os": 0.668393882469567, "bg": 2.879672322756085e-06}, {"x": 0.7625670241286864, "y": 0.8248994638069705, "term": "particular", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 17, "s": 0.628686327077748, "os": 0.6153817286081301, "bg": 1.050174650262478e-06}, {"x": 0.7627345844504021, "y": 0.5889745308310992, "term": "v", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 17, "s": 0.3114946380697051, "os": 0.327693776199943, "bg": 2.3437619248043244e-07}, {"x": 0.7629021447721179, "y": 0.7060991957104558, "term": "2002", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 17, "s": 0.4105227882037534, "os": 0.42465502046550785, "bg": 0.0}, {"x": 0.7630697050938338, "y": 0.9306300268096515, "term": "environment", "cat25k": 9, "ncat25k": 3, "cat": 56, "ncat": 17, "s": 0.8894101876675604, "os": 0.8347223622113963, "bg": 1.4275751431554755e-06}, {"x": 0.7632372654155496, "y": 0.38656166219839144, "term": "performed", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 17, "s": 0.22771447721179627, "os": 0.24217605665913322, "bg": 1.398759812924534e-06}, {"x": 0.7634048257372654, "y": 0.9309651474530831, "term": "outpatient", "cat25k": 9, "ncat25k": 3, "cat": 56, "ncat": 17, "s": 0.8894101876675604, "os": 0.8347223622113963, "bg": 3.711702412987908e-05}, {"x": 0.7635723860589813, "y": 0.912701072386059, "term": "knowledge", "cat25k": 7, "ncat25k": 3, "cat": 45, "ncat": 17, "s": 0.8240616621983914, "os": 0.7926050421231545, "bg": 1.3768391100653845e-06}, {"x": 0.7637399463806971, "y": 0.5467493297587132, "term": "contract", "cat25k": 1, "ncat25k": 3, "cat": 6, "ncat": 17, "s": 0.29038203753351205, "os": 0.3003488502910439, "bg": 6.844432142982924e-07}, {"x": 0.7639075067024129, "y": 0.9059986595174263, "term": "of\ufb01cial", "cat25k": 7, "ncat25k": 3, "cat": 42, "ncat": 17, "s": 0.8103217158176944, "os": 0.7782940125439525, "bg": 0.0}, {"x": 0.7640750670241286, "y": 0.7927278820375335, "term": "tested", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 17, "s": 0.5581434316353887, "os": 0.5619132159307988, "bg": 3.004171026396237e-06}, {"x": 0.7642426273458445, "y": 0.8775134048257373, "term": "comply", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 17, "s": 0.7240281501340483, "os": 0.7105096981494416, "bg": 7.28354167676689e-06}, {"x": 0.7644101876675603, "y": 0.6600201072386059, "term": "around", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 17, "s": 0.367627345844504, "os": 0.3786483961907683, "bg": 2.903049059028009e-07}, {"x": 0.7645777479892761, "y": 0.8879021447721179, "term": "highest", "cat25k": 5, "ncat25k": 3, "cat": 34, "ncat": 17, "s": 0.757372654155496, "os": 0.7318705163857164, "bg": 2.1913462490565124e-06}, {"x": 0.764745308310992, "y": 0.7833445040214477, "term": "generate", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 17, "s": 0.5490951742627346, "os": 0.5465510255461303, "bg": 3.5773362092225676e-06}, {"x": 0.7649128686327078, "y": 0.9324731903485255, "term": "sectors", "cat25k": 9, "ncat25k": 3, "cat": 57, "ncat": 17, "s": 0.912701072386059, "os": 0.8378950267287661, "bg": 1.1160901131157329e-05}, {"x": 0.7650804289544236, "y": 0.9185656836461126, "term": "strengthening", "cat25k": 8, "ncat25k": 3, "cat": 48, "ncat": 17, "s": 0.8324396782841823, "os": 0.8055687049453076, "bg": 2.411394693188051e-05}, {"x": 0.7652479892761395, "y": 0.868632707774799, "term": "inter", "cat25k": 5, "ncat25k": 3, "cat": 29, "ncat": 17, "s": 0.7034182305630027, "os": 0.6947449722799366, "bg": 5.904495175610276e-06}, {"x": 0.7654155495978552, "y": 0.9403485254691689, "term": "corporation", "cat25k": 10, "ncat25k": 3, "cat": 63, "ncat": 17, "s": 0.9492292225201072, "os": 0.8551078223049886, "bg": 2.1509593843481033e-06}, {"x": 0.765583109919571, "y": 0.8647788203753352, "term": "continuing", "cat25k": 4, "ncat25k": 3, "cat": 28, "ncat": 17, "s": 0.699396782841823, "os": 0.6863455688233432, "bg": 3.496304367435794e-06}, {"x": 0.7657506702412868, "y": 0.9229222520107239, "term": "participation", "cat25k": 8, "ncat25k": 3, "cat": 51, "ncat": 17, "s": 0.8423257372654156, "os": 0.817350058927476, "bg": 4.742291335694251e-06}, {"x": 0.7659182305630027, "y": 0.3967828418230563, "term": "initiated", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 17, "s": 0.22771447721179627, "os": 0.24217605665913322, "bg": 5.323352469940487e-06}, {"x": 0.7660857908847185, "y": 0.6908512064343163, "term": "placed", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 17, "s": 0.39359919571045576, "os": 0.4022574992941706, "bg": 1.514306707063509e-06}, {"x": 0.7662533512064343, "y": 0.7139745308310992, "term": "call", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 17, "s": 0.4105227882037534, "os": 0.42465502046550785, "bg": 2.801108482659843e-07}, {"x": 0.7664209115281502, "y": 0.6921916890080428, "term": "guidance", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 17, "s": 0.39359919571045576, "os": 0.4022574992941706, "bg": 2.2505781172538696e-06}, {"x": 0.766588471849866, "y": 0.3267426273458445, "term": "travel", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 17, "s": 0.20576407506702415, "os": 0.2116033404510098, "bg": 1.3887380998988823e-07}, {"x": 0.7667560321715817, "y": 0.7970844504021448, "term": "way", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 17, "s": 0.5581434316353887, "os": 0.5619132159307988, "bg": 2.2234749614402845e-07}, {"x": 0.7669235924932976, "y": 0.6027144772117963, "term": "adequately", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 17, "s": 0.3114946380697051, "os": 0.327693776199943, "bg": 1.0131132738734338e-05}, {"x": 0.7670911528150134, "y": 0.8431635388739946, "term": "violence", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 17, "s": 0.6492962466487936, "os": 0.6381545774361654, "bg": 2.700711293085038e-06}, {"x": 0.7672587131367292, "y": 0.7173257372654156, "term": "respond", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 17, "s": 0.4105227882037534, "os": 0.42465502046550785, "bg": 2.3261967555370753e-06}, {"x": 0.767426273458445, "y": 0.7174932975871313, "term": "nursing", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 17, "s": 0.4105227882037534, "os": 0.42465502046550785, "bg": 1.46847764574503e-06}, {"x": 0.7675938337801609, "y": 0.853887399463807, "term": "n", "cat25k": 4, "ncat25k": 3, "cat": 25, "ncat": 17, "s": 0.6692359249329759, "os": 0.6587871028088212, "bg": 1.9166119820000747e-07}, {"x": 0.7677613941018767, "y": 0.7630697050938338, "term": "maintained", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 17, "s": 0.4819034852546917, "os": 0.5129120251924931, "bg": 2.152448258875924e-06}, {"x": 0.7679289544235925, "y": 0.7538538873994638, "term": "80%", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 17, "s": 0.45593163538873993, "os": 0.46598914833948646, "bg": 0.0}, {"x": 0.7680965147453083, "y": 0.7870308310991957, "term": "violation", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 17, "s": 0.5490951742627346, "os": 0.5465510255461303, "bg": 4.465552222704938e-06}, {"x": 0.7682640750670241, "y": 0.8163538873994638, "term": "showed", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 17, "s": 0.5856233243967828, "os": 0.5901131883804962, "bg": 3.202519884979719e-06}, {"x": 0.7684316353887399, "y": 0.7550268096514745, "term": "recent", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 17, "s": 0.45593163538873993, "os": 0.46598914833948646, "bg": 4.2230408602570725e-07}, {"x": 0.7685991957104558, "y": 0.26072386058981234, "term": "salt", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 17, "s": 0.19034852546916892, "os": 0.18033555215584396, "bg": 1.4824932759176692e-06}, {"x": 0.7687667560321716, "y": 0.346514745308311, "term": "never", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 17, "s": 0.20576407506702415, "os": 0.2116033404510098, "bg": 2.6690023105886623e-07}, {"x": 0.7689343163538874, "y": 0.6141085790884718, "term": "percentage", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 17, "s": 0.3114946380697051, "os": 0.327693776199943, "bg": 1.9214454649944058e-06}, {"x": 0.7691018766756033, "y": 0.6152815013404825, "term": "achieved", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 17, "s": 0.3114946380697051, "os": 0.327693776199943, "bg": 2.7588884921070787e-06}, {"x": 0.7692694369973191, "y": 0.3600871313672922, "term": "waste", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 17, "s": 0.20576407506702415, "os": 0.2116033404510098, "bg": 9.661477527342886e-07}, {"x": 0.7694369973190348, "y": 0.19085120643431636, "term": "engineering", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 17, "s": 0.07171581769436997, "os": 0.14872104461377778, "bg": 4.1726265199183286e-07}, {"x": 0.7696045576407506, "y": 0.460455764075067, "term": "container", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 17, "s": 0.22771447721179627, "os": 0.24217605665913322, "bg": 3.361635099312306e-06}, {"x": 0.7697721179624665, "y": 0.2005697050938338, "term": "detailed", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 17, "s": 0.07171581769436997, "os": 0.14872104461377778, "bg": 6.829975037769288e-07}, {"x": 0.7699396782841823, "y": 0.22302278820375335, "term": "attended", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 17, "s": 0.07171581769436997, "os": 0.14872104461377778, "bg": 2.857854825896706e-06}, {"x": 0.7701072386058981, "y": 0.008880697050938339, "term": "observation", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 2.7135201139678448e-06}, {"x": 0.770274798927614, "y": 0.02262064343163539, "term": "dried", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 5.117722673618741e-06}, {"x": 0.7704423592493298, "y": 0.023458445040214475, "term": "pro\ufb01ciency", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 0.0}, {"x": 0.7706099195710456, "y": 0.03686327077747989, "term": "appetite", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 9.292664261506504e-06}, {"x": 0.7707774798927614, "y": 0.05361930294906166, "term": "epidemiologically linked", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 0.0}, {"x": 0.7709450402144772, "y": 0.054959785522788206, "term": "houses", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 1.125512820054467e-06}, {"x": 0.771112600536193, "y": 0.06501340482573727, "term": "muac", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 0.00010390340650374206}, {"x": 0.7712801608579088, "y": 0.0671916890080429, "term": "rutf", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 0.00010898344092776963}, {"x": 0.7714477211796247, "y": 0.07992627345844504, "term": "nsc", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 2.9977948573710927e-05}, {"x": 0.7716152815013405, "y": 0.10271447721179625, "term": "wild poliovirus", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 0.0}, {"x": 0.7717828418230563, "y": 0.1380697050938338, "term": "ntp", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 1.5167520806269717e-05}, {"x": 0.7719504021447721, "y": 0.1487935656836461, "term": "rti", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 17, "s": 0.03585790884718499, "os": 0.11723780020606067, "bg": 4.278462471592268e-05}, {"x": 0.7721179624664879, "y": 0.15315013404825736, "term": "obstetrics", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 18, "s": 0.0614946380697051, "os": 0.14366739423424174, "bg": 1.8459254595868626e-05}, {"x": 0.7722855227882037, "y": 0.22704423592493297, "term": "malaria", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 18, "s": 0.1873324396782842, "os": 0.17371931492743148, "bg": 8.31434026229665e-06}, {"x": 0.7724530831099196, "y": 0.994470509383378, "term": "medicines", "cat25k": 68, "ncat25k": 3, "cat": 426, "ncat": 18, "s": 0.9969839142091153, "os": 0.9808228690003006, "bg": 0.00013384852958798617}, {"x": 0.7726206434316354, "y": 0.8703083109919572, "term": "50", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 18, "s": 0.7024128686327078, "os": 0.6917599695373557, "bg": 0.0}, {"x": 0.7727882037533512, "y": 0.7431300268096515, "term": "clear", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 18, "s": 0.4324731903485255, "os": 0.44990207652502356, "bg": 6.985160072491541e-07}, {"x": 0.772955764075067, "y": 0.8009383378016086, "term": "d", "cat25k": 3, "ncat25k": 3, "cat": 18, "ncat": 18, "s": 0.5593163538873995, "os": 0.5634978165995254, "bg": 1.9900181188662197e-07}, {"x": 0.7731233243967829, "y": 0.8331099195710456, "term": "16", "cat25k": 4, "ncat25k": 3, "cat": 22, "ncat": 18, "s": 0.6283512064343164, "os": 0.6146794212511504, "bg": 0.0}, {"x": 0.7732908847184986, "y": 0.8183646112600537, "term": "able", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 18, "s": 0.5866286863270777, "os": 0.5904142321902618, "bg": 6.927920177378822e-07}, {"x": 0.7734584450402144, "y": 0.8711461126005362, "term": "become", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 18, "s": 0.7024128686327078, "os": 0.6917599695373557, "bg": 7.94655669117829e-07}, {"x": 0.7736260053619303, "y": 0.7451407506702413, "term": "combination", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 18, "s": 0.4324731903485255, "os": 0.44990207652502356, "bg": 2.1709115223299955e-06}, {"x": 0.7737935656836461, "y": 0.876843163538874, "term": "campaigns", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 18, "s": 0.7111260053619303, "os": 0.6996455737234214, "bg": 1.0923943824622102e-05}, {"x": 0.7739611260053619, "y": 0.8260723860589813, "term": "charge", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 18, "s": 0.6032171581769438, "os": 0.6028533195350175, "bg": 1.3719251419951316e-06}, {"x": 0.7741286863270778, "y": 0.6841487935656837, "term": "handling", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 18, "s": 0.3726541554959786, "os": 0.3873302691522553, "bg": 1.7535233764393216e-06}, {"x": 0.7742962466487936, "y": 0.1554959785522788, "term": "transmitted", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 18, "s": 0.0614946380697051, "os": 0.14366739423424174, "bg": 3.708605496992662e-06}, {"x": 0.7744638069705094, "y": 0.4777144772117963, "term": "intensive", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 18, "s": 0.24346514745308315, "os": 0.26107276566226334, "bg": 4.494280149194469e-06}, {"x": 0.7746313672922251, "y": 0.9323056300268097, "term": "\ufb01nancial", "cat25k": 9, "ncat25k": 3, "cat": 57, "ncat": 18, "s": 0.8495308310991958, "os": 0.8304583290381443, "bg": 0.0}, {"x": 0.774798927613941, "y": 0.5499329758713136, "term": "initiate", "cat25k": 1, "ncat25k": 3, "cat": 6, "ncat": 18, "s": 0.2682640750670241, "os": 0.2885028939629599, "bg": 1.0005025440903753e-05}, {"x": 0.7749664879356568, "y": 0.8264075067024129, "term": "nature", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 18, "s": 0.6032171581769438, "os": 0.6028533195350175, "bg": 9.633074702567704e-07}, {"x": 0.7751340482573726, "y": 0.9391756032171582, "term": "bene\ufb01ts", "cat25k": 10, "ncat25k": 3, "cat": 62, "ncat": 18, "s": 0.9356568364611261, "os": 0.8454683028670571, "bg": 0.0}, {"x": 0.7753016085790885, "y": 0.4849195710455764, "term": "hence", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 18, "s": 0.24346514745308315, "os": 0.26107276566226334, "bg": 3.005688461436429e-06}, {"x": 0.7754691689008043, "y": 0.5956769436997319, "term": "appropriately", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 1.0016127969256096e-05}, {"x": 0.7756367292225201, "y": 0.6328753351206434, "term": "remains", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 18, "s": 0.33679624664879354, "os": 0.3401565301274866, "bg": 2.0098243305313804e-06}, {"x": 0.775804289544236, "y": 0.5529490616621984, "term": "away", "cat25k": 1, "ncat25k": 3, "cat": 6, "ncat": 18, "s": 0.2682640750670241, "os": 0.2885028939629599, "bg": 4.2421769374351283e-07}, {"x": 0.7759718498659517, "y": 0.712298927613941, "term": "stock", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 18, "s": 0.40013404825737264, "os": 0.40924978211161855, "bg": 3.2841173432113545e-07}, {"x": 0.7761394101876675, "y": 0.9517426273458445, "term": "fda", "cat25k": 12, "ncat25k": 3, "cat": 75, "ncat": 18, "s": 0.9688337801608579, "os": 0.875972867309663, "bg": 1.7927180371626597e-05}, {"x": 0.7763069705093834, "y": 0.75, "term": "homes", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 18, "s": 0.4324731903485255, "os": 0.44990207652502356, "bg": 9.244698031481716e-07}, {"x": 0.7764745308310992, "y": 0.7134718498659517, "term": "g", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 18, "s": 0.40013404825737264, "os": 0.40924978211161855, "bg": 2.542926930292428e-07}, {"x": 0.776642091152815, "y": 0.7613941018766756, "term": "goods", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 18, "s": 0.458612600536193, "os": 0.4687164115306053, "bg": 1.2116812433182405e-06}, {"x": 0.7768096514745308, "y": 0.6372319034852547, "term": "meeting", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 18, "s": 0.33679624664879354, "os": 0.3401565301274866, "bg": 4.293039969217582e-07}, {"x": 0.7769772117962467, "y": 0.8693029490616622, "term": "decision", "cat25k": 5, "ncat25k": 3, "cat": 29, "ncat": 18, "s": 0.6980563002680965, "os": 0.6835425745024569, "bg": 1.3180315479263964e-06}, {"x": 0.7771447721179625, "y": 0.7158176943699732, "term": "several", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 18, "s": 0.40013404825737264, "os": 0.40924978211161855, "bg": 5.375269331113533e-07}, {"x": 0.7773123324396782, "y": 0.4996648793565684, "term": "company", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 18, "s": 0.24346514745308315, "os": 0.26107276566226334, "bg": 1.4171975904757273e-07}, {"x": 0.7774798927613941, "y": 0.8222184986595175, "term": "tools", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 18, "s": 0.5866286863270777, "os": 0.5904142321902618, "bg": 4.088926203807717e-07}, {"x": 0.7776474530831099, "y": 0.33277479892761397, "term": "capacities", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 18, "s": 0.2014075067024129, "os": 0.20349536638340593, "bg": 1.2396760077237716e-05}, {"x": 0.7778150134048257, "y": 0.6407506702412868, "term": "come", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 18, "s": 0.33679624664879354, "os": 0.3401565301274866, "bg": 3.3626900050803777e-07}, {"x": 0.7779825737265416, "y": 0.8904155495978552, "term": "examinations", "cat25k": 6, "ncat25k": 3, "cat": 35, "ncat": 18, "s": 0.7540214477211796, "os": 0.7282370323735575, "bg": 1.9420207862179546e-05}, {"x": 0.7781501340482574, "y": 0.7871983914209115, "term": "often", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 18, "s": 0.5201072386058981, "os": 0.5334788718891352, "bg": 7.322579472089616e-07}, {"x": 0.7783176943699732, "y": 0.6089142091152815, "term": "few", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 3.691544957782975e-07}, {"x": 0.778485254691689, "y": 0.6092493297587132, "term": "chart", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 1.4148485297120455e-06}, {"x": 0.7786528150134048, "y": 0.5703753351206434, "term": "disaster", "cat25k": 1, "ncat25k": 3, "cat": 6, "ncat": 18, "s": 0.2682640750670241, "os": 0.2885028939629599, "bg": 2.7502546993687993e-06}, {"x": 0.7788203753351206, "y": 0.646112600536193, "term": "aspects", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 18, "s": 0.33679624664879354, "os": 0.3401565301274866, "bg": 1.8124976733803904e-06}, {"x": 0.7789879356568364, "y": 0.257372654155496, "term": "linkage", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 18, "s": 0.1873324396782842, "os": 0.17371931492743148, "bg": 1.1503366316360403e-05}, {"x": 0.7791554959785523, "y": 0.697553619302949, "term": "associated", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 18, "s": 0.3726541554959786, "os": 0.3873302691522553, "bg": 8.545637097465204e-07}, {"x": 0.7793230563002681, "y": 0.431970509383378, "term": "unless", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 18, "s": 0.2223525469168901, "os": 0.23268679573477946, "bg": 8.341485555637159e-07}, {"x": 0.7794906166219839, "y": 0.342828418230563, "term": "works", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 18, "s": 0.2014075067024129, "os": 0.20349536638340593, "bg": 4.246985418966527e-07}, {"x": 0.7796581769436998, "y": 0.34601206434316356, "term": "always", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 18, "s": 0.2014075067024129, "os": 0.20349536638340593, "bg": 3.282615747669079e-07}, {"x": 0.7798257372654156, "y": 0.6129356568364611, "term": "1996", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 0.0}, {"x": 0.7799932975871313, "y": 0.6132707774798928, "term": "capable", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 2.9953756791190625e-06}, {"x": 0.7801608579088471, "y": 0.4433646112600536, "term": "bank", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 18, "s": 0.2223525469168901, "os": 0.23268679573477946, "bg": 4.789307062155453e-07}, {"x": 0.780328418230563, "y": 0.2691018766756032, "term": "plus", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 18, "s": 0.1873324396782842, "os": 0.17371931492743148, "bg": 4.208655546248347e-07}, {"x": 0.7804959785522788, "y": 0.6184651474530831, "term": "100", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 18, "s": 0.29892761394101874, "os": 0.314881867244268, "bg": 0.0}, {"x": 0.7806635388739946, "y": 0.27865281501340483, "term": "repeat", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 18, "s": 0.1873324396782842, "os": 0.17371931492743148, "bg": 2.7900246296399243e-06}, {"x": 0.7808310991957105, "y": 0.3624329758713137, "term": "mucus", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 18, "s": 0.2014075067024129, "os": 0.20349536638340593, "bg": 4.603017168158081e-05}, {"x": 0.7809986595174263, "y": 0.45308310991957107, "term": "dry", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 18, "s": 0.2223525469168901, "os": 0.23268679573477946, "bg": 1.3725869920679448e-06}, {"x": 0.7811662198391421, "y": 0.30144101876675605, "term": "cho", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 18, "s": 0.1873324396782842, "os": 0.17371931492743148, "bg": 7.317053985773087e-06}, {"x": 0.7813337801608579, "y": 0.01524798927613941, "term": "pregnancies", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 2.6979286652672407e-05}, {"x": 0.7815013404825737, "y": 0.023123324396782843, "term": "residual dbs", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 0.0}, {"x": 0.7816689008042895, "y": 0.025804289544235925, "term": "maternity waiting", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 0.0}, {"x": 0.7818364611260054, "y": 0.026474530831099196, "term": "infra", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 2.0707816165211556e-05}, {"x": 0.7820040214477212, "y": 0.04289544235924933, "term": "mbfhi", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 0.00011539386168763522}, {"x": 0.782171581769437, "y": 0.05445710455764075, "term": "antibody", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 5.778716569522696e-06}, {"x": 0.7823391420911529, "y": 0.056467828418230566, "term": "antibodies", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 6.588062540477697e-06}, {"x": 0.7825067024128687, "y": 0.06618632707774799, "term": "mam", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 3.749503971870388e-05}, {"x": 0.7826742627345844, "y": 0.07355898123324396, "term": "vehicle", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 6.618717247001923e-07}, {"x": 0.7828418230563002, "y": 0.09048257372654156, "term": "ehsp", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 0.00011539386168763522}, {"x": 0.7830093833780161, "y": 0.09132037533512065, "term": "wounds", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 1.0150638291873145e-05}, {"x": 0.7831769436997319, "y": 0.13388069705093833, "term": "nhsrc", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 18, "s": 0.03351206434316354, "os": 0.11375449058797443, "bg": 0.00011539386168763522}, {"x": 0.7833445040214477, "y": 0.9720174262734584, "term": "diagnostic", "cat25k": 20, "ncat25k": 3, "cat": 122, "ncat": 19, "s": 0.9882707774798928, "os": 0.926514387057005, "bg": 2.5026759552035207e-05}, {"x": 0.7835120643431636, "y": 0.7421246648793566, "term": "acceptable", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 19, "s": 0.42208445040214476, "os": 0.4347703588882932, "bg": 4.294473093649843e-06}, {"x": 0.7836796246648794, "y": 0.5876340482573726, "term": "highly", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 19, "s": 0.29121983914209115, "os": 0.3029781792258789, "bg": 1.2045609495794878e-06}, {"x": 0.7838471849865952, "y": 0.7809986595174263, "term": "regarding", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 19, "s": 0.4865951742627346, "os": 0.521034459034056, "bg": 1.3800797358811288e-06}, {"x": 0.784014745308311, "y": 0.743632707774799, "term": "added", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 19, "s": 0.42208445040214476, "os": 0.4347703588882932, "bg": 5.39072646634351e-07}, {"x": 0.7841823056300268, "y": 0.838304289544236, "term": "authority", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 19, "s": 0.6141085790884718, "os": 0.6141323362780948, "bg": 1.4554196640226082e-06}, {"x": 0.7843498659517426, "y": 0.801441018766756, "term": "circumstances", "cat25k": 3, "ncat25k": 3, "cat": 18, "ncat": 19, "s": 0.5519436997319035, "os": 0.5511444344295447, "bg": 3.0543563996402462e-06}, {"x": 0.7845174262734584, "y": 0.905328418230563, "term": "ix", "cat25k": 7, "ncat25k": 3, "cat": 42, "ncat": 19, "s": 0.7900469168900804, "os": 0.7600691096995529, "bg": 1.6613980828283205e-05}, {"x": 0.7846849865951743, "y": 0.964142091152815, "term": "abuse", "cat25k": 16, "ncat25k": 3, "cat": 98, "ncat": 19, "s": 0.9808981233243967, "os": 0.9053181117350593, "bg": 6.39663062675581e-06}, {"x": 0.7848525469168901, "y": 0.6243297587131368, "term": "show", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 19, "s": 0.31115951742627346, "os": 0.3274625997305961, "bg": 2.1787022414851777e-07}, {"x": 0.7850201072386059, "y": 0.6255026809651475, "term": "takes", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 19, "s": 0.31115951742627346, "os": 0.3274625997305961, "bg": 9.294925347721005e-07}, {"x": 0.7851876675603218, "y": 0.8629356568364611, "term": "taking", "cat25k": 4, "ncat25k": 3, "cat": 28, "ncat": 19, "s": 0.6737600536193029, "os": 0.6639043687044421, "bg": 1.3369472439621935e-06}, {"x": 0.7853552278820375, "y": 0.7820040214477212, "term": "treated", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 19, "s": 0.4865951742627346, "os": 0.521034459034056, "bg": 3.039493484910847e-06}, {"x": 0.7855227882037533, "y": 0.8460120643431636, "term": "recommend", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 19, "s": 0.6392426273458446, "os": 0.6250004169702384, "bg": 2.0743469587938936e-06}, {"x": 0.7856903485254692, "y": 0.871313672922252, "term": "actions", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 19, "s": 0.6955428954423593, "os": 0.6809987293833316, "bg": 2.2492302239071965e-06}, {"x": 0.785857908847185, "y": 0.8803619302949062, "term": "valid", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 19, "s": 0.7045911528150135, "os": 0.6967623270788148, "bg": 1.7767955001922336e-06}, {"x": 0.7860254691689008, "y": 0.916387399463807, "term": "charged", "cat25k": 8, "ncat25k": 3, "cat": 47, "ncat": 19, "s": 0.818029490616622, "os": 0.7844249648707037, "bg": 6.0858660371791085e-06}, {"x": 0.7861930294906166, "y": 0.7944034852546917, "term": "whose", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 19, "s": 0.5301608579088471, "os": 0.5364955834668319, "bg": 1.6383648245256663e-06}, {"x": 0.7863605898123325, "y": 0.7474865951742627, "term": "locality", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 19, "s": 0.42208445040214476, "os": 0.4347703588882932, "bg": 1.964837996037167e-05}, {"x": 0.7865281501340483, "y": 0.6876675603217158, "term": "infrastructure", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 19, "s": 0.36427613941018766, "os": 0.3733843011752741, "bg": 1.9726374775272376e-06}, {"x": 0.786695710455764, "y": 0.8131702412868632, "term": "regularly", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 19, "s": 0.5599865951742627, "os": 0.5650410458924129, "bg": 5.362551524594566e-06}, {"x": 0.7868632707774799, "y": 0.23709785522788204, "term": "cards", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 19, "s": 0.14041554959785524, "os": 0.1675099747220769, "bg": 3.459452335748086e-07}, {"x": 0.7870308310991957, "y": 0.9440348525469169, "term": "council", "cat25k": 11, "ncat25k": 3, "cat": 66, "ncat": 19, "s": 0.9428619302949062, "os": 0.8494410325219426, "bg": 1.5016903733520272e-06}, {"x": 0.7871983914209115, "y": 0.8817024128686327, "term": "allocation", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 19, "s": 0.7045911528150135, "os": 0.6967623270788148, "bg": 8.451878525293033e-06}, {"x": 0.7873659517426274, "y": 0.8073056300268097, "term": "incidence", "cat25k": 3, "ncat25k": 3, "cat": 18, "ncat": 19, "s": 0.5519436997319035, "os": 0.5511444344295447, "bg": 1.1278282006735573e-05}, {"x": 0.7875335120643432, "y": 0.6910187667560321, "term": "proportion", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 19, "s": 0.36427613941018766, "os": 0.3733843011752741, "bg": 5.63364466990679e-06}, {"x": 0.787701072386059, "y": 0.6660522788203753, "term": "minor", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 19, "s": 0.34316353887399464, "os": 0.3509333396630456, "bg": 1.860798452666338e-06}, {"x": 0.7878686327077749, "y": 0.4906166219839142, "term": "1997", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 19, "s": 0.23827077747989278, "os": 0.25110717376196157, "bg": 0.0}, {"x": 0.7880361930294906, "y": 0.6913538873994638, "term": "called", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 19, "s": 0.36427613941018766, "os": 0.3733843011752741, "bg": 5.405902365525941e-07}, {"x": 0.7882037533512064, "y": 0.667225201072386, "term": "primarily", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 19, "s": 0.34316353887399464, "os": 0.3509333396630456, "bg": 3.060688980765428e-06}, {"x": 0.7883713136729222, "y": 0.16253351206434316, "term": "oil", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 19, "s": 0.054959785522788206, "os": 0.13886283489097867, "bg": 4.849064150015303e-07}, {"x": 0.7885388739946381, "y": 0.8361260053619303, "term": "recognized", "cat25k": 4, "ncat25k": 3, "cat": 22, "ncat": 19, "s": 0.6025469168900804, "os": 0.6027422396539583, "bg": 4.214939070228646e-06}, {"x": 0.7887064343163539, "y": 0.7164879356568364, "term": "municipality", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 19, "s": 0.3811997319034853, "os": 0.39482527187515437, "bg": 1.058762183485251e-05}, {"x": 0.7888739946380697, "y": 0.6715817694369973, "term": "demand", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 19, "s": 0.34316353887399464, "os": 0.3509333396630456, "bg": 1.239758295837102e-06}, {"x": 0.7890415549597856, "y": 0.7989276139410187, "term": "role", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 19, "s": 0.5301608579088471, "os": 0.5364955834668319, "bg": 9.729598906068763e-07}, {"x": 0.7892091152815014, "y": 0.6745978552278821, "term": "allow", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 19, "s": 0.34316353887399464, "os": 0.3509333396630456, "bg": 8.312977424684723e-07}, {"x": 0.7893766756032171, "y": 0.8590817694369973, "term": "composed", "cat25k": 4, "ncat25k": 3, "cat": 26, "ncat": 19, "s": 0.6576742627345844, "os": 0.6453065064613385, "bg": 9.388193345460794e-06}, {"x": 0.789544235924933, "y": 0.6995643431635389, "term": "importance", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 19, "s": 0.36427613941018766, "os": 0.3733843011752741, "bg": 2.1670919024070337e-06}, {"x": 0.7897117962466488, "y": 0.18012734584450402, "term": "preferably", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 19, "s": 0.054959785522788206, "os": 0.13886283489097867, "bg": 9.48129045103684e-06}, {"x": 0.7898793565683646, "y": 0.18682975871313673, "term": "cup", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 19, "s": 0.054959785522788206, "os": 0.13886283489097867, "bg": 8.821455526488614e-07}, {"x": 0.7900469168900804, "y": 0.282171581769437, "term": "mm", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 19, "s": 0.14041554959785524, "os": 0.1675099747220769, "bg": 7.865800896690065e-07}, {"x": 0.7902144772117963, "y": 0.28267426273458446, "term": "waiting", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 19, "s": 0.14041554959785524, "os": 0.1675099747220769, "bg": 1.3778405125330505e-06}, {"x": 0.7903820375335121, "y": 0.46146112600536193, "term": "charts", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 19, "s": 0.2158176943699732, "os": 0.2238700326063282, "bg": 1.7867458956407556e-06}, {"x": 0.7905495978552279, "y": 0.46347184986595175, "term": "completely", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 19, "s": 0.2158176943699732, "os": 0.2238700326063282, "bg": 1.325760932736222e-06}, {"x": 0.7907171581769437, "y": 0.21447721179624665, "term": "observe", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 19, "s": 0.054959785522788206, "os": 0.13886283489097867, "bg": 5.083564910896545e-06}, {"x": 0.7908847184986595, "y": 0.0010053619302949062, "term": "prenatal", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 1.5971345724575826e-05}, {"x": 0.7910522788203753, "y": 0.007372654155495978, "term": "mainstreaming", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 3.960850123515984e-05}, {"x": 0.7912198391420912, "y": 0.03636058981233244, "term": "bottles", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 4.4020554818854835e-06}, {"x": 0.791387399463807, "y": 0.0435656836461126, "term": "iycf", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 0.00012180424135189886}, {"x": 0.7915549597855228, "y": 0.046414209115281505, "term": "cord", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 3.261711303185851e-06}, {"x": 0.7917225201072386, "y": 0.050435656836461125, "term": "investigated", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 5.947484339334658e-06}, {"x": 0.7918900804289544, "y": 0.051943699731903485, "term": "supplemental", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 5.771603377238527e-06}, {"x": 0.7920576407506702, "y": 0.05328418230563003, "term": "epidemiologically", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 0.0001118571525290019}, {"x": 0.792225201072386, "y": 0.08026139410187667, "term": "heritable", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 19, "s": 0.03116621983914209, "os": 0.11035834041946774, "bg": 8.442361995152306e-05}, {"x": 0.7923927613941019, "y": 0.8620978552278821, "term": "issue", "cat25k": 4, "ncat25k": 3, "cat": 28, "ncat": 20, "s": 0.6648793565683646, "os": 0.6531387246795414, "bg": 7.456938452472903e-07}, {"x": 0.7925603217158177, "y": 0.6799597855227882, "term": "net", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 20, "s": 0.3543900804289544, "os": 0.3603201303910961, "bg": 5.119647222175411e-07}, {"x": 0.7927278820375335, "y": 0.7057640750670241, "term": "\u201c", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 20, "s": 0.3681300268096515, "os": 0.3812865567303089, "bg": 0.0}, {"x": 0.7928954423592494, "y": 0.7446380697050938, "term": "own", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 20, "s": 0.40683646112600536, "os": 0.4205100578737996, "bg": 2.8408636874704225e-07}, {"x": 0.7930630026809652, "y": 0.839142091152815, "term": "changes", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 20, "s": 0.6022117962466488, "os": 0.6027305884582268, "bg": 6.570791634688495e-07}, {"x": 0.7932305630026809, "y": 0.9125335120643432, "term": "member", "cat25k": 7, "ncat25k": 3, "cat": 45, "ncat": 20, "s": 0.7960790884718498, "os": 0.7666081015712843, "bg": 4.5747116660408407e-07}, {"x": 0.7933981233243967, "y": 0.7685991957104558, "term": "of\ufb01cer", "cat25k": 2, "ncat25k": 3, "cat": 15, "ncat": 20, "s": 0.43766756032171583, "os": 0.456293388692952, "bg": 0.0}, {"x": 0.7935656836461126, "y": 0.9058310991957105, "term": "said", "cat25k": 7, "ncat25k": 3, "cat": 42, "ncat": 20, "s": 0.7848525469168901, "os": 0.751166054875771, "bg": 3.9252023816937825e-07}, {"x": 0.7937332439678284, "y": 0.8332774798927614, "term": "pursuant", "cat25k": 4, "ncat25k": 3, "cat": 22, "ncat": 20, "s": 0.5876340482573726, "os": 0.5912313584652827, "bg": 4.585934349729249e-06}, {"x": 0.7939008042895442, "y": 0.7593833780160858, "term": "subsequent", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 20, "s": 0.4262734584450402, "os": 0.43881656743963926, "bg": 4.414171020954264e-06}, {"x": 0.7940683646112601, "y": 0.7831769436997319, "term": "enhance", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 20, "s": 0.45995308310991956, "os": 0.47297415935404263, "bg": 3.1826843582070575e-06}, {"x": 0.7942359249329759, "y": 0.943029490616622, "term": "framework", "cat25k": 10, "ncat25k": 3, "cat": 65, "ncat": 20, "s": 0.9133713136729223, "os": 0.8402010710088991, "bg": 5.193395479540267e-06}, {"x": 0.7944034852546917, "y": 0.920073726541555, "term": "societies", "cat25k": 8, "ncat25k": 3, "cat": 49, "ncat": 20, "s": 0.8186997319034853, "os": 0.7850267204248063, "bg": 1.4416939778875487e-05}, {"x": 0.7945710455764075, "y": 0.8723190348525469, "term": "laws", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 20, "s": 0.6839812332439679, "os": 0.6705072484235046, "bg": 2.1850195930706913e-06}, {"x": 0.7947386058981233, "y": 0.31668900804289546, "term": "suitable", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 20, "s": 0.19487265415549598, "os": 0.1888605839922629, "bg": 2.176345078247649e-06}, {"x": 0.7949061662198391, "y": 0.9477211796246648, "term": "insurance", "cat25k": 11, "ncat25k": 3, "cat": 71, "ncat": 20, "s": 0.949396782841823, "os": 0.8553027770318006, "bg": 9.40163544341349e-07}, {"x": 0.795073726541555, "y": 0.7303954423592494, "term": "targets", "cat25k": 2, "ncat25k": 3, "cat": 12, "ncat": 20, "s": 0.3922587131367293, "os": 0.4013425636921556, "bg": 4.242169270375387e-06}, {"x": 0.7952412868632708, "y": 0.885053619302949, "term": "2008", "cat25k": 5, "ncat25k": 3, "cat": 33, "ncat": 20, "s": 0.7032506702412868, "os": 0.6941138810081956, "bg": 0.0}, {"x": 0.7954088471849866, "y": 0.8481903485254692, "term": "main", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 20, "s": 0.613941018766756, "os": 0.6137158738555362, "bg": 4.401567948542469e-07}, {"x": 0.7955764075067024, "y": 0.8203753351206434, "term": "making", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 20, "s": 0.5608243967828418, "os": 0.5665438699577672, "bg": 6.425151022371638e-07}, {"x": 0.7957439678284183, "y": 0.8346179624664879, "term": "agreement", "cat25k": 4, "ncat25k": 3, "cat": 22, "ncat": 20, "s": 0.5876340482573726, "os": 0.5912313584652827, "bg": 7.522276752460114e-07}, {"x": 0.795911528150134, "y": 0.6903485254691689, "term": "informed", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 20, "s": 0.3543900804289544, "os": 0.3603201303910961, "bg": 1.5576559738689713e-06}, {"x": 0.7960790884718498, "y": 0.40130697050938335, "term": "temperature", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 20, "s": 0.20693699731903487, "os": 0.21564209966064696, "bg": 1.1173903534526838e-06}, {"x": 0.7962466487935657, "y": 0.8423257372654156, "term": "whole", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 20, "s": 0.6022117962466488, "os": 0.6027305884582268, "bg": 1.0056770469299195e-06}, {"x": 0.7964142091152815, "y": 0.7608914209115282, "term": "update", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 20, "s": 0.4262734584450402, "os": 0.43881656743963926, "bg": 6.727532433409128e-07}, {"x": 0.7965817694369973, "y": 0.7506702412868632, "term": "close", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 20, "s": 0.40683646112600536, "os": 0.4205100578737996, "bg": 6.101785661687529e-07}, {"x": 0.7967493297587132, "y": 0.494470509383378, "term": "serving", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 20, "s": 0.2272117962466488, "os": 0.2418198834730464, "bg": 1.6540659919400674e-06}, {"x": 0.796916890080429, "y": 0.602044235924933, "term": "supplement", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 20, "s": 0.2825067024128686, "os": 0.29187846233502074, "bg": 4.0600847429909974e-06}, {"x": 0.7970844504021448, "y": 0.4101876675603217, "term": "house", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 20, "s": 0.20693699731903487, "os": 0.21564209966064696, "bg": 2.0723384177336109e-07}, {"x": 0.7972520107238605, "y": 0.6390750670241286, "term": "yet", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 20, "s": 0.3001005361930295, "os": 0.3156114774806379, "bg": 4.5354223531886617e-07}, {"x": 0.7974195710455764, "y": 0.6420911528150134, "term": "check", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 20, "s": 0.3001005361930295, "os": 0.3156114774806379, "bg": 2.2875529647656594e-07}, {"x": 0.7975871313672922, "y": 0.7985924932975871, "term": "effectiveness", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 20, "s": 0.4876005361930295, "os": 0.5246463956919283, "bg": 4.88426245095854e-06}, {"x": 0.797754691689008, "y": 0.8156836461126006, "term": "therapy", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 20, "s": 0.5531166219839142, "os": 0.5532735859527994, "bg": 2.01184429480679e-06}, {"x": 0.7979222520107239, "y": 0.7635723860589813, "term": "documentation", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 20, "s": 0.4262734584450402, "os": 0.43881656743963926, "bg": 1.5390178829804132e-06}, {"x": 0.7980898123324397, "y": 0.7191689008042895, "term": "authorities", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 20, "s": 0.3681300268096515, "os": 0.3812865567303089, "bg": 2.6310498338661773e-06}, {"x": 0.7982573726541555, "y": 0.5123994638069705, "term": "phases", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 20, "s": 0.2272117962466488, "os": 0.2418198834730464, "bg": 8.04643889558442e-06}, {"x": 0.7984249329758714, "y": 0.5132372654155496, "term": "negative", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 20, "s": 0.2272117962466488, "os": 0.2418198834730464, "bg": 1.6225090551419113e-06}, {"x": 0.7985924932975871, "y": 0.7776474530831099, "term": "core", "cat25k": 2, "ncat25k": 3, "cat": 15, "ncat": 20, "s": 0.43766756032171583, "os": 0.456293388692952, "bg": 1.3577328793617676e-06}, {"x": 0.7987600536193029, "y": 0.1722520107238606, "term": "dietary", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 20, "s": 0.05060321715817695, "os": 0.13428133253816993, "bg": 5.752729601711135e-06}, {"x": 0.7989276139410187, "y": 0.35053619302949063, "term": "planned", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 20, "s": 0.19487265415549598, "os": 0.1888605839922629, "bg": 2.1044207154234415e-06}, {"x": 0.7990951742627346, "y": 0.7014075067024129, "term": "usually", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 20, "s": 0.3543900804289544, "os": 0.3603201303910961, "bg": 6.329824560367046e-07}, {"x": 0.7992627345844504, "y": 0.2074396782841823, "term": "vaccinate", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 20, "s": 0.05060321715817695, "os": 0.13428133253816993, "bg": 8.259619506861383e-05}, {"x": 0.7994302949061662, "y": 0.21648793565683647, "term": "construction", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 20, "s": 0.05060321715817695, "os": 0.13428133253816993, "bg": 4.7147545966303497e-07}, {"x": 0.7995978552278821, "y": 0.0005026809651474531, "term": "postnatal", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 4.7031102844088366e-05}, {"x": 0.7997654155495979, "y": 0.007707774798927614, "term": "fertile", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 1.9904696314048336e-05}, {"x": 0.7999329758713136, "y": 0.019939678284182305, "term": "seal", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 2.411670168411751e-06}, {"x": 0.8001005361930295, "y": 0.09098525469168901, "term": "wound", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 6.523128485898708e-06}, {"x": 0.8002680965147453, "y": 0.13756702412868632, "term": "tuberculin", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 8.548652518646749e-05}, {"x": 0.8004356568364611, "y": 0.14192359249329758, "term": "causality", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 4.183829082214333e-05}, {"x": 0.800603217158177, "y": 0.15147453083109919, "term": "praziquantel", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 20, "s": 0.029490616621983913, "os": 0.10704758503596817, "bg": 0.0001126839918304106}, {"x": 0.8007707774798928, "y": 0.8237265415549598, "term": "assigned", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 21, "s": 0.5613270777479893, "os": 0.5680072346796506, "bg": 3.3931897389295973e-06}, {"x": 0.8009383378016086, "y": 0.7806635388739946, "term": "now", "cat25k": 3, "ncat25k": 3, "cat": 16, "ncat": 21, "s": 0.439343163538874, "os": 0.4588468426788607, "bg": 1.2097438722099813e-07}, {"x": 0.8011058981233244, "y": 0.8835455764075067, "term": "initiatives", "cat25k": 5, "ncat25k": 3, "cat": 33, "ncat": 21, "s": 0.698558981233244, "os": 0.684263578825292, "bg": 6.561503984199899e-06}, {"x": 0.8012734584450402, "y": 0.8170241286863271, "term": "recommendation", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 21, "s": 0.5546246648793566, "os": 0.5553060319908115, "bg": 4.489974243427019e-06}, {"x": 0.801441018766756, "y": 0.7664209115281502, "term": "client", "cat25k": 2, "ncat25k": 3, "cat": 15, "ncat": 21, "s": 0.42828418230563003, "os": 0.4423379677741825, "bg": 1.0359485663047371e-06}, {"x": 0.8016085790884718, "y": 0.8455093833780161, "term": "dosage", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 21, "s": 0.6027144772117962, "os": 0.6028013857064777, "bg": 1.4924932564179694e-05}, {"x": 0.8017761394101877, "y": 0.8976206434316354, "term": "towards", "cat25k": 6, "ncat25k": 3, "cat": 38, "ncat": 21, "s": 0.7471514745308311, "os": 0.7187898923688439, "bg": 3.1796778274975196e-06}, {"x": 0.8019436997319035, "y": 0.9140415549597856, "term": "board", "cat25k": 7, "ncat25k": 3, "cat": 46, "ncat": 21, "s": 0.7952412868632708, "os": 0.7631179759411149, "bg": 6.300750339900794e-07}, {"x": 0.8021112600536193, "y": 0.8873994638069705, "term": "executive", "cat25k": 5, "ncat25k": 3, "cat": 34, "ncat": 21, "s": 0.702245308310992, "os": 0.6916751691796376, "bg": 1.500216733583834e-06}, {"x": 0.8022788203753352, "y": 0.9247654155495979, "term": "accredited", "cat25k": 8, "ncat25k": 3, "cat": 52, "ncat": 21, "s": 0.8225536193029491, "os": 0.7897243178439115, "bg": 1.5668040159977126e-05}, {"x": 0.802446380697051, "y": 0.8679624664879356, "term": "preventive", "cat25k": 5, "ncat25k": 3, "cat": 29, "ncat": 21, "s": 0.6613605898123325, "os": 0.6516518647226996, "bg": 2.3527119946433455e-05}, {"x": 0.8026139410187667, "y": 0.47570375335120646, "term": "findings", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 21, "s": 0.22285522788203754, "os": 0.23313222337823042, "bg": 2.468028002435564e-06}, {"x": 0.8027815013404825, "y": 0.8681300268096515, "term": "then", "cat25k": 5, "ncat25k": 3, "cat": 29, "ncat": 21, "s": 0.6613605898123325, "os": 0.6516518647226996, "bg": 2.7009438188884494e-07}, {"x": 0.8029490616621984, "y": 0.8951072386058981, "term": "request", "cat25k": 6, "ncat25k": 3, "cat": 37, "ncat": 21, "s": 0.7245308310991958, "os": 0.7123659897698116, "bg": 9.285026319007427e-07}, {"x": 0.8031166219839142, "y": 0.6593498659517426, "term": "sick", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 21, "s": 0.3101541554959786, "os": 0.32670491021491865, "bg": 3.6861186423975895e-06}, {"x": 0.80328418230563, "y": 0.6596849865951743, "term": "2006", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 21, "s": 0.3101541554959786, "os": 0.32670491021491865, "bg": 0.0}, {"x": 0.8034517426273459, "y": 0.3145107238605898, "term": "managers", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 21, "s": 0.19135388739946382, "os": 0.18220892615787337, "bg": 1.914730890357443e-06}, {"x": 0.8036193029490617, "y": 0.9078418230563002, "term": "rates", "cat25k": 7, "ncat25k": 3, "cat": 43, "ncat": 21, "s": 0.7820040214477212, "os": 0.7478362897042798, "bg": 9.315760383766823e-07}, {"x": 0.8037868632707775, "y": 0.9612935656836461, "term": "fees", "cat25k": 15, "ncat25k": 3, "cat": 92, "ncat": 21, "s": 0.9753686327077749, "os": 0.8880347966553229, "bg": 4.088493154912699e-06}, {"x": 0.8039544235924933, "y": 0.8471849865951743, "term": "contribute", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 21, "s": 0.6027144772117962, "os": 0.6028013857064777, "bg": 3.988103222214586e-06}, {"x": 0.8041219839142091, "y": 0.7602211796246648, "term": "integrate", "cat25k": 2, "ncat25k": 3, "cat": 14, "ncat": 21, "s": 0.41186327077747986, "os": 0.4250805448058794, "bg": 8.906775957048982e-06}, {"x": 0.8042895442359249, "y": 0.8476876675603218, "term": "currently", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 21, "s": 0.6027144772117962, "os": 0.6028013857064777, "bg": 1.0068466466950056e-06}, {"x": 0.8044571045576407, "y": 0.157171581769437, "term": "infectious", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 21, "s": 0.047084450402144776, "os": 0.1299014956640055, "bg": 6.914958737341107e-06}, {"x": 0.8046246648793566, "y": 0.8052949061662198, "term": "type", "cat25k": 3, "ncat25k": 3, "cat": 18, "ncat": 21, "s": 0.4886058981233244, "os": 0.5280132441974646, "bg": 2.860822577083627e-07}, {"x": 0.8047922252010724, "y": 0.23642761394101877, "term": "4%", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 21, "s": 0.0824396782841823, "os": 0.15612482547776074, "bg": 0.0}, {"x": 0.8049597855227882, "y": 0.8342828418230563, "term": "estimated", "cat25k": 4, "ncat25k": 3, "cat": 22, "ncat": 21, "s": 0.5769101876675603, "os": 0.5801327698215669, "bg": 2.602628448944208e-06}, {"x": 0.8051273458445041, "y": 0.896112600536193, "term": "achieve", "cat25k": 6, "ncat25k": 3, "cat": 37, "ncat": 21, "s": 0.7245308310991958, "os": 0.7123659897698116, "bg": 4.1960899387023615e-06}, {"x": 0.8052949061662198, "y": 0.6677278820375335, "term": "alternative", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 21, "s": 0.3101541554959786, "os": 0.32670491021491865, "bg": 1.0749969855292866e-06}, {"x": 0.8054624664879356, "y": 0.9110254691689008, "term": "2010", "cat25k": 7, "ncat25k": 3, "cat": 44, "ncat": 21, "s": 0.7861930294906166, "os": 0.7530935241200009, "bg": 0.0}, {"x": 0.8056300268096515, "y": 0.6375670241286864, "term": "traditional", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 21, "s": 0.2925603217158177, "os": 0.30451376370761296, "bg": 1.2043294147430396e-06}, {"x": 0.8057975871313673, "y": 0.8429959785522788, "term": "treat", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 21, "s": 0.5879691689008043, "os": 0.5917194995328312, "bg": 4.454722704648442e-06}, {"x": 0.8059651474530831, "y": 0.7751340482573726, "term": "adults", "cat25k": 2, "ncat25k": 3, "cat": 15, "ncat": 21, "s": 0.42828418230563003, "os": 0.4423379677741825, "bg": 2.171325547201179e-06}, {"x": 0.806132707774799, "y": 0.4971514745308311, "term": "proven", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 21, "s": 0.22285522788203754, "os": 0.23313222337823042, "bg": 3.929579813808952e-06}, {"x": 0.8063002680965148, "y": 0.8302613941018767, "term": "1n", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 21, "s": 0.5613270777479893, "os": 0.5680072346796506, "bg": 0.0}, {"x": 0.8064678284182306, "y": 0.7526809651474531, "term": "rescinded", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 21, "s": 0.39896112600536193, "os": 0.40704646032575964, "bg": 9.304502147561195e-05}, {"x": 0.8066353887399463, "y": 0.608411528150134, "term": "certi\ufb01ed", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 21, "s": 0.2662533512064343, "os": 0.2814943977999484, "bg": 0.0}, {"x": 0.8068029490616622, "y": 0.18431635388739948, "term": "fertility", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 21, "s": 0.047084450402144776, "os": 0.1299014956640055, "bg": 8.495651770957227e-06}, {"x": 0.806970509383378, "y": 0.2875335120643432, "term": "nearest", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 21, "s": 0.0824396782841823, "os": 0.15612482547776074, "bg": 3.068752190655436e-06}, {"x": 0.8071380697050938, "y": 0.6204758713136729, "term": "stations", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 21, "s": 0.2662533512064343, "os": 0.2814943977999484, "bg": 2.161114647363591e-06}, {"x": 0.8073056300268097, "y": 0.21514745308310992, "term": "ndhs", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 21, "s": 0.047084450402144776, "os": 0.1299014956640055, "bg": 0.0001410351337750297}, {"x": 0.8074731903485255, "y": 0.021615281501340483, "term": "rda", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 21, "s": 0.028317694369973192, "os": 0.10382048216412826, "bg": 4.648151529739869e-05}, {"x": 0.8076407506702413, "y": 0.026306970509383378, "term": "pmo", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 21, "s": 0.028317694369973192, "os": 0.10382048216412826, "bg": 6.890532408470762e-05}, {"x": 0.8078083109919572, "y": 0.0350201072386059, "term": "rooming", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 21, "s": 0.028317694369973192, "os": 0.10382048216412826, "bg": 8.313242996092776e-05}, {"x": 0.8079758713136729, "y": 0.06920241286863271, "term": "59", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 21, "s": 0.028317694369973192, "os": 0.10382048216412826, "bg": 0.0}, {"x": 0.8081434316353887, "y": 0.07422922252010723, "term": "tables", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 21, "s": 0.028317694369973192, "os": 0.10382048216412826, "bg": 1.1537980049678696e-06}, {"x": 0.8083109919571045, "y": 0.8753351206434317, "term": "application", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 22, "s": 0.6689008042895442, "os": 0.6587339375603467, "bg": 6.92409470972709e-07}, {"x": 0.8084785522788204, "y": 0.8701407506702413, "term": "causes", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 22, "s": 0.6603552278820376, "os": 0.650322500968683, "bg": 4.43262524702296e-06}, {"x": 0.8086461126005362, "y": 0.7044235924932976, "term": "shown", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 22, "s": 0.35170911528150134, "os": 0.35654401350738985, "bg": 9.55583204084672e-07}, {"x": 0.808813672922252, "y": 0.8624329758713136, "term": "financial", "cat25k": 4, "ncat25k": 3, "cat": 28, "ncat": 22, "s": 0.645274798927614, "os": 0.6324953351478844, "bg": 6.727561684609432e-07}, {"x": 0.8089812332439679, "y": 0.8862265415549598, "term": "similar", "cat25k": 5, "ncat25k": 3, "cat": 34, "ncat": 22, "s": 0.6962131367292226, "os": 0.682164893366225, "bg": 9.375301087375881e-07}, {"x": 0.8091487935656837, "y": 0.8895777479892761, "term": "protect", "cat25k": 6, "ncat25k": 3, "cat": 35, "ncat": 22, "s": 0.7010723860589813, "os": 0.6894243183935251, "bg": 3.018430616778434e-06}, {"x": 0.8093163538873994, "y": 0.9121983914209115, "term": "regulation", "cat25k": 7, "ncat25k": 3, "cat": 45, "ncat": 22, "s": 0.7830093833780161, "os": 0.7498875020622094, "bg": 4.578039377424909e-06}, {"x": 0.8094839142091153, "y": 0.810656836461126, "term": "meetings", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 22, "s": 0.4906166219839142, "os": 0.5311659793037412, "bg": 2.0696805405177696e-06}, {"x": 0.8096514745308311, "y": 0.8709785522788204, "term": "13", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 22, "s": 0.6603552278820376, "os": 0.650322500968683, "bg": 0.0}, {"x": 0.8098190348525469, "y": 0.727044235924933, "term": "live", "cat25k": 2, "ncat25k": 3, "cat": 12, "ncat": 22, "s": 0.36544906166219837, "os": 0.375810558948386, "bg": 4.088577344639773e-07}, {"x": 0.8099865951742627, "y": 0.47553619302949063, "term": "past", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 22, "s": 0.2166554959785523, "os": 0.2249781037362798, "bg": 5.097340321094683e-07}, {"x": 0.8101541554959786, "y": 0.6843163538873994, "term": "sustained", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 22, "s": 0.33528820375335117, "os": 0.3365026197975808, "bg": 8.80197428283164e-06}, {"x": 0.8103217158176944, "y": 0.8771782841823056, "term": "he", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 22, "s": 0.6689008042895442, "os": 0.6587339375603467, "bg": 1.2571765374105867e-07}, {"x": 0.8104892761394102, "y": 0.811662198391421, "term": "she", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 22, "s": 0.4906166219839142, "os": 0.5311659793037412, "bg": 2.415434888152699e-07}, {"x": 0.810656836461126, "y": 0.8401474530831099, "term": "benefits", "cat25k": 4, "ncat25k": 3, "cat": 23, "ncat": 22, "s": 0.5774128686327078, "os": 0.5810866402816057, "bg": 1.1704583643705295e-06}, {"x": 0.8108243967828418, "y": 0.9510723860589813, "term": "medicine", "cat25k": 12, "ncat25k": 3, "cat": 74, "ncat": 22, "s": 0.9431970509383378, "os": 0.8501373570980257, "bg": 2.9932658533765874e-06}, {"x": 0.8109919571045576, "y": 0.9130361930294906, "term": "building", "cat25k": 7, "ncat25k": 3, "cat": 45, "ncat": 22, "s": 0.7830093833780161, "os": 0.7498875020622094, "bg": 1.0422873964531226e-06}, {"x": 0.8111595174262735, "y": 0.7945710455764075, "term": "operating", "cat25k": 3, "ncat25k": 3, "cat": 17, "ncat": 22, "s": 0.44001340482573725, "os": 0.461063006772789, "bg": 1.211953271370306e-06}, {"x": 0.8113270777479893, "y": 0.8126675603217158, "term": "networking", "cat25k": 3, "ncat25k": 3, "cat": 19, "ncat": 22, "s": 0.4906166219839142, "os": 0.5311659793037412, "bg": 1.7737236895399512e-06}, {"x": 0.8114946380697051, "y": 0.8515415549597856, "term": "phic", "cat25k": 4, "ncat25k": 3, "cat": 25, "ncat": 22, "s": 0.6035522788203754, "os": 0.602940613913347, "bg": 0.00027245902969803425}, {"x": 0.811662198391421, "y": 0.8480227882037533, "term": "identi\ufb01cation", "cat25k": 4, "ncat25k": 3, "cat": 24, "ncat": 22, "s": 0.5881367292225201, "os": 0.5922462937552638, "bg": 0.0}, {"x": 0.8118297587131368, "y": 0.6891756032171582, "term": "lack", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 22, "s": 0.33528820375335117, "os": 0.3365026197975808, "bg": 1.9879533752870186e-06}, {"x": 0.8119973190348525, "y": 0.6628686327077749, "term": "failure", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 22, "s": 0.3004356568364611, "os": 0.31568323592408276, "bg": 1.7388432451885646e-06}, {"x": 0.8121648793565683, "y": 0.8198726541554959, "term": "cover", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 22, "s": 0.5467493297587132, "os": 0.5445076692487197, "bg": 8.859476551749974e-07}, {"x": 0.8123324396782842, "y": 0.8279155495978552, "term": "guideline", "cat25k": 3, "ncat25k": 3, "cat": 21, "ncat": 22, "s": 0.5554624664879357, "os": 0.5572505931621438, "bg": 1.7903705130140158e-05}, {"x": 0.8125, "y": 0.6643766756032171, "term": "doctors", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 22, "s": 0.3004356568364611, "os": 0.31568323592408276, "bg": 3.3469010584250703e-06}, {"x": 0.8126675603217158, "y": 0.6347184986595175, "term": "longer", "cat25k": 1, "ncat25k": 3, "cat": 8, "ncat": 22, "s": 0.28267426273458446, "os": 0.294092688983577, "bg": 1.1034288758067996e-06}, {"x": 0.8128351206434317, "y": 0.732573726541555, "term": "prepared", "cat25k": 2, "ncat25k": 3, "cat": 12, "ncat": 22, "s": 0.36544906166219837, "os": 0.375810558948386, "bg": 2.0722696734730773e-06}, {"x": 0.8130026809651475, "y": 0.7327412868632708, "term": "mobilize", "cat25k": 2, "ncat25k": 3, "cat": 12, "ncat": 22, "s": 0.36544906166219837, "os": 0.375810558948386, "bg": 5.7541732564643485e-05}, {"x": 0.8131702412868632, "y": 0.24363270777479892, "term": "delay", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 22, "s": 0.07272117962466487, "os": 0.1508756267349579, "bg": 2.1599077827372163e-06}, {"x": 0.813337801608579, "y": 0.3292560321715818, "term": "content", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 22, "s": 0.1881702412868633, "os": 0.1759355311126498, "bg": 2.6428112149512165e-07}, {"x": 0.8135053619302949, "y": 0.1687332439678284, "term": "cold chain", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 22, "s": 0.04423592493297588, "os": 0.12570552820704212, "bg": 0.0}, {"x": 0.8136729222520107, "y": 0.8822050938337802, "term": "representative", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 22, "s": 0.681970509383378, "os": 0.6668342284978004, "bg": 3.5853623994679324e-06}, {"x": 0.8138404825737265, "y": 0.7195040214477212, "term": "educational", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 22, "s": 0.35170911528150134, "os": 0.35654401350738985, "bg": 1.1661822622370377e-06}, {"x": 0.8140080428954424, "y": 0.1712466487935657, "term": "lactating", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 22, "s": 0.04423592493297588, "os": 0.12570552820704212, "bg": 3.890375971008241e-05}, {"x": 0.8141756032171582, "y": 0.26575067024128685, "term": "final", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 22, "s": 0.07272117962466487, "os": 0.1508756267349579, "bg": 4.899905896286449e-07}, {"x": 0.814343163538874, "y": 0.7015750670241286, "term": "minutes", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 22, "s": 0.33528820375335117, "os": 0.3365026197975808, "bg": 6.628401594718854e-07}, {"x": 0.8145107238605898, "y": 0.19906166219839141, "term": "sexually", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 22, "s": 0.04423592493297588, "os": 0.12570552820704212, "bg": 8.18195530233392e-06}, {"x": 0.8146782841823056, "y": 0.37449731903485256, "term": "edema", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 22, "s": 0.1881702412868633, "os": 0.1759355311126498, "bg": 4.217217041605376e-05}, {"x": 0.8148458445040214, "y": 0.21246648793565684, "term": "gmp", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 22, "s": 0.04423592493297588, "os": 0.12570552820704212, "bg": 3.0520574848392357e-05}, {"x": 0.8150134048257373, "y": 0.003351206434316354, "term": "de\ufb01ciencies", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 22, "s": 0.027479892761394103, "os": 0.10067531259851248, "bg": 0.0}, {"x": 0.8151809651474531, "y": 0.06635388739946381, "term": "sd", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 22, "s": 0.027479892761394103, "os": 0.10067531259851248, "bg": 1.5327658128568884e-06}, {"x": 0.8153485254691689, "y": 0.11193029490616623, "term": "dpt", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 22, "s": 0.027479892761394103, "os": 0.10067531259851248, "bg": 4.501960399119253e-05}, {"x": 0.8155160857908847, "y": 0.8994638069705094, "term": "duly", "cat25k": 6, "ncat25k": 3, "cat": 39, "ncat": 23, "s": 0.7220174262734584, "os": 0.7072747978172476, "bg": 3.955052739352456e-05}, {"x": 0.8156836461126006, "y": 0.9611260053619303, "term": "his", "cat25k": 15, "ncat25k": 3, "cat": 92, "ncat": 23, "s": 0.9711796246648794, "os": 0.87818917312552, "bg": 3.482264206885871e-07}, {"x": 0.8158512064343163, "y": 0.7438002680965148, "term": "separate", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 23, "s": 0.3688002680965147, "os": 0.3822501513857407, "bg": 1.975284797659507e-06}, {"x": 0.8160187667560321, "y": 0.938337801608579, "term": "state", "cat25k": 10, "ncat25k": 3, "cat": 62, "ncat": 23, "s": 0.8367962466487936, "os": 0.8114100992093372, "bg": 3.7493148540631575e-07}, {"x": 0.816186327077748, "y": 0.6575067024128687, "term": "mandates", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 23, "s": 0.29306300268096513, "os": 0.3052977363894772, "bg": 2.8139883360183476e-05}, {"x": 0.8163538873994638, "y": 0.7456434316353887, "term": "coordinators", "cat25k": 2, "ncat25k": 3, "cat": 13, "ncat": 23, "s": 0.3688002680965147, "os": 0.3822501513857407, "bg": 2.630083183686471e-05}, {"x": 0.8165214477211796, "y": 0.8508713136729222, "term": "consultation", "cat25k": 4, "ncat25k": 3, "cat": 25, "ncat": 23, "s": 0.5888069705093834, "os": 0.5928033245859894, "bg": 4.647277675567252e-06}, {"x": 0.8166890080428955, "y": 0.80328418230563, "term": "re", "cat25k": 3, "ncat25k": 3, "cat": 18, "ncat": 23, "s": 0.4545911528150134, "os": 0.4629937285724727, "bg": 1.9018481144110636e-07}, {"x": 0.8168565683646113, "y": 0.8806970509383378, "term": "better", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 23, "s": 0.6680630026809652, "os": 0.6573323546263153, "bg": 6.988946472866145e-07}, {"x": 0.8170241286863271, "y": 0.8778485254691689, "term": "focus", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 23, "s": 0.6598525469168901, "os": 0.6491315653276124, "bg": 1.6378838158925776e-06}, {"x": 0.8171916890080428, "y": 0.8724865951742627, "term": "point", "cat25k": 5, "ncat25k": 3, "cat": 30, "ncat": 23, "s": 0.6549932975871313, "os": 0.640621690041085, "bg": 6.028211952318959e-07}, {"x": 0.8173592493297587, "y": 0.881367292225201, "term": "operation", "cat25k": 5, "ncat25k": 3, "cat": 32, "ncat": 23, "s": 0.6680630026809652, "os": 0.6573323546263153, "bg": 1.8591199152795673e-06}, {"x": 0.8175268096514745, "y": 0.927446380697051, "term": "million", "cat25k": 9, "ncat25k": 3, "cat": 53, "ncat": 23, "s": 0.8106568364611261, "os": 0.7787654845929861, "bg": 1.275910200130628e-06}, {"x": 0.8176943699731903, "y": 0.6647117962466488, "term": "received", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 23, "s": 0.29306300268096513, "os": 0.3052977363894772, "bg": 7.083605157457806e-07}, {"x": 0.8178619302949062, "y": 0.8213806970509383, "term": "publication", "cat25k": 3, "ncat25k": 3, "cat": 20, "ncat": 23, "s": 0.520274798927614, "os": 0.5341299122670037, "bg": 1.5492401202390477e-06}, {"x": 0.818029490616622, "y": 0.8785187667560321, "term": "present", "cat25k": 5, "ncat25k": 3, "cat": 31, "ncat": 23, "s": 0.6598525469168901, "os": 0.6491315653276124, "bg": 1.0828939800168962e-06}, {"x": 0.8181970509383378, "y": 0.6022117962466488, "term": "third", "cat25k": 1, "ncat25k": 3, "cat": 7, "ncat": 23, "s": 0.2441353887399464, "os": 0.26258288779632044, "bg": 6.262967801028271e-07}, {"x": 0.8183646112600537, "y": 0.6714142091152815, "term": "1998", "cat25k": 1, "ncat25k": 3, "cat": 9, "ncat": 23, "s": 0.29306300268096513, "os": 0.3052977363894772, "bg": 0.0}, {"x": 0.8185321715817694, "y": 0.33579088471849866, "term": "immune", "cat25k": 0, "ncat25k": 3, "cat": 3, "ncat": 23, "s": 0.14142091152815014, "os": 0.17000119518568213, "bg": 5.990337585474629e-06}, {"x": 0.8186997319034852, "y": 0.16906836461126004, "term": "divided", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 23, "s": 0.040717158176943706, "os": 0.12167845474921662, "bg": 3.5203117588093604e-06}, {"x": 0.818867292225201, "y": 0.1695710455764075, "term": "prophylaxis", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 23, "s": 0.040717158176943706, "os": 0.12167845474921662, "bg": 4.457010738610249e-05}, {"x": 0.8190348525469169, "y": 0.5112265415549598, "term": "previously", "cat25k": 1, "ncat25k": 3, "cat": 5, "ncat": 23, "s": 0.21162868632707776, "os": 0.21730159405156907, "bg": 1.999241787552071e-06}, {"x": 0.8192024128686327, "y": 0.7198391420911529, "term": "panel", "cat25k": 2, "ncat25k": 3, "cat": 11, "ncat": 23, "s": 0.34199061662198393, "os": 0.3452028114244211, "bg": 1.257015881637758e-06}, {"x": 0.8193699731903485, "y": 0.6998994638069705, "term": "survival", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 23, "s": 0.3093163538873994, "os": 0.32560803999077864, "bg": 4.529525402504951e-06}, {"x": 0.8195375335120644, "y": 0.7000670241286864, "term": "municipalities", "cat25k": 2, "ncat25k": 3, "cat": 10, "ncat": 23, "s": 0.3093163538873994, "os": 0.32560803999077864, "bg": 1.5347766434899888e-05}, {"x": 0.8197050938337802, "y": 0.1816353887399464, "term": "dehydration", "cat25k": 0, "ncat25k": 3, "cat": 1, "ncat": 23, "s": 0.040717158176943706, "os": 0.12167845474921662, "bg": 4.0569425697519435e-05}, {"x": 0.8198726541554959, "y": 0.4592828418230563, "term": "hour", "cat25k": 1, "ncat25k": 3, "cat": 4, "ncat": 23, "s": 0.1965482573726542, "os": 0.1938539634035823, "bg": 7.491910089808995e-07}, {"x": 0.8200402144772118, "y": 0.30160857908847183, "term": "pho", "cat25k": 0, "ncat25k": 3, "cat": 2, "ncat": 23, "s": 0.06618632707774798, "os": 0.14588311501288787, "bg": 3.6210131739701295e-05}, {"x": 0.8202077747989276, "y": 0.024128686327077747, "term": "9288", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 0.0}, {"x": 0.8203753351206434, "y": 0.04792225201072386, "term": "indicator", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 4.122507664055417e-06}, {"x": 0.8205428954423593, "y": 0.05144101876675603, "term": "wild", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 1.1428789498393411e-06}, {"x": 0.8207104557640751, "y": 0.0539544235924933, "term": "rash onset", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 0.0}, {"x": 0.8208780160857909, "y": 0.06149463806970509, "term": "im", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 1.227357161440931e-06}, {"x": 0.8210455764075067, "y": 0.09031501340482574, "term": "sanitation", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 1.298646669013641e-05}, {"x": 0.8212131367292225, "y": 0.10204423592493297, "term": "vials", "cat25k": 0, "ncat25k": 3, "cat": 0, "ncat": 23, "s": 0.025971849865951743, "os": 0.09761038077999085, "bg": 4.326341589121697e-05}, {"x": 0.8213806970509383, "y": 0.8830428954423593, "term": "laboratories", "cat25k": 5, "ncat25k": 4, "cat": 33, "ncat": 24, "s": 0.667392761394102, "os": 0.6560614179433886, "bg": 1.212864663985952e-05}, {"x": 0.8215482573726541, "y": 0.6804624664879356, "term": "properly", "cat25k": 2, "ncat25k": 4, "cat": 10, "ncat": 24, "s": 0.2999329758713137, "os": 0.3153097402109115, "bg": 3.1702276092884683e-06}, {"x": 0.82171581769437, "y": 0.3832104557640751, "term": "item", "cat25k": 1, "ncat25k": 4, "cat": 4, "ncat": 24, "s": 0.19336461126005364, "os": 0.18739260670061397, "bg": 1.8864942240263098e-07}, {"x": 0.8218833780160858, "y": 0.9051608579088471, "term": "accordingly", "cat25k": 7, "ncat25k": 4, "cat": 42, "ncat": 24, "s": 0.7441353887399464, "os": 0.7169984844158528, "bg": 1.4236243340107413e-05}, {"x": 0.8220509383378016, "y": 0.8867292225201072, "term": "consistent", "cat25k": 5, "ncat25k": 4, "cat": 34, "ncat": 24, "s": 0.6734249329758714, "os": 0.6637829251965128, "bg": 5.062713048566781e-06}, {"x": 0.8222184986595175, "y": 0.9348190348525469, "term": "individual", "cat25k": 9, "ncat25k": 4, "cat": 59, "ncat": 24, "s": 0.8248994638069705, "os": 0.794564637184352, "bg": 1.745033346010405e-06}, {"x": 0.8223860589812333, "y": 0.6581769436997319, "term": "giving", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 24, "s": 0.2843498659517426, "os": 0.29549027654360405, "bg": 1.506203917006521e-06}, {"x": 0.822553619302949, "y": 0.7689343163538874, "term": "committees", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 24, "s": 0.3946045576407507, "os": 0.4045381856525719, "bg": 4.146874864595232e-06}, {"x": 0.8227211796246648, "y": 0.8111595174262735, "term": "sustain", "cat25k": 3, "ncat25k": 4, "cat": 19, "ncat": 24, "s": 0.45576407506702415, "os": 0.46468135091241375, "bg": 1.9061808801635057e-05}, {"x": 0.8228887399463807, "y": 0.8505361930294906, "term": "inform", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 24, "s": 0.578083109919571, "os": 0.5829879318998938, "bg": 8.201051625871038e-06}, {"x": 0.8230563002680965, "y": 0.2322386058981233, "term": "consultant", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 24, "s": 0.060321715817694375, "os": 0.1411238003601799, "bg": 2.7616133408867e-06}, {"x": 0.8232238605898123, "y": 0.8414879356568364, "term": "best", "cat25k": 4, "ncat25k": 4, "cat": 23, "ncat": 24, "s": 0.5573056300268097, "os": 0.5609045117934708, "bg": 2.52576310612027e-07}, {"x": 0.8233914209115282, "y": 0.8729892761394102, "term": "chief", "cat25k": 5, "ncat25k": 4, "cat": 30, "ncat": 24, "s": 0.64343163538874, "os": 0.6311758543227473, "bg": 2.347234073701672e-06}, {"x": 0.823558981233244, "y": 0.8811997319034852, "term": "multi", "cat25k": 5, "ncat25k": 4, "cat": 32, "ncat": 24, "s": 0.659014745308311, "os": 0.6480626470140267, "bg": 2.020075364683123e-06}, {"x": 0.8237265415549598, "y": 0.8734919571045576, "term": "advocate", "cat25k": 5, "ncat25k": 4, "cat": 30, "ncat": 24, "s": 0.64343163538874, "os": 0.6311758543227473, "bg": 1.336766843726386e-05}, {"x": 0.8238941018766756, "y": 0.23626005361930294, "term": "liver", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 24, "s": 0.060321715817694375, "os": 0.1411238003601799, "bg": 4.1762553221153765e-06}, {"x": 0.8240616621983914, "y": 0.7493297587131368, "term": "direct", "cat25k": 2, "ncat25k": 4, "cat": 13, "ncat": 24, "s": 0.3624329758713137, "os": 0.37080481887529776, "bg": 7.216267761136545e-07}, {"x": 0.8242292225201072, "y": 0.3207104557640751, "term": "capsule", "cat25k": 0, "ncat25k": 4, "cat": 3, "ncat": 24, "s": 0.11310321715817694, "os": 0.1643727844883186, "bg": 1.4887516541685045e-05}, {"x": 0.824396782841823, "y": 0.48843833780160856, "term": "depending", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 24, "s": 0.20492627345844505, "os": 0.21005503292234579, "bg": 2.714472203874834e-06}, {"x": 0.8245643431635389, "y": 0.48894101876675605, "term": "bidding", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 24, "s": 0.20492627345844505, "os": 0.21005503292234579, "bg": 2.968950308166804e-06}, {"x": 0.8247319034852547, "y": 0.49078418230563003, "term": "=", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 24, "s": 0.20492627345844505, "os": 0.21005503292234579, "bg": 0.0}, {"x": 0.8248994638069705, "y": 0.7962466487935657, "term": "corresponding", "cat25k": 3, "ncat25k": 4, "cat": 17, "ncat": 24, "s": 0.4254356568364611, "os": 0.4357811153461847, "bg": 4.666366729306e-06}, {"x": 0.8250670241286864, "y": 0.761896782841823, "term": "progress", "cat25k": 2, "ncat25k": 4, "cat": 14, "ncat": 24, "s": 0.3753351206434316, "os": 0.38799090182683643, "bg": 1.5837696288708866e-06}, {"x": 0.8252345844504021, "y": 0.24597855227882037, "term": "correct", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 24, "s": 0.060321715817694375, "os": 0.1411238003601799, "bg": 1.1612344824738564e-06}, {"x": 0.8254021447721179, "y": 0.7759718498659517, "term": "lower", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 24, "s": 0.3946045576407507, "os": 0.4045381856525719, "bg": 1.0696811854996816e-06}, {"x": 0.8255697050938338, "y": 0.49782171581769435, "term": "met", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 24, "s": 0.20492627345844505, "os": 0.21005503292234579, "bg": 1.363569179001345e-06}, {"x": 0.8257372654155496, "y": 0.6399128686327078, "term": "could", "cat25k": 1, "ncat25k": 4, "cat": 8, "ncat": 24, "s": 0.25904825737265413, "os": 0.2750242494783094, "bg": 2.1148396247719362e-07}, {"x": 0.8259048257372654, "y": 0.7355898123324397, "term": "\ufb01ve", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 24, "s": 0.3445040214477212, "os": 0.3529673580550806, "bg": 0.0}, {"x": 0.8260723860589813, "y": 0.3331099195710456, "term": "con\ufb01rmation", "cat25k": 0, "ncat25k": 4, "cat": 3, "ncat": 24, "s": 0.11310321715817694, "os": 0.1643727844883186, "bg": 0.0}, {"x": 0.8262399463806971, "y": 0.44235924932975873, "term": "occur", "cat25k": 1, "ncat25k": 4, "cat": 4, "ncat": 24, "s": 0.19336461126005364, "os": 0.18739260670061397, "bg": 2.2407890266320577e-06}, {"x": 0.8264075067024129, "y": 0.7883713136729222, "term": "external", "cat25k": 3, "ncat25k": 4, "cat": 16, "ncat": 24, "s": 0.4066689008042896, "os": 0.42046230631593096, "bg": 1.5711928391943636e-06}, {"x": 0.8265750670241286, "y": 0.5782506702412868, "term": "friendly", "cat25k": 1, "ncat25k": 4, "cat": 6, "ncat": 24, "s": 0.22218498659517427, "os": 0.23226083060962055, "bg": 9.251509977491383e-07}, {"x": 0.8267426273458445, "y": 0.013572386058981234, "term": "sdm", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 4.320793729808165e-05}, {"x": 0.8269101876675603, "y": 0.021280160857908847, "term": "nutrients", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 1.0948995019119681e-05}, {"x": 0.8270777479892761, "y": 0.032506702412868634, "term": "aefis", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 0.00015385552325301863}, {"x": 0.827245308310992, "y": 0.03569034852546917, "term": "eccd", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 0.0001395194716862672}, {"x": 0.8274128686327078, "y": 0.11695710455764075, "term": "animal bite", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 0.0}, {"x": 0.8275804289544236, "y": 0.11712466487935656, "term": "pep", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 1.4439021455483445e-05}, {"x": 0.8277479892761395, "y": 0.1260053619302949, "term": "g6pd", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 24, "s": 0.023793565683646115, "os": 0.0946240152825849, "bg": 0.0}, {"x": 0.8279155495978552, "y": 0.37985924932975873, "term": "tuberculosis", "cat25k": 1, "ncat25k": 4, "cat": 4, "ncat": 25, "s": 0.19068364611260055, "os": 0.1812679698006957, "bg": 1.6072844347527037e-05}, {"x": 0.828083109919571, "y": 0.8495308310991957, "term": "dated", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 25, "s": 0.5676943699731903, "os": 0.5734843204993371, "bg": 7.680775893546904e-06}, {"x": 0.8282506702412868, "y": 0.7669235924932976, "term": "serious", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 25, "s": 0.3773458445040214, "os": 0.3931324530050418, "bg": 2.0710003643666266e-06}, {"x": 0.8284182305630027, "y": 0.7262064343163539, "term": "risks", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 25, "s": 0.3413203753351206, "os": 0.34241942015141064, "bg": 3.791418104626027e-06}, {"x": 0.8285857908847185, "y": 0.9162198391420912, "term": "healthy", "cat25k": 8, "ncat25k": 4, "cat": 47, "ncat": 25, "s": 0.7603887399463808, "os": 0.7362270580609103, "bg": 4.694735883939869e-06}, {"x": 0.8287533512064343, "y": 0.4780495978552279, "term": "duration", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 25, "s": 0.2005697050938338, "os": 0.20319754028312265, "bg": 3.2678198984633895e-06}, {"x": 0.8289209115281502, "y": 0.8605898123324397, "term": "study", "cat25k": 4, "ncat25k": 4, "cat": 27, "ncat": 25, "s": 0.5896447721179624, "os": 0.5939813985872225, "bg": 6.784509995582696e-07}, {"x": 0.829088471849866, "y": 0.7947386058981233, "term": "assurance", "cat25k": 3, "ncat25k": 4, "cat": 17, "ncat": 25, "s": 0.4101876675603217, "os": 0.4239911504148325, "bg": 6.862233233746536e-06}, {"x": 0.8292560321715817, "y": 0.8518766756032171, "term": "aims", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 25, "s": 0.5676943699731903, "os": 0.5734843204993371, "bg": 7.771294532140482e-06}, {"x": 0.8294235924932976, "y": 0.8275804289544236, "term": "household", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 25, "s": 0.4879356568364611, "os": 0.5273253482153825, "bg": 3.301185053669375e-06}, {"x": 0.8295911528150134, "y": 0.8528820375335121, "term": "transfer", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 25, "s": 0.5676943699731903, "os": 0.5734843204993371, "bg": 1.6306968373629566e-06}, {"x": 0.8297587131367292, "y": 0.7324061662198391, "term": "indicated", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 25, "s": 0.3413203753351206, "os": 0.34241942015141064, "bg": 3.247916351933331e-06}, {"x": 0.829926273458445, "y": 0.8282506702412868, "term": "l", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 25, "s": 0.4879356568364611, "os": 0.5273253482153825, "bg": 3.633312730738807e-07}, {"x": 0.8300938337801609, "y": 0.7853552278820375, "term": "event", "cat25k": 3, "ncat25k": 4, "cat": 16, "ncat": 25, "s": 0.399798927613941, "os": 0.40884771808399833, "bg": 6.516870931098252e-07}, {"x": 0.8302613941018767, "y": 0.733411528150134, "term": "assess", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 25, "s": 0.3413203753351206, "os": 0.34241942015141064, "bg": 5.7247702220352124e-06}, {"x": 0.8304289544235925, "y": 0.9232573726541555, "term": "healthcare", "cat25k": 8, "ncat25k": 4, "cat": 51, "ncat": 25, "s": 0.7870308310991957, "os": 0.7553957234036177, "bg": 5.2701505158454525e-06}, {"x": 0.8305965147453083, "y": 0.6957104557640751, "term": "manager", "cat25k": 2, "ncat25k": 4, "cat": 10, "ncat": 25, "s": 0.2937332439678284, "os": 0.30555673397306765, "bg": 7.976871994086723e-07}, {"x": 0.8307640750670241, "y": 0.8371313672922251, "term": "rhus", "cat25k": 4, "ncat25k": 4, "cat": 22, "ncat": 25, "s": 0.5408847184986595, "os": 0.5395715750016494, "bg": 0.000217916440636316}, {"x": 0.8309316353887399, "y": 0.4581099195710456, "term": "height", "cat25k": 1, "ncat25k": 4, "cat": 4, "ncat": 25, "s": 0.19068364611260055, "os": 0.1812679698006957, "bg": 1.8675103176725208e-06}, {"x": 0.8310991957104558, "y": 0.6544906166219839, "term": "vial", "cat25k": 1, "ncat25k": 4, "cat": 8, "ncat": 25, "s": 0.2561997319034853, "os": 0.26626938385503374, "bg": 4.9754956837574944e-05}, {"x": 0.8312667560321716, "y": 0.5373659517426274, "term": "fever", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 25, "s": 0.2005697050938338, "os": 0.20319754028312265, "bg": 6.7456264730761805e-06}, {"x": 0.8314343163538874, "y": 0.212298927613941, "term": "processed", "cat25k": 0, "ncat25k": 4, "cat": 1, "ncat": 25, "s": 0.035522788203753354, "os": 0.11408184104098856, "bg": 3.850521567956078e-06}, {"x": 0.8316018766756033, "y": 0.010556300268096515, "term": "residual", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 25, "s": 0.022955764075067022, "os": 0.09171456921522614, "bg": 9.91795274412892e-06}, {"x": 0.8317694369973191, "y": 0.03334450402144772, "term": "born", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 25, "s": 0.022955764075067022, "os": 0.09171456921522614, "bg": 9.476159064076916e-07}, {"x": 0.8319369973190348, "y": 0.037198391420911525, "term": "nutrient", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 25, "s": 0.022955764075067022, "os": 0.09171456921522614, "bg": 1.1841948824781314e-05}, {"x": 0.8321045576407506, "y": 0.8889075067024129, "term": "retained", "cat25k": 6, "ncat25k": 4, "cat": 35, "ncat": 26, "s": 0.6655495978552279, "os": 0.6538549724765771, "bg": 1.7268802930827262e-05}, {"x": 0.8322721179624665, "y": 0.7257037533512064, "term": "prepare", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 26, "s": 0.31333780160857905, "os": 0.3323935515186807, "bg": 3.5513326679568904e-06}, {"x": 0.8324396782841823, "y": 0.8496983914209115, "term": "repealed", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 26, "s": 0.5598190348525469, "os": 0.564282294798511, "bg": 2.9158236029631628e-05}, {"x": 0.8326072386058981, "y": 0.901642091152815, "term": "help", "cat25k": 6, "ncat25k": 4, "cat": 40, "ncat": 26, "s": 0.7009048257372654, "os": 0.6884276686933458, "bg": 2.1590992579426107e-07}, {"x": 0.832774798927614, "y": 0.5442359249329759, "term": "potential", "cat25k": 1, "ncat25k": 4, "cat": 6, "ncat": 26, "s": 0.2117962466487936, "os": 0.21757099585538459, "bg": 9.675352906229592e-07}, {"x": 0.8329423592493298, "y": 0.6265080428954424, "term": "21", "cat25k": 1, "ncat25k": 4, "cat": 8, "ncat": 26, "s": 0.23961126005361932, "os": 0.2579736072612183, "bg": 0.0}, {"x": 0.8331099195710456, "y": 0.8677949061662198, "term": "\u2014", "cat25k": 5, "ncat25k": 4, "cat": 29, "ncat": 26, "s": 0.6042225201072386, "os": 0.6039753544657545, "bg": 0.0}, {"x": 0.8332774798927614, "y": 0.8396447721179625, "term": "'", "cat25k": 4, "ncat25k": 4, "cat": 23, "ncat": 26, "s": 0.5435656836461127, "os": 0.5420814751609422, "bg": 0.0}, {"x": 0.8334450402144772, "y": 0.9368297587131368, "term": "ncdpc", "cat25k": 10, "ncat25k": 4, "cat": 60, "ncat": 26, "s": 0.8185321715817695, "os": 0.784708470953184, "bg": 0.0005512060837769154}, {"x": 0.833612600536193, "y": 0.8847184986595175, "term": "overall", "cat25k": 5, "ncat25k": 4, "cat": 33, "ncat": 26, "s": 0.6494638069705094, "os": 0.6383565737624429, "bg": 1.4879327581498082e-06}, {"x": 0.8337801608579088, "y": 0.7295576407506702, "term": "large", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 26, "s": 0.31333780160857905, "os": 0.3323935515186807, "bg": 4.573470939124586e-07}, {"x": 0.8339477211796247, "y": 0.833612600536193, "term": "financing", "cat25k": 4, "ncat25k": 4, "cat": 22, "ncat": 26, "s": 0.4902815013404826, "os": 0.530317244601747, "bg": 4.115658756842122e-06}, {"x": 0.8341152815013405, "y": 0.8042895442359249, "term": "localities", "cat25k": 3, "ncat25k": 4, "cat": 18, "ncat": 26, "s": 0.41320375335120646, "os": 0.4271555278983228, "bg": 2.5038966892226027e-05}, {"x": 0.8342828418230563, "y": 0.7112935656836461, "term": "practitioners", "cat25k": 2, "ncat25k": 4, "cat": 11, "ncat": 26, "s": 0.2987600536193029, "os": 0.31463390181687256, "bg": 8.329455634055045e-06}, {"x": 0.8344504021447721, "y": 0.8652815013404825, "term": "monthly", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 26, "s": 0.5903150134048257, "os": 0.5945918016074585, "bg": 2.3220369888882143e-06}, {"x": 0.8346179624664879, "y": 0.8654490616621984, "term": "would", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 26, "s": 0.5903150134048257, "os": 0.5945918016074585, "bg": 1.8849609781137914e-07}, {"x": 0.8347855227882037, "y": 0.6655495978552279, "term": "feedback", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 26, "s": 0.26424262734584447, "os": 0.2774118831824917, "bg": 4.6259560636870176e-07}, {"x": 0.8349530831099196, "y": 0.7855227882037533, "term": "regions", "cat25k": 3, "ncat25k": 4, "cat": 16, "ncat": 26, "s": 0.3818699731903485, "os": 0.3977570957619995, "bg": 2.8790422824718183e-06}, {"x": 0.8351206434316354, "y": 0.607573726541555, "term": "chain", "cat25k": 1, "ncat25k": 4, "cat": 7, "ncat": 26, "s": 0.22553619302949066, "os": 0.23801440603071639, "bg": 1.82117411260601e-06}, {"x": 0.8352882037533512, "y": 0.17007372654155495, "term": "defects", "cat25k": 0, "ncat25k": 4, "cat": 1, "ncat": 26, "s": 0.03267426273458446, "os": 0.11049187780878955, "bg": 7.1906732174587405e-06}, {"x": 0.835455764075067, "y": 0.6740951742627346, "term": "targeted", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 26, "s": 0.26424262734584447, "os": 0.2774118831824917, "bg": 6.08663049005375e-06}, {"x": 0.8356233243967829, "y": 0.5824396782841823, "term": "steps", "cat25k": 1, "ncat25k": 4, "cat": 6, "ncat": 26, "s": 0.2117962466487936, "os": 0.21757099585538459, "bg": 1.6594807261815055e-06}, {"x": 0.8357908847184986, "y": 0.5320040214477212, "term": "doors", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 26, "s": 0.19956434316353888, "os": 0.19669383670945711, "bg": 3.0182831528343214e-06}, {"x": 0.8359584450402144, "y": 0.30361930294906164, "term": "w", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 26, "s": 0.05043565683646113, "os": 0.13222753922192226, "bg": 2.2174393200006916e-07}, {"x": 0.8361260053619303, "y": 0.2169906166219839, "term": "postpartum", "cat25k": 0, "ncat25k": 4, "cat": 1, "ncat": 26, "s": 0.03267426273458446, "os": 0.11049187780878955, "bg": 4.307099375949157e-05}, {"x": 0.8362935656836461, "y": 0.018431635388739945, "term": "fortified", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 26, "s": 0.02245308310991957, "os": 0.0888804205445844, "bg": 3.4150605483667805e-05}, {"x": 0.8364611260053619, "y": 0.8233914209115282, "term": "supported", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 27, "s": 0.43733243967828417, "os": 0.4561861652134285, "bg": 2.442683885688196e-06}, {"x": 0.8366286863270778, "y": 0.7422922252010724, "term": "intake", "cat25k": 2, "ncat25k": 4, "cat": 13, "ncat": 27, "s": 0.33646112600536193, "os": 0.33972097247682587, "bg": 9.45926356322418e-06}, {"x": 0.8367962466487936, "y": 0.9614611260053619, "term": "chronic", "cat25k": 15, "ncat25k": 4, "cat": 93, "ncat": 27, "s": 0.9559316353887399, "os": 0.8604094028380614, "bg": 1.7188930844204256e-05}, {"x": 0.8369638069705094, "y": 0.8379691689008043, "term": "2005", "cat25k": 4, "ncat25k": 4, "cat": 23, "ncat": 27, "s": 0.5196045576407506, "os": 0.533147893485086, "bg": 0.0}, {"x": 0.8371313672922251, "y": 0.9927949061662198, "term": "mental", "cat25k": 58, "ncat25k": 4, "cat": 363, "ncat": 27, "s": 0.9958109919571045, "os": 0.9659802452442212, "bg": 2.1674724245404896e-05}, {"x": 0.837298927613941, "y": 0.6573391420911529, "term": "discharge", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 27, "s": 0.2568699731903485, "os": 0.26905660007327303, "bg": 6.287022485361279e-06}, {"x": 0.8374664879356568, "y": 0.8388069705093834, "term": "legal", "cat25k": 4, "ncat25k": 4, "cat": 23, "ncat": 27, "s": 0.5196045576407506, "os": 0.533147893485086, "bg": 7.024406680328763e-07}, {"x": 0.8376340482573726, "y": 0.7677613941018767, "term": "cluster", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 27, "s": 0.3629356568364611, "os": 0.3718676243334918, "bg": 5.6055562273325315e-06}, {"x": 0.8378016085790885, "y": 0.7094504021447721, "term": "critical", "cat25k": 2, "ncat25k": 4, "cat": 11, "ncat": 27, "s": 0.29356568364611263, "os": 0.3054458761981076, "bg": 1.6362363661412145e-06}, {"x": 0.8379691689008043, "y": 0.48642761394101874, "term": "pediatric", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 27, "s": 0.19537533512064345, "os": 0.19051329912410886, "bg": 1.0220783292085552e-05}, {"x": 0.8381367292225201, "y": 0.8351206434316354, "term": "documents", "cat25k": 4, "ncat25k": 4, "cat": 22, "ncat": 27, "s": 0.4584450402144772, "os": 0.46860618906369417, "bg": 1.5135291981172501e-06}, {"x": 0.838304289544236, "y": 0.7330764075067024, "term": "much", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 27, "s": 0.3076407506702413, "os": 0.32285037146101125, "bg": 3.214661547079114e-07}, {"x": 0.8384718498659517, "y": 0.842828418230563, "term": "universal", "cat25k": 4, "ncat25k": 4, "cat": 23, "ncat": 27, "s": 0.5196045576407506, "os": 0.533147893485086, "bg": 2.645119103232677e-06}, {"x": 0.8386394101876675, "y": 0.829088471849866, "term": "sources", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 27, "s": 0.43733243967828417, "os": 0.4561861652134285, "bg": 1.5269651062705682e-06}, {"x": 0.8388069705093834, "y": 0.6682305630026809, "term": "side", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 27, "s": 0.2568699731903485, "os": 0.26905660007327303, "bg": 5.089513011785346e-07}, {"x": 0.8389745308310992, "y": 0.6685656836461126, "term": "mass", "cat25k": 1, "ncat25k": 4, "cat": 9, "ncat": 27, "s": 0.2568699731903485, "os": 0.26905660007327303, "bg": 1.7700449104644905e-06}, {"x": 0.839142091152815, "y": 0.8150134048257373, "term": "background", "cat25k": 3, "ncat25k": 4, "cat": 19, "ncat": 27, "s": 0.4152144772117963, "os": 0.43000367259071615, "bg": 1.7515089678115866e-06}, {"x": 0.8393096514745308, "y": 0.7763069705093834, "term": "database", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 27, "s": 0.3629356568364611, "os": 0.3718676243334918, "bg": 8.073535219706506e-07}, {"x": 0.8394772117962467, "y": 0.24966487935656836, "term": "cold", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 27, "s": 0.044906166219839144, "os": 0.128058528599715, "bg": 1.4096282812652698e-06}, {"x": 0.8396447721179625, "y": 0.787701072386059, "term": "higher", "cat25k": 3, "ncat25k": 4, "cat": 16, "ncat": 27, "s": 0.3723190348525469, "os": 0.3871559084379991, "bg": 1.038301292723744e-06}, {"x": 0.8398123324396782, "y": 0.5713806970509383, "term": "disposal", "cat25k": 1, "ncat25k": 4, "cat": 6, "ncat": 27, "s": 0.20559651474530832, "os": 0.21078456746979068, "bg": 5.4976808949424845e-06}, {"x": 0.8399798927613941, "y": 0.7002345844504021, "term": "next", "cat25k": 2, "ncat25k": 4, "cat": 10, "ncat": 27, "s": 0.2680965147453083, "os": 0.28751137570941937, "bg": 1.7362115550880655e-07}, {"x": 0.8401474530831099, "y": 0.5239611260053619, "term": "ros", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 27, "s": 0.19537533512064345, "os": 0.19051329912410886, "bg": 3.3176883591646474e-05}, {"x": 0.8403150134048257, "y": 0.30764075067024127, "term": "gt", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 27, "s": 0.044906166219839144, "os": 0.128058528599715, "bg": 4.529210086238503e-06}, {"x": 0.8404825737265416, "y": 0.002680965147453083, "term": "tetanus toxoid", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 27, "s": 0.021280160857908847, "os": 0.08611997234483926, "bg": 0.0}, {"x": 0.8406501340482574, "y": 0.0070375335120643435, "term": "couples", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 27, "s": 0.021280160857908847, "os": 0.08611997234483926, "bg": 3.613827467578279e-06}, {"x": 0.8408176943699732, "y": 0.0160857908847185, "term": "fp", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 27, "s": 0.021280160857908847, "os": 0.08611997234483926, "bg": 7.7735792452344e-06}, {"x": 0.840985254691689, "y": 0.7892091152815014, "term": "second", "cat25k": 3, "ncat25k": 4, "cat": 17, "ncat": 28, "s": 0.3766756032171582, "os": 0.3916022718865355, "bg": 5.637140957104231e-07}, {"x": 0.8411528150134048, "y": 0.8619302949061662, "term": "common", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 28, "s": 0.5740616621983914, "os": 0.5772212280160534, "bg": 1.0355863723046924e-06}, {"x": 0.8413203753351206, "y": 0.7039209115281502, "term": "cycle", "cat25k": 2, "ncat25k": 4, "cat": 11, "ncat": 28, "s": 0.2856903485254692, "os": 0.2966955729035484, "bg": 2.6089328120195005e-06}, {"x": 0.8414879356568364, "y": 0.7657506702412868, "term": "e", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 28, "s": 0.3587466487935657, "os": 0.36193972282852477, "bg": 1.4492798317864714e-07}, {"x": 0.8416554959785523, "y": 0.9617962466487936, "term": "physician", "cat25k": 15, "ncat25k": 4, "cat": 93, "ncat": 28, "s": 0.9498994638069705, "os": 0.8556481707180887, "bg": 1.195760524940847e-05}, {"x": 0.8418230563002681, "y": 0.8250670241286864, "term": "orders", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 28, "s": 0.42912198391420914, "os": 0.4453424487733221, "bg": 1.2111120718992252e-06}, {"x": 0.8419906166219839, "y": 0.8977882037533512, "term": "law", "cat25k": 6, "ncat25k": 4, "cat": 38, "ncat": 28, "s": 0.6694034852546917, "os": 0.6590629260101308, "bg": 6.098842555191407e-07}, {"x": 0.8421581769436998, "y": 0.7268766756032171, "term": "selection", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 28, "s": 0.2982573726541555, "os": 0.31375451813649236, "bg": 1.0594803667295936e-06}, {"x": 0.8423257372654156, "y": 0.8632707774798928, "term": "oversee", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 28, "s": 0.5740616621983914, "os": 0.5772212280160534, "bg": 5.0049982951724554e-05}, {"x": 0.8424932975871313, "y": 0.8109919571045576, "term": "participate", "cat25k": 3, "ncat25k": 4, "cat": 19, "ncat": 28, "s": 0.40599865951742625, "os": 0.41937237883640555, "bg": 3.7991224512132054e-06}, {"x": 0.8426608579088471, "y": 0.7280495978552279, "term": "skills", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 28, "s": 0.2982573726541555, "os": 0.31375451813649236, "bg": 1.1158286642296503e-06}, {"x": 0.842828418230563, "y": 0.9592828418230563, "term": "tests", "cat25k": 14, "ncat25k": 4, "cat": 89, "ncat": 28, "s": 0.9368297587131367, "os": 0.848585709142976, "bg": 5.486750891731844e-06}, {"x": 0.8429959785522788, "y": 0.8682975871313673, "term": "remain", "cat25k": 5, "ncat25k": 4, "cat": 29, "ncat": 28, "s": 0.5829423592493298, "os": 0.5866880932500373, "bg": 3.684225545573207e-06}, {"x": 0.8431635388739946, "y": 0.8466823056300268, "term": "survey", "cat25k": 4, "ncat25k": 4, "cat": 24, "ncat": 28, "s": 0.5299932975871313, "os": 0.5358325717504537, "bg": 1.6427924951362683e-06}, {"x": 0.8433310991957105, "y": 0.9041554959785523, "term": "forms", "cat25k": 7, "ncat25k": 4, "cat": 41, "ncat": 28, "s": 0.6942024128686327, "os": 0.6789371085819104, "bg": 2.160516006370704e-06}, {"x": 0.8434986595174263, "y": 0.7109584450402144, "term": "linked", "cat25k": 2, "ncat25k": 4, "cat": 11, "ncat": 28, "s": 0.2856903485254692, "os": 0.2966955729035484, "bg": 3.364154741456945e-06}, {"x": 0.8436662198391421, "y": 0.7312332439678284, "term": "culture", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 28, "s": 0.2982573726541555, "os": 0.31375451813649236, "bg": 1.1607926158963641e-06}, {"x": 0.8438337801608579, "y": 0.49111930294906164, "term": "certi\ufb01cation", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 28, "s": 0.19168900804289546, "os": 0.18462920003699995, "bg": 0.0}, {"x": 0.8440013404825737, "y": 0.8287533512064343, "term": "updated", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 28, "s": 0.42912198391420914, "os": 0.4453424487733221, "bg": 8.923955623099174e-07}, {"x": 0.8441689008042895, "y": 0.7753016085790885, "term": "diet", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 28, "s": 0.3587466487935657, "os": 0.36193972282852477, "bg": 1.911702591893043e-06}, {"x": 0.8443364611260054, "y": 0.8292560321715817, "term": "impact", "cat25k": 3, "ncat25k": 4, "cat": 21, "ncat": 28, "s": 0.42912198391420914, "os": 0.4453424487733221, "bg": 1.5979250714671986e-06}, {"x": 0.8445040214477212, "y": 0.8535522788203753, "term": "expected", "cat25k": 4, "ncat25k": 4, "cat": 25, "ncat": 28, "s": 0.5494302949061662, "os": 0.5467423510455187, "bg": 1.9393058024358924e-06}, {"x": 0.844671581769437, "y": 0.8367962466487936, "term": "improvement", "cat25k": 4, "ncat25k": 4, "cat": 22, "ncat": 28, "s": 0.4391756032171582, "os": 0.45768484381248364, "bg": 2.670530390034969e-06}, {"x": 0.8448391420911529, "y": 0.17560321715817695, "term": "institutes", "cat25k": 0, "ncat25k": 4, "cat": 1, "ncat": 28, "s": 0.02815013404825737, "os": 0.10368697099961482, "bg": 9.27946550278704e-06}, {"x": 0.8450067024128687, "y": 0.6191353887399463, "term": "+", "cat25k": 1, "ncat25k": 4, "cat": 7, "ncat": 28, "s": 0.2156501340482574, "os": 0.22367158867725112, "bg": 0.0}, {"x": 0.8451742627345844, "y": 0.00217828418230563, "term": "toxoid", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 0.00012960382886740142}, {"x": 0.8453418230563002, "y": 0.03351206434316354, "term": "breastfeed", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 0.00010415078057290367}, {"x": 0.8455093833780161, "y": 0.04138739946380697, "term": "breastmilk substitutes", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 0.0}, {"x": 0.8456769436997319, "y": 0.041890080428954424, "term": "infected", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 6.458822526665998e-06}, {"x": 0.8458445040214477, "y": 0.06853217158176944, "term": "bhs", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 7.295523414721846e-05}, {"x": 0.8460120643431636, "y": 0.1003686327077748, "term": "immunized", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 8.223334003926641e-05}, {"x": 0.8461796246648794, "y": 0.13321045576407506, "term": "nhs", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 28, "s": 0.020107238605898126, "os": 0.0834316529799885, "bg": 7.217343069185451e-06}, {"x": 0.8463471849865952, "y": 0.7416219839142091, "term": "procedure", "cat25k": 2, "ncat25k": 4, "cat": 13, "ncat": 29, "s": 0.30294906166219837, "os": 0.32133115804925483, "bg": 2.305045115358315e-06}, {"x": 0.846514745308311, "y": 0.8837131367292225, "term": "mechanism", "cat25k": 5, "ncat25k": 4, "cat": 33, "ncat": 29, "s": 0.6136058981233244, "os": 0.6133709466700841, "bg": 6.857030363925826e-06}, {"x": 0.8466823056300268, "y": 0.8626005361930295, "term": "effects", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 29, "s": 0.5619973190348525, "os": 0.5689055867145796, "bg": 1.378286027332814e-06}, {"x": 0.8468498659517426, "y": 0.7662533512064343, "term": "records", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 29, "s": 0.3441689008042896, "os": 0.3524406961951319, "bg": 8.62040844474803e-07}, {"x": 0.8470174262734584, "y": 0.8176943699731903, "term": "presence", "cat25k": 3, "ncat25k": 4, "cat": 20, "ncat": 29, "s": 0.40968498659517427, "os": 0.42224303392246293, "bg": 3.389213509833889e-06}, {"x": 0.8471849865951743, "y": 0.8974530831099196, "term": "problem", "cat25k": 6, "ncat25k": 4, "cat": 38, "ncat": 29, "s": 0.6610254691689008, "os": 0.6512155653452896, "bg": 9.481755008885678e-07}, {"x": 0.8473525469168901, "y": 0.8672922252010724, "term": "institute", "cat25k": 5, "ncat25k": 4, "cat": 29, "ncat": 29, "s": 0.5745643431635389, "os": 0.5784006142698125, "bg": 1.4935933792713726e-06}, {"x": 0.8475201072386059, "y": 0.7915549597855228, "term": "formulate", "cat25k": 3, "ncat25k": 4, "cat": 17, "ncat": 29, "s": 0.36863270777479895, "os": 0.38169863946439864, "bg": 4.206545018261892e-05}, {"x": 0.8476876675603218, "y": 0.7823391420911529, "term": "how", "cat25k": 3, "ncat25k": 4, "cat": 16, "ncat": 29, "s": 0.36042225201072386, "os": 0.3672982923969213, "bg": 1.5729863517462234e-07}, {"x": 0.8478552278820375, "y": 0.8463471849865952, "term": "2007", "cat25k": 4, "ncat25k": 4, "cat": 24, "ncat": 29, "s": 0.4882707774798928, "os": 0.5274777254015025, "bg": 0.0}, {"x": 0.8480227882037533, "y": 0.8468498659517426, "term": "de\ufb01ned", "cat25k": 4, "ncat25k": 4, "cat": 24, "ncat": 29, "s": 0.4882707774798928, "os": 0.5274777254015025, "bg": 0.0}, {"x": 0.8481903485254692, "y": 0.863941018766756, "term": "ef\ufb01cient", "cat25k": 4, "ncat25k": 4, "cat": 28, "ncat": 29, "s": 0.5619973190348525, "os": 0.5689055867145796, "bg": 0.0}, {"x": 0.848357908847185, "y": 0.8922587131367292, "term": "activity", "cat25k": 6, "ncat25k": 4, "cat": 36, "ncat": 29, "s": 0.6477882037533512, "os": 0.6367847001087857, "bg": 1.626105121366795e-06}, {"x": 0.8485254691689008, "y": 0.7719504021447721, "term": "iec", "cat25k": 2, "ncat25k": 4, "cat": 15, "ncat": 29, "s": 0.3441689008042896, "os": 0.3524406961951319, "bg": 2.6750273430351714e-05}, {"x": 0.8486930294906166, "y": 0.9822386058981233, "term": "philhealth", "cat25k": 28, "ncat25k": 4, "cat": 175, "ncat": 29, "s": 0.9869302949061662, "os": 0.9232803755228387, "bg": 0.0013070178529668984}, {"x": 0.8488605898123325, "y": 0.7332439678284183, "term": "beyond", "cat25k": 2, "ncat25k": 4, "cat": 12, "ncat": 29, "s": 0.2928954423592493, "os": 0.30507415828144935, "bg": 1.7217037619290187e-06}, {"x": 0.8490281501340483, "y": 0.8084785522788204, "term": "quarterly", "cat25k": 3, "ncat25k": 4, "cat": 18, "ncat": 29, "s": 0.3815348525469169, "os": 0.39564975492885324, "bg": 7.1273437966784145e-06}, {"x": 0.849195710455764, "y": 0.4307975871313673, "term": "ritm", "cat25k": 1, "ncat25k": 4, "cat": 4, "ncat": 29, "s": 0.094671581769437, "os": 0.1595877917272786, "bg": 0.00021154524183467422}, {"x": 0.8493632707774799, "y": 0.5185991957104558, "term": "successful", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 29, "s": 0.18900804289544237, "os": 0.17901809040988637, "bg": 1.5684940475766223e-06}, {"x": 0.8495308310991957, "y": 0.2754691689008043, "term": "fee", "cat25k": 0, "ncat25k": 4, "cat": 2, "ncat": 29, "s": 0.03820375335120644, "os": 0.12021358730629028, "bg": 1.2098983107790076e-06}, {"x": 0.8496983914209115, "y": 0.5323391420911529, "term": "stored", "cat25k": 1, "ncat25k": 4, "cat": 5, "ncat": 29, "s": 0.18900804289544237, "os": 0.17901809040988637, "bg": 3.6356164880126505e-06}, {"x": 0.8498659517426274, "y": 0.37432975871313673, "term": "paralysis", "cat25k": 0, "ncat25k": 4, "cat": 3, "ncat": 29, "s": 0.055797587131367295, "os": 0.1399577772833442, "bg": 4.375314475727943e-05}, {"x": 0.8500335120643432, "y": 0.04507372654155496, "term": "lactation", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 29, "s": 0.019604557640750673, "os": 0.0808139162239987, "bg": 4.769352469948968e-05}, {"x": 0.850201072386059, "y": 0.054289544235924934, "term": "igm", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 29, "s": 0.019604557640750673, "os": 0.0808139162239987, "bg": 6.445747917912289e-05}, {"x": 0.8503686327077749, "y": 0.07724530831099195, "term": "bcg", "cat25k": 0, "ncat25k": 4, "cat": 0, "ncat": 29, "s": 0.019604557640750673, "os": 0.0808139162239987, "bg": 7.306092525363477e-05}, {"x": 0.8505361930294906, "y": 0.8666219839142091, "term": "recording", "cat25k": 5, "ncat25k": 5, "cat": 29, "ncat": 30, "s": 0.5626675603217158, "os": 0.5703416013896253, "bg": 4.0428519003648055e-06}, {"x": 0.8507037533512064, "y": 0.8912533512064343, "term": "morbidity", "cat25k": 6, "ncat25k": 5, "cat": 36, "ncat": 30, "s": 0.6412533512064343, "os": 0.6289971698526742, "bg": 7.422665107906995e-05}, {"x": 0.8508713136729222, "y": 0.9287868632707775, "term": "subject", "cat25k": 9, "ncat25k": 5, "cat": 55, "ncat": 30, "s": 0.7612265415549598, "os": 0.7383583224641269, "bg": 6.626908335200563e-07}, {"x": 0.8510388739946381, "y": 0.8171916890080428, "term": "adopted", "cat25k": 3, "ncat25k": 5, "cat": 20, "ncat": 30, "s": 0.4023123324396783, "os": 0.4123021138475529, "bg": 4.294612108487056e-06}, {"x": 0.8512064343163539, "y": 0.8245643431635389, "term": "observed", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 30, "s": 0.41119302949061665, "os": 0.4248583640351849, "bg": 4.2664180655533464e-06}, {"x": 0.8513739946380697, "y": 0.7255361930294906, "term": "maximum", "cat25k": 2, "ncat25k": 5, "cat": 12, "ncat": 30, "s": 0.28619302949061665, "os": 0.29678056362590566, "bg": 1.4178309013510562e-06}, {"x": 0.8515415549597856, "y": 0.886058981233244, "term": "coordinator", "cat25k": 5, "ncat25k": 5, "cat": 34, "ncat": 30, "s": 0.6137734584450402, "os": 0.613541434991856, "bg": 7.992579389572995e-06}, {"x": 0.8517091152815014, "y": 0.8252345844504021, "term": "fully", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 30, "s": 0.41119302949061665, "os": 0.4248583640351849, "bg": 2.0846600900409655e-06}, {"x": 0.8518766756032171, "y": 0.9157171581769437, "term": "working", "cat25k": 8, "ncat25k": 5, "cat": 47, "ncat": 30, "s": 0.7109584450402144, "os": 0.6993061444257569, "bg": 1.0406250702337454e-06}, {"x": 0.852044235924933, "y": 0.6818029490616622, "term": "con\ufb01rmatory", "cat25k": 2, "ncat25k": 5, "cat": 10, "ncat": 30, "s": 0.24447050938337805, "os": 0.26355765190677716, "bg": 0.0}, {"x": 0.8522117962466488, "y": 0.8636058981233244, "term": "sub", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 30, "s": 0.5571380697050938, "os": 0.5608264870572125, "bg": 2.4216848011888632e-06}, {"x": 0.8523793565683646, "y": 0.6283512064343163, "term": "labor", "cat25k": 1, "ncat25k": 5, "cat": 8, "ncat": 30, "s": 0.22101206434316356, "os": 0.22867566755918883, "bg": 1.9906537236107745e-06}, {"x": 0.8525469168900804, "y": 0.9101876675603218, "term": "individuals", "cat25k": 7, "ncat25k": 5, "cat": 44, "ncat": 30, "s": 0.6963806970509384, "os": 0.6822961496375248, "bg": 3.235373581045485e-06}, {"x": 0.8527144772117963, "y": 0.9006367292225201, "term": "integration", "cat25k": 6, "ncat25k": 5, "cat": 39, "ncat": 30, "s": 0.6606903485254692, "os": 0.650478676970644, "bg": 4.210566911949478e-06}, {"x": 0.8528820375335121, "y": 0.9418565683646113, "term": "packages", "cat25k": 10, "ncat25k": 5, "cat": 64, "ncat": 30, "s": 0.807808310991957, "os": 0.7734980168711783, "bg": 4.100008274165634e-06}, {"x": 0.8530495978552279, "y": 0.8959450402144772, "term": "h.", "cat25k": 6, "ncat25k": 5, "cat": 37, "ncat": 30, "s": 0.6476206434316355, "os": 0.6363755535704638, "bg": 0.0}, {"x": 0.8532171581769437, "y": 0.8200402144772118, "term": "adult", "cat25k": 3, "ncat25k": 5, "cat": 20, "ncat": 30, "s": 0.4023123324396783, "os": 0.4123021138475529, "bg": 1.0215015555987514e-06}, {"x": 0.8533847184986595, "y": 0.8691353887399463, "term": "worker", "cat25k": 5, "ncat25k": 5, "cat": 29, "ncat": 30, "s": 0.5626675603217158, "os": 0.5703416013896253, "bg": 7.2017277799386346e-06}, {"x": 0.8535522788203753, "y": 0.6385723860589813, "term": "clean", "cat25k": 1, "ncat25k": 5, "cat": 8, "ncat": 30, "s": 0.22101206434316356, "os": 0.22867566755918883, "bg": 1.6632472710106265e-06}, {"x": 0.8537198391420912, "y": 0.8359584450402144, "term": "encourage", "cat25k": 4, "ncat25k": 5, "cat": 22, "ncat": 30, "s": 0.42593833780160856, "os": 0.4370254131276869, "bg": 4.657041993801478e-06}, {"x": 0.853887399463807, "y": 0.8300938337801609, "term": "manufacturers", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 30, "s": 0.41119302949061665, "os": 0.4248583640351849, "bg": 2.966369225140735e-06}, {"x": 0.8540549597855228, "y": 0.8304289544235925, "term": "exclusive", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 30, "s": 0.41119302949061665, "os": 0.4248583640351849, "bg": 3.4715739020143503e-06}, {"x": 0.8542225201072386, "y": 0.6742627345844504, "term": "avoid", "cat25k": 1, "ncat25k": 5, "cat": 9, "ncat": 30, "s": 0.23693029490616624, "os": 0.24631565699461194, "bg": 2.1184024562170343e-06}, {"x": 0.8543900804289544, "y": 0.5774128686327078, "term": "childhood", "cat25k": 1, "ncat25k": 5, "cat": 6, "ncat": 30, "s": 0.1957104557640751, "os": 0.19230980621601035, "bg": 5.516314384870036e-06}, {"x": 0.8545576407506702, "y": 0.3535522788203753, "term": "regimen", "cat25k": 0, "ncat25k": 5, "cat": 3, "ncat": 30, "s": 0.05144101876675604, "os": 0.13569014742928975, "bg": 3.423383890489062e-05}, {"x": 0.854725201072386, "y": 0.7005697050938338, "term": "schools", "cat25k": 2, "ncat25k": 5, "cat": 10, "ncat": 30, "s": 0.24447050938337805, "os": 0.26355765190677716, "bg": 6.70631091185022e-07}, {"x": 0.8548927613941019, "y": 0.36427613941018766, "term": "skilled", "cat25k": 0, "ncat25k": 5, "cat": 3, "ncat": 30, "s": 0.05144101876675604, "os": 0.13569014742928975, "bg": 8.113282069683505e-06}, {"x": 0.8550603217158177, "y": 0.21162868632707774, "term": "resu", "cat25k": 0, "ncat25k": 5, "cat": 1, "ncat": 30, "s": 0.02546916890080429, "os": 0.097337324632912, "bg": 0.00017135544924147577}, {"x": 0.8552278820375335, "y": 0.022955764075067026, "term": "dbs", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 30, "s": 0.01876675603217158, "os": 0.07826524132384077, "bg": 4.152450291709633e-05}, {"x": 0.8553954423592494, "y": 0.09819034852546916, "term": "zinc", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 30, "s": 0.01876675603217158, "os": 0.07826524132384077, "bg": 1.0028200972501503e-05}, {"x": 0.8555630026809652, "y": 0.8828753351206434, "term": "annual", "cat25k": 5, "ncat25k": 5, "cat": 33, "ncat": 31, "s": 0.5991957104557641, "os": 0.5977115145525256, "bg": 1.4996067984111855e-06}, {"x": 0.8557305630026809, "y": 0.9472184986595175, "term": "poor", "cat25k": 11, "ncat25k": 5, "cat": 71, "ncat": 31, "s": 0.8233914209115282, "os": 0.7901583017797562, "bg": 4.217920343209697e-06}, {"x": 0.8558981233243967, "y": 0.7253686327077749, "term": "collect", "cat25k": 2, "ncat25k": 5, "cat": 12, "ncat": 31, "s": 0.26876675603217154, "os": 0.2888477443502664, "bg": 5.290577592041593e-06}, {"x": 0.8560656836461126, "y": 0.8453418230563002, "term": "record", "cat25k": 4, "ncat25k": 5, "cat": 24, "ncat": 31, "s": 0.43297587131367293, "os": 0.4503113114792268, "bg": 1.072681431996556e-06}, {"x": 0.8562332439678284, "y": 0.7054289544235925, "term": "advise", "cat25k": 2, "ncat25k": 5, "cat": 11, "ncat": 31, "s": 0.25837801608579086, "os": 0.27276693429728316, "bg": 9.725502327984228e-06}, {"x": 0.8564008042895442, "y": 0.9175603217158177, "term": "right", "cat25k": 8, "ncat25k": 5, "cat": 48, "ncat": 31, "s": 0.7086126005361931, "os": 0.6976958770230253, "bg": 5.767846500111265e-07}, {"x": 0.8565683646112601, "y": 0.9245978552278821, "term": "others", "cat25k": 8, "ncat25k": 5, "cat": 52, "ncat": 31, "s": 0.7466487935656837, "os": 0.7179572820788784, "bg": 1.4859937834971868e-06}, {"x": 0.8567359249329759, "y": 0.8113270777479893, "term": "commitment", "cat25k": 3, "ncat25k": 5, "cat": 19, "ncat": 31, "s": 0.37583780160857905, "os": 0.3899060243720734, "bg": 4.301192372248243e-06}, {"x": 0.8569034852546917, "y": 0.6275134048257373, "term": "regardless", "cat25k": 1, "ncat25k": 5, "cat": 8, "ncat": 31, "s": 0.21430965147453085, "os": 0.22217934616027424, "bg": 5.413465203494933e-06}, {"x": 0.8570710455764075, "y": 0.8570710455764075, "term": "increased", "cat25k": 4, "ncat25k": 5, "cat": 26, "ncat": 31, "s": 0.5194369973190349, "os": 0.5329603400182146, "bg": 2.286431136314357e-06}, {"x": 0.8572386058981233, "y": 0.9380026809651475, "term": "purposes", "cat25k": 10, "ncat25k": 5, "cat": 61, "ncat": 31, "s": 0.7875335120643432, "os": 0.7564552502119759, "bg": 3.570365569924746e-06}, {"x": 0.8574061662198391, "y": 0.4793900804289544, "term": "upgraded", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 31, "s": 0.1410857908847185, "os": 0.1685345022002005, "bg": 1.3830323445164305e-05}, {"x": 0.857573726541555, "y": 0.771112600536193, "term": "mobilization", "cat25k": 2, "ncat25k": 5, "cat": 15, "ncat": 31, "s": 0.33327747989276135, "os": 0.3346225246149285, "bg": 4.70772691499585e-05}, {"x": 0.8577412868632708, "y": 0.748156836461126, "term": "five", "cat25k": 2, "ncat25k": 5, "cat": 13, "ncat": 31, "s": 0.29272788203753347, "os": 0.3045198007678861, "bg": 8.422844400296828e-07}, {"x": 0.8579088471849866, "y": 0.6683981233243967, "term": "small", "cat25k": 1, "ncat25k": 5, "cat": 9, "ncat": 31, "s": 0.2262064343163539, "os": 0.23941713524357766, "bg": 3.833549669326391e-07}, {"x": 0.8580764075067024, "y": 0.7627345844504021, "term": "week", "cat25k": 2, "ncat25k": 5, "cat": 14, "ncat": 31, "s": 0.3007707774798927, "os": 0.3197785266302966, "bg": 5.372683279568493e-07}, {"x": 0.8582439678284183, "y": 0.2498324396782842, "term": "needles", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 31, "s": 0.03317694369973191, "os": 0.11295665202279798, "bg": 1.8550424832835374e-05}, {"x": 0.858411528150134, "y": 0.5115616621983914, "term": "natural", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 31, "s": 0.1410857908847185, "os": 0.1685345022002005, "bg": 6.830227597223452e-07}, {"x": 0.8585790884718498, "y": 0.17158176943699732, "term": "saving", "cat25k": 0, "ncat25k": 5, "cat": 1, "ncat": 31, "s": 0.023626005361930293, "os": 0.09431903470866831, "bg": 2.9860740703138327e-06}, {"x": 0.8587466487935657, "y": 0.7880361930294906, "term": "representatives", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 31, "s": 0.342828418230563, "os": 0.349053030665667, "bg": 4.0000073191623286e-06}, {"x": 0.8589142091152815, "y": 0.7887064343163539, "term": "events", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 31, "s": 0.342828418230563, "os": 0.349053030665667, "bg": 4.663913945270399e-07}, {"x": 0.8590817694369973, "y": 0.30445710455764075, "term": "births", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 31, "s": 0.03317694369973191, "os": 0.11295665202279798, "bg": 1.5793172611480057e-05}, {"x": 0.8592493297587132, "y": 0.02898793565683646, "term": "ligtas tigdas", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 31, "s": 0.018599195710455766, "os": 0.07578413301018039, "bg": 0.0}, {"x": 0.859416890080429, "y": 0.849195710455764, "term": "had", "cat25k": 4, "ncat25k": 5, "cat": 25, "ncat": 32, "s": 0.43314343163538876, "os": 0.4516737022229729, "bg": 2.3723077075211957e-07}, {"x": 0.8595844504021448, "y": 0.844671581769437, "term": "many", "cat25k": 4, "ncat25k": 5, "cat": 24, "ncat": 32, "s": 0.4269436997319035, "os": 0.4407210610908439, "bg": 3.50790974451411e-07}, {"x": 0.8597520107238605, "y": 0.823558981233244, "term": "supervision", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 32, "s": 0.39544235924932974, "os": 0.40584351587309947, "bg": 1.0375018755782727e-05}, {"x": 0.8599195710455764, "y": 0.7898793565683646, "term": "normal", "cat25k": 3, "ncat25k": 5, "cat": 17, "ncat": 32, "s": 0.3450067024128686, "os": 0.35430667265007765, "bg": 1.7267271711867446e-06}, {"x": 0.8600871313672922, "y": 0.8321045576407506, "term": "allowed", "cat25k": 4, "ncat25k": 5, "cat": 22, "ncat": 32, "s": 0.40365281501340483, "os": 0.4178150868420765, "bg": 2.408663588245918e-06}, {"x": 0.860254691689008, "y": 0.8451742627345844, "term": "operational", "cat25k": 4, "ncat25k": 5, "cat": 24, "ncat": 32, "s": 0.4269436997319035, "os": 0.4407210610908439, "bg": 6.361465874853495e-06}, {"x": 0.8604222520107239, "y": 0.8026139410187667, "term": "single", "cat25k": 3, "ncat25k": 5, "cat": 18, "ncat": 32, "s": 0.3607573726541555, "os": 0.3677531461886686, "bg": 7.403776266469608e-07}, {"x": 0.8605898123324397, "y": 0.8567359249329759, "term": "awareness", "cat25k": 4, "ncat25k": 5, "cat": 26, "ncat": 32, "s": 0.4539209115281501, "os": 0.46230526671489647, "bg": 5.5653882745905e-06}, {"x": 0.8607573726541555, "y": 0.4762064343163539, "term": "isolation", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 32, "s": 0.11260053619302948, "os": 0.1636274143332146, "bg": 1.0169985815618431e-05}, {"x": 0.8609249329758714, "y": 0.8031166219839142, "term": "identified", "cat25k": 3, "ncat25k": 5, "cat": 18, "ncat": 32, "s": 0.3607573726541555, "os": 0.3677531461886686, "bg": 2.982040334063665e-06}, {"x": 0.8610924932975871, "y": 0.8714812332439679, "term": "detection", "cat25k": 5, "ncat25k": 5, "cat": 30, "ncat": 32, "s": 0.5596514745308311, "os": 0.564119256197889, "bg": 6.938345026776137e-06}, {"x": 0.8612600536193029, "y": 0.8641085790884718, "term": "complete", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 32, "s": 0.546916890080429, "os": 0.5453485775456497, "bg": 8.020090111861143e-07}, {"x": 0.8614276139410187, "y": 0.550603217158177, "term": "accomplishment", "cat25k": 1, "ncat25k": 5, "cat": 6, "ncat": 32, "s": 0.1910187667560322, "os": 0.1813365755085804, "bg": 3.42915567419231e-05}, {"x": 0.8615951742627346, "y": 0.9498994638069705, "term": "establishment", "cat25k": 12, "ncat25k": 5, "cat": 73, "ncat": 32, "s": 0.823558981233244, "os": 0.7904472378803871, "bg": 1.3651673899995249e-05}, {"x": 0.8617627345844504, "y": 0.7717828418230563, "term": "provinces", "cat25k": 2, "ncat25k": 5, "cat": 15, "ncat": 32, "s": 0.30965147453083114, "os": 0.3262556087661252, "bg": 1.4294699525415973e-05}, {"x": 0.8619302949061662, "y": 0.8270777479892761, "term": "manage", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 32, "s": 0.39544235924932974, "os": 0.40584351587309947, "bg": 2.8842403339514953e-06}, {"x": 0.8620978552278821, "y": 0.7742962466487936, "term": "admitted", "cat25k": 2, "ncat25k": 5, "cat": 15, "ncat": 32, "s": 0.30965147453083114, "os": 0.3262556087661252, "bg": 1.0333129089143464e-05}, {"x": 0.8622654155495979, "y": 0.7856903485254692, "term": "meet", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 32, "s": 0.339142091152815, "os": 0.34047548730305466, "bg": 1.025773883085306e-06}, {"x": 0.8624329758713136, "y": 0.8532171581769437, "term": "key", "cat25k": 4, "ncat25k": 5, "cat": 25, "ncat": 32, "s": 0.43314343163538876, "os": 0.4516737022229729, "bg": 8.310561362455007e-07}, {"x": 0.8626005361930295, "y": 0.5023458445040214, "term": "oral", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 32, "s": 0.11260053619302948, "os": 0.1636274143332146, "bg": 1.7511026681669673e-06}, {"x": 0.8627680965147453, "y": 0.7183310991957105, "term": "followed", "cat25k": 2, "ncat25k": 5, "cat": 11, "ncat": 32, "s": 0.25569705093833783, "os": 0.2654780683897487, "bg": 2.708696651707627e-06}, {"x": 0.8629356568364611, "y": 0.6992292225201072, "term": "catchment", "cat25k": 2, "ncat25k": 5, "cat": 10, "ncat": 32, "s": 0.23776809651474534, "os": 0.24932962737943132, "bg": 4.282198949943643e-05}, {"x": 0.863103217158177, "y": 0.890583109919571, "term": "advisory", "cat25k": 6, "ncat25k": 5, "cat": 35, "ncat": 32, "s": 0.6075737265415551, "os": 0.6062530929434128, "bg": 5.5115567885721575e-06}, {"x": 0.8632707774798928, "y": 0.18884048257372654, "term": "lying", "cat25k": 0, "ncat25k": 5, "cat": 1, "ncat": 32, "s": 0.022788203753351208, "os": 0.09139862581935171, "bg": 7.698736765609044e-06}, {"x": 0.8634383378016086, "y": 0.3057975871313673, "term": "congenital", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 32, "s": 0.03083109919571046, "os": 0.10952688981234898, "bg": 3.0422959670787788e-05}, {"x": 0.8636058981233244, "y": 0.028652815013404824, "term": "ligtas", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 32, "s": 0.017761394101876677, "os": 0.07336912146024199, "bg": 0.00020513543746734662}, {"x": 0.8637734584450402, "y": 0.06233243967828418, "term": "iu", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 32, "s": 0.017761394101876677, "os": 0.07336912146024199, "bg": 2.2228466260140436e-05}, {"x": 0.863941018766756, "y": 0.9150469168900804, "term": "implemented", "cat25k": 8, "ncat25k": 5, "cat": 47, "ncat": 33, "s": 0.693867292225201, "os": 0.6785717231130335, "bg": 8.215170092016067e-06}, {"x": 0.8641085790884718, "y": 0.8316018766756033, "term": "referred", "cat25k": 4, "ncat25k": 5, "cat": 22, "ncat": 33, "s": 0.3996313672922252, "os": 0.4087095997148015, "bg": 3.7631010223969172e-06}, {"x": 0.8642761394101877, "y": 0.9091823056300268, "term": "covered", "cat25k": 7, "ncat25k": 5, "cat": 44, "ncat": 33, "s": 0.6697386058981233, "os": 0.6610826179248548, "bg": 4.055391059121466e-06}, {"x": 0.8644436997319035, "y": 0.9153820375335121, "term": "viii", "cat25k": 8, "ncat25k": 5, "cat": 47, "ncat": 33, "s": 0.693867292225201, "os": 0.6785717231130335, "bg": 2.328978386352769e-05}, {"x": 0.8646112600536193, "y": 0.3847184986595174, "term": "hiv", "cat25k": 1, "ncat25k": 5, "cat": 4, "ncat": 33, "s": 0.06082439678284183, "os": 0.1414649970678169, "bg": 2.7522103224251585e-06}, {"x": 0.8647788203753352, "y": 0.9745308310991957, "term": "people", "cat25k": 21, "ncat25k": 5, "cat": 130, "ncat": 33, "s": 0.9731903485254692, "os": 0.8817365012182325, "bg": 6.782968978594897e-07}, {"x": 0.864946380697051, "y": 0.9413538873994638, "term": "attached", "cat25k": 10, "ncat25k": 5, "cat": 64, "ncat": 33, "s": 0.7873659517426274, "os": 0.7555509714034108, "bg": 8.293452088727284e-06}, {"x": 0.8651139410187667, "y": 0.7930630026809652, "term": "last", "cat25k": 3, "ncat25k": 5, "cat": 17, "ncat": 33, "s": 0.34232573726541554, "os": 0.3458765400827984, "bg": 2.3928389623230827e-07}, {"x": 0.8652815013404825, "y": 0.9105227882037533, "term": "strategic", "cat25k": 7, "ncat25k": 5, "cat": 44, "ncat": 33, "s": 0.6697386058981233, "os": 0.6610826179248548, "bg": 4.9291361461651464e-06}, {"x": 0.8654490616621984, "y": 0.7835120643431636, "term": "see", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 33, "s": 0.31266756032171583, "os": 0.33223336698558154, "bg": 1.4375353078107663e-07}, {"x": 0.8656166219839142, "y": 0.9183981233243967, "term": "strengthen", "cat25k": 8, "ncat25k": 5, "cat": 48, "ncat": 33, "s": 0.6982238605898123, "os": 0.6840946333666476, "bg": 2.1108966046358416e-05}, {"x": 0.86578418230563, "y": 0.8780160857908847, "term": "developing", "cat25k": 5, "ncat25k": 5, "cat": 31, "ncat": 33, "s": 0.5603217158176944, "os": 0.5656749182274342, "bg": 2.9711272354598834e-06}, {"x": 0.8659517426273459, "y": 0.5936662198391421, "term": "epidemiological", "cat25k": 1, "ncat25k": 5, "cat": 7, "ncat": 33, "s": 0.1958780160857909, "os": 0.19324218850520625, "bg": 5.5759698005475596e-05}, {"x": 0.8661193029490617, "y": 0.910857908847185, "term": "global", "cat25k": 7, "ncat25k": 5, "cat": 44, "ncat": 33, "s": 0.6697386058981233, "os": 0.6610826179248548, "bg": 1.6424454139399186e-06}, {"x": 0.8662868632707775, "y": 0.7320710455764075, "term": "30", "cat25k": 2, "ncat25k": 5, "cat": 12, "ncat": 33, "s": 0.2588806970509383, "os": 0.2739723002113316, "bg": 0.0}, {"x": 0.8664544235924933, "y": 0.9028150134048257, "term": "end", "cat25k": 6, "ncat25k": 5, "cat": 40, "ncat": 33, "s": 0.6471179624664879, "os": 0.6354079719991859, "bg": 6.602619508792424e-07}, {"x": 0.8666219839142091, "y": 0.7860254691689008, "term": "already", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 33, "s": 0.31266756032171583, "os": 0.33223336698558154, "bg": 9.020903283112645e-07}, {"x": 0.8667895442359249, "y": 0.7982573726541555, "term": "four", "cat25k": 3, "ncat25k": 5, "cat": 17, "ncat": 33, "s": 0.34232573726541554, "os": 0.3458765400827984, "bg": 7.723253163674264e-07}, {"x": 0.8669571045576407, "y": 0.8661193029490617, "term": "card", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 33, "s": 0.5348525469168901, "os": 0.5379353545786703, "bg": 6.714399072840553e-07}, {"x": 0.8671246648793566, "y": 0.7873659517426274, "term": "clinic", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 33, "s": 0.31266756032171583, "os": 0.33223336698558154, "bg": 6.322805410695569e-06}, {"x": 0.8672922252010724, "y": 0.17359249329758714, "term": "serum", "cat25k": 0, "ncat25k": 5, "cat": 1, "ncat": 33, "s": 0.022117962466487937, "os": 0.08857178688958678, "bg": 1.1026550799238455e-05}, {"x": 0.8674597855227882, "y": 0.5762399463806971, "term": "cities", "cat25k": 1, "ncat25k": 5, "cat": 6, "ncat": 33, "s": 0.18850536193029493, "os": 0.17619744909592577, "bg": 1.2973741147916615e-06}, {"x": 0.8676273458445041, "y": 0.26658847184986595, "term": "rapid", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 33, "s": 0.0293230563002681, "os": 0.10621976889258311, "bg": 3.6114746662275112e-06}, {"x": 0.8677949061662198, "y": 0.17577077747989275, "term": "irs", "cat25k": 0, "ncat25k": 5, "cat": 1, "ncat": 33, "s": 0.022117962466487937, "os": 0.08857178688958678, "bg": 1.0076034049289885e-05}, {"x": 0.8679624664879356, "y": 0.5375335120643432, "term": "site", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 33, "s": 0.09450402144772117, "os": 0.15892347103168125, "bg": 8.9981055045322e-08}, {"x": 0.8681300268096515, "y": 0.03367962466487936, "term": "breastfed", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 33, "s": 0.016923592493297585, "os": 0.07101876221711306, "bg": 0.0001312228979980555}, {"x": 0.8682975871313673, "y": 0.1439343163538874, "term": "cgs", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 33, "s": 0.016923592493297585, "os": 0.07101876221711306, "bg": 9.069035975216798e-05}, {"x": 0.8684651474530831, "y": 0.8910857908847185, "term": "principles", "cat25k": 6, "ncat25k": 5, "cat": 36, "ncat": 34, "s": 0.6000335120643432, "os": 0.5995541216493836, "bg": 4.4639489252819765e-06}, {"x": 0.868632707774799, "y": 0.8755026809651475, "term": "major", "cat25k": 5, "ncat25k": 5, "cat": 31, "ncat": 34, "s": 0.5556300268096515, "os": 0.5584686866368924, "bg": 1.0577337611546365e-06}, {"x": 0.8688002680965148, "y": 0.9014745308310992, "term": "included", "cat25k": 6, "ncat25k": 5, "cat": 40, "ncat": 34, "s": 0.6405831099195711, "os": 0.6284287208508655, "bg": 1.6032105808431936e-06}, {"x": 0.8689678284182306, "y": 0.7813337801608579, "term": "once", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 34, "s": 0.3078083109919571, "os": 0.3243077459992888, "bg": 8.913130226269615e-07}, {"x": 0.8691353887399463, "y": 0.94671581769437, "term": "agency", "cat25k": 11, "ncat25k": 5, "cat": 70, "ncat": 34, "s": 0.8063002680965148, "os": 0.7702880573083437, "bg": 2.5926239847633484e-06}, {"x": 0.8693029490616622, "y": 0.8872319034852547, "term": "otherwise", "cat25k": 5, "ncat25k": 5, "cat": 34, "ncat": 34, "s": 0.5784182305630027, "os": 0.5838351612070375, "bg": 2.5317157432007005e-06}, {"x": 0.869470509383378, "y": 0.8389745308310992, "term": "determine", "cat25k": 4, "ncat25k": 5, "cat": 23, "ncat": 34, "s": 0.4019772117962466, "os": 0.4113568563701363, "bg": 2.6499621113531275e-06}, {"x": 0.8696380697050938, "y": 0.9398458445040214, "term": "society", "cat25k": 10, "ncat25k": 5, "cat": 63, "ncat": 34, "s": 0.7679289544235924, "os": 0.7459762420753431, "bg": 1.7397372919566772e-06}, {"x": 0.8698056300268097, "y": 0.8766756032171582, "term": "components", "cat25k": 5, "ncat25k": 5, "cat": 31, "ncat": 34, "s": 0.5556300268096515, "os": 0.5584686866368924, "bg": 2.351802180583746e-06}, {"x": 0.8699731903485255, "y": 0.9039879356568364, "term": "submitted", "cat25k": 7, "ncat25k": 5, "cat": 41, "ncat": 34, "s": 0.6469504021447721, "os": 0.6351564285200615, "bg": 2.9013793873280937e-06}, {"x": 0.8701407506702413, "y": 0.7838471849865952, "term": "marketing", "cat25k": 3, "ncat25k": 5, "cat": 16, "ncat": 34, "s": 0.3078083109919571, "os": 0.3243077459992888, "bg": 9.098500548912537e-07}, {"x": 0.8703083109919572, "y": 0.8193699731903485, "term": "together", "cat25k": 3, "ncat25k": 5, "cat": 20, "ncat": 34, "s": 0.36595174262734587, "os": 0.3760632469513434, "bg": 1.143755493203466e-06}, {"x": 0.8704758713136729, "y": 0.8927613941018767, "term": "encouraged", "cat25k": 6, "ncat25k": 5, "cat": 36, "ncat": 34, "s": 0.6000335120643432, "os": 0.5995541216493836, "bg": 1.0815234617588368e-05}, {"x": 0.8706434316353887, "y": 0.8349530831099196, "term": "likewise", "cat25k": 4, "ncat25k": 5, "cat": 22, "ncat": 34, "s": 0.3920911528150134, "os": 0.39991606755174763, "bg": 1.904713962981884e-05}, {"x": 0.8708109919571045, "y": 0.49514075067024127, "term": "modern", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 34, "s": 0.08227211796246649, "os": 0.15440960800293368, "bg": 1.3602593770482915e-06}, {"x": 0.8709785522788204, "y": 0.7533512064343163, "term": "therapeutic", "cat25k": 2, "ncat25k": 5, "cat": 13, "ncat": 34, "s": 0.26658847184986595, "os": 0.2818389716652124, "bg": 1.0125488191257114e-05}, {"x": 0.8711461126005362, "y": 0.8662868632707775, "term": "thus", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 34, "s": 0.49044906166219837, "os": 0.5307298962228404, "bg": 2.0749871229478562e-06}, {"x": 0.871313672922252, "y": 0.5707104557640751, "term": "advice", "cat25k": 1, "ncat25k": 5, "cat": 6, "ncat": 34, "s": 0.14158847184986595, "os": 0.17126973743462637, "bg": 1.117619381308263e-06}, {"x": 0.8714812332439679, "y": 0.764745308310992, "term": "likely", "cat25k": 2, "ncat25k": 5, "cat": 14, "ncat": 34, "s": 0.28535522788203754, "os": 0.29634440122118094, "bg": 1.7148538821237306e-06}, {"x": 0.8716487935656837, "y": 0.0001675603217158177, "term": "anc", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 34, "s": 0.016588471849865952, "os": 0.06873163606951072, "bg": 4.594889536828378e-05}, {"x": 0.8718163538873994, "y": 0.8381367292225201, "term": "times", "cat25k": 4, "ncat25k": 5, "cat": 23, "ncat": 35, "s": 0.3941018766756032, "os": 0.4027651276002185, "bg": 5.706895004127537e-07}, {"x": 0.8719839142091153, "y": 0.8557305630026809, "term": "six", "cat25k": 4, "ncat25k": 5, "cat": 26, "ncat": 35, "s": 0.42258713136729226, "os": 0.43501396131807685, "bg": 1.702048012988691e-06}, {"x": 0.8721514745308311, "y": 0.7905495978552279, "term": "another", "cat25k": 3, "ncat25k": 5, "cat": 17, "ncat": 35, "s": 0.3125, "os": 0.3299535463878161, "bg": 5.39285499293772e-07}, {"x": 0.8723190348525469, "y": 0.8996313672922251, "term": "supply", "cat25k": 6, "ncat25k": 5, "cat": 39, "ncat": 35, "s": 0.6281836461126006, "os": 0.6146417032075511, "bg": 2.012714371079797e-06}, {"x": 0.8724865951742627, "y": 0.818029490616622, "term": "previous", "cat25k": 3, "ncat25k": 5, "cat": 20, "ncat": 35, "s": 0.36109249329758714, "os": 0.3677970883190908, "bg": 5.445418123707919e-07}, {"x": 0.8726541554959786, "y": 0.9158847184986595, "term": "civil", "cat25k": 8, "ncat25k": 5, "cat": 47, "ncat": 35, "s": 0.6816353887399464, "os": 0.6653256631104695, "bg": 3.2926842098204383e-06}, {"x": 0.8728217158176944, "y": 0.9182305630026809, "term": "offices", "cat25k": 8, "ncat25k": 5, "cat": 48, "ncat": 35, "s": 0.6841487935656837, "os": 0.670938858818682, "bg": 5.3619666660098794e-06}, {"x": 0.8729892761394102, "y": 0.8334450402144772, "term": "source", "cat25k": 4, "ncat25k": 5, "cat": 22, "ncat": 35, "s": 0.3765080428954424, "os": 0.3914198415672761, "bg": 6.323640597550754e-07}, {"x": 0.873156836461126, "y": 0.7099530831099196, "term": "disasters", "cat25k": 2, "ncat25k": 5, "cat": 11, "ncat": 35, "s": 0.23475201072386062, "os": 0.24537444484854815, "bg": 1.824940590249263e-05}, {"x": 0.8733243967828418, "y": 0.9189008042895442, "term": "good", "cat25k": 8, "ncat25k": 5, "cat": 48, "ncat": 35, "s": 0.6841487935656837, "os": 0.670938858818682, "bg": 4.5341757708090614e-07}, {"x": 0.8734919571045576, "y": 0.8523793565683646, "term": "analysis", "cat25k": 4, "ncat25k": 5, "cat": 25, "ncat": 35, "s": 0.41035522788203754, "os": 0.4245553157811479, "bg": 9.579954367005034e-07}, {"x": 0.8736595174262735, "y": 0.9192359249329759, "term": "filipino", "cat25k": 8, "ncat25k": 5, "cat": 48, "ncat": 35, "s": 0.6841487935656837, "os": 0.670938858818682, "bg": 6.305163054935062e-05}, {"x": 0.8738270777479893, "y": 0.8140080428954424, "term": "eligible", "cat25k": 3, "ncat25k": 5, "cat": 19, "ncat": 35, "s": 0.3512064343163539, "os": 0.3555083820652992, "bg": 3.377239743182182e-06}, {"x": 0.8739946380697051, "y": 0.8577412868632708, "term": "active", "cat25k": 4, "ncat25k": 5, "cat": 26, "ncat": 35, "s": 0.42258713136729226, "os": 0.43501396131807685, "bg": 1.4455527463120572e-06}, {"x": 0.874162198391421, "y": 0.734416890080429, "term": "district", "cat25k": 2, "ncat25k": 5, "cat": 12, "ncat": 35, "s": 0.23994638069705096, "os": 0.2602835994445529, "bg": 9.248534257362919e-07}, {"x": 0.8743297587131368, "y": 0.7188337801608579, "term": "orientation", "cat25k": 2, "ncat25k": 5, "cat": 11, "ncat": 35, "s": 0.23475201072386062, "os": 0.24537444484854815, "bg": 7.042897215192509e-06}, {"x": 0.8744973190348525, "y": 0.8615951742627346, "term": "adoption", "cat25k": 4, "ncat25k": 5, "cat": 27, "ncat": 35, "s": 0.4289544235924933, "os": 0.4451911671322925, "bg": 6.823401670434763e-06}, {"x": 0.8746648793565683, "y": 0.3719839142091153, "term": "soon", "cat25k": 0, "ncat25k": 5, "cat": 3, "ncat": 35, "s": 0.03569034852546918, "os": 0.11672649859493806, "bg": 9.825452135633126e-07}, {"x": 0.8748324396782842, "y": 0.02530160857908847, "term": "whsmp", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 35, "s": 0.01541554959785523, "os": 0.06650634889580803, "bg": 0.00022436472730070003}, {"x": 0.875, "y": 0.03451742627345845, "term": "substitutes", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 35, "s": 0.01541554959785523, "os": 0.06650634889580803, "bg": 3.395188823426415e-05}, {"x": 0.8751675603217158, "y": 0.051105898123324396, "term": "outbreak", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 35, "s": 0.01541554959785523, "os": 0.06650634889580803, "bg": 2.057516401345028e-05}, {"x": 0.8753351206434317, "y": 0.08411528150134048, "term": "poliovirus", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 35, "s": 0.01541554959785523, "os": 0.06650634889580803, "bg": 0.0001356765316426745}, {"x": 0.8755026809651475, "y": 0.8238941018766756, "term": "still", "cat25k": 3, "ncat25k": 5, "cat": 21, "ncat": 36, "s": 0.3627680965147453, "os": 0.3716631096374422, "bg": 5.976549874169773e-07}, {"x": 0.8756702412868632, "y": 0.8939343163538874, "term": "so", "cat25k": 6, "ncat25k": 5, "cat": 37, "ncat": 36, "s": 0.589142091152815, "os": 0.5933788634384284, "bg": 2.2050330698399865e-07}, {"x": 0.875837801608579, "y": 0.8011058981233244, "term": "below", "cat25k": 3, "ncat25k": 5, "cat": 18, "ncat": 36, "s": 0.33495308310991956, "os": 0.3352029894105941, "bg": 7.396569252023305e-07}, {"x": 0.8760053619302949, "y": 0.8999664879356568, "term": "adopt", "cat25k": 6, "ncat25k": 5, "cat": 39, "ncat": 36, "s": 0.6084115281501341, "os": 0.6079148967258555, "bg": 1.2948480327503322e-05}, {"x": 0.8761729222520107, "y": 0.8600871313672922, "term": "receive", "cat25k": 4, "ncat25k": 5, "cat": 27, "ncat": 36, "s": 0.4257707774798928, "os": 0.43659744743636086, "bg": 1.4214647815516614e-06}, {"x": 0.8763404825737265, "y": 0.7679289544235925, "term": "having", "cat25k": 2, "ncat25k": 5, "cat": 15, "ncat": 36, "s": 0.28451742627345844, "os": 0.29593173042526144, "bg": 9.300450732667626e-07}, {"x": 0.8765080428954424, "y": 0.8634383378016086, "term": "evaluate", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 36, "s": 0.42979222520107235, "os": 0.44645335305300454, "bg": 7.867542061846748e-06}, {"x": 0.8766756032171582, "y": 0.9272788203753352, "term": "issues", "cat25k": 9, "ncat25k": 5, "cat": 53, "ncat": 36, "s": 0.7017426273458445, "os": 0.6907359353693852, "bg": 1.1833664941876762e-06}, {"x": 0.876843163538874, "y": 0.9448726541554959, "term": "developed", "cat25k": 11, "ncat25k": 5, "cat": 67, "ncat": 36, "s": 0.782171581769437, "os": 0.7491351695164784, "bg": 3.240906609956464e-06}, {"x": 0.8770107238605898, "y": 0.8644436997319035, "term": "accreditation", "cat25k": 4, "ncat25k": 5, "cat": 28, "ncat": 36, "s": 0.42979222520107235, "os": 0.44645335305300454, "bg": 1.8168674281517648e-05}, {"x": 0.8771782841823056, "y": 0.8202077747989276, "term": "improving", "cat25k": 3, "ncat25k": 5, "cat": 20, "ncat": 36, "s": 0.35422252010723865, "os": 0.35981731875185025, "bg": 6.164693643622914e-06}, {"x": 0.8773458445040214, "y": 0.6673927613941019, "term": "start", "cat25k": 1, "ncat25k": 5, "cat": 9, "ncat": 36, "s": 0.20475871313672925, "os": 0.2090703933964856, "bg": 5.547836186698497e-07}, {"x": 0.8775134048257373, "y": 0.6040549597855228, "term": "reduced", "cat25k": 1, "ncat25k": 5, "cat": 7, "ncat": 36, "s": 0.18884048257372654, "os": 0.17790768721421335, "bg": 2.862988680541731e-06}, {"x": 0.8776809651474531, "y": 0.5120643431635389, "term": "complementary", "cat25k": 1, "ncat25k": 5, "cat": 5, "ncat": 36, "s": 0.06635388739946381, "os": 0.14590618514439707, "bg": 1.544036291631549e-05}, {"x": 0.8778485254691689, "y": 0.7220174262734584, "term": "minimum", "cat25k": 2, "ncat25k": 5, "cat": 11, "ncat": 36, "s": 0.2260388739946381, "os": 0.23920213024161607, "bg": 1.868280055021245e-06}, {"x": 0.8780160857908847, "y": 0.27915549597855227, "term": "sexual", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 36, "s": 0.025134048257372654, "os": 0.09697245130146159, "bg": 2.2413817764749583e-06}, {"x": 0.8781836461126006, "y": 0.29892761394101874, "term": "syringes", "cat25k": 0, "ncat25k": 5, "cat": 2, "ncat": 36, "s": 0.025134048257372654, "os": 0.09697245130146159, "bg": 7.347190521350839e-05}, {"x": 0.8783512064343163, "y": 0.0013404825737265416, "term": "anemia", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 36, "s": 0.014745308310991958, "os": 0.06434153147588684, "bg": 3.313672211544834e-05}, {"x": 0.8785187667560321, "y": 0.02111260053619303, "term": "micronutrients", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 36, "s": 0.014745308310991958, "os": 0.06434153147588684, "bg": 0.00014880890869333377}, {"x": 0.878686327077748, "y": 0.09735254691689008, "term": "ors", "cat25k": 0, "ncat25k": 5, "cat": 0, "ncat": 36, "s": 0.014745308310991958, "os": 0.06434153147588684, "bg": 2.6274227026837663e-05}, {"x": 0.8788538873994638, "y": 0.9502345844504021, "term": "list", "cat25k": 12, "ncat25k": 6, "cat": 74, "ncat": 37, "s": 0.7962466487935657, "os": 0.7666512700931423, "bg": 4.694411678660948e-07}, {"x": 0.8790214477211796, "y": 0.7815013404825737, "term": "taken", "cat25k": 3, "ncat25k": 6, "cat": 16, "ncat": 37, "s": 0.2908847184986595, "os": 0.302261678676257, "bg": 1.213761129015869e-06}, {"x": 0.8791890080428955, "y": 0.9624664879356568, "term": "action", "cat25k": 15, "ncat25k": 6, "cat": 94, "ncat": 37, "s": 0.8416554959785524, "os": 0.8159991835657704, "bg": 1.6139413088025426e-06}, {"x": 0.8793565683646113, "y": 0.969671581769437, "term": "accordance", "cat25k": 18, "ncat25k": 6, "cat": 114, "ncat": 37, "s": 0.9369973190348525, "os": 0.848886622781094, "bg": 1.1839985497193923e-05}, {"x": 0.8795241286863271, "y": 0.7443029490616622, "term": "even", "cat25k": 2, "ncat25k": 6, "cat": 13, "ncat": 37, "s": 0.2439678284182306, "os": 0.261738549606992, "bg": 4.064880236352299e-07}, {"x": 0.8796916890080428, "y": 0.7260388739946381, "term": "counseling", "cat25k": 2, "ncat25k": 6, "cat": 12, "ncat": 37, "s": 0.2374329758713137, "os": 0.24764474941102538, "bg": 6.575120415279239e-06}, {"x": 0.8798592493297587, "y": 0.9361595174262735, "term": "republic", "cat25k": 10, "ncat25k": 6, "cat": 60, "ncat": 37, "s": 0.7432975871313673, "os": 0.7165636839021592, "bg": 3.504101189194407e-06}, {"x": 0.8800268096514745, "y": 0.9021447721179625, "term": "condition", "cat25k": 6, "ncat25k": 6, "cat": 40, "ncat": 37, "s": 0.6085790884718499, "os": 0.6083296774984038, "bg": 2.019008387105055e-06}, {"x": 0.8801943699731903, "y": 0.5924932975871313, "term": "multiple", "cat25k": 1, "ncat25k": 6, "cat": 7, "ncat": 37, "s": 0.18682975871313673, "os": 0.17319432981398192, "bg": 1.323639499021101e-06}, {"x": 0.8803619302949062, "y": 0.840985254691689, "term": "daily", "cat25k": 4, "ncat25k": 6, "cat": 23, "ncat": 37, "s": 0.3719839142091153, "os": 0.38641302301369684, "bg": 1.1304781487335057e-06}, {"x": 0.880529490616622, "y": 0.7709450402144772, "term": "reach", "cat25k": 2, "ncat25k": 6, "cat": 15, "ncat": 37, "s": 0.2691018766756032, "os": 0.2890512563614873, "bg": 2.888894746925459e-06}, {"x": 0.8806970509383378, "y": 0.9602882037533512, "term": "practice", "cat25k": 14, "ncat25k": 6, "cat": 90, "ncat": 37, "s": 0.8359584450402144, "os": 0.8077199462324333, "bg": 3.0112663804888717e-06}, {"x": 0.8808646112600537, "y": 0.9395107238605898, "term": "funding", "cat25k": 10, "ncat25k": 6, "cat": 62, "ncat": 37, "s": 0.7488270777479893, "os": 0.7247493531979511, "bg": 4.127254426746143e-06}, {"x": 0.8810321715817694, "y": 0.827245308310992, "term": "line", "cat25k": 3, "ncat25k": 6, "cat": 21, "ncat": 37, "s": 0.3597520107238606, "os": 0.3638323539803493, "bg": 4.138104057421017e-07}, {"x": 0.8811997319034852, "y": 0.9524128686327078, "term": "product", "cat25k": 12, "ncat25k": 6, "cat": 76, "ncat": 37, "s": 0.8068029490616622, "os": 0.7725961177995706, "bg": 5.658085049906e-07}, {"x": 0.881367292225201, "y": 0.4959785522788204, "term": "recall", "cat25k": 1, "ncat25k": 6, "cat": 5, "ncat": 37, "s": 0.061159517426273464, "os": 0.14189633764897125, "bg": 6.757784666248702e-06}, {"x": 0.8815348525469169, "y": 0.2488270777479893, "term": "de\ufb01ciency", "cat25k": 0, "ncat25k": 6, "cat": 2, "ncat": 37, "s": 0.023458445040214475, "os": 0.09409679032911372, "bg": 0.0}, {"x": 0.8817024128686327, "y": 0.8542225201072386, "term": "id", "cat25k": 4, "ncat25k": 6, "cat": 25, "ncat": 37, "s": 0.39929624664879354, "os": 0.4078745296324912, "bg": 1.0308734973563913e-06}, {"x": 0.8818699731903485, "y": 0.8791890080428955, "term": "maintenance", "cat25k": 5, "ncat25k": 6, "cat": 31, "ncat": 37, "s": 0.5350201072386059, "os": 0.5379391801000951, "bg": 2.5994556510502964e-06}, {"x": 0.8820375335120644, "y": 0.7885388739946381, "term": "ao", "cat25k": 3, "ncat25k": 6, "cat": 16, "ncat": 37, "s": 0.2908847184986595, "os": 0.302261678676257, "bg": 2.2494681387242757e-05}, {"x": 0.8822050938337802, "y": 0.618632707774799, "term": "very", "cat25k": 1, "ncat25k": 6, "cat": 7, "ncat": 37, "s": 0.18682975871313673, "os": 0.17319432981398192, "bg": 2.6250213473149367e-07}, {"x": 0.8823726541554959, "y": 0.028820375335120642, "term": "tigdas", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 37, "s": 0.014075067024128687, "os": 0.06223583927417037, "bg": 0.0002371840484111874}, {"x": 0.8825402144772118, "y": 0.9649798927613941, "term": "primary", "cat25k": 16, "ncat25k": 6, "cat": 101, "ncat": 38, "s": 0.8460120643431636, "os": 0.8247508177047926, "bg": 4.247424971873414e-06}, {"x": 0.8827077747989276, "y": 0.8833780160857909, "term": "designated", "cat25k": 5, "ncat25k": 6, "cat": 33, "ncat": 38, "s": 0.5502680965147453, "os": 0.5486068535018178, "bg": 3.7280962857002954e-06}, {"x": 0.8828753351206434, "y": 0.8324396782841823, "term": "recommendations", "cat25k": 4, "ncat25k": 6, "cat": 22, "ncat": 38, "s": 0.3605898123324397, "os": 0.3675815844306036, "bg": 3.330148139142359e-06}, {"x": 0.8830428954423593, "y": 0.8555630026809652, "term": "dissemination", "cat25k": 4, "ncat25k": 6, "cat": 26, "ncat": 38, "s": 0.4008042895442359, "os": 0.41017247817249997, "bg": 2.8409336817324196e-05}, {"x": 0.8832104557640751, "y": 0.8019436997319035, "term": "course", "cat25k": 3, "ncat25k": 6, "cat": 18, "ncat": 38, "s": 0.3011058981233244, "os": 0.32062115747696796, "bg": 6.281947312803087e-07}, {"x": 0.8833780160857909, "y": 0.9075067024128687, "term": "affected", "cat25k": 7, "ncat25k": 6, "cat": 43, "ncat": 38, "s": 0.6320375335120644, "os": 0.6219040473178716, "bg": 6.5817785168149e-06}, {"x": 0.8835455764075067, "y": 0.7908847184986595, "term": "rule", "cat25k": 3, "ncat25k": 6, "cat": 17, "ncat": 38, "s": 0.2945710455764075, "os": 0.30817345903672116, "bg": 1.889241207565882e-06}, {"x": 0.8837131367292225, "y": 0.7918900804289544, "term": "manual", "cat25k": 3, "ncat25k": 6, "cat": 17, "ncat": 38, "s": 0.2945710455764075, "os": 0.30817345903672116, "bg": 2.1995443423940296e-06}, {"x": 0.8838806970509383, "y": 0.8947721179624665, "term": "operations", "cat25k": 6, "ncat25k": 6, "cat": 37, "ncat": 38, "s": 0.5770777479892761, "os": 0.5802695783139051, "bg": 2.4016979428048123e-06}, {"x": 0.8840482573726541, "y": 0.922754691689008, "term": "resource", "cat25k": 8, "ncat25k": 6, "cat": 51, "ncat": 38, "s": 0.6829758713136729, "os": 0.668363149322489, "bg": 1.7750984384329395e-06}, {"x": 0.88421581769437, "y": 0.8130026809651475, "term": "projects", "cat25k": 3, "ncat25k": 6, "cat": 19, "ncat": 38, "s": 0.31367292225201077, "os": 0.3327837182832214, "bg": 1.2269213669324675e-06}, {"x": 0.8843833780160858, "y": 0.9458780160857909, "term": "professionals", "cat25k": 11, "ncat25k": 6, "cat": 69, "ncat": 38, "s": 0.7677613941018766, "os": 0.7451960014797595, "bg": 6.410487413622052e-06}, {"x": 0.8845509383378016, "y": 0.8651139410187667, "term": "clients", "cat25k": 4, "ncat25k": 6, "cat": 28, "ncat": 38, "s": 0.41504691689008044, "os": 0.42992311246837495, "bg": 3.0281614194479127e-06}, {"x": 0.8847184986595175, "y": 0.8966152815013405, "term": "reduction", "cat25k": 6, "ncat25k": 6, "cat": 37, "ncat": 38, "s": 0.5770777479892761, "os": 0.5802695783139051, "bg": 5.125351402634417e-06}, {"x": 0.8848860589812333, "y": 0.1807975871313673, "term": "suspect", "cat25k": 0, "ncat25k": 6, "cat": 1, "ncat": 38, "s": 0.018431635388739945, "os": 0.07571316968001934, "bg": 7.645766539067318e-06}, {"x": 0.885053619302949, "y": 0.05060321715817694, "term": "rubella", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 38, "s": 0.013572386058981234, "os": 0.06018795219698675, "bg": 8.837928668612562e-05}, {"x": 0.8852211796246648, "y": 0.7798257372654156, "term": "pre", "cat25k": 3, "ncat25k": 6, "cat": 16, "ncat": 39, "s": 0.26893431635388737, "os": 0.2888594774941554, "bg": 1.5461568149911767e-06}, {"x": 0.8853887399463807, "y": 0.8667895442359249, "term": "require", "cat25k": 5, "ncat25k": 6, "cat": 29, "ncat": 39, "s": 0.41538203753351205, "os": 0.4314739819511958, "bg": 2.527536769712854e-06}, {"x": 0.8855563002680965, "y": 0.9465482573726541, "term": "physical", "cat25k": 11, "ncat25k": 6, "cat": 70, "ncat": 39, "s": 0.7632372654155496, "os": 0.7433176242548456, "bg": 3.384981841746261e-06}, {"x": 0.8857238605898123, "y": 0.9713471849865952, "term": "ra", "cat25k": 19, "ncat25k": 6, "cat": 119, "ncat": 39, "s": 0.9364946380697051, "os": 0.847952702513338, "bg": 2.092850366166027e-05}, {"x": 0.8858914209115282, "y": 0.886896782841823, "term": "cause", "cat25k": 5, "ncat25k": 6, "cat": 34, "ncat": 39, "s": 0.5517761394101877, "os": 0.5504899114865769, "bg": 2.2048815170672176e-06}, {"x": 0.886058981233244, "y": 0.8899128686327078, "term": "11", "cat25k": 6, "ncat25k": 6, "cat": 35, "ncat": 39, "s": 0.5559651474530831, "os": 0.5585096749332332, "bg": 0.0}, {"x": 0.8862265415549598, "y": 0.8027815013404825, "term": "20", "cat25k": 3, "ncat25k": 6, "cat": 18, "ncat": 39, "s": 0.2980898123324397, "os": 0.31370541272915964, "bg": 0.0}, {"x": 0.8863941018766756, "y": 0.933813672922252, "term": "families", "cat25k": 9, "ncat25k": 6, "cat": 58, "ncat": 39, "s": 0.704088471849866, "os": 0.6964162588128258, "bg": 4.078787199117435e-06}, {"x": 0.8865616621983914, "y": 0.9292895442359249, "term": "prescribed", "cat25k": 9, "ncat25k": 6, "cat": 55, "ncat": 39, "s": 0.6965482573726542, "os": 0.6825145322528849, "bg": 1.8984190309641235e-05}, {"x": 0.8867292225201072, "y": 0.7290549597855228, "term": "does", "cat25k": 2, "ncat25k": 6, "cat": 12, "ncat": 39, "s": 0.2250335120643432, "os": 0.23594064330441572, "bg": 3.244988892498462e-07}, {"x": 0.886896782841823, "y": 0.8900804289544236, "term": "according", "cat25k": 6, "ncat25k": 6, "cat": 35, "ncat": 39, "s": 0.5559651474530831, "os": 0.5585096749332332, "bg": 2.031150269492469e-06}, {"x": 0.8870643431635389, "y": 0.8848860589812333, "term": "goals", "cat25k": 5, "ncat25k": 6, "cat": 33, "ncat": 39, "s": 0.5437332439678284, "os": 0.5422544078749557, "bg": 3.883620619673743e-06}, {"x": 0.8872319034852547, "y": 0.9048257372654156, "term": "fund", "cat25k": 7, "ncat25k": 6, "cat": 41, "ncat": 39, "s": 0.602044235924933, "os": 0.602462582500648, "bg": 2.3724495500085973e-06}, {"x": 0.8873994638069705, "y": 0.5723860589812333, "term": "28", "cat25k": 1, "ncat25k": 6, "cat": 6, "ncat": 39, "s": 0.07221849865951742, "os": 0.1493778665942997, "bg": 0.0}, {"x": 0.8875670241286864, "y": 0.5246313672922251, "term": "deliveries", "cat25k": 1, "ncat25k": 6, "cat": 5, "ncat": 39, "s": 0.0511058981233244, "os": 0.13431634437018947, "bg": 2.1319301356803946e-05}, {"x": 0.8877345844504021, "y": 0.1988941018766756, "term": "motherhood", "cat25k": 0, "ncat25k": 6, "cat": 1, "ncat": 39, "s": 0.018096514745308313, "os": 0.0733745671971992, "bg": 5.6810515626442456e-05}, {"x": 0.8879021447721179, "y": 0.016253351206434317, "term": "completed", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 39, "s": 0.012231903485254693, "os": 0.058196574327209205, "bg": 1.4150269769450743e-06}, {"x": 0.8880697050938338, "y": 0.024798927613941018, "term": "nih", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 39, "s": 0.012231903485254693, "os": 0.058196574327209205, "bg": 1.6563941912379294e-05}, {"x": 0.8882372654155496, "y": 0.053451742627345845, "term": "rash", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 39, "s": 0.012231903485254693, "os": 0.058196574327209205, "bg": 2.8461533689880938e-05}, {"x": 0.8884048257372654, "y": 0.6558310991957105, "term": "reactions", "cat25k": 1, "ncat25k": 6, "cat": 9, "ncat": 40, "s": 0.19470509383378018, "os": 0.1888296906790916, "bg": 1.0806799241098037e-05}, {"x": 0.8885723860589813, "y": 0.8971179624664879, "term": "communities", "cat25k": 6, "ncat25k": 6, "cat": 38, "ncat": 40, "s": 0.5707104557640751, "os": 0.5751469431976359, "bg": 3.6043337955044257e-06}, {"x": 0.8887399463806971, "y": 0.9301273458445041, "term": "chd", "cat25k": 9, "ncat25k": 6, "cat": 56, "ncat": 40, "s": 0.6957104557640751, "os": 0.6815241268214068, "bg": 0.00021644802034611393}, {"x": 0.8889075067024129, "y": 0.891588471849866, "term": "inconsistent", "cat25k": 6, "ncat25k": 6, "cat": 36, "ncat": 40, "s": 0.556970509383378, "os": 0.5601132273410664, "bg": 3.729955171828238e-05}, {"x": 0.8890750670241286, "y": 0.9001340482573726, "term": "definition", "cat25k": 6, "ncat25k": 6, "cat": 39, "ncat": 40, "s": 0.5779155495978552, "os": 0.582380294755333, "bg": 3.4103851581073984e-06}, {"x": 0.8892426273458445, "y": 0.9385053619302949, "term": "different", "cat25k": 10, "ncat25k": 6, "cat": 62, "ncat": 40, "s": 0.7223525469168901, "os": 0.7079799797698956, "bg": 1.1326645389711363e-06}, {"x": 0.8894101876675603, "y": 0.9490616621983914, "term": "mechanisms", "cat25k": 12, "ncat25k": 6, "cat": 72, "ncat": 40, "s": 0.7644101876675604, "os": 0.7448244094075445, "bg": 1.5866685838912057e-05}, {"x": 0.8895777479892761, "y": 0.8696380697050938, "term": "budget", "cat25k": 5, "ncat25k": 6, "cat": 29, "ncat": 40, "s": 0.4100201072386059, "os": 0.4237399219995507, "bg": 2.3225110545215024e-06}, {"x": 0.889745308310992, "y": 0.5338471849865952, "term": "collected", "cat25k": 1, "ncat25k": 6, "cat": 5, "ncat": 40, "s": 0.04758713136729223, "os": 0.1307308275086882, "bg": 4.2532751636518505e-06}, {"x": 0.8899128686327078, "y": 0.11678954423592493, "term": "bite", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 40, "s": 0.011561662198391423, "os": 0.056260433638937624, "bg": 1.2558479343970155e-05}, {"x": 0.8900804289544236, "y": 0.8756702412868632, "term": "bfad", "cat25k": 5, "ncat25k": 6, "cat": 31, "ncat": 41, "s": 0.42191689008042893, "os": 0.434282519790682, "bg": 0.00046149556611725195}, {"x": 0.8902479892761395, "y": 0.9242627345844504, "term": "basis", "cat25k": 8, "ncat25k": 6, "cat": 52, "ncat": 41, "s": 0.667225201072386, "os": 0.6559415353711223, "bg": 3.0890095613980096e-06}, {"x": 0.8904155495978552, "y": 0.9267761394101877, "term": "secretary", "cat25k": 9, "ncat25k": 6, "cat": 53, "ncat": 41, "s": 0.6702412868632708, "os": 0.6610999053952725, "bg": 4.058194158859824e-06}, {"x": 0.890583109919571, "y": 0.8863941018766756, "term": "repealing clause", "cat25k": 5, "ncat25k": 6, "cat": 34, "ncat": 41, "s": 0.5351876675603218, "os": 0.5382214528956673, "bg": 0.0}, {"x": 0.8907506702412868, "y": 0.8706434316353887, "term": "2003", "cat25k": 5, "ncat25k": 6, "cat": 30, "ncat": 41, "s": 0.4121983914209115, "os": 0.4253576975722554, "bg": 0.0}, {"x": 0.8909182305630027, "y": 0.8870643431635389, "term": "maintain", "cat25k": 5, "ncat25k": 6, "cat": 34, "ncat": 41, "s": 0.5351876675603218, "os": 0.5382214528956673, "bg": 4.510722121805194e-06}, {"x": 0.8910857908847185, "y": 0.8946045576407506, "term": "follows", "cat25k": 6, "ncat25k": 6, "cat": 37, "ncat": 41, "s": 0.5579758713136729, "os": 0.5616589414697686, "bg": 4.377116167316276e-06}, {"x": 0.8912533512064343, "y": 0.7582104557640751, "term": "prior", "cat25k": 2, "ncat25k": 6, "cat": 14, "ncat": 41, "s": 0.2384383378016086, "os": 0.2512009305150945, "bg": 1.738826078363422e-06}, {"x": 0.8914209115281502, "y": 0.931132707774799, "term": "respective", "cat25k": 9, "ncat25k": 6, "cat": 56, "ncat": 41, "s": 0.6903485254691689, "os": 0.6758726497708094, "bg": 4.141685878360521e-06}, {"x": 0.891588471849866, "y": 0.9128686327077749, "term": "measures", "cat25k": 7, "ncat25k": 6, "cat": 45, "ncat": 41, "s": 0.6288538873994638, "os": 0.6161957844720188, "bg": 4.2733883288596915e-06}, {"x": 0.8917560321715817, "y": 0.5464142091152815, "term": "sample", "cat25k": 1, "ncat25k": 6, "cat": 6, "ncat": 41, "s": 0.06099195710455765, "os": 0.1417193667426146, "bg": 1.357020070543389e-06}, {"x": 0.8919235924932976, "y": 0.9527479892761395, "term": "address", "cat25k": 12, "ncat25k": 6, "cat": 77, "ncat": 41, "s": 0.7871983914209115, "os": 0.7555054449857468, "bg": 9.001279749320157e-07}, {"x": 0.8920911528150134, "y": 0.8517091152815014, "term": "studies", "cat25k": 4, "ncat25k": 6, "cat": 25, "ncat": 41, "s": 0.3662868632707775, "os": 0.3774685477628021, "bg": 1.2184216379646372e-06}, {"x": 0.8922587131367292, "y": 0.8572386058981233, "term": "s", "cat25k": 4, "ncat25k": 6, "cat": 26, "ncat": 41, "s": 0.3729892761394102, "os": 0.387496459534112, "bg": 2.3698526237288338e-07}, {"x": 0.892426273458445, "y": 0.7156501340482574, "term": "some", "cat25k": 2, "ncat25k": 6, "cat": 11, "ncat": 41, "s": 0.20626675603217162, "os": 0.2116691620209205, "bg": 1.893865369987551e-07}, {"x": 0.8925938337801609, "y": 0.7649128686327078, "term": "field", "cat25k": 2, "ncat25k": 6, "cat": 14, "ncat": 41, "s": 0.2384383378016086, "os": 0.2512009305150945, "bg": 8.112025478957583e-07}, {"x": 0.8927613941018767, "y": 0.17962466487935658, "term": "woman", "cat25k": 0, "ncat25k": 6, "cat": 1, "ncat": 41, "s": 0.01675603217158177, "os": 0.06890894392308766, "bg": 1.184339562559953e-06}, {"x": 0.8929289544235925, "y": 0.017928954423592495, "term": "fortification", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 41, "s": 0.010388739946380699, "os": 0.054378281694800135, "bg": 0.00012851556683984925}, {"x": 0.8930965147453083, "y": 0.030998659517426273, "term": "unicef", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 41, "s": 0.010388739946380699, "os": 0.054378281694800135, "bg": 3.503233014126146e-05}, {"x": 0.8932640750670241, "y": 0.0635053619302949, "term": "sam", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 41, "s": 0.010388739946380699, "os": 0.054378281694800135, "bg": 3.608710829424337e-06}, {"x": 0.8934316353887399, "y": 0.11896782841823056, "term": "rig", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 41, "s": 0.010388739946380699, "os": 0.054378281694800135, "bg": 2.6166257207288132e-05}, {"x": 0.8935991957104558, "y": 0.7804959785522788, "term": "2000", "cat25k": 3, "ncat25k": 6, "cat": 16, "ncat": 42, "s": 0.2575402144772118, "os": 0.2704495282746344, "bg": 0.0}, {"x": 0.8937667560321716, "y": 0.8972855227882037, "term": "chds", "cat25k": 6, "ncat25k": 6, "cat": 38, "ncat": 42, "s": 0.5591487935656837, "os": 0.5631497718753419, "bg": 0.0005127597047786}, {"x": 0.8939343163538874, "y": 0.9195710455764075, "term": "protocols", "cat25k": 8, "ncat25k": 6, "cat": 49, "ncat": 42, "s": 0.6459450402144772, "os": 0.6339524123345893, "bg": 1.7114930519964754e-05}, {"x": 0.8941018766756033, "y": 0.9346514745308311, "term": "issuance", "cat25k": 9, "ncat25k": 6, "cat": 59, "ncat": 42, "s": 0.6983914209115282, "os": 0.6841811649170773, "bg": 4.0237296468001984e-05}, {"x": 0.8942694369973191, "y": 0.8760053619302949, "term": "approval", "cat25k": 5, "ncat25k": 6, "cat": 31, "ncat": 42, "s": 0.41303619302949063, "os": 0.4268777432562735, "bg": 4.129126145963308e-06}, {"x": 0.8944369973190348, "y": 0.931970509383378, "term": "issuances", "cat25k": 9, "ncat25k": 6, "cat": 57, "ncat": 42, "s": 0.6901809651474531, "os": 0.6750343006451033, "bg": 0.0004233736464872817}, {"x": 0.8946045576407506, "y": 0.8917560321715817, "term": "includes", "cat25k": 6, "ncat25k": 6, "cat": 36, "ncat": 42, "s": 0.5501005361930295, "os": 0.5481093456274697, "bg": 1.3832388655079157e-06}, {"x": 0.8947721179624665, "y": 0.7282171581769437, "term": "history", "cat25k": 2, "ncat25k": 6, "cat": 12, "ncat": 42, "s": 0.21246648793565687, "os": 0.21992760596398314, "bg": 5.015964561207182e-07}, {"x": 0.8949396782841823, "y": 0.900804289544236, "term": "accessible", "cat25k": 6, "ncat25k": 6, "cat": 39, "ncat": 42, "s": 0.5630026809651475, "os": 0.5703954490794612, "bg": 8.522977922172691e-06}, {"x": 0.8951072386058981, "y": 0.9705093833780161, "term": "percent", "cat25k": 19, "ncat25k": 6, "cat": 117, "ncat": 42, "s": 0.8892426273458446, "os": 0.8341780364730584, "bg": 3.3704854096774134e-06}, {"x": 0.895274798927614, "y": 0.8076407506702413, "term": "perform", "cat25k": 3, "ncat25k": 6, "cat": 18, "ncat": 42, "s": 0.28284182305630023, "os": 0.29432028235087326, "bg": 3.909945993545135e-06}, {"x": 0.8954423592493298, "y": 0.7754691689008043, "term": "indicators", "cat25k": 2, "ncat25k": 6, "cat": 15, "ncat": 42, "s": 0.23977882037533516, "os": 0.25816110420452526, "bg": 8.113883046062728e-06}, {"x": 0.8956099195710456, "y": 0.6950402144772118, "term": "midwife", "cat25k": 2, "ncat25k": 6, "cat": 10, "ncat": 42, "s": 0.19604557640750672, "os": 0.1933656550881216, "bg": 8.990628998236454e-05}, {"x": 0.8957774798927614, "y": 0.42845174262734587, "term": "nurses", "cat25k": 1, "ncat25k": 6, "cat": 4, "ncat": 42, "s": 0.030998659517426273, "os": 0.10969029924751106, "bg": 8.291793999030402e-06}, {"x": 0.8959450402144772, "y": 0.6960455764075067, "term": "infections", "cat25k": 2, "ncat25k": 6, "cat": 10, "ncat": 42, "s": 0.19604557640750672, "os": 0.1933656550881216, "bg": 1.2080842675948471e-05}, {"x": 0.896112600536193, "y": 0.2037533512064343, "term": "armm", "cat25k": 0, "ncat25k": 6, "cat": 1, "ncat": 42, "s": 0.0160857908847185, "os": 0.06677724655175471, "bg": 0.000245796451956797}, {"x": 0.8962801608579088, "y": 0.21615281501340483, "term": "endemic", "cat25k": 0, "ncat25k": 6, "cat": 1, "ncat": 42, "s": 0.0160857908847185, "os": 0.06677724655175471, "bg": 5.666222592942523e-05}, {"x": 0.8964477211796247, "y": 0.0008378016085790885, "term": "babies", "cat25k": 0, "ncat25k": 6, "cat": 0, "ncat": 42, "s": 0.01022117962466488, "os": 0.0525488933282835, "bg": 6.277040781784506e-06}, {"x": 0.8966152815013405, "y": 0.8795241286863271, "term": "objective", "cat25k": 5, "ncat25k": 6, "cat": 32, "ncat": 43, "s": 0.41353887399463807, "os": 0.4283085463154824, "bg": 6.583378155166272e-06}, {"x": 0.8967828418230563, "y": 0.8669571045576407, "term": "amount", "cat25k": 5, "ncat25k": 6, "cat": 29, "ncat": 43, "s": 0.39326407506702415, "os": 0.4017996200122432, "bg": 1.559256489333148e-06}, {"x": 0.8969504021447721, "y": 0.8941018766756033, "term": "repealing", "cat25k": 6, "ncat25k": 6, "cat": 37, "ncat": 43, "s": 0.5516085790884718, "os": 0.5499150408385637, "bg": 0.00019651891310302135}, {"x": 0.8971179624664879, "y": 0.8597520107238605, "term": "responsibility", "cat25k": 4, "ncat25k": 6, "cat": 27, "ncat": 43, "s": 0.37064343163538876, "os": 0.3831165446315682, "bg": 2.510740049237764e-06}, {"x": 0.8972855227882037, "y": 0.8763404825737265, "term": "provides", "cat25k": 5, "ncat25k": 6, "cat": 31, "ncat": 43, "s": 0.4061662198391421, "os": 0.41966908419572757, "bg": 1.3512807521141016e-06}, {"x": 0.8974530831099196, "y": 0.9405160857908847, "term": "approach", "cat25k": 10, "ncat25k": 7, "cat": 64, "ncat": 44, "s": 0.7035857908847185, "os": 0.6949035823097275, "bg": 3.3503741220080926e-06}, {"x": 0.8976206434316354, "y": 0.8001005361930295, "term": "therefore", "cat25k": 3, "ncat25k": 7, "cat": 18, "ncat": 44, "s": 0.2667560321715817, "os": 0.28243080498173323, "bg": 1.987354782062828e-06}, {"x": 0.8977882037533512, "y": 0.8890750670241286, "term": "2004", "cat25k": 6, "ncat25k": 7, "cat": 35, "ncat": 44, "s": 0.4296246648793566, "os": 0.44593590173517467, "bg": 0.0}, {"x": 0.897955764075067, "y": 0.8801943699731903, "term": "performance", "cat25k": 5, "ncat25k": 7, "cat": 32, "ncat": 44, "s": 0.4081769436997319, "os": 0.42124697201466954, "bg": 1.0855387928607226e-06}, {"x": 0.8981233243967829, "y": 0.9197386058981233, "term": "problems", "cat25k": 8, "ncat25k": 7, "cat": 49, "ncat": 44, "s": 0.6363941018766757, "os": 0.6227117221315583, "bg": 1.5321293706976302e-06}, {"x": 0.8982908847184986, "y": 0.9349865951742627, "term": "without", "cat25k": 9, "ncat25k": 7, "cat": 59, "ncat": 44, "s": 0.6896782841823056, "os": 0.6734531550277707, "bg": 9.384873265373032e-07}, {"x": 0.8984584450402144, "y": 0.9142091152815014, "term": "further", "cat25k": 7, "ncat25k": 7, "cat": 46, "ncat": 44, "s": 0.6050603217158177, "os": 0.6051039069300397, "bg": 1.638744463911515e-06}, {"x": 0.8986260053619303, "y": 0.9698391420911529, "term": "person", "cat25k": 18, "ncat25k": 7, "cat": 114, "ncat": 44, "s": 0.844671581769437, "os": 0.8223479349766948, "bg": 2.1487599720397366e-06}, {"x": 0.8987935656836461, "y": 0.9584450402144772, "term": "relevant", "cat25k": 14, "ncat25k": 7, "cat": 87, "ncat": 44, "s": 0.8056300268096516, "os": 0.7689738802882515, "bg": 5.751389767360016e-06}, {"x": 0.8989611260053619, "y": 0.9024798927613941, "term": "identify", "cat25k": 6, "ncat25k": 7, "cat": 40, "ncat": 44, "s": 0.5604892761394102, "os": 0.5659774192338848, "bg": 4.645226366304855e-06}, {"x": 0.8991286863270778, "y": 0.6325402144772118, "term": "sites", "cat25k": 1, "ncat25k": 7, "cat": 8, "ncat": 44, "s": 0.09416890080428955, "os": 0.1581266589009212, "bg": 5.121443635683685e-07}, {"x": 0.8992962466487936, "y": 0.7124664879356568, "term": "initial", "cat25k": 2, "ncat25k": 7, "cat": 11, "ncat": 44, "s": 0.1997319034852547, "os": 0.19741400942563436, "bg": 2.6388459376730017e-06}, {"x": 0.8994638069705094, "y": 0.40331769436997317, "term": "visit", "cat25k": 1, "ncat25k": 7, "cat": 4, "ncat": 44, "s": 0.029155495978552277, "os": 0.10391135213913527, "bg": 5.123434176447261e-07}, {"x": 0.8996313672922251, "y": 0.8537198391420912, "term": "countries", "cat25k": 4, "ncat25k": 7, "cat": 25, "ncat": 44, "s": 0.35254691689008044, "os": 0.3569526720008445, "bg": 1.6547844350688248e-06}, {"x": 0.899798927613941, "y": 0.7992627345844504, "term": "school", "cat25k": 3, "ncat25k": 7, "cat": 17, "ncat": 44, "s": 0.2577077747989276, "os": 0.2709151647597269, "bg": 3.55302550110663e-07}, {"x": 0.8999664879356568, "y": 0.5371983914209115, "term": "ml", "cat25k": 1, "ncat25k": 7, "cat": 5, "ncat": 44, "s": 0.0378686327077748, "os": 0.117600052219335, "bg": 4.8691260887527415e-06}, {"x": 0.9001340482573726, "y": 0.7650804289544236, "term": "rhu", "cat25k": 2, "ncat25k": 7, "cat": 14, "ncat": 44, "s": 0.22486595174262736, "os": 0.2350828848492012, "bg": 0.0003050135284017554}, {"x": 0.9003016085790885, "y": 0.8798592493297587, "term": "date", "cat25k": 5, "ncat25k": 7, "cat": 32, "ncat": 45, "s": 0.40298257372654156, "os": 0.4143668152009115, "bg": 3.147485822661067e-07}, {"x": 0.9004691689008043, "y": 0.9653150134048257, "term": "members", "cat25k": 16, "ncat25k": 7, "cat": 101, "ncat": 45, "s": 0.8270777479892761, "os": 0.7958999755711726, "bg": 1.2865235215976635e-06}, {"x": 0.9006367292225201, "y": 0.8604222520107239, "term": "identi\ufb01ed", "cat25k": 4, "ncat25k": 7, "cat": 27, "ncat": 45, "s": 0.36209785522788207, "os": 0.3697237166962389, "bg": 0.0}, {"x": 0.900804289544236, "y": 0.8949396782841823, "term": "examination", "cat25k": 6, "ncat25k": 7, "cat": 37, "ncat": 45, "s": 0.5356903485254692, "os": 0.5386713602358545, "bg": 7.4263755243689035e-06}, {"x": 0.9009718498659517, "y": 0.9252680965147453, "term": "reduce", "cat25k": 8, "ncat25k": 7, "cat": 52, "ncat": 45, "s": 0.6457774798927614, "os": 0.6337293703499491, "bg": 4.8327468521006585e-06}, {"x": 0.9011394101876675, "y": 0.23659517426273458, "term": "kg", "cat25k": 0, "ncat25k": 7, "cat": 2, "ncat": 45, "s": 0.018264075067024127, "os": 0.074217540972073, "bg": 4.843008221161019e-06}, {"x": 0.9013069705093834, "y": 0.9133713136729222, "term": "procurement", "cat25k": 7, "ncat25k": 7, "cat": 45, "ncat": 45, "s": 0.5893096514745308, "os": 0.5934198252979059, "bg": 1.6855386124589957e-05}, {"x": 0.9014745308310992, "y": 0.2017426273458445, "term": "birthing", "cat25k": 0, "ncat25k": 7, "cat": 1, "ncat": 45, "s": 0.013907506702412871, "os": 0.060761090688141395, "bg": 0.00011992877273758282}, {"x": 0.901642091152815, "y": 0.9115281501340483, "term": "rationale", "cat25k": 7, "ncat25k": 7, "cat": 45, "ncat": 46, "s": 0.5834450402144773, "os": 0.5879820938772801, "bg": 4.256458649790509e-05}, {"x": 0.9018096514745308, "y": 0.8832104557640751, "term": "serve", "cat25k": 5, "ncat25k": 7, "cat": 33, "ncat": 46, "s": 0.403485254691689, "os": 0.41599252969095135, "bg": 4.269128912886318e-06}, {"x": 0.9019772117962467, "y": 0.9539209115281502, "term": "current", "cat25k": 13, "ncat25k": 7, "cat": 79, "ncat": 46, "s": 0.761058981233244, "os": 0.7377828451180486, "bg": 1.1504873379227377e-06}, {"x": 0.9021447721179625, "y": 0.9435321715817694, "term": "availability", "cat25k": 11, "ncat25k": 7, "cat": 66, "ncat": 46, "s": 0.7027479892761394, "os": 0.6927984151436088, "bg": 2.7689881632678496e-06}, {"x": 0.9023123324396782, "y": 0.875837801608579, "term": "director", "cat25k": 5, "ncat25k": 7, "cat": 31, "ncat": 46, "s": 0.39192359249329756, "os": 0.39915577629551463, "bg": 1.4500439838828551e-06}, {"x": 0.9024798927613941, "y": 0.9654825737265416, "term": "of\ufb01ce", "cat25k": 16, "ncat25k": 7, "cat": 101, "ncat": 46, "s": 0.8238941018766756, "os": 0.7918852845397719, "bg": 0.0}, {"x": 0.9026474530831099, "y": 0.9808981233243967, "term": "persons", "cat25k": 26, "ncat25k": 7, "cat": 162, "ncat": 46, "s": 0.964142091152815, "os": 0.8688432752134276, "bg": 9.73133241543788e-06}, {"x": 0.9028150134048257, "y": 0.9351541554959786, "term": "protection", "cat25k": 9, "ncat25k": 7, "cat": 59, "ncat": 46, "s": 0.672754691689008, "os": 0.663019279981849, "bg": 2.382673687097443e-06}, {"x": 0.9029825737265416, "y": 0.9535857908847185, "term": "package", "cat25k": 13, "ncat25k": 7, "cat": 78, "ncat": 46, "s": 0.7582104557640751, "os": 0.7347298044672881, "bg": 3.149876362907366e-06}, {"x": 0.9031501340482574, "y": 0.9390080428954424, "term": "set", "cat25k": 10, "ncat25k": 7, "cat": 62, "ncat": 46, "s": 0.6905160857908847, "os": 0.6763266961730032, "bg": 6.883767609410538e-07}, {"x": 0.9033176943699732, "y": 0.8408176943699732, "term": "e.g.", "cat25k": 4, "ncat25k": 7, "cat": 23, "ncat": 46, "s": 0.30814343163538876, "os": 0.32439790235911153, "bg": 0.0}, {"x": 0.903485254691689, "y": 0.9254356568364611, "term": "ensuring", "cat25k": 8, "ncat25k": 7, "cat": 52, "ncat": 46, "s": 0.6404155495978553, "os": 0.628393904530927, "bg": 1.8329038789669976e-05}, {"x": 0.9036528150134048, "y": 0.6348860589812333, "term": "visits", "cat25k": 1, "ncat25k": 7, "cat": 8, "ncat": 46, "s": 0.07255361930294907, "os": 0.1507431964418416, "bg": 5.90161838222979e-06}, {"x": 0.9038203753351206, "y": 0.7136394101876675, "term": "since", "cat25k": 2, "ncat25k": 7, "cat": 11, "ncat": 46, "s": 0.19453753351206438, "os": 0.1887051869293364, "bg": 5.311838961444157e-07}, {"x": 0.9039879356568364, "y": 0.7865281501340483, "term": "nurse", "cat25k": 3, "ncat25k": 7, "cat": 16, "ncat": 46, "s": 0.2376005361930295, "os": 0.2486394743691127, "bg": 7.258181111520197e-06}, {"x": 0.9041554959785523, "y": 0.18230563002680966, "term": "iodine", "cat25k": 0, "ncat25k": 7, "cat": 1, "ncat": 46, "s": 0.012902144772117964, "os": 0.05887553072492846, "bg": 5.650763574456626e-05}, {"x": 0.9043230563002681, "y": 0.02329088471849866, "term": "nsrc", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 46, "s": 0.009383378016085792, "os": 0.04573526800334621, "bg": 0.0002731291396135223}, {"x": 0.9044906166219839, "y": 0.06333780160857909, "term": "pimam", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 46, "s": 0.009383378016085792, "os": 0.04573526800334621, "bg": 0.00029486895959333724}, {"x": 0.9046581769436998, "y": 0.09148793565683647, "term": "opv", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 46, "s": 0.009383378016085792, "os": 0.04573526800334621, "bg": 0.00023010930191841124}, {"x": 0.9048257372654156, "y": 0.9375, "term": "group", "cat25k": 10, "ncat25k": 7, "cat": 61, "ncat": 47, "s": 0.6821380697050938, "os": 0.6669240746525191, "bg": 6.704846025865017e-07}, {"x": 0.9049932975871313, "y": 0.9336461126005362, "term": "clause", "cat25k": 9, "ncat25k": 7, "cat": 58, "ncat": 47, "s": 0.6652144772117963, "os": 0.6532582247287193, "bg": 1.4769300363472483e-05}, {"x": 0.9051608579088471, "y": 0.9495643431635389, "term": "comprehensive", "cat25k": 12, "ncat25k": 7, "cat": 73, "ncat": 47, "s": 0.7255361930294907, "os": 0.7137574179548908, "bg": 6.3397343165275076e-06}, {"x": 0.905328418230563, "y": 0.974195710455764, "term": "professional", "cat25k": 20, "ncat25k": 7, "cat": 127, "ncat": 47, "s": 0.8491957104557641, "os": 0.8300827958457719, "bg": 2.8183902686232056e-06}, {"x": 0.9054959785522788, "y": 0.8255697050938338, "term": "selected", "cat25k": 3, "ncat25k": 7, "cat": 21, "ncat": 47, "s": 0.29004691689008044, "os": 0.29806592656045455, "bg": 2.305855370443973e-06}, {"x": 0.9056635388739946, "y": 0.5894772117962467, "term": "injection", "cat25k": 1, "ncat25k": 7, "cat": 7, "ncat": 47, "s": 0.051273458445040214, "os": 0.13454204759581878, "bg": 9.655560239296967e-06}, {"x": 0.9058310991957105, "y": 0.8064678284182306, "term": "logistics", "cat25k": 3, "ncat25k": 7, "cat": 18, "ncat": 47, "s": 0.2558646112600536, "os": 0.265972130324602, "bg": 1.2596008228100145e-05}, {"x": 0.9059986595174263, "y": 0.6771112600536193, "term": "0", "cat25k": 1, "ncat25k": 7, "cat": 9, "ncat": 47, "s": 0.09534182305630026, "os": 0.159815077972836, "bg": 0.0}, {"x": 0.9061662198391421, "y": 0.19922922252010725, "term": "std", "cat25k": 0, "ncat25k": 7, "cat": 1, "ncat": 47, "s": 0.01172922252010724, "os": 0.05704686227262962, "bg": 9.152651351484313e-06}, {"x": 0.9063337801608579, "y": 0.9210790884718498, "term": "process", "cat25k": 8, "ncat25k": 7, "cat": 50, "ncat": 48, "s": 0.6080764075067024, "os": 0.607004973177378, "bg": 1.1064617637976008e-06}, {"x": 0.9065013404825737, "y": 0.8378016085790885, "term": "expanded", "cat25k": 4, "ncat25k": 7, "cat": 23, "ncat": 48, "s": 0.2957439678284182, "os": 0.3127628921619109, "bg": 9.968555525415884e-06}, {"x": 0.9066689008042895, "y": 0.889745308310992, "term": "equipment", "cat25k": 6, "ncat25k": 7, "cat": 35, "ncat": 48, "s": 0.40566353887399464, "os": 0.4189988101103885, "bg": 1.1479128751830488e-06}, {"x": 0.9068364611260054, "y": 0.7448056300268097, "term": "onset", "cat25k": 2, "ncat25k": 7, "cat": 13, "ncat": 48, "s": 0.20207774798927614, "os": 0.20433418867967484, "bg": 2.9250583273413597e-05}, {"x": 0.9070040214477212, "y": 0.9364946380697051, "term": "make", "cat25k": 10, "ncat25k": 7, "cat": 60, "ncat": 48, "s": 0.6683981233243969, "os": 0.6574495242397627, "bg": 5.328114320376065e-07}, {"x": 0.907171581769437, "y": 0.8920911528150134, "term": "long", "cat25k": 6, "ncat25k": 7, "cat": 36, "ncat": 48, "s": 0.4128686327077748, "os": 0.4267592269989785, "bg": 6.644738265717539e-07}, {"x": 0.9073391420911529, "y": 0.9230898123324397, "term": "region", "cat25k": 8, "ncat25k": 7, "cat": 51, "ncat": 48, "s": 0.6132707774798928, "os": 0.6125492862407369, "bg": 1.9248642275629706e-06}, {"x": 0.9075067024128687, "y": 0.8066353887399463, "term": "directly", "cat25k": 3, "ncat25k": 7, "cat": 18, "ncat": 48, "s": 0.24329758713136732, "os": 0.2608222202464724, "bg": 2.258096687936683e-06}, {"x": 0.9076742627345844, "y": 0.9341487935656837, "term": "evidence", "cat25k": 9, "ncat25k": 7, "cat": 58, "ncat": 48, "s": 0.6591823056300268, "os": 0.6481997986125599, "bg": 3.401560289286657e-06}, {"x": 0.9078418230563002, "y": 0.3738270777479893, "term": "lt", "cat25k": 0, "ncat25k": 7, "cat": 3, "ncat": 48, "s": 0.01943699731903485, "os": 0.0807234543706491, "bg": 1.0361560560731086e-05}, {"x": 0.9080093833780161, "y": 0.0, "term": "antenatal", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 48, "s": 0.008880697050938339, "os": 0.04261483579415731, "bg": 0.00014160942056670321}, {"x": 0.9081769436997319, "y": 0.9922922252010724, "term": "drug", "cat25k": 56, "ncat25k": 7, "cat": 351, "ncat": 49, "s": 0.9906166219839143, "os": 0.9355308716006823, "bg": 1.0033011492300474e-05}, {"x": 0.9083445040214477, "y": 0.7432975871313673, "term": "barangays", "cat25k": 2, "ncat25k": 7, "cat": 13, "ncat": 49, "s": 0.20023458445040218, "os": 0.2001030995192717, "bg": 0.0003472173608680434}, {"x": 0.9085120643431636, "y": 0.9215817694369973, "term": "s.", "cat25k": 8, "ncat25k": 7, "cat": 50, "ncat": 49, "s": 0.6017091152815013, "os": 0.6018943257996808, "bg": 0.0}, {"x": 0.9086796246648794, "y": 0.9033176943699732, "term": "term", "cat25k": 7, "ncat25k": 7, "cat": 41, "ncat": 49, "s": 0.5489276139410187, "os": 0.5461155470230552, "bg": 1.5438071885683548e-06}, {"x": 0.9088471849865952, "y": 0.9559316353887399, "term": "required", "cat25k": 13, "ncat25k": 7, "cat": 83, "ncat": 49, "s": 0.760221179624665, "os": 0.7361207504641214, "bg": 1.6521575008504385e-06}, {"x": 0.909014745308311, "y": 0.899798927613941, "term": "result", "cat25k": 6, "ncat25k": 7, "cat": 39, "ncat": 49, "s": 0.4286193029490617, "os": 0.4426777061296619, "bg": 1.3778300413763926e-06}, {"x": 0.9091823056300268, "y": 0.9445375335120644, "term": "organization", "cat25k": 11, "ncat25k": 7, "cat": 67, "ncat": 49, "s": 0.6960455764075067, "os": 0.6821540413140368, "bg": 3.0560030338733565e-06}, {"x": 0.9093498659517426, "y": 0.863103217158177, "term": "14", "cat25k": 4, "ncat25k": 7, "cat": 28, "ncat": 49, "s": 0.3448391420911528, "os": 0.3541100137458747, "bg": 0.0}, {"x": 0.9095174262734584, "y": 0.8257372654155496, "term": "whether", "cat25k": 3, "ncat25k": 7, "cat": 21, "ncat": 49, "s": 0.26776139410187666, "os": 0.2871844959158422, "bg": 1.3291939953699235e-06}, {"x": 0.9096849865951743, "y": 0.8877345844504021, "term": "nationwide", "cat25k": 5, "ncat25k": 7, "cat": 34, "ncat": 49, "s": 0.3949396782841823, "os": 0.40478324041298175, "bg": 1.021874013522225e-05}, {"x": 0.9098525469168901, "y": 0.9187332439678284, "term": "increase", "cat25k": 8, "ncat25k": 7, "cat": 48, "ncat": 49, "s": 0.5869638069705094, "os": 0.5904189499839798, "bg": 2.3573695716932896e-06}, {"x": 0.9100201072386059, "y": 0.8269101876675603, "term": "anti", "cat25k": 3, "ncat25k": 7, "cat": 21, "ncat": 49, "s": 0.26776139410187666, "os": 0.2871844959158422, "bg": 2.2749702974190543e-06}, {"x": 0.9101876675603218, "y": 0.7734584450402144, "term": "addition", "cat25k": 2, "ncat25k": 7, "cat": 15, "ncat": 49, "s": 0.21531501340482576, "os": 0.22289498850134976, "bg": 1.7356755207768972e-06}, {"x": 0.9103552278820375, "y": 0.664544235924933, "term": "transport", "cat25k": 1, "ncat25k": 7, "cat": 9, "ncat": 49, "s": 0.07322386058981233, "os": 0.152729615795899, "bg": 2.4496700505620348e-06}, {"x": 0.9105227882037533, "y": 0.9165549597855228, "term": "place", "cat25k": 8, "ncat25k": 7, "cat": 47, "ncat": 49, "s": 0.5785857908847185, "os": 0.5844936877611593, "bg": 8.676699872156058e-07}, {"x": 0.9106903485254692, "y": 0.8160187667560321, "term": "important", "cat25k": 3, "ncat25k": 7, "cat": 19, "ncat": 49, "s": 0.25636729222520105, "os": 0.2664587912842553, "bg": 9.969543045994486e-07}, {"x": 0.910857908847185, "y": 0.4631367292225201, "term": "deficiency", "cat25k": 1, "ncat25k": 7, "cat": 4, "ncat": 49, "s": 0.02262064343163539, "os": 0.09104839078211346, "bg": 2.200495900434619e-05}, {"x": 0.9110254691689008, "y": 0.003183646112600536, "term": "maternity", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 49, "s": 0.007875335120643433, "os": 0.04112237088614218, "bg": 1.2247224472753861e-05}, {"x": 0.9111930294906166, "y": 0.0041890080428954425, "term": "obstetric", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 49, "s": 0.007875335120643433, "os": 0.04112237088614218, "bg": 0.0001265858755996683}, {"x": 0.9113605898123325, "y": 0.11762734584450402, "term": "schistosomiasis", "cat25k": 0, "ncat25k": 7, "cat": 0, "ncat": 49, "s": 0.007875335120643433, "os": 0.04112237088614218, "bg": 0.00020850930738739966}, {"x": 0.9115281501340483, "y": 0.7995978552278821, "term": "efforts", "cat25k": 3, "ncat25k": 8, "cat": 18, "ncat": 50, "s": 0.23810321715817695, "os": 0.250986253608637, "bg": 3.529297764724451e-06}, {"x": 0.911695710455764, "y": 0.8875670241286864, "term": "found", "cat25k": 5, "ncat25k": 8, "cat": 34, "ncat": 50, "s": 0.3835455764075067, "os": 0.39863814648051843, "bg": 7.231469236329085e-07}, {"x": 0.9118632707774799, "y": 0.9426943699731903, "term": "world", "cat25k": 10, "ncat25k": 8, "cat": 65, "ncat": 50, "s": 0.6834785522788205, "os": 0.6693350302394708, "bg": 5.321040083531445e-07}, {"x": 0.9120308310991957, "y": 0.75921581769437, "term": "expenses", "cat25k": 2, "ncat25k": 8, "cat": 14, "ncat": 50, "s": 0.2042560321715818, "os": 0.207318647518121, "bg": 5.211082849581321e-06}, {"x": 0.9121983914209115, "y": 0.8956099195710456, "term": "purpose", "cat25k": 6, "ncat25k": 8, "cat": 37, "ncat": 50, "s": 0.4093498659517426, "os": 0.4217186377438254, "bg": 2.692373323370933e-06}, {"x": 0.9123659517426274, "y": 0.9371648793565683, "term": "roles", "cat25k": 10, "ncat25k": 8, "cat": 60, "ncat": 50, "s": 0.6583445040214477, "os": 0.647623736441689, "bg": 1.6316148819296724e-05}, {"x": 0.9125335120643432, "y": 0.9083445040214477, "term": "utilization", "cat25k": 7, "ncat25k": 8, "cat": 43, "ncat": 50, "s": 0.5536193029490616, "os": 0.5544144826420474, "bg": 2.7971363339287528e-05}, {"x": 0.912701072386059, "y": 0.24011394101876676, "term": "parents", "cat25k": 0, "ncat25k": 8, "cat": 2, "ncat": 50, "s": 0.01457774798927614, "os": 0.06414894397114163, "bg": 1.695239106792859e-06}, {"x": 0.9128686327077749, "y": 0.10020107238605898, "term": "\u25a0", "cat25k": 0, "ncat25k": 8, "cat": 0, "ncat": 50, "s": 0.007540214477211796, "os": 0.03967366455186577, "bg": 0.0}, {"x": 0.9130361930294906, "y": 0.8448391420911529, "term": "death", "cat25k": 4, "ncat25k": 8, "cat": 24, "ncat": 51, "s": 0.29406836461126007, "os": 0.3060720949225271, "bg": 1.7957864456984169e-06}, {"x": 0.9132037533512064, "y": 0.8838806970509383, "term": "c", "cat25k": 5, "ncat25k": 8, "cat": 33, "ncat": 51, "s": 0.3714812332439678, "os": 0.3846886874429018, "bg": 2.814375454571893e-07}, {"x": 0.9133713136729222, "y": 0.9123659517426274, "term": "apply", "cat25k": 7, "ncat25k": 8, "cat": 45, "ncat": 51, "s": 0.5584785522788205, "os": 0.5622330905135281, "bg": 2.5047769815065663e-06}, {"x": 0.9135388739946381, "y": 0.9224195710455764, "term": "central", "cat25k": 8, "ncat25k": 8, "cat": 51, "ncat": 51, "s": 0.5990281501340483, "os": 0.597498085590402, "bg": 1.7870594765893765e-06}, {"x": 0.9137064343163539, "y": 0.9096849865951743, "term": "priority", "cat25k": 7, "ncat25k": 8, "cat": 44, "ncat": 51, "s": 0.5547922252010724, "os": 0.5559112446893816, "bg": 5.717884456180887e-06}, {"x": 0.9138739946380697, "y": 0.9038203753351206, "term": "full", "cat25k": 7, "ncat25k": 8, "cat": 41, "ncat": 51, "s": 0.4287868632707775, "os": 0.4442745603946582, "bg": 5.930868736762478e-07}, {"x": 0.9140415549597856, "y": 0.8765080428954424, "term": "either", "cat25k": 5, "ncat25k": 8, "cat": 31, "ncat": 51, "s": 0.3612600536193029, "os": 0.36832890341991353, "bg": 1.648986150024559e-06}, {"x": 0.9142091152815014, "y": 0.5931635388739946, "term": "continue", "cat25k": 1, "ncat25k": 8, "cat": 7, "ncat": 51, "s": 0.04121983914209116, "os": 0.12245820536960661, "bg": 1.5070576157740499e-06}, {"x": 0.9143766756032171, "y": 0.4897788203753351, "term": "nutritional", "cat25k": 1, "ncat25k": 8, "cat": 5, "ncat": 51, "s": 0.027144772117962464, "os": 0.0985114727668901, "bg": 1.5676115772034002e-05}, {"x": 0.914544235924933, "y": 0.8295911528150134, "term": "signs", "cat25k": 3, "ncat25k": 8, "cat": 21, "ncat": 51, "s": 0.2603887399463807, "os": 0.2769260588785502, "bg": 4.47045365418607e-06}, {"x": 0.9147117962466488, "y": 0.2664209115281501, "term": "skin", "cat25k": 0, "ncat25k": 8, "cat": 2, "ncat": 51, "s": 0.014242627345844505, "os": 0.0623185450957815, "bg": 1.9237179762661114e-06}, {"x": 0.9148793565683646, "y": 0.028150134048257374, "term": "vaccinated", "cat25k": 0, "ncat25k": 8, "cat": 0, "ncat": 51, "s": 0.007205093833780161, "os": 0.03826768529060004, "bg": 0.00010159787560834218}, {"x": 0.9150469168900804, "y": 0.926441018766756, "term": "prevalence", "cat25k": 9, "ncat25k": 8, "cat": 53, "ncat": 52, "s": 0.603887399463807, "os": 0.6034671430980783, "bg": 4.435987433903788e-05}, {"x": 0.9152144772117963, "y": 0.9239276139410187, "term": "specific", "cat25k": 8, "ncat25k": 8, "cat": 52, "ncat": 52, "s": 0.5995308310991958, "os": 0.5981099280560835, "bg": 1.9241827588784385e-06}, {"x": 0.9153820375335121, "y": 0.824396782841823, "term": "immediate", "cat25k": 3, "ncat25k": 8, "cat": 21, "ncat": 52, "s": 0.2578753351206434, "os": 0.27201591343118403, "bg": 5.877037324299226e-06}, {"x": 0.9155495978552279, "y": 0.9334785522788204, "term": "vii", "cat25k": 9, "ncat25k": 8, "cat": 58, "ncat": 52, "s": 0.6407506702412868, "os": 0.6286758857322168, "bg": 2.4518394646965763e-05}, {"x": 0.9157171581769437, "y": 0.9470509383378016, "term": "limited", "cat25k": 11, "ncat25k": 8, "cat": 71, "ncat": 53, "s": 0.6943699731903485, "os": 0.6790497213646838, "bg": 2.329359177322937e-06}, {"x": 0.9158847184986595, "y": 0.9443699731903485, "term": "various", "cat25k": 11, "ncat25k": 8, "cat": 67, "ncat": 53, "s": 0.6732573726541555, "os": 0.6635688733763119, "bg": 2.623862260525558e-06}, {"x": 0.9160522788203753, "y": 0.9359919571045576, "term": "lead", "cat25k": 10, "ncat25k": 8, "cat": 60, "ncat": 53, "s": 0.6456099195710456, "os": 0.633386716728185, "bg": 3.2926602857921317e-06}, {"x": 0.9162198391420912, "y": 0.9778820375335121, "term": "free", "cat25k": 24, "ncat25k": 8, "cat": 147, "ncat": 53, "s": 0.8900804289544236, "os": 0.8348405627210229, "bg": 3.9431419708166427e-07}, {"x": 0.916387399463807, "y": 0.9177278820375335, "term": "speci\ufb01c", "cat25k": 8, "ncat25k": 8, "cat": 48, "ncat": 53, "s": 0.5631702412868633, "os": 0.5707564068566878, "bg": 0.0}, {"x": 0.9165549597855228, "y": 0.965985254691689, "term": "establish", "cat25k": 17, "ncat25k": 8, "cat": 104, "ncat": 53, "s": 0.8064678284182306, "os": 0.77084828132992, "bg": 1.2422160723295737e-05}, {"x": 0.9167225201072386, "y": 0.155328418230563, "term": "missed", "cat25k": 0, "ncat25k": 8, "cat": 1, "ncat": 53, "s": 0.009886058981233245, "os": 0.04717927256284499, "bg": 5.755989840251563e-06}, {"x": 0.9168900804289544, "y": 0.9061662198391421, "term": "basic", "cat25k": 7, "ncat25k": 8, "cat": 42, "ncat": 53, "s": 0.4267761394101877, "os": 0.43905963247611735, "bg": 2.23129673641849e-06}, {"x": 0.9170576407506702, "y": 0.8262399463806971, "term": "goal", "cat25k": 3, "ncat25k": 8, "cat": 21, "ncat": 53, "s": 0.2565348525469169, "os": 0.2672446377133207, "bg": 3.4111710319668213e-06}, {"x": 0.917225201072386, "y": 0.9204088471849866, "term": "institutions", "cat25k": 8, "ncat25k": 8, "cat": 49, "ncat": 53, "s": 0.573558981233244, "os": 0.5765752421926874, "bg": 5.822064356756925e-06}, {"x": 0.9173927613941019, "y": 0.8205428954423593, "term": "symptoms", "cat25k": 3, "ncat25k": 8, "cat": 20, "ncat": 53, "s": 0.23944369973190352, "os": 0.25741650309008857, "bg": 7.110088816697138e-06}, {"x": 0.9175603217158177, "y": 0.7397788203753352, "term": "province", "cat25k": 2, "ncat25k": 8, "cat": 12, "ncat": 53, "s": 0.1871648793565684, "os": 0.17349101589385724, "bg": 6.220111764882072e-06}, {"x": 0.9177278820375335, "y": 0.3049597855227882, "term": "emergencies", "cat25k": 0, "ncat25k": 8, "cat": 2, "ncat": 53, "s": 0.012734584450402146, "os": 0.058825417397370794, "bg": 2.580550717674614e-05}, {"x": 0.9178954423592494, "y": 0.07506702412868632, "term": "bemonc", "cat25k": 0, "ncat25k": 8, "cat": 0, "ncat": 53, "s": 0.006534852546916889, "os": 0.03557988008227492, "bg": 0.00033973270087497197}, {"x": 0.9180630026809652, "y": 0.9560991957104558, "term": "responsibilities", "cat25k": 13, "ncat25k": 8, "cat": 83, "ncat": 54, "s": 0.7414544235924934, "os": 0.7148017432536036, "bg": 1.6099288188187282e-05}, {"x": 0.9182305630026809, "y": 0.8776809651474531, "term": "timely", "cat25k": 5, "ncat25k": 8, "cat": 31, "ncat": 54, "s": 0.34400134048257375, "os": 0.35162463012803513, "bg": 1.7179414937844876e-05}, {"x": 0.9183981233243967, "y": 0.9353217158176944, "term": "improve", "cat25k": 9, "ncat25k": 8, "cat": 59, "ncat": 54, "s": 0.6389075067024128, "os": 0.6240955398817845, "bg": 3.6677782306780633e-06}, {"x": 0.9185656836461126, "y": 0.8123324396782842, "term": "loss", "cat25k": 3, "ncat25k": 8, "cat": 19, "ncat": 54, "s": 0.2282171581769437, "os": 0.24301875214462493, "bg": 1.752113270618719e-06}, {"x": 0.9187332439678284, "y": 0.9500670241286864, "term": "lgu", "cat25k": 12, "ncat25k": 8, "cat": 73, "ncat": 54, "s": 0.6958780160857909, "os": 0.6819620795134649, "bg": 0.0006802101688742254}, {"x": 0.9189008042895442, "y": 0.9070040214477212, "term": "room", "cat25k": 7, "ncat25k": 8, "cat": 42, "ncat": 54, "s": 0.4168900804289544, "os": 0.43322693588910055, "bg": 1.0871291059464955e-06}, {"x": 0.9190683646112601, "y": 0.8362935656836461, "term": "deaths", "cat25k": 4, "ncat25k": 8, "cat": 22, "ncat": 54, "s": 0.25804289544235925, "os": 0.2721791012957552, "bg": 1.3154709684644396e-05}, {"x": 0.9192359249329759, "y": 0.837298927613941, "term": "rate", "cat25k": 4, "ncat25k": 8, "cat": 23, "ncat": 55, "s": 0.25988605898123324, "os": 0.2768969057505217, "bg": 7.501939900670661e-07}, {"x": 0.9194034852546917, "y": 0.7419571045576407, "term": "preparation", "cat25k": 2, "ncat25k": 8, "cat": 13, "ncat": 55, "s": 0.18867292225201074, "os": 0.17734530859188175, "bg": 5.316445799616903e-06}, {"x": 0.9195710455764075, "y": 0.9408512064343163, "term": "v.", "cat25k": 10, "ncat25k": 8, "cat": 64, "ncat": 55, "s": 0.6553284182305631, "os": 0.6420889449448149, "bg": 0.0}, {"x": 0.9197386058981233, "y": 0.9519101876675603, "term": "her", "cat25k": 12, "ncat25k": 8, "cat": 76, "ncat": 55, "s": 0.7007372654155496, "os": 0.6881831912672624, "bg": 6.679019470690306e-07}, {"x": 0.9199061662198391, "y": 0.8937667560321716, "term": "like", "cat25k": 6, "ncat25k": 8, "cat": 37, "ncat": 55, "s": 0.37717828418230565, "os": 0.39254893907980115, "bg": 3.532365924789448e-07}, {"x": 0.920073726541555, "y": 0.9316353887399463, "term": "same", "cat25k": 9, "ncat25k": 8, "cat": 57, "ncat": 55, "s": 0.6097520107238605, "os": 0.6098776880259826, "bg": 9.526456274709726e-07}, {"x": 0.9202412868632708, "y": 0.8398123324396782, "term": "additional", "cat25k": 4, "ncat25k": 8, "cat": 23, "ncat": 55, "s": 0.25988605898123324, "os": 0.2768969057505217, "bg": 1.1773608275162084e-06}, {"x": 0.9204088471849866, "y": 0.8399798927613941, "term": "intervention", "cat25k": 4, "ncat25k": 8, "cat": 23, "ncat": 55, "s": 0.25988605898123324, "os": 0.2768969057505217, "bg": 1.2663824017007191e-05}, {"x": 0.9205764075067024, "y": 0.9690013404825737, "term": "objectives", "cat25k": 18, "ncat25k": 8, "cat": 111, "ncat": 55, "s": 0.8093163538873995, "os": 0.7772083681401392, "bg": 1.2797420533414989e-05}, {"x": 0.9207439678284183, "y": 0.774798927613941, "term": "revised", "cat25k": 2, "ncat25k": 8, "cat": 15, "ncat": 55, "s": 0.19989946380697052, "os": 0.1983257627996124, "bg": 5.182424680305476e-06}, {"x": 0.920911528150134, "y": 0.8932640750670241, "term": "municipal", "cat25k": 6, "ncat25k": 8, "cat": 36, "ncat": 55, "s": 0.3718163538873994, "os": 0.38517767555966065, "bg": 1.1016371659935986e-05}, {"x": 0.9210790884718498, "y": 0.7997654155495979, "term": "trained", "cat25k": 3, "ncat25k": 8, "cat": 18, "ncat": 56, "s": 0.2164879356568365, "os": 0.22477664485544335, "bg": 1.0632082322776657e-05}, {"x": 0.9212466487935657, "y": 0.9453753351206434, "term": "known", "cat25k": 11, "ncat25k": 8, "cat": 68, "ncat": 56, "s": 0.6662198391420912, "os": 0.6542561416625312, "bg": 2.8601863524432106e-06}, {"x": 0.9214142091152815, "y": 0.772955764075067, "term": "until", "cat25k": 2, "ncat25k": 8, "cat": 15, "ncat": 56, "s": 0.1968833780160858, "os": 0.19464800210654742, "bg": 1.2521812424061159e-06}, {"x": 0.9215817694369973, "y": 0.8208780160857909, "term": "table", "cat25k": 3, "ncat25k": 8, "cat": 20, "ncat": 56, "s": 0.2345844504021448, "os": 0.24420485393146485, "bg": 9.175780394840471e-07}, {"x": 0.9217493297587132, "y": 0.8739946380697051, "term": "network", "cat25k": 5, "ncat25k": 8, "cat": 30, "ncat": 56, "s": 0.3331099195710456, "os": 0.33303840059778433, "bg": 7.626444882082171e-07}, {"x": 0.921916890080429, "y": 0.49983243967828417, "term": "administered", "cat25k": 1, "ncat25k": 8, "cat": 5, "ncat": 56, "s": 0.0217828418230563, "os": 0.08730261617242113, "bg": 1.5862519285312892e-05}, {"x": 0.9220844504021448, "y": 0.9297922252010724, "term": "effectivity", "cat25k": 9, "ncat25k": 9, "cat": 56, "ncat": 57, "s": 0.5978552278820375, "os": 0.5959201719911618, "bg": 0.000579105563769516}, {"x": 0.9222520107238605, "y": 0.9118632707774799, "term": "particularly", "cat25k": 7, "ncat25k": 9, "cat": 45, "ncat": 57, "s": 0.42560321715817695, "os": 0.4358790129681268, "bg": 4.803134808313247e-06}, {"x": 0.9224195710455764, "y": 0.8704758713136729, "term": "adverse", "cat25k": 5, "ncat25k": 9, "cat": 30, "ncat": 57, "s": 0.31233243967828417, "os": 0.32805459016133165, "bg": 1.5170566868284083e-05}, {"x": 0.9225871313672922, "y": 0.941186327077748, "term": "over", "cat25k": 10, "ncat25k": 9, "cat": 64, "ncat": 57, "s": 0.6454423592493298, "os": 0.6332704204794112, "bg": 5.266193767253816e-07}, {"x": 0.922754691689008, "y": 0.8865616621983914, "term": "prevent", "cat25k": 5, "ncat25k": 9, "cat": 34, "ncat": 57, "s": 0.3540549597855228, "os": 0.3595220714092443, "bg": 4.845614979361408e-06}, {"x": 0.9229222520107239, "y": 0.9363270777479893, "term": "component", "cat25k": 10, "ncat25k": 9, "cat": 60, "ncat": 57, "s": 0.6285187667560322, "os": 0.6153046910179406, "bg": 5.840592557567527e-06}, {"x": 0.9230898123324397, "y": 0.806132707774799, "term": "because", "cat25k": 3, "ncat25k": 9, "cat": 18, "ncat": 57, "s": 0.21414209115281502, "os": 0.2208367444592214, "bg": 5.522095379854964e-07}, {"x": 0.9232573726541555, "y": 0.7848525469168901, "term": "severe", "cat25k": 3, "ncat25k": 9, "cat": 16, "ncat": 57, "s": 0.20040214477211798, "os": 0.20111968647531697, "bg": 7.91331902106607e-06}, {"x": 0.9234249329758714, "y": 0.7186662198391421, "term": "contact", "cat25k": 2, "ncat25k": 9, "cat": 11, "ncat": 57, "s": 0.07238605898123325, "os": 0.1497878687562615, "bg": 2.1048193570591246e-07}, {"x": 0.9235924932975871, "y": 0.3383042895442359, "term": "animal", "cat25k": 0, "ncat25k": 9, "cat": 3, "ncat": 57, "s": 0.014410187667560323, "os": 0.0633987267395304, "bg": 1.908437100227156e-06}, {"x": 0.9237600536193029, "y": 0.18213806970509383, "term": "stool", "cat25k": 0, "ncat25k": 9, "cat": 1, "ncat": 57, "s": 0.008378016085790885, "os": 0.04154722105983266, "bg": 3.468941016040862e-05}, {"x": 0.9239276139410187, "y": 0.9634718498659517, "term": "strategies", "cat25k": 16, "ncat25k": 9, "cat": 97, "ncat": 58, "s": 0.7605563002680966, "os": 0.7365654250884682, "bg": 8.339391273397338e-06}, {"x": 0.9240951742627346, "y": 0.9289544235924933, "term": "regular", "cat25k": 9, "ncat25k": 9, "cat": 55, "ncat": 58, "s": 0.582774798927614, "os": 0.5864385514022992, "bg": 3.609026379379863e-06}, {"x": 0.9242627345844504, "y": 0.8103217158176944, "term": "month", "cat25k": 3, "ncat25k": 9, "cat": 19, "ncat": 58, "s": 0.2168230563002681, "os": 0.22656502264993078, "bg": 1.2485811881445076e-06}, {"x": 0.9244302949061662, "y": 0.9031501340482574, "term": "submit", "cat25k": 7, "ncat25k": 9, "cat": 41, "ncat": 58, "s": 0.3942694369973191, "os": 0.4044190814374454, "bg": 2.1349178593049236e-06}, {"x": 0.9245978552278821, "y": 0.9787198391420912, "term": "social", "cat25k": 24, "ncat25k": 9, "cat": 151, "ncat": 58, "s": 0.8461796246648794, "os": 0.8247853199879432, "bg": 2.9883068339982185e-06}, {"x": 0.9247654155495979, "y": 0.903485254691689, "term": "while", "cat25k": 7, "ncat25k": 9, "cat": 41, "ncat": 58, "s": 0.3942694369973191, "os": 0.4044190814374454, "bg": 8.741449885221452e-07}, {"x": 0.9249329758713136, "y": 0.8984584450402144, "term": "involved", "cat25k": 6, "ncat25k": 9, "cat": 38, "ncat": 58, "s": 0.37081099195710454, "os": 0.38371236029861017, "bg": 3.2149949507834507e-06}, {"x": 0.9251005361930295, "y": 0.8210455764075067, "term": "storage", "cat25k": 3, "ncat25k": 9, "cat": 20, "ncat": 58, "s": 0.225201072386059, "os": 0.23599737652689795, "bg": 1.911003442672702e-06}, {"x": 0.9252680965147453, "y": 0.7360924932975871, "term": "x", "cat25k": 2, "ncat25k": 9, "cat": 12, "ncat": 58, "s": 0.08277479892761394, "os": 0.15720512716146062, "bg": 2.7509151459591367e-07}, {"x": 0.9254356568364611, "y": 0.9509048257372654, "term": "advocacy", "cat25k": 12, "ncat25k": 9, "cat": 74, "ncat": 59, "s": 0.6742627345844504, "os": 0.6643923977960894, "bg": 2.7168190093987638e-05}, {"x": 0.925603217158177, "y": 0.9820710455764075, "term": "organizations", "cat25k": 28, "ncat25k": 9, "cat": 175, "ncat": 59, "s": 0.9354892761394102, "os": 0.8452671705640753, "bg": 8.593593274227897e-06}, {"x": 0.9257707774798928, "y": 0.33679624664879354, "term": "virus", "cat25k": 0, "ncat25k": 9, "cat": 3, "ncat": 59, "s": 0.013404825737265418, "os": 0.06017116157462088, "bg": 3.38816125090039e-06}, {"x": 0.9259383378016086, "y": 0.875, "term": "supplies", "cat25k": 5, "ncat25k": 9, "cat": 31, "ncat": 60, "s": 0.3031166219839142, "os": 0.32170205484268144, "bg": 2.3367230196952884e-06}, {"x": 0.9261058981233244, "y": 0.8319369973190348, "term": "complications", "cat25k": 4, "ncat25k": 9, "cat": 22, "ncat": 60, "s": 0.23709785522788204, "os": 0.246325338478385, "bg": 2.1653352275615485e-05}, {"x": 0.9262734584450402, "y": 0.9587801608579088, "term": "issued", "cat25k": 14, "ncat25k": 9, "cat": 88, "ncat": 60, "s": 0.7200067024128687, "os": 0.7054015822899851, "bg": 8.717027328764158e-06}, {"x": 0.926441018766756, "y": 0.6702412868632708, "term": "con\ufb01rmed", "cat25k": 1, "ncat25k": 9, "cat": 9, "ncat": 60, "s": 0.04054959785522789, "os": 0.12093710153468767, "bg": 0.0}, {"x": 0.9266085790884718, "y": 0.0832774798927614, "term": "afp", "cat25k": 0, "ncat25k": 9, "cat": 0, "ncat": 60, "s": 0.005697050938337802, "os": 0.02737585478414778, "bg": 3.458043842232513e-05}, {"x": 0.9267761394101877, "y": 0.9802278820375335, "term": "access", "cat25k": 26, "ncat25k": 9, "cat": 159, "ncat": 61, "s": 0.8465147453083111, "os": 0.8250669899661014, "bg": 2.0155826434898663e-06}, {"x": 0.9269436997319035, "y": 0.8493632707774799, "term": "mg", "cat25k": 4, "ncat25k": 9, "cat": 25, "ncat": 61, "s": 0.2567024128686327, "os": 0.26838503024182914, "bg": 5.7780054043162644e-06}, {"x": 0.9271112600536193, "y": 0.8992962466487936, "term": "approved", "cat25k": 6, "ncat25k": 9, "cat": 39, "ncat": 61, "s": 0.36511394101876676, "os": 0.375576990944629, "bg": 3.8074912619027405e-06}, {"x": 0.9272788203753352, "y": 0.8892426273458445, "term": "12", "cat25k": 6, "ncat25k": 9, "cat": 35, "ncat": 61, "s": 0.3426608579088472, "os": 0.3472594491573159, "bg": 0.0}, {"x": 0.927446380697051, "y": 0.9547587131367292, "term": "terms", "cat25k": 13, "ncat25k": 9, "cat": 81, "ncat": 61, "s": 0.6952077747989276, "os": 0.6802994190624895, "bg": 1.0215165593823097e-06}, {"x": 0.9276139410187667, "y": 0.9003016085790885, "term": "protocol", "cat25k": 6, "ncat25k": 9, "cat": 39, "ncat": 61, "s": 0.36511394101876676, "os": 0.375576990944629, "bg": 6.327323251524102e-06}, {"x": 0.9277815013404825, "y": 0.9416890080428955, "term": "them", "cat25k": 10, "ncat25k": 9, "cat": 64, "ncat": 61, "s": 0.6291890080428955, "os": 0.616309967078506, "bg": 6.19866739411913e-07}, {"x": 0.9279490616621984, "y": 0.7205093833780161, "term": "continuity", "cat25k": 2, "ncat25k": 9, "cat": 11, "ncat": 61, "s": 0.05479222520107239, "os": 0.13862244626840642, "bg": 2.2650088689253527e-05}, {"x": 0.9281166219839142, "y": 0.36662198391420914, "term": "door", "cat25k": 0, "ncat25k": 9, "cat": 3, "ncat": 61, "s": 0.011896782841823057, "os": 0.05713925421187971, "bg": 2.2475516612040623e-06}, {"x": 0.92828418230563, "y": 0.3699731903485255, "term": "formula", "cat25k": 0, "ncat25k": 9, "cat": 3, "ncat": 61, "s": 0.011896782841823057, "os": 0.05713925421187971, "bg": 6.169805185509172e-06}, {"x": 0.9284517426273459, "y": 0.9266085790884718, "term": "between", "cat25k": 9, "ncat25k": 9, "cat": 53, "ncat": 62, "s": 0.5566353887399463, "os": 0.5590123319829791, "bg": 8.99320063201086e-07}, {"x": 0.9286193029490617, "y": 0.9639745308310992, "term": "cost", "cat25k": 16, "ncat25k": 9, "cat": 98, "ncat": 62, "s": 0.7486595174262736, "os": 0.7243031615310005, "bg": 2.010058167754216e-06}, {"x": 0.9287868632707775, "y": 0.9525804289544236, "term": "made", "cat25k": 12, "ncat25k": 9, "cat": 77, "ncat": 62, "s": 0.6725871313672923, "os": 0.6629732137051791, "bg": 9.664014980307815e-07}, {"x": 0.9289544235924933, "y": 0.9671581769436998, "term": "diagnosis", "cat25k": 17, "ncat25k": 9, "cat": 108, "ncat": 62, "s": 0.7816689008042896, "os": 0.7468408630937168, "bg": 2.0057960426352005e-05}, {"x": 0.9291219839142091, "y": 0.9056635388739946, "term": "body", "cat25k": 7, "ncat25k": 9, "cat": 42, "ncat": 62, "s": 0.3760053619302949, "os": 0.3907385975015903, "bg": 1.5196579851893692e-06}, {"x": 0.9292895442359249, "y": 0.23240616621983914, "term": "specimens", "cat25k": 0, "ncat25k": 9, "cat": 2, "ncat": 62, "s": 0.009215817694369974, "os": 0.045551683874229365, "bg": 3.069841042191847e-05}, {"x": 0.9294571045576407, "y": 0.7937332439678284, "term": "phase", "cat25k": 3, "ncat25k": 9, "cat": 17, "ncat": 62, "s": 0.19638069705093836, "os": 0.19348330488249227, "bg": 3.850373885925996e-06}, {"x": 0.9296246648793566, "y": 0.9681635388739946, "term": "systems", "cat25k": 18, "ncat25k": 9, "cat": 110, "ncat": 62, "s": 0.7846849865951744, "os": 0.7509392247301616, "bg": 1.5366194917931207e-06}, {"x": 0.9297922252010724, "y": 0.03837131367292225, "term": "supplements", "cat25k": 0, "ncat25k": 9, "cat": 0, "ncat": 62, "s": 0.005361930294906166, "os": 0.025345884355562842, "bg": 8.877085229110053e-06}, {"x": 0.9299597855227882, "y": 0.9544235924932976, "term": "above", "cat25k": 13, "ncat25k": 9, "cat": 80, "ncat": 63, "s": 0.6833109919571045, "os": 0.669261568162174, "bg": 2.011156716082053e-06}, {"x": 0.9301273458445041, "y": 0.7818364611260054, "term": "24", "cat25k": 3, "ncat25k": 9, "cat": 16, "ncat": 63, "s": 0.19051608579088475, "os": 0.18102600656037, "bg": 0.0}, {"x": 0.9302949061662198, "y": 0.9520777479892761, "term": "f.", "cat25k": 12, "ncat25k": 9, "cat": 76, "ncat": 63, "s": 0.6668900804289544, "os": 0.6555420741024641, "bg": 0.0}, {"x": 0.9304624664879356, "y": 0.7933981233243967, "term": "wide", "cat25k": 3, "ncat25k": 9, "cat": 17, "ncat": 63, "s": 0.19520777479892765, "os": 0.19025747808945082, "bg": 1.8187292556877804e-06}, {"x": 0.9306300268096515, "y": 0.9138739946380697, "term": "conducted", "cat25k": 7, "ncat25k": 10, "cat": 46, "ncat": 64, "s": 0.39577747989276135, "os": 0.4062179966394779, "bg": 8.793964526266333e-06}, {"x": 0.9307975871313673, "y": 0.8880697050938338, "term": "teams", "cat25k": 5, "ncat25k": 10, "cat": 34, "ncat": 64, "s": 0.30998659517426275, "os": 0.3263195730715981, "bg": 5.649173146955198e-06}, {"x": 0.9309651474530831, "y": 0.963304289544236, "term": "distribution", "cat25k": 15, "ncat25k": 10, "cat": 96, "ncat": 64, "s": 0.72436327077748, "os": 0.7121328934516713, "bg": 4.820274629422935e-06}, {"x": 0.931132707774799, "y": 0.8579088471849866, "term": "post", "cat25k": 4, "ncat25k": 10, "cat": 26, "ncat": 64, "s": 0.255529490616622, "os": 0.26468473373756396, "bg": 4.577025817754127e-07}, {"x": 0.9313002680965148, "y": 0.9455428954423593, "term": "partners", "cat25k": 11, "ncat25k": 10, "cat": 68, "ncat": 64, "s": 0.6318699731903485, "os": 0.6211052621394646, "bg": 4.440700201533777e-06}, {"x": 0.9314678284182306, "y": 0.5144101876675603, "term": "samples", "cat25k": 1, "ncat25k": 10, "cat": 5, "ncat": 64, "s": 0.01759383378016086, "os": 0.07264763104722921, "bg": 4.599736281786512e-06}, {"x": 0.9316353887399463, "y": 0.005026809651474531, "term": "baby", "cat25k": 0, "ncat25k": 10, "cat": 0, "ncat": 64, "s": 0.005026809651474531, "os": 0.02344306487503356, "bg": 1.0846714443336657e-06}, {"x": 0.9318029490616622, "y": 0.8228887399463807, "term": "considered", "cat25k": 3, "ncat25k": 10, "cat": 21, "ncat": 65, "s": 0.21229892761394106, "os": 0.21919811939407485, "bg": 2.9814349684637846e-06}, {"x": 0.931970509383378, "y": 0.8909182305630027, "term": "do", "cat25k": 6, "ncat25k": 10, "cat": 36, "ncat": 65, "s": 0.3351206434316354, "os": 0.33623552805410584, "bg": 2.1239374713649594e-07}, {"x": 0.9321380697050938, "y": 0.9277815013404825, "term": "safety", "cat25k": 9, "ncat25k": 10, "cat": 54, "ncat": 65, "s": 0.5529490616621984, "os": 0.5522353553713986, "bg": 2.136895256397802e-06}, {"x": 0.9323056300268097, "y": 0.9534182305630027, "term": "resources", "cat25k": 13, "ncat25k": 10, "cat": 78, "ncat": 65, "s": 0.6667225201072385, "os": 0.6548470942327786, "bg": 1.3144546273518373e-06}, {"x": 0.9324731903485255, "y": 0.7285522788203753, "term": "validation", "cat25k": 2, "ncat25k": 10, "cat": 12, "ncat": 65, "s": 0.05462466487935658, "os": 0.13812290531890487, "bg": 1.7220337800408232e-05}, {"x": 0.9326407506702413, "y": 0.9080093833780161, "term": "practices", "cat25k": 7, "ncat25k": 10, "cat": 43, "ncat": 65, "s": 0.37047587131367293, "os": 0.3829149192684838, "bg": 5.63633181575969e-06}, {"x": 0.9328083109919572, "y": 0.24380026809651476, "term": "malnutrition", "cat25k": 0, "ncat25k": 10, "cat": 2, "ncat": 65, "s": 0.008545576407506705, "os": 0.041898578465123404, "bg": 0.00010289630049405581}, {"x": 0.9329758713136729, "y": 0.2605563002680965, "term": "elimination", "cat25k": 0, "ncat25k": 10, "cat": 2, "ncat": 65, "s": 0.008545576407506705, "os": 0.041898578465123404, "bg": 2.2922193010681227e-05}, {"x": 0.9331434316353887, "y": 0.20559651474530832, "term": "reproductive", "cat25k": 0, "ncat25k": 10, "cat": 1, "ncat": 65, "s": 0.0061997319034852545, "os": 0.03220136644065957, "bg": 2.1798120341477462e-05}, {"x": 0.9333109919571045, "y": 0.917225201072386, "term": "annex", "cat25k": 8, "ncat25k": 10, "cat": 48, "ncat": 66, "s": 0.39946380697050937, "os": 0.40870556631976396, "bg": 2.5974096990012273e-05}, {"x": 0.9334785522788204, "y": 0.9318029490616622, "term": "vi", "cat25k": 9, "ncat25k": 10, "cat": 57, "ncat": 66, "s": 0.5594839142091154, "os": 0.5636085187085453, "bg": 1.3369593555116775e-05}, {"x": 0.9336461126005362, "y": 0.9631367292225201, "term": "promote", "cat25k": 15, "ncat25k": 10, "cat": 96, "ncat": 66, "s": 0.7198391420911529, "os": 0.7050415766197349, "bg": 9.693285305697497e-06}, {"x": 0.933813672922252, "y": 0.9628016085790885, "term": "special", "cat25k": 15, "ncat25k": 10, "cat": 94, "ncat": 66, "s": 0.7183310991957105, "os": 0.6997941397328272, "bg": 1.3081302527203817e-06}, {"x": 0.9339812332439679, "y": 0.8820375335120644, "term": "home", "cat25k": 5, "ncat25k": 10, "cat": 32, "ncat": 66, "s": 0.291387399463807, "os": 0.30321216480954344, "bg": 1.5346499390084308e-07}, {"x": 0.9341487935656837, "y": 0.4058310991957105, "term": "reference", "cat25k": 1, "ncat25k": 10, "cat": 4, "ncat": 66, "s": 0.013237265415549598, "os": 0.05992857131829432, "bg": 1.182036460201681e-06}, {"x": 0.9343163538873994, "y": 0.9406836461126006, "term": "hereby", "cat25k": 10, "ncat25k": 10, "cat": 64, "ncat": 67, "s": 0.588304289544236, "os": 0.592473338608323, "bg": 3.329536137158589e-05}, {"x": 0.9344839142091153, "y": 0.9591152815013405, "term": "assist", "cat25k": 14, "ncat25k": 10, "cat": 88, "ncat": 67, "s": 0.6948726541554959, "os": 0.6793895042748803, "bg": 1.0239169155500413e-05}, {"x": 0.9346514745308311, "y": 0.0020107238605898124, "term": "tetanus", "cat25k": 0, "ncat25k": 10, "cat": 0, "ncat": 67, "s": 0.004691689008042895, "os": 0.020813397751796747, "bg": 0.00013552602301919613}, {"x": 0.9348190348525469, "y": 0.9457104557640751, "term": "regulations", "cat25k": 11, "ncat25k": 10, "cat": 69, "ncat": 68, "s": 0.6095844504021448, "os": 0.6097987988598478, "bg": 6.155442628893396e-06}, {"x": 0.9349865951742627, "y": 0.9271112600536193, "term": "communication", "cat25k": 9, "ncat25k": 10, "cat": 53, "ncat": 68, "s": 0.41337131367292224, "os": 0.42761223631470496, "bg": 3.74088167820033e-06}, {"x": 0.9351541554959786, "y": 0.9743632707774799, "term": "funds", "cat25k": 20, "ncat25k": 10, "cat": 127, "ncat": 68, "s": 0.793230563002681, "os": 0.7628149175574273, "bg": 6.960056485676882e-06}, {"x": 0.9353217158176944, "y": 0.2878686327077748, "term": "weeks", "cat25k": 0, "ncat25k": 10, "cat": 2, "ncat": 68, "s": 0.007372654155495978, "os": 0.03857706835690633, "bg": 1.894867961269332e-06}, {"x": 0.9354892761394102, "y": 0.051273458445040214, "term": "viral", "cat25k": 0, "ncat25k": 10, "cat": 0, "ncat": 68, "s": 0.004524128686327078, "os": 0.01999368078292424, "bg": 2.1650817525317924e-05}, {"x": 0.935656836461126, "y": 0.9373324396782842, "term": "9", "cat25k": 10, "ncat25k": 10, "cat": 61, "ncat": 69, "s": 0.563505361930295, "os": 0.5713762452964013, "bg": 0.0}, {"x": 0.9358243967828418, "y": 0.9331434316353887, "term": "plans", "cat25k": 9, "ncat25k": 10, "cat": 58, "ncat": 69, "s": 0.5552949061662199, "os": 0.557123955959024, "bg": 3.27287052933939e-06}, {"x": 0.9359919571045576, "y": 0.9507372654155496, "term": "rules", "cat25k": 12, "ncat25k": 10, "cat": 74, "ncat": 69, "s": 0.6399128686327078, "os": 0.625533178182867, "bg": 2.9192389184848563e-06}, {"x": 0.9361595174262735, "y": 0.8500335120643432, "term": "status", "cat25k": 4, "ncat25k": 10, "cat": 25, "ncat": 69, "s": 0.22570375335120646, "os": 0.23854576886830536, "bg": 1.4539082771338492e-06}, {"x": 0.9363270777479893, "y": 0.8416554959785523, "term": "\ufb01rst", "cat25k": 4, "ncat25k": 10, "cat": 23, "ncat": 69, "s": 0.21497989276139412, "os": 0.22260512534924976, "bg": 0.0}, {"x": 0.9364946380697051, "y": 0.8443364611260054, "term": "campaign", "cat25k": 4, "ncat25k": 10, "cat": 23, "ncat": 69, "s": 0.21497989276139412, "os": 0.22260512534924976, "bg": 4.911635932460734e-06}, {"x": 0.936662198391421, "y": 0.9222520107238605, "term": "due", "cat25k": 8, "ncat25k": 11, "cat": 51, "ncat": 70, "s": 0.39912868632707776, "os": 0.40774345634452724, "bg": 2.299934495584639e-06}, {"x": 0.9368297587131368, "y": 0.9135388739946381, "term": "i", "cat25k": 7, "ncat25k": 11, "cat": 46, "ncat": 70, "s": 0.3677949061662198, "os": 0.3791067616693172, "bg": 7.516513610308328e-08}, {"x": 0.9369973190348525, "y": 0.9098525469168901, "term": "functions", "cat25k": 7, "ncat25k": 11, "cat": 44, "ncat": 70, "s": 0.36025469168900803, "os": 0.3670815078380839, "bg": 4.373807118443982e-06}, {"x": 0.9371648793565683, "y": 0.9488941018766756, "term": "personnel", "cat25k": 12, "ncat25k": 11, "cat": 72, "ncat": 70, "s": 0.6275134048257374, "os": 0.6142785938872758, "bg": 8.454900814784502e-06}, {"x": 0.9373324396782842, "y": 0.9607908847184986, "term": "human", "cat25k": 15, "ncat25k": 11, "cat": 91, "ncat": 70, "s": 0.6925268096514746, "os": 0.6775099206913238, "bg": 2.001418819475416e-06}, {"x": 0.9375, "y": 0.9415214477211796, "term": "g.", "cat25k": 10, "ncat25k": 11, "cat": 64, "ncat": 70, "s": 0.5775804289544236, "os": 0.5812343370446296, "bg": 0.0}, {"x": 0.9376675603217158, "y": 0.9596179624664879, "term": "disorders", "cat25k": 14, "ncat25k": 11, "cat": 89, "ncat": 70, "s": 0.6888404825737265, "os": 0.6717204041539684, "bg": 1.7776625961733633e-05}, {"x": 0.9378351206434317, "y": 0.9212466487935657, "term": "'s", "cat25k": 8, "ncat25k": 11, "cat": 50, "ncat": 71, "s": 0.3820375335120643, "os": 0.3978633024679119, "bg": 0.0}, {"x": 0.9380026809651475, "y": 0.9865951742627346, "term": "diseases", "cat25k": 39, "ncat25k": 11, "cat": 240, "ncat": 71, "s": 0.9591152815013405, "os": 0.8636143407924848, "bg": 2.5517327927160585e-05}, {"x": 0.9381702412868632, "y": 0.9473860589812333, "term": "collaboration", "cat25k": 11, "ncat25k": 11, "cat": 71, "ncat": 71, "s": 0.6077412868632708, "os": 0.6067551895822237, "bg": 1.5884137965595405e-05}, {"x": 0.938337801608579, "y": 0.9244302949061662, "term": "reports", "cat25k": 8, "ncat25k": 11, "cat": 52, "ncat": 71, "s": 0.3999664879356568, "os": 0.4088862062937951, "bg": 2.1423338945986877e-06}, {"x": 0.9385053619302949, "y": 0.9436997319034852, "term": "total", "cat25k": 11, "ncat25k": 11, "cat": 66, "ncat": 71, "s": 0.5826072386058981, "os": 0.5862607938003254, "bg": 1.2289114258187825e-06}, {"x": 0.9386729222520107, "y": 0.9482238605898123, "term": "less", "cat25k": 11, "ncat25k": 11, "cat": 71, "ncat": 71, "s": 0.6077412868632708, "os": 0.6067551895822237, "bg": 1.9486456933015843e-06}, {"x": 0.9388404825737265, "y": 0.857573726541555, "term": "new", "cat25k": 4, "ncat25k": 11, "cat": 26, "ncat": 71, "s": 0.22637399463806973, "os": 0.23965276266802532, "bg": 1.2503458616169005e-07}, {"x": 0.9390080428954424, "y": 0.21062332439678283, "term": "diarrhea", "cat25k": 0, "ncat25k": 11, "cat": 1, "ncat": 71, "s": 0.005529490616621984, "os": 0.026612752716250798, "bg": 5.752445888059799e-05}, {"x": 0.9391756032171582, "y": 0.9173927613941019, "term": "were", "cat25k": 8, "ncat25k": 11, "cat": 48, "ncat": 72, "s": 0.3691353887399464, "os": 0.3823408602857952, "bg": 4.2030667203480017e-07}, {"x": 0.939343163538874, "y": 0.8770107238605898, "term": "results", "cat25k": 5, "ncat25k": 11, "cat": 31, "ncat": 72, "s": 0.25871313672922247, "os": 0.27322538818622466, "bg": 7.67245605743255e-07}, {"x": 0.9395107238605898, "y": 0.8981233243967829, "term": "target", "cat25k": 6, "ncat25k": 11, "cat": 38, "ncat": 72, "s": 0.30127345844504017, "os": 0.3211083909030674, "bg": 4.1895240114189665e-06}, {"x": 0.9396782841823056, "y": 0.892426273458445, "term": "epidemiology", "cat25k": 6, "ncat25k": 11, "cat": 36, "ncat": 72, "s": 0.2944034852546917, "os": 0.3078605796545887, "bg": 4.55769952648456e-05}, {"x": 0.9398458445040214, "y": 0.5412198391420912, "term": "routine", "cat25k": 1, "ncat25k": 11, "cat": 6, "ncat": 73, "s": 0.01642091152815013, "os": 0.06866851040445088, "bg": 1.2392922793973463e-05}, {"x": 0.9400134048257373, "y": 0.9217493297587132, "term": "15", "cat25k": 8, "ncat25k": 11, "cat": 50, "ncat": 73, "s": 0.37567024128686327, "os": 0.38947152241272603, "bg": 0.0}, {"x": 0.9401809651474531, "y": 0.9569369973190348, "term": "upon", "cat25k": 13, "ncat25k": 11, "cat": 84, "ncat": 73, "s": 0.6580093833780161, "os": 0.6459639501766122, "bg": 3.0124719986410487e-06}, {"x": 0.9403485254691689, "y": 0.7458109919571045, "term": "schedule", "cat25k": 2, "ncat25k": 11, "cat": 13, "ncat": 73, "s": 0.04691689008042896, "os": 0.12900428234761424, "bg": 2.6536429163671415e-06}, {"x": 0.9405160857908847, "y": 0.4457104557640751, "term": "young", "cat25k": 1, "ncat25k": 11, "cat": 4, "ncat": 73, "s": 0.010053619302949063, "os": 0.05118703828818777, "bg": 1.126936041359665e-06}, {"x": 0.9406836461126006, "y": 0.9638069705093834, "term": "ii", "cat25k": 16, "ncat25k": 11, "cat": 98, "ncat": 74, "s": 0.6978887399463807, "os": 0.6831515380951294, "bg": 2.578423210408081e-06}, {"x": 0.9408512064343163, "y": 0.9358243967828418, "term": "part", "cat25k": 10, "ncat25k": 11, "cat": 60, "ncat": 74, "s": 0.4261058981233244, "os": 0.43714616101731374, "bg": 8.843676319677964e-07}, {"x": 0.9410187667560321, "y": 0.9515750670241286, "term": "of\ufb01ces", "cat25k": 12, "ncat25k": 11, "cat": 75, "ncat": 74, "s": 0.6109249329758714, "os": 0.6114307750885747, "bg": 0.0}, {"x": 0.941186327077748, "y": 0.9478887399463807, "term": "established", "cat25k": 11, "ncat25k": 11, "cat": 71, "ncat": 74, "s": 0.5980227882037533, "os": 0.5961289129248103, "bg": 5.6717873192408715e-06}, {"x": 0.9413538873994638, "y": 0.978887399463807, "term": "bureau", "cat25k": 24, "ncat25k": 11, "cat": 152, "ncat": 75, "s": 0.8108243967828418, "os": 0.7798230553263219, "bg": 1.7182430366970918e-05}, {"x": 0.9415214477211796, "y": 0.9137064343163539, "term": "three", "cat25k": 7, "ncat25k": 11, "cat": 46, "ncat": 75, "s": 0.3527144772117963, "os": 0.3587752852608377, "bg": 1.0816634832982576e-06}, {"x": 0.9416890080428955, "y": 0.8175268096514745, "term": "reported", "cat25k": 3, "ncat25k": 11, "cat": 20, "ncat": 75, "s": 0.19118632707774802, "os": 0.18144768327060312, "bg": 3.551312522118603e-06}, {"x": 0.9418565683646113, "y": 0.9750335120643432, "term": "education", "cat25k": 21, "ncat25k": 11, "cat": 132, "ncat": 75, "s": 0.784014745308311, "os": 0.750612749941705, "bg": 1.5502701379416889e-06}, {"x": 0.9420241286863271, "y": 0.9257707774798928, "term": "international", "cat25k": 8, "ncat25k": 11, "cat": 52, "ncat": 75, "s": 0.3770107238605898, "os": 0.39224604885924425, "bg": 8.582493568155989e-07}, {"x": 0.9421916890080428, "y": 0.3312667560321716, "term": "foods", "cat25k": 0, "ncat25k": 11, "cat": 3, "ncat": 75, "s": 0.007707774798927614, "os": 0.040486132609277636, "bg": 7.268415695975963e-06}, {"x": 0.9423592493297587, "y": 0.9326407506702413, "term": "most", "cat25k": 9, "ncat25k": 11, "cat": 58, "ncat": 76, "s": 0.4058310991957104, "os": 0.419119800247488, "bg": 6.434226211384853e-07}, {"x": 0.9425268096514745, "y": 0.8553954423592494, "term": "guide", "cat25k": 4, "ncat25k": 11, "cat": 26, "ncat": 76, "s": 0.21615281501340483, "os": 0.2241726930338686, "bg": 9.54650069133044e-07}, {"x": 0.9426943699731903, "y": 0.8894101876675603, "term": "against", "cat25k": 6, "ncat25k": 11, "cat": 35, "ncat": 76, "s": 0.2675938337801609, "os": 0.2868762498123658, "bg": 1.5043515095384727e-06}, {"x": 0.9428619302949062, "y": 0.9447050938337802, "term": "test", "cat25k": 11, "ncat25k": 11, "cat": 67, "ncat": 76, "s": 0.5673592493297588, "os": 0.5729367098580296, "bg": 1.8414583314647788e-06}, {"x": 0.943029490616622, "y": 0.8562332439678284, "term": "positive", "cat25k": 4, "ncat25k": 11, "cat": 26, "ncat": 76, "s": 0.21615281501340483, "os": 0.2241726930338686, "bg": 3.6141806203418587e-06}, {"x": 0.9431970509383378, "y": 0.9279490616621984, "term": "capacity", "cat25k": 9, "ncat25k": 11, "cat": 54, "ncat": 76, "s": 0.3837131367292225, "os": 0.39881786240161265, "bg": 5.3018988914014906e-06}, {"x": 0.9433646112600537, "y": 0.936662198391421, "term": "about", "cat25k": 10, "ncat25k": 11, "cat": 60, "ncat": 76, "s": 0.41471179624664883, "os": 0.42888351766318017, "bg": 2.216705633322746e-07}, {"x": 0.9435321715817694, "y": 0.9738605898123325, "term": "clinical", "cat25k": 20, "ncat25k": 11, "cat": 126, "ncat": 76, "s": 0.7607238605898123, "os": 0.7374693182865245, "bg": 9.338108404343791e-06}, {"x": 0.9436997319034852, "y": 0.8036193029490617, "term": "criteria", "cat25k": 3, "ncat25k": 11, "cat": 18, "ncat": 76, "s": 0.11243297587131368, "os": 0.16326974411921275, "bg": 5.764263808769198e-06}, {"x": 0.943867292225201, "y": 0.08344504021447721, "term": "polio", "cat25k": 0, "ncat25k": 11, "cat": 0, "ncat": 76, "s": 0.003853887399463808, "os": 0.014356600814701637, "bg": 9.435848028218153e-05}, {"x": 0.9440348525469169, "y": 0.588304289544236, "term": "suspected", "cat25k": 1, "ncat25k": 12, "cat": 7, "ncat": 77, "s": 0.017258713136729224, "os": 0.07192807672717516, "bg": 2.6930603681541765e-05}, {"x": 0.9442024128686327, "y": 0.895274798927614, "term": "coordinate", "cat25k": 6, "ncat25k": 12, "cat": 37, "ncat": 77, "s": 0.2855227882037534, "os": 0.29648400467155334, "bg": 2.5864964691487122e-05}, {"x": 0.9443699731903485, "y": 0.8986260053619303, "term": "breast", "cat25k": 6, "ncat25k": 12, "cat": 39, "ncat": 78, "s": 0.29390080428954424, "os": 0.30568919097297714, "bg": 5.75699955811338e-06}, {"x": 0.9445375335120644, "y": 0.960455764075067, "term": "being", "cat25k": 15, "ncat25k": 12, "cat": 91, "ncat": 78, "s": 0.660857908847185, "os": 0.6508344502017839, "bg": 1.3904016877469045e-06}, {"x": 0.9447050938337802, "y": 0.971514745308311, "term": "into", "cat25k": 19, "ncat25k": 12, "cat": 119, "ncat": 78, "s": 0.7468163538873994, "os": 0.7184821736287046, "bg": 8.841466156725606e-07}, {"x": 0.9448726541554959, "y": 0.9378351206434317, "term": "compliance", "cat25k": 10, "ncat25k": 12, "cat": 61, "ncat": 78, "s": 0.4125335120643432, "os": 0.4256492378534892, "bg": 7.390136581420644e-06}, {"x": 0.9450402144772118, "y": 0.8728217158176944, "term": "rural", "cat25k": 5, "ncat25k": 12, "cat": 30, "ncat": 78, "s": 0.23726541554959787, "os": 0.2466494959322329, "bg": 6.898535383450299e-06}, {"x": 0.9452077747989276, "y": 0.03585790884718499, "term": "breastmilk", "cat25k": 0, "ncat25k": 12, "cat": 0, "ncat": 78, "s": 0.0033512064343163544, "os": 0.013178710509329061, "bg": 0.00034073708420792826}, {"x": 0.9453753351206434, "y": 0.854725201072386, "term": "however", "cat25k": 4, "ncat25k": 12, "cat": 26, "ncat": 79, "s": 0.21129356568364616, "os": 0.21571299103473068, "bg": 1.278389079761848e-06}, {"x": 0.9455428954423593, "y": 0.949396782841823, "term": "iv", "cat25k": 12, "ncat25k": 12, "cat": 73, "ncat": 79, "s": 0.5831099195710456, "os": 0.5870264114092829, "bg": 9.17876058954213e-06}, {"x": 0.9457104557640751, "y": 0.8374664879356568, "term": "period", "cat25k": 4, "ncat25k": 12, "cat": 23, "ncat": 79, "s": 0.19671581769437, "os": 0.19401079203350424, "bg": 1.95743084936542e-06}, {"x": 0.9458780160857909, "y": 0.9619638069705094, "term": "8", "cat25k": 15, "ncat25k": 12, "cat": 93, "ncat": 79, "s": 0.6653820375335121, "os": 0.6534295049019955, "bg": 0.0}, {"x": 0.9460455764075067, "y": 0.9626340482573726, "term": "implement", "cat25k": 15, "ncat25k": 12, "cat": 94, "ncat": 79, "s": 0.6675603217158178, "os": 0.6562634876583112, "bg": 1.644814247704272e-05}, {"x": 0.9462131367292225, "y": 0.9606233243967829, "term": "office", "cat25k": 15, "ncat25k": 12, "cat": 91, "ncat": 79, "s": 0.6585120643431636, "os": 0.6476365504566163, "bg": 1.2729231510947535e-06}, {"x": 0.9463806970509383, "y": 0.9281166219839142, "term": "monitor", "cat25k": 9, "ncat25k": 12, "cat": 54, "ncat": 79, "s": 0.37248659517426275, "os": 0.3871760379952726, "bg": 6.023510895263101e-06}, {"x": 0.9465482573726541, "y": 0.9106903485254692, "term": "adequate", "cat25k": 7, "ncat25k": 12, "cat": 44, "ncat": 79, "s": 0.31317024128686327, "os": 0.3323159452490705, "bg": 1.604066765692794e-05}, {"x": 0.94671581769437, "y": 0.9205764075067024, "term": "blood", "cat25k": 8, "ncat25k": 12, "cat": 49, "ncat": 79, "s": 0.35489276139410186, "os": 0.3605879526203542, "bg": 4.151774136610592e-06}, {"x": 0.9468833780160858, "y": 0.14795576407506703, "term": "ms", "cat25k": 0, "ncat25k": 12, "cat": 0, "ncat": 79, "s": 0.003183646112600536, "os": 0.012621030060189331, "bg": 2.3008092251848734e-06}, {"x": 0.9470509383378016, "y": 0.3389745308310992, "term": "midwives", "cat25k": 0, "ncat25k": 12, "cat": 3, "ncat": 80, "s": 0.006702412868632708, "os": 0.03610751545775609, "bg": 0.0001402076762858142}, {"x": 0.9472184986595175, "y": 0.28803619302949063, "term": "transmission", "cat25k": 0, "ncat25k": 12, "cat": 2, "ncat": 80, "s": 0.005864611260053619, "os": 0.02808143423326348, "bg": 6.689354455269143e-06}, {"x": 0.9473860589812333, "y": 0.9661528150134048, "term": "form", "cat25k": 17, "ncat25k": 12, "cat": 104, "ncat": 81, "s": 0.6906836461126005, "os": 0.6763961387125443, "bg": 1.8343408376018692e-06}, {"x": 0.947553619302949, "y": 0.8530495978552279, "term": "exposure", "cat25k": 4, "ncat25k": 12, "cat": 25, "ncat": 81, "s": 0.2012399463806971, "os": 0.20334562108162663, "bg": 7.704415869541272e-06}, {"x": 0.9477211796246648, "y": 0.9235924932975871, "term": "per", "cat25k": 8, "ncat25k": 12, "cat": 52, "ncat": 82, "s": 0.36008713136729226, "os": 0.3657947082517081, "bg": 1.2223057332715627e-06}, {"x": 0.9478887399463807, "y": 0.973357908847185, "term": "data", "cat25k": 20, "ncat25k": 12, "cat": 125, "ncat": 82, "s": 0.7469839142091153, "os": 0.7186140537545158, "bg": 1.0166482486347962e-06}, {"x": 0.9480563002680965, "y": 0.9616286863270778, "term": "concerned", "cat25k": 15, "ncat25k": 12, "cat": 93, "ncat": 82, "s": 0.656333780160858, "os": 0.6440572302541602, "bg": 1.3564562881767356e-05}, {"x": 0.9482238605898123, "y": 0.9284517426273459, "term": "needed", "cat25k": 9, "ncat25k": 12, "cat": 54, "ncat": 82, "s": 0.3661193029490617, "os": 0.37611414690619543, "bg": 3.5398150852655562e-06}, {"x": 0.9483914209115282, "y": 0.9043230563002681, "term": "area", "cat25k": 7, "ncat25k": 12, "cat": 41, "ncat": 82, "s": 0.29239276139410186, "os": 0.3044837417047176, "bg": 9.454860529911034e-07}, {"x": 0.948558981233244, "y": 0.9314678284182306, "term": "early", "cat25k": 9, "ncat25k": 12, "cat": 57, "ncat": 83, "s": 0.373156836461126, "os": 0.38752060105348135, "bg": 2.7909213839210293e-06}, {"x": 0.9487265415549598, "y": 0.935656836461126, "term": "conditions", "cat25k": 10, "ncat25k": 12, "cat": 60, "ncat": 83, "s": 0.39343163538873993, "os": 0.40196939291885897, "bg": 1.6896172417901232e-06}, {"x": 0.9488941018766756, "y": 0.9299597855227882, "term": "proper", "cat25k": 9, "ncat25k": 12, "cat": 56, "ncat": 83, "s": 0.3701407506702413, "os": 0.38258915157393814, "bg": 9.784708949608678e-06}, {"x": 0.9490616621983914, "y": 0.9302949061662198, "term": "work", "cat25k": 9, "ncat25k": 12, "cat": 56, "ncat": 83, "s": 0.3701407506702413, "os": 0.38258915157393814, "bg": 6.622263453249693e-07}, {"x": 0.9492292225201072, "y": 0.9410187667560321, "term": "means", "cat25k": 10, "ncat25k": 12, "cat": 64, "ncat": 83, "s": 0.40650134048257375, "os": 0.4204517179444747, "bg": 2.7668305502437325e-06}, {"x": 0.949396782841823, "y": 0.878686327077748, "term": "acute", "cat25k": 5, "ncat25k": 12, "cat": 31, "ncat": 83, "s": 0.22587131367292226, "os": 0.23893785694035935, "bg": 1.9928481225972197e-05}, {"x": 0.9495643431635389, "y": 0.8021112600536193, "term": "code", "cat25k": 3, "ncat25k": 13, "cat": 18, "ncat": 84, "s": 0.06652144772117963, "os": 0.1463189300512776, "bg": 8.141854086959312e-07}, {"x": 0.9497319034852547, "y": 0.9567694369973191, "term": "coordination", "cat25k": 13, "ncat25k": 13, "cat": 84, "ncat": 84, "s": 0.6100871313672922, "os": 0.61020378296718, "bg": 3.078768928587496e-05}, {"x": 0.9498994638069705, "y": 0.9666554959785523, "term": "research", "cat25k": 17, "ncat25k": 13, "cat": 106, "ncat": 84, "s": 0.6895107238605899, "os": 0.6723613931018735, "bg": 1.2185324848366699e-06}, {"x": 0.9500670241286864, "y": 0.5613270777479893, "term": "water", "cat25k": 1, "ncat25k": 13, "cat": 6, "ncat": 84, "s": 0.011394101876675604, "os": 0.0561011077468857, "bg": 8.353035088060828e-07}, {"x": 0.9502345844504021, "y": 0.9049932975871313, "term": "low", "cat25k": 7, "ncat25k": 13, "cat": 42, "ncat": 85, "s": 0.2907171581769437, "os": 0.30081541223784813, "bg": 1.3720269270331555e-06}, {"x": 0.9504021447721179, "y": 0.9731903485254692, "term": "and/or", "cat25k": 20, "ncat25k": 13, "cat": 124, "ncat": 85, "s": 0.7225201072386059, "os": 0.7084149161037631, "bg": 0.0}, {"x": 0.9505697050938338, "y": 0.9644772117962467, "term": "existing", "cat25k": 16, "ncat25k": 13, "cat": 99, "ncat": 86, "s": 0.6595174262734586, "os": 0.6486784928334388, "bg": 6.2589635335699256e-06}, {"x": 0.9507372654155496, "y": 0.9621313672922251, "term": "needs", "cat25k": 15, "ncat25k": 13, "cat": 93, "ncat": 86, "s": 0.6439343163538874, "os": 0.6319511371792643, "bg": 2.8892424561233827e-06}, {"x": 0.9509048257372654, "y": 0.9674932975871313, "term": "products", "cat25k": 18, "ncat25k": 13, "cat": 109, "ncat": 88, "s": 0.6826407506702413, "os": 0.6680493410788042, "bg": 9.501077993756036e-07}, {"x": 0.9510723860589813, "y": 0.9545911528150134, "term": "time", "cat25k": 13, "ncat25k": 13, "cat": 81, "ncat": 88, "s": 0.583612600536193, "os": 0.5880457503370914, "bg": 3.7182994510153074e-07}, {"x": 0.9512399463806971, "y": 0.9487265415549598, "term": "10", "cat25k": 12, "ncat25k": 13, "cat": 72, "ncat": 88, "s": 0.5537868632707774, "os": 0.5550968214556365, "bg": 0.0}, {"x": 0.9514075067024129, "y": 0.9830764075067024, "term": "programs", "cat25k": 30, "ncat25k": 13, "cat": 188, "ncat": 88, "s": 0.8232238605898123, "os": 0.7901153090417008, "bg": 3.865262955344344e-06}, {"x": 0.9515750670241286, "y": 0.9480563002680965, "term": "facilitate", "cat25k": 11, "ncat25k": 13, "cat": 71, "ncat": 88, "s": 0.41672252010723865, "os": 0.4327014669429569, "bg": 2.7312330151446873e-05}, {"x": 0.9517426273458445, "y": 0.38337801608579086, "term": "investigation", "cat25k": 1, "ncat25k": 13, "cat": 4, "ncat": 89, "s": 0.007037533512064343, "os": 0.03705623354720322, "bg": 7.526737825633083e-06}, {"x": 0.9519101876675603, "y": 0.8017761394101877, "term": "first", "cat25k": 3, "ncat25k": 13, "cat": 18, "ncat": 89, "s": 0.05445710455764075, "os": 0.1372833425774153, "bg": 3.699390904103944e-07}, {"x": 0.9520777479892761, "y": 0.9636394101876675, "term": "interventions", "cat25k": 16, "ncat25k": 13, "cat": 97, "ncat": 89, "s": 0.6466152815013405, "os": 0.634527654629623, "bg": 6.763909379614958e-05}, {"x": 0.952245308310992, "y": 0.9629691689008043, "term": "number", "cat25k": 15, "ncat25k": 13, "cat": 95, "ncat": 89, "s": 0.6410857908847185, "os": 0.6289178229929732, "bg": 9.580839670308104e-07}, {"x": 0.9524128686327078, "y": 0.9401809651474531, "term": "administration", "cat25k": 10, "ncat25k": 13, "cat": 63, "ncat": 89, "s": 0.38136729222520105, "os": 0.39486134707002163, "bg": 3.906085171878798e-06}, {"x": 0.9525804289544236, "y": 0.6888404825737265, "term": "give", "cat25k": 2, "ncat25k": 13, "cat": 10, "ncat": 89, "s": 0.019269436997319034, "os": 0.08056831794420177, "bg": 1.4042487659880284e-06}, {"x": 0.9527479892761395, "y": 0.9483914209115282, "term": "both", "cat25k": 12, "ncat25k": 14, "cat": 72, "ncat": 91, "s": 0.412701072386059, "os": 0.42653433895361864, "bg": 1.4238253793301197e-06}, {"x": 0.9529155495978552, "y": 0.9009718498659517, "term": "review", "cat25k": 6, "ncat25k": 14, "cat": 39, "ncat": 91, "s": 0.25603217158176944, "os": 0.26625680406886165, "bg": 7.661031982554416e-07}, {"x": 0.953083109919571, "y": 0.6863270777479893, "term": "growth", "cat25k": 2, "ncat25k": 14, "cat": 10, "ncat": 91, "s": 0.01910187667560322, "os": 0.07834666227275539, "bg": 2.5152365434284604e-06}, {"x": 0.9532506702412868, "y": 0.0006702412868632708, "term": "neonatal", "cat25k": 0, "ncat25k": 14, "cat": 0, "ncat": 91, "s": 0.002680965147453083, "os": 0.007337325671017414, "bg": 9.209142148169026e-05}, {"x": 0.9534182305630027, "y": 0.9148793565683646, "term": "providing", "cat25k": 8, "ncat25k": 14, "cat": 47, "ncat": 92, "s": 0.29423592493297585, "os": 0.3074568054067427, "bg": 4.7709149101147615e-06}, {"x": 0.9535857908847185, "y": 0.8907506702412868, "term": "possible", "cat25k": 6, "ncat25k": 14, "cat": 36, "ncat": 92, "s": 0.23676273458445043, "os": 0.24626825355416015, "bg": 2.070801244609789e-06}, {"x": 0.9537533512064343, "y": 0.9555965147453083, "term": "year", "cat25k": 13, "ncat25k": 14, "cat": 83, "ncat": 92, "s": 0.5782506702412868, "os": 0.5832301598147162, "bg": 7.753574306373827e-07}, {"x": 0.9539209115281502, "y": 0.9168900804289544, "term": "mortality", "cat25k": 8, "ncat25k": 14, "cat": 48, "ncat": 92, "s": 0.29557640750670244, "os": 0.31269395384696996, "bg": 3.0139049735136955e-05}, {"x": 0.954088471849866, "y": 0.977044235924933, "term": "stakeholders", "cat25k": 23, "ncat25k": 14, "cat": 146, "ncat": 92, "s": 0.7541890080428955, "os": 0.7283152827508828, "bg": 6.861988261098654e-05}, {"x": 0.9542560321715817, "y": 0.9581099195710456, "term": "providers", "cat25k": 14, "ncat25k": 14, "cat": 87, "ncat": 93, "s": 0.5894772117962467, "os": 0.5934590336156934, "bg": 9.207223056257386e-06}, {"x": 0.9544235924932976, "y": 0.9463806970509383, "term": "take", "cat25k": 11, "ncat25k": 14, "cat": 70, "ncat": 93, "s": 0.40214477211796246, "os": 0.4117774277479854, "bg": 1.2317601216232389e-06}, {"x": 0.9545911528150134, "y": 0.907171581769437, "term": "done", "cat25k": 7, "ncat25k": 14, "cat": 43, "ncat": 93, "s": 0.26692359249329756, "os": 0.2832367306997017, "bg": 2.6375828934363855e-06}, {"x": 0.9547587131367292, "y": 0.9276139410187667, "term": "barangay", "cat25k": 9, "ncat25k": 14, "cat": 54, "ncat": 93, "s": 0.33662868632707776, "os": 0.3399847479668038, "bg": 0.0005986268233684366}, {"x": 0.954926273458445, "y": 0.9329758713136729, "term": "especially", "cat25k": 9, "ncat25k": 14, "cat": 58, "ncat": 93, "s": 0.35288203753351205, "os": 0.35908196587207125, "bg": 5.062995058650941e-06}, {"x": 0.9550938337801609, "y": 0.9807305630026809, "term": "promotion", "cat25k": 26, "ncat25k": 14, "cat": 161, "ncat": 93, "s": 0.7818364611260054, "os": 0.7475741060493768, "bg": 1.884016390645903e-05}, {"x": 0.9552613941018767, "y": 0.9240951742627346, "term": "scope", "cat25k": 8, "ncat25k": 14, "cat": 52, "ncat": 94, "s": 0.3109919571045576, "os": 0.32720575911131977, "bg": 1.2340710274651383e-05}, {"x": 0.9554289544235925, "y": 0.589142091152815, "term": "specimen", "cat25k": 1, "ncat25k": 14, "cat": 7, "ncat": 94, "s": 0.01105898123324397, "os": 0.05459401223669502, "bg": 5.2248144544233216e-05}, {"x": 0.9555965147453083, "y": 0.943867292225201, "term": "integrated", "cat25k": 11, "ncat25k": 14, "cat": 66, "ncat": 94, "s": 0.376843163538874, "os": 0.39177843423459824, "bg": 8.440553642290127e-06}, {"x": 0.9557640750670241, "y": 0.17677613941018766, "term": "pregnancy", "cat25k": 0, "ncat25k": 14, "cat": 1, "ncat": 94, "s": 0.0036863270777479896, "os": 0.01322290692325806, "bg": 8.097324038969096e-06}, {"x": 0.9559316353887399, "y": 0.0003351206434316354, "term": "newborns", "cat25k": 0, "ncat25k": 14, "cat": 0, "ncat": 94, "s": 0.002345844504021448, "os": 0.0063618358160987265, "bg": 0.0001674685261611671}, {"x": 0.9560991957104558, "y": 0.6278485254691689, "term": "methods", "cat25k": 1, "ncat25k": 14, "cat": 8, "ncat": 95, "s": 0.013739946380697051, "os": 0.06063093763999833, "bg": 2.335342801342092e-06}, {"x": 0.9562667560321716, "y": 0.9562667560321716, "term": "out", "cat25k": 13, "ncat25k": 14, "cat": 83, "ncat": 95, "s": 0.5703753351206434, "os": 0.574833227610773, "bg": 4.798399898612504e-07}, {"x": 0.9564343163538874, "y": 0.9514075067024129, "term": "responsible", "cat25k": 12, "ncat25k": 14, "cat": 75, "ncat": 96, "s": 0.40951742627345844, "os": 0.4221785483597562, "bg": 5.210889656257569e-06}, {"x": 0.9566018766756033, "y": 0.967828418230563, "term": "provisions", "cat25k": 18, "ncat25k": 14, "cat": 110, "ncat": 96, "s": 0.6593498659517427, "os": 0.6486226068957194, "bg": 1.3104945516984217e-05}, {"x": 0.9567694369973191, "y": 0.9589477211796247, "term": "procedures", "cat25k": 14, "ncat25k": 14, "cat": 88, "ncat": 96, "s": 0.5837801608579088, "os": 0.588321335856078, "bg": 7.607184034422507e-06}, {"x": 0.9569369973190348, "y": 0.9063337801608579, "term": "old", "cat25k": 7, "ncat25k": 14, "cat": 42, "ncat": 96, "s": 0.257372654155496, "os": 0.2699462518186101, "bg": 1.3799563864784054e-06}, {"x": 0.9571045576407506, "y": 0.9431970509383378, "term": "groups", "cat25k": 10, "ncat25k": 14, "cat": 65, "ncat": 96, "s": 0.3684651474530831, "os": 0.3812895901019832, "bg": 2.5529947599782554e-06}, {"x": 0.9572721179624665, "y": 0.305127345844504, "term": "tb", "cat25k": 0, "ncat25k": 14, "cat": 2, "ncat": 96, "s": 0.0043565683646112595, "os": 0.019240957865161668, "bg": 2.69066187948498e-05}, {"x": 0.9574396782841823, "y": 0.962298927613941, "term": "those", "cat25k": 15, "ncat25k": 15, "cat": 94, "ncat": 97, "s": 0.6040549597855228, "os": 0.603767227374083, "bg": 1.4131071062792566e-06}, {"x": 0.9576072386058981, "y": 0.9428619302949062, "term": "clinics", "cat25k": 10, "ncat25k": 15, "cat": 65, "ncat": 97, "s": 0.3674597855227882, "os": 0.37826522688272013, "bg": 3.7751994563712784e-05}, {"x": 0.957774798927614, "y": 0.6970509383378016, "term": "infection", "cat25k": 2, "ncat25k": 15, "cat": 10, "ncat": 97, "s": 0.017426273458445038, "os": 0.07233460974095751, "bg": 1.3788034357204416e-05}, {"x": 0.9579423592493298, "y": 0.9557640750670241, "term": "every", "cat25k": 13, "ncat25k": 15, "cat": 83, "ncat": 98, "s": 0.5609919571045576, "os": 0.5666832625297953, "bg": 1.9088998331073133e-06}, {"x": 0.9581099195710456, "y": 0.9321380697050938, "term": "assessment", "cat25k": 9, "ncat25k": 15, "cat": 57, "ncat": 98, "s": 0.3362935656836461, "os": 0.3396816538324161, "bg": 5.181761829778388e-06}, {"x": 0.9582774798927614, "y": 0.022453083109919572, "term": "nbs", "cat25k": 0, "ncat25k": 15, "cat": 0, "ncat": 98, "s": 0.002010723860589813, "os": 0.005235833652957378, "bg": 0.00018902516059905548}, {"x": 0.9584450402144772, "y": 0.9497319034852547, "term": "need", "cat25k": 12, "ncat25k": 15, "cat": 73, "ncat": 99, "s": 0.39510723860589814, "os": 0.4051131771931257, "bg": 1.0760455766736416e-06}, {"x": 0.958612600536193, "y": 0.9111930294906166, "term": "two", "cat25k": 7, "ncat25k": 15, "cat": 44, "ncat": 99, "s": 0.2585455764075067, "os": 0.2730589818309057, "bg": 6.474828530183656e-07}, {"x": 0.9587801608579088, "y": 0.5693699731903485, "term": "doses", "cat25k": 1, "ncat25k": 15, "cat": 6, "ncat": 99, "s": 0.009048257372654156, "os": 0.044314547975610796, "bg": 4.175528065115968e-05}, {"x": 0.9589477211796247, "y": 0.07456434316353887, "term": "mnchn", "cat25k": 0, "ncat25k": 15, "cat": 0, "ncat": 99, "s": 0.0016756032171581772, "os": 0.0049828260157667725, "bg": 0.0006345014997308176}, {"x": 0.9591152815013405, "y": 0.9664879356568364, "term": "life", "cat25k": 17, "ncat25k": 15, "cat": 106, "ncat": 100, "s": 0.6400804289544236, "os": 0.6283841777835548, "bg": 1.3425820814928552e-06}, {"x": 0.9592828418230563, "y": 0.9386729222520107, "term": "refer", "cat25k": 10, "ncat25k": 15, "cat": 62, "ncat": 100, "s": 0.3513739946380697, "os": 0.3565198198197624, "bg": 1.1819716490966944e-05}, {"x": 0.9594504021447721, "y": 0.8919235924932976, "term": "materials", "cat25k": 6, "ncat25k": 15, "cat": 36, "ncat": 100, "s": 0.21699061662198393, "os": 0.22765758150963455, "bg": 3.229866269405782e-06}, {"x": 0.9596179624664879, "y": 0.7841823056300268, "term": "emergency", "cat25k": 3, "ncat25k": 15, "cat": 16, "ncat": 100, "s": 0.030663538873994638, "os": 0.1081252424202917, "bg": 5.385040867121563e-06}, {"x": 0.9597855227882037, "y": 0.9656501340482574, "term": "was", "cat25k": 17, "ncat25k": 15, "cat": 103, "ncat": 101, "s": 0.6298592493297587, "os": 0.6181042777119397, "bg": 2.749806362915647e-07}, {"x": 0.9599530831099196, "y": 0.8548927613941019, "term": "collection", "cat25k": 4, "ncat25k": 15, "cat": 26, "ncat": 101, "s": 0.1409182305630027, "os": 0.16817150271050912, "bg": 2.3642429146408988e-06}, {"x": 0.9601206434316354, "y": 0.983411528150134, "term": "agencies", "cat25k": 31, "ncat25k": 15, "cat": 193, "ncat": 101, "s": 0.8051273458445041, "os": 0.768276678952643, "bg": 1.2531266094978087e-05}, {"x": 0.9602882037533512, "y": 0.8852211796246648, "term": "response", "cat25k": 5, "ncat25k": 15, "cat": 33, "ncat": 101, "s": 0.20459115281501342, "os": 0.2087683021155461, "bg": 3.176206553168323e-06}, {"x": 0.960455764075067, "y": 0.9552613941018767, "term": "effect", "cat25k": 13, "ncat25k": 15, "cat": 82, "ncat": 102, "s": 0.4148793565683646, "os": 0.429910711212122, "bg": 4.848039646425091e-06}, {"x": 0.9606233243967829, "y": 0.8240616621983914, "term": "recommended", "cat25k": 3, "ncat25k": 15, "cat": 21, "ncat": 102, "s": 0.054289544235924934, "os": 0.13653754216769365, "bg": 4.658334988367796e-06}, {"x": 0.9607908847184986, "y": 0.9609584450402144, "term": "must", "cat25k": 15, "ncat25k": 15, "cat": 92, "ncat": 102, "s": 0.5787533512064343, "os": 0.5847047697886825, "bg": 1.3238395973573256e-06}, {"x": 0.9609584450402144, "y": 0.8773458445040214, "term": "before", "cat25k": 5, "ncat25k": 15, "cat": 31, "ncat": 102, "s": 0.19939678284182308, "os": 0.19547789093806578, "bg": 9.573231494208434e-07}, {"x": 0.9611260053619303, "y": 0.9396782841823056, "term": "requirements", "cat25k": 10, "ncat25k": 15, "cat": 62, "ncat": 102, "s": 0.3438337801608579, "os": 0.3509409134895326, "bg": 3.3625246606072126e-06}, {"x": 0.9612935656836461, "y": 0.32640750670241286, "term": "pregnant", "cat25k": 0, "ncat25k": 15, "cat": 3, "ncat": 103, "s": 0.004859249329758713, "os": 0.02296783921901524, "bg": 1.0465163174848144e-05}, {"x": 0.9614611260053619, "y": 0.9832439678284183, "term": "philippine", "cat25k": 31, "ncat25k": 16, "cat": 193, "ncat": 104, "s": 0.7930630026809652, "os": 0.7622884230204631, "bg": 0.0001429340068396569}, {"x": 0.9616286863270778, "y": 0.5370308310991957, "term": "epi", "cat25k": 1, "ncat25k": 16, "cat": 5, "ncat": 104, "s": 0.006367292225201072, "os": 0.03511091957717577, "bg": 0.00013395435720342627}, {"x": 0.9617962466487936, "y": 0.9542560321715817, "term": "report", "cat25k": 13, "ncat25k": 16, "cat": 80, "ncat": 105, "s": 0.40264745308310995, "os": 0.4139848480592204, "bg": 1.2912253621899356e-06}, {"x": 0.9619638069705094, "y": 0.9648123324396782, "term": "sector", "cat25k": 16, "ncat25k": 16, "cat": 100, "ncat": 105, "s": 0.6003686327077749, "os": 0.5999644491494063, "bg": 8.357276591039971e-06}, {"x": 0.9621313672922251, "y": 0.7794906166219839, "term": "aefi", "cat25k": 2, "ncat25k": 16, "cat": 15, "ncat": 105, "s": 0.024966487935656836, "os": 0.09630938464117633, "bg": 0.00076904097386222}, {"x": 0.962298927613941, "y": 0.9564343163538874, "term": "reporting", "cat25k": 13, "ncat25k": 16, "cat": 84, "ncat": 106, "s": 0.41236595174262736, "os": 0.42536364876968774, "bg": 9.919695367199452e-06}, {"x": 0.9624664879356568, "y": 0.9812332439678284, "term": "necessary", "cat25k": 27, "ncat25k": 16, "cat": 166, "ncat": 106, "s": 0.7533512064343164, "os": 0.7254969834748917, "bg": 7.460574770908926e-06}, {"x": 0.9626340482573726, "y": 0.9651474530831099, "term": "country", "cat25k": 16, "ncat25k": 16, "cat": 101, "ncat": 107, "s": 0.59936327077748, "os": 0.5977332206238296, "bg": 2.2010193862560085e-06}, {"x": 0.9628016085790885, "y": 0.9817359249329759, "term": "act", "cat25k": 28, "ncat25k": 16, "cat": 175, "ncat": 107, "s": 0.7595509383378016, "os": 0.7352369912834271, "bg": 3.989010587032134e-06}, {"x": 0.9629691689008043, "y": 0.8944369973190348, "term": "testing", "cat25k": 6, "ncat25k": 16, "cat": 37, "ncat": 107, "s": 0.2121313672922252, "os": 0.21875720909159563, "bg": 5.063637795456672e-06}, {"x": 0.9631367292225201, "y": 0.9400134048257373, "term": "team", "cat25k": 10, "ncat25k": 16, "cat": 63, "ncat": 107, "s": 0.3399798927613941, "os": 0.3419193629183429, "bg": 1.9767447376962056e-06}, {"x": 0.963304289544236, "y": 0.9782171581769437, "term": "develop", "cat25k": 24, "ncat25k": 16, "cat": 149, "ncat": 107, "s": 0.7106233243967829, "os": 0.6980945252342501, "bg": 9.155405116036803e-06}, {"x": 0.9634718498659517, "y": 0.948558981233244, "term": "unit", "cat25k": 12, "ncat25k": 17, "cat": 72, "ncat": 110, "s": 0.36226541554959785, "os": 0.37044898327986886, "bg": 3.871249062764221e-06}, {"x": 0.9636394101876675, "y": 0.9036528150134048, "term": "standard", "cat25k": 7, "ncat25k": 17, "cat": 41, "ncat": 110, "s": 0.22469839142091155, "os": 0.23343595266192008, "bg": 2.047605887666985e-06}, {"x": 0.9638069705093834, "y": 0.8609249329758714, "term": "strategy", "cat25k": 4, "ncat25k": 17, "cat": 27, "ncat": 111, "s": 0.09433646112600536, "os": 0.15822746038570856, "bg": 4.801482196678105e-06}, {"x": 0.9639745308310992, "y": 0.2603887399463807, "term": "weight", "cat25k": 0, "ncat25k": 17, "cat": 2, "ncat": 111, "s": 0.004021447721179625, "os": 0.01437965565655075, "bg": 2.4884762080203145e-06}, {"x": 0.964142091152815, "y": 0.9658176943699732, "term": "each", "cat25k": 17, "ncat25k": 17, "cat": 103, "ncat": 112, "s": 0.5874664879356569, "os": 0.5910850831681647, "bg": 1.2602393420767528e-06}, {"x": 0.9643096514745308, "y": 0.017761394101876677, "term": "micronutrient", "cat25k": 0, "ncat25k": 17, "cat": 0, "ncat": 112, "s": 0.0015080428954423592, "os": 0.00253676114318796, "bg": 0.0004749505966566871}, {"x": 0.9644772117962467, "y": 0.9862600536193029, "term": "non", "cat25k": 38, "ncat25k": 17, "cat": 238, "ncat": 113, "s": 0.8217158176943701, "os": 0.7874295834706623, "bg": 3.573940384587041e-06}, {"x": 0.9646447721179625, "y": 0.7652479892761395, "term": "method", "cat25k": 2, "ncat25k": 17, "cat": 15, "ncat": 114, "s": 0.02195040214477212, "os": 0.08787186421145826, "bg": 3.0456275377425853e-06}, {"x": 0.9648123324396782, "y": 0.9723525469168901, "term": "iii", "cat25k": 20, "ncat25k": 17, "cat": 123, "ncat": 114, "s": 0.646112600536193, "os": 0.6340154272142484, "bg": 8.171091907666041e-06}, {"x": 0.9649798927613941, "y": 0.9876005361930295, "term": "patient", "cat25k": 40, "ncat25k": 17, "cat": 250, "ncat": 115, "s": 0.824396782841823, "os": 0.7933991756385854, "bg": 1.7027104421236945e-05}, {"x": 0.9651474530831099, "y": 0.9684986595174263, "term": "committee", "cat25k": 18, "ncat25k": 17, "cat": 111, "ncat": 116, "s": 0.6018766756032171, "os": 0.6021490937576408, "bg": 3.731772122080766e-06}, {"x": 0.9653150134048257, "y": 0.9086796246648794, "term": "city", "cat25k": 7, "ncat25k": 17, "cat": 43, "ncat": 116, "s": 0.22184986595174264, "os": 0.23179492378171124, "bg": 8.135552612822135e-07}, {"x": 0.9654825737265416, "y": 0.9785522788203753, "term": "but", "cat25k": 24, "ncat25k": 18, "cat": 151, "ncat": 117, "s": 0.6950402144772118, "os": 0.679743479640349, "bg": 5.358864569133956e-07}, {"x": 0.9656501340482574, "y": 0.988103217158177, "term": "drugs", "cat25k": 43, "ncat25k": 18, "cat": 267, "ncat": 117, "s": 0.8307640750670241, "os": 0.8023101292346995, "bg": 1.9622122379344834e-05}, {"x": 0.9658176943699732, "y": 0.9929624664879356, "term": "prevention", "cat25k": 60, "ncat25k": 18, "cat": 372, "ncat": 118, "s": 0.9490616621983914, "os": 0.8540948082246276, "bg": 3.3799658250965636e-05}, {"x": 0.965985254691689, "y": 0.9735254691689008, "term": "effective", "cat25k": 20, "ncat25k": 18, "cat": 126, "ncat": 119, "s": 0.6414209115281502, "os": 0.6292715133120167, "bg": 6.424289667602533e-06}, {"x": 0.9661528150134048, "y": 0.9679959785522788, "term": "implementing", "cat25k": 18, "ncat25k": 18, "cat": 110, "ncat": 119, "s": 0.5889745308310992, "os": 0.5929931608442495, "bg": 3.294891967830344e-05}, {"x": 0.9663203753351206, "y": 0.0023458445040214475, "term": "iron", "cat25k": 0, "ncat25k": 18, "cat": 0, "ncat": 119, "s": 0.0010053619302949064, "os": 0.0017204121890115887, "bg": 7.241868393525685e-06}, {"x": 0.9664879356568364, "y": 0.9767091152815014, "term": "i.", "cat25k": 23, "ncat25k": 18, "cat": 145, "ncat": 120, "s": 0.6730898123324397, "os": 0.663352567290882, "bg": 0.0}, {"x": 0.9666554959785523, "y": 0.9760388739946381, "term": "well", "cat25k": 23, "ncat25k": 18, "cat": 142, "ncat": 120, "s": 0.6687332439678284, "os": 0.6580580215311729, "bg": 1.4459361679778703e-06}, {"x": 0.9668230563002681, "y": 0.9686662198391421, "term": "lgus", "cat25k": 18, "ncat25k": 18, "cat": 111, "ncat": 121, "s": 0.5872989276139411, "os": 0.5910536300811383, "bg": 0.0012911340275033809}, {"x": 0.9669906166219839, "y": 0.8751675603217158, "term": "follow", "cat25k": 5, "ncat25k": 18, "cat": 31, "ncat": 122, "s": 0.11293565683646113, "os": 0.1638786373720464, "bg": 4.415896395797314e-06}, {"x": 0.9671581769436998, "y": 0.8022788203753352, "term": "safe", "cat25k": 3, "ncat25k": 18, "cat": 18, "ncat": 122, "s": 0.025804289544235925, "os": 0.09741474151839397, "bg": 4.410823259209921e-06}, {"x": 0.9673257372654156, "y": 0.9152144772117963, "term": "immediately", "cat25k": 8, "ncat25k": 18, "cat": 47, "ncat": 123, "s": 0.22536863270777482, "os": 0.23764360588562394, "bg": 8.907517360423853e-06}, {"x": 0.9674932975871313, "y": 0.9857573726541555, "term": "quality", "cat25k": 37, "ncat25k": 19, "cat": 229, "ncat": 124, "s": 0.7927278820375335, "os": 0.7612919772545017, "bg": 3.719276922203311e-06}, {"x": 0.9676608579088471, "y": 0.9773793565683646, "term": "philippines", "cat25k": 24, "ncat25k": 19, "cat": 147, "ncat": 125, "s": 0.6677278820375335, "os": 0.6565594163156634, "bg": 2.921167358618185e-05}, {"x": 0.967828418230563, "y": 0.9599530831099196, "term": "there", "cat25k": 14, "ncat25k": 19, "cat": 90, "ncat": 125, "s": 0.3817024128686327, "os": 0.39657983113854967, "bg": 6.129876018253842e-07}, {"x": 0.9679959785522788, "y": 0.9433646112600537, "term": "using", "cat25k": 11, "ncat25k": 19, "cat": 66, "ncat": 126, "s": 0.2954088471849866, "os": 0.3104409721117315, "bg": 1.4234821146089268e-06}, {"x": 0.9681635388739946, "y": 0.8119973190348525, "term": "hours", "cat25k": 3, "ncat25k": 19, "cat": 19, "ncat": 126, "s": 0.027312332439678285, "os": 0.09924129080050453, "bg": 1.4605524476174627e-06}, {"x": 0.9683310991957105, "y": 0.9676608579088471, "term": "essential", "cat25k": 18, "ncat25k": 19, "cat": 110, "ncat": 127, "s": 0.5713806970509384, "os": 0.5758213622733456, "bg": 1.2376086393229311e-05}, {"x": 0.9684986595174263, "y": 0.9711796246648794, "term": "e.", "cat25k": 19, "ncat25k": 19, "cat": 118, "ncat": 127, "s": 0.5906501340482573, "os": 0.5948050240939627, "bg": 0.0}, {"x": 0.9686662198391421, "y": 0.9237600536193029, "term": "provincial", "cat25k": 8, "ncat25k": 19, "cat": 52, "ncat": 128, "s": 0.23793565683646115, "os": 0.2505069782757107, "bg": 3.806768434276143e-05}, {"x": 0.9688337801608579, "y": 0.911695710455764, "term": "high", "cat25k": 7, "ncat25k": 19, "cat": 45, "ncat": 128, "s": 0.2139745308310992, "os": 0.22045930457552748, "bg": 1.0007945990945117e-06}, {"x": 0.9690013404825737, "y": 0.8721514745308311, "term": "hearing", "cat25k": 5, "ncat25k": 19, "cat": 30, "ncat": 128, "s": 0.07305630026809651, "os": 0.15155100856247522, "bg": 8.137269138142427e-06}, {"x": 0.9691689008042895, "y": 0.21816353887399464, "term": "rabies", "cat25k": 0, "ncat25k": 19, "cat": 1, "ncat": 128, "s": 0.00217828418230563, "os": 0.00609842866065774, "bg": 0.00019821163932549652}, {"x": 0.9693364611260054, "y": 0.9572721179624665, "term": "refers", "cat25k": 14, "ncat25k": 19, "cat": 85, "ncat": 129, "s": 0.3626005361930295, "os": 0.37139761549832867, "bg": 3.513567295321571e-05}, {"x": 0.9695040214477212, "y": 0.9178954423592494, "term": "staff", "cat25k": 8, "ncat25k": 19, "cat": 48, "ncat": 129, "s": 0.22201742627345847, "os": 0.23186369706501336, "bg": 2.331012860514021e-06}, {"x": 0.969671581769437, "y": 0.9931300268096515, "term": "medical", "cat25k": 60, "ncat25k": 20, "cat": 374, "ncat": 130, "s": 0.913706434316354, "os": 0.8407383970082112, "bg": 6.479525041557989e-06}, {"x": 0.9698391420911529, "y": 0.9304624664879356, "term": "planning", "cat25k": 9, "ncat25k": 20, "cat": 56, "ncat": 130, "s": 0.24430294906166222, "os": 0.26345424997117695, "bg": 3.570372678955428e-06}, {"x": 0.9700067024128687, "y": 0.9643096514745308, "term": "plan", "cat25k": 16, "ncat25k": 20, "cat": 98, "ncat": 130, "s": 0.40063672922252014, "os": 0.40968805767310296, "bg": 2.8312706316041363e-06}, {"x": 0.9701742627345844, "y": 0.03434986595174263, "term": "feeding", "cat25k": 0, "ncat25k": 20, "cat": 0, "ncat": 131, "s": 0.0008378016085790887, "os": 0.0008477756815390425, "bg": 2.2291131881568065e-05}, {"x": 0.9703418230563002, "y": 0.9800603217158177, "term": "under", "cat25k": 26, "ncat25k": 20, "cat": 159, "ncat": 132, "s": 0.6712466487935657, "os": 0.6626941274797916, "bg": 1.8558160456973848e-06}, {"x": 0.9705093833780161, "y": 0.9700067024128687, "term": "levels", "cat25k": 18, "ncat25k": 20, "cat": 115, "ncat": 132, "s": 0.574396782841823, "os": 0.577657276766158, "bg": 7.299804307614522e-06}, {"x": 0.9706769436997319, "y": 0.9388404825737265, "term": "least", "cat25k": 10, "ncat25k": 20, "cat": 62, "ncat": 132, "s": 0.2672587131367292, "os": 0.2834858148481755, "bg": 3.4785119273825853e-06}, {"x": 0.9708445040214477, "y": 0.9837466487935657, "term": "policies", "cat25k": 31, "ncat25k": 20, "cat": 194, "ncat": 133, "s": 0.7226876675603217, "os": 0.7092139887416976, "bg": 7.423035128560329e-06}, {"x": 0.9710120643431636, "y": 0.9716823056300268, "term": "general", "cat25k": 19, "ncat25k": 20, "cat": 120, "ncat": 134, "s": 0.5821045576407506, "os": 0.5851700532083726, "bg": 1.6278398868479521e-06}, {"x": 0.9711796246648794, "y": 0.9597855227882037, "term": "they", "cat25k": 14, "ncat25k": 20, "cat": 90, "ncat": 135, "s": 0.36494638069705093, "os": 0.37452162926023586, "bg": 5.093171087750066e-07}, {"x": 0.9713471849865952, "y": 0.9829088471849866, "term": "provided", "cat25k": 30, "ncat25k": 20, "cat": 188, "ncat": 136, "s": 0.7042560321715818, "os": 0.6965129623460803, "bg": 4.047517606857744e-06}, {"x": 0.971514745308311, "y": 0.9718498659517426, "term": "community", "cat25k": 19, "ncat25k": 20, "cat": 120, "ncat": 136, "s": 0.5777479892761394, "os": 0.5812520306554244, "bg": 1.953070388771249e-06}, {"x": 0.9716823056300268, "y": 0.9673257372654156, "term": "only", "cat25k": 18, "ncat25k": 21, "cat": 109, "ncat": 137, "s": 0.4120308310991957, "os": 0.4253080309798793, "bg": 7.430269671504168e-07}, {"x": 0.9718498659517426, "y": 0.9810656836461126, "term": "administrative", "cat25k": 26, "ncat25k": 21, "cat": 164, "ncat": 137, "s": 0.6704088471849866, "os": 0.6611587207008508, "bg": 1.5575051737243083e-05}, {"x": 0.9720174262734584, "y": 0.8930965147453083, "term": "vaccines", "cat25k": 6, "ncat25k": 21, "cat": 36, "ncat": 138, "s": 0.14024798927613943, "os": 0.16729120395182806, "bg": 9.801599294284851e-05}, {"x": 0.9721849865951743, "y": 0.2349195710455764, "term": "mothers", "cat25k": 0, "ncat25k": 21, "cat": 2, "ncat": 139, "s": 0.002848525469168901, "os": 0.009887403732941558, "bg": 2.918692976165353e-05}, {"x": 0.9723525469168901, "y": 0.9423592493297587, "term": "referral", "cat25k": 10, "ncat25k": 21, "cat": 65, "ncat": 140, "s": 0.2660857908847185, "os": 0.2805481831472625, "bg": 3.8484286068153425e-05}, {"x": 0.9725201072386059, "y": 0.9768766756032171, "term": "standards", "cat25k": 23, "ncat25k": 21, "cat": 145, "ncat": 140, "s": 0.638739946380697, "os": 0.6239658034199076, "bg": 6.909776023853031e-06}, {"x": 0.9726876675603218, "y": 0.9669906166219839, "term": "where", "cat25k": 17, "ncat25k": 21, "cat": 108, "ncat": 141, "s": 0.40281501340482573, "os": 0.41412781491996153, "bg": 1.3803405058884205e-06}, {"x": 0.9728552278820375, "y": 0.9746983914209115, "term": "assistance", "cat25k": 21, "ncat25k": 21, "cat": 131, "ncat": 141, "s": 0.5976876675603217, "os": 0.5952430113263442, "bg": 9.86521469082798e-06}, {"x": 0.9730227882037533, "y": 0.9757037533512064, "term": "evaluation", "cat25k": 22, "ncat25k": 21, "cat": 136, "ncat": 141, "s": 0.6052278820375335, "os": 0.6052140618638745, "bg": 1.1726899146444734e-05}, {"x": 0.9731903485254692, "y": 0.2149798927613941, "term": "infant", "cat25k": 0, "ncat25k": 21, "cat": 1, "ncat": 141, "s": 0.001843163538873995, "os": 0.0050677109787473085, "bg": 2.1398855221524113e-05}, {"x": 0.973357908847185, "y": 0.9740281501340483, "term": "population", "cat25k": 20, "ncat25k": 21, "cat": 127, "ncat": 142, "s": 0.5789209115281502, "os": 0.5850758321993068, "bg": 8.571755873206206e-06}, {"x": 0.9735254691689008, "y": 0.9879356568364611, "term": "patients", "cat25k": 42, "ncat25k": 21, "cat": 259, "ncat": 142, "s": 0.7888739946380697, "os": 0.7587082826746874, "bg": 1.3600448401018005e-05}, {"x": 0.9736930294906166, "y": 0.9160522788203753, "term": "workers", "cat25k": 8, "ncat25k": 21, "cat": 47, "ncat": 142, "s": 0.2044235924932976, "os": 0.20838842311991296, "bg": 7.831552829107023e-06}, {"x": 0.9738605898123325, "y": 0.9601206434316354, "term": "conduct", "cat25k": 14, "ncat25k": 22, "cat": 90, "ncat": 144, "s": 0.3515415549597855, "os": 0.356523744569439, "bg": 1.5462010830543892e-05}, {"x": 0.9740281501340483, "y": 0.9815683646112601, "term": "\u2019s", "cat25k": 28, "ncat25k": 22, "cat": 174, "ncat": 146, "s": 0.6695710455764076, "os": 0.6600738108560703, "bg": 0.0}, {"x": 0.974195710455764, "y": 0.9065013404825737, "term": "project", "cat25k": 7, "ncat25k": 22, "cat": 42, "ncat": 146, "s": 0.19152144772117966, "os": 0.18312411290390224, "bg": 1.5960964303562276e-06}, {"x": 0.9743632707774799, "y": 0.6539879356568364, "term": "vitamin", "cat25k": 1, "ncat25k": 22, "cat": 8, "ncat": 146, "s": 0.006869973190348526, "os": 0.03614817076206761, "bg": 2.27864617049097e-05}, {"x": 0.9745308310991957, "y": 0.012399463806970509, "term": "milk", "cat25k": 0, "ncat25k": 22, "cat": 0, "ncat": 146, "s": 0.0006702412868632708, "os": 0.00032411929174569476, "bg": 1.3729538990292086e-05}, {"x": 0.9746983914209115, "y": 0.9730227882037533, "term": "7", "cat25k": 20, "ncat25k": 22, "cat": 124, "ncat": 147, "s": 0.5623324396782842, "os": 0.5694818147663493, "bg": 0.0}, {"x": 0.9748659517426274, "y": 0.0025134048257372654, "term": "supplementation", "cat25k": 0, "ncat25k": 22, "cat": 0, "ncat": 147, "s": 0.0005026809651474532, "os": 0.0003030556844479948, "bg": 0.00017701907109543498}, {"x": 0.9750335120643432, "y": 0.9701742627345844, "term": "include", "cat25k": 19, "ncat25k": 22, "cat": 116, "ncat": 148, "s": 0.40800938337801607, "os": 0.4207810660902385, "bg": 2.886957630878584e-06}, {"x": 0.975201072386059, "y": 0.9780495978552279, "term": "d.", "cat25k": 24, "ncat25k": 23, "cat": 147, "ncat": 150, "s": 0.609416890080429, "os": 0.6095483281727601, "bg": 0.0}, {"x": 0.9753686327077749, "y": 0.7714477211796247, "term": "nutrition", "cat25k": 2, "ncat25k": 23, "cat": 15, "ncat": 150, "s": 0.015247989276139412, "os": 0.06563570785865386, "bg": 1.130040623248223e-05}, {"x": 0.9755361930294906, "y": 0.8659517426273459, "term": "day", "cat25k": 4, "ncat25k": 23, "cat": 28, "ncat": 152, "s": 0.03803619302949062, "os": 0.11971370302064127, "bg": 8.061838150380534e-07}, {"x": 0.9757037533512064, "y": 0.9819034852546917, "term": "centers", "cat25k": 28, "ncat25k": 23, "cat": 175, "ncat": 153, "s": 0.6601876675603218, "os": 0.6496784876942868, "bg": 1.8271320814006283e-05}, {"x": 0.9758713136729222, "y": 0.9892761394101877, "term": "related", "cat25k": 46, "ncat25k": 23, "cat": 287, "ncat": 154, "s": 0.7954088471849866, "os": 0.7631684703826858, "bg": 3.8109250579859044e-06}, {"x": 0.9760388739946381, "y": 0.9775469168900804, "term": "risk", "cat25k": 24, "ncat25k": 23, "cat": 147, "ncat": 156, "s": 0.5998659517426274, "os": 0.5992352588811504, "bg": 6.601422606571716e-06}, {"x": 0.9762064343163539, "y": 0.975201072386059, "term": "provision", "cat25k": 22, "ncat25k": 23, "cat": 134, "ncat": 156, "s": 0.5698726541554959, "os": 0.5745502574792448, "bg": 2.1164645947767625e-05}, {"x": 0.9763739946380697, "y": 0.9576072386058981, "term": "section", "cat25k": 14, "ncat25k": 24, "cat": 86, "ncat": 157, "s": 0.30278150134048254, "os": 0.3213204705213158, "bg": 2.089745936600823e-06}, {"x": 0.9765415549597856, "y": 0.9872654155495979, "term": "disease", "cat25k": 40, "ncat25k": 24, "cat": 246, "ncat": 157, "s": 0.7535187667560322, "os": 0.7256776099156741, "bg": 1.3244960633462756e-05}, {"x": 0.9767091152815014, "y": 0.9708445040214477, "term": "more", "cat25k": 19, "ncat25k": 24, "cat": 118, "ncat": 158, "s": 0.3959450402144772, "os": 0.40664460716241857, "bg": 3.5726215117277903e-07}, {"x": 0.9768766756032171, "y": 0.947553619302949, "term": "family", "cat25k": 11, "ncat25k": 24, "cat": 71, "ncat": 158, "s": 0.25821045576407503, "os": 0.272685814614115, "bg": 1.7997750917736952e-06}, {"x": 0.977044235924933, "y": 0.9765415549597856, "term": "than", "cat25k": 23, "ncat25k": 24, "cat": 144, "ncat": 160, "s": 0.5832774798927615, "os": 0.5870681531991738, "bg": 1.208936099328226e-06}, {"x": 0.9772117962466488, "y": 0.9803954423592494, "term": "available", "cat25k": 26, "ncat25k": 24, "cat": 159, "ncat": 162, "s": 0.6099195710455764, "os": 0.6100340963242487, "bg": 1.6896661505245407e-06}, {"x": 0.9773793565683646, "y": 0.9755361930294906, "term": "years", "cat25k": 22, "ncat25k": 24, "cat": 135, "ncat": 162, "s": 0.560656836461126, "os": 0.5665278179279117, "bg": 1.7565983771698422e-06}, {"x": 0.9775469168900804, "y": 0.9924597855227882, "term": "control", "cat25k": 57, "ncat25k": 24, "cat": 353, "ncat": 163, "s": 0.8242292225201072, "os": 0.7926870554517766, "bg": 4.7805902255663136e-06}, {"x": 0.9777144772117963, "y": 0.985254691689008, "term": "policy", "cat25k": 35, "ncat25k": 24, "cat": 220, "ncat": 163, "s": 0.7019101876675603, "os": 0.6907820138805812, "bg": 1.991088408151539e-06}, {"x": 0.9778820375335121, "y": 0.989946380697051, "term": "department", "cat25k": 47, "ncat25k": 25, "cat": 293, "ncat": 164, "s": 0.7868632707774799, "os": 0.754367971302123, "bg": 4.625371735787491e-06}, {"x": 0.9780495978552279, "y": 0.9554289544235925, "term": "when", "cat25k": 13, "ncat25k": 25, "cat": 82, "ncat": 165, "s": 0.2860254691689008, "os": 0.2967370671821703, "bg": 7.589102259315378e-07}, {"x": 0.9782171581769437, "y": 0.9758713136729222, "term": "among", "cat25k": 22, "ncat25k": 25, "cat": 137, "ncat": 167, "s": 0.558813672922252, "os": 0.5623967837268699, "bg": 7.260234545459345e-06}, {"x": 0.9783847184986595, "y": 0.7637399463806971, "term": "vaccination", "cat25k": 2, "ncat25k": 25, "cat": 14, "ncat": 167, "s": 0.011226541554959786, "os": 0.05492605630885666, "bg": 0.0001215166758139855}, {"x": 0.9785522788203753, "y": 0.9054959785522788, "term": "&", "cat25k": 7, "ncat25k": 25, "cat": 42, "ncat": 168, "s": 0.09550938337801608, "os": 0.1603589475250946, "bg": 0.0}, {"x": 0.9787198391420912, "y": 0.9835790884718498, "term": "units", "cat25k": 31, "ncat25k": 26, "cat": 193, "ncat": 170, "s": 0.6588471849865951, "os": 0.6477991406839495, "bg": 1.2776150509951425e-05}, {"x": 0.978887399463807, "y": 0.9344839142091153, "term": "age", "cat25k": 9, "ncat25k": 26, "cat": 59, "ncat": 171, "s": 0.21146112600536196, "os": 0.21612708050076268, "bg": 3.4576599095924162e-06}, {"x": 0.9790549597855228, "y": 0.9504021447721179, "term": "food", "cat25k": 12, "ncat25k": 26, "cat": 74, "ncat": 171, "s": 0.2451407506702413, "os": 0.2639749223898239, "bg": 2.715339876515541e-06}, {"x": 0.9792225201072386, "y": 0.9646447721179625, "term": "areas", "cat25k": 16, "ncat25k": 26, "cat": 100, "ncat": 172, "s": 0.33579088471849866, "os": 0.33687063244489535, "bg": 4.448131014727599e-06}, {"x": 0.9793900804289544, "y": 0.3401474530831099, "term": "infants", "cat25k": 0, "ncat25k": 26, "cat": 3, "ncat": 173, "s": 0.0030160857908847183, "os": 0.011356433692642387, "bg": 5.039146437309153e-05}, {"x": 0.9795576407506702, "y": 0.9763739946380697, "term": "one", "cat25k": 23, "ncat25k": 26, "cat": 143, "ncat": 175, "s": 0.557808310991957, "os": 0.5614365609731412, "bg": 6.399363083869008e-07}, {"x": 0.979725201072386, "y": 0.9566018766756033, "term": "coverage", "cat25k": 13, "ncat25k": 26, "cat": 84, "ncat": 176, "s": 0.26742627345844505, "os": 0.2868713008300453, "bg": 1.1835996337669595e-05}, {"x": 0.9798927613941019, "y": 0.9772117962466488, "term": "level", "cat25k": 23, "ncat25k": 27, "cat": 146, "ncat": 178, "s": 0.5589812332439679, "os": 0.562468255022659, "bg": 3.194070495984879e-06}, {"x": 0.9800603217158177, "y": 0.8622654155495979, "term": "b", "cat25k": 4, "ncat25k": 27, "cat": 28, "ncat": 179, "s": 0.027982573726541556, "os": 0.10190367587097149, "bg": 9.85531591622237e-07}, {"x": 0.9802278820375335, "y": 0.9783847184986595, "term": "technical", "cat25k": 24, "ncat25k": 27, "cat": 150, "ncat": 180, "s": 0.5611595174262735, "os": 0.5667142543274603, "bg": 6.401232264367633e-06}, {"x": 0.9803954423592494, "y": 0.9452077747989276, "term": "been", "cat25k": 11, "ncat25k": 27, "cat": 68, "ncat": 181, "s": 0.22319034852546918, "os": 0.23324090224114824, "bg": 8.65587793868881e-07}, {"x": 0.9805630026809652, "y": 0.9073391420911529, "term": "months", "cat25k": 7, "ncat25k": 27, "cat": 43, "ncat": 181, "s": 0.07339142091152816, "os": 0.1527475252575467, "bg": 4.017777301384183e-06}, {"x": 0.9807305630026809, "y": 0.9882707774798928, "term": "information", "cat25k": 43, "ncat25k": 27, "cat": 267, "ncat": 182, "s": 0.7241957104557641, "os": 0.7105585113814644, "bg": 9.625827646856891e-07}, {"x": 0.9808981233243967, "y": 0.9839142091152815, "term": "including", "cat25k": 32, "ncat25k": 27, "cat": 197, "ncat": 182, "s": 0.6472855227882038, "os": 0.6355740400658294, "bg": 3.5336711519846743e-06}, {"x": 0.9810656836461126, "y": 0.9683310991957105, "term": "training", "cat25k": 18, "ncat25k": 28, "cat": 111, "ncat": 185, "s": 0.34215817694369977, "os": 0.34527289703296893, "bg": 3.355221487210199e-06}, {"x": 0.9812332439678284, "y": 0.9442024128686327, "term": "-", "cat25k": 11, "ncat25k": 28, "cat": 67, "ncat": 187, "s": 0.2154825737265416, "os": 0.22356379790516218, "bg": 0.0}, {"x": 0.9814008042895442, "y": 0.23274128686327078, "term": "mother", "cat25k": 0, "ncat25k": 29, "cat": 2, "ncat": 190, "s": 0.002513404825737266, "os": 0.006871970431140184, "bg": 6.649943329148314e-06}, {"x": 0.9815683646112601, "y": 0.9824061662198391, "term": "appropriate", "cat25k": 28, "ncat25k": 29, "cat": 177, "ncat": 191, "s": 0.5908176943699732, "os": 0.5949668059135808, "bg": 1.051676075881058e-05}, {"x": 0.9817359249329759, "y": 0.9736930294906166, "term": "used", "cat25k": 20, "ncat25k": 29, "cat": 126, "ncat": 195, "s": 0.3599195710455764, "os": 0.3655052776230372, "bg": 1.5222273034527906e-06}, {"x": 0.9819034852546917, "y": 0.9328083109919572, "term": "given", "cat25k": 9, "ncat25k": 30, "cat": 58, "ncat": 198, "s": 0.19185656836461126, "os": 0.18599892163748744, "bg": 4.068167905907154e-06}, {"x": 0.9820710455764075, "y": 0.464142091152815, "term": "maternal", "cat25k": 1, "ncat25k": 30, "cat": 4, "ncat": 198, "s": 0.0035187667560321718, "os": 0.013187320274431369, "bg": 0.00010448572205194439}, {"x": 0.9822386058981233, "y": 0.9870978552278821, "term": "its", "cat25k": 39, "ncat25k": 30, "cat": 245, "ncat": 199, "s": 0.682808310991957, "os": 0.6682384625051908, "bg": 1.6884050143210399e-06}, {"x": 0.9824061662198391, "y": 0.9854222520107239, "term": "center", "cat25k": 36, "ncat25k": 30, "cat": 224, "ncat": 199, "s": 0.6578418230563002, "os": 0.645623176977565, "bg": 2.8713834255426416e-06}, {"x": 0.982573726541555, "y": 0.9877680965147453, "term": "service", "cat25k": 41, "ncat25k": 30, "cat": 255, "ncat": 200, "s": 0.6908512064343163, "os": 0.6769050327792017, "bg": 1.7505061857944865e-06}, {"x": 0.9827412868632708, "y": 0.9867627345844504, "term": "system", "cat25k": 39, "ncat25k": 30, "cat": 240, "ncat": 200, "s": 0.670911528150134, "os": 0.6618289678686212, "bg": 2.215021082407053e-06}, {"x": 0.9829088471849866, "y": 0.9847520107238605, "term": "c.", "cat25k": 34, "ncat25k": 30, "cat": 213, "ncat": 201, "s": 0.641588471849866, "os": 0.6300978124588597, "bg": 0.0}, {"x": 0.9830764075067024, "y": 0.9911193029490617, "term": "hospital", "cat25k": 52, "ncat25k": 30, "cat": 321, "ncat": 203, "s": 0.7538538873994638, "os": 0.7277416136997273, "bg": 1.717095928087236e-05}, {"x": 0.9832439678284183, "y": 0.9100201072386059, "term": "days", "cat25k": 7, "ncat25k": 30, "cat": 44, "ncat": 203, "s": 0.055630026809651484, "os": 0.13990358545103282, "bg": 1.6172330520728256e-06}, {"x": 0.983411528150134, "y": 0.9721849865951743, "term": "laboratory", "cat25k": 20, "ncat25k": 31, "cat": 122, "ncat": 204, "s": 0.3418230563002681, "os": 0.34438550932624123, "bg": 2.0205045261780534e-05}, {"x": 0.9835790884718498, "y": 0.9693364611260054, "term": "delivery", "cat25k": 18, "ncat25k": 31, "cat": 112, "ncat": 205, "s": 0.30093833780160856, "os": 0.32056585150657113, "bg": 5.39887961496485e-06}, {"x": 0.9837466487935657, "y": 0.6936997319034852, "term": "dose", "cat25k": 2, "ncat25k": 31, "cat": 10, "ncat": 209, "s": 0.006032171581769437, "os": 0.03129033627080585, "bg": 2.6918457906691652e-05}, {"x": 0.9839142091152815, "y": 0.005697050938337802, "term": "nfp", "cat25k": 0, "ncat25k": 32, "cat": 0, "ncat": 215, "s": 0.00033512064343163545, "os": 1.2330505946289705e-06, "bg": 0.0007741526629051248}, {"x": 0.9840817694369973, "y": 0.99078418230563, "term": "use", "cat25k": 49, "ncat25k": 32, "cat": 308, "ncat": 216, "s": 0.719671581769437, "os": 0.7038931878357229, "bg": 1.4549639954859576e-06}, {"x": 0.9842493297587132, "y": 0.9939678284182306, "term": "hospitals", "cat25k": 64, "ncat25k": 33, "cat": 397, "ncat": 217, "s": 0.7890415549597856, "os": 0.7593410896329793, "bg": 6.664137044179538e-05}, {"x": 0.984416890080429, "y": 0.9790549597855228, "term": "also", "cat25k": 24, "ncat25k": 33, "cat": 152, "ncat": 217, "s": 0.37550268096514744, "os": 0.388168025641483, "bg": 1.195834862451801e-06}, {"x": 0.9845844504021448, "y": 0.9845844504021448, "term": "private", "cat25k": 34, "ncat25k": 33, "cat": 211, "ncat": 217, "s": 0.6082439678284183, "os": 0.6076521554674934, "bg": 4.548394795758556e-06}, {"x": 0.9847520107238605, "y": 0.6298592493297587, "term": "birth", "cat25k": 1, "ncat25k": 33, "cat": 8, "ncat": 218, "s": 0.0051943699731903485, "os": 0.023981258036751107, "bg": 1.2350316284222639e-05}, {"x": 0.9849195710455764, "y": 0.9798927613941019, "term": "6", "cat25k": 25, "ncat25k": 33, "cat": 158, "ncat": 221, "s": 0.38069705093833783, "os": 0.3940053053386629, "bg": 0.0}, {"x": 0.9850871313672922, "y": 0.001675603217158177, "term": "hepatitis", "cat25k": 0, "ncat25k": 33, "cat": 0, "ncat": 221, "s": 0.0001675603217158177, "os": 6.934609504960498e-07, "bg": 7.43535447127228e-05}, {"x": 0.985254691689008, "y": 0.9869302949061662, "term": "through", "cat25k": 39, "ncat25k": 34, "cat": 244, "ncat": 225, "s": 0.6474530831099197, "os": 0.6360604080309586, "bg": 2.73720181677014e-06}, {"x": 0.9854222520107239, "y": 0.9855898123324397, "term": "no", "cat25k": 36, "ncat25k": 34, "cat": 227, "ncat": 229, "s": 0.6134383378016086, "os": 0.6127073007153884, "bg": 9.728781073242708e-07}, {"x": 0.9855898123324397, "y": 0.9795576407506702, "term": "facility", "cat25k": 25, "ncat25k": 34, "cat": 156, "ncat": 229, "s": 0.3679624664879357, "os": 0.38027692608962615, "bg": 1.7357203470493936e-05}, {"x": 0.9857573726541555, "y": 0.9668230563002681, "term": "after", "cat25k": 17, "ncat25k": 35, "cat": 107, "ncat": 234, "s": 0.2597184986595174, "os": 0.2766710352252131, "bg": 1.8271426988160054e-06}, {"x": 0.9859249329758714, "y": 0.9840817694369973, "term": "5", "cat25k": 32, "ncat25k": 35, "cat": 198, "ncat": 234, "s": 0.5633378016085792, "os": 0.5708853203661528, "bg": 0.0}, {"x": 0.9860924932975871, "y": 0.9706769436997319, "term": "has", "cat25k": 19, "ncat25k": 35, "cat": 118, "ncat": 236, "s": 0.2902144772117963, "os": 0.2981866744561119, "bg": 6.764553352521957e-07}, {"x": 0.9862600536193029, "y": 0.9703418230563002, "term": "within", "cat25k": 19, "ncat25k": 36, "cat": 117, "ncat": 237, "s": 0.28418230563002683, "os": 0.29505377483987444, "bg": 2.705354571890077e-06}, {"x": 0.9864276139410187, "y": 0.925603217158177, "term": "surveillance", "cat25k": 8, "ncat25k": 36, "cat": 52, "ncat": 238, "s": 0.06015415549597856, "os": 0.14097823341994142, "bg": 5.448561260428828e-05}, {"x": 0.9865951742627346, "y": 0.9842493297587132, "term": "activities", "cat25k": 33, "ncat25k": 36, "cat": 203, "ncat": 239, "s": 0.5638404825737265, "os": 0.5718947438608536, "bg": 6.646737032202891e-06}, {"x": 0.9867627345844504, "y": 0.9860924932975871, "term": "based", "cat25k": 38, "ncat25k": 36, "cat": 238, "ncat": 241, "s": 0.6110924932975872, "os": 0.6117237465038559, "bg": 3.790791968459344e-06}, {"x": 0.9869302949061662, "y": 0.005361930294906166, "term": "breastfeeding", "cat25k": 0, "ncat25k": 36, "cat": 0, "ncat": 242, "s": 0.0, "os": 8.234521886585355e-08, "bg": 0.0001555502848434245}, {"x": 0.9870978552278821, "y": 0.9579423592493298, "term": "up", "cat25k": 14, "ncat25k": 37, "cat": 87, "ncat": 247, "s": 0.21263404825737267, "os": 0.2201519930157959, "bg": 8.045462499765065e-07}, {"x": 0.9872654155495979, "y": 0.984416890080429, "term": "4", "cat25k": 33, "ncat25k": 38, "cat": 203, "ncat": 251, "s": 0.5564678284182306, "os": 0.55888008157639, "bg": 0.0}, {"x": 0.9874329758713136, "y": 0.9748659517426274, "term": "can", "cat25k": 21, "ncat25k": 38, "cat": 132, "ncat": 252, "s": 0.2949061662198391, "os": 0.30980665536562335, "bg": 6.180410827358722e-07}, {"x": 0.9876005361930295, "y": 0.9886058981233244, "term": "such", "cat25k": 43, "ncat25k": 38, "cat": 270, "ncat": 256, "s": 0.6409182305630027, "os": 0.6288703312700179, "bg": 2.760876775206697e-06}, {"x": 0.9877680965147453, "y": 0.9849195710455764, "term": "monitoring", "cat25k": 35, "ncat25k": 38, "cat": 215, "ncat": 256, "s": 0.5618297587131367, "os": 0.5688996676721644, "bg": 2.245001600457351e-05}, {"x": 0.9879356568364611, "y": 0.9919571045576407, "term": "any", "cat25k": 55, "ncat25k": 39, "cat": 342, "ncat": 257, "s": 0.6997319034852547, "os": 0.687362091269986, "bg": 1.6848231701225205e-06}, {"x": 0.988103217158177, "y": 0.9249329758713136, "term": "during", "cat25k": 8, "ncat25k": 39, "cat": 52, "ncat": 257, "s": 0.04775469168900805, "os": 0.13092582272660386, "bg": 2.990176529813141e-06}, {"x": 0.9882707774798928, "y": 0.9958109919571045, "term": "government", "cat25k": 99, "ncat25k": 39, "cat": 615, "ncat": 262, "s": 0.8357908847184986, "os": 0.8073497377861285, "bg": 8.47770947486066e-06}, {"x": 0.9884383378016086, "y": 0.9339812332439679, "term": "case", "cat25k": 9, "ncat25k": 39, "cat": 58, "ncat": 262, "s": 0.06132707774798928, "os": 0.14276460272926106, "bg": 2.7132983504668016e-06}, {"x": 0.9886058981233244, "y": 0.9946380697050938, "term": "development", "cat25k": 70, "ncat25k": 40, "cat": 438, "ncat": 265, "s": 0.7608914209115282, "os": 0.7375927004435285, "bg": 4.9057223614943e-06}, {"x": 0.9887734584450402, "y": 0.9859249329758714, "term": "support", "cat25k": 37, "ncat25k": 40, "cat": 232, "ncat": 268, "s": 0.5738941018766756, "os": 0.5769430852240989, "bg": 2.6750482992008135e-06}, {"x": 0.988941018766756, "y": 0.9902815013404825, "term": "which", "cat25k": 48, "ncat25k": 41, "cat": 297, "ncat": 273, "s": 0.6481233243967829, "os": 0.6368827612998273, "bg": 1.405972600218504e-06}, {"x": 0.9891085790884718, "y": 0.9814008042895442, "term": "regional", "cat25k": 27, "ncat25k": 41, "cat": 169, "ncat": 273, "s": 0.344671581769437, "os": 0.3537269139410012, "bg": 1.1323866725928238e-05}, {"x": 0.9892761394101877, "y": 0.9850871313672922, "term": "public", "cat25k": 35, "ncat25k": 41, "cat": 217, "ncat": 274, "s": 0.40985254691689005, "os": 0.423710843832552, "bg": 2.8089359667319696e-06}, {"x": 0.9894436997319035, "y": 0.9914544235924933, "term": "treatment", "cat25k": 52, "ncat25k": 42, "cat": 326, "ncat": 283, "s": 0.6611930294906166, "os": 0.6515091455176083, "bg": 1.348619847029306e-05}, {"x": 0.9896112600536193, "y": 0.9827412868632708, "term": "may", "cat25k": 30, "ncat25k": 43, "cat": 187, "ncat": 286, "s": 0.36193029490616624, "os": 0.36878636111944535, "bg": 1.1423265706336466e-06}, {"x": 0.9897788203753352, "y": 0.9333109919571045, "term": "cases", "cat25k": 9, "ncat25k": 43, "cat": 58, "ncat": 286, "s": 0.047922252010723865, "os": 0.13121497254105063, "bg": 7.94751185929337e-06}, {"x": 0.989946380697051, "y": 0.9894436997319035, "term": "b.", "cat25k": 46, "ncat25k": 43, "cat": 288, "ncat": 286, "s": 0.6293565683646113, "os": 0.6168260029635712, "bg": 0.0}, {"x": 0.9901139410187667, "y": 0.9220844504021448, "term": "vaccine", "cat25k": 8, "ncat25k": 44, "cat": 50, "ncat": 292, "s": 0.03300938337801609, "os": 0.11131979084738419, "bg": 9.138517072526825e-05}, {"x": 0.9902815013404825, "y": 0.9906166219839142, "term": "a.", "cat25k": 49, "ncat25k": 45, "cat": 306, "ncat": 297, "s": 0.6365616621983915, "os": 0.6227946543258116, "bg": 0.0}, {"x": 0.9904490616621984, "y": 0.9953083109919572, "term": "facilities", "cat25k": 76, "ncat25k": 45, "cat": 475, "ncat": 303, "s": 0.7536863270777481, "os": 0.7257898513410306, "bg": 2.1943970049470675e-05}, {"x": 0.9906166219839142, "y": 0.9926273458445041, "term": "local", "cat25k": 57, "ncat25k": 47, "cat": 353, "ncat": 311, "s": 0.6586796246648793, "os": 0.6477501036823223, "bg": 4.899364615864949e-06}, {"x": 0.99078418230563, "y": 0.982573726541555, "term": "these", "cat25k": 29, "ncat25k": 47, "cat": 182, "ncat": 312, "s": 0.3359584450402145, "os": 0.33772886718915, "bg": 1.825180134518473e-06}, {"x": 0.9909517426273459, "y": 0.6606903485254692, "term": "child", "cat25k": 1, "ncat25k": 47, "cat": 9, "ncat": 314, "s": 0.0041890080428954425, "os": 0.01871756922640705, "bg": 5.3806576667920795e-06}, {"x": 0.9911193029490617, "y": 0.939343163538874, "term": "immunization", "cat25k": 10, "ncat25k": 48, "cat": 62, "ncat": 321, "s": 0.04406836461126006, "os": 0.12516683263271533, "bg": 0.0002817840239494348}, {"x": 0.9912868632707775, "y": 0.9916219839142091, "term": "guidelines", "cat25k": 53, "ncat25k": 48, "cat": 332, "ncat": 322, "s": 0.6367292225201072, "os": 0.6229847819217724, "bg": 2.8734697894634166e-05}, {"x": 0.9914544235924933, "y": 0.9194034852546917, "term": "women", "cat25k": 8, "ncat25k": 49, "cat": 49, "ncat": 328, "s": 0.025636729222520107, "os": 0.09737385522646885, "bg": 3.1050172553097844e-06}, {"x": 0.9916219839142091, "y": 0.993632707774799, "term": "ensure", "cat25k": 62, "ncat25k": 49, "cat": 387, "ncat": 329, "s": 0.6678954423592494, "os": 0.6568053176959202, "bg": 2.393837046463792e-05}, {"x": 0.9917895442359249, "y": 0.9941353887399463, "term": "order", "cat25k": 66, "ncat25k": 50, "cat": 410, "ncat": 336, "s": 0.6818029490616622, "os": 0.666016851816648, "bg": 4.4280369648489545e-06}, {"x": 0.9919571045576407, "y": 0.9728552278820375, "term": "if", "cat25k": 20, "ncat25k": 51, "cat": 124, "ncat": 338, "s": 0.21715817694369974, "os": 0.2283371167595843, "bg": 8.138815596534939e-07}, {"x": 0.9921246648793566, "y": 0.9864276139410187, "term": "have", "cat25k": 38, "ncat25k": 52, "cat": 239, "ncat": 343, "s": 0.37215147453083114, "os": 0.386674702397063, "bg": 7.440003994745238e-07}, {"x": 0.9922922252010724, "y": 0.9891085790884718, "term": "3", "cat25k": 46, "ncat25k": 52, "cat": 284, "ncat": 343, "s": 0.5601541554959786, "os": 0.565123501430124, "bg": 0.0}, {"x": 0.9924597855227882, "y": 0.9971514745308311, "term": "program", "cat25k": 132, "ncat25k": 52, "cat": 825, "ncat": 345, "s": 0.8362935656836461, "os": 0.8106114262547733, "bg": 7.6221471060710684e-06}, {"x": 0.9926273458445041, "y": 0.9897788203753352, "term": "management", "cat25k": 47, "ncat25k": 52, "cat": 293, "ncat": 347, "s": 0.5625000000000001, "os": 0.5703313919844479, "bg": 4.203421510235886e-06}, {"x": 0.9927949061662198, "y": 0.9932975871313673, "term": "implementation", "cat25k": 61, "ncat25k": 53, "cat": 381, "ncat": 354, "s": 0.6462801608579088, "os": 0.6341095676018084, "bg": 3.112603579824434e-05}, {"x": 0.9929624664879356, "y": 0.9887734584450402, "term": "it", "cat25k": 44, "ncat25k": 53, "cat": 273, "ncat": 355, "s": 0.4031501340482574, "os": 0.41509474033964655, "bg": 4.4642278629422864e-07}, {"x": 0.9931300268096515, "y": 0.153485254691689, "term": "measles", "cat25k": 0, "ncat25k": 53, "cat": 1, "ncat": 356, "s": 0.001172922252010724, "os": 0.001828831087721916, "bg": 0.0004729670201554167}, {"x": 0.9932975871313673, "y": 0.9896112600536193, "term": "will", "cat25k": 47, "ncat25k": 54, "cat": 290, "ncat": 358, "s": 0.5568029490616622, "os": 0.5593059165767627, "bg": 9.553251017539543e-07}, {"x": 0.9934651474530831, "y": 0.988941018766756, "term": "1", "cat25k": 44, "ncat25k": 54, "cat": 277, "ncat": 360, "s": 0.40331769436997317, "os": 0.41525807171055723, "bg": 0.0}, {"x": 0.993632707774799, "y": 0.9901139410187667, "term": "following", "cat25k": 48, "ncat25k": 55, "cat": 296, "ncat": 363, "s": 0.5574731903485255, "os": 0.561061774217112, "bg": 5.963192686306145e-06}, {"x": 0.9938002680965148, "y": 0.9912868632707775, "term": "provide", "cat25k": 52, "ncat25k": 57, "cat": 325, "ncat": 378, "s": 0.5705428954423593, "os": 0.5751331931407231, "bg": 7.75280767157854e-06}, {"x": 0.9939678284182306, "y": 0.9938002680965148, "term": "their", "cat25k": 62, "ncat25k": 58, "cat": 388, "ncat": 383, "s": 0.630529490616622, "os": 0.6183935872589996, "bg": 1.9689409423812817e-06}, {"x": 0.9941353887399463, "y": 0.9904490616621984, "term": "who", "cat25k": 48, "ncat25k": 58, "cat": 300, "ncat": 384, "s": 0.4063337801608579, "os": 0.4197114966280524, "bg": 2.167163322254973e-06}, {"x": 0.9943029490616622, "y": 0.9943029490616622, "term": "an", "cat25k": 66, "ncat25k": 58, "cat": 411, "ncat": 385, "s": 0.6441018766756033, "os": 0.6320037231619271, "bg": 1.0483481872670714e-06}, {"x": 0.994470509383378, "y": 0.9917895442359249, "term": "2", "cat25k": 55, "ncat25k": 62, "cat": 340, "ncat": 415, "s": 0.5586461126005362, "os": 0.562313332044076, "bg": 0.0}, {"x": 0.9946380697050938, "y": 0.9959785522788204, "term": "national", "cat25k": 105, "ncat25k": 63, "cat": 651, "ncat": 419, "s": 0.7483243967828419, "os": 0.7237640192702204, "bg": 8.024308495185042e-06}, {"x": 0.9948056300268097, "y": 0.9956434316353887, "term": "services", "cat25k": 96, "ncat25k": 64, "cat": 596, "ncat": 427, "s": 0.7107908847184986, "os": 0.6988296834268466, "bg": 3.637205407161288e-06}, {"x": 0.9949731903485255, "y": 0.9753686327077749, "term": "should", "cat25k": 22, "ncat25k": 64, "cat": 135, "ncat": 429, "s": 0.20006702412868632, "os": 0.1987100871046888, "bg": 2.8035949255001444e-06}, {"x": 0.9951407506702413, "y": 0.9695040214477212, "term": "screening", "cat25k": 18, "ncat25k": 69, "cat": 113, "ncat": 461, "s": 0.09400134048257372, "os": 0.15733966654382825, "bg": 7.883878436912594e-05}, {"x": 0.9953083109919572, "y": 0.9969839142091153, "term": "doh", "cat25k": 120, "ncat25k": 70, "cat": 749, "ncat": 464, "s": 0.7577077747989276, "os": 0.7323589429744581, "bg": 0.0015575053976614307}, {"x": 0.9954758713136729, "y": 0.9961461126005362, "term": "care", "cat25k": 105, "ncat25k": 77, "cat": 656, "ncat": 512, "s": 0.6931970509383378, "os": 0.6781081059215517, "bg": 1.0352780570723975e-05}, {"x": 0.9956434316353887, "y": 0.9934651474530831, "term": "not", "cat25k": 61, "ncat25k": 77, "cat": 382, "ncat": 513, "s": 0.3952747989276139, "os": 0.4057293616347004, "bg": 6.796263971286295e-07}, {"x": 0.9958109919571045, "y": 0.9951407506702413, "term": "from", "cat25k": 73, "ncat25k": 80, "cat": 455, "ncat": 536, "s": 0.5636729222520107, "os": 0.5717431150431973, "bg": 8.708610959925563e-07}, {"x": 0.9959785522788204, "y": 0.9225871313672922, "term": "children", "cat25k": 8, "ncat25k": 84, "cat": 51, "ncat": 561, "s": 0.01306970509383378, "os": 0.05948374774637316, "bg": 5.91731206138287e-06}, {"x": 0.9961461126005362, "y": 0.9964812332439679, "term": "other", "cat25k": 112, "ncat25k": 94, "cat": 698, "ncat": 625, "s": 0.6554959785522789, "os": 0.6436104306981, "bg": 2.7033250926224205e-06}, {"x": 0.996313672922252, "y": 0.30529490616621985, "term": "newborn", "cat25k": 0, "ncat25k": 101, "cat": 2, "ncat": 676, "s": 0.0013404825737265416, "os": 0.0019262661396117764, "bg": 0.0003214819654781475}, {"x": 0.9964812332439679, "y": 0.9954758713136729, "term": "at", "cat25k": 76, "ncat25k": 103, "cat": 476, "ncat": 687, "s": 0.37164879356568364, "os": 0.3850709778783626, "bg": 1.0235036696249984e-06}, {"x": 0.9966487935656837, "y": 0.996313672922252, "term": "this", "cat25k": 106, "ncat25k": 105, "cat": 661, "ncat": 696, "s": 0.6015415549597856, "os": 0.6014563032334203, "bg": 8.405643638956316e-07}, {"x": 0.9968163538873994, "y": 0.9949731903485255, "term": "/", "cat25k": 73, "ncat25k": 116, "cat": 452, "ncat": 773, "s": 0.3361260053619303, "os": 0.3383671820682793, "bg": 0.0}, {"x": 0.9969839142091153, "y": 0.9966487935656837, "term": "all", "cat25k": 117, "ncat25k": 122, "cat": 726, "ncat": 813, "s": 0.5822721179624665, "os": 0.5851819645821335, "bg": 1.5216732063085762e-06}, {"x": 0.9971514745308311, "y": 0.9968163538873994, "term": "are", "cat25k": 120, "ncat25k": 130, "cat": 747, "ncat": 863, "s": 0.5737265415549597, "os": 0.5769167293488869, "bg": 1.3450694474539966e-06}, {"x": 0.9973190348525469, "y": 0.9978217158176944, "term": "by", "cat25k": 170, "ncat25k": 132, "cat": 1059, "ncat": 878, "s": 0.6729222520107239, "os": 0.6631113882757296, "bg": 1.1562926977550743e-06}, {"x": 0.9974865951742627, "y": 0.9976541554959786, "term": "that", "cat25k": 152, "ncat25k": 133, "cat": 945, "ncat": 888, "s": 0.6437667560321716, "os": 0.6311925500444424, "bg": 1.078125929974598e-06}, {"x": 0.9976541554959786, "y": 0.9973190348525469, "term": "on", "cat25k": 139, "ncat25k": 144, "cat": 864, "ncat": 956, "s": 0.5839477211796247, "os": 0.5883587818822238, "bg": 9.704759420059104e-07}, {"x": 0.9978217158176944, "y": 0.9974865951742627, "term": "is", "cat25k": 144, "ncat25k": 177, "cat": 896, "ncat": 1182, "s": 0.4018096514745308, "os": 0.4109051402749442, "bg": 8.831170656172199e-07}, {"x": 0.9979892761394102, "y": 0.9979892761394102, "term": "as", "cat25k": 177, "ncat25k": 185, "cat": 1105, "ncat": 1235, "s": 0.5824396782841823, "os": 0.5857000017953531, "bg": 2.0820857530000396e-06}, {"x": 0.998156836461126, "y": 0.998156836461126, "term": "with", "cat25k": 179, "ncat25k": 200, "cat": 1114, "ncat": 1329, "s": 0.5616621983914208, "os": 0.568387670562784, "bg": 1.5348248772589693e-06}, {"x": 0.9983243967828418, "y": 0.9984919571045576, "term": "or", "cat25k": 267, "ncat25k": 211, "cat": 1664, "ncat": 1408, "s": 0.6685656836461127, "os": 0.6579879311639771, "bg": 2.3712349416585273e-06}, {"x": 0.9984919571045576, "y": 0.9983243967828418, "term": "a", "cat25k": 266, "ncat25k": 267, "cat": 1657, "ncat": 1775, "s": 0.5988605898123325, "os": 0.5969217538051188, "bg": 7.558231010818039e-07}, {"x": 0.9986595174262735, "y": 0.999162198391421, "term": "health", "cat25k": 426, "ncat25k": 275, "cat": 2654, "ncat": 1832, "s": 0.7221849865951743, "os": 0.707617728258578, "bg": 2.0357002005709247e-05}, {"x": 0.9988270777479893, "y": 0.9989946380697051, "term": "shall", "cat25k": 409, "ncat25k": 299, "cat": 2548, "ncat": 1992, "s": 0.6926943699731903, "os": 0.6776983124268808, "bg": 4.722271068719217e-05}, {"x": 0.9989946380697051, "y": 0.9986595174262735, "term": "be", "cat25k": 285, "ncat25k": 327, "cat": 1775, "ncat": 2176, "s": 0.5576407506702412, "os": 0.5611562219419688, "bg": 3.293817430902686e-06}, {"x": 0.999162198391421, "y": 0.9988270777479893, "term": "for", "cat25k": 389, "ncat25k": 386, "cat": 2420, "ncat": 2572, "s": 0.5996983914209115, "os": 0.5989995537152708, "bg": 1.6826100434240498e-06}, {"x": 0.9993297587131368, "y": 0.9993297587131368, "term": "in", "cat25k": 447, "ncat25k": 460, "cat": 2784, "ncat": 3062, "s": 0.5852882037533512, "os": 0.5899481323328153, "bg": 1.3804465992548907e-06}, {"x": 0.9994973190348525, "y": 0.9994973190348525, "term": "to", "cat25k": 616, "ncat25k": 633, "cat": 3838, "ncat": 4219, "s": 0.585455764075067, "os": 0.5900891035257427, "bg": 1.3276427905955595e-06}, {"x": 0.9996648793565683, "y": 0.9996648793565683, "term": "of", "cat25k": 1104, "ncat25k": 1055, "cat": 6872, "ncat": 7028, "s": 0.6092493297587132, "os": 0.6091217293029952, "bg": 2.113703785691221e-06}, {"x": 0.9998324396782842, "y": 0.9998324396782842, "term": "and", "cat25k": 1273, "ncat25k": 1102, "cat": 7927, "ncat": 7342, "s": 0.6467828418230562, "os": 0.6349250647766707, "bg": 2.349444666831048e-06}, {"x": 1.0, "y": 1.0, "term": "the", "cat25k": 1732, "ncat25k": 1562, "cat": 10788, "ncat": 10401, "s": 0.6390750670241286, "os": 0.6245322852281533, "bg": 1.8316762797116284e-06}], "docs": {"categories": ["geriatric", "mnchn"], "labels": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "texts": ["  I. Rationale  In the Philippines, cancer of the cervix uteri, is the second most common cancer among women after breast cancer. If both sexes are considered it ranks as the fourth most common cancer. The average annual age\u2014standardized rate was 22.5 per 100,000 (1983-1987) population-based Manila and Rizal Cancer Registry).  It has been demonstrated internationally that 90% of squamous cell carcinoma, which accounts for 80-85% of invasive cervical cancers, can be prevented through identification of pre-cancerous lesions by effective screening process and appropriate management of screen detected abnormalities. The Philippine Cervical Control Program utilizes Pap Smear as its screening method in detecting early malignant lesions of the cervix uteri. Cervical cancer prevention efforts, however have had limited success, due to the following reasons: limited screening services, inappropriate screening approach, inadequate health provider training, inadequate cytology services, inadequate supplies, inadequate follow-up diagnostic services, and cultural obstacle to providing services.   II. Objective  The objective of cytoscreening (Paps Smear) in the Cervical Cancer Control Program is to screen as many women at risk as possible for cervical cancer.   III. Strategies  The screening program, shall be implemented in primary and secondary health care facilities, and smear collection should not be limited only to physicians but should be undertaken by other health service providers who are trained on the procedure and on gender sensitivity.  The screening program shall be supported by referral laboratories which shall provide accurate cytological interpretation of smears.   IV. Policy  The laboratories of the Department of Health Retained Hospitals, as well as, the Provincial Hospitals shall serve as the referral laboratories for the interpretation of Paps Smears. Recognising, however that these hospitals do not have enough Pathologists to undertake  the task, Medical Technologists are hereby designated as cytoscreeners and are authorized  to interpret obstetrics and gynecologic Paps Smears provided that:   a). They shall be under the supervision of an Anatomical Pathologist assigned in these hospitals.  b). They shall be trained on the following competencies:  1). Understanding and application of the principles of cytology of OB\u2014GYN smears in a laboratory setting;  2). Preparation of technically acceptable stained smears obtained from the cervix and the vagina;  3). Recording, in a systematic manner, all smears referred to the section of cytology;  4). Understanding the pnnciples of staining using the Papanicolau\u2014 5). Interpretation of these smears; recognizing and describing all normal and abnormal cells exfoliated from the female genital tract: * All abnormal cells that may exfoliate from the female genital tract; * All grades of abnormal cells from mild dysplasia (Cervical Intraepithelial Neoplasm Grade I) to the obvious malignant cells; * Organisms that may be infecting the genital tract and their accompanying in\ufb02ammatory reactions.  6). Correlation of normal and abnormal smears with their histologic counterparts; 7). Correlation of normal smears with menstrual cycle or with exogenous hormone intake;  8). Referring abnormal smears to the attending Pathologist; 9). Preparation of a concise report, using acceptable standards of reporting.   V. Effectivity  This order shall take effect immediately.       ", " I. Rationale  The Department of Health's year 2000 mortality statistics reveal that the current major causes of death in the country today, in order of decreasing prevalence, are: diseases of the heart, diseases of the vascular system, malignant neoplasm, pneumonia, accidents, tuberculosis, chronic obstructive pulmonary diseases, certain conditions originating in the perinatal period, diabetes mellitus, and nephritis / nephrosis. Year 2001 Morbidity data, on the other hand, reveals that the ten leading causes of illnesses, in decreasing order, are: diarrheas, bronchitis, pneumonia, influenza, hypertension, tuberculosis, diseases of the heart, malaria, measles and chickenpox.  It is noteworthy that still, majority of the diseases listed above are highly preventable given the proper access to and the availability of health services and pharmaceutical products. Prominent among the preventable mortality and morbidity diseases listed above include those related to diseases of the heart and the vascular system, pneumonias, chronic obstructive pulmonary diseases, and diabetes mellitus and its related complications. Furthermore, these diseases require lifetime medications and more commonly afflicts the senior citizens.  With the passage of the Expanded Senior Citizen's Act, it is now mandated that senior citizens be granted 20% discount on all medications. This has been the subject of numerous debates between senior citizen's group and the retail drugstores.  The 2001 mandate given by Her Excellency, President Gloria Macapagal Arroyo to the Department of Health is to cut by half the prices of medicines commonly bought by the poor. As such, the Department has done through various initiatives, like the Botika ng Barangay (BnB), wherein low cost high quality drugs and medicines are made available to poor communities and to places where there is no access to these kinds of medicines.  Therefore, with the prevalence of the abovementioned diseases which are highly preventable given the proper lifestyle modifications and access to pharmaceuticals, the issue regarding the access to these chronic medications, especially of the senior citizen's group and the mandate given to the Department of Health, the list of the BnB drugs that are allowed to be sold per Department Memorandum No. 31 series 2001 was recommended to be amended to include the following:  \u2022 Metformin 500 mg tablet \u2022 Glibenclamide 5 mg tablet \u2022 Metoprolol 50 mg tablet \u2022 Captopril 25 mg tablet \u2022 Salbutamol 2 mg tablet \u2022 Salbutamol 2 mg/5 ml syrup (60mL)  Albeit, such recommendation as supported by the National Formulary Committee as shown in Annex A (NFC letter dated 17 February 2005) and by the Bureau of Food and Drugs as shown in Annex B (BFAD letter dated 03 March 2005) should be subject to specific guidelines that will assure rational drug use and accountability.  II. Objective  This Order is formulated in order to:  1. Provide an institutional mechanism for the inclusion of drugs in the BnB drug list; 2. Provide a safety net for dispensing of BnB drugs, which are considered as prescription drugs; and 3. Provide a clear policy statement and procedure for LGUs who wish to operate BnBs by themselves.  III. Scope and Applicability  This Order shall be applicable to all Botika ng Barangays which existence are covered by Administrative Order No. 144 s. 2004 and shall serve as a regulatory basis that will guide the Bureau of Food and Drugs, the Centers for Health Development, the Pharmaceutical Management Unit of the Department of Health and other concerned Agencies and entities.  IV. General Guidelines  1. The Department of Health authorizes the dispensing of the following essential drugs to the Botika ng Barangay subject to the strict implementation of the dispensing guidelines as reflected hereon:  a) Metformin 500 mg tablet b) Glibenclamide 5 mg tablet c) Metoprolol 50 mg tablet d) Captopril 25 mg tablet e) Salbutamol 2 mg tablet f) Salbutamol 2 mg/5 ml syrup (60mL)  2. The Food and Drug Regulatory Officers (FDROs) assigned at each Centers for Health Development (CHDs), under the immediate supervision of the CHD Directors and under the regulatory supervision of the Director of the Bureau of Food and Drugs (BFAD) shall be responsible for the strict monitoring of the dispensing protocols in this Order and shall include such activities under their regular work and financial and operational plans.  3. The Centers for Health Development, particularly the unit so assigned to handle the low cost quality medicines program shall assure the training of Botika ng Barangay operators under their jurisdiction and shall include in their work and financial, and operational plans such training requirement in collaboration with BFAD FDROs in the CHDs. This means that such activities will be considered as routine activities for planning and implementation.  V. Guidelines for Inclusion of Drugs for BnB Use  1. All drugs that are to be included in the Botika ng Barangay drug list shall be jointly and properly reviewed by the Pharmaceutical Management Unit (Pharma 50 Unit) of the Department of Health, the Bureau of Food and Drugs (BFAD) and the National Formulary Committee (NFC). The joint recommendations of the three (3) aforementioned units shall be forwarded to the Secretary of Health and this shall include the list of drugs that are to be adopted in the BnB drug list along with specific and/or rationale why such drugs were recommended.  2. Requests for drugs to be included in the BnB drug list that are recommended by the Centers for Health Development or other stakeholders must all pass through the Pharma 50 Unit. The Pharma 50 Unit shall within reasonable time collect such requests and shall forward the same to the BFAD and NFC.  3. The recommended drugs for inclusion in the BnB drug list shall be approved by the Secretary of Health and shall be released for dissemination through a Department Memorandum. The rationale for the inclusion of such drugs shall be appended as annex(es) of the Department Memorandum. An exception to such, are the subject drugs as mentioned in the rationale in this Order who are approved hereon by the Secretary of Health using this issuance instrument and are added to the BnB drug list mentioned in the Department Memorandum 31 series of 2001, subject to the dispensing guidelines reflected below.  VI. Dispensing Guidelines  1. The Botika ng Barangay shall be allowed to sell prescription drugs and medicines subject to the specific approval of the Department of Health and safety nets and guidelines that will assure rational drug use and accountability.  2. At all times, only the supervising pharmacist alone has the authority to dispense the six prescription drugs and medicines as stated in Item IV (1). The basis of such dispensing shall be a prescription duly signed and issued by a physician.  3. Under no circumstances shall prescription drug substitution be allowed. In cases that another drug is preferred, the patient must return to his primary care physician and secure another prescription.  4. The supervising pharmacist and the BnB operator shall jointly keep a separate record containing the names of patients, their primary care physician, the diagnosis of the patient and the volume of medicines dispensed.  5. The BnB operator and/or the dispensing pharmacist shall advise the patients/consumers to report any adverse reactions or any anomalous effect observed as a suspected consequence on the use of procured medicines. Once such reports are made, the BnB operator, jointly with the supervising pharmacist shall record the name of the patient, the drugs taken, the adverse effects reported, the date of the incident in a logbook and shall accordingly forward the same information to the CHD Director and the Director of the BFAD.  6. The volume of medicines to be dispensed per patient shall be computed to amount to a maximum of one (1) month supply only.  7. If, based on the records, a client buys more than what is allowable based on proper prescription / dosage vis-a-vis volume dispensed, sale shall be withheld to the client pending investigation of the supervising pharmacist, who shall submit the report to the BnB Coordinator of the CHD concerned for proper action.  8. To maximize the time spent by the supervising pharmacist, the BnB operator can, beforehand, prepare the volume to be dispensed.  9. After twelve (12) months of sale to a client (computed from the first purchase to the current purchase) and every twelve months thereafter, a written note from the physician, stating that patient follow-up was made, must be presented in order for sale to the client to be continued.  10. The BnB operators shall only be allowed to sell the above-mentioned drugs and medicines after they have successfully undergone a technical training course that is to be conducted by the Department of Health and in the physical presence of a dispensing pharmacist in accordance to item VI (2) in this order.  VII. Separability Clause  If any part, term or provision of this Order shall be declared invalid or unenforceable, the validity or the enforceability of the remaining parts or provisions shall not be affected, and this Order shall be construed as if it did not contain the particular invalid or unenforceable part, term, or provision.  VIII. Repealing Clause  Previous Orders and similar issuances which specific provisions are inconsistent with those provided hereon are deemed repealed and modified accordingly.  IX. Effectivity  This Order shall take effect immediately. ", " Doctor\u2019s prescription for over-the-counter drugs and medicines as provided for under Administrative Order No. 177. 2004 is a limitation which was not provided for by RA 9257, thereby nulli\ufb01es the right accorded by the legislature to the Senior citizens.   To fully implement the provisions of the Expanded Senior Citizens Act of 2003, the following provision of Administrative Order No. 177 s. 2004 is hereby deleted from the existing issuance:   Chapter V, No. 4, B, 1.2 \u201cTo safeguard the health of senior citizens and to prevent abuse of the RA 9257, a doctor\u2019s prescription is required in the purchase of the over the counter medicines\".   All other provisions Of Administrative Order No. 177 s. 2004 still stands in effect.   All other issuances not consistent with this provision is hereby amended accordingly.  ", " I. RATIONALE   Drug abuse is a major public health and social problem with far\u2014reaching adverse effects. This may lead to criminal acts, poverty, homelessness and even serious disease like HIV/AIDS. Statistics show that drug abuse can affect not only the individual and his/her family but also his/her workplace. It can threaten public safety, impair job performance, result in costly rehabilitation, cause medical, social and other problems affecting employees and employers alike.   RA 9165 also known as the Comprehensive Dangerous Drugs Act of 2002 specifically under Section 2 states that \"it is the policy of the State to safeguard the integrity of its territory; and the well being of its citizenry from the harmful effects of dangerous drugs on their physical and mental well\u2014being, and to defend the same against acts or omissions detrimental to their development and preservation.\" While RA 6713 also known as Code of Conduct and Ethical Standards of Government Officials and Employees under Section 2 states that \"it is the policy of the State to promote a high standard of ethics in the public service. Public officials and employees shall at all times be accountable to the people and shall discharge their duties with utmost responsibility, integrity, competence and loyalty, act with patriotism and justice, lead modest lives, and uphold public interest over personal interest.\" To maintain these ethical standards, public officials and employees must abstain from using dangerous drugs.   The Department of Health (DOH) is committed to provide a safe working environment and promote the well-being and health of its employees. The DOH prohibits the use of prohibited /regulated drugs or the irrational use of prescription medications; reporting to work while under the influence of prohibited drugs; and possessing, distributing or selling prohibited drugs.   The Department considers drug use and abuse as a disease more than a criminal problem. As such, strategies and assistance programs are geared towards counseling, treatment and rehabilitation or other necessary interventions to affected employees.   In order to proactively protect its employees from the ill effects of drug abuse, the DOH will institute a Drug-Free Workplace Program.   Legal Mandate   1. Dangerous Drugs Board (008) Regulation No. 2 series of 2004 mandates each agency foffice to create a Drug-Free Workplace Committee and adopt its own drug abuse policy which shall serve as a legal document that communicates the organization\u2019s position in the use of illegal drugs as well as outlining the responsibilities of the employer, the employees and the employees\u2019 union.   2. Republic Act 9165, otherwise known as the Comprehensive Drugs Act of 2002 and Implementing Rules and Regulations dated November 15, 2002.   3. Republic Act 6713 also known as Code of Conduct and Ethical Standards of Government Officials and Employees.   4. Rule XIV Section 22, The Civil Service Law and Rules (Book V of Executive Order 292 and its Omnibus Rules, As Amended).   Given the above, the DOH is instituting a Drug-Free Workplace Program. Effectively implemented, the DOH-Drug-Free Workplace policies and programs will help the DOH organization in its legal duty to safeguard the health, safety and welfare of its employees as well as in reducing health and safety risks to the public.   II. OBJECTIVE   This Administrative Order is being issued to institute the Drug-Free Workplace Program in the - Department of Health and all its attached agencies and to list down the guidelines for its implementation.   III. SCOPE AND COVERAGE   This shall apply to all employees without distinction as to rank, status and salary of the Department of Health Central Office and attached agencies, Centers for Health Development, DOH Retained Hospitals and DOH Treatment & Rehabilitation Centers.   IV. DEFINITION OF TERMS   1. Agency Head \u2014 refers to Secretary of Health, CHD Directors, Chiefs of Retained Hospitals and Directors of Department of Health - Treatment & Rehabilitation Centers.   2. Committee \u2014 refers to the Drug-Free Workplace Program Committee.   3. Con\ufb01rmatory Test - an analytical test using a device, tool or equipment with a different chemical or physical principle that is more speci\ufb01c which will validate and con\ufb01rm the result of the screening test. It refers to the second or further analytical procedure to more accurately determine the presence of dangerous drugs in a specimen.   4. Counseling \u2014 meetings with a counselor to receive help with personal or psychological problems.   5. Dangerous Drugs \u2014 include those listed in the Schedules annexed to the 1961 Single Convention on Narcotic Drugs, as amended by the 1972 Protocol and in the Schedules annexed to the 1971 Single Convention on Psychotropic Substances as enumerated in the annexes of RA 9165.   6. Dangerous Drug Use \u2014 use of addictive substances that cause changes in behavior and perception.   7. Drug abuse - is the habitual misuse of a chemical substance including illegal drugs, prescription drugs and over-the-counter drugs.   8. Drug Offender '- any employee found to be positive of prohibited drug after undergoing the con\ufb01rmatory test.   9. Drug Dependence \u2014 is a cluster of physiological, behavioral and cognitive phenomena of variable intensity, in which the use of psychoactive drug takes on a high priority thereby involving, among others, a strong desire or a sense of compulsion to take the substance and the difficulties in controlling substance-taking behavior in terms of its onset, termination, or levels of use. This is based on World Health Organization de\ufb01nition.   10. Drug Testing Laboratory \u2014- a laboratory/facility, accredited by the DOH, that performs screening or con\ufb01rmatory testing of illicit drugs   11. DFWC- Drug-Free Workplace Committee   12. Employees \u2014 shall mean any person hired or required to work by an employer. The term employee includes permanent, regular, temporary, casual, part-time and contractual. '   13. \u201cFor Cause or Probable Cause\" Drug Test \u2014- drug testing required when there is a \u201cprobable cause\" or \u201creasonable ground\" to believe that a person is using or is under the influence of dangerous drugs.   14. Inpatient care - a residential treatment program performed in a general or psychiatric hospital or in a center, dedicated to the effective management of physical and psychological conditions arising from drug abuse. The program provides full professional staff that includes therapists, psychologists, and psychiatrists.   15. Mandatory Drug Testing \u2014 refers to the compulsory submission of an employee for drug testing as required by RA 9165 and by the agencies\u2019 internal policies.   16. Outpatient Treatment \u2014 non-residential treatment program where a patient must be seen by a psychologist or psychiatrist so drug use or abuse, among others, can be monitored.   17. Random Drug Testing \u2014 the manner in which the employees are subjected to drug testing wherein selection follows no specific pattern and without prior notice and having an equal chance of being selected.   18. Rehabilitation - the dynamic process, including after-care and follow-up treatment directed towards the physical, emotional, psychological, vocational, social and spiritual change of a drug dependent to enable him/her to live without dangerous drugs, enjoy the fullest life compatible with his/her capacity and potentials and render himlher able to become a law-abiding and productive employee and member of the society.    19. Sell \u2014 any act of giving any dangerous drug and/or controlled precursor and essential chemical whether for money or any consideration.   20. Screening Test\u2014 a test performed to establish potential/presumptive positive result.   21. TRCs-Treatment and Rehabilitation Centers   22. Use \u2014 any act of introducing substances into the body by injection (intravenously or intramuscularly) and/or consumption (either by chewing, smoking, sniffing, eating, swallowing or drinking) of the dangerous drugs.   23. Work Accident \u2014- shall mean an unintended or unexpected occurrence that may or may not result in damage to person, property, work stoppage or interference or any combination thereof of as may arise from their employment.   24. Workplace \u2014 means the office, premises or worksite, where the workers are employed.   V. GENERAL GUIDELINES   1. The following should be observed in any Drug-free workplace program:   i. The Drug-Free Workplace Program must be made known to all employees and of\ufb01cers   ii. The program must aim to provide a safe working environment and promote the well- being and health of employees and should not be used to harass employees.   iii.The program should adhere to the concept that drug addiction is a disease, which can be prevented and treated.   iv. Program implementation must emphasize promotion of a safe and healthy drug-tree environment.   2. The Drug\u2014Free Workplace Program must include the following components: Advocacy, Education and Training; Drug Testing Program for officials and employees; Management, Treatment, Rehabilitation and Referral; Monitoring and Evaluation.   3. Strict confidentiality must be observed in the conduct of the Drug-Free Workplace Program.   VI. IMPLEMENTING GUIDELINES   A. Creation of a Drug-Free Workplace Committee   In order to institutionalize and oversee the implementation of the Drug-Free Workplace Program, a Drug-Free Workplace Committee (DFWC) shall be created in the DOH Central Office and attached agencies, Centers for Health Development, DOH Specialty & Retained Hospitals, DOH Treatment & Rehabilitation Centers. The Committee shall have the following functions:   1. Formulate guidelines for the curtailment and prevention of drug abuse in the workplace;   2. Oversee the implementation of the policies and guidelines on drug-free workplace in their respective workplaces;   3. Conduct advocacy activities on drug abuse prevention & control;   4. Disseminate the policy and guidelines for employees\u2019 knowledge, awareness and compliance.   5. Monitor the implementation of the policies and guidelines and recommend updating it and when necessary;   6. Conduct random drug testing   7. Evaluate positive cases and refer to pr0per health facilities/of\ufb01ces for action.   8. Submits report and recommendation to the heads of concerned agency.   9. Create a sub-committee for every component   The Committee shall consist of the following:   Chairperson  Vice Chairperson   Members:  Personnel Officer  Of\ufb01cer of Employees Union  Program Coordinator for Drug Abuse   The following may also be. invited to participate in the deliberation of the committee;   Legal Of\ufb01cer  Health Promotion and Education Of\ufb01cer  Psychiatrist/DDB - DOH Accredited Physician   B. Health Promotion and Advocacy  The Drug Abuse Program coordinators in cooperation with Health Promotion Of\ufb01cerl Information Of\ufb01cers shall: '   1. Plan and implement advocacy and communication activities including the development of relevant materials to raise the awareness and educate the employees on relevant topics that may include the following among others:  - DOH policies and programs on drug-free workplace  - List of regulated and prohibited drugs  - Adverse effects of drug abuse and/or misuse of dangerous drugs on the person, workplace, family and the community  - Preventive measures against drug abuse  - When, where and how to seek employee assistance services for drug use and abuse  - Salient features of RA 9165   2. Display a billboard, streamer, poster in conspicuous places in the workplace with the standard message: \"DRUG USE IS PREVENTABLE, DRUG ADDICTION IS TREATABLE. KEEP THE WORKPLACE DRUG-FREE\", and other messages deemed appropriate by the Drug-Free Workplace Committees of respective agencies.   3. Make use of available channels of communication to disseminate appropriate messages such as agency website, emails, newsletters, blogs, SMS, meetings, forums and the like.   4. Ensure that health promotion campaigns are extended to families, adjacent communities and other partner/cooperating agencies, in the context of governmental and social responsibility using appropriate channels.   5. Sustain advocacy and communication activities to ensure maximum and long-term commitment to participate in the Drug-Free Workplace initiative.   6. Orient newly hired employees of the Department of Health on the Drug-Free Workplace Program   C. Supervisor\u2019s Training   Supervisors on Drug -free Workplace Program shall be trained to effectively help in dealing with employees' failing performance due to substance abuse, particularly drug addiction.   The Mental Health Program of the Degenerative Diseases Of\ufb01ce of the National Center for Disease Prevention and Control in collaboration with the Dangerous Drug Abuse Prevention and Control Program of the Office for Special Concerns and the Health Human Resources and Development Bureau shall design a course for supervisors focused on providing knowledge, attitude and skills to detect psychosocial issues of co-employees who are experiencing stressful situation brought about by their drug use, abuse or addiction.   The Health Human Resources and Development Bureau in coordination with the Mental Health Program shall conduct training of trainers to be participated in by program coordinators and other designated employees of the Centers for Health Development and DOH specialty/retained hospitals, attached agencies and TRCs who will in turn conduct the training of supervisors in their respective areas of assignment.   Division chiefs and other designated administrative officers of the different of\ufb01ces in the Central Of\ufb01ce, CHDs and DOH specialty/retained hospitals, attached agencies and TRCs shall be the participants of supervisor\u2019s training program.   The supervisors who underwent the training program shall inform/orient all employees of their respective of\ufb01ces and make themselves available for queries and concerns of their co\u2014employees.   The supervisors shall recommend to the Drug-Free Workplace Committee the drug testing, drug use assessment, treatment and rehabilitation, and other administrative actions-deemed necessary for certain co-employees for the following reasons:   Reasons for the conduct of drug test:  - Reasonable Suspicionlprobsble cause - Person in high risk decisionumaking position - Past history of drug use \u2014 Involvement in workplace accidents or \u201cnear miss\" accidents - Discovery of dangerous drugs paraphernalia - Detention by polioeltiling of charge in court for drug related cases - Employees reporting to work after undergoing rehab in treatment and rehabilitation center   D. Conduct of Random Drug testing on Employees:   a) Personnel to be covered: All employees \u2014 regardless of status and position in the of\ufb01ceiagency shalt undergo Random Drug Tests in accordance with the paragraph (d) section 36 ofArticie III of the IRR of RA 9165.   b) Methods of drug test to be employed: Drugs testing methods and activities shall foilow the prescribed DOH Manual of Operations.   c) Drug Testing Procedures   a. All of\ufb01cers and employees shall undergo random drug testing on dates identi\ufb01ed but unannounced by the Committee, upon proper approval of the Agency Head.   b. The random drug testing shall conform with the procedures as prescribed by the DOH Manual of Operations. The same shall be conducted only by DOH-Retained Hospitals with an accredited drug-testing laboratory on a yearly basis.   c. A drug test is valid for one year; however, additional drug testing my be required for just cause as follows:  i. After workplace-related accidents, including near miss;  ii. Following treatment and rehabilitation to establish fitness for returning to work/resumption of job;  iii. In the light of clinical findings and/or recommendation of the committee.  iv. The Agency Head may require at anytime a drug testing of particular employees for cause or probable cause, such as:  a) Past history of drug use  b) Involvement in accidents  c) Possession of dangerous drugs and paraphernalia  d) Detention by police/filing of charge in court for drug-related cases  e) Employees reporting to work after undergoing rehabilitation in a treatment and rehabilitation center  f) \"For cause\" or \u201cprobable cause\" - when there is reasonable ground to believe that a random drug test is necessary such as: (Upon the recommendation of the Committee) - Personal Appearance \u2014 slurred speech, bloodshot eyes, drastic change in appearance - Mental Factor - hot-headedness, irritability, increased difficulty in handling assigned tasks - General Perfbrmance \u2014 sustained missed deadlines, low productivity, increased wastage, public complaints, frequent accidents, carelessness, truancy from the job  - Peer Relations \u2014 isolation, frequent quarrels with of\ufb01cemates, heavy borrowing, frequent mood swings   e. When the confirmatory test turns positive, the Committee shall evaluate the results and the level of care and administrative interventions that may be extended to the Drug User.   i. Result shall be immediately transmitted to the head of the agency/chairperson of the DFWC or designated person who requested the test shall subsequently and immediately inform the concerned personnel   ii. The office/agency shall then take the appropriate action in accordance to the Labor Code and DFW policies.   iii. Strict con\ufb01dentiality and respect for rights of employee must be observed.   f. The person found positive of prohibited drugs shall be issued a Memorandum informing him/her about the result of the con\ufb01rmatory test. He/she shall be given fifteen (15) days to contest the confirmatory test result and may submit an explanation in writing why no administrative charge shall be issued against him/her.   g. The Committee shall decide if the explanation of the Drug User is satisfactory based on the evaluation, validation, and confirmation conducted. It the explanation is not satisfactory, a Memorandum shall be issued referring the employee to the appropriate institution for evaluation, consultation treatment, detoxi\ufb01cation or rehabilitation, as the case may be. If the explanation turns to be satisfactory, hislher case shall now be closed.   d) Process of Contesting the Validity of the Confirmatory Test Result   a. The Drug User shall have fifteen (15) calendar days upon receipt of the Memorandum to contest the veracity and validity of the same screening laboratory examination result. He/she may validly challenge said result through a con\ufb01rmatory test upon compliance to the following procedure, to wit:   i. There must be a request for reexamination   ii. The specimen to be examined must be the original urine sample submitted to the DOH- Retained Hospital with an accredited drug-testing laboratory, during the screening test; and   iii. The Analyst/Head of the Laboratory handling the case shall personally bring the original urine sample to any con\ufb01rmatory laboratory identified by the donor employee, where it shall be re-examined in his/her presence   iv. The Committee shall wait for the report or recommendation of the Confirmatory Laboratory on the contested test result of the Drug User, before it shall take another action on the case.   b. Upon validation and affirmation of the con\ufb01rmatory test result, the Committee shall recommend him/her to the appropriate institution for proper medical and psychiatric intervention without prejudice to the application of paragraph (d) Sec. 36. Rule III of the IRR of RA. 9165.   i. An Assessment Report issued by the appropriate medical institution to the Drug User is hereby required for monitoring purposes. Said Assessment Report shall contain the \ufb01ndings of the assessment and shall be used as a basis of the Committee\u2019s recommendation to the Agency Head for appropriate action.   ii. The Committee shall endorse to the Agency Head whatever recommendation given by the attending Medical Consultant. .   iii. Should the attending Medical Consultant recommend that the drug Offender shall undergo an intensive residential rehabilitation, helshe shall be entitled to receive the benefits applicablellimits to an employee under sick leave status. If helshe has no available sick leave credits, hislher rehabilitation shall be considered on leave without pay.   iv. Confidentiality of Records: All results of the drug testing conducted by the Agency/office shall remain strictly con\ufb01dential. Any officer or employee who intentionally or unintentionally breached the confidentiality of any drug test result shall be charged in accordance with Section 72 of RA 9165.   e)FundinglCost Requirement:   a. The cost of the Drug Testing for government officials and employees shall be funded by the agency through the DDO\u2014NCDPC   b. For first time offenders, the outpatient, residential and aftercare services shall be provided free of charge except for employees who are hired under job orders/service contract, using funds of concerned rehabilitation centers. Reporting for outpatient and aftercare services will be on of\ufb01cial time while duration of con\ufb01nement in residential facilities shall be deducted from their sick leave credits if there's any.   Drug dependency examination is conducted on individuals who are suspected to be drug users, to provide an accurate assessment and diagnosis on the extent of drug abuse, whether helshe is an experimenter, occasional user, or a drug dependent, for proper referral to agencies or appropriate management. It will also be used as a basis for the Court to issue a Court Order for the drug dependent to undergo treatment and rehabilitation pursuant to RA 9165.   This examination is conducted by the DOH-accredited physician on psychological/behavioral medicine authorized to conduct DDE and treatment on persons believed to be using dangerous drugs. This includes procedures such as: intake interview, history-taking, determination of the criteria for drug dependency (use of DSM-IV or ICD-10), mental status examination, physical examination, neurological examination, psychological evaluation, social case study, and detection of dangerous drugs in body specimens through laboratory procedures. Expenses for the DDE shall be shouldered by the DOH.   F. DRUG TREATMENT, REHABILITATION AND AFTERCARE   Treatment and Service providers for the concerned employee shall then follow the approved Manual of operations   1. If upon the assessment of the appropriate medical institution, whether an out-patient consultation or detoxi\ufb01cation is necessary, helshe shall secure a pass slip from of\ufb01ce where helshe is assigned. The pass slip shall re\ufb02ect the time of his/her departure/arrival to and from the of\ufb01ce in going to the appropriate medical institution, and the name of the attending physician visited.   2. The said pass slip shall be noted by the Committee Chairperson for monitoring and shall be submitted to the Personnel Of\ufb01cer to determine the number of hours spent for his/her out\u2014patient consultation or detoxi\ufb01cation. The same shall be deducted from his/her sick leave credits   3. After undergoing the intensive rehabilitation for a period of six months or more, helshe shall be required to submit to the Committee Chairperson a temporary clearance from the rehabilitation center where helshe was treated for evaluation and be used as basis in recommending for his/her re-entry to the Office.   4. Confidentiality of the information during the treatment process shall strictly be observed by the DFWC to guarantee privacy of the drug user employee.   a) Outpatient Service The DOH through the DFWP TWG shall ensure the availability and accessibility of outpatient lcounselling services nationwide.   If the DOH employee tested positive in the drug testing and the subsequent dangerous drug dependency evaluation result does not require treatment and rehabilitation, then outpatient services or counselling will be required. The procedure will be as follows:   i. The drug dependency examination team will provide an assessment report. This report will contain a recommendation that the DOH employee will undergo outpatient services or counselling sessions. The report should contain the length of outpatient/counselling services; the schedule, regularity and number of the sessions. The drug dependency team will prescribe an outpatient service for the concerned DOH employee. The head of the of\ufb01ce of the DOH employee, the assessment team of the mother organization (CHD or DOH hospitall Medical Center) and the DOH employee will be provided a copy of the assessment report.   ii. The concerned DOH employee shall comply with administrative rules and regulations when seeking services for his/her treatment.   iii. At the termination of outpatient service/counselling, the outpatient team must provide certificate of discharge to the Head of the agency.   b) Residential Treatment and Rehabilitation Service   If the drug dependency examination results in a recommendation for the admission of the DOH employee to a residential treatment and rehabilitation center, the employee follows the admission procedures according to Dangerous Drugs Board Regulation No. 3, series 2007   After the prescribed treatment and rehabilitation program of the concerned DOH employee, the TRC shall issue a certi\ufb01cate discharge which will contain the outcome of the treatment and rehabilitation program, recommending the employee\u2019s return to work, and urge the DOH employee to report to the aftercare program prescribed. The head of the office of the DOH employee and the DOH employee will be provided a copy of the discharge certificate.   c) Aftercare Service   The DOH shall provide aftercare programs for the employee in accordance with 008 Regulation 1, series 2006. The employee after evaluation and completion of the residential rehabilitation program shall undergo aftercare program fora maximum period of eighteen (18) months upon the discretion and recommendation of the attending physician. The employee shall submit to the prescribed aftercare program.   VII. OVERALL ENFORCEMENT   A. The Drug Free Workplace Committee shall be responsible for monitoring compliance of this policies and guidelines.   B. The Program Managers/Coordinators concerned shall disseminate this policy and ensure alignment of the existing policies and programs to it.   C. The Head of agency through the Health Education and Promotion Of\ufb01cers/Information Officers shall be responsible in the dissemination of this Policy for public knowledge and awareness.   VIII. CONSEQUENCES OF POLICY VIOLATIONS   A. Any employee who refuses, without any valid reason, to submit himself/herself to drug test will be dealt with in accordance with 008 Board Regulation No.2 series 2004 and RA 9165.   B. Any employee, without any valid reason after being tested positive of drug use that refuse to undergo the recommended medical intemention/rehabilitation program will be administratively dealt with in accordance with 003 Board Regulation No.2 series 2004 and RA 9165.   IX. PENALTY AND SANCTION   First Occurrence: If the officer or employee was reported as drug offender for the first time, he/she shall be advised, through a Memorandum, to undergo drug dependency examination/ assessment and evaluation at the appropriate medical institution for proper medical intervention.   Second Occurrence: If the drug user was again found to be positive of prohibited drugs for the second time, the Committee shall recommend to the Agency Head through a Resolution that he/she be charged an administrative disciplinary action in accordance to the Uniform Rules of Administrative Cases (URAC) and other Civil Service Rules and Regulations. The employee found to be positive of prohibited drugs shall be charged for GRAVE MISCONDUCT.   X. REPORTING   All agencies/offices shall submit to the DOH\u2014Office for Special Concerns (OSC) a yearly compliance report on the drug testing activities conducted on their personnel. Report shall be in a format formulated by OSC. The information shall contain:  \u2014 Total number of employees - Data on the number of personnel tested - Number of personnel who tested positive - Analyte/s tested (Methamphetamine, Tetra hydrocanna binol, etc)  \u2014 Dates of testing - Names of participating DTL who conducted the test   DOH-OSC shall then submit an annual implementation report of drug testing in the workplace to the DOH Executive Committee and the DOB.   XI. REPEALING CLAUSE   All other issuances which are inconsistent with the provisions of this Order, are hereby repealed or modi\ufb01ed accordingly.   XII. SEPARABILITY CLAUSE   Should any provision of this Policy be subsequently declared unconstitutional or invalid, the other provisions not so declared and not affected by such declaration shall remain in full force and effect.   XIII.EFFECTIVITY CLAUSE   This Order shall take effect immediately.  ", "  I. RATIONALE  Republic Act No. 7277, \u201cAn Act Providing for the Rehabilitation, Self-Development, and Self-Reliance of Disabled Persons and Their Integration into the Mainstream of Society and for Other Purposes.\" and otherwise known as \u201cThe Magna Carta for Disabled Persons,\" was passed in July 19, 1991. This speci\ufb01cally required the Department of Health (DOH) to, (1) institute a national health program for PWDs, (2) establish medical rehabilitation centers in provincial hospitals, and (3) adopt an integrated and comprehensive approach to the health development of PWD which shall make essential health services available to them at affordable cost.  Rule IV, Section 4, Paragraph B of the implementing rules and regulations (IRR) of this Act required the Department of Health to address the health concerns of seven (7) different categories of disability, which includes the following: (1) Psychosocial and behavioral disabilities, (2) Chronic illnesses with disabilities, (3) Learning (cognitive or intellectual) disabilities, (4) Mental disabilities, (5) Visual / seeing disabilities, (6) Orthopedic/moving, and; (7) Communication deficits.  In compliance thereof, the DOH piloted in 1995 a community based rehabilitation program in 112 (7.5%) out of 1, 492 towns nationwide. Between 1992 and 2004 it had upgraded DOH hospital facilities to include rehabilitation and allied medical services for PWDs. Today there are about 21 DOH hospitals that have a rehabilitation program/units/centers representing 22% of all DOH hospitals. It had registered 508,270 PWDs in 2004 or about 12% of the target PWD population. (Source: DOH Report 2004). The turn out was in\ufb02uenced by the presence, absence or inadequacy of health services for PWDs at the local or regional level and in DOH health facilities..A Social Weather Station (SWS) survey commissioned by DOH last 2004 revealed that around 7% of the households under the study have at least one family member who is disabled. (Source: SWS Survey 2004) . With the frontline services of the Department of Health devolved to the local government units, the \ufb01nal implementation of this Act now rests with the Local Government Units (LGUs). This Order prescribes the guidelines in the formulation, implementation, and evaluation of health programs for PWDs.  II. DECLARATION OF POLICIES  The Program shall be guided by the following basic policies de\ufb01ned by the Magna Carta for Disabled Persons:  1. The delivery of health services to disabled persons shall be the responsibility and concern of both the government and the private sector and the members of the community at large.  2. Health services for PWDs should be an integral part of all basic health services.  3. Health services should be accessible, appropriate, acceptable, affordable and timely.  4. Services shall incorporate mechanisms for the promotion and protection of the human rights of PWDs and their care-givers as a prerequisite for health care delivery.  The health programs for PWDs should be aligned with the thrusts of the National Objectives for Health, and the Medium Term Development Goals of the Department of Health:  1. More, better and sustained health financing packages for PWDs. All basic and advanced medical, paramedical, allied medical, public health, health administration and health\u2014related services available within the country shall focus on critical interventions to be implemented as a single package to remove handicapping situations surrounding the PWD. It shall develop \ufb01nancing packages appropriate to the economic status of the PWD. Rates of discount shall be given to deserving PWDs according to the criteria set by the Department of Health in accordance with Administrative Order No. 51, s. 2001, entitled, \u201cImplementing Guidelines on the Classi\ufb01cation of Patients and on Availment of Medical Social Services in Government Hosptials,\" which was mandated by RA 747, s. 1954, \u201cAn Act to Regulate Fees to be charged Against Patients in Government and Charity Clinics Classifying patients according to their \ufb01nancial condition.\"  2. Assure the quality and affordability of the services. These services should be appropriate sector\u2014wide and adopt holistic, \ufb02exible and relevant ethical practices of the highest caliber without compromising specialized health or health-related care services.  3. Ensure that the services are accessible and available. It shall ensure availability of providers, equipment and procedures for critical and essential health and health\u2014related services in all localities but specially in distant or marginalized areas or situations.  4. Improve performance. All PWDS shall receive, without prejudice to their condition, the appropriate out-patient, in\u2014patient and public health services available in any health institution within the country.  5. Enhance public-private, public-public, and private-private initiatives. The services should generate public, private and multiple stakeholder acceptance and support. They shall act synergistically with each other at all levels and sectors of the Philippine society to contribute to the total health of the PWDs that is superior to the output of each stakeholder acting individually, sharing resources, knowledge, opportunities, referrals and contacts through an \u201copen communication system of policy and program development, implementation and review within this system.  6. Adopt the primary health care and community based rehabilitation approaches in the local setting.  7. The Department of Health shall serve as the focal organization for this program and will coordinate and integrate the activities, plans and programs of the various stakeholders into an effective and ef\ufb01cient system.  III. OBJECTIVES  This Order de\ufb01nes and establishes the strategic and operational framework for the development, implementation and monitoring of an effective, and ef\ufb01cient promotive, preventive, curative, rehabilitative and palliative health services from conception, birth, growth, maturity and in the terminal phase in the life of PWDs.  IV. SCOPE AND SPHERE OF APPLICATION  This Order shall apply to all stakeholders in the health sector which includes specialty societies, non\u2014govemment organizations, pe0ple\u2019s organizations, business, the academe; local government units, government agencies and others who are delivering primary, secondary, tertiary and / or terminal medical, paramedical, and allied medical care or referral of the PWD at the national, regional and at the local government or private level.  V. DEFINITION OF TERMS  1. Chronic illness \u2014 any disease that lasts for six months or more, which may cause one or more forms of disability, e.g. stroke, diabetes, cancer, etc.  2. Communication disability \ufb02 hearing & speech impairments leading to disabilities.  3. Community based rehabilitation 7 a strategy to address the social, physical and mental determinants of health of PWDs.  4. Disabled child \u2014 child with mental retardation, hearing impairments including deafness, speech or language impairments, visual impairments including blindness, serious emotional disturbance, orthopedic impairments, autism, traumatic brain injury, other health impairments or speci\ufb01c learning disabilities who by reason thereof need special education and related services that might last 12 months or more or may be a cause of death  5. Disabled person - one suffering from restriction of different abilities as a result of a mental, physical or sensory impairment, in performing an activity in the manner within the range considered normal for a human being (regardless of age).   6. Disability shall mean (1) a physical or mental impairment that substantially limits one or more psychological, physiological or anatomical function of an individual or activities of such an individual, (2) a record of such an impairment; or (3) being regarded as having such an impairment.  7. Disability types \u2014 the 7 types of disabilities mentioned in RA 7277 such as psychosocial disability, disability due to chronic illness, learning disability, mental disability, visual disability, orthopedic disability, communication disability.  8. Health \u2014 the presence of complete physical, social, and mental well-being and not merely the absence of disease or in\ufb01rmity.  9. Hearing disability \u2014 moderate or worse hearing impairment in the better ear; that is, the permanent unaided hearing threshold level of the better ear of 41 or 31 decibels or grater in age over 14 or under 15 years old.  10. Hearing impairment - the complete or partial loss of the ability to hear from one or both ears; this is mild or worse hearing impairment, 26 decibels or greater hearing threshold, averaged at frequencies 0.5, 1.0, 2.0, and 4.0 kiloHertz.  11. Impairment \u2014 any loss, diminution or aberration of psychological, or physiological function with or without an accompanying anatomical structural defect.  12. Learning disability \u2014 any disorder in one or more of the basic psychological processes (perception, comprehension, thinking, etc.) involved in understanding or in using spoken or written language  13. Mental disability \u2014 disability resulting from organic brain syndrome (ie. Mental retardation, acquired lesions of the central nervous system, or dementia) and or mental illness (psychotic or non-psychotic disorder).  14. Multiple disability \u2014 a PWD with one or more ofthe 7 types of disabilities.   15. Orthopedic disability 7 disability in the normal functioning of the joints, muscles or limbs.  16. Person with disability (PWD) \u2014 any person with an impairment that substantially limits one or more psychological, physiological or anatomical function of an individual or activities of such an individual based upon the functional assessment of a trained health personnel.  17. Psychosocial disability 7 any acquired behavioral, cognitive, emotional or social impairment that limits one or more activities necessary for effective interpersonal transactions and other civilizing process or activities for daily living.  18. Registration of PWDs \u2014 the process of collecting, storing, analyzing, reporting and using health information as in the Philippine Registry for PWDs.  19. The Philippine Registry for Persons with Disabilities (PRPWD) \u2014 a recording and reporting system prescribed by RA 7277 for the different types of disabilities.  20. Special populations of PWDs i shall refer to PWDs who are physically or socially marginalized, or who are at greater health risk than most PWDs due to certain social or physical factors such as indigent PWDs, PWDs from cultural communities, PWDs who are victims of disasters, PWDs with comorbid health conditions, children with disabilities, women with disabilities, care\u2014givers of PWDs, and elderly disabled.  21. Special areas \u2014 socially or physically marginalized or unreachable areas like urban slums, etc.  22. Visual disability \u2014 person whose better eye cannot see 3/60 or cannot count \ufb01ngers at 3 meters.  VI. STRATEGIC FRAMEWORK  A. Vision, Mission, Goal  Vision. Improve the total well\u2014being of Persons With Disabilities.  Mission. The Department of Health, as the focal organization, shall ensure the development, implementation and monitoring of relevant and ef\ufb01cient health programs and systems for PWDs that are available, accessible, affordable, and acceptable.  Strategic Goal 1. Reduce the prevalence of all types of disabilities 2. Promote, and protect the human rights and dignity of PWDS and their caregivers.  B. Strategic Objectives  1. Develop an integrated national health and human rights program and local models to serve the special health needs of PWDs.  2. Pursue the implementation and monitoring of laws and policies for PWD such as the accessibility law, human rights and other related laws.  3. Ensure that the health facilities and services are equitable, available, accessible, acceptable and affordable to PWD through the development and implementation of essential health package that is suitable to their Special needs and enrollment of into the National Health Insurance Program.  4. Initiate and strengthen collaboration and partnership among stakeholders to improve the facilities devoted to the management and rehabilitation of PWD and upgrade the capabilities of health professional and frontline workers to cater to their special needs.  5. Continue and fast\u2014track the registration of PWD in order to generate data for accurate planning and implementation of programs. The Philippine Registry for Persons With Disability will be continued, monitored and evaluated and developed into an information system that will be incorporated into currently used health service information system.  C. Program Components  A health program shall be developed for each tyme of disability and special population which must contain all of the following essential components:  A. Health promotion  This component shall include patient and caregiver information and education, public information and education and intersectoral collaboration on disability health promotion on the nature and extent of impairments particularly its risk factors, complications and the need/ urgency of early diagnosis and management.  This component shall ensure the advocacy for the following promulgated observances on the following speci\ufb01ed time each year as per issuances from the Of\ufb01ce of the President:     Future related observances promulgated by the Of\ufb01ce of the President shall also become part of this component.  B. Capability Building  This component shall focus on ensuring the capability of national, regional and local health personnel in delivering the appropriate institutional, community or out\u2014reach health care services especially to special areas and special populations. This component shall provide training for regional and local levels; will ensure the availability of and access to training programs by program implementers. It shall include strengthening treatment / management capabilities of existing personnel and operating capabilities of facilities rendering services to PWDs, taking into utmost consideration basic quality assurance and standardization of procedures and techniques appropriate to each facility/locality.  C. The Philippine Registry for Persons with Disabilities (PRPWD)  This component shall make certain that a recording and reporting system for the different types of disabilities shall be established and institutionalized at national, regional and local levels. An information system shall be developed for this purpose. The registry shall record and report the current epidemiologic data, health services, health status, needs and circumstances of PWDs in the country. This is to provide an effective basis for a national health program. All stakeholders of the different types of disabilities or special population shall cooperate and coordinate with the DOH in the reporting of PWD.  D. Networking, Inter\u2014organizational linkages, and Resource Mobilization  This component shall make certain that networking and inter\u2014organizational linkages are available at the local, regional and national levels. This shall include public-private and public-public partnerships aimed at building useful coalitions and networks for the delivery of appropriate health care services at affordable cost especially to the special populations of PWDs. This component shall also focus on ensuring that the highest appropriate quality services are made available and accessible to the people.  E. Monitoring and Evaluation  This component shall compare the accomplishment of implementing units, facilities, organizations or localities with the targets set forth by the health programs for each of the different types of disabilities. Targets and accomplishments shall be jointly agreed upon in proper consultation with the focal point and appropriate implementing units, facilities, organizations or localities taking into consideration the provisions of the local government code as well as the organic act of Muslim Mindanao, and any similar issuances/laws that will be passed in the future.  A review process shall also be a component of each program and be conducted as needed. Results of program evaluation shall be used in formulating policies, program objectives and action plans. The following parameters shall be used in formulating the M & E component:  1. Financial resources allocated 2. Human resources assigned 3. Information and knowledge resources 4. Program or project activities, their outputs, outcomes, and impacts  Appropriate actions and sanctions shall be identi\ufb01ed by stakeholders of each group and special populations during the design and implementation of the M & E component. These should be jointly agreed upon at the national, regional and local levels.  F. Accreditation, and equitable health \ufb01nancing packages.  This component shall be aimed at any legal entity, organizations, localities, or facilities that are implementing medical rehabilitation programs. A system of identifying and classifying these entities, organizations, localities or facilities shall be developed. Parameters for describing their capabilities, infrastructure, and other information prescribed by the DOH shall be identi\ufb01ed. A fair and due process of accreditation with the Department of Health shall be developed in consultation with the various stakeholders and in accordance with existing laws and regulations. Accredited organizations shall be entitled to utilize the bene\ufb01ts of health \ufb01nancing packages developed for this purpose.  Accredited legal entities, organizations, localities or facilities shall be allowed rational compensation by the Philippine Health Insurance Corporation (PHIC) for those expenses considered reimbursable by the PHIC based on the equitable health \ufb01nancing packages jointly developed for the PWD by each group and special populations in consultation with the Department of Health and PHIC.  G. Research and Development  This component shall promote the conduct of researches for purposes of developing local competence in health care and for other purposes that may be necessary.  An annual research agenda for psychosocial, chronic illnesses, learning, visual, orthopedic, speech and hearing impairments or disabilities shall be agreed upon by the various inter\u2014disciplinary teams for each disability typology or specialpopulation. The research agenda shall also include researches about community based rehabilitation, medical assistive devices, clinical assessment of functioning, health and disability, human rights, marketing and investment research and other relevant themes. The agenda will be forwarded to the Health Policy Development Bureau for approval. The various teams shall also incorporate in their program plans creativity enhancement strategies to increase the innovative potential of each team.  The program shall endorse the support of researches / studies in the clinical, epidemiological, public health and knowledge management (trends) areas. It also aims to acquire information that is utilized for continuing public health information and education, policy formulation, planning and implementation.  H. Service Delivery  Service delivery for the speci\ufb01c disabilities at every phase of the disease process, including primary, secondary, and tertiary stages, shall be covered by the principle of best practices while protecting and promoting the human rights of PWDs, their caregivers, and other stakeholders. In collaboration with the government and private sectors and stakeholders, this component shall include systems and procedures for the integration and provision of services at the community level. Each program shall periodically issue clinical practice guidelines that will be developed in consultation with various stakeholders.  This means primary prevention (ie,: health education, or advocacy and other related interventions); secondary prevention (ie: screening, early detection, basic management, counseling, behavioral modi\ufb01cation, referral and/or de\ufb01nitive care); and tertiary prevention (ie: management of complications, continuing care and follow up including rehabilitation) and terminal or palliative care. The following areas will be the priority areas for services to be developed for implementing facilities, localities, or organizations:  1. Community based and institution-based rehabilitation program 2. Clinical assessment of functioning, health and disability 3. Medical assistive devices  Timely and early interventions shall be provided to PWDs such as, but not necessarily limited to the following:  1. Healthy lifestyle and control of other non\u2014communicable diseases 2. Control of communicable and infectious diseases 3. Nutrition 4. Immunization 5. Family health 6. Environmental health and occupational safety 7. Dental health 8. Psychosocial and mental health  Separate activities for the following special populations shall be handled by the appropriate stakeholders aside from the regular 7 types of disabilities:  1. Children with Disabilities 2. Disabled women 3. Mothers with disabled children 4. Elderly disabled. 5. PWDs in Special areas  A Referral System shall form part of the services delivered by this component. This is to ensure that all patients receive quality health care at appropriate levels of health care delivery system. All rural health units should be linked to a referral center speci\ufb01c and appropriate to the type of disability or special population.  A sample matrix for a Health Program for each stage of human development from womb to tomb for each type of disability or special population is shown below:    VII. Implementing Mechanisms  A. National Structure (Annex 1)  1. Under the Policy and Standards Develoment Team for Service Delivery Of\ufb01ce, a Health and Disability Committee shall be established in accordance with Administrative Order No. 2005\u20141862. . Speci\ufb01cally, it shall be lodged at the Degenerative Diseases Of\ufb01ce, National Center for Disease Control and Prevention (NCDPC).  a. Composition:  Chair \u2014 Director NCDPC, Department of Health  Secretariat Degenerative Diseases Of\ufb01ce, National Center for Disease Prevention and Control  Members: Family Health Of\ufb01ce, NCDPC National Center for Health Promotion National Center for Health Facilities Development Bureau of Health Facilities and Services National Epidemiology Center Information Management Service Bureau of Local Health Development Chairpersons from program development and management committees for disability types or special populations. National Anti\u2014Poverty Commission - PWD sector Commission on Human Rights  b. Functions:  1. Acquire and integrate the various programs, projects and activities from the various program development and management committees for each type of disabilities and special populations.  2. Recommend to the Secretary of Health a master plan for disability and health aligned with the various government agencies and their thrusts.  3. Facilitate and coordinate the establishment of medical rehabilitation centers in the various provinces, localities and other organizations within the health system.  4. Assure the development of programs speci\ufb01c for the different disability types and special populations with the participation of the various stakeholders.  2. The Program Development and Management Committee (PDMC). Stakeholders from each of the 7 disability groups and 5 special populations shall be organized into a PDMC for that particular group or population.  a. Composition:  Chairperson Vice\u2014chairperson Members  Membership to the PDMC shall be initially identi\ufb01ed by the Degenerative Diseases Of\ufb01ce or other NCDPC of\ufb01ces concerned in consultation with the various medical, allied medical, paramedic-a1 or public health stakeholders for the \ufb01rst three years of implementation, after which the PDMC will be evaluated and allowed to choose their members or those nominated by their respective organizations. The details about the PDMC for each disability group or special population including their membership and other matters shall be spelled out in a Department Personnel Order issued regularly for this purpose.  b. Functions:  1. Develop a health program for their particular concern in consultation with CHDs and affected or concerned stakeholders in accordance with the guidelines prescribed by this Order.  2. Recommend the health program to the HDS.  3. Develop and disseminate clinical or public health practices, standard operating procedures and guidelines  4. Implement the program  5. Monitor implementation of the program  B. Regional Structure (Annex 2)  l. The health program for PWDs shall be the responsibility of the CHD Director. The Director or his or her designate shall represent the CHD in regional affairs for PWDs.  2. PWD Health Program Point Person. A person shall be identi\ufb01ed in each region or DOH hospital. The person shall be responsible for planning, implementing, and monitoring the  plans and programs of the various groups and special populations. The point person shall be assisted by a PWD for health program assistant. The point person shall be responsible to the Director.  3. In the region a PWD for health program assistant shall be designated in accordance with the provisions of Title 2, Chapter 1, Section 5 of the Magna Carta of Disabled persons which states that, \u201c Five percent (5%) of all casual, emergency and contractual positions of the Department of Health among others shall be reserved for disabled persons.\" The National Anti\u2014Poverty Commission PWD Sector Commissioner shall search and identify a quali\ufb01ed regional PWD assistant and recommend the person to the CHD Director or hospital chief who shall retain the prerogative to accept said regional PWD assistant and apply the usual procedure observed in the Department. The PWD assistant shall report to the CHD Health Program Point Person.  4. Multi-disciplinary team. Various medical, allied medical, or paramedical specialty societies and other stakeholders concerned with any type disability or population of PWD and who have duly registered national organizations who are members of the PDMCs shall also be organized into a regional multi-disciplinary team.  a. Organization:  Chairperson - CHD Director Secretariat PWD health program point person Members Medical, allied medical or paramedical specialty groups  Others deemed necessary by CHD  b.Func\ufb01ons  l. Prepares and recommends regional activities to implement the national health program to the PWD point person 2. Implements the regional program 3. Monitor and evaluate the regional program  C. Roles and Responsibilities  1. Department of Health \u2014 Central Of\ufb01ce shall develop systems, policies and guidelines that will facilitate the implementation of this Program including the monitoring and evaluation of program strategies. Develop the capacity of CHD personnel in assisting the LGUs in implementing the National Health Program for PWD at the local level. As such, the following of\ufb01ces shall have the following responsibilities:  a. The National Center for Disease Prevention and Control (NCDPC) shall (a) develop the plans for the implementation of the National Health Program for PWDs; (b) monitoring and evaluate program operation; (0) lead in the formulation of the health intervention and rehabilitation programs and strategies that will reduce the burden and consequences of risk factors and disabilities and promote health among PWDs; and ((1) ensure the participation of other DOH of\ufb01ces in program activities where needed.  b. The National Center for Health Promotion shall assist the NCDPC in the formulation of standards and development of information, education and communication (IEC) and advocacy strategies for the prevention of disabilities program to ensure the promotion of a healthy and less stressful lifestyle for the Filipinos, as well as to help in ensuring that the public has knowledge of services being offered as part of the program.  c. The National Epidemiology Center and the Information Management Service shall assist NCDPC in the development and institutionalization of a national reporting and surveillance system as well as the development of methodologies for the generation, collection and distribution of information and knowledge on the Philippine Registry for PWDs.  d. The Health Policy Development and Planning Bureau shall (a) assist in the proper and effective implementation, monitoring and evaluation of the National Health Program for PWDs; (b) ensure its formulation into a national program plan of action; (c) assist in developing a health \ufb01nancing scheme/protocol for health care services together with the Philippine Health Insurance Corporation; and (c) the inclusion of the disability prevention in the priorities for the health research agenda.  e. The Health Human Resource Development Bureau shall assist in (a) the development of standards in the curriculum and the training of all types of health professionals, practitioners, and care providers who are responsive, sensitive, which should be consistent with the national and local human development goals and culture; (b) the adequate and equitable distribution of health manpower through provision and protection of plantilla positions in the health care delivery system at the national and regional levels; and (c) the provision of a good incentive and bene\ufb01t program to attract health caregivers in the unserved and underserved areas.  f. The Bureau of International Health Cooperation shall ensure that the program has strong linkages with international health institutions, agencies, units that will continually ensure the inclusion, participation, cooperation and collaboration of the Philippines in the global scene for the prevention of disabilities.  g. The National Center for Health Facilities and Services shall work towards the development of medical rehabilitation units in local government hospitals or health centers as part of a Philippine Hospital System that is responsive to the health needs of PWDs. It shall facilitate the implementation of capability building of government hospitals for delivering services to PWDs. It shall ensure the development and implementation of policies and standards for the establishment or upgrading of health facilities to provide a comprehensive and holistic quality services to PWD and assure an equitable distribution, effective management and ef\ufb01cient operation of said facilities. They shall serve as referral centers and shall be responsible for certifying PWDs who require such services. They shall ensure the development of medical rehabilitation programs within their facilities. DOH hospitals and medical centers shall ensure the availability of quality rehabilitation care services to its clients through the establishment of appropriate capabilities and competencies in their respective units. It shall be responsible for certifying disabilities in accordance with Administrative Order 16-A s, 1999.  h. Bureau of Health Facilities and Services shall ensure the development of guidelines for the accreditation of legal entities, organizations, facilities or localities that conduct community, institutional or out-reach medical rehabilitation programs in consultation with various stakeholders. It shall also develop the capability of regional CHDs to accredit said rehabilitation services.  i. The Bureau of Local Health Development shall assist in the integration of quality health care for PWDs into local health system development.  j. The Centers for Health Development shall lead the region or zone in. implementing the health programs developed for each disability type or special population. It shall:  - Convene and coordinate a multi-disciplinary team of regional health or medical stakeholders for the various types of disabilities or special populations as the case may be. - Collate the implementation plans for the various health programs for the different disability types or special populations developed in consultation with the the multi\u2014disciplinary teams - Provide technical assistance - Designate Health Program for PWD Point Person - Advocate the health programs for PWDs - Develop the capability of local government units - Facilitate the implementation of the national health programs for PWDs ground working and situational analysis in \ufb01nalizing the commitment of the stakeholders (DOH, LGU, PHIC, private sector, NGOs, etc.) - Assist the LGUs in coordinating the actual implementation of the chosen program strategies and activities.  k. The Philippine Health Insurance Corporation shalljointly with the DOH develop and implement guidelines for a health \ufb01nancing package for accredited facilities rendering rehabilitation services to quali\ufb01ed PWDs.  2. Local Government Units- should organize themselves into inter-local Health zones that will manage the implementation of the Program strategies and activities. LGUs shall pass the necessary local legislation (ordinances, resolutions) to implement program strategies. Provide counterpart funds for implementing their investment plan.  3. Non\u2014government organizations and other organizations GOs, NGOs and academe shall be involved in addressing general concerns prevention of the PWDs and promotion of health programs, activities and projects.  4. Professional Organizations for PWD health care, speci\ufb01cally but not limited to the various medical specialties and the different paramedical and / or allied medical organizations, shall ensure the availability of competent, ef\ufb01cient and culturally and gender sensitive health professionals in all provinces in the Philippines.  5. Civil Societies \u2014 shall (1) assist the Local Government Units in achieving their health objectives, (2) shall identify the health needs of the people and bring to the attention of the inter\u2014local health zones, and (3) enhance accountability and transparency of inter-local health zonal management.  6. Donor Agencies - shall provide funding assistance according to the investment plan developed for the health programs.  VIII. Funding  The Department of Health, the Centers for Health Development, and DOH Hospitals shall allocate funds for the provision oftechnical assistance, conduct of regular monitoring and advocacy campaigns or activities in partnership with other stakeholders in the health system. These Of\ufb01ces shall assure that line items in the total General Appropriations Act for the Department of Health shall be for PWD Health Program development, implementation, and monitoring & evaluation  The local government units, NGOs and stakeholders shall also provide counterpart funds to ensure the implementation of the various programs subject to availability of funds and the usual auditing and accounting rules and regulations.  IX. Repealing Clause - all DOH issuances not consistent with the provisions of this Order are hereby repealed or modi\ufb01ed accordingly.  X. Effectivity - This Order shall take effect immediately.   ", "   JOINT ORDER No.2013 - 0033   TO: All PhilHealth Of\ufb01ces, Government Hospitals and All Other Concerned     I. RATIONALE   Republic Act (RA) No. 7875 as amended by RA No. 10606 prescribes that: \u201cthe National Health Insurance Program (NHIP) shall provide all citizens the mechanisms to gain financial access to health services, in combination with other government health programs. The NHIP shall give the highest priority to achieving coverage of the entire population\". Furthermore, Section 3 (c) of the same law emphasizes the need to \u201cprioritize and accelerate the provision of health services to all Filipinos, especially that segment of the population who cannot afford such services\". Moreover, Section 7 clearly mentions that \"all indigents not enrolled in the Program shall have priority in the use and availment of the services and facilities of government hospitals....Provided, however that such government health care providers shall ensure that said indigents shall subsequently be enrolled in the Program\".   Hence, in order to assure that none of the poor are left to chance, it is imperative that patients including their families not covered by PhilHealth at the point of service shall be enrolled accordingly by the admitting institutional health care institution and that PhilHealth shall appropriately reimburses these government health care institutions for the services extended to indigent population.   II. OBJECTIVES   This Manual of Operations and Procedures (MOP) aims to set the governing policies and operational guidelines in the enrollment of Hospital\u2014Sponsored Members (HSM) under the Point of Care Enrollment Program in government hospitals and their immediate availment of PhilHealth bene\ufb01ts. Specifically, this manual aims to:   -Guide the stakeholders concerned in the implementation of the program  -Provide rules and procedures in the identi\ufb01cation, enrolment and availment of NHIP bene\ufb01ts of quali\ufb01ed HSMs   III. COVERAGE   This Manual of Operations and Procedures is intended for the use of all stakeholders and of\ufb01ces concerned in implementing the Point of Care Enrollment Program, to wit:   -PhilHealth Personnel  -DOH-Hospital  -Local Government Units  -DSWD   All DOH\u2014retained hospitals shall mandatorily implement the Point of Care Enrollment Program while participation of LGU\u2014owned hospitals and other government hospitals shall be voluntary and subject to the Corporation\u2019s approval.   IV. GOVERNING POLICIES   PhilIHealth Circular No.32, s. 2013 dated November 07, 2013, with re: \"Implementation of the Point of Care Enrollment Program\" prescribes the governing rules and regulations.   V. MISCELLANEOUS PROVISIONS   Any issues that may arise during the course of implementation not covered by the attached MOP shall be resolved jointly by DOH and PhilHealth.   VI. REPEALING CLAUSE   All provisions of previous issuances that are inconsistent with any provisions of this Order and the Manual of Operations and Procedures attached herewith are hereby amended/modified and/ or repealed accordingly.   EFFECTIVITY   This shall take effect immediately.   ", " I. RATIONALE   The Philippine Cancer Society in 2004 revealed that the Philippines has an estimate of 73,944 new cancer cases annually. The top ten cancer sites are lung (23%); breast (19%); colon and rectum (12%); liver (10%); uterine cervix(10%); prostate(6%); blood (leukemia 6%); stomach(5%); thyroid(5%) and ovary (4%). In the Philippines, the relief and management of cancer pain and palliative care are benchmarked on the World Health Organization's Three-Step Ladder of Cancer Pain Management and the dispensing of _ morphine to Filipino cancer patients has been in existence for years through the Philippine Cancer Pain Control Program of this Department. According to the Pain Society of the Philippines an estimated 50% of patients with cancer requiring pain management remains under-treated due to high cost, poor access to narcotic pain medications, lack of knowledge/acceptance of the program by prescribing professionals, restrictive laws, regulations, policies and \u201copiophobia\" - failure to administer legitimate opioid analgesic because of a fear of the power of these drugs to produce addiction. The World Health Organization reported that the Philippines has an estimated need of 5.3 mg/capita, but has an actual consumption of only 0.23, and has only been able to cover 4.4% of the estimated analgesic (opioid) requirement in the country in 2005. The International Narcotics Control Board (INCB, 2008) reported that the morphine requirement of the Philippines for pain and palliative care amounts to 30 kg but the country was able to procure 5-6 kg only.   lnthe late 1980's, the DOH. through the Philippine Cancer Control Program, procured eight million pesos (P 8M) worth of morphine annually for the indigent cancer (both adult and pediatric) cases. Hospice facilities were the major distribution sites. The annual subsidy for the procurement of morphine in the course of time gradually decreased until the Department of Health stopped the purchase and distribUtion of such pain medications for indigent cases. The use of morphine in pain management and palliative care however, needs to be pursued. Cognizant of this and in an effort to reverse the situation, the Department of Health in 2008 initiated the procurement of P1 1M worth of morphine sulfate for distribution nationwide. Around 500,000 of the 10mg tablets, and 121,250 of the 30 mg morphine sulfate tablets, will be distributed at no cost to indigent cancer patients with moderate to severe pain.     II. STATEMENT OF POLICY   a. All indigent patients, whether out-patient or in\u2014patient, requiring palliative medications, suffering from moderate to severe pain due to cancer, HIV and other diseases, shall receive pain medications (morphine sulfate) at no expense to them, upon presentation of the DOH Prescription Forms indicating the quantity and dosage requirement. Such patients shall include those in the DSWD list under the National Household Targeting System, those with PhilHealth cards indicating Sponsored Program Members and those outside of the above but evaluated by the hospital and or hospice care resident Social Worker.   b. Hospitals shall only allocate a maximum of 20% of the existing stocks of morphine to non-indigent patients but without prejudice to indigent client needs and while supplies are available.   c. Hospice facilities can also refer patients for pain management to distributing hospitals who shall provide the drug upon presentation of the DOH Prescription Form.   d. Morphine sulfate medications shall be distributed by all DOH hospitals, participating Local Government Hospitals, private hospitals and hospice facilities.   e. Services which are not medically necessary, such as cosmetic surgery and other non- palliative interventions shall not be eligible to receive free morphine sulfate.   f. Consistent with the National Insurance Act of 1995 and the Health Sector \"Reform Agenda. all Filipinos shall be encouraged to become members of the Philippine Health insurance (PhilHealth) or at least be a dependent of an active member.   III. OBJECTIVE   To provide guidelines for the distribution and monitoring of Morphine Sulfate towards the enhancement of the quality of life by decreasing the under-treatment of patients with severe pain and by improving the accessibility of opiate analgesics.   IV. SCOPE   This guideline covers all DOH hospitals, selected government and private hospitals, selected hospice and morphine sulfate distribution centers nationwide (see attached list).   V. DEFINITION OF TERMS   a. \u201cDispense\" is any act of giving away, selling or distributing medicine or any. dangerous drug with or withOut the use of prescription.   b. \u201cBBB\" is the Dangerous Drugs Board, which is the main policy making body on Dangerous Drug Prevention and Control.   c. \u201cDSWD\" is the Department of Social Welfare and Development, which is the national agency mandated to identify the poor households.   d. \u201cDOH-Prescribed Prescription Form\" is the \u201cyellow\" prescription form for dangerous drugs that is made of a special kind of paper exclusively issued by and. obtainable from DOH.   e. \u201cHospices\" are facilities which specialize on the type of care, and a philosophy of care which focuses on the palliation of a terminally ill patient's symptoms. These symptoms can be physical, emotional, spiritual or social in nature. Hospice facilities under this guideline should seek accreditation by the National Hospice and Palliative Care Council of the Philippines (Hospice Philippines). Furthermore, they should enter into an agreement with the DOH regarding the utilization of morphine.   f. \u201cLicense\" is a written permission or authorization.   g. \u201cMMD\" is the Materials Management Division, an of\ufb01ce under the Department of Health charged to supervise / manage logistics and supplies.   h. \u201cMorphine\" is a highly potent opiate analgesic drug, is the principal active agent in opium, and is considered to be a prototypical opioid. '   i. \u201cNCDPC\" is the National Center for Disease Prevention and Control Center, an of\ufb01ce under the Department of Health which oversees the Non\u2014communicable Disease Program.   j. \u201cOSC\" is the Office for Special Concerns, an office under the Department of Health which handles the Dangerous Drug Abuse Prevention and Treatment Program.   k. \u201cPDEA\" is the Philippine Drug Enforcement Agency; the of\ufb01ce charged as the implementing arm of the DDB and as such is responsible for the ef\ufb01cient and effective law enforcement of all the provisions on any dangerous drug and/or controlled precursor and essential chemical as provided under RA 9165.   l. \u201cPrescription\" is a written direction by a practitioner that a stated amount of a dangerous drug or drug containing Table I Controlled Chemical, be dispensed for the person named therein.   m. \u201cRetail dispensing\" is the selling that is limited almost exclusively for personal use, both in number of sales, and either directly to walk-in customers or in face-to\u2014face transactions by direct sales. The person buying from the retailer is the ultimate user or consumer of the article or commodity or does not sell it again.   n. \u201cS2 License\" is the license required to authorize physicians, dentists and veterinarians to prescribe (a) dangerous drugs preparation; and/or (b) drug preparations, in parenteral or tablet or capsule form containing Table I controlled chemical as the only active medicinal ingredient or containing Table I controlled chemical and therapeutically insigni\ufb01cant quantities of another active medicinal ingredient.   o. \u201cS3 License\" is the license required to sell, procure, acquire, deal in or with speci\ufb01ed (a) dangerous drugs preparations or (b) drug preparations, in parenteral or tablet or capsule form, containing Table 1 controlled chemicals as the only active medicinal ingredient or containing Table I controlled chemical and therapeutically insignificant quantities of another active medicinal ingredient.   p. \u201cS4 License\" is the license required to sell, procure, acquire, deal in or with speci\ufb01ed (a) dangerous drugs and their preparations, (b) drug preparations, in parenteral or tablet or capsule form, containing Table 1 controlled chemicals for wholesale distribution to license holders, and (c) Table I controlled chemicals used in the manufacture of drugs. The license holder need not obtain another license of the same nature of activity for such controlled chemicals.   q. \u201cTable I Controlled Chemical\" means chemicals enumerated. in the list of substances in Table II of the 1988 UN Convention Against Illicit Traf\ufb01c in Narcotic Drugs and Psychotropic Substances, which is an integral part of the Republic Act 9165 otherwise known as the \u201cComprehensive Dangerous Drugs Act of 2002\".   r. \u201cWholesale distribution,\" means activities by any person, which stands between the manufacturer and the retail seller in purchases, consignments, or contracts for sale of dangerous drugs or controlled chemical and their preparations.   VI. GENERAL GUIDE LINES   The following shall be observed in the management and distribution of opiate analgesic (Morphine sulfate):   a. The DOH Central Bids and Awards Committee shall be responsible for \ufb01nalizing the general speci\ufb01cations and packaging of the drug pursuant to the procurement plan.   b. The National Center for Disease Prevention and Control of the DOH shall be responsible for technical speci\ufb01cations and the quantities, allocation of the drug as well as funding of the procurement of Morphine sulfate preparations starting 2011.   c. The Of\ufb01ce for Special Concerns through the Dangerous Drugs Abuse Prevention and Treatment Program (DDAPTP) shall monitor the distribution and allocation of drug and related logistics.   d. The DOH-Material Management Division (MMD) shall be responsible for coordinating with the Philippine Drug Enforcement Agency (PDEA) in securing the necessary permits for the purpose of purchase and distribution of the drug.   e. Stocks shall be secured by the MMD and shall be allocated depending on the need of a particular region or location as set/identi\ufb01ed. by the NCDPC.   f. Distribution and dispensing units shall comply with the regulatory requirements as provided for under Dangerous Drugs Board (DDB) Regulation No. 3 s. 2003 or the \u201cComprehensive Guidelines on importation, distribution, manufacture, prescription, dispensing and sale of, and other lawful acts in connection with dangerous drugs, controlled precursors and essential chemicals and other similar or analogous substances\" (downloadable at www.pdea.gov.ph):   1) Hospitals and. hospices shall secure from the PDEA the appropriate licenses for wholesale distribution (S-4 license) and retail dispensing (S-3) whichever is applicable;   2) Local stock transfer from one license holder to another or from one activity to another shall be covered by an approved PDEA Form 1\u201404 (LOCAL TRANSFER PERMIT);   3) Dispensing by a current PDEA registered outlet shall require a properly \ufb01lled out DOH prescribed prescription form issued by a current PDEA S\u20142 License holder.   g. Dispensing sites are / shall be informed on the initial shipment of stocks and succeeding shipments thereafter.   1) Initial shipment volume shall be determined at the level of the DOH-Central Of\ufb01ce by the OSC as indicated by the allocation list provided by NCDPC.   2) Succeeding shipments shall be on a need basis while supplies are available.   a) Hospitals shall be required. to inform the OSC, DOH when the available stock reaches the critical volume of thirty percent (30%) of the initial allocation for immediate replenishment;   b) Likewise, hospitals shall also report to the OSC the average monthly consumption and available stock volume, ten (10) months before the expiration date and, as required by the DOH-Central Of\ufb01ce;   c) Hospitals may also submit requests to the OSC for increased allocation using the following basis:   i. anticipated increase in the number of patients;   ii. increased prescribing due to training, residency, or the addition of quali\ufb01ed doctors with pain management patients;   iii. emergency needs such as the large amount dosages needed for the cancer patient to achieve adequate pain control.   h. Only a DOH Accredited Freight Forwarder shall be authorized to transport the medications/supplies. The following are the transport and receiving procedures:   1) Duplicate copy of the approved PDEA permit and respective hospital purchase request shall accompany the shipment and shall form part of the transport documents;   2) The transported medication should be properly insured,   3) Inter-island. transport shall be by airfreight,   4) Supplies shall be received by the designated Supply Of\ufb01cer and/with the Chief Pharmacist following recording and reporting procedures as provided for by DDB Regulation No 3, 2003.   i. Each hospital shall strictly comply with the regulatory control measures set forth by PDEA to include among others the prescribed security for storage, dispensing, distribution, recording and reporting requirements.   j. The hospitals/hospices shall dispense the medications free of charge to indigent patients with moderate to severe pain. Participating hospices, in consonance with Presidential Proclamation No. 1 l 10 ofthe President of the Republic of the Philippines dated July 25, 2006, shall seek accreditation by the National Hospice and Palliative Care Council of the Philippines (Hospici Philippines). Morphine distribution shall comply with the following: 1:er   1) Morphine dispensing shall be covered by a duly accomplished DOH prescription issued by a current PDEA S2 licensed doctor and ilentist. The prescription shall be presented to the Hospital pharmacy;   2) Patients or their families shall submit an accomplished \u201cStatement of Commitment\" to return any \u201cunused\" medications when instances arise that the patient would no longer need the Morphine. The Morphine shall be returned to the same dispensing hospital pharmacy following existing prescribed reporting system;   3) The patient, family, guardian or person duly authorized in behalf of the patient should ensure the security of Morphine against loss, theft or misuse/abuse;   4) Reporting and recording of dispensed medication shall follow DDB Regulation No 3, 2003 using the same required register, forms and attachments and;   5) During the transition when hospices are seeking accreditation of Hospice Philippines, hospices can refer clients with morphine prescription to distributing hospitals following the above\u2014 mentioned procedures (refer to 8a), pending their accreditation. This 15 to ensure smooth delivery of services to clients in need of pain management.   k. The MMD-DOH, upon approval by NCDPC shall distribute medications to non-DOH hospitals and hospice/palliative units upon presentation and receipt of a request letter from the concerned service provider. A Memorandum Of Agreement (MOA) between the Department of Health and a non-DOH government hospital or a hospice facility shall be undertaken. The said facility shall be responsible in securing approval of the PDEA Transport permit.   l. Hospitals who wish to distribute to authorized hospice/palliative care and other service units shallibe required to secure a PDEA\u2014S4 License (for the wholesale distribution).   m. Hospice/ palliative care and other service units shall be required to secure a PDEA-S3 License to authorize them to dispense directly to patients and shall follow all of the above\u2014mentioned procedures in-compliance to DDB Regulation No 3, 2003.   1) S4 and S3 application forms can be downloaded at the PDEA website: www. pdea. gov. ph  2) Applications by government hospitals/facilities are free of charge.   n. The DOH, PDEA, DDB and other authorized agencies may conduct inspection and monitoring visits to ensure compliance to this Order.   VII. ROLES AND RESPONSIBILITIES   a. National Center for Disease Prevention and Control (NCDPC):   1) Shall include funds for the procurement of pain management medications in its operational plan, work and \ufb01nancial plan and procurement plan from hereon;   2) Shall provide technical assistance in determining types and quantity of medications to be procured, taking into consideration the dosage requirements and the \u201cstep \u2014 ladder\" approach;   3) Shall determine the quantity / allocation of the medications per hospital / region;   4) Shall participate in technical working group discussion;   5) Shall monitor movement of said logistic and its utilization and;   6) Shall provide input on the messages to be developed on pain management.   b. Central Of\ufb01ce Bids and Awards Committee (COBAC):   1) Shall be responsible in advertising and / or posting of bidding documents to interested bidders;   2) Shall facilitate the procurement process from eligibility screening, evaluation of bids, awarding of contract and post quali\ufb01cations and;   3) Shall monitor the procurement activities for proper reporting to relevant agencies when required.   c. Materials Management Division (MMD) \u2014Administrative Service:   1) Shall coordinate with PDEA for the issuance of necessary permits for the transfer, transportation and distribution of Morphine Sulfate tablets;   a) The PDEA Local Purchase Form will be prepared by the Pharmacist with valid S4 license before procurement for approval at the Compliance Service of the PDEA.   b) The approved Local Purchase Form will be submitted to the Procurement Division for processing of the procurement.   c) The supplier will notify schedule of delivery to the MMD \u2014- DOH Quirino Warehouse and the items will be received together with other documents in accordance to the quantity and specification stated in the Purchase Order.   d) DOH Hospitals with valid PDEA S3 License can request for the Morphine Sulfate by sending their PDEA Local Purchase Form and a copy of their valid S3 License to the MMD \u2014 DOH Quirino Warehouse. The Pharmacist will coordinate with the Compliance Service of PDEA for approval of the transaction.   e) The copy of the approved Local Purchase Form, Invoice Receipt and Bill of Lading will be prepared together with the stocks of Morphine Sulfate requested by the DOH Hospital.   f) F01 the transportation of Morphine Sulfate tablets, the DOH contracted forwarder will be assigned for the distribution to the DOH Hospitals.   g) The original copy of the Local Purchase Form will be \ufb01led by the Pharmacist and the transaction recorded in the Dangerous DrugBook needed for the semi\u2014 annual reporting to the PDEA.   2) Shall take charge of the security of the inventory;   a) Morphine Sulfate tablets are placed in a secure storage room at the MMD - DOH Quirino Warehouse upon receipt from the supplier and inspection by the DOH inspection team and FDA inspectors for FDA test analysis sampling.   b) Storage place and premises are in \ufb01t condition, appropriate temperature and has sufficient space.   c) Adequate supervision should be properly carried out at all times by the Pharmacist and Supply Of\ufb01cer who have access in handling Morphine Sulfate tablets.   d) Report of monthly inventory of stocks will be submitted to the OSC - DDAPTP prepared by the Pharmacist and veri\ufb01ed by the Of\ufb01cer-In\u2014Charge of MMD.   3) Shall assist in the monitoring of logistics distribution and drug utilization;   a) Coordination with the DOH Hospital Pharmacist regarding the sending of their Local Purchase Form for approval at the Compliance Service of PDEA.   b) Veri\ufb01cation of the proper distribution of Morphine Sulfate tablets and documents to the DOH Hospitals.   c) Assists in the information dissemination regarding the availability of Morphine Sulfate tablets at the DOH Central Of\ufb01ce Warehouse.   d) Assists in the monitoring of the utilization of Morphine Sulfate tablets by the DOH Hospitals.   d. Dangerous Drug Abuse Prevention and Treatment Program - Of\ufb01ce for Special Concerns (DDAPTP-OSC):   1) Shall assist in the formulation of related policies for approval of the Dangerous Drugs Board; -   2) Shall convene the technical working group to- discuss among others the availability and accessibility of opioid analgesic for pain and palliative care;   3) Shall determine the volume of shipment for distribution to sites based on the allocation as initially submitted. to NCDPC and the subsequent requests of the respective sites as approved by NCDPC and;   4) Shall assist in the monitoring of logistic distribution and drug utilization.   e. National Center for Health Promotions (NCHP):   1) Shall assist in the dissemination on information pertaining to pain management;   2) Shall develop necessary Information Education and Communication materials on pain management and morphine sulfate use and;   3) Shall help mobilize support groups for easy access and utilization of the pain management medications.   f. Information Management Service (IMS):   1) Shall assist in the development of an IT\u2014based reporting system of pain medication utilization which shall be housed under the Department of Health website and;   2) Shall help capacitate hospitals, hospices and other partners in the use of the IT reporting system.   g. Centers for Health Development (CHDs):   1) Shall assist in the monitoring of pain management medication distribution and utilization;   2) Shall help identify and mobilize support groups and organizations that can facilitate easy access and utilization of the pain management medications and;   3) Shall provide feedback to the NCDPC and the DDAPTP of the necessary arrangement that will help improve distribution and utilization systems.   h. Hospitals:   1) Shall ensure the security of the pain medications which should follow the PDEA set standards;   2) Shall be responsible in securing all the necessary permits for the transportation, utilization and dispensing of the pain medications;   3) Shall determine eligibility of recipient to receive pain medications and;   4) Shall submit regular utilization reports to the NCDPC, DDAPTP and CHDs.   VIII. SEPARABILITY CLAUSE   In the event that any provision of this guideline is declared invalid for any reason, the other provisions shall remain in effect.   IX. EFFECTIVITY   This guideline shall take effect after \ufb01fteen (15) days after publication in the of\ufb01cial gazette or in a newspaper of general circulation.  ", "  I. POLICY BASIS AND RATIONALE :  The Department of Health is mandated by R.A.No 747 of 1954, An Act to Regulatefees to be charged Against Patients in Government and Charity Clinics Classifying Patients according to their Financial Condition, to set the necessary rules and regulations for the dueexecution of the provisions of this Act.  This policy issuance is one of the responses of the DOH to the need for people-centered hospitals that are responsive to the demands of the present socio\u2014economic situation in which most Filipinos \ufb01nd themselves. Based on the latest statistical data gathered from all regions, the National Statistics and Coordinating Board (NSCB), has described the poverty situation as follows: In 2000:  (a) The Poverty Incidence [proportion of families to the total number of families] stood at 34.2 %,  (b) The Magnitude of Poor Families [number of families whose annual per capita income falls below the annual per capita poverty threshold] was 5,215,989;  (c) The Per Capita Poverty Thresholds [annual per capita income required...to satisfy essential nutritional requirements (2,000 calories) and other basic needs] ranged from P10, 868 for Region VIII to P18, 001 for NCR and averaged P13, 916 for the whole Philippines; and  Addressing the poverty situation by means of providing accessible and affordable health care services, especially public hospital services, constitutes the main rationale for this Order.  II. PURPOSE OF THIS ORDER  This Administrative Order aims to:  1. Update and improve existing policies on availment of medical social services and mode of payment for hospital services rendered in government hospitals to indigent patients, especially those who qualify for and avail of Medical Social Services;  2. Set realistic guidelines for evaluating and classifying patients, specially those who are legitimately indigent or have limited capacity to pay their hospital bills; and  3. Enable the Medical Social Service Units of g0vernment hospitals nationwide to  (a) classify hospital patients; (b). use criteria that are objective and reasonable, simplified and \"implementable\", but subject to controls and limitations; and (c) help make health resources available to the periphery.  III. COVERAGE/SCOPE:  This Administrative Order covers all government hospitals, National, Local, and those ran by other government agencies.  IV. GENERAL GUIDELINES  A. Criteria for Classi\ufb01cation of patients  The criteria for the classi\ufb01cation of patients seeking Medical Seeial Service assistance in hospitals shall be based on the following:  1. The latest Per Capita Poverty Threshold (PCPT), by Region, as determined by the proper government authority, speci\ufb01cally the National Statistics and Coordinating Board (NSCB);  2. Regional location of the hospital or health facility;  3. Income or paying capacity of the patient or in cases where the patient is a minor or a dependent, the income or paying capacity of his / her parents, immediate relatives, or guardian as the case maybe;  4. Level of social \ufb01inctioning ofthe patient  5. Modifiers\" arising from speci\ufb01c situations or circumstances;  6. Hospital room or ward where the patient is con\ufb01ned or treated;  7. Costs or bill of expenses charged for hospital services rendered;  B. Categories of Patients  On the basis of their income or paving capacity. patients shall be classified as follows:  1. Class A - Pay  1.1 A patient admitted to a. hospital suite, private room. or semi-private room as a pay patient;  1.2 A patient who may or may not be a. quali\ufb01ed Philippine Health Insurance Corp. (PHIC or Phil health). beneficiary and who shall pay in full all fees 3 charges for hospital and professional services, including any excess amount that is not reimbursable by Phil health, if any.  2. Class B - Pay Ward  2 1 A patient admitted to a Pay Ward (3 beds or more);  2. 2 A patient who can and shall pay in full all fees 1' charges for professional and hospital services rendered at the Pay Ward level, including expenses in excess ofamonnts payable by Phil health, if any.  3. Class C - Ward  3.1 A patient or family who are the \"working poor\", those with fulltinie work but their income is not suf\ufb01cient to meet their treatment eXpenses in full.  3.2 A patient admitted to a ward;  3.3 A patient with or without Phil health bene\ufb01ts who (a) cannot pay in full the excess of hospital expenses chargeable to Phil health; or (b) has monthly income per capita that falls under Sub-Class C-1, C-2, or C-3 as affected by the modifying circumstances (modi\ufb01ers) described herein.  To determine how much a patient shall pay as his / her actual share of hospital expenses incurred, Class C patients shall be further categorized as follows:  3.3.1 Class C-1   Patients whose monthly income per capita is above the 180 % but not more than 220 % of the latest PCPT for the region in which the hospital is located.  Example: A patient who is con\ufb01ned in a hospital located in the National Capital Region (NCR) should at least have a monthly income per capita of P2, 700.00 but not more than P3, 300.18 in order to be categorized as a Class C\u2014l patient. [The 2000 PCPT for the National Capital Region is Pl, 500.08 monthly].  3.3.2 Class C-2  Patients whose income is above the 140 %, but not more than 180 % marked up of the latest PCPT for the region in which the hospital 1S located  Example: A Class C-2 patient con\ufb01ned in a Region IV hospital should have a total monthly income per capita of more than P1, 785.81 but less than P2, 296.04. [The 2000 PCPT for Region IV is Pl, 275.58 monthly per capita].  3.3.3 Class C\u20143  Patients Whose monthly per capita income is equal to but not more than the 140 % marked up of the latest PCPT for the region where the hospital is located  Example: A Class C-3 patient admitted to a Region V hospital should have a. monthly per capita equal to P1, 084.42 but not more than Pl, 51819. [Region V\u2019s 1997 PCPT = P1, 084 monthly].  4. Class D \u2014 Full Social Services  4.1 A patient or family who cannot provide for the basic food and non-food requirements, which is called the poverty threshold. Their income is below the latest PCPT of the region in which the hospital is located  4.2 Patients covered by Republic Acts, special laws, Executive Orders, local ordinances, or other national policy instruments that are issued because of speci\ufb01c circumstances or situations of the target groups or sectors of society.  C. MODIFYING CIRCUMSTANCES  The Patient\u2019s capacity to pay shall be further eValuated on the basis of these modi\ufb01ers:  1. Modi\ufb01ers related to personal circumstances:  1.1 Patients in crises situations 1.2 Patients who are differently-abled or have physical /mental disabilities or limitations 1.3 Patients who have no known family relatives or guardians. 1.4 Patients who are orphans, \"senior citizens\", war veterans, or widows with no concrete source of \ufb01nancial support.  2. Modi\ufb01ers related to Community Situations  2.1 Patients coming from \"squatter\" areas or urban slums; 2.2 Patients dislocated from their homes or communities as a result of disasters or calamities caused by nature, by accidents, or by human failures or intentions. Examples of such situations include inclement weather and violent climate disturbances, typhoons, \ufb02oods, droughts, \ufb01res and wars or armed con\ufb02ict, among others; and  2.3 Patients. belonging to economically disadvantaged or marginalized ethnic groups or indigenous cultural communities (ICCs).  3. Modi\ufb01ers related to the Nature of Illness / Disease I  3.1 Patients with chronic diseases needing long-term and costly treatment, e. g. chronic kidney disease, chronic lung ailments, and cancer  3.2 Patients with acute or chronic diseases for which no curative medicines are currently available or diseases known to require hospital services, drugs of health care equipment that are expensive or beyond their means. Examples of such diseases include HIV/AIDS, cancer, etc.  D. Modes of Cost -Sharing  Given the patients capacity to pay and the modifying circumstances, the following cost\u2014sharing arrangement shall be applied:     V. SPECIFIC PROCEDURES  1. The patient walks in or is brought or referred to the OPD or Emergency Unit.  2. The physician-on-duty conducts an evaluation;  2.1 Can patient be treated in the hospital based on the hospital\u2019s facilities and competence. 2.2 Cannot be treated in the hospital  3. If it can be treated , the patient is referred to the hospital\u2019s Medical Social Service for evaluation:  3.1 Purpose of evaluation: a) assess \ufb01nancial capacity of patient and family, and b) determine level of social functioning of patient.  3.2 How to evaluate on the basis of criteria:  a) Assess the Patient and family\u2019s \ufb01nancial capacity through Intake Interview using the MSS Form no. 1 (as attached in this order )for short term treatment, and for long term treatment, validated by the following requirements; Certi\ufb01cate of Employment, Income Tax Return or Certi\ufb01cation of Exemption, Certi\ufb01cation from Assessor\u2019s Of\ufb01ce, and / or Treasurer\u2019s Of\ufb01ce, Barangay Certi\ufb01cate and DSWD\u2019s Social Case Study Report if the patient resides outside the hospital\u2019s catchments area or a Home Visit Report if within the hospital\u2019s catchments area.  b) Assess the level of social functioning, which is the ability of people to perform the tasks of daily life and to engage in mutual relationships with other people in ways that are gratifying to themselves and to others and meet the needs of an organized community using the Person-in\u2014 Environment as organizing construct. The Medical Social Worker shall describe the patient\u2019s problem complex, its severity and duration, in the following areas,  - Problems in Social Functioning (Familial Roles, Interpersonal Roles, Occupational Roles, and Special life situation Roles) - Problems in Environment ( Economic/Basic Needs System {Food/nutrition, shelter, employment, economic resources, transportation, discrimination}, Education and Training, Health, Safety and Social Services System{Health/Mental Health, Safety, Access to Social Services, Discrimination), Voluntary Association System {Religious, Community Groups}, Affectional Support System - Problems in Mental Health (Current mental disorder or condition that is relevant to the understanding of the patient\u2019s problem) - Problem on Physical Health( Current physical disorder or condition that is potentially relevant to the understanding of patient\u2019s problem)  c) Getting the aggregate monthly income of the household and dividing it with the number of household members determine the monthly income per capita.  d) The Poverty Threshold shall be used as the baseline for determining indigency or for classifying patients according to their capacity to pay.  e) For purposes of the Order and for the year 2001 and thereafter, the latest Poverty Thresholds by region (2000) provided by NEDA or NSCB shall apply until such time that the PCPT\u2019s are revised or updated.   f) Patient / Relative shall sign the Intake Survey Sheet after the initial interview to certify that the informations he/she disclosed are true.  g) Patients who are covered by the \u201cmodifiers\" listed in this Order shall be evaluated by the Medical Social Service to determine their \ufb01nancial capacity to contribute to their hospitals expenses. Based on the \ufb01ndings, the Medical Social Service shall determine the mode of cost sharing to be applied to them.  4. The Medical Social Worker shall inform the patient about his/her classi\ufb01cation and the patient\u2019s \ufb01nancial contribution (if any) corresponding to the patient\u2019s class (Class A, B, C-1, C-2, C-3 or D).  4.1 If \ufb01nancially needy;  a) The MSW issues pre-numbered MSS cards, renewable each year  b) Upon admission, the patient may be accommodated as belonging to any of the categories, if warranted by further \ufb01nancial or social evaluation, the patient may be moved to a category below or above the initial category.  c) Changes in the classi\ufb01cation shall primarily be based on the changes in patient\u2019s income, while the patient\u2019s share shall be adjusted based on the modi\ufb01ers   d) Whenever necessary or appropriate, the patient or his / her accompanying family relatives or guardian shall be motivated not to depend totally on \u201csocial services\" for the payment of hospital charges, instead \ufb01nd other resources to ensure maximization of medicinal assistance and continuing of treatment.  e) Pay patients who are to be transferred to the service ward shall avail of the discount only after the reclassi\ufb01cation of the Medical Social Worker. Service patients who shall transfer to a pay ward shall have to be reevaluated as to his capacity to pay treatment expenses in the pay ward. If he was found to have withhold vital information that lead to his wrong classi\ufb01cation, he shall pay all services and accommodation since the start of his / her admission. On the other hand, if his circumstances changed unexpectedly 0r due to an unexpected benefactor, he can still avail of the discounts on his accounts for his stay in the service ward.  f) Payment-in-kind schemes that are the non-cash payment in exchange for hospital goods and services can be implemented as an alternative mode of recovering cost of hospitalization, and in encouraging patient's participation in his/her treatment expenses.  4.2 If \ufb01nancially not needy  a) If the patient is found not eligible for MSS assistance he/she shall be informed by the Medical Social Worker about the estimated cost of his/her treatment or hospitalization.  5. The Medical SocialWorker shall provide the patient and family the appropriate clinical intervention according to their level of social functioning no matter what classi\ufb01cation-they have.  6. The Medical Social Worker still reserves the right to client participation and that his / her basic function to assess, evaluate and orient patient regarding their primary responsibility of meeting their health needs will not be compromised.  7. For monitoring purposes, the hospital shall submitquarterly reports on the availment of medical social services to the DOH National Center for Health Facility Development (NCHFD).  VI. Responsibilities of implementing units or persons  1. The National Center for Health Facility Development (NCHFD)  1.1 Shall monitor compliance with the guidelines on availment of Medical Social Service by government hospitals and make the appropriate recommendations as may be needed.  1.2 Shall coordinate or facilitate the implementation of this Order.  1.3 Consolidate and analyze submitted reports.   2. Hospital  2.1 Requires the Medical Social Service Unit to formulate additional implementing guidelines to cover the unique needs of the hospital.  2.2 Approves the additional Implementing Guidelines  2.3 Requires the Medical Social Worker to submit monthly report on the classi\ufb01ed patients.  2.4 In health facilities where a Medical Social Service unit or person is not available, of\ufb01cially designates the proper unit or person who shall do classi\ufb01cation of patients in coordination with the Local Social Welfare Of\ufb01ce.  3. The Medical Social Service Unit  3.1 The Medical Social Service of the hospital concerned shall evaluate and classify patients seeking admission or treatment in hospitals to determine his / her eligibility for medical social services in accordance with the guidelines prescribed in this Order.  3.2 Submits anannual psychosocial pro\ufb01le of patients served.  3.3 Documents social issues and concerns in relation to the implementation of these guidelines.  4. Local Government Units  4.1 Monitor compliance with the guidelines on availment of Medical Social Service by government hospitals under its management and make the appropriate recommendations as may be needed.  4.2 Approves the additional Implementing Guidelines needed to address the unique needs of their locality.  5. The Medical Social Workers League  5.1 The League shall coordinate or consult with NCHFD and the DOH Medical Social Work Adviser on matters that are connected with or may arise from this Administrative Order.  VII. Repealing Clause  Department Order No. 435-B s. 1990 dated October 22, 1990 is repealed by this Order. Provisions of other administrative issuances inconsistent with this Administrative Order are also repealed, superseded or modi\ufb01ed accordingly.  VIII. Effectivity  This Administrative Order shall take effect upon approval.      ", " I. Rationale  The Philippine Health Agenda (PHA) builds on the gains of earlier reform policies such as the Health Sector Reform Agenda (1999), FOURmula One for Health (2005) and Kalusugan Pangkalahatan (2010). It aligns with the National Economic Development Authority's AmBisyon Natin 2040, and emphasizes the country's commitment to the global 2030 Agenda for Sustainable Development. The PHA aims to uphold every Filipino's right to health as enshrined in the 1987 Philippine Constitution - to make these rights explicit and tangible and in line with President Rodrigo Duterte's promise to the people of \"tunay na pagbabago\" or real positive change that people can feel.   PHA seeks to fulfill the global call for Universal Health Coverage, adopting \"All for Health towards Health for All\" as the rallying point to realize the vision of a Healthy Philippines by 2022.   II. Objectives  This issuance shall define the Philippine Health Agenda and provide guidance in the design and implementation of relevant policies, plans and programs.   III. Scope and Coverage  This issuance shall apply to the DOH central office bureaus and units, DOH regional offices; DOH hospitals (Specialty, Special, Retained, Sanitaria, and Treatment and Rehabilitation Centers); Food and Drug Authority, DOH attached agencies such as: the Philippine Health Insurance Corporation (PhilHealth), the Commision on Population (Popcom), the National Nutrition Council )NNC), Philippine National AIDS Council (PNAC) and the Philippine Institute of Traditional and Alternative Health Care (PITAHC); all public and private hospitals and health care facilities, health care providers and support staff; local government units (LGU's); other national government agencies (NGAs); development partners; civil society organizations; academic institutions; medical societies and organizations and all other institutions relevant for the implementation of the PHA.  IV. Policy Framework  A. Goals: The PHA aims to (1) ensure the best health outcomes for all, without socio-economic, ethnic, gender, and geographic disparities; (2) promote health and deliver healthcare through means that respect, value and empower clients and patients as they interact with the health system; and (3) protect all families especially the poor, marginalized, and vulnerable against the high costs of healthcare.   B. Values: All actions shall be implemented in accordance with the values of quity, quality, and efficiency, transparency, accountability, sustainability, and resilience.   C. Guarantees: The health system shall guarantee:  1. Population - and individual - level interventions for all life stages that promote health and wellness, prevent and treat the triple burden of disease, delay complications, facilitate rehabilitation and provide palliation.   a. All Life Stages (ALS) refers to services for pregnant women, children, adolescents, adults, and older persons.  b. Triple Burden of Disease pertains to the (1) backlog of communicable diseases and neglected tropical diseases; (2) increasing challenges of noncommunicable diseases such as cancer, diabetes, heart disease, and their risk factors like obesity, smoking, poor diet, sedentary lifestyles, as well as malnutrition; and (3) problems related to globalization, urbanization and industralization like injuries, substance use and abuse, mental illness, pandemics, travel medicine, and health consequences of climate change.   2. Access to health interventions through functional Service Delivery Networks (SDNs) that:  a. Consist of primary care networks (PCNs) linked to level 3 hospitals and specialty care, where each PCN is an aggrupation of one district or Level 1 or Level 2 hospital and between 5 to 10 rural health units of private outpatient clinics.   b. Ensure well-equipped and fully-staffed network of health facilities, either static or mobile, that are close to the people.  c. Render services that are compliant with clinical practice guidelines, available 24/7, and are resilient during disasters.   d. Practice gatekeeping and utilize telemedicine to expand access to specialty services (e.g tele-radiology, dermatology, pathology or psychiatry).   3. Financial freedom when accessing these interventions through Universal Health Insurance such that the:   a. National Health Insurance Program (NHIP) enrolls 100% of Filipinos where formal sector premiums are paid through payroll and non-formal sector where premiums are paid by tax subsidies.   b. NHIP's support value is 100% (or zero-copayment) for the poor and those admitted in basic accomidation; and a predictable (fixed co-payment) for those admitted in non-basic, private accomodation.   c. NHIP covers a comprehensive range of services and becomes the main revenue source of public health care providers.   D. Strategies: The strategies needed to fulfill the guarantees may summarized by the word \"ACHIEVE\".   1. Advance quality, health promotion, and primary care; 2. Cover all Filipinos against health related financial risk;  3. Harness the power of strategic human resources for health development;  4. Invest in eHealth and data for decision making; 5. Enforce standards, accountability, and transparency; 6. Value All Clients and Patients, especially the poor, marginalized and vulnerable; 7. Elicit multisectoral and multistakeholder support for health.   V. General Guidelines  A. All DOH offices, units, hospitals, and attached agencies shall align their policies, programs, and activities to the PHA. They shall advocate for the PHA to all stakeholders and partners.   B. All national government agencies/entities with funds and activities related to health, such as but not limited to the Government Service Insurance System (GSIS), Philippine Charity Sweepstakes Office (PCSO), Philippine Amusement and Gaming Corporation (PAGCOR), Philippine General Hospital (PGH), Hospitals of State Universities and Colleges (SUCs), Department of Education (DepEd), Department of Social Welfare and Development (DSWD), agencies under the Housing and Urban Development Coordinating Council (HUDCC) and Department of Labor and Employment (DOLE), are strongly encouraged to align their policies, programs, and funds for health with PHA.   C. The following essential to policy documents shall be formulated by the DOH, upon issuance of this Order, to supplment the PHA;  1. Implementation Plan and Operational Guidelines which shall describe the management arrangements fo facilitate implementation, monitoring and evaluation, including accountabilities for all DOH offices, attached agencies, and stakeholders.   2. National Objectives for Health 2016-2022, which will identify priorities and provide a compendium of indicators, correspondings targets and data sources that shall be used to track performance of the health sector.   3. Health Research Agenda which shall provide focus and direction on health research and development efforts and serve as basis for allocation of grants.  4. PHA Monitoring & Evaluation System which shall outline the logical framework, and the moitoring and evaluation plan for PHA cosisting for but not limited to indicators, targets, sources of data, collection mechanisms, and reports to track health and DOH performance.   5. Ambisyon for Health 2040 which shall situate the PHA in the long term and provide stategic direction for the health sector in line with Ambisyon 2040.   VI. Specific Guidelines for Realizing the Guarantees  To realize the 3 Guarantees of the PHA, the DOH and its attached agencies shall develop policies, plans, and programs in support of ACHIEVE.   A. Advance Quality, Health Promotion and Primary Care  1. DOH shall require health providers to conduct annual health the visits for all the poor families, marginalized, vulnerable and special populations (e.g. DSWD Listahanan-identified poor, Indegenous Peoples, Persons with Disabilities, Senior Citizens)  2. DOH Shall develop an explicit list of primary care entitlements, along with clinical practice guidelines, that will become the basis for licensing/accrediation standards, contracting arrangements for PCNs, and benefit expansion of PhilHealth.   3. DOH shall transform select DOH hospitals in Luzon, Visayas, and Mindanao into mega-hospitals or hospitals with multi-specialty training capabilities and reference laboratory.   4. DOH shall support LGU's in advancing local health policies (resolutions or ordinances) that improve access to lfiesaving interventions and reduce exposure to risk factors for premature death and disability (e.g. city-wide smoke-free or speed limit ordinances)  5. DOH shall establish expert bodies for health promotion, surveillance and response.   B. Cover all Filipinos against Health-related Financial Risk  1. DOH, Philhealth, other NGA's, all LGU's, and all other concerned shall collectively work for revenue generating measures, such as but not limited to, further increasing excise taxes for tobacco and alcohol, imposing taxes on sugar-sweetened beverage and supporting other health promoting taxes, increasing NHIP premium rates, and improviding collection efficiency from the public and private formal sector.   2. DOH and Philhealth shall lead in aligning all health financial programs (GSIS, MAP, PCSO, PAGCOR) to support Universal Health Insurance  3. PhilHealth shall expand benefits of NHIP to cover outpatient diagnostics, medicines, and blood and blood products, as guided by health technology assessment.  4. Philhealth shall review and update costing of current case rates to ensure that they cover the full cost of care and that they link payment to quality of service rendered.   5. Philhealth shall enhance and enforce its contracting policies (e.g. setting up of primary care trust funds, network based contracting, income retention for LGUs health providers with retained budget support incentives)  C. Harness the Power of Strategic Human Resources for Health (HRH) Development  1. DOH in corrdination with the HRH Network shall review and revise the curriculum of health professionals to make it more primary care-oriented and responsive to local and global needs.   2. It shall review and streamline HRH compensation packages, including financial and non-financial incentives for those serving in high-risk or geographically-isolated and disadvantaged areas (GIDA), and support the full implementation of Magna Carta for Health Care Workers.  3. It shall update frontline staffing complement standards from profession based to competency based.   4. It shall make available fully-funded scholarships for HRH hailing from GIDA areas or IP groups.   5. It shall formulate mechanisms for mandatory return of service schemes for all health graduates.    D. Invest in eHealth and Data for Decision Making  1. DOH and Philhealth shall mandate the use of electronic medical records in all health facilities  2. DOH, PhilHealth, FDA shall make online submission of clinical, drug dispensing and administrative and financial records as prerequisite for registration, licensing and contracting  3. DOH, PhilHealth, FDA shall commission nationwide surveys to supplement unavailable or incomplete administrative data, streamline information systems and administrative data collections systems, and support efforts to improve local civil registration and vital statistics.   4. DOH, PhilHealth, FDA shall automate major business processes and invest in warehousing and business intelligence softwares.   5. DOH in coordination with academic partners and research institutions shall facilitate ease of access of researchers to available data.    E. Enfore Standards, Accountability and Transparency  1. DOH shall initiate publication of health information that can tirgger better performance and accountability (e.g. prices of common drugs and services, non-compliant/erring providers, national objectives for health targets, and various health scorecards)  2. DOH shall set up a dedicated performance monitoring unit that will employ appropriate mechanisms to tack performance or progress of reforms, including but not limited to medical audits and third-party monitoring.   F. Value All Clients and Patients, especially the poor and vulnerable  1. DOH shall ensure the poorest 20 million Filipino are priozitized in all health programs and supported in non-direct health expenditures (e.g. transporation, subsidy)  2. DOH in coordination with other partners and stakeholders shall make all health entitlements simple, explicit, and widely published to facilitate understanding.   3. DOH shall set up participation and redress mechanisms  4. DOH and its attached agencies shall reduce turnaround time and improve transparency of processes at all DOH offices and health facilities.  5. All health care facilities shall eliminate queuing and guaranteee decent accomodation and clean restrooms in government hospitals.    G. Elicit Multi-sectoral and Multi-stakeholder Support for Health  1. DOH and PhilHealth shall harnass and align the private sector in planning supply-side investments, forming SDNs, and expanding PhilHealth contracting to immediately include the private sector (e.g. Z benefits, primary care benefit)  2. DOH shall ensure convergence and develop a health policy agenda with other NGAs (DILG, DENR, DSWD, DepEd, HUDCC, among others) in addressing social determinants through Health in All Policies and other multisectoral approaches.   3. DOH shall require health impact assessment and corresponding public health management plan as a prerequisite for initiating large-scale, high-risk development projects in the areas of mining, power plants, oil rigs, etcs.  4. DOH shall foster collaboration and partnership with CSOs with other stakeholder on budget development, and monitoring.    VII. Key Roles and Responsibilites  A. The DOH shall be the main policymaking regulatory agency and lead convener for PHA. Along with its attached agencies, the DOH shall take the lead in developing specific, policies, plans, programs, and guidelines, raising and consolidating resources and using this leverage performance, advocating for pro-health reforms, and informing the public and operating DOH-retained hospitals.   B. PhilHealth, specifically, shall develop its technical, financial and administrative capacity to become the national purchaser for health services medium term.   C. Local Government Units shall develop policies and plans in support of PHa, and as may be appropriate to their locality; mobilize and utilize resources; and, the partner with the private sector to ensure adequate health investments and to make service delivery networks functional.   D. The Development Partners, within the context of Sector Development Approach for Health and subject to agreements with DOH shall provide official development assistance consistent with PHA, alugn and harmonize their systems and processes with government proceducres and insitutional reform processes to the best extent possible, cooperate in the establishment of mechanism to track development assitance for the PHA, and ensure the sutainbility and institutionalization of assistance projects to appropriate agencies/offices.   E. The Civil Sociery Organizations and other professionals organizations shall promote good governance through advocacy, monitoring, community mobilization and education, and implementation of development.   F. The Academic and Research institutions shall assist the DOH, PhilHealth, LGUs, and all others to concerned in health sector in producing more responsive HRH and providing the best evidence and policy and decision making.    VII. Repealing and Separability Clause  All orders, rules, and regulations, and other issuances inconsistent with or contracy to this Order are hereby repealed, amended, or modified accordingly. All provisions of existing issuances which are not affected by this ORder is declared unauthorized or rendered invalid by any court of law or competent authority, those provisions or parts not affected by such declaration shall remain valid and in effect.   IX. Effectivity  This Order shall take effect immediately. ", " In order to effectively reduce the incidence, morbidity and mortality from cancer in the Philippines, the National Cancer Control Center of the Department of Health under the leadership of Dr. Tranquilino Elica\u00f1o, shall undertake the following functions and responsibilities:  1. To study and evaluate the cancer problem in the Philippines and formulate effective nationwide policies to solve this problem.  2. To assume leadership and serve as the nucleus and coordinating body for all cancer work in the Department of Health.  3. To establish and guide the effective operation of satellite cancer centers attached to strategically located medical centers or the eleven (11) regional hospitals throughout the Philippines.  These regional cancer centers aside from giving cancer control service will in turn serve as coordinating bodies for cancer work in provincial hospitals and other smaller Department of Health agencies all the way down to the barangay level.  4. To plan, establish and carry out an effective nationwide program of cancer prevention, detection, diagnosis, pre-treatment evaluation, treatment, rehabilitation and continuing care.  a. To establish and supervise the operation of Tumor Boards in regional and training hospitals throughout the Philippines.  b. To advise on the upgrading of existing cancer management facilities in Department of Health agencies throughout the Philippines, or in instances where there are no facilities available, to advise and help in the selection of modern facilities.  c. To establish rapport and coordinate with other agencies both government and private, local and international, who are in one way or another doing work in cancer and related fields. One project for early cancer detectioIn which may be feasibly started on a small scale and then expanded on a nationwide basis is the tie\u2014up with the Family Planning Program by taking pap smears of all women utilizing the services of the thousands of Family Planning Clinics throughout the Philippines thereby serving as a mass screening procedure for early detection of cervical cancer.    d. The relation of cigarette smoking and cancer can be stressed as one of the nationwide programs of cancer prevention. A study of the tar and nicotine content of local cigarettes should be dine and the results evaluated and made known to the public for their protection.  5. To establish and carry out an effective training program in the various specialized fields of Oncology for medical and paramedical personnel not only from the greater Manila area but most specially those coming from regional centers, provincial hospitals, rural health units and other Department of Health agencies in the rural areas.  6. To establish and regularly carry out, by coordinating with the Department of Public Information and the National Mass Media Production Center, an effecive program of Nationwide Cancer Education for the public aimed at emphasizing that most cancers can be cured provided that the public take note of the early warning signs and signals of this disease because the best chances of cure is through early detection and correct diagnosis and the giving of proper treatment promptly.  7. To be responsible for cancer epidemiology in the Philippines and to collect data and statistics in order to establish a reliable cancer registry of nationwide scope which is essential to better understanding of cancer as a disease and to improve care and treatment of cancer patience.  8. To provide excellent serv1ces and job opportunities in modern cancer centers throughout the country for the numerous medical and paramedical personnel who graduate every year and most specially for cancer experts who return to the Philippines after extensive training abroad.  9. To encourage research on malignancies which are prevalent in the Philippines and research into the possibility of finding raw materials in the Philippines which can be compounded locally into useful drugs in order to lower the prohibitive price of chemotherapeutic agents to fit the pocketbook of low\u2014income patients.  10. To set up a building at the corner of Rizal Avenue and Quiricada streets in order to adequately house the central activities of the National Cancer Control Center. This building shall contain the most modern equipment for clinical serv1ce, cancer training, epidemiology and research.  This Order shall take effect immediately. ", " Republic of the Philippines Department of Health OFFICE OF THE SECRETARY   I. RATIONALE/ BACKGROUND   The right to health is one of the fundamental rights enshrined in Article II of the Constitution. Section 15 states that \u201cthe State shall protect and promote the right to health of the people and instill health consciousness among them.\"  Under Republic Act (RA) No. 7394 or the Consumer Act of the Philippines, \u201cIt is the policy of the State to protect the interest of the consumer, promote his general welfare andto establish standards of conduct for business and industry. Towards this end, the State shall implement measures to achieve the following objectives: a) Protection against hazards to health and safety; b) Protection against deceptive, unfair and unconscionable sales acts and practice; c) Provision of information and education to facilitate sound choice and the proper exercise of rights by consumer.\" Article 10, on Injurious, Dangerous and Unsafe Products, of the same RA provides that, \u201cWhenever the departments find, by their own initiative or by petition of a consumer, that a consumer product is found to be injurious, unsafe and dangerous, it shall, after due notice and hearing, make the appropriate order for its recall, prohibition 'or seizure from public sale or distribution. Provided that, in the sound discretion of the Department it may declare a consumer product to be imminently injurious, unsafe or dangerous, and order its immediate recall, ban or seizure from public sale or distribution, in which case the seller, distributor, manufacturer or producer thereof shall be afforded a hearing within forty-eight (48) hours from such order.\"   Section 3 of RA No. 9711 or the FDA Act of 2009 declares that, \u201cIt is hereby declared a policy of the State to adopt, support, establish, institutionalize, improve and maintain structures, processes, mechanisms and initiative that are aimed, directed and designed to protect and promote the right to health of the Filipino people.\" Section 5 of the FDA Act of 2009 provides that, \u201cSection 4 of RA No. 3720, as amended, is hereby further amended to read as follows: Sec. 4. To carry out the provisions of this Act, there is hereby created an office to be called the Food and Drug Administration. (FDA) in the Department of Health (DOH). Said administration shall be under the Office of the Secretary and shall have the following functions, powers and duties: xxx (k) After due process, to order the ban, recall, and/or withdrawal of any health product found to have caused the death, serious illness or serious injury to the consumer or patient, or is found. to be imminently injurious, unsafe, dangerous, or grossly deceptive, and to require all concerned to implement the risk management plan which is a requirement for the issuance of the appropriate authorization.\"    The WHO Framework Convention on Tobacco Control was rati\ufb01ed by the Republic of the Philippines in 2005 and entered into force on 4 September 2005. Speci\ufb01cally, under Article 5 on the General Obligations, Article 5.3 states that, \u201cIn setting and implementing their public health policies with respect to tobacco \"control, Parties shall act to protect these policies from commercial and other vested interests of the tobacco industry in accordance with national law.\"   RA No. 9711 de\ufb01nes \u2019health products\u2019 as food, drugs, cosmetics, devices, biologicals, vaccines, in-vitro diagnostic reagents and household/urban hazardous substances and/or a combination of and/or a derivative thereof. It shall also refer to products that may have an effect on health which require regulations as determined by the FDA. It also de\ufb01nes 'health- related device\u2019 as any device not directly used in health care but has been determined by the FDA to adversely affect the health of the people. As the national competent authority on health products and health-related device, the FDA has put in place systems and processes for licensing the establishments, issuing market authorization for products, approving labels and labeling materials, conducting inspection and post-marketing surveillance, approval of promotional and advertisement materials, and laboratory testing.   The World Health Organization has clearly stated that the safety and efficacy of ENDS or electronic cigarettes as smoking cessation aid have not yet been scientifically demonstrated. The potential risks they pose for the health of users remain undetermined. WHO stated that \u201cuntil such time as a given ENDS is deemed safe and effective and of acceptable quality by a competent national regulatory body, consumers should be strongly advised not to use electronic nicotine delivery systems including e\u2014cigarettes.\"   Electronic cigarette or ENDS products and. its manufacturers and distributors are hereby regulated to ensure protection of the safety and welfare of consumers. The timely and appropriate regulation of ENDS or electronic cigarettes underscores the primacy of public health and re affirms its primary function to promote, protect, preserve, and restore the health of the people.   II. OBJECTIVES   Consistent with the policy of the State to promote the right to health of all the people and instill health consciousness among them, this Administrative Order is being issued with the following objectives:   a. To ensure the safety, efficacy and quality of electronic cigarette or ENDS as health product or consumer product, and   b. To serve as guidelines for electronic cigarette or ENDS manufacturers and distributors in securing a FDA license to operate and a Certificate of Product Registration (CPR).   III. SCOPE AND COVERAGE   This Administrative Order shall apply to all FDA\u2014licensed establishments which seek to apply for a market authorization or CPR of all electronic cigarette or ENDS in the country. Electronic cigarettes or ENDS are combination drugs and medical devices and are not tobacco product or conventional cigarettes and shall comply with the FDA standards and requirement for health products to ensure the safety, efficacy and quality.    IV. DEFINITION OF TERMS For the purpose of this Administrative Order, the following terms are de\ufb01ned:   1. Electronic cigarettes or ENDS (electronic nicotine delivery systems) are a category of consumer products designed to deliver nicotine to the lungs after one end of a plastic or metal cylinder is placed in the mouth, like a cigarette or cigar, and inhaled to draw a mixture of air and vapors from the device into the respiratory system. They contain electronic vaporization systems, a rechargeable battery and charger, electronic controls and replaceable cartridges that may contain nicotine and other chemicals. Some brands are claimed to deliver a range of nicotine concentrations or no nicotine at all.   2. Ingredient cartridge means the concentrations of chemicals including propylene glycol, nicotine and several others, used to produce the odors and flavors that simulate those of cigarettes. The manufacturers have not fully disclosed the chemical combinations included during the manufacture or synthesized during electronic vaporization that produce the sensory effects of cigarettes. Furthermore, the manufacturers have not proven that constituent chemicals, which include organic chemicals that may be acceptable for use in foods and cosmetics, are safe for inhalation when vaporized and delivered to the lung.   3. Smoking cessation aid means an FDA-approved medicine, drug products or articles, used or employed to treat nicotine dependence or addiction or as an intervention to help people quit smoking.   4. FDA shall mean the Philippine Food and Drug Administration.   5. Drug means articles that are a) recognized in official pharmacopoeias and formularies, including of\ufb01cial homeopathic pharmacopoeias, or any documentary supplement to any of them, which are recognized and adopted by the FDA; b) intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals; 0) intended to affect the structure of any function of the body of human beings or animals (other than food; or (I) intended for use as a component of any articles speci\ufb01ed in clauses (a), (b), or (c).   6. Health-related device means any device not directly used in health care, but has been determined by the FDA to adversely affect the health of the people.   V. REGULATORY STANDARDS AND POLICIES   The following standards and policies shall be implemented by the FDA for ENDS or electronic cigarettes, as shown in Annex 1 of this Administrative Order:   1. Electronic cigarettes or ENDS are combination drugs and medical device and are not tobacco products and shall be regulated as medicinal product.   2. Electronic cigarettes or ENDS shall pass the safety, efficacy and quality evaluation of the FDA before a market authorization is issued as health product and health\u2014related device.     3.Clinical trials shall be allowed by the FDA, subject to the existing rules and regulations on clinical trial application and approval process, including ethical approval process. Patients or subjects may enroll following the requirements of Good Clinical Practice, to protect the rights, health and interest of the patients or subjects.   4. The FDA shall require a LTO from the manufacturers and distributors before applying for a Certificate of Product Registration.   5. A CPR shall be required as market authorization before a product is used or offered for sale.   6. The FDA shall evaluate the safety, ef\ufb01cacy and quality of the device and ingredient cartridge of ENDS or electronic cigarettes. Standards for drugs and drug products shall be used by the FDA in evaluating ENDS.   7. The cartridge containing the ingredients or what the industry call as \u201celectronic juice\" shall pass the safety, ef\ufb01cacy and quality standards of the FDA. As appropriate, the mixture of ingredients in the cartridge shall be subjected to safety evaluation and the quality. The delivery of the dose of nicotine shall be subjected to pharmaceutical standard.   8. The device that produces the mist shall pass the safety, ef\ufb01cacy and quality as a health\u2014related device. Manufacturers shall meet the requirements of the current Good Manufacturing Practice (cGMP).   9. Both the cartridge and device shall be made child-proof to prevent accidental ingestion or leakage of ingredients and misuse of the device.   11. Claims of \u201ccessation aid to smoking\" or \u201cless harmful alternative or reduced harm compared to smoking\" shall be acceptable provided that health product safety, efficacy and quality standards are met and all FDA requirements are complied with by the FDA-licensed establishments.  10. Application for a CPR shall not be construed as approval of the application. Based on the outcome of the FDA evaluation, the application for a CPR may be disapproved. The FDA shall inform the applicant on the deficiencies of requirements or the reason(s) behind the disapproval of the application.   12. If ENDS and electronic cigarettes have been issued CPRS as market authorization, the FDA shall conduct Post-Market Surveillance and regulate the advertisement, promotion of the health product and the marketing activities of establishments.   13. ENDS or e-cigarettes are not exempted from 'clean air laws,\u2019 which restrict the places in which cigarette smoking is allowed, until adequate evidence is provided that use of the product will not expose nonusers to toxic emissions.    14. The FDA shall issue speci\ufb01c guidelines, including requirements on the issuance of the License to Operate and Certi\ufb01cate of Product Registration as well as for other purposes to ensure implementation of this Administrative Order.   VI. MONITORING AND SURVEILLANCE   Regardless of the outcome of the CPR application and evaluation of ENDS or electronic cigarette, the use of ENDS or electronic cigarettes in public areas shall not be allowed in areas or facilities that prohibit smoking.   The DOH shall implement the provisions of the RA 7394, or the Consumer Act of the Philippines, in monitoring the effects of prolonged exposure and against promotion of dual use and/or gateway to cigarette use, with the FDA. As provided by RA 9711, the Director General of the FDA may call on the assistance of any Department office or agency and deputize members of the Philippine National Police or any law enforcement agency for the effective implementation of the FDA Act of 2009.   VII. SEPARABILITY CLAUSE   If, for any reason, any section or provision of this Order is declared invalid, illegal or unconstitutional, such invalidity or unconstitutionality shall not affect the other provisions of this Order, which shall remain in full force and effect.   VIII. REPEALING CLAUSE   The provisions of other existing provisions or issuances found inconsistent or contrary with this Order are hereby repealed or modi\ufb01ed accordingly.   IX. EFFECTIVITY   This Order shall take effect fifteen (15) days following the date of its publication in a newspaper of general circulation.    ", "   I. RATIONALE   Non-communicable diseases are the top causes of death worldwide, killing more than 36 million people in 2008. Cardiovascular diseases were responsible for 48% of these deaths, cancers 21%, chronic respiratory\u2019diseases 12%, and diabetes 3% based on the World Health Organization report on Non-communicable Diseases Country Pro\ufb01les 2011part. In the Philippines, cardiovascular diseases, cancers, chronic respiratory diseases and diabetes are among the top killers causing more than half of all deaths annually. Hypertension and diseases of the heart are among the ten leading causes of illnesses each year. These lifestyle related non-communicable diseases have common risk factors which are to a large extent related to unhealthy lifestyle particularly tobacco use, unhealthy diet, physical inactivity and alcohol use (National Objectives for Health 2005\u20142010).   These evident data have pushed international organizations to take actions and drive the entire world to prevent these kinds of diseases, which are long in duration and generally slow in progression. Recognizing the urgency of the situation, the Department of Health (DOH) as-the principal health agency in the Philippines, took on the lead in making policies and programs that could lessen these cases. In April 14, 2011, Administrative Order No. 2011-0003 or the National Policy on Strengthening the Prevention and Control of Chronic Lifestyle Related Non Communicable Disease was issued. The Order states that the Department of Health shall provide leader-ship in addressing lifestyle related non-communicable diseases and institute measures in ensuring that the programs for prevention are met and implemented. Section XI, Item No. 5 states that the National Epidemiology Center and the Information Management Service shall establish and sustain public health and hOSpital surveillance systems including registries, for lifestyle-related diseases and other non-communicable diseases.   On the other hand, in the Asia Paci\ufb01c Region, it is estimated that injuries caused about 2.7 million deaths in 2002, or over 7000 deaths daily, which constituted 52% of wOrldwide injury deaths. .111 response to the injury-related problems, the Department of Health has created Administrative Order No. 2007-0010, dated March 19, 2007, the National Policy on Violence and Injury Prevention. This established a national policy .and strategic framework for injury prevention activities for DOH and other government agencies, local government units, non\u2014government organizations, communities and indiViduals. Related to injury is violence against women and children which is not merely a health concern and requires a whole range of medical, social, and non-medical interventions and services. Administrative Order No. LB, 3. 1997 established a Women and Children Protection Unit in All DOH Hospitals. Further, the DOH supports the program on persons with disabilities and has created Administrative Order N0.16-As.1999 which established the Guidelines on the issuance of Certi\ufb01cation of Disability to Persons with Disabilities.     To make available the data on chronic non-communicable diseases, injury, violence and disabilities, the Uni\ufb01ed Registry Systems were developed by the DOH. These are the Integrated Chronic Non-Communicable Diseases, Online National Electronic Injury Surveillance System, Philippine Registry for Persons with Disabilities, and Violence Against Women and Children Registry System. This Order mandates all government and private clinics and hospitals to submit reportable cases of chronic non-communicable diseases, injuries, violence, and disabilities to the DOH Information Management Service, and de\ufb01nes the implementing procedures and guidelines related thereto.   II. DECLARATION OF POLICIES   1. This Order complements the following issuances or provisions:   2. The 1987 Philippine Constitution mandates the following: Article II Section 15 for the protection and promotion of the right to health of the people and instills health consciousness among them; and (2) Article 13, Section II, which specifies that the state shall adopt an integrated and comprehensive approach to health development which shall endeavor to make essential goods, health and other social services available to all the people at affordable cost. There shall be priority for the needs of the under\u2014privileged, sick, elderly, disabled, women and children. The state shall endeavor to provide free medical care to paupers.   3. Republic Act No. 4921, extending the Scope of the Cancer Detection and Diagnostic Center of the Dr. Jose Reyes Memorial Hospital to include also Cancer Treatment and Research   4. Administrative Order No. 2011-0003 or the National Policy on Strengthening the Prevention and Control of Chronic Lifestyle Related Non Communicable Disease.   5. Administrative Order No. 2009-0012 on Guidelines Institutionalizing and Strengthening the Philippine Renal Disease Registry under the DOH.   6. Administrative Order No. 2007-0010, National Policy on Violence and Injury Prevention Administrative Order No. 16-A, s. 1999 Guidelines on the Issuance of Certi\ufb01cation of Disability to Persons with Disabilities   7. Administrative Order No.1-B,s.1997 Establishment of 3 Women and Children Protection Unit in All DOH Hospitals   8. Administrative Order No. 16-A s. 1995 on Diabetes Mellitus Prevention and Control Program in the Philippines.   9. Administrative Order No. 89-A s. 1990, amendment to A. O. No. 188-A s. 1973 on the Philippine National Cancer Control Program   10. Administrative order No.19 s.1987 transferring the funCtions of the Cancer Control Center to the Jose Reyes Memorial Hospital and to the Non Communicable Disease Control Services   11. Administrative Order No.188-A s. 19 73, Authority and Functions of the National Cancer Control Center of the DOH   12. Department Memorandum No. 2008-0204 on Collection and Submission of Philippine Renal Disease Registry Forms.    III. OBJECTIVES   The issuance of this Order aims to achieve the following objectives:    1. Provide standard recording and submission of reportable cases related to chronic non- communicable diseases, injuries, violence, and disabilities which are diagnosed or con\ufb01rmed accordingly to the DOH.   2. Collect data that are essential for public health planning, use, and/or implementation.   3. Establish clear operating guidelines and/or procedures in the implementation of he registry system  4. De\ufb01ne rules to protect the con\ufb01dentiality of data.    SCOPE OF APPLICATION   This Order shall apply to all DOH Central Of\ufb01ce, Centers for Health Development Of\ufb01ces, ProvinciaI/District/City/Municipality Health Of\ufb01ces, and government and private Clinics and hospitals including medical professional societies/associations.   DEFINITION OF TERMS   For purposes of this Order, the following terms are de\ufb01ned as follows:   1. BHFS  Bureau of Health Facilities and Services   2. CHD   Center for Health Development   3. Clinical Diagnosis    Diagnosis based on a study of the signs and symptoms of a disease. (The American Heritage\u00ae Medical Dictionary Copyright \u00a9 2007, 2004 by Houghton Mif\ufb02in Company. Published by Houghton Mif\ufb02in Company. All rights reserved https://medical-dictionary.thefreedictionary.com/clinical+diagnosis  4. COPD   Chronic Obstructive Pulmonary   5. DOH   Diseases Department of Health  6. ICNCDRS   Integrated Chronic Non-Communicable Disease Registry   7. Injury  An injury is the physical damage that results when a human body is suddenly or brie\ufb02y subjected to intolerable levels of energy. It can be a bodily lesion resulting from acute exposure to energy in amounts that exceed the threshold of physiological tolerance, or it can be an impairment of function resulting from a lack of one or more vital elements (i.e. air, water, warmth), as in drowning, strangulation or freezing. The time between exposure to the energy and the ppearance of an injury is short. (INJURY SURVEILLANCE GUIDELINES Published In conjunction with the Centers for Disease Control and Prevention, Atlanta, USA, by the World Health Organization, 2001)   8. IMS   Information Management Service    9. NCDPC  National Center for Disease Prevention and Control   10. NCHFD National Center for Health Facility Development   11. NEC  National Epidemiology Center   12. Medical Associations  Refer to associations like Medical Societies, Specialty Divisions and Specialty Societies, Af\ufb01liate Societies, and other related associations.   13. Reportable Case  Refers to diagnosed or con\ufb01rmed chronic Anon-communicable disease, injury, violence, or disability.   14. Reporting Health Facilities  Refer to government and private clinics, hospitals, medical societies and other professional organizations with existing information systems.    15. URS (Uni\ufb01ed Registry Systems)   Collection of data related to patients with diagnosed/con\ufb01rmed cases on chronic non-communicable diseases, injuries, violence, and disabilities.   VI. GENERAL GUIDELINES   1. The Uni\ufb01ed Registry Systems shall serve as tools and mechanisms to collect information on reportable cases on chronic non-communicable diseases, injuries, violence, and disabilities that have been diagnosed or con\ufb01rmed as such in the country as basis for sound and rational planning, implementation, monitoring and evaluation of health programs; development of health services, health policies and programs, and inputs to studies and other related undertakings.   2. Professional societies and those with existing information systems shall upload the required data to the DOH Information Management Service to generate national data.   3. The security, con\ufb01dentiality, and integrity of data shall at all times be secured and/or protected.  4. Monitoring shall be conducted by the NCDPC, NEC, and/or IMS in coordination with the NCHFD and BHFS, to evaluate compliance of reporting facilities, strengthen quality assurance, and monitor the performance of the uni\ufb01ed registry systems.   SPECIFIC GUIDELINES   A. Uni\ufb01ed Registry Systems\" Reporting   The Uni\ufb01ed Registry Systems shall serve as tools and mechanisms to collect information on reportable cases on chronic non-communicable diseases, injuries, violence, and disabilities that have been diagnosed or con\ufb01rmed as such in the country as basis for sound and rational planning, implementation, monitoring and evaluation of health programs; development of health services, health policies and programs, and inputs to studies and other related undertakings.   Data submitted through the Uni\ufb01ed Registry Systems can be accessed by the Bureau of Health Facilities and Development and CHDs, and can be included in the required hospital statistical reports.   1. Reporting health facilities refer to government and private clinics and hospitals. All reporting health facilities shall report diagnosed or con\ufb01rmed cases of chronic non-communicable diseases like cancer, diabetes, stroke, COPD, renal diseases, blindness, mental health, cardiovascular and other chronic non-communicable diseases; injuries, violence, and disabilities on a regular basis to the URS.   2. Regular basis shall refer to the frequency of reporting, namely:   i Chronic Non-Communicable Diseases  Monthly   ii Injuries  Daily   iii Violence  Daily   iv Disabilities  Monthly   3. When there is a reportable case, the reporting health facility, through the concerned doctor or authorized personnel, shall \ufb01ll up the appropriate standard recording form. The standard recording forms are as follows:   1 Cancer Registry Form Annex 1.0   ii COPD Registry Form Annex 2.0   iii Diabetes Registry Form Annex 3.0   iv Stroke Registry Form Annex 4.0   v. Patient Injury Registry Form Annex 5.0   vi Fireworks Injury Surveillance Patient Annex 6.0  Information Sheet   vii Violence Against'Women and Children -- Annex 7.0 Patient Information Sheet   viii Persons with Disability Registration Form Annex 8.0   4. Reporting health facilities shall use the Online Data Entry or Data Uploading that is applicable to their current settings, situations, and/or capacities to submit their reportable case to the DOH IMS. The official website address is - https://uhmisl .dohgov.ph/UnifiedRegistryNC.   5. For Chronic Non-Communicable Disease and Persons with Disability monthly reporting, the period for entering or uploading data shall be every \ufb01rst \ufb01ve (5) working days of the month. The submitted data shall already be validated or checked by the reporting health facilities and considered as clean and o\ufb02icial.   6. The URS shall be available twenty-four (24) hours per day and seven (7) days a week. In any situation where the URS is unavailable due to problems in the DOH\u2019s Internet Service Provider, database and application servers, and other concerns, an email message shall be sent to all reporting health facilities. Same _ users shall be noti\ufb01ed by email once the URS becomes available.   7. Information Technology support shall be available during working days, i.e. Monday to Friday. Request for issuance of user names and passwords, and other system administration services shall be addressed on the following working day.   B. Data Uploading   Professional societies and those with existing information systems shall upload the required data to the DOH Information Management Service to generate national data. .   1. Of\ufb01ces with information systems being funded by the DOH like the Philippine Cancer Society, Renal Disease Control Program, and others shall upload data to the DOH IMS.   2. Medical Associations are encouraged to upload data to the DOH IMS to ensure a coordinated and systematic approach to data collection and analysis of data.   3. Data Dictionaries for Uploading shall be given to standardize the data to ensure interoperability and data sharing.   4. A Memorandum of Agreement between the DOH and those facilities with existing information systems shall be issued for systematic data uploading, con\ufb01rmation of roles, duties and responsibilities, and commitment to upload the data.    C. Security of Data   The security, con\ufb01dentiality, and integrity of data shall at all times be secured and/or protected   1. Each reporting health facility shall only be given one (1) account, i.e. user name and password for close monitoring of . compliance and accountability. Heads of Reporting Health Facilities, i.e. Chiefs, Directors, or equivalent, shall disseminate accountable to any misuse or abuse in the use of the accounts.   2. Users of the URS shall be managed through the System Administration \u2014 Users\u2019 Account Function of the system and to be administered by the IMS.   3. Passwords can be changed by the reporting health facilities but the user names are permanent and cannot be modi\ufb01ed.   4. Reporting facilities shall ensure that the data are validated or checked before uploading. Submitted data cannot be edited or modi\ufb01ed. Reporting health facilities shall undergo the following processes to request for editing:  i. Fill up the Incident Report (Annex 9.0) with the approval signature of the head of the reporting health facility or duly authorized personnel.   ii. Submit the Incident Report to the NCDPC via personal delivery or mail.   iii. Wait for con\ufb01rmation that the changes or modi\ufb01cations have been done or entered.   5. Reporting health facilities can only access the data that they submitted, and shall not be able to view the data of other health facilities. A written request for an electronic copy of their submitted data in excel, word, xml, or csv formats shall be required from the Head of the Reporting Health Facilities or duly authorized personnel.   6. Information about the reportable cases shall be available at a consolidated, summary or statistical level. Personal details are restricted.   7. DOH personnel handling the URS shall not disclose the contents of the registry or any individually-identi\ufb01able information which may have come to his knowledge in the course of performing any duty or function under this Order or carrying any act in relation to this Order. Any person who fails to comply with this shall be guilty of an offense and shall be legally liable.   8. The NCDPC shall evaluate and approve request for data including individually-identi\ufb01able information. In determining whether to approve the request for data or disclosure, the following shall be critically considered:    i. Objectives of the national public health programs including public health safety and bene\ufb01ts  ii. Use of the data   iii. Identity of the of\ufb01cers or persons to whom the data will be given or disclosed iv. Measures to protect the data   The URS shall keep an audit trail of all data accesses. The NCDPC shall suspend, terminate or lift the users\u2019 accounts if any provisions of the procedures or guidelines are violated, or the security, con\ufb01dentiality or integrity of the systems andlor data is compromised.   Monitoring valuation of Registry System   Monitoring shall be conducted by the NCDPC, NEC, and/or IMS in coordination with the NCHFD and BHFS, to evaluate compliance of reporting facilities, strengthen quality assurance, and monitor the performance of the uni\ufb01ed regisny systems    1. The NCDPC in coordination with the NBC and/or IMS shall create and maintain a harmonized standard system monitoring tool and reporting form to be used during monitoring.   2. Monitoring activities shall be done on a quarterly basis with the following factors to consider in selecting the health facilities to monitor:   i. Non-compliance in reporting data   ii. Irregular reporting of data   iii. Delayed reporting of data   iv. With de\ufb01ciency \ufb01ndings as validated or assessed by the NCDPC, NBC, and/or IMS.   v. With verbal or written complaints reported or \ufb01led by concerned of\ufb01ces, individuals, or other organizations.   vi. Other factors that may identi\ufb01ed during system implementation.   3. An annual review of the system and its implementation issues shall be conducted to evaluate its performance based from the monitoring conducted quarterly. It shall be conducted with the concerned stakeholders in each registry system.   Sanctions for Non-compliance   Administrative Order No. 2011-0020, Section V. Guidelines, A. Streamlining of Licensure and Accreditation of Hospitals, Speci\ufb01c Guidelines, f. Reports, states that \u201can annual updated consolidated hospital statistical reports shall be prepared by DOH- CO/CHD in accordance with the format posted in at DOH website\". Failure to comply with any of these rules and regulations and its related issuances shall constitute a violation'and shall be penalized following Section IV. Guidelines A. Violations and B. Sanctions of A0. No. 2007-0022 re: \u201cViolations Under the One\u2014Stop Shop Licensure System for Hospitals.\"   VIII. ROLES AND RESPONSIBILITIES   1. Reporting Health Facilities (Government Hospitals, Private Hospitals and Clinics and Professional Societies with existing registry) shall:   a. Designate full time and backup personnel who shall be responsible for entering or uploading data into the systems. A   b. Enter or upload quality data, i.e. accurate, valid, reliable, and/or timely on a regular basis.   c. Report erroneous submitted data to the NCDPC for proper correction or editing.   d. Report problems that are encountered during operations through the online reporting system.   National Center for Disease Prevention and Control shall:   a. Manage the overall implementation of the registry system including direction and guidance in the continuing operations, system enhancement, .and data management.   b. Formulate processes, procedures, policies and guidelines related to the registry system.   c. Address 1ssues, concerns, and/or problems accordingly like respond to queries about the forms, reports and standard operating procedures or processes.   d. Formulate policies, procedures, guidelines, and relevant protocols to ensure continuous operations, and develops program interventions as needed.   e. Validate data according to agreed level of validation to confirm its quality.   f. Review management, statistical, and other reports with the end objective of providing the necessary recommendations or comments.   g. Compile and publish reports on non-communicable diseases data.   h. Provide funds to support studies/researches as a result of data \ufb01ndings.   i. In collaboration with the concerned specialty societies shall analyze and interpret the data generated from the system.   j. Suspend, terminate or lift the user accounts if reporting facilities failed to comply with the reporting standards and/or divulged any form information without any prior authorization from the DOH.   k. Issue a Memorandum of Agreement between the DOH and those facilities with existing information systems for systematic data uploading, con\ufb01rmation of roles, duties and responsibilities, and commitment to upload the data.   National Epidemiology Center shall:   a. Support the development of processes, procedures, policies and guidelines related to the registry system.   b. Address issues, concerns, and/ or problems accordingly.   c. Assist in the formulation of policies, procedures, guidelines, and relevant protocols to ensure continuous operations, and develops program interventions as needed.   d. Review management, statistical, and other reports with the end objective of providing the necessary recommendations or comments.   e. Validate data according to agreed level of validation to con\ufb01rm its quality.   f. Provide funds to support studies/researches as a result of data \ufb01ndings.   g. Monitor the implementation of the system.   h. Supervise data management.    Information Management Service shall:   a. Maintain the registry software.   b. Address technical problems accordingly.   c. Train users on how to operate the registry system.   d. Assist 1n the formulation of policies, procedures, guidelines, and relevant protocols to ensure continuous operations, and develops program interventions as needed.   e. Perform database and network management activities.   f. Manage the help desk support to ensure continuous operations.   g. Provide funding on information and communication technology resources based on the DOH Information System Strategic Plan or other DOH directives or issuances.   National Center for Health Promotion shall:   a. Translate the salient \ufb01ndings into messages and materials that are appropriate for speci\ufb01c population segments.   b. Conduct communication activities through various media channels to elicit public opinion and generate public discussion favorable to disease prevention and control.    National Center for Health Facility Development shall:   a. Provide implementation support like deve10ping guidelines and policies to ensure continuous compliance of hospitals to this directive.  b. Monitor the implementation of the system operation.    7. Bureau of Health Facilities and Services shall:   a. Provide implementation support like deve10ping guidelines and policies to ensure continuous compliance of hospitals to this directive.  b. Monitor the implementation of the system operation.   8. Center for Health Development shall:   Ea. nsure timely entry or uploading of quality data into the registry system.   b. Report erroneous data for correction or editing using the Incident Report Form.  c. Report problems that are encountered during operations.   d. Participate in the evaluation of the registry system to further improve the functionalities or performance of the system.   e. Provide technical assistance such as training and monitoring activities and lead the regions to ensure the implementation of all the systems.   9. Local Government Units (Provincial Health Office, District Health Of\ufb01ce and Municipal Health Of\ufb01ce) shall:   a. Provide implementation support to ensure continuous compliance of to this directive.   b. Ensure availability of all data collection, processing, monitoring and reporting forms or tools in each reporting facility.   c. Provide technical assistance such as training and monitoring activities to ensure the implementation of all the systems.   10. Professional Societies (Medical, Nursing, and other Paramedical Societies), Development Partners and Private Organizations   a. Professional societies with existing information systems shall upload the required data to the DOH Information Management Service to generate national data.   b. Shall provide expert inputs on the analysis and interpretation of the data gathered from the registries.   c. Shall participate in the evaluation of the registry system to further improve the functionalities or performance of the system.   IX. REPEALING CLAUSE  Provisions from previous issuances that are inconsistent or contrary to the provisions of this Order are hereby rescinded and modi\ufb01ed accordingly.   x. SEPARABILITY   If any provision of this Order is declared invalid, the other provisions not affected thereby shall remain valid and subsisting.   XI. EFFECTIVITY   This order shall be effective immediately.   ", "  I. RATIONALE:  The proportion of older persons is expected to rise worldwide. In the 1998 World Health Report, there were 390 million older people and this \ufb01gure is expected to increase further (WHO). This growth will certainly pose a challenge to country governments, particularly to the developing countries in caring for their aging population. In the Philippines, the population of 60 years or older was 3.7 million in 1995 or 5.4% of total population. In the CY 2000 census, this has increased to about 4.8 million or almost 6% (N SCB). At present there are 7M senior a (6.9% of the total population), 1.3M of which are indigents.   With the rise of the aging population is the increase in the demand for health services by the elderly. A study done by Racelis et a1 (2003) on the share of health expenditure of Filipino elderly on the National Health Account, the elderly are \"relatively heavy consumers of personal health care (22%) and relatively light consumers of public health care (5%).\" From out-of-pocket costs, the aged are heavy users of care provided by medical centers, hospitals, non-hospital health facilities and traditional care facilities.  Cognizant of the growing concerns of the older population, laws and policies were developed which would provide them with enabling mechanisms for them to have quality life. RA 9257 or the Expanded Senior Citizens Act of 2003 (predecessor of RA 9994) provided for the expansion of coverage of bene\ufb01ts and privileges that the elderly may acquire, including medically necessary services. Parallel to this objective is the Department's desire to provide affordable and quality healthservices to the marginalized population, especially the elderly, without impeding currently pursued objectives alongside health systems reform.  II. OBJECTIVES:  This Order is being issued pursuant to Section 9 of R. A. 9994 otherwise known as \u201cThe Expanded Senior Citizens Act of 2010\" to achieve the following objectives:  1. To provide fair, just and quality health care for the senior population, at the same time pursuing \ufb01nancial viability of hospitals amidst economic and \ufb01nancial constraints.  2. To establish guidelines and mechanisms in implementing the 20% Senior Citizens' discount on health related sale of goods and services and for other purposes.  III. SCOPE AND APPLICATION  This order shall apply to the whole hierarchy of the DOH and its attached agencies, as well as Local Government Units (LGUs) and other public and private providers of health care. It applies to all hospitals and health\u2014related facilities from the government and private sectors, the health care professionals and other related health care facilities and services. This also applies to drug stores, hospital pharmacies and similar establishment dispensing medicines and medical devices.  IV. DEFINITION OF TERMS  Consistent with the pertinent de\ufb01nitions used in the Implementing Rules and Regulations of RA 9994, the following terms shall be de\ufb01ned as follows:  1. Senior Citizen or Elderly\u2014 shall refer to any Filipino citizen who is a resident of the Philippines, and who is sixty (60) years old or above. It may apply to senior citizens with \"dual citizenship\" status provided they prove their Filipino citizenship and they have been residents for at least six (6) months in the Philippines.  It shall also include senior citizens who are recipients of the DSWD National Household Targeting System for Poverty Reduction Program and/or those classi\ufb01ed under. Administrative Order No. Sl-A s. 2001, Implementing Guidelines on Classi\ufb01cation of Patients and on Availment of Medical Social Services in Government Hospitals.  2.Medicines\u2014 shall refer to both prescription and non\u2014prescription medicines and articles approved by the Food and Drug Administration (FDA), intended for use in the diagnosis, cure, mitigation, treatment and prevention of disease and injury but do not include food and devices or their components, parts or accessories.  3.Medical Devices- shall refer to instruments, apparatus, machines, implants or in vitro reagents intended for use in, or actually used in the diagnosis, treatment, monitoring or prevention of disease or injury and does not achieve any of the intended purposes by means of chemical action within or on humans and not dependent on being metabolized to achieve as a result.  4. Medical Services - in the context of this Administrative Order, this shall refer to hospital room and services, medical supplies, professional services of physicians and other health care professionals, and diagnostic and laboratory tests that are necessary for the diagnosis and/or treatment of an illness or injury.  5. Dental Services - shall refer to the services related to oral examination, cleaning, permanent and temporary \ufb01lling, extractions and gum treatments, restoration, replacement or repositioning of teeth, or alteration of the alveolar or periodontium process of the maxilla and the mandible that are necessary for the diagnosis and/or treatment of a dental illness or injury.  6. Diagnostic And Laboratory Tests - shall refer to X-ray, CT-scans, blood chemistry exams, histopathology and immune pathology, hematology, urine analysis, parasitology and bacteriology tests, serology, blood banking and all other diagnostic radiology, clinical laboratory and other diagnostic examinations that are necessary for the diagnosis and for treatment of an illness or injury. For specialized diagnostics, this should be appropriate to the disease/injury.  7. Health Care Professional - shall refer to any doctor of medicine, nurse, midwife, dentist or other health care professional or practitioners i.e. nutritionists, psychologists, counselors, patient educators duly licensed to practice in the Philippines.  8. Establishments Dispensing Medicines - shall refer to drug stores, hospital pharmacies (government or private), medical and optical clinics and similar establishments dispensing medicines, duly licensed and/or franchised by the FDA and the local govemment units.  9. Government Health Facilities \u2014 shall refer to hospitals, outpatient clinics including health centers and rural health units, clinical laboratories, diagnostic radiology centers, and other outpatient health facilities operated and maintained partially or wholly by the national, provincial, city or municipal government, or other political unit; or by any department; division, board or agency thereof. The facilities include Department of Health (DOH)-retained hospitals; specialty hospitals which are govemment-owned and controlled corporations (GOCCs); medical clinics in GOCC; and hospitals/health facilities owned and managed by local government units, state colleges and universities, the Department of National Defense, the Department of Interior and Local Government, and other government agencies.  The government hospitals consist of the service or charity or subsidized inpatient and outpatient section/department and the non-subsidized pay section.  Private Hospitals And Medical Facilities \u2014 shall refer to all pay inpatient and outpatient health and medical facilities privately owned, established and operated with \ufb01inds through donation, principal, investment, or other means, by any individual, corporation, association, or organization. The facilities include hospitals, clinical laboratories, diagnostic radiology centers, doctor's clinics, dental clinics and other health facilities that are licensed by the Bureau of Health Facilities and Services (BHFS) of the DOH and/or local government units.  11. Identi\ufb01cation Document - shall refer to any document or proof 'of being a senior citizen which shall be used for the availment of bene\ufb01ts and privileges under the law, such as the following:  a) ID issued by the city or municipal mayor of Of\ufb01ce of Senior Citizens Affairs (OSCA) or of the barangay captain of the place where the senior citizen or the elderly resides;  b) The passport of the elderly person or senior citizen concerned; and  c) Other documents or government issued certi\ufb01cates such as birth certi\ufb01cate, voter's ID that establish the senior citizen or elderly person is a citizen of the Republic and who is at least sixty (60) years of age  V. GENERAL GUIDELINES  Subject to the provisions of RA 9994, its implementing rules and regulations, this Order and the availability of the medicines and services, the health-related privileges for senior citizens and their sources of funding of the privileges shall be as follows:  1. Subsidized Services in In-patient and Out-patient Sections of Government Health Facilities:  Fully subsidized (free) medical and dental services, and diagnostic and laboratory fees for all senior citizens con\ufb01ned in service wards of government facilities shall be provided in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary/indicated (that is, the patient was assessed by a doctor and the request for a laboratory/diagnostic exam/s was made and signed by the said doctor).  2. Non-subsidized Services in Pay Sections of Government Health Facilities  Medical and dental services, diagnostic and laboratory fees and professional fees of attending physicians and other health professionals for all senior citizens con\ufb01ned in pay sections (both in\u2014 and out\u2014 patient sections) of govermnent health facilities shall be granted twenty percent (20%) discount and VAT exemption, provided these are in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary.  3. Twenty Percent (20%.) discount in Private Health Facilities  All senior citizens shall be granted the privilege of twenty percent (20%) discount and VAT exemption on medical and dental services, and diagnostic and laboratory fees such as but a limited to x-rays, computerized tomography scans and blood tests, including professional fees of attending doctors in all private hospitals and medical facilities.  The services shall include the use of specialized treatment rooms and equipment such as for hemodialysis and radiotherapy.  4. Exclusion to the SC DiscOunt (no discount) in Government Health Facilities and Private Health Facilities    Services that are not medically necessary for treatment and diagnosis shall not be provided with any discount. This shall include but not limited to cosmetic surgeries procedures, executive check-up packages and physical examinations, without clinical evidence of effectiveness and ef\ufb01ciency. Senior citizens who avail of health services in government health facilities shall be classi\ufb01ed in accordance with A0 Sl-A s. 2000.   Senior citizens who are classi\ufb01ed Class A and B shall be given 20% discount and VAT exemption for special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests. Senior citizens who are classi\ufb01ed Class C and D shall be given full discount and VAT exemption.  5. Geriatric/Senior Citizens' Wards  Throughout the country a senior Citizens' ward shall be established in every government hospital. This geriatric ward shall be for the exclusive use of senior citizens who are in need of hospital con\ufb01nement by reason of their health conditions. However, when urgency of public necessity or emergency purposes so require, such geriatric ward may be used for emergency purposes, after which, such senior Citizens' ward shall be reverted to its nature as geriatric ward.  Initially, when the facility still does not have the necessary space for a geriatric/senior citizens' ward, beds may be prioritized for the use of SCs who will be admitted.  6. Medical Devices  6.1 All medical devices (implants, supplies, kits, equipment including the use of radiation devices, dental, and laboratory, hospital implement or apparatus) used/consumed during check-up or con\ufb01nement of a senior citizen regardless of the number of days of stay in the hospital or any health facilities shall be covered by the twenty percent (20%) discount and VAT exemption.  6.2 All medical devices to be used during the recovery at home, or for monitoring of a particular ailment or disease, or to aid the maintenance of a treatment shall also be covered by the 20% discount and VAT exemption provided that the prescription for the use of a particular medical device shall be provided by the physician (e.g. cane, crutches, adult diaper, wheelchair, commode chair, bed pan, body support, fracture sock, medical support stockings, oxygen therapy unit (gauge and tank set), IV \ufb02uid and stand, forcep, swabs, hospital bed, walker, urine bag, bandage, hearing aid, eyeglasses, intraocular pen injector, hot/ cold pack, therapeutic massager, therapeutic mattress/ pad, all prosthesis, catheter, therapeutic warmer, glucometer set including lancets and test strips, insulin syringe and needle, thermometer, blood pressure apparatus, syringe and needles, IV set, dialyzer, adhesive strip, mask, gauze, gloves, dressing, cotton, brace, and other devices subject to clearance from the Center for Device Regulation, Radiation Health and Research (CDRRHR).  6.2 The twenty percent (20%) discount and VAT exemption shall apply to the purchase of eyeglasses, hearing aids, dentures, prosthetics, arti\ufb01cial bone replacements like steel and which includes implants, plates, rods, and screws. The same discount and exemption shall also apply to walkers, crutches, wheelchairs whether manual or electric-powered, canes, geriatric diapers, and other essential medical supplies accessories and equipment for senior citizens.  6.3 The twenty percent (20%) discount and VAT exemption shall apply only once on the purchase for personal use of senior citizen of non-disposable medical devices (e. g. glucometer, blood pressure apparatus, weighing scale).  6.5 Purchase of any medical devices granted the twenty percent (20%) discount and VAT . exemption shall be recorded in the Purchase Booklet for control and monitoring.  7. Professional Fees  Professional fees of licensed health professionals including massage therapists, psychologists, speech therapists, nurse, midwife, dentist or other health care professional or practitioner i.e. nutritionists, psychologists, counselors, patient educators duly licensed to practice in the Philippines in all private hospitals, medical facilities and outpatient clinics and home health care facilities shall be subject to the twenty percent (20%) discount and VAT exemption.  All senior citizens shall be granted the twenty percent (20%) discount and exemption from the VAT on the professional fees of licensed professional health workers providing home health care services as endorsed by private hospitals or employed through home health care employment agencies.  8. Mandatory PhilHealth Coverage  All indigent senior citizens shall be covered by the national health insurance program of PhilHealth. The local government units where the indigent senior citizens reside shall allocate the necessary funds to ensure the enrollment and lifetime coverage of their indigent senior citizens, in accordance with the pertinent laws and regulations.  PhilHealth shall also explore the inclusion of bene\ufb01t packages speci\ufb01c to the senior citizens.  9. Influenza and Pneumococcal Vaccinations The DOH shall administer free vaccinations against the in\ufb02uenza virus and pneumococcal disease for indigent senior citizen patients. Neglected, abandoned, unattached or homeless senior citizens in government-run residential homes, centers and facilities shall likewise be entitled to free vaccinations.  10. Funding Sources  10.1 For Government: The amount necessary to carry out the provisions of RA 9994 in government health facilities upon its effectivity shall be charged out of the funds of the concerned DOH or LGU health facility. Thereafter, any such sum as needed for the regular implementation of this Act shall be included in the subsequent General Appropriations Act under the DOH line item. Each hospital and CHDs shall also allocate at least1% of their MOOE for this purpose.  Local Governments Units shall be encouraged to allocate funds for the provision of additional bene\ufb01ts of the senior citizens in their lecality.     10.2 For Private: For the twenty percent (20%) discount in private establishments, the cost of the discount shall be partially funded through the deduction of the discount from gross income for the same taxable year that the discount is granted, subject to proper documentation and to the provisions of the National Internal Revenue Code, as amended. The rest of the cost of the discount not funded through the above- described manner shall be borne by the provider of the privileges.  VI. PROCEDURAL GUIDELINES  1. Government Health Facilities  1.1 Subsidized Services in In-patient and Out\u2014patient Sections of Government Health Facilities:  a. A hospital bed in a service ward that is deemed medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines(CPGs) or hospital treatment protocols shall be granted free (fully subsidized) to the senior citizen. This shall be charged to the hospital budget.  b. Laboratories and diagnostics services provided to an inpatient senior citizen in a service ward that are medically necessary/indicated (that is, the patient was assessed by a doctor and the request for a laboratory /diagnostic exam/s was made and signed by the said doctor) as determined by his/her attending physician, shall be fully subsidized (free) subject to the following:  - Diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols  - Evidence-based health screening tests that had been extensively tested for the local setting and endorsed by the DOH as medically necessary for individual cases shall be provided free (fully subsidized) by the government facility.  c. All inpatient labOratories and diagnostics provided to senior citizens admitted to a bed in the service ward which are deemed not medical necessary for the illness or injury for which he/she is con\ufb01ned shall only be granted a 20% discount.  d. Free laboratory and diagnostic services shall be granted to an outpatient senior citizen, provided the following are met:  - Diagnosis and/or treatment by the attending physicians shall be in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols and have been determined medically necessary.  - Evidence\u2014based health screening tests that had been extensively tested for the local-setting and endorsed by the DOH as medically necessary for individual cases and shall be provided free by the government health facility.  - The laboratory and diagnostic services have been determined by his/her attending physician as medically necessary.  - The requesting physician is a government-employed physician in the same government health facility where the laboratory or diagnostic tests shall be conducted.  All outside requests for laboratory and diagnostic tests from physicians who are not employed by the government facility and are based in either a government or private health facility shall only be granted a 20% discount upon \ufb01nal evaluation of the recipient government facility as medically necessary.  The attending dentist of the senior citizen shall make the determination as to the medical necessity of the dental service that will then be granted free.  In case the senior citizen is a PhilHealth member or a dependent, government health facilities must ensure that the charges for services not included in the subsidized services shall be deducted and charged to the senior citizen's PhilHealth bene\ufb01ts coverage. It is only after these deductions are made that the PhilHealth accredited health facilities can exercise its right to PhilHealth reimbursement or coverage for the subsidized services.  1.2 Non-subsidized Services in Pay Sections of Government Health Facilities  The following enumerates the medically necessary care levels for the diagnosis and/or treatment of an illness or injury that shall be granted twenty percent (20%) discount and shall apply to pay sections of government health facilities:  a) A hospital bed in pay sections of government health facilities is deemed medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols. This shall be charged to the senior citizen and granted 20% discount.  b. All inpatient and outpatient laboratory and diagnostic examinations in pay sections shall be granted 20% discount; provided that such diagnosis and/or treatment by the attending physicians shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.  The health facilities shall designate medical of\ufb01cers for senior citizens (MOSC) to facilitate the determination of the medical necessity of requested laboratory or 1 diagnostic examinations.    c) All inpatient laboratories and diagnostics that are provided to senior citizens admitted to a bed beyond the service ward level shall only be granted a 20% discount.  d) In case the senior citizen is a PhilHealth member or dependent, the 20% discount shall not be charged to the senior citizen's PhilHealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder shall be charged to his/her PhilHealth bene\ufb01ts.  1.3 All government health facilities shall display in a conspicuous area the hospital room rates, laboratory and diagnostic tests fees, prices of medicines and all other fees and rates in strategic places in the health facility (e.g. admitting section, ER, OPD, billing section,etc.). The above-described price lists shall be regularly updated and submitted annually to the National Center for Health Facility Development-DOH and PhilHealth  1.4 All government health facilities shall post this Administrative Order in conspicuous places where consumers/patients can have access to the information and policies set forth by this document.  1.5 Of\ufb01cial receipts shall be issued for every paid-for medical and dental services, laboratory and diagnostic tests, and medicines provided. The receipts shall state the usual rates or fees and the discounted price; and  1.6 No \"Income Means Test\" nor any other tests shall be applied to the senior citizens as a precondition for the availment of free services as herein described, except when availing for services meant only for indigent patients.  1.7 All government health facilities shall set up a grievance mechanism for senior citizens such as Public Assistance Complaint Units (PACU) to entertain questions/queries with regards to senior citizens bene\ufb01t under RA 9994. The PACU concerned should inform in writing the actions taken on the complaint of the senior citizen furnishing copy thereof to the DOH.  Private Health Facilities  2.1 The following enumerates the medically necessary care levels for the diagnosis and/or treatment of an illnes or injury that shall be granted twenty percent (20%) discount, and shall apply to private hospitals:  a) A hospital bed in a private hospital is deemed medically necessary to diagnose and treat an illness or injury and shall be granted a twenty percent (20%) discount; provided the requirements stated below are followed:  -The available room and board accommodation deemed as medically necessary shall be granted 20% discount.  - All existing privileges that are currently part of a hospital bed shall also accrue to the senior citizen.   b) All inpatient and outpatient laboratory and diagnostic examinations shall be granteda twenty percent (20%) discount provided that such diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.  The health facilities shall (apply for all type of health facilities) designate medical of\ufb01cers for senior citizens (MOSC) to facilitate the determination of the medical necessity of requested laboratory or diagnostic examinations.  c) All dental services that are deemed to be medically necessary by the attending dentist shall be granted a twenty percent (20%) discount.  2.2 In case the senior citizen is a PhilHealth member or dependent, the 20% discount shall not be charged to the senior citizen's PhilHealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder may be charged to his/her PhilHealth bene\ufb01ts.  2.3 Professional fees for inpatient and outpatient medical and dental services shall be provided with a 20% discount and a corresponding of\ufb01cial receipt shall be issued by the concerned physician or dentist.  2.4 Of\ufb01cial receipts shall be issued for every paid medical and dental services provided the twenty (20%) discount shall be granted to the total bill which shall include the professional fees. The billing statement showing the regular rates or fees and the discounted price shall be attached to the of\ufb01cial receipt. In case of partial payment, the 20% discount on the total bill shall already apply.  2.5 Private hospitals and health facilities shall display in a conspicuous area the hospital room rates, laboratory and diagnostic tests fees, prices of medicine 3 and all other fees and rates in strategic places in the health facility (e.g. admitting section, ER, OPD, billing section, etc.). The above-described price lists shall be regularly updated and submitted annually to the National Center for Health Facility Development\u2014DOH and PhilHealth.  2.6 Private hospitals shall set up a grievance mechanism for senior citizens such as Public Assistance Complaint Units (PACU) to entertain questions/queries with regards to senior citizens bene\ufb01t under RA 9994. The PACU concerned should inform in writing the actions taken on the complaint of the senior citizen furnishing copy thereof to the DOH.  Establishments Dispensing Medicines  3.1 A 20% discount and exemptions from VAT of all drugs and medicines registered with FDA shall be granted to all senior citizens. The 20% discount granted to senior citizen shall be computed in the following manner:  a) The VAT shall be initially deducted from the Retail Price of the medicine to obtain the Net Retail Price; and  b) The 20%0 discount shall be deducted from the Net Retail Price to obtain the Senior Citizen's Price.   By way of illustration, if the Retail Price (inclusive of VAT) of a certain drug is P100.00, the Senior Citizen's Price shall be computed as follows:  Retail Price (inc. of VAT) Less: P100.00 10.71 VAT (FIDO/1.12) P 89.29 17.86 Net Retail Price Less: 20% P 71.43 Discount Senior Citizens' Price  3.2 The 20% discount is non\u2014transferable. It shall be applied exclusively to drugs and medicines for the use of Senior Citizens. Drugs in formulation, such as pediatric formulations medically prescribed for use of Senior Citizens shall also be granted a 20% discount.  3.3 As a general rule, any single dispensing shall be in accordance with the prescription' issued by a physician and shall not cover more than one (1) month supply to ensure safety and potency of the drugs.  For partial \ufb01lling, the establishment's pharmacist shall indicate the quantity partially \ufb01lled in the purchase slip booklet and the un\ufb01lled balance on the prescription. The Senior Citizen shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity.  3.4 During operating hours, licensed establishments dispensing medicines shall not be allowed to schedule or limit a period of time for the availment of the Senior Citizens\u2019 discount.  3.5 Of\ufb01cial receipts shall be issued to the Senior Citizens for every transaction on medicines which shall contain the Retail Price and the Senior Citizens' Discount Price.  3.6 There shall be a priority lane for elderly and a generic menu card shall be displayed at the facility of all drugstores.  3.7 Drugstores shall \ufb01ll-up the Purchase Booklet. The Purchase Slip Booklets shall be used to record the kind of OTC medicine purchased, how many, when and where it was purchased. Likewise, this shall help the drugstores to monitor the last purchase made for a certain medicine.  3.8 All drug retail stores shall post this Order in conspicuous places where the Senior Citizens can access information on the 20% discount on medicines.  3.9 Likewise, the 20% discount shall be applied by all drug stores, hospital pharmacies medical and optical clinics, dialysis centers/clinics, supermarkets, convenience stores and similar establishments dispensing medicines authorized by law and duly licensed by the FDA and the local government units.  Health Care Professionals  Health Care Professionals shall have the following responsibilities:  4.1Inscribe his name, address, contact number and PRC number in the request for diagnostics and laboratory tests, and medicine prescription;  4.2 To curb abuse of availing discounts for use of non\u2014senior citizens, the health professionalshall make sure that prescriptions made are for the exclusive use of the senior citizen;  4.3 Inform the senior citizen of his regular fees for the services required;  4.4 Provide an of\ufb01cial receipt for the rendered professional services to the senior citizen that states the regular fees and the discounted fees.  5. Free In\ufb02uenza and Pneumococcal Vaccination  5.1 The DOH shall administer free vaccinations against the in\ufb02uenza virus and pneumococcal disease for indigent senior citizen patients. Neglected, abandoned, unattached or homeless senior citizens in government\u2014run residential homes, centers and facilities shall likewise be entitled to free vaccinations.  5.2 The DOH shall anchor its indigent list of senior citizens on the DSWD target of social pensioners based on their National Household Targeting System for Poverty Reduction (NHTPRS) still under the RA 9994.  5.3 The social pension ID issued by the DSWD shall also be used by the DOH for immunization purposes. Likewise, an immunization card/record shall be provided by the DOH for all eligible senior citizens.  5.4 For residential homes and other facilities catering to indigent senior citizens, vaccines shall be made available through the DOH-CHDS to comply with cold-chain requirements under the Expanded Program on Immunization.  5.5 The DOH shall provide the necessary training and orientation of vaccination teams for this purpose.  5.6 The national government shall provide free seasonal \ufb02u and pneumococcal vaccines to the indigent Senior Citizens through an additional appropriation under the GAA on top of the DOH regular budget or through a preventive bene\ufb01t package of the PhilHealth.  6. Documentary Requirements  6.1 All hospitals and drug retail outlets shall require Senior Citizens or their representative to present the following requirements for the availment of the 20% discount:  a) Identi\ufb01cation card (ID) issued by the city or municipal mayor or Of\ufb01ce for Senior Citizens Affairs (OSCA) or the barangay captain of the place where the Senior Citizen resides. The said ID shall be recognized nationwide.  b) Except for over\u2014the-counter (OTC) drugs, a doctor's prescription shall be presented. A prescription shall have the following information: name, age, sex, and address of the Senior Citizen, as well as the date, generic name of themedicine, dosage form, dosage strength, quantity, name and signature, address of the prescribing physician, professional license number and narcotic license or S2 number, if applicable. The drugstores may limit the dispensing of OTC drugs to not more than a week supply.  c) Purchase slip booklets shall be used to record the kind of OTC medicine purchased, how many, when and where it was purchased. Likewise, this shall help the drugstores to monitor the last purchase made for a certain medicine.  6.2 For purposes of veri\ufb01cation, all hospitals, both government and private facilities shall require senior citizens to present other documents such as the passport of the elderly person concerned to establish the senior citizen is a citizen of the Republic of the Philippines and who is at least sixty (60) years of age  7. PhilHealth shall explore bene\ufb01t packages speci\ufb01c to the senior citizens  8. All government projects/programs that sell medicines to Senior Citizens and that already offer substantial discount to consumers or is partially subsidized by the government, shall be exempted from the Senior Citizens discount, (e.g. Botika ng Barangay, P I 00)  9. Double discounts shall not be allowed. The Senior Citizens shall have the option'to choose either promotional campaigns and other forms of discounts on certain medicines, or the Senior Citizens discount provided that only the Senior Citizens' discount shall be exempted from VAT.  10, In cases where Senior Citizens are also Persons with Disability (PWD), the Senior Citizen may opt to use either the Senior Citizens or the PWD discount provided that only the Senior Citizens' discount shall be exempted from VAT.  All complaints on non\u2014compliance to the 20% discount on medicines shall be lodged to the respective LGU OSCA where the purchase was made or where the elderly resides, whichever is convenient for the senior citizen.  VII. OFFENSES AND PENALTIES  Non-compliance with these guidelines shall result in sanctions and penalties stated in Section 7 of RA. 9994, as follows:    Any person who refuses to honor the senior citizen card issued by the govemment or violates any provision of RA. 9994 and its implementing rules and regulations and this Order shall suffer the following penalties:  1. For the \ufb01rst violation, a \ufb01ne of not less than Fifty thousand pesos (Php 50,000.00) but not exceeding One hundred thousand pesos (Php 100,000.00) and imprisonment of not less than two (2) years but not more than six (6) years; and  2. For any subsequent violation, a \ufb01ne of not less than One hundred thousand pesos (Php 100,000.00) but not exceeding Two hundred thousand pesos (Php 200,000.00) and imprisonment for not less than two (2) years but not more than six (6) years.  3. Any person who abuses the privileges granted herein shall be punished with a \ufb01ne of not less than \ufb01fty thousand pesos (Php 50,000.00) but not more than One hundred thousand pesos (Php 100,000.00) and imprisonment of not less than six (6) months.  4. If the offender is an alien or a fereigner, he/she shall be deported immediately after service of sentence without further deportation proceedings.  5. If the offender is a corporation, partnership, organization or any similar entity the of\ufb01cials thereof directly involved such as the president, general manager, managing partner, or such other of\ufb01cer charged with the management \"of the business affairs shall be liable therefor.   6. Upon \ufb01ling of an appropriate complaint, and after due notice and hearing, the proper authorities may also cause the cancellation or revocation of the business permit, permit tooperate, franchise and other similar privileges granted to any person, establishment or business entity that fails to abide by the provisions provision of R.A. 9994, its implementing rules and regulations, and this Order.  VIII. JURISDICTION  Jurisdiction over the offenses de\ufb01ned under this Order shall belong to the appropriate courts, according to laws existing at the time of the commission of theoffenses.   XI. SEPARABILITY CLAUSE  Should any part, term or provision of this Order be. declared unconstitutional, invalid or unenforceable, the validity of all other remaining provisions shall remain. valid and effective.  X. REPEALING CLAUSE  This Order shall repeal Administrative Order 177 series of 2004 and all other. administrative issuances, circulars and memoranda inconsistent with this Order.  XI.  This Order will take effect immediately effect thirty (30) calendar days after its publication in the Of\ufb01cial Gazette or in a newspaper of general nationWide circulation and upon \ufb01ling with the University of the Philippines Law Center three (3) certi\ufb01ed copied of this Order. ", "        It is now an established fact that smoking is toxic, hazardous, and addicting. The adverse health effects of smoking result in serious illnesses, notably lung cancer, cardiovascular diseases and chronic obstructive pulmonary diseases, among others. Smoking is also the single most important risk factor in the country today and this habit must be put under control in order to promote and safeguard the constitutional right of every citizen to a healthy life.   Thus, health workers need to fully understand their role in advocating a healthy lifestyle. Health facilities must indeed be the windows to a tobacco\u2014free world and by serving as role models to the people they serve. One way to realize this is to create a smoke-free environment in all health facilities under the Department of Health.   For this purpose, regional health offices, hospitals/medical centers, and all other health facilities under the administrative supervision of the Department of Health are hereby declared \u201cSMOKE FREE ZONES\"   Henceforth, smoking in the building compounds of these facilities as well as the sale of cigarettes, cigars and other tobacco products shall be strictly prohibited.   Moreover, chiefs of health care facilities are enjoined to print, as appropriate, the caption \"SMOKING IS DANGEROUS TO HEALTH\" on their official stationeries and other legal papers.   All Heads of Offices, Chiefs of Medical/Specialty/Special Hospitals and others concerned are directed to lead in the anti-smoking campaigns in their respective areas of assignment. Ample time and appropriate means of communication should be provided for everyone to understand the DOH No Smoking Policy, inclusive of the c1ients/beneficiaries/patients/visitors, in health facilities. Supervisors concerned are also enjoined to design and provide measures and mechanisms such as sanctions/appropriate penalties, and or granting incentives/awards towards the effective implementation of this activity. Copy of such measures shall be submitted to the Office of the Secretary within a period not to exceed sixty (60) days upon receipt of this Order.   This Order takes effect immediately.  ", "   I. RATIONALE   The irrational use of medicines remains as one of the most crucial causes of unsuccessful treatment outcomes, health hazards and wastage of resources that lead to increased healthcare costs.   The World Health Organization estimated that fifty per cent (50%) of medicines worldwide are prescribed, dispensed or sold inappropriately with half of all patients failing to take medicines correctly. In the Philippines, an analysis of the practices pertaining to the National Formulary and the rational use of medicines among healthcare providers and patients in government facilities revealed a similar situation (unpublished study, National Center for Pharmaceutical Access and Management, 2012). All of the facilities had a lack of supply of medicines that led to sub-optimal or failed treatment and irrational practices that were resorted to by the physicians when these were regarded as the better recourse or when the prescribed medicines were unavailable and the patients could not afford to buy them. A rampant practice is rationing, often termed as \u201cdibydiby\", where limited stocks of medicines, including antibiotics, are divided among the patients needing them so that only a few days supply are given out with the rest prescribed. Other practices included dispensing whatever alternative medicines were available, prescribing maximum doses of antibiotics for longer periods of time when the \ufb01rst-line antimicrobials were unavailable, and irrational combination of medicines. The inadequate supply of medicines was mainly due to the vast number of indigent patients seeking medical attention or the poor support from the government officials and inadequate fund allocation for health which many perceived was not a priority of the elected officials.   The substandard quality of many generic medicines supplied to the rural and city health units contributed to suboptimal treatment and further eroded the physicians con\ufb01dence in using them. Among the patients, poverty continued to be the main driving force that led to the practice of buying medicines piecemeal (\u201ctingi\") that 13 allowed in many pharmacies, inappropriate self\u2014medication, and failure to buy or complete required doses of the medicines. Other problems included high cost of medicines, operational inefficiencies, limitations inherent in the formulary, geographical isolation, corruption and political mendicancy, and poor health literacy of patients and some healthcare providers. Irrational practices that include inappropriate polypharmacy, mis\u2014use of antibiotics leading to antimicrobial resistance, over\u2014use of over\u2014the\u2014counter medicines, and \u201cshotgun\" therapy are likewise encountered among private practitioners and consumers in the country. Moreover, the adverse consequences of the extensive use of antimicrobials in the treatment of diseases in animals, particularly poultry and livestock, and the unrestrained addition of these and other medicines in animal feeds to promote growth extend to human health. All these underscore the need to promptly address the barriers to the rational use of medicines (RUM) in the country.     Integrating the rational and responsible use of medicines into the healthcare system will ensure that only the most necessary and scienti\ufb01cally proven ef\ufb01cacious and cost\u2014effective medicines are utilized in situations where there are clear and valid indications for them. The need, then, to develop a comprehensive conceptual framework of the National Plan of the RUM arises. This framework will set the approach to the formulation of guiding principles and key strategies that will support and be harmonized with existing policies from different sectors to achieve both the optimum therapeutic outcomes in the use of medicines and the economic objectives thereof.   II. OBJECTIVES   A. General Objective   This issuance sets the guidelines that aim to institutionalize the rational use of medicines towards optimal health outcomes in all sectors.   B. Speci\ufb01c Objectives   This issuance aims to:   1. ensure active involvement of all stakeholders in promoting the rational and responsible use of medicines; and   2. identify the target-speci\ufb01c strategies that will address the problems encountered in the practice of RUM.   III. SCOPE AND COVERAGE   This issuance shall apply to all stakeholders of RUM- bureaus, national centers and attached agencies of the Department of Health and other key government agencies; local government units (LGUs); government-owned or controlled corporations (GOCCs); health professionals and other health care providers, both public and private; professional organizations and societies; health non- governmental organizations; research and development partners; health educators; the pharmaceutical industry; consumers and consumers\u2019 groups; patients and patients\u2019 groups; and the media.   IV. DEFINITION OF TERMS The following are the operational definitions for the terms used in the guidelines:   A. Adverse Drug Event (ADE) refers to any untoward medical occurrence during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with such treatment.   B. Adverse Drug Reaction (ADR) refers to a response to a drug which is noxious and unintended, and which occurs at doses normally used for the prophylaxis, diagnosis or treatment of disease, or for the modification of physiological function.   C. Administration of the medicine refers to the remedial giving of the prescribed medicine to the patients by the physicians, dentists, veterinarians, nurses, and midwives authorized to administer medicines.   D. Antimicrobial Resistance (AMR) refers to the resistance of a microorganism (including bacteria, viruses and some parasites) to an antibiotic to which it was previously sensitive. AMR which is a- consequence of the use or misuse of an antimicrobial agent develops when a microorganism mutates or acquires a resistance gene. Resistant organisms withstand attack by antimicrobial or anti parasitic agents so that standard treatments become ineffective, allowing infections to persist and spread.   E. Consumer refers to a natural person who is a purchaser, lessee, or recipient or prospective purchaser, lessee or recipient of health consumer products, services or credit.   F. Dispenser refers to a validly registered pharmacist or a certified pharmacy assistant under the supervision of a pharmacist who fills a prescription or a doctor's order on the patient's chart.   G. Drug/Medicine refers to any chemical compound or biological substance, other than food, intended for use in the diagnosis, prevention and treatment of disease in humans or animals, including but not limited to:   (1) any article recognized in the latest edition of the Philippine National Formulary, the of\ufb01cial Philippine Pharmacopoeia or an internationally recognized pharmacopoeia or formulary, or a supplement to any of them;   (2) any article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;   (3) any article other than food intended to affect the structure or any function of the human body or animals;   (4) any article intended for use as a component of any article specified in clauses (l), (2), and (3) not including devices or their components, parts, or accessories; and   (5) a herbal and/or a traditional medicine which is an article of plant or animal origin used in folk medicine which is:   (i) recognized in the Philippine National Formulary;   (ii) intended for use in the treatment or cure or mitigation of disease symptoms, injury or body defects in humans;   (iii) other than food, intended to affect the structure or any function of the human body;   (iv) in \ufb01nished or ready-to-use dosage form; and   (v) intended for use as a component of any of the articles speci\ufb01ed in clauses (i), (ii), (iii), and (iv).   H. Drug/Medicine Establishment refers to a duly licensed organization or company involved   in the manufacturing, importation, exportation, wholesale, repackin\u2019g and/or distribution of medicines. '   I. Drug/Medicine Outlet refers to a drugstore, pharmacy and any other business retail establishment licensed to sell medicines to end\u2014users.   J. Essential Medicine refers to a medicine that satiates the priority health care needs of the population and which is selected based on evidence of its efficacy, safety and comparative cost-effectiveness.   K. Formulary Executive Council (FEC) is the body that recommends to the Secretary of Health the medicines for inclusion in and deletion from the Philippine National Formulary and exemption from the Executive Order No. 49 (Directing the Mandatory Use of the Philippine National Drug Formulary Volume I as the Basis for Procurement of Drug Products by the Government) based on the evidence of their ef\ufb01cacy, safety and comparative cost-effectiveness.   L. Government-Owned or \"Controlled Corporation (GOCC) refers to an agency vested with functions relating to public needs whether governmental or proprietary in nature and owned by the Government of the Republic of the Philippines directly or through its instrumentalities (GOCC Governance Act of 201 l).   M. Informal setting refers to any free clinic, medical, surgical and dental mission, outreach program, disaster response or others of the same nature where medicines are dispensed without a pharmacist.   N. National Clinical Practice Guideline (NCPG) refers to a systematically developed statement based on the best evidence-based studies that is designed to assist health practitioners and patients in making decisions about appropriate health care for speci\ufb01c clinical circumstances and adopted at the national level.   O. Pharmacovigilance refers to the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.   P. Pharmacy and Therapeutics Committee (PTC) is the primary multi\u2014disciplinary body of the hospital or government health unit that governs issues related to medicines such as evaluation, selection, rational use and other related matters. This replaces the previous name of the committee, i.e. Drugs and Therapeutic Committee.   Q. Philippine Medicines Policy is the framework that provides the directions for improving access to essential medicines by all Filipinos in all levels of health care at all. times. This incorporates the principles embodied in the SARAH Medicines Access Framework that refers to these \ufb01ve complementary pillars: Safety, ef\ufb01cacy and quality; Affordability and availability; Rational Use of Medicines; Accountability, transparency and good governance; and Health system support.   R. Philippine National Formulary (PNF) is the integral component of the Philippine Medicines Strategic Directions on Access to Medicines for Filipinos (201 1-2016) that lists the essential medicines of proven efficacy, safety and quality at affordable cost that are to be made available and accessible at all times.   S. Polypharmacy refers to the practice of using \ufb01ve or more medicines in a single prescription.   T. Prescriber refers to a validly registered physician, dentist or veterinarian who provides a written order and instruction known as the prescription for the use of a speci\ufb01c pharmaceutical product for a speci\ufb01c patient and which includes the doctor\u2019s order on the patient\u2019s chart for the use of a speci\ufb01c medicine.   U. Rational Use of Medicines is the fundamental concept where patients receive medicines, when these are needed, that are appropriate for their clinical needs, in doses that meet the individual requirements for an adequate period of time, at the lowest possible cost, and that are administered by the right person.   V. \u201cShotgun\" therapy refers to the inappropriate use of any treatment with a broad spectrum of effects and expected to treat a condition with an unknown cause.   V. GENERAL GUIDELINES   A. The NCPAM shall be the lead DOH agency that shall develop the implementing strategies for the RUM.   B. The NCPAM shall develop the policies in partnership with relevant government agencies . and pursue a collaboration with health professional organizations, teaching institutions, the pharmaceutical industry, consumer and patient groups, and the media.   C. The strategic action plan to improve adherence to the RUM shall consist of the following four phases:   1. First phase: The commitment of all the stakeholders shall be gained using information campaigns and other strategies to raise the issue of RUM as a requisite component to achieve optimal health outcomes and the judicious use of resources. These will be aimed towards positive behavior change.   2. Second phase: Concrete strategies that target the speci\ufb01c problems identified as barriers to the rational and responsible use of medicines and that conform to the principles of RUM shall be collectively developed and adopted. These strategies include the following:   a. Evidence-based National Clinical Practice Guidelines (NCPGs) that shall serve as the primary bases for rational prescribing and dispensing in the health sector and as a component of the foundation for education and training of all healthcare providers;   b. The Philippine National Forrnularv System (PNF S) Implementation Strategy that shall develop the Philippine National Formulary and enforce its mandatory use pursuant to Administrative Order No. 2012\u20140023 entitled \u201cRevised Implementing Guidelines for the Philippine National Formulary System (PNFS).\"   c. A Manual of Guidelines for Rational Prescribing, Dispensing, Administration and Management of Medicines for all health facilities, medicine outlets as well as informal settings for dissemination by DOH together with the health professional regulatory boards and organizations/societies;   d. The Antimicrobial Resistance (AMR) Policy that shall provide guidelines in conformity to the six point policy package of the World Health Organization (WHO) and shall integrate, coordinate, strengthen, and develop sustainable, well \ufb01nanced, and collaborative systems and mechanisms to combat AMR in the Philippines;    e. A Manual of Operations for the Pharmacy and Therapeutics Committee that shall empower these committees in all the secondary and tertiary health facilities, and all organizations and government agencies that procure medicines;   f. A Policy for Health Education that shall promote good health practices pertaining to the use of medicines; establish in health teaching institutions a basic training in pharmacotherapy that is problem-oriented and based on RUM; and encourage among health professional organizations a continuing medicines education programs.    g. A Manual of Operations for the Proper Donation and Acceptance of Medicines to assure their quality, safety and ef\ufb01cacy for dissemination by DOH together with the health professional regulatory boards, health organizations/societies, pharmaceutical industry, concerned government agencies and the academic institutions.   h. A Manual of Operations for Informal Settings that shall establish the appropriate conduct of and regulations for the medical, surgical and dental missions, free clinics, outreach programs, disaster response and activities of the same nature.   i. A Policy on Medicines Promotion that shall set acceptable standards and de\ufb01ne parameters based on the principles of RUM for the ethical and responsible promotion of medicines by both the public and private sectors;   j. A National Medicines Information System (NMIS) that shall provide stakeholders with independent and unbiased evidence-based information.   k. Research Programs on Healthcare Technology and Medicines that shall provide data that will be the bases for future RUM strategies and interventions.    3. Third Phase: The policy with its strategic action plans shall be implemented by the relevant stakeholders who are enumerated in Section VII of this issuance.   4. Fourth Phase: The implementation of the policy shall be monitored by the NCPAM, Food and Drug Administration (FDA), Philhealth and the health professional regulatory boards. The result of the monitoring and evaluation shall be the basis for the amendment, revision or repealing of the policy.   VI. SPECIFIC GUIDELINES   A. Education of all stakeholders and the public to raise awareness of the RUM as a priority health issue and to gain their commitment to abide by the principles of RUM shall be undertaken.    1. Priorities shall be focused on the following issues:   a. RUM as a prerequisite for the achievement of optimal health outcomes and the attainment of more efficient use of resources; principles of RUM and the provisions stated in its policy;   0. extent of the problem of irrational and irresponsible practices and their negative impact on health outcomes including disease prevention and control, the productivity of the individual, and the socio-economic condition of the community;   d. factors that contribute to irrational prescribing, dispensing, administration and utilization of medicines and the solutions to rectify them; and   e. roles and responsibilities of the stakeholders in the promotion of RUM.   2. The following advocacy-strategies shall be utilized:   a. development of education and communication plans adapted to the different healthcare levels and sectors of society;   b. production and dissemination of instructional and educational materials;   c. issuance of health policy advisories;   d. public campaigns;   e. promotional activities in partnership with professional associations/societies, the pharmaceutical industry, and consumer and patient organizations; and   f. information dissemination using multimedia.   B. National Clinical Practice Guidelines (NCPGS)   1. Evidence\u2014based NCPGs shall be developed to address the prevalent diseases or medical conditions at the primary, secondary and tertiary levels of healthcare, with the guidelines adapted to the competencies of the available healthcare providers, the local socio-economic conditions, and the particular need of the community.   2. These shall be reviewed, updated and published regularly and shall be made available to healthcare providers, relevant stakeholders and the general public.   3. These shall take into account special therapeutic needs of vulnerable populations such as infants and children, pregnant and lactating women, patients with chronic conditions and disabilities and the elderly.   4. These shall be intensively disseminated to all healthcare providers and educators. The NCPGs shall serve as the primary guide in the delivery of health services in all levels of care.   5. These shall be incorporated into the training programs of medical and allied courses.   6. These shall be considered as one of the bases for the medicine\u2019s inclusion in or exclusion from the PNF. For the management of diseases for which there are no locally appraised NCPGs, the DOH may refer to the internationally accepted CPGs provided the medicines to be utilized are listed in the updated edition of the PNF.    C. Philippine National Formulary (PNF)   1. The DOH and its attached agencies and all government agencies including the LGUs and the GOCCs such as the Social Security System (SSS), Government Service Insurance System (GSIS), and Philippine Health Insurance Corporation (PhilHealth) shall recognize the Philippine National Formulary System and enforce the mandatory use of the PNF in the procurement of medicines in their reSpective jurisdictions as stated in the A0 2012-0023.   2. The formulary shall be reviewed and updated regularly to ensure that it continues to conform to the RUM. '   3. A mechanism for Health Technology Assessment (HTA) and other evidence-based criteria shall be established to ensure that only cost\u2014effective and life-saving medicines are included in the list that shall in turn be based on the current NCPG.   4. All updates shall be published and posted in the DOH and NCPAM websites.   5. All pharmaceutical establishments and health facilities shall have a copy of the PNF Manual. The PNF Manual shall be the basis of the medicine outlets\u2019 patient counseling and shall be used in giving consumer advice when information about essential medicines is requested. Such shall form part of the essential documentary requirements to be monitored by FDA and BHFS for purposes of issuing or renewing their License to Operate (LTO) in the Philippine market.   D. Rational Prescribing, Dispensing, Administration and Management of Medicines   1. The guidelines shall conform to the NCPGs, Good Pharmacy Practice Guidelines and the standards of practice in the prescribing, administration and management of medicines as well as the norms of ethics on professional behavior. These will be crafted in close partnership with the health professional regulatory boards and the associations of health professionals involved in prescribing, dispensing and administration, and take into consideration the interests of consumers.   2.' The review of prescriptions and the use of medicines shall be conducted regularly to monitor compliance to generic prescribing, RUM and the NCPGs. These shall not impinge on the principles of physician-patient and pharmacist-patient confidentiality.   3. All human and veterinary health and health\u2014related courses shall incorporate the modules for rational prescribing, dispensing, administration and management of medicines in their respective curricula.    4. RUM shall be included in the school curricula for health education to be developed in coordination with the Department of Education (DepED), Commission on Higher Education (CHED), Technical Education and Skills Development Authority (TESDA) and other stakeholders.   5. Consumer information activities shall be provided in cooperation with relevant stakeholders in accordance with existing policies and ethical rules and guidelines.   6. Education of both public and private officials involved in medicines management on RUM and the awareness of the role of medicines in health maintenance as a prerequisite for socio-economic progress shall be implemented.   7. Consultation with a competent health provider regarding the proper use of medicines by the patient shall be emphasized.   8. The need for strict adherence to treatment based on NCPGs shall be emphasized.   9. The prescription and dispensing of complete treatment package, especially for antibiotics, shall be promoted.   10. The unconditional compliance with the rational and responsible use of medicines shall be enforced.   E. Antimicrobial Resistance (AMR) Policy   A comprehensive and sustainable national plan to combat AMR in the country shall be developed that shall include, but not limited to the following:   1. establishment of short and long term programs to address the different aspects of response to AMR, including advocacy and regulation and management of antimicrobial resistance and use;   2. strengthening of the surveillance system and laboratory detection capacity for antimicrobial resistance and use in both humans and animals;   3. ensuring the availability, accessibility and afford ability of quality antimicrobial medicines and their rational use in humans and animals, particularly poultry, livestock and aquaculture that shall include the banning of the use of antibiotics and other medicines as additives in feeds to promote growth of animals raised for human consumption;   4. development of relevant and utilizable essential medicines list for human and veterinary use;   5. institutionalization of infection prevention and control in healthcare and veterinary facilities and the community through training and education; and   6. conduct of research towards the development of new antimicrobials and innovative technologies to improve diagnosis and treatment.   Pharmacy and Therapeutics Committees (PTCs)   1. All secondary and tertiary health facilities, all companies and organizations and other government agencies procuring and/or dispensing medicines shall establish a multidisciplinary PTC with well-de\ufb01ned roles and functions.   2. Selection of members of PTCs shall be based on well-de\ufb01ned qualification that include willingness to disclose and manage all con\ufb02icts of interests.   3. Members of the PTCs shall include a physician, a pharmacist and a nurse.   4. The PTCs\u2019 main responsibilities shall include, but not limited to the following:   a. preparation of formulary in line with NCPGs and the PNF and based on prevailing morbidity and mortality pro\ufb01les in their respective facilities, cost\u2014effectiveness, relative safety pro\ufb01les among patients and other criteria on which the concept of essential medicine is based;   b. ensuring rational prescribing, dispensing, administration and utilization of medicines through policy formulation and implementation;   c. ensuring compliance of health providers and patients with standards on RUM through monitoring of prescription audits, medication reconciliation and patient chart reviews;   d. reporting of findings of RUM monitoring and recommendation of actions to the management;   e. tailoring procurement of medicines based on hospital guidelines.   G. Proper Donation and Acceptance of Donated Medicines   1. This policy shall apply to the following: (a) all donated medicines to be delivered to public and private health facilities;(b) medicines to be dispensed during local and foreign medical and surgical missions or in free clinics and related activities; and (c) medicines that will be dispensed in private local or foreign-run charitable organizations;   2. Medicines to be donated or accepted as donations shall ful\ufb01ll all of the following requirements:   a. inclusion in the latest edition of the PNF;   b. orphan drugs and drugs for compassionate use may be considered as donations upon approval of the FDA and NCPAM Directors;   c. shelf\u2014life of at least 12 months from the time of arrival in the Philippines for international donations, and 6 months for locally sourced medicines;   d. for locally sourced medicines, an updated and complete Certificate of Product Registration issued by the FDA; likewise, the manufacturer must have an updated Certificate of Good Manufacturing Practice from the FDA;   e. for medicines donated by foreign countries, the certificate of approval from the medicine regulatory agency of the donor country or a certification that the medicines conform to the provisions of the ASEAN Harmonization.   3. In addition, the donors and recipients of the medicines shall comply with the core principles, the pertinent guidelines, requirements and due processes stipulated in the current guidelines on the processing and clearance of foreign donations by the Department of Health.   H. Medicines Promotion Policy   1. The pharmaceutical companies shall ensure that the information materials about their products are truthful, correct, evidence-based and compliant with existing ethical guidelines on advertisement and promotion. The information must be balanced, containing both the bene\ufb01ts provided by the products and the risks involved in their use. Exaggerated or false claims, misleading information and activities that circumvent existing ethical and legal rules and regulations are strongly prohibited and shall be penalized accordingly.   2. In the interest of public safety and protection of public health, the FDA shall exert its authority to approve the technical content and validity of the information materials or medicines prior to use and dissemination. Direct-to-consumer promotion of ethical medicines shall be prohibited.   3. Professional behavior of health providers shall comply with existing codes of conduct on promotion of health products. Health providers are discouraged from engaging in activities that promote particular brands of medicines or health products.   4. Samples of medicines shall be judiciously and. rationally distributed and used. The distribution of an antimicrobial sample as a complete treatment package shall be encouraged.   I. National Medicines Information System (NMIS)   1. A National Medicines Information System shall be set up to build a network that shall provide timely and objective information and tools to all health planners, managers, educators, implementers and other stakeholders. Its tasks shall include the following progressive phases of development:   a. development of the RUM website;   b. archiving of data from the committees or agencies assigned to develop the speci\ufb01c strategies of the RUM;   c. linkage of databases from different sources; and   VII.   d. development of tools to ensure the practice of RUM by prescribers, dispensers and patients.   2. The databases it shall manage shall include those on prescribing, dispensing and administration practices as well as medicine consumption and management.   3. It shall establish guidelines on accessing information from its databases and assure security.   4. The system shall ensure that the web-presence of the RUM strategies promotes its objectives.   J. Research Programs on Healthcare Technology and Medicines   1. Research on healthcare technology and rational use of medicines shall be included in the yearly DOH. Health Research Agenda.   2. The results of the research studies shall be used as evidence in developing new policies or amending existing ones. These shall also be published in the NMIS.   VII. IMPLEMENTATION ARRANGEMENTS   A. Roles and Responsibilities:   1. Office of the Secretary of Health (OSEC) The Secretary of Health upon recommendation of the of\ufb01ce of the Assistant Secretary or Undersecretary of Health in charge of NCPAM shall issue appropriate policies, standards and guidelines to further implement the RUM Strategies.   2. National Center for Pharmaceutical Access Management (N CPAM) The NCPAM shall facilitate the deveIOpment and updating of the policies and strategies for  RUM and their implementation; monitor and evaluate together with FDA and Philhealth the impact of RUM strategies; ensure objectivityand completeness of medicines information; ensure provision of relevant and quality information on RUM to the public; and provide the DOH Executive Committee with updated information regularly.   3. National Center for Disease Prevention and Control (NCDPC) The NCDPC shall: develop and update national policies, standards, clinical/treatment guidelines; set national objectives and priorities pertinent to disease prevention and control; include RUM in capacity enhancement initiatives in their health programs; and assist NCPAM in monitoring RUM implementation.   4. National Center for Health Promotion (NCHP) The NCHP shall be the lead agency in the development of a communication plan for RUM in coordination with NCPAM, NCDPC and PIA.   5. Materials Management Division (MMD) The MMD shall ensure proper storage, distribution and disposal of medicines.   6. Bureau of Health Facilities and Services (BHFS)  The BHFS, thru their inspection and monitoring activities shall ensure that all hospitals have active PTCs and a copy of the latest edition of PNF.   7. Information Management Service (IMS) The IMS shall assist in the development and maintenance of the NMIS and ensure that only updated and valid information are posted in the system.   8. Formulary Executive Council (FEC)  The FEC shall be responsible in selecting medicines to be included in and deleted from the Philippine National Formulary based on evidence of their safety, ef\ufb01cacy and cost- effectiveness and on the burden of the disease. It shall assist the DOH in providing guidance to health providers on the rational and most ef\ufb01cient use of essential medicines. The FEC shall consider nationally accepted and peer reviewed NCPGs in the selection of medicines for the national formulary.   9. Food and Drug Administration (FDA)  The FDA shall ensure the safety, ef\ufb01cacy and quality of medicines, especially generic medicines. It shall provide an updated list of medicines it has certi\ufb01ed and the necessary technical input and essential data requirements such as relative availability of the medicines in terms of inventory and market authorizations to the FEC and Secretariat. It shall lead the development of the policy on medicines promotion and its implementation as well as the development of the NMIS in collaboration with the NCPAM.    10. Philippine Health Insurance Corporation (Philhealth)  The Philhealth shall develop and implement a performance monitoring system for all its engaged providers to safeguard against irrational medicine use. This shall be based on NCPGs or on peer\u2014reviewed, currently accepted clinical protocols. It shall also develop a system to manage the prescribed medicines that are not listed in the PNF as well as those exempted by the Corporation; develop policies consistent with laws, regulations, and national policies on RUM; work with the NCDPC in crafting the national policy that will set the guidelines on the development of NCPGs; and adhere to the NCPGs that shall serve as the bases in designing their health care bene\ufb01t packages.   11. Research Institute for Tropical Medicine (RITM) The RITM shall strengthen the Antimicrobial Resistance Surveillance Program and provide training and technical assistance to capacitate its laboratory services nationwide.    12. Bureau of Customs (BOC)  The BOC, in coordination with the FDA, shall undertake measures to prevent the entry of spurious, falsi\ufb01ed, substandard and counterfeit medicines in the country. It shall coordinate with the DOH in the implementation of the policy on donated medicines.   13. Commission on Higher Education (CHED)  The CHED, through the technical panel for health professions and their respective technical committees for health professions education, shall be encouraged to integrate the concepts and principles of RUM in the curricula of all human and veterinary health and health-related courses. .   14. Department of Agriculture (DA)  The DA shall be encouraged to update and implement RUM guidelines on veterinary health and in the monitoring and evaluation of RUM and AMR strategies designed for veterinary health.   15. Department of Education (DepEd) The DepEd shall be encouraged to integrate the concepts and principles of RUM in the K to 12 basic education program.    16. Department of Interior and Local Government (DILG)   The DILG in coordination with the Centers for Health Development (CHDs) and local government executives shall ensure that principles of RUM are applied in all local health policies and that all concerned personnel shall comply with the provisions of RUM policy.   17. Department of Labor and Employment- Bureau of Working Conditions (DOLE- BWC)   The DOLE\u2014BWC shall be encouraged to develop policies aligned with the concepts and principles of RUM that shall be implemented in the work place and their attached agencies.   18. Professional Regulation Commission (PRC) The PRC through the health professional regulatory boards shall be encouraged to ensure that health professionals abide by the concepts and principles of RUM.   19. Philippine Information Agency (PIA) The PIA shall be requested to provide technical assistance in planning and implementing information dissemination programs on RUM.    20. Advertising Board of the Philippines (AdBoard)  The AdBoard, being the umbrella organization of the advertising/marketing communications industry, shall coordinate with the FDA to ensure that all programs or campaigns for the promotion of pharmaceutical products shall conform to its Code of Ethics to guarantee truthful advertising/ marketing communication and self-regulation. In addition, it shall assist the government in the implementation of the policy on RUM and the promotion of its principles.   21. Health Professionals  All health professionals shall prescribe, dispense, administer and recommend medicines rationally and responsibly in conformity to the health needs, socioeconomic criteria and ethical standards; provide all the appropriate and accurate information on the diseases and medicines to all patients, patient organizations and the public; demand truthful and accurate information from the pharmaceutical industry, the media and advertising companies.  22. Health Professional Organizations/Societies   These organizations and societies shall continually educate their members regarding RUM and encourage them to commit to the unconditional promotion of quality use of medicines at all times.    23. Academic and Training Institutions   These institutions shall promote the RUM by introducing the concept of essential medicines and problem-oriented pharmacotherapy based on the established clinical practice guidelines in the training of the students in all health and health-care related courses. They shall incorporate RUM in their curricula and encourage the use of interactive teaching methods and assist in the provision of continuing education for health professionals and other health care providers on RUM.   24. Pharmaceutical Industry   The industry shall conform to the highest standards of manufacturing and distribution practices to assure the quality of the medicines; provide, in the context of transparency and ethical business practices, complete, accurate and unbiased information on pharmaceutical products to the public; comply with established promotional criteria; and respond to the needs of the Philippines especially in the provision of affordable quality medicines.   25. Consumer/Patient Groups and Non\u2014Government Organizations (NGOs) They shall ensure responsible use of medicines; help in monitoring the quality and truthfulness of information given to the public; share responsibility with the government for education of consumers; maintain vigilance and demand compliance with prescribed criteria for advertising; \"and draw attention of concerned government agencies to suspected infringements   26. Patients and Carers They shall use medicines correctly and responsibly; ensure the proper storage of the medicines; practice their right to seek information from the health professionals on their disease and its treatment including the medicines prescribed for it; demand from the pharmaceutical industry and the drug/medicines establishments unconditional compliance with regulations assuring quality of the medicines; and demand that medicines promotions comply with ethical standards.   27. Drug/Medicines Establishment and Outlets These establishments and outlets shall adhere to the principles of RUM; ensure that all of the medicines they carry are FDA registered; assure that the high quality of these medicines is maintained by following the prescribed storage condition; and ensure that all the pharmacy assistants are certi\ufb01ed and supervised by validly registered pharmacists.   28. Mass Media They shall provide relevant, balanced and truthful information on the medicines and other health matters; participate in public education; and give favorable publicity to those partners that comply with ethical standards in medicines promotion.   B. Source of Funding:   The NCPAM shall ensure the sustainability of the implementation of the RUM policies and programs of the government. Funds for activities of the programs shall be regularly allocated in accordance to the work and \ufb01nancial plan of DOH\u2014NCPAM RUM that shall include the cost of administration, monitoring, research and development and other implementation expenses such as advocacy and IEC campaigns. Moreover, all other DOH of\ufb01ces involved in RUM shall allocate funds in support of relevant RUM programs.   VIII. MONITORING AND EVALUATION OF THE IMPLEMENTATION OF THE RUM STRATEGY   A. Key performance indicators that will track the impact of the RUM policy shall be classi\ufb01ed into three categories, namely, over\u2014all structure, prescribing patterns and dispensing practices (Annex A).The performance indicators which include the pharmaceutical and economic indicators shall be established by the Review Committee.   B. Monitoring and evaluation of the RUM policy shall start three years after its effectivity and yearly thereafter.    IX. ADMINISTRATIVE FINES, PENALTIES AND SANCTIONS   Individuals, groups/organizations, establishments and agencies, whether government or private, found violating the provisions of this Order shall be administratively sanctioned in accordance with the existing laws, rules and regulations.   X. SEPARABILITY CLAUSE   If any provision in this Guidelines or application of such provision to any circumstances is held invalid, the remainder of these Guidelines shall thereby not be affected.   XI. REPEALIN G CLAUSE All previous Orders inconsistent in part or in whole to this Administrative Order are hereby rescinded or amended accordingly. XII. EFFECTIVITY This Order shall be effective within \ufb01fteen (15) days from publication in the Of\ufb01cial Gazette.   ", " I. BACKGROUND AND RATIONALE   Cardiovascular diseases (CVD), cancers, chronic respiratory diseases and diabetes (DM) are among the top killers in the Philippines, causing more than half of all deaths annually. Hypertension and diseases of the heart are among the ten leading causes of illnesses each year. These diseases are collectively known as Lifestyle Related Non-Communicable Diseases (NCDS), as defined in the National Objectives for Health 2005-2010, particularly because these diseases have common risk factors which are to a large extent related to unhealthy lifestyle.   The risk factors involved are tobacco use, unhealthy diet, physical inactivity and alcohol use. The Food and Nutrition Research Institute (FNRI) National Nutrition and Health Surveys in 1998 to 2008 (Acuin and Duante, 2010) showed that there is increasing prevalence in the associated risk factors between 1998 to 2008: hypertension from 21% to 25.3 %; diabetes from 3.9% to 4.8%; among adults who are overweight, there has been a significant increase from 20.2% to 26.6%; and those with high blood cholesterol levels had increased from 4% to 10.2%. Furthermore, the study found out that the following groups are at risk for NCDs: age group from the 40\u2019s onwards and those with Body Mass Index (BMI) 3 23, dyslipidemia, high waist circumference and waist hip ratios. Moreover, dietary intake trends show increasing consumption of energy dense foods high in fats and sugars, while almost the entire adult population has low levels of physical activity in all domains: occupation, non-occupation, leisure, transportation. '   Children and adolescents are also exposed to the above-mentioned risks. Latest data from the Global Adult Tobacco Survey in 2009 shows prevalence of tobacco use (current smokers) among population 15 years old and above to be 28.3% (17.3 million Filipinos); 47.7% of these are men (14.6 million) and 9% are women (2.8 million). On the other hand, the prevalence rate of overweight among adolescents 9-11 years old has increased two folds from 2.4% in 1993 to 4.8% in 2005. Similarly, the prevalence rate of overweight for children 6-10 years old doubled from 0.8% in 2001 to 1.6% in 2005. (Source: Philippine Nutrition Facts and Figures 2005). About 30% of teenage students are physically inactive, spending three or more hours per day sitting and watching television, playing computer games, talking with friends, or doing other sitting activities. (Source: Philippines Global School\u2014based Student Health Survey, 2007). And, data shows that in 2008 hazardous alcohol intake stands at 26.9% (FNRI\u2014NNHeS 2008).   The Philippine Renal Disease Registry (PRDR) illustrates that for 2009, diabetic nephropathy, a complication of diabetes remained the most common etiology of end stage renal disease while clinical hypertensive nephrosclerosis, a complication of hypertension ranked as the second most common etiology of end stage renal disease. Unless something is done to control these non-communicable diseases, renal complications will escalate to a degree that will compromise the current capacity to care for these types of patients.   Other non\u2014communicable diseases which are not lifestyle-related include violence and injury. These are also major problems in the country. Thus, a policy on the prevention of violence and injury came into effect through Administrative Order No. 2007-0010.   The cost of care of lifestyle-related non\u2014communicable diseases may cause people to fall into poverty and create a downward spiral of worsening poverty and illness. They also undermine the country's economic development. In response to the increasing prevalence of lifestyle related diseases in the country, vertical programs on the prevention and control of cardiovascular diseases, cancers and diabetes were put in place in the mid 1990\u2019s. The individual programs however, were focused on treatment and management of those who were already sick and thus were competing with each other for resources and for attention upon \ufb01eld implementation.   Recent evidence shows that the most cost-effective way of controlling these non- communicable lifestyle related diseases is by the prevention of the emergence of the risk factors in an integrated manner, employing health promotion strategies across the life course and intervening at the level of family and community. This is essential because the causal risk factors causing these illnesses are deeply entrenched in the social and cultural framework of the society. Thus, an integrated comprehensive program for the prevention and control of these non- communicable lifestyle related diseases has to be put in place.   II. STATEMENT OF POLICY   The prevention and control of chronic lifestyle related non communicable diseases shall be guided by the following policy statements.   1. The country shall adopt an integrated, comprehensive and community based response for the prevention and control of chronic, lifestyle related NCDs.   The underlying causes of NCDs are multi-faceted and are deeply rooted into the community and individual\u2019s socio-economic status, cultural orientations and personal preferences. Key measures and interventions that help prevent and control NCDs lie beyond the health sector. An integrated, comprehensive and community-based approach shall be adopted in responding to these issues.   2. Health promotion strategies shall be intensified to effect changes that would lead to a significant reduction in mortality and morbidity due to chronic, lifestyle related NCDs.   There are three major changes that need to take place in order to achieve significant reduction in the morbidity and mortality due to NCDs. These require (i) changes in lifestyle of the individual and of the population, (ii) changes in the environment supportive to the desired improvement of lifestyles, and (iii) change in the way the overall health care delivery system works. It is believed that these three changes can be realized through health promotion. Health promotion entails 5 action areas which include (i) building healthy public policy (ii) creating supportive environments, (iii) strengthening community action, (iv) developing personal skills through information and education (v) reorienting health care services toward prevention of illness and promotion of health.   3. Complementary accountabilities of all stakeholders must be ensured and actively pursued in the implementation of an integrated, comprehensive and community based response to chronic, lifestyle related NCDs.   With devolution, the primary mandate of delivering basic health services was transferred to the LGUs. The DOH shall encourage LGUs to perform adequately in the area of NCD prevention and control.   Also, since new directions in the health sector requires maximizing the participation of the private sector and Other stakeholders, public-private sector collaboratiOn shall be explored in the area of financing, service delivery, surveillance, capability building and other areas as necessary.   III. GUIDING PRINCIPLES   1. Equity. NCDs are highly prevalent among populations of low socio-economic status, thus the delivery of NCD prevention and control services should therefore be made accessible to all Filipinos with bias to those who are most vulnerable and disadvantaged.   2. Sustainability. The desired reduction of disease burden and death due to NCDs can only be attained through unified and sustained efforts by all the concerned sectors at various levels of operations thus it is important for sustainability measures to be built-in to every NCD prevention and control initiative.   3. Rights-Based. Respect of rights, gender and culture should characterize the delivery of NCD prevention and control services. .   4. Continuum of Care throughout the Life Cycle. In order to generate optimum health for all, actions for NCD prevention and control should take into account the consistent practice of healthy lifestyle throughout the life cycle and must ensure that these are emphasized and pursued in various health programs using the life cycle approach.   5. Evidenced-Based. Designing and implementing approaches for NCD prevention and control in the country must be based on scientific evidence thus the capability of stakeholders to collect, analyze and utilize these evidences must be enhanced.   IV. SCOPE AND COVERAGE   This Administrative Order provides the framework for action for effectively implementing an integrated and comprehensive program for the prevention and control of lifestyle related diseases in the Philippines. It covers all units and instrumentalities' including attached agencies of the DOH. It also applies to local government units (LGUs), non government organizations (N GOs), professional organizations, private sector, and other relevant partners in the health sector.   V. DEFINITION OF TERMS   For purposes of this Order, the following terms are defined as follows:   1. Alcohol control \u2014 refers to a range of strategies that aim to improve the health of the population by eliminating or reducing their consumption of alcohol.   2. Comprehensive \u2014 refers to a feature of the lifestyle related diseases prevention and control program that uses a combination of strategies that encompasses health promotion, disease prevention, and control of disease targeted at entire population and at individuals who are high risk and those who are already sick.   3. Healthy diet - refers to balance of food intake which: (1) achieves energy balance and a healthy weight; (2) limits energy intake from total fats and shift fat consumption away from saturated fats to unsaturated fats and towards the elimination of trans-fatty acids; (3) increase consumption of fruits and vegetables, and legumes, whole grains and nuts; (4) limit the intake of free sugars; and (5) limit salt (sodium) consumption from all sources.   4. Healthy lifestyle - refers to having regular healthy diet, regular and adequate physical activity, and non- use of tobacco and alcohol.   5. Healthy settings or settings for health - The place or social context in which people engage in daily activities in which environmental, organizational and personal factors interact to affect health and wellbeing.   6. Integrated \u2014 refers to a feature of the lifestyle related diseases prevention and control program that uses a combination of strategies focused on common major risk factors that cut across speci\ufb01c diseases (tobacco use, alcohol use, unhealthy diet and physical inactivity) viewed from a life course perspective, and employing an inter sectoral and cOllaborative approach.   7. Lifestyle-related diseases - refers to chronic, non-communicable diseases particularly cardiovascular diseases, cancers, chronic respiratory diseases and diabetes.   8. MDG Max - refers to the country\u2019s commitment to \ufb01ght poverty by including the prevention and control of Non\u2014Communicable Diseases as one of the Millennium Development Goals.   9. Physical activity - refers to any bodily movement produced by skeletal muscles that requires energy expenditure. It is recommended that individuals engage in regular and adequate levels of physical activity appropriate for age and conditions throughout their lifetime.   10. Tobacco control- refers to a range of supply, demand and harm reduction strategies that aim to improve the health of a population by eliminating or reducing their consumption of tobacco products and exposure to tobacco smoke    VI. GOALS AND OBJECTIVES OF THE PROGRAM ON THE PREVENTION AND CONTROL OF CHRONIC LIFESTYLE RELATED NON-COMMUNICABLE DISEASES:   Goals:   To reduce morbidity, mortality and disability rates due to chronic lifestyle related NCDs through an integrated and comprehensive program on the prevention and control of lifestyle related diseases.   Objectives:   1. To develop and promote an integrated and comprehensive program on the prevention and control of lifestyle related diseases in the country.   2. To engage all province-wide or city-wide health systems to adopt an integrated and comprehensive program on the prevention and control of lifestyle related diseases.   3. To achieve improvement in the following Key Performance Indicators frOm 2011 to 2016:   Common Risk Factors  a. Reduction in prevalence of current smoking among adult males from 56.3 to 40.0.  b. Reduction in prevalence of current smoking among adolescent female from 8.80 to 7.2  c. Reduction in prevalence of adults with high physical inactivity from 60.5 to 50.8  d. Increase in per capita total vegetable from 111.0 (g/day) to 133.0 (g/day)   Intermediate Risk Factors  a. Reduction in prevalence of hypertension among adult males from 24.2 to 19.6.  b. Reduction in prevalence of adults with high fasting blood sugar from 3.4 to 3.4.  c. Reduction in the prevalence of central obesity (high waist circumference) among adult females from 18.3 to 12.81  d. Reduction in prevalence of high total serum cholesterol among adults from 8.5 to 8.5   Disease Control  a. Reduction in mortality from non-communicable diseases at 2% per year through the MDG max initiative.   VII. ACTION FRAMEWORK FOR THE PREVENTION AND CONTROL OF CHRONIC LIFESTYLE RELATED NON-COMMUNICABLE DISEASES:   The Action Framework for the National Program on the Prevention and Control of Chronic Lifestyle Related Non-Communicable Diseases is based on the Causation Pathway Model for Major Chronic Diseases as contained in the WHO Western Paci\ufb01c Regional Action Plan for Addressing Non-Communicable Diseases, where the underlying determinants, common risk and intermediate risk factors that would lead to lifestyle-related diseases are identified (Figure 1)   Figure 1. Causation Pathway Model for Major Chronic Diseases    The action framework (Figure 2) has seven action areas as follows: (1) Environmental interventions; (2) Lifestyle interventions; (3) Clinical interventions; (4) Advocacy; (5) Research, surveillance, monitoring, and evaluation; (6) Networking and coalition building; and (7) Health system strengthening. It draws primarily from the WHO Western Paci\ufb01c Regional Framework for Addressing Non-communicable Diseases and emphasizes the requirement for integrated comprehensive approaches that encompass and address the various levels of determinants and risks for non\u2014communicable lifestyle related diseases (Figure 2).   Figure 2: Action Framework for the Prevention and Control of Chronic Lifestyle-Related Non-communicable Diseases     The framework clearly identi\ufb01es areas for intervention according to the causation pathway shown in Figure l by utilizing a comprehensive approach that simultaneously seeks to effect change at three levels: 1) Environment Interventions such as policy and regulatory . interventions seek to create a supportive environment for healthier choices. They address the multiple environmental determinants brought about, for example, by globalization and urbanization that give rise to the development of unhealthy lifestyles. 2) Lifestyle Interventions address the common risk factors and intermediate risk factors by providing population-based lifestyle interventions (for example, information and education and behavioural interventions for those who are already at risk). 3) Clinical Interventions, palliation and rehabilitation address the capacity of the health system to treat and manage diseases through screening, risk factor modification, clinical management, palliation and rehabilitation. To support change in these three levels of interventions, additional actions are needed in the following areas: advocacy; research, surveillance, monitoring and evaluation; networking and coalition building across all sectors of the government and society, and health system strengthening through primary health care to make it more responsive to chronic care.   The framework highlights the balance between \"healthy choices\" and \"healthy environments\" because it recognizes that supportive environments are needed to empower healthy choices. It also redistributes responsibility across the whole of society, with government, the health sector, the private sector, nongovernmental organizations, communities, families and individuals all sharing accountability for putting in place the necessary elements that promote healthy lifestyles and quality care for non-communicable lifestyle related diseases.   VIII. GENERAL GUIDELINES   1. The DOH shall develop systems, policies, and guidelines that will facilitate the operationalization of the program on the prevention and control of lifestyle-related diseases in the country.   2. Environmental interventions shall aim at providing and encouraging healthy choices for all to be implemented in three (3) major health promotion settings: community, school and workplace. As the underlying determinants of noncommunicable diseases often lie outside the health sector, multi-sectoral actions shall be implemented involving both public and private sectors.   3. Program interventions shall include:   A. Population based lifestyle interventions and preventive strategies using the life course perspective and focused on major risk factors particularly tobacco use, unhealthy diet, physical inactivity, and alcohol use, and, include other relevant risk factors such as but not limited to the following: hypertension, high blood sugar, overweight and obesity, and impaired lung function. Strategies shall be integrated in other health programs and health- related initiatives to effectively address lifestyle-related non-communicable diseases and their social and economic determinants.   B. Service packages for clinical interventions of diabetes, cardiovascular diseases, cancers and chronic respiratory diseases addressing the following unique features of NCDs such as:   i. The limitation of definitive treatment, the lifelong duration of management and the extensive self management involved must be addressed by service delivery providers.   ii. The multi drug regimens, drug interactions and drug cost that has to be regulated. '   iii. The acute attacks and exacerbations from failed prevention, financial barriers in access to acute care and financial risk that must be addressed by adequate financing.   iv. The co\u2014morbidities requiring coordination by various providers and teams that must be managed by proper governance infrastructure.   4. Health care settings shall provide access and availability of services that collectively span the care continuum and to include (a) prevention and health promotion; (b) lifestyle interventions to modify risk factors; (c) screening; (d) clinical interventions for high-risk individuals and groups and those who are already sick; (e) rehabilitation; and (f) palliation. A fictional referral system shall be in place to facilitate access and ensure continuity of care across health facilities at various levels.   5. Primary level health facilities such as rural health centers and primary hospitals shall provide appropriate services particularly on early detection and screening and primary prevention. Community participation shall also be enhanced to strengthen awareness on prevention and control of lifestyle-related diseases and to provide a supportive environment conducive for behavior change towards healthy lifestyle.   6. Interventions shall address health equity concerns and take into consideration the needs of the most vulnerable and marginalized sectors.   7. Services shall cater to various age groups addressing age-related needs throughout the human life cycle.   8. Research, surveillance, monitoring, and evaluation shall be institutionalized for sound policy formulation, planning, and decision-making processes. Capability of stakeholders to collect, analyze, disseminate, and utilize evidences shall be enhanced.   9. Networking and partnership with other sectors shall be strengthened to ensure synergies, avoid overlapping and duplication of activities, and prevent unnecessary competition in the implementation of initiatives. Commitment of stakeholders to the national plan of action on addressing lifestyle-related diseases shall be strengthened.   10. Sustained funding and financial protection for the poor and vulnerable groups shall be pursued.   11. Monitoring and evaluation mechanisms shall be put in place to ensure effective implementation and planning for subsequent actions.   IX. SPECIFIC GUIDELINES   The DOH shall provide leadership in addressing lifestyle related non-communicable diseases and institute the following measures:   1. Develop a national program and plan of action on prevention and control of lifestyle-related diseases, advocate and provide template for the integration of the said program and plan into the annual health action plans of local government units and other partners.   2. Strengthen health systems by:   a. Establishing program structure and provide funding for addressing lifestyle-related diseases.   b. Strengthening human resources capacity and use innovative approaches to health workforce development, with a special focus on primary health care to equip health care providers with the necessary skills, knowledge and attributes to deliver effective services for lifestyle-related diseases.   c. Facilitating resource mobilization and establish sustainable financing mechanisms to channel funding to initiatives on prevention and control of lifestyle-related diseases, such as through earmarking tobacco and alcohol taxes for disease prevention and health promotion.   d. Promoting equitable access to and rational use of cost-effective health products and services related to lifestyle related disease prevention and management.   e. Strengthening referral mechanisms to ensure continuity of care and complementation of services within the health system.   3. Collaborate with local government units, private sector, and other partners to:   a. Deliver evidence-based and cost\u2014effective primary, secondary, and tertiary prevention interventions for lifestyle related diseases with emphasis on primary health care.   b. Adopt, implement and monitor the use of evidence-based guidelines and establish standards of health care for cardiovascular diseases, cancers, diabetes and chronic respiratory diseases, and integrate whenever feasible their management into primary health care.   c. Develop and disseminate health service frameworks and packages, clinical practice guidelines and evidence-based decision-making support tools to health care providers to ensure timely screening, diagnosis, and treatment of lifestyle reWases.   d. Establish and support programmes to empower individuals and communities to develop health literacy, to take on self-care responsibilities and to become resources for themselves and others in disease management and prevention.   e. Implement and monitor cost\u2014effective approaches for the early detection of breast and cervical cancers, diabetes, hypertension, and other lifestyle-related diseases.   e. Establish and support effective partnerships and develop collaborative networks with other stakeholder in order to encourage and promote community participation and grassroots mobilization and establish a broad base of support thus ensuring acceptability and effectiveness of policy and population-based interventions.   4. Engage in health promotion and advocacy initiatives through the following:   a. Developing, implementing and sustaining health promotion initiatives on promoting healthy diet, physical activity, tobacco control, non-consumption of alcohol and other healthy lifestyle habits.   b. Utilizing media and social marketing to promote healthy choices and to increase knowledge and aWareness of risk factors of lifestyle-related diseases.   c. Incorporating prevention and control interventions into the \"Healthy Settings\" approach.   d. Operationalizing as appropriate the WHO Framework Convention on Tobacco Control (FCTC), Republic Act 9211 or Tobacco Regulation Act of 2003, WHO Global Strategy on Diet and Physical Activity, and WHO Western Pacific Regional Strategy for the Reduction of Alcohol-Related Harm.   e. Designing and implementing an advocacy campaign to mobilize political and grassroots support and raise the priority accorded to lifestyle-related diseases.   5. Ensure the inclusion of lifestyle-related diseases in the national uni\ufb01ed health research agenda by:   a. Investing in epidemiological, behavioral and health system research for the prevention and control of lifestyle related diseases.   b. Working with partners and academic institutions for implementation of research initiatives.   c. Disseminating research \ufb01ndings and utilize the same for policy and program development and/or strengthening.   6. Strengthen surveillance, monitoring, and evaluation systems for lifestyle- related diseases and their determinants.   7. Advocate for the establishment and strengthening of regulatory mechanisms to include among others the following: (i) \ufb01scal policies that reinforce healthy lifestyle choices through pricing, taxation, subsidies and other market incentives; (ii) regulation on the sale, marketing, advertising and promotion of unhealthy commodities; and (iii) regulation on the built environment to promote physical activity and social interaction and to protect people from hazardous exposures such as second hand smoke.   X. IMPLEMENTATION ARRANGEMENT   The oversight for the implementation of this Order shall rest with the Undersecretary for Policy, Standards Development and Regulation and Health Sector Financing Joint Clusters supported by the Technical Working Group (TWG) on Lifestyle Related Disease Prevention and Control chaired by the Director of the National Center for Disease Prevention and Control (N CDPC), and co-chaired by the Director of the National Center for Health Promotion (N CHP). The members of the TWG consist of representatives from the National Center for Health Promotion, NCDPC- Degenerative Disease Office, National Epidemiology Center (N EC), Health Policy Development and Flaming Bureau (HPDPB), Bureau of Local Health Development (BLHD), and the Chairperson, Philippine Coalition for the Prevention and Control of Non- Communicable Diseases (PCPCNCD) and such other bureaus and offices deemed relevant and competent by the PSDR\u2014HSF Cluster Head.   Figure 3: Composition of the Technical Working Group    XI. ROLES AND RESPONSIBILITIES   The following offices and institutions shall assume the following roles and responsibilities:   1. The TWG shall provide direction and technical support on policies and plans pertaining to the prevention and control of lifestyle related diseases. It shall also provide the forum for coordinating all aspects of the implementation of lifestyle related diseases policies and programs.   The NCDPC-Degenerative Disease Of\ufb01ce and the National Center for Health Promotion shall provide the secretariat to the Technical Working Group.   2. The National Center for Disease Prevention and Control (N CDPC) shall:   a. Oversee the implementation of the national policy and program on the Prevention and Control of Lifestyle-Related Diseases. 1   b. Establish standards and package of services on lifestyle-related diseases and ensure their quality, access, and availability at all levels of the health system.   c. Provide technical assistance to the LGUs and other partners on clinical interventions for lifestyle\u2014related diseases. I   d. Support the design of health financing of personal care related to lifestyle related diseases in collaboration with PhilHealth and other partners.   e. Conduct regular monitoring and evaluation of the burden of disease related to lifestyle related diseases.   f. Ensure participation of other DOH offices and bureaus and coordinate with partners within and outside the health sector for the effective implementation of the national program.   3. The National Center for Health Promotion (N CHP) shall:   a. Lead in the development and implementation of the National Healthy Lifestyle Program as a major strategy for the prevention and control of lifestyle-related diseases.   b. Advocate with other government agencies, non-government organizations, private sector, development partners, and other relevant stakeholders for support in policy development and resource generation towards the creation of supportive environments for lifestyle modification.   c. Provide technical assistance to ensure environmental interventions at the 3 health promotion settings: community, school and workplace.   d. Facilitate organization and development of a multi-sectoral coalition for the prevention and control of lifestyle related diseases.   4. The Health Policy Development and Planning Bureau (HPDPB) shall:   a. Support the development of relevant policies on NCD prevention and control.   b. Assist in securing adequate \"funding for Prevention and Control of Lifestyle-Related Diseases.   c. Facilitate and support program evaluation studies and researches.   5. The National Epidemiology Center (N EC) and the Information Management Service (IMS) shall:   a. Establish and sustain public health and hospital surveillance systems including registries, for lifestyle\u2014related diseases and other non-communicable diseases.   b. Facilitate collection, analysis, and dissemination of data on mortality, morbidity and risks on lifestyle\u2014related diseases.   c. Support conduct of population-based surveys on risk factors and lifestyle-related diseases.   6. The Health Human Resource Development Bureau (HHRDB) shall:   a. Develop, update as necessary and implement training and development plan of health professionals, particularly those in primary health care facilities and hospitals on the prevention and management of lifestyle-related diseases.   b. Facilitate integration of prevention and control of lifestyle-related diseases in the academic curriculum of health professionals.   7. The National Center for Health Facility Development (N CHF D) shall:   a. Ensure access and availability to quality hospital and facility-based services on lifestyle- related diseases.   b. Establish standards for an efficient hospital referral system.   c. Facilitate development and implementation of hospital\u2014based information and surveillance system to gather data particularly on mortality and morbidity from lifestyle- related diseases.   8. The National Center for Pharmaceutical Access and Management (N CPAM) shall develop guidelines and standards and provide mechanisms to ensure that affordable, but quality medicines for lifestyle-related diseases are always available, especially to the poor.   9. The Bureau of International Health Cooperation (BIHC) shall coordinate with international development partners and other countries for technical and resource assistance on prevention and control of lifestyle-related diseases.   10. The Philippine Health Insurance Corporation (PHIC) shall develop and implement health insurance package fOr clients at risk and afflicted with lifestyle-related diseases to reduce financial burden and impoverishment of individuals and families resulting from said diseases.   11. The National Nutrition Council (NN C) shall provide technical assistance and contribute to the advocacy on healthy lifestyle, particularly on healthy diet.   12. The Philippine Coalition for the Prevention and Control of Non-Communicable Diseases (PCPCNCD) shall provide support to the advocacy on healthy lifestyle.   13. The Centers for Health Development (CHDs) shall provide technical assistance and lead the regions to ensure local implementation of the National Program on Prevention and Control of Lifestyle\u2014Related Diseases.   14. DOH hospitals shall ensure provision of quality promotive, preventive, curative, rehabilitative, and palliative care for patients with lifestyle related diseases;   15. The Local Government Units (LGUs) shall adopt and implement the National Program on Prevention and Control of Lifestyle-Related Diseases and provide services and products in primary health care facilities and hospitals in their localities.   16. Non-government organizations, professional groups, other government organizations, private sector, the Academe, and Civil Societies shall assist in the implementation of the National Program on Lifestyle-Related Diseases.   XII. FUNDING   The Department of Health Central Office and Centers for Health Development shall provide funds for technical assistance, monitoring, and health promotion campaigns to ensure the operationalization of this policy and program framework. Local government units shall provide funds to provide products and services in their respective communities. Other government agencies, non government organizations and other stakeholders shall provide counterpart funds as appropriate to ensure the implementation of the National Program on Prevention and Control of Lifestyle-Related Diseases.   XIII. REPEALING CLAUSE   All previous Orders and other related issuances inconsistent or contrary to the provisions of this Administrative Order are hereby repealed, amended or modified accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.   XIV. EFFECTIVITY   This Order shall take effect immediately.  ", "  I. Background  Drug abuse is identified as one, of the first ten health problems in the Philippines during a nationwide focused group discussion conducted by the Essential  National Health Research. While no reliable statistics exist on the magnitude of the Philippine drug abuse problem, the problem is undoubtedly considered serious.  Several agencies have attempted to respond to the problem. The Department of Health (DOH) through Dangerous Drug Board (DDB) formulated a National Treatment and Rehabilitation Program for Drug Dependents which has since served as a guide for the conduct of national efforts to treat and rehabilitate drug dependents with the DDB as the overall coordinator of anti-drug abuse efforts nationwide. Ever since its inception, there has been a modest increase in the number of treatment and rehabilitation facilities nationwide. Currently, there are 28 residential rehabilitation centers of which 10 are government and 18 non-governmental. The governmental residential rehabilitation facilities remain over-utilized while residential facilities run by non-governmental organizations are under-utilized. It is also noted that the existing centers are inequitably distributed. In 1976, the DOH via an Ad-Hoc committee proposed to establish treatment and rehabilitation centers in every region. Due to the staggering budgetary requirements however, only the Welcome Station was established in the grounds of the National Center for Mental Health (NCMH). In 1999, an Anti\u2014Drug Abuse Task Force Technical Committee came up with recommendations for the prevention, control and management of drug abuse. The plan unfortunately never took off from the drawing boards because of what once again turned out to be prohibitive budgetary requirements.  Clearly, the problem of drug abuse is widely recognized and attempts have been made to address the need for more efficient and equitably distributed rehabilitation centers. If the response is to be adequate however, there is a need for a more comprehensive but stepwise approach in order to allow for gradual budgetary allocation and integration.    II. Policy  It shall be the policy of DOH to develop and provide preventive, therapeutic and rehabilitative services for substance abusers. These services must be culturally adapted to Philippine setting.   III. The National Substance Abuse Treatment and Rehabilitation Program  The term Substance Abuse is used to encompass the following substance related disorders:   1. Substance Abuse  A maladaptive pattern of use leading to clinically significant impairment or distress, as manifested by one or more of the following occurring in a 12 month period.  1.1 Recurrent substance use resulting in a failure to fulfill major role obligations at work, school or home (e.g. repeated absences, poor work performance related to substance use; substance related absences, suspensions and expulsions from school or neglect of children or household)  1.2 Recurrent substance use in situations in which it is physically hazardous (e.g. driving automobile or operating a machine, when impaired by substance use).   1.3 Recurrent substance related legal problems (arrest for substance related disorderly conduct).  1.4 Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g. arguments with spouse about consequences of intoxication).  2. Substance Intoxication  2.1 The development of a reversible substance\u2014specific syndrome due to recent ingestion of a substance.  2.2 Clinically significant maladaptive behavioral or psychological changes that are due to the effect of the substance on the central nervous system (e.g. belligerence, mood liability, cognitive impairment, impaired judgement, impaired social or occupational functioning) and developed during or shortly after use of the substance.  2.3 Symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.  3. Substance Withdrawal   3.1 The development of a substance-specific syndrome due to the cessation of (or reduction in) substance use that has been heavy and prolonged.  3.2 The substance\u2014specific syndrome causes clinically significant distress or impairment in social, occupational or other important areas of functioning.   3.3, The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.   4. Substance Dependence  A maladaptive pattern of substance use, leading to clinically significant impairment or distress as manifested by 3 or more of the following, occurring at any time in the same 12 month-period.   4.1 Tolerance, as defined by either of the following:  a. Need for markedly increased amount of the substance to achieve intoxication or desired effect.  b. Markedly diminished effect with continued use of the same amount of the substance.   4.2 Withdrawal as manifested by either of the following:  a. the characteristic withdrawal syndrome for the substance b. the same (or closely related) substance is taken to relieve or avoid withdrawal symptoms   4.3 The substance is often taken in larger amounts or over longer periods than was intended.  4.4 There is a persistent desire or unsuccessful efforts to cut down or control substance use.   4.5 A great deal of time is spent in activities necessary to obtain the substance (e.g. visiting multiple doctors or driving long distance) to use the substance, (chain smokers) or to recover from its effects.   4.6 Important social, occupational or recreational activities are given up or reduced because of substance use.  4.7 The substance use is continued despite knowledge or having a persistent or recurrent physical problem or psychological problem that is likely to  have been caused or exacerbated by the substance (e.g. current cocaine use despite recognition of cocaine-induced depression, or continued drinking despite recognition that an ulcer was made worse by alcohol consumption.)  A. Rationale  While there have been past efforts to respond to the Philippine drug  abuse problem, much remains to be done particularly with respect to  prevention, treatment and rehabilitation. The current program aims to address  the multidimensional substance abuse problem not only through research  information education campaign but also through actual provision of therapeutic, rehabilitative and aftercare services.  B. Program Vision   The establishment and operation of a Substance Abuse Prevention, Treatment and Rehabilitation Center in each region that is truly appropriate and sensitive to the Philippine setting. These centers shall have facilities for  1. Information dissemination and education 2. Diagnosis  3. Treatment 4. Rehabilitation 5. Referral 6. Training 7. Research  C. Linkages   The DOH shall establish intra\u2014agency, inter-agency and multi-sectoral linkages to broaden and deepen the scope of the program and enhance its operationalization. Once the budget of the NSAPTRP has been integrated in the DOH budget allocation, it will be gradually phased-in to become a unit of the mental health program of the DOH.  D. Program Goals and Objectives:  General Objective:  To establish a substance abuse prevention treatment and rehabilitation center which is integrated with the general hospital care system in each region.   Specific Objectives:  1. To design functional and structural models for prevention, treatment and rehabilitation centers within identified DOH\u2014retained tertiary level general hospitals. 2. To formulate general, clinical, and administrative policies in the operation of DOH prevention, treatment and rehabilitation centers.  3. To train trainors on drug treatment and rehabilitation with the end in view of multiplying trained personnel. 4. To develop a program based on successful experience of models on drug rehabilitation that is culturally adapted, appropriate and effective in the Philippine setting. 5. To evolve mechanisms to phase\u2014in the budgetary requirements of the program to the DOH annual budget.  6. To review it and strengthen collaborative relationship with existing governmental (GO) and non-governmental organizations (NGO) involved in substance abuse prevention, treatment, and rehabilitation. 7. To undertake research activities pertinent to substance abuse. 8. To provide technical assistance to agencies whether governmental or non\u2014governmental interested in establishing similar services.   E. Strategies  To achieve the program\u2019s goals and objectives, the DOH, in collaboration with the other agencies and various governmental and non-governmental organizations shall implement the following strategies:   1. Networking  A system of communication and collaboration with NGO\u2019s, Local Government Unit\u2019s (LGU), research institutions, and agencies shall be established through the National Substance Abuse Prevention, Treatment and Rehabilitation Program. A close working relationship with researchers, academic institutions and funding agencies shall also be effected. Networking activities shall be undertaken by the substance abuse prevention, treatment and rehabilitation centers in each region.  2. Advocacy   Activities that will generate public visibility and wider public understanding of substance abuse shall be undertaken. This shall be done through multi-media campaigns, distribution of information/education materials and official pronouncements.  3. Resource Development  Nationwide training and resource development shall be established and conducted. The Department shall involve itself in institution building.  4. Legislative agenda  The development of legislations that will facilitate the development, establishment and maintenance of the National Substance Abuse Prevention, Treatment and Rehabilitation Program shall be undertaken. The Department shall also collaborate with concerned NGOs and agencies to work for the passage of legislations beneficial to the program.   5. Research  Researches in substance abuse shall be initiated and encouraged by the substance abuse prevention, treatment and rehabilitation centers in collaboration with DOH Essential National Health Research Program and Philippine Council for Health Research and Development. Technology transfer of research results shall likewise be promoted.   6. Generation of financial resources  A Substance Abuse treatment and Rehabilitation Foundation shall be established to generate and manage funds other than DOH budgetary allocation for projects and activities undertaken by the Program.    IV. Program Organization  A. The Program  The National Substance Abuse Prevention, Treatment and Rehabilitation Program shall be established under the Office of Health Facilities and Standards Regulation. The Program shall give advice, and staff support to the Secretary on the development, implementation, monitoring and evaluation of the Program. The Program shall be under the Program Manager who shall manage the day to day affairs. The Program Manager will have the support of a core staff consisting of a Financial Analyst, Administrative Officer and a Clerk.  The Program Manager will coordinate and collaborate with the Chiefs of Hospitals in the operation and management of the substance abuse prevention, treatment and rehabilitation centers. The Chief of Hospital shall have administrative supervision over the coordinator of each center while the Program Manager shall have technical supervision over the said coordinator.   To assist the Program Manager in the development of comprehensive plan, a multi-sectoral working committee shall be created composed of selected representatives from NGOS, the academe, other agencies and key officials of the DOH.  The following services/offices of the Department will likewise provide support and technical assistance to the Substance Abuse Treatment and Rehabilitation Program: - Bureau of Food and Drug - Essential National Health Research - Community Health Service  \u2014 Foreign Assistance Coordinating Service \u2014 Office of Legal Affairs (Legal Service) \u2014 Local Government Assistance Monitoring Service  \u2014 UP-National Poisons Control Information Service(UP-NPCIS)  B. The Center   1. The center shall be an integral part of the tertiary level general hospital. 2. The budget for each center will be administered by the Chief of Hospital. A book of accounts will be kept. 3. Appointments will be initially approved by the Secretary of Health until the centers\u2019 budgetary allocation is incorporated in the hospital. 4. The Center will function as a referral center for diagnostic service and expert advise in addition to their service function. 5. Each center will be composed of a detoxification unit and rehabilitation unit which will be separate but adjacent to each other. 6. Each center shall be attached to tertiary level general hospital for the following reasons: a. There is a need for Medical Specialists and hospital personnel during detoxification. b. Treatment of substance abuse falls under the responsibility of medical health professionals. c. There is a need for access to ancillary and other facilities d. There is a need to facilitate sustainability of the service in terms of manpower and other budgetary needs. e. Each center shall have continuity of service from detoxification to inpatient rehabilitation and treatment aftercare services both in the hospital as outpatient and in the community. 7. The center and its staff shall be administratively under the chief of Hospital and the respective Service Heads. Considering the unique role and training of the centers\u2019 staff, they shall be permanently assigned to the center except for emergency cases and/or other cases mutually agreed upon by the Center Coordinator, Chief of Hospital and Program Manager  8. Each center shall provide for the following services: a. Service   - information and education - diagnosis  - detoxification  - treatment of psychotic drug dependents - rehabilitation  - outpatient services - community outreach - drug detection services b. Training \u2014 training for service providers - in-service training \u2014 training for trainors  c. Research will be conducted along such areas  - cultural and other behavioral determinants of drug abuse among Filipinos - messages to be developed in preventive and promotive campaign \u2014 epidemiologic study on extent of drug abuse  \u2014 important elements in the maintenance of drug-free states during aftercare - effective aftercare program for Filipinos  C. Role of the Tertiary Level General Hospital  1. As part of its administrative function, provide for the budget appropriated for the unit for its operation after it is included in the DOH general appropriations  2. Provide additional manpower from the hospital plantilla if need be for the effective implementation of the center's activities 3. Strengthen, promote and encourage information dissemination and education on substance abuse in coordination with government agencies as well as non-governmental agencies 4. Strengthen and support the activities of the center not only through service but also through the training of health workers as well as the encouragement of the coordinative functions with field health, social and local officials and personnel in areas where they conduct regular periodic visits. 5. Support and encourage the innovative activities of personnel in areas where not only services are needed but also training of non-health workers as well as undertake research activities. 6. Link with other government and non\u2014government organizations to enhance and support the NSAPTRP of DOH, 7. Intensify and or strengthen the training of medical and psychiatric residents in the field of substance abuse treatment and rehabilitation, in psychosocial interventions and in community based rehabilitation program.  An organizational chart on the DOH National Substance Abuse Prevention, Treatment and Rehabilitation Program is presented in Annex A   V. Funding As a priority program, the Department of Health shall endeavor to include the NSAPTRP in the national budgetary allocation and increase its allocation of funds from funding sources.  ", "  Administrative Order No. 2007-009 entitled Operational Framework for the Sustainable Establishment of the Mental Health Program, dated March 9, 2007, is hereby amended as shown below:  V. IMPLEMENTING MECHANISMS  A.1. National Program Management Committee  a. Composition  To ensure coordination and sustainability of the National Mental Health Program, a National Program Management Committee (NPMC) shall be organized in the Department of Health. The Chair of the Committee shall be the Assistant Secretary for Special Concerns, Co\u2014Chaired by the Medical Center Chief, National Center for Mental Health.  All other provisions of Administrative Order No. 2007-0009, still remain in effect.   ", " I. RATIONALE  The 1987 Philippine Constitution mandates the right of every Filipino to health. The State, under Section II of Article Xlll, shall adopt an \u201cintegrated and comprehensive approach to health development which shall endeavor to make essential goods, health and other social services available to all the people at affordable cost\".  Republic Act No. 6675 also known as the Generics Act of 1988, prescribes that it is the policy of the State to \u201censure the adequate supply of drugs with generic name at the lowest possible cost\".  To promote equity in health, the Botika ng Barangay program was established to ensure the availability and accessibility of affordable, safe and effective, quality essential drugs to the public, with priority for the marginalized, underserved, critical and hard to reach areas. Such endeavor was developed as early as 1996 as embodied in Administrative Order 23-A s. 1996 entitled, \u201cGuidelines on the Development and Establishment of Botika ng Barangay (BnB)\". This was further strengthened by Administrative Order 144 s. 2004, entitled, \u201cGuidelines for the Establishment of Botika ng Barangays (BnBs) and Pharmaceutical Distribution Networks (PDN)\" as part of the initiatives of the Half\u2014Priced Medicines Program.  In line with the framework of FOURmula One for Health (F1) in providing equity in health, responsive health systems and better health outcomes, and in pursuit of strengthening the Botika ng Barangay framework, the Philippine International Trading Corporation (PITC), in collaboration with DOH, shall institute an innovative strategy that will-ensure the accessibility and availability of quality essential drugs through the expansion of its distribution network using qualified Botika ng Bayan outlets nationwide. Mindful of the intentions of Administrative Order 144 s. 2004, the DOH and PITC shall implement the Expanded Drug Access Program using traditional convenience stores as BNB Express Outlets. The PITC shall be in charge of identifying and accrediting these convenience stores that will offer for sale medicines available in Botika ng Barangay. Said BNB Express Outlets shall be under the supervision of PlTC\u2019s Botika ng Bayan.  The DOH in turn, intends to provide inter-agency technical assistance to PITC to synergize current strategies in bringing down the cost of medicines and in enhancing drug access.  ll. SCOPE This Order shall only be applicable to all Botika ng Bayan (BNB) outlets identified by PITC acting as distribution networks as well as to all PITC-accredited and licensed convenience stores that shall be known as BNB Express outlets.  Ill. OBJECTIVES This Order is formulated in order to:  A. identify areas of collaboration between the Department of Health and PITC in relation to the Expanded Drug Access Pilot Program;   B. Provide essential procedures that will be undertaken for the operation of selected Botika ng Bayan as distribution-network as well as accreditation of convenience stores under the Botika ng Bayan identified by PiTC; and  C. Provide clear definition of roles and responsibilities among stakeholder entities.  IV. DEFINITION OF TERMS  A. BNB Express Outlets -\u2014 refers to convenience stores accredited by PITC and licensed by BFAD to sell drugs and medicines made available in Botika ng Barangay outlets. These outlets shall be managed by a Botika ng Bayan as identified by PITC, with a trained operator and a supervising pharmacist.  B. BNB Express Outlet Operator -\u2014 refers to trained personnel on the standards of operating and managing a BNB Express Outlet under the supervision of a registered pharmacist.  C. Botika ng Barangay \u2014 refers to a drug outlet managed by a legitimate community organization (CO)/non-government organization (NGO) and/or the Local Government Unit (LGU), with a trained operator and a supervising pharmacist. Said outlet is specially licensed by the Bureau of Food and Drugs (BFAD) to sell, distribute, offer for sale and/or make available low-priced generic home remedies, over-the\u2014counter (OTC) drugs and selected prescription drugs.  D. Botika ng Bayan \u2014 refers to a drug outlet managed by PITC that offers for sale low cost quality drugs and medicines. Said outlet, upon identification of PITC, shall also act as a distribution network to BNB Express Outlets and Botika ng Barangays within the area.  E. Philippine international Trading Corporation (PITC) - a government owned and controlled corporation that is responsible for identifying qualified Botika ng Bayan (BNB) outlets as PITC distribution networks and accrediting convenience stores to carry medicines sold in Botika ng Barangay.  F. Supervising Pharmacist \u2014 refers to a licensed pharmacist who shall be responsible for the quality standards in the operation of the BNB Express outlet.  V. GENERAL GUIDELINES  A. The PITC shall be responsible for identifying qualified Botika ng Bayan (BNB) outlets as distribution networks to accredited convenience stores that shall be known as BNB Express Outlets. The BNB may also supply essential medicines to existing Botika ng Barangays within the area.  B. The PITC shall facilitate the application of its selected BNBs as distributor in accordance with existing BFAD rules and regulations. The BNB under the distribution network shall be covered by a distributorship agreement, which explicitly identifies PITC as its principal source of drugs and determinant of its retail price offers.  C. The BNB shall operate as a centralized re-order, remittance, collection, warehouse and distribution facility for essential drugs and medicines which shall supply the inventory of BNB Express Outlets and Botika ng Barangays within the CHD\u2019s catchment area.  D. Only drugs included in the latest edition of the Philippine National Drug Formulary under the Botika ng Barangay Program shall be sold in BNB Express Outlets.  E. The stocks intended for distribution by the BNB to BNB Express Outlets and Botika ng Barangays shall be separate from those dispensed to individual consumers.  F. The PITC shall ensure that each BNB has ample stock of essential drugs and medicines at any given time. Only drugs covered with Certificate of Product Registration (CPR) shall be carried in the inventory of the BNB.  G. The PITC shall ensure that their suppliers are covered with a Certificate of Good Manufacturing Practice (CGMP) and are capable of providing needed drugs and medicines that are of good quality.  H. The DOH and PITC through its pharmacist shall ensure close coordination between the CHDs and the BNBs.  l. The PITC shall identify and accredit convenience stores as BNB Express Outlets, after ensuring compliance of the latter with the requirements (except on the requirement for a Local Government Unit co\u2014signatory in the accomplishment of the Memorandum of Agreement) for the issuance of a Special License to Operate (SLTO) as per pertinent provisions of A0 144 s. 2004. The BNB Express Outlets shall be classified by the Bureau of Food and Drugs as variants of Botika ng Barangay.  J. The BFAD shall ensure the timely issuance of SLTO in accordance with the conditions set forth in this Order as well as those stipulated in A0 144 s. 2004.  K. Accredited and licensed BNB Express outlet owners and/or operators shall only be allowed to sell drugs and medicines after they have successfully undergone a technical training course provided initially by DOH through CHDs.  L. The drug prices under the BNB shall be subject to price monitoring of the CHDs through its frontline Food and Drug Regulatory Of\ufb01cers (FDROs).  M. The PITC must ensure that the prices of the drugs it carries for BNB are lower than the prevailing market price, such that the transfer price shall result to a lower price than the prevailing market price inclusive of the margins or mark-ups of the BNB Express Outlets and existing Botika ng Barangays. The prevailing market price is the average price of a particular drug in three major drugstore chains within a period of three (3) months or as determined by DOH in accordance with the Price Act.  VI. SPECIFIC GUIDELINES  Additional Requirements to be imposed on the BNBs  1. A separate Memorandum of Agreement for this purpose shall jointly be perfected by BNBs supervising the BNB Express Outlets, PITC and the concerned CHD defining their accepted roles and responsibilities as provided in this Order (Annex A). The MOA template in annex B of A0 144 s. 2004 will not be used for the purpose of this Order.  2. The Petition Form provided as annex A in A0 144 s. 2004 shall be applicable for purposes of this Order (Annex B).  3. The BNB owner or his duly authorized representative shall be responsible in accounting the BNB Express outlets to assure custodial fidelity of assets and properties.  4. Appropriate security measures must be established by the BNB Express outlets and the proponent BNB in assuring the protection of the assets of the BNB Express outlets.  5. The BNB Express Outlet operator shall be primarily responsible and accountable for the maintenance of the BNB Express Outlet and the assets thereat, including sales.  B. Stock Replenishments Only drugs re\ufb02ected on the approved list of drugs to be dispensed speci\ufb01cally by the BNB Express Outlets as covered by the appropriate DOH issuance and have passed the BFAD Quality Assurance Protocol shall be procured by the BNB Express Outlet.  2. Actual procurement of drug products shall be undertaken by the BNB Express Outlet only from its supervising BNBs. Sourcing of drugs and medicines from other suppliers is prohibited. Violation of such provision is subject to the suspension/revocation of its accreditation as BNB Express Outlet.  3. The BNB Express outlet, in partnership with its supervising BNBs shall be responsible for the inventory, accounting and selling of drugs made available in the said outlet.  C. Rational Drug Use  1. The BNB Express outlet shall be monitored by a supervising pharmacist who shall at all times, adhere to rational drug use practices in dispensing medicines. The supervising pharmacist may be the pharmacist of the supervising BNB or a hired pharmacist by the PITC. The BNB Express Outlet may hire its own pharmacist, provided that coordination with PITC is assured.  2. The quantity of medicines to be dispensed shall be in accordance with the prescribed therapeutic regimens so as to preclude possible selling of OTC drugs in bulk to a single patient.  3. The BNB Express outlet operator and the supervising pharmacist shall assure that no drugs shall find their way to the trade for reselling.  D. Project Monitoring  1. The CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative, and the PITC shall be jointly responsible in monitoring the performance of the BNB Express Outlet.  2. The CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative and the PITC shall have authority to check on the records of the BNB Express Outlet notwithstanding and without prejudice to the regulatory functions of the Bureau of Food and Drugs.  3. The BNB Express Outlet must maintain the integrity and transparency of their records which shall be made available whenever asked for by the CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative and the PITC and other regulatory units.  4. Monitoring reports shall be periodically submitted by the CHD to the Pharma 50 PMU Project Executive Of\ufb01cer every quarter or as often as practicable.  5. Any violation in the compliance of this Order may be subject to the suspension/revocation of the SLTO provided in Section Vl-E of A0 144 s. 2004.  VII. SEPARABILITY CLAUSE If any provision in these Guidelines, or application of such provision to any circumstance, is held invalid, the remainder of these Guidelines shall not be affected.  VIII. REPEALING CLAUSE The provisions of previous issuances, which are inconsistent with those provided in this Order, are hereby rescinded and modified accordingly.  IX. EFFECTIVITY  This Order shall be effective immediately.         ANNEX A      -WITNESSETH-  WHEREAS, the 1987 Philippine Constitution mandates that the State shall protect and promote the right to health of the Filipino people and instill the consciousness among them;  WHEREAS, under Section ll, Article Xlll, the State shall adopt an integrated and comprehensive approach to health development which shall endeavor to make essential goods, health and other social services available to all people at affordable cost;  WHEREAS, Republic Act No. 6675, otherwise known as the Generics Act of 1988, prescribes that it is the Policy of the State to \u201censure the adequate supply of drugs with generic names at the lowest possible cost;  WHEREAS, the Botika ng Barangay (BNB) program of the DOH promotes equity in health by ensuring the availability and accessibility of affordable, safe and effective, quality essential drugs to all, with priority for the marginalized, underserved, critical and hard to reach areas;  WHEREAS, Executive Order 442 appoints PITC as the lead coordinating agency, responsible for the procurement, sourcing and marketing of quality essential and low-priced medicines through parallel drug importations and local sourcing as well as ensuring the widest distribution of these medicines nationwide through its Botika ng Bayan program;  WHEREAS, in pursuit of strengthening the Botika ng Barangay framework, PITC, in collaboration with DOH, shall institute an innovative strategy that will ensure the accessibility and availability of quality essential drugs through the expansion of its distribution network to accredited convenience stores supplying medicines sold in Botika ng Barangay under the supervision of PlTC\u2019s Botika ng Bayan outlets, as well as in existing Botika ng Barangays nationwide;  NOW THEREFORE, for and in consideration of the foregoing, the Parties have agreed as they hereby agree to pursue the following:  ARTICLE I  DOH-PITC EXPANDED DRUG ACCESS PILOT PROGRAM USING CONVENIENCE STORES AS BNB EXPRESS OUTLETS  1. Operations of the Botika ng Bayan as Distribution Network  1.1 The PITC shall be responsible for identifying qualified Botika ng Bayan (BNB) outlets as distribution networks to accredited convenience stores in every CHDs nationwide that shall carry medicines sold in Botika ng Barangay as well as to existing Botika ng Barangays within the area.  1.2 The PITC shall facilitate the application of its selected BNBs as distributor in accordance with existing BFAD rules and regulations. The BNB under the distribution network shall be covered by a distributorship agreement, explicitly identifying PITC as its principal source of drugs that shall determine its retail price offers.  1.3 The BNB shall operate as a centralized re-order, remittance, collection, warehouse and distribution facility for essential drugs and medicines which shall supply the inventory of accredited convenience stores and Botika ng Barangays within the CHD\u2019s catchment area.  1.4 Only drugs included in the latest edition of the Philippine National Drug Formulary under the Botika ng Barangay Program shall be sold in BNB Express Outlets.  1.5 The stocks intended for distribution by the BNB to BNB Express Outlets and Botika ng Barangays shall be separate from those dispensed to individual clients.  1.6 The PITC shall ensure that each BNB has ample stock of essential drugs and medicines at any given time. Only drugs covered with Certificate of Product Registration (CPR) shall be carried in the inventory of the BNB.  1.7 The PITC shall ensure that their suppliers are covered with a Certificate of Current Good Manufacturing Practice (CGMP) and are capable of providing needed drugs and medicines that are of good quality.  1.8 The DOH and PITC through its pharmacist shall ensure close coordination between the CHDs and the BNBs.  2. Accreditation of Convenience Stores as BNB Express Outlets  2.1 The PITC shall identify and accredit convenience stores as BNB Express outlets, upon ensuring compliance with the requirements for issuance of a special license to operate as per pertinent provisions of A0 144 s. 2004, except on the requirement for a Local Government Unit co-signatory in the accomplishment of the Memorandum of Agreement. The BNB Express Outlets shall be classified by the Bureau of Food and Drugs as variants of Botika ng Barangay.  2.2 Accredited and licensed BNB Express outlet owners and/or operators shall only be allowed to sell drugs and medicines after they have successfully undergone a technical training course.  2.3 The DOH through CHDs shall provide initial training to BNB owners and accredited convenience store owners.  3. Drug Prices under the BNB  3.1 The drug prices under the BNB shall be subject to price monitoring of the CHDs through its frontline Food and Drug Regulatory Officers (FDROs).  3.2 The PITC must ensure that the prices of the drugs it carries for BNB are lower than the prevailing market price, such that the transfer price result to a lower  price than the prevailing market price inclusive of the margins or mark-ups of the BNB Express Outlets and existing Botika ng Barangays.  4. Accountability and Security Requirements  4.1 The BNB owner or his duly authorized representative shall be responsible in accounting the BNB Express outlets to assure custodial fidelity of assets and properties.  4.2 Appropriate security measures must be established by the BNB Express outlets and the proponent BNB in assuring the protection of the assets of the BNB Express outlets.  4.3 The BNB Express Outlet operator shall be primarily responsible and accountable for the maintenance of the BNB Express Outlet and the assets thereat, including sales.  5. Stock Replenishments  5.1 Only drugs reflected on the approved list of drugs to be dispensed specifically by the BNB Express Outlets as covered by the appropriate DOH issuance and have passed the BFAD Quality Assurance Protocol shall be procured by the BNB Express outlet.  5.2 Actual procurement of drug products shall be undertaken by the BNB Express outlet from its supervising BNBs.  5.3 The BNB Express outlet, in partnership with its supervising BNBs shall be responsible for the inventory, accounting and selling of drugs made available in the said outlet.  6. Rational Drug Use  6.1 The BNB Express outlet shall be monitored by a supervising pharmacist who shall at all times, adhere to rational drug use practices in dispensing medicines. The supervising pharmacist may be the pharmacist of the supervising BNB or a hired pharmacist by the PITC.  6.2 The quantity of medicines to be dispensed shall be in accordance with the prescribed therapeutic regimens so as to preclude possible selling of OTC drugs in bulk to a single patient.  6.3 The BNB Express outlet operator and the supervising pharmacist shall assure that no drugs shall find their way to the trade for reselling.  7. Project Monitoring  7.1 The CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative, and the PITC shall be jointly responsible in monitoring the performance of the BNB Express outlet.  7.2The CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative and the PITC shall have authority to check on the records of the BNB Express outlet notwithstanding and without prejudice to the regulatory functions of the Bureau of Food and Drugs.  7.3 The BNB Express outlet must maintain the integrity and transparency of their records which shall be made available whenever asked for by the CHD, the Pharma 50 PMU, the BNB owner or his duly authorized representative and the PITC and other regulatory units.  7.4 Monitoring reports shall be periodically submitted by the CHD to the Pharma 50 PMU Project Executive Officer every quarter or as often as practicable.  7.5 Any violation in the compliance of this Order may be subject to the suspension/revocation of the SLTO provided in Section Vl-E of A0 144 s. 2004.  ARTICLE II OTHER TERMS  1. Any amendments or modifications hereto shall be subject to mutual agreement of the parties in writing.  2. None of the parties hereto may assign in whole or in part any of its obligations/responsibilities without prior written approval of the other parties.  ARTICLE III EFFECTIVITY This agreement shall be effective upon signing hereof by the parties concerned,  IN WITNESS WHEREOF, the Parties hereto affix their signatures on the date and place written above.              Annex B    ", "   1. Background  The 1987 Philippine Health Statistics reports that malignant neoplasms is the no. 5 leading cause of mortality and the no. 10 leading cause of morbidity. In recognition of the current and emerging importance of non-communicable diseases like cancer, E. O. 119 reorganizing the Department of Health provides a Non-Communicable Disease Control Service whose mandate includes planning, and management of Cancer Control activities. This order provides for guidelines on the Philippine Cancer Control Program (PCCP) to be organized and managed by the Non-Communicable Disease Control Service.  2. Policy  It is the policy of the Department of Health (DOH) to plan, organize and implement a Philippine Cancer Control Program targeted towards the reduction of Cancer morbidity and mortality and the improvement of survival rates and quality of life of Cancer victims. The Non-Communicable Disease Control Service is the central office responsible for staff support gig the PCCP. All DOH agencies as well as cooperating institutions shall be responsible for executing Program activities.  3. The Program   The Philippine Cancer Control Program (PCCP) is a systematic, comprehensive and integrated approach towards the 'control of Cancer that can significantly alter or reduce morbidity and mortality utilizing Primary and Secondary Prevention at the community level, Tertiary Prevention in specified medical centers in the different regions of the country, Rehabilitation and Cancer Pain Relief activities at both the hospital and community level.  4. Components of the Program  4.1 Cancer Epidemiology and Clinical Research  The documentation and understanding of cancer epidemiology here and abroad shall be the basis of cancer control plans and activities.  4.2 Public information and Health Education  The dissemination of Public Information and the conduct of health education on the nature of cancer, the known risk factors, the need for early diagnosis and prompt -treatment and the constantly improving prospects of survival shall be an important element of the Program.   4.3 Integration of Cancer Prevention and Early Detection at the Community Level  The Program shall provide- for the integration of Cancer prevention and early detection activities at the lowest possible level of community health interventions.  4. 4 Upgrading Cancer Management Capabilities  The Program shall include the strengthening of the principal DUH cancer management facility which is the Jose R. Reyes Memorial Medical Center. It shall also include the appropriate upgrading of Regional Medical Centers.  4.5 Hospital Tumor Boards and Hospital Cancer Registries   To monitor the validated incidence and prevalence of Cancer and to serve as a data base for Cancer Control planning, hospitals shall establish Tumor Boards and Cancer Registries.  4.6 Cancer Pain Relief  The Program shall have a Cancer Pain Relief component.  5. IMPLEMENTING GUIDELINES  5.1 Epidemiology and Clinical Research  5.1.1 The Epidemiology Unit shall be based at the Riza1 Medical Center. It shall submit to Non-Communicable; Disease Control Service an annual report, on the incidence, prevalence, morbidity and mortality rates of Cancer.   5.1.2 Cancer Registration, the process of continuing systematic collection of data on the occurrence and characteristics of reportable neoplasms, shall be adopted as a basic strategy of disease surveillance.  5.1.3 Population-based cancer registry, the recording of cancer cases from a geographically defined population shall be utilized to report and monitor cancer incidence periodically.  5.1.4 Existing registries shall be supported and encouraged. The Rizal Medical Center Population-based Cancer Registry for Rizal province andI13 municipalities of Metro Manila, the Philippine Cancer Society-Cancer Registry for the 4 cities of Metro Manila, the Aboitiz Cancer Foundation-Cebu Cancer Registry for Metro-Cebu shall be supported and encouraged by the Program. Additional registries for other populations\u009d in the Philippines, especially for large ethnic populations in Muslim Mindanao and the Cordilleras shall be established.  5.1.5 Clinical cancer research shall be planned, supported and coordinated by the Program.   5.2 Public Information and Health Education  The Program shall have Cancer Information Desks at the national and regional levels for the dissemination of cancer information.    5.3 Integration of Cancer Prevention and Early Detection at the Community Level   5.3.1 The existing program in the pilot provinces shall be supported and monitored.   5.3.2 Administrative support shall be provided for the expansion of the program to other provinces within the pilot regions and to other regions of the country.  5.3.3 The program shall provide for the establishment of a regional core of trainers from the medical centers/regional and provincial hospitals.   5.4 Strengthening the Cancer Management Capabilities of Jose R. Reyes Memorial Medical Center (JRRMMC) and other Medical Centers  5.4.1 The Jose R. Reyes Memorial Medical Center (JRRMMC) and the other pilot medical centers shall institute, a manpower development program in the various oncologic sub-specialties.  5.4.2 The program shall develop clinical and administrative policies and procedures.  5.4.3 The necessary resources for cancer diagnosis, treatment and rehabilitation shall be provided.  5.5 Establishment of Hospital Tumor Boards (HTB) and Hospital Tumor Registries (HTR)  5.5.1 By the end of 1990, all hospitals and medical centers with accredited residency training programs shall have a functional tumor board and hospital tumor registry.  5.5.2 The program shall establish an effective, treatment protocol for the use of all participating hospitals.    5.6 Cancer Pain Relief Program  5.6.1 The Cancer Pain Relief Program shall be implemented utilizing the 2-step ladder method of pain control.   5.6.2 A hospital physician shall be designated to  monitor all cancer pain activities.  5.6.3 Hospitals shall make available morphine tablets for use by indigent patients.  6. Advisory Council  The program shall have an. advisory Council composed of experienced specialists and technical experts in the fields of oncology and related disciplines in medicine coming from the private and the government sectors designated by the secretary of Health to formulate policies and provide direction in the implementation of the PCCP. It shall-have a Chairman and an Executive Officer. The chairman shall call and preside overall council meetings, provide direction in the formulation of policies/plans and programs and performs other duties as may be assigned. The Executive Officer shall perform liaison work between the Advisory council, Office of Public Health Services (OPHS) and the Office for Hospitals and Facilities Services (OHFS). He shall be responsible for the preparation and submission of periodic reviews of program\u2019s progress, monitor program implementation at field level and hospital levels recommend policies and programs to the Council and perform other duties as may be assigned.  7. Timetable of Implementation  The Program Components based on the identified pillars shall be implemented in three (3) Phases of activities as follows:  PHASE I (1989-1990) - inc1udes the conceptualization, development, reproduction and dissemination of IEC materials in support of the on-going training programs in four (4) regions of the country. Specifically the Biennium 1989-1990 c for the implementation of the DOH CANCER PAIN RELIEF PROGRAM- to include-hospitals and Community-based activities. During this period, the cooperation of the academe, NGOs, tri-media and other government entities Are enhanced.    PHASE II (1991-1992)- specifically deals with intensified public information and health education campaign on preventable cancers-as well as the adoption of specific intervention measures aimed at reducing the incidence, morbidity and mortality of cancer. During this period, full implementation of low-cost effective therapy on cancer pain shall be\u009d realized. Likewise, program oncologists will be able to present initial clinical results of the treatment for the indigent patients with curable cancers. The biennium 1991-1992 calls for continuing education and training of implementers from within the expanded regions and outside of pilot areas.  PHASE III (1993-1994) - deals with evaluation of program implementation, reporting and documentation of the highlights of the 5-year PCCP activities as well as the formulation of the next 5-year program plan.  8. Repealing Clause  All Orders, Circulars, Administrative issuances which are inconsistent with this Order are hereby repealed or amended accordingly.  9. Effectivity  This Order shall take effect immediately.    ", "   I. RATIONALE:  The proportion of older population is expected to rise worldwide. In the 1998 World Health Report, there were 390 million older people and this \ufb01gure is expected to increase further (WHO) older was 3.7 million in 1995 or 5.4% of total population. In Y2000 census, this has increased to about 4.8 million or almost 6% (NSCB)  With the rise of the aging population is the increase in demand for health services by the elderly. A study done by Racelis et al (2003) on the share of health expenditure of Filipino elderly on the National Health Account, the elderly are \"relatively heavy consumers of personal health care (22%) and relatively light consumers of public health care (5%).\" From out\u2014of\u2014pocket costs, the aged are heavy users of care provided by hospitals, non-hospital health facilities and traditional care facilities.  Cognizant of the growing concerns of the older population, laws and policies were developed that would provide them with enabling mechanisms for them to have quality life. RA 9257 or the Expanded Senior Citizens\u2019 Act of 2003 provides for the expansion of coverage of bene\ufb01ts and privileges that the elderly may acquire, including medically necessary services. Parallel to this objective is the Department\u2019s desire to provide affordable and quality health service to the marginalized population, especially the elderly, without impeding currently pursued objectives alongside health systems reform.  This guideline is being issued in support to the Implementing Rules and Regulations of RA 9257. Policies and guidelines are discussed to guide the hospitals in implementing the provisions of RA 9257 so asto provide fair, jusf'and quality health. care to the senior population, at the same time pursuing financial viability of hospitals amidst economic and \ufb01nancial management constraints.  II. COVERAGE AND SCOPE  This Administrative Order applies to all hospitals and health-related facilities from government and private sector, the health care professionals and the Philippine Health Insurance Corporation, and other related healthcare facilities and services. This also applies to drug stores, hospital pharmacies and similar establishments dispensing medicines.  III. DEFINITION OF TERMS  Consistent with the pertinent de\ufb01nitions used in the Implementing Rules and Regulations of RA 9257, the follovving terms shall be defined as follows:  1. MEDICINES\u2014 shall refer to both prescription and non-prescription medicines and articles approved by the Bureau of Food and Drugs (BFAD), intended for use in the diagnosis, cure, mitigation, treatment and prevention of disease and injury but do not include food and devices or their components, parts or accessories.  2. MEDICAL DEVICE-Si shall refer to instruments, apparatus, machines, implants or in-vitro reagents intended for use in, or actually used in the diagnosis, treatment, monitoring or prevention of disease or injury and does not achieve any of the intended purposes by means of chemical action within or on humans and not dependent on being metabolized to achieve as a result.  3. MEDICAL SERVICES- in the context of this Administrative Order, this shall refer to hospital room and services, medical supplies, professional services of physicians and other health care professionals, and diagnostic and laboratory tests that are necessary for the diagnosis and/or treatment of an illness or injury.  4. DENTAL SERVICES\u2014 shall refer to the services related to oral examination, cleaning, permanent and temporary \ufb01lling, extractions and gum treatments, restoration, replacement or repositioning of teeth, or alteration of the alveolar or periodontium process of the maxilla and the mandible that are necessary for the diagnosis and/or treatment of a dental illness or injury  5. DIAGNOSTIC AND LABORATORY TESTS- shall refer to X\u2014ray, CT\u2014scans, blood chemistry exams, histopathology and immunopathology, hematology, urine analysis, parasitology and bacteriology tests, serology, blood banking, and all other diagnostic radiology, clinical laboratory and other diagnostic examinations that are necessary for the diagnosis and/or treatment of an illness or injury. For specialized diagnostics, this should be appropriate to the disease/injury.  6. HEALTH CARE PROFESSIONAL- shall refer to any doctor of medicine, dentist, nurse, midwife, or other health care professional or practitioner duly licensed to practice in the Philippines.  7. ESTABLISHMENTS DISPENSING MEDICINES - shall refer to drug stores, hospital pharmacies (government or private), medical and optical clinics and similar establishments dispensing medicines, duly licensed and/or franchised by the BFAD and the local government units.  8. GOVERNMENT HEALTH FACILITIES- shall refer to hospitals, outpatient clinics including health centers and rural health units, clinical laboratories, diagnostic radiology centers, and other outpatient health facilities operated and maintained partially or wholly by the national, provincial, city or municipal government, or other political unit; or by any department, division, board or agency thereof. The facilities include Department of Health (DOH)-retained hospitals; specialty hospitals which are government-owed and controlled corporations (GOCCs); medical clinics in GOCC; and hospitals/health facilities owned and managed by local government units, state colleges and universities, the Department of National Defense, the Department of Interior and Local Government, and other government agencies.  The government hospitals consist of the service or charity or subsidized in\u2014patient and outpatient section/department and the non-subsidized pay section.  9. PRIVATE HOSPITALS \u201cAND MEDICAL FACILITIES- shall refer to all pay inpatient and outpatient health and medical facilities privately owned, established and operated with funds through donation, principal, investment, or other means, by any individual, corporation, association, or organization. The facilities include hOSpitals, clinical laboratories, diagnostic radiology centers, doctor\u2019s clinics, dental clinics and other health facilities that are licensed by the Bureau of Health Facilities and Services (BHFS) of the DOH and/or the local government units.  10. IDENTIFICATION DOCUMENT - shall refer to any document or proof of being a senior citizen which shall be used for the availment of benefits and privileges under the law, such as the following:  a. TD issued by the city or municipal mayor or Office of Senior Citizens Affairs (OSCA) or of the barangay captain of the place where the senior citizen or the elderly resides;  b. The passport of the elderly person or senior citizen concerned; and  c. Other documents that establish the senior citizen or elderly person is a citizen of the Republic and who is at least sixty (60) years of age  IV. POLICY STATEMENT  Subject to these guidelines an_;d_the availability of the medicines and services, the health-related privlleges for senior citizens and their sources of funding of the privileges are as follows:  1. Subsidized Services in In-patient and Out\u2014patient Sections of Government Health Facilities:  Free medical and dental services, and diagnostic and laboratory fees for all senior citizens con\ufb01ned 1n servlce wards of government facilities provided these are in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary.  2. Non-subsidized Services in Pay Sections of Government Health Facilities  Medical and dental services, and diagnostic and laboratory fees for all senior citizens con\ufb01ned in pay sections (both in and out patient sections) of government health facilities are granted twenty percent (20%) discount, provided these are in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary.  3. Twenty Percent (20%) discount in Private Health Facilities  All senior citizens are granted the privilege of twenty percent (20%) discount on medical and dental services, and'diagnostic and laboratory fees such as, but not limited to, x-rays, computerized tomography scans and blood tests, including professional fees of attending doctors in all private hOSpitalS and medical facilities.  The services shall include the use of specialized treatment rooms and equipment such as for hemodialysis and radiotheraphy.  4. No discount in Government Health Facilities and Private Health Facilities  Services that are not medically necessary for treatment and diagnosis shall not be provided with any discount. This shall include but not limited to cosmetic surgeries procedures, executive check-up packages and physical examinations, without clinical evidence of effectiveness and ef\ufb01ciency. Likewise, no discount is granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  5. Twenty percent (20%) discount in the Purchase of Medicines  The grant of twenty percent (20%) discount shall be provided in the purchase of medicines from all establishments dispensing medicines for the exclusive use of the senior citizens.  6. Membership in PhilHealth  Consistent with the National Health Insurance Act of 1995 and the Health Sector Reform Agenda, all Filipinos shall be encouraged to be PhilHealth members or at least be a dependent of active PhilI-Iealth members. Senior citizens who are not yet Non-paying PhilHealth members may become PhilHealth members if they are sponsored or enrolled by their Local GovernmentUnit (LGU) or they enroll themselves as inidividually paying members.  7. Funding Sources  For Government: The amount-necessary to carry out the provisions of this Act in government health facilities'upon its effectivity shall be charged out of the funds of the Office of the President. Thereafter, any such sum as needed for the regular implementation of this Act shall be included in the subsequent General Appropriations Act.  For CY 2004 and CY 2005, government hospitals shall submit quarterly the number of senior citizens served and the unit costing per senior citizen-to their respective National Government Agency or LGU for reimbursement at the Office of the President.  Starting CY 2006, the National Government Agencies or LGUs shall include in their budget proposals the funding necessary to implement programs and services required by this Administrative Order.  For Government Owned and Controlled Corporation, total amount ,of discounts granted to senior citizens shall be charged to the Quanti\ufb01ed Free Service.  For Private: For the twenty percent (20%) discount in private establishments, the cost of the discount shall be partially funded through the deduction of the discount from gross income for the'same taxable year that the discount is granted, provided that the total amount of the claimed tax deduction net of value added tax if applicable, shall be included in their gross sales receipts for tax purposes and shall be subject to proper documentation and to the provisions of the National Internal Revenue Code, as arhended. The rest of the cost of the discount not funded through the above\u2014described manner shall be borne by the provider of the privileges.  V. IMPLEMENTING RULES AND MECHANISMS on the AVAILMENT of PRIVILEGES  1. Subsidized Services in In-patient and Out-patient Sections of Government-Health Facilities:  A) Hospital Bed  A hospital bed in a service wardis deemed medically necessary to diagnose and treat an illness, or injury in, accordance with the available Clinical Practice. Guidelines (CPGs) or hospital treatment protocols is granted free to the senior citizen. This will be charged to the hospital budget.  B) Laboratories and Diagnostic Services for Inpatient Senior Citizens  Laboratories and diagnostics services provided to an inpatient senior citizen in a service ward that are medically necessary as determined by his/her attending physician, shall be \"free\" subject to the following:  (l) Diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGS) or Hospital Treatment Protocols.  (2) Evidence-based health screening tests that had been extensively tested for the local setting and endorsed by the DOH as medically necessary for individual cases shall be provided free by the government facility.  All inpatient laboratories and diagnostics provided to senior citizens admitted to a bed in the service ward which are deemed not medical necessary for the illness or injury for which he/she. is confined shall only be granted a 20% discount.  No discount is granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests  C) Laboratories and Diagnostics Services for Outpatient Senior Citizens  Free laboratory and diagnostic services shall be granted to an outpatient senior citizen, provided the following are met.  (1) Diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGS) or Hospital Treatment Protocols and have been determined medically necessary.  (2) Evidence- based health screening tests that had been extensively tested for the local setting and endorsed by the DOH as medically necessary for. individual cases. and shall be provided free by the government facility.  (3) The laboratory and diagnostic services have been determined by his/her attending physician as medically necessary.  (4) The requesting physician is a government-employed physician in the government facility where the laboratory or diagnostic tests shall be conducted.  All outside requests for laboratory and diagnostic tests from physicians who are not employed by the government facility and are based in either a government or private health facility, shall only be. granted a 20% discount upon final evaluation of the recipient government facility as medically necessary.  No discount is granted on special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  D) Dental Services  The attending dentist of the senior citizen shall make the determination as to the medical necessity of the dental service that will then be granted free.  E) PhilHealth\u2014related Bene\ufb01ts  In case the senior citizen is a PhilHealth member or a dependent, government facilities must ensure that the charges for services not included in the subsidized services shall lie\u2014deducted and charged to the senior citizen\u2019s Philhealth benefits coverage. It is only after these deductions are made that the Philhealth accredited health facilities can exercise its right to PhilHealth reimbursement or coverage for the subsidized services.  2. Non-subsidized Services in Pay Sections of Government Health Facilities  The following enumerates the medically necessary care levels for the diagnosis and/or treatment of an illness or injury that will be granted twenty percent (20%) discount and shall apply to pay sections of government health facilities:  A) Hospital Bed  A hospital bed in pay sections of goriernment health facilities is deemed medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols. This will be charged to the senior citizen and granted 20% discount.  B) Laboratory and Diagnostic Examinations  All inpatient and outpatient laboratory and diagnostic examinations in pay sections shall be granted 20% discount, provided that such diagnosis and/or treatment by the attending physician shall be 1n accordance with the available Clinical Practice Guidelines (CPGI'IIs) or hOSpital treatment protocols.  The health facilities may designate medical of\ufb01cers for senior citizens (MOSC) to facilitate the determination of the medical necessity of requested laboratory or diagnostic examinations.  All inpatient laboratories and diagnostics that are provided to senior citizens admitted to a bed beyond the service ward level shall only be granted a 20% discount.  No discount 13 granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  C) PhilHealth-related Benefits  In case the senior citizen is a PhilHealth member or dependent, the 20% discount shall not be charged to the senior citizen\u2019 5 Philhealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder may be charged to his/her PhilHealth bene\ufb01ts.  3. Twenty Percent (20%) Discount in Private Health Facilities  The following enumerates the medically necessary care levels for the diagnosis and/or treatment of an illness or injury that will be granted twenty percent (20%) discount, and shall apply to private hospitals:  A) Hospital Bed  A hospital bed in a private hospital is deemed medically necessary to diagnose and treat an illness\u2014er 1njury and is hereby granted a twenty percent (20%) discount, provided the requirements stated below are followed.  (1) The smallest available room and board accommodation shall be deemed as medically necessary and shall be granted 20% discount.  (2) If there is no available smallest room and board accommodation at the time of confinement, all other room and board accommodations shall only be granted with a discount equivalent in amount to the 20% discount in the smallest available room and board accommodation.  (3) All existing privileges that are currently part of a hospital bed shall also accrue to the senior citizen.  B) Laboratory and Diagnostic Examinations  All inpatient and outpatient laboratory and diagnostic examinations shall be granted a twenty percent (20%) discount based on the smallest room and board accommodation provided that such diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.  The health facilities may designate medical officers for senior citizens (MOSC) to facilitate the deTermination of. the medical necessity of requested laboratory or diagnostic examinations.  C) Dental Services  All dental services that are deemed to be medically necessary by the attending dentist shall be granted a twenty percent (20%) discount.  D) PhilHealth-related Bene\ufb01ts  In case the senior citizen is a PhilHealth member or dependent, the 120% discount shallnot be charged to the senior- citizen\u2019s Philhealth benefits coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder may be charged to his/her PhilHealth bene\ufb01ts.  E) Professional Fees  Professional fees for inpatient and outpatient medical and dental services shall be provided with a 20% discount and a corresponding official receipt shall be issued by the concerned physician or dentist.  4. Twenty Percent (20%) Discount in the Purchase of Medicines for the Exclusive Use of Senior Citizens  The following guidelines shall be strictly observed in the sale of medicines to senior citizens at 20% discount.  A. All establishments, though their registered pharmacist, shall have full discretion and responsibility in dispensing medicines including the generic alternatives to the prescribed medicine in accordance with the provision of the Generics Act of 1988 Iand relevant laws.  B. Discounts granted by the Expanded Senior Citizens Act on purchases of medicines shall be given by establishments in their sale of said medicines.  1. The discount for the purchase of medicines shall be supported by the following:  1.1 Senior Citizen\u2019s identi\ufb01cation document as stated in the Definition of Terms;  1.2 Doctor\u2019s prescription stating the name of the senior citizen, age, sex, address, date, generic name of the medicine, dosage form, dosage strength, quantity, name and signature, address, contact number of the prescribing physician or dentist, professional license number, professional tax receipt number and narcotic license number, if applicable. To safeguard the health of senior citizens and to prevent abuse of RA 9257, a doctor\u2019s prescription is required in the purchase of over-the-counter medicines.  Only prescriptions which contain the above information shall be honored.  1.3 Purchase booklet'issued by the OSCA to senior citizens for free, containing the following information: OSCA ID number, control number, date of 1ssue, name of senior citizen, sex, address, date of birth, picture, signature of the senior citizen and information on medicines purchased (name of medicine, quantity, attending physician, PTR and address, name of servicing drug store, and naine of dispensing pharmacist). All purchases of medicines shall be recorded in the purchase booklet  1.4 Authorization letter of the senior citizen who is residing in the Philippines at the time of purchase, currently dated and identi\ufb01cation card of the representative, in case the medicine is bought by the representative of the senior citizen.  2. As a general rule, any single dispensing must be in accordance with the prescriptipn issued by a physician and should not be more than one (1) month supply.  Drug stores are required to maintain a special record book for senior citizens registered and subject to inspection by the BFAD and BIR.  3. For partial \ufb01lling, the establishments pharmacist will indicate the quantity partially \ufb01lled 1n the special record book and the un\ufb01lled balance on the prescription. The senior citizen shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity.  4. Drug outlets offering special discounted prices leSs than 20% of the regular retail prices of drugs can deduct the percentage discount of the Promotional Campaign from the total 20% discount as required by R. A. 9257. Thus, a total discount of 20% for Senior Citizens will still be observed.  These discount privileges shall be non-transferable and exclusive for the bene\ufb01ts of the senior citizen  All establishments as de\ufb01ned above are enjoined to comply with the above-cited guidelines and all Chairpersons of OSCA are instructed to report non-compliance of the above guidelines.  5. RESPONSIBILITIES OF STAKEHOLDERS  A. For purposes of verification; all hospitals, both government and private facilities shall requi1e senioi citizens to preSent any of the following requirements.  1. An Identi\ufb01catidn Card issued by the City or Municipal Mayor/ Of\ufb01ce of Senior Citizens Affairs or of the barangay captain of the place where the senior citizen or the elderly resides, 2. The passport of the elderly person or senior citizen concerned, 3. Other documents that establish the senior citizen is a citizen of the Republic and who is at least sixty (60) years of age  B. Responsibilities of Government Facilities  1. All government facilities are required to post hOSpital room rates, laboratory and diagnostic tests fees, medicine prices, and all other fees and rates in conspicuous places near or at the main entrance to their respective facility. The above-described price lists shall be submitted annually to the National Center for Health Facility Development- DOH and PHIC.  2. All government facilities are also required to post this Administrative Order in conspicuous places where consumers/patients can have access to the information and policies set forth by this document.  3. Of\ufb01cial receipts shall be issued for every paid- for medical and dental services, laboratory and diagnostic tests, and medicines provided. The receipts shall state the usual rates or fees and the discounted price, and,  4. No \u201cIncome Means Test\" nor any other tests shall be applied to the senior citizens as a precondition for the availment of free services as herein described.  C. Responsibilities of Private Hospitals and Medical Facilities  1. Private hospitals and medical facilities shall post the price list of all room rates in the Admitting Section of all private hospitals and medical facilities. The prices of diagnostics and laboratory tests based on room and board accommodation, medical supplies\u2014and medicines shall be made available upon request of the senior citizen. The list shall ensure validation of the discount granted to senior citizens  2. Of\ufb01cial receipts shall be issued for every paid-for medical and dental services and medicines provided. The twenty percent discount shall be granted upon full payment of the bill. The billing statement showing the usual rates or fees and the discounted price shall be attached to the of\ufb01cial receipt;  3. Set up a grievance mechanism for senior citizens to entertain questions with regards to discounts on professional fees;  4. Inform in writing copy furnished the aggrieved party the necessary sanction for health professionals who refuse to grant the proper discount; and,  D. Responsibilities of Health Care Professionals  Health Care Pre\ufb01essionals shall have'the following responsibilities, to wit::  1. Inscribe his. name and PRC number in the request for diagnostics and laboratory tests, and medicine prescription;  2. To curb abuse of availing discounts for use of non\u2014senior citizens, the health professional shall make sure that prescriptions made are for the exclusive use of the senior citizen.  3. Inform the senior citizen of his usual fees for the services required;  4. Provide an of\ufb01cial receipt for the rendered professional services to the senior citizen that states the usual fees and the discounted fees  E. Responsibility of Drugstores  Drugstores are obliged to make available upon the senior citizen's request a generic menu card and shall provide an of\ufb01cial receipt for drugs and medicines which states the usual prices and the discounted prices of the drugs and medicines  VI. APPLICATION OF PENALTIES AND OTHER SANCTIOINS  1. Penalties for persons  a.) Any person who violates any provision of this Act shall suffer the following penalties:  i.) For the \ufb01rst violation, a \ufb01ne of not less than Fifty Thousand Pesos (P50,000) but not exceeding One hundred thousand pesos (P100,000) an imprisonment of not less than six (6) months but not more than two (2) years, and ii.) For any subsequent violation, a \ufb01ne of not less than One hundred thousand (P100, 000) but not exceeding Two hundred thousand Pesos (P200, 000) and imprisonment for not less than two (2) years but not more than six (6) years.  b.) Any person who abuses the privileges granted herein shall be punished with a \ufb01ne of not lees than \ufb01ve thousand pesos (PSI, 000) but not more than Fifty Thousand pesos (P50, 000)and imprisonment of not less than six (6) months.  c.) If the offender is an alien or a foreigner, he/she shall be deported immediately after service of sentence without further deportation proceedings.  2. Penalties for Corporations  a.) If the offender 1s a corporation, organization or any similar entity, the of\ufb01cials thereof directly involved shall be liable therefore.  b.) Upon \ufb01ling of an appropriate complaint, and'after due notice and hearing, the proper authorities may also- cause the cancellation or revocation of the business permit, permit to operate, franchise and other similar privileges granted to any business entity that fails to abide by the provisions of this Act.  VII. SEPARABILITY CLAUSE  Should any of these clause or part of this order be declared unconstitutional, all other remaining portions not so declared shall remain valid and effective.  VIII. IREPEALING'CLAUSE  This order shall revoke Administrative Order 171 series 2004 and all other orders inconsitent with this order  IX. EFFECTIVITY  This Order shall take effect immediately after publication in two (2) national newspapers of general circulation.        ", " I. RATIONALE  Cancers \ufb01gure among the leading causes of morbidity and mortality worldwide,with approximately 14 million new cases and 8.2 million cancer related deaths in 2012 (WHO). It is expected that annual cancer cases will rise (from 14 million in 2012 to 22 million within the next 2 decades and over 200,000 children will be affected yearly (WHO). Every year cancer drains an estimated $2 trillion from the world economy in terms of lost output and the cost of treatment, equivalent to around 1.5% of global GDP, as well as wreaking terrible suffering on millions of individuals, families and communities (World Economic Forum 2014). In a recent study conducted by The George Institute for Global Health, University of Sydney, a study of new cancer patients in the Association of Southeast Asian Nations (ASEAN) region called the Asean CosTs In ONcology (ACTION) showed that a cancer diagnosis in Southeast Asia is disastrous, even within only 12 months, for over 75% of new patients. The ACTION Study adds compelling evidence to the argument for policies that improve access to care and provide adequate \ufb01nancial protection from the costs of cancer.  Cancer is still the third leading cause of morbidity and mortality in the country after diseases of the heart and the vascular system (Philippine Health Statistics 2011). In the WHO Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 report, the estimated incidence of cancer in the Philippines for bOth men and women (excluding melanoma skin cancer) reached more than 43,000 and will increase by 64% within 5 years. About 3,500 new cases of cancer will be diagnosed in children every year -\u2014 the equivalent of almost 10 children every day (Philippine Children\u2019s Medical Center).  A recent assessment revealed shortcomings in the Philippine Cancer Control Program (PCCP) which began in 1990 and urgent recommendations were made toreverse the 'cancer epidemic\". Hence, there is an urgent need to revise and strengthen the Administrative Order No. 89\u2014A s. 1990 to \ufb01ll in the gaps and to further improve the PCCP which shall be known now as the Philippine Cancer Prevention and Control Program.     II.OBJECTIVES  A. General  This order is aimed to set overall policy directions and identify the roles and functions of DOH, its of\ufb01ces and partner agencies in reducing the impact of cancer and improve the well-being of Filipino people with cancer and their families by providing holistic services from cancer prevention, screening, diagnosis, palliative care and treatment, until recovery and end-of\u2014life or hospice care.   III. Specific   1)To operationalize the National Cancer Registry and Surveillance System  2)To reduce mortality and improve overall survival and quality of life of people with various cancer types through early diagnosis and prompt treatment;  3)To reduce the incidence of prioritized cancers associated with the most common avoidable risk factors;  4)To ensure that prioritized cancer control services are provided in an equitable and sustainable way at all levels of care;  5)To increase and expand the coverage of cancer treatment, including but not limited to the use of innovative drugs and psychosocial support in the preventive, treatment, and survivorship stage of the patient and family, if necessary;  6)To set regulatory and accreditation standards for cancer institute / center, as an integral part of DOH and government hospitals including private hospitals as applicable, that follows a multi\u2014disciplinary and interdisciplinary team approach to cancer management; and  7)To develop and update regularly a compendium of guidelines or standards for prioritized cancers including childhood cancer   III. SCOPE  This issuance shall apply to all stakeholders of cancer control \u2014 bureaus, national centers, services and attached agencies of the Department of Health and other key government agencies; local government units (LGUs); government-owned and - controlled corporations (GOCCs); health professionals and other health care providers, both public and private; anti-cancer health product providers; professional organizations and societies, civil society organizations (CSOs); non- government organizations (N GOs), research and development partners; academe; patients and patients\u2019 groups.        IV. KEY DEFINITIONS  A. Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and neoplasms. One de\ufb01ning feature of cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs, the latter process is referred to as metastasizing. Metastases are the major cause of death from cancer. (WHO February 2015)  B. Cancer Control aims to reduce the incidence, morbidity and mortality of cancer and to improve the quality of life of cancer patients in a de\ufb01ned population, through the systemic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment, and palliative care. (WHO Cancer Control Knowledge Into Action 2008)  C. Cancer Diagnosis comprises the various techniques and procedures used to detect or con\ufb01rm the presence of cancer. Diagnosis typically involves evaluation of the patient\u2019s history, clinical examinations, review of laboratory test results and radiological data, and microscopic examination of tissue samples obtained by biopsy or \ufb01ne-needle aspiration. (WHO Cancer Control Knowledge Into Action 2008)  D. Cancer Prevention refers to measures and interventions that will decrease the likelihood or risk of an individual of acquiring cancer.  E. Cancer Survivorship starts at the time of disease diagnosis and continues throughout the rest of the patient's life. Family caregivers and friends are also considered survivors. It has three distinct phases: living through, with and beyond cancer. (MD Anderson Cancer Center)  F. Cancer Treatment is the series of interventions, including psychosocial and nutritional support, surgery, radiotherapy, chemotherapy and hormone therapy, that is aimed at curing the disease or prolonging the patient\u2019s life considerably (for several years) while improving the patient\u2019s quality of life. (WHO Cancer Control Knowledge Into Action 2008) Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. Patients may also have immunotherapy, targeted therapy, or hormone therapy. Source: National Cancer Institute '  G. Hospice care is end-of\u2014life care provided by health professionals and volunteers. They give medical, psychological and spiritual support. The goal of the care is to help people who are dying to have peace, comfort and dignity.  H. Interdisciplinary refers to integrating knowledge and methods from different disciplines, using a real synthesis of approaches, e.g. oncologist \u2014 nurse \u2014 social worker ~ caregiver. Multidisciplinary refers to people from different disciplines working together, each drawing on their disciplinary knowledge, e. g. oncologist \u2014 surgeon \u2014 radiologist. The cancer care team may include not only the surgeon, radiation oncologists, and medical oncologists but also the expert in diagnostic imaging, the pathologist, the genetic counselor, the oncology nurse, the physical therapist, the hospital pharmacist, and others. Well-coordinated multi\u2014 and interdisciplinary care is the current standard, where patients can obtain consults and see specialists who all practice in one central location. Source: https://www. medscape.org/viewarticle/575352  I. Palliative Care is treatment to relieve, rather than cure, symptoms caused by cancer. It can help people live more comfortably. Relief from physical, psychosocial and spiritual problems can be achieved in over 90% of advanced cancer patients through palliative care. (WHO February 2015)  J. Patient Navigation refers to individualized assistance offered to patients, families, and caregivers to help overcome health care system barriers and facilitate timely access to quality medical and psychosocial care. Cancer patient navigation works with a patient from pro-diagnosis through all phases of the cancer experience.  K. Premature Mortality refers to deaths that occur before a person reaches the average life expectancy as speci\ufb01ed by Phil. Stat Authority (68.5 as of 2013).   V. IMPLEMENTING MECHANISM  A. General Guidelines  1. The National Cancer Control Committee (NCCC) shall lead in the implementation of National Cancer Control Program.  2. The Regional Cancer Control Committee shall adopt the national policies and standards. and oversee their implementation at the regional level.   3. The Provincial Cancer Control Committee shall adopt the regional policies and standards and implement them at the local or grassroots level.  4. The Experts Group shall formulate and update protocols and standards on cancer screening, diagnosis, and treatment.  5. The NCCC shall come up with a compendium of all updated protocols and standards on cancer prevention, screening, diagnosis, treatment, and palliative care.  6. The NCCC shall develop the Comprehensive Cancer Management Guidelines for hospitals and community-based facilities.  7. The NCCC shall develop the Implementing Guidelines on Cancer Patient Navigation.  B. Speci\ufb01c Guidelines  1. The National Cancer Control Committee shall be created to lead in the implementation of the Philippine Cancer Prevention and Control Program (PCPCP).       l.l Composition        1.2 Roles and Functions of NCCC  a) Shall set the roadmap of Philippine Cancer Prevention and Control Program (PCPCP) b) Shall plan, establish and implement policies, guidelines and standards throughout the continuum of holistic health care (preventive, promotive, curative, rehabilitative and palliative) thru multidisciplinary and interdisciplinary team and patient-centered approach c) Shall advise or recommend upgrading of existing cancer management facilities in the country d) Shall be the coordinating body for all cancer works in the country e) Shall ensure the implementation of PCPCP down to the local government units f) Shall establish and carry out an effective nationwide cancer education program and its dissemination g) Shall provide technical and \ufb01nancial support on cancer prevention, early detection, palliative care, treatment and hospice care h) Shall establish and carry out effective training program i) Shall ensure the collection and analysis of data from registry and surveillance j) Shall implement, monitor and evaluate the PCPCP regularly through implementation review and impact evaluation k) Shall empower and engage all the stakeholders to actively work on and participate in on various areas of PCPCP l) Shall endorse support for researchers in the clinical, epidemiological, public health and knowledge management areas and in collaboration with international institutes m) Shall provide other forms of assistance as may be identi\ufb01ed and approved by the Secretary of Health  1.3 Sub-committees of the NCCC shall be created. (see Annex)  2. Regional Cancer Control Committee (RCCC) shall also be created in every region which shall formulate and implement policies, programs, activities, and projects related to cancer control.  2.1 Composition  a) NEDA\u2014Regional Development Council b) DOH-Regional Of\ufb01ce c) PhilHealth Regional Of\ufb01ce d) Of\ufb01ce of the Governor e) Provincial Health Of\ufb01ce  2.2 RCCC shall formulate and implement policies, programs, activities and projects related to cancer prevention and control. The members of the committee shall hold a regular meeting to be presided by the DOH-Regional Of\ufb01ce representative being the chair.  3. The Of\ufb01ce of the Governor and Provincial Health Of\ufb01ce Shall create their own Provincial Cancer Control Committee (PCCC) which shall be composed of the City / Municipal Health Of\ufb01cers and all stakeholders of cancer control as members. PCCC shall hold regular meetings to be presided by the Provincial Health Of\ufb01cer being the chair.   C. Roles and Responsibilities  1. Of\ufb01ce of the Secretary of Health (OSEC)  The Secretary of Health upon recommendation of the Of\ufb01ce of the Undersecretary or Assistant Secretary of Health in charge of DPCB shall approve appropriate policies, standards and guidelines to further implement this Order.   2. Disease Prevention and Control Bureau (DPCB)  The DPCB shall provide overall direction, coordination and oversight; establish standards and package of services on cancer control and ensure their quality, access, and availability at all levels of the healthcare system; and support the design of health \ufb01nancing as related and applicable to cancer screening, diagnosis, and treatment in collaboration with PhilHealth and other partners.  3. Health Promotion and Communications Service (HPCS)  The HPCS shall be the lead agency in the development of promotion and communication plan including IEC materials and tools for cancer control in coordination with DPCB and other relevant of\ufb01ces/agencies.  4. Health Facility Development Bureau (HFDB)  The HFDB shall upgrade and enhance health facilities at all levels of care so as to make them capable of providing appropriate cancer control services.  5. Health Facilities and Services Regulatory Bureau (HFSRB)  The HFSRB shall ensure compliance of health facilities at all levels of health care to the prescribed standards on physical facility, equipment and personnel.  6. Health Human Resource Development Bureau (HHRDB)  The HI-IRDB shall provide technical assistance in the development of learning interventions for health professionals involved in cancer control.  7. Bureau of Local Health Systems Development (BLHSD)  The BLHSD shall ensure the adoption, implementation and sustainability of cancer control program down to the grassroots level through the regional and provincial cancer control committees.  8. Pharmaceutical Division (PD)  The PD shall support the National Cancer Control Program in assuring the sustainable supply of essential cancer medicines through supply chain strengthening that will ensure affordability, availability and rational use of medicines.  9. Knowledge Management and Information Technology Service (KMITS)  The KMITS shall oversee the operation and maintenance of the health facility/hospital-based National Cancer Registry.  10. Epidemiology Bureau (EB)  The BB shall establish and sustain the National Cancer Surveillance Systems; oversee the management and dissemination of data related to canoer control; and support the conduct of population\u2014based cancer registry.  ll. Bureau of International Health Cooperation (BIHC)  The BIHC shall coordinate with international development partners and other external institutions for technical and resource assistance for the implementation of this Order.  12. Logistics Management Division (LMD)  The LMD shall ensure proper storage, distribution, and disposal of all forms of evidence-based therapies.  13. Food and Drug Administration (FDA)  The FDA shall ensure the safety, ef\ufb01cacy and quality of all health products used for cancer diagnosis and management.  14. Philippine Health Insurance Corporation (PhilHealth)  PhilHealth shall work with DPCB in crafting the national policy that will set the guidelines for designing health care bene\ufb01t packages; and develop and implement health insurance packages for clients requiring cancer screening, diagnosis, and treatment services to reduce \ufb01nancial burden and impoverishment of individuals and their families.  15. Regional Of\ufb01ces (ROS)  The ROS shall provide technical assistance to the LGUs and ensure the operationalization of regional cancer control committee and establish the standards and guidelines for an ef\ufb01cient hospital referral system within the locality.  l6. DOH Hospitals The DOH hospitals, especially those with cancer institute or center, shall ensure provision of quality cancer screening, diagnosis and treatment for eligible patients.  17. Local Government Units (LGUs)  The LGUs shall adopt the establishment of regional and provincial cancer control committees and provide services and necessities in selected health care facilities and hospitals in their localities.   18. Department of Labor and Employment\u2014Bureau of Working Conditions (DOLE-BWC) / Civil Service Commission (CSC)  The DOLE-BWC and CSC shall be encouraged to develop workplace policies and procedures that are relevant to cancer prevention and control.  19. Philippine Council on Health Research and Development (PCHRD)  PCHRD as the lead agency of Philippine National Health Research System (PNI-IRS) shall coordinate research and development of the National Cancer Control Program.  20. Non-government organizations (NGOs), professional groups, other national government agencies / organizations, private sector, and the academe (DepEd and CHED) shall adopt, provide support and assist in the implementation of this Order.   D. Monitoring and Evaluation  1. Key performance and outcome indicators and tools shall be developed in coordination with the Health Policy Development and Planning Bureau to track the progress and impact of this Order.  2. Monitoring and evaluation of this policy shall start three, (3) years after its effectivity and yearly thereafter.  E. Funding  The Department of Health (DOH) shall allocate funds for the implementation of this Order at all levels of care, as may be drawn from regular budget allocations, special funds such as Sin Tax Revenues and other funding sources.  VI. SEPARABILITY CLAUSE  If any provision of this Order is declared unauthorized or rendered invalid by any court of law or competent authority, those provisions not affected thereby shall remain valid and effective.  VII. REPEALING CLAUSE  Administrative Order No. 89-A s. 1990 and other previous Orders inconsistent in part or in whole to this Order are hereby rescinded or amended accordingly.  VIII. EFFECTIVITY  This Order shall be effective \ufb01fteen (15) days after publication to the of\ufb01cial gazette or in newspaper of general circulation.     ", "  I. Rationale Background  The 1987 Constitution provides that:  \"The State shall protect and promote the right to health of the people and instill health consciousness among them\" (Section 15, Article II).  \"The State shall adopt an integrated and comprehensive approach to health development which shall endeavor to make essential goods health and other social services available to all the people at affordable cost\" (Section II, Article XIII).  \"The State shall establish and maintain an effective food and drug regulatory system and undertake appropriate health manpower development and research responsive to the country\u2019s health needs and problems\" (Section 12, Article XIII)   Generics Act of 1988 (R.A. 6675)  Paragraph 1 to 5, Section 2 of the Generics Act of 1988 (R.A. 6675) declare as the policy of the state, among others, the following:   To promote, encourage and require the use of generic terminology in the importation, manufacture, distribution, marketing, advertising and promotion, prescription and dispensing of drugs.   To ensure the adequate supply of drugs with generic names at the lowest possible cost and endeavor to make them available for free to indigent patients;  To encourage the extensive use of drugs with generic names through a rational system of procurement and distribution;  To emphasize the scientific basis for the use of drugs, in order that health professionals may become aware and cognizant of their therapeutic effectiveness; and  To promote drug safety by minimizing duplication of medications and/or use of drugs with potentially adverse drug interactions.  In line with the above mandate, it is imperative that DOH funded hospitals as health care organizations shall provide adequate and continuous supply of quality, safe and efficacious drugs at affordable cost, consistent with the needs of the patient/consumers.  To meet this need, the hospital shall maintain a pharmaceutical service, to be known as the DOH Botica that conforms with ethical, professional standards and legal requirements. It is to constitute the concept and practice of pharmaceutical care service of pharmacist to patients/consumers and the general public.  Moreover, through this project, the DOH objective is to make drugs and medicines affordable to the Filipino people alleviating the burden of high cost of the same, and to deliver total consumer satisfaction through effective client\u2014friendly services. The Botica can offer services on the following: counselling of patients on dosage and frequency of administration, prescribed regimen and other health care informations for good drug compliance which would include among others, blood pressure\u2014taking, advice for care of elderly, travel medicines consultations and other activities associated with self-care:   II. Policy Guidelines  1. The DOH Botica must adhere to the pertinent provisions of the following laws, rules and regulations:  1.1 RA 5921 as amended, known as an Act Regulating the Practice of Pharmacy and Setting Standards of Pharmaceutical Education in the Philippines and for other purposes.  1.2 RA 4226, known as the Hospital Licensure Act.  1.3 R.A. No. 3720 as amended, known as the Food, Drugs, Devices and Cosmetics Act, its rule and regulations in licensing drug establishments and drug outlets under the authority of the Bureau of Food and Drugs (BFAD) as provided for in A.O. 56 s. 1989, the Revised Regulations for the Licensing of Drug Establishments and Outlets.  1.4 R.A. No. 6425 as amended, known as the Dangerous Drugs Act of 1972 under the authority of the Dangerous Drug Board in the registration and for the issuance of a license to deal in dangerous drugs and exempt preparations as provided in Article II Section 2 (a) of the Dangerous Drugs Board Regulation No.4 s. 1991.  1.5 R.A. 6675, known as the Generics Act of 1988 its rules and regulations in the Prescribing and Dispensing Requirements as provided for in A.O. 62 and 63 s. 1989, respectively.   1.6 Executive Order No. 49 of 1993, Directing the Mandatory Use of the Philippine National Drug Formulary (PNDF) Volume I current edition as the Basis for Procurement of Drug Products by the Government.  1.7 Administrative Order No. 47 s 1999 dated November 1999 re: Guidelines in the Implementation/Operations of the Expansion of the Gamot sa Presyong DOH.  2. The building design of the DOH Botica, including details and appropriate signages, shall comply with the approved DOH Model Plan. Its location in the hospital main building or compound should be on the ground floor and shall be highly accessible and visible to all its intended beneficiaries.  3. The operation and management of the DOH Botica Project shall be directly handled by a pharmacist with sufficient technical and support staff to perform the tasks exclusively for this project.  4 Beneficiaries  The beneficiaries will include in and out-patients of the hospital and the general public.  5.1 Pharmaceuticals and biologicals for sale  5.1.1. Pharmaceutical dispensed with ordinary prescription form  * Ethical or prescription drugs * Exempt prohibited and regulated drugs  5.1.2 Pharmaceutical dispensed with special prescription form  * Prohibited and Regulated Drugs  5.1.3 Pharmaceuticals dispense without prescription  * Nonprescription or over the counter drugs * Household remedies   5.2 Medical Supplies  5.3 Nutritional and Hygienic Products; Toiletries  6 Funds  6.1 The existing Revolving Fund (RF) for drugs and medicines shall be the initial funding source including that of the Murang Carnot Presyong  DOH, if any. 6.2 The existing ceiling of the RF shall be maintained. The RF shall consist of the stock on hand and for delivery and cash in bank at any given time which shall not exceed the approved ceiling. However, an increase in the ceiling shall be determined and recommended by the Secretary of Health to the Department of Budget and Management for approval.  7 Selling Price of Drugs and Medicines  7.1 Drugs and medicines, biologicals, medical supplies, etc shall be sold at a maximum mark-up of 30% to be added to the cost.  8 Disposition/use of profit (Revolving Fund)  All proceeds (cost plus profit) from sales of D/M, biologicals, medical supplies, nutritional and other hygienic products etc. shall be deposited in an authorized government depository bank and shall be made available for procurement of the above-mentioned items for replenishment (2.4 NBC No. 321,and COA C.R. No. 128)  9 For monitoring and Control of Sales/Collection  9.1 A cashier shall be designated to handle the collection / recording / reporting of sales who shall be bonded in accordance with existing rules and regulations.  10 Accounting and Recording  10.1 The funds for the DOH Botica shall be treated as Revolving Trust Fund in accordance with Joint NB Circular No. 321 / COA Circular No. 128. 10.2 The project fund shall be accounted / reported separately from the existing revolving funds for drugs and medicines established under Batas Pambansa Blg. 40 (1980 GAA) authorized under Joint NB Circular No. 321 and COA Circular No. 280. 10.3 Support ledgers records shall be maintained on the purchase and sale of drugs and medicines, medical supplies and others.  11. Reporting  A regular RF monthly report on the sale of drugs and medicines, biologicals, etc. indicating issuances to in and out-patients and the general public shall be prepared / submitted by the DOH Botica Pharmacist In\u2014Charge noted by the Chief Pharmacist to the hospital accounting office copy furnished COH and AO, HOMS and NDPP on or before the 5th working day of the following month.  12. Procurement and Warehousing Unit  12.1 Procurement of drugs and medicines shall be in accordance with the DOH Procurement System.  12.1.1 An Annual Drug Procurement Program (ADPP) shall be prepared by Pharmacist In\u2014charge covering the requirement including medical supplies, etc. of the DOH Botica Project prior to the budget year. The said ADPP shall be based on the selection / evaluation of the drugs and medicines by the Therapeutics Committee.  12.1.2 The list of drug requirement of the hospital shall be forwarded to PLS, DOH Central Office at a designated date for bidding.  12.1.3 Hospitals concerned are furnished with a Price Schedule (Winning Bid Prices) by the DOH, PLS Central Office as the basis for procurement.   12.2 Inspection and acceptance of deliveries  The inspection and acceptance team shall conduct technical inspection and acceptance as to the batch, lot number, expiry date etc.  The number of products for sampling shall be taken at random from the delivery to be subjected to BFAD laboratory test at no cost to the end order but chargeable to the supplier/ distributor.  12.3 Warehousing - Receipts / Inspection / Storage and Issuance of stocks from the DOH Botica.  The stocks of drugs, medicines, etc. shall be separated from the regular hospital stocks for the issuance to the indigent in patients. To ensure the efficacy and potency of drugs and medicines, appropriate storage facilities shall be provided particularly those needing refrigeration.   III. Repealing Clause  All prevIous Orders InconsIstent in part or in whole to this Administrative Order are hereby rescinded or amended accordingly.   IV. Effectivity  This order takes effect immediately.  ", " I. BACKGROUND AND RATIONALE   The United Nations Sustainable Development Goals (SDGs) target to reduce by one third premature mortality from non-communicable diseases through prevention and promotion of mental health and well\u2014being, and to strengthen the prevention of substance abuse and treatment of mental disorders by 2030.   Mental, neurological and substance use (MNS) disorders account for 10.4% of the global disability-adjusted life years (DALYs) and 2.3% of global years life lost (Y LL). Based on the 2015 Global Burden of Disease Study, they are the leading cause of years lived with disability (YLD) with 28.5% of YLDs. The World Health Organization (WHO) estimates that 154 million people suffer from depression and 25 million from schizophrenia. Around 877,000 people die by suicide every year. As many as 50 million people suffer from epilepsy and 24 million from Alzheimer\u2019s disease and other dementias. The global burden of disease attributable to alcohol and illicit drug use amounts to 5.4% of the total burden of disease with at least 15.3 million persons with drug use disorders.   In 2004, a multi\u2014country study showed that between 75%-85% of people in low and middle-income countries do not receive the needed mental health services. There was attention to MNS disorders in the WHO Global Strategy to Reduce Harmful Use of Alcohol (2010); WHO Global Mental Health Action Plan 2013-2020; Third UN World Conference on Disaster Risk Reduction (2015); and the WHO Resolution on the Global Burden of Epilepsy (2015)   In a 2004 WHO study, up to 60% of people attending primary care clinics daily in the Philippines are estimated to have one or more MNS disorders. Results of the 2000 Census of Population and Housing showed that mental illness and mental retardation rank 3rd and 4th respectively among the types of disabilities in the country. Data from the Philippine General Hospital in 2014 show that epilepsy accounts for 33.44% of adult and 66.20% of pediatric neurologic out-patient visits per year. In 2014, the Philippine Drug Enforcement Agency (PDEA) and Dangerous Drug Board (DDB) revealed that majority of arrested drug personalities were males between 30-39 years old, while the most commonly used and seized drugs were methamphetamine hydrochloride (shabu) and cannabis (marijuana). The 2011 WHO Global School-Based Health Survey has shown that in the Philippines, 16% of students between 13-15 years old have ever seriously considered attempting suicide while 13% have actually attempted suicide one or more times during the past year. At present, there is a pressing need for reliable data for a comprehensive picture of the magnitude of MNS disorders in the Philippines.   Mental health and well-being are intertwined with personal well-being, family relationships, and contributions to society. Problems with mental health and well-being can adversely compromise learning, creativity, productivity, contribution to family and society, and overall quality of life. The value of investing in mental health is well-established. The World Economic Forum estimated in 2013 that the cumulative global impact of mental disorders alone, in terms of lost economic output will amount to US$ 16 trillion over the next 20 years.   Recognizing the role of mental health and well-being in national development, the DOH articulated a National Mental Health Policy in 2001 (DOH AO No. 8 s. 2001). Through the Operational Guidelines for the Establishment of a Sustainable Mental Health Program (DOH AO No. 2007-0009) and efforts of civil society organizations (CSOs), many mental health facilities have been improved; pockets of community mental health programs have been established; a handful of local government units have signed ordinances that advance the care for persons with mental illness; and a limited coverage for hospitalization has been made available. Recently, the national government increased the budget for the mental health program in order to provide access to medications and develop models of care. Disasters have paved the way to increasing premium on psychosocial support.   In spite of these steady and noteworthy efforts, the effective and widespread implementation of a rational, uni\ufb01ed response to address MNS disorders remains to be seen. Much remains to be done to promote mental health and well-being, prevent MNS disorders, and treat and assist in the rehabilitation of persons with MNS disorders. Strategies to address discrimination, stigrnatization, and human rights violations of those suffering from such illnesses are still lacking. Moreover, social protection concerns such as gender-based violence and internal displacement have been rising in the recent years, further compromising the overall well\u2014being of the population, particularly women and children.   Mental health and well\u2014being is a concern of all. Addressing concerns related to MNS contributes to the attainment of the SDGs. Through a comprehensive mental health program that includes a wide range of promotive, preventive, treatment and rehabilitative services; that is for all individuals across the life course especially those at risk of and suffering from MNS disorders; integrated in various treatment settings from community to facility that is implemented from the national to the barangay level; and backed with institutional support mechanisms from different government agencies and CSOs, we hope to attain the highest possible level of health for the nation because there is no Universal Health Care Without mental health.   It is in this context that there is a need to enhance the existing National Mental Health Program (NMHP) in keeping with the National Mental Health Policy, global initiatives for mental health care and the present Philippine context as well as to operationalize a more inclusive, responsive, integrated, and comprehensive mental health program.   II. OBJECTIVES   This policy aims to provide the framework for action for effectively implementing a comprehensive mental health program in the country. Speci\ufb01cally it aims to:   1. Guide all program managers, health care providers, various stakeholders at all levels of care in the implementation of mental health program.   2. De\ufb01ne the roles and responsibilities of different DOH of\ufb01ces, the Philippine Health Insurance Corporation, LGUs, and higher level referral health facilities in the implementation of a comprehensive mental health program.   3. Generate support of various stakeholders in the implementation of a comprehensive mental health program in the country.   III. SCOPE AND COVERAGE   This policy applies to all units and instrumentalities including attached agencies of the Department of Health and local government units. It also applies to non-govemment organizations, professional organizations, private sector and other relevant partners from the health and non-health sectors.  IV. DEFINITION OF TERMS   A. Mental Health \u2014 state of well-being in which an individual realizes his or her own abilities, can cope With the normal stresses of life, can work productively and is able to make a contribution to his or her community   B. Mental Disorders \u2014 range of mental and behavioral disorders that fall within the International Statistical Classi\ufb01cation of Diseases and \"Related Health Problems, 10th revision (ICD-lO) that appear as abnormalities of thought, feeling or behavior   C. Neurological Disorders \u2014 diseases of the central and the peripheral nervous systems including, but not limited to epilepsy, Alzheimer\u2019s disease and other dementias, and developmental disorders   D. Substance abuse \u2014 harmful or hazardous use of psychoactive substances including alcohol and illicit drugs   E. Psychosocial disabilities \u2014 any acquired behavioral, cognitive, emotional or social impairment that limits one or more activities necessary for effective interpersonal transactions and other activities for daily living   F. Well-being \u2014 an individual\u2019s condition of holistic health in its physical, cognitive, emotional, social, cultural, environmental, psychological and spiritual dimensions   G. Psychosocial Support \u2014 any type of non\u2014pharmacologic service or intervention that aims to protect and promote psychosocial well-being   H. Service providers \u2014 psychiatrists, neurologists, other physicians, psychologists, therapists, counselors, nurses or community-based workers who are trained to provide a range of services and interventions in the promotion, prevention, treatment, rehabilitation and aftercare of MNS disorders   V. GUIDING PRINCIPLES   Policies, plans and interventions for the promotion of mental health and well-being; prevention, treatment and rehabilitation of persons with MNS disorders shall adhere to the following principles:   A. Universal health coverage. Following the principle of equity, persons with MNS disorders should be able to access, without the risk of impoverishing themselves, essential health and social services that facilitate their recovery and the highest attainable standard of health.    B. Upholding of human rights. Must be compliant with the Convention on the Rights of Persons with Disabilities and other international, regional and national human rights instruments.   C. Life course approach. Must take into account health and social needs throughout the life course from conception, infancy, childhood, adolescence and adulthood through older age.   D. Evidence-based practice. Must be based on scienti\ufb01c evidence and/or best practice, taking cultural considerations into account.   E. Multisectoral approach. A comprehensive and coordinated response for mental health requires partnership with multiple public and private sectors in health, education, housing, social services, labor, police and legal.   F. Empowerment of persons with psychosocial disabilities. Persons with psychosocial disabilities should be empowered and involved in advocacy, policy, legislation, service provision, monitoring, research and evaluation of programs and activities concerning them.   VI. ACTION FRAMEWORK FOR THE NATIONAL MENTAL HEALTH PROGRAM:   A. Goal:   To promote mental health and well\u2014being; prevent MNS disorders and other forms of addiction; provide care, enhance recovery; and reduce morbidity, disability and mortality of persons suffering from these disorders cognizant of their human right to access quality health care   B. Objectives:   1. To provide inclusive, responsive, integrated and comprehensive MNS and psychosocial support services across different levels and settings of care  2. To implement strategies for the promotion, prevention, treatment and rehabilitation of MNS disorders and other forms of addiction in the context of general health services  3. To strengthen information systems, evidence and research for MNS disorders and other forms of addiction   The Action Framework for the National Mental Health Program of the Philippine Department of Health adopts some elements from the Regional Agenda for Implementing the Mental Health Action Plan in the Western Paci\ufb01c Region 2013-2020 while remaining consistent with the National Mental Health Policy (DOH AO No. 8 s. 2001).     The action framework shows the three strategic approaches on which the National Mental Health Program is anchored:   A. Health systems approach. This approach recognizes the following components for an effective health system to address MNS conditions: governance, \ufb01nancing, information systems, service delivery, medicines and other psychosocial interventions, workforce, and user and family associations.   B. Whole-of\u2014government approach. The government shall exercise leadership and governance particularly in creating institutional, legal, \ufb01nancial and service provisions that would promote mental health and well-being of the population, prevent illness and address the needs of those suffering from MNS disorders.   C. Whole\u2014of\u2014society approach. The whole society includes civil society organizations from different sectors especially groups of people suffering from MNS disorders, those with psychosocial disabilities, families and carers as well as mental health service providers. They help in reducing stigma and discrimination and aid in creating effective policies, laws and services.   The five components of the National Mental Health Program shall be as follows:   1. Wellness of Daily Living \u2014 promoting, attaining and maintaining the mental health and well\u2014being of all persons across the life course (from pregnancy to old age) and in different settings (such as schools, workplace, communities) through healthy and effective coping as well as prevention of suicide   2. Extreme Life Experience \u2014 developing and enhancing resiliency and addressing the mental health and psychosocial needs and consequences of persons, families and communities that experience critical incidents and events (such as trauma, domestic violence and disasters)   3. Mental Disorders \u2014 promoting mental health and well-being; preventing mental disorders; assessing, diagnosing and treating mental disorders; and improving of the quality of life of persons with psychosocial disability through rehabilitation, and community integration   4. Neurologic Disorders \u2014 promoting neurologic health and preventing common neurologic disorders such as, but not limited to epilepsy, dementia, and developmental disorders; assessing, diagnosing and treating neurologic disorders; and improving the quality of life of persons with neurologic disorders   5. Substance Abuse and Other Forms of Addiction \u2014 promoting protective factors, reducing risk factors and preventing the development of substance abuse and other forms of addiction in different settings (family, school, workplace, community and industry)   Through the three strategic entry points, program components and based on the guiding principles, it is hoped that the promotion of mental health and well-being; prevention of MNS disorders, substance use and other forms of addiction; provision of care; enhancement of recovery; and reduction of morbidity, disability and mortality will be attained.   VII. GENERAL GUIDELINES   A. The country shall adopt a whole-of\u2014government, whole-of-society approach. Social determinants of health such as economic, socio-cultural, environmental and political conditions may affect a person\u2019s risk for and outcomes from MNS disorders. This approach requires an integrated government response and cooperation from different sectors and stakeholders, including civil society organizations.   B. Strategies to promote mental health and well-being and prevent MN S disorders shall be implemented to protect and promote overall well-being of the population. It is vital to protect and promote the mental health and well\u2014being of the general population at all stages of life, especially those who are at-risk and marginalized. MNS disorders lead to decreased productivity, economic loss and poverty. Poverty, in turn, increases the risk for developing MNS disorders and reduces people\u2019s ability to access appropriate servrces.   C. Inclusive, responsive, integrated and comprehensive services shall be provided across different levels of care. Considering the great burden of disease attributable to MN S disorders, community services that have clear and ef\ufb01cient linkage with facility\u2014based services shall be available in order to ensure a continuum of care. Recovery-based community services for those who have MNS disorders should be delivered by competent service providers.   D. Information systems, evidence and research shall be strengthened for appropriate policies, plans and evaluation. Important information and indicators like prevalence, service coverage, health outcomes and quality of life create a more comprehensive picture of the problem as well as effective interventions. New knowledge from research facilitates the creation of evidence-based policies and practices that can be implemented, monitored and evaluated.   E. The NMHP shall adopt a balanced approach between community-based services, primary, secondary and tertiary health care, and specialized facility-based services to ensure continuum of care.   F. Interventions for promotion, prevention, treatment and rehabilitation shall be inclusive and responsive to the needs of the populations at risk and marginalized, and sensitive to culture, age, gender and disability.   G. Research, surveillance, monitoring and evaluation shall be institutionalized for sound policy formulation and decision\u2014making.   H. Collaboration with other government agencies and relevant stakeholders from various sectors shall be strengthened to harmonize efforts in the development of plans and implementation of the NMHP within the framework of an effective mental health system.   I. The NMHP shall advocate for the passage of a national legislation that shall guarantee the promotion and protection of the rights and freedoms of persons with MNS disorders.   VIII. SPECIFIC GUIDELINES   The DOH shall provide leadership in the implementation of the NMHP by instituting the following measures:   A. The NMHP shall be integrated to all relevant plans and programs of the DOH and its attached agencies.   B. The integration of NMHP action plan shall be advocated in all health development and investment plans as well as policies of other government agencies, local government units and other partners including civil society organizations.   C. The NMHP shall aid in strengthening health systems through establishing program . structures across all levels of care, improving capacity of human resources for health, facilitating resource mobilization and establishing sustainable \ufb01nancing mechanisms, and promoting equitable access of cost-effective pharmacologic and non-pharmacologic interventions in the promotion, treatment and management of MNS disorders.   D. With partner organizations, the DOH shall establish, support and promote programs to empower individuals, families and communities to improve literacy, take self\u2014care responsibilities, become resources for others and participate in reducing stigma and discrimination of persons with MNS disorders.   E. Support program integration across different levels of health care from community- based to facility-based services, as well as different settings (home, schools, workplace, industry) that facilitate the continuum and complementation of care.   F. Promote equitable access to the rational use of a wide range of pharmacologic and non- pharmacologic interventions in the promotion of mental health, treatment and management of MNS disorders and improvement of quality of life at all times including pre-emergency settings.   G. The DOH shall promote and facilitate the conduct of research, monitoring and evaluation that generates relevant and timely information for sound program planning and implementation, policy formulation, service development and \ufb01nancial risk protection.   H. Establish interconnectedness, collaboration and linkages and other partnership mechanisms between and among different government agencies and civil organizations including patient-family groups and private institutions.   IX. IMPLEMENTATION ARRANGEMENT   A. Technical oversight for the implementation of this Order shall rest with the Oversight Committee chaired by the Undersecretary/Assistant Secretary of Health, Of\ufb01ce for Technical Services. The Oversight Committee, composed of technical content experts from professional organizations, shall review the outputs and recommendations of the Technical Working Group (TWG), and serve as the advisory body to the Secretary of Health.   B. The TWG, chaired by the Disease Prevention and Control Bureau, shall provide recommendations and technical support on the development and implementation of policies and plans for the mental health program. Members shall consist of representatives from relevant bureaus and of\ufb01ces of the DOH such as Health Promotion and Communications Service, Health Emergency Management Bureau, Dangerous Drugs Abuse Prevention and Treatment Program, Health Facilities and Development Bureau, Philippine Health Insurance Corporation, Pharmaceutical Division of the Health Policy Development and Flaming Bureau, National Center for Mental Health and CSOs, patient/family care groups that will be convened for the purpose. The Disease Prevention and Control Bureau \u2014 Essential Non-Communicable Disease Division shall serve as the Secretariat of the TWG.   C. Implementation of the national mental health program shall utilize existing institutional arrangements among facilities in the Service Delivery Network from national to subnational levels including the National Center for Mental Health; Treatment and Rehabilitation Centers; DOH Regional Of\ufb01ces; medical service and public health unit of DOH hospitals, medical centers and specialty hospitals; and primary health care centers in an integrated and coordinated manner.   D. Relevant stakeholders including representative for the League of Mayors of the Philippines, Development Partners, and other concerned organizations maybe invited in the TWG meetings as necessary.   X. ROLES AND RESPONSIBILITIES   A. The Disease Prevention and Control Bureau (DPCB) shall:   1. Lead the implementation of the NMHP.   2. Develop standards and package of services as well as mechanisms for guaranteeing quality, access, and availability at all levels of the health system in collaboration with the Philippine Health Insurance Corporation and other partners.   3. Provide technical assistance to DOH Regional Of\ufb01ces, Hospitals, Attached Agencies and partners.   4. Conduct an annual Program Implementation Review.   B. The Health Promotion and Communications Service shall, in consultation with the DPCB, develop and implement an effective national communications plan/campaign to promote mental health and wellness of daily living.   C. The Health Emergency Management Bureau (HEMB) shall lead in the coordination and collaboration with key actors at different levels (municipality/city to national) on the assessment of needs related to MNS and provision of appropriate assistance on Mental Health and Psychosocial Support Services (MHPSS) in disasters, epidemics, humanitarian and other emergency settings.   D. The Dangerous Drug Abuse Prevention and Treatment Program (DDAPTP) of the Of\ufb01ce for Special Concerns shall:   1. Lead the development and implementation of promotive and preventive programs to reduce exposure to risk factors of substance abuse and other forms of addiction.  2. Develop models and standards for treatment and management of substance use disorders as well as rehabilitation and after care programs.   E. The Health Facility Development Bureau (HFDB) shall;   1. Review/develop standards of mental health facilities pertaining to upgrading of infrastructure, capability system, operations and sustainability.  2. Facilitate development and implementation of hospital-based information and surveillance system to gather relevant health data particularly on mortality, morbidity and disability.   F. The Philippine Health Insurance Corporation (PHIC) shall:   1. Provide guidance in identifying the necessary information needed for the development of health insurance packages for persons with MNS disorders.  2. Develop and implement health insurance packages for persons at risk and those suffering from MNS disorders that will include identi\ufb01cation, assessment, diagnosis, management, rehabilitation and other appropriate support services.   G. The Pharmaceutical Division of the Health Policy Development and Planning Bureau shall:   1. Develop guidelines and mechanisms to ensure an effective supply chain for affordable and quality medicines of persons with MNS disorders at all levels (municipality/city to national)  2. Regularly review and update the essential medicines list for MNS disorders.   H. The National Center for Mental Health and regional mental health facilities, as special facilities for mental disorders, shall develop models and standards for tertiary level mental health care as well as psychosocial rehabilitation programs.   I. The Health Policy Development and Planning Bureau shall:   1. Facilitate/advocate for inclusion of MNS components in all relevant DOH policies.  2. Include mental health in the National Uni\ufb01ed Health Research Agenda and National Objectives for Health.   J. The Health Facilities and Services Regulatory Bureau shall set standards that would promote safety and accessibility of hospitals with psychiatric beds, drug abuse treatment and rehabilitation centers (DATRCs) and psychiatric care facilities.   K. The Health Human Resource Development Bureau (HHRDB) shall:   1. Set standards and policies for the learning and development of Human Resources for Health (HRH).  2. Develop competency standards and implement a learning development plan for HRH providing MNS services at different levels of care in coordination with the DPCB.   L. The Epidemiology Bureau (EB) shall:   1. Assist in the development, implementation and management of public health and hospital\u2014based surveillance systems including registries on violence, injury and MNS disorders.  2. Support the conduct of population-based surveys on risk factors associated with violence, injury and MNS disorders.   L. The Knowledge Management Information Technology (KMITS) shall:  1. Lead in the integration and harmonization of information systems related to MNS within the DOH including the development of IT systems, training of users of the systems and ensuring continuous operation of the systems.  2. Provide funding on information and communication technology resources based on the Information System Strategic Plan or other DOH directives or issuances.   N. The DOH Regional Of\ufb01ces shall lead and provide technical assistance to local government units and regional hospitals in the implementation of an appropriate mental health program including community\u2014based mental health services.   O. The DOH Retained Hospitals shall ensure provision of quality promotive, preventive, curative, rehabilitative and palliative care for persons with MNS disorders as well as those involved in violence and injury.   P. Treatment and Rehabilitation Centers shall promote quality services on the prevention, treatment, rehabilitation and aftercare of people affected with substance abuse and other forms of addiction.   Q. Local Government Units shall adopt and implement the National Mental Health Program and provide services and products in primary health care facilities and hospitals in their localities as well as provide the training needs for personnel at peripheral health units, district/provincial hospitals and other related facilities.   R. Private sector, civil society organizations, patientlfamily and other care groups shall be encouraged to organize activities and programs that will aid in the promotion of mental health and well\u2014being; prevention, treatment, rehabilitation and aftercare of people with MNS disorders; and prevention of discrimination and stigmatization due to these disorders.   XI. FUNDING   The Department of Health 4 Disease Prevention and Control Bureau and Regional Offices shall provide funds for technical assistance, monitoring and health promotion and communication. It can also augment funds of local government units for local implementation. Local Government Units, other government agencies and civil society organizations are encouraged to provide counterpart \ufb01mds as appropriate to ensure the implementation of the National Mental Health Program.   XII. REPEALING CLAUSE   Administrative Order No. 2007-0009 and 2007-0009A \u201cOperational Framework for the Sustainable Establishment of a Mental Health Program\" is hereby repealed. Other related issuances inconsistent or contrary to the provisions of this Administrative Order are hereby repealed, amended or modi\ufb01ed accordingly. All other provisions of existing issuance which are not affected by this Order shall remain valid and in effect.   XI. EFFECTIVITY The Order shall take effect upon approval and 15 days after publication in an of\ufb01cial gazette or national newspaper.  ", " I. RATIONALE/BACKGROUND   The right to health is one of the fundamental rights enshrined in Article II of the Constitution. Section 15 states that \u201cthe State shall protect and promote the right to health of the people and instill health consciousness among them.\" Likewise, under Republic Act No. 7394 or the Consumer Protection Act, Filipinos have the right to obtain accurate information as to the nature, quality and quantity of the contents of consumer products, as well as the right to be protected from deceptive, unfair and unconscionable sales acts or practices.'   As a State-Party to the International Covenant on Economic, Social and Cultural Rights, the Philippines recognized the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. . The right to health includes the right to health\u2014related education and information. Access to information, including the right to seek, receive and impart information and ideas concerning health issues is considered an integral component of the right to health.   There is unequivocal scienti\ufb01c evidence establishing that death, disease and disability result from tobacco consumption and exposure to tobacco smoke. At present, there are about 5 million deaths a year worldwide directly related to tobacco and WHO estimates this to double by 2020, if present trends continue unchecked. By then, 70% of mortality would be taking place in developing countries. In the Philippines, 240 Filipinos die everyday or over 87,000 a year from what is clearly a preventable disease. Tobacco products contain toxic compounds and over forty carcinogens, including carbon monoxide, arsenic, benzene, butane, formaldehyde, lead, toluene, and nicotine, among others. Nicotine, a by\u2014product unique only to tobacco, is the substance that eventually leads the smoker to addiction.   Recognizing the magnitude of the tobacco epidemic, the Philippines, along with other States, - signed the Framework Convention on Tobacco Control (FCTC) _ the only public health treaty initiated by the World Health Organization (WHO). The FCTC requires State parties to adopt a comprehensive range of measures designed to reduce the devastating health and economic impacts of tobacco.   On 4 September 2005, following its ratification through the concurrence of two-thirds of the Philippine Senate in accordance with the Constitution, the FCTC was transformed into municipal law. As such, the FCTC became legally binding upon state organs.   As a State Party to the FCTC, the Philippines is duty\u2014bound to comply with FCTC provisions in good faith, in observance of the principle of pacta sum servanda, such that, the failure of the Philippines to perform its treaty obligations under the FCTC constitutes an internationally wrongful act under the doctrine of state responsibility, a norm of general international law that every internationally wrongful act of a State entails international responsibility of that State.   Article 11 of the FCTC provides that Parties shall, within three years after entry into force of the treaty, adopt, and implement effective measures to ensure that each unit packet and package of tobacco products and any outside packaging and labelling of such products (i) carry rotating health warnings that shall, among others, cover 50% or more but no less than 30% of the principal display area, placed in the principal language or languages and may be in the form of pictures or pictograrns, and approved by the competent national authority; and (ii) do not promote tobacco products by means that are false, misleading, deceptive or likely to create an erroneous impression about its characteristics, health effects, hazards, or emissions. The inclusion of a speci\ufb01c timeframe of three years in Article 11 underscores the mandatory and prescriptive nature, as well as the exigency, of the Philippines\" obligation to adopt and implement effective measures in compliance with said provision.   Article 5.2 of the FCTC mandates Parties to adopt and implement not just effective legislative, but also executive, administrative and/or other measures in developing appropriate policies for preventing and reducing tobacco consumption, nicotine addiction and exposure to tobacco smoke. '   Under the Constitution and the Administrative Code of 1987, the Department of Health (Department) is the competent national authority mandated to ensure the propagation of health information. In its discussion of the Department\u2019s power to regulate private industries in the area of health information, the Supreme Court held that \u201c[h]ealth is a legitimate subject matter for regulation by the DOH (and certain other administrative agencies) in exercise of police powers delegated to it. The sheer span of jurisprudence on that matter precludes the need to further discuss it.\" The Supreme Court, in its examination of the nature, purpose, and depth of the regulatory powers of the Department, cited the Administrative Code, which tasked the Department to carry out the state policy pronounced under Section 15, Article II of the 1987 Constitution, which is \u201cto protect and promote the right to health of the people and instill health consciousness among them.\" To this end, the Department was \u201cgranted under Section 3 of the Administrative Code the power to propagate health information and educate the population on important health, medical and environmental matters which have health implications.\"   The Department is likewise mandated, under the Consumer Protection Act, to protect the interests of the consumer, promote his general welfare, and establish standards of conduct for business and industry. To this end, the Department has the duty to implement measures that ensure the provision of information necessary for the protection of public health and the protection of consumers against deceptive practices.   Evidence shows that health information with pictures communicates health risks better especially to children and young people as well as the illiterate, and increase the motivation of tobacco users to quit and to decrease their tobacco consumption.   Pursuant to Department Order 2009-0116, the Department may promulgate an Administrative Order (Order) that prescribes policies, rules and regulations, and procedures in accordance with or pursuant to law to supplement provisions of the law or provides means for carrying them out, and is primarily applicable to individuals and organizations outside the Department.   Through this Order, the Philippines, through the Department, is taking a de\ufb01nitive step towards complying with its binding international obligations under the FCTC.   Through this Order, the Department underscores the primacy of public health and af\ufb01rms its primary function to promote, protect, preserve, and restore the health of the people.    II. OBJECTIVES   It is the policy of the State to promote the right to health of all the people and instill health consciousness among them. The State af\ufb01rms this as one of the fundamental rights of a human being. Towards this end, the State shall implement effective measures to achieve the following objectives:   a. Provide necessary information about the health consequences, addictive nature, and mortal threat posed by tobacco consumption and exposure to tobacco smoke through measures that are scienti\ufb01cally proven to be effective in increasing public awareness of the health effects of tobacco use and in reducing tobacco consumption;   b. Protect consumers from deceptive labels, packaging, descriptions and practices related to tobacco use;   c. Implement measures to prohibit means that are false, misleading, deceptive or likely to create an erroneous impression about the characteristics of tobacco, its health effects, hazards or emissions, so as to promote tobacco products in tobacco product packages.   To achieve these objectives, the Department shall ensure that effective, distinct, and highly visible graphic health information is placed on tobacco product packages.   Moreover, the Department shall ensure that tobacco product packaging and labelling do not promote a tobacco product by any means that are false, misleading, deceptive, or likely to create an erroneous impression about the product and its characteristics, health effects, hazards or emissions.   III. SCOPE AND COVERAGE   These policies and guidelines shall apply to all tobacco products and to all tobacco manufacturers, importers, exporters, wholesalers, distributors, retailers, concessionaires, and other sellers of tobacco products, as well as their agents and representatives, which are operating, existing, and/or found within the Republic of the Philippines.   IV. DEFINITION OF TERMS   a. \u201cGraphic Health Information\" means statements, and/or other information, acCompanied by related full\u2014color pictures or pictograms, which inform about the contents and substances, in descriptive form, of tobacco products as well as inform against health dangers and other problems related to tobacco products, tobacco consumption, exposure to tobacco smoke, or other effects of tobacco use.   b. \u201cTobacco Product Package\" means the packet and package of tobacco products and any outside packaging and labelling of tobacco products for sale, distribution, exportation, importation, trade, exchange, or exhibition, such as, but not limited to, packs, tins, boxes, pouches, \ufb02ip-tops, slide and shell packages, cartons, transparent wrappers, clear packaging, packages containing one product unit, master cases, or other containers of tobacco products.   c. \u201cTobacco Products\" means products entirely or partly made of leaf tobacco as raw material, which are manufactured to be used for smoking, sucking, chewing or snuf\ufb01ng, or by any other means of consumption.   d. \u201cInsert\" means any communication inside an individual package and] or carton purchased at either wholesale or retail by consumers, such as a lea\ufb02et or brochure.   e. \u201cOnsert\" means any communication affixed to the outside of an individual package and for carton purchased at either wholesale or retail by consumers, such as a brochure beneath the outer cellophane wrapping or glued to the outside of the cigarette package.   V. SPECIFIC PROVISIONS   The Department hereby promulgates the following rules and regulations governing packaging and labelling of tobacco products:   A. Graphic Health Information   1. Scope of Graphic Health Information. - Each unit packet and package of tobacco products, including package inserts and onserts, and any outside packaging and labelling of such products for sale, distribution or importation within the country, shall bear large, clear, visible, and legible \ufb01ill\u2014color graphic health information, as attached in Annex 1.   2. Size and Position of Graphic Health Information. - The graphic health information shall occupy the upper portions of each tobacco product packet or package and no less than thirty percent (30%) of the front panel and sixty percent (60%) of the back panel (or all corresponding panels of the unit packet or package if in non\u2014standard packaging) in a manner that ensures maximum visibility.   3. Rotation. - There shall be a minimum of eight (8) variations of graphic health information that shall appear concurrently within a twenty four (24) month period. The variations shall appear on an equal number of retail tobacco product packages for each brand and for each package size and type.   4. Transitions. - During transition periods, when an old set of graphic health information is being replaced by a new set, there shall be a phase-in period of sixty (60) days between sets of graphic health information, during which time both sets may be used concurrently.   5. Templates. - The templates of graphic health information, which contain speci\ufb01c printing and other requirements, shall be issued by the Department on its own, or upon consultation with organizations with established track record of, and expertise in public health policies and duly recognized by the Department as such. The template(s) shall be approved by the Secretary within thirty (30) days from its submission and shall be deemed automatically approved if not acted upon thereafter.   These templates shall be issued by the Department every two (2) years or as the need for it arises.   6. Strict Adherence. - The tobacco manufacturers, importers, exporters, wholesalers, distributors, retailers, concessionaires, and other sellers, shall strictly follow the templates and shall submit their packagings and labelings for approval to the Department no later than three (3) months before they are to be used. The Department shall act on the packaging and labeling of the unit packet and package of tobacco products within thirty (30) days from its submission and shall be deemed automatically approved if not acted upon thereafter.     B. Misleading Descriptors   1. General Prohibition. \u2014 Each unit packet and package of tobacco products, including package inserts and onserts, and any outside packaging and labelling of such products  for sale, distribution or importation within the country shall not promote a tobacco product by any means that are false, misleading, deceptive or likely to create an erroneous impression about the product\u2019s characteristics, health effects, hazards or emissions, including any term, descriptor, trademark, \ufb01gurative or any other sign (including colors, images, or numbers) or any package or product design feature that directly or indirectly create or are likely to create the false impression that a particular tobacco product or brand is less harmful than any other tobacco product or brand.   Use of misleading descriptors on tobacco product packages such as, but not limited to, \u201clow tar\", \u201clight\", \u201cultra-light,\" \u201cmild,\" \u201cextra,\" \u201cultra,\" and similar terms in any language that might mislead consumers, is prohibited. Use of corresponding symbols or colors signifying the same is also prohibited. No misleading descriptor shall be used as part of a brand name or trademark for tobacco products introduced after the effectivity of this Order.   2. Prohibition on Misleading Information. \u2014 Information that may imply that one variant or brand is safer than the other is prohibited, such as statements indicating that the tobacco product contains \u201creduced levels\" of contents, substances, and emissions. Figures for emission yields, such as for tar, nicotine and carbon monoxide, shall be prohibited, including when used as part of a brand name or trademark.   VI. COMMON PROVISIONS   1. Compliance. \u2014 Tobacco product packages that do not comply with this Order shall be prohibited after ninety (90 days) from the effectivity of this Order. Non\u2014compliant products must be withdrawn no later than such date. Absolutely no extensions of time to comply with the provisions of this Order shall be granted to tobacco manufacturers or any other affected party.   Imported tobacco products meant to be sold in the Philippines, even if they are in product packages that carry graphic health information compliant with the country of origin shall comply with this Order within thirty (30) days from this Order\u2019s effectivity.   2. Duty Not to Sell/Display Non-compliant Products. - Manufacturers, importers, exporters, wholesalers, distributors, retailers, concessionaires and other sellers shall not sell and] or display tobacco products that do not comply with this Order.   3. Burden of Costs on Tobacco Companies. - All costs relative to the packaging and labelling of tobacco products shall be borne by the respective tobacco manufacturers, importers, and/ or exporters responsible for packaging and labelling of the products.   4. Monitoring Teams. - There shall be Monitoring Teams at the national, regional, provincial, city, municipal, and barangay levels (in coordination with respective Local Government Units), as well as in civil society, to ensure compliance with, and implementation of, this Order.   Monitoring Teams shall be composed of:   a. National Level:   i. National Center for Health Promotion (NCHP)  ii. Non-Government Organizations (N GOs) as deputized by the Department.  iii. Any other office/agency designated by the Department.   b. Regional/Provincial/City/Municipal/Barangay Level:   i. Centers for Health Development (CHDs)  ii. Provincial Health Offices  iii. City Health Of\ufb01ces  iv. Municipal Health Offices/ Rural Health Units  v. Barangay Health Of\ufb01ces  vi. NGOs as deputized by the Department  vii. Any other of\ufb01ce/ agency designated by the Department.   5. Monitoring Teams; Functions and Responsibilities. - Monitoring teams shall have the following responsibilities:   a. Monitor compliance with, as well as problems encountered in, the implementation of this Order and submit timely reports thereon;   b. Monitor labels and packages of tobacco products within the scope of the Order and marketing practices in various distribution centers and points of sale establishments;   c. Verify reports of violations of this Order;   d. Submit timely reports on their monitoring and veri\ufb01cation and follow-up on the actions and/or resolutions with the concerned of\ufb01ce/agency; and   e. Such other functions and responsibilities as may be assigned by the Department.   6. Contents of Violation Reports. - Reports of alleged violations shall include: (i) the speci\ufb01c location where the violation was found and the corresponding date; (ii) a picture or sample of the violative label or packaging; (iii) as. much as possible, a picture of the violative product as displayed in the point of sale/distribution outlet; and (iv) such other information as the Department may later require. Monitoring Teams shall keep proper documentation of all reported violations, which documentation may be made available to the public.   7. Cooperation/Coordination with Organizations. \u2014 The Department and Of\ufb01cial Monitoring Teams may engage other civil society organizations, individuals, and other agencies, to closely monitor implementation of and compliance with this Order in their respective areas of jurisdiction, and submit timely reports to the Department or the monitoring teams of any alleged violation.   8. Public Vigilance. \u2014 The Department, monitoring teams, other agencies, and stakeholders, shall encourage the public to report what they deem to be violations under this order.   9. Where to Report. \u2014 Reports of violations shall be submitted to the Of\ufb01ce of the Secretary, or any other of\ufb01ce/agency designated by the Secretary, at the national level, and to the CHDs at the local level. The concerned of\ufb01ce/agency shall provide immediate feedback within \ufb01ve (5) working days on actions taken based on the received reports of alleged violations.   VII. VIOLATIONS   The Department, or any office designated by the Secretary of Health, shall investigate any reported violations of this Order, and after due notice and hearing, if found responsible thereof, apply such administrative sanctions and penalties, including seizure, recall and condemnation, where appropriate, on the concerned manufacturers, importers, exporters, wholesalers, distributors, retailers, concessionaires, sellers, or other concerned individuals/entities.   VIII. SEPARABILITY CLAUSE   If, for any reason, any section or provision of this Order is declared invalid, illegal or unconstitutional, such invalidity or unconstitutionality shall not affect the other provisions of this Order, which shall remain in full force and effect.   IX. REPEALING CLAUSE   The provisions of other existing provisions or issuances found inconsistent or contrary with this Order are hereby repealed or modi\ufb01ed accordingly.   X. EFFECTIVITY   This Order shall take effect \ufb01fteen (15) days following the date of its publication in a newspaper of general circulation. ", "  Pursuant to Sec. 9 of Republic Act No. 6675, otherwise known as the Generics Act of 1988, the following policies and guidelines for the implementation of the said Act are hereby promulgated to govern the sale by Drug Outlets of generic alternatives at discounted prices.  Section 1. Definition of Terms. The following terms as defined under Sec.3 of the aforesaid Act for purposes of this Order are hereby adopted:  Drug Outlets refer to Drugstores, Pharmacies and any other business establishments which sell drugs or medicines;  Generic drugs are drugs not covered by patent protection and which are labeled solely by their international non proprietary or generic name;  Branded generic drugs which carry a brand or proprietary name in addition to its generic or official name.   Section 2. Guidelines on Sale of Generic Alternatives. The following guidelines shall be strictly observed on sale of generic alternatives at discounted prices:  1. All drug outlets, through their registered pharmacists, shall have full discretion and responsibility in dispensing the generic alternatives to the prescribed medicine in accordance with the provisions of the Generics Act.  2. Discounts granted by the Senior Citizens Act or RA 7432 and relevant laws on purchases of medicines and other drug products shall be given by drug outlets on their sale of generic drugs.  Section 3. Repealing Clause  All Administrative Orders, Rules and Regulations and other Administrative Issuances or parts thereof, inconsistent with the provisions of the Administrative Order are hereby repealed and modified accordingly.   Section 4. Effectivity  This Order shall take effect fifteen (15) days after its publication in two (2) newspapers of general circulation.  ", "  I. Rationale  Tobacco use is the second major cause of death in the world. It is currently responsible for the death of one in ten adults, which is about 5 million deaths each year, a number that will double by year 2020 if nothing is done. If current consumption pattern persist, about 1 billion people in the 21St century will be killed by their addiction to tobacco, with 300 million deaths in the Western Pacific Region alone. Report from the WHO stated that there is as much as 3.4 percent annual increase in the number of people smoking in developing countries. One-third of the world\u2019s total male population smokes cigarettes.  The 2005 \u2014 2006 Tobacco and Poverty Study in the Philippines, a collaborative effort by the World Health Organization (WHO). Department of Health (DOH) and University of the Philippines \u2014 Manila (UP\u2014Manila) showed the following: Sixty four percent of the poorest monthly expenditure is food followed by other expenses. Tobacco comprise 2.5% of their monthly expenditure has a bigger share than clothing (23%), education (1.4%) and health (0.9%). When only those poorest households with tobacco expenditure were considered, the household tobacco expenditure ($16) is almost 16 times as much as the per capita monthly expense on health, eleven times as much for education, seven times as much for clothing and twice as much as for housing. The total per capita expenditure of clothing, housing, health and education is only $1.3, which is even lower than the monthly household expenditure on cigarettes alone.  According to the 2003-2004 National Nutrition and Health Survey (NNHS) conducted by the Food and Nutrition Research Institute of the Department of Science and Technology (FNRI-DOST), 35 out of 100 Filipinos (34.8 percent) are smokers. Despite the concerted anti-smoking campaigns of the DOH and other medical organizations, adult male smokers even increased from 53.8 percent in 1998 to 56.3 percent in 2003. The prevalence for adult female smokers has slightly decreased from 12.6 percent in 1998 to 12.1 percent in 2003.  The Global Youth Tobacco Survey reported that there are approximately four in 10 students aged 13-15 years (42.8 percent in 2000 and 14.9 percent in 2003) in the Philippines who ever smoked cigarettes, i.e., even one or two puffs. It was also found out that adolescent boys were significantly more likely to have ever smoked than adolescent girls. About one in eight students who had ever smoked took their first Cigarette before 10 years of age.  The spread of the tobacco epidemic is facilitated by a variety of complex factors with cross-border effects, such as trade liberalization, foreign direct investment and other activities such as global marketing, transnational tobacco advertising, promotion and sponsorship and the international movement of contraband and counterfeit cigarettes. In response to the tobacco epidemic, the Philippines passed the landmark legislation, RA. 9211 othenrvise known as the Tobacco Regulatory Act of 2003. It regulates the package use, sale and distribution and advertisements of tobacco products. And it also embodies the promotion of healthy environments, creation of health programs and withdrawal clinics (section 33). Moreover, the passage of Republic Act 9334 focuses on the increase of excise tax rates of tobacco products. Furthermore, Article 13, section 11 of the 1987 Philippine Constitution enjoins the state to protect and promote the right to health of every Filipino by making quality and adequate health care available and accessible especially the under privileged. This entails the adoption of an integrated and comprehensive approach to health development, implying a multi-sectoral partnership and multi-level health care delivery system.  Globally, country negotiations were done under the auspices of the WHO to develop the Framework Convention on Tobacco Control, the first public health treaty passed ever. The FCTC is an evidence-based treaty that reaffirms the right of all people to the highest standard of health and was developed in response to the current globalization of the tobacco epidemic. On September 23, 2003 the Philippines became a signatory to the FCTC and on February 22, 2005 the Senate Committee on Foreign Relations filed Resolution No. 195 concurring in the ratification of the FCTC.  Being a party to the WHO Framework Convention on Tobacco Control (FCTC), it is mandated that parties should provide a framework for tobacco control measures to be implemented at the National, regional and local levels (FCTC, Article 3). Furthermore, under the WHO Western Pacific Region Action for Tobacco Control for 2005-2009, member states are directed to attain ratification of the WHO FCTC in all Western Pacific Region, strengthen national capacity for tobacco control to enable implementation of comprehensive tobacco control strategies in an effective and sustainable manner, develop and formally adopt measures to ensure sustainability of tobacco control programs in all WPR member states.  Thus, this National Tobacco Prevention and Control Program is hereby formulated. It shall set directions as to how the prevention and control of tobacco related diseases will be implemented in a comprehensive, systematic, integrated and holistic manner. Similarly, this program shall complement and build upon existing initiatives in the country.  II. Statement of Principle  The National Tobacco Prevention and Control Program shall be guided by the following principles:  A. Leadership  Cognizant of the critical importance of leadership and political will in government to effect action, the Department of Health shall be the lead agency in the promotion of prevention and control of tobacco related diseases.  B. Partnership and Shared Responsibility  Creating conditions conducive to the prevention and control of tobacco related diseases is the responsibility of all sectors and is affected by government at all levels, the private sector, non-government organizations, families, schools, workplaces and communities. A multisectoral collaboration and partnership with tobacco control advocates at the national, regional and local levels shall be established. It shall take into account the mandates and activities of the various stakeholders involved in the prevention and control of tobacco related diseases and forged agreements and commitments in advocacy and awareness campaigns, research, information exchange, referrals and resource sharing.  C. Legislation and Enforcement  All sectors need to work together in pursuit of policies that create environment for the prevention and control of tobacco related diseases. Government at all levels have important role to play in developing tobacco control policy. Law and ordinances shall be strictly promulgated and monitored to ensure that activities on the prevention and control of tobacco related diseases are in place.  D. Health Promotion  Strategies on the prevention and control of tobacco related diseases shall include advocacy, information, education and communication activities addressed to policy makers, other government and non-government agencies, private sectors including media, the general public and other stakeholders concerning the underlying socio\u2014economic and environmental conditions brought about by tobacco use.  E. Evidenced-Based Practices  To prevent the continued waste of valuable resources on practices that may not be effective, practitioners, researchers and policy makers need to work closely to develop and implement a national research agenda that supports the Strategy. This includes the setting up and institutionalization of a tobacco monitoring and surveillance system.  III. Scope  This issuance covers the DOH at the Central Office, Centers for Health Development, hospitals, medical centers and other DOH attached agencies, in collaboration with the local government units and other devolved health services. It shall also include the public and private sectors such as national agencies, academe, media, professional associations, civil society, non-government organizations and international development agencies.  IV. Program Framework  A. Vision:  Filipinos are free from tobacco related diseases.  B. Mission:  A rational and unified response to the prevention and control of tobacco related diseases.  C. Goal:  Protect present and future generations from devastating health, social and environmental consequences of tobacco use and exposure.  D. Objectives:  1. General Objective  To reduce the burden of disease and death caused by tobacco through a substantial reduction in prevalence of tobacco use, exposure to tobacco smoke and disparities related to tobacco use and it\u2019s effects.  2. Specific Objectives:  a. To strengthen national, regional and local infrastructure and capacity for the prevention and control of tobacco related diseases, using the WHO FCTC as the guiding tool.  b. To develop an integrated and multi-sectoral based program for the prevention and control of tobacco related diseases.  c. To advocate for the implementation and monitoring of laws and policies for the prevention and control of tobacco related diseases.  d. To strengthen social mobilization and community participation in the prevention and control of tobacco related diseases activities through information and education campaigns and implementation of national smoke free policies.  e. To initiate and strengthen collaboration and partnership among stakeholders, external development agencies and civil societies devoted to the prevention and control of tobacco related diseases.  V. Definition of Terms  For purpose of this order, the following terms shall be defined as:  1. FCTC \u2014 Framework Convention on Tobacco Control is an evidenced based treaty that reaffirms the right of all people to the highest standards of health. This was developed in response to the current globalization of the tobacco epidemic.  2. Global Youth Survey - a component survey of the global tobacco surveillance system of the World Health Organization and the United States Center for Disease Control for the Framework Convention on Tobacco Control. It was developed to track tobacco use among young people across countries, using a common methodology and core questionnaire.  3. Tobacco Products - any product manufactured wholly or partly from tobacco intended for use by smoking, inhalation, chewing, sniffing or sucking, with the exception of medicinal preparations containing nicotine.  4. Tobacco Use - the consumption of tobacco products by burning, chewing, inhalation, or other forms of ingestion.  5. Smoke- Free Area - an area where smoking or holding a lighted cigarette, cigar or pipe is banned.  6. Smoker - someone who, at the time of survey smokes any tobacco product either daily or occasionally.  7. DOH - refers to the Department of Health  8. Civil Society - refers to a broad array of organizations that are essentially private and outside the institutional structures of government, but at the same time are not primarily commercial and do not exist principally to distribute profits to their directors or owners. Civil society includes organizations such as registered charities, non-governmental organizations, professional societies and advocacy groups.  9. International Organizations - includes United Nations agencies, donors and development banks that have crucial role in the prevention and control of tobacco related diseases.  VI. General Guidelines  A. The Department of Health cognizant of the public health significance of the devastating effect of tobacco use and its impact on society shall institutionalize the National Tobacco Prevention and Control Program.  B. The National Tobacco Prevention and Control Program shall be in accordance with the thrust of the Fourmula One for Health, National Objectives for Health (2005\u20142010), Medium Term Development Plan of the Department of Health (2002-2010) and Millenium Development Goals (2005-2015).  C. The Program shall focus on areas where health interventions are possible, effective and able to be implemented with a clear and actionable role for all sectors. There are five priority programs for the prevention and control of tobacco related diseases:  1. Tobacco Dependence and Cessation:  It shall design and ensure implementation of effective program aimed at promoting the cessation of tobacco use, in such location as educational institutions, health care facilities, workplaces and sporting environments.  2. Protection from exposure to tobacco smoke:  Based on scientific evidence, it has been unequivocally established that exposure to tobacco smoke causes death, diseases and disability.  This subprogram ensures the provision for protection from exposure to tobacco smoke in indoor workplaces, public transport, indoor public places and as appropriate, other public places.  3. Education, Communication and Training:  It shall promote and strengthen public awareness in the prevention and control of tobacco related diseases using all available and appropriate communication tool.  4. Regulation of Tobacco Product Disclosure:  It shall ensure and advocate for the public disclosure of information about the toxic contents and emissions of tobacco products.  5. Regulation of the contents of Tobacco Products:  It shall ensure the establishment of guidelines for testing and measuring the contents and emissions of tobacco products and shall advocate for the regulation of these contents and emissions.  D. Each of the abovementioned subprogram shall be developed and must contain all of the following essential and substantial component.  1. Health Promotion:  This component shall focus on individual information and education, public information and education and intersectoral collaboration on the prevention and control of tobacco related diseases. It shall ensure the advocacy of and other related activities pertaining to the prevention and control of tobacco related diseases.  2. Partnership Building and Networking:  This component shall make certain that networkings and inter-organizational linkages are available at the national, regional and local levels.  3. Human Resource Development:  This component shall focus on ensuring the capability of national, regional and local health facilities in ensuring the implementation of appropriate tobacco control initiatives and activities. It shall provide capability building services and activities for regional and local levels and shall assure the availability and access to training programs by program implementers.  4. Surveillance:  This component shall ensure the implementation of a regular standardized global/regional surveys on tobacco control activities and shall create a national data base for tobacco control that includes information taken from other existing sources of data, such as school and national surveys.  5. Monitoring and Evaluation:  A system of monitoring program plans and activities shall be developed.  6. Research and Development:  It shall develop and ensure implementation of a research agenda that addresses local needs and data gaps, such as initiating an analysis of the relationships between tobacco use and poverty and evaluating the results of the global youth tobacco survey, etc.  7. Resource Mobilization:  It shall advocate to bilateral and multisectoral donors to make funds and resources available for the prevention and control of tobacco related diseases, whether directly or as a component of funding grants to related programs such as health services development, health promotion, sustainable development, and healthy environments.  E. The National Tobacco Prevention and Control Program shall be one of the Programs of the Degenerative Disease Office of the National Center for Disease Prevention and Control. A National Program Coordinator shall be designated to perform technical and administrative functions pertaining to the operation of the National Tobacco Control Program. A support secretariat shall be established. They shall be composed of staff from the Degenerative Disease Office  F. To ensure a comprehensive approach to the prevention and control of tobacco related diseases, coordination with programs from the Family Health Office and Environmental and Occupation Health Office shall be intensified. Coordination with other DOH Office/Bureaus such as the National Center for Health Promotion, National Epidemiology Center, Health Policy Development and Planning Bureau, Health Human Resource Development Bureau, Bureau of International Health Cooperation, and the Bureau of Local Health Development shall be ensured.  G. To ensure coordination and sustainability of the National Tobacco Prevention and Control Program, a program management committee shall be organized. Under the program management committee, five program development teams shall be established to correspond to the five subprograms of the National Tobacco Control Program. Each Center for Health Development shall establish/organize a Regional Tobacco Control Team to ensure implementation of the National Tobacco Prevention and Control in their respective areas.  VII. National Tobacco Prevention and Control Program Structure  A. National Program Management Committee  1. Composition  To ensure coordination and sustainability of the National Tobacco Prevention and Control Program, a Program Management Committee shall be organized in the Department of Health. The Chair of the Committee shall be the Undersecretary for Health Operations Cluster, Vice-Chaired by the Director of the National Center for Disease Prevention and Control. The Committee shall be composed of tobacco control advocates from the academe, non\u2014government organizations, donor organizations specialty societies, government agencies such as DepEd, etc.  2. Function  a. To ensure the development of preventive and control measures for tobacco related diseases for each sub-programs. and components with active cooperation and participation of various tobacco control advocates and stakeholders for the prevention and control.  b. To integrate the various programs, projects and activities from the various program development and management groups for each subprogram.  c. To manage the various sub-programs and components of the National Tobacco Prevention and Control Program  d. To recommend to the Secretary of Health a master plan for the prevention and control of tobacco related diseases.  B. Program Development and Management Team  Under the Program Management Committee, Program Development and Management Teams shall be organized corresponding to the five sub-programs of the National Tobacco Prevention and Control Program. The operation of each sub-program of the National Tobacco Prevention and Control Program shall be lead by a Program Development and Management Team.  1. Composition  a. Members to the Program Development and Management Team shall be composed of tobacco control advocates coming from the academe, non-government organizations, government agencies, civic organizations and donor organizations and specialty societies.  b. Each sub-program shall have a designated chairperson and a vice-chairperson. They shall be nominated by members of the Program Development and Management Team. Furthermore, a secretariat shall be created to a support each program development and Management team, members of the secretariat shall be composed of DDO-NCDPC staff. They would be acting on an ex-officio capacity.  c. To ensure the dedication of the members of each program development and management team, bilateral agreements shall be developed and fostered upon.  2. Functions of the Program Development and Management Team:  a. Formulates and recommends policies, standards, guidelines approaches on each specific subprograms on tobacco-control   b. Develop a program for each specific subprogram in consultation with tobacco control advocates and stakeholder  c. Recommends the program to the National Program Management Committee for approval  d. Develops operating guidelines, procedures, protocols on tobacco control   e. Ensures the implementation of the program among stakeholders, government agencies and the private sector  f. Provides technical assistance pertaining to tobacco control measures.  C. Regional Tobacco Control Team  To ensure an efficient and effective multisectoral implementation of the National Tobacco Prevention and Control Program, a Regional Tobacco Control Team shall be established at the Centers for Health Development  1. Composition  a. Members of the Regional Tobacco Control Team shall be composed tobacco control advocates from government agencies, non\u2014government organizations, civil societies, academe, specialty societies and representatives from the local government units.  b. The Regional Tobacco Control Team shall be chaired by the Director of the Centers for Health Development, the vice\u2014chair shall be nominated by members of the Regional Tobacco Control Team. A Secretariat shall be created to support the team.  c. To ensure the dedication of the members, bilateral agreements shall be developed between the Center for Health Development and members of the team.  d. A regional coordinator for the National Tobacco Control Program shall be designated by the Center for Health Development Director. The coordinator shall be responsible for the technical and administrative concerns of the program.  2. Functions of the Regional Tobacco Control Program Team:  a. Oversee the planning and operation of the National Tobacco Prevention and Control Program at the Regional level  b. Provide technical assistance on the issues and concerns pertaining to the implementation of the different sub-programs of the National Tobacco Prevention and Control Program  c. Strengthen technical and managerial capability at the local level to ensure LGU participation on the implementation of the National Tobacco Prevention and Control Program  d. Advocate for the establishment of LGU team for the prevention and control of tobacco related diseases.  e. Ensure the conduct of monitoring and evaluation of regional activities on the implementation of the National Tobacco Prevention and Control Program.  f. Regularly update the National Program Management Committee on the status of the implementation of the National Tobacco Prevention and Control program.  VIII. Roles and Responsibilities:  The DOH shall develop systems, policies and guidelines that will facilitate the implementation of the National Tobacco Prevention and Control Program including the monitoring and evaluation of each program activities. Develop the capacity of CHD personnel in assisting the LGUs to ensure the implementation of the National Tobacco Prevention and Control Program. The following offices shall have the following responsibilities:  1. The National Center for Disease Prevention and Control (NCDPC) 1) shall develop plans for the implementation of the National Tobacco Prevention and Control Program 2) monitor and evaluate program operation 3) ensure the participation of other DOH offices in program activities where needed.  2. National Center for Health Promotion (NCHP) shall be responsible in the formulation of standards and development of information, education, communication and advocacy strategies for the implementation of the National Tobacco Prevention and Control Program, as well as the ill effects of Tobacco use.  3. The National Epidemiology Center (NEC) and the Information Management Service (IMS) shall be responsible in the development and institutionalization of a national reporting and surveillance for the National Tobacco Prevention and Control Program.  4. The Health Policy Development and Planning Bureau (HPDPB) Shall be responsible in the proper and effective implementation, monitoring and evaluation of the National Tobacco Prevention and Control Program, ensure its formulation into a national program plan of action.  5. The Health Human Resource Development Bureau (HHRDB) shall be responsible in the development of standards in the curriculum and the training of all types of health professionals, who are responsive, sensitive which should be consistent with the national and local human development goals and culture.  6. The Bureau of International Health Cooperation (BIHC) shall ensure that the National Tobacco Prevention and Control Program has strong linkages with international health institutions, agencies, units that will continually ensure the inclusion, participation, cooperation and collaboration of the Philippines in the global scene for tobacco control.  7. The Bureau of Local Health Development (BLHD) shall be responsible in the integration of the National Tobacco Prevention and Control Program into the local health system of LGU.  8. The Centers for Health Development (CHDs) shall lead the region or zone to ensure the implementation of the National Tobacco Prevention and Control Program. It shall:  a. convene the Regional Tobacco Control Committee b. provide technical assistance c. designate point person for the National Tobacco Prevention and Control Program d. advocate the National Tobacco Prevention and Control Program to LGUs, stakeholders e. develop the capability of local government units; and, f. assist the LGUs in coordinating the actual implementation of program strategies and activities.  9. Non-Government Organizations and other organizations, and the Academe shall be involved addressing general concerns of the National Tobacco Prevention and Control Program.  10. Civil Societies shall assist the local government units in achieving their health objective vis a vis the National Tobacco Prevention and Control Program, shall identify health needs of the people in relation to tobacco related ill effects and bring attention to local health authorities.  11. Donor Agencies shall provide funding assistance according to the investment plan developed for the National Tobacco Prevention and Control Program.  IX. Funding  The Department of Health and Center for Health Development shall provide funds for technical assistance, monitoring and advocacy campaign to ensure the implementation of the program. Furthermore, other government agencies, non-government organizations and other stakeholders are encouraged to allocate/contribute counterpart funds to ensure the implementation of the National Tobacco Prevention and Control Program.  X. Repealing Clause  Other related issuances inconsistent with the provisions of this Administrative Order are hereby revised, modified or rescinded accordingly. All other provisions of existing issuances which are not affected by this order shall remain valid and in effect.  XI. Separability Clause  In the event that any provision of this Order is held invalid, the validity of the remaining provisions shall not be affected  XII. Effectivity  This Order shall take effect immediately.      ", "  I. RATIONALE  Cervical Cancer is the second most common cancer among Filipino women and ranks fifth for both sexes. Its incidence rate has persisted from the 1980\u2019s to the present with an annual age\u2014standardized rate of 22.5 cases per 100,000 women (UP\u2014DOH Cervical Cancer Screening Study Group).  Cervical cancer while preventable 1s a killer disease. Of the thousands of Filipino women diagnosed of having cervical cancer 56% will die within 5 years from the time of diagnosis (UP\u2014DOH Cervical Cancer Screening Study Group). Experiences in many developed countries however showed reductions in cervical cancer incidence and prevalence by as much as 90% through well- organized screening programs detecting and subsequently treating cervical cancer precursors. and early lesions (WHO Technical Paper). Studies have shoinn, early detection and appropriate medical management can lead to a 5\u2014year survival Irate among 100% of women detected with precursor or very early disease stage and. {38- 90% of women detected with early lesions (Sorta LSJ, 1987; UICC,1994)  Current cancer screening is best described in general as \"convenience-screening\". There 1s also an acknowledged lack of public knowledge and awareness of the bene\ufb01ts of cancer-screening tests (lUP-DOH Cervical Cancer Screening Study Group). Further if there is any awareness among the client population the cost of screening tests becomes a limiting factor for not availing of the service.  This Administrative Order hope to establish an organized cervical cancer screening program that, 13 accessibleto target clients at all levels of the Health Care Delivery System that shall lead to subsequent diagnosis and medical management of detected cases. The initiative shall ultimately bring about a reduction in cervical cancer incidence and prevalence.  II. POLICY STATEMENTS  1. An organized screening program for cervical cancer shall be established in the Health System Standard screen methods appropriate for the facility shall be made available as follows.      2. Acetic Acid Wash (36%) shall be used as the screening method of choice for cervical cancer in the Philippines and shall be established at Local Health Units (RHUs/HCs), District Hospitals and Provincial Hospitals with no papanicolau smear (pap smear) capability.  3. Acetic Acid Wash (3-5%) shall be .used as a triage method before Pap smear at District, Provincial and Regional Hospitals with Pap smear capability. .  4. Colposcopy with biopsy as needed shall be a diagnostic test after positive or suspicious sereen-\ufb01ndings. The testIshall be provided at appropriate tertiary level health facility.  5. Pap smear shall be a monitoring diagnostic test in instances of cervical intraepithelial neoplasia stage 1 (CIN-l) \ufb01ndings and non\u2014availability of colpcscopy facility The test shall be provided at secondary and tertiary level facilities with the required infrastructure and logistics.  6. Women 25\u201455 years old shall undergo acetic acid wash cervical cancer screening at least once every 5-7 years  7. Acetic Acid Wash shall be advocated as an alternative screening method for cervical cancer by the health and welfare sector in government, non-government organizations, professionals, and civil societies at national and local level.  8. Positive or suspicious lesion noted upon screening shall be referred immediately to a referral facility where competent specialists shall do con\ufb01rmatory tests such as colposcopy and tissue biopsy  9. Referral centers for cervical cancer diagnostic tests and treatment shall be established in tertiary facilities.  10. Gender sensitive counseling and disclosure shall be a component of any training program for cervical cancer prevention and control. Gender as well as culture sensitivity of health staff involved in cervical cancer screening and treatment shall be emphasized as part of quality health service delivery.  11. Sustainability of the screening program shall be ensured through local \ufb01nancing e.g. subsidy from the local government unit or the health facility concerned, PhilHealth \ufb01nancing, or fee for service (user fee)' scheme.  12. A standard system of recording and reporting shall be developed and adopted at service delivery points.  13. Periodic evaluation shall be done at all levels to assess the progress of Acetic Acid Wash and its impact on cervical cancer prevention and control initiative  14. A regular yearly public information and education campaign aimed at changing behavior shall be done via mass media and inter-personal communication within each health center to inform and entice target women about the cervical cancer screen services.  III. OBJECTIVES  This Administrative Order shall facilitate the attainment of the following objectives:  General Objectives:  1. To establish and sustain an alternative method for cervical cancer screening at the Local Health Unit level (RHUs/HCs) for women 25-55 years old.  2. To establish referral centers for diagnosis and management at local, regional and national levels.  Specific Objectives  A. Establishment of cervical cancer sciteening facilities.  1. To establish and sustain acetic acid wash (AAW) screening facilities at the Local Health Units (RHUIs/HCs).  2. To institute and maintain a registry of target women within the catchment area.  3. To screen 50- 70% of women 25\u2014 55 years old for precursor of cervical cancer lesion at an interval of 5-7 years.  4. To develop competence of doctors, nurses and midwives at Local Health Units (RHUs/HCs) to implement AAW screen method and appropriate referral for con\ufb01rmatory tests, diagnosis and treatment  5. To identify and maintain referral centers for Papanicolau smear (pap smear), colposcopy, and biopsy.  6. To increase public awareness on the bene\ufb01ts of screening tests in the prevention and control of cervical cancer.  7. To effect an improvement in the health seeking behavior of target clients through an increase in the number of women aged 25 \u2014 55 years availing of screening test.  IV. COVERAGE AND SCOPE  This Administrative Order shall apply to public and private health providers of health facilities at all levels of the Health Care Delivery System in the country.  V. GUIDELINES AND PROCEDURES  The following guidelines shall govern the establishment of the Cervical Cancer Screening Program:  1. Identify Local Government Units (LGUs) with relative readiness-for acetic acid wash screen program. Prepare screen start-off at Local Health Units (RHUs/HCIs), District HOSpitals (DHs), and Provincial Hospitals (PHs)  2. Schedule and prepare next batch of health facilities within provinces for acetic acid wash screen coverage in the next 2\u2014 7 years.  3. Start a facility-basedregistry of target women 25 \u2014 55 years of age.  Invasive cervix cancer in the Philippines has its peak at age group 35 - 55 years (UIP\u2014PGH-DQH Cervical Cancer Screen Study Group).  4. Target screen coverage of 50\u2014 70% of women at an interval of 5 \u2014 7 years per woman.  Many studies assumed an initial attendanCe of 50\u2014 70%, and concluded that it is more cost-effective to increase attendance and perform fewer screenings than to screen a portion of the population at risk many times (Fans MC e1al,1996)  Occurrence of precursor and or early cervix cancer lesions is about age 25 years, 10 years before 35 years, when cervix cancer becomes clinically apparent. Carcinoma-ianitu (stage 0) takes as long as 10 years to develop into invasive disease (UP-PGH\u2014DOH Cervical Cancer Screen S iudy Group).  As long as the compliance of women to go for a regular interval of screens is 100%, even screening only once in the women s lifetime can signi\ufb01cantly reduce disease incidence (WHO), particularly if test is done at age 36\u2014 45 years (Fans MC eta], 1996).  Moreover, 84% disease reduction has been observed where screening is done every 5 years and 64% where screening is done every 10 years (WHO).  Screen intervals of less than 3 years and more than eight \u2014 10 years proved inef\ufb01cient (Fairs MC et al, I996).  5. Train health staff (doctor, nurse, midwife) assigned to do acetic acid wash screen  6. Provide the necessary logistics for acetic acid wash screen  7. Standardize screen and referral methods.  8. Identify screen referral hospitals within municipalities, provinces or regions.  9. Train medical staff on cytology I(pap smear and biopsy), colposcopy and treatment methods.  10. Conduct public information and education campaign through mass media, inter-personal communication within health centers, focus groups and other fora.  All health providers in the public and private sector shall comply with the following procedures in dealing with clients for and who have undergone acetic acid wash screen:  A. Doing the acetic acid wash screen.  1. Instruct the client not to douche or use any type of lubricant, and preferably refrain from intercourse for at least 24 hours prior to examination.  2. Inform the client of the necessity of an internal examination and requeSt her to assume a lithotomy position so that her hips are slightly over the edge of the'examination table. Reassure her that she will not be hurt and ask her to breath quietly through her mouth. Do not hurry the procedure; this will avoid upsetting the patient and gain relaxation of the abdomen.  3. Inspect the vulva and the vagina for any signs of abnormality, e. g. infection, discharge or bleeding\u2014 and gently separate the labia with \ufb01nger and thumb to expose the entrance to the vagina. Use a light source or a speculight.  4. Gently insert the bivalve speculum (appropriate size and moistened with warm water/saline) halfway into the vagina with blades parallel to the labia and at the same time gently pressing the area of the posterior commissure.  5. Gently rotate the 'speculum about 450 clockwise if right-handed, counterclockwise if left\u2014 handed before opening the blades. Open the blades. With little manipulation the cervix will usually come into view If this proves, imposSible, larger speculum may be used.  6. Once the cervix is visualized, lock the Speculum in the open position.  7. Inspect the vaginal walls -\u2014 they should be normally light pink with longitudinal and circular folds.  8. InspectI the cervix, with unaided eye - It is noiinally pink 1n color, with smooth surface. The external os is generally seen as a red, horizontal; or oval opening about 0.5 cm in size. - It is not uncommon to see what appears to be \"cervical erosion\" \u2014 an irregular-shaped red area extending from and surrounding the os The margin, however, is clearly de\ufb01ned. This, in fact, is cervical ectopion (ectopy)\u2014 a condition in which cells lining the cervical canal extend beyond the os on to the surface of the cervix. - Suspect cancer if any of the following are found-- -(1) grossly misshapen cervix, (2) ulcer or mass on the cervix, (3) ulcer has raised irregular poorly de\ufb01ned margin, (4) mass is irregular and ragged, (5) tissue is friable and bleeds easily on contact.  9. A large cotton swab immersed in 3% acetic acid is placed on the cervix for about 2 minutes. The cotton swab is removed, followed by immediate visual inspection, with aid of speculoscope if available. The following are possible \ufb01ndings: - Abnormal cervical areas would torn whitish (fades 1n 5 minutes). The patient is for immediate referral to hoSpital for colposcopy (if exam done initially in the community), or for immediate colposcopy and then biopsy if needed at hospital setting. Atypical blood vessels and/or irregular surface contour of cervix may also be seen which 1s, suspicious of cancer - If with normal cervical. examination results, advise patient to have another screen within 5 years from-last screen.  B. Acetic acid wash screen can be aided by magni\ufb01cation.  1. Acetic Acid visualization of the cervixcan be aided by use of magni\ufb01cation.  2. A speculoscope can provide a 4 6- -power magni\ufb01cation. - Pre\u2014focusing the speculoscopy- optic prior to perfOrming the \ufb01rst speculoscopy examination will save time and best prepare the examiner for this visual examination.  - To pre-focus the optic, the rubber eye shield should be placed up to the eye for viewing. (If the examiner is wearing eye glasses, fold the rubber eye shield back to place eyepiece closer to the eye glasses for wider \ufb01eld of view).  - At a distance of 14-16 inches away (equivalent to string length of speculosc0pe) from any printed material, slowly adjust the lens by, rotating the focusing ring until the printed material comes into focus. The optic has various markings indicating the focal distance.  - Remember which marking is \u201cin focus\" for you to facilitate quick adjustment of the optic with each use.  - With each examination, hold the speculoscopy optic towards the eye at a distance of approximately 16 inches from the cervix. By moving closer to or farther away from the patient, the cervix will be infocus.  - The normal cervical epithelium 1s a smooth, even pale pink color with no aceto\u2014white areas.  - Aceto-white areas on the cervix or vagina can be visualized with speculoscopy due to the fact that abnormal epithelium, which has a high nucleari\u2019cytoplasm ratio, appears white, particularly after washing with 3% acetic acid.  - Whitening is due to the nuclear protein becoming opaque (intercellular dehydration & coagulation of protein, makes epithelium white in areas where cell nuclei are densely packed in layers). These aceto\u2014white areas are well demarcated and contrast with heavy epithelium.  - Positive Acetic Acid screen \ufb01ndings can be \ufb02at white cervical epithelium, characterized by mosaicism (groups of small white epithelial cobbles), or new bizarre irregularly branching blood vessels.  C. Refer screen positive women to gynecology/colposcopy unit.  1. Immediately refer to Hospital for Colposcopy.  - If colposcopy shows (-I|-) cervical lesion, do biopsy; , - If cervix exam is (+) and colposcopy is (-), repeat colposcopy after 6 months; - If colposcopy is (- ), re-assure patient and advise cervix examination within 5 years. - If colposcopy is not available, Pap smear can be done as a diagnostic test after a positive screen test.  D. Con\ufb01rm presence of precursor/early cancer lesion by colposcopy.  1. The colposcopy is a stereoscopic microscope, which utilizes a bright light under 6- 60x magni\ufb01cations. The basic parts are:  - An optical magni\ufb01er which may range up to 60x - A controllable illumination system - A mounting device whichpermits movement and directed of the apparatus  2. A green \ufb01lter is included in the optical. system, which is used for enhancement of the cervical vascular system A teaching tube, video. camera and monitor unit may be attached in the basic unit for teaching/demonstrating purposes.  3. When conducting a colposcopic examination. the followingI instruments must be prepared: - Examination table and stool - Bivalve speculum - Cotton balls, gauze, cotton tip applicators, orange sticks, forceps saline, acetic-acid, iodine - Iris hooks and ermett tenaculum  - Endocervical speculum - Biopsy instruments: Eppendorf, Kevorkain, Tischler, Burke or Townsend - Endocervical curette: Kevorkain, Sims or Chanen  4. Ideally, colposcopic examination is done prior to any internal examination and biopsy. Sexual contact and douching 1s discouraged the night before the examination. Infections of the lower genital tract are treated prior to examination as this may give a falsely positive reaction to the staining agents.  - Examination 15 best carried out on the 18th-12th day of menstrual cycle. During this period, mucus is abundant and the external 05 is open. - Menopausal womeanith atrophic cervical mucosa are treated with estrogen for 8-10 days and colposcopy is done on the last day of treatment. - When the patient is placed in a lithot'omy position, the external genitalia is examined thoroughly. A dry speculum is inserted halfway into the vagina and is Opened carefully, avoiding scraping the mucosa of the cervix. - Mucus is carefully removed using a cotton swab or dry gauze. During the inspection, the surface of the cervix should be moistened with normal saline This increases the visuality of the vascular pattern. - Routine examination utilizes a 16x magni\ufb01cation. A green \ufb01lter 13 inserted to get an optical contrast of the vessels. - The transformation zone isidenti\ufb01ed by locating just the original squamous-columnar junction, which marks the lower border of the transformation zone. In menopausal women, the squamo-columnar junction may be near the cervical opening and the transformation zone pulled deeper into the cervical canal - Particular attention is placed on the vascular pattern within the transformation zone. The colposcopic examination is deemed satisfactory when the transformation zone is viewed in its entirety and the extent of the lesion deep into the cervical canal visualized.  E. If colposcopy \ufb01nds a positive or suspicious lesion, do biopsy  1. After inspection under the'saline technique, 3\u20145% acetic acid is applied for about 2 minutes to help coagulate the mucus. Acetic acid will also temporarily remove the water from the cellsinareas where there is a high nuclear density and the epithelium will become white. The effect of acetic acid lasts for only a few minutes, thus application with acetic acid may be repeated several times.  2. The following features should be noted down:  - Exact location, extent, borders or margins of the lesions - Its consistency, contour and color reaction to acetic asid  3. In patients with abnormal colposcopic \ufb01ndings, biopsy is taken from the most suspicious lesion.  4. A limitation of colposcopy is its inability to detect lesions deep in the endocervical canal. In such situation, and in cases where the squamo-columnar junction is not visible, an endocervical curetting or conization is indicated. Colposcopic appearances are reported as Grade I II and III:  - Grade I (insigni\ufb01cant)\u2014 flat epithelium, \ufb01ne caliber, regular shaped vessels, absence of atypical vessels small inter-capillary distance, corresponds to normal metaplastic, epithelium to minor dysPlasia. - Grade II (signi\ufb01cant).u \ufb02at, whiter epithelium, dilated caliber, regularly shaped vessels, absence of atypical vessels, unusually increased intercapillary distance; corresponds to major dysplasia or carcinoma-in- situ. - Grade III (highly Signi\ufb01cant) \u2014\u2014 very white epithelium, dilated caliber, irregular shaped coiled, often \"atypical vessels. increased but variable intercapillary distance and usually irregular surface contour (papillary epithelium or microexophytic epithelium); corresponds to carcinoma-in-situ or pre\u2014clinical invasive carcinoma. Atypical vessels and irregular surface contour often indicates invasive carcinoma.  5. The revised Reid\u2019s Schema (Table l)- uses colposcopic scoring to predict the histological diagnosis of the cervix lesion whether it is HSIL (high grade squamous intraepithelial; score of &gt;9), LSIL (low grade squamous intraepithelial lesion, 7- 8 score) or ISM (immature squamous metaplasia or atrOphic epithelium, &lt;5 score).  F. If positive on biopsy, do treatment.  G. Accomplish Cervix Cancer Screen Registry.  1. Establish system of registry collection Hard form accomplished 1n the \ufb01eld.  2. Written \ufb01lled-up forms will be converted to electronic \ufb01le, with main-frame at central DOH or at Philippine Cancer Society. Central DOH to summarize and give feedback to \ufb01eld centers.  Table 1. Revised Reid\u2019s Schema \u2014 Colposcopic Scoring     VI. IMPLEMENTING MECHANISMS  A. Roles and Responsibilities  1. Department of Health  1.1. Women\u2019 s Health and Development Program, Family Health Of\ufb01ce National Center for Disease Prevention and Control  1. Formulate plans, policies and standards for the institutionalization of Cervical Cancer Screening Program and adoption of Acetic Acid Wash as a cervical cancer screening method.  2. Provide consultative and advisory services to Centers for Health Development (CHD), Local Government Units (LGIU) and stakeholders relative to cervical cancer screening.  3. Provide technical assistance in the conduct of relevant training, advocacy, information, education, communication campaigns at the CHD and LGU levels.  4. Establish network at the national level.  5. Advocate for the establishment and maintenance of a Cervical Cancer Registry and database at the National Epidemiology Center  6. Provide technical assistance to the National Center for Health Promotion relative to the development of relevant prototype materials for information, education and communication campaigns.  7. Mobilize resources for cervical cancer prevention and control initiatives.  1.2 Centers for Health Development  1. Implement policies and standards relative to establishment of Cervical Cancer Screening Program and adoption of Acetic Acid Wash as a cervical cancer screening method in health facilities within the region.  2. Provide technical assistance to LGUs, local NGOs and other stakeholders on matters pertaining to cerv1cal cancer prevention.  3. Conduct relevant training, professional updates, orientation sessions, workshops, meetings and similar fora for health workers.  4. Monitor implementation of cervical cancer soreening at the LGU level.  5. Establish network at the regional level.  6. Collaborate with health facility service providers at all levels relative to cervical cancer screening.  7. Develop database for cervical cancer at the CHD level.  8. Submit quarterly- report to WI-IP-NCDPC using a standard reporting form.  9. Allocate necessary funds for monitoring and training.  1.3 Regional Hospitals and Medlcal Centers  1. Implement policies and standards relative to establishment and sustenance of Cervical Cancer Screening Program, diagnosis and treatment.  2. Provide technical assistance to LGUs, local NGOs and other stakeholders on matters pertaining to cervical cancer prevention when necessary.  3. Conduct relevant training, professional updates, orientation sessions, workshops, meetings and similar fora for health workers.  4. Develop and maintain database for cervical cancer in collaboration with CHD.  5. Develop revenue-generating schemes and allocate adequate funds to support cervical cancer screen, diagnostic and treatment services.  6. Collaborate with CHD in the conduct of advocacy and IEC activities.  2. Local Government Units  1. Implement policies and standards relative to establishment of Cervical Cancer Screening Program as follows.  o Acetic Acid Wash - Local Health Units (RHUs/HCs) - District Hospitals - Provincial Hospitals o Pap smear with Acetic Acid Wash triage - Provincial Hospitals (with infrastructure and logistics)  2. Provide the necessary infrastructure and logistics for cervical cancer screening using Acetic Acid Wash method.  - Competent health human resource to provide acetic acid wash screening and referral services. - Funds to procure supplies and other logistics. - Information materials on cervical cancer prevention and available screening services.  3. Develop revenue-generating schemes to support cervical cancer screening using acetic acid wash and to ensure its sustainability.  4. Keep relevant records and reports for submission to Provincial Health Of\ufb01ce.  3. Private Health Sector  1. Provide cervical cancer screening services, where available, according to quality standards set by the Department of Health, Women\u2019 s Health Program in its Cervical Cancer Screening Guidelines and Procedures.  2. Through their duly recognized societies and organizations, provide representation in national and local task forces and help ensure quality implementation of screening among their members  3. Assist the Women s Health. Program' 1n the development of quality assurance guidelines and standards for cervical cancer screening program.  4. Collaborate with the Women\u2019s Health Program in information and advocacy campaigns, operations research, establishment of database, and other related initiatives.  5. Provide expert assistance in tertiary service training of various \ufb01eld services-related to cervical cancer screening.  6. Assist in the conduct of Continuing Medical Education (CME) activities and in the conduct of operations research  B. Structure  The establishment of an organized Cervical Cancer Screening Program and the adoption of Acetic Acid Wash (AAW) as alternative cervical cancer screening method shall be the responsibility of the National Coordinator, Women Cancers and Other Gynecological Conditions Component of the Women\u2019s Health Program (WHP) The National Coordinator shall be under the supervision of the Director, National Center for Disease Prevention and Control.  At the Centers for Health Developmentgthe CHD Director shall designate the WHP Coordinator and Philippine Cancer Control Program (PCCP) Coordinator to assist the Provincial Health staff in the establishnwnt of AAW screen facilities at the local government level and overseeing its implementation at health service delivery points. Please refer to Annex A for the Organizational Structure.  D. Funding  The Department of Health, National Center for Disease Prevention and Control shall allocate Program funds to augment cervical cancer screening \ufb01inding requirement for training, IEC, and other relevant activities. The Health facilities operated by the DOH shall likewise allocate funds to support cervical cancer screening activities for poor women, for the non\u2014poor reasonable user fees may be charged and for PhilHealth members, reimbursements shall be applied.  At the Local Government Unit level, the LGU operating the health facility shall allocate funds to enable the health facilities to deliver cervical cancer screening procedures to target poor clients. It may also charge reasonable user fees to non\u2014poor clients Iand for PhilHealth members, reimbursements shall be applied.  Revenues generated from user fees and PhilHealth reimbursements shall be used as revolving fund of the facility to enable it to become self-suf\ufb01cient in terms of cervical cancer screening and referral.  VII. EFFECTIVITY  This Order shall take effect \ufb01fteen days after \ufb01ling with the University of the Philippines Law Center.   ", " I. BACKGROUND  Life expectancy is increasing Worldwide. According to the 2006 revision of the United Nations World Population Prospect Report for 2005- 2006 the Life Expectancy at birth in the Philippines is 4.5 years higher than the World average of 67.2 years and is the 5th highest among Southeast Asian countries.   The increasing number of older Filipinos is the result of increasing life expectancy and reduction of fertility rate. Its implication in health care delivery has been recognized by the Government with the issuance of Republic Act (RA) No. 9994, the Expanded Senior's Citizens Act of 2010, which is an act granting additional bene\ufb01ts and privileges to senior citizens, further amending RA No. 7432, otherwise known as \u201cAn AC1 to Maximize the Contribution of senior Citizens to Nation Building, Grant Benefits and Special Privileges and for other purposes.   RA 9994 Section 5.C on Health states that \u201cThe DOH, in coordination with local government units (LGU\u2019s), NGOs and POs fOr senior citizens, shall institute a national health program and Shall provide an integrated health- service for senior citizens... \" Throughout the country, there shall be established a \u201cSenior citizens\u2019 ward\" in every government hospital. This geriatric ward Shall be for the exclusive use for senior citizens who are in need of hospital confinement by reason of their health conditions. However, when urgency of public necessity purposes so require such geriatric ward may be used for emergency purposes, after which, such \"Senior citizens\u2019 ward\" shall be reverted to its nature as geriatric Ward.   Full implementation of this R. A. needs the guidance and the availability of the National Standards on Patient Safety not only in hospitals or acute care setting but also in Long Term Care provision including that of nursing homes, community ambulatory and home care which Constitute the whole continuum of care to address the Special health needs of the Filipino Older Persons.   II. OBJECTIVES  A. To provide policy guidelines for standards of care for older persons in all healthcare settings: acute and sub\u2014acute care, rehabilitation facility, continuing care retirement community and long term care.  B. To identify the basic rights of older persons, providing them dignity, safety, and protection from exploitation and any form of abuse or neglect.  C. To provide a guideline to safe and secure environments for older persons in all settings of care.  D. To strengthen the collaborative efforts among various Stakeholders engaged in the health service delivery for older persons to be accessible, of quality, more effective and efficient.  III. SCOPE  This Order shall cover the standards of care for older persons in acute care, sub-acute care, continuing care retirement community, rehabilitation and long term care facilities of government healthcare facilities in the Philippines.  III. DEFINITION OF TERMS  A. Acute Care - care that is generally provided for a short period of time to treat a new \"illness or a \ufb02are-up of an existing condition. This type of care may include treatment at home, hospital or emergency department.  B. Comprehensive Geriatric Assessment (CGA) \u2014 a process which includes a multidimensional assessment of a person with increasing dependency, including medical, physical, functional, cognitive, pharmacotherapeutic status and social-environmental situation. May use standardized assessment instruments and an interdisciplinary team to support the process.  C. Community Based Care\u2014 The blend of health and social services provided to an individual or family in his/her place of residence for the purpose of promoting, maintaining or restoring health or minimizing the effects of illness and disability. These services are usually designed to help older people remain in the community. They can include home health care service, adult daycare, barangay health services and family support networks.  D. Complex Health Needs- serious or severe interrelated multiple health conditions[adapted from http ://www.gov.scot/Publications/2007/01/18133419/4     E. Decisional Capacity \u2014 an older person having four abilities: understanding, appreciation, reasoning and expression of choice. Understanding means that appropriately conveyed information is comprehended, retained long enough to be recalled in a discussion, and the relationships between interventions and outcomes are perceived. Appreciation involves the recognition of how appropriately conveyed information relates to a person\u2019s specific circumstance, and can make insights about the relative advantages and disadvantages of a proposed solution.  Reasoning involves the manipulation of information to compare various alternatives and their consequences, and the justification of a rationale as a framework for such comparisons. Lastly, the expression of choice means the ability to communicate or convey a clear choice or decision. (Adapted from Hazard\u2019s Geriatric Medicine and Gerontology Textbook, 6th edition)  F. Frailty \u2014 a clinical state of being vulnerable to illness/es and having poor health outcome resulting from age associated decline in reserve and function causing a combination of problems with mobility, strength, fatigue, weight loss and reduced activity.  G. Frail older person \u2014 an older person needing of substantial level of care and support   H. Geriatric Care - providing prioritized patient-centered care for the older person with complex health needs in all healthcare settings by optimizing function and / or well being, integrating goals and values of the patient and their family in their plan of care and coordinating healthcare and healthcare transitions with other healthcare providers. (adapted from American Geriatric Society(AGS) and Association of Directors of Geriatric Academic Programs\" (ADGAP) Entrustable Professional Activities (EPAs) for geriatricians)  I. Home Health Care Service - refers to health or supportive. care provided to the older person at home by licensed health care professionals to include, but not limited to, physicians, nurses, midwives, physical therapist, caregivers and barangay health workers. (adapted from RA 9994)   J. Long Term Care - A range of health care, personal care and social services provided to individuals who, due to frailty or level of physical or intellectual disability, are no longer able to live independently. Services may be provided in a person\u2019s home, in the community or in residential facilities (e. g. nursing homes or assisted living facilities).  K. Long Term Care Facilities - An establishment primarily engaged in providing inpatient nursing and rehabilitative services to individuals requiring long term care  L. Multidisciplinary Team - Consists of members of different disciplines, involved in the same task (assessing people, setting goals and making care recommendations) and working alongside each other, but functioning independently.  M. Older Person \u2014 a person who is sixty (60) years old and above and is synonymous with the de\ufb01nition of senior citizens as described in RA 9994.  N. Quality of Life - The product of the interplay between social, health, economic and environmental conditions which affect human and social development. It is a broad-ranging concept, incorporating a person\u2019s physical health, psychological state, level of independence, social relationships, personal beliefs and relationship to salient features in the environment. As people age, their quality of life is largely determined by their ability to access needed resources and maintain autonomy and independence.  O. Rehabilitation facilities \u2014 provides services designed to improve function and/or prevent deterioration of functioning. Such services may include physical therapy, occupational therapy, and/or speech therapy.  P. Sub\u2014acute Care \u2014 is a bridge between acute care and home care. It is medical and skilled nursing services provided to persons who are not in the acute phase of an illness but who require a level of care higher than that provided in a long- term care setting.  Q. Surrogate Decision Making \u2014 decisions made on a patient's behalf when the patient has lost decisional capacity  R. Surrogate Decision Maker \u2014 a person who gives surrogate decision making, a proxy  V. GENERAL GUIDELINES  A. The standards of care for the older persons shall follow the principles of Patient-Centered Care and Senior Friendly Environments as described in this Order.  B. The standards of care for the older persons shall be integrated in the DOH licensing standards, facility development plans, and PhilHealth accreditation standards for all healthcare facilities.   VI. SPECIFIC GUIDELINES A. PATIENT CENTERED CARE  1. DIGNITY The right of the older person to maintain integrity and self\u2014respect to enjoy good quality of life and equity in access to the services necessary for optimal health must be ensured.   a. Processes should be respectful of older persons\u2019 values, cultural and religious belief.   b. The institution should respond to older persons\u2019 and families request for spiritual and religious support.  c. Policies should ensure utmost respect, timeliness and appropriateness of response to older persons\u2019 need.  d. End of Life Care Policies should be in place, monitored and implemented.  2. PRIVACY The state of being free from unsanctioned intrusion  a. There should be older persons\u2019 safeguard for ensuring privacy in all procedures, examinations and treatments.  b. There should be arrangements to ensure the patient\u2019s/resident\u2019s privacy with particular regard to personal self\u2014care and discussions/conversation of sensitive information with patient and family.   3. INFORMED CHOICE The process of choosing options to make acceptable healthcare decisions based on accurate information and knowledge between the healthcare provider and the older person or his surrogate decision maker.  a. The healthcare provider should inform the decision maker regarding goals of care strongly based on comprehensive geriatric assessment (CGA) and respectful of the patient\u2019s dignity.  b. Full-disclosure of available services, procedures and costs should be communicated and documented to the patient or surrogate decision maker for an informed decision.  c. Information on alternative sources of care and services should be provided when healthcare facility cannot provide the care and services.  d. All information should be clearly stated in a manner that is culturally sensitive and understandable to the decision maker.  e. Proper documentation of the procedural consent and advanced directives of the patient/ surrogate decision maker and care plan should be stated  4. CONFIDENTIALITY  Privacy in the context of privileged communication (such as patient-doctor consultations) and medical records are safeguarded.  a. The healthcare facility respects that older person\u2019s health information is strictly con\ufb01dential.  b. The care provider and patient or surrogate decision maker must accompany and enforce a con\ufb01dentiality agreement.  c. Policy and procedures to prevent loss or misuse of patient information are in place and implemented  d. The older person or surrogate decision maker is consulted for disclosure on what information is provided to his/her relatives or representative in relation to his/ her care and to whom this is provided.  5. PROMOTION OF QUALITY OF LIFE BASED ON BEST AVAILABLE EVIDENCE  a. All older patients with a positive risk screen should have a Comprehensive Interdisciplinary Geriatric Assessment for individual special complex needs.  i. Appropriate screening is undertaken to identify frail older patients at risk of adverse health outcomes e. g. falls and injuries.  ii. Following the assessment an interdisciplinary care plan is developed, implemented and monitored on a continued long  b. Rehabilitation programs are-in place to prevent functional decline of older persons.  c. Services should adopt Clinical Practice Guidelines available like Infection Prevention and Control and Antibiotic Stewardship in the management of acute medical, chronic degenerative conditions, and geriatric syndromes like polypharmacy, dementia, depression and delirium, etc.  6. SAFETY AND SECURITY Freedom from harm and injury is ensured in all healthcare settings.  a. Policies on older persons abuse/neglect are in place, strictly implemented and monitored.  b. Policies on appropriate use of physical and chemical restraints are documented and implemented.  c. Secured facilities are provided for the safekeeping of money and valuables of the older person/resident on their behalf. The provider\u2019s level of responsibility for the older person\u2019s possession is explicit and understood by the service user including their family.  d. Policies on disaster and hazard mitigation are in place in all healthcare settings.   e. All healthcare facility workers should be appropriately credentialed and privileged.   f. All healthcare facility workers should receive training in protecting the older person\u2019s interest including those with cognitive impairment  7. PARTICIPATION Older persons are helped to exercise choice & control over their lives, make choices/decisions about daily aspects of life &how to spend one\u2019s time  a. Each patient\u2019s rights to consultation & participation in the organization of the residential care setting & his life within it, are re\ufb02ected in all policies & practices  b. Regular family consultation or conferences are actively sought for health service delivery improvement  c. Feedback from the family and older persons or surrogate decision maker is actively sought to evaluate service delivery improvement and participation  d. Older persons and families are informed about their rights to refuse or discontinue treatment   e. The healthcare facility shall inform the older person and their surrogate decision maker as to the consequences and their responsibilities related to their decisions  f. Documentation of the participation and decisions by the older person and family are done accordingly  8. CONTINUITY AND INTEGRATION OF CARE Person-centered, coordinated and uninterrupted health care services bringing together all elements of care tailored to the needs and preference of the older person, carer and family to avoid confusion, repetition, delay and gaps in delivery.  a. There is an established entry/transfer criterion to guide the institutions/provider as to the appropriate level of care for the resident/patient when the need arises.  b. Coordination and continuity of care should be evident and documented when patient is in transition from acute hospital to nursing care homes or community or back to their own homes and vice versa  c. The required document (electronic medical record-recommended) should include the patient\u2019s functional and cognitive status, plan of care, and advance care directives, current problem list, current treatment regimen including all necessary equipment needed, allergies, meals and preferences, recent labs, consultations and results.  d. Documents regarding the care provided by healthcare facility are made available to patients or surrogate decision maker.  e. Discharge planning should commence within 24 hours of admission in an acute care facility.   f. Comprehensive Geriatric Assessment should be updated prior to discharge in chronic care facilities and made available to accepting facilities or carer and vice versa.  g. Medication reconciliation should be provided continually.  h. Provision for home care services or a visit by a member of the multidisciplinary team when the patient is at home should be in place and properly documented.  i. Utmost effort must be exercised in order to avoid early re-admissions and frequent hospitalization.  B. ENVIRONMENTAL Planning and design characteristics or elements needed to provide an appropriate physical environment for older people.  1. General Environmental Conditions  a. Rehabilitation Support  i. The environment enables older persons to have opportunities to participate in incidental activities, such as making a cup of tea or accessing the library, cafe or garden and to assume other non-patient roles.  ii. The environment is suitable for the functional and therapeutic activities taking place within.  iii. The environment provides opportunities for contextual relevant activities, such as using showers and basins similar to ones patients are likely to use at home.  iv. Provision for spaces that encourages social interaction between patients, visitors, staff and other users.   b. Adapted to the Individual  i. A protocol or policy is in place to ensure the physical environment is adapted as required to suit individual patients\u2019 needs. This protocol or policy would cover issues such as patient\u2019s personal items, restraint use, size and heights of furniture and equipment and room for gait aids and elder person placement in relation to nurses\u2019 station and toilets. (refer to \u201cUseful Tools Tips)   ii. Flexible arrangements for patients so as they would have a certain level of control over their immediate physical environment.  iii. Practice is consistent with protocol or policy as outlined above (recommendation i).  c. Night Time Audit   i. Noise in persons rooms at night 13 kept to a minimum, recommended at 35- 45 db.   ii. Disruption at patients\u2019 room at night is kept to a minimum.  iii. Noise levels of alarm and telephones are decreased at night.  iv. Lighting is suf\ufb01cient for night toileting.  v. Adequate night lighting is in all patient areas.  vi. Older persons have easy access to night lights.  vii. Provision for illuminated light switches to allow for easy location in the dark.  viii. Satellite/decentralized Nurse Station is recommended to allow easy access and monitoring of patients at night.  d. Level of Stimulation  i. Different \ufb01mctional areas are clearly demarcated by color, sign, physical layout. and use of partitions to assist patients to focus on tasks.  ii. Overstimulation such as calling out and loud speaking, background noise, loud noises, crowding, disruptive behavior from other patients is avoided.  iii. Under stimulation such as repetitive spaces with little activity, large open space is avoided.  iv. Use of public address systems is minimized. If possible, have announcements made by speakers who have low\u2014pitched voices (frequencies below 4000 Hz).  e. Level of Comfort and State of Disposition  i. The environment respects dignity and privacy.  ii. Small, comfortable and quiet areas are available for private social interaction between patients and visitors and patients and staff.  iii. Furniture is comfortable.   iv. In lounge or sitting areas, chairs are placed in small circles to encourage social interaction among patients and their families as well as staff and other users.  v. Rooms are fresh and fragrant\u2014smelling.  vi. Rooms are kept at a temperature comfortable for the patient through use of effective cooling and heating systems.  vii. Natural elements, such as views of gardens and trees and images or photomurals of natural scenes, are provided to decrease agitation and reduce stress levels.  f. Perceptible Environmental Conditions i. Glare is avoided. ii. Lighting 13 adequate throughout (for example, 75 watts). iii. Stairs are well-lit day and night, with light switches at top and bottom. iv. Lighting in all areas is at a consistent level so patients are not moving from darker to lighter areas and vice versa. v. Walls are in a contrasting color to \ufb02oors. vi. Handrails are in a contrasting color to walls.  2. Physical Environment Conditions  a. Access and Circulation  i. Provision of accessible parking spaces as required 1n all pertinent codes and laws.  ii. Covered walkway/canopy from the parking area/drOp off, allowing easy access for wheeled equipment. There should be no steps or steep gradients.  iii. Conventional steps with contrasted edges are available.  iv. All areas are accessible with provisions of ramps for changes in elevation having a gradient of not more than 1:12 or 8%.  v. External paths are level, non-slip and free of trip hazards, overhanging branches, shrubs, leaves, weeds and moss. _  vi. External and internal paths are clearly defined so as to guide the patients to their starting point without allowing them to become lost.  vii. Maintenance and monitoring of internal and external paths.  viii. Internal and external paths allow the patient to see into areas that might invite participation in an activity other than wandering.  ix. Internal and External paths, with a minimum of 2.50 meters. Width, are suf\ufb01ciently clear and wide to allow two people who are each using a frame to pass.  x. There are suf\ufb01cient seats and toilets along internal and external paths for regular rest   xi. Automatic sliding doors are used in Main Entrance and Hall doorways to avoid banging of heads.  xii. All doors are wide enough, min. of 900 mm single\u2014leaf, for easy clearance of wheelchairs, scooters and were required, beds.  xiii. Exits for patients with dementia are secure. Development of a patient alert system is recommended to notify the staff of a patient wandering out of the ward or hospital.  xiv. Full length glass panels or doors are avoided or clearly marked for visibility.   xv. Buttons in lifts are easy to reach and easily understood (for example, it is clear which the ground \ufb02oor is and which is the exit floor).   xvi. Reception is evident and accessible on arrival, and incorporates a high-low design to accommodate wheelchair users.  xvii. Waiting rooms are private and comfortable with access to food, drinks, toilets and a public telephone (including a phone link to request a taxi).  xviii. Reception and waiting rooms, as well as consulting rooms and treatment areas are in close proximity of each other.  xix. Handrails in corridors, paths, on all steps and in lifts are in accordance with AS 1428.1, Design for Access and Mobility.  xx. Windows are restricted by providing steel grilles and in the extent to which they open so that patients cannot climb out.  xxi. Areas where patients are not to enter (for example, cleaner\u2019s cupboards, and storerooms) are kept locked or camou\ufb02aged (for example, painted the same color as the wall, has a hidden door handle).  b. Orientation  i. Staff can be identi\ufb01ed and distinguished from patients and families.  ii. There are views to outdoors and landmarks to assist orientation.  iii. Provision for visual anchors to help patients and visitors to easily locate their position within the facility. These  anchors are characterized by elements that stand out and can be easily seen along the circulation paths.  iv. Large clocks and calendars are displayed.  c. Signage i. Signage is adequate. This includes having signs at eye level and on the \ufb02oor and using primary colors on all key areas that patients are required to go to.  ii. Signs using icons or symbols are familiar to older people, are easy to discern, have little detail and clearly represent their meaning.  iii. Directional signs are ef\ufb01ciently and adequately placed so as to enable patients of independent way-\ufb01nding.  iv. Text is easy to read and there is not too much information on one sign.  d. Surface Treatments i. Flooring is free of clutter and hazards, such as cords and loose rugs.  ii. Flooring is in good condition, \ufb01rmly attached and appropriate for tasks undertaken.   iii. Floor surfaces are non\u2014slip.  iv. There is an absence of raised edges on the \ufb02oor/ground. Joining strips between different \ufb02oor surfaces are as smooth as possible so as not to create resistance when wheeled equipment is being used.  v. Changes in \ufb02oor surface are clearly de\ufb01ned.  vi. Appropriate \ufb02oor cleaning equipment is available for the types of floor coverings.   vii. Floor cleaning procedures are developed and take into account safety of patients and staff.  e. I Equipment and Furniture  i. Furniture is secure enough to support a patient should they overbalance.  ii. Arms on chairs and commodes are secured and sturdy.  iii. Unused furniture is stored in a separate area when not in use. Adequate storage space is provided for equipment, mobility aids and furniture so that it is easy to access when required.  iv. Properly positioned so they do not have the potential to strike other objects when in the open position.  v. Chair legs stand straight, rather than sticking out on angles and posing a tripping hazard.  vi. Chairs have non-slip, easily cleaned fabric.  vii. Devices such as telephones, speakers and warning sounds can be adjusted to the needs of the individual.  viii. Equipment and mobility aids, which promote patient independence and patient and staff safety (for example, wheelchairs, footrests, pressure cushions, mobility aids, electric beds, slide sheets), are available when needed.   ix. All features on wheelchairs work effectively, including footrests being easy to move, wheels and brakes being in good working condition with good tread on tires, and wheels are moving freely. The type of wheel/tire must be appropriate for the \ufb02oor surface to maintain push/pull forces for staff to within acceptable limits and to facilitate independence for wheelchair users.  x. Gait aids have rubber stoppers in place and are in good condition, and wheels and brakes are in good working condition with good tread on tires and wheels moving freely.  xi. There is a proactive maintenance program in place for equipment.  3. Space-based Conditions a. Toilet and Bathroom  i. Patients can see toilet facilities from areas they frequently occupy.  ii. There is a suf\ufb01cient number of toilets close to activity areas so patients do not have to travel too far.  iii. Toilet \ufb02ush and sink taps are accessible and user-friendly (for example, automatic or lever handles).  iv. Receptacles for soap are designed so as not to-create a striking hazard (for example, where practicable they are recessed into the wall).  v. There is adequate space in the bathroom for patient, staff member and all patient\u2014handling equipment used.  vi. Hand basins in bathrooms allow wheelchair access- doors should have a min. width of 900mm.   vii. Walls around shower/bath and sink are marked in contrasting colors to the shower/bath and sink.  viii. Toilet paper dispensers are accessible.  ix. Grab rails in bathrooms are adequate to match patient and staff needs.   x. Chair and commode heights are adjustable so that patients can rise and sit with ease. Toilet heights are raised using over-toilet frames as required.  xi. Water temperature of taps is limited so that it cannot scald.  xii. Doors into bathrooms and toilets open outwards so an older person cannot fall against the door and block access.  b. Bed-based Bathroom  i. Shower bases are step\u2014less The gradient of the bathroom \ufb02oor must be assessed to ensure.  ii. Adequate drainage after the shower is used (otherwise, it\u2019s a slip hazard)  iii. The \ufb02oor gradient of the shower base is located far enough away from the toilet to avoid wheelchairs rolling away from the toilet doWn the slope.  iv. Receptacles for soap, shampoo and washers are easy to reach, including when seated, and do not require bending over to reach them.  v. Taps in showers are easily accessible for patients and staff (on side rather than back wall). Commodes and shower trolleys have rubber stoppers in place and are in good condition, and wheels and brakes are in good working condition with good tread on tires and wheels moving freely.   vi. Clothing hooks and towel rails are easily accessible from the seated position. In addition to this, IV hooks must be provided in place of IV stands and trolleys while inside the toilet and bath.  vii. Provision of grab bars for assisted use of all \ufb01xtures.  viii. If possible, a glass sliding door to the shower area shall be used to separate the water closet and lavatory to keep the area dry and prevent patients from slipping.  c. Bedroom  i. Wash basin must be provided at the entrance of bedrooms for carer\u2019s hand washing before attending to the patient.  ii. Firm mattresses are used to provide support when moving in bed.  iii. Bed height is adjustable but kept at lowest height for patient safety. Beds are able to be adjusted to an appropriate height for the carer to undertake patient handling and patient care tasks without bending. Electric beds are recommended.   iv. Color of the bed and sheets. is in contrasting color with the \ufb02oor.  v. Bed wheels and brakes are in good working condition with good tread on tires and wheels moving freely.  vi. There is access to a bedside table positioned so that placing items on it does not require undue stretching and twisting.  vii. A gender mix is avoided in patient rooms.  viii. Patients are encouraged to bring personal belongings to promote recognition of their room and increase comfort. Personal belongings are assessed for suitability in the health facility so that they do not create hazards for patients or staff.  ix. Patients\u2019 rooms are numbered and personal memorabilia is used for assisting patients to \ufb01nd their room.  x. Where a television is provided, the appropriate design and placement of it in the patient\u2019s room enhances the older person\u2019s comfort. This includes positioning for easy viewing and listening, and easy-to-use controls.  xi. Patients have a choice of whether to eat in communal dining areas or in their bedroom.  xii. Ceilings are designed to support ceiling hoists.  xiii. The environment is made accessible for visitors. '  xiv. Call bells work.  xv. Call bell positioning is \ufb02exible, allowing for right and left hand use by patients, and the buttons are easy to push. They should also be within easy reach when the patient is lying in bed or in the toilet or shower. Tum-off buttons for staff are easily accessible.  xvi. Light switches are within easy reach and accessible to patient (no higher than patient\u2019s shoulder height).  xvii. A patient reading light is mounted at each bed head.  VII. ROLES AND RESPONSIBILITIES  A. The Health Facilities and Services Regulatory Bureau- shall ensure that licensed healthcare facilities are compliant to the standards of care for older persons.  B. The Health Facility Development Bureau-shall coordinate/collaborate with the different concerned bureaus of the DOH\u2014CO in the provision of technical assistance, capability building, consulting and advisory services in the implementation of the principles of the standards of care for older persons in healthcare facilities.  C. The Health Human Resources Development Bureau-shall in coordination with National Center for Geriatric Health (N CGH) incorporate in the development of human resource for health the principles of standards of care for older persons.  D. The Disease Prevention and Control Bureau-Degenerative Disease Office- shall in the development of plans, programs policies, projects and strategies for disease prevention and control, provision of coordination, technical assistance, capability building, consulting and advisory services follow the principles of standards of care for older persons in this guideline.  E. The National Center for Geriatrics Health under JRRMMC \u2014 shall incorporate the standards of care for older persons in its mandate to provide gerontological education, training and specialization of the medical and allied professionals, community capability training, research and program development.  F. The PhilHealth - shall ensure-the principles of standards of care of older persons in accrediting licensed healthcare facilities are observed and followed.  G. The Health Promotion and Communications Service- shall in consultation with HFDB and DPCB develop and implement national communication plans/ campaigns to promote the standards of care of older persons.  H. The DOH-Regional Of\ufb01ces- shall oversee the implementation of policies and programs and enforcement of regulatory policies at the regional level of this guideline.  I. The DOH Hospitals, LGus and other concerned Healthcare Facilities \u2014 shall ensure that the standards of care for older persons in this guideline are complied with.  VIII. EFFECTIVITY  This Order shall take effect immediately.   ", "  I. BACKGROUND AND RATIONALE  The World Health Organization (WHO) Report of 2003 showed that mental, neurological and substance use disorders are leading causes of disability worldwide and are responsible for 33 percent of overall years lived with disability (YLDs). These disorders also contribute largely to the global burden of disease representing 13 percent of overall disability-adjusted life years (DALYs). More than 150 million people suffer from depression at any point in time and nearly 1 million commit suicide every year. About 25 million suffer from schizophrenia, 38 million from epilepsy, and more than 90 million from alcohol or drug abuse disorders.  Moreover, it is estimated that mental health problems and mental illness will affect more than 20% of the adult population in their lifetime and between 10-15% of young people in any one year. Many will recover spontaneously and of the remainder, the vast majority can be treated and will fully recover. However, a smaller number of people will experience longer periods of distress and disability.  Recognizing the public health impact of mental illness, the WHO' has identi\ufb01ed mental health as a global priority. It adopted mental health as the theme for World Health Day 2001 and the focused subject for the World Health Report for 2001. It has increased its support to countries undertaking interventions to improve mental health and thereby reduce the burden of mental illness. WHO developed the Regional Strategy for Mental Health to serve as guidelines in the formulation of policies and programs designed to respond to the challenges posed by mental health problems.  In the Philippine setting, the disability survey done in 2000 by the National Statistics Of\ufb01ce (NSO) found put that mental illness was the 3rd most common form of disability in the country. The prevalence rate of mental disorders was 88 cases per 100,000 population and was highest among the elderly group. This \ufb01nding was supported by a more recent data from the Social Weather Station Survey commissioned by DOH in 2004. It reveals that 0.7 percent of the total households have a family member af\ufb02icted with mental disability. The Baseline Survey for the National Objectives for Health in 2000 stated that the more frequently-reported symptoms of an underlying mental health problem were sadness, confusion, forgetfulness, no control over the use of cigarettes and alcohol, and delusions.  The most recent study on the prevalence of mental health problems was conducted by the National Epidemiology Center (DOH-NEC) in 2006 which showed revealing results though the target population was limited only to government: employees from the 20 national agencies in Metro Manila. Among 327 respondents, 32 percent were found to have experienced a mental health problem at least once in their lifetime. The three most prevalent diagnoses were: speci\ufb01c phobias (15 %), alcohol abuse (10%), and depression (6%). Males were most likely to have substance-related problems than females. Mental health problems were signi\ufb01cantly associated with the following respondent characteristics: ages 20-29 years, those who have big families, and those who had low educational attainment. The prevalence rate generated from the survey was much higher than those that were previously reported by 17 percent.  To address these concerns, several policies were made to deal with mental health and mental disorders in the country. One major policy was RA 9165, known as the Comprehensive Dangerous Drug Act which was promulgated as a measure to prevent problems in drug abuse which is recognized as both a direct and an indirect cause of mental illness among the economically productive age group. In 2001, the DOH formulated the National Mental Health Policy (Administrative Order No. 8 s. 2001), which prescribed the national policy framework towards the attainment of a good state of mental health for all Filipinos. The mental health strategy aims to improve mental health and integrate services for people with mental disorders. Implementation shall be guided by the succeeding policy statements, i.e., leadership, collaboration and partnership, empowerment and participation, equity, standards for quality mental health services, human resource development, health service delivery system, mental health care, stability and sustainability, information system, legislation and monitoring and evaluation.  The mental health policy was reaf\ufb01rmed in the National Objectives for Health, which outlined the goals, and objectives to be achieved by the health sector by 2010. It also speci\ufb01ed strategies for national reform from an institutionally based mental health system to one that is consumer focused with an emphasis on supporting the individual in their community.  In order to facilitate the overall implementation of these goals, priority targets and strategies aligned to health systems goals of improving the health status in the country, this Order is hereby established to provide policy guidelines and procedures for establishing mental health program at the national and local levels.  II. OBJECTIVE  To provide general guidelines for stakeholders in the government and private sector on the development and implementation of the National Policy on Mental Health through plans and programs, in order to protect the rights and freedom of persons with mental disease, thereby reducing-the burden of mental and neurological disorders in the country.  III. SCOPE AND COVERAGE  This issuance covers the Department of Health including its attached agencies, the local government units, non-government organizations and other devolved health services.  It shall also include the public and private sectors such as national agencies, including government-owned and controlled corporations, faith-based organizations, academe, media, professional associations, civil society and international development agencies whose activities contribute to the improvement of the state of mental health of the Filipino people.  IV. GENERAL GUIDELINES  A. National Objectives for Health and F1 encompasses mental health and applies to the promotion of mental health as follows:  1. The goals of the mental health program are to reduce mental health prevalence; reduce mortality from suicide and intentional harm, and reduce the risk for mental disorder through the promotion of mental health in the general population and improvement in the quality of life for those suffering from such condition;  2. Service Delivery:  a) To integrate-mental health services into the existing Mental Health programs in the DOH retained hospitals, LGU health facilities, NGOs and other concerned agencies;  b) To increase the number of DOH retained hospitals/medical centers and LGU health facilities capable of providing mental health services by 10% every year;  c) To improve the competencies of health service providers on Mental Health Program;  d) To develop a technical assistance package for national agencies, local government units, private sector and NGOs relating to Mental Health policies and programs by end 2008  e) Strengthen school and workplace mental health programs  3. Financing:  a. To mobilize resources for MH from the private sector and funding agencies;  b. To facilitate the expansion of the Philippine Health Insurance benefits package for Mental Health by 2008  4. Regulation:  a. Regulate custodial home care and clinics providing, mental health services in coordination with the Bureau of Health Facilities Services.  5. Governance:  a. To establish a coordinating mechanism for the successful implementation, monitoring and evaluation of the National Mental Health Program which necessitates institutionalization of a functional management structure  b. To establish and implement a Mental Health research, monitoring and evaluating system by the end of 2008  B. The National Mental Health Program focuses on four priority sub-programs:  1. Wellness of Daily Living  Focuses on attaining and maintaining the well- being of person/s across the life cycle through the promotion of healthy lifestyle with emphasis on coping with stress and other psychosocial issues.  Objectives:  1. To increase awareness among the population on mental health and psychosocial Issues. 2. To ensure access of preventive and promotive mental health services.  Strategies: a) Healthpromotion b) Resource mobilization c) Capability building d) Networking and referral e) Research development f) Information Management system g) Development of standardized guidelines for Mental Health services h) Development of health benefit package (\ufb01nancial) i) Development of model Mental Health community services  2. Extreme Life Experience  Focuses on addressing the psychosocial consequences and maintaining mental health of person/s who experiences incidents that are out of the ordinary, such as disaster, epidemic, trauma, etc., which threatens personal equilibrium  Objectives: 1. To categorize/ prioritize the extreme life experience which may be the concern of mental health 2. To identify programs to address the psychosocial consequences and mental health issues 3. To identify strategies / interventions to implement this program as a result of these extreme life experiences 4. To undertake necessary researches to guide in the implementation and development of programs 5. To sustain the multi-sectoral collaboration with other stakeholders for a uni\ufb01ed mental health program  Strategies: a. Capacity building in psychosocial care in the midst of extreme life expenences > Orientation and values formation > Training of Trainers at the national and regional level > Training of direct service provider at the city / municipality and barangay levels Involving both 60/ non-government groups > Development of relevant/ expanded mental health training modules   b. Advocacy Program > For a continuing awareness of all policy 1 decision makers on the importance of mental health concepts i skills in addressing extreme life experiences > Continuing corrections on misconceptions, negative prejudice / stigma and active discrimination existing in the community and current laws.  c. Establishment/ development of~mental health services supported by LGUs  d. Organization of a functional technical working group to oversee the implementation of the program  f. Conduct of relevant researcher  g. Quantitative - evidence based data to guide psychosocial Interventions  h. Qualitative \u2014 capture human dimensions and extreme life experiences integration and institutionalization of mental health program in disaster programs, rehabilitation programs, chronic illnesses programs.  3. Substance Abuse and other forms of addiction  Focuses on the promotion of protective factors and prevention against the development of substance abuse and other forms of addiction in the following key settings (Family, School, Workplace, Community, Health Care Setting, Industry) through existing DOH programs and responsible agencies;  Objectives:  1. To provide implementers accurate, technical information about the psychosocial issues of substance abuse and other forms of addiction.  2. To promote protective factors against the development of substance abuse and other forms of addiction in the following key settings (Family, School, Workplace, Community, Health Care Setting, Industry) through existing DOH programs and responsible agencies  3. To rationalize and enhance the Substance abuse and other forms of addiction program to different key settings as a form of deterring factor.  4. Enhance detection of substance abuse through accurate clinical assessment and analytical testing.  5. To develop CPGs for different substance abuse disorders and other forms of addiction at different levels of care.  6. To provide and sustain a healthy drug free/alcohol impairment free lifestyle by enhancing protective factors in the different key setting  7. To have a good aftercare support program  Strategies:  a. Develop Capability Building program intended for the health workers related to the speci\ufb01c target population.  b. Establish/ Develop linkages with major agencies that deal with primary intervention of substance abuse and other forms of addiction  c. Clearing house to pool technical information regarding substance abuse and other forms of addiction  d. Advocacy as a strategy \u2014 protective mechanisms/ life skills management  e. Develop an integrated standard of care for all programs being used by the treatment and rehabilitation centers.  > General Standards > Ethical Standard > Quali\ufb01cations > Certi\ufb01cations for both Professional and Para-Professional. > Facility as a whole  4. Mental Disorder  Focuses on the promotion of mental health and prevention of mental illness, such as clinically behavioral or psychological syndromes, across the lifespan of an individual (i.e. children, adolescents, adults, elderly, special populations such as the military, Overseas Filipino Workers, refugees, and persons with disabilities)  Objectives  1. Early detection 8 control of symptoms, maintenance of treatment and adherence to the treatment. 2. Re-integration in the community with adherence to the treatment, thereby improving their quality of life. 3. Compliance to treatment guidelines and protocols.  Strategies: a) Psycho-education (including priority programs of the DOH) develop modules for TOT b) training of trainers and educators c) Multimedia campaign (quad-media) d) Develop a socio-culturally sensitive regional model for the promotion of mental health and prevention of mental disorders with an integrated hospital and community based system of service delivery > Island- based > Urban & Rural e) Develop treatment guidelines for the following: > ADHD, suicide, autism (children),  > Schizophrenia, mood disorders, depression, bipolar & mood disorders, > Anxiety disorders (adults); dementia (elderly) f) Address the \u201ctreatment gaps\" g) In patient service/day treatment for the elderly h) Establishment of National Institute for the Care of the Elderly (NICE) i) Monitoring and evaluation  C. Mental Health Program adopts the following key approaches and strategies  The subsequent strategies shall be implemented to achieve the objectives of the National Mental Health Program.  1. Health Promotion and Advocacy  Enrichment of advocacy and multimedia information, education and community (IEC) strategies targeting, the general public mental health patients and their families, and service providers shall be done through the promulgation of Observances issued by the Of\ufb01ce of the President.     A shift in perspective and a wider adoption of new concepts are needed. To this end, advocacy shall be directed at increasing awareness of both decision-makers and the general public on the importance of mental health. Advocacy and public information campaign shall be strengthened by developing individual, household, community and institutional resources to promote awareness in the prevention, control and management of mental disorders. Advocacy for positive health seeking behavior to increase the proportion of the high risked population such as victims of violence, disasters, etc. who seek help for personal and emotional problems. Furthermore, policy-makers, program planners and implementers have to be. convinced that mental health is part of public health and that new approaches are required to address the gap in mental health program in health service delivery.  A more informed understanding of mental health in the wider community to address stigma and negative community attitude should be ensured. An increased support for family and consumer advocacy and self help groups shall be guaranteed  2. Service Provision - Enhancement of service delivery at the national and local levels will enable the early recognition and treatment of mental health problems. To ensure continuity of care, mental health services for people with persistent disabilities shall be established close to home and the workplace. Treatment for mental disorders shall be integrated into the broad areas of health care and general health services, particularly primary health care for accessibility and service provision  3. Policy and Legislation - National legislation, policies, standards and plans of action for the promotion of mental health and the prevention and treatment of mental disorders shall be developed and institutionalized, ensuring that they are consistent with current principles and approaches. The formulation of policies, program standards and guidelines shall emphasize the development of ef\ufb01cient and effective structures, systems, and mechanisms that will ensure equitable, accessible, affordable and appropriate health services for the mentally ill patients, victims of disasters, and other vulnerable groups.  4. Encouraging the development of a research culture and capacity - The program shall support researches and studies relevant to mental health, with focus on the following areas: clinical behavior, epidemiology, public health, treatment options, and knowledge management. It aims to acquire evidence-based information that will contribute to public health information and education, policy formulation, planning and implementation. Evidenced\u2014based policies and practices will maximize the limited resources available to the program. In line with this, a national research agenda for mental health shall be established.  5. Capability Building - The capability of national, regional and local health workers in delivering ef\ufb01cient, effective and appropriate mental health care services shall be strengthened. Training shall be conducted on psychosocial care, the detection and management of speci\ufb01c psychiatric morbidity, and the establishment of mental health facilities  6. Public-Private Partnership - Inter-sectoral approaches to mental health promotion and the prevention and treatment of illness to provide a supportive environment for diagnosis, treatment and prevention shall be provided, e.g. labor organizations to ensure that appropriate support services are available at the workplace. Networking with other government agencies, non-government organizations, academe and private service providers and other stakeholders at the local, regional and national levels shall be pursued to develop partnerships and expand the involvement of stakeholders in: a) advocacy, promotion and provision of mental health services; b) conduct of relevant studies, researches and surveys; 0) training of mental health workers; (1) sharing of researches, data and other information on mental health issues and concerns; and e) sharing of resources.  7. Establishment of data base and information system - This is needed to determine the magnitude of the problem, its epidemiological characteristics and knowledge and practices to serve as basis for shifting the program from being institutional and treatment focused to being preventive, family focused and community oriented.  8. Development of model programs - Best practices/models for prevention of substance abuse and risk reduction for mental illness can be replicated in different LGUs in coordination with other agencies involved in mental health and substance abuse prevention programs.  9. Monitoring and Evaluation - A regular program review process shall be conducted. Results of program monitoring and evaluatiOn shall be used in formulating and modifying policies, program objectives and action plans to suStain the mental health initiatives and ensure continuing improvement in the delivery of mental health care. The formulation and implementation of the monitoring and evaluation component will depend on program and project activities, their outputs, outcomes and impacts, and the-availability of \ufb01nancial, human and information resources.  V. IMPLEMENTING MECHANISMS  A. Management Structure  The successful enhancement, implementation, monitoring and evaluation of the National Mental Health Program necessitates institutionalization of a functional management structure that groups mental health stakeholders into committees and teams: the National Program Management Committee (NPMC), the Program Development and Management Teams (PDMT), the Regional Mental Health Teams (RMHT), and the Local Government Unit Teams for Mental Health (LGUTMH).  1. National Program Management Committee  a. Composition  To ensure coordination and sustainability of the National Mental Health Program, a National Program Management Committee (NPMC) shall be organized in the Department of Health. The Chair of the Committee shall be the Undersecretary of Health of the Policy and Standards Development Team for Service Delivery, Co-Chaired by the Director IV of the National Center for Disease Prevention and Control. The Committee shall be composed of mental health advocates from central and regional DOH units; DOH retained hospitals, medical centers and other attached agencies; other public agencies: the academe; local government units, donor organizations, media, professional associations, civil society and international development agencies.  b. Functions  To ensure comprehensive management of the National Mental Health Program, the National Program Management Committee shall have the following functions:  , Oversee the development of mental health measures for sub-programs and components;  , Integrate the various progtams, projects and activities from the various program development and management groups for each sub-program;  , Manage the various sub-programs and components of the National Mental Health Program;  , Oversee the implementation of prevention and control measures for mental health Issues and concerns;  , Recommend to the Secretary of Health a master plan for mental health aligned with the mandates and thrusts of various government agencies.  2. Program Development and Management Teams  a. Composition  Under the NPMC, Program Development and Management Teams (PDMT) shall be established corresponding to the four sub- -programs of the National Mental Health Program. A PDMT shall oversee the operations of a sub- program of the National Mental Health Program.  Members of the PDMT shall be composed of mental health advocates coming from the academe, non-government organizations, government agencies, civic organizations and donor organizations, and specialty societies or associations.  Each sub-program shall have a designated Chairperson and a Vice-chairperson. Members of the Program Development and Management Team shall nominate them. Furthermore, a secretariat shall be created to support the Program Development and Management Team. Members of the secretariat shall be composed of DDO-NCDPC staff. They would be acting on an ex\u2014officio capacity.  To ensure the dedication of the members of each Program Development and Management Team, bilateral agreements shall be developed and fostered upon.  b. Functions  The functions of the Program Development and Management Teams shall be the following:  , Formulate and recommend policies, standards, guidelines approaches on each specific sub- -programs on mental health; , Develop a plan of action for each speci\ufb01c sub-program in consultation with mental health advocates and stakeholders , Develop operating guidelines, procedures, protocols for the mental health sub-program. Ensure the implementation of the program among all stakeholders; , Provide technical assistance to other mental health teams aCcording to sub-program thrusts.  3. Regional Mental Health Teams  3. Composition  , To ensure an ef\ufb01cient and effective multisectoral implementation of the National Mental Health Program at the regional level, a Regional Mental Health Team (RMHT) shall be established in each of the Centers for Health Development (CHD). Members of the RMHT shall be composed of mental health advocates from government agencies, non-government organizations, civil societies, academe, specialty societies or associations, and representatives from the local government units.  , The RMHT shall be chaired by the Director of the Center for Health Development. A Vice-chairperson shall be nominated by members of the Regional Mental Health Team. A secretariat shall be created to support the team;  , To ensure the dedication of the members, bilateral agreements shall be developed between the Center for Health Development and members of the team;  , A Regional Coordinator for the National Mental Health Program shall be designated by the Center for Health Development Director. The coordinator shall be responsible for the technical and administrative concerns of the program within the region.  b. Functions  The functions of the RMHT shall be the following:  , Oversee the planning and operation of the National Mental Health Program at the regional level;  , Provide technical assistance on the issues and concerns pertaining to the implementation of the different subprograms of the National Mental Health Program;  , Strengthen technical and managerial capability at the local level to ensure LGU participation on the implementation of the National Mental Health Program;  , Ensure establishment of LGU teams for mental health;  , Ensure the conduct of monitoring and evaluation of the implementation of the National Mental Health Program at the regional level;  , Regularly update the Program Development Management Team on the status of the regional implementation of the National Mental Health Program.  4. Local Government Unit Mental Health Teams  To ensure efficient and effective management of the National Mental Health Program at the local level, it is suggested that an LGU Mental Health Team (LGUMHT) be established by respective local government executives.  a. Composition  The suggested members of the LGUMHT are the local health board members, technical health staff, civil society groups, non- government organizations and other stakeholders  b. Functions  Suggested functions of the LGU Mental Health Team are the following: - Enact necessary legislative issuances (e.g. ordinances, resolutions, etc.) in support of National Objectives for Health, Fourmula One for Health, RA 9165, RA 9211, A0 8 s. 2001, and the National Mental Health Program; , Promote and advocate the implementation of the Community-based Mental Health Program among their respective localities and constituents;  5. Other Partners and Stakeholders  Other stakeholders who may or may not belong to the above-mentioned committees or teams may contribute to the. implementation of the National Mental Health Program by:  , Ensuring the availability of competent, ef\ufb01cient, culturally and gender-sensitive health care professionals who provide mental health services;  , Identifying mental health needs of the population and refer findings to the appropriate mental health care provider;  , Promoting and advocating for the implementation of the program within their respective areas of responsibility;  VI. FUNDING  The Department of Health and Centers for Health Development shall allocate funds for technical assistance, monitoring and advocacy campaigns. Other government agencies, local government units, non-government organizations, donors and other stakeholders involved in mental health activities are encouraged to contribute funds and other resources to ensure the implementation of the National Mental Health Program at all levels.  VII. REPEALING CLAUSE  Provisions of Administrative Order No. 8 s. 2001 and other related issuances inconsistent with this Administrative Order are hereby revised, modi\ufb01ed or rescinded accordingly. All other provisions of existing issuances which are not affected by this order shall remain valid and in effect.  VIII. SEPARABILITY CLAUSE  In the event that any provision of this Order is held invalid, the validity of the remaining provisions shall not be affected  IX. EFFECTIVITY  This Order shall take effect immediately.   ", "  The National Diabetes Commission created through the Republic Act No. 8191 (also known as National Diabetes Act of 1996), in compliance with Section 7 of the said Act, formulated the long range Master Plan for the National Diabetes Prevention and Control Program in its effort to reduce the high rate of increase in diabetes prevalence as well as the morbidity and mortality rates. The focus of the program is on the primordial and primary level of prevention which calls for the development and strengthening of the awareness campaigns and the continuing education of health personnel and concerned individuals to prevent the disease and its complications.  On August 25, 1998, through a Department Order No. 142-G FAE series 1998, signed by then Secretary of Health, Dr. Felipe A. Estrella, the Committee for the Accreditation of Diabetes Educators in the Philippines was created to determine the standards and procedures for the accreditation of training courses, trainers and trainees on diabetes, its prevention and control.  The Department of Health hereby issues the following \u201cStandards for Diabetes Education in the Philippines.\"   I. Title  This administrative issuance shall be known as the Standards for Diabetes Education in the Philippines.   II. Purpose  The Committee on Accreditation under the National Diabetes Commission (now the Oversight Committee) is tasked with the following: 1. To develop a framework on diabetes education 2. To formulate the standards of practice for Diabetes Educators 3. To develop the core curriculum for Diabetes Educators 4. To create a body that would accredit or certify Diabetes Educators 5. To develop/establish mechanisms for accreditation/certification of Institutions and individuals.   III. Scope 1. Role of the Diabetes Educators A Diabetes Educator has a multidimensional role with boundaries for accountability that interface with the other members of the health team. Diabetes Education involves the education of patients with diabetes, their families and appropriate support systems, on diabetes self-management and related issues. It Is also intended to include increasing public diabetes and its socioeconomic implications as well as educating other health personnel who do not specialize in diabetes care and management.  2. Basic topics to be included in the contents of the education package: . Epidemiology of Diabetes Mellitus . Physiology of Diabetes Mellitus . Basic principles in the prevention of Diabetes Mellitus . Genetic counselling . Principles and strategies of diabetes education . Exercise and activity . Nutritional management . Pharmacological interventions . Self-monitoring of glycemic control . Psychological assessment and support . Behavior modification . Stress management . Problem solving skills . Prevention and management of acute and chronic complications . Economics in the treatment of diabetes . Use of health care delivery system 3. The specialty practice shall include the following settings: . the schools . the community . the workplace . the hospital  4. Recommended Standards for Diabetes Education Program includes: 4.1.Structure standards  4.1.1. Human resources  a. Diabetes educators b. Training faculty 4.1.2. Physical resources 4.1.3. Curriculum of the Diabetes Education Program 4.1.4. Coordination and Administration Flow 4.2. Process Standards and Indicators for Diabetes Education 4.3. Outcome Standards for Diabetes Education and Diabetes Educators and their indicatOrs  A Council for the Accreditation and Certification of Diabetes Educators in the Philippines (CADEP) shall be established to uphold the highest level of standard for diabetes education and practice in the country. The Council shall be composed of health care professionals from various disciplines to be recommended by the Oversight Committee for Diabetes (National Diabetes Commission).    V. Effectivity  This Administrative Order shall take effect upon approval by the Secretary of Health.     ", " I. Rationale   Tobacco is the leading preventable cause ofdeath, killing 5.4 million people per year from lung cancer, heart disease and other diseases, according to the World Health Organization (WHO) Report on the Global Epidemic, 2008.   Smoking in the Philippines is among the highest in the world today. In 2003. the country ranked 9th highest in the world for adult male smokers, according to the World Lung Foundation and the American Cancer Society. In the same year, the country ranked 16th highest in the world for female adult smokers. Even among the world\u2019s youth, the country counts among the heaviest tobacco users with Filipino girls occupying 2nd place and Filipino boys occupying the 4th slot, in 2003. In the country, tobacco\u2014related diseases comprise 6-8% of deaths from all causes; or one in every five students ages 13\u201415 currently smoke and 35% of adults are current smokers.   It is equally alarming to note that hundreds of thousands of people who have never smoked die each year from illnesses related to inhalation of other people's tobacco smoke. Half of all children worldwide are exposed to tobacco smoke, particularly in the home. More than 50 studies on environmental smoke and lung cancer risk in people who have never smoked, especially spouses of smokers, have been conducted during the last 25 years. Most ofthese studies showed an increased risk, especially for persons with higher exposures.   The increasing evidence on the impact on health of expenditure to tobacco smoke demands greater protection of smokers and nonsmokers. Scienti\ufb01c evidence has firmly established that there is no safe level of exposure to environmental tobacco smoke (ETS) or second-hand tobacco smoke (SHS), a pollutant that causes serious illnesses in both adults and children. SHS contain thousands ofknown chemicals, at least 250 of which are known to be carcinogenic or otherwise toxic. Thus, increased protection would lead to a change in the perception of smoking and in behavior toward smoking, along with a reduction of smoking itself.   The WHO issued the guidelines on Article 8 of the FCTC on the protection from exposure to tobacco smokc and these are adopted by the Conference of the Parties to the WHO FCTC in 2007. Principle One ofthe guidelines state:   \"Effective measures to provide protection \ufb01'om exposure to tobacco smoke, as envisions by Article 8 of the WHO Framework Convention, require the total elimination of smoking and tobacco smoke in a particular space or environment in order to create a 100% smoke-free environment. There is no safe level ofexposure to tobacco smoke, and notions such as a threshold value for toxicity \ufb01'om second-hand smoke should be. rejected, as they are contradicted by scientific evidence. Approaches other than 100% smoke free environments, including ventilation, airfiltration and the use of designated smoking areas (whether with separate ventilation systems or not), have repeatedly been shown to be ineffective and there is conclusive evidence. scientific and otherwise, that engineering approaches do not protect against exposure to tobacco smoke. \"   Implementing 100% smoke\u2014free environments is the only effective way to protect the population from the harmful effects of exposure to SHS.   This Administrative Order supports the earlier Administrative Order No. 2007-0004 dated January 15, 2007 which serves as IRR to the Tobacco Regulation Act of 2003 (RA 9211).   II. Objectives   1. To protect the pOpulation from the damaging effects caused by tobacco smoke by promoting a comprehensive 100% Smoke-Free Environment.   2. To encourage LGUs to actively ensure 100% Smoke\u2014Free Environment, the DOH shall develop an awards system.    III. Scope and Coverage   This Administrative Order shall cover all DOH of\ufb01ces/units at the Central Of\ufb01ce, the Centers for Health DeveIOpment, Hospitals and attached Agencies as well as all levels of Local Government Units (Provincial, City, Municipal and Barangay).   IV. De\ufb01nition of Terms: As used in the context of this Order, the following terms are defined as follows:   1. 100% Smoke\u2014Free Environment \u2014 referred to as a complete ban on smoking which provides effective protection from ETS.   2. ETS \u2014 refers to environmental tobacco smoke or equally refers to second\u2014hand tobacco smoke (SHS) or other people's smoke. It is the combination of smoke emitted from the burning end of a cigarette or other tobacco products usually in combination with the smoke exhaled by the smoker. Terms such as \u201cpassive smoking\" and \u201cinvoluntary exposure to tobacco smoke\" should be avoided since the tobacco industry may use these terms to support a position that \u201cvoluntary exposure is acceptable.\"   3. FCTC \u2014 Framework Convention on Tobacco, the world\u2019s first public health evidence\u2014based treaty adapted by WHO Member States, including the Philippines on 21 May 2003 during the 56l World Health Assembly. This treaty is the first international legal instrument designed to reduce tobacco\u2014related deaths and diseases around the world. It reaffirms the right of all people to the highest standards of health.   4. Smoker \u2014 a person who smokes any tobacco product either daily or occasionally.   5. Tobacco use \u2014 the consumption of tobacco products by burning, chewing, inhalation and other forms of ingestion.   V. Policies and Guidelines   The Department of Health shall adopt a 100% Smoke-Free Environment Policy in all health facilities, hospitals and all DOH-attached agencies nationwide and shall recommend the adoption of this policy to all LGUs and private health facilities nationwide.   To promote a 100% Smoke-Free Environment in all health facilities, hospitals. CH DS and DOH-attached agencies, the following strategies and approaches must be institutionalized:   a. The prohibition of tobacco use in all health facilities. hospitals and DOH\u2014attached agencies premises, including, but not limited to: offices, grounds, motor pool areas, canteen/cafeteria/food preparation areas, dormitories, quarters.   b. The ban on sale of tobacco products within one hundred (100) meters from any point of the perimeter of offices of DOH and attached agencies, hospitals and health facilities;   c. Display of tarpaulins, posters and other relevant information materials on the ill effects of smoking (e.g. Smoker\u2019s Body and Picture\u2014Based or Graphic Health Warnings) in strategic places of buildings, compounds and premises.   d. The conduct of trainings, meetings, workshops and any health human resource development activity only in smoke\u2014free establishments.   e. All things being equal, the preferential recruitment and selection of non\u2014smoking individuals to plantilla positions over those who smoke but possess the same qualifications for the position.   f. Provision of information and/or assistance on where to go and what to do if the employees would want to quit smoking.   g. Disciplinary action shall be imposed 0n smoking personnel who fail to uphold the policy. Smokers will be required to attend sessions on smoking cessation until a desired behavior is achieved.   h. Placing stiffer penalties like an administrative ease for not following office rules pursuant to Civil Service Rules and Regulations.   i. The above guidelines should be made integral part of any policies and programs related to implementing and advocating healthy workplaces.    3. The Department of Health shall identify and recognize LGUs enforcing 100% Smoke Free Environment. In so doing, the Department shall:   a. Develop standard protocoltchecklist that promote and integrate Tobacco Prevention and Control in the Continuing Quality Improvement Program. Acereditation/certiftcation by the health authorities of premises as offering a 100% Smoke\u2014Free Environment becomes vital part of the LGU regulatory function. Accreditation certification is awarded after the competent authorities have ascertained that the suggested activities have been carried out and alter verifying the information provided and the impact on users and the community.   b. Develop a set of criteria and mechanisms to identify champions of 100% Smoke- Free Environment.   c. Develop an awards system and provide incentives to DOH offices, hospitals, health facilities and local government units that meet quality standards of Tobacco Prevention and Control. Launching of \"Red Orchid Awards\" will be on May 31, 2009; the first awarding ceremony shall be on May 31, 2010 and subsequently on May 31 every year in the observance of\u201cWor1d No Tobacco Day.\"   VI. Roles and Responsibilities   In promoting 100% Smoke Free Environment, different offices within the DOH and attached agency have the following roles and responsibilities:   1. National Center for Health Promotion   a. Develop and sustain high intensity advocacy campaign on 100% smoke free environment including prototypes of picture-based health warnings and promotion of smoking cessation services  2. National Center for Disease Prevention and Control   a. Develop guidelines and provide package of cessation services to clients, including behavioral therapy and pharmacologic therapy   b. Provide technical expertise on the development of capacity building module on cessation   c. Develop an effective referral system for personnel who want cessation services in coordination with NCHFD and schedule counseling sessions for personnel with multidisciplinary team ofexperts, as applicable   3. Health Policy Development and Planning Bureau   a. Develop policy. guidelines and/or memorandum of agreement with partners that would operationalize smoke-free environment in different settings such as workplaces, educational facilities and sporting environment   b. Provide multi\u2014year investment planning and resource generation on 100% smoke-free environment in coordination with BIHC   4. Bureau of Local Health Development   a. Provide policy guidance and technical assistance to local government units in the development of 100% smoke-free ordinance or resolution and in the implementation ofthe ordinance or resolution   b. Ensure the development and maintenance of database on anti-smoking initiatives by the Centers for Health Development   5. Health Human Resource Development Bureau   a. Develop training package on cessation in coordination with NCDPC   b. Ensure implementation of the conduct of human resource development activities only in smoke-free establishments   c. Ensure implementation of the provision on preferential recruitment and selection of nonsmokcr over smoker to vacant plantilla posts   d. Ensure implementation of the ban on sale of tobacco products within 100 meter perimeter of offices of DOH in coordination with security personnel and deputize enforcers of the ban on sale, as applicable   e. Develop and maintain database on smoking status of employees and action taken to address the smoking behavior   6. National Center for Health Facilities and Development   a. Provide technical expertise on establishment of smoking cessation clinics in DOH hospitals   b. Develop a database on hospital\u2014based experts on smoking cessation and database on facility-based smoking cessation programs   c. Promote the enhanced outpatient benefit package on smoking cessation developed by PHIC for overseas workers in all hospitals   7. National Epidemiology Center   a. Provide technical assistance on development of surveillance system for tobacco industry monitoring   b. Provide technical assistance on the conduct of tobacco control researches and on local adaptation of Global Tobacco Surveillance System, sueh as Global Youth Tobacco Survey, etc.   8. Field Implementation Management Office   a. Monitor and evaluate CHD and hospital implementation of this AO.   b. Undertake search and validation of LOU, Ilospital or DOH Attached Agencies Regional Office nominees for 100% Smoke\u2014Free Awards.   c. Document best practices   9. Bureau oflnternational Health Cooperation   a. Provide multi-year investment planning and resource generation from international partners on 100% smoke-free environment in coordination with HPDPB   10. Bureau of Food and Drugs   a. Ensure that nicotine replacement therapy in the form of patches and gums is included in the list of essential drugs as per recommendation of the World Health Organization   b. Ensure proper labeling oftobacco products   c. Implement ban on tobacco promotions.   d. Document and file legal action on violations of tobacco companies on advertisements and promotional activities.    11. Philippine Health Insurance Corporation   a. Develop guidelines on outpatient benefit package for youth smokers and if feasible depending on actuarial studies conducted, for adult smokers   b. Conduct intensive campaign on the enhanced outpatient benefit package on smoking cessation for overseas workers in coordination with NCH FD   VII. Funding   The Department of Health, Centers for Health Development and DUH attached agencies shall provide the necessary funding support for technical assistance, advocacy. monitoring and promotion of 100% Smoke\u2014Free Environment. Awards. advertisements and conduct of awarding ceremony or events, and provision of grants to consistently performing local government units shall be sourced from NCDPC or NCHP budget line items.    VIII. Repealing Clause   Other related issuances inconsistent with the provisions of this Administrative Order are hereby revised, modified or rescinded accordingly. All other provisions of existing issuances which are not affected by this order shall remain valid and in effect.   IX. Effectivity   This order shall take effect 15 days after publication.  ", "  I. RATIONALE  Smoking is dangerous to health and the hazard this has posed to human welfare has prompted health authorities especially the World Health Organization (WHO) to consider tobacco as a \"silent epidemic\". It is one of the main risk factors for acquired lung diseases (ALD), diabetes mellitus (DM), lung cancer and cardiovascular diseases (CVD). The death rate from all CVDs for smokers is 2 to 3 times that for non\u2014smokers. This death toll from tobacco use is expected to reach 8.4 million by 2040, 70% of which will occur in developing countries according to the WHO.  In the Philippines, 80,000 deaths in 1990 were attributed to smoking. It is estimated that smoking -related deaths this year could be greater. Smoking also enhances the risk for diabetes. In the Philippines, lung cancer as the leading cause of death ranked number 10 in 1965, then number 5 in 1985, and the most recent DOH statistics indicate that cancer had caused 4 deaths every hour in 1993. Mortality from lung cancer has doubled among women, while among men, it had stabilized at 10%. A Philippine Global Youth & Tobacco Survey in 2000 showed that 16.5 million of Filipinos are currently smoking, 85% of whom want to stop smoking. It also showed that these current smokers start at the age of 10-14 years \u2014 40% are schoolboys and 19% are schoolgirls.  Smoking inside public places, also enhances the exposure of non-smokers to environmental tobacco smoke (ETS). Children and younger adults are particularly vulnerable. Infants have a greater incidence of acquiring acute respiratory infections such as pneumonia and bronchitis. Involuntary smoke reduces the growth rate of lung function in children, and contributes to the deveIOpment and triggering of asthma. It is estimated that ETS causes 150,000 to 300,000 excess cases of lower reSpiratory infections every year among infants 18 months or younger.  Smoking also has known negative economic impacts. The Department of Health (DOH) estimates that P 46 billion were spent for the medical care of smokers who developed any of the several diseases attributed to the habit.  A number of smoking cessation initiatives have been undertaken by the DOH since 1982. The Lung Center of the Philippines started what could be considered as the Philippines first anti-smoking educational campaign in that year.  In 1987, the then Non-Communicable Diseases Service under the Office of Public Health Services, developed the Philippine Cancer Control Program (PCCP) under a broader Cardiovascular Disease Program (CVDP). A priority concern of the PCCP was the lung cancer prevention program under which tobacco control was viewed as its primary prevention strategy with the following objectives:  1. To reduce the national prevalence of smoking from 46.6% in 1987 to 36.6% by the year 1997. 2. To render all DOH health facilities smoke\u2014free by 1993 3. To reduce the prevalence of smoking among the 18 year-old youth and below) from 22.7% in 1987 to 12% by 1997 4. To ban smoking among elementary and high school students, 5. To monitor & evaluate the impact of the five year plan.  As a result, Department Circular (DC)147ua, s 1987 on \u201cThe creation of a smoke\u2014free environment within the DOH\" was issued. All government security forces were subsequently instructed to strictly enforce DC 147-a by Department Order (DO) 154-e, s 1990. The smoking ban was extended to cover all regions through an Administrative Order (A0) 15 s. 1993. In March 22, 1993, labeling and advertisement of cigarette products was regulated by A0 10 in accordance with Republic Act 7394 otherwise known as the \u201cConsumers Act of 1992.\"  In 1999, the DOH revised its program for tobacco control to resPond to developments outside of the country. The Framework Convention on Tobacco Control (FCTC) under the World Health Organization (WHO) required governments to support tobacco control initiatives including smoking cessation. Article 5 Section 24 of Republic Act 8749, otherwise known as the Philippine Clean Air Act of 1999 provides that smoking is prohibited inside a public building or an enclosed public place including public vehicles and other means of transport or in any enclosed area outside of one\u2019s private residence, private place of work or any duly designated smoking area. The local government unit is mandated to enforce this provision.  By 2001, DO 288-43 3 2001 was issued creating a tobacco control task force and designating point persons for a National Tobacco Control Program with the following components: international agreements, national legislation, advocacy, smoking cessation, economic alternatives for farmers, education, and epidemiology. A Technical Working Group (TWG) for the development of a smoking cessation program was created by DO 70-e s 2002 and as repealed by DO 193 s 2002, the TWG was mandated to implement the National Tobacco Control and Lifestyle Program for the Department of Health which had three components : (1) advocacy, education and promotion, (2)smoking cessation and healthy lifestyle and (3) epidemiology, surveillance and research cluster.  Last June 21, 2003, Republic Act 9211, an \u201cAct Regulating the Packaging, Use, Sale, Distribution and Advertisements of Tobacco Products and for Other Purposes,\" was signed into law. Section 33 paragraphs (b) and (0) required that the DOH establish \u201cwithdrawal clinics\".  This Order provides the specific guidelines in implementing a National Smoking Cessation Program (NSCP) for such provisions.  II. COVERAGE AND SCOPE  This Order covers all DOH offices, attached agencies, retained DOH hospitals and health facilities, permanent or temporary (such as field hospital or clinic tents) and fixed or mobile units (ambulances, vehicles, etc.). Further, Local Government Units (LGUs) and other institutions with health facilities such as schools, industrial establishments, and other government or private agencies or establishments are encouraged to participate in the NSCP.  The scope of the NSCP shall be confined to the provision of smoking cessation services to current smokers.  III. DEFINITION OF TERMS  A. Smoking cessation \u2014 the systematic, safe, and sustainable process of withdrawing nicotine from a smoker's body.  B. Smoker - a habitual, chronic user of nicotine.  C. Smoking \u2014 refers to the act of using a cigarette or other tobacco product, regardless of whether or not it is being inhaled.  D. Environmental tobacco smoke (ETS) - cigarette smoke that contaminates indoor air.  B. Side stream smoke (SSS) \u2014 smoke emitted from the smoldering of cigarettes between puffs.  F. Mainstream smoke (MSS) - produced when a smoker inhales cigarette smoke.  G. Smoke free environment (SFE) - indoor air free of ETS.  H. NSCP coordinator \u2014 any licensed physician who had undergone training on the NSCP who is connected with the hospital or health facility as a permanent employee.  I. Current smoker - a smoker who had used nicotine within one (1) year from the most recent day of diagnosis regardless of amount.  J. Successful quitting \u2014 the absence of nicotine products or by-products in the breath, urine or blood of a nicotine addict or a self-report from a smoker of an abstinence from smoking validated by a smoking cessation coordinator for at least one year from the day of last clinic visit when patient was already free of any abnormal levels of nicotine metabolite.  K. Smoking cessation clinic (SCC) \u2014 refers to the withdrawal clinic prescribed by RA 9211, s 2003.  IV.PROGRAM  A.VISION  Reduced prevalence of smoking and minimizing smoking \u2014related health risks.  B. MISSION  To establish a national smoking cessation program (NSCP).  C. OBJECTIVES  1. To promote and advocate smoking cessation in the Philippines.  2. To provide smoking cessation services to current smokers interested in quitting the habit.  V. GENERAL POLICIES  As the agency mandated to promote and protect the health of the Filipino peOple, the Department of Health adopts the following policies and principles in the implementation of the NSCP.  1. The DOH fully supports the World Health Organization\u2019s Tobacco Free Initiative as embodied in the Framework Convention on Tobacco Control (FCTC) recognizing that health is a basic constitutional right.  2. To control the tobacco epidemic, the DOH shall cooperate and coordinate with all other stakeholders at all levels of government, and with all sectors of Philippine society. The DOH will also serve as a role model in the NSCP within its own facilities and among its own personnel.  3. The DOH shall provide technical assistance to DOH health facilities and other participating LGUs, schools, industrial establishments and other government or private agencies supporting the NSCP subject to the availability of resources.  VI. PROGRAM COMPONENTS. The program shall have the following components:  A. TRAINING  1. An NSCP training committee shall be institutionalized. This shall be composed of the following:  a. Chairperson - Degenerative Disease Office \u2014 National Center for Disease Prevention & Control  b. Vice-chairperson \u2014 Smoking Cessation Program Manager from Lung Center of the Philippines.  c. Members - a pool of technical experts in smoking cessation from recognized government, non\u2014government or private hospitals or agencies.  2. The training committee shall define, review and regularly recommend to the Chairperson training programs that are consistent with the latest good clinical practices approved by specialty associations, and the rules and regulations from the DOH.  3. All DOH health personnel, LGUs, selected school, industrial and other government health practitioners shall be trained on the policies and guidelines on smoking cessation.  4. Training centers shall be identified by the DOH whose track record, facilities and presence of specialists in smoking cessation contribute to the success of the NSCP.  B. ADVOCACY  1. A smoke-free environment (SFE) shall be maintained in all DOH facilities, offices, attached agencies and retained hospitals and other participating agencies.  2. A smoke\u2014free environment shall also be maintained in other participating non-DOH facilities, offices, attached agencies and retained hospitals, field or mobile units.  3. Advocacy plans, strategies and activities shall be developed at all levels. These shall be directed at increasing the utilization of smoking cessation clinics, health education programs, advocacy and other activities of the NSCP.  4. Observance and celebration of the World No Tobacco Day (WNTD) shall be celebrated every 31St of May and shall he participated by all DOH officials, staff and employees and all officials of participating non-DOH offices.  5. Observance and celebration of World No Tobacco Month shall be celebrated on June each year and shall be participated by all DOH officials, staff, and employees, and all officials of participating non \u2014 DOH offices.  6. Generate knowledge, and strategies and activities that can help the Tobacco Control Program resolve the issues it addresses.  C. HEALTH EDUCATION  1. Health education shall serve as an important tool to assist smokers quit their habit, empowering the smoker's immediate family assist their patient and facilitate the implementation of smoking cessation process.  2. The following activities shall be conducted:  a. Smokers and at least one immediate family member shall regularly participate in health education lectures.  b. Health education campaigns shall be conducted in the neighborhoods or communities where smokers reside to improve the success rate of established SCCs, and the NSCP as a whole.  c. Health education campaigns shall also be conducted in schools, industrial establishments and offices of other government agencies that will implement the NSCP.  D. SMOKING CESSATION SERVICES  D.1. SMOKING CESSATION CLINICS  1. There shall be at least one smoking cessation clinic (SCC) in every zone. CHD may also establish SCCs in their offices to cater to CHD employees. Zones or CHD may however, establish more than one SCC depending upon their resources.  2. Other health facilities in LGUs, schools, industrial establishments, and other government or private agencies implementing the NSCP may also establish a smoking cessation clinic.  3. The SCC shall be lodged at the Out-Patient Department of any DOH retained hospitals or non\u2014DOH hospital or in a designated room of any other DOH or participating non\u2014DOH office selected for this purpose.  4. It shall be headed by an NSCP coordinator who shall be assisted by a trained Health Education & Promotion Officer at the CI-le or a trained Registered Nurse from the OPD of any DOH or participating non-DOH hospital, or office.  5. The services rendered in these SCCs shall include case finding, screening, diagnosis, treatment, case holding, health education, support group, laboratory procedure, reporting and recording of program activities.  6. The procedures and practices for these services shall be consistent with the latest good clinical practices taught by the NSCP Training Committee.  7. The referral system shall begin with the individual NSCP coordinators in every implementing health facility, hospitals or office or agency. Smoking cessation clinics in every health zone shall accept referrals from these NSCP coordinators. Designated training centers shall serve as the end-point of the referral system.  8. Patients who develop an adverse reaction to the pharmacological interventions prescribed by the DDO shall be reported to the Bureau of Food and Drugs in accordance with BFAD\u2019s most current procedures. The NSCP Coordinator or the referral clinic shall submit an incident report to the DDO.  9. Adverse reactions to any non\u2014pharmacological interventions prescribed by the NSCP training committee shall be reported to the nearest NSCP coordinator.  10. The daily administration and management of the SCC shall conform to the current issuances from the DOH concerning hospital or program management & administration.  11. The SCC shall maintain an SCC information system consistent with the latest teachings from the most recent training seminar.  D.2. SMOKERS' FAMILY SUPPORT GROUP (SFSG)  1. At least one (1) member of the smoker-patient's immediate family either parents, brothers or sisters and all children must be recruited in this Support Group.  2. The recruitment process must be voluntary. The family member's consent should be obtained after fully disclosing the protocol(s) for smoking cessation and assuring that they understood the same.  3. The support group will assist smokers, the NSCP coordinator and the smoking cessation clinic succeed in the treatment trial.  4. Every family member recruited shall be registered in the Smoker\u2019s Family Support Group Register.  5. Members of this support group will meet at least once every two weeks after recruitment to discuss the current needs and problems of the patient and its possible solution.  6. Members of the support group whose patients succeeded or dropped out of the treatment process will be graduated from the Smokers\u2019 Family Support Group.  E. RESEARCH AND DEVELOPMENT  1. Research and development activities shall also be part of the NSCP  2. These activities Ishall be towards understanding the nature of nicotine dependence among Filipinos.  3. The development of psychological, psychiatric, behavioral and other non\u2014pharmacological treatment approaches appropriate to Filipino patients and their value systems and norms shall be conducted.  4. The development of pharmacological approaches appropriate to Filipino patients shall also be undertaken.  VII. ROLES AND FUNCTIONS  A. Department of Health -National Center for Disease Prevention and Control  i. Degenerative Diseases Office  The NSCP shall be lodged at the Degenerative Diseases Office of the Department of Health. The DDO shall be the lead agency in the development, implementation and monitoring of the program as well as in the provision of technical and other services such as:  1. Coordinate the development, implementation, and monitoring of the NSCP.  2. Monitor, assess and evaluate the implementation of the NSCP  3. Establish smoking cessation clinics in selected hospitals or health facilities  4. Train NSCP coordinators  5. Source and assist in sourcing funds for the NSCP  6. Design prototype information materials and health education materials; and  7. Design and maintain an information system including smoking cessation clinic registry, family support group registry, and other databases that will ensure the success of the program  ii. Environmental and Occupational Health Office  The Environmental and Occupational Health Office shall assist the DDO in the development of strategies and activities in converting implementing units into a smoke-free environment.  iii. Family Health Office  The Family Health Office shall assist DDO in the development of strategies and activities to provide smoking cessation services to adolescents, pregnant mothers and other special groups targeted by the Family Health Office.  b. Other DOH offices:  i. National Center for Health Facility Development. The National Center for Health Facility Development shall assist the BBC in the coordinative activities of the NSCP.  ii. National Center for Health Promotion. The National Center for Health Promotion shall assist the DDO in the deveIOpment and design of advocacy and health promotion campaigns for the NSCP.  iii. The Health Human Resources Development Bureau shall advise DDO in the development of the human resources training program  iv. Centers for Health Development. The Centers for Health Development shall perform the following reSponsibilities in support of the National Comprehensive Smoking Cessation Program:  1. Advocate the objectives and goals of the NSCP; 2. Promote the utilization of smoking cessation clinics. 3. Celebrate the World No Tobacco Day (WNTD); 4. Encourage LGUs, schools, industrial establishments, and other government institutions within their catchment areas to participate in the NSCP; 5. Coordinate with the DDO in the implementation of the NSCP; 6. Assist DDO in maintaining the information system of the NSCP; 7. Coordinate with the smoking cessation clinics and catalyzes the referral of current smokers; 8. Undertake public health education campaigns; and 9. Monitor the implementation and progress of the program and shall give feedback to the DDO on whatever evaluation results were collected from the implementing units  v. Specialty Hospitals, Retained Hospitals and Medical Centers  1. The Lung Center of the Philippines shall:  a. Act as Vice-chairperson in the NSCP Training Committee; and b. Coordinate and undertake research and development activities to improve the clinical services of the smoking cessation clinics  2. The Philippine Heart Center shall recommend the latest technical interventions and researches that would contribute in the enhancement of programs related to the implementation of NSCP.  3. The Chiefs of Hospitals and Medical Centers are required to implement the NSCP in their facilities with the following functions:  a. Render its facilities and compounds a smoke-free environment (SFE); b. Participate in the celebration of WNTD; c. Promote and advocate to current smokers, immediate family members and communities to participate in the NSCP; and d. Coordinate with the DOH in implementing the NSCP. e. Recommend to DDO a NSCP Coordinator and shall submit his/her name to the DDO for monitoring purposes.  B. Other Government Agencies, Local Government Units and other Health Facilities. All government agencies, local government units and other health facilities are encouraged to participate in this program.  VIII. Funding  Funds for the establishment, operation and evaluation of the NSCP shall be charged against the funds of the Hospitals as Centers for Wellness for hospital-based NSCP and the CHD funds for CHD NSCP subject to the usual accounting and auditing rules and regulations.  IX . Effectivity  This administrative order shall take effect immediately.    ", " I. BACKGROUND   On February 12, 2008, President Gloria Macapagal Arroyo directed the Department of Health (DOH), the Department of Labor and Employment and the Philippine Overseas Employment Administration to deal with the concerns on the repatriation of Overseas Filipino Workers (OFWs) purportedly as an aftermath of psychological and/or psychiatric disorders.   In response to the Presidential Directive, the DOH through the Bureau' of Health Facilities and Services (BHFS) conducted more stringent inspections, monitoring and spot-checking activities of DOH accredited medical clinics providing psychological examinations for overseas work applicants by including a psychologist as a member of the regulatory team. This was followed by the creation ofa technical working group in view of Department Personnel Order No. 2008 \u2014 3392 to review and evaluate the standards and requirements of psychological tests which measure emotional and environmental adaptability of OFWs.   Pursuant to Administrative Order (AO) No. l s. 2003 entitled \u201cOperational Guidelines in the Conduct of Pre-Employment Medical Examination of Overseas Workers and Seafarers,\" applicants for overseas work are required to undergo PEME at medical clinics accredited by the DOH. Part of the PEME is psychological screening and evaluation which includes the following battery of psychological tests: 1) Draw a Person Test (DAPT) or House Tree Person Test, 2) Sack\u2019s Sentence Completion Test (SSCT), 3) Bender Gestalt Motor Visual Test, and 4) Raven\u2019s Progressive Matrices or Purdue Non-Language Test.   Subsequently, on February 28, 2009, the DOH through the BHFS, issued AO No. 2009 \u2014 0002 \u201cAddendum to A0 No. 1 s. 2003 Operational Guidelines in the Conduct of Pre\u2014Employment Medical Examination for Overseas Workers and Seafarers\" which states in part that psychologists without a master\u2019s degree and a course in psychological assessment are advised to use the 16 Personality Factors Test, Filipino version, in lieu of the DAPT and the SSCT\". In addition, to enhance the capability of psychometricians and psychologists working in DOH accredited medical clinics, annual orientation workshops and trainings have been conducted by the DOH in coordination with I the National Center for Mental Health and the Philippine Psychological Corporation in 2008 and 2009 respectively. This Order took into account the recommendations of competent authorities and is a result of several reviews and consultations made with concerned stakeholders including the academe.   In view of the foregoing and with the advent of Republic Act (RA) No 10029 known as \u201cPhilippine Psychology Act of 2009\", it is evident that the DOH has aligned its activities and issuances with the aforementioned RA way before it was approved and then published last March 25, 2010, to professionalize the conduct of psychological examinations for overseas work applicants.   II. OBJECTIVE   This Order aims to standardize and update the conduct of psychological examinations for overseas work applicants.   III. SCOPE OF APPLICATION   This Order applies to all DOH accredited medical clinics providing psychological services for overseas work applicants.   IV. DEFINITION OF TERMS   For purposes of this Order, the following terms and acronyms shall have the following definition:   A. Accreditation \u2014 the formal authorization issued by the DOH to an individual, partnership, corporation or association to Operate a medical facility for overseas workers and seafarers.   B. Applicant \u2014 refers to a person who is applying for work abroad and is required to undergo PEME prior to deployment.   C. BHFS \u2014 acronym for the Bureau of Health Facilities and Services, the regulatory body of the DOH.   D. DOH \u2014 acronym for the Department of Health.   E. DOH Accredited Medical Clinics \u2014 refers to medical facilities for overseas workers and seafarers.   F. Inspection/ Monitoring Tool \u2014 the checklist utilized by the regulatory officers during inspection or monitoring visits to evaluate compliance of DOH accredited medical clinics to minimum standards and requirements in the conduct of psychological examinations for overseas work applicants.    G. OFW \u2014 acronym for Overseas Filipino Worker.   H. PEME \u2014 acronym for Pre-Employment Medical Examination. It refers to the complete medical examination that is implemented on an applicant as a requirement for screening to determine whether he is physically and mentally fit to work.   I. Psychologist \u2014 an individual who is duly licensed as professional psychologist in accordance with RA 10029. Psychologists shall take full responsibility for the supervisionof psychometrician(s) and their work in the DOH accredited medical clinic as stipulated under Article III Section 3. (c) and (d) ofRA 10029 known as \u201cPhilippine/V\" Psychology Act of 2009.\"   J. Psychometrician \u2014 an individual who is duly licensed as psychometrician in accordance with RA 10029 known as \u201cPhilippine Psychology Act of 2009.\"   K. Raven\u2019s Progressive Matrices or Purdue Non-Language Test \u2014 non-verbal psychological tests measuring a person\u2019s intellectual capability through abstract reasoning.   L. 16 PF Test \u2014 acronym for 16 Personality Factors Test. It is a self-report personality inventory developed by Raymond B. Cattell to measure the 16 personality dimensions that emerged from his factor analysis of a wide range of traits. The most recent edition being referred to in this Order is the 5th edition ofthe original test.   V. POLICIES   A. General Policies   1. Psychological examinations for overseas work applicants shall be performed only in DOH accredited medical Clinics.   2. All DOH accredited medical clinics shall follow the standards, criteria and requirements in the conduct of psychological examinations prescribed in the inspection/ monitoring tool for accreditation of medical facilities for overseas workers and seafarers.   3. A full time psychologist registered with the BHFS shall take the full responsibility of the psychological screening and evaluation which includes, but is not limited to, the following:   a) A minimum battery of psychological tests namely 16 PF Test (English or Filipino), Raven\u2019s Progressive Matrices or Purdue Non\u2014Language Test;   b) An autobiography;   c) A comprehensive interview.   4. All DOH accredited medical clinics shall notify the BHFS in writing within 15 days of any change in personnel, physical facility and/ or any additional psychological test above the minimum requirement stipulated in V.A.3.a). Should psychological test(s) above the minimum requirement be added to the battery, the management of DOH accredited medical clinics shall ensure that their personnel have the required qualification and training to administer, score, interpret and write reports on such test(s).   5. The enhanced psychological test shall be at no added cost to the applicant.   B. Speci\ufb01c Policies   1. Standards   a) Every DOH accredited medical clinic shall be organized to provide qualit, effective and efficient psychological services for overseas work applicants.  b) There shall be documented administrative and technical policies and procedures which includes but is not limited to, human resources; materials and supplies for the psychological examinations to be provided; documents, records and communication; physical facilities/ work environment for the operation and maintenance of the psychological facility; referral for further psychological evaluation, which will ensure the quality of psychological results.   c) The aforementioned policies and procedures in the conduct of psychological examinations for overseas work applicants shall be in accordance to the manual of operating procedures being formulated by the DOH through the BHFS.   d) The DOH shall establish an electronic uploading system for the submission of standard data of all DOH accredited medical clinics which shall, without fail, submit monthly consolidated, electronic and hard copy reports to the BHFS every \ufb01rst week of each succeeding month following the psychological evaluation format posted at the DOH website.   e) All DOH accredited medical clinics, through their Organization, shall establish and maintain an information technology system, through a service provider of their own choice, that shall ensure accurate and reliable psychological and medical results for transmission at no cost to DOH. The aforesaid results established and maintained through an information technology system shall be at no added cost to the applicant.   2. Validity of results  Psychological test results shall have to be valid to be issued a PEME certificate. The 16 PF Test results are generally valid for 12 \u2014 18 months upon completion, or less if individuals undergo major and significant changes in their work and/ or life circumstances.   3. Accreditation  The accreditation of medical facilities for overseas workers and seafarers may be revoked, suspended or modi\ufb01ed in full or in part for any false statement by the management and/ or staff of the medical facility, or as shown by the record of inspection or monitoring activities or for a violation of, or failure to comply with any of the terms, conditions or provisions of these policies, rules and regulations.   VI. VIOLATION/PENALTY   Any violation of RA 10029, this Order and/ or its related issuances by any DOH accredited medical clinic shall be penalized under Section IX Paragraph 2 of A0 No. 181 s. 2004.   VII. REPEALING CLAUSE   Provisions from previous issuances that are inconsistent or contrary to the provisions of this Order are hereby rescinded and modified accordingly.   VIII. SEPARABILITY CLAUSE   In the event that any provision or part of this Order is declared unauthorized or rendered invalid by any court of law or competent authority, those provisions not affected by such declaration shall remain valid and effective.   IX. EFFECTIVITY   This Order shall take effect \ufb01fteen (15) days after its approval and publication in a newspaper of general circulation and shall. be subject for review three (3) years after its implementation.  ", " I. RATIONALE   In accordance with the principles of the 1987 Philippine Constitution to uphold the rights of the elderly and the relevant provisions of Republic Act No. 9257, this Administrative Order is being issued to support Section 4(1) of the Implementing Rules and Regulations of Republic Act No. 9994 implementing the twenty percent (20%) Senior Citizens\u2019 discount on medicines, medical equipment and other health-related provisions and to establish guidelines and mechanisms of compulsory rebates in the sharing of burden of the Senior Citizens\u2019 discounts among retailers, manufacturers and distributors, taking into consideration their reSpective margins. This Order is meant to guide drug stores, hOSpitals, medical-and allied health workers as well as Senior Citizens in executing mechanisms of fair discounts for beneficiaries while preserving the economic viability of companies and drug retail outlets through a just and transparent system of compulsory rebates.   II. OBJECTIVES   This Order is being issued to achieve the following objectives:   1. To establish guidelines and mechanisms in implementing the 20% Senior Citizens\u2019 discount in drugs and medicines, medical equipment and other health related provisionsof RA 9994; -   2. To create procedures for compulsory rebates and the sharing of burden of the Senior Citizens\u2019 discounts among Retailers, Manufacturers and Distributors, taking into consideration their margins by establishing a formula for said discounts; and   3. To set up a system of monitoring the compliance of drug companies, distributors and retailers to the 20% disCount.   III. COVERAGE AND SCOPE   This Administrative Order shall. apply to all private and government hospitals, health related facilities, health care professionals, the Philippine Health Insurance Corporation, all related health-care establishments, pharmacies and other retail outlets dispensing medicines to all Senior Citizens.   IV. DEFINITION OF TERMS   For purposes of this Order, the following terms shall have the following de\ufb01nitions based on the Implementing Rules and Regulations of RA 9994 and RA 9711:   1. Senior Citizen or Elderly \u2014 refers to any Filipino citizen who is a resident of the Philippines, and 'who is sixty (60) years old or above. It may apply to senior citizens with \u201cdual citizenship\" status provided they prove their Filipino citizenship and they have been residents for at least six (6) months in the Philippines.   2. Indigent Senior Citizen \u2014 refers to any senior citizen or elderly who is frail, sickly, or with disability and without pension or regular source of income, compensation or \ufb01nancial assistance from his/her relatives to support his/her basic needs, as determined by DSWD in consultation with the National Coordinating and Monitoring Board (N CMB). '   3. Medicines \u2014 refers to any chemical compound or biological substance, other than food, intended for use in the treatment, prevention or diagnosis of disease in humans or animals, including but-not limited to:   (1) any article recognized in the of\ufb01cial United States Pharmacopoeia, National Formulary (USP-NF), of\ufb01cial Homeopathic Pharmacopoeia of the United States, Philippine Pharmacopoeia, Philippine National Drug Formulary, British Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia, Indian PharmaCOpoeia, any national compendium or any supplement to any of them; \"   (2) any article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;   (3) any article other than food intended to affect the structure or any function of the human body or animals;   (4) any article intended for use as a component of any articles specified in clauses (1), (2), and (3) not including devices or their components, parts, or accessories; and   (5) herbal and/or traditional drugs which are articles of plant or animal origin used in folk medicine which are:   (i) recognized in the Philippine National Drug Formulary;   (ii), intended for use in the treatment or cure or mitigation of disease symptoms, injury or bodydefects in humans;   (iii) other than food, intended to affect the structure or any function of the human body;   (iv) in \ufb01nished or ready- to\u2014'use dosage form; and   (v) intended for use as a component of any of the articles Speci\ufb01ed in clauses (i), (ii), (iii) and (iv)   4. Medical Devices \u2014 means any instrument, apparatus, implement, machine, appliance, implant, in-vitro reagent or calibrator, software, material or other similar or related article intended by the manufacturer to be used alone, or in combination, for human beings for one or more of the speci\ufb01c purpose (5) of: diagnosis, prevention, monitoring, treatment or alleviation of, or compensation for an injury; investigation, replacement, modi\ufb01cation, or support of the anatomy or of a physiological process; supporting or sustaining life; preventing infection; control of conception, disinfection of medical devices; and providing information for medical or diagnostic purposes by means of in\u2014vitro examination of specimens derived from the human 'body. This device does not achieve its primary intended action in or on the human body by pharmacological, immunological or metabolic means but which may be assisted in its intended function by such means.   5. Medical Services \u2014 refer to public and private hospital services, professional services of physicians and other health care professionals, and diagnostic and laboratory tests that are requested by a physician as necessary for the diagnosis and/or treatment of an illness or injury.   6. Dental Services \u2014 refer to oral examination, cleaning, permanent and temporary \ufb01lling, extractions and gum treatments, restoration, replacement or repositioning of teeth, or alteration of the alveolar or periodontium process of the maxilla and the mandible that are necessary for the diagnostic and/or treatment of a dental illness or injury.   7. Diagnostic and Laboratory Test - refer to diagnostic examinations that are necessary for the diagnosis and/or treatment of an illness and injury, including but not limited to X-ray, CT Scans, ECG, 2D Echo, gastroenterology, blood chemistry exams, histopathology and immunopathology, hematology, urine analysis, parasitOlogy and bacteriology test and serology.   8. Distributor/ Wholesaler \u2014\u2014 means any establishment that procures raw materials, active ingredients and/or \ufb01nished products from local establishments for local distribution on wholesale basis.   9. Manufacturer \u2014 in relation to a health product, means an establishment engaged in any and all operations involved in the production of health products including preparation, processing, compounding, formulating, \ufb01lling, packing, repacking, altering, ornamenting, \ufb01nishing and labeling with the end in view of its storage, sale or distribution: Provided, that the term shall not apply to the compounding and \ufb01lling of prescriptions in drugstores and hospital pharmacies. 'A trader shall be categorized as a Manufacturer.   10. Retailer -\u2014 refers to a licensed establishment carrying on the retail business of sale of drugs and medicines to customers.   11. Wholesaler-Retailer- any establishment transacting business of either wholesale or retail at any given time.   12. Non-Traditional Outlets - means supermarkets, convenience stores, other retail establishments duly licensed by the FDA to sell non-prescription/over-the-counter medicines to the public   V. GUIDELINES AND MECHANISMS FOR THE AVAILMENT OF PRIVILEGES ON MEDICINES BY ALL SENIOR CITIZENS   V.I GENERAL RULES   a. A 20% discount and exemption from Value Added Tax (VAT) shall be granted to Senior Citizens subject to the rules embodied 1n this Order.   b. The 20% discount granted to Senior Citizens shall be computed in the following manner:  (a) The VAT shall be initially deducted from the Retail Price of the medicine to obtain the Net Retail Price; and  (b) The 20% discount shall be deducted from the Net Retail Price to obtain the Senior Citizen\u2019s Price.   By way of illustration, if the Retail Price (inclusive of VAT) of a certain drug is P100.00, the Senior Citizen\u2019s Price should be computed as follows:   Retail Price (inc. of VAT)   P100.00  Less: VAT (P100/1.12)          10.71  Net Retail Price             P 89.29  Less: 20% discount             17.86  Senior Citizens\u2019 Price       P 71.43   c. The 20% discount is non-transferable. It shall be applied exclusively to drugs and medicines for the use of Senior Citizens. Drugs in formulation, such as pediatric formulations medically prescribed for use of Senior Citizens shall also be granted a 20% discount.   d. The national government shall provide free seasonal \ufb02u and pneumococcal vaccines to the indigent senior Citizens through an additional apprOpriation under the General Appropriations Act on top of the DOH regular budget or through a preventive bene\ufb01t package of Philhealth.   All government projects/programs that sell medicines to Senior Citizens and that already offer substantial discount to consumers or is partially subsidized by the government, is exempted from the Senior Citizens\u2019 discount (e.g Botika ng Barangay, P100).   e. All complaints on non-compliance with the 20% discount on medicines shall be lodged with the respective LGU OSCA Of\ufb01ce where the purchase was made or where the Senior Citizen resides, whichever is convenient to the latter.   f. All establishments as de\ufb01ned above are enjoined to comply with the above-cited guidelines. Otherwise, applicable penalties and sanctions shall be imposed.   VII - DOUBLE DISCOUNTS   a. Double discounts will not be allowed. Senior Citizens will have the option \u2019to choose either promotional campaigns and other forms of discounts on certain medicines, or the Senior Citizens discount provided that only the Senior Citizens\u2019 discount is exempted from VAT.   b. In cases where Senior Citizens are also Persons with Disability (PWD), the Senior Citizen may opt to use either the Senior Citizens or the PWD discount provided that only the Senior Citizens\u2019 discount is exempted from VAT.   V.III \u2014 DOCUMENTARY REQUIREMENTS   a. All hospitals and drug retail outlets shall require Senior Citizens or their representative to present the following requirements for the availment of the 20% discount:   1. Identi\ufb01cation card (ID) issued by the city or municipal mayor or Of\ufb01ce for Senior Citizens Affairs (OSCA) or the barangay captain of the place where the Senior Citizen resides. The said ID should be recognized nationwide.   2. Except for over-the\u2014counter (OTC) drugs, a doctor\u2019s prescription should be presented. A prescription should have the following information: name, age, sex, and address of the Senior Citizen, as well as the date, generic name of the medicine, dosage form, dosage strength, quantity, name and signature, address of the prescribing physician, professional license number, and narcotic license or S2 number, if applicable.   3. Purchase slip booklets shall be used to record the kind of OTC medicine purchased, how many, when and where it was purchased. Likewise, this will help the drugstores to monitor the last purchase made for a certain medicine.   V.IV- RESPONSIBILITIES OF RETAILERS, HOSPITAL PHARMACIES AND ALL OTHER LICENSED ESTABLISHMENTS DISPENSING MEDICINES   a. As a general rule, any single dispensing must be in accordance with the prescription issued by a physician and should not cover more than one (1) month supply of medicines for the Senior Citizens. :   For partial \ufb01lling, the establishment\u2019s pharmacist will indicate the quantity partially \ufb01lled in the purchase slip booklet and the un\ufb01lled balance on the prescription. The Senior Citizen shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity.   The drugstores may limit the dispensing of OTCs for a supply of one ( 1) day but not to exceed to a maximum of seven (7) days supply.   b. During operating hours, all licensed establishments dispensing medicines are Strictly prohibited from scheduling or limiting the time for the availment of the Senior Citizens\u2019 discount.   c. Of\ufb01cial receipts should be issued to the Senior Citizens for every transaction on medicines which shall contain the Retail Price and the Senior Citizens\u2019iDiscount Price.   d.  should be a priority lane for elderly and a generic menu card displayed at the facility of all drugstores.   e. All drug retail stores and health facilities are required to post this Order in conspicuous places where the Senior Citizens can access information on the 20% discount on medicines.   V.V \u2014 PHILHEALTH   a. Only those medicines which are included in the PNDF will be reimbursed by the Philippine Health Insurance Corporation (Philhealth).   b. In case the Senior Citizen is a Philhealth member or dependent, the VAT exemption and the 20% discount shall not be charged to the senior Citizens\u2019 Philhealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the Senior Citizen is expected to shoulder may be charged to his/her Philhealth bene\ufb01ts.   VI. GUIDELINES AND MECHANISMS IN THE SHARING OF BURDEN 50F THE SENIOR CITIZENS\u2019 DISCOUNTS AMONG RETAILERS, MANUFACTURERS AND DISTRIBUTORS '   1. The Retailers, Manufacturers/Distributors, Wholesalers-Retailers and Wholesalers may apply certain terms and conditions agreeable to all parties on how the burden to Senior Citizens discount shall be shared. Such undertaking including rebates mechanism agreed upon should be formalized and the copy of which should be furnished the DOH through the National Center for Disease Prevention and Control (NCDPC) and the National Center for Pharmaceutical Access and Management (NCPAM).   2. In the sharing of burden of the Senior Citizens discounts among Retailers, Manufacturers/Distributors, Wholesalers-Retailers . and Wholesalers, taking into consideration their respective margins, the following rules shall apply: (Please see Annex A)   2.1 30% of the 20% of the Senior Citizens\u2019 discOunt shall be the share of the Retailers which can be claimed as tax deduction.   2.2 If the Retailer is granted a sales discount of sixteen percent (16%) or more for a speci\ufb01c product by the Manufacturer/Distributor, Wholesalers-Retailers and Wholesalers no rebates will be due to the Retailer. This discount will be construed as the share of the ManufacturerfDistributor, Wholesalers-Retailers and Wholesalers.   2.3 If the Retailer is granted a sales discount of less than sixteen percent (16%) for a speci\ufb01c product by the Manufacturer/Distributor, Wholesalers-Retailers and Wholesalers, then the Manufacturer/Distributor, Wholesalers-Retailers and Wholesalers shall share the entire 70% of the 20% payable to the Retailers.   3. The sharing between the Manufacturer/Distributor and Wholesalers or Wholesalers- Retailers shall also be governed by the following rules: (Please see step 2, Annex A)   3.1 In the event that the Wholesaler or Wholesaler-Retailer passes a discount of 16% or more to a Retailer, then no rebates shall be due to the Retailer.   3.2 If a Manufacturer/Distributor gives a discount of 16% or more for a speci\ufb01c product to Wholesaler or Wholesaler-Retailer, but the Wholesaler or Wholesaler-Retailer gives a discount of less than 16% to the Retailer, then the Wholesaler or Wholesaler\u2014Retailer shall rebate the whole 70% of the Senior Citizens\u2019 discount to the Retailer.   3.3 If a Manufacturer/Distributor gives a discount of less than 16% to a Wholesaler or Wholesaler\u2014Retailer, then the Manufacturer/Distributor shall burden the 70% of the 70% of the Senior Citizens\u2019 discount, while the Wholesaler or Wholesaler-Retailer shall in addition to the burden provided in Section 2.1 above, also burden the 30% of the 70% of the Senior Citizens\u2019 discount. 1   4. The establishments providing the rebates (e.g., Manufacturers, Distributors, Wholesalers and Wholesalers-Retailers) may require the establishment claiming the rebates to present documentary evidence showing actual discounts granted-to Senior Citizens (such as but not limited to audited \ufb01nancial statements, of\ufb01cial reCeipts and records, and BIR submissions) as a condition for claiming the rebates.   5. Rebates can be claimed either in the form of money or medicines.   VII. EFFECTIVITY AND REVIEW   These guidelines and mechanisms shall be retroactive to July 06, 2010 and shall be further reviewed and evaluated three (3) months a\ufb01er e'ffectivity and implementation.   VIII. PENALTIES AND SANCTIONS   Non compliance with this guideline will result in sanctions and penalties stated in Section 7 Of RA. 9994, which is the amended Section 10 of RA 9257.   IX. SEPARABILITY CLAUSE   If any part, term or provision of this Order shall be declared invalid or unenforceable, the validity or enforceability of the remaining portions or provisions shall not be affected and this Order shall be construed as if it did not contain'the particular invalid or unenforceable part, term or provision.   X. REPEALING CLAUSE   All administrative issuance, bureau circulars, and memoranda inconsistent with this Order are hereby withdrawn, repealed and/or revoked accordingly.  ", "  II. BACKGROUND/ RATIONALE   Pursuant to Article II, Section 15 of the 1987 Philippine Constitution, the State shall protect and promote the right to health of the people and instill health consciousness among them.   There is unequivocal scientific evidence establishing that death, disease, and disability result from tobacco consumption and exposure to tobacco smoke. In the Philippines, at least 240 Filipinos die everyday, or approximately 87,000 per year, from tobacco-related diseases. Tobacco products and emissions contain numerous toxic compounds and over seventy carcinogens, including carbon monoxide, arsenic, benzene, butane, formaldehyde, lead, toluene, and nicotine, among others.   On 4 September 2005, following its rati\ufb01cation through the concurrence of the Senate of the Philippines, the World Health Organization\u2019s Framework Convention on Tobacco Control (WHO FCTC) entered into force in the country and since then, has formed part of the law of the land, in accordance with Section 21, Article VII of the 1987 Constitution.   The State accepts that, as a State-Party to the WHO FCTC, a treaty that reaf\ufb01rms the right of all people to the highest standards of health, the Philippines is obliged to inform every person of the health consequences of tobacco consumption and exposure to tobacco smoke; to enact effective measures to curb and reduce tobacco use, especially among the youth; and to protect public health policy from the commercial and vested interests of the tobacco industry.   The State is cognizant of the Philippines\u2019 duty under Article 11 of the FCTC, which is to adopt and implement by September 2008 effective health warnings on tobacco products that should describe the harmful effects of tobacco use.   Republic Act (RA) No. 10643, otherwise known as \u201cThe Graphic Health Warnings Law\" (RA 10643), requires graphic health warnings on cigarette packages and other tobacco product packages one (1) year after the issuance of the templates by the Department of Health (hereafter, the \u201cDepartment\") pursuant to: (a) the State\u2019s policy to protect and promote the right to health of the people and instill health consciousness among them; and (b) the State\u2019s obligations as a party to the WHO FCTC.   II. OBJECTIVES   Pursuant to Section 15 of Republic Act No. 10643, otherwise known as \u201cThe Graphic Health Warnings Law,\" this Order shall contain the Templates and Guidelines on the use of templates of Graphic Health Warnings.   III. SCOPE OR COVERAGE   This Order shall apply to all manufacturers, importers and distributors of tobacco products that are introduced in the Philippine market.   IV. DEFINITION OF TERMS   a. \u201cInsert\" means any communication inside an individual package and/or carton purchased at either wholesale or retail by consumers, such as a lea\ufb02et or brochure.   b. \u201cGraphic Health Warnings\" refer to the photographic image printed on the tobacco product package that accurately depicts the hazards of tobacco use and is accompanied by textual warning related to the picture.   c. \u201cMastercase\" means any box, container, or packaging of any form that is commonly used to store or contain cartons, reams or any other tobacco product packaging used for shipping or transport.   d. \u201cOnsert\" means any communication af\ufb01xed to the outside of an individual package and/or carton purchased at either wholesale or retail by consumers, such as a brochure beneath the outer cellophane wrapping or glued to the outside of the cigarette package.   e. \u201cPrincipal Display Surface\" means:   (1) In the case of a package and carton that has at least two   (2) equal-sized sides or surfaces, other than the top and bottom, that may be displayed or visible under normal or customary conditions of sale or use, the areas of each of the two (2) largest surfaces;   (2) In the case of a spherical, cylindrical or conical container of tobacco products, the two (2) largest surfaces that are predominantly displayed; and   (3) In the case of a package and carton that do not have a particular side or surface that is predominantly displayed or visible under normal or customary conditions of sale or use or those that are not described under Paragraphs c(1) and c(2) of this Section, \ufb01fty percent (50%) of the three (3) dominant sides or the total surface thereof, whichever is bigger, which will ensure that the Graphic Health Warnings are visibly shown.   f. \u201cSide Panel\" refers to the surface of the pack that is deemed the largest surface available beyond the principal display areas where graphic health warnings must appear.   g. \u201cTobacco Product Package\" means the packet and package of tobacco products and any outside packaging and labelling of tobacco products for sale and distribution in the domestic market, importation, trade, exchange, or for exhibition, such as, but not limited to, packs, tins, boxes, pouches, \ufb02ip-tops, slide and shell packages, cartons, packages containing one (1) product unit, or other containers of tobacco products containing the logo or trademark of the tobacco companies, primarily intended for consumers or for retail sale.   h. \u201cTobacco Products\" means products entirely or partly made of leaf tobacco as raw material, which are manufactured to be used for smoking, sucking, chewing or snuf\ufb01ng, or by any other means of consumption.   V. TEMPLATES   The twelve (12) templates of Graphic Health Warning speci\ufb01ed under Annex \u201cA\" of this Order shall be used in cigarette packages and other tobacco product packages.   These 12 templates shall be printed simultaneously and these shall be rotated periodically for each brand family and also for each variant, so that every twenty\u2014four (24) months, the variations of the warnings shall appear in the market with approximately equal frequency and equal display of health warnings and messages on retail packages.   VI. GUIDELINES   The Graphic Health Warnings shall be printed in accordance with the technical standards of presentation in the templates and the guidelines set forth in this Order and its Annexes.   1. Size   The Graphic Health Warnings shall be printed on \ufb01fty percent (50%) of the principal display surfaces of any tobacco product package, including package inserts and onserts; it shall occupy \ufb01fty percent (50%) of the front and \ufb01fty percent (50%) of the back panel of the packaging. The printing of the Graphic Health Warnings shall be done without the use of any border, frame or any other design that will effectively lessen the size of the warning.    2. Position   The Graphic Health Warnings shall be located at the lower portions of the panels or principal display areas.   3. Inserts, Onserts, and Any Outside Packaging and Labelling   The Graphic Health Warnings shall be printed on \ufb01fty percent (50%) of the principal display surfaces of any tobacco product package, including package inserts, onserts, and any outside packaging and labeling.   4. Wrappers or Sleeves   No part of the warning shall be obliterated, obscured, folded, severed or become unreadable when a wrapper or sleeve on the package is removed. Nothing shall be printed or applied on a location where it is likely to obscure or cover in part or in whole the Graphic Health Warnings.   5. Visibility   The printing of the Graphic Health Warning shall be done without the use of any design that will effectively lessen the size of the warning or reduce its clarity and vividness. To preserve the appearance and integrity of the Graphic Health Warnings, tobacco product packaging and labelling shall not include any features designed to modify the warnings, including, but not limited to heat activated inks, inks or embellishments designed to appear gradually over time, or inks that appear \ufb02uorescent in certain light.   6. Color and Printing Quality   6.1 The Graphic Health Warnings shall be printed in four colors /\u2014cmyk-/ screen 133 lines per inch based on a source \ufb01le of 300 dpi.   6.2 The printing of the Graphic Health Warnings shall be done using current available technology for purposes of providing vivid and realistic pictures. The primary consideration in determining the printing quality should be the overall effect on the tobacco packaging, i.e., the Graphic Health Warnings should be as clear, vivid and vibrant as the rest of the tobacco packaging. Any ink used in the printing of the Graphic Health Warnings shall be of such a quality that will not fade, bleed, or modify the appearance of the warning over time.   6.3 The Graphic Health Warnings shall be printed or inscribed on the package in a color which contrasts conspicuously with the background of the package or its labels, as provided by these guidelines and templates.   6.4 The Graphic Health Warnings shall be reproduced in the same quality, color and proportion as provided by the Department in the templates or in the digital form, whichever is clearer and more vivid, without modi\ufb01cation.   6.5 The composite images of the Graphic Health Warnings shall be contained in a digital storage device and/or an electronic repository that shall be maintained by the Department and which shall be available to public upon request.   7. Language   The text warning accompanying the photographic image shall be printed in Filipino on the front panel and English on the back panel. In the case of other containers where there is only one (1) external surface area, the accompanying text shall be printed alternately in English or Filipino.   8. Mastercases   All mastercases that contain the logo or trademark of tobacco brands shall contain the textual health warning \"SMOKING KILLS,\" which shall be printed in the same single color and in bold print as the trademark logo. The textual health warnings shall be of equal prominence and visibility as the logo or trademark of tobacco companies. Such textual warnings on the mastercase shall occupy at least \ufb01fty percent (50%) of each principal display panel of the mastercase.   9. Side panel   Tobacco product packages found in the market, shall bear, on one (1) side panel, additional health warnings, hotlines and/or websites for tobacco-related concerns, or tips on how to stop smoking, which shall be prominently displayed without the use of any border, frame or any other design that will effectively lessen the size of the textual warning, in accordance with the templates provided. Such information shall occupy thirty percent (30%) of the display surface of one side panel   10. Misleading Descriptors   One year after the issuance of templates, no cigarette packs or other tobacco product packages shall bear any number or descriptor such as low tar, light, ultra\u2014light, or mild, extra, ultra, and similar terms in any language that claims or misleads a consumer to believe that a tobacco product or variant is healthier, safer, or less harmful. The Department shall not approve any proposal, proof or other submission of Graphic Health Warnings that is af\ufb01xed to a tobacco product package that bears any such number or descriptor.   VII. NEW TEMPLATES   The Department of Health shall issue new templates every two (2) years from issuance of this Order to be used by all manufacturers, importers and distributors of tobacco products tha tare introduced in the Philippine market. Unless new templates are released by the Department of Health, the templates speci\ufb01ed under Annex \u201cA\" hereof shall continue to be used by all covered manufacturers, importers and distributors.   The guidelines speci\ufb01ed in this Order shall also govern any new templates to be issued by the Department of Health.   VIII. REPEALING CLAUSE   All Administrative Orders, Circulars, Memoranda or parts thereof inconsistent with this Administrative Order are hereby repealed or modi\ufb01ed accordingly.   IX. SEPARABILITY CLAUSE   In case any provision of this Administrative Order is declared contrary to law or unconstitutional, other provisions that are not affected thereby shall remain in force and effect.   X. EFFECTIVITY   This Administrative Order shall be published in a newspaper of general circulation and shall take effect immediately.    ", "   I BACKGROUND AND RATIONALE   The National Policy on Strengthening the Prevention and Control of Chronic Lifestyle Related Non Communicable Diseases (Administrative Order No. 2011\u20140003 dated April 14 2011) prescribes the strategy or comprehensive approach the country has adopted in reducing the morbidity, mortality and disability rates .due to chronic lifestyle-related non communicable diseases (NCDS). The policy also clearly de\ufb01nes the Action Framework for the Prevention and Control of the NCDS which cOnSists of areas for intervention at three levels, i.e. environmental, lifestyle and clinical. To support the changes in these three levels of interventions, additional actions Should be instituted in the areas .of: 1-) advocacy; 2) - research, surveillance, monitoring and evaluation; 3) networking and coalition building across all sectors of the government and SOCiety, and 4) health system strengthening through primary health care to make it more responsive to chronic care. Moreover, service packages for clinical interventions of diabetes, cardioVascular diseases, cancers and chronic respiratory diseases must be provided in these settings.    Currently, the main focus of clinical health care for NCDS in the Philippines is hospital-centered acute care. Patients with NCDS usually seek treatment at the hospitals when cardiovascular disease, cancer, diabetes and chronic respiratory disease have reached the point of acute events or long-term complications. This is a very expensive approach that will not contribute to a signi\ufb01cant reduction .of the NCD burden. It also denies people the health bene\ufb01ts of taking care of their conditions at an early stage. A strategic objective in the \ufb01ght against the NCD epidemic is the early detection and care using cost-effective and sustainable health-care interventions that are integrated in the primary health care facilities Such as barangay health stations, rural health units, community health centers and the like.   The World Health Organization has endorsed a set of low-cost individual treatment - protocol consisting of early screening and timely treatment in a primary health care setting (WHO PEN, Geneva 2010). The approach involves the financing and the strengthening of health care in order to improve access by high-risk individuals and by people with NCDS to essential technologies and medicines. These set of interventions are cost effective especially when compared to costly procedures that maybe necessary when detection and treatment are late and the patient reaches advanced stages of the disease.     In consideration of the commitment to a 2% yearly reduction in mortality due to NCDS in the country and to contribute to the global reduction of 25% by 2025, the Philippines adapted the WHO PEN. It shall be called the Philippine Package of Essential Noncommunicable Disease Interventions (Phil PEN)- The -prOtocol for the Integrated Management-of Hypertension and-Diabetes (APPENDIX .1) will'be institutionalized in primary health care settings all over the country.  II POLICY STATEMENT   The provision of quality clinical interventions and services for lifestyle related non- communicable diseases in the country folloWs the policy statements espoused by the National Policy on Strengthening the Prevention and Control Of- Chronic Lifestyle Related Non Communicable Diseases (Administrative Order No. 2011\u20140003 dated April 14, 2011).   This states that the country shall adopt an integrated, comprehensive-and community ' based response for the prevention and control of chronic, and lifestyle related NCDS, intensifying health promotion strategies to effect changes in lifestyle, environmental Support and delivery of health care services while fostering complementary accountabilities Of all stakeholders.   III GOAL AND OBJECTIVES   This policy and guide aims to ensure the appropriate provision: of quality clinical interventions and services for lifestyle-related NCDS in-the country: Speci\ufb01cally, it aims to:   1. Guide health Workers and; prOviders at primary health care facilities in implementing the Phil PEN to identi\ufb01ed populatiOn groups and client needs   2. De\ufb01ne the roles and responsibilities of the different DOH of\ufb01ces, the Philippine Health Insurance Corporation, theLGUS and other agencies in the implementation of the Phil PEN, including higher level referral facilities.   3. Generate the support of various stakeholders in implementing the Phil PEN policy and guidelines in the country.    IV SCOPE AND COVERAGE   This policy applies to all-units and instrumentalities including attached agencies of the DOH and local government units (LGUs). It also applies to non-government organizations, professional organizations, private sector, and other relevant partners in the health sector.    V DEFINITION OF TERMS   1. Diabetes mellitus \u2014 a group of metabolic disorders characterized by high blood sugar  levels, i.e. a fasting-plasma glucose concentration above 7.0 mmol/l (126 mg/dl) or a postprandial (approximately 2hOurS after a main meal) plasma glucose concentration above 11.0 mmol //(200mg/1) on two separate occasions.   2. Phil PEN Protocol on the Integrated Management of Hypertension and Diabetes.   3. The Philippine Package of Essential Noncommunicable Disease Interventions Protococol on the Integrated Management of Hypertension and Diabetes adopted from the WHO PEN and adopted for country use.   4. Protocol on the Integrated Management of Hypertension and Diabetes. The \ufb01rst clinical protocol develOped under WHO PEN that makes use of the total risk approach using hypertension, diabetes and tobaccouse as the entry points. It speci\ufb01cally involves the use of the WHO/ISH risk prediction charts to determine the risk of developing a cardiovascular event, i.e. heart attack or stroke over a ten period and . management guidelines for risk reduction appropriate referral, regular follow-up, core set of technologies and essential medicines.   5. Risk Factor Assessment is the key process of evaluating individuals for the presence or absenCe of common risk factors that expose them to increased likelihood of develOping NCDS.   6. Risk Screening is the presumptive identi\ufb01cation of unrecognized disease or the presence intermediate risk factors by the appliCation of test and procedures which can be applied rapidly.  7. Risk Strati\ufb01cation estimating the level of risks of indiViduals for a fatal or non-fatal cardiovascular event in 10 years.   8. Total Risk Approach is a structured method to identifying, assessing and managing. the major risk factors shared by cardiovascular diseases (CVD), cancer,'diabetes and chronic respiratOry disease.   9. WHO PEN World Health-Organization Package of Essential Noncommunicable   10. Disease Intervention provides a minimum set of interventions for detection , prevention, treatment and care of CVD and risk factors (heart disease,- stroke, hypertension), diabates, chronic respiratory disease (asthma and COPD) and cancer deemed feasible for implementation even in low resource settings with a modest increase in investment, that can be delivered by primary care physicians and non- physician health workers in primary health care settings.   VI: GENERAL GUIDELINES:   1. The Phil PEN Protocol on the Integrated'Managernent of Hypertension and Diabetes shall be used in all primary health care facilities in the-country, i.e. barangay health stations, rural health centers, community health centers, and the like.   2. All relevant health care providers shall undergo training on the use of the protocol to ' be provided by the DOH-NCDPC in coordination with NCPAM and PhilHealth.   3. The National Center for PharmaceutiCal Access Management Shall support the implementation of the Phil PEN by providing the complete treatment packs for lifestyle related diseases pursuant to Administrative Order 2011\u20140013 dated September 12, 2011 (Implementing Guidelines on theDOH Complete Treatment Pack (COMPACK) to Ensure Sustainable Access to Essential Drugs and Medicines for the Marginalized Sector) until such time that the PhilHealth bene\ufb01t packages shall have been fully instituted. -   4. The PhilHealth bene\ufb01t packages shall be provided for the long term support of the implementation of the Phil PEN Protocol on Integrated Management of Hypertension and Diabetes.   5. The referral system must be established and duly guided, while higher referral centers must be properly equipped to deal with referrals coming from the primary Care level facilities. '   6. All primary health care facilities in the country should be reorganized to address chronic long term care of patients taking into account patient load, logistical requirements and recording and reporting accountabilities    VII SPECIFIC GUIDELINES AND PROCEDURES:   These Speci\ufb01c guidelines and procedures shall be instituted at the primary health care level facilities all over the country, i.e. (barangay health stations, rural health units, community health centers and the like, whatever is appropriate. A manual of operatiOn will be issued containing more details.   1. Target Population  All individuals aged 25 years old and above with no established cardiovascular disease (angina pectoris, coronary heart disease, myocardial infarction and transient ischemic attacks), cerebrovascular-disease (CeVD) or peripheral vascular disease (PVD) or have not undergone coronary revascrilarizatiOn or carotid endarterectomy will undergo Risk Factor Assessment. (WHO 2007) I   2. Flow of Activities or Service Pathway  The \ufb02ow of activities (service pathway) In the assessment, \"screening and management of pctential clients at risk of NCD shall follow the algorithm illustrated 1n APPENDIX 2.   3. List of Essential Devices The following equipment, devices and supplies are needed in. the implementation of the Phil PEN protocol on the management of hypertension and diabetes and should be made available at the health care facility:   -Stethoscope  -Blood Pressure measurement device, non-mercurial   -Measuring Tape, non-extensible  -Height Board   -Weighing Scale.  -Glucometer with test strips*  -Cholesterol Meter with test strips  -Test tube or glass container for the urine   -Tests strips for checking urine ketones and protein    4. List of Essential Drugs/Medicines   The following drugs and medicines are needed In the implementation of the Phil PEN protocol on the management of hypertension and diabetes and should be made available at the health care facility:   -Thiazide diuretics  -a Beta blockers  -Angiotensin converting enzyme inhibitors  -Calcium Channel blockers (sustained release formulations)   -Aspirin  -Metformin  -Glibenclamide  -Gliclazide  -Simvastatin   5. Risk Assessment and Screening Risk Factor Assessment is the key process of evaluating individuals for the presence or absence of common risk faCtors that expose them to increased likelihood of developing NCDS. Risk factor assessment involves asking speci\ufb01c questions . to determine the individual\u2019s age, sex, family history of diseases assoCiated with NCDS among \ufb01rst degree relatives, theuse Of alcohol and tobacco, physical inactivity and diet. Risk Screening is the presumptive identi\ufb01cation of unrecognized diseaSe or the presence of intermediate risk factors by the application Of tests and'procedures which can be applied rapidly. The primary goal of risk screening is to detect a disease in its early \"stages to be able to treat it and prevent its further deveIOpment. It must be understood that screening is not a _ diagnostic measure bat 'it is a preliminary step in the assessment of the individual\u2019s chances of becoming unhealthy. (DOH, 2009) This involves tests to measure central adiposity and obesity, raised blood pressure, raised blood glucose and raised blood cholesterol.   Following the service pathway in APPENDIX 2, risk assessment will be performed on individuals 25 years old and above. Only those with any of the following will undergo . risk screening:   -Age greater than 40 years  -Tobacco/Cigarette Smoking  -Central Adiposity'  -Raised Blood Pressure  -Diabetes  -Family History of Hypertension, Stroke or Heart Attack  -Family History of Diabetes or Kidney Disease   At the primary health care facilities, the NCD Risk Assessment and Screening Form (refer to APPENDIX 3) will be used to record the results Of the riSk assessment and screening. The questionnaire to determine probable angina, heart attack, stroke & TIA (WHO, 2002) and the tests to determine the presence of urine protein and urine ketones are incorporated In this form In order to determine individuals who need to be referred to  a higher level of Care for further diagnosis and management.    In \ufb01lling-out the NCD Risk Assessment and Screening Form, an indiVidual 13 considered at risk if he or she:   I has a \ufb01rst degree relative with any of the following conditions: hypertension, stroke, heart attack, diabetes and kidney disease.   - currently smokes or stopped smoking for less than a year or is exposed to cigarette smoke (passive smoker)  - consumes exceSsive alcohol. Excessive alcohol intake is de\ufb01ned as having more than 2 drinks for males and more than 1 drink in females or having 5 drinks in one occasion.  - consumes high fat/high salt food frequently - consumes less than 3 servings of vegetables and 2 servings of fruits daily  - has less than 2 1/2 hours of moderate intensity physical activity weekly  - has a body mass index (BMI) equal to or more than 23 - I has a waist circumference equal toor more than 90. centimeters in-males or 80 centimeters in females  - has a blood pressure reading above 120 mmHg systolic or 80 mmHg diastolic, taken as the mean of two readings on each of two occasions  - has a fasting blood glucose concentration above 7. 0 mmol/l or 126 mg/dl or a random blood glucose concentration above 11.0 mmol/l or 200 mg/dl - has a total blood-cholesterol concentration above 5.3 mmol/l or 200 mg/dl    6. Referral  Coordination mechanisms with the next referral level should be established fOr clients who need specialist or hospital care. Following Action 3 of the WHO PEN Protocol for the Integrated Management of Hypertension and Diabetes, individuals With any of the conditions below will be referred to a higher level facility:   -Blood Pressure of 2140 (systole) or >90 mmHg (diastole) in people below 40 years old (to exclude secondary hypertension)   -Known heart disease, stroke, TIA, DM, kidney disease (for assessment as necessary) Angina, claudication   -Worsening heart failure   -Raised Blood Pressure 2140/90 (in DM above 130/80 mmHg) in Spite of treatment with 2 or 3 agents   -Any proteinuria   -Newly diagnosed diabetes \"with urine ketones 2+ or in leanperson of below 30 years old . DM with fasting blood glucose > 14 Immol/l despite maximal metformin with or without sulphonylurea    -DM with severe infection and/or foot ulcers   7. Risk Strati\ufb01cation - Following risk assessment and screening, the level of risks Of individuals who are not referred to a higher level facility will be estimated using the WHO/ISH Risk Prediction Charts for the Western Paci\ufb01c Region (refer to Appendix 3).   Classi\ufb01cation of the lO\u2014Year Risk of Fatal or Non-fatal. Cardiovascular Event:       Charts are not necessary for making treatment decisions-in individuals. Who are. at high cardiovascular risk because they have established cardiovascular disease or very high levels of individual risk factors. All of them need intensive lifestyle interventions and appropriate drug therapy. They include people:   -with established cardiovascular disease   -without established CVD who have a total cholesterol > 8 mmol/l (320 mg/dl) or low- density lipoprotein (LDL') cholesterol 2 6 mmol/l (240 mg/dl) or TC/HDL- C (total cholesterol/high density lipoprotein cholesterol) ratio > 8\"   -without established CVD who have persistent raised blood pressure (>160\u2014170/100\u2014 105 mmHg)   -with type 1 or 2 diabetes, with overt nephropathy or other signi\ufb01cant renal diSease I with renal failure or renal impairment.   8. Risk Management Management guidelines for risk reduction Will follow Action 5 of the WHO PEN Protocol for the Integrated Management of Hypertension and Diabetes (WHO 2010) and the Pocket Guidelines for Assessment and Management of Cardiovascular Risk WHO 2007).   VII IMPLEMENTATION ARRANGEMENT   The oversight in the implementation of the Phil PEN lies with the National Center for Disease Prevention and Control, Degenerative Disease Of\ufb01ce in collaboration with the National Center for Pharmaceutical Access Management and the Philippine Health InsuranCe Corporation.   IX ROLES AND RESPONSIBILITIES   The following of\ufb01ces and institutions shall provide support to LGUS 1n the adoption of Phil PEN:   1. Department of Health    The DOH shall provide leadership in the adoption of Phil PEN by (1) promoting Phil PEN for nationwide adoption and formation of partnershipamong several stakeholders; (2) providing of technical support, logistics and \ufb01nancial assistance to LGUS' and (3) monitoring progress of nationwide implementation of Phil PEN.   National Center for Disease Prevention and Control (NCDPC) The NCDPC shall be the over-all coordinator for the adoption of Phil PEN among LGUS. shall:   -Provide policy directions In the adoption and institutionalization of Phil PEN for _ LGUS.    -Provide technical support to the CHDS 1n extending support to the LGUS. I In collaboration with the CHDS, provide logistics and \ufb01nancial assistance to the LGUS.   -Develop a reporting and monitoring system in the adoption of Phil PEN among LGUS In collaboration with the National Epidemiology Center.   -Coordinate with other natiOnal centers and bureaus in the central of\ufb01ce in the adoption of Phil PEN such as:   -Development of IEC plans and materials with the National Center for Health Promotion (N CHP) '  -Coordinate with the National Center for Pharmaceutical Access and Management. (NCPHM) in ensuring access and availability of affordable quality generic non-communicable disease medicines.   National Center for Pharmaceutical Access and Management (N CPAM) The NCPAM In collaboration with the NCDPC and Centers for Health Development (CHD) shall:   -Set the policy direction in the provision of affordable quality generic non-communicable disease medicines particularly for the poor.   -Oversee and supervise the provision of affordable quality generic non\u2014 communicable disease medicines including the pre and post procurement activities.   National Center for Health Promotion (NCHP) The NCHP Shall:   -Provide the necessary IECS that will advocate the adoption of Phil PEN among LGUS as well as development of behavioral change communication Schemes targeting various stakeholders 1n the community.   -Advocate with other government agencies, non-government, private sector, development partners and other relevant stakeholders for support on policy - development and \ufb01mding 1n the creation of an environment that will encourage healthy lifestyle.   Health Policy Development and Planning Bureau (HPDPB)  The HPDPB shall support the development of relevant policies In the adoption of Phil PEN as well as the facilitation of program evaluation studies and researches.   National Epidemiology Center  The National Epidemiology Center shall support the development of the indicators and possible sources   Centers for Health Development (CHD)  The DOH CHD shall serve as local coordinator 1n the adoption of Phil PEN. The rOles of the CHDS shall be as follows.   -Ensure that the health systems at the local level are supportive and responsive to the essential elements required in the adoption of Phil PEN.   -Build local coalitions composed of local government, civil society, academe, private sector and other relevant partners in the health sector that would support adoption of Phil PEN.   -Promote the adOption of Phil PEN among LGUS in the region.   -Provide technical support to LGUS in the adoption of Phil PEN. Assist LGUS in accessing available \ufb01nancial grants and support of the DOH, development partners and donors.   2.PHILIPPINE HEALTH INSURANCE CORPORATION (PHIC)  In order to ensure the adoption of Phil PEN, the PHIC shall:   -Develop and implement an insurance package for individuals at risk and af\ufb02icted with lifestyle related disease.   -Advocate the adoption of Phil PEN in the health facilities nationwide by linking to \ufb01nancial incentives. -  3. Local Government Units (LGUS)  The Local Government Units shall adopt and implement the PHIL PEN and provide services and products in primary health care facilities and hospitals in their localities as well as provide the training needs for personnel at peripheral health units , district hospitals and laboratories.   4. Referral Centers Higher level facilities such as district, provincial hospitals, medical centers, regional hospitals and specialty hospitals must be equipped to handle referral for lower level facilities and provide the necessary support to the implementation of the PHIL PEN.   X FUNDING   The Department of Health Central Of\ufb01ce and Centers for Health Development shall provide funds \"for technical assistance, monitoring and health promotion campaigns to ensure ' the operationalization of this Order. Local Government Units shall provide funds to provide products and services in their respective communities. Other government agencies, non- govemment organizations and other stakeholders Shall provide counterpart funds and technical assistance as appropriate to ensure the effective implementation of the PHIL PEN Protocol in the country.    XI REPEALING CLAUSE   All previous Orders and other related issuances inconsistent or contrary to the provisions of this Administrative Order are\" hereby repealed, amended or modi\ufb01ed _ accordingly. All other provisions of existing issuances which are-not affected by this Order shall remain valid and in effect.   XII EFFECTIVITY   This Order Shall take effeCt immediately. ", "   I. Background  Blindness as a health problem leads to enormous human suffering, due to the loss of functional ability, and self-esteem. It has considerable economic implication manifestingas either loss of productivity, income and can lead to social dependency.  An estimated 180 million of the world\u2019s population are visually disabled Of these, around 45 million are blind and cannot walk about unaided. Within the Western Pacific Region, World Health Organization (WHO) estimates that there are 8 million people blind Prevalence rates vary from country to country. More than 80% of these 8 million live in only three countries, China, Vietnam and the Philippines.  The 3rd Philippine National Survey of Blindness conducted last year showed that about 3,500,000 (4.62%) Filipinos are visually impaired in one or both eyes. They are either afflicted with bilateral low vision (1.64%), monocular low vision (1.33%), monocular blindness (1.07%), or bilateral blindness (0.58%). Cagayan Valley had the highest prevalence of visual impairment (blind and low vision) which reached 7.75%, while the lowest was found in GARAGA at 1.67%. The age' group between 60 to 74 years old showed the highest prevalence rates, while the age groups 0 to 20 age groups had the lowest.  To prevent blindness, all stakeholders, through the leadership of the Department of Health, need to strengthen the Prevention of Blindness Program. The program aims to reduce the current prevalence of bilateral blindness to less than 0.3%. This program also aims to prevent or reduce blindness in long run.  This order prescribes the guidelines for the operation of the National Prevention of Blindness Program.  II. Coverage and Scope  This Administrative Order covers all Health and health related professionals, facilities, offices,bureaus and all other organizations and individuals involved in blindness prevention activities.  III. Definition of Terms  A. Blind \u2014 person whose better eye cannot see 3/60 or cannot count fingers at 3 meters.  B. Cataract \u2014 results from a change Of transparency of the normal crystalline lens In the eye. This condition causes gradual loss of vision and blindness.  C. Error of Refradtion \u2014 is a distance visual acuity of less than 20/30 in one or both eyes (including those with eyeglasses) with no other eye disease present and without confirmation by refraction  D. Low Vision \u2014 refers to a person whose better eye cannot see 6/18 (20/70) but can see 3/60 or count fingers at 3 meters.  E. Primary Eye Care -\u2014 comprises of simple but comprehensive set of preventive and curative activities that can be carried out by primary health workers.  F. Visual acuity \u2014 measurement Of the person\u2019s sharpness of vision. A person\u2019s visual acuity is his abilityto see objects clearly, and this ability is tested by the use Of a visual acuity chart or other ways like ability to count fingers or to perceive light.  G. Vitamin A Deficiency \u2014 is a condition in which the body stores of Vitamin A are depleted to the extent that physiological functions are impaired. Depletion of stored Vitamin A occurs over time when the diet contains too little to replace the amount used by tissues.  IV. General Policies  The program shall be guided by the following policies:  A. The DOH as the lead agency for the promotion and protection of people\u2019s health shall ensure the provision of the highest quality of appropriate .eye care through the development of national standards for ethical practice, facility development and service provision.  B. The DOH shall establish strong collaboration and partnership with other stakeholders in all levels of government, all sectors, and civil society, includingthe academe, the medical or paramedical specialty societies, non-government organizations, people\u2019s organizations, business, local government units, and others who can contribute to quality eye care.  C. The DOH and its partners and other stakeholders shall empower and actively involve persons who are at riskof acquiring eye diseases, and those with visual illnesses already and/or the immediate family of these persons in every phase before, during and after the disease process.  D. Eye care providers shall be adequately trained to become competent health providers at every level-of government from the devolved local government units to specialty hOspitals of both government and private sectors by DOH and its partner agencies.  E. Vision 2020 shall be adopted as the framework for evolving strategies and activities in the implementation Of this memorandum.  V. Program Vision, Mission, Goals and Objectives  A. Vision:  All Filipinos enjoy the right to sight by year 2020  B. Mission:  The Department of Health, Local Health Units, partners and stakeholders commit to: 1. Strengthen partnerships among and with stakeholders to eliminate avoidable blindness in the Philippines 2. Empower communities to take proactive roles in the promotion of- eye health and prevention of blindness 3. Provide access to quality eye care services for all 4. Work towards poverty alleviation through preservation and restoration of sight to indigent Filipinos  C. Goal:   Reduce the prevalence of avoidable blindness in the Philippines through the provision of quality eye care  D. Objectives  General Objective no 1: Increase Cataract Surgical Rate from 730 to 2,500 by the year 2010  Specific:  1. Conduct 74,000 good outcome cataract surgeries by 2010 2. Ensure that all health centers are actively linked to a cataract referral center by 2008 3. Advocate for the full coverage of cataract surgeries by PhilHealth 4. Establish provincial sight preservation committees in at least 80% of provinces by 2010 5. Mobilize and train at least one primary eye care worker per barangay by 2010 6. Mobilize and train at least one mid- level eye care health personnel per municipality by 2010 7. Improve capabilities of at least 500 Ophthalmologists in appropriate techniques and technology for cataract surgery 8. Develop quality assurance system for all ophthalmologic service facilities by 2008 9. Ensure that 76 provincial, 16 regional and 56 DOH retained hospitals are equipped for appropriate technology for cataract surgery  General objective no 2: Reduce visual impairment due to refractive errors by 10% by the year 2010  1. institutionalize visual acuity screening for all sectors by 2010 2. Ensure that all health centers are actively linked to a referral center by 2008 3. Distribute 125,000 eye glasses by 2010 4. Ensure that hospitals and of health centers have professional eye health care providers by 2010 5. Ensure establishment of equipped refraction centers in municipalities by 2008 6. Establish and maintain an eyeglass bank by 2007  General objective. no 3: Reduce the prevalence of visual disability in children from 0.43% to 0.20% by the year 2010  1. Identify children with visual disability in the community for timely intervention 2. Improve capability of 90% of health workers to identify and treat visual disability In children by 2010 3. Establish a completely equipped primary eye care facility in municipalities by 2008  VI. Program Components  A. Advocacy and Health Education  This includes patient information and education, public information and education and intersectoral collaboration on eye health promotion and the nature and extent of visual impairments particularly its risk factors and complications and the, need/urgency of early diagnosis and management.  B. Capability Building  This component shall focus on ensuring the capability of national and local government health facilities in delivering the appropriate eye health care services especially to the indigent sector Of the population Program shall provide training for coordinators at regional and provincial levels; will ensure the availability of and access to training programs by program implementers. It shall include strengthening treatment/management capabilities of existing personnel and operating capabilities of facilities conducting cataract operations etc. taking into outmost consideration basic quality assurance and standardization of procedures and techniques appropriate to each facility/locality.  C. Information Management  The program shall develop an information management system for purposes Of reporting and recording. As far as practicable, this system shall consider and will build on any existing mechanism. The system shall be national in scope, although the mechanism shall consider the regional and coal needs and capabilities.  D. Networking, Partnership Building and Resource Mobilization  An important component of the program is networking and partnership building .to ensure that services are available at the local level. This shall include public-private and public-public partnerships aimed at building coalitions and networks for the delivery of appropriate eye health care services at affordable cost especially to the indigent sector. This component shall also focus on ensuring that the highest appropriate quality services are made available and accessible to the people.  E. Supervision, Monitoring and Evaluation  The program shall be coordinated by a national program coordinator from the Degenerative Disease Office of the National Center for Disease Preventionand Control, Department of Health. The national program coordinator shall oversee , the implementation of program plans and activities with the assistance of the regional coordinators from the Centers for Health Development.  A system of mOnitoring program plans and activities shall be developed and implemented taking into consideration the provisions of the local government code as Well as the organic act of Muslim Mindanao, and any similar issuances/laws that will be passed in the future.  A program review shall be .conducted as needed. Results of program evaluation shall be used in formulating policies, programobjectives and action plans.  F. Research and Development  The program shall encourage the conduct of researches for purposes of developing local competence in eye health care and for other purposes that may be necessary.- The development and dissemination of clinical practice guidelines for eye health shall form part of the research agenda of the program.  The program shall support researches/studies in the clinical behavior (KAP) and epidemiological(trends)areas. It also aims to acquire information that is utilized for continuing public health information and education, policy formulation, planning and implementation.  G. Service Delivery  Service delivery for the Prevention of Blindness Program shall be covered by the principle of best practices. In collaboration with the local government units and stakeholders, the program shall develop systems and procedures for the integration and provision of services at the community level. This means primary prevention concentrating on health education, advocacy and primary eye interventions; Secondary prevention; screening/early detection/basic management/ counseling, referral and/or definitive care and tertiary prevention: management of complications, continuing care and follow up including rehabilitation. The following areas will be the priority areas for services to be provided by the National Prevention of Blindness Program:  1. Cataract Surgeries 2. Errors of Refraction 3. Childhood Blindness  Activities for the Vitamin A Deficiency Disorder, for practical purposes, shall be led by the Family Health Office also of the NCDPC.  A Referral System shall form\" part of services delivered by the program. This is to ensure that all patients receive quality eye health care at appropriate levels OfIhealth care delivery system. All rural health units should be linked to an eye. care referral center.  VII. Roles and Responsibilities  A. Roles and Responsibilities  1. Department of Health - Central Office shall develop systems, policies and guidelines that will facilitate the implementation of the Prevention of Blindness Program including the monitoring and evaluation of program strategies. Develop the capacity Of CHD personnel in assisting the LGUs in implementing the Prevention of Blindness Program at the local level.  As such, the following offices shall have the following responsibilities:  a. The National Center for Disease Prevention and Control (NCDPC) shall (a) develop the system for the implementation of the National Prevention 'Of Blindness Program; (b) provide technical assistance and conduct monitoring and evaluate program operation.(c) lead in the formulation Of the health intervention and rehabilitation programs and strategies that will reduce the burden and consequences of eye diseases and disabilities and promote visual health and (d) ensure the participation of other DOH offices in program activities where needed.  b. The National Center for Health Promotion shall assist the NCDPIC in the formulation of standards and development of information, education and communication (IE0) and advocacy strategies for the prevention of blindness program to ensure the promotion of a healthy and less stressful lifestyle for the Filipinos, as well as to help in ensuring that the public has knowledge of services being offered as part of the program.  c. The National Epidemiology Center and the Information Management Service shall assist NCDPC in the development of a national reporting and surveillance system as well as the development of methodologies for the generation, collection and distribution of information and knowledge on the possible establishment of the national registry for blind persons.  d. The Health Policy Development and Planning Bureau shall (a) assist in the proper and effective implementation, monitoring and evaluation of the National Prevention of Blindness Policy; (b) ensure its'formulation into a national program plan of action; (c)'assist in developing a health financing scheme/protocol for eye health bare services together with the Philippine Health Insurance Corporation; and (c) the inclusion of the prevention of blindness in the priorities for the health research agenda.  e. The Health Human Resource Development Bureau shall assist in (a) the development of standards in the curriculum and the training of all types of health professionals, practitioners, and care providers who are responsive, sensitive, which should be consistent with the national and local human development goals and culture; (b) the adequate and equitable distribution of health manpower through provision and protection of plantilla positions in the health care delivery system at the national and regional levels; and (c) the provision of a good incentive and benefit program to attract health caregivers in the unserved and underserved areas.  f. The Bureau of International Health Cooperation shall ensure that the program has strong network linkages with international health institutions, agencies, units that will continually ensure the inclusion, participation, cooperation and collaboration of the Philippines in the global scene for the prevention of blindness.  g. The Bureau of Local Health Development shall assist in the integration of quality eye care 'into local health system development.  h. The Centers for Health Development shall facilitate the implementation of procedure/guidelines in the LGU pilot areas for the Prevention of Blindness Program from ground working and situational analysis to finalizing the commitment of the key player (DOH, LGU, PHIC, private sector, NGOs, etc.) provide technical assistance to LGUs in selecting program strategies and assist the LGUs in cOordinating the actual implementation of the chosenprogram strategies and activities.  i. DOH hospitals and medical centers shall ensure the availability of quality eye care services to its clients through the establishment of appropriate capabilities and competencies in their respective units.  2. Local Government Units- should organize themselves into inter-local Health zones that will manage the implementation of Prevention Of Blindness Program strategies and activities. LGUs shall pass the necessary local legislation (ordinances, resolutions) to implement program strategies. Provide counterpart funds for implementing their investment plan.  3. The National Committee for Sight Preservation (NCSP) - a non-profit organization composed of GOs, NGOs and academe involved in prevention of blindness and promotion of eye health programs, activities and-projects, as well as to act as an advisory group to the Department of Health\u2019s National Prevention of Blindness Program. It will be the lead partner agency of the Department of Health in ensuring that the Prevention of Blindness Program is implemented nationwide, in strong collaboration with local government units, non-government agencies and other concerned organizations and government agencies.  4. Professional Organizations for eye health care, specifically but not limited to the Philippine Academy of Ophthalmology and the different Optometric organizations, shall ensure the availability of competent, efficient and culturally and gender sensitive eye care health professionals in all provinces in the Philippines.  5. Civil Societies - shall 1) assist the Local Government Units in achieving their health Objectives 2) shall identify the health needs of the people and bring to the attention of the inter-local health zones 3) enhance accountability and transparency of inter-local health zone management.  6. Donor Agencies - shall provide funding assistance according to the investment plan developed for the Prevention of Blindness Program.  VIII.. Implementing Mechanisms  A. Program Administration  The Prevention of Blindness Program shall be one of the programs of the National Center for Disease Prevention and Control, which may later become a sub-component of the center\u2019s program for persons with disabilities.  Program administration shall focus on the following guiding principles 1) leadership of the Department of Health, Center for Health Development and stakeholders 2) intersectoral coordination and collaboration 3) flexibility and adaptability to situations 4) strengthening linkages and networking 5) COSt sharing initiatives.  B. Coordination with Other NCDPC Program and DOH Offices  To ensure a comprehensive approach to blindness prevention, coordination-with the other programs (Maternal and Child Health and Nutrition Program) and other DOH Offices such as the National Center for Health Facility Bureau and the Bureau of Health Facilities and Standards shall be instituted.  C. The Program Management Committee (PMC)  For the years 2005 - 2010, a Program Management Committee (PMC) shall be organized to ensure the implementation of the National Sight Plan. The Program Management Committee shall be chaired by the Director IV, National Center for Disease Prevention and Control, with the Chair of the National Committee forSight Preservation as vice\u2014chair. The composition, other roles and responsibilities of this PMC shall be spelled out in a Department Order that will be issued for this purpose. The Undersecretary for Health Operations shall have over\u2014all supervision of the program.  The Program Management Committee (PMC) shall be the main coordinating body for the program. Its members shall include the Division chief of the Degenerative Disease Office in charge of this program, the national focal person for this program and a representative from the league of municipalities, Philippine Academy of Ophthalmology, two representatives from the. Optometry group and two representatives from the NGO-Igroup. Members who represent their organizations in this committee shall be those nominated by their respective organizations which may be renewed or replaced annually.  The Project Management Committee (PMC) shall have the following responsibilities: 1. Recommends to the Secretary of Health activities and plans 2. Monitoring of implementation of program activities 3. Others as may be identified and approved by the Secretary of Health  IX. Funding  The Department of Health and the Centers for Health Development shall provide funds for technical assistance, monitoring and advocacy campaigns (IEC materials). Furthermore, the local government units, NGOs and stakeholders shall contribute counterpart funds to ensure the implementation of the National Prevention of Blindness Program.  X. Effectivity  This Order shall take effect immediately.   ", " I. RATIONALE   In the pursuit of achieving \u201cAll for Health towards Health for All\", the Philippine Health Agenda (PHA) de\ufb01nes the blueprint of the government\u2019s strategies to have an inclusive and responsive health care for all Filipinos. The PHA guarantees the provision of health services to all Filipinos especially the poor, marginalized, and vulnerable such as the persons with disabilities (PWDs). In response, the Department of Health (DOH) ensures that relevant policies and plans for the Health and Wellness Program for PWDs are crafted and implemented in accordance with the PHA and current governing laws.   The Republic Act (RA) 10754, otherwise known as \u201cAn Act Expanding the Bene\ufb01ts and Privileges of Persons with Disability\", was enacted into law on March 23, 2016 and its corresponding Implementing Rules and Regulations (IRR) was signed on December 1, 2016. This law expands the bene\ufb01ts and privileges of PWDs by amending Republic Act 7277, otherwise known as the \u201cMagna Carta for Persons with Disabilities\". In particular, Section 1 of RA 10754 amends Seetion 32 of RA 7277 entitling the PWDs to at least twenty percent (20%) discount and exemption from the value-added tax (VAT) on the purchase of certain goods and services from all establishments for the exclusive use, enjoyment, or availment of the PWD.   As mandated in Rule IV, Secs. 6.4 and 6.5 of the IRR of RA 10754, the DOH, in coordination with Philippine Health Insurance Corporation (PhilHealth) and Food and Drug Administration (FDA), shall issue the corresponding guidelines, circulars or directives related to the purchase of health and medical goods and availment of services from medical establishments.   In this regard, the DOH is hereby repealing DOH Administrative Order (AO) 2009\u20140011 to include the additional bene\ufb01ts and privileges stated in the RA 10754 and its IRR.   II. OBJECTIVES   To provide guidelines for the implementation of at least 20% discount and VAT exemption in all medical, and health- related services for PWDs.   III. SCOPE AND COVERAGE   This Administrative Order applies to all private and government hospitals and other health facilities, health care professionals, PhilHealth, pharmacies and other establishments providing medical and health-related care and services to PWDs.   IV. DEFINITION OF TERMS   Annex A provides the relevant and pertinent de\ufb01nition of terms as adopted from RA 7277, RA 9442, and RA 10754.   V. GENERAL GUIDELINES   1. All PWDs are entitled to at least 20% discount and VAT exemption upon requirements determination and compliance by both the provider/establishment and PWD.   2. At least 20% discount and VAT exemption shall cover purchase of generic and branded medicines, medical and assistive devices, costs of medical, dental, and rehabilitation services, and diagnostics and laboratory fees, as prescribed by the attending physician for all PWDs.   3. Diagnosis or treatment shall be in accordance to the latest Clinical Practice Guidelines (CPGs) or hospital treatment protocols, for all service wards and pay sections of government hospitals and facilities, and in all private hospitals and medical facilities.   4. Services which are medically necessary for the prevention, diagnosis, treatment, rehabilitation, or palliation of the PWD shall be provided the discount and exemption.   5. All PWDs shall be enjoined to become PhilHealth members (member or dependent of active PhilHealth member). The national government through the National Household Targeted System or Listahan, LGUs, NGOs, or private individual and/or group shall support the PhilHealth enrollment of non-PWD members. PWDs may also opt to enroll themselves as individual paying members.   6. All government and private hospitals, medical facilities, and hospitals including drugstores and other licensed establishments dispensing medicines shall develop appropriate and strategic communication materials to disseminate information and policies set forth by this issuance accessible to all PWDs; designate express lanes for PWDs; and issue of\ufb01cial receipts in every payment of drugs and medicines, medical/assistive devices, and other services stating the usual rates or fees, retail price, discounts and VAT exemption.   7. All health facilities shall provide holistic quality care to PWDs and their families and treat them with professional conduct and respect in support of this Order.   VI. IMPLEMENTING RULES AND MECHANISMS FOR THE AVAILMENT OF PRIVILEGES   1. At least 20% discount and VAT exemption shall apply to the following:   a. Generic and branded medicines as well as food for special medical purposes in establishments dispensing medicines;   b. Medical and assistive devices not limited to the list enumerated in Annex B. Purchase of any the following medical devices shall be recorded in the Purchase Booklet for control and monitoring:   i. Medical and assistive devices used/consumed during check-up or con\ufb01nement of a PWD regardless of the number of days of stay in the hospital or any health facilities and during recovery at home, or for monitoring of a particular ailment or disease, or to aid the maintenance of a treatment.   ii. Medical and assistive devices used during recovery at home, or for monitoring of a particular ailment or disease, or to aid the maintenance of a treatment, with the approval / referral of the physician.   c. Professional fees of attending doctors in the pay section of government and private hospitals and facilities; and   d. Costs of medical, dental, and rehabilitation services; diagnostic and laboratory services including the use of special reagents, dyes, contrast media, and radioactive isotopes; and psychological, behavioral, and developmental tests \u2014 for both in-patient and out-patient PWDs in government and private hospitals and facilities   2. The hospital bed for a PWD con\ufb01ned in a service ward of a government facility shall be classi\ufb01ed based on AO 51\u2014A s. 2001 known as the Implementing Guidelines on the Classi\ufb01cation of Patients on Availment of Medical Social Services in government health facilities. The balance shall be paid by the PWD based on his/her Medical Social Worker Classi\ufb01cation. '   3. Discounting and computation of the 20% Discount and VAT exemption:   a. At least 20% discount and VAT exemption shall be granted upon full payment of the hospital bill. The billing statement showing the usual rates or fees and the discounted prices shall be attached to the of\ufb01cial receipt.   b. At least 20% discount and VAT exemption shall be deducted upon purchase of the medicines and medical and/or assistive devices, with compliance to the necessary documentary requirements for the availment of discounts and exemption.   c. All PhilHealth accredited health care institutions shall \ufb01rst deduct 12% VAT exemption from the total health care institution charges, then deduct the 20% PWD discount from the difference. Other PhilHealth bene\ufb01ts shall be deducted from the remaining amount. It is only after deducting the appropriate discount from the total bill or statement of account that the accredited health care institution can \ufb01le claim for bene\ufb01t package.   d. The discount privileges and VAT exemption shall be non-transferable and exclusively for the bene\ufb01t of the PWD.   e. Double discounts shall not be allowed. The PWD shall avail of the establishment\u2019s offered discount or at least 20% discount and VAT exemption provided herein, whichever is higher and more favorable. In cases where the person with disability is also a senior citizen entitled to a 20% discount and VAT exemption under his/her valid senior citizen identi\ufb01cation card (ID), the person with disability shall use either his/her PWD ID Card or Senior Citizen ID card to avail of the at least 20% discount and VAT exemption.   f. Drug stores offering special discounted prices less than 20% of the regular retail price can deduct the percentage discount of their promotional campaign from the total of twenty percent (20%) discount. as required by RA 10754. Thus, a total discount of 20% for PWD shall still be applied.   4. Purchase of All Medicines and Medical and Assistive Devices and Documentary Requirements for the Exclusive Use of the PWDs   A. The following documentary requirements shall support the availment of the discount and exemption for compliance of PWDs:   i. PWD identi\ufb01cation (ID) card as issued by Local Government Unit (LGU) through the City/Municipal Social Welfare and Development Of\ufb01ce (C/MSWDO) or the Persons with Disability Affairs Of\ufb01ce (PDAO) of the place where the PWD resides in accordance with NCDA-Administrative Order #001. National Council on Disability Affairs (NCDA) shall issue a temporary PWD ID to PWDs in emergency situations such as but not limited to hospital con\ufb01nement, provided that the PWD ID number coding shall be retained in accordance with the of\ufb01cial residence of the PWD.   ii. Except for over-the-counter (OTC) drugs, a doctor\u2019s prescription shall be presented for medicines and food for special medical purposes. A prescription shall have the following information : (1) name of the PWD, (2) age, (3) sex, (4) address, (5) date, (6) generic name of the medicine, (7) dosage form, (8) dosage strength, (9) quantity, (10) signature over printed name of physician, (11) physician\u2019s address, (12) contact number of physician or dentist, (13) professional license number, (14) professional tax receipt number and (14) narcotic license number, if applicable. The drugstores may limit the dispensing of OTCs to not more than a week\u2019s supply. Only prescriptions that contain the above information shall be honored.   A doctor\u2019s prescription shall also be presented for medical and assistive devices in accordance with preceding paragraph.   iii. Purchase booklet issued by the local social/health of\ufb01ce to PWDs for free containing the following basic information:   1. PWD ID number  2. Booklet control number  3. Name of PWD  4. Sex  5. Address  6. Date of Birth  7. Picture  8. Signature or thumb mark of PWD  9. Information of medicine to be purchased such as name of medicine, quantity, attending physician and his/her license number, name of servicing drug store and name of dispensing pharmacist  10.  Authorization letter of the PWD who is residing in the Philippines at the time of purchase, currently dated and the identi\ufb01cation card of the authorized person or representative, in case the medicine is bought by the representative or caregiver of the PWD. Purchase booklets shall be used to record the kind of OTC medicine purchased, how many, when and where it was purchased. Likewise, this shall help the drugstores to monitor the last purchase made for a certain medicine.  11. In cases wherein the PWD is a minor or mentally or physically incapacitated to execute an authorization letter, the parent or legal guardian or representative shall be allowed to make the purchase on behalf of the PWD, upon proof of their valid identi\ufb01cation card. The name of the said guardian or representative shall be indicated at the back of the PWD ID and shall be the exclusive representative of the PWD.   B. Establishments / Providers dispensing medicines and assistive devices   i. As a general rule, any single dispensing of medicines must be in accordance with the prescription issued by a physician and should not exceed one (1) month supply.   ii. Drug stores are required to maintain a special record book for PWD subject to inspection by the FDA and Bureau of Internal Revenue.   iii. For partial \ufb01lling, the establishment\u2019s pharmacists shall indicate the quantity partially \ufb01lled in the purchase booklet (special record book) and the un\ufb01lled balance on the prescription. The PWD shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity. Fully \ufb01lled prescription shall be surrendered by the PWD to the establishment\u2019s pharmacists.   5. Responsibilities of Stakeholders   a. All Government Facilities shall:  i. Post hospital room rates, laboratory tests, diagnostic tests fees, medicine prices, and all other rates and fees in noticeable or strategic places in their respective facilities (e. g. near or at the main entrance of facilities); and   ii. Submit the aforementioned price list annually to the Health Facility Development Bureau of the DOH and PhilHealth; and   iii. Provide mechanisms to address queries or complaints from PWDs.   b. Private Hospitals and Medical Facilities and Establishments shall:   i. Post the price of all room rates in the Admitting Section. The prices of diagnostics and laboratory tests based on room and board accommodation, medical supplies and medicines shall be made available upon request of the PWD. The list shall ensure validation of the discount and VAT exemption granted to PWDs.   ii. Provide mechanisms to address queries or complaints from PWDs with regard to discount and VAT exemption on professional fees; and   iii. Inform in writing, copy furnished the aggrieved party, the necessary sanction for the health professionals who refuse to grant the proper discount and VAT exemption.   c. Drugstores and other licensed establishments dispensing medicines   i. Drugstores shall make available upon the PWD\u2019s request, a generic menu card and shall issue of\ufb01cial receipt for drugs and medicines, which states the usual prices and the discounted prices and VAT exemption of the drug or medicine.   ii. During operating hours, all licensed establishments which dispense medicines shall be prohibited from scheduling or limiting the time of the PWDs to avail the discounts.   d. Health Care Professionals shall: i. Inscribe his/her name and PRC number in the request for diagnostic and laboratory tests, and prescription;   ii. Ensure that prescriptions made are for the exclusive use of the PWD to curb abuse of availing discounts for use of non-PWD citizens;   iii. Inform the PWD of the usual fees for the services required;   iv. Provide an of\ufb01cial receipt for the rendered professional services to the PWD that states the usual fees and the discounted fees and VAT exemption.   6. Mechanism of Endorsement of Complaints   All complaints on non-compliance with the 20% discount and VAT exemption shall be lodged with the NCDA and/or to the respective LGU-PDAO where the purchase was made or where the PWD resides, whichever is convenient for the PWD in accordance with Section 15 of Rule VI of the IRR of RA 10754.   VII. SEPARABILITY CLAUSE/ REPEALING CLAUSE   This Order repeals DOH Administrative Order (A0) 2009-0011. All other issuances that are inconsistent herewith are hereby revised or modi\ufb01ed.   If any portion or provision of this Order is declared void or unconstitutional, the remaining portions or provisions thereof shall not be affected by such declaration.   VIII. EFFECTIVITY   This Order shall take effect immediately after its publication in two (2) newspapers of general circulation ", " I. RATIONALE   Access to medicines is a mold-sectoral issue that cuts across health, social welfare, trade, financing even environment and policies that affects many stakeholders, patients, industry, healthcare professionals, civil societies, government, and the private sector. Chapter 1, Section 3 of the Republic Act (RA) No. 9502 otherwise known as the \u201cUniversaiiy Accessible Cheaper and Quality Medicines Act of 2008,\" states that all doubts :in the implementation and interpretation of the provisions of this Act, including, its implementing rules and regulations, shall be resolved in favor of protecting public health. Issues on medicines access can be best deliberated by these relevant groups in. order to assist the government in. creating policies that are fair and transparent.   The Implementing Rules and Regulations (IRR) of RA 9502, Chapter 5, Rule 28, states that the Secretary of Health (80H) may create advisory bodies and consultative councils from which advice may he sought in the implementation of a drug or medicine price monitoring and regulation policy. The Department Personnel Order No. {3130) 2,009m\u2014517l formed the Advisory Council for price regulation, however the Council was renamed as Advisory Council for the implementation of RA E1502, through DPO No. 3013\u20145044, as concurred by the members after a thorough deliberation that centered on the overall implementation of the Law. Moreover, RA 9582. has\" amended policies on Intellectual Property, wherein patent. exhaustion allowed the government to access high cost medicines that are of importance to the public, as well as the use of the Trade-Related Aspects of Intellectual. Property (TRIPS) flexibilities.   Several council meetings were already held since the enactment of the Law that focused on strategic implementation areas such as the price regulation, health. care financing, policies on Senior Citizens discount, Philippine National. LForrnulary {PNF}, 'Medicines Access Programs (Merits), and other regulatory policies of. the DOH and the Food and Drug Administration (FDA). Thus, it is imperative that the Advisory Council is reconstituted to address the needs of the people, especially on healthcare. Moreover, it serves as an avenue to tiring together the government, private and professional organizations, academe, civil society and support groups to discuss relevant issues surrounding medicines access and to come up with sound policy recommendations. This multi-staheholder collaboration would ensure the transparency of government actions and promote people empowerment.    II. OBJECTIVES   This Order aims to institutionalize the creation of the Advisory Council for the implementation, of RA. 9502 to achieve a balanced representation, among key stakeholders involved in the access and use of essential. medicines. The government. recognizes that partnership with the different sectors is vital. in the implementation of the Law.   III. SCOPE AND COVERAGE   This Order shall apply to the Department of l\u2014lealth and its attached agencies [Food and Drug Administration (FDA) and Philippine Health. Insurance Corporation (Philliealth\ufb02, Department of Trade and Industry (Bill) and its attached agencies [National Consumers Affairs Council (NCAC), PlTC Pharma. inc. (PH) and intellectual Property Office (IPO)], Department of Finance (DOF) and its attached agencies [(Bnreaa of Internal Revenue (BIR) and Bureau of. Customs (SUCH, Department of Social Welfare and Development (DSWD), Office for Senior Citizens Affairs (OSCA), National Council on Disability Affairs (NCDA), Professional Regulation Commission (PRC), the developmental partners of the DOH such as the World l\u2014iealth Organisation (WHO), European Union (EU), and member organisations involved in the implementation of RA. 9502.   IV. DEFINITION OF TERMS   A. Con\ufb02ict of Interest shall mean a situation created when. persons or entities in the public and/or private sectors that have personal, financial, or any other interest in the pharmaceutical and/or medical device industry, such as but not limited to, having existing ownership or investment there-in, being an. officer or inernher of the Board of Directors of a corporation (including its subsidiaries, affiliates and branches) or a. partner in a partnership engaged therein and receiving any contrihation there from. This includes receiving or accepting any offer or contribution there from.   B. Drug Price Reference Index: (DPRI) refers to the list of ceiling prices of essential medicines for government bidding and procurement set by the DOH for all DOH Retained Hospitals and Regional Health Offices (RHO's)  C. Essential Medicines refer to medicines that. satisfy the priority health care needs of the population and which are selected based on the evidence of their efficacy, safety and comparative costmeffectiveness. These medicines shall he made available and affordable at all times.   D. Maximum Retail Price (MRP) refers to the maximum price of medicines imposed at all levels of the supply chains, including but not limited to the manufacturer, trader, distributor, Wholesaler, and retailer\u2019s price for a period of time as determined by the President of the Philippines.   E. Patient Sapport Gronp refers to societies and organisations, specialising both in general health improvement as well as illness\u2014specific objectives, offer support groups as integral components of treatment plans for patients and their families. They may offer a variety of services, including educational materials, consultations, group therapy, team. building activities, and other resources to teach individnals hew te cope and adapt it) the lifestyie that is often dictated by their illnesses.   F. Philippine Natienal Fermnlary (PNii) is the integral cempenent eff - the Philippine Medicines Strategic Directiens en Access te Medicines fer Filipinos (2011:2016) that lists the essential medicines eff preveri efficacy, safety and qaality at affordable cast that are in he made averilahle and accessible at all times.   G. Ratienal Use at\u201c Medicines (RUM) refers tn the fandanrental concept where patients receive medicines, when these are needed, that are appropriate fer their clinical needs, in doses that. meet the individual requirements for an adequate period of time, at the lewest possible cent, and that are administered by the right persen.   H. TRIPS Flexibilities refer in range at\" rights, safeguards and eptiens that Member States ef the World Trade Organisatien (WTO) can expleit in their iniplenientatien cf. the TRlPS Agreement. These include but act lirnited te compulsory licensing, parallel inrpertatien, previsiens relating to patentahle subject matter, preyisiens relating te esceptiens is patent rights, preyisiens relating te data pretectien, and previsiens relating in abuse of rights, competition and the centrel of anti-cernpetitiye practices.   V. GENERAL GUIDELINES   A. The DOH and Department at Trade and industry (DTI), as cewirnplementers of RA 9562, shall create the everall irarnewerlr in the executien cf the said law which includes the oversight of the Advisory Centicil in terms of organizational structure, consultation process, and decision making.   B. The Advisory Council shall be composed of a broad membership representing health, trade, finance, and secial welfare secters that are affected by cross\u2014cutting issues that: affect medicines access.   C. The Advisory Council shall ensure the participatien of important stakehe\u2019lders from the public and private secters, recognizing that their interests/Views must he censidered by pelicy rnakers in crafting regulatien and policy on medicines. These include healthcare pretessienals, healthcare erganizatiens, the industry, acadenie, patients and patient erganizatiens and civil society.   D. The bread functiens at the Advisery Council shall pertain is stated preyisiens of RA 9502 which include:   1. Intellectual Property 2. Drug price monitoring and regulation 3. Financing  4. Strengthening at the Feed and Drug Administration  5. Rational Use at Medicines 6. Pharmacy and healthcare professional practice 7. Pharmaceuitical supply chain  VI. SPECIFIC GUIDELINES   A. Membership   The Members of the Advisory Council for the Implementation of RA 9502 are as follows:   Chairperson: Cluster Head in charge of the Pharmaceutical Division, Department of Health   Co-Chair: Eepartment of Trade & Industry   Members:     The member organisations shall be determined based. the on following criteria:   1. Persons of moral and intellectual integrity. 2. Willingness to declare its perspective on relevant issues discussed by the Council.  3. Wiiiingness to disclose con\ufb02icts of interest.   The Advisory Council members shall conform. to the principles of transparency and integrity and shall therefore declare all. the necessary circumstances. A member with his/her change in position of interest shall declare his/her con\ufb02ict of interest during the Advisory Council meeting (Annex A).     B. Specific Functions of the Advisory Council.   1. Discuss issues pertaining but. not limited to the following:   a. intellectual Property - TRiPS flexibilities including parallel importation   b. Drug price monitoring and regulation  DPRI, Electronic Drug Price Monitoring System (EDPMS), Senior Citizens/Persons with Disabilities (.PWDs) discounts, Maximum Retail Price   c. Financing \u2014 PhilHealth packages and DOH budget for essential medicines   d. Strengthening of the Food and Drug Administration   e. Rational Use of Medicines \u2014 Philippine National Formulary, Antimicrobial Resistance. ethical. marketing practices   f. Pharmacy and healthcare professional practice Pharmaceutical supply chain   2. Upon comprehensive discussion and deliberations of all issues. the Chair shall consider the different views and interests of the members. The recommendations must be fair and transparent to all parties, safeguarding the welfare of the general public and re\ufb02ecting the values of the bigger society. in such circumstances when there are Vital issues that need to be resolved but no quorum can be established to convene the meeting, the Chair may issue a memorandum through ad referendum requesting for the positions of its members.   3. The Chair and Comchair shall. balance the different positions of the Council members in adherence to the objectives of RA 9502. The recommendations made by the Council must he in line with the protection of public health and the objectives of RA 9503.. The recommendations of the Council. must express the intent of the law and not the personal or corporate interest of the members/associations.   4. Once the Council\u2019s recommendation is reached. it will be fowarded by the Chair to the SOl-l who W'iii strike the final decision.   3. The oversight and secretariat functions of the Advisory Council shall be under the DOM - Pharmaceutical Division (PD) as the duly delegated office by the SOH to monitor the implementation of RA 9502 based on Administrative Order (A0) No. 2010-0005. The secretariat shall compose of three (3) members who will perform the following functions:   a. Documentation of meetings  b. Converting of the Advisory Council Members  c. Arranging the venue and food for the conduct of the meeting  d. Preparation and dissemination of necessary documents to the Advisory Council members   C. Frequency of Meetings of the Advisory Council members   The Council shall meet quarterly or not less than. once every year or as the need arises. A quorum is established when majority (50% e l.) of the total number of the Council members is present in every meeting. it is the responsibility of the Council members to ensure that his/her organization. is represented in the Council meetings. Each Coerrcil. member shall have an alternate, and for any changes, the Advisory\" Council secretariat shall be informed.   D. Creation of Technical Working Groups (TWG)   The Advisory Council shall create technical working groups (TWGs) with respective offices to act as Chair taking responsibility for crafting regulation and policies that fall under their jurisdiction. The Chair shall be responsible in convening relevant stakeholders and conducting consul tati one as necessary.     II. ROLES AND RESPONSIBILITIES  A. Department of Health  The Department of Health shall:   1. Act as chair in the conduct of the Advisory Council meetings.  2. Undertake overall coordination with internal and external partners.  3 Undertake the overall management of the Advisory Council Secretariat function.   B. Food and and Drug Administration  The Food and Drug Administration shall share its views and updates on the quality assurance of medicines.   C. Philippine Health Insurance Corporation  The Philippine Health Insurance (Liorporation shall. share its Views and updates on government financing including reimbursements of medicines and health. servrces.   D. Bepartment of Trade and industry The Department of. Trade and Industry shall:   1. Act as co\u2014chair in the conduct of the Advisory Council meetings.  2. Share its Views on issues regarding the implementation of pricing; policies for medicines.   E. National Consumer Affairs Council  The National Consumer Affairs Council shall share its Views and updates related to consumer protection.   F. PITC Pharma Inc.   The PITC Pharrna Inc. shall share its views and updates on the sourcing of medicines.   G. Intellectual Property Office  The intellectual Property Office shall share its views and updates regarding patents, international agreements and. the TRTPS \ufb02eaibilities.   H. Department of Finance and its attached agencies  The Department of Finance and its attached agencies shall share their views and updates related to financing discounts on medicines, and other matters pertaining to the pricing of medicines.   I. Department of Social Welfare and Development and Office for Senior Citizens Affairs  The Department of Social Welfare and Development and Office for Senior Citizens Affairs shall share their views and updates on issues related to the Senior Citizens discounts on medicines.   J. National Council on Disability Affairs  The National Council on Disability Affairs shall. share its views and updates on disability issues. and relay concerns of the disability-\"related organizations.   K. Professional Regulation Commission  The Professional Regulation C ommissiou shall share its views and inputs related to the professional and occupational standards and ethics and career updates in the country.   L. Developmental partners and Member Organizations  The developmental partners and member organizations shall share their views and updates on issues discussed related to the implementation of the law. and may give policy recommendations to the government.   VIII. FUNDING SUPPORT OF THE PROGRAM   The funding of all meetings and activities by the Advisory Council and its Technical Working Groups shall be borne by the DOHw Pharmaceutical Division subject to usual accounting rules and regulations   IX. SEPARABILITY CLAUSE   If any provision in this Guideline or application of such provision to any circumstance is held invalid, the remainder of this issuance shall not be affected thereby.   X. EFFECTIVTTY   This Order shall be effective Within fifteen (l5) days from publication in the Official Gazette. ", "  For purposes of implementing a uniform protocol in the conduct of papanicolaou smear (pap smear) for eligible female client, this Department promulgates the following to become the standard protocol for this activity:   THE PAPANICOLAOU SMEAR (PAP SMEAR)   I. DEFINITION OF TERM:   Papanicolaou Smear - refers to a diagnostic tool, a test used in the screening and early detection of cancer of the lower genital tract particularly that of the cervix (cervical cancer). This is one of the best known, cost effective cancer screening method.   II. COVERAGE/ELIGIBLE CLIENTS  The objective of papanicolaou smear collection in the Cervical Cancer Component (Women\u2019s Health and Safe Motherhood Project) is to collect satisfactory smears from as many women-at\u2014risk as possible and as cheaply as possible. The aim is to screen women 35-55 years of age once in their lifetime.    A. Indications  1. Patients at risk for developing Cervical cancer - Sexually active women especially those between ages 25 - 55 years - Multipara - Those with history of STD 2. Those with history of postcoital bleeding, abnormal vaginal discharge. 3. Those with visible signs of change in the tissues. - cervical erosion - presence of condyloma/wart    III. SPECIFIC GUIDELINES/STANDARD PROTOCOL    A. Materials Needed  - Speculum - Clean slide - Spatula ( Ayers spatula or popsicle stick), cotton tipped applicator or pledget dipped in NSS or cervical brush - Fixative (95% ethanol or hair spray)  \u2014 Pencil    B. Procedure  1. Using a pencil, label the clean slide with the patient\u2019s name. 2. Moisten the speculum with water and NSS and insert the speculum to get a good view of the cervix. Do not use lubricant. 3. Identify the squamocolumnar junction (S-Q). The S - Q junction is the area of the cervix where the smooth, typically pink and shiny squamous epithelium and the reddish columnar epithelium winch presents a rough surface meet. The S - Q junction may be up within the endo-cervical canal if the entire surface surrounding the cervical  os appears smooth and pink. 4. Introduce the Ayers spatula with the narrow end in the endocervical canal and gently but firmly scrape the squamocolumnar junction by rotating the spatula 360 degrees.  5. Insert a cotton pledget dipped in NSS and swab the endocervix gently but firmly to gather cells from the endocervical canal. A cervical brush maybe used when available.  6. Spread materials from the S- Q junction and endocervical canal on a clean properly labeled slide. 7. A swab from the lateral vaginal walls may be obtained and spread on the slide especially if maturation index determination is indicated. 8. Quickly immerse the slide in the fixative solution for 30 minutes. If ethanol is not available hairspray may be used. 9. After fixation, air dry slide before sending to laboratory.   Points to remember in taking specimen for Pap Smear  1. Advise patients to refrain from vaginal douche and sexual contact at least 24 hours, before taking the smear.  2. Although the smear may be taken at anytime during the patient\u2019s menstrual cycle, the best time to take a smear is one week after menstruation when there are less red and other cells that may obscure abnormal cells. 3. In the presence of copious discharge suggestive of infection, the infection should be treated first to minimize the chance of a false (-) or (+) result. 4. Be ready with correctly labeled slides and the fixative before taking the smear. 5. Fix the specimen on the slide immediately in order to minimize changes in the cells. If aerosol hair spray is used, hold it about 1 foot from slide.   Transport to Laboratory  Before sending the slides to the laboratory, pack the specimen properly by placing pads  on both ends of the slides to prevent them from breaking or sticking to each other. Label the package correctly and fill up request form.   Specialized Procedures  1. Refer for colposcopic examination when pap smear is abnormal or when the cervix appears abnormal.  2. To diagnose the presence of endocervical lesion, endocervical curettage is done. 3. Conization of the cervix may be resorted to under the following circumstances:  - when the endocervical curettage is positive - when the limits of the colposcopically abnormal areas is not fully visualized (unsatisfactory colposcopy) - when the punch biopsy specimen cannot definitely rule out invasion  4. For patients with histopathological findings indicating cervical cancer, a complete evaluation, including clinical staging, must be done as soon as possible.   5. Treatment of invasive cervical cancer should be based on the clinical stage and surgical risk involved.  6. Recommend the appropriate management indicated for the condition. Management of Cervical cancer and its precursors \u2014 CIN  - CIN I \u2014 may be observed or treated with local ablation  - CTN II \u2014 local ablation: Cryotherapy, electrocautery, LEEP  - CIN III   Stage IA \u2014 Microinvasive disease - simple hysterectomy:   Stage IB and IIA - Invasive disease \u2014 radical hysterectomy, radiotherapy  7. Establish continuing professional but women-friendly relations with patients.  8. Maintain connections with referring health workers and facilities.  This Order supersedes issuances inconsistent herewith.     ", "  Inadequacy of funds has been the basic problem in the implementation of devolved health services. It resulted in non-payment of Magna Carta for Public Health Workers and Salary Standardization of devolved health workers.  In response to this national issue the Department of Health, through the 1997 General Appropriations Act provides for the granting of P69 M DOH Assistance to Local Government Units (ALGU) to partially subsidize the  implementation of RA 7305 (Magna Carta Benefits for the Public Health Workers) specifically for devolved DOH personnel.  The ALGU shall be based on current implementation level of RA 7305 and allocated according to Devolution Financing Burden (DFB) Ratio of LGUs as calculated by DOH and DBM. Under the DFB Ratio scheme, LGUs categorized as needing assistance shall be granted priority in the allocation of augmentation funds.  In this respect, the following guidelines shall govern the utilization, disbursement and reporting of these funds namely:   A.) Benefits Covered Under this subsidy  The specific benefits and amounts to be covered are as follows:  a) subsistence allowances b) laundry allowance  c) salary differentials of Rural Health Physicians (RHPs) d) RATA of RHPs    B.) Computation of Subsidy (See Annex 1)   C.) Utilization of Funds:   1. Devolved health workers detailed or transferred to other areas shall claim the amount provided for in their respective mother units. Hence, total number of devolved health workers shall be based on organization Staffing and Classificatlon Actual Summary (OSCAS).  2. LGUs that have already paid the full magma carta benefits authonzed by DOH shall instead use the subsidy to cover other benefits such as Salary standardization, other health workers benefits and local priority health programs. The DIRFO may issue a clearance/authorization for the LGU to utilize the fund for the aforecited reasons other than the payment of Magna Carta benefits provided that the LGU certifies that all Magna Carta benefits have been paid.  3. Newly hired personnel occupying devolved positions shall be entitled to all benefits stipulated in this guidelines.   D.) Funds Flow  1. The Department of Budget and Management shall issue a Notice of Cash Allocation (NCA) to the Department of Health.  2. The Department of Health shall sub-allot funds to the DOH-Integrated Regional Field Office (DIRFO) equivalent to the funding requirement of all LGUs under their concern as reflected in an allocation list to be provided by the Central Office.  3. DIRFOS shall issue funding checks to the current account of recipient LGUs; a Memorandum of Agreement shall be Signed between the DIRFO and the Local Chief Executive defining each party\u2019s responsibilities in the disbursement and utilization of these funds.  4. DOH Representatives to the Local Health Board of the recipient LGUs shall deliver the funding checks to the Local Chief Executives concerned during their LHB meetings.   E.) Reporting of Utilization of Funds  1. Copies of proofs of receipt by concerned devolved health workers shall be provided to the DIRFOs by the respective Local Government Units.  2. DOH Representatives to the Local Health Board or other designated personnel shall monitor the utilization this subsidy.  3. DIRFOS are required to monitor the utilization and consolidated reports shall be provided for by DIRFOS within six-months (6) from the release of the subsidy as agreed upon in the Memorandum of Agreement with recipient LGUs.   F.) Comprehensive Health Care Agreement (CHCA) as the covering MOA  1. The CHCA defines the responsibilities of both DOH and recipient LGUs.  2. Funding checks shall be released to the Local Government Units concerned upon concurrence to the guidelines Local Chief Executive concerned.  3. In the event that the Local Government Units will not agree to these guidelines, the DIRFO shall release the subsidy directly to devolved health workers through payroll.  All disbursement of funds shall be subject to existing accounting and auditing rules and regulations.    ", "   I. RATIONALE   According to the World Health Organization (2014), the world population is rapidly aging. Between 2000 and 2050, the proportion of the world's population over 60 years will double from about 11% to 22%. The absolute number of people aged 60 years and over is expected to increase from 605 million to 2 billion over the same period.   The Philippine Statistics Authority most recent estimate of the current population pegs it at 92,337,852 (N SO 2010) with 6.8 percent of the population aged 60 years old and over (estimated to be at 97 M as of 2013). This is in comparison to the 6.0 percent of senior citizens in just a decade earlier. The greatest concentration of senior citizens is in Region IV\u2014A (12.2 percent), NCR (11.9 percent) and Region III (11.3 percent). This \ufb01gure is not showing any indication of slowing down. By the end 2016 it would be 7.8 percent of the population. There will be 13.8% or approximately 19.6 million Filipinos over the age of 60 by 2040.   Faced with this impending demographic trend of population aging, the Philippines is preparing to meet its considerable effects across all sectors of society. In accordance with the 1987 Philippine Constitution Article II Section IX, the Republic Act of 9257 (The Expanded Senior Citizen\u2019s Act of 2003) and Republic Act 9994 (Expanded Senior Citizens Act of 2010), sustainable measures are being undertaken to promote the health and wellness of senior citizens as well as to alleviate the conditions of senior citizens suffering from degenerative diseases/palliative conditions.   The decadal average annual (exponential) growth rate cf 3.64 percent of the population 60 years and over makes the older population growth rate faster than the total population, meaning the doubling time of the older population is shorter than the total population. What does this means in terms of functional health? A local study conducted by the Population Institute of the University of the Philippines (UP) looking at the Active Life Expectancy and Functional Health Transitions among Filipino Older Persons (Cruz, Saito, Natividad, 2007) showed that as we anticipate future expansions in the size of older population, a corresponding increase in the projected number with disability is expected, more for females than males. The expected declines in functional health (speci\ufb01cally, in the ability to perform the normal everyday activities of daily living) due to the presence of chronic degenerative ailments like osteoporosis, dementia, sarcopenia, osteoarthritis, hearing and visual impairment, fractures among others can result in signi\ufb01cant restrictions in lifestyles, modi\ufb01cation in recreational and leisure activities, social isolation, poor nutrition, depression, and an overall decrease in the quality of life.   Future policies should thus be able to respond to such eventualities with appropriate mechanisms for prevention of severe declines in functional health, with wellness programs as well as health services particularly long term care services for the increased number of inactive older people needing support.   The Philippines is clearly faced with a two-fold burden of \ufb01rst, addressing communicable and degenerative dis-eases aggravated by the absence of a national geriatric health agenda to oversee the development of research\u2014based programs and second, implementing integrated delivery of geriatric services in every tertiary hospital as well as community-based health care program promoting healthy aging. Universal Health Care encompasses addressing the needs of the Filipino Senior Citizen, and the formalization of this policy is a necessary step towards ensuring systems will be put in place to achieve better health outcomes for our senior citizens.   Indeed, this Order supports the call of the Philippine Plan of Action for Senior Citizens 2012- 2016 which envisions, \u201ca society for all ages where the senior citizens are empowered to achieve active aging.\"   II. OBJECTIVES   This Order provides a national policy that shall guide the national and local actions towards the implementation of the Health and Wellness Program for Senior Citizens.   III. SCOPE   This Order shall cover all units and instrumentalities including attached agencies of the DOB. It shall also apply to local government units (LGUs), non-government organizations (N GOs), professional organizations, private sector, organizations of senior citizens, and other relevant partners in the health sector.   IV. LEGAL BASIS/ MANDATE   This issuance on Health and Wellness Program for Senior Citizens shall be guided by the following policy statements:   1. Madrid International Plan of Action on Aging (Adopted by the Second World Assembly on Ageing in 2003). This sets out priority areas and action points towards the goal of ensuring that societies and individuals live with security and dignity while maintaining their full participation and human rights.   2. Regional Framework for Action on Aging and Health in the Western Pacific 2014-2019. It considers current evidence and new ideas as a starting point for further discussions within countries and in the Region.   3. The 1987 Philippine Constitution on Article II Section IX provides that \u201cThe State shall adopt an integrated and comprehensive approach to health development which shall endeavour to make essential goods, health and other social services available to all people at affordable cost. There shall be priority for the needs of the underprivileged sick, elderly, disabled, women and children.\"   4. Aquino Health Agenda through Administrative Order No. 2010-0036 and Section 7 of Executive Order 43 series 2011, the so called Kalusugan Pangkalahatan (KP) aims to achieve universal health care for all Filipinos.   5. Philippine Plan of Action for Senior Citizens (2012-2016) will serve as a strategic framework in developing action plans to further address the challenges brought about by socio-economic and environmental drifts. And also as a guide for all government agencies, local government units, civil society organizations and other stakeholders in planning, policy formulation and program development to promote and protect the rights and the best interest of the Filipino senior citizen.   6. Republic Act No. 9257 (2003) \u201cAn Act Granting Additional Bene\ufb01ts and Privileges to Senior Citizens to Senior Citizens amending for the purpose Republic Act no. 7432, otherwise known as \u201cAn Act to Maximize the Contribution of Senior Citizens to Nation Building, Grant Bene\ufb01ts and Special Privileges and for other purposes\"   7. Republic Act No. 9994 (Enacted February 15, 2010) \u201cAn Act Granting Additional Bene\ufb01ts and Privileges to Senior Citizens, Further Amending Republic Act No. 7432\". The Expanded Senior Citizens Act of 2010 is anchored on augmenting the bene\ufb01ts and services given to the elderly. This law is centered on securing the roles and funCtions of the implementing body and concerned agencies.   V. DEFINITION OF TERMS   For purposes of this issuance, the following terms, abbreviations and de\ufb01nitions apply:   1. Aging refers to a lifelong process of growing older in all respects (cellular, organ, whole- body) throughout the life-course (WHO).   2. Health System is de\ufb01ned as \u201call organizations, people and actions whose primary intent is to promote, restore or maintain health.\" (WHO)   3. Senior Citizen or Elderly refer to any Filipino citizen who is a resident of the Philippines, and who is sixty (60) years old or above. It may apply to senior citizens with dual citizenship   status provided they prove their Filipino citizenship and they have been residents for at least six (6) months in the Philippines.    VI. STATEMENT OF PRINCIPLES   1. The Health and Wellness Program for Senior Citizens (HWPSC) shall consider the following in the development of supportive policies and guidelines:   VISION:   A country where all Filipino senior citizens are able to live an improved quality of life through a healthy and productive aging.   MISSION:   Implementation of a well designed program that shall promote the health and wellness of senior citizens and improve their quality of life in partnership with other stakeholders and sectors.   GOAL:   Quality of Life among older persons is promoted and contributes to the nation building.   2. HWPSC intends to achieve the following objectives:    -To ensure better health for senior citizens through the provision of focused service delivery packages and integrated continuum of quality care in various settings   -To develop patient-centered and environment standards to ensure safety and accessibility of all health facilities for the senior citizens   -To achieve equitable health \ufb01nancing to develop, implement, sustain, monitor and continuously improve quality health programs accessible to senior citizens   -To enhance the capacity of health providers and other stakeholders including senior citizens group in the implementation of health programs for senior citizens   -To establish and maintain a database management system and conduct researches in the development of evidence-based policies for senior citizens   -To strengthen coordination and collaboration among government agencies, non- government organizations, partner agencies, and other stakeholders involved in the implementation of programs for senior citizens   3. HWPSC shall adopt the WHO Regional Framework on aging and health. These are the four pillars or action areas where the program interventions are based on:   a. Fostering an age\u2014friendly environments through action, engagement and collaboration across sectors and stakeholders, including communities, families and older persons   b. Promoting healthy aging across the life-course and prevent functional decline and disease among senior citizens   c. Reorienting and strengthening health systems to make them responsive to the needs of senior citizens through the provision of acceptable, accessible and effective health services across the continuum of care.   d. Strengthening the evidence-based policy- and decision-making on aging and health.   4. HWPSC shall focus on six program components where health interventions are possible, effective and able to be implemented with a clear and actionable role for all sectors.    a. The Policy, Standards and Regulation component shall develop a uni\ufb01ed patient- centered and supportive environment standards to ensure safety and accessibility of senior citizens to all health facilities and to promote healthy ageing in order to prevent functional decline among senior citizens.   b. The Health Financing component shall promote health \ufb01nancing schemes and other funding support in all concerned government agencies and private stakeholders to provide programs that are accessible to senior citizens.   c. The Service Delivery component shall ensure access of senior citizens to essential geriatric health services including preventive, promotive, treatment, and rehabilitation services from the national to the local level.   d. The Human Resources for Health component shall capacitate the health care providers in both national and local government to be able to effectively provide technical assistance and implement the program for senior citizens.   e. The Health Information component shall establish an information management system and maintain a repository of data.   f. The Governance for health component shall coordinate and collaborate with the local government units and other stakeholders to ensure an effective and ef\ufb01cient delivery of health services at the hospital and community level.   VII. IMPLEMENTING GUIDELINES   1. HWPSC shall be in accordance with the thrust of Universal Health Coverage \u2014 Aquino Health Agenda, National Objectives for Health 2011-2016 and Millenium Development Goals (2005-2015), supported by the recommendation of the WHO Regional Framework for Action on Aging and Health in Western Paci\ufb01c (2014\u20142019), as applicable.   2. HWPSC shall be one of the programs of the Disease Prevention and Control Bureau. A HWPSC National Program Coordinator shall be designated to perform technical and administrative functions pertaining to the operation of the Health and Wellness Program for Senior Citizens.   3. A Technical Working Group shall be organized to ensure coordination and sustainability of the HWPSC which is composed of representatives from DOH, different national government agencies, specialty societies, non-govemment organizations, and other recognized stakeholders. The membership, participation and functions shall be indicated in a pertinent department issuance. The TWG shall provide direction and technical support on policies and plans pertaining to the health and wellness program for senior citizens.    4. To ensure a comprehensive approach of the health and wellness program for senior citizens, integration of the health and wellness program for senior citizens into the other programs of the Disease Prevention and Control Bureau (DBCB) shall be intensi\ufb01ed.   5. In coordination with local government units, NGO\u2019s and PO\u2019s for senior citizens, DOH shall institute a national health program and shall provide an integrated health service for senior citizens.   6. In coordination with academic institutions and societies, DOH shall train community based- health workers including senior citizens and health personnel to specialize in the geriatric care and health problems of senior citizens.   7. The oversight for the implementation of this Order shall rest with the Assistant Secretary of Health, Of\ufb01ce for Technical Services supported by the Technical Working Group (TWG) on Health and Wellness Program for Senior Citizens chaired by the Director of the Disease Prevention and Control Bureau.   VIII. ROLES AND RESPONSIBILITIES   1. Department of Health \u2014 Central Of\ufb01ce shall ( 1) develop systems, policies and guidelines that will facilitate the implementation of the Health and Wellness Program for Senior Citizens including the monitoring and evaluation of each program activities; (2) develop capacity of the regional of\ufb01ces personnel in assisting the LGUs to ensure the implementation of the Health and Wellness Program for Senior Citizens Program.   As such, the following of\ufb01ces shall have the following responsibilities:   a. The Disease Prevention and Control Bureau shall (1) develop plans and policies for the implementation of the Health and Wellness Program for Senior Citizen; (2) provide technical assistance and conduct monitoring and evaluation of program operation; (3)   ensure the participation of other DOH of\ufb01ces/stakeholders in program activities where needed.   I). The Epidemiology Bureau and the Knowledge Management Information Service shall be responsible in the development of a national reporting and surveillance system as well as the development of methodologies for the generation, collection and distribution of   information and knowledge on the possible establishment of the national registry for senior citizens.   c. The Health Promotion and Communication Service \"shall be responsible in the formulation of standards and development of information, education, communication,   and advocacy strategies for the implementation of the health and wellness of senior citizens.    d. The Health Policy Development and Planning Bureau (HPDPB) shall ensure the integration of the Health and Wellness Program for Senior Citizens in the national program plan of action, including inclusion in the DOH Research Agenda proposals.   e. The Health Human Resource Development Bureau (HHRDB) shall be responsible in the development of standards in the curriculum and the training of all types of health professionals, who are responsive, culturally sensitive and consistent with the national and local human resource development goals.   f. The Bureau of International Health Cooperation shall ensure that the program has strong network linkages with international health institutions and agencies that will ensure the inclusion, participation, cooperation and collaboration of the Philippines in the global scene for senior citizens.   g. The Bureau of Local Health Systems and Development shall be responsible in the integration of the program into the local health system.   h. The Health Facilities Development Bureau shall ensure that the capacity of government hospitals (DOH and local government hospitals) shall be upgraded and enhanced to provide adequate quality care services, by undertaking capacity needs assessment, - capacity enhancement investment, and capacity utilization monitoring.   i. The Health Facilities and Services Regulatory Bureau shall (1) ensure the safety and accessibility of health facilities through compliance with the prescribed standards on physical facility, equipment and personnel (2) ensure the establishment of accreditation /licensing guidelines and requirements for geriatric wards, hospitals and chronic care facilities including but not limited to nursing homes, group living, assisted living, transitional or intermediate care, hospice care facilities.   2. The Regional Of\ufb01ces shall lead the region in the implementation of the programs and projects for the health and wellness program for senior citizens. It shall also provide technical assistance and guidance to the LGUs in the implementation of program strategies and activities.   3. The DOH hospitals and medical centers shall ensure the availability of quality care services to its clients through the establishment of appropriate capabilities and competencies in their respective units. It shall also establish a senior citizens ward in every government hospital.   4. The Philippine Health Insurance Corporation (PHIC) shall develop appropriate relevant health service packages for senior citizens.   5. Local Government Units shall organize themselves into service delivery networks that will manage and implement the health and wellness program for senior citizens activities. LGUs shall pass the necessary local legislation (ordinances, resolutions) to implement program and activities. It shall also provide counterpart funds for implementing their investment plan.    6. Non-Government Organizations, academe and other organizations shall initiate, assist, coordinate in addressing general concerns of the Health and Wellness Program for Senior Citizens.   7. Civil Societies shall assist the Local Government Units in achieving their health objectives and identify the health needs of the senior citizens and advocate program support for them.   8. Donor and Technical Partner Agencies shall provide technical assistance and guidance, necessary funding according to the investment plan developed for the Health and Wellness Program for Senior Citizens, as well as in accordance with partnerships entered into with local government units and other stakeholders.   IX. FUNDING   The Department of Health Central Of\ufb01ce and Regional Of\ufb01ces shall provide the essential funds for program or project implementation, technical assistance, monitoring, and health promotion campaigns to ensure the operationalization of this policy and system framework. Local government units shall be enjoined to provide funds in the implementation of the program. Furthermore, other government agencies, non-government organizations and other stakeholders are encouraged to provide counterpart funds as appropriate to ensure the implementation of this Order.   X. EFFECTIVITY This Order shall take effect \ufb01fteen (15) days after its publication in two (2) newspaper of general circulation.   ", " I. RATIONALE   Republic Act No. 7277, \u201cAn Act Providing for the Rehabilitation, Self- Development, and Self-Reliance of Persons with Disability and Their Integration into the Mainstream of Society and for Other Purposes,\" and otherwise known as \u201cThe Magna Carta for Disabled Persons,\" was passed in March 24, 1992. This speci\ufb01cally required the Department of Health (DOH) to, (l) institute a national health program for PWDs, (2) establish medical rehabilitation centers in provincial hospitals, and (3) adopt an integrated and comprehensive approach to the health development of PWD which shall make essential health services available to them at affordable cost.   Rule IV, Section 4, Paragraph B of the implementing rules and regulations ([RR) of this Act required the Department of Health to address the health concerns of seven (7) different categories of disability, which includes the following: (1) Psychosocial and behavioral disabilities, (2) Chronic illnesses with disabilities, (3) Learning (cognitive or intellectual) disabilities, (4) Mental disabilities, (5) Visual/ seeing disabilities, (6) Orthopedic/moving, and; (7) Connnunication de\ufb01cits.   In addition, Republic Act No. 9442, otherwise known as, \u201cAn Act Amending Republic Act No. 7277, otherwise known as the \u201cMagna Carta for Disabled Persons, and for Other Purposes,\" states in Section 1 that \u201c... a new chapter, to be denominated as 'Chapter 8. Other privileges and Incentives\u2019 is hereby added to Title Two of Republic Act No. 7277, otherwise known as the \"Magna Carta for Disabled Persons\", with new Sections 32 and 33, to read as follows:   \"CHAPTER 8. Other Privileges and Incentives \"SEC. 32. Persons with disability shall be entitled to the following:   (a) At least twenty percent (20%) discount for the purchase of medicines in all drugstores for the exclusive use or enjoyment of persons with disability;   (b) At least twenty percent (20%) discount on medical and dental services including diagnostic and laboratory fees such as, but not limited to, x-rays, computerized tomography scans and blood tests, in all government facilities, subject to guidelines to be issued by the Department of Health (DOH), in coordination with the Philippine Health Insurance Corporation (PHILHEALTH);   (c) At least twenty percent (20%) discount on medical and dental services including diagnostic and laboratory fees, and professional fees of attending doctors in all private hospitals and medical facilities, in accordance with the rules and regulations to be issued by the DOH, in coordination with the PHILHEALTH. . .\"   The Implementing Rules and Regulations also stipulates in Rule IV Section 6, paragraph 10 that, \u201cExpress lanes for persons with disability shall be provided in all private, commercial and government establishments, in the absence thereof, priority shall be given to them in all the transactions of the establishments\". LGUs shall ensure that this provision is implemented within their area of jurisdiction. There should be an assigned person in all government agencies/of\ufb01ces and private establishments and to provide a section or desk manned by trained personnel to assist persons with disability. The personnel assigned shall be part of the existing human resource in all other government agencies/offices and private establishmth as the case maybe or whenever possible.   Cognizant of the needs of the persons with disabilities and the economic and \ufb01nancial viability of the medical practitioners and hOSpitals, this Order is issued to support the Implementing Rules and Regulations of RA 9442. Policies and guidelines are enumerated herewith to guide the hospitals and medical, allied medical, paramedical or medical social worker practitioner so as to provide a fair, just and quality health care to PWDs while maintaining the \ufb01nancial and economic viability of the hospitals.   II. OBJECTIVES:   To prescribe the procedures and guidelines for the implementation of the 20% discount in all health related services for PWDs   III. COVERAGE AND SCOPE   This Administrative Order applies to all private and government hospitals, health- related facilities, the health care professionals, the Philippine Health Insurance Corporation, and related health-care establishments, pharmacies and other establishment dispensing medicines.   IV. DEFINITION OF TERMS   Consistent with the pertinent de\ufb01nitions used in the Implementing Rules and   Regulations of RA 7277 and RA 9442, the following terms shall be de\ufb01ned as follows:   1. ASSISTIVE DEVICES - Any device that is designed, made, or adapted to assist a person to perform a particular task or activity for daily living. For examples, hearing aides, electronic voice products, talking watches and related talking electronic equipment, canes, crutches, walkers, wheel chairs, and shower chairs are all assistive devices.   2. BIRTHING HOME OR CENTER - A medical facility designed to provide a comfortable, homelike setting during childbirth and that is generally less restrictive than a hospital in its regulations, as in permitting the practice of midwifery   3. CHRONIC ILLNESS- words to describe a group of health conditions that last a long time. It may get slowly worse over time or may become permanent or it may lead to death. It may cause permanent change to the body and it will certainly affect the person\u2019s quality of life.   4. CLINIC means a place in which patients avail of medical consultations or treatments on an outpatient basis. However, any clinic or dispensary where there is at least six (6) beds or cribs or bassinets installed for twenty-four hour use by patients shall be construed to fall within the de\ufb01nition of a hospital as described in RA 4226, the Hospital Licensure Act.   5. COMMUNICATION DISABILITY- An impairment in the process of speech, language or hearing: a) Hearing impairment is a total or partial loss of hearing function which impedes the communication process essential to language, educational, social and/or cultural interaction b)\"Speech and Language Impairments\" mean one or more speech/language disorders of voice, articulation, rhythm and/or the receptive and expressive processes of language.   6. CHILD WITH DISABILITY \u2014 persons below eighteen (18) years of age and those over but with mental capacity as that of a child and are unable to fully take care of themselves or protect themselves because of mental retardation, hearing impairments including deafness, speech or language impairments, visual impairments including blindness, serious emotional disturbance, orthopedic impairments, autism, traumatic brain injury, other health impairments or speci\ufb01c learning disabilities who by reason thereof need special education and other services.   7. DENTAL SERVICES \u2014 services related to oral examination, cleaning, permanent and temporary \ufb01lling, extractions and gum treatments, restoration, replacement or repositioning of teeth, or alteration of the alveolar or periodontium process of the maxilla and the mandible that are necessary for the diagnosis and / or treatment of a dental illness, injury or condition.   8. DIAGNOSTIC AND LABORATORY TESTS \u2014 any procedure conducted for diagnostic purposes. It shall include such procedures as x-rays, CT-scans, MRI scans, PET scans, blood chemistry exams, histopathology and immunopathology, hematology, urine analysis, parasitology and bacteriology tests, serology, blood banking and all other diagnostic radiology, clinical laboratory and other diagnostic examinations that are necessary for the diagnosis of the disability or medical condition of a disabled person. It shall also include clinical psychological tests, assessment of speech conditions, and tests for hearing acuity, visual acuity, learning impairment, and related psychosocial conditions like drug testing.   9. DISABILITY -The interaction between persons with impairments and attitudinal and environmental barriers that hinders their full and effective participation in society on an equal basis with others.   10. DISABILITY TYPES \u2014 the 7 types of disabilities mentioned in RA 7277 are psychosocial disability, disability due to chronic illness, learning disability, mental disability, visual disability, orthopedic disability, and communication disability.   11. ESTABLISHMENTS DISPENSING MEDICINES AND ASSISTIVE DEVICES \u2014 drug stores, assistive device stores, government or private hospital pharmacies, medical clinics, optical clinics, audiology centers, and similar establishments dispensing medicines and selling assistive devices duly licensed or franchised by the BFAD and/or the local government unit.   12. GOVERNMENT HEALTH FACILITY 4* hospitals, outpatient clinics, health centers, rural health units or stations, clinical laboratory, diagnostic radiology center, audiology centers, optical clinics, psychological testing centers, drug testing centers, and other outpatient health facilities operated and maintained partially or wholly by the national, provincial, city or municipal government, or other political unit; or by any department, division, board or agency thereof. The facilities include DOH retained hospitals, specialty hospitals which are government owned and controlled corporations (GOCCs); medical clinics in GOCCs; and hospital or health facilities owned and managed by local government units, state colleges and universities, the Department of National Defense, the Department of Interior and Local Government and other government agencies.   13. GOVERNMENT HOSPITAL is a hospital operated and maintained either partially or wholly by the national, provincial, municipal, or city government or other political subdivision, or by any department, division, board or other agency thereof.   14. HEALTH CARE PROFESSIONAL \u2014 any licensed physician, dentist, nurse, midwife, allied medical practitioner, paramedical practitioner, or other health care professional or practitioner duly licensed to practice in the Philippines.   15. HEARING DISABILITY \u2014 moderate or worse hearing impairment in the better ear; that is, the pennanent unaided hearing threshold level of the better ear of 41 or 31 decibels or greater in age under 15 years old.   16. HEARING IMPAIRMENT - the complete or partial loss of the ability to hear from one or both ears; with 26 decibels or greater hearing threshold, averaged at frequencies 0.5, 1.0, 2.0, and 4.0 kilohertz.   17. HOSPITAL - means a place devoted primarily to the maintenance and operation of facilities for the diagnosis, treatment and care of individuals suffering from illness, disease, injury or deformity, or in need of obstetrical or other medical and nursing care. The term shall also be construed as any institution, building or place where there are installed beds or cribs or bassinets for twenty-four hour use of longer by patients in the treatment of diseases, diseased-condition, injuries, deformities or abnormal physical and dispensaries, and such other means by which they may be designated.   18. IDENTIFICATION DOCUMENT \u2014 any document or proof of being disabled which shall be used for availment of benefits and privileges under the law, such as the PWD identification card duly signed by anyone of the following: The Mayor, Barangay Captain or Chairperson of the National Council for the Welfare of Disabled Persons (NCWDP) now the National Council on Disability Affairs (NCDA), during the \ufb01rst 3 years. The signatory of the PWD identi\ufb01cation card after this period shall be the Chairperson of the NCDA.   19. IMPAIRMENT \u2014 any loss, diminution or aberration of psychological or physiological function with or without an accompanying anatomical structural defect.   20. LEARNING DISABILITY \u2014 any disorder in one or more of the basic psychological processes (perception, comprehension, thinking, etc.) involved in understanding or in using spoken or written language   21. MEDICAL DEVICES \u2014 an instrument, apparatus, equipment, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: (I) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in persons with disabilities, (2) intended to affect the structure or any function of the body of PWDs, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.   22. MEDICAL SERVICES \u2014 shall refer to the hospital room accommodation, hospital services, medical supplies, professional services of physician, allied medical practitioner, or paramedical practitioner and other health care professionals, diagnostic services, and laboratory services that are necessary for the prevention, diagnosis, treatment, rehabilitation, and palliation of a persons disability, illness or injury. This should not be limited to hospital services but should include clinics and other health facilities.   23. MEDICALLY NECESSARY- Services required to preserve and maintain the health status of a person in accordance with the accepted standards of the medical practice in the medical community or services which are absolutely necessary in treating a patient and which could adversely affect the patients\u2019 condition if it were omitted.   24. MEDICINES \u2014 refers to both prescription and non\u2014prescription medicines and drugs approved by the Bureau of Food and Drugs, intended for the prevention, diagnosis, cure, mitigation, treatment, rehabilitation, and palliation of diseases, injury or other medical conditions.   25. MENTAL DISABILITY \u2014 disability resulting from organic brain syndrome (i.e. Mental retardation, acquired lesions of the central nervous system, or dementia) and or mental illness (psychotic or non-psychotic disorder).   26. MULTIPLE DISABILITY \u2014 a PWD with one or more of the 7 types of disabilities.   27. ORTHOPEDIC DISABILITY \u2014 disability in the normal functioning of the joints, muscles or limbs.   28. PERSON WITH DISABILITY (PWD) \u2014include those who have long\u2014term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their \ufb01ll and effective participation in society on an equal basis with others.   29. PRIVATE HOSPITAL is one which is privately owned, established and operated with funds raised or contributed through donations, or by private capital or other means, by private individuals, association, corporation, religious organizations, forms, company or joint stock association.   30. PRIVATE HOSPITALS AND MEDICAL FACILITIES \u2014shall refer to all pay inpatient and outpatient health and medical facilities privately owned, established and operated with funds through donation, principal, investment or other means, by any individual, corporation, association or organization. The facilities include hospitals, clinical laboratories, diagnostic radiology centers, doctor\u2019s clinics, dental clinics and other health facilities that are licensed by the Bureau of Health Facilities and Services (BHFS) of the DOH and/or the local government.   31. PSYCHOSOCIAL DISABILITY\u2014 any acquired behavioral, cognitive, emotional or social impairment that limits one or more activities necessary for effective interpersonal transactions and other civilizing process or activities for daily living such as but not limited to deviancy or anti-social behavior.   32. Service Ward in government facility shall be the same as the Class D classi\ufb01cation of Administrative Order No. Sl-A s. 2000 otherwise known as the implementing guidelines on Classi\ufb01cation of Patients and on availment of Medical Social Services in Government Hospitals. Class D classi\ufb01cation is provided full social services.   33. UNBRANDED GENERIC MEDICINES \u2014 drugs not covered by patent protection and which are labeled solely by their international non\u2014proprietary or generic name and without a brand name.   34. VISUAL DISABILITY .. A person with visual disability(Impairment) is one who has impairment of visual functioning even after treatment and/or standard refractive correction, and has visual acuity in the better eye of less than (6/18 for low vision and 3/60 for blind), or a visual \ufb01eld of less than 10 degrees from the point of \ufb01xation. A certain level of visual impairment is de\ufb01ned as legal blindness. One is legally blind when your best corrected central visual acuity in your better eye is 6/60 or worse or your side vision is 20 degrees or less in the better eye   V. POLICY STATEMENT   The following are the privileges for PWDs :   1. All persons with disability in all service wards of government facilities are entitled to a 20% discount for the costs of medical, dental, and rehabilitation services, diagnostic and laboratory fees, as well as psychological or developmental tests, provided that these are in accordance with the available Clinical Practice Guidelines or Hospital Treatment Protocols. The remaining balance of the hospital bill shall be subjected to classi\ufb01cation by the Medical Social Worker based on the existing DOH guidelines. If the PWD deserves a free service after evaluation, then such services shall be given free.   2. All persons with disability that are con\ufb01ned in the pay sections of the government health facilities are granted twenty (20%) discount for medical and dental services, and diagnostic and laboratory fees, provided that these are in accordance with the available Clinical Practice Guidelines or Hospital Treatment Protocols. For outpatient the same rule shall be followed.   3. All PWDs are granted the privilege of twenty percent (20%) discount in a_ll private hospitals and medical facilities for the costs of medical, dental, rehabilitation, occupational and physical and speech therapies_or services, and diagnostic and laboratory fees such as, but not limited to, x-rays, CT-scans, blood tests and others, including professional fees of attending doctors.   4. Services which are not medically necessary for the prevention, diagnosis, treatment, rehabilitation or palliation shall not be provided with any discount. This shall include but not limited to cosmetic surgical procedures, executive check-up packages, and physical examinations, without clinical evidence of effectiveness and ef\ufb01ciency. 20% discount is granted to specials reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.   5. The grant of twenty percent (20%) discount shall be provided in the purchase of branded medicines and unbranded generic medicines from all establishments dispensing medicines for the exclusive use of the PWDs.   6. PhilHealth Privileges   Consistent with the National Health Insurance Act of 1995 and the Health Sector Reform Agenda, all Filipinos shall be encouraged to be PhilHealth members or at least be a dependent of active PhilHealth members. Persons with Disability who are not yet non\u2014paying PhilHealth members may become PhilHealth members if they are sponsored or enrolled by their Local Government Unit (LGU) or voluntarily enroll themselves as individually paying members.   PhilHealth must make available reimbursement schedules to health care practitioners provided it is consistent with PhilHealth\u2019s legal mandates and policies.   VI. IMPLEMENTING RULES AND MECHANISMS FOR THE AVAILMENT 0F PRIVILEGES   1. Subsidized Services in In\u2014Patient and Out-patient Sections of Government Health Facilities   a. Hospital Bed \u2014 Hospital bed for a PWD con\ufb01ned in a service ward shall be classi\ufb01ed based on A0. No. 51-A s. 2000 known as the implementing guidelines on the Classi\ufb01cation of Patients and on availment of Medical Social Services in Government Health facilities. Those classified as Class D shall be free of charge provided that it is necessary to diagnose and treat an illness or injury and in accordance with the available Clinical Practice Guidelines or Hospital Treatment Protocols.   b. Laboratories and diagnostics services provided to an in\u2014patient PWD in a service ward that are medically necessary as determined by his/her attending physician, shall be given 20% discount, provided that:   i. Diagnosis and/or treatment by the attending physician shall be in accordance with the Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols.   ii. Evidence-based health screening tests that had been extensively tested for the local setting and endorsed by the DOH as medically necessary for individual cases shall be provided free by the government facility.   iii. This shall also be subjected to the classi\ufb01cation of the Medical Social Worker.   All laboratories and diagnostics provided to PWDs admitted in the service ward which are deemed not medically necessary for the illness or injury for which he/she is con\ufb01ned shall not be given a 20% discount.   c. Laboratories and Diagnostic Services for Out-patient PWDs   All PWDs shall be given 20% discount for laboratory and diagnostic services. The balance shall be paid by the Out-Patient PWD based on his/her Medical Social Worker Classi\ufb01cation, provided that:   i. Diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical. Practice Guidelines (CPGs) or HOSpital Treatment Protocols and have been determined medically necessary.   ii. Evidenced-based health screening tests had been extensively tested for the local setting and endorsed by the DOH as medically necessary for individual.   iii. The laboratory and diagnostic services have been determined by his/her attending physician as medically necessary.   iv. The requesting physician is employed in the government health facility where the laboratory or diagnostic tests shall be conducted.   All requests for laboratory and diagnostic tests from physicians who are not employed in the government health facility shall only be granted a 20% discount upon \ufb01nal evaluation of the recipient government facility as medically necessary.   d. Dental services   All dental services that are deemed to be medically necessary by the attending dentist shall be granted free of charge.   e. PhilHealth\u2014Related Bene\ufb01ts   In case the PWD is a PhilHealth member or a dependent, government facilities must ensure that the charges for services shall be deducted and charged to the PWDs PhilHealth bene\ufb01ts coverage. It is only after these deductions are made that the PhilHealth accredited health facilities can exercise its right to the PhilHealth reimbursement or coverage for the subsidized services.   f. Rehabilitation and Other specialized Services prescribed by attending physician or by a rehabilitation specialist including the purchase of assistive devices by PWD shall be given 20% discount.   2. Non-Subsidized Services in Pav Sections of Government Health F acilities   The PWDs con\ufb01ned in the pay sections of govermnent health facilities shall be granted twenty percent (20%) discount for the following services:   a. Hospital Bed \u2014 A hospital bed in a pay sections which is deemed  medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.   b. Laboratories and Diagnostic Services for In-patient PWD   i. All in-patient and out-patient laboratory and diagnostic examinations for PWD in pay sections shall be granted 20% discount; provided that such diagnosis and/ or treatment by the attending physician shall be in accordance with available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.   ii. All inpatient laboratories and diagnostics that are provided to PWD admitted to a health facility other than the service ward shall only be granted a 20% discount.   iii. Twenty percent discount is granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.   c. Dental services   All dental services that are deemed to be medically necessary by the attending dentist shall be granted a twenty percent (20%) discount.   d. PhilHealth-Related Bene\ufb01ts   In case the PWD is a PhilHealth member or a dependent, government facilities must ensure that the charges for services shall be deducted and charged to the PWDs PhilHealth bene\ufb01ts coverage. It is only after these deductions are made that the PhilHealth accredited health facilities can exercise its right to the PhilHealth reimbursement or coverage for the subsidized services.   e. Rehabilitation and other specialized Services prescribed by attending physician or by a rehabilitation specialist including the purchase of assistive devices by PWD shall be given 20% discount.   3. Twenty percent (20%) Discount in Private Health Facilities   The PWDs con\ufb01ned in the private health facilities shall be granted twenty percent (20%) discount for the following services:   a. Hospital Bed \u2014 A PWD con\ufb01ned in a private hospital is granted a twenty percent (20%) discount for the hospital bed, provided the requirements stated below are followed:   i. The available room and board accommodation shall be deemed as medically necessary to diagnose and treat illness, injury or disability.   ii. All existing privileges that go with the hospital bed shall also accrue to the PWD.   b. Laboratories and Diagnostic Services   i. All in-patient laboratories and diagnostics services of PWD shall be granted a twenty percent (20%) discount based on the preferred room and board accommodation provided that such diagnosis and / or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.   ii. All out-patient laboratories and diagnostic services shall be granted a 20% discount provided that such diagnosis and/or treatment by the attending physician shall be in accordance with Clinical Practice Guidelines (CPGs) or Hospital treatment protocols.   c. Dental Services   All dental services that are deemed to be medically necessary by the attending dentist shall be granted a twenty percent (20%) discount.   d. PhilHealth-Related Bene\ufb01ts   In case the PWD is a PhilHealth member or a dependent, the 20% discount shall not be charged to the PWD\u2019s PhilHealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the PWD is eXpected to shoulder may be charged to his/her PhilHealth bene\ufb01ts.   e. Rehabilitation and other specialized Services prescribed by attending physician or by a rehabilitation specialist including the purchase of assistive devices by PWD shall be given 20% discount.   f. Professional Fees   Professional fees for in-patient and outpatient medical, dental, and other health care professional services shall be provided with a 20% discount. The concerned physician or dentist must issue corresponding of\ufb01cial receipt.   4. Guidelines for the nventv percent (20%) discount in thuurchase of all medicines for the Exclusive Use ofPWD   a. All establishments through their registered pharmacist must have full   discretion and responsibility in dispensing all medicines for exclusive use of PWD.   b. Discounts shall be granted to PWDs on the purchase of all medicines provided that it is supported by the following:   i. PWD identi\ufb01cation card as stated in the De\ufb01nition of Terms.   ii. Doctor\u2019s prescription stating the name of the PWD, age, sex, address, date, generic name of the medicine, dosage form, dosage strength, quantity, signature over printed name of physician, physician\u2019s address, contact number of physician or dentist, professional license number, professional tax receipt number and narcotic license number, if applicable. To safeguard the health of PWDs and to prevent abuse of RA 9257, a doctor\u2019s prescription is required in the purchase of over-the-counter medicines. Only prescriptions that contain the above information shall be honored.   iii. Purchase booklet issued by the local social/ health of\ufb01ce to PWDs for free containing the following basic information:  a) PWD ID number  b) Booklet control number  c) Name of PWD  d) Sex  e) Address  f) Date of Birth  g) Picture  h) Signature of PWD  i) Information of medicine purchased:  i.1 Name of medicine  i.2 Quantity  i.3 Attending Physician  i.4 License Number  i.5 Servicing drug store name  i.6 Name of dispensing pharmacist   j) Authorization letter of the PWD who is residing in the Philippines at the time of purchase, currently dated and the identi\ufb01cation card of the authorized person or representative, in case the medicine is bought by the representative or care giver of the PWD.   c. As a general rule, any single dispensing of medicine must be in accordance with the prescription issued by a physician and should not exceed a one (1) month supply.   Drug stores are required to maintain a special record book for PWD subject to inspection by the BFAD and BIR.   d. For partial \ufb01lling, the establishment\u2019s pharmacists will indicate the quantity partially \ufb01lled in the special record book and the un\ufb01lled balance on the prescription. The PWD shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity.   e. Drug stores offering Special discounted prices less than 20% of the regular retail price can deduct the percentage discount of their promotional campaign from the total of twenty percent (20%) discount as required by RA 9442. Thus, a total discount of 20% for PWD will still be observed.   These discount privileges shall be non-transferable and exclusive for the bene\ufb01ts of the PWD.   All establishments as de\ufb01ned above are enjoined to comply with the above\u2014cited guidelines.   For purposes of veri\ufb01cation, all hospitals, both government and private facilities shall require PWDs to present any of the following requirements:   i. A PWD ID Card issued and signed by the Barangay Captain, Mayor, or NCDA Chairperson   Responsibilities of Stakeholders   a. Government Facilities   All government facilities are required to post hospital room rates, laboratory tests, diagnostic tests fees, medicine prices, and all other fees and rates in conspicuous places near or at the main entrance to their respective facility. The above-described price lists shall be submitted annually to the National Center for Health Facility Development \u2014 DOH and PHIC.   i. All government facilities are also required to post this Administrative Order in conspicuous places where PWDs can have access to the information and policies set forth by this document.   ii. Of\ufb01cial receipts must be issued to every payment for medical and dental services, laboratory and diagnostic tests, and medicines provided. The receipts shall state the usual rates or fees and the discounted price; and,   iii. No \u201cIncome Means Test\" or any other tests shall be applied to the PWD as a precondition for the availment of free services as herein described.   b. Responsibilities of Private Hospitals and Medical Facilities   i. Private hospitals and medical facilities must post the price of all room rates in the Admitting Section of all private hospitals and medical facilities. The prices of diagnostics and laboratory tests based on room and board accommodation, medical supplies and medicines shall be made available upon request of the PWD. The list shall ensure validation of the discount granted to PWDs.   ii. Of\ufb01cial receipts must be issued to every payment for the medical and dental services and medicines provided. The twenty percent discount shall be granted upon full payment of the bill. The billing statement showing the usual rates or fees and the discounted prices shall be attached to the of\ufb01cial receipt.   iii. Set a grievance mechanism for PWDs to entertain questions with regards to discounts on professional fees.   iv. Inform in writing copy furnished the aggrieved party the necessary sanction for health professionals who refuse to grant the proper discount.   c. Responsibilities of the Health Care Professionals   i. Inscribe his/her name and PRC number in the request for diagnostics and laboratory tests, and prescriptions;   ii. Make sure that prescriptions made are for the exclusive use of the PWD to curb abuse of availing discounts for use of non- PWD citizens.   iii. Inform the PWD of the usual fees for the services required.   iv. Provide an of\ufb01cial receipt for the rendered professional services to the PWD that states the usual fees and the discounted fees.   d. Responsibilities of Drugstores   i. Drugstores are obliged to make available upon the PWD\u2019s request, a generic menu card and shall provide an of\ufb01cial receipt for drugs and medicines, which states the usual prices and the discounted prices of the drug or medicine.   ii. Drugstores are obliged to have a designated special lane for PWDs   e. Rehabilitation Centers shall provide quality care to PWDs and their families and to treat them with compassion and respect.   f. Behavioral testing centers shall provide test that measures general or speci\ufb01c behavior within educational, vocational, community or house settings. It shall also provide measurements and interpretations of behavior in relation to adaptive or social skills and appropriateness of behavior in relation to adaptive or social skills and appropriateness or dysfunctions within settings or situations.   g. Hospices and Palliative Care Centers shall provide a holistic quality care for patients addressing their physical, psycho-social, emotional, and spiritual pains.   6. Applications of Penalties and other Sanctions   a. Penalties for Persons who violates any provision   Any person who violates any provision of this Guideline shall suffer the following penalties:   i. For the \ufb01rst violation, a \ufb01ne of not less than \ufb01fty thousand pesos (P50,000.00) but not exceeding one hundred thousand pesos (P100,000.00) and an imprisonment of not less than six (6) months but not more than two (2) years; and,   ii. For subsequent violations, a \ufb01ne of not less than one hundred thousand pesos (P100,000.00) but not exceeding two hundred thousand pesos (P200,000.00) and imprisonment of not less than two (2) years but not more than six (6) years.   iii. Any person who abuses the privileges granted herein shall be punished with a \ufb01ne not less than \ufb01ve thousand pesos (P5,000.00) but not more than \ufb01\ufb02y thousand pesos (P50,000.00) and imprisonment of not less than six (6) months.   iv. If the offender is an alien or a foreigner, he/she shall be deported immediately after the service of sentence without further deportation proceedings.   b. Penalties for Corporations   i. If the offender is a corporation, organization or any similar entity, the of\ufb01cials thereof directly involved shall be liable therefore.   ii. Upon \ufb01ling of an appropriate complaint, and after due notice and hearing, the proper authorities may also cause the cancellation or revocation of the business permit, permit to operate, franchise, and other similar privileges granted to any business entity that fails to abide by the provisions of this Act   Funding Sources   a. Initially, the funding shall be sourced out from the Philippine Charity Sweepstakes Of\ufb01ce budget allocation for government hospitals that are providing free medical services to PWDs. Starting CY 2010, the National Government Agencies or LGUs shall include in their budget proposals the funding necessary to implement programs and services required by this Administrative Order.   b. For Government Owned and Controlled Corporation, total amount of discounts granted to PWDs shall be charged to the Quanti\ufb01ed Free Service.   c. For Private health facilities, the cost of the discount shall be funded through the deduction of the discount from gross income for the same taxable year that the discount is granted, provided that the total amount of the claimed tax deduction net of value added tax if applicable, shall be included in their gross sales receipts for tax purposes and shall be subject to proper documentation and to the provisions of the National Internal Revenue Code as amended   VII. REPEALING CLAUSE   Provisions from previous issuances that are inconsistent or contrary to the provisions of this Order are hereby rescinded and modi\ufb01ed accordingly.   VIII. EFFECTIVITY   This Order shall take effect immediately after publication in two (2) national newspapers of general circulation.  ", "  I. Introduction  The attainment of a better quality of life through the promotion of mental health has now become an imperative and essential goal for all countries and its people. Local and international data show the extreme burden mental health problems and disorders impose on individuals, families, communities and countries. International data show that about one percent of the population is affected with severe mental and neurological disorders, and another 4- 5% suffers from mild to moderate neurological problems, including the abuse of alcohol and drugs. Given the changing and fast-paced lifestyle of people amid a very dynamic socio-economic and political environment, this burden from mental ill health, disorder and disability is expected to increase exponentially as enunciated by the World Health Organization (WHO).  Similarly, the Philippines has long been confronted with a volatile socio-economic condition compounded by natural and man-made disasters, garbage crisis, and drug menace.  In a local baseline survey in 1964-67 in Sta. Cruz, Lubao, Pampanga, Manapsal of the DOH Division of Mental Hygiene, Bureau of Disease Control, found that the prevalence of mental disorders was 36 per 1,000 adults, children and adolescents. The 1980 WHO Collaborative Studies for Extending Mental Health Care in General Health Care Services (involving seven countries) showed that 17 percent of adults and 16 percent of children who consulted at three health centers in Sampaloc, Manila have mental disorders. Depressive reactions in adults and adaptation reaction in children were most frequently found. In Sapang Palay, San Jose Del Monte, Bulacan, the prevalence of adult schizophrenia was 12 cases per 1,000 population in 1988\u20141989 (Manalang et al).  In Region 6 (Iloilo, Negros Occidental and Antique), Perlas et al. in 1993-94 showed that the prevalence of the following mental illness in the adult population were: psychosis (4.3 percent), anxiety (14.3 percent), panic (5.6 percent). For the children and adolescent, the top \ufb01ve most prevalent psychiatric conditions were: enuresis (9.3 percent), speech and language disorder (3.9 percent), mental subnormality (3.7 percent), adaptation reaction (2.4 percent) and neurotic disorder (1.1 percent).   The current DOH bed capacity for mental disorders is 5,465. Of these, 4,200 beds are in the NCR (at the National Center for Mental Health). The rest of the country share the remaining 1,265 beds (CAR-40 beds, Region 2-200 beds, Region 3\u2014500 beds, Region 11-200 beds). Regions 1,4,10,12, CARAGA and ARMM do not have inpatient psychiatric facilities. Only 27 DOH medical centers and regional hospitals have mental health services. Cavite is the only province with a psychiatric facility.  These situations have hampered the delivery of basic services, aborted the national development, and reduced the quality of life of the Filipino. Life has become severely stressful to most, whether rich or poor, young or old. The resiliency of the Filipino people to adapt to his present life situation is being stretched too far. Warning signs of restlessnessabound such as increasing reports of suicide and substance abuse. Decline in the socio-economic condition may translate into mental-ill health and therefore mental health disorders and mental disabilities.  However, the provision of mental health services in the country, has remained illness-oriented, institution-based, fragmented, inadequate, inequitable, inaccessible, prohibitive, and neglected.  The Department of Health (DOH), the national lead agency for health recognizes the magnitude of the mental health problem as contained in the National Objectives for Health (NOH) 1999-2004. Among the objectives set forth are the following:  > reduction of morbidity, mortality, disability and complications from mental disorder > promotion of healthy lifestyle through the promotion of mental health and less stressful life.  However, the DOH has constraints in attaining these objectives given the limited government resources. Within the health sector, mental health has to compete for resources against other equally important health objectives. Concomitant reforms. are therefore being pursued in hospitals, public health, local health systems, regulation as well as financing with the end-view of improving the health of all Filipinos as embodied in the Health Sector Reform Agenda.  The WHO, on the other hand, called for a timely global action to attend to the crisis in mental health. The year 2001 has been dedicated to mental health \u201cin recognition of the burden that mental and brain disorders pose on people and families affected by them and with the aim to highlight the important advances made by researchers and clinicians in reducing suffering and the accompanying disability.\" All sectors have been enjoined \"to work towards a day when good health will also mean good mental health.\" This action emphasizes the faCt that mental health is a concern of all.  In summary, it is within this whole context that the development of a national mental health policy is pursued. The core issues in mental health are the lack of conscious awareness of mental health as an integral component of total health care and of the general health care system and the lack of political will to implement a comprehensive national mental health program. The formulation of the national mental health policy by the DOH, is therefore a very signi\ufb01cant step towards the advocaCy for mental health.  This issuance prescribes the national policy framework towards the attainment of a good state of mental health for all Filipinos.  II. Coverage and Scope  The National Mental Health Policy shall apply to all sectors, disciplines and institutions whether government, non\u2014government or private entities whose functions and activities contribute to the improvement of the state of mental health of the Filipinos.  Furthermore, this policy shall permeate health systems, programs and services at the national and local levels.  The mental health problems, disorders and disabilities shall include substance abuse and brain disorders such as epilepsy, dementia and cerebral palsy among others.  III. Vision - Better Quality of Life through Total Health Care for all Filipinos  The National Mental Health Policy is a commitment to ensure a community of Filipinos who are mentally healthy, able to contribute to the development of the country and attain a better quality of life through access to an integrated, well\u2014planned, effectively organized and ef\ufb01ciently delivered health care system that responds not only to the physical health needs but also to mental health needs of Filipinos.  IV. Mission - A Rational and Uni\ufb01ed Response to Mental Health  The National Mental Health Policy provides the direction for a coherent, rational, and uni\ufb01ed response to the nation\u2019s mental health problems, concerns and efforts through the formulation and' implementation of the national mental health programme strategy.  V. Goal - Quality Mental Health Care  The National Mental Health Policy sets to achieve quality mental health care through the development of ef\ufb01cient and effective structures, systems, and mechanisms that will ensure equitable, accessible, affordable, appropriate, ef\ufb01cient and effective delivery to all its stakeholders by quali\ufb01ed, competent, compassionate, and ethical mental health care professionals and service providers.  VI. Objective - Implementation of a Mental Health Program strategy  The National Mental Health Policy shall be pursued through a Mental Health Program strategy prioritizing the promotion of mental health, protection of the rights and freedoms of persons with mental diseases. and the reduction of the burden and consequences of mental ill-health, mental and brain disorders and disabilities.  VII. Policy-Statements:  A. Leadership  Cognizant of the critical importance of leadership and political will in government to effect action, the Department of Health shall be the lead agency in the promotion and protection of the people\u2019s mental health.  Corollary to this, the Local Governments as embodied in the Local Government Code of 1991 shall ensure the delivery of basic mental health services.  B. Collaboration and Partnership  Cognizant of the multifaceted causation and management of mental health problems and disorders, the DOH shall ensure the creation of an enabling environment for collaboration and partnership among (a)sectors, e. g. academe, non-governmental organizations, other government agencies, civil society, professional societies, legislators, policymakers, business sector, pharmaceutical companies, (b) disciplines e. g. medical, nursing, social work, psychology, social sciences, arts, administration, and (0) levels of government, e. g. municipal, province, city, national.  C. Empowerment and Participation  Cognizant of the need for the empowerment and active participation of (a) persons at risk to develop, (b) persons with mental illnesses, (c) their families, in the effective treatment and management of mental health problems and disorders, they shall be involved in the planning and decision\u2014making on matters that concern and pertain to them.  D. Equity  Cognizant of the immediate need to provide equitable and accessible quality mental health care, protective and non-disCriminating mechanisms in the mobilization, allocation and utilization of resources from all sectors in all regions, provinces, cities and municipalities shall be created.  E. Standards for Quality Mental Health Services  Cognizant of the importance of ensuring the provision of the highest quality of care for mental health, national standards for ethical practice, facilities and services shall be developed and enforced.  F. Human Resource Development  Cognizant of the urgent need to develop adequate, appropriate and competent mental health care providers and ensure mental \ufb01tness of workforce in all sectors, disciplines and levels of government:  a) the curriculum and training for mental health care providers shall be responsive to the national and local culture and human development goals, b) a good incentive and bene\ufb01t system shall be formulated and provided for the mental health care providers, and c) the staff development programs shall include promotion of the mental health of the workforce.  G . Health Service Delivery System  Cognizant of the numerous requirements and dif\ufb01culties in the provision of an equitable, accessible, affordable and appropriate quality mental health care,  > the integration into the general health care programs, services, and systems of hospitals, health centers, and other health units of the government and private sectors, and > the availability of essential treatment and drugs shall be the priority.  H. Mental Health Care  That Mental Health is an integral component of Total Health Care and that the holistic approach is the essence of health care, programs, services, and activities shall address the biological, psychological, behavioral and social activities shall address the biological, psychological, behavioral and social aspects in the care of persons with mental health problems, diseases and disabilities.  I. Stability and Sustainability  Cognizant of the prohibitive cost and \ufb01nancial burden of mental health care, regular government appropriation and attractive investment package's shall be secured and mechanisms such as subsidies, national health insurance and tax incentives shall be explored.  J. Information System  Cognizant of mental illness as an emerging global health problem and the need for accurate data in the surveillance of mental diseases and disorders, a national and local system of information generation, sharing and exchange shall be created and instituted in aid of developing appropriate programs, services, policies and legislation.  K. Legislation  Cognizant of the need to guarantee the promotion and protection of the rights and freedoms of persons with mental and brain disorders, the formulation and passage of a Mental Health Act shall be advocated.  L. Monitoring and Evaluation  Cognizant of the need to sustain the mental health initiatives and ensure continuing improvement in the delivery of mental health care, a regular review, monitoring and evaluation of existing policies, programs, facilities and services shall be done.  VIII. Roles and Responsibilities  A. General Roles and Responsibilities  1. The Department of Health (DOH) shall establish, strengthen and sustain capacities for. implementation of the National Mental Health Policy within the DOH and in the executive and legislative branches of government, including partnership with non-government organizations and the private sector.  2. All units, centers, bureaus of the DOH shall implement as a priority the mental health policies through initiatives such as programs, projects and investment incentives and packages relevant to their functions and responsibilities consistent with the National Objectives for Health and the Health Sector Reform Agenda.  3. In the planning and development of mental health programs projects and other initiatives, all units are to enSure (a) a holistic and comprehensive approach, (b) the collaboration and partnership with appropriate sectors, disciplines, and levels cf government (0) the active participation and empowerment of persons with mental health problems, disease and disabilities, their families and communities, (d) the continuity of care at all levels, and (e) their equitable distribution at the different regions, and (f) the provision and maintenance of reSources for mental health.  B. Specific Roles and Responsibilities  1. The National Center for Disease Prevention and Control shall (a) oversee the implementation of the national mental health policy, and; (b) lead in the formulation of the mental health and neurological disease prevention, control, intervention and rehabilitation programs and strategies that will reduce the burden and consequences of mental diseases and disabilities and promote mental health.  2. The National Center fer Health Promotion shall lead in the formulation of the standard and the development of mental health information, education and communication (IEC) and \"advocacy strategies to ensure the promotion of a totally healthy and less stressful lifestyle for the Filipinos.  3. The National Epidemiology Center and the Information Management Service shall ensure the development of a national reporting and surveillance systems and methodologies in the generation, availability, accessibility, sharing, exchange, and distribution of information and knowledge on mental health and the establishment of the national registry of mental and neurological cases.  4. The National Center for Health Facility Development shall ensure the development and implementation standards in the creation of mental health facilities as well as the equitable distribution, effective management and ef\ufb01cient operation of all these facilities in the country.  5. The Health Policy Development and Planning Bureau shall (a) assist in the proper and effective implementation, monitoring and evaluation of the National Mental Health \"Policy, (b) ensure its formulation into a national program plan of action, (c) its development into legislative actions, and (d) the inclusion of mental health in the priorities for the health research agenda.  6. The Health Human Resource Development Bureau shall ensure (a) the development of standards in the curriculum and the training of all types of mental health professionals, practitioners, and care providers who are responsive, sensitive, and consistent with the national and local human development goals and culture, (b) the adequate and equitable distribution of mental health manpower through provision and protection of plantilla positions in the health care delivery system at the national and regional levels, and (c) the provision of a good incentive and bene\ufb01t program to attract mental health caregivers in the unserved and underserved areas.  In addition, the HHRDB shall ensure the provision of standards, programs and mechanisms that will address the maintenance of a physically and mentally healthy workforce within and outside DOH.  7. The Bureau of Health Facilities and Services shall ensure the provision of quality mental health services through adequate regulatory mechanisms and facilitative licensing procedures for mental health facilities to ensure the availability of highest possible mental health care.  8. The Bureau of Food and Drugs shall developthe policies, structures and systems that will ensure the provision of affordable essential drugs, the review and update of the national formulary for drugs and treatment used in the management of mental health and neurological diseases.  9. The Bureau of International Health Cooperation shall establish strong network linkages with international mental health institutions, agencies, units that will continually ensure the inclusion, participation, cooperation and collaboration of the Philippine in the global scene.  10. The Bureau of Local Health Development shall ensure the development of systems for the integration of quality mental health into the primary care level.  11. The Centers for Health Development shall ensure the inclusion of mental health in their priority agenda and thus, develop .the systems, structures, mechanisms for cost-sharing and \ufb01nancial and technical assistance as a start-up support to LGUs and Other partners, and building capabilities for the effective implementation of the national mental health policy, program and strategy in their respective areas.  12. The DOH hospitals, medical centers, and sanitaria shall ensure the availability of quality mental health care to its clients through the establishment of appropriate capabilities and competencies in their respective units.  13. Local Government Units shall ensure the availability, accessibility, affordability and equitableness of appropriate and culturally sensitive mental health services at the inter-local health zones, local hospitals, health centers, Communities and homes.  14. Private sector, the academe and non-govemment organizations shall be partners in the advocacy, promotion and provision of mental health services and in the training of mental health care providers.  IX. Special Provisions  A. The National Center for Mental Health and regional mental health facilities as special facilities for mental disorders shall ensure the development of models and standards for tertiary level of mental health care.  B. Collaborating centers shall be created at the national and regional levels to ensure the coherent and rational implementation of the natiOnal mental health policy, program and strategy. In line with this, a National Collaborating Center for Mental Health and Psychiatry (NCC \u2014 MHP) is hereby created at the East Avenue Medical Center to serve as the convergence arena for mental health initiatives.  C. The Technical Working Group on Hospital Rationalization and Streamlining shall immediately address the inequitable distribution- \"of human resource and bed requirements of psychiatry and neurology units by ensuring their proper allocation 1n all DOH hospitals.  This Order shall take effect immediately.   ", " I. RATIONALE   The Philippine Health Agenda (PHA) 2016-2022, seeks to ensure \ufb01nancial protection for all Filipinos. In 1995, the Philippine Health Insurance Corporation (PhilHealth) was created to provide the National Health Insurance Program (NHIP) on a universal coverage. However, a signi\ufb01cant proportion of Filipinos continue to have no access to adequate health services due to \ufb01nancial reasons. Because of low compliance rate of 40-50% to the DOH No Balance Billing Policy and uniform Costing of PhilHealth bene\ufb01ts, high out-of-pocket expense at an average of 56% of the total health expenditure was estimated in 2013.   Thus, pursuant to Section 13 of the General Appropriations Act of 2017, the Assistance to Indigent Patients Budget shall \ufb01nd the Medical Assistance Program (MAP) of the Department of Health (DOH) to provide \ufb01nancial assistance to poor and indigent patients seeking medical services in government health facilities.   Administrative Order No. 2016-0010 entitled \u201cRevised Guidelines for the Implementation of the Medical Assistance Fund Program in Government Hospitals Starting 2016\" has not explicitly discussed the role of PhilHealth and other \ufb01nancing programs. Overlaps of these different sources of funds make the system prone to fraud and weaken the purchasing power of PhilHealth, leading to inef\ufb01cient fund utilization and ultimately, hindering the achievement of full \ufb01nancial risk protection.   Hence, there is a need to redirect the \ufb01nancing provisions of MAP and to expand and align its coverage with the thrusts of DOH. The revised guidelines will position MAP to supplement and augment provisionally, but not duplicate other existing health \ufb01nancing schemes to ensure that all Filipinos are provided with adequate health care service.   II. OBJECTIVES   1. To de\ufb01ne the bene\ufb01ciaries of MAP;   2. To establish guidelines for the implementation of MAP, including but not limited to accessing, processing, monitoring and evaluation of the program; and,   3. To establish mechanisms of accountability and transparency in the use of the MAP fund.    III. SCOPE AND COVERAGE   These guidelines shall apply but not be limited to DOH of\ufb01ces, attached agencies and government health facilities involved in the implementation of MAP, whose intended bene\ufb01ciaries are all Filipinos, classi\ufb01ed as indigent or poor seeking health and medical services in government health facilities.   IV. DEFINITION OF TERMS   1. Medical Assistance Fund - refers to the fund intended for medical assistance to indigent and poor patients.   2. DOH Retained Hospital - refers to a hospital under the management and administration of the DOH.   3. DOH Specialty hospital - refers to the four (4) corporate hospitals under the Secretary of Health, namely: Philippine Heart Center, Lung Center of the Philippines, National Kidney and Transplant Institute and the Philippine Children\u2019s Medical Center '   4. Local Government Unit (LGU) Hospital - refers to a hospital managed by the local government units, usually the provincial government.   5. State Universities and Colleges (SUC) Hospital - refers to hospitals managed by State Universities and Colleges.   6. Department of National Defense (DND) Hospital- refers to a hospital managed by the Department of National Defense.   7. Indigent Patient- refers to patient who has no visible means of income, or whose income is insuf\ufb01cient for the subsistence of his/her family, as identi\ufb01ed by the Department of Social Welfare and Development (DSWD), LGU social worker or the medical social worker of the health facility.   8. Poor Patient - refers to those not classi\ufb01ed as indigent but are otherwise considered poor or with \ufb01nancial dif\ufb01culty to access adequate medical care and/or pay hospital bills because of certain unavoidable circumstances, as certi\ufb01ed by the medical social worker of the health facility where the patient is con\ufb01ned, such as but not limited to:   a. Senior citizens, persons with disability (PWD), orphans, abused women and children as de\ufb01ned by RA 9262 or the Anti-Violence Against Women and Their Children Act of 2004 and RA 7610 or the Special Protection of Children Against Abuse, Exploitation and Discrimination Act;   b. Patients with catastrophic illness or any illness as a primary condition that is life or limb-threatening and requires prolonged hospitalization, extremely expensive therapies or other special but essential care that would deplete one's \ufb01nancial resources, unless covered by special health funding policies '   c. Unemployed or without gainful employment,   d. Suspected or con\ufb01rmed victims of torture as de\ufb01ned by Republic Act No.9745 or the Anti-Torture Act of 2009;   e. Soldiers and police rendered disabled to be gainfully employed and their dependents and dependents of soldiers and police killed in action;   f. Rebel returnees, prisoners of war and their dependents;   g. Victims of calamities or disasters such as but not limited to typhoons, earthquake, whose place of residence are of\ufb01cially under a state of emergency or calamity.   V. GENERAL GUIDELINES   1. MAP shall serve as a transitory measure, to be re-evaluated annually, in paying for medical and surgical services not currently paid for or suf\ufb01ciently reimbursed by PhilHealth or other \ufb01nancing sources.   2. The DOH shall facilitate ef\ufb01cient sub\u2014allotment, payment and/or transfer of MAP fund to government hospitals   3. The DOH shall coordinate with other branches of government for the implementation of the MAP.   4. The DOH shall recommend the standard process for screening requests, documentation and reporting to be implemented by all MAP providers.   5. Government health facilities implementing the MAP shall judiciously enforce ef\ufb01cient use of funds through screening of bene\ufb01ciaries, facilitate proper documentation and quarterly reporting of utilized funds to the Secretary of Health.   6. The DOH, through the Public Assistance Unit (PAU), Regional Of\ufb01ces and participating government health facilities shall coordinate to provide patients with \ufb01nancial assistance and educate and empower potential bene\ufb01ciaries about its availability and how to avail medical assistance.   IMPLEMENTATION MECHANISMS   1. Bene\ufb01ciaries  a. Indigent and poor patients seeking outpatient and inpatients services in authorized government health facilities,  b. Patients who are con\ufb01ned in the pay ward of authorized government health facilities due to reasons beyond their control, as certi\ufb01ed by the hospital, such as but not limited to:  i. Emergency cases  ii. Non-availability of ward services  iii. Cases of communicable disease requiring isolation  iv. Cases requiring intensive care  v. Chronic and catastrophic cases requiring prolonged admission  c. Patients con\ufb01ned in suite rooms, private rooms or private ward by choice will not be covered by MAP.   2. Eligibility  a. Bene\ufb01ciary must be classi\ufb01ed as indigent as evidenced by any one of the following documents:  i. Inclusion in the NHTS list or 4Ps membership card  ii. Sponsored Philhealth card or Member Data Record (MDR)  iii. Certi\ufb01cate of Indigency or social worker case summary from DSWD, LGU social worker or medical social worker of the facility.   b. Bene\ufb01ciary must be certi\ufb01ed as poor by the medical social worker of the government health facility based on the medical social worker case summary. In case of an outpatient, patients assessed in out-patient departments of quali\ufb01ed government facilities shall be eligible to avail MAP \ufb01mds.'   3. Service Coverage a. MAP shall be used for the following drugs, medicines, goods and other services prescribed by the physician of the government health facility such as but not limited to:   i. Laboratory, imaging and all other diagnostic procedures,  ii. Drugs and medicines included in the Philippine National Drug Formulary (exemptions to be cleared by Pharmaceutical Division),  iii. Supplies, orthopedic/assistive devices, prosthesis, blood and blood products;  iv. Dental services, except those that are for aesthetic purpose and not medically indicated,  v. All clinically indicated medical and surgical procedures, whether emergency or elective,  vi. Prescribed post\u2014hospitalization rehabilitation services, aftercare program, appropriate mental and psychological support, including those done on an outpatient basis,  vii. In case of non\u2014availability of clinically indicated drugs, medicines, tests, services or procedures in government health facilities, the concerned government health facility may enter into contract with DOH-accredited private health facility to provide the needed drug, test, service or procedure to the patient, charged against the DOH hospital  viii. All hospital bills including professional fees, provided that the expenses for professional fees shall not exceed \ufb01fty percent (50%) of the approved assistance,  ix. All other medical, health, documentary and related services billed by th hospital, including payment of PhilHealth insurance premium under Point of Care program subject to the guidelines speci\ufb01ed in PhilHealth Circular No. 32 series of 2013. '   4. Mechanism and Documentary Requirements to Access MAP   a. following documentary requirements shall be submitted to avail MAP:   i. For all: Proof of eligibility as listed under Section V1.2.  ii. For Outpatients: prescriptions, diagnostic test requests and medical abstract or medical certi\ufb01cate (if consultation was not done at the OPD of the health facility)  iii. For elective procedures: treatment protocol and estimated cost  iv. For Inpatients: hospital bill for inpatients showing PhilHealth, HMO or other health insurances, PWD, Senior Citizen, Government Employees and other authorized discounts have been deducted   b. The amount of coverage shall be based on the following:  i. All indigent patients shall be eligible for full assistance, in excess of PhilHealth bene\ufb01t package and other more easily available charities or subsidies.  ii. Amount of coverage for non-indigents but poor patients shall be guided by the medical social worker case summary evaluation, assessment and recommendation, which should be approved by the Chief of Hospital and Medical Director.   c. For cases referred to DOH Regional Of\ufb01ce or Central Of\ufb01ce for approval, the following must be submitted.   i. Letter of endorsement from the Chief of Ho spital/Medical Center Chief  ii. Updated medical social worker case summary report  iii. Updated medical abstract  iv. Latest hospital bill statements after PhilHealth and other routine or privilege deductions   5. Fund Administration and Authorization   a. Medical assistance to patient shall be based on need as recommended by the medical social worker attending physician\" approved by the Chief of Hospital/Medical Center Chief of institution involved and DOH authorized of\ufb01cials, subject to availability of funds.  b. No money or cash shall be released.  c. Not more than 1% of the sub-allotted/transferred funds shall be used for MOOE of the Regional Of\ufb01ces and government health facilities, for the purpose of MAP fund administration  d. Utilization of fund shall be authorized by the of\ufb01cials with corresponding allowable amount per patient indicated in Table 1.   Table 1: Approving Authority for the Release of Funds     6. Transfer of Funds   a. Funds shall be transferred by DOH Central Of\ufb01ce thru the issuance of the Sub- Allotment Advice (SAA) to the Regional Of\ufb01ces, DOH Retained and Specialty Hospitals.   b. The DOH Central Of\ufb01ce shall transfer funds directly to DOH Specialty Hospitals through the issuance of checks in favor of the hospitals concerned or as direct credit to their accounts subject to the Memorandum of Agreement (MOA) between the Secretary of Health and the Medical Director of the Specialty Hospital concerned.   c. Transfer of MAP funds to DND and SUC Hospital shall be effected after signing of the MOA among and between the DOH Secretary and the Chiefs of the concerned DND Hospitals and SUC President of the concerned SUC Hospitals.   d. The DOH Regional Of\ufb01ce shall transfer MAP funds to the LGU hospitals through the following:   i. Memorandum of Agreement among and between the Regional Of\ufb01ce Director, the Provincial Governor and the Chief of the LGU hospital concerned. i.i. Fifty percent (50%) of the agreed amount shall be transferred upon the signing of the MOA, while the remaining 50% shall be released upon submission of the Liquidation Reports of the previously transferred funds. The Liquidation Reports shall be supported by the list of patients\u2019 names, current addresses and/or contact numbers, gender, age, nature of assistance and amount charged to the MAP funds. For LGU hospitals with outstanding fund transfers, availment of MAP funds may be allowed through the reimbursement basis supported by the list of patients\u2019 names, current addresses and/ or contact number, gender, age, nature of assistance and amount charged to MAP funds.  ii. Issuance of the Memorandum of Agreement between the DOH Regional Of\ufb01ce Director and the Chief of the LGU hospital. Funds shall be transferred through a reimbursement basis.   e. The DOH Regional Of\ufb01ce may transfer funds to the DOH Retained Hospitals within their jurisdiction including unutilized funds that will lapse in four (4) months.   f. Fund transfer shall be limited to the availability of allotment balance of MAP speci\ufb01ed in RA No. 10924 known as the General Appropriations Act for FY 2017. Additional request of availment either through the MOA or reimbursement shall be granted on a case to case basis subject for the approval by the Secretary of Health or authorized representatives.   g. Downloaded or transferred MAP funds shall be utilized in accordance with the Special Provision No. 7 of the GAA for 2017 and subject to existing COA and accounting rules, regulations and guidelines. The respective Heads of recipient health facilities and signatories to the MOAs shall be responsible and be held accountable on the disbursement of MAP funds.   h. For transparency and monitoring purposes, transferred funds shall be posted in the EWEBPAIS.    7. Recording and Reporting   a. All DOH hospitals and Regional Of\ufb01ces shall log real time all MAP cases into the Enhanced Web-Based Public Assistance Information System (EWEBPAIS) the following information:   i. Date of fund release, complete name, age, date of birth, type of assistance, address, PhilHealth number, \ufb01nal and complete diagnosis, type of assistance  ii. The DOH Knowledge Management and Information Service shall develop and maintain the EWEBPAIS and ensure secured access and integrity of the system.    b. The DOH and recipient government hospitals shall post on its website the following:   i. Name of recipient government hospitals and indigent patients, whether con\ufb01ned or out patient, types of medical assistance or services and/or drugs and medicines given  ii. The heads of agencies and web administrator or their equivalent shall be responsible for ensuring that the said information are posted on the agencies\u2019 website.   c. DOH Retained Hospitals/LGU hospitals/SUCS hospitals shall submit a quarterly scanned copy of . fund utilization report, stamp received by COA to the DOH Regional Of\ufb01ce.   d. The DOH Regional Of\ufb01ce shall submit a consolidated report on the fund utilization of government health facilities to OSec, copy furnished Financial and Management Service and PAU every 15th of the month following the end of each quarter.   8. Monitoring and Evaluation   a. Regular monitoring of fund utilization and program implementation review should be conducted by the Public Assistance Unit, DOH Regional Of\ufb01ces, DOH Retained and Specialty Hospitals to assess the impact of this \ufb01nancing scheme particularly on the targeted clientele.   b. The Of\ufb01ce of the Secretary and PAU in consultation with target implementing of\ufb01ces shall draft and formulate monitoring and evaluation tools, systems and other mechanisms for the improvement of process \ufb02ow.   VII. ROLES AND RESPONSIBILITIES   1. Department of Health - Central Of\ufb01ce  a. Of\ufb01ce of the Secretary (OSec)   i. Provide oversight and direction of program implementation  ii. Review and evaluate utilization reports quarterly and annually  iii. Review request and authorize release of funds as speci\ufb01ed in Table 1   b. Cluster Head of the Of\ufb01ce of Administration, Finance and Procurement (OAFP) and Assistant Secretaries   i. Review request and authorize release of funds to participating of\ufb01ces and government hospitals as speci\ufb01ed in Table 1  ii. Assist in ensuring that MAP funds shall be used according to the 2017 GAA and other accounting and auditing rules and regulations   b.1. DOH Financial Management Service   i. Shall facilitate transfer of funds to Regional Of\ufb01ces, SUCs, DND, DOH Specialty, and Retained hospitals  ii. Shall provide technical assistance on \ufb01nancial issues and concerns   b. Public Assistance Unit   i. Coordinate with government hospitals and other health facilities for referral of patients and \ufb01nancial and administrative concerns in implementing the program  ii. Consolidate, screen and evaluate utilization reports and submit \ufb01ndings to OSec quarterly and annually  iii. Formulate and implement monitoring and evaluation tools and systems.  iv. Report any suspected abuse or mishandling of funds to the Head Executive Assistant, OSec.   c. DOH\u2014 Knowledge Management and Information Service  i. Provide training and technical assistance in the usage, maintenance and upgrading of EWEBPAIS.   2. DOH Regional Of\ufb01ce  a.' Manage allocated funds and facilitate ef\ufb01cient transfer to LGU and DOH hospitals  b. Regional Director shall review request and authorize release of \ufb01mds as speci\ufb01ed in Table 1.  c. Monitor fund utilization and program implementation in the region.  d. Report any suspected abuse or mishandling of funds to the Public Assistance Unit   3. Government health facilities  a. Chief of Hospital/President of the University/Head of Agency  i. Review requests and authorize release of funds as speci\ufb01ed in Table 1   b. Medical Social Worker or Duly Designated Hospital Staff  i. Screen eligibility of patients thoroughly, ensure completeness and authenticity of documents before recommending patient for coverage  ii. Ensure that all indigent and poor patients are informed about the availability of fund through poster and IEC materials  iii. Facilitate enrolment of all patients not yet members of PhilHealth   VIII. REPEALING CLAUSE   All other issuances and/or'their provisions which are inconsistent with this Order are hereby repealed.   IX. EFFECTIVITY CLAUSE   This administrative order shall take effect 15 days after publication in a newspaper of general circulation or in the DOH website.  ", "  I. Background:  With the Alma  Ata Declaration, the Department of Health (DOH) adopted the Primary Health Care as a major strategy to pro-actively address health  problems in the country thereby, promoting the health of the country and of the Filipinos. Correspondingly, the DOH hospitals conceptualized and subsequently implemented the Hospitals as Centers of Wellness Program.  The transformation of hospitals as Centers of Wellness is by itself, a declaration of life in its totality. With the implementation of the Hospitals as Centers of Wellness Program (HCWP), the public health found its way into the hospital. People\u2019s participation in health promotion and disease prevention gained its ground. Furthermore, quality of patient care was upgraded and personnel well-being and work satisfaction were enhanced.  Existing policies related to HCWP are embodied in Department Circulars No. 195, s. 1993 and No, 182-C, s. 1996. For the HCWP to be responsive and dynamic not only to DOH hospitals but as well as to LGU hospitals, the need for its modi\ufb01cation becomes evident.  II. Objectives:  The HCWP seeks to attain the following:  1. Integrate Promotive / Preventive / Primary health care into curative and rehabilitative services;  2. Provide mechanisms for people\u2019s active participation in hospital activities such as treatment, maintenance of cleanliness, establishment of support groups, networking activities, etc.  3. Install programs which shall promote personnel development, safeguard personnel rights and ensure a caring, communicating, compassionate and competent hospital staff; and  4. Formulate policies and systems, which will ensure equitable quality health care, that are relevant to community needs and the local culture, the comfort and relief of patients, relatives and the personnel as well.    III. Policies of the HCWP:  For the HCWP to be responsive and dynamic, the following policies are hereby issued:  1. Health promotion, disease prevention and primary health care shall be integrated into the, conventional curative and rehabilitative services.   2. Establishment of support groups among patients, families and other volunteers.  3. Personnel well-being shall be promoted.  4. Technical support and opportunities for capability enhancement in pursuit of organizational and service excellence shall be provided by the National, Regional or local health agencies.     III.  Guidelines and Strategies:  1. The policy on the integration of health promotion, disease prevention and primary health care into the conventional curative and rehabilitative Services shall be attained through:  1.1. Organization of Promotive / Preventive Program (PPP) Committee in the hospitals with the following members:  Chairperson:  Chief of Hospital  Members :  Chief of Clinics / Senior Resident Physician   Training Officer/optional)   Designated HEPO   Coordinator of the different PPP Programs   Administrative Officer   Chief Nurse  1.2. Designation a Health Education and Promotion Officer.  1.3. Identification of priorities based on the leading causes of mortality and morbidity in the locality.  1.4 Strengthening of DOH hospital-based priority programs: 1.4.1 Tuberculosis 1.4.2 Diabetes  1.4.3 Asthma 1.4.4. Dengue  1.4.5. Reproductive Health  1.5. Intensfying health education programs for patients and their families, hospital personnel and the general public. All other appropriate programs suitable to the needs of specific localities shall be encouraged.   1.6. Development, production and utilization of specific health education materials by the hospitals, with the technical assistance of the Regional Health Education and Promotion Officer.  1.7. Establishment of linkages with non\u2014government organization, volunteer civic organizations,  people\u2019s organization and other government agencies.   1.8. Strengthen collaboration among hospital-based specialists and public health experts.  2. The policy on the establishment of support groups among patients, their families and other volunteers:  2.1 Organization of patients and their families into health clubs and other support groups.  2.2 Optimal participation of health personnel, beneficiaries and communities in the planning, implementation and evaluation of promotive / preventive programs in hospitals.  2.3 Development of a core of lay educators / counselors.  3. The policy on the promotion of personnel well-being:  3.1. Conduct of seminar-workshops and similar activities aimed at values clarification, identification of roles / contributions to the Program.  3.2. Implementation of Human Resource Development Program for hospital personnel.  4. The policy on the provision of technical support and opportunities for capability enhancement in pursuit of organizational and service excellence:  4.1. Coordination with the Central Office, Regional Health Office, Local Government Units, other health facilities in the locality for technical and administrative support.  4.2 Identification of resource and logistic requirements for fund sourcing.     III. Ten Steps to Become a Center of Wellness:  1. Develop policies on converting the hospital into a Center of Wellness.  2. Implement a continuing hospital-wide orientation and values clarification.  3. Organize a hospital Preventive / Promotive / Primary Health Care (PPP) Committee to oversee and implement the program.  4. Train hospital personnel on Preventive / Promotive / Primary Health Care programs.  5. Promote excellence in hospital services and operations to ensure a competent and well-managed hospital.  6. Ensure peoples-friendly staff by promoting personnel welfare and job satisfaction.  7. Provide an environment conducive to health through clean and green premises, opportunities for interaction, psycho-social and spiritual support.  7. Establish a well-equipped health education area for the regular conduct of hospital-wide health education activities.  8. Mobilize the personnel, patients their families and other volunteers into support groups.  9. Establish linkages with the public health offices, other government / non-government organizations, volunteer groups, for service complementation, resource mobilization and program support.  Hospitals are enjoined to comply with the above policies and guidelines, to transform the hospitals as Centers of Wellness.  All other provisions that are not contradictory in the afore-stated Department Orders, shall still stand the effect.  ", " I. RATIONALE   In\ufb02uenza and pneumococcal disease together are responsible for hospitalizations, deaths and is a substantial disease burden worldwide. _ Most of the serious complications of these diseases occur among the elderly and other people with underlying chronic medical conditions.   In most countries, majority of the cases of in\ufb02uenza occurs in the elderly. Observational studies from Europe, America and Asia have established that immunizing the elderly not only prevents direct outcomes of in\ufb02uenza infection and complications including hOSpitalization and death, but also direct outcomes, such as death from other causes or acceleration of the worsening condition of their health status. Meta-analyses of 20 cohort studies conducted between 1965 and 1991 add further support for the value of in\ufb02uenza immunization in the elderly, demonstrating prevention of respiratory illness by 56%, pneumonia by 53%, and hospitalization by 50% and death by 68%. Immunization is strongly recommended by the World Health Organization (WHO) and many national health authorities.   The WHO estimates that more than 1.6 million people die from pneumococcal infections every year. It remains a major cause of mortality worldwide. Elderly subjects are most affected, with an incidence rate of 40 per 100,000 for people aged 80 \u2014 85 years. Age- related impairment of the immune system and other defense mechanisms often compounded with decrease physical activity and poor nutrition increase the risk of severe pneumococcal disease in the elderly. Immunization remains the best preventive tool as the growing issue of antibiotic resistance often hampers treatment. In recognition of this tool, a growing number of countries and health bodies now recommend pneumococcal immunization of elderly and at-risk groups. Immunization with the 23-valent polysaccharide vaccine protects from invasive pneumococcal infections. WHO recommends the use of pneumococcal polysaccharide vaccine for the elderly and other at-risk groups].   In February 2010, President Gloria Macapagal-Arroyo signed into law Republic Act (RA) No. 9994, otherwise known as the \u201cExpanded Senior Citizens Act (ESCA) of 2010\". It is an act granting additional bene\ufb01ts and privileges to senior citizens, further amending RA No. 7432, otherwise known as \u201cAn Act to Maximize the Contribution of Senior Citizens to Nation Building, Grant Bene\ufb01ts and Special Privileges and for Other Purposes\".   Pursuant to Article II, Section 4 of RA 9994, the Department of Health (DOH) is mandated to procure pneumococcal and in\ufb02uenza vaccines to be administered for free to\" indigent senior citizens in communities who are recipients of the Department of Social Welfare and Development\u2019s National Household Targeting System for Poverty Reduction (DSWD - NHTS\u2014PR) of the country. Senior citizens in government\u2014run residential homes and facilities shall likewise be entitled to free immunizations under these Rules.   To ensure an effective and ef\ufb01cient management of routine immunization for the indigent senior citizens in all health units, government\u2014run residential homes and facilities, this guideline is hereby developed. Consultations with the Health and Well\u2014being of Older Persons (HWOP), Expanded Program for Immunization (EPI), National Epidemiology Center (NEC), National Center for Health Promotion (NCI-IP) and their regional/provincial and municipal counterparts will be done to warrant the successful implementation of this guideline. Likewise, coordination with other government of\ufb01ces like the DSWD and the Of\ufb01ce for Senior Affairs (OSCA), other Non-Governmental Organizations like the Coalition- of Citizens for the Elderly (COSE), National Federation of Senior Citizens\u2019 Associations of the Philippines (NF SCAP), and Confederation of Older Persons Association of the Philippines (COPAP) among others will be done.   II. SCOPE AND COVERAGE   This order shall apply to all Centers for Health Development (CHD) of the DOH, city/municipal health centers, government  managed centers/residential institutions for senior citizens and other institutions providing immunization services for indigent senior citizens nationwide.   III. PROGRAM GOAL   1. To reduce the morbidity and mortality of indigent senior citizens against pneumonia and in\ufb02uenza diseases.   2. To reduce transmission of resistant strains and pneumococcal resistance to antimicrobial drugs among indigent senior citizens.   IV. DEFINITION OF TERMS   For purposes of this Order, the following terms shall have the following de\ufb01nitions based on the Implementing Rules and Regulations of RA 9994.  SENIOR CITIZEN OR ELDERLY \u2014 refers to any Filipino citizen who is a resident of the Philippines, and who is sixty (60) years old or above. It may apply to senior citizens with \u201cdual citizenship\" status prOvided they prove their Filipino citizenship and have at least six (6) months residency in the Philippines.   INDIGENT SENIOR CITIZEN \u2014 refers to any elderly who is frail, sickly, or with disability, and without pension or regular source of income, compensation or \ufb01nancial assistance from his/her relatives to support his/her basic needs, as determined by the DSWD in consultation with the National Coordinating and Monitoring Board (NCMB).   RESIDENTIAL CARE FACILITY \u2014 refers to a facility that provides twenty four (24) ' hour residential care services operated for the purpose of promoting the well being of abandoned, neglected, unattached or homeless senior citizens. The facility may be run by government or non- \u2014stock non- pro\ufb01t organization and IS accredited by the DSWD to serve a minimum of 10 clients.   V. GENERAL GUIDELINES   1. The DOH shall procure pneumococcal and in\ufb02uenza vaccines starting CY 2011 onwards and administer for FREE a yearly dose of in\ufb02uenza vaccine and a single dose of pneumococcal vaccine to all indigent senior citizens.   2. The DOH shall calculate the pneumococcal and in\ufb02uenza vaccines based on the list of indigent senior citizens in the NHTS-PR of the DSWD, in residential care facility (ex: govemment\u2014run residential facilities and in DSWD-accredited non-govemmental home care facilities), as stipulated under the RA 9994.   3. Only health workers trained and skilled at giving injections are authorized by the DOH to give immunizations in designated city/municipal health centers, government- run residential facilities and DSWD\u2014accredited non-governmental home care facilities for senior citizens.   VI. IMPLEMENTING GUIDELINES   1. Target setting   A. Age Group   A1. All indigent senior citizens 60 years of age and above should receive the following vaccines:   i. One (1) dose of pneumococcal vaccine throughout his/her lifetime   ii. One (1) dose of in\ufb02uenza vaccine every year   A2. An indigent senior citizen who has received a penumococcal vaccine in the last 5 years and was &lt 60 years of age at the time of immunization should receive another close of pneumococcal vaccine.   A3. An indigent senior citizen who has received a pneumococcal vaccine when he/she was 60 years old and above at the time of immunization is not required to receive another dose of pneumococcal vaccine.   B. Geographical coverage   B1. All indigent senior citizens 60 years old and above living in residential care facilities and in the communities identi\ufb01ed.   B2. All personnel and staff employed in residential care facilities. Vaccination of these employees against these diseases will ensure protection because they are constantly in contact with the senior citizens.   C. Immunization Schedule   Routine immunization activity will commence as soon as the vaccines are made available at the City/Municipal Health Centers.   2. Immunization Strategy   A. A facility-based (i.e. residential care facility, city/municipal health center) immunization strategy shall be the main strategy with a catch-up/mop-up vaccination to track those who were listed but did not come to the facility for vaccination or vaccination was temporarily deferred due to sickness. DOH hospitals will be alternative sites for immunization.   B. Preparatory activities 4 weeks before the date of immunization   1. Make a line list of target bene\ufb01ciaries   i. List the name of all indigent senior citizens 60 years of age and above living in residential care facilities, including all personnel and staff employed in the above residential care facilities. Use the Master List for Indigent Senior Citizen Recording Form (Annex 1).   ii. List the name and address of all indigent senior citizens 60 years old and above living in communities based on the NHTS- PR of DSWD. Use the Master List for Indigent Senior Citizen Recording Form (Annex 2).   2. Orient the target bene\ufb01ciaries regarding when, where, how, what to do for the upcoming immunization activity.   3. Vaccine Information   A. Type of Vaccine   1. Pneumococcal Polyvalent Vaccine 25 micrograms/0.5 mL (polysaccharide from each capsular type) in 0.5 pre-\ufb01lled syringe. It is an inactivated vaccine containing twenty\u2014three (23) killed pneumococcal strains.   2. In\ufb02uenza Polyvalent Vaccine 0.5 mL vial + pre-\ufb01lled syringe diluent or 0.5 mL suspension in a pro-\ufb01lled syringe or ampule. It contains three (3) killed in\ufb02uenza viruses.   3. The CY 2011 supply of both the pneumococcal and in\ufb02uenza vaccines are in pre-\ufb01lled syringe preparation. However, in future procurements, formulations may change as long as it is in the latest edition of the Philippine National Drug Formulary.   B. Dosage   1. The standard dosage is 0.5 mL Pneumococcal Polyvalent Vaccine and is given once in his/her lifetime. There is no need to re-vaccinate unless he/she has received pneumococcal vaccine in the last 5 years and was &lt 60 years old at the time of vaccination.   2. The standard dosage is 0.5 mL In\ufb02uenza Polyvalent Vaccine and is given every year because in\ufb02uenza viruses change from year to year.   C. Route of Administration   Simultaneous administration of pneumococcal and in\ufb02uenza vaccines is safe and effective during the same immunization schedule but at different sites (Left deltoid muscle \u2014 pneumococcal vaccine intramuscularly; Right deltoid muscle \u2014- in\ufb02uenza vaccine intramuscularly). It is not recommended, however, to mix the 2 vaccines in one (1) syringe before injection.   D. Vaccine Distribution, Storage and Handling   1. Pneumococcal and In\ufb02uenza vaccines procured by the DOH shall be stored at the Research Institute for Tropical Medicine (RITM). An allocation list of vaccines shall be submitted by the National Health and Well-being of Older Persons (HWOP) Program focal person to RITM for delivery and distribution to the different CHDs. The delivery and distribution of these vaccines shall follow the mechanism used by the EPI.   2. The CHD \u2014\u2014 HWOP will prepare the distribution list for the provincial/municipal/city health care centers based on the total estimated indigent senior citizens residing in residential care facilities and in communities.   3. Pneumococcal and in\ufb02uenza vaccines shall be stored at temperatures between +2\u00b0 to +8\u00b0C. Both vaccines should not be allowed to freeze.   In\ufb02uenza vaccines supplied by DOH comes with a \u201cVaccine Vial Monitor\" (VVM). On the other hand, pneumococcal vaccine does not have a VVM. VVM should be regularly read before using the vacCine.   4. Proper labeling of pneumococcal and in\ufb02uenza vaccines shall be done e.g. name of vaccine, expiry date, etc.   5. Safe injection practices shall be strictly observed in the administration and disposal of these vaccines.   E. Disposal of used syringes and needles   1. All vaccination teams shall be provided with a safety collector box (SCB) to dispose the used vial/syringes, cotton and other immunization wastes.   2. All health facilities shall identify areas for the temporary storage of the \ufb01lled\u2014SCB until its \ufb01nal waste disposal as recommended in the EPI.   3. The Sanitary Inspector (SI) shall ensure that such immunization wastes - shall be \ufb01nally disposed in the recommended waste disposal method. -   F. Contraindications   Senior citizens with coronary heart disease, chronic obstructive pulmonary disease, diabetes mellitus, dementia, stroke, malnutrition, chronic liver disease, chronic renal disease, use of immunosuppressive drugs because of cancer can still be given pneumococcal and in\ufb02uenza vaccines.   There are no contraindications for the administration of pneumococcal and in\ufb02uenza vaccines. The only absolute contraindication to in\ufb02uenza vaccine is a known history of allergy to eggs and egg products (egg proteins), chicken feathers, vaccine components, antibiotics such as neomycin or polymyxin, latex gloves, or those currently taking steroids.   For a senior citizen who has fever, signs of acute illness like cough, or any \ufb02u-like illness or other pertinent signs and symptoms of an acute infection at the time of immunization, postponement of immunization is advised until the _ senior citizen has fully recovered from his/her acute illness. Thus, a quick health assessment by the health worker is required before administration of the vaccines.   G. Possible mild and adverse events   The risks from pneumococcal and in\ufb02uenza vaccines are similar to most inactivated vaccines, although not everybody gets them.   Mild Events:  - Injection-site abscess \u2014\u2014 occurrence of a \ufb02uctuant or draining \ufb02uid-\ufb01lled lesion at the site of injection with or without fever.  - Lymphadenitis (includes supporative lymphadenitis) \u2014 occurrence of either: at least one lymph node, 1.5 cm in size (one adult \ufb01nger width) or larger; or a draining sinus over a lymph node.  - Severe local reaction \u2014 redness and/or swelling centered at the site of injection and one or more of the following: swelling beyond the nearest joint; pain, redness and swelling of more than 3 days duration; or requires hospitalization.   These reactions usually begin soon after the immunization, can last from 1 \u2014 2 days to 1 week after immunization and spontaneously disappear without treatment.   The risk of any vaccine causing life threatening allergic reactions to the vaccine is extremely small. Although very rare, any one of the following signs has to be watched out for.   Central Nervous System (CNS) Adverse Events:  - Acute paralysis such as Guillain Barre Syndrome (GBS) \u2014 acute onset of rapidly progressive, ascending, symmetrical \ufb02accid paralysis, without fever at onset of paralysis and with sensory loss.  - Encephalopathy - is an acute onset of major illness temporarily linked with immunization and characterized by any two of the following three conditions: seizures; severe alteration in level of consciousness lasting for 1 day or more; and distinct change in behavior lasting 1 day or more.  - Encephalitis \u2014 is characterized by encephalopathy and signs of cerebral in\ufb02ammation and, in many cases, CSF pleocytosis and/or virus isolation.  - Meningitis \u2014- acute onset of major illness with fever, neck stiffness/positive meningeal signs (Kernig, Brudzinski). Symptoms may be subtle to similar to those of encephalitis.  - Seizures - lasting for several minutes to more than 15 minutes and not accompanied by focal neurological signs or symptoms. Febrile seizures or afebrile seizures. Onset is usually 0 to 2 days.   Other Adverse Events:   - Anaphylactoid Reaction (acute hypersensitivity reaction) \u2014 exaggerated acute reaction, occurring within 2 hours after immunization, characterized by one or more of the following: (1) wheezing and shortness of breath due to bronchospasm; (2) laryngospasm/laryngeal edema; (3) one or more skin manifestations, c.g. hives, facial edema, or generalized edema. '  - Neuritis - dysfunction of nerves supplying the arm/shoulder without other involvement of nervous system. A deep steady, often severe aching pain in the shoulder and upper arm followed by weakness and wasting in arm/shoulder muscles. Sensory loss maybe present, but is less prominent. May present on the same or the opposite site to the injection and sometimes affects both arms. Onset is usually 2 to 28 days.  - Hypotensive-hyporesponsive episode (shock collapse) \u2014\u2014 sudden onset of paleness, decrease level or loss of responsiveness, decrease level or loss of muscle tone (occurring within 24 hours of vaccination). The episode is transient and self\u2014limiting.  - Persistent screaming \u2014 inconsolable continuous crying lasting at least 3 hours accompanied by high pitched screaming. Onset 0 to 24 hours.  - Sepsis \u2014 acute onset of severe generalized illness due to bacterial infection and con\ufb01rmed by positive blood culture.  - Thrombocytopenia \u2014\u2014 platelet count of 100,000 cells or less per mm3. Onset is 15 to 35 days.  - Toxic shock syndrome \u2014 abrupt onset of fever, vomiting and watery\u2014 diarrhea within a few hours of immunization, often leading to death within 24 to 48 hours.   If these adverse events do occur, it is usually within a few minutes to a few hours after the immunization. It is important to seek consult with a doctor, and inform him/her about the reaction, the date and time it happened, and when the vaccination was given. Appropriate medical treatment and supervision are readily available in case of anaphylactic reactions.      4. Calculation of Pneumococcal and In\ufb02uenza Vaccine Needs   Data required:   A. Total number of indigent senior citizens in residential care facilities, including total number of personnel in residential care facilities.   B. Total number of indigent senior citizens residing in all municipalities based on the NHTS-PR of the DSWD. A   The formula is as follows:   Annual vaccine required = A + B MULTIPLIED BY wastage factor (based on vaccine vial preparation).   1. wastage factor of 1.1 or 10% (single dose vaccine vial)  2. wastage factor of 1.25 or 20%(multi-dose vaccine vial)   5. Vaccine Administration A. Vaccines shall cover all indigent senior citizens 60 years old and above living in:   1. residential care facilities for indigent senior citizens  2. in the community based on the NI-ITS-PR of the DSWD   B. The City/Municipal/Provincial Health Of\ufb01cer and CHD shall plan the immunization schedule for the residential care facility and for the community for senior citizens.   C. Vaccinator teams that will be assigned to immunize senior citizens in residential care facilities shall get their vaccine allocation for the day in the CHO/MHO where the above center/residential institution is located. The vaccinator team shall get the vaccines and place it in a standard vaccine carrier prior to the immunization schedule.   D. Remaining unused vaccines after immunization schedule shall be returned to the CHO/MHO at the end of the day and shall be used \ufb01rst in the next immunization.   1. Depending on the vaccine preparation, the following steps are to be undertaken:   a. For any vaccine without VVM   i. Any unopened vaccine vial that needs to be returned back to the health facility for storing shall be marked 'X\u2019 if \ufb01rst time to be taken out. This 'X\u2019 marked vaccine should be allocated for use on the following day.   ii. In case this unopened vaccine vial marked 'X\u2019 was not . again utilized at the end of the day and needs to be returned back to the health facility, marked this vaccine as 'XX\u2019 and shall be used \ufb01rst the following day.   6. Recording and Reporting Forms   A. The following are the recording and reporting forms that shall be used every immunization activity.   1. Master List for Indigent Senior Citizens Recording Form  2. Form 1A: Residential Care Facilities for Senior Citizens Summary Reporting Form  3. Form 1B: City/Municipal Level Summary Reporting Form , Form 2: Provincial Level Summary Reporting Form  5. Form 3: Center for Health Development Summary Reporting Form   B. Master List for Indigent Senior Citizen Recording Form shall be used by the vaccination team to record all vaccines to indigent senior citizens. This Master List for Indigent Senior Citizen Recording Form shall be kept at the facility (CitylMunicipal Health Units and residential care facilities).   C. Form 1A: Residential Care Facilities for Senior Citizen Summary Reporting Form shall be used by all residential care facilities for senior citizens. A member of the vaccination team shall accurately and completely \ufb01ll-up this summary form. The form will be submitted every 1St week of January of the succeeding year to the C/MHO where the said facility is located.   D. Form 1B: City/Municipal Level Summary Reportng Form shall be used by all C/MHOs. A C/MHO staff member shall accurately and completely \ufb01ll-up this summary form. This form will be submitted every 2nd week of January of the succeeding year to the PHO, together with the immunization coverage of the city/municipality using the formula below.   Immunization Coverage of Municipality 'X\u2019 =   1. Number of senior citizens given pneumococcal vaccine X 100 Number of target senior citizens   2. Number of senior citizens given in\ufb02uenza vaccine X 100 Number of target senior citizens   E. Form 2: Provincial Level Summary Reporting Form shall be used by all PHOs. A PHO staff member shall accurately and completely \ufb01ll-up this summary form. This form will be submitted every 3rd week of January of the succeeding year to the CHD together with immunization coverage of the province.   Immunization Coverage of Province 'X\u2019 =  1. (Number of senior citizens given pneumococcal vaccine X 100)/ (Number of target senior citizens)  2. (Number of senior citizens given in\ufb02uenza vaccine X 100)/ Number of target senior citizens   F. Form 3: Center for Health Development Summary Reporting Form shall be used by all CHDs. The CHD shall collate all the. reports from the provinces and accomplish the CHD Summary Report Form. This form will be submitted every 4th week of January of the succeeding yearto the National Center for Disease Prevention and Control together with the regional immunization coverage and their provincial immunization coverage.   7. Surveillance of Events following Immunization (AEFI)   A. The pneumococcal and in\ufb02uenza vaccines have been in use worldwide for more than 20 years and outcomes of trials have suggested that both pneumococcal and in\ufb02uenza vaccines are safe and immunogenic vaccines. However, a vaccine, like any medicine, could cause an adverse event, such as a severe allergic reaction but the risk of any vaccine causing serious harm, or death, is extremely small.   B. All minor and serious adverse events following immunization should be properly documented (using the AEFI form). '   C. Report both minor and serious adverse events following immunization using the protocol of AO No. 2010\u20140017: Guidelines in Surveillance and Response to Adverse Events Following Immunization.   D. Appropriate medical intervention of any AEFI should be instituted immediately using protocol of AO No. 2010\u20140017: Guidelines in Surveillance and Response to AEFI.   VII. IMPLEMENTING MECHANISMS   A. Roles and Responsibilities   1. Department of Health   a. Health and Well-being of Older Persons Program (HWOP) focal person, National Center for Disease Prevention and Control   1. Coordinates with the EPI Manager in the development of immunization policies and guidelines.   2. Coordinates and supervises the overall immunization activity.   3. Coordinates with NBC for any reported AEFI cases.   4. Prepares the vaccine allocation list.   5. Ensures timely distribution of pneumococcal and in\ufb02uenza vaccines to the CHDs.   6. Sets-up a speakers bureau. .   7. Orients Regional HWOP coordinators and other stakeholders on the immunization activity.   8. Conducts monitoring visits, in coordination with the regional HWOP to the LGUs. -   9. Analyzes and feedbacks the accomplishment reports of the immunization activity.   10. Reproduce and distribute Master List of Indigent Senior Citizen Recording Form by CY 2012.   b. National Center for Health Promotion   1. Develop and implement a communication plan in relation to the immunization activities for the indigent senior citizens in close coordination with NCDPC.   2. Develop and implement the national AEFI risk communication plan, including myths, misconceptions and rumors.   3. Develop prototype 1ca\ufb02ets/brochures/messages/advisories, Frequently Asked Questions (FAQs) targeting different audiences in coordination with NCDPC.   4. Assist the sub-national levels to develop and implement their respective risk communication plan, including monitoring and evaluation tools.   5. Monitor and evaluate implementation of communication plan at all levels and provide feedback to all stakeholders.   c. National Epidemiology Center   1. Oversee the design and implementation of AEFI surveillance.   2. Assist NCDPC in the development of post-vaccination monitoring operational plan and recording form for minor events.   3. Provide AEFI surveillance information for policy and program use.   4. Coordinate AEFI surveillance activities with FDA both at the national and regional levels.   5. Provide quality control of the AEFI reporting system.   d. Centers for Health Development   1. Regional HWOP, in coordination with the EPI, RESU and HEPO regional coordinators and other stakeholders, shall:   a Develop an immunization plan.  b. Conduct training of health workers.  c. Ensure the timely distribution of vaccines to the Provincial/City Health Of\ufb01ce and to the \ufb01nal immunization points (residential care facilities for indigent senior citizens and RHU).  d. Conduct supervisory and monitoring visits to the LGUs.  e. Ensure timely submission of accomplishment reports to the Central Of\ufb01ce.  f. Reproduce and distribute Master List for Indigent Senior Citizen Recording Form for CY 2011.  g. Reproduce and distribute Summary Reportng Forms 1A, 18, 2 and 3.  h. Translate and print lea\ufb02ets/key messages/Frequently Asked Questions (FAQs) in the local language for dissemination.  i. Coordinate with the Regional DSWD and other non- governmental senior citizens\u2019 organizations on the implementation of the immunization plan.  j. Document AEFI surveillance and response activities.  k. Submit report of AEFI cases and minor events following immunization.   e. DOH Hospitals   1. Clinically manage and report all AEFI cases.  2. Provide AEFI investigation team with medical records of immunization cases.   2. Local Government Unit (Province/CityMunicipality)   a. Submit annual updated list of senior citizen residents in residential care facilities.  b. Conduct micro-planning and orientation of health workers.  c. Ensure that the vaccines are given to the targeted eligible population - indigent senior citizens.  d. Implement immunization activity.  e. Conduct inventory and monitoring of vaccines.  f. Allocate'funds for the procurement of cotton and other supplies.  g. Provide funds for the traveling and incidental expenses for the health workers during the conduct of immunization campaign.  h. Ensure timely submission of accomplishment reports from the city/municipality to the province and the CHD.  i. Mobilize human resources during the conduct of the activity.  j. Report and conduct initial AEFI investigation.   3. Partner Agencies (Department of Social Welfare and Development)   a. Submit annual updated list of indigent senior citizens disaggregated according to age breakdown (60-69 years old; 70-79 years old; 80-89 years old and 90- 99 years old), including the name and address based on the NHTS\u2014PR to DOH.  b. Submit annual updated list of senior citizen residents in DSWD-managed residential institutions.  c. Support immunization efforts of the DOH.   4. Private Sectors/Professional Organizations and Societies (Philippine College of Geriatric Medicine, National Center for Geriatric Health, etc)   a. Support and assist immunization efforts of the DOH (ex. vaccination teams).  b. Provide technical assistance.  c. Member of speaker\u2019s bureau.   5. Senior Citizens\u2019 Organizations   a. Provide assistance and support to immunization effets of DOH by issuing memorandum to its members.  b. Collaborate with the local health of\ufb01ces in validating the NHTS-PR list of indigent senior citizens.  c. Disseminate information and advocacy.   VIII. EFFECTIVITY   The order shall take effect immediately.  ", " I. RATIONALE   The 1987'Constitution of: the Philippines provides that the State shall adopt an integrated and comprehensive approach to health development, which shall endeavor to make essential goods, health and other social services available to all the people at affordablevcost (Section 11, Article XIII).   The Local Government Units ('LGUs) are mandated under the Local Government Code of 1991 to implement various health programs, projects and initiatives to ensure that people will be provided with basic health services.   Currently, the DOH is undergoing the, Health Sector Reform Agenda (HSRA), which is implemented by a \"system called FOURmuI-a One (F1) for Health, by strengthening the Half\u2014Priced Medicines. Program, thereby instituting a project that will ensure accessibility and availability of affordable quality essential drugs and medicines to DOH and LGU hospitals. FOURmuIa One (F1) for Health is directed towards achieving better health outcomes, more responsive health system and more equitable healthcare financing.   The National Drug Policy Pillars call for peeple empowerment, quality assurance, rational use, self-reliance and tailored procurement in ensuring access to essential drugs. In ensuring access to essential medicines, it has become imperative to couple it with rational use considering its cost \"effective implications in the long term. The World Health Organization (WHO), 1985, defines rational drug use as patients receiving medications appropriate to their clinical needs, in doses that meet their oWn individual requirements, fer an adequate period of time, and at the lowest cost tothem and to their community.   PITC Pharma, Inc. (PPI) was transferred to the DOH, pursuant to the Office of the Government Corporate Counsel Certification dated 23 July 2007, stating that it is a government-owned and controlled corporation (GOCC), and by virtue of Executive Order No. 649-A, Section 2-A, designating the Secretary of Health as'Ex-Officio Chairman thereof.   Accordingly, the DOH desires to undertake a project that would ensure access to dings which are packaged within an affordability parameter of 100.00 Philippine peso or lower, which shall be piloted in 100 hospitals. (DOH and selected LGUs). This envisaged Project shall be aptly called and identified as P100 Project.   II. SCOPE AND COVERAGE   This Order is issued to provide systems and procedures for the P100 Project foir DOH \u2014 NDP-PMU 50, PITC Pharma, lnc., local government executives and participating hospitals (DOH and LGU hospitals\ufb01or an increased access to low-cost quality: drugs for the benefit of the Filipino people, especially the marginalized sector.   III. OBJECTIVES   1. The paramount goal of this Project is to increase patients\u2019 access to low-cost quality drugs, taking into consideration rational drug use, economies of scale in procurement and a unified pricing scheme.  2. To identify source of funds for the project and procedures for funds management.   IV. DEFINITION or TERMS   1. Department of Health (DOH) \u2014 is a National Government Agency organized and existing under and by virtue of the laws of the Philippines with principal offices located at the San Lazaro Compound, Rizal Avenue, Sta. Cruz hereinafter referred to as \u201cDOH.\"   2. FOURmula ONE for Health (F1) -\u2014- is the implementation framework for Health. Sector Referms in the Philippines for the medium term covering 2005-2010, designed to implement critical health interventions as a single package, backed by effective management infrastructure and financing arrangements.   3. National Drug Policy-Pharmaceutical Management Unit (NDP- PMU 50) \u2014- is a unit created under the Department of Health in response to the pledge of Her Excellency President Gloria Macapagal-Arroyo dunng the 12th Congress State of the Nation Address (SONA) held on 23 July 2001 to identify strategies, operational activities and targets to attain the said pledge to lower the prices of drugs and medicines frequently bought by the poor by 50%.  4. Bureau of Food and Drugs (BFAD) - is a world-class regulatory agency under the DOH that ensures the safety, efficacy purity and quality of processed foods drugs, diagnostic reagents medical devices, cosmetics and hazardous substances being made available  to the public pursuant to Republic Act No 3720; as amended, known as the Food, Drug, Devices and Cosmetic Act.   5. PITC Pharma, Inc. (PPI) \u2014- is a government-owned and controlled  corporation (GOCC) pursuant to the Office of the Government Corporate Counsel Certification dated 23 July 2007 and is transferred to the DOH by virtue of Executive Order No. 649- A dated 10 April 2008   6. Philippine Health Insurance Corporation (PHIC) \u2014 is a government corporation established pursuant to. Republic Act No. 7825 instituting National Health Insurance Program for all Filipinos.   7. Philippine National Drug Formulary (PNDF), Volume l, current edition - is the essential drugs list (EDL) for the Philippines of proven efficacy, safety and quality at affordable cost prepared by experts and specialists mandated by Republic Act No 6675 known as the Generics Act of 1988   8. Therapeutics Committee (TC) \u2014 is the highest professional body of the hospitals responsible on drug related issues such as drug evaluation, selection, rational use of drugs- and other drug related matters.  9. License to Operate. (LTO) \u2014 is a grant of permission to undertake a trade or carry out a buSiness activity, subject to regulation or supervision by the licensing authority, the Bureau of Food and Drugs.   10. Certificate of Product Registration (CPR) - is the certificate issued by the Bureau of Food and Drugs for the purpose of marketing or free distribution of a product after evaluation of its safety, efficacy and quality.   11. Current Good Manufacturing Practices (cGMP) - it is the current system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use. It is thus concerned with both manufacturing and quality control process and procedures.  12. Local Government Unit (LGU) \u2014 refers to the territorial and political Subdivision of the Republic of the, Philippines as defined in the Local Government Code.   13. Trust Fund - is an established account for the proceeds for the sales of drugs and medicines procured through the DOH-DTl Parallel Importation Scheme which have been remitted by the participating hospitals for the purpose of re\u2014ordering new stocks and recorded as trust liability in the DOH books of account and deposited with the National Treasury in accordance with Executive Order No. 338 s. 1996.  V. IMPLEMENTING GUIDELINES   1. The implementation of P100 Project shall be in accordance with the strategic thrust of- the Health Sector Reform Agenda and shall consider the specified spectrum of reforms. FOURmula One (F1) for Health in its planning and execution parameters. Instituting the project will ensure:    1.1 Decreased health ex'penditures for essential erogs through support programs for sustainability   1.2 Responsive essential drug; list and a dynamic Philippine National Drug Form-ulary System ('PNDFS), incentives and attainment of the highest degree of regulations such as PhilHealth reimbursement and Registration/Good Manufacturing Practice ,(GMP) benefits for affordable, quality essential drugs, quality assurance and ethical frameworks.  1.3 Existence of special 'botika\u2019s, hospital services, expanded benefit packages for PhilH-ealth, and rational prescribing, dispensing and use   1.4 Existence of strengthened Therapeutics Committee/PNDFS tailored procurement, improved effective logistics management, Essential Drug Price Monitoring System (\u2019E'DPMS) and prising policies, Medicines Transparency Alliance (MeTA), and legislative measures, policy and strategic planning   2. PlTC Pharma, inc. (PPI), identified partner procurement agency shall be responsible in ensuring the procvurement, supply, and/or distribution of quality and affordable essential drugs authorized by the DOH to be included in the P100 drug packages to the participating DOH and LGU hospitals to be sold to patients and the generai public. Memoranda of Agreement between the PPI and DOH, and among DOH, PPI and Local Government Executive on roles and responsibilities shall be issued.   3. The basis for determining quantities, of drug packages to be procured shall be the. Requisition and Issue Slip (RIS) submitted by the participating hospitals, as approved by the DOH Project Executive Officer.   4. Drugs and medicines to be sold at the participating DOH and LGU hospitals should be in accordance with the Essential Drugs List (EDL), Philippine National Drug Formulary (PNDF) Volume I, current edition.   5. The 20% discount on drugs for Senior Citizens and persons with disabilities (PWD) is already included in the selling price offered by participating hospitals under the P100 Project. Hence, Senior Citizens and PWDs are no longer entitled to the above discount.   6. A DOH Memorandum shall be issued to effect the limitations on the requirements on prescribing and dispensing of P100 drug packages.  7. The P100 drug packages are selected and evaluated based on but not limited to the following:   7.1 Leading morbidity and mortality   7.2 Most prescribed and fast-moving drugs   7.3 Clinical treatment gUidelines   7.4 Cost-effectiveness of a drug package considering the savings, which is advantageous to the patients.   8. The participating hospitals must either be:    8.1 A DOH hospital accredited by the Philippine Health Insurance Corporation (P'HIC') with functional Therapeutics Committees (TCs); or    8.2 LGU hospitals accredited by the PHlC with hospital pharmacy/pharmacist(s) and functional TCs.     8.2.1 For sustainability, it is recommended that an approved Ordinance by the Sangguniang Panlalawigan for the establishment of a Revolving Fund for drugs and medicines for all selected pilot LGU hospitals; shall be in place to institute control measures in stock operations and resale.   9. PPI shall be guided with the following basic reqmrements inter alia as provided by relevant rules and regulations in the procurement supply and distribution of essential drugs under the P100 Project:    9.1 The essential drugs: must be covered with valid Bureau of Food - and Drugs (BFAD) certificate of product registration (CPR);    9.2 The principal suppliers must have valid License to Operate (LTD) and must have Certificate of current Good Manufacturing Practice (CGMP);    9.3 The minimum information requirement for the P100 package shall be. in accordance with the approved design by the DOH and shall be conveyed to PP'i through a Memorandum of Agreement (MOA).    9.4 The shelf-life of P100 drug packages upon delivery to. the participating heapitais should not be less than eighteen (18) months for solid dosage forms and sixteen (16\u2019) months for liquid dosage forms, to be subjected for inspection by the inspection committee of the hospital concerned.    9.5 The P100 drug packages inspected at. PITC Pharma, Inc. warehouse Shauld be delivered to recipient; hospitals within two (2) months from the date of release of the BFAD Test Analysis. In case the remaining shelf-life of the drug package/s delivered tothe recipient hospital is less than 18 months for solid.dosage forms and 16 months for liquid dosage forms, P'Pl shall include a certificate as to its replacement if not consumed six (6) months prior to the expiry date.    9.6 The selling price will be P100 or lower per drug package (with a markwup inclusive therein) to be sold at DOH and LGU hospitals.    9.7 The essential medicines under the P100 Project that shall be procured and distributed through the PP! shall be financed by the DOH subject to. the usual accounting and auditing rules and regulations, and, other administrative issuances relating to procurement \u00abof medicines.   10. The products under the P100 Project shall be distinctly packaged and shall be granted special Permits by the BFAD for purposes of promotion and advocacy. The packaging materials to be used shall be submitted to BFAD for the issuance of such special Permit.   VI. FUND MANAGEMENT   A. Fund Management Conditions for DOH and LGU Hospitals.   The following fund management conditions shall be observed by participating DOH and LGU Hospitals covered in this Order:   1. The participating hospitals shall be authorized to earn income as result of the National Drug Policy-Pharma 50 Project Management  Unit NDP-PMU 50) with mark-up that will be added to the acquisition cost procured by PPI.   2. The sales minus the mark\u2014up of participating hospitals shall be used solely for the purpose of re\u2014ordering P100 drug packages based on their purchase requests.   3. To ensure sustainability of this project, ten percent (10%) of the totai profit earned by the hospital shall serve as infusion fund for the reordering of P100 drug packages and the rest shall be utilized for upgrading/repair/rehabilitation of hospital pharmaceutical facilities and equipment.   4. Total acquisition cost from the sales of drugs and medicines plus 10% of the profit covered by this Order shall be remitted in checks payable to the Department of Health\u2014GMA 50, relative to the establishment of the trust fund approved by the Department of Budget and Management (DEM) for the eventual re-ordering to PPI of drugs and medicines based on their purchase requests.   5. Remittances from the participating hospitals shall be recorded as trust fund and shall be deposited to any Authorized Government DepositaryBank (AGDB).   6. Sales of P100 drug packages of the participating hospitals shall be recorded Under separate subsidiary ledger to be treated as Trust Liability in the DOH books of account and deposited to the Bureau of Treasury per EC). No. 1996-338.  B. Funds for P100 Project/Transfer of Funds   1. Funds for the P100 project shall be taken from the DOH Appropriation for the operation of the National Pharmaceutical Policy Development under A.III.a.5,RA. No. 9498.   2. Specific guidelines: and procedures shall be issued relative to but not limited to the processing of orders for delivery of drugs procured to participating 100 DOH and pilot LGU hospitals and payment procedures, including packaging, advocacy, inventory, conduct of survey to assess the project, and others.   3. Upon approval of the policy on P100 Project and the MOA between  the DOH and PPI; DOH\u2014Finance Service will immediately transfer funds based on available allotment and Notice of Cash Allocation to PPI subject to usual accounting rules and regulations.   Liquidation of the previous fund transfer is a requirement to be submitted to the Material Management Division (MMD) for review/validation of deliveries/issuances of drugs and medicines to recipient hospitals as follows:   4.1 Certificates of Product Registration (CPRs)  4.2 Certified True Copy of the BFAD Certificates of Analysis  4.3 Sales Invoice (SI)  4.4 Requisition and Issue Slip (RIS) 4.5 Invoice Receipt of Property (IRP)  4.6 Delivery Receipt  4.7 Request for Inspection and Acceptance  4.8 inspection and Acceptance Report  4.9 BFAD Test Analysis  4.10 Batch Certification for antibiotics   Recommendations based on the above shall be endorsed by MMD to DOH\u2014 Finance Service for approval to effect another transfer of funds.   VII. REPORTING   The following reporting conditions and arrangements shall be observed for the purpose of this project:   1. Under the direct supervision and control bythe Office of the Health Regulation Cluster, the NDP-PMU 50, is the operational unit that shall provide the overall direction and administration of the project.   2. All communications received by the DOH Central Office and for appropnate actions relating to P100 Project shall be referred to and shall be addressed to the NDP-PMU 5O   3. In addition to the usual accountability reports, based on budgeting/accounting and auditing rules and regulations, the participating hospitals covered by this Order shall prepare a quarterly report of sales and inventory (Form A) The participating DOH hospitals shall submit a report of sales and inventory five (5 ) days after the preceding month to NDP PMU 5O DOH Central Office including the status/Issues eg. Adverse Drug Event etc./progress of this undertaking. The LGU participating hospitals shall submit the same report five (5) days after the preceding month to their respective provincial chief executives, in turn submitted to CHD concerned. CHDs shall endorse said report to NDP-PMU 50.   4. Liquidation documents as stated above (VI.B.4) shall be submitted to the MMD by PPI for review/validation of deliveries/issuances of drugs and medcines to participating hospitals. MMD shall then endorse to the DOH\u2014Finance Service for approval, copy fUrnished NDP PMU 50.   VIII. MONITORING AND EVALUATION   1. The NDP\u2014PMU 50 Office, and in Collaboration with and direct support of the CHDs. shall monitor the implementation of the project based on a prepared monitoring tool.   The NDP\u2014PMU 50 shall evaluate the monitoring reports as the basis for addressing issues and concerns encountered thereto for further improvement in the operations of the Project.   IX. SEPARABEILITY CLAUSE   If any provtsion in this Guidelines or application of such provision to any circumstances is held invalid, the remainder of these Guidelines shall thereby not be affected.   X. REPEALING CLAUSE   All previous Orders inconsistent in part or in whole to this Administrative order are hereby rescinded or amended accordingly.   XI. EFFECTIVITY   This Order takes effect immediately.  ", " I. RATIONALE   Pursuant to Republic Act 9502, otherwise known as the Universally Accessible Quality and Cheaper Medicines Act of 2008 mandating the Department-of Health (DOH) to increase access to essential medicines for the country\u2019s priority diseases, the National Center for Pharmaceutical Access and Management UNCPAM) of the Department of Health is now pursuing a free medicines access program for vulnerable and special populations affected by diseases which cause a signi\ufb01cant health and economic burden 1n the country.   Cancer is'now the third 1e ading cause of mortality in the Philippines claiming thousands of lives every year. It is considered a catastrophic disease owing to its impact . to health, productivity and overall quality of life and the high cost of therapy that causes impoverishment of patients and their families. Based on the latest data from the Philippine Cancer Registry, breast cancer is now the top site of malignancy affecting mostly women in their most productive years of life. Thus far, at least 10,000 breast cancer cases are being reported annually in the Philippines with a mortality rate of about 40% (Philippine Cancer Facts and Statistics 2010).   Thus, to help improve the cure and survival rates of cancer patients and alleviate their \ufb01nancial hardships in paying for costly cancer treatment, DOH will target the most cost-effective and commonly used adjuvant chemotherapy for Stage I-llla breast cancer in women. The free medicines access program for Cancer is not only meant to provide ready access to anti-cancer drugs but to promote early\u2014screening and cancer awareness among Filipinos emphasizing that detecting, treating and managing cancer in the early stages improves the overall prognosis and survival rates for patients.   II. OBJECTIVES: This Administrative Issuance sets the guidelines that shall:   1. Provide access to free adjuvant chemotherapy for poor women with early stage, operable breast cancer;   2. Ensure effective implementation of the Medicines Access Program for early stage breast cancer.   3. Provide system and procedures for the DOH Free Medicines Access Program for Early Stage Breast Cancer.   4. Identify the source of fund for the Program and procedures for funds management.   III. SCOPE AND COVERAGE   This issuance shall cover all concerned of\ufb01ces of this Department particularly the NCPAM and NCDPC, participating government hospitals, PPI and any pharmaceutical \ufb01rm w hich shall be contracted to source and procure t he cancer medicines to be included in this program.   IV. DEFINITION OF TERMS   1. Department of Health (DOH) \u2014 is a National Government Agency organized and existing under and by virtue of the laws of the Philippines, which ensures accessibility and quality of health care in line with the administration 5 thrust to prioritize delivery of services to the masses and improve the quality of life of all Filipinos, especially the poor   2. National Center for Pharmaceutical Access and Management (NCPAM) \u2014- is the center created under the Of\ufb01ce of the Secretary of Health, based on A0 No. 2010-0005 dated 08 January 2010, formerly known as the National Drug Policy \u2014 Pharmaceutical Management Unit 50 (NDPPMU 50), in response to the need for an institutional of\ufb01ce to realize the objectives of Republic Act No. 9502, otherwise known as the \u201cUniversally Accessible Cheaper and Quality Medicines Act of 2008\".   3. Food and Drugs Administration (FDA) \u2014 formerly known as the Bureau of Food and Drugs, this of\ufb01ce was strengthened by Republic Act No. 9711, known as the \u201cFood and Drug Administration Act of 2009\".   4. PITC Pharma, Inc. (PPI) \u2014 is a government-owned and controlled corporation (GOCC) created pursuant to the Of\ufb01ce of the Government Corporate Counsel Certi\ufb01cation dated 23 July 2007 and has been transferred to the DOH by virtue of Executive Order No. 649-A, dated 10 April 2008.   5. Pharmaceutical Firm \u2014 any company duly organized and existing on identi\ufb01ed partner of the DOH that has agreed and committed to supply and deliver to DOH hospitals products of reduced and affordable acquisition cost through a mechanism such as regular public bidding.   6. Philippine National Drug Formulary (PNDF), Volume 1, current edition \u2014 is a list of essential drugs prepared and periodically updated by the DOH on the basis of health conditions in the Philippines as well as of international accepted criteria. It shall consist of a core and complementary list.   7. Therapeutics Committee (TC) \u2014 is the highest professional body of the hospitals responsible for drug related issues such as drug evaluation, selection, rational use of drugs and other drug related matters.   8. License to Operate (LTO) \u2014 is a document that grants permission to its holder to undertake a trade or carry out a business activity, subject to regulation or supervision by licensing authorities such as the Food and Drug Administration.   9. Certi\ufb01cate of Product Registration (CPR) \u2014 is the certi\ufb01cate issued by FDA for the purpose of allowing the. marketing or free distribution of a product that has been evaluated for its safety, ef\ufb01cacy and quality.   10. Current Good Manufacturing Practices (cGMP) \u2014 is the current system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use. It is concerned with both manufacturing and quality control process and procedures.   11. Five-,year Survival Rate \u2014 is the percentage of patients enrolled in the program who are alive \ufb01ve years after diagnosis or treatment   12. Disease-Free Survival \u2014 is the length of time after treatment during which a patient survives with no sign of the disease   13. HER-2 - is a protein involved in normal cell growth. It is found on some types of cancer cells, including breast and ovarian. It is a type of receptor tyrosine kinase. Also called c\u2014erbB-2, human EGF receptor 2, and human epidermal growth factor receptor 2.   14. Adverse Drug Events (ADE) \u2014 is a unexpected and unintended injury that happens from the use of a drug. This may be mild, moderate, or severe. It may include medical problems resulting from overdoses, lack of ef\ufb01cacy or misuse or abuse of the medicine.   V. IMPLEMENTING GUIDELINES   1. The implementation of this Program shall be in accordance .with the strategic thrust of the Aquino Health Agenda (AHA) was launched to improve, streamline and scale up reform interventions espoused in the HSRA and implemented under F1. This approach shall strengthen the National Health Insurance Program '   2. The DOH-NCPAM shall ensure the sustainability of funds, administrative and technical support which shall guarantee its future development and expansion to bene\ufb01t more cancer patients in the long term.   3. The DOH-NCPAM shall contract the services and expertise of the Philippine Cancer Society, Inc. (PCSI) in managing the Patient Navigator Program which shall be the implementing mechanism that will ensure timely and appropriate access to medicines and other services for cancer patients. The PCS shall be responsible for the a) hiring and training of patient navigators, _b) monitoring of patients in terms of treatment response and occurrence of adverse drug experiences, 3) research, 4) coordination with hospitals and health providers, 5) assistance to patients and their families to overcome healthcare barriers and 6) the provision of psychosocial support.   4. This Program shall be included in the Annual Procurement Plan (APP) of the DOH-NCPAM for medicines as well as the cost of administration, monitoring and research and development of the program.   5. Government hospitals and cancer centers with adequate expertise, equipment, . support facilities and experience in treating breast cancer and having a multidisciplinary team of cancer specialists shall be identi\ufb01ed as pilot sites /access centers for this-program. (Annex A)   6. The identi\ufb01ed partner hospital institutions shall agree on the use of standard treatment protocols for early stage breast cancer based on their experience on the use of such protocols, the ef\ufb01ciency of the treatment and the relative safety pro\ufb01le of the treatment regimens to Filipino patients. The use of the standard treatment protocols in these partner hospital institutions will be implemented using strict multi-disciplinary team approach to breast cancer management. (Annex B)   7. An Experts Committee shall be created composed of health providers and experts from the pilot institutions as well as representatives frOm the Philippine Cancer Society, Inc. (PCS'I), the Philippine College of Surgeons (PCS), the Philippine Society for Medical Oncologists (PSMO), the Philippine Society of PathologiSts (PSP), the DOH-NCPAM, the DOH National Center for Disease Prevention and Control (NCDPC) and the Food and Drug Administration (FDA).   The Experts Committee shall be responsible for crafting the clinical practice - guidelines for early stage breast cancer in the pilot hospitals and the review and revision of such protocol. The Experts Committee shall also provide its expert advice with regard to the management of patients included in the program.   8. The basis for determining quantities of Anti-cancer Medicines to be procured annually by DOH shall be the Requisition and Issue Slip (RIS) submitted by the identi\ufb01ed participating government hospitals to NCPAM.   The said hospitals shall appropriately forecast and plan the targeted number of patients to be served annually and the quantity of medicines to be procured based on current local morbidity data on breast cancer and ALL.   9. The procurement of chemotherapeutic drugs shall be in accordance with the prescribed or accepted/adopted common treatment protocols approved by the DOH and are listed in the Essential'Medicines List (EML) or Philippine National Drug Formulary (PNDF) Volume 1, current edition   10. PITC Pharma, Inc. (PPI), the DOH partner procurement agency or any pharmaceutical \ufb01rm that has complied with the procurement requirements set for the anticancer drugs shall be responsible in ensuring the continuous and adequate supply and distribution of the drugs to the participating DOH hospitals and other government cancer centers.   11. The DOH- NCPAM shall provide funds to the National Kidney and Transplant Institute (N KTI) as the National Reference Laboratory (NRL) for Hematology, Immunohematology, Immunopathology, Automated Urinalysis and diseases, for the purpose of Estrogen and Progesterone receptor (ER/PR) testing for all eligible patients.   12. All participating hospitals shall send the specimen for Estrogen and progesterone receptor (ER/PR) testing to NKTI, to determine the most appropriate treatment for patients included in the program.   13. PPI and/er any pharmaceutical \ufb01rm or its authoriZed distributor shall commit and agree to forward stocks to the hospital pharmacy and make the anticancer drugs available to the attending oncologists of the patients in time for the scheduled chemotherapy, where necessary. Hospital pharmacy shall ensure the observance of strict storage requirements for the anticancer medicines. (Annex C)   14. The DOH\u2014NCPAM through PPI shall assist the participating hospitals in ensuring the safe storage and handling of medicines included in the program particularly ' chemotherapeutic drugs with special storage requirements through arranging the temporary provisions of biorefs with the suppliers (i.e, for agents requiring refrigeration between 2-8 \u00b0C) and/or orientation of hospital staff on the safe preparation and administration of chemotherapeutic drugs t no cost to the hospital.   15. This Program shall offer eligible cancer patients in participating hospital access to the full chemotherapy course free of charge. Other routine care costs (i.e. surgery for breast cancer, consultations, hospitals stays, transfusions, lab tests, treatment of infections) not covered by the said program shall be shouldered by the patient with support from PhilHealth (for sponsored members) and/or referred to foundations and other funding institutions by the hospital\u2019s public assistance unit.   16. No medicines procured under this Program shall be resold to patients, to the hospital pharmacy or other drug establishments.   17. Government of\ufb01cials and employees violating the provisions of this Order shall be administratively sanctioned in accordance with the existing Civil Service laws, rules and regulations.   VI. PATIENT ELIGIBILITY, ENROLMENT, MONITORING AND FOLLOW \u2014 UP   This Program will Offer free treatment to early stage breast cancer patients (Stage I-IIIa) in identi\ufb01ed government hospitals based on a set of medical and social eligibility criteria. Priority groups shall be indigent patients with limited \ufb01nancial resources and patients enrolled in the PhilHealth Sponsored Program. (Annex D)   a. A fully eligible cancer patient shall be referred by his/her surgeon/oncologist to the Patient Navigator Program managed by the PCSI as the duly recognized private nongovernment organization with the expertise on cancer treatment and management. The candidate patient and his/her attending physician must accomplish and submitthe' following documents to receive the continuous free supply of anticancer medicines (Annex G, H, I, I): '   a Patient Consent Form  b. Patient Enrolment and Information Form  c. Medical. Follow-up Form (i.e. to be accomplished by the attending physician monthly or every after treatment/follow-up)  d. Patient Closure Form (i.e. in the event that treatment is terminated due to serious adverse event, voluntary withdrawal of the patient, death or any other reason speci\ufb01ed)   The DOH-NCPAM shall receive the Certi\ufb01ed True Copies of the forms biannually with a summary Form (Annex L) signed by the MAP Coordinator detailing the total numbers of bene\ufb01ciaries, treatment outcomes, drop\u2014out rates and the occurrence Of adverse drug experiences.   2. The Hospital Director/Chief Of Hospital of the participating Hospital shall assign MAP Program coordinator/s for the said DOH-PCSI program, responsible for the overall management of the program, the maintenance of the registry of cancer patients enrolled thereto, monitoring of the stock levels Of anticancer drugs as well as their storage conditions and coordination with DOH/PCSI for all issues and concerns relevant to the Program.   3. The PCSI and the participating hospitals shall monitor the treatment outcomes of patients enrolled in the free medicines access program in terms of ef\ufb01cacy of treatment , the occurrence Of adverse drug events/experiences and disease-free survival post-treatment. The recipient hospital shall submit reports (Annex F, G, H and I) to the PCSI which shall in turn provide quarterly updates to the DOH-NCPAM on the status of implementation of the program and other concerns/issues relevant to the Program.   4. All suspected adverse drug experiences (ADEs) following administration of a drug' under the Program shall be reported to the hospital drug therapeutics committee and reported to FDA for prOper documentation and evaluation using the standard FDA ADE Reporting Form. ADEs shall also be re\ufb02ected in the patient monitoring form and submitted to the PCSI as the implementation and .monitoring arm of the Patient Navigator Program. (Annex M) .   5. Quarter-Ending-Month Report of Patient Utilization (Annex K) duly accomplished by the chief pharmacist shall be submitted to the DOH-- NCPAM.   6. The DOH-NCPAM in partnership with the participating cancer centers, academic institutions and DOH hospitals shall conduct continuous research, assessment and monitoring of the Medicines Access Program with regard to treatment outcomes, safety and toxicity issues on the regimens used. The  NCPAM may use the'information collected to generate high-quality research that will contribute to the improvement of cancer care and treatment in the country. -   VII. FUND MANAGEMENT   A. Fund Management Conditions for DOH HoSpitals   The following fund management conditions shall be Observed by participating DOH Hospitals covered by this Order:   1. Under this Program, anti-cancer drugs which DOH procured shall be given to DOH hospitals in kind and without cost. These drugs shall then be available to eligible patients.   2. The initial source of \ufb01nd for the said program is P/A/P A.III.a.5 \u2014\u2014 National Pharmaceutical Policy Development including provision of drugs and medicines, medical and dental supplies to make affordable quality drugs available, Republic Act NO. 9524, the General Appropriations Act.   VIII. ROLES AND RESPONSIBILITIES   A. National Center for Pharmaceutical Access and Management (NCPAM):   1. Serve as the principal agency in the implementation of this program \u201cEARLY STAGE BREAST CANCER MEDICINES ACCESS PROGRAM (Stage I\u2014 IIIa)\".   2. NCPAM shall Obligate funds to \ufb01nance the Purchase order(s) based on the available allotment and Notice of Cash Allocation to PPI subject to the usual accounting and auditing rules and regulations.   3. Allow eligible breast cancer patients to access the free drugs and medicines under this endeavor which are listed in the PNDF Volume 1, current edition.   4. Ensure that PPI, as the procurement agency of the NCPAM, shall supply/distribute anti-cancer drugs directly to hospitals for use according to the multi-disciplinary team approach to breast cancer management, for the treatment of eligible breast cancer patients.   5. Require all participating hospitals tO submit report on compliance/non- compliance with the multi-disciplinary team approach to breast cancer management guidelines and recommendations if any, embodied in this Order for appropriate action.   6. Approve the list Of identi\ufb01ed and quali\ufb01ed breast cancer patients recommended by the participating hospitals.   7. Coordinate inspection by the DOH inspection team upon delivery Of the breast cancer drugs and medicines and shall be distributed by PPI to participating hospitals within-its jurisdiction not more than two (2) months upon delivery.   8. Together with PCSI, initiate a strategic communications and awareness campaign on breast cancer that will ensure that the program gains will generate a momentous support and create long lasting, sustainable change in the f1 ght against breast cancer.   B. PHILIPPINE CANCER SOCIETY (PCS)   1. Ensure implementation of the guidelines and activities set forth in the Patient Navigation Program by the Participating Hospitals and nearby communities.   2. Recruit and train Patient Navigators to be assigned in the Participating A Hospitals/Cancer Centers.   3. Network with and orient the Project Coordinators and concern staff of the Participating Hospitals/Cancer Centers on the Patient Navigator Program.   4. Manage the Navigation Program schemes and activities from the enrollment of patients up to completion of Stage I to IIIA multi-disciplinary breast cancer treatment, including 5-years survival follow-up.   5. Provide a progress report and regular feedback to the DOH and other pertinent stakeholders on the issues and concerns encountered thereto in collaboration with the DOH-NCPAM to further improve the implementation of the Program;   6. Facilitate an on-line Breast Cancer Registry for use of DOH and all pilot Hospitals, incorporating data needed as per patient reporting forms.   7. Conduct research studies 1n collaboration with the participating parties to the Program.   8. Together with DOH, ' initiate a strategic communications and awareness campaign on breast cancer that will ensure that the program gains will generate a momentous support and create long lasting, sustainable change In the \ufb01ght against breast cancer.    C. IDENTIFIED BREAST CANCER HOSPITALS/CENTERS:   1. Ensure the presence of the following basic requirements for the implementation of this Program: -   a) pharmacy services  b) supplies and logistics for breast biopsy, particularly core needle biopsy equipment and buffered formalin solution, and  c) other basic diagnostic ancillary services for breast cancer patients;   2. Identify and recommend to the DOH-NCPAM and the PCSI the potential bene\ufb01ciaries of the Program based on the eligibility criteria set in the treatment and management protocol;   3. Agree to participate in the PCSI-Patient Navigation Program which shall be the mechanism for navigating patients in the healthcare system and providing them assistance in accessing health services including surgery, medicines, radiotherapy, counseling, psychosocial support and other ancillary services for the multi-disciplinary team approach to breast cancer care and management;   4. Provide a counseling room / breast clinic/area for patient navigators;   5. Agree to Implement the Standard Treatment Protocol as drafted and approved by the Expert Committee.   6. Identify a Breast Cancer Medicines Access Program (BCMAP) Coordinator for coordination purposes with the PCSI\u2014Navigation Program and the DOH- NCPAM and the Hospital Pharmacy.   7. Devise, recommend, and continuously improve the coordination mechanism to ensure that the drugs and medicines are accessible to all the bene\ufb01ciaries as approved by the DOH;   8. Ensure compliance with all the requirements stated in this directive   D. PITC PHARMA INC. (PPI) shall:   1. Procure breast cancer drugS'and medicines at the most reasonable cost;   2. Quote prices that are \ufb01xed for a period of six (6) months which include transportation costs from the PPI'forwarder to the recipient hospital, insurance charges and other incidental deliverycosts;   3. Notify the DOH-NCPAM point person of the program on the arrival Of the breast cancer drugs and medicines at the PPI warehouse/forwarder at least one (1) week prior to the expected date and on the succeeding days thereafter until the actual date of delivery;    4. Ensure the availability Of breast cancer drugs and medicines;   5. Ensure that drugs and medicines delivered shall be in accordance with the Essential Drugs List, the PNDF Volume I, current edition;   6. Observe strictly the proper handling and storage (including their forwarder) of the cancer medicines in accordance with speci\ufb01c temperature and container requirements, among others. '   IX. OVERALL RESPONSIBILITY  The Medicines Access Program shall be under the direct supervision and control of the DOH Undersecretary of the Health Regulations Cluster with the ANCPAM as the Operational unit that shall provide the overall direction and administration of this Program. All communications concerning the Program shall be addressed to DOH\u2014NCPAM.   IX. SEPARABILITY CLAUSE   If any provision in this Guidelines or application of such provision any circumstances shall be held invalid, the remainder of the provisions thereby shall not be affected.   X. EFFECTIVITY  This Order shall take effect immediately. ", " I. BACKGROUND AND RATIONALE   Health-related public policies and laws have provided the impetus for comprehensive reform strategies identi\ufb01ed in the Health Sector Reform Agenda (HSRA) launched in 1999 and its implementation framework, the FOURmula One (F1) for Health in 2005. Since then, substantial gains in health sector improvements have been achieved in the areas of social health insurance coverage and bene\ufb01ts, execution of Department of Health (DOH) budgets and its use to leverage local government unit (LGU) performance, LGU spending in health, systematic health investment planning through the Province-wide Investment Plan for Health (PIPH)/ Citywide Investment Plan for Health (CIPH)/ Annual Operational Plan (AOP) process, capacities of government health facilities, and the implementation and monitoring of public health programs.   However, poor Filipino families have yet to experience equity and access to critical health services, despite all of these achievements.   DOH and PhilHealth recently conducted a joint Bene\ufb01t Delivery Review highlighting the need to increase enrollment coverage, improve availment of bene\ufb01ts and increase support value for claims in order for the National Health Insurance Program (NHIP) to provide Filipinos substantial \ufb01nancial risk protection. More importantly, bene\ufb01t delivery for the sponsored program (poorest quintile) was found to be lowest among our people. To date, only 53 percent of the entire population is covered by the program, with 42 percent availment rate, and 34 percent support value or a total bene\ufb01t delivery ratio of 8 percent.   Public hospitals and health facilities have also suffered neglect due to the inadequacy of health budgets in terms of support for upgrading to expand capacity and improve quality of services. As of October 2010, eight hundred ninety two (892) rural health units (RHUS) and ninety nine (99) government hospitals have yet to qualify for accreditation by PhilHealth. Data have also shown that the poorest of the population are the main users of government health facilities. This means that the deterioration and poor quality of many government health facilities is particularly disadvantageous to the poor who needs the services the most.   Moreover, weaknesses in management and compensation of human resources for health have not been adequately addressed and inadequacies in health information systems to guide planning and implementation of health programs also need urgent attention.   Lastly, while the Philippines is on target for most of its Millennium Development Goals (MDG), it is lagging behind in reducing maternal and infant mortality. These two indicators are still at 162 per 100,000 live births and 25 per 1,000 live births respectively (2005 FPS and 2008 NDHS), with 2015 MDG targets at 52 and 19, respectively. There is also wide difference in outcomes and program performance in these priority public health programs across geographic areas and income groups that particularly affect the poor.   To address these challenges, the Aquino Health Agenda (AHA) is being launched to improve, streamline and scale up reform interventions espoused in the HSRA and implemented under F1. This deliberate focus on the poor will ensure that as the implementation of health refomis moves forward, nobody are left behind.   To successfully implement the Aquino Health Agenda, the Philippine health system will require the following components: enlightened leadership and good governance practices; accurate and timely information and feedback on performance; \ufb01nancing that lessens the impact of expenditures especially among the poorest and the marginalized sector; competent workforce; accessible and effective medical products and technologies; and appropriately delivered essential services.   This Order provides the objectives, strategic thrusts, and implementation framework- to implement the Universal Health Care (UHC)   II. SCOPE AND COVERAGE   This issuance shall apply to the entire health sector, including the public and private sectors, the DOH bureaus, national centers, hospitals, attached agencies especially PhilHealth and external development partners involved in the implementation of the Universal Health Care.   This Order shall also provide for the guidelines, approaches and resources needed to affect and in\ufb02uence public-private partnership, and bene\ufb01t families, civil society, private and public health care providers, and local government units as they decide, behave and transact in the local health system that will provide the backdrop for the Aquino Health Agenda.   III. OVERALL GOAL AND OBJECTIVES:   Overall Goal:   The implementation of Universal Health Care shall be directed towards ensuring the achievement of the health system goals of better health outcomes, sustained health \ufb01nancing and responsive health system by ensuring that all Filipinos, especially the disadvantaged group in the spirit of solidarity, have equitable access to affordable health care.   General Objective:   Universal Health Care is an approach that seeks to improve, streamline, and scale up the reform strategies in HSRA and F1 in order to address inequities in health outcomes by ensuring that all Filipinos, especially those belonging to the lowest two income quintiles, have equitable access to quality health care.   This approach shall strengthen the National Health Insurance Program (NHIP) as the prime mover in improving \ufb01nancial risk protection, generating resources to modernize and sustain health facilities, and improve the provision of public health services to achieve the Millennium Development Goals (MDGs).   IV. DEFINITION OF TERMS   1. Bene\ufb01t Delivery Ratio (BDR)\u2014\u2014 the cumulative likelihood that any Filipino is (a) eligible to claim (registered, paid contributions); (b) aware of entitlements and is able to access and avail of health services from accredited providers; and (c) is fully reimbursed by PhilHealth as far as total health care expenditures are concerned.   2. Catastrophic Expenditures wout\u2014of-pocket spending on health that can drive a household to poverty or further into poverty. This is often expressed as a percentage of household income. High incidence of catastrophic spending re\ufb02ects'poor \ufb01nancial risk protection in the health sector.   3. Casemix system - refers to a payment mechanism that reimburses or pays for health care costs in terms of case groups/ bundled cost categorized in terms of their resource use.   4. Community Health Team (CHT) \u2014 is a group of health volunteers assigned in each barangay/priority population area led by a midwife that tracks eligible population for public health services, assists families in assessing and acting on health needs, provides information on available services in the locality, and facilitates the organization of transportation and communication systems, outreach services and linkages with other providers in the service delivery network (e.g. Barangay Health Station, Rural Health Unit, other small private and public hospitals and facilities).   5. Continuum of Services - integrated and coordinated packages of health services that encompass health promotive and preventive services, to in\u2014hospital care support and treatment services and post-hospital rehabilitative services. These packages of services are made available at strategic access points where utilization is maximized by clients who need them most.   6. Geographically Isolated and Disadvantaged Area (GIDA) \u2014\u2014 communities with marginalized population physically and socio\u2014economically separated from the mainstream society such as island municipalities, upland communities, hard-to\u2014reach areas, and con\ufb02ict- affected areas.   7. Income Quintiles\u2014 economic classi\ufb01cation of population based on average monthly income. The lowest income quintile (Q1) with an average monthly family income of P3,460.00 while the next lowest quintile (Q2) is P6,073.00.   8. Local health system \u2014~ all organizations, institutions and resources devoted to undertaking local health actions. These include provinces, and their component LGUs, Cities, private and public health care providers, local partners, and families.   9. Monitoring and Evaluation for Ef\ufb01ciency and Effectiveness (ME3) \u2014 the monitoring and evaluation framework used by the health sector to assess the implementation of reforms in the country.   10. National Household Targeting System (NHTS) \u2014 a data bank and an information management system managed by the Department of Social Welfare and Development (DSWD) that identi\ufb01es who and where the poor are. The system generates and maintains the socio-economic database of poor households.   11. No balance billing policy \u2014-\u2014 refers to the policy that NHIP members who belong to the poorest income quintile and their bene\ufb01ciaries will not be required to pay out of pocket for costs for their con\ufb01nement subject to the speci\ufb01c terms and conditions of this policy.   12. Public Private Partnership (PPP) \u2014 A cooperative venture between the public and private sectors, built on the expertise of each partner, that best meet clearly de\ufb01ned public needs through the appropriate allocation of resources, risks and rewards. This partnership may range from health care provision to logistics management, from information and communication technology to capacity building of health providers.   13. Service Delivery Network (SDN) - a health service delivery structure composed of a network of health service providers at different levels of care. SDN can be as small as an Inter\u2014Local Health Zone (ILHZ) or as large as a regional SDN with the regional hospital serving as the end referral hospital.   14. Service Delivery Package (SDP) n includes services that will be provided within the catchment area of the SDN and will 1) target the country\u2019s MDG commitments; 2) eliminate endemic diseases; 3) intensify disease prevention and control for both communicable and non-communicable diseases; 4) improve family health care; and 5) manage health emergencies and disasters.   15. Support Value - proportion of the health care bill covered by PhilHealth when con\ufb01ned to a health facility.   16. Universal Health Care - a focused approach to health reform implementation, ensuring that all Filipinos especially the poor receive the bene\ufb01ts of health reform. This is a deliberate focus on the poor to ensure that they are given \ufb01nancial risk protection through enrollment to PhilHealth and that they are able to access affordable and quality health care and services in times of needs.   V. GENERAL GUIDELINES   A. The Aquino Health Agenda (AHA) is a focused approach to health reform implementation in the context of HSRA and F1, ensuring that all Filipinos especially the poor receive the bene\ufb01ts of health reform. AHA shall be attained by pursuing three strategic thrusts:   1. Financial risk protection through expansion in NHIP enrollment and bene\ufb01t delivery \u2014 the poor are to be protected from the \ufb01nancial impacts of health care use by improving the bene\ufb01t delivery ratio of the NHIP;   2. Improved access to quality hospitals and health care facilities - government\u2014 owned and operated hospitals and health facilities will be upgraded to expand capacity and provide quality services to help attain MDGs, attend to traumatic injuries and other types of emergencies, and manage non-communicable diseases and their complications; and   3. Attainment of the health\u2014related MDGs \u2014 public health programs shall be focused on reducing maternal and child mortality, morbidity and mortality from TB and malaria, and the prevalence of HIV/AIDS, in addition to being prepared for emerging disease trends, and prevention and control of non-communicable diseases.   B. The six (6) strategic instruments shall be optimized to achieve the AHA strategic thrusts:   1. Health Financing \u2014 instrument to increase resources for health that will be effectively allocated and utilized to improve the \ufb01nancial protection of the poor and the vulnerable sectors   2. Service Delivery \u2014 instrument to transform the health service delivery structure to address variations in health service utilization and health outcomes across socio-economic variables   3. Policy, Standards and Regulation - instrument to ensure equitable access to health services, essential medicines and technologies of assured quality, availability and safety   4. Governance for Health - instrument to establish the mechanisms for ef\ufb01ciency, transparency and accountability and prevent opportunities for fraud   5. Human Resources for Health - instrument to ensure that all Filipinos have access to professional health care providers capable of meeting their health needs at the appropriate level of care   6. Health Information - instrument to establish a modern information system that shall:   a. Provide evidence for policy and program development  b. Support for immediate and ef\ufb01cient provision of health care and management of province-wide health systems   C. The success of the AHA shall be measured by the progress made in preventing premature deaths, reduce maternal and newborn deaths, controlling both communicable and non\u2014communicable diseases, improvements in access to quality health facilities and services and increasing NHIP bene\ufb01t delivery rate, prioritizing the poor and the marginalized (such as the Geographically Isolated and Disadvantaged Area (GIDA) population, indigenous population, older persons, differently\u2014abled persons, internally- displaced population, and people in con\ufb02ict- affected areas). These performance measures are the results of effective interaction between families and health care providers (both public and private) in local health systems.   D. The DOH shall facilitate the implementation of the AHA by in\ufb02uencing the manner by which Provinces and component LGUs, and Cities govern local health systems.   E. In implementing the Aquino Health Agenda, the DOH recognizes that LGUs have the primary mandate to \ufb01nance and regulate local health systems, including the provision of the right information to families and health providers.   F. Consistent with the Presidential commitment of zero~corruption in the government, the implementation of UHC shall be founded on participatory governance, transparency and accountability at the national, sub-national, and local government levels to better respond to the health needs of all Filipinos.   G. Broad and sustained participation among all stakeholders shall be purposive, coordinative, harmonized and productive. UHC shall harness the strength of revitalized public\u2014private partnership especially in services needing heavy capital investments.   H. UHC shall be client\u2014centered and respond ef\ufb01ciently to the medical needs and social expectations consistent with accepted standards of care.   I. In order to implement the Aquino Health Agenda, the DOH shall engage local health systems (Provinces and their component LGUs, Cities, private and public health care providers, local partners, and families) through the formation of regional clusters based on their catchment areas.   VI. SPECIFIC GUIDELINES   A. Financial risk protection through improvements in NHIP bene\ufb01t delivery shall be achieved by:   1. Redirecting PhilHealth operations towards the improvement of the national and regional bene\ufb01t delivery ratios;   2. Expanding enrolment of the poor in the NHIP to improve population coverage;   3. Promoting the availment of quality outpatient and inpatient services at accredited facilities through reformed capitation and no balance billing arrangements for sponsored members, respectively;   4. Increasing the support value of health insurance through the use of information technology upgrades to accelerate PhilHealth claims processing, etc.; and   5. A continuing study to determine the segments of the population to be covered for speci\ufb01c range of services and the proportion of the total cost to be covered/supported   B. Improved access to quality hospitals and other health care facilities shall be achieved by:   1. A targeted health facility enhancement program that shall leverage funds for improved facility preparedness to adequately manage the most common causes of mortality and morbidity, including trauma;   2. Provision of \ufb01nancial mechanisms drawing from public-private partnerships to support the immediate repair, rehabilitation and construction of selected priority health facilities;   3. Fiscal autonomy and income retention schemes for government hospitals and health facilities;   4. Uni\ufb01ed and streamlined DOH licensure and PhilHealth accreditation for hospitals and health facilities; and   5. Regional clustering and referral networks of health facilities based on their catchment areas to address the current fragmentation of health services in some regions as an aftermath of the devolution of local health services.   C. Health-related MDGS shall be attained by:   1. Deploying Community Health Teams that shall actively assist families in assessing and acting on their health needs;   2. Utilizing the life cycle approach in providing needed services, namely family planning; ante-natal care; delivery in health facilities; essential newborn and immediate postpartum care; and the Garantisadong Pambata package for children 0-14 years of age;   3. Aggressively promoting healthy lifestyle changes to reduce non-communicable diseases;   4. Ensuring public health measures to prevent and control of communicable diseases, and adequate surveillance and preparedness for emerging and re\u2014 emerging diseases; and   5. Harnessing the strengths of inter\u2014agency and inter-sectoral cooperation to health especially with the Department of Education and Department of Social Welfare and the Department of Interior andLocal Government.   VII. ROLES AND RESPONSIBILITIES   A. DOH shall:   1. Develop guidelines and protocols to organize the community health team and service delivery network, implement a functional referral system, deliver health service packages, contract with private providers, implement clinical practice guidelines, generate, retain, and use hospital revenues, and establish hospital pricing system to maximize bene\ufb01ts from PhilHealth;   2. Institutionalize the PIPH/CIPH/AOP as a process to engage and guide the LGUs in identifying their needs and proposing interventions based on these needs, pooling resources at the regional level, and strengthening the coordination among provinces, their component LGUs, and cities;   3. Utilize its resources for public health grants and commodities to leverage the performance of LGUs in organizing the community health team and service delivery network, delivering health service packages, and providing critical inputs like supplies, drugs and commodities;   4. Engage partners in policy development and implementation of strategies including the media in providing accurate and timely information to the public regarding the implementation of the AHA;   5. Advocate with Congress to pursue legislation that will support health reform priorities;   6. Engage professional groups, the academe, NGOs and other private sector partners in establishing clinical guidelines, collaborative networks for service provision and fees, training, advocacy, and monitoring and evaluation, using systems that have been developed in HSRA and F1 (e.g. ME3);   7. Consolidate available resources and provide grants for upgrading of local health facilities to comply with PhilHealth accreditation standards, especially in areas where most of the poor are found; and   8. Operate DOH-retained hospitals and facilities to become effective instruments to in\ufb02uence local systems performance.   B. PhilHealth shall:   1. Expand NHIP coverage by ensuring the annual registration and enrolment of poor families while leveraging for local counterparts and providing member and provider services to promote utilization of NHIP bene\ufb01ts; Secure \ufb01nancial risk protection for outpatient services by linking capitation payments with discrete outpatient services;   2. Secure \ufb01nancial risk protection for inpatient services by implementing a no-balance\u2014billing policy in government hospitals for our poorest population;   3. Improve management of the NHIP by investing in modern information and communication technology to link members and providers with PhilHealth of\ufb01ces.   4. Seeking other \ufb01nancial instruments and strategies to maintainfimprove \ufb01nancial sustainability   C. Local Government Units are encouraged and assisted to:   1. Develop policies and plans appropriate to their locality and consistent with the implementation of the AHA, including the installation of instruments to sustain provision of services such as systems covering logistics management, health information, monitoring and evaluation, and referrals within the service delivery network;   2. Mobilize and utilize resources such as Internal Revenue Allotment (IRA), PhilHealth reimbursements, user\u2014fees, capitation fund, and other resources to organize and sustain the community health teams and service delivery networks including provision of supplies, drugs and commodities;   3. Allow their local hospitals and other public health facilities appropriate incentives such as income retention, socialized pricing, and improved hospital pricing to improve their capacity to deliver services; and   4. Organize Community Health Teams and Service Delivery Networks in partnership with the private sector for effective delivery of health service packages, and whenever appropriate, contract private providers to supplement available services or provide other services that cannot be delivered by existing public providers (e.g. family planning services such as tubal ligation or perform caesarean sections).   D. The Development Partners, within the context of Sector Development Approach for Health and subject to agreements with the DOH, shall:   1. Provide of\ufb01cial development assistance consistent with the national thrusts and directions for health as further articulated in this Order;   2. Align and harmonize their systems and processes with government procedures and institutional reform processes to the best extent possible;   3. Cooperate in the establishment of mechanisms to track development assistance for the AHA; and   4. Ensure the sustainability and institutionalization of assistance projects to appropriate agencies/of\ufb01ces.   VIII. IMPLEMENTATION ARRANGEMENTS   1. DOH of\ufb01ces shall be clustered according to the three major strategic thrusts of UHC especially in ensuring access to health by the poor. a. Financial risk protection \u2014\u2014 health care \ufb01nancing cluster   b. Attaining MDGs \u2014 policy, standards and regulation cluster   c. Health facilities enhancement \u2014 service delivery cluster   The sectoral and internal management support cluster shall provide governance and management support to all the clusters. The functional clusters and their specific tasks shall be described in a separate Department Order to be issued in line with this AO.   2. Strengthening of local health systems shall be facilitated and coordinated by the Centers for Health Development through the regional clusters. These are aggregations of local health systems at the regional level organized for the purpose of inter-LGU cooperation. It shall assume the following functions:   i. Oversee operations and concerns of hospitals covering the same catchment;  ii. Pool resources from the DOH Central Of\ufb01ce, LGUs, PhilHealth, the private sector and development partners to allow for consortium of training, sharing, hiring and management of hospital personnel, procurement of essential drugs and commodities and constructionfupgrading of facilities;   iii. Decide on equitable allocation of budgets in support of improving hospital and health facility operations; and   iv. Provide policy directions that will facilitate private\u2014public sector partnership in the provision of health care and promote corporate practices that will sustain provision of quality and affordable health care.   3. The UHC implementation plan and operational guidelines shall be jointly formulated by the DOH and other stakeholders within two (2) months after issuance of this AO. All DOH of\ufb01ces, DOH attached agencies especially PhilHealth, and DOH-retained hospitals shall ensure coherence of their activities, projects and individual operational plans to the UHC strategic thrusts. All clusters shall advocate for the adoption and implementation of UHC plan by all stakeholders and partners.   4. Progress of AHA implementation shall be monitored and evaluated quarterly. All cluster heads shall be responsible for achieving the agreed targets for 2011\u20142016. By end of 2012, at least eighty \ufb01ve (85) percent of all UHC targets by reform component should have been achieved. By end of 2014, all UHC targets should be sustainable and supported by the appropriate policy issuances.   IX. REPEALING CLAUSE   The provisions of previous Orders and other related issuances inconsistent or contrary to the provisions of this Administrative Order are hereby revised, modified, repealed or rescinded accordingly. All provisions of existing issuances which are not affected by this Order shall remain valid and in effect.   X. EFFECTIVITY This Order shall take effect immediately.  ", "  I. RATIONALE:  The proportion of older population is expected to rise worldwide. In the 1998 World Health Report, there were 390 million older people and this \ufb01gure 1s expected to increase \ufb01nther (WHO) This growth will certainly pose a challenge to country governments, particularly to the developing countries, in caring for their aging population. In the Philippines, the population of 60 years or older was 3.7 million in 1995 or 5.4% of total population. In Y2000 census, this has increased to about 4.8 million or almost 6% (NSCB).  With the rise of the aging population is the increase in the demand for health services by the elderly. A study done by Racelis et al (2003) on the share of health expenditure of Filipino elderly on the National Health Account, the elderly are \u201crelatively heavy consumers of personal health care (22%) and relatively light consumers of public health care (5%).\" From out-of-pocket costs, the aged are heavy users of care provided by hospitals, non-hospital health facilities and traditional care facilities  Cognizant of the growing concerns of the older population, laws and policies were developed that would provide them with enabling mechanisms for them to have quality life. RA 9257 or the Expanded Senior Citizens\u2019 Act of 2003 provides for the expansion of coverage of bene\ufb01ts and privileges that the elderly may acquire, including medically necessary services Parallel to this objective is the Department\u2019s desire to provide affordable and quality health service to the marginalized population, especially the elderly, without impeding currently pursued objectives alongside health systems reform.  This guideline is being issued in support to the Implementing Rules and Regulations of RA 9257. Policies and guidelines are discussed to guide the hospitals in implementing the provisions of RA 9257 so as to provide fair, just and quality health care to the senior population, at the \u201csame time pursuing \ufb01nancial viability of hospitals amidst economic and \ufb01nancial management constraints.  II. COVERAGE AND SCOPE  This Administrative Order applies to all hospitals and health-related facilities \ufb01om government and private sector, the health care professionals and the Philippine Health Insurance Corporation, and other related healthcare facilities and services. This also applies to drug stores, hospital pharmacies and similar establishments dispensing medicines.  III. DEFINITION OF TERMS  Consistent with the pertinent de\ufb01nitions used in the Implementing Rules and Regulations of RA 9257, the following terms shall be de\ufb01ned as follows:  l. MEDICINES- shall refer to both prescription and nonprescription medicines and articles approved by the Bureau of Food and Drugs (BFAD), intended for use in the diagnosis, cure, mitigation, treatment and prevention of disease and injury but do not include food and devices or. their components, parts or accessories.  UNBRANDED GENERIC MEDICINES \u2014- shall refer to drugs not covered by patent protection and which are labeled solely by their international non-proprietary or generic name and without a brand name.  2. MEDICAL DEVICES - shall refer to histruments, apparatus, machines, implants or in-vitro reagents intended for use in, or actually used in the diagnosis, treatment, monitoring or prevention of disease or injury and does not achieve any of the intended purposes by means of chemical action within or on humans and not dependent on being metabolized to achieve as a result.  3. MEDICAL SERVICES- in the context of this Administrative Order, this shall refer to hospital room and services, medical supplies, professional services of physicians and other health care professionals, and diagnostic and laboratory tests that are necessary for the diagnosis and/ or treatment of an illness or injury.  4. DENTAL SERVICES- shall refer to the services related to oral examination, cleaning, permanent and temporary \ufb01lling, extractions and gum treatments, restoration, replacement or repositioning of teeth, or alteration of the alveolar or periodontium process of the maxilla and the mandible that are necessary for the diagnosis and/or treatment of a dental illness or injury  5. DIAGNOSTIC AND LABORATORY TESTS\u2014 shall refer to X\u2014ray, CT\u2014scans, blood chemistry exams, histopathology and immunopathology, hematology, urine analysis, parasitology and bacteriology tests, serology, blood banking, and all other diagnostic radiology, clinical laboraton and other diagnostic examinations that are necessary for the diagnosis and/or treatment of an illness or injury. For specialized diagnostics, this should be appropriate to the disease/injury.  6. HEALTH CARE PROFESSIONAL; shall refer to any doctor of medicine, dentist, nurse, nddudfe, or other health care professional or practitioner duly licensed to practice in the Philippines.  7. ESTABLISHMENTS DISPENSING MEDICINES - shall refer to drug stores, hospital pharmacies (government or private), medical and optical clinics and similar establishments dispensing medicines, duly licensed and/or \ufb01anchised by the BFAD and the local government units.  8. GOVERNMENT HEALTH FACILITIES\u2014 shall refer to hospitals, outpatient clinics including health centers and rural health units, clinical laboratories, diagnostic radiology centers, and other outpatient health facilities operated and maintained partially or wholly by the national, provincial, city or municipal government, or other political unit; or by any department; division, board or agency thereof. The facilities include Department of Health (DOH)-retained hospitals; specialty hospitals which are government-owned and controlled corporations (GOCCs); medical clinics in GOCC; and hospitals/health facilities owned and managed by local government units, state colleges and universities, the Department of National Defense, the Department of Interior- and Local Government, and other government agencies.  The government hospitals consist of the service or charity or subsidized impatient and out\u2014patient section/department and the non-subsidized pay section.  9. PRIVATE HOSPITALS AND MEDICAL FACILITIES- shall refer to all pay inpatient and outpatient health and medical facilities privately owned, established and operated with funds through donation, - principal, investment, or other means, by any individual, corporation, association, or organization. The facilities include hospitals, clinical laboratories, diagnostic radiology centers, doctor\u2019s clinics, dental clinics and other health facilities that are licensed by the Bureau of Health Facilities and Services (BHFS) of the DOH and/or the local government units.  10. IDENTIFICATION DOCUMENT - shall refer to any document or proof of being a senior citizen which shall be used for the availment of bene\ufb01ts and privileges under the law, such as the following:  a. ID issued by the city or municipal mayor or Of\ufb01ce of Senior Citizens Affairs (OSCA) or of the barangay captain of the place where the senior citizen or the elderly resides;  b. The passport of the elderly person or senior citizen concerned; and  c. Other documents that establish the senior citizen or elderly person is a citizen of the Republic and who is at least sixty (60) years of age  IV. POLICY STATEMENT  Subject to these guidelines and the availability of the medicines and services, the health-related privileges for senior citizens and their sources of funding of the privileges are as follows:  1. Subsidized Services in In-patlent and Out-patient Sections of Government Health Facilities:  Free medical and dental services, and diagnostic and laboratory fees for all senior citizens con\ufb01ned in service wards of government facilities provided these are in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary.  2. Non-subsidized Services in Pay Sections of Government Health Facilities  Medical and dental services, and diagnostic and laboratory fees for all senior citizens con\ufb01ned in pay sections (both in and out patient sections) of government health facilities are granted twenty percent (20%) discount, provided these are in accordance with available Clinical Practice Guidelines or Hospital Treatment Protocols, and therefore, medically necessary.  3. Twenty Percent (20%) discount in Private Health Facilities  All senior citizens are granted the privilege of twenty percent (20%) discount on medical and dental services, and diagnostic and laboratory fees such as, but not limited to, x\u2014rays, computerized tomography scans and blood tests, including professional fees of attending doctors in all private hospitals and medical facilities.  The services shall include the use of specialized treatment rooms and equipment such as for hemodialysis and radiotheraphy.  4. No discount in Government Health Facilities and Private Health Facilities  Services that are not medically necessary for treatment and diagnosis shall not be provided with any discount. This shall include but not limited to cosmetic surgeries procedures, executive check-up packages and physical examinations, without clinical evidence of effectiveness and ef\ufb01ciency. Likewise, no discount is granted to Special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  5. Twenty percent (20%) discount in the Purchase of Unbranded Generic Medicines  The grant of twenty percent (20%) discount shall be provided in the purchase of unbranded generic medicines from all establishments dispensing medicines for the exclusive use of the senior citizens.  6. Membership in PhilHealth  Consistent with the National Health Insurance Act of 1995 and the Health Sector Reform Agenda, all Filipinos shall be encouraged to be PhilHealth members or at least be a dependent of active PhilI-Iealth members. Senior citizens .who are not yet Non-paying PhilHealth members may become PhilHealth members if they are sponsored or enrolled by their Local Government Unit (LGU) or they enroll themselves as irr'dividually paying members.  7. Funding Sources  For Government: The amount necessary to carry out the provisions of this Act in government health facilities upon its effectivity shall be charged out of the funds of the Of\ufb01ce of the President. Thereafter, any such sum as needed for the regular implementation of this Act shall be included in the subsequent General Appropriations Act.  For CY 2004 and CY 2005, government hospitals shall submit quarterly the number of senior citizens served and the unit costing per senior citizen to their respective National Government Agency or LGU for reimbursement at the Office of the President.  Starting CY 2006, the National Govemment Agencies or LGUs shall include in their budget proposals the funding necessary to implement programs and services required by this Administrative Order.  For Government Owned and Controlled Corporation, total amount of discounts granted to senior citizens shall be charged to the Quanti\ufb01ed Free Service.  For Private: For the twenty percent (20%) discount in private establishments, the cost of the discount shall be partially funded through the deduction of the discount from gross income for the same taxable year that the discount is granted, provided that the total amount of the claimed tax deduction net of value added tax if applicable, shall be included in their gross sales receipts for tax purposes and shall be subject to proper documentation and to the provisions of the National Internal Revenue Code, as amended. The rest of the cost of the discount not funded through the above-described manner shall be home by the provider of the privileges.  V. IMPLEMENTING RULES AND MECHANISMS on the AVAILMENT of PRIVILEGES  l. Subsidized Services in Impatient and Out-patient Sections of Government Health Facilities:  A) Hospital Bed  A hospital bed in a service ward is deemed medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols is granted free to the senior citizen. This will be charged to the hospital budget.  B) Laboratories and Diagnostic Services for Inpatient Senior Citizens  Laboratories and diagnostics services provided to an inpatient senior citizen in a service ward that are medically necessary as determined by his/her attending physician, shall be \u201cfree\" subject to the following:  (1) Diagnosis and/or treatmenf by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols.  (2) Evidence\u2014based health screening tests that had been extensively tested for the local setting and endorsed by the DOH as medically necessary for individual cases shall be provided free by the government facility.  All inpatient laboratories-and diagnostics provided to senior citizens admitted to a bed in the service ward which are deemed not medicaliprecessary for the illness or injury for which he/she is con\ufb01ned shall only be granted a 20% discount.  No discount is granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  C) Laboratories and Diagnostics Services for Outpatient Senior Citizens  Free laboratory and diagnostic services shall be granted toan outpatient senior citizen, provided the following are met:  (1) Diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols and have been determined medically necessary.  (2) Evidence-based health screening tests that had , been extensively tested for. the local setting and endorsed by the DOH as medically necessary for individual cases and shall be provided free by the government facility.  (3) The laboratory and diagnostic services have been determined by his/her attending physician as medically necessary.  (4) The requesting physician is a government-employed physician in the government facility where the laboratory or diagnostic tests shall be conducted.  All outside requests for laboratory and diagnostic tests from physicians who are not employed by the government facility and are based in either a government or private health facility, shall only be granted a 20% discount upon \ufb01nal evaluation of the recipient government facility as medically necessary.  No discount is granted on special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  D) Dental Services  The attending dentist of the senior citizen shall make the determination as to the medical necessity of the dental service that will then be granted free.  E) PhilHealth-related Benefits  In case the senior citizen is a PhilI-Iealth member or a dependent, govennnent facilities must ensure that the charges for services not included in the subsidized sendces shall be deducted and charged to the senior citizen\u2019s Philhealth bene\ufb01ts coverage. It. is only after these deductions are made that the Philhealth accredited health facilities can exercise its right to PhilHealth reimbursement or coverage for the subsidized services.  2. Non-subsidized Services in Pay Sections of Government Health Facilities  The following enumerates the medically necessary care levels for the diagnosis and/or treatment of an illness or injury that will be granted Menty percent (20%) discount and shall apply to pay sections of government health facilities:  A) Hospital Bed  A hospital bed in pay sections of government health facilitieslis deemed medically necessary to diagnose and treat an illness or injury in accordance with the available Clinical Practice Guidelines (CPGs) or Hospital Treatment Protocols. This will be charged to the senior citizen and granted 20% discount.  B) Laboratory and DiagnostieExaminations  All inpatient and Outpatient laboratory and diagnostic examinations in pay sections shall be granted 20% discount; provided that such diagnosis and/or treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.  The health facilities may designate medical of\ufb01cers for senior citizens (MOSC) to facilitate the determination of the medical necessity of requested laboratory or diagnostic examinations.  All inpatient laboratories and diagnostics that are provided to senior citizens admitted to a bed beyond the service ward level shall only be granted a 20% discount.  No discount is granted to special reagents, dyes, contrast media, and radioactive isotopes used in laboratory and diagnostic tests.  C) PhilHealth\u2014related Benefits  In case the senior citizen is a Philliealth member or dependent, the 20% discount shall not be charged to the senior citizen 3 Philhealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder may be charged to his/her PhilHealth bene\ufb01ts.  3. Twenty Percent (20%) Discount in Private Health Facilities  The following enumerates the medically. necessary care levels for the diagnosis and/or treatment of an illness or injury that will be granted twenty percent (20%) discount, and shall apply to private hospitals:  A) Hospital Bed  A hospital bed in a private hospital is deemed medically necessary to diagnose and treat an illness or injury and is hereby granted a twenty percent (20%) discount; provided the requirements stated  below are followed:  (1) The smallest available room and board accommodation shall be deemed as medically necessary and shall be granted 20% discount.  (2) If there is no available smallest room and board accommodation at the time of con\ufb01nement, all other room and board accommodations shall only be granted with a discount equivalent in amount to the 20% discount in the smallest available room and board accommodation.  (3) All existing privileges that are currently part of a hospital bed shall also accrue to the senior citizen.  B) Laboratory and Diagnostic Examinations  All inpatient and outpatient laboratory and diagnostic examinations shall be granted a twenty percent (20%) discount based on the smallest room and board accommodation provided that Such diagnosis andfor treatment by the attending physician shall be in accordance with the available Clinical Practice Guidelines (CPGs) or hospital treatment protocols.  The health facilities may designate medical officers for senior citizens (MOSC) to facilitate the determination of the medical necessity of requested laboratory or diagnostic examinations.  C) Dental Services  All dental services that are deemed to be medically necessary by the attending dentist shall be granted a twenty percent (20%) discount.  D) PhilHealth-related Bene\ufb01ts  In case the senior citizen is a PhilHealth member or dependent, the 20% discount shall not be charged to the senior citizen\u2019s Philhealth bene\ufb01ts coverage. Only the 80% of the fees or charges that the senior citizen is expected to shoulder may be charged to hisfher PhilHealth bene\ufb01ts.  E) Professional Fees  Professional fees for inpatient and outpatient medical and dental services shall be provided with a 20% discount and a corresponding of\ufb01cial receipt shall be issued by the concerned physician or dentist.  4. Twenty Percent (20%) Discount in the Purchase of Unbranded Generic Medicines for the Exclusive Use of Senior Citizens  The following guidelines shall be strictly observed in the sale of unbranded generic medicines to senior citizens at 20% discount:  A. All establishments, through their registered pharmacist, shall have full discretion and responsibility in dispensing medicines including the generic alternatives to the prescribed medicine in accordance with the provision of the Generics Act of 1988 and relevant laws.  Discounts granted by the Expanded Senior Citizens Act on purchases of unbranded generic medicines shall be given by establishments in their sale of said medicines.  1. The discount for the purchase of unbranded generic medicines shall be supported by the following:  1.1 Senior Citizen\u2019s identi\ufb01cation document as stated is the De\ufb01nition of Terms;  1.2 Doctor\u2019s prescription stating the name of the senior citizen, age, sex, address, date, generic name of the medicine, dosage form, dosage strength, quantity, name and signature, address, contact number of the prescribing physician or dentist, professional license number, professional tax receipt number and narcotic license number, if applicable. To safeguard the health of senior citizens and to prevent abuse of RA 9257, a doctor\u2019s prescription is required in the purchase of over-the-counter medicines.  Only prescriptions which contain the above information shall be honored.  1.3 Purchase booklet issued by the OSCA to senior citizens for free, containing the following information: OSCA ID number, control number, date of issue, name of senior citizen, sex, address, date of birth, picture, signature of the senior citizen and information on medicines purchased (name of medicine, quantity, attending physician, PTR and address, name of servicing'drug store, and name of dispensing pharmacist). All purchases of- medicines shall be recorded in the purchase booklet;  1.4 Authorization letter of the senior citizen who is residing in the Philippines at the time of purchase, currently dated and identi\ufb01cation card of the representative, in case the medicine is bought by the representative of the senior citizen.  2. As a general rule, any single dispensing must be in accordance with the prescription issued by a physician and should not be more than one (1) month supply.  Drug stores are required to maintain a special record book for senior citizens registered and subject to inspection by the BFAD and BIR.  3. For partial \ufb01lling, the establishment\u2019s pharmacist will indicate the quantity partially \ufb01lled in the special record book and the un\ufb01lled balance on the prescription. The senior citizen shall retain the partially \ufb01lled prescription and present the same later to complete the prescribed quantity.  4. Drug outlets offering special discounted prices less than 20% of the regular retail prices of drugs can deduct the percentage discount of the Promotional Campaign from the total 20% discount as required by RA 9257. Thus, a total discount of 20% for Senior Citizens will still be observed.  These discount privileges shall be non-transferable and exclusive for the benefits of the senior citizen.  All establishments as de\ufb01ned above are enjoined to comply with the above-cited guidelines and all Chairpersons of OSCA are instructed to report non-compliance of the above guidelines.  5. RESPONSIBILITIES OF STAKEHOLDERS  A. For purposes of veri\ufb01cation, all hospitals, both government and private facilities shall require senior citizens to present any of the following requirements:  1. An Identi\ufb01cation Card issued by the City or Municipal Mayor/ Of\ufb01ce of Senior Citizens Affairs or of the barangay captain of the place where the senior citizen or the elderly resides;  2. The passport of the elderly person or senior ci\ufb01zen concerned;  3. Other documents that establish the senior citizen is a citizen of the Republic and who is at least sixty (60) years of age  B. Responsibilities of Government Facilities  1. All government facilities are required to post hospital room rates, laboratory and diagnostic tests fees, medicine prices, and all other fees and rates in conspicuous places near or at the main entrance to their respective facility. The above-described price lists shall be submitted annually to the National Center for Health Facility Development\u2014 DOH and PHIC.  2. All government facilities are also required to post this Administrative Order in conspicuous places where consumers/patients can have access to the information and policies set forth by this document.  3. Of\ufb01cial receipts shall be issued for every paid-for. medical and dental services, laboratory and diagnostic tests, and medicines provided. The receipts shall state the usual rates or fees and the discounted price; and,  4. No \u201cIncome Means Test\" nor any other tests shall be applied to the senior citizens as a precondition for the availment of free services as herein described.  C. Responsibilities of Private Hospitals and Medical Facilities  l. Private hospitals and medical facilities shall post the price list of all room rates in the Admitting Section of all private hospitals and medical facilities. The prices of diagnostics and laboratory tests based on room and board accommodation, medical supplies and medicines shall be made available upon request of the senior citizen. The list shall ensure validation of the discount granted to senior citizens.  2. Of\ufb01cial receipts shall be issued for every paid\u2014for medical and dental services and medicines provided. The twenty percent discount shall be granted upon full payment of the bill. The billing statement showing the usual rates or fees and the discounted price shall be attached to the of\ufb01cial receipt;  3. Set up a grievance mechanism for senior, citizens to entertain questions with regards to discounts on professional fees;  4. Inform in writing copy furnished the aggrieved party the necessary sanction for health professionals who refuse to grant the proper discount; and,  D. Responsibilities of Health Care Professionals  Health Care Professionals shall have the following responsibilities, to wit:  1. Inscribe his name and PRC number in the request for diagnostics and laboratory tests, and medicine prescription;  2. To curb abuse of availing discounts for use of non-senior citizens, the health professional shall make sure that prescriptions made are for the exclusive use of the senior citizen.  3. Inform the senior citizen of his usual fees for the services required;  4. Provide an official receipt for the rendered professional services to the senior citizen that states the usual fees and the discounted fees  E. Responsibility of Drugstores  Drugstores are obliged to make available upon the senior citizen\u2019s request a generic menu card and shall provide an of\ufb01cial receipt for drugs and medicines which states the usual prices and the discounted prices of the drugs and medicines  VI. APPLICATION OF PENALTIES AND OTHER SANCT IONS  1. Penalties for persons  a.) Any person who violates any provision of this Act shall suffer the following penalties:  i.) For the first violation, a \ufb01ne of not less than Fifty Thousand Pesos (P50,000) but not exceeding One hundred thousand pesos $100,000) an imprisonment of not less than six (6) months but not more than two (2) years; and  ii.) For any subsequent violation, a \ufb01ne of not less than One hundred thousand (P100,000) but not exceeding Two hundred thousand Pesos (P200,000) and imprisonment for not less than two (2) years but not more than six (6) years.  b.) Any person who abuses the privileges granted herein shall be punished with a \ufb01ne of not less than \ufb01ve thousand pesos -(P5,000) but not more than Fifty Thousand pesos (P50,000)and imprisonment of not less than six (6) months.  c.) If the offender is an alien or a foreigner, he/she shall be deported immediately after service of sentence without further deportation proceedings.  2. Penalties for Corporations  a.) If the offender is a corporation, organization or any similar entity, the of\ufb01cials thereof directly involved shall be liable therefore.  b.) Upon \ufb01ling of an appropriate complaint, and after due notice and hearing, the proper authorities may also cause the cancellation or revocation of the business permit, permit to Operate, franchise and other similar privileges granted to any business entity that fails to abide by the provisions of this Act.  VII. EFFECTIVITY  This Order shall take effect immediately after publication in two (2) national newspapers of general circulation.   ", "  I. RATIONALE   With an ageing world population and the escalating incidence of communicable and non-communicable diseases, the demand for end of life and palliative care is increasing every year. According to the Global Atlas of Palliative Care (2014), over 20 million people are in need of such care, 6 percent of which comprise children. On top of this, around 20 million more require palliative care before death. Despite the \ufb01gures, only a few countries have implemented equitable palliative care programs through a public health approach. In addition to this scenario, opioid analgesics are not easily accessible or available to patients who are suffering from moderate to severe pain worldwide.   In the Philippines, it is estimated that of the 80,000 new patients diagnosed with cancer every year, more than 75% are in advanced stages and will need some pain relief and palliative care. It was reported that most of these patients prefer to die in their homes. The \ufb01rst palliative care program in the country started in 1991 but was formally introduced in 1993-1994. Hospice Philippines is the umbrella palliative care organization under which all the existing palliative care service providers are enrolled. At present, there are about 40 hospice and 272 individual service providers that offer palliative and end of life care to the undetermined huge number of Filipinos in need of such services. (Mission Report of Integrated Missions of PACT -- Programme of Action for Cancer Therapy-- to DOH, March 2011)   Our Constitution guarantees the right of the people to quality health care, as such the Department of Health (DOH) recognizes the need to integrate palliative and hospice care into our health care delivery system to provide holistic health care ranging from promotive, preventive, curative to rehabilitative. The inclusion of palliative and hospice care in the hospitals or health facilities and in the community and home- based levels addresses the goals of Universal Health Care or Kalusugan Pangkalahatan.      II. OBJECTIVES   A. General   This order is aimed to set overall policy directions and identify the roles and functions of DOH, its of\ufb01ces and partner agencies in the provision of palliative and hospice care in hospitals, health facilities, communities and home-based levels.   B. Speci\ufb01c   1) To develop national standards for palliative and hospice care services;   2) To improve the capacity to provide quality palliative and hospice care service delivery throughout the country;   3) To encourage positive attitudinal shifts among health professionals by strengthening and incorporating principles of long-term supportive and palliative care into the educational curricula (medical, nursing, pharmacy, and social work courses);  4) To promote behavior change in the community by increasing public awareness and improving skills and knowledge regarding palliative and hospice care leading to community-owned initiatives supporting health care system; and   5) To re\ufb01ne the legal and regulatory systems and to ensure wider access and availability of opioids for medical and scienti\ufb01c use while maintaining measures for preventing diversion and misuse.    III. SCOPE  This issuance shall apply to all concerned and relevant stakeholders of palliative and hospice care such as, but not limited to, bureaus, national centers, services and attached agencies of the Department of Health and other key government agencies, local government units (LGUs), health care providers, civil society organizations (CSOs), and the academe.   IV. DEFINITION OF TERMS   A. Palliative care is an approach that improves the quality of life of patients and their families facing the problem associated with life\u2014threatening illness, through the prevention and relief of suffering by means of early identi\ufb01cation and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual. Palliative care for children is the active total care of the child\u2019s body, mind and spirit, and also involves giving support to the family. (WHO 2002)    B. Hospice care is end of life care provided by skilled health care providers and volunteers. The goal of the care is to help people who are dying to have peace, comfort and dignity by providing medical, psychological and spiritual support. Hospice programs also provide services to support a patient\u2019s family.   C. Life-threatening / life-limiting illnesses include end-organ failure, mental illness, dementia, rabies, Acquired Immune De\ufb01ciency Syndrome (AIDS), cancer, chronic obstructive pulmonary disease (COPD), rare diseases, malignant hyperthermia, serious physical injuries, post-acute myocardial infarct (AMI), post-stroke, blood dyscrasias, drug-resistant tuberculosis (TB), congenital disorders, among others.   V. GENERAL GUIDELINES   A. The Department of Health through the Disease Prevention and Control Bureau shall develop guidelines, policies and standards that shall facilitate the implementation and institutionalization of palliative and hospice care in the country. Considering that palliative and hospice care cuts across all medical diagnoses, population groups and diverse professions and sectors, the DOH shall ensure the involvement of all concerned stakeholders, both private and government in all the plans and programs that will be developed.   B. Palliative and Hospice Care shall cater to various age groups tailored to age\u2014 related health needs throughout the human life cycle. It must be integrated into the country\u2019s health system and shall be institutionalized at all levels of care from primary to tertiary levels care through the service delivery network.   C. Palliative and Hospice Care requires a holistic and multidisciplinary approach which include but is not limited to physician care, nursing care, medications for pain management and control, medical supplies, medical equipment, counselling (psychological), surgery, chemotherapy and radiation therapy.   D. Primary Level Health Facilities such as Rural Health Units shall provide palliative and hospice care through a community home-based care approach (CHBC). DOH shall provide guidelines for the CHBC approach in collaboration with existing non-government organizations, private institutions and religious organizations already providing home-based care throughout the country.   E. Secondary and Tertiary Level Health Facilities such as Hospitals shall provide palliative care which includes consultation services, inpatient palliative care units or co-management models. Hospice care in hospitals shall be provided to terminally ill patients. It shall provide access to support services and other health care professionals.    F. Research and advocacy on palliative and hospice care shall be coordinated by DOH with other agencies, educational institutions and organizations.   G. Training of health professionals on palliative and hospice care shall be spearheaded by DOH in collaboration with other sectors and other relevant disciplines.   H. DOH in partnership with local government units and relevant organizations and institutions shall ensure sustained funding, generation and mobilization of resources needed for the continued provision of palliative and hospice care in health care facilities.   VI. SPECIFIC GUIDELINES   1. Palliative and Hospice Care (PHC) shall be one of the programs of the Degenerative Disease Of\ufb01ce of the Disease Prevention and Control Bureau. The Lifestyle Related Disease Division Program Manager shall be designated to perform technical and administrative functions pertaining to the implementation of the Palliative and Hospice Care in all levels of health care.   2. A Task Force for Palliative and Hospice Care shall be formed to ensure coordination and sustainability of the PHC Program which is composed of representatives from DOH, PhilHealth, Hospice Philippines Incorporated and the Philippine Society of Hospice and Palliative Medicine (PSHPM), Philippine Alliance of Patient Organizations (PAPO), and the Philippine Children\u2019s Medical Center (PCMC). The membership, participation and functions of the task force shall be stipulated in a pertinent department issuance. The task force shall provide direction, technical support and shall oversee the implementation of guidelines, policies and plans pertaining to Palliative and Hospice Care.   3. Integration of Palliative and Hospice Care into other programs of the Disease Prevention and Control Bureau (DPCB) shall be established to ensure ef\ufb01cient execution of relevant policy actions.   4. Partnership and coordination with the local government units, non-government organizations and other institutions within the service delivery network shall be led by DOH.   VII. IMPLEMENTING MECHANISM   A. ROLES AND RESPONSIBILITIES   1. Disease Prevention and Control Bureau (DPCB)   The DPCB shall provide overall direction, coordination and oversight; establish standards and package of services on palliative and hospice care and ensure their quality, access, and availability at all levels of the healthcare system; and support the design of health \ufb01nancing as related and applicable to palliative and hospice care in collaboration with PhilHealth and other partners.   2. Health Promotion and Communications Service (HPCS)   The HPCS shall lead in the development of promotion and communication plan including IEC materials and tools for palliative and hospice care in coordination with DPCB and other relevant of\ufb01ces/ agencies.   3. Health Facility Development Bureau (HFDB)   The HFDB shall upgrade and enhance health facilities at all levels of care so as to make them capable of providing palliative and hospice care services and iii-charge of operational standards.   4. Health Facilities and Services Regulatory Bureau (HFSRB)   The HFSRB shall ensure compliance of health facilities at all levels of health care to the prescribed standards on physical facility, equipment and personnel.   5. Health Human Resource Development Bureau (HHRDB)   The HHRDB shall provide technical assistance in the development of learning interventions for health professionals involved in palliative and hospice care and facilitate integration of palliative and hospice care in the academic curriculum of health professionals.   6. Bureau of Local Health Systems Development (BLHSD)   The BLHSD shall ensure the adoption, implementation and sustainability of the palliative and health care system down to the local government units.   7. Pharmaceutical Division (PD)   The PD shall ensure the inclusion of medicines for palliative and hospice care in the Essential Drugs List of the Philippine National Formulary and shall make them available at all levels of care. Those medicines shall be used for, but not limited to, the following symptoms: (WHO Essential Medicines in Palliative Care, January 2013)   -Agitation  -Anorexia  -Anxiety  -Constipation  -Delirium  -Depression  -Diarrhea  -Dyspnea  -Fatigue  -Insomnia  -Nausea and vomiting  -Pain  -Respiratory tract secretions   8. Knowledge Management and Information Technology Service (KMITS)   The KMITS shall develop and maintain the palliative and hospice care registry including the software for monitoring.   9. Epidemiology Bureau (EB)   The EB shall establish and sustain surveillance systems including registries for cases requiring palliative and ho spice care; oversee management and dissemination of data related to palliative and hospice care; and support the conduct of population-based surveys on the impact evaluation of an integrated palliative and hospice care.   10. Bureau of International Health Cooperation (BIHC)   The BIHC shall coordinate with international development partners and other external institutions for technical and resource assistance for the implementation of this Order.   11. Food and Drug Administration (FDA)   The FDA shall ensure the safety, ef\ufb01cacy and quality of medicines for palliative and hospice care.   12. Philippine Health Insurance Corporation (PhilHealth)   PhilHealth shall work with DPCB and Hospice Philippines in crafting policies for the development of the National Clinical Practice Guidelines (NCPGs) for Palliative and Hospice Care. The NCPGs shall serve as the basis in designing health care bene\ufb01t packages and as a guide in the implementation of health insurance packages for clients requiring palliative and hospice care services.   13. Regional Of\ufb01ces (ROS)   The ROs shall provide technical assistance to the LGUs, oversee the local institutionalization of palliative and hospice care system and establish standards for an ef\ufb01cient hospital referral system within the locality.   14. DOH Hospitals   The DOH hospitals shall ensure provision of quality palliative and hospice care for eligible patients.   15. Local Government Units (LGUs)   The LGUs shall adopt and implement the palliative and hospice care system and provide services and necessities in all health care facilities and hospitals in their localities.   16. Professional Regulation Commission (PRC)   The PRC through the health professional regulatory boards shall ensure that health professionals comply with the requirements for the training and practice of palliative and hospice care based on the standards.    17. Department of Labor and Employment\u2014Bureau of Working Conditions (DOLE-BWC) / Civil Service Commission (CSC)   The DOLE-BWC and CSC shall be encouraged to develop and implement workplace policies and procedures that are relevant to palliative and hospice care.   18. Non-government organizations, professional groups, other national government agencies / organizations, private sector, and the academe shall adopt, assist and support the implementation of this Order.   B. MONITORING AND EVALUATION   1. Key performance and outcome indicators and tools shall be developed in coordination with the Health Policy Development and Flaming Bureau to track the progress and impact of this palliative and hospice care system.   2. Monitoring and evaluation of this policy shall start three (3) years after its effectivity and yearly thereafter.   C. FUNDING   The concerned of\ufb01ces of the Department of Health (DOH) shall allocate funds for the implementation of this Order at all levels of care, as may be drawn from regular budget allocations, special funds such as Sin Tax Revenues and other funding sources.    If any provision of this Order is declared unauthorized or rendered invalid by any court of law or competent authority, those provisions not affected thereby shall remain valid and effective.   IX. REPEALING CLAUSE   All previous Orders inconsistent in part or in whole to this Administrative Order are hereby rescinded or amended accordingly.   X. EFFECTIVITY   This Order shall be effective \ufb01fteen (15) days after publication to the of\ufb01cial gazette or in newspaper of general circulation.   ", "   I. Background   Blindness as a health problem leads to enormous human suffering, due to the loss of functional ability and self-esteem, and contributes to significant reduction of quality of life and a shortened life span. It has considerable economic implications manifesting on loss of productivity and Income, and can lead to social dependency.   Worldwide, 285 million people are visually impaired, with 39 million of them blind. Within the Western Pacific Region, the World Health OrganizatiOn (WHO). estimates that there are more than 8 million people blind, with more than 80% living in only three countries ~\u2014 China, Vietnam and the Philippines. Ninety percent (90%) of visually impaired people worldwide live in low- and middle-income countries, which- includes the Philippines.   Globally, of all the main causes of blindness, cataract accounts for more than  half (50%). Up to 80% of all blindness in adults is preventable or treatable, while among children, the major causes of avoidable blindness include cataract, refractive _ errors, glaucoma, and low vision, retinopathy of prematurity, corneal scarring.   The 3rd Philippine National Survey of Blindness conducted in 2002 showed that about 3,500,000 (4.62%) Filipinos are visually impaired in-one or both eyes. They are either afflicted with bilateral low vision (1.64%), monocular low vision (1.33%), monocular blindness (1.07%), or bilateral blindness (0.58%). Cagayan Valley had the highest prevalence of visual impairment (blind and-low vision), which reached 7.75%, while the lowest was found in CARAGA at 1.67%. The age group between 60 to 74 years Old showed the highest prevalence rates, while the age groups 0 to 20 age groups had the lowest. In the Philippines, the top three main causes of bilateral blindness are cataract (62.1%), error of refraction (10.3 %), and glaucoma (8.0%). The main causes of low vision are refractive errors (53%), cataraCt (40.8%) and maculopathy (2.2%).   The poorer sectors of the population, where a greater percentage of the burden of blindness lies, face the challenging barriers in accessing eye health care, wherein many. of those who are already blind will likely remain blind and those at risk of becoming blind will likely become blind. Aligning with the objectives of VisiOn 2020 impact program, the health reform agenda of the DOH is directed towards improving access of the poor to quality health care, including eye health care, guided by the strategic priorities 'of the Universal Health Care framework of the Aquino Health Agenda (AO 2010-0036).   II.   To prevent blindness, all stakeholders, through the leadership of the Department of Health, need to Strengthen the Prevention of Blindness Program. The program aims to reduce the current prevalence of bilateral blindness due to all causes to less than 0.5%.   A comprehensive eye and visual health program is envisioned through effective disease control for avoidable blindness, capacity enhancement of government health facilities, provision of capable public health oriented eye Care professionals, and strategic partnerships. - With the central feature of facilities and infrastructure I enhancement of government facilities, at national and local government level, to provide eye care services, referral systems connecting all health facilities from community level up to tertiary level facilities 'will be established to ensure adequate intervention for all eye diseases and conditions.   This policy provide updates on the guidelines according to international and local situation.   II. Coverage and Scope   This Administrative Order covers all Health and health related professionals, facilities, of\ufb01ces, bureaus and all other organizations and individuals involved in blindness prevention activities.   III. Objectives   General objective:   To reduce the current prevalence of bilateral blindness due to all causes to less than 0.5%.   Specific objective 1: To reduce the prevalence of cataract blindness by 50% by year 2016   Strategies:   1. Perform at least 216,000 good outcome cataract surgeries by year 2016  2. Ensure that all health facilities are actively linked to a cataract referral center by year 2016   3. Advocate for more equitable access to cataract intervention services and enabled facilities   4. Develop quality assurance system for all opthalmologic service facilities by year 2016.  5. Ensure that DOH and local government hospitals shall provide specialized services (manpower, equipment, facilities) using appropriate techniques and technology.   6. Maximize the utilization of services in DOH and local. government hospitals   Specific objective 2:  To reduce blindness and visual impairment due to refractive errors by 10% per year by the year 2016   Strategies:   1. Institutionalize visual acuity screening for all sectors by 2016   2. Create a database for refractive errors in all optometric centers linked with DOH Blindness Registry System   3. Ensure that all health facilities are actively linked to an optometric center by year 2016.  4. Advocate for the coverage of optometric services for blinding and disabling visual impairment cause by refractive errors by PhilHealth   5. Facilitate institutionalization of vision screening program$ for public school children at Grade 1 level to reach at least 30% in provinces by year 2016.   Specific objective 3:  To reduce the prevalence of blindness and visual impairment in children by 50% by the- year 2016 '   Strategies:   1. Identify \"and register visually impaired and blind children in the community for timely intervention.   2. Establish referral mechanism and identify referral facilities for visually impaired and blind children (0-19 years)   3. Establish a pediatric. eye referral center in at least one government tertiary hospital for Luzon, Visayas and Mindanao by the year 2016   IV. Definition of Terms   A. Blind \u2014- person whose presenting distance visual acuity in the better eye is worse than 3/60 (20/400), or cannot count \ufb01ngers at 3 meters.   B. Cataract \u2014 results from a change of transparency of the normal crystalline lens in the eye. This condition causes gradual loss of vision and blindness.    C. Childhood Blindness - refers to diseases or conditions that happen in early life, that lead to blindness, which includes congenital. cataract, retinopathy of prematurity, amblyopia, xerophthalmia, among others. Childhood blindness can\u2019t always be treated in the same way as adult blindness, as a child\u2019s eye is smaller and less developed. Specialist training, equipment, and facilities, including additional support funds, are often required. '   D. Error of Refiaction \u2014 is a condition where the refractive power of the eye (which is a combined function mostly of the cornea and lens) reduces the distance visual acuity of to less than 20/30 or of the near vision to less than 20/70 in one or both eyes (including those with eyeglasses) with no other eye disease present and without confirmation by refraction. - = '   E. Low Vision ~\u2014 A person with low vision refers to one who has impairment of visual functioning even after treatment and/or standard refractive correction, and has a ' visual acuity of less than 6/18 to light perception, or a visual field of less than 10 degrees from the point of fixation, but who uses, or is potential-1y able to use vision for planning and/or execution of a task if provided with a low vision aid.   F. Primary Eye Care \u2014 comprises of simple but comprehensive set of preventive, promotive and educational activities to address minor eye diseases that can be carried out by appropriately trained primary health care workers.   G. Visual acuity - measurement of the person's sharpness of vision. A person's visual ' acuity is his ability to see objects clearly, and this ability is tested by the use of a visual acuity chart or other ways like ability to count fingers or to perceive light.   H. Vitamin A Deficiency \u2014 is a condition in which the body\u2019s stores of Vitamin A are depleted to the extent that physiological functions are impaired. Depletion of stored Vitamin A occurs over time when the diet contains too little to replace the amount used by body tissues.   I. Visual Impairment \u2014 refers to blindness or low vision.   V. General Policies  The program shall be guided by the following policies:   A. The DOH as the lead agency for the promotion and protection of people's health shall ensure the provision of the highest quality of appropriate eye care through the development of national standards for ethical practice, facility development and service provision.   B. The DOH shall establish strong collaboration and partnership with other stakeholders in all levels of government, all sectors, and civil society, including the academe, the medical or paramedical specialty societies, non\u2014government organizations, people's organizations, business, local government units, and others who can contribute to quality eye care.   C. The DOH and its partners and other stakeholders shall empower and actively _ involve persons who are at risk of acquiring eye diseases, and those with visual illnesses already and/or the immediate family of these persons in every phase before, during and after the disease process.   D. Eye care providers shall be adequately trained to become competent health providers at every level of government from the devolved local government units to specialty hospitals of both government and private sectors by DOH and its partner agencies.   E. Vision 2020 shall be adopted as the framework for evolving strategies and activities in the implementation of this memorandum, supported by the recommendations in the five objectives of WHO Action Plan for the Prevention of Avoidable Blindness and Visual Impairment 2009\u20142013 and the Universal Access to Eye Health: A Global Action Plan, 2014\u20142019, as applicable.    VI. Program Vision, Mission, and Goals   A. Vision: All Filipinos enjoy the right to sight by year 2020   B. Mission: The Department of Health, Local Health Units, partners and stakeholders commit to:   1. Provide access to quality eye care services for all   2. Strengthen partnerships among and with stakeholders to eliminate avoidable blindness in the Philippines   3. Empower communities to take proactive roles in the promotion of eye health and prevention of blindness   4. Work towards the preservation, restoration and rehabilitation of sight of indigent Filipinos as a strategy in poverty alleviation.   C. Goal:    Reduce the prevalence of avoidable blindness in the Philippines through the provision of quality eye care   VII. Program Components   A. Advocacy and Health Education   This includes patient information and education, public information and education and inter-sectoral collaboration on eye health promotion and the nature and extent of visual impairments particularly its risk factors and complications and the need/urgency of early diagnosis and management.   B. Capability Building   This component shall focus on ensuring the capability of national and loCal government health facilities in delivering the appropriate eye health care services especially to the indigent sector of the population. Program shall provide training for coordinators at regional and provincial levels; will ensure the availability of and access to training programs by program implementers. It shall include-strengthening treatment/management capabilities of existing personnel and operating capabilities of facilities conducting cataract operations among others, taking into outmost consideration the basic quality assurance and standardization of procedures and - techniques appropriate to each facility/locality.   C. Information Management   The program shall develop an information management system for purposes of reporting and recording. As far as practicable, this system shall conSider and will build on any existing mechanism. The system shall be national in scope, although the mechanism shall consider the regional and local needs and capabilities.    D. Networking, Partnership Building and Resource Mobilization   An important component of the program is networking-and partnership building to ensure that serviCes are available at the local level. This shall include public- private and public-public partnerships aimed at building coalitions and networks for the delivery of appropriate eye health care services at affordable cost especially to the indigent sector. This component shall also focus on ensuring that the highest appropriate quality services are made available and accessible to the people.    E. Supervision, Monitoring and Evaluation   The program shall be coordinated by a national program . coordinator from the De-generative Disease Office of the National Center for Disease Prevention and Control, Department of Health. The national program coordinator shall oversee the implementation of program plans and activities with the assistance of the regional coordinators from the Centers for Health Development.   A system of monitoring program plans and activities shall be developed and implemented taking into consideration the provisions of the local government code as well as the organic act of Muslim Mindanao, and any similar issuance/laws that will be passed in the future.   A program review shall be conducted as needed. Results of program evaluation shall be used in formulating policies, program objectives and action plans.   F. Research and Development   The program shall encourage the conduct of researches for purposes of developing local competence in eye health care and for other purposes that may be necessary. The development and dissemination of clinical practice guidelines for eye health shall form part of the research agenda of the program. '   The program shall support researches/ studies in the clinical behavior (KAP) and epidemiological (trends) areas. It also aims to acquire information that is utilized for continuing public health information and education, policy formulation, planning and implementation.   G. Service Delivery   Service delivery for the Prevention of Blindness Program shall be covered by the principle cf best practices. In collaboration with the local government units and- stakeholders, the program shall develop systems and procedures for the integration and provision of services at the community level. This means primary prevention concentrating on health education, advocacy and primary eye interventions; Secondary prevention; screening/early detection/basic management! counseling, referral and/or definitive care and tertiary prevention: management of - complications, continuing care and follow up including rehabilitation. The following areas will be the priority areas for services to be provided by the National Prevention of Blindness Program:   1. Cataract Surgeries   2. Errors of Refraction   3. Childhood Blindness   4. Other eye diseases emerging as a public health concern  (e. g. diabetic retinopathy, age-related macular degeneration)    In addition, minor eye diseases will be addressed in the context of strengthened primary eye care in Barangay Health Stations and Rural Health Units, while other major eye conditions and other cases requiring specialized care will be addressed within functional referral systems which will be established as part of the comprehensive eye care program and integration with existing health programs (e.g., for the elderly, diabetes control, etc.), utilizing government health facilities, with links as required with private health facilities and hospitals.   Activities for the Vitamin A Deficiency Disorder, for practical purpose-s, shall be led by the Family Health Office also of the NCDPC.   A Referral System shall form part of services delivered by the program. This is to ensure that all patients receive quality eye health care at appropriate levels of health care delivery system. All rural health units should be linked to an eye care referral center.   VIII. Roles and Responsibilities   1. Department of Health -- Central Office shall develop systems, policies and guidelines that will facilitate the implementation of the Prevention of Blindness Program at the local level.   As such, the following offices shall have the following responsibilities:   a. The National Center for Disease Prevention and Control (N CDPC) shall:   1) Develop the system for the implementation of the National Prevention of Blindness Program;   2) Provide technical assistance and conduct monitoring and evaluation of program operation, through a focal coordinating unit;   3) Lead in the formulation of the health intervention and rehabilitation programs and strategies that will reduce the burden and consequences of eye diseases and disabilities and promote visual health; and   4) Ensure the participation of other DOH offices in program activities where needed.   5) Ensure optimal use of allocated resources and support establishment of strategic public-private partnerships for program implementation. '   b. The National Center for Health Promotion shall assist the NCDPC in the _ formulation of standards and development of information, education and communication (IEC) and advocacy strategies for the prevention of blindness program to ensure the promotion of a health and less stressful lifestyle for the Filipinos, as well as to help in ensuring that the public has knowledge of services being offered as part of the program   c. The National Epidemiology Center and the Information Management Service shall assist NCDPC in the development of a national reporting and surveillance system as well as the development of methodologies for the generation, collection and distribution of information and knowledge on the possible establishment of the national registry for blind persons.   d. The Health Policy Development and Planning Bureau shall:   1) Assist in the proper and effective implementation, monitoring and evaluation of the National Prevention of Blindness Policy;   2) Ensure its formulation into a national program plan of action;   3) Assist in developing a health financing scheme/protocol for eye health care services together with the Philippine Health Insurance Corporation; and   4) Ensure inclusion of prevention of blindness in the priorities for the health research agenda.   The Health Human Resource Development Bureau shall assiSt in the:   1) Development of standards in the curriculum and the training of all types of health professionals, practitioners, and care providers who are responsive, sensitive, which should be consistent with the national and local human development goals and culture;   2) Adequate and equitable distribution of health manpower through provision and protection of plantilla positions in the health care delivery system 'at the national and regional levels; and   3) Provision of a good incentive and benefit program .- to attract health caregivers in the unserved and underserved areas.   f. The Bureau of International Health Cooperation shall ensure that the program has strong network linkages with international health institutions, agencies, units that will continually ensure the inclusion, participation, cooperation and collaboration of the Philippines in the global scene for the prevention of blindness.   g. The Bureau of Local Health Development shall assist in the integration of quality eye care into local health system development.   h. The National Center for Health Facilities Development shall ensure that the capacity of government ' hospitals (DOH and local government hospitals) ' shall be upgraded and enhanced to provide adequate quality eye care services, to be undertaken through capacity needs assessment, capacity enhancement investment, and capacity utilization monitoring. For local government hospitals, guidance documents issued for local government hospitals to undertake a parallel process at local level.     i. The Centers for Health Development shall facilitate the implementation of procedure/ guidelines in the LGU pilot areas for the Prevention of Blindness Program from ground working and situational analysis to finalizing the commitment of the key player (DOH, LGU, PHIC, private sector, NGOs, etc.) provide technical assistance to LGUs in selecting program strategies and assist the LGUs in coordinating the actual implementation of the chosen program strategies and activities.   j. DOH hospitals and medical centers shall ensure the availability of quality eye care services to its clients through the establishment of appropriate capabilities and competencies in their respective units.   2. Local Government Units  should organize themselves into inter-local Health zones that will manage the implementation of Prevention of Blindness Program strategies and activities. LGUs shall pass the necessary local legislation (ordinances, resolutions) to implement program strategies. Provide counterpart funds for implementing their investment plan.   3. The National Committee for Sight Preservation (NCSP), a coalition of GOs, NGOs . and professional associations, committed to the preservation of sight through partnership building, sharing of technical expertise, and contributing to program ' development, as well as to serving as an advisory group to the Department of Health\u2019s National Prevention of Blindness Program, will be the lead technical partner agency of the DOH in helping to ensure that the PBP is implemented nationwide, in strong collaboration with local government units, non-government organizations, and other concerned organizations and government agencies.   4. National professional organizations for eye health care (recognized by the Philippine Professional Regulatory CommisSion, Philippine Medical Association and Security Exchange Commission) which includes the Philippine Academy of Ophthalmology and the different Optometric Organizations, shall collaborate with and support the Department of Health in helping to ensure that competent, efficient, gender\u2014sensitive and public health-/community work-oriented eye health care professionals are available to support activities and initiatives of the Department of Health, CHDs, and local government units in the implementation of the National Prevention of Blindness Program.   5. Civil Societies \u2014 shall 1) assist the Local Government Units in achieving their health objectives 2) shall identify the health needs of the people and bring to the attention of the inter-local health zones 3) enhance accountability and transparency of inter- local health zone management.   6. Donor and Technical Partner Agencies \u2014 shall provide funding and/or technical assistance according to the investment plan developed for the Prevention of Blindness Program, as. well as in accordance with partnerships entered into with local government units and other stakeholders. The objectives, initiatives and planned activities of prospective donor and technical partner agencies in prevention of blindness must be in accordance with the strategic directions and objectives of the National PreventiOn of Blindness Program, with proper coordination mechaniSms to be established and implemented.  IX. Implementing Mechanisms A. Program Administration   The Prevention of Blindness Program shall be one of the programs of the De generative Disease Office, National Center for Disease Prevention and Control.   Program administration shall focus on the following guiding principles 1) leadership of the Department of Health, Center for Health Development and stakeholders 2) inter\u2014sectoral coordination and collaboration 3) flexibility and adaptability to situations 4) strengthening linkages and networking 5) cost sharing initiatives.   B. Coordination with Other NCDPC Program and DOH Offices   To ensure a comprehensive approach to blindness prevention, coordination with the other programs and other DOH Of\ufb01ces such as the National Center for Health Facility Development and the Bureau of Health Facilities and Services shall be instituted.   C. The Program Management Committee (PMC)   For the years 2012-2016, a Program Management Committee (PMC) shall be organized to ensure the implementation of the National Sight Plan. The Program Management Committee shall be chaired by the Director of the National Center for Disease Prevention and Control. The composition, other roles and responsibilities of this PMC shall be spelled out in a Department Order that will be issued for this purpose. The Assistant Secretary for Health responsible for the technical cluster which includes the NCDPC and the National PBP shall have oven-all supervision cf the program.   The Program Management Committee (PMC) shall be the main coordinating body for the program. Its members shall include  1. The Division Chief of the Degenerative Disease Office in charge of this program (DOH-NCDPC)   2. The national focal person for this program (DOH\u2014NCDPC)   3. One representative from the Philippine Academy of Ophthalmology   4. Representative from the Optometry group   5. One representative from National Committee for Sight Preservation   6. One representative from Department of Education   7. One representative from Department of Social Welfare and Development   8. One representative from Department of Interior Local Government   9. One representative from Philippine Health Insurance Corporation   Members who represent their organizations in this committee shall be those nominated by their respective organizations, which may be renewed or replaced annually.    The Program Management Committee (PMC) shall have the following reSponsibilities:    1. Recommends to the Secretary of Health activities and plans   2. Monitoring of implementation of program activities   3. Others as may be identified and approved by the Secretary of Health  X. Funding  The Department of Health and the Centers for Health Development shall provide funds for technical assistance, monitoring and advoCacy campaigns (IEC materials). The Department Of Health encourages, and shall also actively pursue opportunities for, public\u2014 ' private partnerships to secure support in terms of financial considerations, donation of equipment and facilities, provision of Capability building prOgrams, proviSion'of logistics, etc., in support of the implementation of the National Prevention of Blindness Program. Furthermore, the local government units, non- government organizations ' and other _ stakeholders shall be encouraged to contribute counterpart support funds to help ensure the implementation of the National Prevention of Blindness Program.  XI. Repealing Clause   This Administrative Order repeals AO No. 179 s. 2004 and other previous issuances that are inconsistent with the provisions of this order.   XII. Effectivity   This Order shall take effect immediately.  ", " The Department of Health (DOH)is mandated to promote and, protect the health of the citizenry. Along this line, it declares its total commitment to the prevention and control of smoking and other tobacco uses Being the principal government agency to look after the implementation of anti-smoking measures, it must set the example by assuring a smoke-free environment within the DOH compound.   To attain this end the entire DOH compound is hereby declared a SMOKE-FREE ZONE. Henceforth, smoking inside the DOH offices, buildings and ground shall be strictly prohibited.   The sale of cigarettes, cigars and other tobacco products within the DOH prem1ses is strictly prohibited as earlier directed under DO-154-E s. 1990   Official stationeries and other legal papers in the Office of the Secretary, Offices/Serv1ces/Bureaus in the Department of Health shall bear the caption \"Smoking is Dangerous to Your Health\".   1 All HEADS of Offices/Services/Bureaus and Others concerned are hereby directed to lead in the promotion of a Smoke-Free DOH compound and instruct their staff to communicate the No Smoking policy of the Department to Office clients/visitors at any given opportunity. Further, they be responsible for the observance of this policy by employees under them and discipline them when necessary. First time offenders will be given verbal warning by their supervisors. Second time offenders will be required to make a written explanation to their head of office/service/bureaus and sent to their respective counselors for Counseling. Three time recidivists will be asked to report to the Office of the Secretary and get a written note addressed to their superiors to be permitted back to their respective offices. Violations will be registered in the Personnel Records for future reference.     The Chief of the Security Force is hereby directed to take all necessary steps to ensure that SECURITY GUARDS of the Department proper and those assigned in the different Bureaus/Services/Offices do not smoke within the DOH compound whether Off or on duty. Security guards will be deputized to call the attention of these caught smoking within the DOH compound, escort them out if necessary and to report the Violations including prohibited peddling of cigarettes within the DOH compound, to the Office of the Secretary for appropriate action.     VISITORS who are smokers coming to the DOH are hereby directed to extinguish their cigarette and deposit with the Security Guard at the gate all remaining cigarettes and cigarettes paraphernalia (including lighters, matches, etc.) to be claimed upon leaving the DOH premises. Security Guards are directed to confiscate cigarettes brought inside the DOH compound by any person with appropriate warning.  The Undersecretary for Financial Management Services is hereby directed to set aside an annual budget for the implementation of a Smoking Control Program for the Department of Health from funds not otherwise appropriated for specific programs/activities.  This Order shall take effect upon issuance of its Implementing Guidelines.  ", " I. RATIONALE   As the current Administration gears'toward the achievement of Universal Health Care (UHC) by 2016, it has to ensure additional resources for essential medicines, which is one the vital components of any functioning health system to enable it to deliver quality health services that will bring about better health outcomes for its people. With the epidemiological shift that the Philippines is now experiencing where the top leading causes of deaths and diseases are both communicable and non-communicable diseases (NCDs),with a pre-dominance of NCDs, the - availability and affordability of needed maintenance drugs to optimally control diseases like hypertension, diabetes, asthma and COPD bring the issue of access to medicines to focus as health facility surveys conducted by the DOH and WHO consistently show poor availability of these medicines in the public sector (WHO 2009). Several issues contribute to the problem such as the lack of national and local \ufb01nancing for medicines, inef\ufb01cient pharmaceutical procurement practices, poor management and the lack of human resources to prescribe and dispense medicines at the point of service delivery.   Furthermore, with the paramount goal to increase patient\u2019s access to low cost quality medicines while at the same time emphasizing the importance of rational drug use, the P100 Program was launched by the DOH and piloted in government hospitals in 2008 providing affordable treatment packs in the public sector although these were still sold to patients.   One of the measures that the government may avail of to promote and ensure access to quality drugs and medicines is to enter into mutually and socially beneficial agreements with pharmaceutical companies, under certain conditions such as pooled procurements of essential drugs for DOH programs to increase their affordability and improve availability in public health facilities.   Public-private partnerships (PPPs) are meant to improve outcomes and increase efficiency in operations as well as expand the limited reach of government by attaining what it cannot attain when acting alone. Partnerships are meant to achieve win-win situations that lead to better health outcomes. PPPs serve a list of purposes that help us achieve a common collective goal, mainly better health outcomes in pursuit of nation building.   AMENDED by No. 2011-0013A Date Mar 22, 2012 Posted on/by Mar 22, 2012    In relation to the foregoing, this Department has issued Administrative Order No. 2008- 0013 dated May 30, 2008, entitled Implementing Guidelines for the Department of Health (DOH) P100 Project for DOH and Pilot LGU Hospitals,\" so as to reach the poorest segments of the population with quality affordable medicines, this issuance need to be revised to further \ufb01rm- up the policies/guidelines; procedures/systems that shall ensure availability of the DOH Complete Treatment Packs in .the poorest localities in the country, particularly municipalities covered by the Conditional Cash Transfer Program of the Department of Social Welfare and Development (DSWD) otherwise known as the Pantawid Pamilycmg Filipino Program (4P5) of the national government.   In this revised AO, the P100 Program shall now be branded as the DOH Complete Treatment Pack program, a medicines access program designed to reach the poorest of the poor with complete treatment regimens for the top most common diseases in the country which contribute to increasing morbidity and mortality and high out-of\u2014pocket spending for medicines and health services to majority of Filipinos.   To provide choice and to ensure access and availability of affordable quality generics to other segments of the population otherwise not included in the 4Ps program of the national government, the DOH Complete Treatment Packs shall also be made available in public hospital pharmacies as approved by the DOH based on parameters of regulatory compliance and adherence to rational drug use concepts and practices.   II. OBJECTIVES   This Order is being issued to set the guidelines to achieve the following objectives:   1. To increase patients\" access to quality essential medicines, taking into consideration rational drug use and availability up to the grassroots level.   2. To improve primary health care in the poorest communities by addressing the needs of the population for essential medicines as part of primary and secondary prevention especially for chronic non-communicable diSeases.   3. To provide complete - treatment regimens to indigent patients as maybe indenti\ufb01ed by PhilHealth and other targeting systems.   III. SCOPE AND COVERAGE   This Order is issued to provide the implementing guidelines, systems and procedures for the Complete Treatment Pack Program of the DOH \u2014 NCPAM in partnership with DOH Hospitals, Local Government Units, Rural Health Units and DSWD for an increased access to low-cost quality essential medicines for the bene\ufb01t of the Filipino people, especially the marginalized sector. '   IV. DEFINITION OF TERMS   1. Authorization- means a permission embodied in a document granted by the FDA to a natural or juridical person who has submitted an application to implement the manufacture, importation, exportation, sale, offer for sale, distribution, transfer, and/or where appropriate, the use, testing, promotion, advertising, or sponsorship of health products. The authorization can take the form of a permit, a license, a certi\ufb01cate of registrationyof accreditation, of compliance, or of exemption, or any similar document. (Sec. 9, RA 9711)   2. Certificate of Product Registration (CPR) \u2014 is a document issued by the FDA allowing the marketing or distribution of a product after evaluation of its safety, ef\ufb01cacy and quality.   3. Current Good Manufacturing Practices (cGMP) \u2014 is the current system of ' quality assurance aimed at ensuring that products are consistently manufactured at a quality appropriate for intended use. It is thus concerned with both manufacturing\u2019and quality control process and procedures.   4. Department of Health (DOH) \u2014 is a National Government Agency organized. and existing under and by virtue of the laws of the Philippines with principal of\ufb01ces located at the San Lazaro Compound, Rizal Avenue, Sta. Cruz, hereinafter referred to as \u201cDOH.\"   5. Food and Drug Administration (FDA) \u2014 refers to the Food and Drug Administration created under Republic Act No. 9711. (Secs. 5 & 9, RA 9711)   6. National Center For Pharmaceutical Access and Management (NCPAM) \u2014 is a National Center of the DOH created by virtue of A0 No. 2010\u20140005 dated 08 January 2010.. Previously known as the National Drug Policy \u2014\u2014 Pharmaceutical. Management Unit 50 (NPD-PMU 50), in response to the need for an institutional of\ufb01ce to realize the objectives of RA No. 9502 , otherwise known as the \u201cUniversally Accessible Cheaper and Quality Medicines Act of 2008.\" -   7. National Household Targeting System for Poverty Reduction\u2014 is a'system for identifying who and where the poor families are in the country. This system guarantees the generation and establishment of a socio-economic database of poor households. This includes \ufb01rming up of a uni\ufb01ed, functional, objective and' transparent targeting system for the poor who are bene\ufb01ciaries of social protection programs.   8. Philippine Health Insurance Corporation (PHIC) w is a GOCC established pursuant to RA No. 7825 instituting National Health Insurance Program for all Filipinos. '   9. Philippine National Drug Formulary (PNDF), Volume 1, current edition I\u2014 is a document containing the list of essential medicines prepared and periodically- updated by the DOH on the basis of health conditions in the Philippines as well as internationally accepted criteria. It consists of a core list and a complementary list of medicines.   10. Therapeutics Committee (TC) -\u2014 is the highest professional body of each hospital responsible for medicines - related issues, such as evaluation, selection, rational use and other related matters.   11. Universal Health Care- a focused approach to health reform implementation, ensuring that all Filipinos especially the poor receive the bene\ufb01ts of health reform. This is a deliberate focus on the poor to ensure that they are given \ufb01nancial risk protection through enrollment to PhilHealth and that they are able to access affordable and quality health care and services in times of needs.   V. IMPLEMENTING GUIDELINES   The implementation of DOH ComPack program shall be in accordance with the strategic thrusts of the Universal Health Care Agenda.   V.I GENERAL GUIDELINES:   1. The DOH ComPack program shall be implemented in priority areas identi\ufb01ed by the DSWD as part of the Conditional Cash Transfer (CCT) program. It may also beimplemented in other LGUs as part of the Province-wide Investment Plan for Health (PIPH) of the DOH particularly those LGUs aiming to increase availability of essential medicines in their public health facilities.   2. The DOH ComPack program medicines can-be availed. of by 'Philhealth\u2019s eligible sponsored members'and their quali\ufb01ed dependents in PHIC\u2014accredited hospitals as take\u2014home medications as per PHIC Board Resolution No. 1214, S. 2009. '   3. The DOH ComPacks shall be sourced only from legitimate suppliers with valid Current Good Manufacturing Practice (CGMP) and a Certi\ufb01cate of Product- Registration (CPR) for drugs included 1n the program.   4. Quality analysis for samples of the DOH ComPacks shall be conducted by the . FDA or accredited private laboratories in coordination with DOH\u2014NCPAM and CHDs before delivery to the RHUs as well as randomly in the \ufb01eld.   5. The DOH ComPack program medicines shall be prescribed, dispensed and used following existing standard treatment guidelines recognized by DOH and PhilHealth (pls. see annex A).   6. The DOH ComPack Program medicines shall be packed using FDA- approved packaging materials for the purpose of promoting and advocating the program.   7. The DOH ComPack medicines shall be selected and evaluated based on, but not limited to the following factors:   7.1 Leading morbidity and mortality  7.2 Most prescribed and fast-moving medicines  7.3 Clinical treatment guidelines  7.4 Cost-effectiveness of medicines package   8. DOH ComPack medicines like other drugs and medicines shall be procured in accordance with the Essential Medicines List (EML), Philippine National Drug F ormulary (PNDF) Volume I, current edition.   9. The DOH ComPack Program shall be implemented in Rural Health Units (RHUS) and in the LGUS in partnership with the Department of Social Welfare & Development (DSWD), and the Department of Interior and Local Government (DILG).   10. The DOH ComPack Program medicines shall be provided free to bene\ufb01ciaries,- areas covered by the DSWD CCT program.   11. The Program shall fund the procurement of ComPack medicines until such time that an out-patient bene\ufb01t package for drugs has been implemented by PHIC.   12. Non\u2014compliance to this guidelines such as giving the DOH ComPacks to non- CCT enrolled members will be sanctioned based on the relevant existing rules and regulations of the Civil Service Commission (CSC).   V.II SPECIFIC GUIDELINES   A. RURAL HEALTH UNITS (RHU)   1. The DOH through its ComPack program shall grant all identi\ufb01ed RHUS under the CCT program of the DSWD with a medicines package for the most prevalent diseases such as hypertension, diabetes and common infections.   2. The DOH ComPack program target shall include the families enrolled with the 4Ps program of the DSWD. These families shall receive full DOH subsidy for medicines under the following conditions:   a.) Must have a DSWD ID No.  b.)Must be registered in an RHU included in the CCT program  c.) Must be seen and diagnosed by an RHU physician  d.)Must adhere to the treatment regimen and comply with the follow\u2014 up schedules as advised by the physician   3. The Municipal Health Of\ufb01cer (MHO) of the CCT municipality shall determine the _ annual quantity needed by the population in the catchment area of the RHU using the quanti\ufb01cation tool which is attached and made part of this issuance. This document shall be forwarded to the respective Center for Health Developments (CHDS) who Shall consolidate the \ufb01gures in the Quanti\ufb01cation Tools to be submitted to DOH-NCPAM.   4. The DOH \u2014 NCPAM, CHDS and LGUS Shall adhere to the schedule of activities provided below:     5. The DOH ComPacks shall be delivered to the RHUS quarterly. The schedule of delivery are March, June, September and December of every year, respectively.   6. The MHO as the delegated authority of the; LGU Shall ensure ef\ufb01cient and effective implementation of the DOH ComPack program in his/her locality.   6.a) The MHO shall accept the DOH ComPacks and Shall ensure their proper storage and warehousing.   6.b) The MHO shall inform and coordinate with the CHD relative to Slow moving drugs and inventories. .   6.c) The MHO shall accomplish the following reports to be submitted quarterly to the CHD to assess the effectiveness of the implementation of the program:    a.) RHU Patient Registry report  b.) RHU Stocks & Inventory Report   6.d) The MHO shall coordinate with the CHD on all other issues and concerns regarding the DOH ComPack program.   B. DOH and LGU HOSPITALS   1. DOH and LGU hospitals Shall sell the DOH ComPack through consignment, provided that:   1.1 The hospital is accredited by the Philippine Health Insurance Corporation (PHIC). 1.2 The hospital has a functional Therapeutics Committees (TCS);  1.3 The hospital has a hospital pharmacy/pharmacist(s).  1.4 The hospital Shall adhere to the existing rules and procedures on consignment   2. DOH and LGU hospitals shall directly transact with the winning suppliers who shall have the sole proprietorship for the selling of the DOH ComPacks medicines in government hospitals Should they be interested in carrying the said products.   3. The winning supplier Shall be allowed to factor\u2014in the cost of the other value-added services (raw materials, packaging, warehousing, sorting and distribution) up to a maximum of 8% based on the Annual Budget Ceiling (ABC) set by this Department using the rates for such services in the previous year for all consignment products.   4. DOH & LGU hospitals that will carry the DOH ComPack medicines are allowed to put a 10% mark-up ab0ve their acquisition cost, to come up with the \ufb01nal selling price. This Department upon the recommendation of NCPAM shall set the selling price of the DOH ComPack medicines in'government hospitals.   5. The \ufb01nal selling price of the DOH ComPack medicines is inclusive of all applicable discounts and taxes in all government health facilities.   6. As part of the No balance\u2014billing policy of this Department for the sponsored members of PHIC, government hospitals that Shall carry the DOH ComPacks shall provide those for free to the said patients during hospitalization.   7. Participating DOH & LGU hospitals Shall prepare quarterly reports of sales and inventory including the status/issues e.g. Adverse Drug Event, etc., \ufb01ve (5) days after the end of the preceding quarter duly Signed by the Chief of Hospitals using the Report Form which is hereto attached as Annex B.   8. Participating DOH & LGU hospitals shall submit the above-mentioned reports directly to the DOH\u2014 NCPAM.   VI. ROLES AND RESPONSIBILITIES   The following roles and responsibilities of all parties concerned shall be observed for the purpose of the implementation of this program:   National Center for Pharmaceutical Access & Management (NCPAM)   The NCPAM in collaboration with CHD and in support of the implementing partners shall:   1. Set the policy direction of the DOH ComPack program.   2. Oversee program implementation including planning, target setting, budgeting and supervising overall operation including the pre and post procurement activities.   3. Monitor progress of the program implementation including analyzing of monitoring reports received from the CHDS and the MHOS in the identi\ufb01ed municipalities.   4. Conduct random sampling of medicines as part of quality analysis, in coordination with the CHDS and the FDA.   5. Address issues and concerns encountered in the implementation of the program to guide further improvement.   6. Provide technical assistance to the regional, provincial, city/municipal level on the over-all implementation of the program.   7. Conduct regular assessment of the program together with the concerned parties.   Center for Health Development (CHD)   The CHDS shall:   1. Effectively supervise the implementation of the program in their respective DOH & LGU hospitals and RHUS.   2. Collect, consolidate and analyze the monitoring and other reports from RHUS on a quarterly basis.   3. Prepare summary of the reports collected from RHUS and submit this to NCPAM quarterly with recommendations on improving program implementation.   4. Resolve regional issues and other concerns needing actions on the operationalization of the program.   5. Enforce a mechanism of moving stocks of drugs and medicines among RHUS with low levels of utilization in coordination with the concerned municipality.   Food and Drug Administration (FDA)   For the effective implementation of this undertaking, the FDA shall:   1. Provide atechnical staff to be part of the Technical Working Group (TWG) of the bidding process.   2. Provide a fast-lane for the issuance or renewal of the amended Certi\ufb01cate of Product Registration (CPR) of the suppliers of the DOH ComPacks.   3. Release the amended CPR within ten (10) working days after application.   4. Approve the packaging design and speci\ufb01cations of the DOH ComPacks.   5. Collect sample, tests and release the result of analysis (RA) of the delivered DOH ComPacks at the warehouses of the service provider.   6. Conduct random inspection and sampling of the DOH ComPacks delivered at the RHUS for con\ufb01rmatory testing.   7. Recall the product/s that fail in the result of analysis.   8. Impose penalties on the manufacturer and/or supplier of the product that failed and did not conform to product specifications based on FDA\u2019S existing relevant rules and regulations.   Central Of\ufb01ce Bids and Awards Committee (C OBAC)   The COBAC shall procure the DOH ComPacks in accordance with the RA 9184 and its IRR.   Material and Management Division (MMD)   1. Receive the goods from the local supplier as to quantity and speci\ufb01cation stated in the Purchase Order (PO).   2. Prepare reports of notice of delivery of goods:   b. Arrival Report to End-User  c. Request of Inspection and Acceptance to End\u2014User  d. Notice of Delivery to Commission on Audit (COA)  e. Request of Inspection to the FDA  f. Request of Inspection to the DOH Inspection and Acceptance Committee (IAC)   3. Oversees the inspection of drugs and medicines by the DOH-IAC together with the End-User and COA.   4. Manages the Service Provider for the warehousing, packaging of DOH ComPacks and for distribution to the different recipients.   5. Prepare the Issuances such as the Invoice Receipt of Property and Bill of Lading for the use of the Service provider in the distribution of the goods.   6. Prepare report of Issuances upon completion of deliveries/distribution and for submission to the Finance Service with the following attached documents:   a. Invoice Receipt  b. Sales Invoice  c. Purchase Order  d. Notice to Proceed  e. Inspection and Acceptance Report  f. Delivery Report   7. Prepares voucher for payment to the Service Provider and Suppliers.   Finance Service (FS)   The FS shall:   1. Facilitate the processing of payment of the supplier and the service provider.   2. Pay the suppliers in a timely manner upon submission of all necessary documents.   National Center for Disease Prevention and Control (NCDPC)   The NCDPC shall:   1. Develop Standard Treatment Guidelines (STG) to guide the use and dispensing the DOH ComPacks at the grassroot level.   2. Assist NCPAM and CHDS in the orientation and training of the MHOS on the proper dispensing and use of medicines included in the DOH ComPack program through adherence to National Standard Treatment Guidelines (N STG).   3. Assist in determining the list of medicines to be included in the DOH ComPack program based on national and local disease prevalence data and existing Standard Treatment Guidelines (STGs). \u2019   Department of Social Welfare & Development (DSWD)  As the national agency responsible for targeting/ enlisting the poor, the DSWD Shall:   1. Identify the bene\ufb01ciaries through the National Household Targeting System (NHTS).   2. Provide the DOH data on 4P3 and other related programs that will help in the proper implementation of the DOH ComPack program.   3. Assist the DOH in the monitoring and evaluation of Program speci\ufb01cally at the municipality level.   4. Participate in coordination meetings with partner agencies at all levels pertinent to the implementation of DOH ComPack program.   5. Assist in the advocacy and promotion of the DOH ComPack program.   Department of Interior and Local Government (DILG)   The DILG shall:   1. Encourage LGUS to incorporate pro-poor programs on health and nutrition in their plans and budget.   2. Assist the DOH in the implementation, monitoring and evaluation of the DOH ComPack program at the LGU level.   3. Assist in the advocacy and promotion of the DOH ComPack program.   Local Government Unit (LGUS)   The LGUS shall:   1. Assign inspection team from the provincial and municipal levels to inspect the DOH ComPack drugs delivered to the RHUS.   2. Authorize the MHO and for the Rural health Nurse (RHN) to facilitate the acceptance of the deliveries of the DOH ComPacks.   3. Help the DOH in promotion and advocacy of the program.   4. Participate in coordination meeting with DOH & other partner agencies at the provincial level in the implementation of DOH ComPack program.   VII. SEPARABILITY CLAUSE    If any provision in these Guidelines or application of such provision to any circumstance is held invalid, the remainder of these Guidelines Shall thereby not be affected.   VIII. REPEALING CLAUSE   AdminiStrative order No 2008- 0013 and all previous Orders inconsistent in part or in whole to this Administrative Order are hereby rescinded/ repealed.   IX. EFFECTIVITY   This Order takes effect immediately.  ", "  I. BACKGROUND   Persons with disabilities (PWDs), according the UN Convention on the Rights of Persons With Disabilities, include those who have long-term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their full and effective participation in society on an equal basis with others.   The International Classi\ufb01cation of Functioning, Disability and Health (ICF) refers to disability as \u201can umbrella term covering impairments, activity limitations, and participation restrictions. An impairment is a problem in body function or structure; an activity limitation is a dif\ufb01culty encountered by an individual in executing a task or action; while a participation restriction is a problem experienced by an individual in involvement in life situations\". The lCF\u2019s de\ufb01nition of disability denotes a negative interaction between a person (with a health condition) and his or her contextual factors (environmental and personal factors). A comprehensive approach in interventions is then necessary for persons with disabilities (PWDs) as it entails actions beyond the context of health, but more on helping them to overcome dif\ufb01culties by removing environmental and social barriers (WHO, 2013).   Globally, over 1 billion people, or approximately 15% of the world\u2019s population, have some form of disability. About 110 to 190 million people 15 years and older have signi\ufb01cant dif\ufb01culties in functioning. Moreover, the rapid spread of chronic diseases and population ageing contribute to the increasing rates of disability. About 80% of the world\u2019s PWDs live in low-income countries, wherein majority are poor and cannot access basic services. With their conditions, PWDs need greater attention and considerations in terms of health needs, without discrimination. However, reports show that PWDS have less access to health services and therefore have greater unmet needs (WHO, 2012.)   In the Philippines, the results of the 2010 Census of Population and Housing (CPH, 2010) show that of the household population of 92.1 million, 1.443 million Filipinos or 1.57%, have a disability. Region IV-A, with 193 thousand PWDs, was recorded to have the highest number of PWD among the 17 regions, while the Cordillera Administrative Region (CAR) had the lowest number with 26 thousand PWDs. There were more males, who accounted for 50.9% of the total PWD in 2010, compared to females, with 49.1% with disability. For every 1 \ufb01ve (5) PWD, one (18.9%) was aged 0 to 14 years, three (59.0%) were in the working age .2 group (15\u201464 years old), and one (22.1%) was aged 65 years and above (NSO, 2013).   The mandate of the DOH' to come up with a national health program for PWD was based on Republic Act No. 7277, \u201cAn Act Providing for the Rehabilitation and Self-Reliance of Disabled Persons and Their Integration into the Mainstream of Society and for Other Purposes\" or otherwise known as \u201cThe Magna Carta for Disabled Persons\" and the Implementing Rules and Regulations (IRR) of RA 7277. This document stipulated that the DOH is required to: (1) institute a national health program for PWDs, (2) establish medical rehabilitation centers In provincial hospitals, and (3) adopt an integrated and comprehensive program to the Health Development of PWD, which shall make essential health services available to them at affordable cost. In response to this, the DOH issued Administrative Order No. 2006\u20140003, which speci\ufb01cally provides the strategic framework and operational guidelines for the implementation of Health Programs for PWDs.   In 2013, a Medium Term Strategic Plan (2013-2017) was developed to strengthen the existing health program for PWDs. However, in the review done for the purpose, it was noted that in the implementation of the program in the past years, there were operational issues and gaps identi\ufb01ed that need to be addressed. These include among others, the need to strengthen multi-sectoral action to harmonize efforts of stakeholders; clarify delineation of roles and responsibilities of concerned government agencies working for PWDs; strengthen national capacity, both facilities and manpower, to provide rehabilitation services for PWDs from primary to tertiary level of care; provide access to health facilities and services for PWDs; and, strengthen registration database for PWDs.   Recently, the World Health Organization released the Global Disability Action Plan 2014- 2021. This document intends to help countries direct their efforts towards speci\ufb01c actions in order to address health concerns of persons with disabilities. The Action Plan identi\ufb01ed three major objectives: to remove barriers and improve access to health services and programmes; (2) to strengthen and extend rehabilitation, habilitation, assistive technology, assistance and support services, and community-based rehabilitation; (3) to strengthen collection of relevant and internationally comparable data on disability and support research on disability and related services.   Considering all of the above, there is a need to align the current needs and challenges in the implementation of the Health and Wellness Program for Persons With Disabilities (HPPPWD) with the thrusts and goals of Kalusugang Pangkalahatan or Universal Health Care, the Global Disability Action Plan 2014\u20142021, and, the direction the program should take in the succeeding years as articulated in the newly developed strategic plan, thus, this revision of Administrative Order No. 2006\u20140003.   II. OBJECTIVES   This Order provides the new framework that shall guide national and local actions towards strengthening implementation of the Health and Wellness Program for Persons with Disabilities (HPPWD) in attaining UHC and the above Disability Action Plan 2014\u20142021.   III. SCOPE AND COVERAGE   This Order shall cover all units and instrumentalities including attached agencies of the DOH. It shall also apply to local government units (LGUs), non-government organizations WGOS), professional organizations, private sector, organizations of persons with disabilities, and other relevant partners in the health sector.   IV. HEALTH AND WELLNESS PROGRAM FOR PERSONS WITH DISABILITIES U   The health and wellness program for persons with disabilities shall consider the following in the development of supportive policies and guidelines:   A. Vision: A country where all persons with disability, including children and their families, have full access to inclusive health and rehabilitation services.    B. Mission: A program designed to promote the highest attainable standards of health and wellness for PWDs by fostering a multi-sectoral approaCh towards a disability inclusive health agenda.   C. Objectives:   -To address barriers and improve access and reasonable accommodations of PWDs to health care services and programs.  -To ensure the accessibility, availability, appropriateness and affordability of habilitation and rehabilitation services for PWDs, including children with disabilities.  -To ensure the development and implementation of policies and guidelines, health service packages, including \ufb01nancing and provider payment schemes for health services of PWDs.  -To enhance capacity of health providers and stakeholders in improving the health status of PWDs. -To strengthen collaboration and synergy with and among stakeholders and sectors of society to improve response to a disability inclusive health agenda through regular dialogues and interactions.  -To provide the mechanism in facilitating the collection, analysis and dissemination of reliable, timely and complete data and researches on health\u2014related issues of PWDs in order to develop and implement evidence-based policies and interventions.   D. Action Framework for the Health and Wellness Program of Persons with Disabilities   The Action Framework for the Health and Wellness Program of Persons with Disabilities is adapted from the three major objectives of the WHO Global Disability Action Plan 2014\u2014 2021. As applied in the country, program actions or interventions shall focus on the following areas: 1) removal of barriers and improve access to health services and programs; (2) strengthening and expansion of rehabilitation, habilitation, assistive technology, and community-based rehabilitation; (3) strengthen collection of relevant and internationally comparable data on disability and support research on disability and related services.   Figure 1 depicts the Action Areas that the Health and Wellness Program for Persons with Disabilities shall focus its interventions along the thrusts and goals of Kalusugang Pangkalahatan or Universal Health Care.   Action Area 1: Removal of barriers and improve access to health services and programs. People with disabilities, including children, encounter a range of attitudinal, physical and systemic barriers when they attempt to access health care such as physical barriers related to the architectural design of health facilities or health providers\u2019 lack of adequate knowledge and skills in providing services for persons with disabilities, among many others.   Therefore, actions or interventions shall be under taken to ensure that persons with disabilities have access, on an equal basis with others, to health facilities and services. It is important to identify all of these barriers and institute collective actions to remove these barriers and improve access of persons with disabilities to health services and programs.   Action Area 2: Strengthening and expansion of rehabilitation, habilitation, assistive technology, and community based rehabilitation. Habilitation and rehabilitation are \u201csets of measures that assist individuals, who experience or are likely to experience disability, to achieve and maintain optimal functioning, in interaction with their environments\". Encompassing medical care, therapy and assistive technologies, they shall begin as early as possible and be made available as close as possible to where people with disabilities live.    Increasing government investments in habilitation, rehabilitation and provision of assistive technologies are expected actions or interventions that must be put in place. This is going to be bene\ufb01cial in the long run because they build human capacity and can be instrumental in enabling people with limitations in functioning to remain in or return to their home or community, live independently, and participate in all aspects of life. They can reduce the need for formal support services as well as reduce the time and physical burden for caregivers.   Action Area 3: Strengthening collection of relevant and internationally comparable disability data and support disability researches. Data is needed to strengthen health care systems, as it informs policy and interventions. These can be collected through dedicated disability surveys, or disaggregating data from other data collection efforts by disability status, and research.   Interventions along this action area should ensure that data collected would be internationally comparable and results of researches and studies done are used for informing policy and resource allocation. The use of the Philippine Registry for Persons with Disability is an intervention that shall be strengthened and made fully operational.   Figure 1: Action Framework for the Health and Wellness Program for Persons with Disabilities         V. GENERAL GUIDELINES:   A. The DOH shall develop systems, policies, and guidelines that shall facilitate the operationalization of the Health and Wellness Program for Persons with Disabilities in the country. Cognizant that disability is a cross-cutting issue involving all sectors and diverse actors particularly the persons with disabilities themselves, the Department of Health shall ensure that in the development and implementation of the Health and Wellness Program for Persons With Disabilities, this wide range of Stakeholders and partners, both private and government, shall be consulted, with issues and recommendations incorporated in the ensuing plans and programs that shall be developed.   B. The DOH shall develop mechanisms to ensure a disability inclusive health agenda, in particular, that policies and programs developed for health and development, disability dimensions are included and highlighted.   C. The program is designed to ensure improved health and well-being for persons with disabilities. As such promotion of health and wellness shall be the core strategy with prevention activities focusing on early identi\ufb01cation and intervention to prevent the development of secondary or co-morbid health conditions that are often associated with disability, prevention of the development of new impairments and prevention of existing impairments becoming worse.   D. Health services and programs developed for PWDs shall cater to various age groups addressing age-related health needs throughout the human life cycle.   E. Primary level health facilities such as rural health centers and primary hospitals shall provide appropriate services particularly on early detection, screening and proper referral.   F. Secondary and tertiary health facilities such as hospitals shall provide appropriate rehabilitation services and shall be fully equipped and manned accordingly.   G. Community participation shall also be enhanced to strengthen awareness on prevention activities as described above.   H. Interventions shall address health equity concerns and take into consideration the needs of the most vulnerable and marginalized sectors.   I. Research, surveillance, monitoring, and evaluation shall be institutionalized for sound policy formulation, planning, and decision-making processes. Capability of stakeholders to collect, analyze, disseminate, and utilize evidences shall be enhanced.   J. Networking and partnership with other sectors shall be strengthened to ensure synergies, avoid overlapping and duplication of activities, and prevent unnecessary competition in the implementation of initiatives. Commitment of stakeholders to the national plan of action on addressing PWD health and wellness concerns shall be strengthened.   K. Sustained funding and \ufb01nancial protection for the poor and the marginalized groups shall be pursued.   L. Monitoring and evaluation mechanisms shall be institutionalized to aid implementation and planning for subsequent actions.   VI. SPECIFIC GUIDELINES   A. The DOH shall provide leadership in promoting health and wellness for persons with disabilities and institute the following measures:   1. Develop a national program and plan of action on the health and wellness for PWDs, advocate and provide template for the integration of the said program and plan into the annual health action plans of local government units and other partners.   2. Strengthen health systems by:   a. Establishing program structure and provide funding for the purpose.   b. Strengthening human resources capacity and use innovative approaches to health workforce development, with a special focus on primary health care to equip health care providers with the necessary skills, knowledge and attributes to deliver effective services in promoting health and wellness for PWDs.   c. Facilitating resource mobilization and establishing sustainable \ufb01nancing mechanisms.   d. Promoting equitable access to and rational use of cost-effective health products and services related to the promotion of health and wellness for PWDs, particularly assistive devices and rehabilitation services.   e. Investing on strengthening and expanding rehabilitation services at all levels of care.   f. Strengthening referral mechanisms to ensure continuity of care and complementation of services within the health system.   g. Ensuring operationalization of the online registration of persons with disabilities at the level of primary health care.    3. Collaborate with local government units, private sector, and other partners to:   a. Deliver evidence-based and cost\u2014effective primary, secondary, and tertiary prevention interventions to promote health and wellness for PWDs with emphasis on primary health care.   b. Adopt, implement and monitor the use of evidence-based guidelines and establish standards of health care for PWDs and integrate whenever feasible their management into primary health care.   c. Develop and disseminate health service frameworks and packages, clinical practice guidelines and evidence\u2014based decision\u2014making support tools to health care providers to ensure timely screening, diagnosis, and management of disabilities.   d. Establish and support programmes to empower individuals and communities to deveIOp health literacy, to take on self-care responsibilities and to become resources for themselves and others in promoting health and wellness.   e. Implement and monitor cost-effective approaches for the early detection, screening, diagnosis and management of various disabilities.   f. Establish and support effective partnerships and develop collaborative networks with other stakeholders in order to encourage and promote community participation and grassroots mobilization and establish a broad base of support thus ensuring acceptability and effectiveness of policy and interventions.   4. Engage in health promotion and advocacy initiatives through the following:   a. Developing, implementing and sustaining health promotion initiatives on promoting health and wellness for PWDs with prevention activities focusing on early identi\ufb01cation and intervention to prevent the development of secondary or co\u2014morbid health conditions that are often associated with a disability, prevention of the development of new impairments and prevention of existing impairments becoming worse through improving access to health care and population-based public health programmes, and barrier removal.   b. Utilizing media and social marketing to increase knowledge and awareness in the promotion of health and wellness for PWDS.   c. Designing and implementing an advocacy campaign to mobilize political and . grassroots support and raise the priority accorded to health and wellness of PWDs.     5. Ensure the inclusion of health and wellness of PWDs in the national uni\ufb01ed health research agenda by:   a. Investing in epidemiological, behavioral and health system research for health and wellness of PWDs.   b. Working with partners and academic institutions for implementation of research initiatives.   c. Disseminating research \ufb01ndings and utilize the same for policy and program development.   6. Strengthen surveillance, monitoring, and evaluation systems for health and wellness of PWDs.   7. Develop standards for rehabilitation services including assistive devices.   8. Advocate for the establishment and strengthening of regulatory mechanisms to include among others the following:   a. Fiscal policies that would make assistive devices/technology available through pricing, taxation, subsidies and other market incentives;   b. Enhanced regulation on the provision of 20% discount on all health related services for PWDs,   c. Enhanced regulation on the implementation of universal design to all health related infrastructures, equipment and other implements.   B. Implementation Arrangement   The oversight for the implementation of this Order shall rest with the Assistant Secretary of Health, Of\ufb01ce for Technical Services supported by the Technical Working Group (TWG) on Health and Wellness for Persons with Disabilities chaired by the Director of the Disease Prevention and Control Bureau.   The members of the TWG consist of representatives from the Health Promotion and Communications Service, Disease Prevention and Control Bureau\u2014Essential Non- Communicable Disease Division, Family Health Of\ufb01ce, Of\ufb01ce of Special Concerns, Knowledge Management Information Technology Service, Epidemiology Bureau, Health Policy Development and Planning Bureau, Bureau of Local Health Development, and the Executive Director of the National Council On Disability Affairs and such other bureaus and of\ufb01ces deemed relevant and competent by the Cluster Head.   C. Roles and Responsibilities   The following of\ufb01ces and institutions shall assume the following roles and responsibilities:   1. The TWG shall provide direction and technical support on policies and plans pertaining to the health and wellness program for persons with disabilities. It shall also provide the forum for coordinating all aspects of the implementation of policies and programs. The Disease Prevention and Control Bureau Essential Non- Communicable Disease Division shall provide the secretariat to the Technical Working Group.   2. The Disease Prevention and Control Bureau (DPCB) shall: a. Oversee the implementation of the national policy and program on the Health and Wellness Program for Persons with Disabilities.   b. Establish standards and package of services on the program and ensure their quality, access, and availability at all levels of the health system.   c. Provide technical assistance and augmentation funds to the LGUS and other partners on implementation of these service packages.   d. Support the design of health \ufb01nancing for the health care needs of PWDs in collaboration with PhilHealth and other partners.   e. Conduct regular monitoring and evaluation on the implementation of the program.   f. Ensure participation of other DOH of\ufb01ces and bureaus and coordinate with partners within and outside the health sector for the effective implementation of the national program.   3. The Health Promotion and Communications Bureau (HPCB) shall:   a. Provide the lead in the development and implementation of a national advocacy campaign to promote and health and wellness for PWDs.   b. Advocate with other government agencies, non-government organizations, private sector, development partners, and other relevant stakeholders for support in policy development and resource generation towards the promotion of health and wellness for PWDs.   c. Provide technical assistance to ensure health promotion interventions at the 3 health ' promotion settings: community, school and workplace.   4. The Health Policy Development and Planning Bureau (HPDPB) shall:   a. Support the development of relevant policies on health and wellness for PWDs.   b. Assist in securing adequate funding for the program.   c. Facilitate and support program evaluation studies and researches.   5. The National Epidemiology Center (EB) and the Knowledge Management Information Technology Service (KMITS) shall:   a. Establish and sustain public health and hospital surveillance systems including the online registry for PWDs.   b. Facilitate collection, analysis, and dissemination of data on PWDs.   c. Support conduct of population-based surveys on disability.   6. The Health Human Resource Development Bureau (HHRDB) shall:   a. Develop, update as necessary and implement training and development plan of health, medical and allied, professionals, particularly those in primary health care facilities and hospitals on addressing health and rehabilitation needs of PWDs.   b. Facilitate integration of health and wellness of PWDs in the academic curriculum of health professionals.   c. Ensure availability and equitable distribution of disability related health professionals   7. The Health Facility Development Bureau (HFDB) shall:   a. Ensure access and availability to quality hospital and facility-based services and universally designed infrastructure and facilities including rehabilitation, habilitation, assistive devices, and other support services for persons with disabilities.   b. Establish standards for an ef\ufb01cient hospital referral system.   c. Facilitate development and implementation of hospital-based information and surveillance system to gather data particularly on mortality and morbidity on Q?\" persons with disabilities. Q '   8. The National Center for Pharmaceutical Access and Management (NCPAM) shall develop guidelines and standards and provide mechanisms to ensure that affordable, but quality  medicines are always available for persons with disabilities, and to ensure that PWDs are given priority.   9. The Bureau of International Health Cooperation (BIHC) shall coordinate with international development partners and other countries for technical and resource assistance on the promotion of health and wellness for PWDS.   10. The Philippine Health Insurance Corporation (PHIC) shall develop and implement health insurance package for persons with disabilities that will include screening, diagnosis, treatment and management, rehabilitation and provision of assistive device and other appropriate support services to reduce the \ufb01nancial burden and impoverishment of individuals and families with disabilities.   11. The Regional Of\ufb01ces (ROS) shall provide technical assistance and lead the regions to ensure local implementation of the Health and Wellness Program for PWDS.   12. DOH hospitals shall ensure provision of quality rehabilitation services for PWDs   13. The Local Government Units (LGUs) shall adopt and implement the National Program on Health and Wellness for PWDs and provide services and products in primary health care facilities and hospitals in their localities.   14. Non\u2014government organizations, professional groups, other government organizations, private sector, the Academe, and Civil Societies shall assist in the implementation of the Health and Wellness Program for Persons with Disabilities.   D. Funding   The Department of Health- Disease Prevention and Control Bureau and Regional Of\ufb01ces shall provide funds for technical assistance, monitoring, and health promotion campaigns, and to augment funds for local implementation, to ensure the operationalization of this policy and program framework. Local government units shall be encouraged to provide funds for products and services in their respective communities as well as other government agencies, non government organizations and other stakeholders to provide counterpart funds as appropriate to ensure the implementation of the Health and Wellness Program for PWDS.   VII. REPEALING CLAUSE   Administrative Order 2006-0003 and other related issuances inconsistent or contrary to the provisions of this Administrative Order are hereby repealed, amended or modi\ufb01ed accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and In effect.   VIII. EFFECTIVITY   This Order shall take effect immediately.   ", " I. RATIONALE   Non-communicable Diseases (N CDs) continue to be the top causes of deaths among Filipinos. Of these, hypertension remains the leading illness. Diabetes continues to be signi\ufb01cantaaffecting around 5% of our adult population (Source: FNRI - National Nutrition Survey, 2013).   To address the call for health interventions that are cost-effective and sustainable, the focus is on the most vulnerable risk group using two most common and easily detectable clinical manifestations of NCDs: hypertension and diabetes. By accelerating case detection of patients with risk factors, illnesses will most likely be found at an early stage, that is, before the onset of any damage to target organs.   Campaigns are needed to detect as many patients as possible in the early stages of hypertension and diabetes. Organizing patients into active Health Clubs is one of the strategies to ensure continuity of care, raise the effectiveness of lifestyle changes and prevent complications.   The following guidelines are hereby issued to strengthen the \ufb01ght against NCDs at the primary health facilities speci\ufb01cally, the health centers and barangay health stations. These guidelines reiterate the policies and thrusts outlined in the \u201cNational Policy on Strengthening the Prevention and Control of Chronic Lifestyle Related Non-Communicable Diseases (N CD)\u2019.\u2019 (DOH A0 2011- 003), and \u201cImplementing Guidelines on the Institutionalization of Philippine Package of Essential NCD Interventions (PhilPEN) on the Integrated Management of Hypertension and Diabetes for Primary Health Care Facilities\" (DOH A0 2012 \u2014 0029).   II. OBJECTIVES   A. General objectives   These guidelines aim to guide various stakeholders in health care in creating and sustaining Hypertension-Diabetes Health Clubs.   B. Speci\ufb01c objectives   1. De\ufb01ne the process of accelerating the identi\ufb01cation of patients based on the PhilPEN protocol, of creating a Patient Registry and of recruiting these patients into health clubs.   2. De\ufb01ne the services and activities of the health club that will ensure at least 90% continuity of care to hypertensive and diabetic patients according to the PHIL PEN guidelines on lifestyle changes and the DOH guidelines on community activities especially patient education and motivation.   3. Promote better access to maintenance medications and management of pharmaceutical supply chain.   4. De\ufb01ne the roles and responsibilities of the different DOH of\ufb01ces and agencies, the LGUs and other stakeholders in organizing and sustaining health clubs.   5. Create a mechanism for conduct of patient clubs that can be applicable for other diseases entities.   III. SCOPE AND COVERAGE   This issuance applies to all DOH units including its attached agencies, local government units (LGUs), non-government organizations, professional organizations, the private sector and other relevant partners in the health sector.   Chronic Lifestyle Related NCDs affect the vulnerable age groups in all economic levels. Case \ufb01nding and treatment shall no longer be limited to priority areas identi\ufb01ed through the Conditional Cash Transfer (CCT) program or to families under the National Household Targeting System (NHTS) for Poverty Reduction.   IV. DEFINITION OF TERMS   A. PhilPEN Protocol - is the Philippine Package of Essential Non Communicable Disease Interventions for low-resource settings adopted from WHO PEN. This protocol consists of guidelines for the integrated management of hypertension and diabetes through a total risk approach. The individual client/patient is assessed and managed based on using the risk prediction chart. The prediction charts can estimate the client/patients risk of having a cardiovascular event (CV risk) in the next ten years. This will be applied to all patients screened for and found to have NCDs.   B. Health Facilities \u2014 these are facilities that provide screening and management of diseases like hypertension and diabetes. May include but not limited to city health of\ufb01ces, rural health units (RHUS) and barangay health stations.   C. DOH Hypertension and Diabetes Registry \u2014 a registry of patients diagnosed with hypertension and diabetes in the health facilities, linked to iClinicSys of RHUs and Integrated Chronic Non Communicable Disease Registry of hospitals.   D. DOH Health Clubs \u2014 an organization that consist of of\ufb01cers with rules andby-laws and a common goal of improving the health and wellness of its members. Initially, these shall be organized in health facilities such as RHUs and expanded to barangays.   V. GENERAL GUIDELINES   A. ACCELERATED CASE FINDING. Accelerated case finding is applicable for persons 40 years old and above.   B. MANDATORY REGISTRY. All RHUs/health centers shall have a registry of all hypertensive and diabetic patients to closely monitor their health conditions and for provision of medications.   C. VOLUNTARY ENROLLMENT. All diagnosed patients with hypertension and/or diabetes in all public and private health facilities shall be encouraged to enroll in designated Hypertension-Diabetes Health Clubs in their health center but will remain voluntary. The list of health clubs shall be submitted to DOH Central Of\ufb01ce after validation of the Provincial and Regional Of\ufb01ces.   D. SERVICE DELIVERY NETWORK. Each health facility shall ensure that there is a network of higher facilities and providers within the province or city\u2014wide health systems where referrals and other health care services can be provided.   E. STANDARDIZIN G DIAGNOSTICS. Fasting Blood Sugar/Glucose (FBS) with 8 \u2014 10 hours fasting shall be the standard of screening for diabetes instead of random blood sugar to promote ef\ufb01ciency in use of resources and facilitate follow\u2014up. This shall be initially through the capillary method (glucometer) and con\ufb01rmed using the venous FBS.   F. FOLLOW \u2014 UP OF PATIENTS. All patients with diagnosed hypertension and diabetes, regardless of membership into a Health Club, shall be scheduled for regular follow-up and re-evaluation by a physician based on PhilPEN.   G. ADOPTION OF PhilPEN PROTOCOL. The PhilPEN protocol shall be the basis for further assessment, screening, management and follow\u2014up of patients seen in the facilities. Risk assessment of persons between 25 and 39 years old apparently healthy, with risk factors or with early manifestation of disease shall continue as de\ufb01ned in this protocol.   VI. SPECIFIC GUIDELINES   STAGE 1: Accelerated case \ufb01nding among the highest risk group   A. Identifying patients with hypertension and diabetes   1. Case Finding shall be done during:   a. Community campaign, or  b. Household visits   2. Case Finding shall be done through:   a. Blood pressure (BP) measurement of all persons 40 years old and above measured twice, 15 -30 minutes apart, by a Barangay Health Worker (BHW).  b. Risk assessment of clients 25 years old and above who visit the health center for other clinical complaints, based on PhilPEN.   3. Those found to have BP 2140/90 on both readings shall be referred to the local government staff (midwife or nurse) who shall verify the elevated BP reading one week later   4. All those veri\ufb01ed to have elevated BP 2140/90 by the health center midwife or nurse shall be:   a. Referred to the physician/Municipal Health Of\ufb01cer (MHO) to con\ufb01rm diagnosis of hypertension and examined for any sign or symptom of underlying causes (eg. renal disease) and target organ damage. Using PhilPEN, risk prediction can be done to estimate the cardiovascular risk of the patient.  b. Have their fasting blood sugar/ glucose (FBS) tested  c. Started on the \ufb01rst line antihypertensive medicine as prescribed by the doctor and if not contraindicated based on the available drugs provided by DOH (Amlodipine 5 mg, 1 tablet, daily) and test blood cholesterol if available  d. Registered in the health center Hypertensive Patient Registry Strongly encouraged to enroll in the Hypertension-Diabetes Health Club,  f. Assessed for secondary hypertension and/ or signs and symptoms of some target organ damage and then referred to a hospital for further evaluation   5. All other persons without hypertension but have a family history of diabetes, are obese and with signs and symptoms of possible diabetes shall also have their fasting blood sugar/glucose (FBS) tested.   6. All patients found to have high capillary F BS ( 2 7.0 mmolfl or 126 mg/dl) shall have their FBS retested using venous blood done by a medical technologist either in the health center laboratory, local hospital laboratory or a private laboratory and shall be:   a. Referred to the physician/MHO to con\ufb01rm diagnosis of diabetes and examined for any sign or symptom of target organ damage. Using PhilPEN, risk prediction can be done to estimate the cardiovascular risk of the patient.   b. Started on the \ufb01rst line anti\u2014diabetic drug as prescribed by the doctor and if not contraindicated (Metformin 500 mg daily).   c. Registered in the health center. Diabetic Patient Registry   d. Strongly encouraged to enroll in the Hypertension-Diabetes Health Club   e. Assessed for signs and symptoms of target organ damage and then referred to a hospital for further evaluation   B. Enrollment to the NCD Registries   1. Newly diagnosed patients shall be registered in the speci\ufb01c Chronic Disease Registry.   2. A patient who has both hypertension and diabetes shall be registered in both the Hypertension and Diabetes registries.   3. Deaths and geographic transfers 1n and out of their speci\ufb01c health facility shall now be recorded in the Chronic Disease Registries and reported to the DOH Regional Of\ufb01ces through the appropriate LGUs.   4. National Chronic Disease registries shall also be maintained by DOH through the Knowledge Management and Information Technology Service (KMITS).   C. Health Education   1. All patients registered in the hypertensive and diabetic patient registries shall have their \ufb01rst health education session given by the health facility nurse or midwife.   2. Topics on \ufb01rst health education session shall be composed of but not limited to the following:   a. Diet changes needed for their speci\ufb01c condition (e. g. increase intake of fruits and vegetables)   b. Increased physical activity (at least 30 minutes brisk walking three times a week),   c. Cessation of smoking and reduction of alcohol intake, when relevant, and   d. Prevention of common infections   3. Subsequent health education sessions to reinforce the health messages may be given by the midwife or a BHW specially trained for this task.   D. Follow-up   1. All patients with hypertension shall have their BP taken by the BHW at least once a week to verify that their BP is under control. Follow-up of these patients with the physician shall be monthly until BP is controlled and 3 \u2014 6 months thereafter. Those found to still have BP 2140/90 shall be referred back to the physician who may decide to:   a. Increase the dose of the current medication, OR   b. Shift medication to the second line drug if not contraindicated (Losartan 50 mg daily), OR   c. Add Losartan on top of Amlodipine   2. All patients with diabetes shall have repeat capillary FBS testing every three (3) months. Those found to still have F BS &gt 7.0 mmol/l or 126 mg/dl shall be re-evaluated by the health center physician or any physician who may decide to:   a. Increase the dose of the current medication, OR   b. Shift to the second line drug (Gliclazide 80 mg daily), OR   c. Refer the patient to a hospital for further evaluation   3. Patient treatment booklet shall be given to the patient and shall be used to monitor the dispensing of medications and health promotion activities. The booklet shall contain all the essential clinical information that should be assessed and monitored on a regular basis.   4. Clients who are 40 years old and above who still do not manifest any signs of hypertension or diabetes but are known smokers, have a family history of diabetes and/or are obese should continue to be followed up at least every 3 to 6 months since they are still considered low to moderate risk or with S 20% CV risk.   5. Summary of above-listed procedures (Annex A)    STAGE 2: THE ORGANIZATION AND MAINTENANCE OF HEALTH CLUBS   1. Enrollment   a. All patients with Chronic Lifestyle Related NCDs shall be encouraged to enroll in an appropriate health club in their respective health centers.   b. Patients who agree to enroll in the club shall \ufb01ll m up the application form (Annex B) and will be issued an ID and patient booklet.   c. The club member shall be informed of scheduled activities from which incentives can be provided if attended (e. g. 1 activity \u2014 I raf\ufb02e ticket; total of 3 raf\ufb02e tickets can be equivalent to a discount voucher for diagnostics/ gift items)   d. There shall be only one club for hypertensive and diabetic patients since many diabetics are also hypertensive and the activities to promote lifestyle changes are the same for both types of patients.   2. Establishing Other Health Clubs   a. Other health clubs for other types of chronic diseases such as Arthritis Health Club or Cancer Survivor Health Club may also be established as deemed necessary by the health facility.   b. Each health club shall elect their own of\ufb01cers and they are encouraged to meet at least once a month and election every year.   3. Core Activities of the Hypertension and Diabetes Health Club shall include:   a. Lifestyle improvement activities such as changes of diet, increased physical activities, cessation of smoking, reduction of alcohol intake;   b. Health education especially on prevention of common infections and proper use of medications, among others;   c.Periodic measurement of BP and FBS including reminders when these have to be repeated, eg. through mobile phones;   d. Replenishment of free medications; and   e. Mental health improvement activities to encourage bonding among members and to relieve stress.   4. Membership Number   a. Each club member shall be given a unique chronological Club membership number in the following format:   i. DOH Heath Facility Code (FC) of the National\" Health Facility Registry System \u2014 Year of enrollment in the club \u2014particular health club and chronological number of patient   ii. Example for the \ufb01rst club member who is registered in Payatas B Health Center, #17 Bulacan St.,2n'd District, Quezon City. Enrolled in the Hypertension and Diabetes Health Club, year 2016: FC102 \u2014- 2016 \u2014 H/D Club - 1   5. ID   a. Each patient shall receive a unique identi\ufb01cation (ID) card color-coded according to their clinical classi\ufb01cation as follows:   i. YELLOW: (&lt 20% risk score) the patient has hypertension OR diabetes only (no signs or symptoms of target organ damage).   ii. ORANGE: (20-30% risk score) the patient has hypertension AND diabetes without any sign or symptom of target organ damage.   iii. RED: (&gt 30% risk score) the patient has hypertension and / or diabetes AND signs of target organ damage.   b. When the clinical condition of the patient improves or deteriorates, he/ she shall be given an adjusted color ID.   c. Red coded patients shall also be enrolled in hospital\u2014based health clubs but they will retain their unique facility-based Club membership number. They can be active in either clubs but shall claim their free medications only from their respective RHUs.   6. Medications  a. Newly diagnosed hypertensive and diabetic patients shall:  i. Receive a prescription good for 3 months from the City/Municipal Health Of\ufb01cer  ii. Receive maintenance medications in the Rural Health Units where they are registered on a monthly basis.   b. Previously diagnosed hypertensive and/or diabetic patients who come to the health facility just to ask for free medications shall be:   i. Thoroughly evaluated: measure BP, test capillary FBS (glucometer), assess clinical signs and symptoms for target organ damage and underlying causes (eg. renal disease for hypertensive patients) based on PhilPEN   ii. Registered in the appropriate Chronic Disease Registry in the health facility.   iii. Strongly encouraged to enroll in a Hypertension-Diabetes Health Club.   iv. Given health education reiterating the lifestyle messages mentioned in First Health Education   v. Maintained on their current medications until the next follow- -up   c. Claiming of DOH maintenance medications   i. Patients shall personally claim their medicines in their respective RHUs. Alternatively, other people may claim for them as long as with authorization letter and patient booklet.   ii. Club members may collect their free medications \ufb01'om another RHU/Hypertension - Diabetes Health Club within the same region provided:   a. Both clubs are informed and agree to the modi\ufb01ed arrangement.   b. The drug allocation for these selected patients shall be transferred to the RHU where the patient will obtain his/her medicines to respond to the needs of the patient and at the same time avoid duplication of drug dispensing.   c. Inter-regional arrangements will only be possible at a later time when the national electronic registry system is in place.   7. DOH Health Clubs may engage in other activities, such as:   a. Peer group engagement in health education, regular activities like exercises and sustained medication to ensure continuity of care leading to better health outcomes.   b. Social activities like get-togethers to further raise the understanding of health messages (eg. the meals served should be diabetic-\ufb01'iendly or hypertensive- \ufb01iendly) -   c. Own fund raising activities to get free or discounted laboratory tests such as cholesterol test and ECG, among others.   d. Involvement of family members to encourage participation especially health promotion activities.   8. Af\ufb01liations  a. Patient-initiated health clubs, such as those organized in schools, workplace or churches, may be recognized as af\ufb01liated chapters in the Barangay where the school, workplace or church is located.   b. The health club may start with a few members that is health center/RHU \u2014 based and over time, with additional members, health promotion activities could be organized through a club in each Barangay.   c. The Barangay\u2014based club shall maintain its links with the Main RHU-based Club through speci\ufb01c activities that need the presence of physicians (e. g. during follow- up health assessment).   VII. MONITORING AND EVALUATION   1. The Task Force for Health Clubs shall develop a monitoring and evaluation mechanism to measure the inputs, processes and outcomes expected from the implementation of this issuance. The monitoring will be based on existing mechanism that is currently used for PhilPEN implementation and for inventory/utilization reports of medications.   2. The DOH Hypertension and Diabetes Club shall be measured in terms of:   a. Performance indicators to measure attainment of targets in terms of patients identi\ufb01ed and treated, health clubs organized and functional, and NCD drug utilization '   b. Indicators of the effectiveness of health clubs in preventing adverse health outcomes.   3. Periodic reports on the performance of various DOH of\ufb01ces and agencies shall be written and disseminated through quarterly monitoring and performance evaluation meetings with appropriate DOH of\ufb01ces and stakeholders.   4. Guidelines for monitoring of drug reactions at the RHU level will be developed by the Pharmaceutical Division in collaboration with the Food and Drug Administration.   VIII. ROLES AND FUNCTIONS   1. Disease Prevention and Control Bureau (DPCB) shall:   a. Provide technical assistance to various stakeholders in clarifying the integration of this guideline with the policies/guideline mentioned above (A0 2012-0029 and A0 2011-0003). '   b. Assist the DOH Regional Of\ufb01ces in translating the national DOH guidelines into simple, locally useful \ufb01eld implementers\u2019 manuals and tools by providing samples and models of patient manuals for adaptation to \ufb01eld conditions.   c. Oversee the development of a practical mechanism to harmonize and monitor inputs, processes and outcomes related to these chronic diseases   2. Bureau of Local Health System Development (BLHSD) shall:   a. In collaboration with DPCB and PD, provide technical assistance to the LGUS, through the DOH Regional Of\ufb01ces, on the formation and maintenance of Hypertension-Diabetes Health Clubs and other health clubs especially in clarifying the role of BHWs and LGUS and translating the national DOH guidelines into simple, locally useful \ufb01eld implementers\u2019 manuals and tools through samples and models of well-organized health clubs.   b. Facilitate the organization of health clubs by assisting the DOH Regional Of\ufb01ces in advocating for support for health clubs among the Local Chief Executives and through the BHW Federation, and various NGOs working in the communities, among others.   c. Collaborate with DPCB and other DOH units in developing a practical mechanism to harmonize and monitor inputs, processes and outcomes related to the organization and maintenance of health clubs.   3. Knowledge Management and Information Technology Service (KMITS) shall:   a. Maintain the National Chronic Disease Registry based on data \ufb01'om the various sources especially the LGUS.   b. Facilitate the submission of timely Chronic Disease Registry reports by the DOH Regional Of\ufb01ces by assisting them develop their recording system through capability building.   c. Through the Logistics Management Division, ensure the timely and secure distribution and accounting of essential drugs and medicines purchased by DOH for NCDs and assist in developing ef\ufb01cient and secure mechanisms for drug distribution and monitoring.   4. Health Promotion and Communication Service (HPCS) shall:   a. Provide technical support in the development of promotion and IEC materials and the conduct of advocacy and health education activities for Hypertension-Diabetes Health Clubs.   b. Advocate among other government agencies, non-government organizations, private sector, development partners and other relevant stakeholder towards a supportive environment for health clubs.   5. DOH Regional Of\ufb01ces shall:   a. Provide technical assistance to LGUS and various stakeholders within their Region by disseminating and clarifying the   i. Integration of this guideline with the polcieses/ guidelines mentioned above (A0 2012- 0029 and A0 2011- 0003).   ii. Updating and maintenance of Chronic Disease Registries and the importance of compliance with the Phil PEN protocol.   iii. Role of BHWs and LGUS.   iv. Adapting nationally-developed \ufb01eld implementers\u2019 manuals and tools into local manuals and tools.   b. Facilitate the formation of Hypertension-Diabetes Health Clubs among the LGUS within their Region by assisting them in identifying methods, interventions and resources and by providing a responsive and supportive health system   c. Oversee the monitoring of the inputs, processes and outcomes of the activities of Hypertension-Diabetes Health Clubs within their Region based on the monitoring, feedback and evaluation mechanism developed for health clubs.   6. Development Management Of\ufb01cer (DMO)/DOH Representatives shall:   a. Be the overall coordinator of the Hypertension and Diabetes Health Club within his/her catchment area/LGU   b. Ensure that guidelines and procedures for the club are understood by the LCE and health facility staff/providers   c. Solicit the active participation of the LCE especially provision of support to the club   d. Assist in monitoring and evaluation of the activities and operations of the club   7. Pharmaceutical Division shall:   a. Collaborate with the KMITS-LMD and the Procurement Service to ensure the timely purchase and distribution of essential medicines for NCDs.   b. Collaborate with DPCB and BLHSD in developing an ef\ufb01cient and secure drug distribution and monitoring system for drugs and medicines purchased by the PD for NCDs and distributed through Hypertension-Diabetes Health Clubs.   c. Assist the DOH Regional Of\ufb01ces in disseminating important information on the proper use, handling and utilization of drugs and medicines.   d. In collaboration with FDA, develop guidelines for monitoring drug reactions at the RHU level (pharmacovigilance).   8. Philippine Health Insurance Corporation (PHIC or PhilHealth) shall:   a. Incorporate the NCD medicines that are not yet covered by DOH in the primary care package that would be reimbursed to the Health Care Provider through PhilHealth \ufb01nancing   b. Develop other Diagnostic Services in the primary care package that will complement the programs of DOH through Health Clubs   c. Facilitate/Assist the enrollment of patients in the Chronic Disease Registry in the PhilHealth programs e. g. Sponsored Program, Informal Sector and orient in their rights, privileges and how to avail of PhilHealth bene\ufb01ts   9. City Health Of\ufb01ces/Rural Health Units shall:   a. Develop their facility-based Hypertension and Diabetes Club using this guideline   b. Identify a point person within the facility (6. g. MHN) who will oversee the plans and activities of the club. T 0 guide club of\ufb01cers and members in ensuring that plans are carried out and provide assistance in coordinating with other RHU staff or stakeholders if resource persons are needed during activities.   c. Ensure sustainability of health clubs through regular follow-up of patients and registry and conduct of activities that promote education/ awareness   d. Submit monitoring and evaluation reports on a regular basis   e. Ensure close coordination with the Regional and Provincial Health Of\ufb01ces, LGUS and other stakeholders   10. Local Government Units shall:   a. Implement and support the formation of the club per primary health care facility within their area.   b. Provide support to PHOs/CHOs/MHOs in the logistics needed by the club.   IX. FUNDING   The Department of Health Central Of\ufb01ce through DPCB, BLHSD and HPCS shall provide funds for technical assistance, commodities such as glucose strips, monitoring, capacity building and health promotion campaigns to ensure that the above-mentioned activities are implemented. Likewise, the Regional Of\ufb01ces through counterpart departments/divisions of central of\ufb01ce shall allocate funds for the same strategies.   The Pharmaceutical Division shall allocate funds and procure maintenance medications needed for chronic diseases.    Local government units shall provide funds for health facility activities in their respective communities. Other government agencies, non-government organizations and other stakeholders and partners in health shall provide funds as appropriate to ensure the implementation of this guideline.   X. REPEALING CLAUSE   The provisions of Department of Health Administrative Order 2011\u20140013 (Implementing Guidelines on the DOH Treatment Pack) limiting the distribution of ComPack medicines to CCT priority areas and NHTS families are hereby repealed. All other previous Orders and other related issuances inconsistent or contrary to the provisions of this Administrative Order are also hereby repealed, amended or modi\ufb01ed accordingly. All other provision of existing issuances which are not affected by this Order shall remain valid and in effect.   XI. EFFECTIVITY   This Order takes effect immediately.  ", "  1. Background  The first national diabetes prevalence survey conducted by the Department of Health was done in 1982. The result showed a prevalence rate of 4.1% in a randomly selected population of 12,297, ages ranging from 20-65 years old. For a developing country, this figure is a notable public health problem. According to WHO, the prevalence rate of diabetes is expected to double every ten(10) years. With the present population of 65 million, the problem posed by diabetes as a disease can be tremendous. It is now estimated to affect at least 3 million Filipinos.  Currently, there is no existing national program addressing this chronic disabling disorder except for the present clientele being served at private clinics and hospital centers. Many do not have access to health services and some can avail only of inadequate health services.  In recognition of the current and emerging importance of diabetes, a concerted effort has been organized to commonly address the diverse problems of the disease. In the National Conference for the Hospitals as Centers of Wellness Program, the action plan of the Diabetes Consortium was cited for implementation. It called for active support and participation from all sectors concerned. Integration of public health and clinical components must be emphasized utilizing and encompassing ail aspects of preventive strategies. The Non-Communicable Disease-Control Service (NCDCS), Office for Public Health Services, is mandated and tasked, through Executive Order No. 119 s. of 1987, to anchor the Diabetes Mellitus Prevention and Control Program (DMPCP}.     2. Policy It is the policy and responsibility of the Department of Health, in support to the 42nd World Health Assembly Resolution on Diabetes Mellitus as a major public health problem, to plan, organize and implement a nationwide Diabetes Prevention and Control Program. The program shall aim to reduce morbidity and mortality from diabetes including its complications and thus, improving the quality of life of the diabetics in the country. The Non\u2014Communicable Disease Control Service shall be the lead agency responsible for the over-all management and implementation of the Diabetes Prevention and Control Program. All DOH agencies concerned as well as cooperating government and non\u2014government institutions/organizations shall be tapped in the implementation of program activities identified.     3. The Program The Diabetes Mellitus Prevention and Control Program is a comprehensive, integrated approach aimed at curbing the alarming morbidity and mortality from diabetes and its complications and the improvement of the quality of life of the diabetics. It utilizes all levels of preventive care in the community and hospital settings with the appropriate medical/therapeutic support.    4. Components of the Program  4.1 Health promotion and education  This includes patient information and education; public information and education and; intersectoral collaboration on the nature and extent of diabetes, particularly its risk factors and complications and the need/ urgency of early diagnosis and management.  4.2 Manpower development and Strengthening of existing diabetes management capabilities.  The program shall provide continuing training and education(refreshers/updates) of core trainers and implementors, both in the national and field level. It shall include strengthening of treatment/management capabilities of existing and proposed diabetes clinics taking into utmost consideration basic quality assurance and standardization of procedures and techniques appropriate to each locality (community and hospital settings).   4.3 Service delivery/ Integration of diabetes prevention and control at the community level  The program shall provide for the integration and provision of services at the lowest possible level of community health care interventions. This means primary prevention concentrating on nutrition, exercise and anti\u2014smoking advocacy; secondary prevention: screening/ early detection, simple/basic management/counseling, referral and/or definitive care and; tertiary prevention: management of complications, continuing care and follow\u2014up, including rehabilitation)  4.4 Monitoring/Evaluation  To monitor/ assess and evaluate program implementation, its processes and adequacy. Baseline data will be established. It shall be a built\u2014in component and there will be a periodic, process and impact evaluation every year and five years thereafter and /or depending on the need of the program.   4.5 Research  The program shall support research/studies in the clinical(registry shall be established), behavioral(knowledge, attitudes and practices) and epidemiological(trends and determinants of diabetes) areas.    5. Implementing Guidelines  5.1 Health promotion and education  This shall be a coordinative and collaborative activity. The program shall identify specific messages, prepare and design communications plan with the support and guidance from the Public Information and Health Education Service(PIHES). Each of the collaborating agencies and organizations shall have Information Desks at the national and regional levels for the dissemination of diabetes information.   5.2 Manpower development and Strengthening of diabetes management capabilities  The core of trainers(medical centers/regional hospitals/regional health offices) and field implementors(provincial/district and municipal) shall have access to continuing training and education as provided in a specific protocol.  The necessary resources for diabetes diagnosis, management and rehabilitation appropriate at every level of care shall be provided from internal and external sources.  5.3 Service delivery   The program shall develop specific administrative and clinical policies and procedures for the delivery of basic health care services for diabetes appropriate at each level of care. This shall be embodied in a manual of operations.  5.4 Monitoring and evaluation  An annual review of program implementation will help to compare the actual and projected program processes and outcomes. At the completion of the first year of the program, an assessment can be made whether strategies to meet the objective have been implemented. After 3\u20145 years, program priority objectives and strategies could have been identified and corresponding reprogramming shall be effected.  5.4 Research   Important biomedical and treatment advances are being made for diabetes. Translation or application of research findings may improve patient welfare. Research support and activities are needed- but they should be compatible with national resources and overall priorities.    6. Advisory Council  The program shall have an Advisory Council to advise on issues of planning, policy, priority setting, training, research, resource allocation, program operation and evaluation.  Membership shall be both multidisciplinary and intersectoral, representing the diabetes field, health care, academic, research, business, voluntary and consumer communities. They shall be recognized by the Secretary of Health upon recommendation from leading experts in the field of diabetes and related disciplines as selection comes from a pool of credible nominees. A high level of commitment is desired because ultimately the success of the program is based on the committee\u2019s enthusiasm, commitment and willingness to advocate for resources.  Specifically, it shall advise on objectives and priorities in a timely and systematic way. They shall meet regularly to review program progress and make recommendations. Staff support should be available from the Non-Communicable Disease Control Service(to be headed by a designated National Diabetes Program Coordinator/ Assistant Executive Officer for the Program) and a corresponding/counterpart from a leading concerned non-government organization for technical and administrative matters.  This shall be composed of a Chairman, an Executive Officer and five members from concerned agencies/organizations. The Chairman shall call and preside over all council meetings, provide direction in the formulation of policies/plans and programs and performs other duties as may be assigned. The Executive Officer(Director of Non\u2014 Communicable Disease Control Service) shall perform liaison work between the Advisory Council, Office of Public Health Services, Office for Hospitals, Facilities, Standards and Regulations, etc.. He shall be responsible for the preparation and submission of periodic reviews of program\u2019s progress, monitor program implementation at field and hospital leVel, recommend policies and programs to the Council and performs other duties as may be assigned.  The Council shall be advisory and recommendatory to the Secretary of Health and shall submit periodic reports.    7. Timetable of Implementation   Phase I- Immediate: 1995   7.1 Establish/strengthen multi-sectoral coordination/collaboration. Identify concerned government and non-government organizations in the implementation of a diabetes mellitus prevention and control program.  7-2. Support legislative agenda. Lobby for adequate appropriations necessary for implementation of the program.  7.3 Strengthen the Consortium of Government Diabetes Clinics under the Hospitals as Centers of Wellness Program to address/absorb current and prospective cases  7.4 Establish baseline data, conduct a national prevalence study as a basis of implementation of strategic intervention measures for the prevention and control of diabetes mellitus in the country.   Phase II\u2014 Intermediate: 1996\u20141999  7.5 Identify/ Implement apprppriate strategies and allocation of needed resources particularly for the comprehensive, integrated community\u2014based interventions.   Phase III\u2014 Long-term: 2000 and onward  7.6 To have established effective surveillance system for diabetes mellitus and its related risk factors and complications,  7.7 To have established health promotion and education strategies for health care providers to the community, the family and individuals affected.   7.8 An improved health care program for diabetes in the field health services, thus reducing morbidity, disability and mortality from diabetes and its complicatons and eventually, adapt the program for other chronic diseases(cardiovascular, blindness, rehabilitaton, etc.) prevention and control in the community utilizing the INTERHEALTH model of the WHO.    8. Repealing clause   All Orders, circulars, Administrative issuances which are inconsistent with this Order, are hereby repealed or amended accordingly.     9. Effectivity  This Order takes effect fifteen (15) days after publication in the Official Gazette or in two newspaper of general circulation.    ", " I. Background and Rationale   Pregnancy is a time to promote healthy behavior and parenting skills. Good antenatal care (ANC) is important in the development of the unborn and links the woman and her family with the formal health system. Inadequate care during the antenatal periodbreaks the continuum of care which can compromise health of both mothers and newborns. While ANC indirectly saves the lives of mothers by promoting and establishing good health during pregnancy and the postnatal period the time periods of highest risk, it improves the health and survival of the newborns directly by reducing stillbirths and neonatal deaths.   Antenatal Care (ANC) coverage in the country can be considered a success story with 78% of women having at least 4 ANC visits recorded in 2014 (National Safe Motherhood Program Report). However, to achieve the full life-saving potential that ANC promises to mothers and babies, an enhancement of the current ANC practice is necessary along with strict compliance to protocol by health professionals attending to births at all levels of the health system.   II. Objectives   This Order seeks to improve the quality of antenatal care through the provision of technical guidance in the shift in ANC concept from the high risk approach to the four-visit model of focused ANC and the consequent service delivery scheme of the ANC package.   III. Scope of Application   This Order shall apply to all providers of maternal and newborn care services in the public and private sector and at all levels of the health care delivery system.   IV. Definition of Terms and Acronyms   1. Antenatal Care (ANC) also known as prenatal care is a type of preventive healthcare accorded to pregnant women with the goal of providing regular check- ups that allow doctors, nurses and midwives to identify, prevent and treat potential health problems throughout the course of the pregnancy while promoting healthy lifestyles that bene\ufb01t both mother and child.   2. High Risk ANC is a method of providing antenatal care with the objective of classifying pregnant women as low risk or high risk based on pre-determined criteria. This approach is hard to implement effectively since a woman may have more than 1 risk factors and not all high risk develop complications in like manner that some low risk women develop complications particularly during childbirth.   3. Focused ANC is an individualized goal oriented ANC that provide specific evidence\u2014based interventions to women, carried out at certain critical times in the pregnancy. This comprise the following essential elements:   a. Pregnancy Tracking or the identification and surveillance of the pregnant woman and her expected child.   b. Screening for conditions and diseases such as anemia, STIs (sexually transmitted infections) particularly syphilis, HIV (human immunodeficiency virus) infection, Hepatitis B infection, mental health problems, and/or signs of stress or domestic violence.   c. Recognition and management of pregnancy-related complications, particularly hypertensive disorders of pregnancy.   d. Recognition and treatment of underlying and concurrent illness.   e. Preventive measures, including tetanus toxoid immunization, deworming, iron and folic acid supplementation, calcium carbonate supplementation, iodine oil capsule supplementation in areas with low urinary iodine excretion levels; and, in malaria endemic areas, intermittent preventive treatment of malaria in pregnancy (IPTp) and insecticide treated bed nets (ITN).   f. Advice and support to the woman and her family for developing healthy home behaviors and a Birth Plan.   4. Birthing Center is a healthcare facility also known as birthing home, lying \u2014in and ' paericultare center. It can be a Rural Health Unit, Health Center, City/ Municipal/ Commanity/Medicare/District Hospitals that provide birthing services. It can also be the unit in secondary and tertiary hospitals where maternity care services are provided such as the out-patient obstetrics department, delivery room and maternity ward. It provides antenatal care, birthing care and postnatal care. It is staffed by doctors who are general practitioners or with specialization in obstetrics, nurses or nurse-midwives and midwives trained on basic emergency obstetrics and newborn care.   5. Maternal Health Services refer to a range of services that covers care during the periods that include, but are not limited to, antenatal, delivery, and postpartum periods. (RPRH Law IRR). -   V. Guiding Principles   All health workers 1n Birthing Centers shall be guided by the following principles in the provision of ANC:   1. ANC is an important entry point in the provision of integrated care. Conditions such as sexually transmitted infections, tetanus, HIV, tuberculosis, malaria, diabetes, some nutritional de\ufb01ciencies and other conditions that may arise can be addressed during ANC:  - Prevention of Maternal and Neonatal Tetanus. ANC provides an opportunity to immunize pregnant women with the recommended (at least) 2 doses of tetanus toxoid and provide advice and schedule towards the completion of the immunization at postpartum.  - Prevention and case management of maternal malaria in endemic areas. Asymptomatic malaria infection of the placenta can result to maternal anemia and contribute to low birth weight and preterm birth. ANC offers a means to increase the coverage of key interventions for malaria in pregnancy: IPTp (intermittent prevention and treatment of malaria in pregnancy) and ITN (insecticide treated bed nets).  - Prevention of maternal anemia, neural tube defects and malnutrition. Anemia during pregnancy increases the risk of dying from hemorrhage. It is also associated with an increased risk of stillbirth, low birthweight, prematurity and neonatal death. Thus, irOn and folic acid supplementation, deworming, malaria prevention, improved obstetric care, and management of severe anemia are essential in the prevention of neural tube defects and control of maternal anemia and malnutrition during pregnancy.  - Prevention of sexually transmitted infections (STIS) and mother-to-child transmission of HIV (PM T C 7). Universal syphilis screening and treatment during ANC has been established to be feasible and cost effective intervention since syphilis complications are severe yet therapy is cheap and effective. On the other hand, through the opt-out system or the health worker initiated HIV counseling and testing, ANC 1s a key entry point for the prevention of mother- to- child transmission of HIV (PMTCT) services.   2. ANC o\ufb02ers an opportunity to develop a Birth Plan. The National Safe Motherhood Program recommends that health workers assist all pregnant women to have a written plan for dealing with childbirth and any unexpected adverse event such as obstetric complications that may occur anytime during pregnancy, childbirth and the immediate postnatal period.   3. ANC visits provide opportunities to promote lasting health, o\ufb02ering benefits that continue beyond the pregnancy period. This includes birth preparedness and extends to cover health information and counselling for pregnant women, their families and communities.   VI. Specific Guidelines   ANC presents the first opportunity for a woman to connect with the health system and thus an entry point for integrated care. To ensure that women and newborns bene\ufb01t from ANC the following shall guide skilled health professionals in the provision of antenatal care:   1. Pregnancy Tracking shall be done in all communities by the Barangay Health Workers (BHW's) and shall be used as an opportunity to encourage women to access antenatal care at the nearest birthng center.   2. All pregnant Women shall be provided with focused antenatal care (ANC).   a. The first ANC visit shall be considered crucial for early identi\ufb01cation of underlying conditions such as chronic hypertension, diabetes, anemia and the like and shall be done as early as possible preferably during the \ufb01rst trimester. Likewise, this visit shall distinguish women who require the standard 4-visit model from those requiring special attention and more visits.   b. The last visit shall be at around the 37 weeks or near the expected date of delivery to ensure that appropriate advice and care have'been provided to prevent and manage dif\ufb01cult labor and problems such as multiple births, post- maturity and mal-presentation.   3. Focused antenatal care interventions for healthy women with no underlying medical problems shall be provided over 4 visits at speci\ufb01ed interval: 1 visit during the lSt trimester (8- 12 weeks), 1 visit during the2 ndtrimester (24- 26 weeks) and 2 visits during the 4\u201c trimester at 2 weeks interval (32 weeks and 36- 38 weeks). For women with underlying medical conditions, focused antenatal care may require more visits upon doctor\u2019s advice.   4. All pregnant women shall be required to have a written Birth Plan (contained in Mother-Baby Book, Mother and Child Book, Rekord ni Nanay, Nanay and Baby Book, other similar health records) at the \ufb01rst ANC visit. The women should discus-s and review this plan with a health worker at every ANC visit and 1 month before the expected date of delivery. The birth center nurse or midwife shall ensure the identi\ufb01cation of the following elements in the plan:   a. Desired place of delivery;  b. Name and location of the nearest birthing center;  c. Name of birth attendant,  d. Name and location of the nearest referral hospital;  e. Funds for birth-related and emergency expenses;  The birthing center staff should orient the woman about Philhealth membership benefits and enrolment at the point of care in case she is not a member yet.  f. Desired birth companion;  g. Things to prepare for the newborn and things to bring on delivery date;  h. Available support from community workers, e.g. BHWs in looking after the home and children while the woman is away to give birth;  i. Transport from home to a health facility, including contact person, contact number and cost;  j. Transport from the birthing center to a referral facility in case of obstetric emergency, including contact person, contact number and cost;  k. Identi\ufb01cation of at least 2 blood donors in case of emergency including contact numbers.   5. Health professionals in birthng centers shall effectively use each visit to provide opportunities to promote lasting health and offer bene\ufb01ts that continue beyond pregnancy and delivery. Thus, each woman accessing antenatal care shall be given a Mother and Child Book. The Mother and Child Book shall be used not only as a tool to prepare for birth but also to provide information and learning about pregnancy and child care. With the aid of the Mother and Child Book health workers should be able to inform, educate and give advice about \u2014   a. Proper nutrition and rest  b. Promotion of early and exclusive breastfeeding  c. Smoking cessation  d. Avoidance of alcohol and drugs  e. Personal hygiene including oral health  f. Guidance about family planning  g. Newborn and child care including immunization schedule  h. Child nutritional status through the growth monitoring chart that includes weight and height monitoring   Likewise, all essential information and birth center visit \ufb01ndings shall be accurately recorded in the Mother and Child Book. The coverage of 4 or more ANC visits disaggregated by trimester is important because the effectiveness of certain interventions such as iron with folic acid and calcium carbonate supplementation, tetanus toxoid vaccination and provider initiated counselling and testing (PICT) for HIV, syphilis and hepatitis B depend on repeated visits and the trimester in which they occur. This guides the woman and health providers as well on actions to take-and make referrals ef\ufb01cient.   The Mother and Child Book is a record that should be held by the woman. The Birthing Center nurse or midwife should instruct the woman to bring the Book during every health center visit and at the time of delivery.   All birthing centers shall guarantee the provision of focused ANC by establishing and maintaining a network of service providers (service delivery network) as necessary to ensure that all the essential services are delivered to every pregnant woman. The network of service providers may include hospitals, specialized clinics such as the Social Hygiene Clinic and laboratories both in the public and private sector. '   All birthing center staff at each level of the health care delivery system shall comply with the ANC goals and activities at each visit based on the 4-visit model as applied in focused ANC:       8. Where the required services are not available at the Birthing Center, e.g., HIV ,_ testing, syphilis testing, etc, the Birthing Center head shall be responsible for referring the woman to an appropriate facility for the tests and/or treatment and ensure that the referral and the services required has been adequately served.   9. The result of the tests as well as the recommended medical management and treatment shall be appropriately compiled in the Individual Record at the Birthing Center. Relevant information shall be recorded in the Mother and Child Book for future reference.   10. Antenatal care services as provided for in this Guideline shall be part of the Maternity Care Package and shall be reimbursed by PhilHealth to appropriate facility providing speci\ufb01c service(s).   11. The following indicators shall be the indicators for quality antenatal care and shall be reported as part of the National Safe Motherhood Program Results Matrix starting 2017 (Please refer .to the ANC Utilization Report matrix in the attached annex of this policy):   a. Proportion of women who gave birth with a written birth plan.  b. Proportion of women who gave birth who had at least 4 ANC visits.  c. Proportion of women who gave birth who had at least 2 tetanus toxoid vaccination during their pregnancy. ' '  d. Proportion of women who gave birth who receive IPTp for malaria during their pregnancy. '  e. Proportion of women who gave birth who tested positive for HIV during their pregnancy.  f. Proportion of women who gave birth who tested positive for syphilis during their pregnancy.  g. Proportion of women who gave birth who were referred to a treatment hub or given treatment at the birthing center.   VII. Effectivity   This order shall take effect immediately.  ", " 1.0. Background/Rationale  Modern Natural Family Planning (NFP) methods were recognized as effective along with other methods in the Philippine Family Flaming Program (PFPP) when these were included in the method mix of the PFPP in 19911 (DC No. 101-A s1994). However, detailed guidelines were not issued until October 1996 (DC No. 299-A s1996) on Lactational Amenorrhea Method (LAM) and May 1997 (DC No. 130 s1997) on the institutionalization of the other NFP methods.  Initial trainings on NFP were conducted but these were limited to core courses. Training quality and follow-up were also poor. Thus, mainly due to the lack of adequate resources and programming support, NFP usage is as low as 0.1% among currently married women aged 20 - 39 years old (NSO 1999 PP Survey). Random visits of trained health providers confirm the low level of technical expertise and confidence on NFP among frontline health providers at the health service units and hospitals.  Considering a modern method contraceptive prevalence rate of only 32.4, as many as 67.6% of currently married women stand to benefit from using modern NFP methods. Considering further that NFP is the only method acceptable to the Catholic Church, the strong potential contribution of the method to health risk reduction through partnerships between church and government units cannot be over emphasized. It is also observed that many women on temporary methods, such as oral contraceptives and condoms, suddenly stop usage when supplies run out or side effects are felt. More often than not, they could not immediately visit the health facility to shift to another method. If couples were routinely trained on NFP, they could practice the method during the transitions while they are not yet able to get their refill of pills or condoms or are not yet able to return for counseling.  Mainstreaming NFP is also important in order to enforce the policy of providing full information to couples in their choice of PP methods. Until NFP is made easily and adequately available, decisions on contraceptive choices cannot be said to be genuinely informed choices.  To accelerate the mainstreaming of NFP, there is urgent need to raise Fertility Awareness so that NFP can be more easily understood and applied as a family planning method. Largely due to lack of accurate information and health education, the term \"natural\" is still loosely used by many Filipinos to refer to all practices that do not involve devices or drugs, for instance, the use of ampalaya price to prevent pregnancy. Sometimes, the term is also used to refer to not having any family planning method at all. These misconceptions are found not only among the poor sectors of society but also among health providers and elite groups. Awareness of the fertile and infertile phases of a woman's cycle (fertility awareness) is low, especially among adolescents.  In addition, there are other confusing messages that hinder the mainstreaming of NFP in the Philippines, such as:  1. That the level of education affects the couple's success in NFP: The level of formal education does not appear to be a factor in a person's ability to learn NFP. In a WHO 5-country study, 93% of the women, representing a wide range of socioeconomic and educational levels, were able to correctly identity fertile and infertile phases during the first cycle. An NFP center where 48% of women are illiterate was just as successful at NFP compared to 2 other centers where the women had postgraduate education.  2. That breastfeeding mothers and women with irregular cycles cannot use NFP: While this may apply to the rhythm method, this does not apply to the modern NFP methods. Breastfeeding mothers and women with irregular cycles can still successfully use the modern NFP methods.  3. That there is the need to have complete abstinence from intercourse for a whole month before using the cervical mucus method: This is not necessary and only creates undue tension in the couple. In addition, many women have already instinctively noticed the changes in their cervical mucus even before formal instructions about it.  4. That women with alcoholic husbands cannot use NFP. While it is generally believed that drunk men demand sexual intercourse, studies in Bukidnon showed that all the men really wanted was attention and care from their wives. Medical studies also show that drunk men cannot sustain an erection.  The main bulk of current frontline health providers of family planning services in the Philippines, especially at the local government health centers and stations, have not yet been adequately trained on the modern NFP methods. The general attitude is that NFP does not work and that this is a tedious method to teach and to monitor. Of the few government health providers trained in NFP, only some have applied the method successfully thus far. Most of the successful NFP counselors are found among non-government organizations and church groups.  It seems that among the proponents of hormonal contraceptives and sterilization, there are fears that NFP might replace what they consider as \"more effective\" methods of family planning. They are worried that undue quantities of resources may be diverted to training on NFP methods that they consider less effective.  Recently, Congress allocated additional resources amounting to PhP 50 million for activities to mainstream NFP. This initiative is an opportunity to facilitate the mainstreaming of NFP in PFPP.  2.0. Coverage and Scope  This strategic plan focuses on the policies, standards, strategies and activities needed to mainstream the Natural Family Planning (NFP) methods within the PFPP from Year 2002- 2006 This plan shall apply to all government and non-government institutions providing services in family planning, safe motherhood, adolescent health and other reproductive health services. Considering the various previous issuances on this subject, this plan will integrate and reformulate all previous related policies, guidelines and instructions to provide a more comprehensive, practical and operationally relevant framework on mainstreaming NFP. This plan shalLalso guide the utilization of the funds provided for this purpose.  3.0. Definition of Terms and Classification of NFP Methods  The following shall be the standard definition and classification of NFP methods:  Natural Family Planning (NFP) refers to an educational process of planning or preventing pregnancy based on observation by the couple of naturally occurring signs and symptoms of the fertile and infertile phases of the woman's menstrual cycle. People who use NFP to avoid or delay pregnancy abstain from intercourse on potentially fertile days; while those wanting to achieve pregnancy use NFP to identify the fertile phase and hence maximize the probability of pregnancy.  NFP is not really a method of contraception but rather a technique for determining the fertile period. The abstinence during this period is what prevents pregnancy.  Fertility Awareness (FA) refers to the recognition of fertile and infertile phases of a woman's reproductive cycle. It is not NFP since it is limited and not correlated with the timing of intercourse. This can be used as an introduction or orientation  o young people who are not yet sexually active, especially girls who just had their first few menstrual periods.  NFP methods have been classified as either traditional or modern. Since 1994 (DC No. 101-A s1994), the rhythm method has been deleted from the official program methods of the PFPP, while the withdrawal method has never been officially endorsed from the beginning. Thus, only the modern NFP methods are recognized as official NFP methods of the PFPP.  Traditional Methods of Natural Family Planning  Rhythm or calendar method - This was the first NFP method developed from as early as the 19205 based on the observation that for most women, ovulation occurs about 2 weeks after the first day of menstruation. Abstinence from intercourse was based mainly on counting the days in the calendar. However, since a significant number of women may not have regular periods, and that many women may change their menstrual pattern due to various reasons, including illness, this method was not regarded as reliable. Newer NFP methods based on day-to-day monitoring of physiologic signs of fertility have now been developed.  Withdrawal - While this method is not really classified by the World Health Organization ONHO) as NFP, many Filipino couples consider this among the \"natural\" family planning methods since it also does not involve the use of devices, gadgets or drugs. The penis is withdrawn from the vagina just before ejaculation. However, the timing of the male should be perfect for this method to succeed. It was also noted that some sperms may be secreted into the vagina even before ejaculation.  Modern Methods of Natural Family Planning  Cervical Mucus Method - This has also been referred to as the ovulation or Billings' method. This involves the daily observation of the naturally occurring changes of the cervical mucus during the various stages of a woman's menstrual cycle based on sensation of dryness or wetness and the appearance and character of the cervical mucus (whether clear, slippery like raw egg white or cloudy and thick). Wet days are considered relatively fertile days, while dry days are relatively infertile days. The fertile phase begins at the time the wet mucus appears and ends on the third day after the peak of wet mucus. The post-ovulatory or late infertile phase begins on the fourth day after peak mucus until the first day of the next menstruation. In this method, a pre-ovulatory or early infertile phase can also be detected. However, to avoid confusing residual ejaculate with mucus, couples should avoid consecutive days of intercourse during the early 'dry' phase. Vaginal infections may increase discharge and sensation of wetness.  Basal Body Temperature Method (BBT) - This method involves the daily charting of the woman's body temperature at rest, before she does any other activity, at the same time each day, after at least 3 hours of uninterrupted sleep. A woman's BBT rises right after her ovulation period due to the rise in progesterone level, and remains high until the next menstruation. This \"thermal shift\", i.e. the rise in temperature, marks the time when ovulation has occurred. The post-ovulatory (late) infertile phase begins on the third day after the temperature shift is observed. This method can be used only to identity the post- ovulatory infertile phase of the woman's cycle. In the beginning, temperature-taking might not be easy for women who have not previously used a thermometer. There are some problems in breakage so reserve thermometers should be available. Errors in charting can also occur. Women who have irregular hours of sleep, like nurses who go on duty in some evenings, may not be able to use this method during those days.  Sympto-Thermal Method (STM) - This method combines the observations of the cervical mucus and rise in BBT, as well as other signs of ovulation such as tenderness of the breasts, mid-cycle pain, spotting or bleeding, and abdominal heaviness. Women may also observe changes in the position, degree of opening, and texture of the cervix, or include calendar calculations. The fertile phase is marked by the appearance of wet cervical mucus until the third day of elevated temperature or the fourth day after the peak of mucus, whichever comes first.  Lactational Amenorrhea Method (LAM) - This method takes advantage of the normal physiologic response of the woman's body to a suckling infant, which is to inhibit ovulation. By instituting \"full (exclusive) or nearly full\" breastfeeding immediately after giving birth, this method can prevent ovulation until about 6 months after delivery. Full breastfeeding, also called exclusive breastfeeding, means that the infant is fed only breast-milk on demand. The infant does not receive any other feed such as water, juices, vitamins, minerals or other milks or food. Nearly full breastfeeding means that, in addition to breast-milk, the infant also receives vitamins, water, juice or ritualistic food sparingly or infrequently. Breastfeeding should be started immediately after birth and should continue on demand day and night with no, more than 4-hour intervals between day feeds and no more than 6-hour intervals between night-feeds This method should be supplemented with other family planning methods once the postpartum woman menstruates or, even if she has not yet menstruated, when the infant turns 6 months old.  NFP Innovations  Recently, there are efforts to simplify some of the NFP methods. The two methods currently under study are:  Two-Days Wet and Dry Method - This is a variation of the Cervical Mucus Method emphasizing \"wet and dry\" days: wet days for those days when the cervical mucus is clear and slippery; and dry days for those days when the cervical mucus is cloudy, thick and scanty. Research will have to confirm the effectiveness of this simplified approach.  Standard Days Method (SDM) - This is a calendar-based method wherein, through computer modeling using menstrual cycle data from large groups of women, a population-based fertile window is identified. These findings are translated into a necklace where the population-based fertile window is colored differently. A rubber is used to mark the days of the woman's cycle. Some groups feel that the long period of abstinence using the SDM might discourage couples from using NFP altogether. This long period of abstinence in SDM might have been the factor that led couples to use condom during the fertile days in the local studies on SDM, leading to reduced method effectiveness. While SDM is still under study, it should be used only as an adjunct with the other already established modern NFP methods and should not be preferred over the other NFP methods.  4.0. Other General Technical Considerations  The following information shall be recognized as the important technical basis for the acceptance of NFP as an effective method of family planning:  4.1. Advantages ofNFP  The advantages of NFP include:  \u2022 NFP promotes close involvement of the man and shared responsibility of the couple for planning their family, enhances communication and cooperation and respect for each other within the family \u2022 NFP promotes self awareness and self-discipline, develops self-reliance, independence and confidence especially since it is not dependent on medically qualified personnel \u2022 There are no physical side effects and no contraindications, virtually all couples can use NFP \u2022 NFP can be used to plan the family in two ways: either to avoid or to achieve a pregnancy   The use of NFP would be must successful if the following are met:  \u2022 NFP techniques are initially taught by trained NFP teachers with a period of instruction of about 3 months or the equivalent of 3 menstrual cycles \u2022 There is strong commitment and motivation of both partners, including the discipline to keep daily records of signs of fertility  So far, the only observed adverse effect of NFP is that some couples experience emotional stress due to the need to abstain from intercourse for about 8-16 days depending on the method and menstrual cycles of the woman. Tension may also be caused by uncertainty about the effectiveness of the methods.  4.2. Effectiveness of NFP  The effectiveness of NFP, as expressed in terms of number of pregnancies that occur in 100 women using the method for at least 12 months, is estimated to be 95%-99%, or a theoretical failure rate between 1% - 5%, depending on the NFP method used. (Sympto-thermal Method about 99%, Cervical Mucus and BBT methods about 98%, and Standard Days Method about 95.25%).  Comparing all family planning methods, sterilization is rated to be most effective (failure rate of less than 1%) while hormonal contraceptives (oral, injectable or implantable) and intrauterine devices have theoretical failure rates between 0.3% to 3%. Barrier contraceptives or spermicides (e.g. condom, diaphragm, cervical cap, cervical foam) have theoretical failure rates between 1% to 5%.  It should be noted that while in many of these the method itself may be theoretically extremely effective, the way the method is used in practice may make it less effective.  4.3. Classification of NFP providers and users  The following shall be the terms used for NFP providers and users:  4.3.1. NFP Teacher/Counselor: is a person (medical, paramedical or non-medical/ non-paramedical) trained and duly accredited by the Department of Health (DOH) or by a DOH-accredited NFP training institution to explain NFP and to coach/ supervise NFP acceptors and users. The NFP teacher/counselor should have successfully used the method herself/ himself for at least 4 months and should have had experience in supervising at least 3 NFP acceptors and users for at least 4 months.  4.3.2. NFP New Acceptor: is a couple or a client who has used NFP for 3 menstrual cycles, validated by an NFP Teacher/ Counselor. A-couple or client who has been using NFP for less than 3 months are considered \"learning users\".  4.3.3. NFP Current User: is a couple or a client who has used NFP for at least 4 menstrual cycles (the 3rd cycle previously validated by an NFP Teacher/Counselor). The couple/ client is reported as a continuing user for as long as they remain on the method.  4.3.4 NFP Drop Out: is a couple or a client who either stops using NFP or starts to use an artificial method, for instance, condom, in addition to NFP.  4.3.5. Method Failure: refers to pregnancies resulting in spite of correct and consistent use of NFP by a Current User.  5.0. Goals and Objectives  The overall goal is to reduce health risks to women and children due to short birth intervals and too frequent pregnancies and childbirth. With better-spaced children and better-planned family size, parenting will be more effective leading to a more productive and caring family life. These goals are going to be achieved through improvement of family planning services by mainstreaming NFP as one of the modern methods of family planning. With the emphasis of NFP on couple communication, cooperation and shared responsibility, the social goals will be more likely achieved through NFP than any other family planning method.  The specific objectives of this plan are: By Year 2006,  1. To raise fertility awareness of at least 75% of young women immediately before or soon after menarche and of 75% of young men at puberty in preparation for responsible sexuality and family life  2. To train or retrain at least 75% of frontline health providers on modern NFP methods  3. To raise NFP use rate to 20% among currently married women / couples who are not yet using any method of contraception  There are also wider developmental goals in terms of promoting sustainable socio-economic development and social and family responsibility.  6.0. General Policies  The following general policies shall guide the mainstreaming and provision of NFP services:  6.1. Training:  6.1.1. A Basic Course on Modern NFP Methods designed specifically for this purpose shall be provided by DOH and other DOH-accredited NFP training institutions to all health facility staff and volunteers who are involved in services for FP, safe motherhood, adolescent health and other reproductive health elements.  6.1.2. NFP shall be incorporated as an integral part of the Basic FP Course of the DOH as soon as there are trainers at the national, regional and local government levels. Basic Courses already incorporating NFP shall be called the Enhanced FP Course.  6.1.3. Health facility staff who have previously completed the Basic FP Course may go through the Basic Course on Modern NFP Methods only; while those who have not yet been trained in the Basic FP Course shall be trained using the Enhanced FP Course.  6.1.4. Volunteers, especially from religious groups, who may want to be trained only on NFP may be given only the Specific Basic Course on Modern NFP Methods.  6.2. Service Delivery  6.2.1. All modern NFP methods shall be routinely and thoroughly explained and offered to couples/ clients before they make their final method choice. The couple shall be allowed to select their method according to their preferences and lifestyle. This means that no NFP method shall be \"positioned as a better method\" over other NFP methods in any predefined situation.  6.2.2. Due to limited resources, the logistics to be provided through DOH shall be limited to essential training and counseling supplies and materials such as manuals, modules and low-cost charts. The cost of devices such as thermometers (preferably regular thermometers) and other devices such as necklaces shall not come from funds of the DOH since these are better shouldered by the user to allow choice according to their preference.  6.2.3. All DOH facilities especially the DOH retained hospitals shall incorporate NFP in their reproductive health services especially in maternal and child health clinics.  6.3. Advocacy  6.3.1. Fertility Awareness orientation shall be the main mechanism of advocacy for NFP and may be targeted to the health providers, the general public aged 15-49 years, especially adolescents and young adults in various settings such as the school, community, and other venues of education and communication  6.3.2. Advocacy and information, communication and education materials shall be based on prototype messages and materials that shall be distributed by DOH or accredited partner agencies.  7.0. Strategies  The following shall be the strategies to mainstream NFP:  7.1. Policy and organizational strengthening, Policies shall be clarified and widely disseminated to distinguish fertility awareness (that is, recognition of fertile and infertile phases of a woman's reproductive cycle, including cervical mucus and basal body temperature changes) from NFP so that fertility awareness training can begin at adolescence. The concept of abstinence and family planning can then be more easily added when the adolescents enter into married life. Policies will also be slowly redirected so that, as soon as there are adequately trained staff on NFP at the frontline levels, NFP will eventually be regarded not only as one among several methods that couples can choose from but as a basic method that all couples should know, regardless of method finally chosen by the couple. NFP will be the back-up method for any other temporary FP method since NFP empowers the couple and does not lead to dependence on medical/ paramedical personnel.  7.2. Advocacy and orientation on Fertility Awareness: To lay down a wide net of awareness of the advantages of NFP and to dispel myths on NFP, orientations will be conducted at various levels and using multi-media communication. The following activities can be done: orientation of various church groups (ecumenical), development of EEC materials, symposia in schools,  churches, communities, seminars on adolescent awareness and responsible sexuality, among others.  7.3. Training and certification of frontline health providers: Since the availability of competent and well-oriented trainers is key to the success of NFP mainstreaming, focus will be on training or, if needed, retraining of midwives, nurses, doctors at all levels especially the local government level. Private practitioners shall also be recruited within the church network to include NFP in their services. Volunteer couples and Barangay Health Workers shall also be trained in NFP services. In order to ensure high quality services and to avoid confusion on the methods being taught, certification of-NF P providers will be necessary. Validation of proficiency and renewal of certificates will be done based on the quality of NFP services provided.  7.4. Raising the capability of facilities and services: As soon as there are adequate numbers of health staff trained in NFP, they can very easily include in their counseling activities advice for infertile couples on how to achieve a pregnancy, thus improving FP services to include fertility services through NFP. FP clinics with good NFP services can be repositioned as Fertility Clinics that will also provide advice to couples who cannot achieve a pregnancy. This will enhance the dual role ofNFP and will increase the understanding and demand for the method. Current clinic-based services shall be expanded to include home and community NFP services.  7.5. Networking and development of support groups at all levels especially in the community: Successful NFP users/ couples shall be organized to support new NFP users so that the training is reinforced at the home level. Invaluable experience and visible strategies of NGOs shall be utilized.  7.6. Monitoring and evaluation: Agreed measurable indicators shall be developed in order to monitor the various components of the plan. The important items to be monitored include the following: implementation of activities and strategies according to the plan, gaps in the plan that, were detected, additional resources needed, improvement in techniques of advocacy or training, or linkages, and changes in selected social indicators such as improved family stability or communication, changes in family size and structure such as longer birth spacing, client satisfaction, and others.  8.0. Organization and Management  In order to ensure wide and open participation, a multi-sectoral National NFP Committee and multi-sectoral Regional and Local NFP Committees shall be created as ad hoc bodies to oversee the planning and coordination of NFP mainstreaming activities. These committees shall cease to exist when NFP is considered successfully integrated within the PFPP. The continuation of these committees shall be assessed every 5 years.  8.1. Composition of NFP Committees:  The NFP Committees at the national, regional and LGU levels shall be composed of individuals from government or non-government organizations who are already actively involved in NFP using all modern NFP methods, with adequate experience in proper training and counseling on the modern NFP methods. Individuals who are not yet actively involved in NFP may also become members of the NFP committees provided they have been trained by DOH or DOH-accredited agencies on the Basic Course for Modern NFP Methods.  At the Regional level, the DOH Regional Director, after training on NFP, shall be the chairperson of the Regional NFP Committee.  An appropriate Department Order shall be issued to govern the specific membership and subcommittees of the National NFP Committee Appropriate Regional Orders shall be issued to define the specific membership and subcommittees of the Regional NFP Committees.  8.2. Functions of NFP Committees:  The NFP Committees at various levels shall have the following functions:  National NFP Committee:  1. Based on the National NFP Strategic Plan Year 2002-2006, coordinate the preparation of the National NFP Operational Plan for each year; and recommend this to the Secretary of Health for approval;  2. At the end of each Five-Year National NFP Strategic Plan, coordinate the planning for the succeeding Five-Year Strategic Plans;  3. Review and recommend Regional NFP Operational Plans for approval of the Secretary of Health;  4. In coordination with the appropriate DOH units, oversee the funding allocation and utilization of NFP funds that come from government and non-government sources;  5. In collaboration with the appropriate DOH units, coordinate the proper implementation of the national activities based on the approved National NFP Operational Plan;  6. Perform other functions that may be required by the Secretary of Health.  Regional NFP Committee:  1. Based on the National NFP Strategic Plan Year 2002-2006, coordinate the preparation of Regional NFP Operational Plan for each year, and endorse this to the National NFP Committee for review and endorsement to the Secretary of Health for approval;  2. Review and approve local government proposals for NFP activities incorporating these in the Regional NFP Operational Plan for each year;  3. Perform other functions that may be required by the Secretary of Health.  Sub-regional NFP Committees may also be created depending on the operational and managerial demands at the local levels. The Regional NFP Committee or the Local Chief Executive may initiate Local NFP Committees when necessary.  The National NFP Committee shall report to the Undersecretary of Health specifically assigned to be the adviser of the committee.  8.4. Funding mechanism and process:  NFP funds appropriated by Congress through the Department of Health and other funds that may be donated to the DOH by non-government agencies shall be allocated based on the appropriateness of the operational plans as these conform with the national strategic plan. Only activities duly incorporated in approved NFP operational plans shall be funded. Thus, Regional Health Directors shall endorse funding for regional and sub-regional activities by endorsing the Regional NFP Operational Plan to the National NFP Committee. For year 2002, this process shall be implemented immediately upon effectivity of this Order. In Year 2003 and succeeding years, Regional NFP Operational Plans shall be submitted to the National NFP Committee for review not later than the end of November of the preceding year. The Regional NFP Committees shall be involved in any revision or enhancement needed to get the plans approved. Duly-approved Operational Plans shall be officially approved with funding allocations.  Activities may be reprogrammed through the same process of endorsement and approval through the Regional and National NFP Committees. Allocation of Regional funds for NFP shall also be based only on approved NFP Operational Plans.  9.0. Timetable and Budget  The following shall be the phases of the plan:  YEAR 1 Awareness-raising and basic technical capability building and networking YEAR 2 Monitoring of progress, expansion of services and networks, sustenance of awareness-raising and capability building activities YEAR 3 Mid-term evaluation and redirection (if needed) YEAR 4 Expansion of coverage and higher quality improvement of services YEAR 5 End of term evaluation and phase out or strategic planning for next 5 years  In the first year of implementation, P50 million pesos have been allocated by Congress. This shall be used to create high awareness and acceptance of NFP among the health staff and general public as well as technical capability building and networking.  In the succeeding years, DOH shall allocate funds according to the specific activities identified for the year. DOH should also identify other sources of funds from partners and donors.  10.0. Reporting, Monitoring and Evaluation  10.1. Reporting Forms and Procedures: The items listed in section 4.3. shall be incorporated in the existing DOH reporting and FHSIS forms for Family Planning.  10.2. Monitoring and Evaluation Procedures: Monitoring of plan implementation and performance shall be incorporated in regular monitoring activities of the DOH.  Additional or special monitoring and evaluation activities shall be incorporated in the specific operational plans as necessary.  11.0. Repealing Clause  This Order revises, modifies or rescinds all other orders and circulars that are inconsistent or conflict with the provisions of this Order, especially DC 101-A s. 1991, DC 229-A s. 1996, DC 130 s. 1997, AO 43 s. 2000, AO 49 s. 2001 and AO 50 s. 2001. All other previous provisions that are still consistent with this Order shall continue to be in effect.  12.0. Effectivity  This order shall take effect immediately. ", " I. Rationale  The Fifth (5th) National Nutrition Survey of the Food and Nutrition Research Institute of the Department of Science and Technology (DOST) shows that micronutrient malnutrition, particularly deficiencies in Vitamin A, Iron and Iodine, is still a major public health problem. To address this problem, the Philippines has adapted the main strategy of fortification of commonly consumed foods to increase the micronutrient intake of the population particularly of the at-risk groups of women and children and thus, eliminate the problem of micronutrient malnutrition. In support of this strategy, two (2) major laws have been passed. Republic Act 8172 or the Asin Law which was enacted in 1995, mandates that all salt for human and animal consumption be fortified with iodine. Republic Act 8976 or the Food Fortification law of 2000, mandates the fortification of flour with Vitamin A and iron, sugar with Vitamin A, cooking oil with Vitamin A and rice with iron by November 7, 2004. Articles 7, 12, 21 and 22 of Republic Act 7394, Consumer Act of the Philippines further requires the Department of Health to establish standards of identity and quality of foods.  In support of all these laws, Administrative Order (AO) No. 4-A s. 1995 was issued by the DOH to establish guidelines for the micronutrient fortification of processed foods. As distinguished from the Sangkap Pinoy Seal, the Diamond Sangkap Pinoy Seal (DSP) shall be awarded to all manufacturers of staples who have applied for the Diamond Sangkap Pinoy Seal and have complied with the quality standards according to the IRR of RA 8172 and RA 8976.  Under this order, a DSP seal is to be awarded to manufacturers of staple foods. This Order prescribes the guidelines for the awarding of Diamond Sangkap Pinoy Seal.  II. Coverage  This order shall cover manufacturers of staples, namely rice, sugar, cooking oil, flour and salt nationwide.  III. Definition of Terms  For the purpose of these guidelines, the following definitions shall apply:  a) Fortification shall mean addition of micronutrients to staple foods such as rice, sugar, cooking oil, flour and salt based on the recommended standard set by BFAD\u2014DOH. This also means the addition of micronutrient to processed foods at levels above the natural state.  b) Micronutrients are nutrients needed by the body in small amount but must be supplied.  c) Staples shall refer to food items that are widely and regularly consumed by the general public. These include rice, sugar, cooking oil, flour and salt.  d) Diamond Sangkap Pinoy Seal shall refer to the seal of good nutrition quality that will be awarded as an incentive to BFAD registered staple manufacturer who will fortify their products according to standards.  e) Food Manufacturers refers to millers, refiners, processors of food, repackers and importers  f) BFAD means Bureau of Food and Drugs  g) DOH means Department of Health  h) RDA means Recommended Dietary Allowance  i) CHD means Center for Health Development  j) LGU means Local Government Units  k) NFA means National Food Authority  l) SRA means Sugar Regulatory Administration  m) PCA means Philippine Coconut Authority  IV. Statement of Policies  a. Food Fortification staples shall be encouraged to address the micronutrients deficiency in the Filipino diet, based on the daily needs using the Recommended Dietary Allowance (RDA).  b. RA 8172 or ASIN Law (1995) and RA 8976 or Food Fortification Law (2000), the major products will be fortified as follows:  1. rice with iron 2. sugar with vitamin A 3. cooking oil with vitamin A 4. flour with vitamin A and iron 5. salt with iodine  Only when the levels of fortification are met shall the product be claimed as \u201cfortified with\".  c. The Diamond Sangkap Pinoy Seal shall be advocated by the BFAD, in coordination with other national agencies and local government units to staple manufacturers.  d. The BFAD, in coordination with other agencies, National Food Authority (NFA), Sugar Regulatory Administration (SRA) and Philippine Coconut Authority (PCA) shall assist in monitoring compliance of all registered staple manufacturers to RA 8976 and RA 8172.  V. Procedural Guidelines  A. Requirements  1. Duly accomplished application forms 2. A certified true copy of LTO issued by the BFAD 3. Results of product analysis of vitamin A, iron and iodine from a BFAD recognized laboratory 4. Sample of label with the Diamond Sangkap Pinoy Seal  B. Process of Application  1. The food company applying for the Diamond Sangkap Pinoy Seal shall submit all the documentary requirements to BFAD.  2. Applicants should pay a processing fee of P 500.00 to BFAD cashier for every application.  3. Upon receipt of the application, BFAD conducts a desk review to check completeness of the documentary requirements.  3.1 If documentary requirements are incomplete, the BFAD informs applicant thru a notice of deficiency and defers conduct of further evaluation until company submits complete requirements.  4. BFAD conducts a plant inspection to evaluate compliance with current Good Manufacturing Practices (cGMP) and Quality Control (QC) system for product fortification if documentary requirements are complete.  4.1 If LTO was issued earlier in compliance with these two requirements, BFAD may choose to forgo plant inspection.  4.2 It may also choose to forego the plant inspection for those receiving government assistance for the development of fortification technology, provided that a certification of assistance issued by the government concern is submitted with the application papers. For rice fortification, BFAD submits to NFA the documentary requirements for NFA evaluation.  5. BFAD conducts a plant visit (if needed), using the checklist on the fortification process as provided in Annex 1 of the IRR of RA 8976.  6. BFAD makes a final evaluation of the applicant based on the plant visit (if done) and review of documentary requirements.  C. Awarding of the Diamond Sangkap Pinoy Seal  1. If applicant is approved, BFAD prepares the Letter of Diamond Sangkap Seal Award and Diamond Seal of Certificate of Acceptance for the signature of the Secretary of Health.  2. If application is disapproved, BFAD informs the applicant thru a letter or notice of deficiencies/notice of denial. The letter of disapproval/reconsideration contains instruction on appropriate corrective actions.  3. Manufacturers of disapproved application may apply again for the seal after instituting corrective action required.  4. Compliant food manufacturer will be provided with a Diamond Sangkap Pinoy Seal Certificate of Acceptance and a Letter of Award.  5. These companies shall display the Diamond Sangkap Pinoy Seal issued by the Department of Health in the plant site.  6. The same companies shall use Diamond Sangkap Pinoy Seal on the approved product label.  VI. Validity/Effectivity/Revocation  The effectivity of the Diamond Sangkap Pinoy Seal and the Letter of Award shall be from the date of issue and shall be valid for an indefinite period unless revoked for a cause as when monitoring indicates non-compliance and failure to immediately implement corrective action.  VII. Administrative Sanctions  The BFAD, in coordination with NFA, SRA and PCA, after warnings, notice and hearings, may impose any or all of the following administrative sanctions in case of violation of any of the provision of this order as provided for in RAs 8976 and 8172.  a) Order the recall of the products declared/found as mislabeled fortified staples b) Order the correction of labeling of fortified foods staples c) Include in the list of non-compliant food manufacturer for publication d) Impose administrative fines provided for in RA 8976 and RA 8172 e) Suspend or cancel LTO of the manufacturing firm f) Suspend or cancel the use of the Diamond Sangkap Pinoy Seal  VIII. Effectivity  This Order shall take effect immediately. ", "   I. Rationale   The introduction of Newborn Screening (NBS) in the Philippines in 1996 and the enactment of the Newborn Screening Act in 2004 are signi\ufb01cant milestones in the Philippine health sector. Since then, the National Comprehensive Newborn Screening System has been developed and in the course of its implementation has collected over 2.5 million \ufb01lter cards containing residual dried blood spots (DBS) currently in storage at the various Newborn Screening Centers. These residual DBS obtained from newborn screening have generated interest here and around the world as objects of public health research. Likewise, maintenance costs and space requirements of these residual DBS have risen. In this light, this Administrative Order is being issued.   11. Objective   To set the guidelines for the retention, storage and use of residual DBS and to ensure that the con\ufb01dentiality and privacy interests attached to the residual DBS are taken into consideration.   III.Scope and Coverage   This Administrative Order applies to all implementers of the Newborn Screening Program, both public and private, research and academic institutions.   IV. Definition of Terms   1. Residual Dried Blood Spots (DBS) refers to the dried blood spot materials remaining after samples for newborn screening have been punched out.   2. Newborn Screening Data Card refers to the portion of the \ufb01lter card that contains all the identifying and demographic data of the patient accompanying the dried blood specimens.    3. Newborn Screening Reference Center (NSRC) refers to the central facility at the National Institutes of Health that de\ufb01nes testing and follow-up protocols, maintains an external laboratory pro\ufb01ciency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, oversees content of educational materials and acts as the Secretariat of the Advisory Committee on Newborn Screening.   4. RA 9288: Newborn Screening Act of 2004 refers to the act promulgating a comprehensive policy and a national system for ensuring newborn screening.   5. RA 9470: National Archives of the Philippines Act of 2007 refers to the policy that enforces proper management, control and regulation of record disposition in all government of\ufb01ces/institutions.  6. Records Disposition Schedule refers to document prepared and submitted by the Newborn Screening Reference Center to the National Archives that governs the disposition of all the records of the National Comprehensive Newborn Screening System.   V. Policies and Procedures   A. General Guidelines   1. All residual DBS shall be stored as long as possible and may be retrieved for non- screening purposes.    2. All newborn screening data shall be secured to protect the privacy of the newborn and its family.    3. Should the need arise, all residual DBS and data cards shall be disposed of so that the con\ufb01dentiality of information is assured.   4. Residual DBS shall be available for screening\u2014related and non-screening purposes.   B. Speci\ufb01c Guidelines   1. Storage of Residual DBS and Data Cards   a) All residual DBS shall be placed under the custody of the Newborn Screening Reference Center (NSRC) at the University of the Philippines National Institutes of Health.   b) Residual DBS, with a unique laboratory identi\ufb01cation number, shall be stored in a secure and centralized storage facility. Residual blood spots shall be stored in a low humidity environment at 4\u00b0C or lower.   c) All samples shall be stored as long as possible, subject to space limitations and the NSRC\u2019s policy on disposal.   d) Upon receipt, all Newborn Screening Data Cards shall be encoded, veri\ufb01ed, and the data maintained in a highly secure database.   2. Retention of Newborn Screening Data   a) Multiple (electronic) copies of stored data shall be maintained.   b) Stored data shall include all information contained on the Newborn Screening Data Card and newborn screening results.   c) The NSRC shall conduct periodic reviews of its computing practices to help ensure that the information collected will remain accessible and readable in the future. The review may address computing issues including data storage, backup, retrieval and management, technological obsolescence, vendor lock-in, data formats and standards, and security.   3. Disposal of Residual DBS and Newborn Screening Data Cards   a) Residual DBS are classi\ufb01ed as non-infectious materials (Classi\ufb01cation of Infectious Substances, Dangerous Goods Regulation, International Air Transport Association, 2010).   b) When the need arises, destruction (and/or disposal) of the residual DBS shall be conducted in an appropriate manner according to the Health Care Waste Management Manual of the DOH and approved by the National Archives of the Philippines.   c) Newborn screening data cards shall be destroyed by shredding after encoding and scanning of the data cards in accordance with the approved Records Disposition Schedule by the National Archives of the Philippines.   4. Screening and Non\u2014Screening Uses of Residual DBS   a) A Special Committee on the Use of Residual DBS (henceforth abbreviated as \u201cSpecial Committee\") shall be created to ensure the appropriate use of the samples.   The primary task of the Special Committee is to evaluate the relevance of the proposed research requests and to assess the capacity of the researcher/requesting body to care for the residual specimens.   b) The Chair of the Special Committee will be a designated representative of the Secretary of the Department of Health. '   c) The Special Committee shall prioritize requests that benefit the patient or his/her family and address public health risks.   d) Requests for the purposes of litigation, criminal investigation, insurance, and employment shall not be approved.   e) Use of Residual DBS for Newborn Screening Purposes   i. Screening-related uses refer to the use of the blood spots for newborn screening and the processes associated with it such as test re\ufb01nement, treatment ef\ufb01cacy studies, new test validation, and results veri\ufb01cation.    ii. Screening\u2014related uses shall not require approval of the Special Committee prior to use of residual specimens. It is the responsibility of the NSRC to maintain patient con\ufb01dentiality and ensure that specimens remain in the custody of NSRC.    f) Use of Residual DBS for Non-screening Purposes   i. Potential use of the samples include, but are not limited to, the following:   1. Patient/Family Studies   2. Public Health Research    ii. All requests for the use of residual DBS for non\u2014screening uses shall go through the Special Committee and the NIH Technical Review Board and ethics review by the UPM Research Ethics Board  iii. In patient/family studies, it may be bene\ufb01cial that the samples be re-linked to the individual from which the sample was taken. This process shall require consent of the source individuals or their legal guardians, in case of minors.    iv. For purposes of public health research, all samples released must be de~identi\ufb01ed. Only samples permitted for research will be released. Any request deemed by the Special Committee and the UPM Research Ethics Board to be consent-requiring shall not be approved. A return or destruction process must be approved as part of the request.  v. Researchers must submit the following documentation to the Special Committee prior to the review of the request   1. Credentials of all requesting investigators   2. Capsule proposal which includes the purpose and anticipated bene\ufb01ts of the study   vi. Upon approval of the capsule proposal, the requesting party is asked to prepare a full proposal for technical review by the NIH Technical Review Board, ethics review by the UPM Research Ethics Board and \ufb01nal approval of the Special Committee.    vii. All costs incurred in the retrieval, preparation, and processing of the request and sample shall be shouldered by the requesting party.   The proceeds shall go to the NSRC for the maintenance of the storage facility.   These guidelines shall be reviewed periodically by NCDPC-DOH.   VI. Repealing Clause   All issuance that are inconsistent with the provision of this Order are hereby repealed/rescinded.   VII. Effectivity   This Order shall take effect \ufb01fteen (15) days after its approval and publication in the of\ufb01cial gazette or newspaper of general circulation.   ", "  1.0 BACKGROUND  1.1 The DOH Women\u2019s Health and Safe Motherhood Project (WHSMP) Maternal Care Delivery Component includes a civil works sub-component which will physically prepare \u201cunreadable text\" provincial and district hospitals, rural health units such as main health centers and barangay health stations, lying-in clinics and maternity waiting homes, to accommodate the unique special requirements of the WHSMP in pursuit of its objectives.  1.2 The Civil Works Sub-Component will upgrade the Obstetrics/gynecology departments or units of said hospitals, repair/renovate rural health units, and construct lying-in clinics and maternity waiting homes at selected provinces.  2.0 ORGANIZATION AND MACHINERY  2.1 The Civil Works Sub-Component shall have four major \u201cunreadable text\" of work. These are SITE AND FACILITIES \u201cunreadable text\", PROJECT DEVELOPMENT (Preparation of Schematic \u201cunreadable text\" and Design Development Plans), PROJECT \u201cunreadable text\" (Preparation of Detailed Architecture and Engineering Plans and Other Contract Documents) and PROJECT IMPLEMENTATION including Bidding and Awarding of \u201cunreadable text\" and Construction.  2.2 The Provincial Management Office (PMO) of the WHSMP shall \u201cunreadable text\" overall responsibility for management, construction and technical performance of this particular WHSMP component and sub-component with technical assistance from the Health Infrastructure Service (INFRA), DOH.  2.3 The Civil Works Sub-Component falls under the Component Management of Maternal Care Delivery which shall be responsible for developing project guidelines and for providing technical supervision over component deliverables.  2.4 The engineering units of the Regional Health Offices (RHO), being the regional technical arm of the INFRA as far as health infrastructure projects is concerned, shall also render technical assistance to the WHSMP by ensuring the proper implementation of the project guidelines in their areas of jurisdiction.   2.5 The four major phases of work will be accomplished with the aid of a private consulting firm collaboration - Philippine Center for Population, and Development and DCCO Engineering Corporation, hereafter referred to as the Consultant.  2.6 The Local Government Units (LGU) through a Memorandum of Agreement with the DOH, shall support the conduct of the major phases of work by providing the access to data, the human resource counterpart, etc., for facilities investigation, project development and project implementation.  3.0 GUIDELINES FOR THE FOUR MAJOR PHASES OF WORK  3.1 SITE AND FACILITIES INVESTIGATION  3.1.1 This phase of work will include investigation of existing hospital and rural health unit sites and structures to determine, among others, their architectural and structural integrity, the state of usefulness and availability of utility systems, and the prevailing environmental conditions.  3.1.2 The Consultant shall conduct the above work for all involved hospitals, rural health units, lying-in clinics and maternity waiting homes.  3.1.3 The Consultant shall submit a Final Report for this phase of work on a per province basis.  3.1.4 The Regional Health Office engineering units shall assist the Consultant by conducting the introductory meetings of the Consultant with the Offices of Governors, Mayors, and Chiefs of Hospitals prior to the start of this phase of work.  3.1.5 The Regional Health Office engineering units shall also provide the appropriate assistance to the Consultant in the gathering of data and in their continuing visits to the involved sites and structures.  3.1.6 The INFRA shall assist the PMO in monitoring the work of the Consultant during the conduct of this phase of work.  3.2 PROJECT DEVELOPMENT  3.2.1 This phase of work will include the preparation and approval of schematic plans for the repair/renovation/upgrading of hospitals/rural health units and for the construction of lying-in clinics and maternity waiting homes.  3.2.2 The Consultant shall perform the above work for all projects under the WHSMP civil works sub-component with technical advise from the INFRA.  3.2.3 The Consultant shall submit a Report consolidating the approved schematic plans on a per province basis.  3.2.4 The INFRA shall assist the PMO in the review, evaluation and final approval of the schematic plans.  3.2.5 As a rule, the schematic plans will be approved by the end-user (Chief of Hospital for hospitals and the Municipal Health Officer for the rest of the rural health units), the Program Manager (WHSMP), upon recommendation of the INFRA, and the Project Director (WHSMP), in that order.  3.3 PROJECT DOCUMENTATION  3.3.1 This phase of work will include the preparation and approval of the necessary contract documents needed for bidding and awarding of the projects for construction such as the Detailed Architecture and Engineering Plans, Technical Specifications and Detailed Estimates.   3.3.2 The Consultant shall prepare the said contract documents for all civil works projects under the WHSMP.  3.3.3 The INFRA shall assist the PMO in the review, evaluation and final approval of the contract documents.  3.3.4 As a rule, the contract documents will be approved following the order set forth in item 3.2.5 above.  3.4 PROJECT IMPLEMENTATION  3.4.1 This phase of work will include public bidding, awarding of contracts, construction period and final project acceptance and turnover.  3.4.2 The public bidding of projects and awarding of contracts will be conducted following the provisions of PD 1594 (Rules and Regulations for the Implementation of Government Infrastructure Projects), as amended, and AO 17 s. 1993 of the DOH.  3.4.3 The public bidding of projects will be done on the Regional Health Office level in order to tap the services and resources of the local private sector as much as possible.  3.4.4 As a general rule, contracts will be awarded on the Regional Health Office level and approved by the Regional Health Director, Program Manager, (WHSMP), upon recommendation of the INFRA, and Project Director (WHSMP), in that order.  3.4.5 The regular supervision of construction of projects will be done by the engineering units of the Offices of the Governor and Mayor concerned as provided for in the Memorandum of Agreement between the DOH and Local Government Units.  3.4.6 As a general rule, the standard procedures to be followed for and during construction, from contract information, problem solving, to contractor\u2019s performance evaluation, shall be based on the provisions set forth in PD 1594, as amended.  3.4.7 The Regional Health Office engineering units shall regularly monitor the construction work activities in their areas of jurisdiction. They shall prepare monthly status reports for submission to the WHSMP, copy furnished the INFRA.  3.4.8 As a general rule, the completed projects will be accepted by the end-user, Regional Health Director, Program Manager (WHSMP), upon recommendation of the INFRA, and Project Director (WHSMP), in that order.  3.4.9 The completed projects will be turned over to the Local Government Units by the Regional Health Directors, representing the WHSMP and the DOH.   This Administrative Order takes effect immediately.   ", "  Pursuant to Presidential Proclamation No.4 dated July 29, 1998, which gives the DOH the leadership 1n the Philippine Measles Elimination Campaign, the following guidelines are hereby adopted.   The mass measles vaccination of children between 9 months to less than 15 years old in schools and communities is hereby extended from October 14,1998 to November 30,1998 in order to ensure that 100% of the target children are covered. It is recognized that several unforeseen circumstances caused delays in the activities especially typhoons that caused disruption of classes.  Everyone is commended for the job already completed especially vaccination in the public schools and in a significant number of private schools. However, since the remaining groups of children who still need to be vaccinated are those most difficult to reach, ie. students in the most conservative private schools and children in difficult circumstances (street children, children in labor, children in armed conflict) - social mobilization should be intensified and new strategies have to be adopted as follows:  1. The mass measles vaccination activity shall be called Ligtas Tigdas Campaign instead of Ligtas Tigdas \u201cMonth\" 2. In schools where vaccination sessions have been conducted but student coverage is 80% or below, additional school- ased vaccination rounds should be rescheduled to raise the coverage to 100%. Adequate social mobilization and IEC MUST be done before vaccination. This should include, among others, a meeting with school administrators, school physicians/ nurses, key faculty and parents; leaflets for parents through the pupils/students; and IEC for the students themselves.  3. In schools where vaccination coverage is above 80%, school-based vaccination or health center-based vaccination may be done to reach 100% coverage. Children who were not vaccinated because of refusal by the parent should bring home with them additional IEC. There is still confusion over the need to vaccinate children who already had prior vaccination or measles. If the pediatricians are the ones advising the parents to refuse, talk to the pediatrician, explain the campaign, provide reassurance and correct technical misconceptions. 4. When classes are cancelled due to typhoons or other causes, immediately re-schedule vaccination at the first possible time. 5. In private schools where vaccination has not yet been conducted to date: * Send immediately the list of the schools with the following information to the Maternal and Child Health Service of the Department of Health (school administrator/directress/rector, address, telephone/FAX numbers), if Catholic the congregation managing the school, and the stated reason for not allowing vaccination in the school). MCHS will facilitate sending of letter by the Secretary and can send MCHS staff to assist in discussions with school authorities. * Request the concerned local government executive to also write a letter to the school * Arrange for two orientation meetings: the first for the key school personnel and the second for the parents. Be sure the school administrators are already convinced before talking to the parents because the parents will get confused if the school authorities give a different message. Emphasize that the school need not have any responsibility for vaccinating or treating adverse events since these will all be provided for by the vaccinating team. They may, however, choose to assist the team. Provide enough copies of the School Information Guide.  * Provide copies of the attached sample lea\ufb02et to all students (annex 1). The attached lea\ufb02et has been specially designed to answer the common questions asked by parents of children in private schools. * Offer several alternatives for the venue of the vaccination. If parents prefer to have their children vaccinated by their pediatrician, arrange for the pediatricians to have the vaccines. Alternately, you may be able to get a private hospital or the Pediatric Society Chapter to sponsor the vaccination in the particular private school. Attached is a copy of the Memorandum of Agreement with the Philippine Pediatric Society, annex 2. 6. For community-based vaccinations, 100% vaccination of preschoolers is high priority. If vaccination in private schools is lagging behind due to difficulties, vaccination of preschoolers should be completed before resuming vaccination in the difficult private schools. To do this, November 18, 1998, ASAP Day for this year, is also hereby declared Bulilit Measles Immunization Day or BMID and will now  include measles immunization of children under 6 years old who have not yet been vaccinated since September 16. Social mobilization and IEC in the communities should be integrated. Vitamin A will also be given for children between 1 to 5 years old. 7. Other special approaches are necessary especially in congested urban poor communities where street children are mobile and where working children may be hidden in factories or homes. In the National Capital Region (NCR), food especially soup, is being provided before or after vaccination to attract street children. Non\u2014government agencies have been mobilized to sponsor this \u201csoup kitchen\" approach.  8. For areas with peace and order problems, special dialogues are being conducted by UNICEF. Please remember that the children in these areas will need multiple antigen since they may have not been covered by routine vaccination. Doctors to the Barrios  should ensure that all the children in their areas receive their vaccinations. Mountain climbers, missionaries and other NGOs should be tapped for this activity. Please facilitate provision of all essential logistics. To meet the deadline for completion of vaccination, DOH Regional staff  should facilitate identification and mobilization of all resources. 9. On power failures and blackouts, remind cold chain managers and field implementers that the measles vaccine is stable at room temperature for about one week. Thus, vaccines which have been exposed to 37\u00b0C for 5 days or less can still be refrigerated again and used for vaccination. Only vaccines which have been exposed to high temperatures above 37\u00b0C or for a period longer than 5 days should be discarded. During power failure, make sure the vaccines are transported and stored to the nearest facility with generators. 10. Use only the diluent provided for the speci\ufb01c vaccine preparation. As much as possible, avoid using commercial distilled water. Also, strictly follow the guidelines on using ALL diluent regardless of the volume in the diluent vial. Some suppliers have allowances for additional vaccine doses. 11. On the incineration of used needles and syringes, other private facilities may be tapped aside from government hospitals. The NCR, for instance, was able to tap the Manila Memorial Park. 12. There are additional funds available for sub-allocation for social mobilization, evaluation, surveillance and other PMEC activities. The DOE Regional Immunization Officers should request MCHS for additional funds through their Health Directors as soon as possible. 13. Provincial, City, District and Municipal level staff should monitor problems weekly, especially schools or communities that are lagging behind. Coverage reports may not be readily available but problems should be immediately identified and solved. Especially look out for big, private schools, street children, children hidden in factories, evacuation areas, and peace and order areas. 14. As predicted, concern over adverse events following immunization has died down following more experience with the campaign. However, please ensure that the necessary precautions are sustained and that the reported AEFIs are consolidated for reporting. 15. Documentation of all activities should continue. Photos, videos and reports should be collected and eventually sent to the MCHS in order to document the good performing areas and the personnel who deserve commendation after the campaign.  The Ligtas Tigdas Campaign has been extended but activities should be completed as soon as possible to prevent the expected rise of cases starting December. When measles cases start rising, it is no longer advisable to conduct mass vaccinations.  For immediate compliance.   ", "  I. BACKGROUND AND RATIONALE  Under-\ufb01ve mortality has declined from 54 to 48 to 40 percent as reported in the 1993,NDHS, the 1998 NDHS and the 2003 NDHS respectively. Yet, malnutrition remains a challenge in the Philippines, directly or indirectly responsible for around 60 percent of deaths among children under \ufb01ve years old. Only 68 percent of children 0-5 years old are normal in weight\u2014 for-age using the NCHS/ WHO standards (1998 NDHS, FNRI). On the other hand, based on the 2003 National Nutrition Survey, 27.6 percent of the same age is underweight and 30 percent are stunted. Low birth babies were about 13 percent (2003 NDHS).  As of the latest NDHS (2003), report shows that early initiation of breastfeeding within an hour after birth occurred in 54 percent of newborns. Thirteen percent of children born five years before the survey were never breastfeed. Only 33.5 percent of infants less than 6 months old are exclusively breastfed but exclusive breastfeeding is very low for 4-5 months at 16 percent. The median duration of exclusive breastfeeding in the Philippines is very short for only less than a month.  The median duration of breastfeeding is fourteen months and children in the rural areas are breastfed longer by ten months than those in the urban areas. Children whose mothers have no or little education are breastfed three times longer than those whose mothers have college education. Mothers whose deliveries are attended by traditional birth attendants are more likely to breastfeed and breastfed longer than those mothers whose deliveries are assisted by medically trained personnel (83 percent compared with 93 percent). Similarly, children delivered in a health facility are less likely to be breastfed than those who were born at home (81 and 90 percent respectively).  Complementary feeding starts very early in the Philippines as shown by the 2003 NDHS report. Among breastfeeding infants under two months of age, 14 percent are given infant formula, 5 percent are given other milk/cheese/yogurt, and 6 percent each received other liquids and solid or semisolid food. The same report shows that 87 percent of 6-7 months old infants were given any solid or semisolid food.  The decline of breastfeeding, compounded by inappropriate complementary feeding practices, is a cause for alarm because of the consequent undernutrition and risk for childhood mortality and morbidity.  The Global Strategy for Infant and Young Child Feeding jointly developed by the World Health Organization and UNICEF is the result of a comprehensive two-year participatory process and grounded on the best available scienti\ufb01c and epidemiological evidence. The Strategy emphasized the need for comprehensive national policies on infant and young child feeding.  The Philippines adopted this strategy to revitalize our attention and commitment to infant and young child nutrition and its impact on survival and development of children.  This policy will serve as a guide for health workers and other concerned parties on infant and young child (1-3 yrs.) feeding including appropriate feeding practices in exceptionally dif\ufb01cult circumstances and ensuring the protection, promotion and support of exclusive breastfeeding and timely and adequate complementary feeding with continued breastfeeding.  II. Guiding Principles  This policy framework is guided by the following principles:  1. The 1987 Philippine Constitution mandates through Article XV Section 3, that \u201cThe State shall defend the right of children to assistance including proper care and nutrition, special protection from all forms of neglect, abuse, cruelty, exploitation, and other conditions prejudicial to their development.  2. This framework is a way of renewing the country\u2019s commitment to the UN Convention on the Rights of the Child, and a response to the Executive Order 310 dated November 3, 2000, which mandates the adoption and implementation of the National Strategic Framework for Plan Development for Children, 2000-2025 (Child 21).  3. The policy framework will build on gains and achievements of the implementation of existing laws, policies and initiatives speci\ufb01cally: Executive Order 51 \u2014 Philippine Code of Marketing of Breast-milk Substitutes (1986); Republic Act 7600 \u2014 \u201c The Rooming \u2014In and Breastfeeding Act of 1992\" - February 5, 1992; Republic Act No. 8172 \u2014 An Act Promoting Salt Iodization Nationwide and For Related Purposes (ASIN Law); Republic Act 8976 \u2014 An Act Establishing the Philippine Food Forti\ufb01cation Program and for Other Purposes- Food Forti\ufb01cation Law; Republic Act No. 8980 -\u2014 An Act Promulgating a Comprehensive Policy and A National System for Early Childhood and Development ( ECCD) Providing Funds Therefore and For Other Purposes or ECCD Act; and the Philippine Plan of Action for Nutrition 1999-2004.  4. The policy framework is a response to Executive Order 286 issued by the President of the Philippines on February 23, 2004, directing national government agencies and other concerned agencies to actively support and implement programs on the \u201cBright Child\". All members of the Council for the Welfare of Children / National ECCD Coordinating Council in partnership with the local governments, communities and families shall promote the Bright Child by pursuing the delivery of integrated services at home and facility  III. PROGRAM GOALS AND OBJECTIVES  General Objective:  The overall objective is to improve the survival of infants and young children by improving their nutritional status, growth and development through optimal feeding.  Speci\ufb01c objectives:  - All newborns are initiated to breastfeeding within one hour after birth - All infants are exclusively breastfed for 6 months - All infants are given timely, adequate and safe complementary foods - Breastfeeding is continued up to two years and beyond  IV. COVERAGE AND SCOPE  This policy shall cover the whole health sector, whether government or private, including professional groups, private sector, LGUs, and other stakeholders at all levels nationwide.  V. POLICY GUIDELINES  A. Target Bene\ufb01ciaries  - Infants, 0-11 months - Young children, 1 year up to 3 years old  B. Breastfeeding Practices  1. Early Initiation of Breastfeeding.  Breastfeeding is an unequalled way of providing ideal food for the healthy growth and development of infants. It is also an integral part of the reproductive process with important implications for the health of mothers. Infants shall be initiated to breastfeeding within one hour after birth. This will stimulate early onset of full milk production and promote bonding of mother and child. All medically trained personnel including doctors, nurses, and midwives and other birth attendants shall ensure that newborns are supported to their early initiation to breastfeeding. The health care delivery system in all facilities shall ensure that all newborns are initiated to breastfeeding within an hour after delivery.  2. Exclusive Breastfeeding for the \ufb01rst six months.  Infants shall be exclusively breastfeed for the \ufb01rst six months of life to achieve optimum growth and development. Exclusive breastfeeding means giving breastmilk alone and no other foods or drinks, not even water, with the exception of vitamins and medicine drops. Exclusive breastfeeding from birth is possible except for a few medical conditions, and unrestricted exclusive breastfeeding results in ample milk production. The conclusion of experts in their systematic review of the optimal duration of breastfeeding that there was no observable de\ufb01cits in growth for infants exclusively breastfed for 6 or more months. In addition, this also reduces morbidity due to gastro-intestinal infections and their mothers are more likely to remain amenorrheic for six months postpartum.  3. Extended breastfeeding up to two years and beyond.  Breastfeeding shall be continued as frequent and on demand for up to two years of age and beyond. Although volume of breast-milk consumed declines as complementary foods are added, breast-milk contribute signi\ufb01cantly as it provides one third to two thirds of average total energy intake towards the end of \ufb01rst year (Prentice, 1991, Heining et al, 1992a).  B. Complementary Feeding Practices  1. Appropriate complementary feeding.  Infants shall be given appropriate complementary foods at age six months in order to meet their evolving nutritional requirements. Appropriate complementary feeding means:  a. timely \u2014 meaning that they are introduced when the need for energy and nutrients exceeds what can be provided through exclusive and frequent breastfeeding;  b. adequate \u2014\u2014 meaning that they provide suf\ufb01cient energy, protein and micronutrients to meet a growing child\u2019s nutritional needs;  c. safe \u2014 meaning that they are hygienically stored and prepared, and fed with clean hands using clean utensils and not bottles and teats or arti\ufb01cial nipples;  d. properly fed \u2014 meaning that they are given consistent with a child\u2019s signals of appetite and satiety, and that meal frequency and feeding method \u2014 actively encouraging the child, even during illness, to consume suf\ufb01cient food using \ufb01ngers, spoon or self-feeding \u2014 are suitable for age.  2. Ensure access to appropriate complementary foods.  Appropriate complementary feeding interventions shall encourage diversi\ufb01ed approaches to ensure access to foods that will adequately meet energy and nutrient needs of growing children, such as use of home\u2014 and community-based technologies to enhance nutrient density, bio-availability and the micronutrient content of local foods.  3. Use of locally available and culturally acceptable foods.  Appropriate complementary food shall include locally available and culturally acceptable foods that meet the energy and nutrient need of young children. Mothers, particularly of infants and young children, shall be provided with sound and culture-speci\ufb01c nutrition counselling and recommendations of a widest array of indigenous foodstuffs. The agriculture sector has a particularly important role to play in ensuring that suitable foods for use in complementary feeding are produced, readily available and affordable.  4. Low-cost complementary foods / industrially processed foods.  In addition, low\u2014cost complementary foods, prepared with locally available ingredients using suitable small-scale production technologies in community settings, shall be encouraged to meet the nutritional needs of older infants and young children. Industrially processed complementary foods also provide an option for some mothers who have the means to buy them and the knowledge and facilities to prepare and feed them safely. Processed\u2014food products for infants and young children shall, when sold or otherwise distributed, meet applicable standards recommended by the Codex Alimentarius Commission and also the Codex Code of Hygienic Practice for Foods for Infants and children.  D. Micronutrient supplementation  Based on DOH Administrative Order 119 s. 2003 dated December 2, 2003 issued by the Secretary of Health - Updated Guidelines on Micronutrient supplementation, the following are the priority targets for micronutrient supplementation:  - Universal Vitamin A supplementation shall continue to be provided to infants and children 6-71 months of age. Vitamin A supplementation shall be given to children at risk, particularly those with measles, persistent diarrhea, severe pneumonia and malnutrition to help re-establish body reserves of Vitamin A and protect against severity of subsequent infections and or prevent complications. Postpartum women shall be given Vitamin A capsule within one month after delivery to increase Vitamin A concentration of her breastmilk as well as Vitamin A status of their breastfed children. Children with xerophthalmia, although rare, shall be treated. Children during emergencies shall be a priority for Vitamin A supplementation following schedule for universal supplementation and for high-risk children.  - Iron supplementation shall be provided to pregnant and lactating women and low birth weight babies and children 6-11 months of age. In addition, anemic and underweight children 1-5 years of age shall also be provided with iron supplements.  - Iodine supplementation shall be provided to women of reproductive age group, school age children and adult males in areas when the urinary iodine excretion of less than 50ug/L in more than 20% of the population, goiter prevalence among school children is greater than 5% and high prevalence of goiter among males.  E. Universal salt iodization (USL).  Families shall be encouraged and educated to use iodized salt in the preparation of food for older infants and young children.  F. Food Forti\ufb01cation.  Food forti\ufb01cation of staple foods will help ensure that older infants and young children receive adequate amounts of micronutrients. The Department of Health as mandated by law shall also continue to encourage manufacturers to fortify processed foods and food products based on the BFAD standards.  G. Exercising other feeding options  - Most mothers can and should breastfeed, just as most infants can and should be breastfed.  - For those few health situations where infants cannot, or should not, be breastfed, the choice of the best alternative \u2014 expressed breast milk from an infant\u2019s own mother, breast milk from a healthy wet\u2014nurse or a human - milk bank, or a breast-milk substitute fed with a cup, which is a safer method than a feeding bottle and teat - depends on individual circumstances.  - Only under exceptional circumstances can a mother\u2019s milk be considered unsuitable for her infant. There are three metabolic disorders that may interfere with breastfeeding, namely galactosemia, phenylketonuria and maple syrup urine disease.  a) Galactosemia - infants suffering from this disease cannot be fed either breastmilk or other infant or milk formula since lactose must be eliminated from the diet of these infants. Specially formulated milk-based, but lactose-free preparations or soya\u2014based formula are required.  b) Phenylketonuria \u2014 infants suffering from phenylketonuria may be breastfed while their phenylalanine blood levels are monitored. Breastmilk should be supplemented with or replaced by a special low-phenylalanine formula if concentrations reach dangerous levels  c) Maple syrup urine disease \u2014 as in the case of phenylketonuria, breastmilk can be combined with special synthetic formulas low in the non-tolerated amino acids.  - Feeding with a suitable breastmilk substitute  - In limited cases, for infants who do not receive breast milk, feeding with a suitable breast-milk substitute \u2014 for example an infant formula or other specially prepared formula that conform with applicable Codex Alimentarius standards, or a home-prepared formula with micronutrient supplements \u2014\u2014 shall be demonstrated only by health workers, or other community workers if necessary, and only to the mothers and other family members who need to use it; and the information given shall include adequate instructions for appropriate preparation and the health hazards of inappropriate preparation and use. Infants who are not breastfed, for whatever reason, shall receive special attention from the health and social welfare system since they constitute a risk group.  F. Feeding in exceptionally difficult circumstances  1. As a general rule, the following is the range of feeding options for infants and young children in certain circumstances and during times of crisis:  a) Breastfeeding is the \ufb01rst and best feeding option for infants b) Expressed breastmilk, fed by cup c) Breastfeeding from healthy wet nurse d) Human milk from milk bank, fed by cup e) Infant formula, (preferably generically labelled), fed by cup  2. Families in dif\ufb01cult situations including but not limited to natural or human\u2014induced calamities, shall require special attention and practical support to be able to feed their children adequately. Wherever possible, mothers and babies shall remain together and be provided the support they need to exercise the most appropriate feeding option under the circumstances.  3. Health workers shall ensure the protection, promotion and support on breastfeeding and timely, safe and appropriate complementary feeding. In exceptional cases, when a small number of infants have to be fed on breast-milk substitutes and milk supplements, ensure that substitutes/supplements, such as infant formula is safe, suitable and prepared in accordance with applicable Codex Alimentarius standards, or a home\u2014prepared formula with micronutrient supplements.  4. Arti\ufb01cial feeding is difficult in these situations because the basic needs for arti\ufb01cial feeding such as clean water, \ufb01iel and utensils are scarce. Transport and adequate storage conditions of breastmilk substitutes cause additional problems. To minimize the risks of artificial feeding and avoid commercial exploitation of crises, the following procedures are recommended:  a) donations of breastmilk substitutes, feeding bottles, teats and commercial baby foods should be limited, if not refused  b) if needed, breastmilk substitutes should never be part of a general distribution. Distribution should only be to infants with a clear need, and for as long as the infant need them (until a maximum of 1 year or until breastfeeding is re-established).  c) Bottles and teats should never be distributed, and their use should be discouraged. Cup feeding should be encouraged instead.  d) Information on adequate preparation and the hazards of inappropriate preparation of breastmilk substitutes or milk supplements should be given.  e) Uncontrolled distribution of infant formula or milk supplements during difficult situations can lead to early and unnecessary cessation of breastfeeding. More detailed guidelines shall be developed in collaboration with the national disaster coordinating body and health teams and provided to local government units and others concerned.  5. Infants and young children who are malnourished are most often found in environments where improving the quality and quantity of food intake is particularly problematic. To prevent a recurrence and to overcome the effects of chronic malnutrition, these children need extra attention both during the early rehabilitation phase and over the longer term. Nutritionally adequate and safe complementary foods may be particularly difficult to obtain and dietary supplements may be required for these children. Continued frequent breastfeeding and, when necessary, relactation are important preventive steps since malnutrition often has its origin in inadequate or disrupted breastfeeding.  6. The proportion of infants with low birth weight is about 13%. Most are born at or near term and can breastfeed within the \ufb01rst hour after birth. Breast milk is particularly important for preterm infants and the small proportion of term infants with very low birth weight; they are at increased risk of infection, long-term ill health and death.  Feeding options for HIV positive mothers.  Despite that HIV infection is reported to be slow and low in the Philippines, there is a need to address concern on the absolute risk of HIV transmission through breastfeeding for more than one year, which is globally between 10-20%. On the other hand, there is a need to balance the concern of HIV transmission through breastfeeding with the increased risk of morbidity and mortality when infants are not breastfed. All HIV-infected mothers shall receive counselling, which includes provision of general information about meeting their own nutritional requirements and about the risks and bene\ufb01ts of various feeding options, and speci\ufb01c guidance in' selecting the option most likely to be suitable for their situation. Feeding options for HIV positive mothers include exclusive breastfeeding, wet-nursing, expressing and heat-treating breastmilk, breastmilk from banks, commercial infant formula and home modi\ufb01ed animal milk. Mothers shall be supported in their feeding options.  Children living in special circumstances.  Children living in special circumstances also require extra attention \u2014 for example, orphans and children in foster care, and children born to adolescent mothers, mothers suffering from physical or mental disabilities, drug\u2014 or alcohol-dependence, or mothers who are imprisoned or part of disadvantaged or otherwise marginalized populations.  G. SUPPORT SYSTEMS  1. Mothers, fathers and other caregivers shall have access to objective, consistent and complete information about appropriate feeding practices, free from commercial in\ufb02uence. In particular, they need to know about the recommended period of early initiation, exclusive and continued breastfeeding; the timing of the introduction of complementary foods; what types of food to give, the quantity, frequency; and how to feed these foods safely. Where fathers are concerned, research shows that breast-feeding is enhanced by the support and companionship they previde as family providers and caregivers.  2. Mothers shall have access to skilled support to help them initiate and sustain appropriate feeding practices, and to prevent difficulties and overcome them when they occur. Knowledgeable health workers are well placed to provide this support, which shall be a routine part not only of regular prenatal, delivery and postnatal care but also of services provided for the well baby and sick child  3. \u201cInfant and Young Child Feeding Specialist\" to respond to common problems of mothers to initiate and sustain exclusive and continued breastfeeding practices and other feeding difficulties shall be accessible to mothers. The most common reasons for never breastfeeding and those who stop breastfeeding include insufficient milk, breast and nipple problem, weaning age and child re\ufb01Jse can be corrected through objective, consistent, accurate and complete information. Some of these problems need an expert to assist mothers to breastfeed. This specialist can be a doctor, nurse, midwife or an effective community health volunteer who have undergone an appropriate training.  4. Community-based networks offering mother-to-mother support, and trained breastfeeding counsellors working within, or closely with, the health care system, also have an important role to play in this regard.  5. A communication and marketing plan shall be develop to generate high political support at all levels including communities and families.  6. The Mother Baby Friendly Hospital Initiatives (MBFHI) shall be reviewed, accelerated and sustained. Efforts shall focus on the sustenance of certi\ufb01ed MBF hospitals in the country to comply with the 10 steps to Success\ufb01ll Breastfeeding. Expansion of the initiatives to other hospitals, health centers and clinics shall be part of the acceleration strategy.  7. The Rooming In and Breastfeeding Act (RA. 7600) shall be strictly enforced in all the hospitals of the country to ensure the ful\ufb01lment of the right of mothers to breastfeed and right of children to be breastfed. Rooming - In facilitates mother and child bonding and early full milk production since breastfeeding is on demand.  8. All health facilities, public or private, in the health care system in the Philippines shall provide a supportive environment to Infant and Young Feeding practices through compliance to the Philippine Code of Marketing of Breast-milk Substitutes. The facility shall not display any breastmilk substitutes or any poster or sampling of such but instead provide an enabling environment to improve and promote breastfeeding and appropriate complementary feeding practices for\u2019infants and health and nutrition of mothers.  9. Hospitals shall support and provide an enabling environment for mothers to ensure continued breastfeeding and adequate complementary feeding to their hospitalised sick children. Whenever feasible, mothers shall be allowed their breastfed children to stay with their hospitalised sick mother.  10. Continuing training programs for promoting, protecting, support and improving Infant and Young Feeding shall be institutionalised for pre-service and in-service health providers. Knowledgeable health workers with the right attitude and practice can make a difference in the growth and development of children.  11. Work places Shall provide an enabling environment for breastfeeding mothers who return to work. This can include breastfeeding rooms, refrigerators for storage of breastmilk, creches, and breaks for breastfeeding or expressing milk among others. Ten steps shall also be de\ufb01ned to facilitate systematic implementation.  12. Mothers shall also be able to continue breastfeeding and caring for their children after they return to paid employment. This can be accomplished by implementing maternity protection legislation and related measures consistent with ILO Maternity Protection Convention, 2000 No. 183 and Maternity Protection Recommendation, 2000 No. 191. Maternity leave, day-care facilities and paid breastfeeding breaks shall be available for all women employed outside the home.  13. The Department of Health as the lead agency shall ensure the fulfillment of the rights of children to the highest attainable standard of health care and nutrition. It shall enjoin all partners from both the government and non-government and private sector and from the international organizations to form a strong alliance for the ful\ufb01lment of the IYCF Strategy\u2019s aims and objectives.  14. Consistent with the accepted principles for avoiding con\ufb02ict of interest, The Department shall not forge partnerships with manufacturers and distributors of infant formula, milk supplements, complementary foods, feeding bottles and teats and other related products.  VI. IMPLEMENTING MECHANISM  A. Management  1. At the national level, the over-all management of the IYCF shall be the responsibility of a Management Committee of the Department of Health. The chair of this Committee shall be the Undersecretary for Health Operations, co-chaired by the Undersecretary'for External Affairs. The Directors, or their alternates of the following of\ufb01ces shall make up the members of the Management Committee:  - National Center for Disease Prevention and Control (NCDPC) - National Center for Health Facility Development (NCHFD) - Bureau of Food and Drugs (BFAD) - Bureau of Health Facility Services (BHFS) - National Center for Health Promotion (NCHP) - Bureau of Local Health Development (BLHD) - Dr. Jose Fabella Memorial Medical Center (also designated IYCF National Training Institution)  The NCDPC staff shall act as the Secretariat and convenor of the Committee.  2. National IYCF Coordinators or focal persons from concerned offices shall be designated for the major components of the program: - Mother and Baby Friendly Hospital Initiatives \u2014 NCHFD - Enforcement of E0. 51 (Milk Code) and RA. 7600 \u2014 BFAD - Public Health Initiatives - NCDPC  3. An IYCF Interagency Group shall be created to provide technical assistance to the DOH in planning, coordination, monitoring, evaluation and research. It shall recommend policies, guidelines and standards on IYCF. This interagency group shall be composed of representatives from government and nongovernment organizations, international organizations, health professionals and private sector.  4. Designation of coordinators at different levels at regional / provincial / city shall also be pursued to accelerate IYCF and sustain the gains in MBFHI in the nineties.  5. Existing multi-sectoral \ufb01lnctional committees at regional / provincial / city / municipalities shall be mobilized to perform similar functions with that of the national interagency group  B. Supervision, Monitoring and Evaluation  1. Periodic monitoring and evaluation of the progress of the implementation of the IYCF Strategy shall be established, institutionalized and integrated with other MCH reviews. Indicators shall be de\ufb01ned and agreed upon by major stakeholders. Monitoring of the different indicators shall be integrated into the DOH Monitoring Coaching Team and the regular hospital assessment system.  2. National as well as regional monitoring teams shall be strengthened to ensure strict compliance to the laws in support of IYCF.  3. Incentive and Award system shall be planned to sustain efforts on promoting, protecting and improving infant and young child feeding. The National Nutrition Council gives regular awards for local government units. Indicators for IYCF shall be integrated into this award system.  4. Models of good practice shall be documented and disseminated to stakeholders including local government units.  C. Research and Development  Continuing clinical and population-based research and investigation of behavioural concerns are essential ingredients for improving feeding practices. Crucial areas include improving access to breastfeeding support, programmatic approaches and community\u2014based interventions for improving breastfeeding and complementary feeding practices, improving maternal nutritional status and pregnancy outcome, and interventions for preventing mother\u2014to\u2014child transmission of HIV in relation to infant feeding.  VII. REPEALING CLAUSE Any existing provisions of DC 76-A s. 1992 (Guidelines on Rooming\u2014in, BF & Breastmilk Feeding), or issuances found inconsistent with this Order shall be repealed  VIII. EFFECTIVITY  This Order shall take effect immediately   ", "  I. RATIONALE  The WHO experts on child health estimates that 19% of under five (5) year-old deaths in the Philippines can be traced to inappropriate feeding practices including formula feeding. In the first two (2) months of life, an infant who is not breastfed is up to twenty\u2014five (25) times more likely to die from diarrhea and four (4) times more likely to die from pneumonia than an exclusively breastfed child.  Only sixteen percent (16%) of infants at five (5) months of age were exclusively breastfed. Thirty-nine percent (39%) are using infant formula in their \ufb01rst twelve (12) months of life. Thirteen percent (13%) of infants were never breastfed, making the Philippines the lowest in ever\u2014breastfed rates among \ufb01fty-six (56) countries that have conducted a Demographic Health Survey (DHS) in the past ten (10) years.  In 2003, the infant mortality rate (IMR) was 29 per 1000 live births. Improvements in the health and nutrition status of infants and young children through exclusive and extended breastfeeding as well as proper complementary feeding will significantly contribute to the achievement of the Millennium Development Goal (MDG) of reducing infant mortality by two-thirds by the year 2015.  Almost all children can be breastfed and the decision of the pregnant mother to breastfeed starts even before the delivery of the newborn. It is therefore in the health facilities where the opportunity to drive across the message to breastfeed can be initiated and nurtured by providing emphasis on the greater social roles of the health  The results of the National Demographic Health Survey (NDHS) conducted in 2003 showed that deliveries attended by health professionals or those delivered in health facilities are less likely to be breastfed.  The Mother-Baby Friendly Hospital Initiative Program of the Department of Health was launched in 1992 pursuant to RA 7600 otherwise known as the \u201cRooming-In and Breastfeeding Act of 1992\". To implement this Act, all hospitals, both government and private offering maternity and. newborn care services may be accredited as Mother-Baby Friendly by implementing the Ten Steps to Successful Breastfeeding which is a nationally adopted UNICEF/WHO global criteria.  The Mother-Baby Friendly Hospital Initiative (MBFHI) aims to facilitate and protect breastfeeding in private and public hospitals and help mothers and their newborns start with breastfeeding soon after birth. MBFHI in the Philippines reached a peak in the late nineties, when the Department of Health certi\ufb01ed 1,427 or 83% of the 1,713 targeted hospitals and lying-in clinics.  However, MBFHI implementation weakened due to several factors. In 2006, a retrospective study conducted by the University of the Philippines (UP) on the Philippine MBFHI experience in 15 regions covering 98 government and private hospitals revealed poor compliance to the ten steps to successful breastfeeding. The study showed that while 92.9% of the participating hospitals sustained its accreditation, the breastfeeding policies were communicated only during orientation in 59.1% of respondents and during meetings in 42%.  Fifty-two percent (52%) of the participating hospitals had lactation coordinators. The survey showed that in only 63% were the mothers assisted in the initiation of breastfeeding Within half an hour of birth; while only 52% of post-partum mothers were assisted to breastfeed and maintain lactation. A signi\ufb01cant proportion of hospitals, 60.2%, allowed provision of milk formula in speci\ufb01c circumstances while only 43% of personnel did not allow food or drinks other than breastmilk.  A signi\ufb01cant number of the babies were provided non-breastmilk for the following reasons: mother is incapable of breastfeeding or is sick (35.7%); baby is sick (21.4%); mother refused to breastfeed (5.9%); doctor\u2019s order (1.7%); baby had cleft palate (2.1%); mother delivered by Caesarean Section (1.7%); it is hospital routine to give water and sugar (1.3%). Only 27.6% of health facilities fostered the establishment of breastfeeding support groups.  As such, appropriate interventions and enabling mechanisms should be revitalized to protect, promote and support/sustain breastfeeding practices within health facilities.  Reassessment of previously certi\ufb01ed hospitals need to be done, assess new ones and continue capacity building of health workers. There is a need to integrate mother\u2014friendly indicators such as positioning during labor and delivery, initiation/skin to skin contact in vaginal/abdominal deliveries, minimal use of anesthesia and episiotomies, encourage spouse involvement and/or other family support to a woman before, during and after delivery. Likewise, addressing emerging issues affecting breastfeeding should also be considered.  This Administrative Order aims to guide heath workers in revitalizing the mother-baby friendly hospital initiative, towards a more sustainable action to protect, promote, and support breastfeeding.  II. LEGAL MANDATES  The following laws and administrative issuances provide the mandate for the appropriate support, promotion and protection of breastfeeding:  1. Executive Order No. 51 dated 20 October 1986, otherwise known as \u201cNational Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements and Related Products\" calls for the intensi\ufb01cation of the dissemination of information on breastfeeding and proper nutrition and the regulation of advertising, marketing, distribution of breastmilk substitutes and other related products including bottles and teats and prohibiting the use of health facilities and health workers in the promotion and marketing of the products covered by the Code.  2. Under Article 24 of the 1989, the United Nations Convention on the Rights of the Child emphasized the social responsibility of the member States to protect children and to provide them with appropriate support and services, emphasizing their right to the highest attainable level of health care services and guarantees the provision of and access to adequate nutrition for all infants and young children.  3. Republic Act 7600 otherwise known as the \u201cRooming-In and Breastfeeding Act\" of 1992 provides that rooming-in shall be observed within 30 minutes after birth. For normal spontaneous deliveries, breastfeeding should be done within one hour after birth and for Caesarean Section (C/ S) deliveries, 3\u20144 hours after birth, to ensure support for early, exclusive and continuous breastfeeding.  4. The Philippine and Infant and Young Child Feeding (IYCF) policy as adopted from the WHO and UNICEF \u201c2002 Global Strategy on Infant and Young Child Feeding\" calls for a renewed and accelerated action towards the promotion of appropriate infant and young child feeding practices.  5. PHIC Circular No. 26 s.2005 has included the Mother-Baby Friendly Hospital Initiative as part of its accreditation requirements for all hospitals in order to encourage, support and promote breastfeeding in the primary, secondary and tertiary levels of hospital facilities recognizing that breastfeeding is essential for the health and well-being of the infant and the mother.  6. Administrative Order No. 2005\u20140023 of the Department of Health identi\ufb01ed Fourmula One for Health as the implementing mechanism for health sector reforms, thereby ensuring better health outcomes, a more responsive public health system, and a more equitable health care \ufb01nancing for Filipinos. This involves critical reform initiatives which focuses on F1 Health Priority Programs/Projects/Activities (PPA\u2019s) for the National Investment Plan for Health, where the Breastfeeding Program is one of the priorities for Public Health Program Development.  III. OBJECTIVES  This Administrative Order aims to:  A. Transform all health institutions with maternity and newborn services in both the government and the private sector and other health facilities into facilities that fully protect, promote and support rooming-in, breastfeeding and mother-baby friendly practices.  B. Build the critical capacity and commitment of health care staff in protecting, promoting and providing support for appropriate infant and young child feeding practices.  C. Establish linkage with the primary health care facilities and community support groups to sustain the practice and ensure an enabling environment for optimal feeding practices.  IV. COVERAGE AND SCOPE  These guidelines shall, apply to all government, private and other health facilities nationwide providing maternity and newborn care services regardless of their current MBFHI certi\ufb01cation/accreditation status.  V. DEFINITION OF TERMS  A. Breastmilk substitute \u2014 means any food being marketed or otherwise represented as a partial or total replacement for breastmilk, Whether or not suitable for that purpose. B. Complementary food \u2014 means any food, whether manufactured or locally prepared, suitable as a complement to breastmilk or to infant formula, when either becomes insufficient to satisfy the nutritional requirements of the infant. Such food is also commonly called \u201cweaning food\" or \u201cbreastmilk supplement\" C. Exclusive breastfeeding \u2014 providing breastmilk as the sole source of nutrition for infants D. Health workers \u2014 any person working in the health care system, whether professional or non\u2014professional, including voluntary and unpaid workers, in public or private practice. E. Infant \u2014 a child within zero (0) to eleven (11) months and 29 days of age F. Infant formula \u2014- the breastmilk substitute formulated industrially in accordance with applicable Codex Alimentarius standards, to satisfy normal nutritional requirements of infants up to six (6) months of age, and adopted to their physiological characteristics G. Lactation Management \u2014 the general care of a mother-infant nursing couple during the mother\u2019s prenatal, immediate post-partum and post-natal periods. It deals with educating and providing knowledge and information to pregnant and lactating mothers on the advantages of breastfeeding, the physmlogy of lactation, the establishment and maintenance of lactation, the proper care of the breasts and nipples, and such other matters that would contribute to successful breastfeeding. H. Low birth weight infant \u2014 a newborn weighing less than two thousand \ufb01ve hundred (2,500) grams at birth. I. Rooming-In \u2014 the practice of placing the newborn in the same room as the mother right after delivery up to discharge to facilitate mother-infant bonding and to initiate breastfeeding. The infant may either share the mother\u2019s bed or be placed in a crib beside the mother. J. Skilled birth attendant \u2014 refers to professional health workers such as doctor, nurse, midwife with the training or educational background to perform safe and clean deliveries.  VI. IMPLEMENTING GUIDELINES  In order to become a Mother-Baby Friendly facility, a set of criteria based on the current guidelines of the UNICEF/WHO have been developed and adopted locally for the purpose of setting the standards which shall be the basis for the requirements among others to be institutionalized through licensing, accreditation and other regulatory mechanisms in the pursuit of quality maternity and newborn care service. delivery in the hospital facilities.  A. To become a Mother-Friendly Institution, the following are the required steps to be followed by the health facilities according to the UNICEF/WHO Global Criteria: (See Annex A: Steps to a Mother-Friendly/ Safe Motherhood Initiative)  1. The hospital facility shall incorporate mother-friendly labor and birthing practices in the health facilities\u2019 policies or standard operating procedures, including:  a. Clean birthing technique b. Delayed cord clamping (3 minutes) c. Placenta removal and disposal d. Collaboration/consultation with other maternity services, including maintaining communication with all caregivers when referral or transfer is necessary e. Linking the mother and the baby to appropriate community resources, including pre-natal and post-natal discharge follow-up and breastfeeding support  2. Train staff responsible on maternity services on essential and emergency obstetric and newborn care.  3. Educate the staff in non-drug methods of pain relief that can provide options in minimizing the use of analgesics or anesthetic drugs.  4. Motivate and refer pregnant women for STD/HIV/AIDS screening and voluntary counseling and treatment.  5. Provide the best available care, including quality antenatal, delivery, postpartum and newborn care with timely referral.  6. Birthing mothers may be offered access to a birth companion of her choice who can provide emotional and physical support during labor. A labor-support professional can provide this support until the mother delivers.  7. Birthing mothers may be allowed the freedom to walk, move about and assume the positions of her choice during labor and birth as a feasible option that shall not be limited to the lithotomy position.  8. Women may be allowed to drink during labor, upon the discretion of the attending physician.  9. The performance of obstetrical procedures shall be rationalized to minimize or avoid unnecessary procedures and instrumentation that may inhibit breastfeeding. A baby born by Caesarean Section is less likely to have early skin to skin contact and more likely to have nursery care increasing the risk of cross infection as well as restricting breastfeeding. The option to perform invasive procedures such as rupture of membranes, episiotomies, acceleration or induction of labor, instrumental deliveries or caesarean section speci\ufb01cally required for a complication shall be governed by implementing guidelines to be set by the National Management Committee based on the Global criteria on mother friendly care.  10. Encourage all mothers and families with sick premature newborns or infants with congenital problems, to touch, cuddle, breastfeed and care for their babies to the extent compatible with their condition.  11. Encourage postpartum mothers to have at least two postpartum visits.  12. Maintain records for self-assessment, reporting and monitoring purposes.  13. The hospital as a workplace must have in its hospital policy the following:  o Milk Code enforcement o Breastfeeding breaks - two additional breaks to allow mothers to express breastmilk o Breastmilk storage facilities - there shall be a refrigerator exclusively for the storage of expressed breastmilk from the mother - Breastfeeding room or a safe designated area in the hospital - this is a physical facility where mothers can express breastmilk and where a refrigerator is located, exclusively used for the storage of breastmilk. A hand washing facility must be accessible. o Support group - other hospital personnel ready or available to assist and counsel the mother to be successful in breastfeeding or a peer counselor from among the successful breastfeeding mothers  Working mothers need a supportive environment. Employers must give due consideration in adjusting work schedules of breastfeeding mothers such that those working on \u201cshift\" basis shall be assigned on a morning schedule.  Women in paid employment can be helped to continue breastfeeding by being provided with the minimum enabling conditions such as paid maternity leave, part-time work arrangements, on-site cr\u00e9ches, day-care facilities or facilities for expressing and storing breastmilk and paid breastfeeding breaks. Mothers should be able to continue breastfeeding and care for their infants after they return to paid employment  B. To become a Baby-Friendly Institution, the following are the recommended steps to be followed by the health facilities according to the UNICEF/WHO Global Criteria: (See Annex B: Ten Steps to Successful Breastfeeding))  The Ten (10) Steps to Successful Breastfeeding:  1. Development of a written breastfeeding policy that is routinely communicated to all health care staff  Indicator: Implementation of a current breastfeeding protocol that has been communicated to all staff during orientation or during department level meetings  2. Training of all health care staff in skills neceSsary to implement the policy on breastfeeding within the \ufb01rst six months upon entry into the hospital  Indicator: Schedule of staff that will attend in\u2014service training that teach the skills necessary to implement the breastfeeding protocol  3. Providing information to all pregnant women about the bene\ufb01ts and management of breastfeeding in the OPD during pre-natal and in the wards during the postpartum period  Indicator: Written, non-commercial pre-natal information on breastfeeding Schedule of parents referred to breastfeeding classes / childbirth education classes  4. Assisting mothers to initiate breastfeeding within one hour after birth for normal spontaneous deliveries and within 3-4 hours after birth for C/S deliveries.  Indicator: Infant is placed on the mother\u2019s chest to promote pre-feeding sequence of behavior that leads to proper latching and sucking  5. Training mothers how to breastfeed and maintain lactation, even if they should be separated from their infants  Indicator: A breast pump should be available for expressing milk and milk is expressed at least eight times in 24 hours Provision for milk banking in the hospital facility for the collection and storage of expressed breast milk  6. Giving newborn infants no food or drink other than breast milk, unless medically indicated and educating mothers on the importance of exclusive breastfeeding unless other food/drink are medically indicated  Indicator: No sterile water, glucose water or milk formula in the clinical wards  7. Practicing rooming\u2014in to allow mothers and infants to remain together 24 hours a day  Indicator: All babies are roomed-in and only pathologic babies are placed in a nursery (NICU)  8. Encouraging breastfeeding on demand  Indicator: Mothers are taught behavioral feeding cues for them to feed their infants on cue for 8 to 12 times each 24 hours  9. Giving no arti\ufb01cial teats or paci\ufb01ers (also called dummies or soothers) to breastfeeding infants  Indicator: No arti\ufb01cial nipples and paci\ufb01ers or any feeding paraphernalia in the wards  10. Fostering the establishment of breastfeeding support groups and referring mothers to them upon discharge from the hospital  Indicator: Organized peer breastfeeding support groups supervised by a lactation consultant/ staff nurse  Documented regular monitoring and coaching activities with the roster of breastfeeding support groups recognized as peer counselors within their catchment area to further strengthen / sustain the 10th Step  C. Responsibilities of the Hospital Sta\ufb02 Relative to EO 51:  The Health Worker\u2019s Responsibilities under the Milk Code:  1. Protect, promote and support breastfeeding with the capacity to explain the following: o The bene\ufb01ts and superiority of breastfeeding o Proper maternal nutrition in preparation for/ maintenance of breastfeeding o The risk of partial or non-breastfeeding, such as but not limited to the following: - the health hazards of inappropriate foods or feeding methods - the health hazards of unnecessary or improper use of infant formula and other breastmilk substitutes \u2014 the \ufb01nancial and social implications in the use of breastmilk substitutes  2. Refuse any gifts/ samples, offered by manufacturers or distributors as well as the representatives of the milk companies  3. Never pass any samples or gifts to pregnant women, mothers of infants and young children and members of their families that will undermine breastfeeding  4. Refrain from accepting or availing of any contribution made by the representatives of the milk industry for fellowships, study tours, research grants, attendance to professional conferences or the. like, intended for the health workers or the management staff of the health facility.  5. Be aware that any form of support/logistics and other incentives for health professionals and administrators working for infant and young child health should in no way create con\ufb02ict of interest.  6. Ensure that the health facility is not used for the display, dissemination and distribution of products within the scope of the Code.  D. Capacity Building  The trainers who have satisfactorily undergone the prescribed 40 hours standard training with the National Lactation Management Training Center (Dr. Jose Fabella Memorial Hospital) and other designated Regional Lactation Management Training Centers shall be responsible in the conduct of Lactation Management Courses for local government unit (LGU) and private health facilities.  Coaching and mentoring services shall be conducted by the CHD Coordinators/ Assessors within three months after the training as a follow-up activity.  Government and private health facilities providing maternity and newborn care services shall conduct continuing education/orientation on mother-baby friendly, rooming-in and breastfeeding practices with their staff.  E. Roles and Responsibilities  The National Management Committee shall provide the over-all management of the IYCF program duly supported by its National Technical Working Group (NTWG). The members of the TWG shall provide technical assistance and conduct performance audit to ensure quality assurance on program implementation.  The CHD Coordinators/ Assessors Team shall provide the technical assistance, conduct assessment/ reassessment, conduct monitoring, facilitate the accreditation process and build the critical capacity of both the government and private health facilities in their respective regions in the implementation of MBFHI.  The Dr. Jose Fabella Memorial Hospital shall continue to serve as the designated National Lactation Management Center for all government and private health facilities providing newborn and maternity care services within the National Capital Region (NCR). A continuing program of training shall be in place to capacitate the core of trainers at the Centers for Health Development (CHD) and supervise core of trainers on program implementation on a regular basis. It shall also spearhead efforts to promote the Kangaroo Mother Care for all newborns especially the premature infants to improve their survival.  VII. ASSESSMENT AND ACCREDITATION PROCESS  The health facility shall appraise its practices, using the Self\u2014Appraisal Tool, after studying the Global Criteria. Upon accreditation, it shall fully implement and sustain the ten steps to successful breastfeeding. The creation of a functional Breastfeeding Committee in the health facility, with recording and reporting mechanisms, may facilitate MBFHI program implementation and promote its sustainability.  The self-assessment tool shall be submitted to the regional assessors team in the Centers for Health Development (CHD), who shall be responsible in assessing/ validating the compliance with the MBFHI steps to successful breastfeeding, for the issuance of a Certi\ufb01cate of Commitment which shall be valid for two years.  The Certi\ufb01cate of Commitment shall be issued by the Regional Director based on the recommendation of the regional MBFHI assessor team upon validation of its readiness through the self-assessment scheme. The health facility shall then apply for Accreditation with the Center for Health Development (CHD) after two years, at which time a re-asses'sment shall be conducted by the regional MBFHI assessor team and submit their recommendation to the Regional Director.  In case of non-compliance or backsliding, the regional assessor team shall assist the health facility to enable them to comply and qualify for accreditation.  Accreditation shall be conferred to the health facility which has sustained compliance to the MBFHI steps to successful breastfeeding and has integrated mother-friendly steps in its MBFHI program implementation, upon the recommendation of the Regional Director to the Secretary of Health (See Annex C, Flow Chart on the Accreditation Process)  A Plaque of Accreditation shall be issued by the Secretary of Health, upon the recommendation of the Regional Director through the Field Implementation and Coordination Of\ufb01ce, based on the \ufb01ndings of the regional MBFHI assessor team, that the health facility has successfully sustained its commitment to comply with the MBFHI steps to successful breastfeeding and integrated mother\u2014friendly steps within a period of two (2) years, which period shall be reckoned from the date of the issuance of the Certi\ufb01cate of Commitment. Thereafter, a periodic re-assessment shall be conducted by the regional MBFHI assessor team every three years, to ensure sustainability of MBFHI implementation.  VIII. REPEALING CLAUSE  The provisions of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.  IX. EFFECTIVITY  This Order shall take effect immediately.    ", " I. BACKGROUND AND RATIONALE  In 2005, the countries of the Western Paci\ufb01c Region of the World Health Organization (WHO) adopted the goal of measles elimination. To achieve this, the WHO recommends that countries strengthen three areas of their Expanded Programme for Immunization. These areas are: 1) universal high population immunity through increased coverage; 2) high case-based quality surveillance; and 3) adequate laboratory support for con\ufb01rmation of diagnosis.  World Health Organization guidelines in support of the goal of measles elimination state that any person satisfying the suspect case de\ufb01nition of measles shall be immediately reported, investigated and a blood specimen collected to con\ufb01rm whether the suspected case is indeed a case of measles. Effective surveillance for measles entails establishing case-based surveillance that includes investigation and laboratory testing of specimens from all suspected cases. Such surveillance system will also identify rubella cases through laboratory con\ufb01rmation. As the country progresses towards measles elimination, reporting of rubella cases will be implemented and incorporated into the measles surveillance system.  The laboratory plays an important role in measles surveillance. In the elimination phase, it is well established that surveillance based on clinical recognition of cases is inaccurate and that laboratory con\ufb01rmation of all suspected cases is critical for effective surveillance and proper program planning. It is in this light that con\ufb01rmation of suspected measles cases through laboratory testing needs to be enhanced.   1. Monitoring and verifying virus transmission:  -Con\ufb01rmation of suspect cases/ outbreaks: con\ufb01rm the clinical diagnosis, especially in the early stages of an outbreak  -Identi\ufb01cation of measles and rubella virus strains and genetic characteristics of Viral isolates  -Differentiate endemic or imported cases: monitor circulation of wild genotypes to de\ufb01ne pathways of transmission! importation   2. Monitoring susceptibility pro\ufb01le of the population  -Determination of the age distribution of susceptibility to measles and rubella in order to assess population at risk and appropriate intervention to reduce risk.  -Evaluation of the impact of the immunization campaigns  Quality measles surveillance requires laboratory con\ufb01rmation of at least 80% of the reported suspected measles cases. However, during elimination phase, all suspected measles cases require laboratory con\ufb01rmation. This shall serve as the evidence of the country\u2019s achievement and maintenance of the elimination status.  11. OBJECTIVES   A. General Objective:  This administrative issuance sets the guidelines for strengthening laboratories in support of the goal of measles elimination.  B. Speci\ufb01c Objectives:  -To strengthen measles case-based surveillance  -To strengthen detection of rubella cases through measles surveillance and laboratory con\ufb01rmation  -To evaluate impact of the measles and rubella routine and supplemental immunization activities in interrupting measles transmission and achieving control of rubella through ef\ufb01cient laboratory con\ufb01rmation  -To establish the use of dried blood spot (DB8) and nasopharyngeal swab (NPS) as other methods of con\ufb01rming suspect cases  -To implement standards for the collection, handling, storage and transport of DB8 and NPS samples  III. SCOPE AND COVERAGE  This issuance shall apply to the entire health sector, to include public and private health facilities both at the national and local government units involved in disease surveillance and response activities (refer to A0. No. 2007-0036: Guidelines on the Philippine Integrated Disease Surveillance and Response).  IV. DEFINITION OF TERMS, ABBREVIATIONS & ACRONYMS  Case Investigation Form   Refers to reporting form that allows collection of standard (CIF) information to acquire epidemiological study of disease incidence and disease patterns  Cluster   De\ufb01ned as two or more persons presenting with manifestations of a suspect measles case that are detected with onset of illness within a period of 7 to 21 days and in the same geographical area and/or are epidemiologically linked  Contacts  Are all persons living in a household of other close quarters with the case during the infectious period (5 days before to 5 days after the onset of rash)  Disease Reporting Unit (DRU)  This includes all health facilities (rural health units, hospitals, laboratories, seaports and airport are considered DRUs)  Epidemiologically-Linked Measles Case  De\ufb01ned as a suspected measles case who was not discarded and who:   -had contact with a laboratory con\ufb01rmed case or another epidemiologically-linked case within 7 -21 days before rash onset and  -the other epidemiologically-linked or laboratory con\ufb01rmed case was infectious at the time of contact (ie. contact was 5 days before and 5 days after rash onset)  Immuno globulin Class M (IgM)  An antibody detected to con\ufb01rm suspect measles cases  Provincial Epidemiology and Surveillance Unit (PESU)   Refers to the unit established in the Provincial Health Of\ufb01ces that provides services on public health surveillance and epidemiology  Philippine Integrated Disease Surveillance and Response (PIDSR)  Refers to the Philippines process of coordination, prioritizing, and streamlining of core surveillance activities (e.g., data collection, reporting, laboratory and epidemiological con\ufb01rmation, analysis and feedback), support functions (e.g., training, monitoring, \ufb01nancial and logistics) and response (e.g.. epidemic investigation) with the aim of making the system more ef\ufb01cient and effective in providing timely, accurate and relevant information for action   Regional Epidemiology and Surveillance Unit (RESU)   Refers to the unit established in the Centers for Health Development or the DOH regional of\ufb01ces that provide services on public health surveillance and epidemiology   Research Institute For Tropical Medicine (RITM)  It houses the Department of Virology which is the national measles reference laboratory    Rural Health Unit (RHU)  Refers to the unit established in the rural health units that provides services on public health surveillance and epidemiology   Suspected Measles Case  Any individual, regardless of age, with history of fever (38\u00b0C or more) or hot to touch, generalized non-vesicular rash of 3 or more days duration; and at least one of the following cough, coryza, or conjunctivitis  V. DECLARATION OF POLICIES  A. Global Immunization Vision Strategy (GIVS) proposed a new measles ' mortality reduction of 90% by 2010 with the following major challenges: (i) measles mortality reduction activities in several large countries with high measles burden, (ii) enhanced efforts are needed to improve immunization systems to ensure that at least 95% of infants are vaccinated with measles before their \ufb01rst birthday, (iii) continue conduct \u201cfollow-up\" SIAs every 3-4 years until their routine system are capable of providing two opportunities for measles immunization to >90% of every birth cohort, (iv) disease surveillance at district, provincial and national levels need to be strengthened to enable case-based surveillance with testing of clinical specimens from suspected cases in the laboratories. This was endorsed in the World Health Assembly 2005  B. In 1996, the Regional Of\ufb01ce of the Western Paci\ufb01c (WPRO) established a \u201cPlan of Action (POA) for Accelerated Measles Control\". By 2003, the region\u2019s vision had moved to elimination with the publication of the \u201cWestern Paci\ufb01c Regional FDA for Measles Elimination\", that covered the years 2003- 2005. The Regional Of\ufb01ce published the Field Guidelines for Measles Elimination in 2004 and in 2005, a second Regional Committee (RC) resolution established 2012 as the target date for measles elimination '  C. In light of the proven ef\ufb01cacy and safety of the Regional Advisory (RA) 27/3 bases rubella vaccine, WHO recommends its use in all countries where control or elimination of Congenital Rubella Syndrome (CRS) is considered a public health priority. Current efforts in global measles control shall be used as an opportunity to pursue control of rubella through the use of Measles Rubella (MR) and Measles Mumps Rubella (MMR) vaccines  D. WHO\u2014UNICEF comprehensive strategy for reducing measles mortality among priority countries with the following goals: (i) achieving and maintaining high coverage (>90%) of the lSt dose of measles\u2014containing Vaccine (MCVl) among all children by the age of 12 months in every district through routine immunization services, (ii) ensuring that all children receive a second opportunity for measles immunization, (iii) enhancing measles surveillance with integration of epidemiological and laboratory information, and (iv) providing appropriate clinical management for measles cases   VI. IMPLEMENTING MECHANISM  The primary function of the laboratory in measles surveillance is con\ufb01rming suspect measles cases, either through serology, molecular detection of the virus or virus isolation. The testing of serum specimen for the presence of anti\u2014measles IgM antibodies remains the gold standard for laboratory con\ufb01rmation of suspect cases occurring both sporadically, in clusters or during outbreaks. Other means of con\ufb01rmation includes testing of DBS for presence of anti-measles IgM antibodies and/or culture and isolation of measles virus from suspect or clinically con\ufb01rmed measles cases.  In countries with measles elimination goal and implementing case-based surveillance, the recommendation is to collect either serum or DBS specimen within the \ufb01rst 28 days of rash onset from all suspect measles cases. While the collection of NPS/ OPS specimen for viral isolation must be within the \ufb01rst 5 days of rash onset. Viral isolation provides evidence of elimination of indigenous measles virus, including outbreak source and transmission pathways.  A. Laboratory Procedures for Case Con\ufb01rmation  1. Use of Serum Samples for IgM testing  A single serum sample obtained at the \ufb01rst contact with the patient at any time within 28 days after rash onset shall be taken from ALL suspected measles @. Serum sample collection remains the GOLD STANDARD for con\ufb01rming suspect cases under surveillance. Measles-speci\ufb01c IgM antibodies appear within the \ufb01rst few days of rash onset and decline rapidly after one month. Specimen shall be sent to RITM within 72 hours after collection with the completely \ufb01lled~ up Measles Case Investigation Form (Annex A.).  Provided that the epidemiological linkage among cases has been established within a household, specimen shall be taken from the index case (\ufb01rst person that \ufb01t the case de\ufb01nition of suspected measles case).  In line with this, it is very important to identify accurate information regarding the exposure history of suspect measles case. The CIF shall contain basic epidemiological information on time, date, place and history of contact with a known measles case. This will help identify origin and path of measles virus transmission.  Patients admitted at hospital facilities and those DRUs (RHU/Health Centers) that have the capacity to collect, store and transport shall have serum sample collected. Procedures for collection, storage and transport of sample are contained in the Annex B.  2. Use of alternative sample (dried blood spot)  Dried blood spot samples shall only be used as an alternative means of specimen collection where there is dif\ufb01Culty in extracting blood (e.g. very young infants, no medical technologist or certi\ufb01ed phlebotomist), maintaining the specimen at 2-8\u00b0C during storage and transport (i.e. selected island barangays, municipalities or RHUs, and provinces, lack of specimen storage facilities and no local courier). Collection shall be done by medical, paramedical and other trained personnel (doctors, medical technologists, nurses, midwives, etc).  3. Use of Oropharygeal and/or Nasopharyngeal swab for virus isolation  To monitor transmission pathways of measles virus during outbreaks, it is important to collect sample for viral isolation and characterization. Oropharyngeal and Nasopharyngeal swab (OPS/NPS) are the most appropriate specimens for virus isolation, OPS/NPS shall be collected as soon as possible within \ufb01ve (5) days of rash onset from any cluster of suspected measles cases. The probability that the measles virus can be isolated is highest during the \ufb01rst 3 days of rash     In collecting NPS, the response team shall consider the guide below in collecting samples of cases in a cluster/ outbreak:  -3 cases - collect at least 1-2 samples  -5 cases - collect a minimum of 3 samples  -10 cases \u2014 collect a minimum of 5 samples ->=10 cases \u2014 collect a minimum of 10 samples  Viral isolation is signi\ufb01cant to con\ufb01rm whether the transmissions of indigenous measles strains have been fully eliminated or not. This will certify if the country has achieved the measles elimination goal.  Single or sporadic measles case with history of travel or unknown history of travel shall be collected with samples for both IgM testing (eg. Serum or DB S) and viral isolation (NPS) to determine transmission pathway and differentiate between importation and indigenous transmission.  B. Roles and Responsibilities  1. Research Institute for Tropical Medicine  a. Shall receive all specimens from the DRUs and other allied health units  b. Shall inform the RESU if specimen/s arrives at RITM in bad condition and if recollection is needed  c. ' Shall process/test the specimens and send timely result to the National Epidemiology Center (NEC), National Center for Disease and Prevention Control (N CDPC) and RESUS  d. Shall build and develop laboratory capacity and networking of laboratories at the national and local levels if needed  e. Shall collaborate with WHO to strengthen molecular surveillance and ' virus identi\ufb01cation and share laboratory results (both serology and virus identi\ufb01cation) on a monthly basis with WHO country of\ufb01ce  2. National Epidemiology Center  a. Shall oversee the implementation of high quality measles surveillance in all regions, province and cities  b. Shall monitor and provide technical support to all regions, provinces and cities that are experiencing low surveillance performance  c. Shall facilitate the provision of logistics for specimen collection to all RESUs   d. Shall facilitate/ensure transport of specimens from the RESU/PESU and RHU  e. Shall ensure the adequacy & timeliness of specimen collected  f. Shall perform the overall coordination and data management   3. Center for Health Development  a. Shall coordinate and investigate suspect measles cases  b. Shall monitor and provide technical support to all provinces and cities that are experiencing low surveillance performance  c. Shall be responsible for regional level surveillance data management  d. Shall ensure the proper and timely collection, storage and transport of specimens to the National Measles Reference Laboratory (e. g. RITM)  e. Shall facilitate the provision of logistics to the hospitals and LGUs Shall send laboratory results to concerned LGUs  4. PESU/PHO/RHU  a. Shall coordinate the reporting and investigation of suspect measles cases  b. Shall be responsible for provincial/city level surveillance data management  c. Shall ensure the proper and timely collection, storage and transport of specimens to the national reference laboratory, RITM and or CHD   d. Shall facilitate the provision of logistics to the hospitals and LGUs  e. Shall ensure that CIFs are completely filled up sealed in a separate plastic bag and enclosed in the shipping box  f.Shall send laboratory results to concerned LGUs  5. All Hospitals  a. All suspected measles cases inpatient and out-patient wards shall be completely investigated with proper documentation  b.Shall collect blood specimen for all suspected measles cases at \ufb01rst contact or within 28 days from rash onset following the standard procedure in specimen collection  c.Shall properly label, store and/transport blood specimens to ESU/RITM  d. Shall ensure that CIFs are completely filled up sealed in a separate plastic bag and enclosed in the shipping box  e. Shall keep specimen collection kits properly and check for the expiration date.  Shall coordinate with CHD/ESU for the laboratory results  C. Funding Requirements  Budgetary requirements such as laboratory expenses, logistic support and other laboratory requirements for testing shall be charged against the Research Institute for Tropical Medicine through the support of Department of Health and World Health Organization. The freight and handling of specimen shall be charged against the different CHDs, subject to the usual accounting and auditing rules and regulations.  VII. REPEALING CLAUSE  The provisions of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing issuance which are not affected by this Order shall remain valid and in effect.   VIII. EFFECTIVITY  This order shall take effect immediately. ", " Administrative Order No. 2016-0035 dated September 19, 2016 entitled \u201cGuidelines on the Provision of Quality Antenatal Care in All Birthing Centers and Health Facilities Providing Maternity Care Services\", hereby amends section VI. Specific Guidelines item 3 and item 7.   Item 3 shall now read as follows:   \u201c3. Focused antenatal care interventions for healthy women with no underlying medical problems shall be provided over 4 visits at speci\ufb01ed interval: 1 visit during the 1St trimester (8- 12 weeks), 1 visit during the 2nd trimester (24-26 weeks) and 2 visits during the 3\u2019\u201c trimester at 2 weeks interval (32 weeks and 36-38 weeks). For women with underlying medical conditions, focused antenatal care may require more visits upon doctor\u2019s advice.\"   The table in item 7 that specify Preventive Measures shall now read as follows:       As thus amended, all othe1 provisions of AO N0. 2016- 0035 not affected by the aforementioned amendments shall 1emain valid and in effect   This order shall take effect Immediately.  ", " The additional Rules and Regulations promulgated to fully implement Rule Vl Sec. 24 Licensing and Accreditation, Letter e) of Republic Act 9288 otherwise known as \u201cNewborn Screening Act of 2004,\" is hereby amended to state:  e) The following administrative fines shall be imposed on health facilities that refuse to provide NBS services and/or collect more than the maximum allowed NBS fee:  First o\ufb02ense - warning Second o\ufb02ense - administrative fine of \ufb01fty thousand pesos (P50,000.00) Third o\ufb02ense - administrative \ufb01ne of one one hunddred thousnd pesos (P100,000.00)  As thus amended, all other provisions of Administrative Order No. 2008-0026 dated August 8, 2008, stands in effect. This order shall take effect \ufb01fteen (15) days after publication in the of\ufb01cial gazette or newspaper of general publication. ", "  I. RATIONALE  The exact magnitude of Sexually Transmitted Diseases occurring in children is unknown. However, the United Nations Children\u2019s Fund (UNICEF) has observed that the  prevalence of STDs among children, especially those who are in the prepubertal age, has been increasing in the past decade. UNICEF has attributed this to the problems of \u201cchild prostitution\" and sexual abuse, which have been reported to be likewise increasing in frequency in recent years.  When STDs occur in children beyond the neonatal period, causes as sexual abuse must be considered. Because of the deleterious consequences of sexual abuse on the mental, psychological, and physical health of a child, health care providers should give special attention to the management of STDs as an important part of pediatric health care.  Many health care providers are not aware of the link between STDs and the sexual abuse and exploitation of children. In some cases, children who were sexually abused are not screened for STDs. Conversely, children found with STD are not routinely examined or investigated to determine the possible cause of the infection; sometimes, they are just presumed to have acquired the STD through non-sexual means.  This Administrative Order is therefore issued to guide and call the attention of health care providers on the need to include the diagnosis and treatment of sexually transmitted diseases in children, especially when transmission through sexual means cannot be ruled out. Guidelines covering the legal and psycho-social aspects of sexual abuse and exploitation are not included this Order.    II. PURPOSE  General:  To provide health care workers, with a standard protocol on the management of  STDs in children which is consistent with the National STD Case Management Guidelines issues by the DOH.  Specific:  (a) To set the procedures in evaluating children with STD, (b) To provide guidelines for the treatment of children with STD.    III. INFORMATION, GUIDELINES, AND PROCEDURES   A. Evaluating Children with Possible STD    1. General Considerations  1.1 Evaluation of children with STDs requires open-mindedness among health care providers. A careful investigation on the nature and mode of transmission of the STD pathogen should be done.  1.2 Pathogens related to STDs can be transmitted sexually or non-sexually. In determining the mode of transmission, health workers shall consider the following: a) Sexually-abused children are often unable to report sexual abuse because of fear, embarrassment, guilt, and lack of verbal skills among others.  b) Some sexually transmitted diseases occurring in adults may occur through non-sexual means. Because some degree of intimacy which may be normal and non-abusive - often exists among household members, the possibility of sexual and non-sexual transmission should not be overlooked.  c) STDs can be acquired before birth, during birth, and through breast feeding.  1.3 Non-sexual transmission of pathogens commonly associated with STDs should be considered in the following instances:  a) Rectal or genital Chlamydia infection in children may be acquired perinatally and can persist up to three years;  b) Bacterial vaginosis and Genital Mycoplasma infections have been identified in both non-abused and abused children.  c) Genital warts, although suggestive of sexual abuse, are not specific for sexual abuse in the absence of other evidences. In the absence of sexual abuse, genital warts in the first year of life may result from contact with the virus during delivery.  d) Molluscum contagious is frequent due to ease of casual transmission.  1.4 Sexual transmission: The diagnosis of STD in a child beyond the neonatal age suggests the possibility of sexual abuse.  2. Examination of the Child  2.1 Health care workers should minimise psychological and physical trauma to the child by carefully reviewing all available information on the child, such as social situation, clinical history, results of physical examinations, and other reports to avoid duplication of questions or investigators.  2.2 The safety, health, and well-being of the child should be the primary concerns of the health care provider. To ensure these, the health worker should always keep in mind the following general considerations:  a) Institutions, groups, or individuals with special skills and services in interviewing and examining children suspected of having been abused should be involved from the start of the work-up if possible.  b) As far as practicable, health workers doing examinations and collecting specimens should have special training in child abuse evaluation. They should be aware that the clinical manifestations of STDs in children differ from the manifestations in adults.  c) Physical examination and the available and appropriate laboratory tests should be completed before treatment is initiated for children who show signs and symptoms of STD.  d) A child with STD who has been medically documented to have been sexually abused must be placed in a safe and secure environment pending further investigation and social or legal disposition of the case.  e) Absence of abnormalities on physical examination does not exclude the possibility of sexual abuse. Many children who have been abused do not show specific physical findings to confirm the occurrence of sexual abuse. Oral sexual contact, fondling and external genital contact are common forms of abuse which do not result in visible physical changes in the child.  f) Presence of multiple STDs in a child may indicate sexual abuse by more than one person.  2.3 Scheduling the Initial and Follow-up Examination   a) Scheduling of examinations should depend on the history and circumstances surrounding the sexual abuse.  b) If the initial exposure is recent, infectious agents or organisms acquired during such exposure may be of inadequate number or may not have produce adequate concentrations of biological/chemical indicators to be detected by available laboratory tests.  c) Follow-up examinations should be done about 2 weeks and 12 weeks after the last sexual exposure and should include repeat physical examination and collection of necessary specimen.  d) A single examination may suffer if the child was abused for an extended period of time, or if the last suspected episode of abuse took place for sometime before the child received the medical evaluation.  e) The timing and nature follow-up examinations should always be considerate of the patient\u2019s psychological and social needs.  2.4 Laboratory Examinations:  Laboratory evidence of STD shall be done with tests that has high specificity to avoid legal and psychosocial consequences of false positive diagnosis. The following are recommended:  a. Initial examination and after 2 weeks as follow-up examination:  i. Gram staining of all genital and anal discharges  ii. Culture for N. gonorrhoea and Chlamydia trachomatis (where available) collected from specimens from the pharynx and anus in both sexes, the vagina in girls and the urethra in boys. Cervical specimens shall not be collected from the prepubertal girls. Because of the presence of columnar epithelium in the child\u2019s vagina, N. gonorrhoea and Chlamydia trachomatis that infect the cervix in adult will cause vaginitis in children. In boys, a meatal specimen of urethral discharge is an adequate substitute for an intraurethral swab specimen when the discharge is present. Only one standard culture system for the isolation of N. gonorrhoea shall be used.  iii. Wet mount microscope examination of a vaginal swab specimen for Trichomonas vaginalis infection. The presence of clue cells or other  indicators of bacterial vaginoses as an indicator of sexual exposure in the presence or absence of vaginal discharge is unclear.  iv. Tissue cultures for herpes simplex virus and dark field microscopy or direct fluorescent antibody testing for T. pallidum (where available) from a specimen collected from vesicles or ulcers in children of all ages.  v. I, Collect1on of a serum sample to be preserved for subsequent analysis if follow-up serologtcal tests are posmve If the last sexual exposure-  v. Collection of a serum sample to be preserved for subsequent analysis if follow-up serological tests are positive. If the last sexual exposure occurred more than 12 weeks before the initial examination, serum shall be tested immediately for antibody to STD agents. Agents for which suitable test are available include syphilis, HIV and Hepatitis B virus. The choice of agents for serological test shall be made on a case to case basis.  vi. Examine for the presence of venereal warts.  vii. Examine for pregnancy in females.  b. Examination at 12 weeks following assault:  i. An examination at this time is recommended to allow time for antibody to infectious agents to develop. Serological tests for the following agents shall be considered: Syphilis, HIV and Hepatitis B virus.  ii. Hepatitis B Virus test shall be interpreted carefully, since Hepatitis B virus may be transmitted by non sexual modes as well as sexually  c. In the absence of laboratory examinations, children who are in the post menarche stage shall be managed based on the National STD case management guide.   B. Treatment of STDs in Children:  1. Prophylactic or presumptive treatment are not generally indicated when sexual abuse of children is suspected. The infection rate in children is low such that prophylactic treatment will prevent few infections. In addition, the risk of complications from STD in children is low.  2. In the presence of congenital or neonatal infections, the following are recommended:  a. Gonococcal Infection: Gonococcal Ophthalmia * Ceftriaxone 25-50 mg. / kg bw. Single does by IM to a maximum of 125 mg.  b. Chlamydial Infection: Conjunctivitis and Pneumonia * Erythromycin 50 mg. / kg.bw. / day in 4 divided doses for 2 weeks  c. Syphilis  i. Early Congenital Syphilis: less than 2 years old with abnormal CSF *Aqueous procaine penicillin, 50,000 IU / kg.bw. by IM for 10 days ii. Early Congenital Syphilis: less than 2 years old with normal CSF *Benzathine Penicillin, 50,000 IU/kg.bw., IM single dose iii. Congenital Syphilis: greater than 2 years duration *Aqueous procaine penicillin, 200,000 IU / kg.bw. by IM for 10 days, not to exceed 1.2. M units daily iv. For penicillin allergic children after the first month of life  *Erythromysin 50 mg. / kg.bw. orally, 4 times daily for 30 days.  3. In the presence of documented STD beyond the neonatal period, the following are recommended:  a. Gonococcal Infections: Uncomplicated ano-genital infections: * Ceftriaxone 25-50 mg./kg.bw. single dose by IM to a maximum of 125 mg. * Plus treatment for Chlamydia Trachomatis  b. Chlamydia Trachomatis Infections: Uncomplicated Ano-genital infections: Children who weigh less than 45 kg. * Erythromycin 50 mg./kg.bw./day in 4 divided doses for 10-14 days Children who weigh greater than 45 kg. but are less than 8 years of age * Erythromycin 500 mg. 4 x a day for 7 days Children who weigh greater than 45 kg., more than 8 years of age * Doxycycline 100 mg. 2 x a day for 7 days  c. Syphilis (1) Primary, secondary and latent syphilis of less than 2 years duration * Benzathine Penicillin 50,000 IU/kg.bw., IM, single dose (2) Late latent syphilis more than 2 years duration * Benzathine Penicillin, 50,000 IU/kg.bw., IM, single dose, weekly for 3 weeks  d. Genital Herpes * Acyclovir 20 mg./kg.bw., 5 x a day for 7-10 days or until resolution is achieved  e. Genital Warts * Podophyllin, 10-25% in compound tincture of benzoin  f. Trichomonas Vaginalis * Metronidazole 15 mg./kg.bw., per day in 2-3 divided doses for 7 days   g. Bacterial Vaginoses * Metronidazole 15 mg./kg.bw./ per day in 2-3 divided doses for 7 days or * Clindamycin 20-30 mg./kg.bw./ day in 3-4 divided doses for 7 days   h. Genital Candidiasis * Clotimazole cream, 1% apply 3 x day for 2 to 3 weeks.    IV EFFECTIVITY  This Order takes effect upon approval and signing by the Secretary of Health.   ", "   I. BACKGROUND AND RATIONALE   Despite the many gains in improving nutritional status of children under-5 in the Philippines, there remain persistent nutrition issues which impact their survival and long-term development. To address these issues, the Philippines in 2013 signed up to be part of the global Scaling-Up Nutrition (SUN) Movement, which unites governments, civil society, businesses and citizens in a worldwide effort to end under\u2014nutrition.   One pressing issue is acute malnutrition or \u201cwasting\". According to the 2013 National Nutrition Survey of the Food and Nutrition Research Institute, wasting for children under \ufb01ve years has gradually increased from 6.9% in 2009 to 7.9% in 2013, which, as per World Health Organization\u2019s public health problem threshold for global acute malnutrition, is considered poor.   Wasting is the life-threatening form of malnutrition. If not properly treated with evidence-based interventions, children with severe acute malnutrition are 9.4 times more likely to die compared to normal children. Nutrition situation is threatened to worsen during times of emergencies when the risk of developing wasting is high. In recognition of this, SUN countries, including the Philippines, have identi\ufb01ed the reduction of wasting in children as a key nutrition target for reduced child mortality and long-term development. The increasing national trend of wasting and the life-threatening nature of the condition make it a public health nutrition issue that needs to be urgently addressed in both development and emergency scenarios.    Globally, acute malnutrition has been effectively managed in the last decade through an intervention called Integrated Management of Acute Malnutrition (IMAM). Death rates have been signi\ufb01cantly reduced to less than 10% (from as high as 30\u201450%) through a largely community-based programme using standardized medical and therapeutic care protocols. The intervention is recognized by UNICEF and WHO as the only established, evidence-based intervention which successfully addresses the problem of acute malnutrition and saves children\u2019 s lives. It also falls into the category of \u201chighly cost-effective\" intervention in terms of Disability- Adjusted Life Years (DALYS) averted, a key measure of the cost-effectiveness of a public health intervention used by WHO.    In the Philippines, IMAM has already been demonstrated for the past 5 years both in the emergency and non\u2014emergency programs. A draft protocol has been contextualized and adopted by the IMAM Technical Working Group and aptly named it as the Philippine Integrated Management of Acute Malnutrition (PIMAM). It has used successfully in response to major emergencies such as Tropical Storm Sendong, Typhoons Pablo and Yolanda, Bohol earthquake, Zamboanga City Siege, and the prolonged armed con\ufb02ict in Central Mindanao. In 2014 alone, almost 3,500 children with severe acute malnutrition (SAM) have received life-saving care in all emergency areas. Several municipalities and cities with high burdens of severe acute malnutrition have adopted this protocol through their rural health units. In particular, Davao City has included PIMAM into its regular nutrition programs and the city\u2019s health workers are already I accustomed to the protocol, integrating it in the routine Integrated Management of Childhood Illnesses (IMCI) and Operation Timbang (OPT) Plus.   This Order provides the policies and strategic framework to guide a multi-sectoral approach in the adoption and implementation of PIMAM.   II. GOAL AND OBJECTIVES   A. Goal   To improve the survival of children under 5 years by ensuring access to evidence-based, effective, and life-saving interventions to prevent and treat acute malnutrition.   B. General Objective   To provide the policy, strategy, and standards to health, nutrition, \"and social service providers, including government partners, civil society organizations, and donors involved in the effective and ef\ufb01cient implementation of the Philippine Integrated Management of Acute Malnutrition.  C. Speci\ufb01c Objectives   1. To provide implementing units at all levels of the health and nutrition sector an evidence- based and standardized protocol to prevent, identify, refer, and manage children under 5 years old with acute malnutrition in communities, especially during emergencies and disasters.    2. To ensure that the health and nutrition sector will have the capacities, essential supplies and commodities, and logistics required that will enable implementing units to effectively deliver quality services.   3. To standardize and integrate indicators, reporting and monitoring tools and systems, and \"evaluation mechanisms into existing information systems that will help in planning and sustainable programming at all levels especially for emergencies and disasters.    4. To de\ufb01ne roles and functions of DOH Of\ufb01ces and its Attached Agencies, Local   Government Units, and partner agencies in the implementation and monitoring of PIMAM.   III. SCOPE AND COVERAGE   This Order is issued for the guidance of the health, nutrition, education, social welfare, food security and agriculture sectors, both public and private, involving DOH of\ufb01ces, its attached agencies, hospitals, other healthcare facilities, Local Government Units, other National and Local Government Agencies, Civil Society, Professional Societies, donors, and other stakeholders involved in nutrition.   IV. DECLARATION OF POLICIES   This order is guided by the following issuances:   1. Sphere 2011, The Sphere Project: Humanitarian Charter and Minimum Standards in Humanitarian Response 2011   2. Republic Act 7160, or the \u201cLocal Government Code of 1991\"   3. Republic Act 10121 and its Implementing Rules and Regulations or the \u201cPhilippine Disaster Risk ReduCtion and Management Act of 2010\"   4. Republic Act 10028 and its Implementing Rules and Regulations or the \u201cExpanded Breastfeeding Promotion Act of 2009\"   5. National Objectives for Health 2011-2016 which identi\ufb01ed as one of the strategies in attaining better health outcomes is to \u201cAdopt and implement appropriate guidelines for the community-based management of acute malnutrition\"   6. Philippine Plan of Action for Nutrition 2011-2016 which aims for the integration of the management of severe and moderate acute malnutrition as a vital service in the community and health facility.   7. Integrated Management of Childhood Illness Chart Booklet which integrates the identi\ufb01cation and management of acute malnutrition together with common childhood illnesses at the community level.   8. NNC Governing Board No. 1 82009, the National Policy for Nutrition Management in Emergencies and Disasters, which indicates that PIMAM is a key service that shall be available in emergency and disaster situations.   V. DEFINITION OF TERMS   1. Acute malnutrition (or Wasting and/or edema) \u2014 occurs when an individual suffers from current, severe nutritional restrictions, a recent bout of illness, inappropriate childcare practices or their combination resulting to sudden weight loss or the development of bilateral pitting edema. This can be reversed with appropriate treatment.    a. Severe Acute Malnutrition (SAM) or Severe Wasting Very low weight-for\u2014height de\ufb01ned as less than 3 standard deviations below the median (&lt -3SD) of the WHO growth standards, characterized by visible severe wasting, or by the presence of bipedal. pitting edema (WHO), or a Mid-Upper Arm Circumference (MUAC) measurement of &lt 115 millimeters (&lt 11.50m).   b. Moderate Acute Malnutrition (MAM) or Wasting Low weight-for\u2014length/height de\ufb01ned as between 2 and 3 SD below the median (&lt-2 and &gt= SD) of the WHO growth standards or a MUAC measurement of &lt 125mm and 2 115mm (&lt 12.50m and &gt= 11.50m).   2. Appetite test \u2014 The most important criterion to decide if a patient shall be sent for in- or out-patient management. SAM cases 'with poor appetite indicates the presence of severe infection or major metabolic abnormality even in the absence of other signs, and shall be admitted for Inpatient Therapeutic Care.   3. Mid-Upper Arm Circumference (MUAC) \u2014 MUAC is a measure of muscle wasting and has been shown to have the highest correlation with risk of mortality of any anthropometric indicator. It is also a simple and transparent measure and therefore the most appropriate for use in decentralized services.   4. Ready\u2014to-Use Food (RUF) \u2014 WHO recommended energy-dense, mineral and vitamin- enriched foods that deliver both macro and micronutrients and are ideally suited to the treatment of acute malnutrition in the community and at home.   a. Ready-to-Use Therapeutic Food (RUTF) - an energy and nutrition-dense paste, containing 520-550 kcal/100g recommended by the WHO for the home-treatment of severe acute malnutrition. While RUTF must be consumed along with clean drinking water, no other foods besides breast milk are necessary for the rehabilitation of the severely malnourished child.   b. Ready-to-Use Supplementary Food (RUSF) \u2014\u2014- types of RUF that are speci\ufb01cally designed either for the treatment-or prevention of MAM in children 6\u201459 months of age. It is eaten by the child in addition to breast milk and other family foods for about 3 months. It contains 534-543 kilocalories/ 100grams.   5. Therapeutic Milk \u2014 a low protein formulation that delivers the right balance of macro and micronutrients recommended by the WHO for the treatment of severe acute malnutlition with complications in a health facility/hospital. Therapeutic milk is speci\ufb01cally formulatedfor management of SAM and is not equivalent to any commercial milk formula. _   a. F\u201475 Therapeutic Milk \u2014\u2014 a type of therapeutic milk suited to stabilize the condition and restore normal metabolic function and nutrition-electrolyte balance of patients suffering from severe acute malnutrition while their medical complications are being I treated during phase 1 of treatment.   b. F-100 Therapeutic Milk \u2014 a therapeutic milk formulation similar to RUTF for the recovery of patients suffering from severe acute malnutrition in- the nutritional rehabilitation phase of treatment (transition phase and phase 2).   VI. GENERAL GUIDELINES   1. Mothers and caregivers of children under 5 years shall have access to information and PIMAM health services including the prevention, diagnosis, management, and referral of acute malnutrition, especially during emergencies and disasters.   2. All public health and nutrition programs including but not limited to' IMCI, EPI, IYCF, micronutrient supplementation, and growth monitoring shall integrate PIMAM principles and strategies to provide clear policy guidanCe for alloCating and mobilizing needed resources to ensure the continuity of and access to evidence-based and life-saving nutrition interventions.   3. PIMAM services in development and emergency settings shall be available and accessible at all communities and health facilities. Intermediary LGUs, Regional Of\ufb01ces for Health, and DOH- Central Of\ufb01ce shall provide technical support and assume augmentation and surrogate roles in times of disasters.   4. All Local Government Units, through their Local Health Of\ufb01ces, shall be responsible in enhancing the capacities of their communities to identify, refer, and manage cases of acute malnutrition.   5. Competent PIMAM service providers shall be developed and established at all levels with the capacities to deliver quality services both under routine health program and during emergencies. '   6. All implementing agencies (LGUs, Hospitals, NGOs) shall establish and implement mechanisms, tools, and systems for supplies management and monitoring and evaluation of service delivery during routine health programs and emergencies.   7. All implementing agencies shall develop, implement, and sustain information management systems and strategies to ensure that appropriate, timely and evidence-based information are available at all times and levels. Systems shall be put in place for making the information available and accessible in the case of disasters and emergencies.   8. Coordinating, advocacy, networking, and partnership mechanisms shall be established and/or strengthened at all levels for effective and ef\ufb01cient PIMAM service delivery during routine health programs and emergencies.   9. The components of PIMAM shall be Community mobilization, Inpatient Therapeutic Care (ITC), Outpatient Therapeutic Care (OTC), and Targeted Supplementary Feeding (TSFP). These components shall sit within a multi-sectoral range of health and nutrition interventions and services which focus on tackling the determinants of undernutrition in the 'critical 1000 day window\u2019  VII. SPECIFIC GUIDELINES   The components of PIMAM, and the guidelines, processes, and procedures are outlined in Figure 1 and described in detail in the Manual of Operations for the Management of SAM (https://www.doh.gov.ph/non-serials.html)   A. Community Mobilization   Community mobilization shall involve engaging the community to understand their needs and ensure that the service is accessible, available and appropriate; sensitizing the community to make them aware of acute malnutrition, its effects, and that treatment is available; and, \ufb01nding cases of acute malnutrition, referring them for treatment and following up at-risk cases when needed.   B. Assessment and Diagnosis   1. Acute malnutrition shall be diagnosed by assessing the child to be of inadequate weight relative to height based on the WHO Child Growth Standards and/or by identifying muscle wasting using Mid Upper Arm circumference (MUAC) and for bilateral pitting edema;   2. Acute malnutrition shall be classi\ufb01ed as moderate or severe according to the degree of wasting in comparison to speci\ufb01c cut-off points or reference standards. Children with bilateral pitting edema are always classi\ufb01ed as having severe acute malnutrition.   3. Assessment shall be made in the CPD of an Inpatient Therapeutic Care (ITC) facility or in an Outpatient Therapeutic Care (OTC) facility (BHS, BHC, or RHU). Other venues such as daycare centers shall also be used as the need arises.   4. Once a child has been diagnosed with SAM, it is important to make sure that he or she shall be correctly assigned to outpatient or inpatient care based on his or her condition. This is based on whether the child has appetite (conduct Appetite Test using RUTF) and/or any medical complication based on IMCI criteria.   a. Identification of Acute Malnutrition in infants &lt 6 months of age   i. Severe Acute Malnutrition (any of the following)  1. Presence of bilateral pitting edema  2. W/L &lt -3 SD   ii. Moderate Acute Malnutrition 1 . W/L &lt -2 SD and &gt= -3 SD   b. Identi\ufb01cation of Acute Malnutrition in children aged 6-59 months   i. Severe Acute Malnutrition (any of the following)   1. MUAC &lt 115 mm (or &lt 11.50m)  2. Presence of bilateral pitting edema  3. Weight-for-Height (W/H) or Weight-for\u2014Length (W/L) &lt -3 SD   ii. Moderate Acute Malnutrition (any of the following)   1. MUAC &lt 125mm (&lt 12.5cm) and &gt= 115 mm (&gt= 11.50m)  2. W/H or W/L &lt \u20142 SD and &gt= -3 SD   c. Categorizing severity of pitting edema   i. Mild (+) \u2014 both feet  ii. Moderate (++) \u2014 both feet plus lower legs, hands and lower arms  iii. Severe (+++) \u2014 both feet, legs, hands, arms and face (generalized)   d. Categorizing results of the Appetite test using RUTF   i. Pass \u2014 The child takes at least 3-4 mouthfuls of RUTF.   ii. Fail -\u2014 The child does not take at least 3-4 mouthfuls of RUTF and is considered to lack suf\ufb01cient appetite for outpatient treatment and shall be admitted for inpatient care.   C. Criteria for Admission   1. Infants &lt 6 months   a. Inpatient Therapeutic Care \u2014 all infants who meet the following shall be admitted for ITC:   Bilateral pitting edema or W/L &lt -3 SD AND one of the below   -Recent weight loss/inability to gain weight Any of the medical complications outlined for children 6\u201459m (see below)  -Any medical issue needing more detailed assessment or intensive support (e.g. disability)  -Ineffective feeding (attachment, positioning and suckling) directly observed Infant is lethargic and unable to suckle  -No possibility of breastfeeding (e.g. death of mother)  -Depression of the mother/caregiver or other social circumstances   b. Outpatient Breastfeeding Support \u2014 all mothers with infants who meet the following shall be provided with intensive outpatient breastfeeding support and counselling: -   i. W/L &lt -2 SD and none of the complications requiring inpatient care, or  ii. Mother is malnourished or ill   2. Children 6-59 months: a. Inpatient Therapeutic Care 4 all children who meet ANY ONE of the following criteria shall be admitted for ITC:   i. Have Grade 3 (+++) Bilateral pitting edema OR   ii. MUAC &lt 115 mm or W/H or W/L &lt \u20143 SD AND any grade of edema) OR   iii. MUAC &lt 115mm or W/ H or W/L &lt -3 SD plus ANY ONE of the following:   -Failed appetite test with RUTF  -Intractable (empties contents of stomach)  -Fever &gt 38.5\u00b0C axillary or 39.0\u00b0C rectal  -Hypothermia &lt 35\u00b0C axillary or &lt 35.5\u00b0C rectal  -&gt= 50 breaths/min from 6 to 12 months  -&gt= 40 breaths/min from 1 to 5 years  -&gt= 30 breaths/min for over 5 year olds  -Any chest in\u2014drawing (for children &gt 6 months)  -Very pale (palms, palate, nailbeds, eye palpebrae)  -Extensive skin infection requiring Intra-Muscular antibiotics  -Very weak, apathetic, or unconscious  -Any recent \ufb01ts or convulsion  -Recent history of diarrhea/vomiting with of sunken eyes   b. Outpatient Therapeutic Care \u2014 all children who meet ALL of the following shall be admitted for OTC:   i. Have Grade 1 or 2 (+ and ++) Bilateral pitting edema or MUAC &lt 115mm or W/H or W/L&lt \u20143SD  ii. Passed the appetite test   iii. Do not have medical complications   c. Targeted Supplementary Feeding \u2014 all children aged 6-59 months who meet ANY ONE of the following criteria shall be admitted for TSFP   i. Have MUAC 2 115mm and &lt 125mm or W/H or W/L &gt= -3SD and &lt -2 SD  ii. No bilateral pitting edema  iii. All children with SAM discharged as cured   D. Criteria for Discharge   1. Infants &lt 6 months   a. Infants with SAM shall be considered cured if ALL of the following are met:   i. Breastfeeding effectively (based on assessment)   ii. Has adequate weight gain (5g/kg/d)   iii. W/L 2 -2 SD for 2 consecutive visits (where capacity exists to measure)   iv. Once the infant reaches 6 months of age, MUAC shall be taken at this point to assess whether the infant quali\ufb01es for enrolment in OTC as a child and to receive RUTF    2. Children 6-59 months with either SAM or MAM   a. For those admitted on MUAC, edema, or both MUAC and W/H SD, ALL of the following shall be met:   i. MUAC &gt= 125mm (&gt= 12.50m) for 2 consecutive visits  ii. No edema for 14 days  ii. Clinically well   b. For those admitted on W/H SD, ALL of the following shall be met:   i. W/H or W/L &gt= -2 SD for 2 consecutive visits  ii. No edema for 14 days  iii. Clinically well   E. Referral and Management   1. Inpatient Therapeutic Care (ITC) for infants and children shall focus primarily on the nutritional stabilization of the child and appropriate management of medical complications. Inpatient care shall be provided in order to:   a. Recover infants &lt 6 months with SAM who require intensive treatment.   b. Stabilize children with SAM aged 6 to 59 months who also have medical complications or a lack of demonstrated appetite suf\ufb01ciently to allow them to continue their nutritional rehabilitation with OTC.    c. Provide complete nutritional rehabilitation in inpatient care for children with SAM where there is no access to OTC.   d. Children in outpatient care may also be referred to inpatient care for a period of more intensive treatment/monitoring when they are not responding appropriately to treatment as an outpatient.   ITC has 3 distinct phases described below. Children aged less than 6 months shall be treated using speci\ufb01c protocols for this age group.   a. Phase 1/Stabilization: Patients with an inadequate appetite and/or an acute major medical complication shall be initially admitted for stabilization treatment. F75 shall be used during this phase to stabilize and reverse physiological and metabolic abnormalities and correct electrolyte imbalances. There is no expectation for wasted children to gain weight during Phase 1.   b. Transition Phase: This phase marks the transition from stabilization to OTC where these facilities exist, or to Phase 2 inpatient care when it is not possible to refer to OTC. Clinically, the return of appetite, and/or the improvement of clinical signs and symptoms related to the medical complication shall indicate entry into this phase. In this phase, the diet shall be transitioned from F75 to RUTF (or to therapeutic milk _ F100 for Phase 2 inpatient care). Wasted children start to gain weight, while children with edema may continue to lose weight until the edema is resolved. Once the child is taking the prescribed amount of RUTF and complications are adequately resolved they shall be referred to OTC to continue their treatment at home.   c. Phase 2: Where it is not possible to refer to OTC,'children shall remain as inpatients until cured of acute malnutrition. This phase shall continue treatment with F100 therapeutic milk or RUTF, increasing the intake so as to promote rapid weight gain. The child shall remain under treatment until the criteria for discharge are reached.   2. Outpatient Therapeutic Care (OTC) provides treatment for children with SAM who have appetite and no medical complications. These children can be treated at home with simple routine medicines and RUTF. All cases admitted to OTC shall be provided with oral antibiotics in line with IMCI guidelines.   3. Targeted Supplementary Feeding Program (TSFP) provides treatment for children with MAM. These children can be treated at home with RUSF or locally available supplementary food (forti\ufb01ed with micronutrient poWders) and intensive nutrition counselling plus routine health care (consistent with IMCI guidelines, outpatient treatment of infections or referral to hospitals), in line with national Supplementary Feeding Guidelines   F. Recovery and Links with Existing Programs   The child being treated for acute malnutrition suffers from some combination of nutritional de\ufb01cit and infection and often may come from the poorest families in the community.    In order to continue healthy growth and prevent relapse, follow up care shall be sought. Depending on services available locally, the following shall be considered by health and nutrition community workers and hospital staff:    1. Referral to a supplementary feeding program.   2. Strengthen on\u2014 going IYCF support coupled with intensive nutrition counselling (e. g. IYCF Peer counselling, Family Development Sessions, Pabasa sa Nutrisyon) with referral to milk bank facilities or provision for wet/ cross nursing options.   3. Micronutrient supplementation in line with national guidelines.   4. Referral to Mother support groups and activities on Promotion of Good Nutrition.   5. Enrollment in routine growth monitoring program Operation Timbang Plus (if not yet enrolled).   6. Referral to a food security and livelihood program.   7. Social welfare services available and referral to any relevant programs.   8. Ensure enrolment and coverage of the child and mother in Phil Health or other social safety nets, as required by the family.   G. Supplies and Logistics   1. The overall management of all drugs, supplies, therapeutic and supplementary commodities, and diagnostic I tools for PIMAM, and the development and dissemination of corresponding guidelines and protocols shall be the responsibility of the DOH and the local government units.   2. The local governmentunits shall ensure that policies and guidelines for SAM treatment supplies management are implemented properly at their level. They shall also actively participate in the monitoring and evaluation of the implementation of these policies and guidelines.   3. Quanti\ufb01cation and ordering shall be based on utilization rate, projected 1ncrease of cases due to strengthened case \ufb01nding and provision of buffer stocks for emergencies. Buffer stocks shall be maintained at 20% to be lodged at the DOH Regional Of\ufb01ces or Provincial Health Of\ufb01ces as needed.   4. Medicines and nutrition supplies shall be stored under appropriate conditions and accounted for through proper recording and reporting. Stock status shall be re\ufb02ected in the National Online Stock Inventory Reporting System (N OSIRS)   5. The DOH Regional Of\ufb01ces, PHOs, and CHOs shall ensure that drugs and diagnostic supplies are promptly distributed to the next level. The DOH Central Of\ufb01ce shall deliver the commodities to the DOH Regional Of\ufb01ces. DOH Regional Of\ufb01ces shall deliver the commodities to the PHOs/CHOs. PHOs and CHOs shall ensure the prompt delivery of the commodities to RHUs/Hospitals which shall serve as the Point of Care under the Service Delivery Network.   6. Disposal of expired and damaged medicines and nutritional supplies shall follow government rules and regulations.   7. The DOH Regional Of\ufb01ces shall be responsible for the reproduction of all forms used 1n the treatment of SAM to be distributed to PHOs/CHOs, RHUs, and hospitals.  8. LGUs shall set aside funds for the emergency procurement of suf\ufb01cient quantities of drugs and nutrition supplies in times of impending shortage to ensure continuous availability of SAM treatment commodities at their service delivery points.   Figure 1. Flowchart for Inpatient and Outpatient Therapeutic Care and TSFP.           H. Monitoring and Evaluation of PIMAM   1. Monitoring and data collection in order to report on PIMAM indicators shall be performed through meetings, registration and reporting from community and health facility level, and through speci\ufb01c assessments conducted at municipality level of coverage.   2. Monthly collation and analysis shall be performed at the health facilities. Quarterly and annual consolidated and analyzed reports shall be submitted to the next higher level using the prescribed schedules, forms and templates in line with the Manual of Operations.   3. Among the many indicators to be monitored in PIMAM, there are core indicators that can facilitate ef\ufb01cient monitoring and evaluation and even bottleneck analysis. The following SAM indicators shall be measured both at the community and the facility level disaggregated by age and gender:    a. Number of admissions \u2014 total number of SAM children admitted into the program  during the reporting month.   b. SAM Cure Rate \u2014 number of admitted SAM children &lt 5 years successfully discharged cured as a percentage of all discharged SAM cases during the reporting month; Discharge is the sum of children cured, died, defaulted, and non-cured (Target: >75% cured).   c. SAM Default Rate \u2014 number of admitted SAM children &lt 5 years who defaulted (recorded as absent for 3 consecutive sessions - 3 visits in OTC or 3 days in ITC) as a percentage of all discharges during the reporting month (Target: &lt 15% defaulted).   d. SAM Death Rate -\u2014 number of admitted SAM children &lt 5 years who died during treatment as a percentage of all discharges during the reporting month (Target: &lt 10% died).   e. SAM Non-Cured Rate w number of admitted SAM children &lt 5 years discharged as non-cured as a percentage of all discharged SAM cases during the reporting month; non-cured is de\ufb01ned as not reaching discharge criteria after 4 months in the program as long as all possible interventions and follow-up have been attempted.   f. RUTF or F75 Stock-out Rate \u2014 number of health facilities with stock-outs of RUTF or F75 in the last 3 months as a percentage of all health facilities managing these commodities.   g. SAM Human Resources Rate \u2014- number of health workers who have been trained on SAM management as a percentage of all health workers in SAM implementation/target areas.   h. Geographical Access \u2014 number of health facilities offering SAM treatment as a percentage of all health facilities 1n SAM implementation/target areas.   i. Utilization Rate \u2014~ number of children &lt 5 with SAM who were admitted for SAM treatment as a percentage of identi\ufb01ed SAM cases in implementation/target areas).   The following MAM indicators shall be measured by all PIMAM implementers and program managers:   a. MAM Cure Rate \u2014 proportion of children 6-59 months with MAM discharged as cured out of total number of discharged MAM cases; Discharge is the sum of children cured, died, defaulted, transferred (children who transferred from one SFP to another), and non-responder (Target: &gt 75%).   b. MAM Default Rate \u2014 proportion of children 6-59 months with MAM recorded as ' absent for 3 consecutive sessions out of total number of discharged MAM cases (Target: &lt 15%).   c. MAM Death Rate \u2014 proportion of children 6- 59 months with MAM who died while in treatment out of total discharged MAM cases (Target: &lt 3%).   d. MAM Non-Responder Rate - proportion of children 6-59 months with MAM who had been referred for medical investigation and are discharged non-responder according to discharge criteria after 4 months of treatment out of total discharged MAM cases (Target: &lt 15%).  I. PIMAM in Emergencies and Disasters   a. Where PIMAM is implemented, a support for BNS / BHW in screening for cases of SAM in the community, aiming to augment rather than replace current services; volunteers / assistants may provide ancillary help at the BHS / RHU.   - Provision of mobile OTC teams for communities unable to access health care and/or the establishment of temporary OTC sites in camps where health centers and / or health staff are affected by disaster.  - Provision of additional resources such as medicines and RUTF \u2014 based on calculated post-emergency caseload; buffer stocks from regular program may be used to ensure that children who need. it are provided the service immediately.  - Implementation of IYCF in emergencies services.  - Temporary ITC sites if hospital services for cases of SAM with complications where hospital services become inaccessible.  - If TSFP is available, ensure proper screening and referral of children with MAM.   b. Where no SAM treatment service is currently implemented, the implementation will likely require the assistance of neighboring local government units or local or international NGOs with previous experience on PIMAM. Coordination of programming for the treatment of SAM shall be done through the relevant local authorities and the Nutrition Cluster.   -The focus is on achieving high treatment coverage and early admission to treatment before complications can develop. As such, community mobilization and OTC services shall always be prioritized over ITC.  -Before implementation, the emergency program must have a well-de\ufb01ned and sustainable 'transition strategy\u2019.   VIII. IMPLEMENTING MECHANISMS A. Roles and Responsibilities   1. Department of Health Central Of\ufb01ce: The Heads of the Technical Services and Health Operations Clusters, shall oversee that these guidelines are implemented in the different of\ufb01ces of the Department.   DOH-Central Office shall:   a. Create the National Program Management Team (NPMT) and serve as the policy- making body and leader in promoting the importance of standardized PIMAM services both during development and times of emergencies and disasters among the government and private sector including planners, decision makers, policy makers and-the general public.   b. Formulate, in coordination with members of the Health Sector, and implement policies, guidelines, protocols and standards and service packages and integrate all related programs to allow a holistic approach, not just focusing on malnutrition.   c. Provide assistance and guidance to all implementing agencies in strengthening and \ufb01nancing service delivery.   d. Provide training on the guidelines/protocol to \"relevant stakeholders; conduct dialogues with relevant Stakeholders and review the implementation of the program   e. Spearhead the conduct of studies, management of information, and documentation of best practices to support and initiate evidence-based reforms.   Disease Prevention and Control Bureau (DPCB) shall:   a. As the NPMT lead, ensure that all of the functions set by the NPMT shall be carried out effectively and ef\ufb01ciently.   b. Regularly convene the NPMT to plan and address issues and other concerns that may arise during the course of the scale\u2014up and program implementation and provide members with the program technical and administrative updates.   c. Generate additional membership of potential partners for an enhanced program implementation. '   d. Lead in the integration, standardization, and dissemination of indicators, tools, and recording and reporting forms. -   e. Facilitate the report (number and status of cases, interventions done, utilization of logistics) generation and analysis per facility and generate evidences and studies based on programming data and coordinate with relevant DOH Bureaus/Of\ufb01ces for integration.   f. Ensure that storage facilities have at least a 20% buffer stock of therapeutic products and routine medicines for the treatment of SAM and other materials and tools to last for 3 months.   g. Address possible issues and concerns on procurement or production of logistical. needs (RUTF/RUSF, MUAC tapes, weighing scales, height boards, standard weights for calibration-2kg).   h. Facilitate the development of system for inventory, transport and tracking of necessary logistics to the end\u2014user.   National Nutrition Council (NNC) shall:   a. As NPMT co-lead, provide assistance to the DPCB in the ful\ufb01llment of the functions set for PIMAM implementation in the country.   b. Provide both Technical / Management support.   c. Utilize the existing Philippine Plan of Action for Nutrition (PPAN) strategy for enhancing the effective PIMAM program implementation, speci\ufb01cally it shall incorporate the program\u2019s screening activity in the conduct of the regular Operation Timbang (OPT) and annual Monitoring and Evaluation of Local Level Program Implementation (MELLPI).   d. Generate support from the council members to facilitate the effective and ef\ufb01cient PIMAM program implementation.   Health Emergency Management Bureau (HEMB) shall:   a. Serve as the lead coordinating of\ufb01ce for the Quad cluster during times of emergencies and disasters and provide support to the National Nutrition Cluster.   b. Facilitate the coordination of response activities and information sharing among DOH Of\ufb01ces and Bureaus and cluster partners during emergencies.   c. Coordinate the augmentation of human resource and logistics in emergencies when assistance from the national government is needed.   d. Ensure the integration of PIMAM indicators in the SPEED and HEARS reporting systems for emergencies and disasters.   Health Promotion and Communication Service (HPCS) shall:   a. Lead in the advocacy and promotion activities.   b. Develop and produce appropriate advocacy and communication strategies, IEC materials and collaterals.   c. Support the NPMT 1n the dissemination of the IEC materials and collaterals.   d. Provide technical assistance in the local version translation of the IEC materials.   Epidemiology Bureau (EB) shall:   a. With the NPMT, facilitate the integration and consequent updating of PIMAM indicators under the F SHIS and regular reporting systems of the department.   b. Support enhancement of surveillance systems and facilitate information sharing among DOH Bureaus and Units and cluster partners especially on cases of communicable diseases.   Bureau of Local Health Systems and Development (BLHSD) shall:   a. Support the advocacy for the implementation of PIMAM program in all LGUs.   b. Spearhead the integration of PIMAM program performance indicators in the LGU scorecard and to provide technical assistance in the conduct of M&E.   Health Facility Development Bureau (HFDB) shall:   a. Facilitate the setting up and/ or dedication of ITC areas in all hospitals with due priority for DOH Hospitals.   b. Provide technical support to ITCs through the dietary department in all hospitals.   c. Facilitate the organization and conduct of the capacity development for ITC.   Health Facilities and Services Regulatory Bureau (HFSRB) shall identify speci\ufb01c PIMAM requirements that will be incorporated in the checklist for routine licensing applications (new and renewal of license) of health facilities and PHILHEALTH I accreditation.   Knowledge Management Information Technology Service (KMITS) shall provide technical assistance to the NPMT in ensuring the functionality, maintenance, and integration of PIMAM into existing health information management systems (iClinicsys, PHIE, FHSIS, PIDSR, disease registries, and others).   Pharmaceutical Division shall expedite the registration of PIMAM commodities in the PNDF and issuance of clearance for commodities, drugs and medicines as needed.   Food and Drug Administration (FDA) shall:   a. Provide technical assistance in the acceptance of international and local donations, especially food and drugs.   b. Facilitate the acceptance and clearance of food, drugs and supplies which are necessary for PIMAM program implementation. '   Health Human Resource Development Bureau (HHRDB) shall:   a. In coordination with other NPMT members, standardize the training of trainers (PIMAM, active screening, Essential Nutrition Action, Breast feeding community Initiative, mother-to-mother network group).   b. Develop or conduct other related learning and educational development activities.   Bureau of International Health Cooperation (BIHC) shall:   a. Facilitate the processing of international donations of commodities or grants,   b. Facilitate the acceptance of international donations of foods, drugs and supplies, and administer such in accordance with the terms of the grant or donation.   Health Policy Development and Planning Bureau (HPDPB) shall, in coordination with other NPMT members, review and provide technical assistance in the development of the PIMAM protocol.   2. DOH Regional Of\ufb01ces and National Nutrition Council Regional Of\ufb01ces   The DOH Regional Directors shall directly oversee the implementation and adoption of these policies within their Regions, create Regional PIMAM management teams, and provide feedback, suggestions, and policy recommendations to the Secretary of Health.   The Regional PIMAM Management Teams, led by the Family Health Medical Of\ufb01cer, shall be responsible for the implementation and adoption of these guidelines in their respective regions.   The Regional Of\ufb01ces for Health, being the lead of the PIMAM Regional Management Team, and Regional National Nutrition Councils, as co-lead, shall:   a. Formulate plans, procedures and protocols to implement this policy and guidelines.   b. Provide and implement a mechanism of coordination and collaboration with hospitals (both government and private), LGUs, partners, and other stakeholders, to ensure the timely and effective service delivery.   c. Support monitoring and evaluation activities.  d. Provide technical assistance and logistics support to implementing agencies and regions. Design, update, and conduct necessary training to enhance capabilities of PIMAM implementers.   e. Conduct studies and facilitate technical resource development that will contribute to improving service delivery.   f. Identify, develop and enhance capacity of the members of the health and nutrition sector.   g. Plan for and manage supplies ef\ufb01ciently and effectively.   h. Develop/improve and sustain a safe and ef\ufb01cient referral system of children with acute malnutrition.  i. Through the respective Development Management Of\ufb01cers, ensure the supportive supervision, monitoring, and coordination of PIMAM implementation at the LGU level including logistics coordination.   3. Local Government Units   \"The Provincial/Municipal/City Chief Executives shall directly oversee the implementation and adoption of these policies within their locality, create Local PIMAM   Management Teams, and provide feedback, suggestions, and policy recommendations to the Regional Of\ufb01ces for Health.   The Local PIMAM Management Team, led by the Provincial/City/Municipal Health Of\ufb01cer, shall be responsible for the implementation and adoption of these guidelines in their respective locality. They shall report to the Provincial/City/Municipal Chief Executive.   The LGUs shall:   a. Institutionalize (structure, organization and policies, people, resources, systems, partners) health emergency management in their responsible areas.   b. Formulate plans, procedures and protocols to implement their policy and guidelines   c. Enforce existing local policies and guidelines.   d. Consider the principles set in this policy in their respective health and nutrition plans and systems.    e. Identify, develop and enhance capacity of the members of the health and nutrition sector.   f. Plan for and manage supplies ef\ufb01ciently and effectively.   g. With support from the Regional Of\ufb01ces for Health, develop/improve and sustain a safe and ef\ufb01cient referral system of children with acute malnutrition in their respective LGUs.   4. Hospitals   The Medical Center Chiefs/Chief of Hospitals shall administer these-regulations and- support all the policies and guidelines mentioned in this Order. He/she shall lead in the dissemination of these guidelines, their integration of the same in the hospital and the creation of Hospital PIMAM Management Teams. He/ she shall ensure the availability of personnel and funds to suppert all the needed training and responses. He/ she shall submit reports to the respective Regional Of\ufb01ce, LGU, or DOH-CO.   The Hospital PIMAM Management Team, led by the Chief of Clinics, shall directly oversee the implementation of these guidelines in their respective hospitals. He/ she shall report to the Chief of Hospital/Medical Center Chief.   Hospitals shall:   a. Formulate plans, procedures and protocols to implement this policy and guidelines.   b. Implement all policies, and adhere to all standards, requirements and systems.   c. Provide and implement a mechanism of coordination and collaboration with hospitals (both government and private), LGUs, partners, and other stakeholders, to ensure the timely and effective service delivery.   d. Support monitoring and evaluation activities.   5. Philippine Health Insurance Corporation shall develop strategies to ensure coverage for children requiring treatment of severe acute malnutrition including, but not limited to: out\u2014patient treatment with routine medicines and therapeutic food provided in capacitated health facilities, in\u2014patient treatment of severe acute malnutrition with medical complications, reimbursements, point-of-care service delivery in non-PhilHealth accredited institutions/health service providers during emergencies and disasters.   6. Other Government Agencies shall   a. Adopt these guidelines in their of\ufb01ces, as appropriate, and provide feedback and report sensitive interventions with the DOH.   b. Adhere to and observe all requirements and standards on PIMAM especially those needed to respond to emergencies and disasters in accordance to the thrust of the Department of Health.   c. Coordinate and participate in inter-agency activities with the Department of Health on Health Emergency Management.   d. Support the DOH/LGUs/Hospitals in providing technical assistance (through the conduct of assessment or trainings) and logistics support, as appropriate.   7. Academe and Professional Societies shall:   a. Adopt these guidelines in their institutiononrganizations as appropriate and provide feedback and report to DOH nutrition sensitive interventions.   b. Adhere to and observe all requirements and standards on public health especially those needed to respond to emergencies and disasters 1n accordance to the thrust of meDOH. ' ' '   c. Coordinate and participate in inter-agency activities with the DOH.   d. Support the DOH/LGUs/Hospitals in providing technical assistance through the conduct of assessment or trainings.  e. Ensure that all curricula relevant to PIMAM are updated and implemented and that bodies of evidence on PIMAM are generated and disseminated.   8. Non-Government Organizations/Agencies, Development Partners Private Sector and Civil Society Groups shall:   a. Adopt these guidelines in their locality, as appropriate, and provide feedback and report to DOH.   b. Participate in information dissemination, advocacy activities and training.   c. Adhere to and observe all requirements and standards needed to respond to emergencies and disasters in accordance to the thrust of the Department of Health.   d. Provide development/technical assistance to strengthen capacities and systems during scale-up and implementation of the program consistent with the above principles.   e. Coordinate with appropriate DOH Of\ufb01ces for assistance in the implementation of this policy and services during development and emergencies.   IX. REPEALING Clause   All orders, rules and regulations or any provisions thereof inconsistent with this Order are hereby repealed and modi\ufb01ed accordingly.   X. EFFECTIVITY   This Order shall take effect immediately.    ", "  Section I. AUTHORITY  This Order is issued pursuant to Article 7. 17. 21 and 22 of R. A. 7394 known as the Consume Act of the Philippines.   SECTION II OBJECTIVES  1. The Department of Health issues these guidelines to improve the nutritional quality of the nation\u2019s food supply.  2.1 ThePe. guidelines shall serve as a basis for the rational addition of nutrient(s) to processed foods, so that the nutritional quality of the Filipino diet can be improved and maintained.  2.2. These guidelines are intended to avoid over\u2014or\u2014under fortification that may create imbalance in the diet as well as avoid misleading label claims to gain competitive marketing advantage.   SECTION III. DEFINITION OF TERMS  For purposes of these Guidelines. the following definitions shall apply:  1. Fortification shall mean the addition of nutrients to processed foods at levels above the natural state.  2. Processed food shall refer to food that has been subjected to some degree of processing (e.g. milling, drying, concentrating, canning, etc.) which partially or completely changes the physico\u2014chemical and/or sensory characteristics of the raw material.   3. Unprocessed food shall refer to food that has not undergone any treatment resulting in substantial change in the original state but which may have  been divided boned, skinned, peeled, ground, cut, cleaned, trimmed, fresh frozen or chilled.  4. Department means Department of Health.  5. RDA means Recommended Dietary Allowances.   IV. STATEMENT OF POLICIES  1. Food fortification shall be vital where there is a demonstrated need to increase the intake of an essential nutrient by one or more population groups, as manifested in dietary, biochemical or clinical evidences of deficiency. It shall also be considered important to compensate for nutrient losses due to processing storage.  2. The Department recognises that the nutritional deficiency problems in the Philippines,  based on recent nutrition surveys include deficiencies in energy, iron, vitamin A, thiamin, riboflavin, and iodine (Annex A). Filipino diet is also deficient in ascorbic acid, calcium and folate to a minor extent.  Food fortification shall thus be mainly carried out to fill up these inadequacies in Filipino diets; based on present day needs as measured using the most recent RDAs (Annex B).  3. Food fortification shall not be encouraged in alcoholic beverages and candies because excessive consumption as a result of undue promotion of these fortified products may lead to health problems.  4. Food fortification shall be highly encouraged for foods that are widely consumed particularly by at-risk population groups. Examples of such foods are:   5. Fortification shall be recommended for processed foods replace or simulate traditional foods to compensate for nutritional inferiority due to use of substitute ingredients.   SECTION V. COVERAGE  These Guidelines shall apply to all fortified foods except dietary supplements and foods for which established standards include specifications for nutrient composition or levels of fortification, e.g. breastmilk substitutes, follow-up formula.   SECTION VI. FOOD FORTIFICATION GUIDELINES    1. A nutrient shall be considered an appropriate fortificant only when the nutrient:  a) stable in the food vehicle under normal conditions of storage, distribution and use;  b) is physiologically available from the food:  c) present at level at which there is reasonable assurance that consumption of the food containing the added nutrient(s) will not result in an excessive intake of the nutrients(s) considering cumulative amounts from other sources in the diets; and   d) is suitable for its intended purpose and in compliance with applicable provisions of R.A. 3720 and regulations governing the safety of substance in foods.  2. Processed foods may be fortified with nutrients that are not considered deficient in the Filipino diet if the purpose is to restore losses in the food due to processing or to preserve/maintain a balance of nutrients in the processed food.  3. Fortification is appropriate when essential nutrient(s) is (are) added in proportion to the total caloric content of food  Processed foods that contain at least 40 kilocalories per normal serving (that is, 2% of a 2000 kilocalories) may be fortified to balance the nutrient-caloric content of the food.  4. Processed foods that are consumed not for its caloric contribution to the diet (e.g. condiments, seasoning/spices) may be fortified only with essential nutrients that are deficient in the Filipino diet. PROVIDED such foods are appropriate vehicles for the particular nutrients(s) and are widely consumed by the general population or are intended for intervention programs to address micronutrient deficiency in specific target populations.  5. The fortification level shall be in accordance with the following principles, unless otherwise provided in a separate guideline/standard for specific processed food.  A nutrient(s) shall be considered appropriately added to the food when it is/(they are) at levels above the natural state within the conditions stated n 5.1 to 5.11.  5.1 For essential nutrients that are deficient in the Filipino diet, the added nutrients shall supply at least 1/3 of the RDA of the target consumer (refer to Annex E Table 1), except that vitamin C shall be supplied at not less than 100% of the RDA in fortified Juices/flavored drinks. These levels shall be uniformly distributed in the total number of servings likely to be consumed in a day.  Hence, the minimum fortification level shall be computed in the following manner:   where A = 1/3 RDA of the target consumer B = no. of servings likely to be consumed per day C = serving eaten (amount of food normally eaten at one time)  To get fortification level per serving, divide A by B. In the case of processed foods that will be cooked before consumption, the losses due to the prescribed cooking directions may be compensated accordinglv when determining the amount of nutrient(s) to be added.  Examples of fortification levels computed as above:  Ready\u2014to\u2014eat flour\u2014based products (e.g. bread, snack food) fortified with iron and B-complex vitamins - assuming 2 servings are likely to be consumed by a male adult (20-39y, 56kg) in a day, and at 30 grams/serving, shall be fortified as follows:  thiamin......... O.22 mg/serving (=0.72 mg/100g) riboflavin ..... 0.22 mg/serving (=0.72 mg/100g) iron............ 2.0 mg/serving (=6.7 mg/100g)   Margarine fortified with vitamin A and thiamin - assuming 2 servings are likely to be consumed by a male adult. (20-39y, 56kg) in a day, and at 15 grams/serving, shall be fortified as follows:  vitamin A. ........... 87.4 ug RE/serving (= 583 ug RE/100g)  thiamin .............. 0.21 mg/serving (=1.4 mg/100g)  Packaged fruit-flavored drinks fortified with vitamin C = assuming 2 servings are likely to be consumed by a male adult (20-39y, 55kg) in a day, and at 250 mL per serving shall be fortified as follows:  vitamin C ........... 38 mg/serving (= 30 mg/200 mL serving)   5.2 For nutrients that are essential but have not been established to be deficient in the Filipino diet, the added nutrients shall supply at least 1/5 (or 20%) of the RDA of the target consumer. (refer to Annex E, Table 2).  5.3 For nutrients that are essential but have no established RDA, the added nutrients shall supply at least 20% of the estimated safe and adequate levels for daily intake as recommended by the Food and Nutrition Board of the U.S. National Research Council (refer to Annex E, Table 3)  5.4 For processed foods to be  fortified with nutrient(s) with known toxicity (e.g. vitamins A, D, E, K, Zn, Se}, the level of such nutrient(s) in the food shall not exceed 150% of the RDA for the target consumed per day.  5.5 For essential amino acids, fortification levels shall be in accordance with the recommendations of the Joint FAO/WHO/UNU Expert Consultation on Energy and Protein Requirements. (WHO TRS 724, 1985) Food manufacturers who wish to fortify their products with amino acids are required to consult a qualified professional with expertise in human nutrition and shall submit a certificate ofc such consultation.  5.6 For nutrients that have not been established essential for humans, fortification with each nutrients shall be at a significant level above the natural state as determined by the precision of the analytical methods at its lowest detection limit.  5.7 The reference RDAs to be used in compliance with the above fortification guidelines are shown in the tables in Annex E.  5.8 For nutrients with Philippine RDA, the reference RDA shall be those of a Filipino male adult, 20\u201439y, 56kg.  5.9 For nutrients without established Philippine RDA, the USRDA shall be used particularly of the male adult, 19\u201424y,72 kg.   5.10 For processed foods specifically intended for children (after infancy and below 10 years}, the reference RDA shall be that of a child in the 4 to 6 years age group.   5.11 Where no RDA has been prescribed for a nutrient, safety considerations shall be applied and the safety of the use of such nutrient in a particular food shall he supported by the user/claimant (producer/distributor).   SECTION VII LABELING OF FORTIFIED PROCESSED FOODS   The following label declarations shall be required for fortified processed foods, in addition to other requirement under BFAD\u2019s food labeling regulations.   1. Only when the levels of fortification provided in Section 6 are met and when the nutrient content analysis at any point in time within the shelf\u2014life of the product, show at least 80% to 90% of the claimed fortification level depending on the nutrient analyzed and the precision of the analytical methods used, shall the claim \"FORTIFIED\" be considered valid.  2. Fortification claims shall be based on the processed food packaged and purchased by the consumer.  3. The fortification level shall be appropriately presented the label indicating the following information:   *by weight for solid food and volume for liquid food  3.1 If the Food as packaged is not ready-to eat and will be consumed after simply mixing with water (or other edible liquid), the amount of nutrient fortificant shall be declared in terms of %RDA per the specified amount needed to make one serving of the ready\u2014to\u2014eat food.  3.2 If the food is not ready\u2014to\u2014eat as packaged and is used as an ingredient for the preparation of another food, the amount of the nutrient fortificant added shall be declared as % RDA per 100 grams of the packaged food and optionally, as % RDA per specified amount used in a given product recipe.  3.3 The % RDA per 100 kcal of the packaged food may also be declared on the label when such food contains at least 40 kcal per serving.  4. The terms \u201cenriched\u201c added with \"supplemented with\" and other similar terms shall be equivalent to the term \"fortified\". Descriptive terms like \u201crich in\", \u201cgood source of\", \u201cexcellent source of\" shall not necessarily imply fortification and shall be used in accordance with BFAD\u2019s food labelling regulations.    SECTION VIII. COMPLIANCE AND ADMINISTRATIVE SANCTIONS  1. These guidelines shall be applied in the registration of fortified processed food products in the BFAD.  2. The BFAD itself or BFAD in coordination with the recognized agencies or institutions listed in Annex \u201cF\" shall monitor the micronutrient of fortified processed food.  3. A processed food claiming fortification shall be considered mislabelled unless the fortification levels comply with these guidelines except when the deviation from the fortification levels herein set are justified and are properly declared in the labelling.  4. The BFAD, after notice and hearing, may impose any or all of the following administrative sanctions in cases of non-compliance with these guidelines.  4.1 Order the recall  of the products declared/found as mislabelled fortified food  4.2 Order the correction of the labelling of the fortified food products  4.3 Impose administrative fines provided for by existing laws  4.4 Suspend or cancel the registration of the product.   SECTION IX. TRANSITION PERIOD  1. All manufacturers or food processors are given six (6) months from effectivity to comply with these guidelines.  2. All food products that are not otherwise adulterated or mislabelled produced before the expiration of this 6-month period shall be allowed to stay in the market up to the expiration of their shelf\u2014life.   SECTION X. EFFECTIVITY   This Order shall be effective after its publication in two newspapers of general circulation at least once a week for a period of not less than one (1) month pursuant to Art. 8 of RA 7394.   ", " I. BACKGROUND   The Philippines is a signatory to the United Nations Millennium Development Goals (MDGS). Emphasis has been heavily placed on accelerating improvements in the attainment of the MDGs 4 and 5 that aim to reduce under-\ufb01ve children and maternaldeaths all over the world by 2015.   In July 2000, the Department of Health issued Administrative Order No. 79, s. 2000 on Safe Motherhood Policy with the goal of ensuring safe motherhood and healthy newborns and reduction of maternal and perinatal morbidity and mortality. Likewise, Administrative Order , 2008-0029 was issued on 09 September 2008 on Implementing Health Reforms for Rapid Reduction of Maternal and Neonatal Mortality (MNCHN policy).   The 2006 Family Planning Survey (FPS) showed a slow decline of maternal deaths from 209 (1993, NDS)) to 162 for every 100,000 live births (maternal mortality ratiO). The World 4 Health Organization (WHO), United Nations Population Fund (UNF PA) and the World Bank (WB) 2005 Joint Report estimated around 4,600 mothers die annually in the Philippines, with this MMR. The 2008 National Demographic and Health Survey (NDHS) showed infant mortality rate (IMR) at 25 deaths per 1000 live births. Neonates under 28 days old account for 57.9 percent of infants deaths , of which, 46.1 percent of these were less than one week old. Newborn death is closely linked with maternal condition during delivery.   History and research have shown that although women and babies need pregnancy care, care in childbirth is the most important for the survival of the mother-newborn pair. One\u2014third of births around the world, take place at home without the assistance of skilled birth attendance. In the Philippines, 38 percent of births are not attended by skilled birth attendants (SBAs) or skilled health workersland 58 percent of births are occurring at home. (NDHS 2008). Commonly reported direct causes of maternal deaths in Philippine Health Statistics are hypertension (28.4%), post-partum hemorrhage (17.2%) and pregnancy with abortive outcome (8.3%). Among the neonates, the leading causes of deaths are asphyxia, sepsis and ' prematurity.  Life-saving drugs are locally available to immediately manage the above pregnancy-related - complications. However, accessibility to these drugs and the pro\ufb01ciency of frontline health workers to administer them whenever and wherever they are needed, are wanting.   In this country, midwives are the \ufb01ontline health providers of maternal and child care. They are everywhere and based on the recent count, there were approx. 18,000 midwives employed in the public sector while the rest are in various form of occupation.   Currently, there are limitations on the scope of functions midwives can do to address the leading causes of maternal and newborn deaths. These limitations can be'mitigated by an enabling policy environment that will support and empower midwives to save the lives of mothers and newborns, who are entitled to their rights to life and the highest attainable standard to health.   There is wisdom in investing on capacity building of midwives so that they can better . respond to the emergency situations through administration of these life-saving drugs, especially in hard\u2014to\u2014reach areas among the 42,000 villages where lives of mothers and newborns are at stake in the-absence of doctors or referral facilities.   II. OBJECTIVE   To strengthen the capacity of midwives to adequately and appropriately respond to pregnancy\u2014related complications and reduce maternal and newborn morbidity and mortalities through administration of life-saving drugs and medicines.   III. General Principles:   - Every pregnancy should be planned and supported  - Every delivery should be safe  - Service delivery should be gender and culture-sensitive  - A three\u2014pronged approach shall be utilized  - -de1iveries by skilled health personnel with a continuum of care approach  - -easy access to emergency obstetric and newborn care 7  - -universal access to family planning and reproductive health services - Facility-based deliveries are highly encouraged o SyStem-wide approaches shall be utilized  - Rights based approach shall be utilized    IV. Definition of Terms   1. BEmONC \u2014 Basic Emergency Obstetric and Neonatal Care   2. E/EmONC \u2014\u2014 Essential and Emergency Obstetric and Neonatal Care   3. ENC protocol \u2014 Essential Newborn Care protocol   4. Midwife\u2014persons who, having been regularly admitted to an educational programme duly recognized in the country in which it is located, having successfully completed the prescribed course of studies in midwifery and acquired the requisite quali\ufb01cations, are registered and licensed to practise midwifery (WHO,ICM,FIGO).   5. Life-Saving Drugs are drugs and medicines used to prevent and manage pregnancy-related complications such as but not limited to Magnesium Sulphate, Oxytocin, Steroid and oral antibiotics.   6. Emergency conditions are conditicns that put the mother and the newborn at risk of complications or dying if not timely prevented or managed. These include the following:   a. Pre-eclampsia\u2014 a condition speci\ufb01c to pregnancy , arising after the 20th week of gestation, characterized by hypertension and proteinuria.   b. Eclampsia\u2014condition peculiar to pregnancy or newly delivered woman, characterized by convulsion followed by coma. The convulsions may occur in the anteparturn, intrapartum or early postpartum periods.   c. Post\u2014partumHemcrrhage\u2014 blood loss greater than 500ml or more from the genital tract after delivery.   d. Premature Labor- active contraction of the uterus before the 37thl completed week of pregnancy   e. Infections   V. Scope and Coverage   This Order shall apply to all registered/licensed midwives that provide skilled midwifery services and likewise intend to obtain Maternity Care Package (MCP) and Newborn Care Package (N CP) accreditations \ufb01om PhilHealth, the whole hierarchy of DOH and its attached agencies, as well as LGUs, and other development partners implementing the MNCHN strategy.   VI. General Guidelines:   Under this. order and in addition to the existing functions de\ufb01ned in section 23 of the Midwifery Act of 1992, the midwives are hereby allowed to administer life saving drugs such as magnesium sulphate, oxytocin, steroids and oral antibiotics, provided they are appropriately trained and certi\ufb01ed pro\ufb01cient to perform the necessary care and services to _ prevent maternal and newborn deaths. '   These interventions are meant to be provided under emergency conditions when no physician is available.   VII. Implementing Guidelines   1. All practicing midwives who intend to obtain accreditation as E/EmONC providers, shall undertake in-service training, which is two-part: formal/didactic and practicum, using the approved modules and other instructional materials that would upgrade their knowledge and skills on essential and emergency obstetrics and newborn care (E/EmONC);   2. A post training evaluation shall include written examination, practicum at the hospital training facilities and application of skills to their areas of work. The midwife must pass a post-training evaluation after formal part of the training before being allowed to undergo practicum. Certi\ufb01cate of pro\ufb01ciency shall be issued upon satisfactory completion of practicum Within six months.   3. Every midwife should be supervised by the municipal, district, city or provincial health of\ufb01cer or senior midwife supervisors with the technical guidance of Philippine Obstetrical and Gynecological Society (POGS) for maternal care and with the Philippine Society of Newborn Medicine (PSNbM) and/or Philippine Pediatrics Society (PPS) members for newborn/neonatal care, wherever possible;   4. Midwives shall be provided with legal assistance, if this becomes necessary in relation to their performance as E/EmONC providers such as in administering life saving drugs;   5. The fallowmg life saving drugs should be in accordance with the clinical practice protocol: ' a. Magnesium sulphate (MgSO4) shall be used for the prevention and management of eclampsia. b. Oxytocin shall be administered for active management of third stage of labor ' (AMTSL) and initial management of post\u2014partum hemorrhage. c. Steroids shall be administered in cases of preterm labor. (1. Antibiotics shall be administered in cases of infections.   VIII. Roles and Responsibilities   A. POGS shall:   1. Conduct training of midwives in appropriate training institutions all over the country;   2. Issue pro\ufb01ciency certi\ufb01cation to midwives they directly trained practicing in areas they covered;   3. Conduct monitoring, coaching, or \ufb01eld visits with other stakeholders to assist and provide advise to midwives in their \ufb01eld of assignment;   4. Conduct or participate in regular maternal death reviews in accordance with the Maternal Death Review (MDR) protocol;   5. In collaboration with Philippine Society for Newborn Medicine, Philippine Pediatric Society (PSNbM/PPS), and/or Perinatal Association of the Philippines, Inc. (PAPI), it shall conduct perinatal death review in accordance with the Perinatal Death Review (PDR) protocol.   B. PSNbM/PPS and/or PAPI shall:   1. Coordinate with POGS in the conduct of training of midwives especially in the areas of newborn care;   2. Coordinate with POGS in the conduct of monitoring, coaching or \ufb01eld visits with other stakeholders to assist and advise midwives on newborn care in their \ufb01eld of assignment;   3. Coordinate with POGS in the conduct of regular maternal and new born death reviews in accordance with the MDR and PDR protocol;   C. Midwives AsSociations shall:   1. Update their roster of members to ensure that all practicing, licensed midwives are appropriately trained on essential. and emergency obstetrics and newborn care (E/EmONC);   2. Ensure proper representation in the conduct of Maternal and Perinatal mortality and morbidity reviews; and   3. Conduct monitoring and internal audit to ensure that all midwives adhere to standards, norms and quality assurance protocols;   D. LGUs shall:   1. Ensure that LGU midwives have thenecessary and updated licenses to practice and provide LGU midwives \ufb01nancial support to undergo the ' training er capacity enhancement on E/EmONC;   2. Ensure that LGU facilities have adequate supplies, equipment, drugs and medicines, at all times and develop the infrastructures to ensure utmost delivery of quality E/EmONC for all mothers and newborns;   3. Ensure that LGU-managed hospital facilities shall be accessible for the conduct of training, as well as maternal and perinatal death reviews.   4. Activate, sustain and expand the membership of the local health board to inelude representatives of local chapters of POGS, midwives association and PPS/PSNbM and/or PAPI to ensure effective implementation of this. order ;   5. Ensure enrolment of indigent families and PhilHealth MCP accreditation-of all birthing facilities in their jurisdiction ; and   6. Set-up a functional referral system and service delivery network utilizing both public and private health facilities and providers to ensure continuum of care.   E. DOH:   E. 1. National Center for Disease Prevention and Control \u2014provide technical assistance to CHDsand LGUs and ensure compliance to standards and protocols governing administration of life\u2014saving drugs and medicines. It shall coordinate with Health Human Resource Development Bureau (HHRDB) in identifying training hospital facilities.   E.2 Health Human Resource Development Bureau \u2014provide technical assistance and human resource support in the training and education of midwives.   E.3. Bureau of International Health Cooperation \u2014ensure proper coordination of technical assistance from development parmers in support of training, education and facility improvement;   E.4. DOH-Centers for Health Development (CHD)\u2014 provide technical . assistance, monitoring and evaluation on the implementation of this order at the local level.   E.6 DOH\u2014retained hospitals\u2014 serve as training facilities, and ensure access to clinical materials for the midwives who are undergoing training   F.  Development partners~support implementation of this order through technical ' and \ufb01nancial assistance in training, research, education and facility enhancement - _ needed to further this issuance. ' '   IX Monitoring and EValuation   Quality assurance and clinical audit should be conducted at least once a menth, bythe DOH\u2014CI\u2014IDS\u2019 Local Health Support Division and its retained hospitals and progress report Shall be submittcdto the Of\ufb01ce of the Secretary. An annual implementation review' shall be done with the stakeholders.   X. Repealing clause   The provisions of previous Orders and otherrelate'd issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing, issuances which are not affected by this Order shall remain valid and in effect.    XI. Effectivity   This Order shall. take effect iinrnediately 15 days after publication in major newspapers. ", " TO: All Bureau Directors, Regional Health Directors, Provincial, City and Municipal Health Officers, Provincial/City Nurse Supervisors and Others Concerned.  With the formulation and development of the Expanded Program on Immunization, the BGC immunization component of the National Tuberculosis Program is now integrated in the Expanded Program in Immunization which is concerned with all the immunization programs in the country.  Specifically, the following lines of relationship and coordination between the various health personnel involved at various levels of administration shall be maintained.  1. National Level  1. The National Immunization Committee (NIC) as created by Department Order No. 28-A. s. 1976, is charged with the development of immunization programs against specific preventable diseases including BCG immunization against tuberculosis.  2. The T.B Control Services, Bureau of Health and Medical Services, shall provide technical assistance to the said Committee in the planning, programming and evaluation of the BCG immunization program.  2. Regional Level  1. The Regional Immunization Officers shall assists the Regional Health Directors in the implementation of the Regional Immunization Programs including BCG immunization, as well as provide technical supervision over the field health personnel involved in immunization.  2. The Regional Tuberculosis Coordinators as designate, shall provide technical assistance to the Regional Immunization Officers in the field of BCG immunization especially with regards to assessment and training.  3. Provincial/City levels  1. The Provincial/City Nurse Supervisors shall assist the Provincial/City Health Officers in the implementation of the Immunization Programs in their respective areas and provide technical supervision over the public health nurses involved in immunization.  2. The Provincial TB Coordinators shall provide technical assistance to the Provincial/City Nurse Supervisors in the field of BCG immunization especially with regards to the training of health personnel on BCG techniques and shall serve as independent assessors of BCG immunization musing the scar survey technique.  3. Nursesof the Philippine Tuberculosis Society, depending on the availability of vaccines, may undertake BCG immunization on contacts and other population groups who may require protection, and shall submit their corresponding monthly reports on immunization performed to the Provincial/City Health Officers for incorporation in the prescribed EPI reports.  4. Municipal Level  1. The immunization teams composed of nurses and midwives of the rural health units shall undertake the actual implementation of immunization programs including BCG immunization. In accordance with the Expanded Programs in Immunization (EPI), BCG immunization is now given to infants (3-14 months) and when in conjunction with DTP, on the right arm, and to school entrants, during designated immunization rounds twice a year.  2. Other medical and health personnel in the locality as those in the hospitals, clinics and priavte practitioners, depending on the availability of vaccines, may undertake BCG immunization on contacts of T.B. cases, and such other population groups as may require protection, and shall submit reports on immunization performed to the local health officers who shall consolidate such reports in the prescribed EPI reports.  3. Reports of all immunization including BCG from the local level must came only from the Local Health Officers in accordance with the prescribed reporting procedure in the EPI, and to be submitted thru their corresponding Provincial/City Health Officers and Regional Health Directors, whos shall consolidate such reports, to hte NIC. The NIC shall process and analyze these reports from the fields and provide all agencies concerned with such information portaining to BCG immunization.  The understanding and participation of all medical and health personnel involved in BCG immunization in accordance with the above lines of coordination and relationship which shall serve as their guidelines in such participation, is hereby enjoined.  This Order shall take effect immediately. ", "  1. RATIONALE  WHO reports that in 1996, approximately 150 million women in the developing countries will become pregnant annually, of which, 7 million will result to stillbirths or infant deaths in the first week of life from pregnancy-related complications. Reports further show that Southeastern and Southern Asia contribute 55% (323, 000 out of 600,000) of the maternal deaths of the world.  In the Philippines, women in the reproductive age group (15-44 y.o.) is estimated to be 14 million. Nine (9) million of these are either married or have partners of which 6 million is considered to be \u201chigh risk\" should they become pregnant as they are either too young (less than 18 years old ) or too old (more than 35 years old ); have had four or more pregnancies; have too close or unspaced pregnancies (less than 15 months) and are concurrently ill.  Based on a total fertility rate (TFR) of 3.7% in 1998, an estimate of 2.3 million Filipino women are expected to become pregnant per year. Of these, roughly 2 million will give birth. The 1998 National Demographic Health Survey (NDHS) shows that 65.5% of these women deliver at home; only 57% of all deliveries are either attended by doctors, nurses or midwives while 43% are attended by traditional birth attendants or relatives.  The Maternal Mortality Rate (MMR) based on the 1998 NDHS was 172 per 100,000 livebirths or a total of 3,614 maternal deaths per year or 10 mothers dying per day due to pregnancy related complication. Post partum hemorrhage is the leading cause of maternal death followed by hypertensive complications, sepsis and abortion. Perinatal Death Rate (PDR) is 18 per 1000 live births. Infant Mortality Rate (IMR) is 36 per 1000 livebirths, very much higher than neighbor countries Malaysia and Singapore with 9.1 per 1000 livebirths & 4.1 per 1000 livebirths, respectively.   2. GUIDING PRINCIPLES  The Philippines is committed to pursuing the principles enunciated in the Cairo and Beijing conferences on Population and Women\u2019s, respectively, for the promotion of safe motherhood and women's health, and to ensure healthy newborns.  The following principles form the basis for the programming for the reduction of maternal and perinatal mortality and morbidity in the country: * Promotion of women\u2019s rights and gender-sensitivity * Access to quality health and nutrition services * Focusing on health promotion, education and advocacy * Establishing linkages and developing collaboration to ensure sustainability * Mobilizing families and communities to address family planning and maternal and newborn-care * Empowering communities to recognize and correct gender discrimination and prevent violent and abusive behavior towards women and girls * Reporting and reviewing all maternal deaths  At threshold of the new millenium, the Philippines is restating its commitment to the aspiration of a healthy nation through a more vibrant and vigorous Safe Motherhood Initiatives.   3. GOAL:  To ensure safe motherhood & healthy newborns.  General Objective:  Reduction of maternal and perinatal morbidity and mortality.  Specific Objectives:  The following specific objectives to ensure safe motherhood & healthy newborn are lifted from National Objectives for Health;  1. Reduce maternal mortality ratio to 86 deaths per 100,000 livebirths by year 2004 (Baseline 172 deaths per 100,000 live births in 1998, NDHS) 2. Reduce the proportion of LBW to 12% of total live birth. (Baseline 16.6 percent in 1998 NDHS, 1997 FHSIS)  3. Reduce mortality rate among neonates to 3.8 deaths per 1,000 live births. (Baseline 7.8/ 1,000 livebirths in PHS 1994)   4. COVERAGE & SCOPE  This is a multi\u2014level, multi\u2014sectoral technical guidelines/ prescriptions on Safe motherhood and newborn care. Target coverage of services are all women of reproductive age group (15- 44 y.o.). Pregnancy is a special condition needing special caring / attention not withstanding the fact that some of the pregnant women maybe in need of higher level of emergency obstetric care at anytime before, during and after delivery. Furthermore, attention should be given to indigenous women, women among highly marginalized groups (fisherfolks, farmers, urban slums, etc.) and teenage/ adolescent groups. Approaches/ strategies should be specific/ culture\u2014based and gender\u2014sensitive.  All newborns up to 28 days of life are also target of interventions and services under this policy.    5. GUIDELINES AND PROCEDURES :   I. ENSURING QUALITY MATERNAL & NEWBORN CARE  Good quality maternal and newborn health services:  * Are accessible and available as close as possible to where the women live, and at the lowest possible facility that can provide the services safely and effectively. * Are acceptable to potential users and responsive to local cultural and social norms, such as preferences for privacy, confidentiality and care by female health workers. * Have on hand all essential supplies and equipment;  * Provide comprehensive care and linkages to other reproductive health services; * Provide for continuity of care and follow-up; * Are staffed technically competent health care providers who rely on clear guidelines/protocols for treatment; * Are staffed by workers who provide respectful and non-judgmental care that is responsive to women\u2019s needs; * Involve the client in decision making, and see clients as partners in health care and active participants in protecting their own health; and * Offer economic and social support to health care providers that enable them to do the best job they can; * Encourage partner as well as family and community involvement in pre-natal and post natal services.  Elements of Quality Maternal and Newborn Care  A. Prenatal  Pregnant Women should have at least four (4) pre-natal visits for;  * Health promotion: advice on nutrition (e.g. iodized salt utilization) and health care, breastfeeding, newborn care as well as counseling to alert women to danger signs and help plan for birth ; * Assessment: history taking, physical examination and screening tests like hemoglobin/ hematocrit determination, urinalysis using the Home Based Mother\u2019s Record (HBMR), dental check-up and prophylaxis * Prevention: Tetanus Toxoid immunization, Micronutrient supplementation (low-dose Vit. A, Multiple micronutrient supplementation, Ferrous sulfate) and early detection and management of complications. * Treatment: Management of sexually transmitted infections, anemia, toxemia or other risk conditions.  B. Natal/ Delivery Care  All Deliveries should be attended by a \u201cskilled attendant\" and is within 2 hours from a first level referral or well-equipped hospital that can handle emergency obstetric cases and should have the following services:  * Provide good \"quality care that is hygienic, safe and sympathetic on an on-going basis. * Recognizes and manage complications, including instituting life-saving measures for mother and baby when called for. * Monitor progress of labor using partograph * Refer promptly and safely when higher\u2014level care is needed * Ensure the support/ presence of husband/ partner  A skilled attendant (doctor, nurse, midwife or TBA) is de\ufb01ned as one with the training and educational background or accredited by the DOH to perform safe and clean deliveries.   C. Postpartum and Newborn Care  The post-partum mother together with her newborn should have at least 2 post \u2014 partum visits one month apart for the following services:  * Newborn screening for 6 congenital metabolic disorder * Apgar scoring, proper cord care * Identification and management of problems in mothers and newborn in the 1st 24 hours * Immediate and safe referral of cases needing higher level care * Initiate exclusive breastfeeding * Counseling and health promotion on exclusive breastfeeding, follow-up immunization, family planning, micronutrient supplementation, personal hygiene and care of newborn. * BCG immunization and complete assessment of the newborn using Growth Monitoring Chart (GMC)   II. CAPABILITY & CAPACITY BUILDING  Training should be based on the need of women, the family and community utilizing the competency-based approach. Furthermore, improving the capability of all health workers who provide health care services for women of reproductive age, must be complemented by education of the women, the family and the community. The effectiveness of all strategies and activities for safe motherhood rest on how we can mobilize and motivate the women together with their families and the community to take care of themselves and to avail of all the services from competent caring gender sensitive health care providers.   III. SOCIAL MOBILIZATION  Social Mobilization is a dynamic process of generating and sustaining the active and coordinated participation of all sectors at various levels to facilitate and accelerate the improvement of the situation of children, women and other vulnerable groups.  The elements of this strategy are; advocacy, information, education and communication (IEC), networking, alliance building and programme sustainability.  The integration of a maternal and health care package into the Philippine Social Health Insurance scheme and/ or the establishment of community-based health care financing projects/ programs will contribute greatly in ensuring that basic essential maternal and newborn care and emergency obstetric care are made available at any levels of the health care delivery system.  Continuous coordination with legislative branch of government to operationalize commitment of government for Safe Motherhood and Newborn Care.  Maintain and strengthen network with national and international funding donors for financial/ logistical support/ assistance.    IV. COMMUNITY PARTICIPATION  The community should have a clear vision and goal for women as partners both in the family life and development. Mobilizing the community especially women as partners for Safe Motherhood is essential since strategies and approaches for improving the well-being of mothers can work best when there is effective community participation. Community participation is a process whereby women, their families and communities organize themselves for problem-solving, formulating ideas, technologies and approaches. Discussion and decision-making for action based on available options is an important strategy. Collectively implement projects/ activities which are culture-sensitive, environment friendly and technologically sound is essential Monitoring of programme and assessing its impact to women/ children/ family/ community must be undertaken and community participation with service providers.   V. MONITORING & EVALUATION   Conduct regular monitoring, evaluation and reflection and assessment of best practices to heighten the women\u2019s and community's consciousness on safe motherhood and generate commitment to address violence against women in the home, community and workplace.  Maternal death reviews must be conducted in all maternal deaths regardless of the place of occurrence. Furthermore, maternal and perinatal disabilities/ deaths must be reported and line listed at the health facility.   VI. RESEARCH AND DOCUMENTATION  Research on important aspect & other emerging issues which impact on maternal health and survival will be encouraged, promoted and supported. The  goal is to promote increased investments in health research in general and specifically on issues around safe motherhood. This may encompass knowledge, attitude and practices on one hand to effectiveness and efficiency of program strategies, interventions and activities on the other.  Documentation of traditional/ indigenous practices will be pursued as well as documentation of successful and doable initiatives will be promoted to facilitate sharing of lessons as well as replication and scaling up of cost-effective, technologically-sound interventions.   6. IMPLEMENTATION MECHANISM  A. National Level  All DOH bureaus, centers, programs & projects delivering safe motherhood services will be integrated within the Center for Disease Prevention & Control under the Health Operations Cluster. The Center for Family Health (CFH) takes overall responsibility for policy development, standard setting, coordination and integration of all activities. This office is also tasked to ensure the all safe motherhood services are given importance in terms of technical, logistics and other support systems.  B. National Level  The Center for Family Health shall convene Technical Working Group on Safe Motherhood to be composed of the following:  Chair:   Head, Center for Family Health Co\u2014 Chair:  Focal Person, Women\u2019s Health & Development   Focal Person, Child-Health & Development   Focal Person, Reproductive Health   Focal Person, Nutrition   Focal Person, Dental Health   Focal Person, Center for Health Promotion   Representative from:    External Affairs Cluster    Uni\ufb01ed PMO    Local Health Assistance Cluster     Retained Hospital    NGO     Other GOs & partner agencies on Safe Motherhood Concerns    Foreign Assisted Projects: UNICEF, UNFPA  The TWG will develop a Technical Framework for Safe Motherhood, recommend strategies to immediately and aggressively address maternal mortality and morbidity and recommend a program design to integrate public and hospital intervention for safe motherhood.   The TWG shall always be represented in the National Reproductive Health Management Committee to ensure integration and consistency in policies across all ten RH elements. Functions composition and role of the RH Management Committee is reflected in A.O. 43 s. 2000  C. Support Services  Other support services include: Human Resource Development Institute, Bureau of Local Health Development, National Epidemiology Center, Health Policy and Planning Institute, Bureau of Health Facilities and Services, Center for Health Promotion, Philippine Health Insurance Corporation (PHIC) and projects which may be called to provide assistance to the Technical Working Group as the need arises.  D. Regional Health System  The Centers for Health Development are directed to revitalize / utilize existing Regional Safe Motherhood Management Committees. These committees shall be integrated into the newly organize Reproductive Health (RH) Task Force at the Regional level. The Regional RH Task Force shall oversee the Safe Motherhood initiatives of local governments within the catchment of the Center for Health Development. The Task Force shall be chaired by the Head of the Health Operations Cluster and Membership should follow the composition of the National RH Management Committee as contained in A.O. #43 s. 2000.  8. QUALITY ASSURANCE  All standards and concepts to ensure quality health services set by the Sentrong Sigla shall be applied to all aspects of safe motherhood implementation.   7. FUNDING  Funding Support of safe motherhood activities will be lodged primarily in the Center for Family health with augmentation from other concerned bureaus and centers. The gender and development (GAD) budget shall be utilized for safe motherhood implementation at all levels: national, regional and local as well as from specific FAPS in the targeted areas.   8. EFFECTIVITY  This Order shall take effect within 15 days frOm publication in an official gazette.     ", " I. Rationale   To ensure the maximum and appropriate utilization of the Newborn-Screening (NBS) 4% Fund by the Department of Health Regional Of\ufb01ces (DOH ROS) and DOH Autonomous Region in Muslim Mindanao (DOH-ARMM), the Advisory Committee on Newborn Screening (ACNBS) recommended the review of the NBS 4% Fund utilization and the subsequent release of Administrative Order 2013-0015 on April 16, 2013, which sets the guidelines on its utilization.   As provided in Section 16 of the Republic Act 9288, the said NBS 4% Fund shall be set aside from the NBS Fees for the DOH \u2014 Centers for Health Development (presently referred to as Regional Of\ufb01ces - ROs) or their future equivalent to be used solely for follow- up services, education and other activities directly related to the provision of newborn screening services. Such provision shall thereby contribute in ensuring the sustainability of the National Comprehensive Newborn Screening System (N CNBSS) and in subsequently reaching the vision of saving all Filipino newborns from mental retardation and death.   However, almost three years after the review of the fund utilization in 2012 and the release of the AO 2013-0015, gaps were still identi\ufb01ed in the 4% Fund Utilization. Thus, during the meeting of the National Technical Working Group on Newborn Screening held on April 30, 2015, a thorough review of the fund utilization was recommended. The result of the review is embodied in the revision of AO 2013-0015 as outlined in this Administrative Order.   II. Objective   To expand the guidelines on the Newborn Screening 4% fund utilization of DOH-ROS and DOH-ARMM and to ensure appropriateness and maximized use for the NCNBSS.   III. Coverage   Provisions of this Administrative Order shall apply to all DOH-ROS, DOH-ARMM, Newborn Screening Reference Center (N SRC), Newborn Screening Centers (NSCs) and Newborn Screening Continuity Clinics.  IV. De\ufb01nition of Terms   a. Newborn Screening is an essential public health strategy to detect and manage congenital disorder to prevent mental retardation and death.   b. RA 9288: Newborn Screening Act of 2004 refers to the act promulgating a comprehensive policy and a national system for ensuring newborn screening.   c. Department of Health Central O\ufb02ice is the lead agency in implementing the Republic Act 9288 or the Newborn Screening Act Of 2004.   d. Department Of Health Regional O\ufb01ice is the satellite of\ufb01ces of the Department of Health in every region, where each has a designated Newborn Screening (NBS) Coordinator as the key implementer of newborn screening program at the regional level.   e. Newborn Screening Continuity Clinics refers to an ambulatory clinic based in a tertiary hospital identi\ufb01ed by the DOH to be part of the NCNBSS. It is equipped to facilitate continuity of care of con\ufb01rmed patients in its area of coverage.   f. Newborn Screening Center (NSC) refers to a facilityequipped-with a newborn screeninglaboratory that complies with the standards established by the National Institutes of Health (NIH), and provides all required laboratory tests and recall/follow\u2014up programs for newborns with heritable conditions.   g. Newborn Screening Reference Center (NSRC) refers to the central facility at the National \"Institutes of Health (NIH) that de\ufb01nes testing and follow-up protocols, maintains an external laboratory pro\ufb01ciency testing program, oversees the national ' testing database and case registries, assists in training. activities in all aspects of the program, oversees content of educational materials and acts as the Secretariat of the Advisory Committee on Newborn Screening.   V. Policies and Procedures   a. General Guidelines   The earmarked amOunt to DOH-ROs/DOH-ARMM shall be for the purpose of implementing the newborn screening program and facilitating achievement of required outputs.   The 4% of the NBS Fee shall be set aside for the DOH ROS and DOH-ARMM to be used for follow-up services, education and other activities directly related to the provision of newborn screening services, incentive for RHU collecting health units, ' staff development of NBS personnel, capital outlay needed for NBS program implementation, and cost of repeat samples [Section 22, IRR of RA9288].   At least 30% of the total amount requested from the 4% NBS funds and transferred to each region shall be used for its Maintenance and Other Operating Expenses (MOOE). Excluded from the said MOOE are the salaries and wages of NBS personnel.   B. Speci\ufb01c Guidelines   1. The 4% share of the DOH-ROS and DOH-ARMM shall be used for the following NBS-related activities:   a) Follow\u2014up service of patients with positive screening result by personnel hired for the NBS unit based at DOH-ROs/DOH- ARMM:  The line item budget shall be used for the following:   (1) Salaries and wages of Nurse and/or Medical Coordinator on contract of service and designated vehicle driver (if applicable);  (2) Traveling expenses of monitoring Visits;  (3) Per diem of monitoring teams; and  (4) Other related expenses.   b) Follow\u2014up service of patients con\ufb01rmed positive by personnel hired for the NBS unit based at Newborn Screening Continuity Clinics.   The line item budget shall be used for the following:   (1) Salaries and wages of Nurse/Genetic Counselor and/or Medical Coordinator on contract of service;  (2) Traveling expenses of monitoring visits/attendance to trainings/conferences;  (3) Per diem of monitoring team;  (4) Indigency funds for laboratory tests and long-term management; and  (5) Other related expenses.   c) Education and other activities directly related to the provision of NBS services.   The line item budget shall be used for the following:   (1) Meetings with municipal/provincial/Newborn Screening Facility Coordinators;  (2) Venue and food of participants during the conduct of lectures/trainings/orientation seminars;  (3) Supplies and materials needed for the conduct of lectures/trainings/orientation seminars;  (4) Honoraria of resource persons/facilitators;  (5) Traveling expenses and per diem for the conduct of training/orientation seminars;  (6) Printing and reproduction of advocacy and information materials; and  (7) - Other training/seminar and campaign related expenses.   d) Incentives for RHU collecting health units of AT LEAST 2% of the 4% funds of the DOH\u2014ROs/DOH-ARMM.   Incentive may be in the form of;   (1) NBS kits;  (2) Sponsorship to newborn screening - related local meetings and conferences;  (3) Promotional materials/giveaways; or  (4) Telecommunication expenses related to newborn screening activities.   e) Staff development of the personnel of the NBS unit based at the DOH\u2014ROs/DOH-ARMM and Continuity Clinics.   The line item budget shall be used for the following:   (1) Registration fees of trainings/seminars/conventions/ of\ufb01cial meetings;  (2) Traveling and accommodation expenses;  (3) Per diem of staff directly involved in the program; and  (4) Attendance to international conferences approved by DOH\u2014 Screening & Evaluation Committee for Training & Development (SECTD). Approval shall be based on the following: -   (a) An of\ufb01cial country representative involving a highly specialized \ufb01eld that is related in the program management or policy development; and   (b) The conference focus on newborn screening program management and policy development; and   (c) Paper or poster presenter/s on newborn screening- related services/innovation; or   (d) Oral presenter/invited resource person representing the country either in plenary or in parallel session.   Post travel report shall be submitted two weeks after travel.   f) Capital outlay   The line item budget shall be used for the following:   (1) Purchase of Of\ufb01ce Equipment, Communication Equipment, IT Equipment and Software, Furniture and Fixtures needed in the implementation of the NBS program;   (2) Purchase of Motor Vehicle for NBS program, which shall abide by the following rules:   (a) Each RO can acquire one (1) vehicle subject to government procurement process. Request for a second vehicle shall require approval of the Advisory Committee on Newborn Screening (ACNBS);   (b) The type of vehicle is limited to SUVs/4-wheel drive or its equivalent. The vehicle will have a vehicle wrap using a prescribed DOH\u2014NBS standard design approved by the DOH;   (c) The motor vehicle shall be for of\ufb01cial use only and shall be primarily for monitoring and evaluation of the implementation of NBS program at health facilities, government and private, at all levels, patient recall, advocacy, technical and logistics assistance to Local Government Units (LGUs), Non\u2014 governmental organizations (N GOs), Academic Institutions and other stakeholders; monitoring and supervision activities on NBS facilities; for other functions of\ufb01cially related to the implementation of the NBS Program;   (d) The vehicle shall be for of\ufb01cial NBS use only; and   (e) The designation of driver will be dependent on the set up of each region with the objective of ensuring proper usage and maintenance of their vehicle.   g) Maintenance and operating expenses of the program   The line item budget shall be used for the following:  (1) Telephone bills/Call Cards (Landline and mobile phones);  (2) Of\ufb01ce Supplies and Other Supplies Expenses;  (3) Internet Expenses;  (4) Representation Expenses;  (5) Repairs and Maintenance of acquired Properties & Equipment; and  (6) Other Administrative Overhead related expenses.   h) Cost of repeat samples due to insuf\ufb01cient and contaminated samples of patients in their catchment area.   2. NBS Nurse Coordinators shall be in-charge of the monitoring of funds transferred to DOH-ROs/DOH-ARMM.   3. All disbursement of funds shall be subject to existing accounting and auditing rules and regulations.   4. These guidelines shall be reviewed periodically by the Family Health Of\ufb01ce of the Department of Health (F HO-DOH) for technical processes and Newborn Screening Reference Center for the usage of fund.   C. Roles and Responsibilities   1. DOH ROS/DOH-ARMM shall:   a) Maintain a Trust Fund account for the 4% earmarked amount;   b) Take charge of the overall management and disbursement of the transferred fund;   c) Submit the following approved documents, namely: (1) Internal Operating Budget (IOB) for the calendar year, (2) Work and Financial Plan (WFP), (3) Accomplishment report, and (4) any supplemental plans to DOH-Disease and Prevention Control Bureau.   d) Prepare and submit to NSRC the request letter for fund transfer along with the original copy of approved documents, namely: (1) Fund utilization report (FUR) veri\ufb01ed by Resident COA; (2) Internal Operating Budget (IOB) for the calendar year; (3) Work and Financial Plan (WFP); (4) Accomplishment report and (5) supplemental plans (if any); and   e) Utilize the unexpended balance of the 4% funds from the previous year/s for the NBS activities of the following year.   2. NSRC shall:   a) Review fund transfer request based on the approved and submitted FUR, IOB, WF P and Accomplishment Report. Findings shall be elevated to the DOH-FHO;   b) Request funding and payment approval from UP Manila of the funds for transfer to DOH-ROs/DOH-ARMM; and _   c) Transfer earmarked funds to DOH\u2014ROS and DOH\u2014ARMM within 45 working days from date of receipt of requests.   D. Procedural Guidelines   1. A Memorandum of Agreement (MOA) shall be executed between NSRC, NSCs and DOH\u2014ROs/DOH-ARMM on the collection and transfer of 4% of NBS fees;   2. NSRC shall collect from NSCs the percentage of the NBS fees for DOH- ROS/DOH-ARMM;   3. NSRC shall notify the DOH-ROs/DOH-ARMM on the availability of 4% of NBS fees;   4. DOH-ROs/DOH-ARMM shall request from NSRC the amount for transfer as indicated in the DOH\u2014ROs/DOH-ARMM Annual Internal Operating Budget (IOB);   5. NSRC shall transfer earmarked funds to the DOH\u2014ROS/DOH-ARMM; and   6. DOH Central of\ufb01ce shall facilitate monitoring and evaluation of fund utilization of and fund requests from DOH\u2014ROs/DOH-ARMM, in coordination with NSRC. Assessment shall be reported and resolutions to critical issues shall be discussed by the DOH Central Of\ufb01ce with the   VI. Repealing Clause   AO No. 2013-0015 and all other Orders whose provisions are inconsistent with this Order are hereby repealed/modi\ufb01ed.   VI. Effectivity   This Order shall take effect \ufb01fteen (15) days after its approval and publication in the of\ufb01cial gazette or newspaper of general circulation.  ", "  I. Background  Pursuant to the provisions of Presidential Proclamation No. 1064 entitled \u201cEnjoining All Sectors of Society to Participate in the Acute Flaccid Paralysis (AFP) Surveillance Component of Polio Eradication Campaign of the Philippines,\" all public and private hospitals with 100 beds for more, all neurological societies especially on pediatric neurology, and all medical and pediatric societies are enjoined to actively participate in the AFP  surveillance component of the polio eradication in the Philippines.  Acute paralysis in a child is such a frightening condition for parents that most of the children who are affected are brought to the hospital. Thus surveillance of Acute Flaccid Paralysis (AFP) for polio eradication is  essentially a. hospital-based surveillance, The active daily identification of  AFP cases among admissions and Out Patient Department (OPD) and  Emergency Room (ER) consultations in big hospitals (more than 100 bed capacity) can effectively catch most of the AFP cases. Early identification that is during the first 14 days after the onset of paralysis, is important in order to collect 2 steel specimens for poliovirus culture.  To ensure an effective Implementation of AFP surveillance in the Philippines an operational manual entitled \u201cSurveillance of Acute Flaccid Paralysis: An Operational Manual for Field Health Workers 1996\" has been issued out through the Maternal and Child Health Service (MCHS) (Annex A).    II. Coverage  All public hospitals and facilities - whether these are devolved to the local government units or retained under the Department of Health (DOH) and all 100-bed capacity private hospitals shall abide to these requirements to ensure an effective and efficient implementation of active AFP surveillance in all hospitals in the Philippines.    III. Roles and Functions   A. Hospital Director/Chief of Hospital  A.1 Create/designate a hospital AFP surveillance team composed of doctors nurses and a medical technologist. The team shall have a clear and written assignments through a hospital circular or a memorandum of agreement duly signed by the hospital director.  A.2 Manage the institutionalization of Standard operating Procedures (SOP) for all AFP cases through issuance of memorandum circular and ensure its implementation.  A.3 Permit/allow AFP SurveIllance Officer (AFSO)/Regional AFP Surveillance Officer (RASO) to scan hospital logbooks on Admission, ER, OPD and other relevant records in the Pedia, Neuro or medical departments, etc. where missed AFP cases could be detested and followed -up.  A.4 Allow a regular daily search for identification of AFP cases among hospital admissions and consultations as listed in relevant hospital logbooks and records. AFP cases might not always be recorded as AFP in logbooks and records, thus all conditions presenting with AFP should be identified.  A.5 Direct hospitals with less than 100 beds, district hospitals and private clinics which are not certified AFP surveillance sites, which admitted AFP cases, to hold/confine the patient in the hospital. The attending physician shall immediately order collection of two (2) stool samples 24 hours apart and report/the admission to the EPI coordinator of the Provincial Health Office (PHO)/City Health Office (CHO) and the Regional Epidemiology and Surveillance Unit (RESU).   B. AFP Hospital Team  B.1 Admit all identified AFP cases regardless of any suspected underlying cause(s). B.2 Collect, label, store and transport stool specimens  Two (2) stool specimens shall be collected for each AFP case. The  first stool specimen shall be collected upon admission whereas the second stool specimen shall be collected after twenty four (24) hours. If the patient cannot defecate, rectal suppositories may be used.  A stool specimen should be approximately the size of an adult\u2019s thumb and placed in a bottle provided for or in any sealable, leak- proof dry clean bottle. The stool bottles shall be labelled as follows:     The bottle containing the stool specimen should be placed in a plastic bag. For each specimen, laboratory report form should be properly filled-up (Annex F \u201cSurveillance of Acute Flaccid Paralysis: An Operations Manual for Field Workers\"). \"Surveillance of Acute Flaccid Paralysis: An Operations Manual for Field Workers\").  Stools should be stored in the refrigerator (4 to 8\u00b0C) until collected  by the AFPSO or other RESU staff or any designated health personnel. If the specimens have not been collected by the responsible person within 48 hours, the RESU or AFPSO need to be immediately informed or the specimens can be shipped directly to the Research Institute of Tropical Medicine (RITM), Alabang, Muntinlupa.  B.3 Report all AFP cases within 24 hours of admission/consultation to the RESU or AFPSO/RASO or Regional Field Health Offices (RFHOs).  A RESU staff/RASO/AFPSO together with the attending physician shall conduct an immediate case investigation within 48 hours after admission but preferably within 24 hours after admission.  B.4 Filling-up of case investigation form  The paediatric resident/reporting physician should be with the RESU staff/RASO/AFPSO when this is accomplished. When a RESU staff is not available, alternately responsible are the Regional Immunization Officer (RIO)/Regional Nurse Coordinator (RNC) or EPI Coordinator (PHO/CHO) together with the pediatric resident/reporting physician.   All information asked on the form shall be properly and completely filled-up.  Two (2) copies of the report has to be prepared, one copy for the RESU staff and the other to the EPI Coordinator.  B.5 Transport of Stool Specimen  If the reporting health facility is near the RHFO, the RESU staff/RASO/AFPSO shall send the stool specimen to RITM through the DHL branch in the area. If far from RESU but near DHL, hospital AFP nurse shall be responsible. Alternately responsible persons are the RIO/RNC or EPI Coordinator (PHO/CHO). Refer to the Memorandum of Agreement between the Department of Health and DHL Philippines Corporation (Annex E \u201cSurveillance of Acute Flaccid Paralysis: An Operations Manual for Field Workers\").  B.6 Safekeeping of unused stool collection kits and forms. Stool collection kits and forms will be provided and replaced by the RESU.  B.7 Refer the patient for rehabilitation before discharge, if necessary.  This Administrative Order shall take effect immediately.     ", "  l. Background/ Rationale  In 2000, the National Nutrition Council (NNC) Governing Board with the Department of Health (DOH) as one of its members had agreed to adopt the International Reference Standards (IRS) in determining the nutritional status of Filipino children. This decision however required the revision or changes of existing Philippine Reference Standards(PRS)\u2014based national guidelines or reference tables and charts presently used at the field level and the retooling of field workers in using the international Reference Standards (IRS) based materials. UNICEF supported the Food and Nutrition Research Institute (FNRI) in developing the International Reference Standards Growth Tables and Charts for Philippine Use.  The DOH in collaboration with FNRI and UNICEF revised the widely used Growth Monitoring Charts to an Early Childhood Care and Development (ECCD) Card and ensured an IRS adapted material. FNRI in coordination with DOH, NNC and selected Local Government Units conducted orientationltrainings on IRS on Weight and Height Measurements.  In order to fast track the implementation and mainstreaming of IRS in the health and nutritional assessment system of the country, this Order clarifies and outlines the adoption of IRS in the existing growth\u2014monitoring programs and activities.  II. Coverage and Scope  The International Reference Standards growth tables and charts shall be used in all public health and hospital facilities in the country. The reference tables and charts include weight for age for boys and girls of 0 \u2014 72 months; length/height for age for boys and girls of 0 - 72 months; and weight for length for boys and girls (49 \u2014103 cm) and weight for height for boys and girls (55 - 137 cm).  III. Growth Monitoring Programs and Activities  1. Low Birth Weight Monitoring  The WHO cut off point for low birth weight for both sexes of 2.5 kilograms still prevails as the national standard. The plotting of the weight value 2.3 kg. at 0 month age in the iRS based ECCD card represents the lower limit value for the series of standard of measurement for girls to monitor their growth. The weight at 0 month in the chart does not mean the birth weight value of children.  2. Integrated Management of Childhood Illnesses (IMCI)  The IMCI Weight for Age Chart adapts the IRS growth chart. The curve lines in the existing IMCI module growth chart shall be read and interpreted as the very low weight for age representing the 3 standard deviations (SD) from the median, the low weight for age line representing the 2 SD and the upper line as the median curve. The weights of children falling between the 2 SD and the upper line are considered normal for weight for age.  The field health workers use the IMCI chart as a quick reference guide in assessing the present nutritional status of a sick child seeking services at the health centers. The IMCi chart is not a growth\u2014monitoring tool like ECCD card but rather as a rapid nutritional assessment tool for case management of sick children.  3. Early Childhood Care and Development (ECCD) Growth Monitoring Card (GMC)  The ECCD card serves as the record of essential services a child should receive from birth up to 6 years of age. The growth chart as indicated in the ECCD card is based from the RS values. The GMC originally in yellow color is now produced as white card and contain two colored curve lines. These two colors are red representing the curve lines for girls and the blue lines for boys. The weights falling within the upper and lower curves are categorized as normal weight for age. While the weights falling above the upper lines are categorized as overweight and the weights falling below the lower iines are categorized as underweight.  The expressed desire of some health workers to include the FNRI IRS Prototype chart instructional procedure for age computation and for weight and height measurement shall be considered as a possible instructional poster material for the different health centers.  Considering the limited supply of the ECCD card for nationwide use, the existing yellow charts in the field could still be used until the one~year transition period of 2003.  4. Operation Timbang (OPT)  The target age group for Operation Timbang shall be reduced from 0-83 months to 0\u201471 months for consistency with the national policy and thrust.  The annual conduct of Operation Timbang at the field level shall be continuously done using the weight for age as indicator. The IRS weight for age table shall be used in determining the Weight for Age values of children during the mass weighing activities of Operation Timbang. The Local Government Units (LGUs) are encouraged to use the OPT results for their local planning, monitoring and evaluation activities.  In addition, the annual targets for OPT will be computed at 17.5% of the total population.  5. Regular Nutritional Assessment Procedure at the Public Health and Hospital Facilities  The regular anthropometrical assessment activities at the Rural Health Units, Barangay Health Stations, ProvinciaIIDistrlct/Municipal Hospitals and Retained Hospitals, for the 0 - 18 yrs of age shall be done using the IRS growth tables and sheds.  IV. General Guidelines  In the development and distribution of growth monitoring materials, the following guidelines shall be adopted:  1. All existing PRS based materials and references shall be replaced with IRS adopted materials.  2. The IRS reference tables and charts shall be made available to the public and private practitioners and agencies involved in growth monitoring activities.  3. Tobacco industries, pharmaceuticals and drug companies engaged in the business or function of manufacturing and/or marketing a product within the scope of the Milk code shall not be allowed to sponsor the production and reproduction of growth monitoring materials.  V. Implementing Mechanism  A. Department of Health  The Department of Health shall take the leadership in advocating the adoption of International Reference Standards in growth monitoring activities.  1. Center for Family and Environmental Health (CFEH)  The Center for Family and Environmental Health of the National Center for Disease Prevention and Control shall serve as the lead office for growth monitoring and shall perform the following functions:  - Development of policies, standards and guidelines pertaining to growth monitoring;  - Provision of technical assistance to Central Office Clusters/Bureaus, CHDs and Retained Hospitals relative to IRS based growth monitoring materials;  - Development of IRS based tools and materials for growth- monitoring;  - Promotion of the adoption of IRS among concerned agencies and practitioners;  - Development of training programs to orient and retool field health workers on IRS tables and charts;  - Monitor and evaluate the field implementation of IRS; and  - Establish coordination and networking with FNRI, NNC and other stakeholders in planning, implementation, monitoring and evaluation of IRS adoption.  2. Center for Health Development (CHD)  The CHDs shall be responsible for the following:  - Translation of growth monitoring national policies and framework for regional and local applications;  - Providion of technical assistance to LGUs, NGOs, academes and other stakeholders relative to IRS adoption;  - Advocacy for the adoption, utilization and reproduction of IRS materials to LGUs, NGOs and other stakeholders;  - Reproduction of IRS prototype growth monitoring materials;  - Conduct of orientation and training on IRS adoption; and  - Monitor the implementation of IRS adoption in the region.  3. Retained Hospitals  All retained hospitals shall be responsible for the following:  - Ensuring all growth tables and charts in the hospital are IRS based;  - Conducting orientation and/or training of hospital staff in using the IRS based tables and charts; and  - Monitoring the implementation of IRS adoption in the hospital.  B. Local Government Units (LGUs)  All LGU health facilities including the devolved hospitals, Rural Health Units and Barangay Health Stations shall be responsible for the following:  - Ensuring all growth charts and tables in the LGU health facilities are IRS based;  - Conducting orientation and training of field health workers including barangay health workers and barangay nutrition scholars in using IRS based tables and charts;  - Monitoring and evaluating the IRS implementation in their localities; and  - Establishing coordination and networking among concerned agencies in IRS implementation.  VI. Repealing Clause  Any existing provisions or issuances found inconsistent with this Order should be repealed.  VII. Effectivity  This Order shall take effect immediately.   ", " I. RATIONALE   The United Nations 2030 Agenda for Sustainable Development has included the control of viral hepatitis as one of its goals, as stated, Goal 3.3: \u201cBy 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, Water borne diseases and other communicable diseases.\" The initial strategies were outlined in the WHO Global Health Sector Strategy on Viral Hepatitis (GHSS), 2016-202], and detailed plans were described in the Regional Action Plan for Viral Hepatitis in the Western Pacific (RAPVH). The GHSS and RAPVH encompass the control of hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E, with a focus on hepatitis B and hepatitis C due to the public health burden they represent.   According to latest data from the National NutritiOn and Health Survey (NN HS), an estimated 7.3 million adult Filipinos (16.7% of the adult population) are chronically . infected with the hepatitis B virus (HBV). This prevalence is more than double the 8% average prevalence rate of HBV infection in the Western Paci\ufb01c region. For hepatitis C _ virus (HCV) infection, small-scale studies suggest that up to 700,000 to 1 million Filipinos are infected. Furthermore, reports submitted to the Department of Health (DOH) from 2012\u20142015 showed a case fatality rate of 0.82% to 1.29% for hepatitis B, and 3.28% to 10.34% for hepatitis C. In addition, the hepatitis B prevalence in 2015 among men who have sex with men (MSM) and people who inject drugs (PWID) were 7.12% and 7.76%, respectively; and the hepatitis C prevalence among PWID was as high as 51.91%.   In response to the need for a comprehensive and multi-sectoral action to control hepatitis B and hepatitis C, a private-sector led National Viral Hepatitis Task Force (NVHTF) was convened in 2013. The NVHTF is a multi-sectoral coalition of stakeholders with a shared interest in viral hepatitis prevention and control. The coalition released a call to action to control viral hepatitis nationwide.   The DOH shall institutionalize all prior and current efforts, including that of the NVHTF, on viral hepatitis control with this Administrative Order, which hereby provides policies on the prevention and control of viral hepatitis under the NASPCP.' This is in line with the \ufb01rst guarantee of the Philippine Health Agenda (PHA) to address the triple burden of disease in all life stages.   II. OBJECTIVES   A. General Objective:   To prescribe policies for Prevention and Control of Viral Hepatitis under the NASPCP   B. Speci\ufb01c Objectives:   (1) To identify the elements and components for Prevention and Control of Viral Hepatitis   (2) To describe the roles and responsibilities of agencies and of\ufb01ces involved   III. SCOPE   This issuance covers all health facilities, public and private, national and local government units and other health institutions providing hepatitis\u2014related services. It shall also include other public and private associations such as the academe, media, professional associations, civil societies, non-government organizations and international development agencies.   IV. DEFINITION OF TERMS   For the purpose of this Order, the following terms shall be de\ufb01ned as:   1. Viral hepatitis - in\ufb02ammation of the liver due to a viral infection. There are \ufb01ve main hepatitis viruses, referred to as types A, B, C, D and E.   2. Hepatitis B- a viral infection (caused by the hepatitis B virus) that attacks the liver and can cause both acute and chronic disease.   3. Hepatitis C\u2014 a viral infection (caused by the hepatitis C virus) that attacks the liver and can cause both acute and chronic disease.   4. Mother-to-child transmission \u2014 transmission of infection from an infected mother to an uninfected child from exposure to maternal blood and body \ufb02uids during delivery.   5. Birth dose vaccination \u2014 administration of hepatitis B vaccine within 24 hours of birth.   6. Vulnerable populations needing hepatitis B vaccination \u2014 population groups given priority for vaccination due to a high risk of infection or vulnerability to the impact of infection. These include persons who received blood transfusions before 1995, persons on long-term hemodialysis, persons with a history of incarceration, persons with a history of unhygienic body modi\ufb01cations, children born to mothers with hepatitis B and hepatitis C, sexual partners and other close contacts of infected patients, men who have sex with men (MSM), male and female sex workers, those with a history of illicit drug use (i.e., intranasal use, or persons who inject drugs [PWID]), persons living with HIV, those with occupational exposure such as healthcare workers, newborns and infants, patients with hepatitis C, and patients with cirrhosis or persistently elevated liver enzymes due to any cause.   V. GENERAL GUIDELINES   A. The prevention and control of Viral Hepatitis shall be an integral part of the NASPCP under the Disease Prevention and Control Bureau.   B. The Prevention and Control of Viral Hepatitis shall be guided by the following principles:   1. Goals and values of the Philippine Health Agenda. The program and health services shall also be established utilizing the PHA strategies (ACHIEVE) as appropriate.  2. Human rights for all persons diagnosed with hepatitis B and hepatitis C shall be promoted and protected especially in the workplace.   C. This shall be implemented and aligned according to existing mandates:   - RA 10152 \u2014 An Act Providing for Mandatory Basic Immunization Services for Infants and Children, repealing for the Purpose of Presidential Decree No. 996, as Amended.  - RA 10526 - An Act Declaring the Month of January of Every Year as \"Liver Cancer and Viral Hepatitis Awareness and Prevention Month\" and for Other Purposes.  - DOLE Department Advisory No. 05, Series of 2010. Guidelines for the Implementation of a Workplace Policy and Program on Hepatitis B.   D. The NASPCP shall be supported by the Steering Committee, a Technical Working Group and Experts Panel, as stipulated in DPO number 2016-0604 and 2016- 0604A (https://home2.doh.gov.ph/ais_public/dppdf/dpo2016-0604(1).pdf and https://home2.doh.gov.ph/ais_public/dppdf/dpo2016-0604-a.pdf)  E. The above Technical Working Group shall develop a national viral hepatitis prevention and control strategic plan for the implementation of policies and guidelines.   F. The activities of the strategic plan on viral hepatitis shall align with the Philippine Health Agenda 2016-2022 and Sustainable Development Goals.   VI. SPECIFIC GUIDELINES   The priority components for the prevention and control of Viral Hepatitis under NASPCP are the following:   1. Advocacy and awareness -- The program in coordination with the Health Promotion and Communications Service (HPCS) shall intensify advocacy activities on viral hepatitis. This shall include, but not limited to, nationwide multimedia campaign, annual observance of World Hepatitis Day every July 28 and January as \"Liver Cancer and Viral Hepatitis Awareness and Prevention Mont \", public and private health provider education, community organization of infected persons, and creation and strengthening of policies to address stigma and discrimination.   2. Robust research and information system   a. The NASPCP shall collaborate with the Epidemiology Bureau (EB) and other relevant stakeholders to develop a national investment case for action on hepatitis with a focus initially on chronic hepatitis B and hepatitis C, informed by the local epidemiological context; and to harmonize databases and surveillance systems related to viral hepatitis.   b. The strategic plan shall also include research agenda to address the identi\ufb01ed needs and to guide future policy-making for the prevention and control of viral hepatitis.   3. Halting transmission - The NASPCP shall coordinate with Family Health Of\ufb01ce to improve hepatitis B vaccination with emphasis on the timely administration of the birth dose to prevent mother-to~child transmission, as well as vaccination of vulnerable populations, infection control, and harm reduction. The strategies for viral hepatitis shall be integrated with other DOH programs, suCh as the HIV/STI program and cancer control program, among others.   4. Access to effective hepatitis treatment - The program Shall work with the Pharmaceutical Division, PhilHealth and other partners to adopt an effective, accessible, public health approach for the treatment of patients with viral hepatitis, as appropriate.   Furthermore, it shall adopt the hepatitis B treatment guidelines of the WHO (Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection, March 2015) that recommends the use of Tenofovir- and Entecavir-based treatment regimens.   5. Monitoring and Evaluation   Categories of indicators for monitoring and evaluation will include baseline information on incidence, prevalence, etc.; operational indicators; and target outcomes. These indicators will be the gauge of the program in terms of achieving its goal of preventing and controlling the spread of viral hepatitis. Such indicators will be obtained from the following:   a. Situational analysis including burden of disease A SWOT analysis of the NASPCP interventions on viral hepatitis will be conducted at least once every 3 years.   b. Seroprevalence of hepatitis B and hepatitis C   c. Indicators re\ufb02ecting the infection control practices of health facilities   d. Birth-dose coverage and 3-dose coverage of the hepatitis B vaccine The strategic plan intends to strengthen routine immunization services to achieve and sustain at least 95% coverage with the three doses of Hepatitis B vaccine by 1 year of age in each birth cohort at the national level, and deliver a timely birth dose (within 24 hours of birth) with a target of reaching at least 95% of births at the national level.   e. Coverage of hepatitis B and hepatitis C treatment in the poorest families   As a strategy of NASPCP, key indicators to measure success across the viral hepatitis screening, care and treatment cascade shall be identi\ufb01ed and monitored.   A comprehensive monitoring and evaluation plan for the strategic plan shall be developed to include the following: (i) de\ufb01nitions, (ii) baseline, (iii) C performance indicators, (iv) source of data, (v) frequency of collection, and if! (vi) of\ufb01ce responsible for collection.   G. Roles and Responsibilities   The following of\ufb01ces and institutions shall assume the following roles and responsibilities:   a. The Technical Working Group (TWG) shall provide technical support in the development of policies and plans pertaining to the prevention and control of viral hepatitis. It shall also provide the forum for coordinating all aspects of the implementation of the policies and strategies.   b. The Experts Panel shall provide appropriate advice to the DOH on issues and concerns related to viral hepatitis including guidelines on screening, diagnosis and treatment. They shall provide evidence-based recommendations.   c. The Disease Prevention and Control Bureau (DPCB) shall:   i. facilitate the dissemination of the policy;   ii. oversee the implementation of the NASPCP;   iii. establish standards and package of services related to viral hepatitis and ensure their quality, access, and availability at all levels of the health system;   iv. provide technical assistance and augmentation of funds to the Regional Health Of\ufb01ces, LGUs and other partners on the implementation of these services;   v. ensure capacity building at all levels, including the private sector, for the implementation of program policies and standards;   vi. develop a monitoring and evaluation system on the implementation of strategies and activities for viral hepatitis;   vii. ensure participation of other DOH of\ufb01ces and bureaus and coordinate with partners within and outside the health sector for the effective implementation;   viii. coordinate with Philippine Health Insurance Corporation (PHIC or PhilHealth) to develop and implement health insurance packages in the prevention, diagnosis and treatment of viral hepatitis.   d. The Epidemiology Bureau (EB) shall:   i. provide leadership in the development and implementation of an effective national surveillance, and generation of treatment cascade data, monitoring and evaluation system for viral hepatitis;  ii. develop technical products for the dissemination of up-to-date epidemiologic data to stakeholders.   e. The Pharmaceutical Division of the DOH shall:  i. undertake policy reviews to provide evidence in conceptualizing and implementing strategies that shall improve access to essential medicines for viral hepatitis at all levels;  ii. provide mechanisms to ensure access to quality medicines for persons with viral hepatitis.   f. The Health Promotion and Communication Service (HPCS) shall:  i. provide leadership in the development and implementation of an effective national communications plan/campaign on viral hepatitis;  ii. provide technical assistance to ensure the implementation, monitoring and evaluation of health promotion interventions against viral hepatitis.   g. The Family Health Of\ufb01ce (FHO) shall ensure full implementation of the Expanded Program on Immunization (EPI), Which includes the timely administration of the hepatitis B birth dose vaccination.   h. The Health Facility Development Bureau (HFDB) shall:  i. provide leadership in the development and implementation of effective infection control programs against viral hepatitis in health facilities;  ii. provide technical assistance to ensure the implementation, monitoring and evaluation of infection control programs against viral hepatitis.   i. Health Facilities and Services Regulatory Bureau (HFSRB) shall ensure that infection control policies in healthcare facilities are enforced.   j. The Research Institute for Tropical Medicine (RITM) shall:  i. coordinate and assist the NASPCP DPCB, other DOH units and private entities to generate data through conduct of relevant research and disseminate these data;  ii. provide technical assistance in maintaining a surveillance system for viral hepatitis.   k. The STD AIDS Central Cooperative Laboratory (SACCL) shall provide technical expertise and quality assurance services on the diagnosis of viral hepatitis infections.   l. The DOH Regional Offices shall lead and provide technical assistance to the local government units to ensure implementation of the strategic plan of NASPCP on viral hepatitis.   m. DOH-retained hospitals shall ensure provision of quality promotive, preventive, curative, rehabilitative, and palliative care for patients with viral hepatitis.   n. The Local Government Units (LGU) shall:   i. integrate viral hepatitis agenda into existing health committees and legislations that encourages the implementation of the strategic plan on viral hepatitis at appropriate levels (Provincial/City/Municipal/Barangay).   ii. ensure development and sustainability of local'programs on viral hepatitis through accessing technical resources and funding support of other relevant programs such as HIV, STI, safe motherhood and reproductive health programs.   o. The Civil Society Organizations (CSOs), developmental partners and other - relevant government agencies shall assist the DOH and other stakeholders in the implementation and advocacy for the prevention and control of viral hepatitis.   p. The Hepatology Society of the Philippines (HSP) along with other medical/professional societies shall:   i. be responsible for the continuing education activities of health care providers on viral hepatitis;  ii. support the universal screening of pregnant mothers for Hepatitis B;  iii. assist the DOH in the information dissemination on general vaccination strategies to ensure compliance;  iv. actively participate in the development of the treatment strategies for .. viral hepatitis. +   7. Funding   The Department of Health through the National AIDS and STI Prevention and Control Program (NASPCP) and. other concerned bureaus/offices of the Department shall provide funds to support the implementation of the activities for the prevention and control of viral hepatitis.   VII. REPEALING CLAUSE   Other related issuances inconsistent with the provisions of this Administrative Order are hereby revised, modi\ufb01ed or rescinded accordingly. All other provisions 0f Administrative Order No. 2 5.1997 dated February 20, 1997 and Administrative Order No. 2006 \u2014 0015 dated June 23, 2006 which are not affected by this order shall remain valid and in effect.   VIII. SEPARABILITY CLAUSE   In the event that any provision of this Order is held invalid, the validity of the remaining provisions shall not be affected.   IX. EFFECTIVITY   This Order shall take effect immediately.  ", "  I. Rationale:  Newborn screening enables early detection and management at certain inborn metabolic disorders, which, if left untreated, may lead to mental retardation and even death. This procedure was introduced almost four decades age in developed countries. In the Philippines, newborn screening was initiated by the University of the Philippines-National Institutes of Health in 1996. In a period of 3 years, statistical information were collected for same of the disorders:    While the incidence, is low from a public health point of view, DOH is putting high priority for newborn screening in as much as the provision of quality life even for a fraction of our 2 million babies born annually deserves as much attention as survival.   II. Policy Statements:  1. The Philippine Newborn Screening Project is a collaboration between the Department at Health (DOH) and the University of the Philippines - National Institutes of Health (UP\u2014NIH)  2. The project shall be lodged at the Family Health and Nutrition Cluster of the DOH.  3. All DOH retained and renationalized hospitals shall participate in the project by year 2000. All other hospitals both private and government shall participate in the project by year 2004.  4. At the initial phase of the project up to year 2004, the screening process shall be primarily hospital based. It is envisioned that by year 2004, newborn screening shall be part at standard newborn care and be a national program.   5. Pilot tests involving selected health facilities shall be started prior to wide-scale community based newborn screening. It is envisioned that by year 2010, all newborn babies will be screened.  6. The scope of the project shall include 6 disorders namely: Congenital hypothyroidism, congenital adrenal hyperplasia, phenylketonuria, glucose 6 phosphate dehydrogenase deficiency, homocystinuria end galactosemia. The screening fee is currently priced at P450.00. The cost is inclusive of all materials, supplies and freight which are incidental to the screening process.   7. Expenses for the screening process shall be borne by the parents, unless the hospital or the local government or NGO has a scheme providing full or partial subsidy depending on the financial capability of the parents. The Philippine Health Insurance Corporation shall hopefully implement a new package for newborn care in its insurance scheme.  8. DOH funds allocated for newborn screening shall at the initial phase of the project until year 2004 be utilized for advocacy, training of health workers and management of babies found to be positive for any of the six disorders.  9. Newborn screening shall be done through a heel prick to be performed by trained health workers. The procedure shall be done preferably on the 48th hour of life. However, in cases of early discharge, the sample collection must be done not earlier than the 24th hour from birth. In case a baby is discharged earlier than the 24th hour, the baby should be brought back to the health facility for screening within the first week at life.  10. DOH shall draft and finalize the policies pertaining to the project. It shall make the directional plan, secure funds for the project and be active in advocacy.  11. UP-NIH shall provide technical advice. At the initial phase, it will act as central laboratory taking charge of screening all specimens. UP-NIH will assist DDH in training laboratory perscnnel and in setting-up satellite laboratories by year 2001. In addition, it shall be responsible for monitoring laboratories for quality assurance.    12. DOH and UP\u2014NIH shall conduct trainings for health workers to enable them to harness their skills at advocacy, organizing newborn screening teams in hospitals, RHUs, private clinics (e.g. lying\u2014in clinics) to implement the project. Medical specialists shall be selected to undergo short course on the diagnosis and management of common metabolic disorders. Medical technologists at selected hospitals shall be trained in setting up the satellite laboratories. Physicians, nurses and health promotion officers shall be trained on genetic counselling.  13. UP-NIH is also tasked to came up with treatment protocols for each of the disorders in question and assist DOH in the preparation of IEC materials.  14. Currently the UP-NIH is the repository of all statistical information related to the project. By year 2001, the DDH registry of diseases shall be revised to include congenital metabolic disorders.  15. A newborn screening surveillance system shall be established in all regions to track down the number of infants with congenital metabolic disorders and the percentage cf infants for whom appropriate management has been instituted.  16. The regional health office (RHO) shall designate newborn screening coordinators to coordinate with DOH in the implementation of the policies. The regional coordinators shall include newborn screening in the regional plan, monitor and evaluate the project. In addition, they shall advocate for newborn screening through enactment of local ordinance by LGU.  17. Newborn screening coordinators shall be designated at all levels to oversee the implementation in the province, city and catchment municipalities.  18. The RHO/PHO/CHO shall monitor the implementation of the project. They shall collate and analyze performance reports provided by UP-NIH, conduct field visits, hold conferences among implementors to discuss issues and recommend solutions.  19. The LGU may assist in the recall of patients with positive results through the PHO, CHO and district offices. They may also devise a financing scheme to assist indigent patients.  20. At the initial phase of the project up to year 2004, the hospitals, whether private or government shall be the implementing unit of the project. Each hospital shall organize a hospital coordinating team composed preferably by a pediatric consultant, an obstetrics-gynecology consultant and the chief nurse.   21. The hospital coordinating team shall perform the following tasks: a. increase awareness among the hospital medical-nursing staff   b. devise strategies whereby parents or mothers are informed of newborn screening as early as the first prenatal visit. c. ensure that babies are screened through a heel prick after obtaining parental consent. d. ensure that all filter papers are promptly sent to the laboratory. e. inform parents about the results. f. recall patients with positive screen for confirmatory test. g. manage and monitor patients who are confirmed to have any of the six disorders.  22. In addition to the above tasks, the hospital coordinating team shall see to it that administrative matters including correspondence, information and statistical data are collected and financial concerns are handled efficiently.  23. The NGO and other GO\u2019s shall be tapped for advocacy, financial support and assistance in recall.  24. DOH, in collaboration with UP-NIH shall undertake a comprehensive evaluation of the project by year 2003. However, special studies may be conducted to address issues and problems that surface in the reports.  25. Research and development concerning newborn screening processes and the diseases with which it is concerned is strongly encouraged and must be included in the regional/provincial/city plans.   III. Effectivity  This Order shall take effect immediately.   ", "  I Rationale  Section-11 at ISA 928S known as the Newborn Screenlng Act of 2004 stipulates that in Order to ensure that newberri screemng will be accessible to all newborns, the Advisory Committee on Newborn Screemng (ACNBS) shall review and the Newborn Screening Center (NSC) recommend the newborn screening fee to be charged by the Newborn Screening Centers.  Section 19\u2014d of the Implementing Rules and RegulatIon of RA 9288 clearly stated, \"A health facility may collect a reasonable fee for the collection of samples which shall not be greater than the maximum allowable service fee prescribed by DOH\".  The General Policy Statement of DOH Administrative Order 121 s. 2003 no.5 also stated that Newborn ScreenIng (NBS) Fee Shall be regulated by DOH to prevent exorbitant overhead cost thereby making newborn screening more affordable to parents who wanted to have their newborns screened.  Based on the study conducted on the actual cost incurred in the collection and testing of the Newborn Screening Dried Blood Spot and with due consideration of the prevailing cost at reagents and supplies the ACNBS decided to set a \ufb01xed amount for the following:  a) NBS Fee or Cost of the NDS Specimen Commection Kit to be charged by the Newbord Screening Center (NSC) and;  b) Maximum allowable service fee to be charged by the health facility such as hospitals, lying-ins, rural health units/health centers collecting the newborn screening samples.  II. OBJECTIVES  To realize the goal at the Department in making newborn screening more accessible or affordable to the general public, this Administrative Order aims:  1. To standardIze the NBS Fee or Cost of the NBS Specimen Collection Kit to be charged by the NSC  2. To set the maximum allowable service fee to be charged by all health facilities collecting newborn screening samples.  III. COVERAGE  This Administrative Order shall be applicable to all newborn. screening centers and all health facilities such as hospitals, lying-ins or birthing facilities rural health units health centers and the like from both the government and private seetors currently collecting blood samples for newborn screening.  IV. NEWBORN SCREENING EIEESI:  The newborn screenlng fee or cost for the newborn screening specimen collection kit and maximum allowable service fee for the collection of newborn screening samples are hereby prescribed as follows:    V. REPEALING CLAUSE.  The provIsIon of A.O. No 1 s. 2000 (Policies en the Nationwide Implementation of Newborn ScreenIng System) and AD. No. 121 s. 2003 (Strengthening Implementation of the. National Newborn screening System) and related issuance inconsistent or contrary with the provision of this administrative order are hereby rescinded or revoked.  VI. EFFECTIVITY  This order shall take effect ffteen (15) days after filing with the University of the Philippines Law Center.   ", " I. BACKGROUND AND RATIONALE   Republic Act. No. 10121 or the Philippine Disaster Risk Reduction and Management Act of 2010 (DRRM Act) defines the National Disaster Response Plan (NDRP) and mandated the Department of Health (DOH) as member of the Council to manage the health consequences of disasters through the provision of health services. Based on this mandate the DOH has '_deve10ped the National DRRP for Health and capacitated all the regional of\ufb01ces. It was during the onslaught of the super typhoon Yolanda that this plan was tested. The DOH led the Health. Cluster in the provision of essential services for its four sub-clusters namely medical and public health, water and sanitation hygiene, nutrition in emergencies, and mental health and psychosocial support.   However, despite the concerted efforts for a multisectoral response several post-Yolanda evaluation workshops and reports found gaps in the capacity and capability of the government, including the health system. There are identified areas without clear policies, guidelines, and standards that caused ineffective policy implementation and weak coordinating mechanisms. Hence, there is a need to formalize the guidelines in the provision of the essential service packages for the four sub-cluster through this Order to set standards in the delivery of health services for emergencies in disasters to be reinforced and complied by all implementing agenmes.   II. OBJECTIVES   To set the standards for the effective, efficient and timely delivery of essential health services in emergencies and disasters.   Specifically:   a. Set guidelines in the delivery of essential health services in emergencies and disasters.   b. De\ufb01ne the essential service components for health, nutrition, water and sanitation hygiene, and mental health and psychosocial support that need to be available and accessible before, during, and after emergencies and disasters.    c. Delineate the roles and responsibilities of concerned of\ufb01ces, stakeholders, and partners in the delivery of essential health service packages.   III. SCOPE AND COVERAGE   This Order is issued for the guidance of the health sector both government and private, - which includes DOH Central and Regional Of\ufb01ces, its attached agencies, hospitals and other healthcare facilities, local. government units, other national government agencies, international and local non-government organizations, development partners, professional societies, and other stakeholders involved in disaster risk reduction and management, emergency preparedness and response operations.   IV. GENERAL GUIDELINES   1. The EHSP shall be implemented in all humanitarian crises guided by the principles of humanity, neutrality and impartiality and likewise implemented at the onset of an emergency or disaster and shall continue until restoration of the regular health services.   2. The EHSP in Emergencies and Disasters shall set standards of minimum services relative to promotive, preventive, diagnostic, and curative phases during emergencies and disasters at all levels. It shall be made available and accessible to the affected population with the same need, regardless of their age, gender, creed and ethnic origin.   3. The package of essential health services will focus on the four (4) DOH\u2014led clusters or Health sub-clusters namely Medical and Public Health, Nutrition, Water and Sanitation Hygiene, and Mental Health. and Pyschosocial Support.   4. All levels of governance shall allocate budget for capacity building, human and non.\u2014 human resource mobilization, and localized promotion and advocacy materials (See Annex B) for the implementation of the EHSP out of the funds of the national government agencies allotted in the national DRRM fund and General Appropriations Act (GAA) and LGUS\u2019 fund through the local DRRM fund, and/or through the Disaster Management Assistance Fund. -   5. The Local Government Units shall have the primary responsibility and accountability in providing the essential health service package with assistance from stakeholders that are involved directly or indirectly in the delivery of health services.   V. SPECIFIC GUIDELINES   A. Essential Health Service Package   The four (4) Health sub\u2014cluster Essential Service Packages (ESP) aim to provide a focused approach for all affected individuals especially the vulnerable and marginalized populations during emergencies and disasters. The priority in providing the ESPS may change as required by the nature of the emergency (e. g. Complex Emergencies) or disaster and the local context. This package of services is assumed to cover the anticipated and historical health needs of the affected population but shall always be informed by assessments.   1. Medical and Public Health ESP   a. Description   The health requirements of the general population and vulnerable groups shall be met primarily through the following component services: Maternal and Child Health, Prevention and Control of Communicable Diseases, Sexual and Reproductive Health, Management of Injuries, and Control of Non~Communicable Diseases in accordance with accepted national and international standards.   b. Components   1. Health Services for saving lives including those that are needed for search and rescue right after disaster strikes such as Basic Life Support, Standard First Aid, and Pre- hospital Care. .Also includes prepositioned \ufb01rst-aid/survival/family health kits and breastfeeding kits.   2. Health Services to prevent and control disaster-related morbidities including communicable diseases and vaccine preventable diseases.   i. Provision of effective injury and proper wound care.  ii. Provision of prophylaxis for \ufb02ood-borne diseases such as leptospirosis and acute watery diarrhea.  iii. Provision of tetanus toxoid to those with dirty wounds and those involved in rescue or clean\u2014up operations   3. Health. Services that need to be continued in the disaster sites including non\" communicable diseases (e. g. lifestyle-related diseases, and degenerative diseases.)   4. Maternal, Newborn and Child Health, Essential Intrapartum and Newborn Care (EINC), Basic Emergency Obstetric and Newborn Care (BEmONC) including ensuring clean and safe deliveries, infant and young child feeding counseling, measles and OPV immunization for children aged 6 months to 15 years, vitamin A supplementation for children 6 months to under-\ufb01ve years old, iron-folio acid supplementation for pregnant and lactating women, under-\ufb01ve children feeding support, and provision of safe havens (child\u2014friendly space and woman-friendly space.)   5. Sexual and Reproductive Health (SRH) services in the evacuation centers/communities with, and treatment, prevention and support services, provision of breastfeeding and counseling support to human-immunode\ufb01ciency virus (HIV) and sexually-transmitted infections (STIs). Refer to A0 2016-0005 on MISP for SRH.   6. Early treatment and continuation of essential therapies for acute/ chronic conditions/exacerbations including trauma and injuries, skin infections, non\u2014 communicable diseases (e. g. lifestyle-related diseases, degenerative diseases, bronchial asthma, pulmonary tuberculosis, cardiovascular disease, diabetes mellitus and other endemic diseases.)   7. Health. Support Services for the vulnerable population:  i. Services for older persons (OP), people with disabilities (PWDS), people with special needs (PWSNS), and people with pro-existing mental illness.  ii. Services for the clinical and legal assistance for survivors of sexual violence.  iii. Systems of referral, communication, and safe transport and pro-hospital care of patients requiring definitive care.   2. Nutrition ESP   a. Description   In coordination with the Food and Non\u2014food Items (NF I) Cluster, the nutritional requirements of the general population and vulnerable groups shall be met primarily through nutrition assessment, infant and young child feeding, food assistance, management of acute malnutrition, and micronutrient supplementation in accordance with accepted national and international standards. These must be supported with nutrition education as well as interventions related to food, health, mental health and psychosocial support, water, sanitation, and hygiene, social welfare, food security and livelihood.   b. Components   1. Mobilization of community health and nutrition volunteers and peer support groups within 24 hours.   2. Conduct of infant and young child feeding (optimal and appropriate breastfeeding and complementary feeding) assessment and counselling within 24 hours.   3. Conduct of rapid nutrition assessment after 72 hours. Mid\u2014upper arm circumference (MUAC) measurement (including clinical examination for the presence of bilateral edema) must be conducted if weight and height measurements are not possible.   4. Immediate provision of high-dose vitamin A supplements to target groups unless a similar dose was given in the past four weeks and iron-folate within 24 hours as defined in the current guidelines for micronutrient supplementation. Likewise the provision of Micronutrient Supplement Powder to children 6\u201423 months within 72 hours. Refer to DM 2011-0303.   5. Posting and distribution of nutrition promotion and advocacy materials within 24 hours.   6. Appropriate management and referral of severe acute malnutrition cases with complications appropriately within 72 hours.   7. Organization of targeted supplementary feeding covering children 6-59 months, pregnant, and lactating women within 72 hours and beyond, when the prevalence of global acute malnutrition (GAM) is 10-14%.   8. Nutritional assessment and appropriate response interventions and management of acutely malnourished children, pregnant and lactating women, children with micronutrient de\ufb01ciencies and those children who are stunted.   9. Provision of counselling services and supportive nutrition care for promotion, protection, and support to infant and young child feeding practices, such as exclusive breast feeding, re\u2014lactation, and special dietary restrictions within 72 hours.   10. Monitoring of any act that is against the Milk Code, particularly the prohibited distribution or marketing of infant formula and milk donations as well as promotion materials in any form.   3. Water, Sanitation and Hygiene (WASH) ESP   a. Description   The WASH requirements of the general population shall be met primarily through the following component services: Hygiene Promotion, Water Supply, Excreta Disposal, Vector Control, Solid Waste Management, and Drainage in accordance with accepted national and international standards.   b. Components   1. Assessment and evaluation of the WASH conditions in the pie-identified evacuation centers within 0-2 hours upon arrival to the area.   2. Provision of safe water and adequate water storage facilities and protection of water supply sources within 3-6 hours upon arrival. to the affected area.   3. Hygiene promotion to encourage proper behavior through hand washing, hygiene practices and use of WASH facilities within 12 hours.   4. Implement non-harmful vector control measures (such as bed nets, repellent, lotions, etc.) within 24 hours.   5. Provision of receptacles/bins and storage facilities for solid waste management within 24 hours.   6. Provision of sanitation facilities, excreta disposal facilities, and implementation of sanitation techniques within 24 hours.   7. Conduct of water quality surveillance, disinfection and treatment within 24 hours and regularly thereafter.   8. Implement drainage of WASH facilities to prevent contamination of water sources and vector breeding places within 24 hours and regularly thereafter.   9. Immediate provision of separate toilet facilities for males and females that are easily accessible, adequate in number, well lighted and suf\ufb01ciently close to dwellings.   4. Mental Health and Psychosocial Support (MHPSS) ESP   a. Description   The mental health and psychosocial support requirements of the general population and vulnerable groups shall be met primarily by ensuring that social considerations are taken into account in all relief efforts, as well as by providing psychological \ufb01rst aid and gradated psychological interventions in accordance to the accepted national and international standards. (e. g. IASC 2007 Guidelines for mental health and psychosocial support in emergency settings.) These considerations and interventions must be supported with activities \u2014 services, promotion and education related to food, health, water, sanitation, and hygiene, and livelihood.   b. Components   1. Provision of support to staff who experienced extreme events upon manifestation of signi\ufb01cant behavioral changes.   2. Referral of more severe, complex or high risk cases to specialists and facilities within 12 hours.   3. Utilization of existing communal, cultural, spiritual and religious healing practices as approaches to MHPSS, as appropriate within 12 hours.   4. Community Mental Health Education through fliers, fora and other information, education and communication (IEC) materials within 24 hours.   5. Coordinated assessment of mental health and psychosocial issues using global assessment tools and guidelines (e.g. WHO/UNHCR 2012 MHPSS assessment toolkit, IASC 2013 Assessment guide.)   6. MHPSS interventions for survivors of sexual violence if requested by the survivor and supported with signi\ufb01cant signs and symptoms based on the assessment tool.   7. Protection and promotion of responder\u2019s well-being during preparation, deployment and follow-up phases.   8. Provision for psychotropic medications and sedatives when necessary.   9. Provision of psychological first aid for the general population, and provision of access and referral to a graded and speci\ufb01c MHPSS interventions. Access to such MHPSS supports and interventions should be ensured for vulnerable groups. The affected population should be provided with, regular updates on information including disaster/emergency status, relief efforts, and legal rights.   B. Roles and Responsibilities   1. DEPARTMENT OF HEALTH CENTRAL OFFICE (DOH\u2014CO) AND ITS ATTACHED AGENCIES   a. Health Emergency Management Bureau (HEMB)   1) Oversee the management of the EHSP during emergency and disaster.   2) Develop, review and update policies, plans, guidelines, protocols, and standards on the provision of essential health service packages in emergencies and disasters in coordination with members of the health sector.   3) Provide technical assistance and allocate funds to augment \ufb01nancial and logistical needs of implementing offices/agencies. (Refer to Annex A)   4) Coordinate with the DOH Regional Offices, LGUs and other implementing agencies the integration of EHSP in their operational plans and programs.   5) Monitor the implementation of the EHSP and ensure its compliance to standards.   b. Disease Prevention and Control Bureau (DPCB)   1) Assist HEMB develop, review and update policies, plans, programs, guidelines, protocols, and systems related to the provision of essential health service package.   2) Ensure that the essential health service package are mainstreamed in the program plans and allocate funds hereof.   c. Epidemiology Bureau (EB)   1) Develop policies, plans, programs, guidelines, protocols and tools to support reporting and monitoring of the essential health service package in emergencies and disasters.   2) Conduct studies and disseminate \ufb01ndings of such to build evidence to improve and support uninterrupted delivery of health services. '   d. Health Promotion and Communications Service (HPCS)   1) Lead in the development and implementation of health promotion, advocacy, and risk communication plans, IEC materials and advisories/bulletins for essential health service packages with technical assistance from HEMB and DPCB.   2) Conduct stakeholders\u2019 analysis for promotion. and advocacy   e. Health Facility Development Bureau (HFDB)   1) Lead in the implementation of the policy on Hospitals Safe \ufb01om Disasters. Refer to A0 2013-0014.   2) Support implementation of the rules and regulations governing the licensure of ambulances and ambulance service provides.   3) Ensure implementation of guidelines on safe ambulance services and mobilization of blood and its components.   4) Provide technical assistance to all health facilities in planning and facility enhancement and support the upgrading of national referral hospitals and laboratories.   f. Bureau of Local Health Systems Development (BLHSD)   1) Provide technical assistance in the development of and strengthening mechanisms for delivering essential health service packages at the regional and local levels.   h. Health Facilities Services Regulatory Bureau (HFSRB)   1) Ensure that licensing requirements for health facilities include standards development and quality assurance policies related to disaster risk reduction and management in health.   i. Health Human Resource Development Bureau (HHRDB)   1) Support the development training programs, designs, manuals for various stakeholders and partner on EHSP.   2) Identify and coordinate with institutions that can support capacity building activities that will support EHSP.   j. Bureau of International Health Cooperation (BIHC)   1) Lead in the facilitation and coordination of international humanitarian assistance related to the four (4) Health sub\u2014clusters.   2) Assist in mobilizing fund support for the EHSP among potential international humanitarian partners.   k. Logistic Management Division\u2014 Administrative Service (LMD\u2014AS)   1) Proposition an adequate supply of EHSP goods and commodities.   2) Track the timely distribution of EHSP goods and commodities.   3) Develop partnerships with private sector for the transport and safe warehousing of EHSP supplies.   l. National Nutrition Council (NNC)   1) Develop appropriate policies, plans, programs, guidelines, protocols, and systems on food and nutrition during emergencies and disasters.   2) Provide technical assistance to implementing agencies and LGUs on nutrition management in emergencies and disasters.   3) Ensure that nutrition programs and local nutrition action plans contribute to emergency preparedness, mitigation, response, and recovery activities.   4) Facilitate the coordination of the delivery of nutrition services in areas affected through the national and local nutrition cluster.   5) Coordinate with other Health-sub clusters and with other relevant clusters, 1 e Food and Non\u2014food Item (NFI), and Camp Management for concerns related to nutrition in emergencies response operation.   m. Philippine Health Insurance Corporation   1) Support affected population in emergencies and disasters including, but are not limited to : ambulatory care (out-patient services), clinics, ambulance services and hospital care packages, reimbursements, and services in non-PhilHealth accredited institutions or health service providers.   2. DOH REGIONAL OFFICES (ROS) and DOH ARMM   1) Oversee the implementation of these policies within the region.   2) Formulate and develop plans, procedures and protocols to implement and adopt this policy and guidelines and allocate funds.   3) Implement a mechanism of coordination and collaboration with hospitals, LGUs, and other stakeholders to ensure timely and effective delivery of the EHSP.   4) Provide technical assistance and augment logistics to LGUs and other implementing agencies.   5) Monitor EHSP implementation of LGUs and provide feedback and policy recommendations to the Secretary of Health thru the Area Cluster Head.   6) Conduct rapid and comprehensive needs assessment pre and post-disaster in the provision of essential health service packages.   3. DOH HOSPITALS   1) Formulate plans, procedures and protocols to implement this policy and guidelines and integration of the provisions.   2) Ensure availability of funds to support implementation of the EHSP.   3) Implement a mechanism of coordination and collaboration with other hospitals (both government and private), partners, and other stakeholders, to ensure timely and effective service delivery.   4) Deploy medical response teams as necessary.   5) Act as receiving facility and referral center.   6) Submit reports; provide feedback and policy recommendations to the R0.   4. LOCAL GOVERNMENT UNITS (LGU)   1) Formulate plans, procedures and protocols to implement and adopt these guidelines and provide funds thereof. .   2) Ensure that the EHSP are pro-positioned before external aid comes in during emergencies and disasters.   3) Ensure EHSP implementation and service delivery such as information management, resource management, and monitoring and evaluation.   4) Establish coordination and collaboration mechanisms among different partners and stakeholders.   5) Maintain a service delivery network with hospitals for referral of treatment and care of special cases through mutually agreed arrangements such as Memorandum of Understanding/Agreement.   6) Sustain a pro-hospital care system in emergencies and disasters.   7) Submit reports; provide feedback, suggestions, and policy recommendations to the PHO/RO.   5. OTHER GOVERNMENT AGENCIES/NON\u2014GOVERNMENT ORGANIZATIONS/ AGENCIES, DEVELOPMENT PARTNERS, PRIVATE SECTOR, AND CIVIL SOCIETY ORGANIZATIONS (C808)   1) Adhere to and observe all requirements, policies and standards on EHSP during emergencies and disasters.   2) Coordinate and participate in inter\u2014agency activities with the Department of Health on Health Emergency Management.   3) Support the DOH/Regional Of\ufb01ces/LGUs/Hospitals in needs assessments, planning and mobilize own resources and help build capacities.   4) Provide feedback and report to Health sub\u2014cluster where they belong.   VI. REPEALING CLAUSE   Upon review of related orders and issuances, there is none found that is inconsistent with the provisions cited in this Administrative Order. Hence, statements in this issuance shall hold true and \ufb01rm.   VII. EFFECTIVITY   This Order shall take effect immediately.  ", " WHEREAS, Section 15 Article II of the 1987 Constitution of the Philippines states that \"The State shall protect and promote the right to health of the people and instill health consciousness among them\";  WHEREAS, Section 2, Article II of the 1987 Constitution of the Philippines states in part that \"The Philippines x x x adopts the generally accepted principles of international law as part of the law of the land x x x\".  WHEREAS, the Philippines has adopted the WHO and UNICEF \"2002 Global Strategy on Infant and Young Child Feeding\", and the various World Health Assembly Resolutions to implement the same, and therefore is legally and morally obligated to follow their provisions.  WHEREAS, towards this end, the State shall support the \"2002 Global Strategy on Infant and Young Child Feeding\" and exerts efforts to address the provision of safe and adequate nutrition for infants and young children, by the protection, promotion and support of breastfeeding;  WHEREAS, the WHO/UNICEF Global Strategy on Infant and Young Child Feeding recommends not only exclusive breast milk for newborns, but also indigenous, fresh and natural foods in combination with continued breastfeeding for infants and young children. It is guided by the World Health Assembly Resolutions, Codex Alimentarius, and consistent with national laws or national policies;  WHEREAS, adequate and proper nutrition is an important and universally recognized component of each child's right to the enjoyment of the highest attainable standard of health as provided for in the United nations Convention on the Rights of the Child, which the Philippine Senate, in accordance with its constitutional prerogative under Section 21, Article VII, of the 1987 Constitution, ratified on July 26, 1990, and which mandates the Philippines to implement various international agreements relevant to Infant and Young Child Feeding;  WHEREAS, the use of breastmilk, which is widely recognized as the best source of nutrition for babies, promotes the development of emotional bonding between the mother and child, bestows upon the newborn infant protection against infection, provides for the mother natural contraception after delivery, and protects the mothers from closely spaced pregnancy.  WHEREAS, with the resultant healthier population and the reduction in infant and under five mortality rates, the country will be closer in reaching its targets for the Millennium Development Goals;  WHEREAS, breastfeeding is the most far-reaching and the least costly strategy for the alleviation of poverty.  NOW THEREFORE, Pursuant to the authority under Section 12(b)(1) of Executive Order No. 51 dated 20 October 1986, otherwise known as \"National Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements and Related Products,\" the Department of Health, through the Honorable Secretary of Health, hereby promulgate the ensuing revised rules and implementing regulations:  RULE I  ENABLING PROVISIONS  SECTION 1. Title. a The following shall be referred to as the \"Revised Implementing Rules and Regulations of Executive Order No. 51, otherwise known as the 'Milk Code', Relevant international Agreements, Penalizing Violations Thereof, And For Other Purposes\".  SECTION 2. Purpose. - These Revised Rules and Regulations are hereby promulgated to ensure the provision of safe and adequate nutrition for infants and young children by the promotion, protection and support of breastfeeding and by ensuring the proper use of breastmilk substitutes, breastmilk supplements and related products when these are medically indicated and only when necessary, on the basis of adequate information and through appropriate marketing and distribution.  SECTION 3. Scope and Coverage. - These Revised Rules and Regulations shall apply to the marketing, and practices related thereto, of the following products: breastmilk substitutes, including infant formula; other milk products, foods and beverages, including bottle-fed complementary foods, when marketed or otherwise represented to be suitable, with or without modification, for use as a partial or total replacement of breastmilk; feeding bottles and teats. It also applies to their quality and availability, and to information concerning their use.  SECTION 4. Declaration of Principles - The following are the underlying principles from which the revised rules and regulations are premised upon:  a. Exclusive breastfeeding is for infants from 0 to six (6) months. b. There is no substitute nor replacement for breastmilk. c. Appropriate and safe complementary feeding should start from six months onwards in addition to breastfeeding. d. Breastfeeding is still appropriate for young children up to two (24 months) years of age or beyond. e.  Infant or milk formula may be hazardous to a child's health and damage child's formative development. f. Advertising, promotions, or sponsorships of infant formula, breastmilk substitutes and other related products are prohibited. g. Other related products such as, but not exclusive of, teats, feeding bottles, and artificial feeding paraphernalia are prohibited in health facilities. h. Government and all concerned stakeholders must continuously accomplish an information, dissemination campaign/strategy, and do further research on the advantages of breastmilk and the hazards of breastmilk substitutes or replacements. i. Milk companies, and their representatives, should not form part of any policymaking body or entity in relation to the advancement of breastfeeding.  RULE II  DEFINITION OF TERMS  SECTION 5. Definition of Terms. - For purposes of these Revised Rules and Regulations, the term:  (a) \"Advertising\" refers to any representation by any means whatsoever for the purpose of promoting the sale or distribution of breastmilk substitutes/supplements and other related products under the scope of this Code;  (b) \"BFAD\" refers to the Bureau of Food and Drugs of the Department of Health;  *Section 4 (f) was declared null and void as per Supreme CourtDecision under G.R. No. 173034 dated October 9, 2007  (c) \"Breastmilk substitute\" means any food being marketed or otherwise represented as partial or total replacement of breastmilk whether or not suitable for that purpose;  (d) \"Committee\" shall refer to the Inter-Agency Committee created under E.O. No. 51, s. 1986 composed of the Secretary of Health, as Chairman, and the Secretary of Trade and industry, the Secretary of Justice, and the Secretary of Social Welfare and Development, as members;  (e) \"Complementary\" means any food, except milk substitutes, whether manufactured or locally prepared, suitable as a complement to breastmilk to satisfy the nutritional requirements of the infant;  (f) \"Container\" means any form of packaging of products for sale as a normal retail unit, including wrappers;  (g) \"Distributor\" means a person, corporation or any other entity in the public or private sector engaged in the business (whether directly or indirectly) of marketing at the wholesale or retail level a product within the scope of this Code;  (h) \"DoH\" refers to the Department of Health;  (i) \"Exclusive breastfeeding\" means giving only breastmilk without water, liquids, teas, herbal preparations, or other food and fluid intake for the first six months of life;  (j) \"Gifts of any sort\" means any form of financial, personal or commercial reward, inducement, incentives and other favors provided directly or indirectly by manufacturers, distributors, and their representatives, of products within the scope of the Code;  (k) \"Health care system\" means governmental, non-governmental or private institutions or organizations engaged, directly or indirectly, in health care for mothers, infants and pregnant women; and nurseries or child care institutions;  (l) \"Health Facilities\" means health care systems including but not limited to health centers, clinics, birthing and parenting classes venues, hospitals, maternal centers/clinics, birthing homes, barangay health stations, health and nutrition posts and lying in clinics;  (m) \"Health Worker\" means a person working in a component of such health care system, whether professional or non-professional, including volunteer workers. It also includes health workers in private practice. Traditional and other birth attendants, their assistants and other community volunteers involved in health and nutrition promotion and education shall likewise be covered;  (n) \"Infant\" shall refer to a person within the age bracket of 0 - 12 months;  (o) \"Infant Formula\" means one of the breastmilk substitutes formulated industrially in accordance with applicable Codex Alimentarius standards;  (p) \"Label\" means any tag, brand, mark, pictorial or other descriptive matter, written, printed, stenciled, marked, embossed or impressed on, or attached to, a container of any product within the scope of this Code;  (q) \"latching on\" means that with the assistance of the health worker and immediately after its delivery, the infant is placed to the breast of the mother in order to initiate sucking;  (r) \"Manufacturer\" means a corporation or other entity in the public or private sector engaged in the business or function (whether directly or through an agent or an entity controlled by or under contract with it) of manufacturing a product within the scope of this Code;  (s) \"Marketing firm\" refers to an entity that does marketing or provides marketing services;  (t) \"Marketing Materials\" and/or \"Services\" means the promotion, distribution, selling, advertising, public relations, information services, internet promotion and communication and information dissemination, in whatever form, including but not necessarily limited to, mail, email, text messages, telephone calls, website advertising, television, motion pictures, stage plays and radio programs, whether live or taped;  (u) \"Marketing personnel\" means any person whose functions involve the marketing of a product or products within the scope of this Code;  (v) \"Medically Indicated\" means special milk formula indicated for infants with inborn errors of metabolism, i.e. galactosemia, phenylketonuria* and maple syrup urine disease;  (w) \"Milk company\" shall refer to the owner, manufacturer, distributor, of infant formula, follow-up milk, milk formula, milk supplement, breastmilk substitute or replacement, or by any other description of such nature, including their representatives who promote or otherwise advance their commercial interests in marketing those products;  (x) \"Natural and indigenous food\" means locally grown or produced foods which are neither artificial nor processed;  (y) \"Other milk products, foods and beverages\" refers to any provision or drink marketed as a partial or total replacement of breastmilk;  (z) \"Other related products\" refers to all materials used to administer breastmilk substitutes; such as, but not limited to, feeding bottles, teats and other artificial feeding paraphernalia;  (aa) \"Products Within the scope of this Code\" shall pertain to breastmilk substitutes and infant formula, including bottle-fed complementary foods, as well as teats and other commodities which intend to replace or substitute, in whole or in part, breastmilk and breastfeeding;  (bb) \"Promotions\" means employing any method, scheme, or design, of directly or indirectly, encouraging or enticing people, or group of persons, in whatever form, whether by chance or skill, to purchase or acquire products within the scope of the Code;  (cc) \"Sample\" refers to single or small quantities of a product provided for free;  (dd) \"Sponsorships\" shall refer to milk companies, and their agents/representatives, hosting, initiating, or otherwise providing games, sport or cultural events, charities, dances/balls, conventions, meetings, youth and women seminars or classes, and other like activities, for the purpose of promoting, directly or indirectly, their products covered within the scope of this Code;  (ee) \"Supplies\" refers to quantities of a product provided for use over an extended period, free or at a low price, for social purposes, including those provided to families in need.  (ff) \"Young Child\" means a person from the age of more than twelve (12) months up to the age of three (3) years (36 months).  RULE III  INFORMATION AND EDUCATION  SECTION 6. Responsibility. - The Department of Health shall take measures to promote, protect, support and monitor appropriate infant and young child feeding (IYCF) practices. Appropriate IYCF practices include the following:  \u2022 Proper Latching-on immediately after birth and initiation of breastfeeding within the first thirty (30) minutes thereafter \u2022 exclusive breastfeeding from 0 - 6 months \u2022 appropriate complementary feeding from 6 months onwards \u2022 continuous breastfeeding up to two (2) years of age or beyond  The goals will be achieved by providing women access to the support that they require - in the family, the community, and the workplace. DOH shall provide objective, updated and consistent information and training of health workers and the general public on infant and young child nutrition in partnership with the local governments and civil societies without any conflict of interest.  SECTION 7. - Hazards and Complete Information on Breastmilk Substitutes and Replacements. - It is the responsibility of the State to inform the general public on the Wizards of the production, preparation and use of breastmilk substitutes and other products covered by the Code. When medically indicated and only when necessary, the use of breastmilk substitutes is proper if based on complete and updated information.  SECTION 8. Information and Education. - The government shall ensure that objective and consistent information is provided on infant and young child feeding, for use by families and those involved in the field of infant nutrition. This responsibility shall cover the planning, provision, design and dissemination of information, and the control thereof.  a) In this regard, The Department of Health in collaboration with the national agencies, local government units, including non - governmental organizations and members of civil society, shall :  a.1. Plan, provide, design, disseminate and regulate information related to infant and young child nutrition and the implementation of the Milk Code;  a.2. Formulate and implement a communication plan, which among others will indicate key messages on infant and young child nutrition;  a.3. Create a Technical Working Group to serve as a clearing house for all information and training materials on infant and young child nutrition and the Milk Code; and  a.4. Assist Local Government Units (LGU's) and other partners in developing strategies to promote breastfeeding and infant and young child nutrition.  b) Informational and educational materials intended to reach pregnant women and mothers of infants, including women of reproductive age, which materials shall include clear information on all of the ensuing; (1) the benefits and superiority of breastfeeding; (2) maternal nutrition, and the preparation for and maintenance of breastfeeding; (3) the negative effect on breastfeeding of introducing partial bottle-feeding; (4) the difficulty of reversing the decision not to breastfeed; and (5) where needed, the proper use of infant formula, whether manufactured industrially or home-prepared. When such materials contain information about the use of infant formula, they shall include the social and financial implications of its use; the health hazards of inappropriate foods or feeding methods; and in particular, the health hazards of unnecessary or improper use of infant formula and other related products including information that powdered infant formula may contain pathogenic microorganisms and must be prepared and used appropriately.  c) The promotion, protection and support of breastfeeding and the proper implementation of the Milk Code shall be an integral part of all information, education, and communication plans and training activities of the Department of Health (DOH), as well as that of the Department of Education (DEPED), Department of Social Welfare and Development (DSWD), Local Government Units (LGU's), and other such concerned agencies/individuals.  RULE IV  RESEARCH  SECTION 9. Research, Ethics Committee, Purpose. - The DOH shall ensure that research conducted for public policy purposes, relating to infant and young child feeding should, at all times, be free from any commercial influence/bias; accordingly, the health worker or researcher involved in such must disclose any actual or potential conflict of interest with the company/person funding the research. In any event, such research and its findings shall be subjected to independent peer review. Towards accomplishing these ends;  a. Assistance for research and clinical trials given by manufacturers and distributors are allowed only upon approval by an ethics committee led by DOH. The same committee shall monitor said researches.  b. The researches shall be conducted in accordance with an approved protocol. Any changes in the protocol after it has been approved will be subject to a new review and approval by the Ethics Committee.  c. Assistance for research maybe allowed subject to the following conditions:  c.1. Researches involving well or ill infants and children as subjects shall be limited to physiological factors and therapeutic studies;  c.2. These studies should in no case be harmful to the subject; and  c.3. Should be limited to those with potential benefits for the particular subject.  d. Recipients of research awards shall not allow themselves, their organizations or their subjects, to be used directly or indirectly for any promotional activity related to products within the scope of the Code. These may be by way of display of posters and streamers patronizing the Company, their products, and/or as lecturers/speakers or testimonials in the promotion of the products that undermine breastfeeding.  e. Assistance for support of laboratory costs, reagents and other materials shall be allowed only upon approval and review by the Ethics Committee regarding their use based on a submitted protocol.  SECTION 10. Public Disclosure. - For transparency purposes, a disclosure and/or disclaimer of the sponsoring company should be done by the company itself, health worker, researcher involved through verbal declaration during the public presentation of the research and in print upon publication.  RULE V  ADVERTISING, PROMOTION, MARKETING And SPONSORSHIPS  SECTION 11. Prohibition* No advertising, promotions, sponsorships, or marketing materials and activities for breastmilk substitutes intended for infants and young children up to twenty-four (24) months, shall be allowed, because they tend to convey or give subliminal messages or impressions that undermine breastmilk and breastfeeding or otherwise exaggerate breastmilk substitutes and/or replacements, as well as related products covered within the scope of this Code.  Section 12. Authority of the Inter-Agency Committee (IAC). - The Inter Agency Committee (IAC) shall review all advertising, promotion or other marketing materials, whether written, audio, visual, cinema, theater, audio-visual and electronics, including but not limited to mail, email, text messages, telephone calls and website advertising, and for communication and information dissemination in any form, for products within the scope of this Code.  The Committee shall develop/update substantive and procedural guidelines for reviewing advertising, promotional and marketing materials, including its screening when deemed appropriate. All such materials must have been approved and consented to in writing by the Committee before the Company's first public or commercial exhibition.  All approved advertisement and/or promotional materials for milk supplements, complementary food, feeding bottles & teats and related products must bear the messages both in English and in Filipino.  The DOH based on the latest scientific information and products may modify the messages, provided that wide dissemination of the message to all concerned is ensured.  SECTION 13. \"Total Effect\". - Promotion of products within the scope of this Code must be objective and should not equate or make the product appear to be as good or equal to breastmilk or breastfeeding in the advertising concept. It must not in any case undermine breastmilk or breastfeeding. The \"total effect\" should not directly or indirectly  *Section 11 was declared null and void as per Supreme Court Decision under G.R. No. 173034 dated October 9, 2007  suggest that buying their product would produce better individuals, or resulting in greater love, intelligence, ability, harmony or in any manner bring better health to the baby or other such exaggerated and unsubstantiated claim.  SECTION 14. Prior Written Consent and Approval of Committee. - No advertising, promotion or other marketing materials whether written, audio, visual, audio-visual, and electronic for products within the scope of this Code, which are marketed as partial or total replacement of breastmilk, including bottle-fed complementary foods shall be printed, published, distributed, exhibited, and broadcasted or in any manner released to the public without the prior written consent and approval of the Committee.  No blanket or general approval shall be allowed. Such written approval must be specific in product and time bound.  SECTION 15. Content of Materials. - The following shall not be included in advertising, promotional and marketing materials:  a. Texts, pictures, illustrations or information which discourage or tend to undermine the benefits or superiority of breastfeeding or which idealize the use of breastmilk substitutes and milk supplements. In this connection, no pictures of babies and children together with their mothers, fathers, siblings, grandparents, other relatives or caregivers (or yayas) shall be used in any advertisements for infant formula and breastmilk supplements;  b. The term \"humanized\", \"maternalized\", \"close to mother's milk\" or similar words in describing breastmilk substitutes or milk supplements;  c. Pictures or texts that idealize the use of infant and milk formula.  RULE VI  PROHIBITED ACTS  SECTION 16. All health and nutrition claims for products within the scope of the Code are absolutely prohibited. For this purpose, any phrase or words that connotes to increase emotional, intellectual abilities of the infant and young child and other like phrases shall not be allowed.  SECTION 17. False or misleading information or claims of products within the scope of the Code are prohibited.  SECTION 18. No financial or material inducements or gifts of any sort to promote products within the scope of this Code shall be offered or given by milk companies nor accepted by health workers and/or members of their families.  SECTION 19. Manufacturers, distributors and marketing firms or their representatives of products within the scope of this Code are prohibited from donating or giving directly or indirectly, samples and supplies to any member of the general public, to hospitals, and other health facilities, including their personnel and members of their families.  SECTION 20. Manufacturers, distributors and marketing firms or their representatives of products within the scope of this Code are prohibited from using the health workers and the health care system in the dissemination, distribution and promotion of products within the scope of the Code.  SECTION 21. Gifts of any sort from milk companies/manufacturers, distributors, and representatives of products within the scope of this Code, with or without company name or logo or product or brand name shall not be given to any member of the general public, to hospitals and other health facilities, including their personnel and members of their families.  SECTION 22. No manufacturer, distributor or representatives of products covered by the Code shall be allowed to conduct or be involved in any activity on breastfeeding promotion, education and production of Information, Education, and Communication (IEC) materials on breastfeeding, holding of or participating as speakers in classes or seminars for women and children activities and to avoid the use of these venues to market their brands or company names.  SECTION 23. There shall be no point of sale advertising, giving of samples or any promotion devices to induce sales directly to the consumers at the retail level, such as special displays, discount coupons, premiums, rebates, special sales, bonus and tie-in sales, loss-leaders, prices or gifts for the products within the scope of this Code.  SECTION 24. Neither the container nor the label of milk products within the scope of this Code shall have pictures of babies and children together with their mothers, fathers, siblings, grandparents, other relatives or caregivers (or drains) or such other pictures and graphics of similar import.  RULE VII  CONTAINERS/ LABELS  SECTION 25. Appropriate Use. - Containers and labels shall be designed to provide the necessary information about the appropriate use of the products within the scope the Code and in such a way as not to undermine, or equate it to, breastfeeding.  SECTION 26. Content. - Each container/label shall contain such message, in both Filipino and English languages, and which message cannot be readily separated therefrom, relative the following points:  a) The words or phrase \"Important Notice\" or \"Government Warning \" or their equivalent;  b) A statement of the superiority of breastfeeding;  c) A statement that there is no substitute for breastmilk;  d) A statement that the product shall be used only on the advice of a health worker as to the need for its use and the proper methods of use;  e) Instructions for appropriate preparation, and a warning against the health hazards of inappropriate preparation, and  f) The health hazards of (the use) unnecessary or improper use of infant formula and other related products including information that powdered infant formula may contain pathogenic microorganisms and must be prepared and used appropriately.  SECTION 27. Infant Feeding Warning. - Food products within the scope of this Code marketed for infant feeding, which do not meet all the requirements of an infant formula but which can be modified to do so, shall carry on the label, a warning that the unmodified product should not be the sole source of nourishment of an infant.  SECTION 28. BFAD's Authority. - The labels of food products within the scope of this Code shall, in addition to the requirements in the preceding paragraphs, conform to the rules and regulations of the BFAD.  RULE VIII  QUALITY AND STANDARD  SECTION 29. Quality. - The quality of products is an essential element for the protection of the health of infants and young children and therefore shall be of highly recognized standard.  SECTION 30. Standards. - Food products within the scope of this Code shall, when sold or othenNise distributed, meet applicable standards recommended by the Codex Alimentarius Commission and also the Codex Code of Hygienic Practice for Foods for Infants and Children.  SECTION 31. Against Adulteration and the Like. - To prevent quality deterioration, adulteration or contamination of food products within the scope of this Code, distribution outlets, shall not be allowed to open cans and boxes for the purpose of retailing them by the cup, bag or in any other form.  RULE IX  HEALTH WORKERS And The HEALTH CARE SYSTEM  SECTION 32. Primary Responsibility of Health Workers. - It is the primary responsibility of the health workers to promote, protect and support breastfeeding and appropriate infant and young child feeding. Part of this responsibility is to continuously update their knowledge and skills on breastfeeding. No assistance, support, logistics or training from milk companies shall be permitted.  SECTION 33. Role of Academe and Others. - The academe and allied health institutions shall ensure basic education and training on Infant and Young Child Feeding (ICYF) and lactation management.  SECTION 34. Classes, Seminars For Women. - In order to protect women of reproductive age, including pregnant mothers, milk companies and their representatives, shall not be allowed to hold any activity in the guise of classes, seminars, recreation activities, fora, and the like, regardless whether or not such activities are intended to promote the products covered by the Code.  SECTION 35. No Promotions. - The health workers and the health care system shall not be used for dissemination, distribution and promotion of products within the scope of this Code. No health care facility should be used for promotions of products within the scope of this Code nor as venues that undermine breastfeeding.  RULE X  MONITORING And IMPLEMENTATION  SECTION 36. Monitoring, Implementation, Functions. - The Department of Health shall be primarily responsible for the monitoring, implementation and enforcement of the Milk Code and these Implementing Rules and Regulations.  In coordination with other agencies involved in the implementation of the Code, the Department shall adopt such appropriate monitoring guidelines for the national, regional and provincial levels. It shall likewise provide regular training on monitoring compliance and enforcement on violations of the Milk Code for all persons engaged in or volunteering to help in the monitor and implementation of the Code. The Department may request for the assistance of non - governmental organizations, civil society, and concerned international agencies in order to better monitor the implementation of these rules.  Accordingly, a monitoring team, composed of the ensuing, is hereby created and established :  National level:  \u2022 National Center for Disease Prevention and Control (NCDPC) \u2022 National Center for Health Facilities and Development (NCHFD) \u2022 Government/Non-government Organizations/Civil Societies without any conflict of interest with the breastfeeding culture, and/or direct or indirect connection, financial or otherwise, or with commercial interest within the scope of the Code \u2022 Ad Hoc International Agencies such as the United Nations Children's Emergency Fund (UNICEF) and/or the World Health Organization (WHO)  Regional/Provincial/City/Municipal/Barangay levels (in collaboration with their respective Local Government Units):  \u2022 Center for Health Development Offices \u2022 Provincial Health Offices \u2022 City Health Offices \u2022 Municipal Health Offices/Rural Health Units \u2022 Barangay Health Office \u2022 GOs/NGOS/Civil Societies  The Monitoring Team shall have the following functions:  \u2022 Monitors compliance as well as problems encountered in the implementation of the Milk Code. \u2022 Reviews/acts on reports of violations of the provisions of the Code. \u2022 Verifies reports of violations of the Milk Code. \u2022 Monitors labels of products within the scope of the Code and marketing practices in various distribution centers. \u2022 Recommends sanctions or punitive actions for violations of the Milk Code to the Bureau of Food and Drugs. \u2022 Submits regular reports on the status of the Milk Code implementation to the Bureau of Food and Drugs.  SECTION 37. Report to the Secretary of Health. - Monitoring Teams comprised of duly accredited teams from non-governmental organizations, and/or civil society may report their findings to the Office of the Secretary of Health who shall appropriately respond thereto with sufficient dispatch.  SECTION 38. Role of DoH/BFAD in IAC. a The Department of Health shall convene and chair the Inter - Agency Committee (IAC) with BFAD acting as its Member/Secretariat.  RULE XI  FILING Of ADMINISTRATIVE And CRIMINAL COMPLAINT  SECTION 39. Role of Bureau of Food and Drugs (BFAD). - The Bureau of Food and Drugs (BFAD) shall investigate and verify reports of violations; when appropriate, apply administrative sanctions against the violators; and/or file criminal complaints against persons and entities found to have violated, singly or repeatedly, the provisions of the Code or these implementing rules and regulations.  SECTION 40. National Level Violations.- Reports of violations of the Milk Code committed at the national level shall be filed and investigated at the Bureau of Food and Drugs.  SECTION 41. Regional/Provincial Level Violations. - Problems/violations arising at the regional/provincial levels shall be filed, investigated and resolved at these levels. The regional/provincial level shall notify BFAD of any action taken relative to the aforesaid problems/violations. Violations that require prosecution or imposition of administrative sanction as stated in these rules shall be elevated to the BFAD for appropriate action.  SECTION 42. Meaning of National/Regional/Provincial Level Violations. When the violation consists of commercial exhibition or advertisement for those products within the scope of this Code and found In areas beyond regions, then the violation is deemed to be national. When found or existing in a specific region only, then regional and so on down to the other geographical areas.  SECTION 43. Issuance of Cease and Desist Orders (CDO's). - Immediately upon receipt of the report of violation, the investigating officer shall conduct an ex parte examination of the evidence presented. If a prima facie case is established, a Cease and Desist Order (CDO) shall be issued by the BFAD Director or the DoH Regional Director, as the case may be.  Non-compliance with the CD0 shall be ground for the imposition of administrative sanctions as stated in Section 47 (f) hereof. The issuance of the CD0 shall be without prejudice to the imposition of the appropriate administrative sanction, If so warranted, after due notice and hearing.  SECTION 44. Authority of the IAC To Issue CDO. The IAC Secretariat shall have the authority to determine if any advertising, marketing, or promotional material violates these Rules and Regulations. In such case, the IAC Secretariat shall issue a CDO, signed by the IAC Chairperson stopping the further release, printing, broadcast, or dissemination of the violative advertising, marketing, or promotional material.  In instances where the CD0 is not complied with, the rules stated in second paragraph of the preceding section shall apply.  SECTION 45. Role of the Department of Justice. - The Department of Justice (DoJ) shall cause the criminal prosecution of the violators of this Code.  RULE XII  ADMINISTRATIVE SANCTIONS  SECTION 46.* Administrative Sanctions. - The following administrative sanctions shall be imposed upon any person, juridical or natural, found to have violated the provisions of the Code and its Implementing Rules and Regulations:  a) violation - Warning;  b) 2nd violation - Administrative fine of a minimum of Ten Thousand (P10,000.00) to Fifty Thousand (P50,000.00) Pesos depending on the gravity and extent of the violation, including the recall of the offending product;  c) 3rd violation - Administrative Fine of a minimum of Sixty Thousand (P60,000.00) to One Hundred Fifty Thousand (P150,000.00) Pesos. depending on the gravity and extent of the violation, and in addition thereto, the recall of the offending product, and suspension of the Certificate of Product Registration (CPR);  d) 4th violation e Administrative Fine of a minimum of Two Hundred Thousand (P200,000.00) to Five Hundred (P500,000.00) Thousand Pesos, depending on the gravity and extent of the violation; and in addition thereto, the recall of the product, revocation of the CPR, suspension of the License to Operate (LTO) for one year;  e) 5th and succeeding repeated violations - Administrative fine of One Million (P 1,000,000.00) Pesos, the recall of the offending product, cancellation of the CPR, revocation of the License to Operate (LTO) of the company concerned, including the blacklisting of the company to be furnished the Department of Budget and Management (DBM) and the Department of Trade and Industry (DTI);  *Section #6 an declared null and void as per Supreme Court Decision under G.R. No. 173034 dated October 9, 2007  f) An additional penalty of Two Thousand Five Hundred (P2,500.00) Pesos per day shall be made for every day the violation continues after having received the order from the IAC or other such appropriate body, notifying and penalizing the company for the infraction.  For purposes of determining whether or not there is \"repeated\" violation, each product violation belonging or owned by a company, including those of their subsidiaries, are deemed to be violations of the concerned milk company and shall not be based on the specific violating product alone.  SECTION 47. Fees, Charges and Fines. - All fees collected, charges imposed and administrative fines that have accrued as a consequence of the implementation of these Rules shall be for the account and income of the Bureau of Food and Drugs.  SECTION 48. Against Public Employees.- In accordance with the Administrative Code and pertinent Civil Service rules and regulations, erring government employees found to be liable, and depending on the gravity of said violation, shall be imposed the appropriate penalty by the disciplining authority.  SECTION 49. Liability of Manufacturers/Distributors. - Manufacturers and Distributors of the products covered by the Code shall be directly liable for any violation of the provisions of the Code and its IRR. Should the offense be committed by a juridical person, the Chairman of the Board of Directors, the president, general manager, or the partners and/or the persons directly responsible therefore, shall be made accountable.  Agents/Representatives of the Manufacturers or Distributors of the products within the scope of the Code, who commit any violation of the provisions of the Code and its implementing rules and regulations shall be jointly and solidarily liable with the said manufacturers and distributors.  RULE XIII  CRIMINAL PENALTIES  SECTION 50. Penalties. - Any person who violates the provisions of this Code or these rules and regulations shall, upon conviction, be punished by a penalty of two (2) months to one (1) year imprisonment or a fine of not less than One Thousand Pesos (P1,000.00) nor more than Thirty Thousand Pesos (P30,000.00) or both. Should the offense be committed by a juridical person, the Chairman of the Board of Directors, the president, general manager, or the partners and/or the persons directly responsible therefore, shall be penalized.  RULE XIV  MISCELLANEOUS PROVISIONS  Section 51. Donations Within the Scope of This Code. - Donations of products, materials, defined and covered under the Milk Code and these implementing rules and regulations, shall be strictly prohibited.  Section 52. Other Donations By Milk Companies Not Covered by this Code. Donations of products, equipments, and the like, not otherwise falling within the scope of this Code or these Rules, given by milk companies and their agents, representatives, whether in kind or in cash, may only be coursed through the Inter Agency Committee (IAC), which shall determine whether such donation be accepted or otherwise.  SECTION 53. Construction. - All doubts in the implementation and interpretation of the provisions of these implementing rules and regulations shall be resolved in favor of and for the promotion of breastfeeding and against breastmilk substitutes and replacements.  SECTION 54. Supplemental Administrative Issuances. - The Secretary of Health, or his duly authorized representative, may issue such additional implementing rules and regulations as may be necessary to further clarify any part of this IRR.  SECTION 55. Continuous Review on Prescription Policy. - The Department of Health shall evaluate every year, or as necessary, its policy of whether or not to subject the sale of infant formula or breastmilk substitutes, to prescription.  SECTION 56. Extending Prohibition For Brandnames and Company Logo Identification. a The Department shall periodically review whether or not to allow or prohibit the use of brandnames or company logos of products within the scope of this Code which are similar to the brandnames or logos utilized for products not covered by this Code, including the physical appearance of the container, taking into consideration the possibility of product confusion, the balance between a free market economy as against the decline and fall of breastfeeding rates among mothers and women of reproductive age, and public welfare and benefit being its ultimate yardstick. Accordingly, any modification of existing policy should first undergo public consultations with all concerned stakeholders before its actual implementation.  RULE XV  FINAL PROVISIONS  SECTION 57. Repealing Clause. - All orders, issuances, and rules and regulations or parts thereof inconsistent with these revised rules and implementing regulations are hereby repealed and modified accordingly.  SECTION 58. Separability Clause. - If for any reason, any part or provision of these Revised Rules and Implementing Regulations, be declared invalid or unconstitutional, such invalidity or unconstitutionality shall not affect the other provisions which shall remain in full force and effect.  SECTION 59. Effectivity. a These Revised Rules and Regulations shall take effect fifteen (15) days after its publication in a newspaper of general circulation with the requisite copy submitted to the University of the Philippines Law Center.  ---oOo---  Approved by the National Executive Committee of the Department of Health in its Regular Meeting of 15 May 2006, at the Office of the Secretary, San Lazaro Compound, Rizal Avenue, Sta. Cruz, City of Manila ", "  I. Background/Rationale  Recognizing the need to match population growth with economic growth to move the country towards sustainable development, the government expressed the urgency of adopting population management policies that will take into consideration reproductive health approaches that respect Filipino culture and values and promotes equality between men and women.  In 1998, the Department of Health established the Reproductive Health (RH) Program which aims to provide universal access to quality RH services, including Family Planning (FP) as one of the critical elements. The goal of the Reproductive Health/Family Planning Program is to provide information and services to all men and women of reproductive age whenever and wherever these are needed. Quality FP services which includes provision of safe and effective family planning methods will be made accessible, available and affordable in all health care facilities nationwide.  One strategy employed by the DOH is to broaden the array of effective modern FP methods available for clients, giving them wider options for selecting a method consistent with their beliefs and appropriate to their health status, helping couples achieve their desired family size.  As demonstrated by previous surveys, Expanding Options, Improving Access (1997), IRH Georgetown University, 15% of couples who use any family planning method are actually using periodic abstinence to avoid pregnancy. Most are abstaining from intercourse based on an incorrect understanding of when the woman is likely to get pregnant, as they have not received any formal instructions on how to use natural family planning methods (NFP).  In the Philippines, there remains a signi\ufb01cant unmet need for family planning, which partially can be met by expanding the availability and accessibility of NFP services. While utilization of NFP is low comprising 0.2 % of total FP users (NDHS, 1998\u2014 Phils.), the NFP experience in the Philippines has much to offer in the area of expanding choice for family planning. Its full potential therefore could be tapped to help those who are still looking for a method to suit them best.  Towards this end, the DOH in partnership with the Institute for Reproductive Health (IRH) tested a new natural family planning method known as Standard Days Method (SDM) or \u201cNecklace Method\". This method is now of\ufb01cially adopted for use in the country and will be mainstreamed in the Philippines Family Planning Program.  II. The Standard Days Method or \u201cNecklace Method\"  SDM popularly referred to as \"Necklace Method\" is a simple method which is primarily based on abstinence from unprotected intercourse on days 8-19 for women whose cycles are between 26-32 days to avoid pregnancy.  The popular name is derived from the mnemonic device, a necklace (or collar in Spanish) with 32 plastic beads. The necklace represents a woman\u2019s menstrual cycle, with the colored beads representing different phases of the cycle. The single red bead represents the \ufb01rst day of this cycle followed by 6 brown beads, which accounts for the \ufb01rst 7 safe days or infertile days. 12 white beads follows the strand which represents fertile days where couples are advised to refrain from unprotected sexual intercourse (days 8\u201419). The last 13 brown beads represents the remaining 13 safe days (days 20-32). Each day, the woman moves a tight \ufb01tting rubber ring along the necklace. Based on the color of the bead where the ring is located, the couples are given the cue for action whether to have or refrain from having sexual intercourse.  For clients who used the method correctly with abstinence, it is 95% effective. For those who used it correctly but with back\u2014up methods (e.g. condoms) on fertile days, it is 94% effective. For typical use (sometimes correctly used and sometimes incorrect on fertile days), it is 88% effective. The ef\ufb01cacy study for SDM conducted in the Philippines (1999 to 2001) showed that it is highly acceptable to women, their partners and health providers. The method is natural, affordable and easy to learn and use as it requires no calculations, observations or charting.  III. Implementing Guidelines A. Scope and Coverage  The Standard Days Method shall be adopted as a new addition to NFP methods made available in health facilities nationwide. The method therefore should not replace other existing modern FP methods (arti\ufb01cial or natural) currently available in the country.  SDM shall be attractively positioned as a better method to use for couples who are:  a. using periodic abstinence or rhythm incorrectly; b. relying on withdrawal; and those c. who are using condoms inconsistehtly and irregularly.  As these couples constitutes about 18% of all family planning users who continue to use traditional methods (NDHS, 1998-Phils.), shifting them to the more reliable modern NFP is already a substantial achievement for Family Planning Program in the country.  Moreover, SDM should also be routinely offered as an additional option for couples in search for a suitable NFP method.  B. Mainstreaming of Services  Mainstreaming of SDM to Family Planning services shall be implemented in phases. Initial implementation should cover Metro Manila, including the identi\ufb01ed priority urban poor areas. Based on the subsequent evaluation of this phase, mainstreaming of SDM should be expanded to other regions in the country.  SDM should be made available in the following service delivery areas:  a. hospitals b. rural health units (RHUs) c. barangay health stations (BHS) d. NGO clinics; and during e. home visits of Volunteer Health Workers (VHWs)  The method shall be of\ufb01cially reported as \u201cNecklace Method.\" The client is considered new acceptor (NA) upon receiving the necklace. One month afterwards, the client is now considered a current user (CU).  IV. Institutional Arrangements  To support mainstreaming of SDM to FP services and ensure the smooth implementation of this new method, the following stakeholders shall be responsible for the corresponding identi\ufb01ed roles and functions:  1. The Center for Family and Environmental Health shall oversee the overall implementation of the method. Speci\ufb01cally the CFEH shall:  a. develop policies, standards and guidelines relative to SDM implementation b. develop the training curriculum and instructional materials c. develop prototype IEC materials d. conduct training of trainers at the regional, provincial/city levels e. provide technical assistance to implementing partners f. mobilize resources to support mainstreaming activities g. develop recording and reporting system for SDM as a program method h. monitor and evaluate progress and status of SDM implementation  2. The Centers for Health Development shall be responsible for the management of implementation of SDM at the regional level, including :  a. training of trainers at provincial/city level b. reproduction of prototype IEC and training materials c. provision of technical assistance to LGU and NGO partners d. monitoring 81 evaluation of method implementation at the regional level, LGU and NGO partners e. management of information systems f. resource mobilization to support SDM related activities  3. The Institute of Reproductive Health shall assist in the mainstreaming of SDM in Family Planing services by:  a. providing technical assistance in the conduct of initial training of trainers b. conduct operations research on SDM service delivery mechanisms c. review and evaluate training program and IEC materials developed for SDM as necessary d. mobilize resources to support implementation of the method in the Philippines  V. Monitoring & Evaluation  For ef\ufb01cient and effective planning and project implementation, regular monitoring and evaluation activities shall be conducted as follows:  a. Quarterly SDM review at the provincial level with participation from NGOs, health staff at city and municipal level shall be initiated by the PHO in collaboration with CHD FP coordinator b. Bi-annual project review to be conducted by CHD c. Annual project review to be called by the NCDPC\u2014CFEH  VI. Effectivity  This Order shall take effect immediately.    ", " 1. Cause of maltreated children in hospitals must be duly certified and reported to the nearest MSSD Unit Office.  2. Steps should be taken to prevent \"simulation\" of births in the name of persons other than the biological parents and that cases of \"simulated\" births should be reported to the nearest MSSD Unit Office.  3. Attach copy of the cerficate of consent form.  This Order shall take effect immediately. ", " I. RATIONALE  Diarrhea remains to be the leading cause of morbidity and mortality in children under five years old around the world. It is estimated to cause more than 3 million deaths of children in developing countries each year (Bhutta et al., 2000). It also contributes to malnutrition among children who survived the disease. In the Philippines, diarrhea is one of the ten leading causes of death among children and the prevalence has not improved in the last five years. The National Demographic and Health Survey (NDHS) in 2003 reported that 11 percent of the children under five years of age had diarrhea and this figure indicated an increase of 57% from the 7% level in the 1998 NDHS data. The 2006 Dept of Health Field Health Service Information System reported that in 2006, Acute Watery Diarrhea is second among the ten leading causes of morbidity. There were 572,256 cases with a rate of 707.7 per 100,000 population of children under five years of age. Death due to acute diarrhea is usually due to severe dehydration which can be prevented with proper management.  The WHO and UNICEF recommends ,to Member States the new guidelines in the management of acute diarrhea that will shorten its duration, lessen the episodes and prevents immediate recurrence. Thus, an updated guideline is needed to adequately manage the disease.  The potential goals in the management of diarrhea are correction of dehydration and electrolyte imbalance, reduction of diarrheal dehydration and stool output, prevention of recurrence, prevention of malnutrition related complications, improvement of mucosal barrier and maximization of nutrient bioavailability. (Sathiyasekaran, 2005).  For over 25 years, Oral Rehydration Salts (ORS) solution has been used to prevent and treat dehydration from diarrhea, as recommended by WHO and UNICEF. This single formulation of glucose-based ORS has successfully contributed to the global reduction in mortality from diarrhea during that period. But despite this significant contribution of the standard ORS, it has been well established that it does not reduce stool output or duration of diarrhea. For this reason, researches have been made to develop an \"improved\" or \"newly formulated\" ORS. This would be at least as safe and effective as the standard ORS but, in addition, it would reduce the stool output.  The newly formulated ORS contains reduced amount of glucose and salts and total osmolarity to increase water and electrolyte adsorption. Hyposmolar solution will shorten the duration of diarrhea and the need for unscheduled intravenous fluids. Studies have shown that this newly formulated ORS solution reduces the need for supplemental IV fluid therapy, the incidence of vomiting and stool volume by 33%, 30% and 20%, respectively. This recent improvement in the management of diarrhea is officially recommended by WHO and UNICEF.  In addition, another important advancement in the management of diarrhea is now being recommended by WHO and UNICEF as an adjunct to the use of newly formulated ORS. This is the incorporation of zinc supplement in the management of diarrhea. Zinc supplements given during an acute diarrhea reduce the duration and severity of the disease and prevent subsequent episodes of diarrhea. Studies Show that 10 - 20 mg of zinc for 14 days reduced the number of episodes of diarrhea within 2 - 3 months after the supplementation regimen.  This new approach is based on a number of scientific evidences from 17 efficacy studies, 12 on acute and 5 on persistent diarrhea (Harvey, 2005). These studies have demonstrated that zinc in addition to the newly formulated ORS reduces both the duration and severity of acute diarrhea as compared to the use of ORS alone. The incorporation of zinc supplement reduces the duration of acute diarrhea by 25%, duration of persistent diarrhea by 29% and treatment failure or death in persistent diarrhea by 40%.  Vomiting is the only reported adverse effect of zinc but at the dose used in the zinc tablet, there is only a small chance of nausea or vomiting. In addition, the recommended dosage of 20 mg per day for 10-14 days showed no threat of toxicity.  The most economical form of zinc is the 20 mg dispersible, scored tablets which quickly disintegrate in less than a minute with small amount of clean water or breast milk (5ml) in a spoon. This form is suitable for children. Zinc drops and syrups are also available (WHO/UNICEF/USAID/JHSPH 2006)  The cost of Zinc supplementation for 14 days ranges from Php 62.00 (tablet) to Php130.00 (syrup). This amount is very negligible as compared to the cost of hospitalization that will be incurred when the child develops diarrhea with severe dehydration. The hospitalization expenses will range from Php2,100.00 (government hospital) to Php 9,000.00 when the sick child is confined in a private hospital.  These two recent advances in managing diarrheal disease - newly formulated ORS and zinc supplementation - can drastically reduce the number of child deaths and therefore, considered cost-effective. Global studies have noted significant reductions in the need for expensive hospitalization and use of unnecessary antibiotics and other drugs.  With the complete implementation of these new recommendations, it has been estimated that deaths due to diarrhea can be prevented by almost 90%. This can contribute significantly to the attainment of the Millennium Development Goal 4 - reduce child mortality of under-five children by two thirds.  II. LEGAL MANDATES  The government's commitment to protect the health of children is embodied in international covenants and in the national strategy like Child 2021-2025 and the Millennium Development Goals. The adoption of the IMCI strategy which combines curative and preventive strategies is considered a factor in the decline in mortality of young children.  The following laws and administrative issuances provide the mandate for the appropriate support and promotion on the use of zinc supplementation and reformulated ORS in the management of diarrhea:  A. Under Article 24 of the 1989, the United Nations Convention on the Rights of the Child emphasized the social responsibility of the member of the States to protect children and to provide them with appropriate support and services, emphasizing their right to the highest attainable level of health care services and guarantees the provision of and access to adequate nutrition for all infants and young children.  B. The National Objectives for Health 2005-2010 emphasized the need to reduce the mortality of under-five year old children due to diarrhea from the baseline data of 5.3 deaths per 100,000 (Philippine Health Statistics 2000) under five children to less than 1 death per 100,000 under-five children.  C. One of the components of Fourmula One Fl) as the implementation framework for the Health Sector Reform in the Philippines is Health Service Delivery. It is aimed at improving availability of basic service, particularly for the poor. The inclusion of inexpensive zinc (with ORS) in the armamentarium in Integrated Management of Childhood Illness ensures availability of basic and essential care for one of the leading preventable causes of under-five mortality in the Philippines.  D. The creation of the Food and Waterborne Diseases Prevention and Control Program (AO no.29-As. 1997; Section V) under Program Components and Strategies provides that clinical care of Food and Waterborne Diseases (FWBD) will focus on case management using ORS and rational use of diagnostic tests for FWBD. This strategy necessitates the Maternal and Child Health Service (MCHS) to provide policies and guidelines in the control of diarrheal diseases (CDD) in children 5 years and below, particularly in case management.  E. Department Circular no. 179 s. 1993 emphasized the Policies and Guidelines for the National Control of Diarrheal Disease Program which stresses the Assessment of Dehydration, Rehydration with ORS solution, Assessment of bloody stools and recommendation for antibiotics and limitation of use of drugs to Amoebiasis and Giardiasis.  III. OBJECTIVES  This Administrative Order aims to contribute to reduced child malnutrition and child deaths through more effective management of diarrhea among young children. More specifically, it aims to:  1. Transform all health institutions in both the government and the private sector and other health facilities into facilities that can promote and support the new advances/recommendations in the management of diarrhea. 2. Build critical capacity and commitment of health care staff in promoting, providing support and using the new recommendations in the management of diarrhea. 3. Link all levels of health care, including primary health care facilities with community support groups to adopt the new recommendations in the management of diarrhea as a routine practice both in the home and health facility. 4. Improve/strengthen the system of procurement, distribution and utilization system of logistics particularly Zinc and ORS.  IV. COVERAGE AND SCOPE  These guidelines shall apply to all government, private and other health facilities nationwide.  V. DEFINITION OF TERMS  A. Dehydration - loss of a large amount of water and salt from the body.  B. Diarrhea - the passage of unusually loose or watery stools, usually at least three times in a 24-hour period.  C. Dysentery - also called acute bloody diarrhea, the passage of unusually loose or watery stools with the presence of blood  D. Persistent diarrhea - the passage of unusually loose or watery stools, which lasts for 14 days or longer  E. Reformulated ORS - a new formula with reduced concentration of glucose and salt (NaCl) to avoid the possible effects of hypertonicity on net fluid absorption. It has a composition of 75meq/l sodium, 75 mmol/l glucose, and a total osmolarity of 245 mOsm/l  F. Zinc - an essential mineral that is found in almost every cell in the body. It stimulates the activity of approximately 100 enzymes, which are substances that promote biochemical reactions in the body. It also supports a healthy immune system, is needed for wound healing, helps maintain your sense of taste and smell, and is needed for DNA synthesis. Zinc also supports normal growth and development during pregnancy, childhood, and adolescence.  G. Zinc deficiency - one of the major risks to child health, linking deficiency to 10% of diarrhea, 6% of lower respiratory tract infections, and 18% of malaria morbidity.  VI. IMPLEMENTING GUIDELINES  The revised clinical guidelines on the management of diarrhea in children include the following:  A. The objectives of the treatment of diarrhea are to:  1. Prevent dehydration, if there are no signs of dehydration; 2. Treat dehydration, when it is present; 3. Prevent nutritional damage, by feeding during and after diarrhea; and 4. Reduce the duration and severity of diarrhea, and the occurrence of future episodes, by giving zinc supplements.  B. Use of reformulated Oral Rehydration Salts (ORS) for oral rehydration therapy  The new formulation has lower osmolarity ORS solution, with reduced glucose to prevent undesirable effect of hypertonicity on net fluid absorption (Implementing the new recommendation on the clinical management of diarrhea WHO/UNICEF/USAID/JHSPH 2006).    The Reformulated ORS is already approved for use in the Philippines and is already included in the Philippine National Drug Formulary (PNDF) Volume 1; 6th edition (2005).  ORS should be given to:  Children under 2 years old, approximately 50-100 ml (1/4 large cup) of ORS after each loose stool. Give older children 1/2 to 1 large cup of ORS.  Older children and adults should drink as much as they want.  ORS or recommended home-fluids such as buko juice, soup, and clean water should be continued until diarrhea stops. This may last for several days.  C. Use of Zinc Supplement    * Not yet manufactured in the country, but is now being used in selected provinces/municipalities under the UNICEF Country Program for Children 6 (CPC VI), in USAID assisted areas in Mindanao and in International Aid Zinc Study areas also in Mindanao.  D. The steps to treat diarrhea are shown below:  1. The first step in treating the child with diarrhea is to assess the child for signs of dehydration. Ask the mother of the caretaker about the child's history. Then check for the signs and symptoms of dehydration and signs of other possible important problems (refer to Table 2).  2. The next step is to select treatment and treat appropriately for degree of dehydration. In determining the degree of dehydration and the appropriate plan to treat dehydration, use the table below:    Advise family members about home treatment of diarrhea. Counsel mother on giving ORS and zinc, good food choices, including continued breastfeeding.  TREATMENT PLAN A: TREAT DIARRHEA AT HOME  Counsel the mother on the 4 rules of Home Treatment:  Give extra fluid Give zinc supplements Continue feeding When to return to health facility  Rule 1: GIVE EXTRA FLUID (as much as the child will take)  A. TELL THE MOTHER \u2022 Breastfeed frequently and for longer at each feed \u2022 If the child is exclusively breastfed, give ORS or clean water in addition to breastmilk \u2022 If the child is not exclusively breastfed, give one or more of the following: ORS solution, food-based fluids (such as soup, rice water) or clean water.  B. TEACH MOTHER HOW TO MIX AND GIVE THE ORS. GIVE THE MOTHER 2 PACKETS OF ORS TO USE AT HOME.  C. SHOW THE MOTHER HOW MUCH FLUID TO GIVE IN ADDITION TO THE USUAL FLUID INTAKE:  Up to 2 years - 50 to 100 ml after each loose stool 2 years or more - 100 to 200 ml after each loose stool  Tell the mother to:  \u2022 Give frequent sips from a cup. \u2022 If the child vomits, wait for about 10 minutes before asking the child to sip from the cup again, but more slowly. \u2022 Continue giving extra fluid until the diarrhea stops. \u2022 Remind mother not to use sports drinks in the management of diarrhea because of its low sodium content which can cause hyponatremia and its very high carbohydrates content which can provoke osmotic diarrhea and worsen the dehydration.  Rule 2: GIVE ZINC SUPPLEMENTS  A. TELL THE MOTHER HOW MUCH ZINC TO GIVE (REFER TO TABLE 1 FOR DOSE AND DURATION)  B. SHOW THE MOTHER HOW TO GIVE ZINC SUPPLEMENTS  For infants up to 6 months dissolve the tablet in a small amount of expressed breastmilk, ORS or clean water, in a small cup or spoon. For infants and children 6 months up to 59 months old tablets can be chewed or dissolved in a small amount of clean water in a cup or spoon  C. REMIND THE MOTHER TO GIVE ZINC SUPPLEMENTS FOR THE FULL 14 DAYS  Rule 3: CONTINUE FEEDING  A. If the child is breastfeeding, breastfed more frequently and for longer period at each feed  B. Give the child above 6 months of age foods with the highest amount of nutrients and calories. Depending on the age of the child, give mixes of cereal, meat or fish. Add oil to these foods to make them energy-rich. Dairy products and eggs are also suitable. Fresh fruit juices and bananas are helpful because they contain potassium.  C. Avoid high fiber or bulky foods such as coarse fruits and vegetables and whole grain cereals. These are hard to digest.  D. Avoid very dilute soups. These are recommended as fluids but are not sufficient because they fill up the stomach of the child without providing sufficient nutrients. Do not give foods with lots of sugar. These foods can worsen diarrhea.  E. Encourage the child to eat as much as he/she wants. Offer food every 3-4 hours (six times each day) or more often to a young child. Small frequent feedings are best because they are more easily digested and preferred by the child.  Rule 4: WHEN TO RETURN  A. The caretaker should bring the child to a health worker if the child shows any of the following:  \u25a0 Passes many stools, \u25a0 Is very thirsty, \u25a0 Has sunken eyes, (These three signs suggest the child is dehydrated) \u25a0 Seems not to be getting better after 3 days, \u25a0 Has a fever, \u25a0 Does not eat or drink.  Treatment Plan B: Treat some dehydration with ORS  A. Give in clinic/health center the recommended amount of ORS over 4-hour period    \u2022 If the child wants more ORS than shown, give more. \u2022 For infants less than 6 months who are not breastfed, also give 100-200 ml clean water during this period.  B. ADVICE THE MOTHER  \u25a0 Give frequent small sips from a cup. \u25a0 If the child vomits, wait 10 minutes. Then continue, but more slowly. \u25a0 Continue breastfeeding whenever the child wants.  C. AFTER 4 HOURS:  \u2022 Reassess the child and classify the child for dehydration. \u2022 Select the appropriate plan to continue treatment. \u2022 Begin feeding the child in clinic.  D. IF THE MOTHER AND CHILD MUST LEAVE BEFORE COMPLETING TREATMENT:  \u2022 Show her how to prepare ORS solution at home. \u2022 Show her how much ORS to give to finish 4-hour treatment at home. \u2022 Give her enough ORS packets to complete rehydration. Also give her 2 packets as recommended in Plan A. \u2022 Explain the 4 rules of home treatment as shown in Treatment Plan A:  Treatment Plan C: Treatment of Diarrhea with Severe Dehydration  A. Refer to hospital for treatment B. Treat according to Plan B or A when child's condition improves.  TREATMENT OF DYSENTERY  Treat for 5 days with an oral antibiotic for Shigella in the area. Advice mother when to return immediately to the health center.  TREATMENT OF SEVERE PERSISTENT DIARRHEA (Diarrhea of 14 days or more with dehydration)  \u2022 Treat the child for dehydration before referral unless the child has another severe classification \u2022 Give Vitamin A \u2022 Refer to hospital  PERSISTENT DIARRHEA (diarrhea of 14 days or more with no dehydration),  Advice mother on feeding, give multivitamins and minerals including Zinc for 14 days, give Vitamin A, follow-up in 5 days and advise mother when to return to the health center  VII. REPEALING CLAUSE  The provision of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modified, repealed or rescinded accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.  VIII. EFFECTIVITY  This order shall take effect immediately. ", "  I. BACKGROUND:  President Gloria Macapagal\u2014Arroyo signed Executive Order No. 663 last September 21, 2007 entitled \u201cImplementing the National Commitment for \u201cBAKUNA ANG UNA SA SANGGOL AT INA attaining World Health Organization\u2019s goal to eliminate measles and neonatal tetanus, eradicate polio, control hepatitis B and other vaccine\u2014preventable diseases.  To achieve this goal, requires that at least 95% of our children and pregnant women/mothers are fully immunized annually. However, annually, 500,000 children remain unprotected to the bene\ufb01ts of vaccine resulting in numerous outbreaks/epidemics of vaccine preventable diseases nationwide.  The Department of Health (DOH) with the collaboration of the national, international and the local government units will embark on a mass measles vaccination campaign for all children ages 9 months to 48 months old nationwide on October 15, 2007 to November 15, 2007.  II. POLICY STATEMENTS  Immunization is a basic right of the child and therefore no child shall be deprived of this right. The State regards children as one of the most important assets of the nation and therefore every effort should be exerted to promote their welfare and full development of their potentials for a useful and quality life.  III. OBJECTIVES  This Administrative Order is issued to provide further guidance on the roles and protection of health workers in accordance with the E0 663 for the Knock-out Tigdas 2007.  IV. SCOPE AND COVERAGE  This Administrative Order shall apply to all health workers / health professionals who shall provide immunization and other child health interventions to all eligible children/mothers nationwide as speci\ufb01ed in the Guide to Knock-out Tigdas for Health Workers either during mass immunization campaigns and routine/outreach immunization.  V. DEFINITION OF TERMS  For the purpose of this Administrative Order, the following terms/acronyms have been defined:  AEFI \u2014 Adverse Event Following Immunization  CHD \u2014 Center for Disease Prevention and Control  DOH \u2014 Department of Health  Health workers/health professionals - refers only to doctors, nurses and midwives  ISSS \u2014 Immunization Safety Surveillance System  ISSSB \u2014 Immunization Safety Surveillance System Board  LGUs - Local Government Unit  NCDPC \u2014 National Center for Disease Prevention and Control  NEC \u2014 National Epidemiology Center  RESU - Regional Epidemiology Surveillance Unit  SIA \u2014 Supplemental Immunization Activities. Special immunization activities designed to reach populations that are not reached by routine \ufb01xed or outreach activities. These are conducted by teams once, twice, or three times a year in a form of mass vaccination campaign, nationwide or sub-national.  VI. GENERAL GUIDELINES:  A. Provision of Immunization among Infants/Children and Women/Mothers  1. On October 15 \u2014 November 15, 2007, all 9 months \u2014 48 months old children (or born between October 15, 2003 and January 15, 2007) shall be administered measles vaccination FREE OF CHARGE using a door-to-door strategy. A Guide for Knock\u2014out Tigdas for Health Workers shall be followed by all health workers to implement the campaign.  2. All local government units (LGUs) shall ensure that every child/mother have received complete immunizations following the guidelines of the Department of Health (DOH). All vaccine administration (i.e. vaccines, needles and syringes, services) shall be FREE of CHARGE in public hospitals, lying\u2014in clinics, health centers, barangay health stations, designated immunization sites (\u201cBakuna Centers\") during routine immunization sessions and door-to\u2014door in special campaigns.  3. Doctors, nurses and midwives shall all administer the vaccine regardless of the route of immunization - intramuscular, oral, subcutaneous, and intradermal, either during routine/outreach or supplemental immunization. Trained volunteers (e.g. Barangay Health Workers, Barangay Nutrition Scholars) shall be allowed to administer oral polio vaccines (OPV) in the immunization sites previously mentioned.  4. Auto\u2014disable syringes should be used in every immunization session. Used needles and syringes, empty vaccine vials/ampules, used cottonballs are considered infectious and shall be disposed using DOH recommended disposal methods and sites. Sanitary inspectors shall facilitate proper disposal at least monthly.  B. Precautions for Unsafe Injections Among Healthworkers  1. Unsafe injection practices should be avoided at all cost. DOH guidelines, Administrative Order No 39s.2003, the EPI Cold Chain Manual and A Guide for Knock \u2014out Tigdas for Health Workers, related to safe injections should always be complied during routine, outreach and campaign immunization sessions.  2. All severe AEFIs should be routinely reported to Regional Epidemiology Surveillance Unit (RESU) and National Epidemiology Center (NEC). The local epidemiology surveillance unit or its equivalent shall initiate the timely investigation of AEFI and properly coordinate with the RESU.  3. No immunization activities should be stopped without instruction from the National Center for Disease Prevention and Control (NCDPC), DOH.  4. Treatment of such cases shall follow the existing standard clinical care management. DOH retained hospitals shall treat all cases shown to be related to vaccine administration (during routine or campaign) FREE OF CHARGE.  5. Concerned public health professional shall not be held liable for any AEFI as long as DOH standard operating procedures on safe injection practices are complied.  6. Health workers and volunteers who have had untoward events such as animal bites, injuries and other incidents that occurred during routine or campaign activities shall receive standard medical care and prophylaxis care FREE OF CHARGE from DOH retained hospitals  C. IMPLEMENTING MECHANISMS  Roles and Responsibilities:  1. National Center for Disease Prevention and Control (NCDPC)  The EPI\u2014 National Center for Disease Prevention and Control shall provide the standards, policies and guidelines for immunization including campaigns and ensures adequate and potent vaccines are procured and delivered nationwide. Auto-disabled needles and syringes, hub cutters and other immunization supplies shall be provided to the CHDs.  All technical staff of the NCDPC shall monitor/validate the immunization activities of the various LGUs and shall continuously provide directives as necessary to improve immunuization coverage and reach all children in all barangays nationwide. A standard validation tool, Rapid Coverage Assessment, shall be utilized by all validators for the Knock-out Tigdas.  2. National Epidemiology Center (NEC)  NEC of the Department and RESU shall assist in the investigation of any reported Adverse Events Following Immunizations (AEFI) and provide feedback with the concerned offices or LGUs. Likewise, NEC shall make functional at all times the Immunization Safety Surveillance System Board (ISSSB) and shall provide final report related to AEFI investigation to the Secretary of Health.  NEC through its existing system shall strengthen the laboratory-based measles surveillance and provide feedback to concerned offices/LGus as necessary.  3. Legal Office of DOH (National/Regional)  The Legal Of\ufb01ce of the DOH and or the Office of the Solicitor General shall provide appropriate legal assistance to public health professionals as necessary in any cases for acts committed in the performance'of their duty and in good faith or in any case. after appropriate investigation by RESU/NEC.  4. Center for Health Development (CHDs) and Hospitals  The CHDs shall ensure that all the vaccines are potent, adequate and timely delivered to their catchment areas, provide technical assistance to include supervisory/monitoring/validation to LGUs to ensure that all eligible children receives needed immunization and other child health intervention. In the monitoring/validation the prescribed integrated child survival monitoring tool for routine and the conduct for Rapid Coverage Assessment (Section 12, Guide to Knock\u2014out Tigdas for Health workers) shall be followed for these specific activities.  The hospitals shall likewise provide immunization to eligible children within their facilities and report accomplishments to CHDs. They shall also ensure treatment of any referrals related to the activities such as mentioned in Section B under General Guidelines.  5. Local Government Units (LGUs)  All local government units shall ensure that all the eligible children are given the appropriate child health interventions \u2014 measles immunization and /or other vaccines (if necessary) , Vitamin A capsule and deworming tablet, search for follow-up missed children and submit accomplishment report according to the scheduled specified in the KOT guidelines.  6. Private Sectors/Professional Organizations  All health professionals shall ensure that every child receives the measles vaccines and other child health interventions. They shall submit the number of children immunized in the private clinics and health facilities to the nearest government health center.  In the event that a professional organization convention coincides with the conduct of the mass campaign, the members shall be responsible to ensure that all eligible children shall be provided the needed intervention.  VII. Repealing Clause  Any existing provision or issuance found in consistent with this order shall be repealed.  VIII. Effectivity  This Order shall take effect immediately.    ", " I. BACKGROUND AND RATIONALE   The Philippines has been certi\ufb01ed polio-free in 2000, together with all other countries in the WHO Western Paci\ufb01c Region (WPR). The last wild poliovirus (WPV) was detected in Cebu in 1993. Although certi\ufb01ed as polio-free, the country remains at risk for WPV importation from endemic countries and areas with WPV transmission. Particularly vulnerable are communities with high population in-migration and out\u2014migration and international travel entry points (e.g. Mindanao, Manila, Cebu, Palawan, etc.).   In some cases, a WPV importation into polio-free countries does not result in secondary spread or re\u2014established local transmission because of high coverage with three doses of oral poliovirus vaccine (OPV3) and herd immunity and adequate sanitation standards (i.e. potable water sources, sanitary toilet facilities and proper garbage disposal). However, if a WPV importation occurs into polio-free areas with pockets of low OPV immunization coverage and/or sub-optimal Acute Flaccid Paralysis (AFP) surveillance, transmission can spread quickly resulting to large outbreaks. This happened in 2005 in Yemen and Indonesia and most recently Tajikistan and Democratic Republic of Congo in 2010. Since 2003, outbreaks following WPV importations took place in over 20 countries that were previously polio-free.   Conditions favoring the spread of imported WPVs like low OPV3 coverage and substandard AFP surveillance, pose also a risk for the emergence of circulating vaccine derived poliovirus (cVDPV). It already happened in the Philippines in 2001, when three cVDPV cases were detected in Cagayan de Oro, Laguna and Cavite.   The Philippines has gone a long way in maintaining its polio-free status. In 2006, the country has accomplished the recommended laboratory containment of WPV by completely destroying all WPV isolates and stocks in the different laboratories nationwide. Thus, it is no longer possible to reintroduce WPV into the community from laboratories. The Philippines is also implementing strategies to achieve and maintain at least 95% OPV3 coverage and quality AFP surveillance in all areas. All efforts shall continue until all countries in the world are certi\ufb01ed polio-free and Global Poliovirus Eradication is achieved.   This WPV importation preparedness and response plan of action shall be used to secure political commitment, to plan for making emergency funds available to support response activities, to of\ufb01cially create the necessary committee for an effective and ef\ufb01cient response, to provide opportunity for capacity building and strengthening of routine vaccine preventable disease (VPD) surveillance, EPI and laboratory capacity and to improve reporting, response and feedback mechanisms at all levels.   II. OBJECTIVES   1. To set the guidelines pertaining to preparedness and response mechanisms in case a WPV importation is con\ufb01rmed, which shall cover:   - Improving and enhancing AFP/polio surveillance;  - Implementing an outbreak response immunization including polio supplemental immunization activities (SIA);  - Strengthening laboratory capacity;  - Intensifying advocacy and risk communication; and  - Enforcing local and international linkages for an effective response and control measures   2. To provide the policies and guidelines for the effective and ef\ufb01cient implementation, monitoring and evaluation of the response activities aimed at preventing WPV secondary or re\u2014established transmission.   III. SCOPE AND COVERAGE   This issuance shall apply to the entire health sector, to include public and private, national agencies and local government units, external development agencies, and the community involved in disease surveillance and response activities.   This issuance shall apply to both con\ufb01rmed case(s) of WPV importation and cVDPVs.   IV. DEFINITION OF TERMS/ACRONYMS   1. Acute Flaccid Paralysis Refers to a syndrome in which there is a sudden onset of (AFP) \ufb02oppy paralysis or lameness usually of the arms and legs. Other accompanying symptoms include fever, extreme tiredness, headache, nausea, vomiting, muscle pain and stiffness in the neck and back.   2. AFP Case Refers to any child less than 15 years of age with acute onset of \ufb02oppy paralysis, or a person of any age in whom poliomyelitis is suspected by a physician   3. Close contacts Refer to household contacts or contacts whom the suspected case spends regular time with (Le, in settings like playgrounds, schools, etc.)   4. Cluster of AFP cases Refers to the occurrence of two or more AFP cases in one province or city with the date of paralysis onset of within 1 month of each other.   5. Circulating Vaccine- derived Poliovirus (cVDPV) Refers to a subclassi\ufb01cation of VDPV found in areas with gaps in OPV coverage; considered in the context of person-to- person transmission when non\u2014identical but related VDPVs are identi\ufb01ed in at least 2 AFP cases   6. Disease Surveillance Coordinator (DSC) Refers to the staff of government and non-government health facilities (e.g. hospitals, clinics, RHUs) who have received training on PIDSR with an of\ufb01cial designation as disease surveillance coordinator by the head of the facility. The DSC is responsible for the reporting of and collection of specimen from identi\ufb01ed noti\ufb01able case/s.   7. Disease Surveillance Of\ufb01cer (DSO) Refers to the fulltime staff of the Epidemiology and Surveillance Unit (ESU) of the City Health Of\ufb01ces (CHOs) of chartered cities, Provincial Health Of\ufb01ces (PHOs) and Centers for Health Development (CHDs) who received training on basic epidemiology, public health surveillance and PIDSR with an of\ufb01cial designation as disease surveillance of\ufb01cer by the head of the of\ufb01ce. The D80 is responsible for the investigation and the timeliness of specimen collection from reported/ identi\ufb01ed noti\ufb01able case/s.   8. Expanded Program on Immunization (EPI) Refers to the routine immunization program implemented in the Philippines offered at health centers and other health facilities, which has an outreach immunization component.   9. Epidemiology Refers to the study of the distribution and determinants of health-related states or events in speci\ufb01ed populations, and the application of this study to the control of health problems.   10. Epidemiology and Surveillance Unit (ESU) Refers to the unit established in the Centers for Health Development (CHDs), Provincial Health Of\ufb01ces (PHOs), City Health Of\ufb01ces (CHOS), and Rural Health Units (RHUs) that provide services on public health surveillance and epidemiology   11. Global Reference Laboratory (GRL) Refers either to the National Institute of Infectious Diseases (NIID) Reference Laboratory in Japan or the Center for Disease Control (CDC) in the US which receives samples testing inconclusively by Intratypic Differentiation (ITD) as referred by the Regional Reference Laboratory for further characterization and \ufb01nal classi\ufb01cation of polioviruses   12. Local Chief Executive (LCE) Refers to the principal executive of\ufb01cial of Local Government Units   13. Hot Case Refers to an AFP case that is less than 5 years old, with less than 3 doses of OPV and has fever at the onset of asymmetrical paralysis; 0R an AFP case or a person of any age whose stool specimen/s has poliovirus isolate   14. International Air Transport Association (IATA) Refers to an organization that represents, leads and serves the airline industry and which members comprised of the world's leading passenger and cargo airlines    15. International Health Regulations (IHR) Refers to the international legal agreement that took effect since 2005 and is binding on 194 countries across the globe, including all the Member States of WHO with the aim of helping the international community prevent and respond to acute public health risks that have the potential to cross borders and threaten people worldwide   16. Intratypic differentiation (ITD) Refers to the tests used to analyze polioviruses and identify its speci\ufb01c genotype   17. Monovalent Oral polio Vaccine (mOPV) Refers to an attenuated vaccine administered orally that protects against the single serotype present in the formulatio  18. National Certi\ufb01cation Committee (NCC) Refers to the national review panel for maintenance of polio- free certi\ufb01cation   19. Non-polio Enterovirus (NPEV) Refers to enterovirus (i.e. echovirus, coxsackie virus) other than poliovirus isolated from specimens   20. National Poliovirus Reference Laboratory (NPRL) Refers to the Research Institute for Tropical Medicine (RITM) which is the WHO-accredited poliovirus reference laboratory for the Philippines   21. National Response Committee (NRC) Refers to the committee formed at the national level that shall be responsible in the coordination, and supervision, monitoring and evaluation of the implementation of the response to con\ufb01rm importation of wild poliovirus or cVDPV   22. Oral poliovirus vaccine (OPV) Refers to an attenuated vaccine administered orally that protects against either one (mOPV), two (bOPV) or three (tOPV) serotypes of poliovirus present in the formulation   23. Philippine Integrated Disease Surveillance and Response (PIDSR) Refers to the system whose framework embodies an integrated functional disease surveillance and response system institutionalized from the national level down to the community level   24. Rapid Coverage Assessment (RCA) Refers to a strategy of randomly selecting a speci\ufb01ed number of households to validate and ensure high immunization coverage. In this method, vaccinators ensure that previously missed children are revisited and vaccinated.  25. Regional Commission for the Certi\ufb01cation (RCC) of Poliomyelitis Eradication Refers to the commission in the Western Paci\ufb01c Region that conducts active oversight to support maintenance of poliomyelitis-free status and conduct of annual meetings to review the situation and requirements in each Member State  26. Regional Reference Laboratory (RRL) Refers to the Victorian Infectious Disease Reference Laboratory (VIDRL) in Australia, to which the RITM sends polioviruses isolated from AF stool specimens for confirmation of virus isolation and intratypic differentiation.   27. Round 0 Refers to the Outbreak Response Immunization (ORI) that is conducted in area(s) with known positive wild poliovirus case   28. Supplemental Immunization Activity (SIA) Refers to an immunization activity conducted in a larger-scale with an aim to interrupt transmission of a vaccine\u2014preventable disease; In the context of a polio outbreak, it consists of at least three-rounds immunization activity using either mOPV, bOPV or tOPV that should be started not later than 4 weeks after the con\ufb01rmation of a case of wild-poliovirus or VDPV   29. Trivalent Oral polio Vaccine (tOPV) Refers to an attenuated vaccine administered orally as drops that works against all three polio strains   30. Vaccine-derived Poliovirus (VDPV) Refers to live, attenuated strains of the vaccine poliovirus that have undergone mutation and recombination and differ from (original) Sabin strains by 1 to 15% of VP1 nucleotides, the extent of genetic change of which is indicative of prolonged replication   31. World Health Assembly (WHA) Refers to the supreme decision-making body for WHO. It generally meets in Geneva in May each year, and is attended by delegations from all 194 Member States   32. Wild Poliovirus (WPV) Refers to the wild poliovirus that is targeted for global eradication Consisting of three types: poliovirus type 1, type 2 and type 3   33. Zero Reporting Refers to the regular, scheduled reporting of \u201czero case\" when no cases have been detected by the reporting unit   V. IMPLEMENTATION GUIDELINES   A. Preparedness   The preparedness plan for wild polio virus importation shall have the following: surveillance and risk assessment, laboratory surveillance activities, immunization program activities as well as establishment of the national and sub-national response committee.   B. Response to Wild Poliovirus Importation   The response plan to wild polio virus importation shall include the following activities: strengthening surveillance and risk assessment activities, assessing the risk of transmission, enhancing laboratory surveillance activities for poliovirus and activities to enhance immunization program.   C. Post-Outbreak Assessment and Response   Post-outbreak assessment and response should contain activities pertaining to post outbreak response immunization, complete documentation of the outbreak response, dissemination and feedback and destruction of WPV from the laboratory.   NOTE: See ANNEX 1 for the details of the Implementation Guidelines Sections A-C.   D. Circulating Vaccine Derived Poliovirus (CVDPV) Isolation   A con\ufb01rmed case of cVDPV shall be considered and treated the same way as WPV depending on the result of the risk assessment for Polio of all provinces and cities.   E. Budgetary Requirements   All activities related to the outbreak response shall be charged against the funds of the Of\ufb01ce of the Secretary of Health.   VI. REPEALING CLAUSE   The provisions of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.   VII. EFFECTIVITY   This order shall take effect immediately.  ", " 1. RATIONALE   The strategy of encouraging mothers to give birth in adequately-equipped primary level facilities such that they can be attended by skilled health professionals is the current consensus towards a more effective approach to address high maternal and neonatal mortality rates in the country. It seeks to establish in every province, a network of health facilities that can provide cost-effective basic emergency obstetric and neonatal care where all women should have acCess to high quality pre\u2014natal, delivery and post-partum care including access to referral services for obstetric complications.   Certi\ufb01cation standards from a certifying body in the DOH assure health provider safety and con\ufb01dence on the implementation of standards that have a clear scope of practice which cannot be compromised. The standards set for the practice of professional health care providers, equipment and \"infrastructure service requirements developed through a participatory process for purposes of certi\ufb01cation can be further linked to an accreditation process of health facilities with an incentive scheme. '   Thru a certi\ufb01cation process, the health professionals are expected to have the requisite knowledge and skills in providing quality, culturally relevant, appropriate care for women, newborn and child\u2014bearing families. It places critical emphasis on both personal professional accountability coupled with the adoption of health infrastructure benchmark for well-equipped and functional health facilities to handle emergency obstetric and neonatal cases brought to their care.   This Administrative Order is hereby issued to establish a certi\ufb01cation process which shall be the service standard for health facilities with skilled health professionals providing basic emergency obstetrics and newborn care.   II. DECLARATION OF POLICY   This issuance complements the provisions of (1) Administrative Order No. 2008\u20140029 on Health Reforms for the Rapid Reduction of Maternal and Neonatal Mortality, (2) AdministratiVe Order No. 2009\u20140025 on Adopting New Policies and Protoc'ol on Essential Newborn Care Protocol and (3) Administrative Order No. 2010\u20140014 on Administration of Life-Saving Drugs and Medicines by Midwives to Rapidly Reduce Maternal and Neonatal Morbidity and Mortality.   III. OBJECTIVES   In general, this policy and guide aims to ensure the appropriate provision of quality care for emergency obstetrics and newborn care in the country. Speci\ufb01cally, it aims to:   (1) Ensure quality assurance, public protection and safety in the delivery of maternal and newborn health care services; and    (2) Guide health care providers on professional standards of care for emergency obstetrics and neonatal care to promote the compliance/adherence to facility\u2014based deliveries   IV. SCOPE OF APPLICATION   This Order shall apply to all national, regional and local government public health facilities that are recipients of national government support with the Health Facilities Enhancement Program (HFEP) of the DOH linked to the Conditional Cash Transfer (CCT) convergence sites and all relevant stakeholders whose functions and activities contribute to the delivery and provision of Basic Emergency Obstetrics and Newborn Care (BEmONC) services nationwide.   V. DEFINITION OF TERMS   1. Basic Emergency Obstertric and Newborn Care (BEmONC) \u2014 capable network of facilities and providers that can perform the following six signal obstetric functions: (1) parenteral administration of oxytocin in the third stage of labor; (2) parenteral administration of loading dose of anti-convulsants; (3) parenteral administration of initial dose of antibiotics; (4) performance of assisted deliveries (Imminent Breech Delivery); (5) removal of retained products of conception; and (6) manual removal of retained placenta. These facilities are also able to provide emergeny newborn interventions, which include the minimum: (1) newborn resuscitation; (2) treatment of neonatal sepsis/infection; and (3) oxygen support. It shall also be capable of providing blood transfusion services on top of its standard functions.   2. BEmONC Capable Facility - a health facility that can either be a primary/district hospital, RHU operating 24/7 or an RHU/BHS that operate on an on\u2014call basis after regular of\ufb01ce/ clinic hours. Such facilities can be certi\ufb01ed by the DOH after meeting the standard requirements for certi\ufb01cation.   3. CCT Convergence Site - cities or municipalities within a province that have been identi\ufb01ed by the National Household Targeting System of the DSWD as recipients of the FOUR P\u2019s Program of the Department of Social Welfare and Development.   4. Certi\ufb01cation- A process and procedure of external assessment or examination by which an individual or facility is determined to possess a minimally acceptable body of knowledge and/or skills with the capacity to provide the standards of care with adequate resources which includes drugs, supplies, standard equipment and physical infrastructure.   5. Skilled Health Professional\u2014 duly licensed practicing health care professionals which include doctors, nurses and midwives   VI. GENERAL GUIDELINES   1. Certi\ufb01cation Process   Each health facility shall apply for certi\ufb01cation with the Centers for Health Development of the DOH within their respective area or jurisdiction and ensure compliance to technical standard requirements upon application. A Certi\ufb01cate of Compliance shall be conferred by the CHD to a BEmONC capable facility that meets the following requirements:   1.1 Public health facilities shall operate 24/7 and have been upgraded under the Health Facilities Enhancement Program (HFEP) of the DOH with the provision of the standard equipment and health facility infrastructure to \ufb01inction as a BEmONC capable facility   1.2 Have a staff complement trained as BEmONC teams composed of a doctor, nurse and midwife that have undergone the competency based BEmONC training in a DOH designated training center and issued a Certi\ufb01cate of Attendance as skilled health professionals   A Certi\ufb01cate of Compliance issued by the Centers for Health Development shall be valid for one year.   2. Regional Team of Assessors   The Centers for Health Development shall establish an adequate number of staff to constitute the regional team of assessors who will validate the compliance of the health facility to BEMONC service standards applying for BEmONC Certi\ufb01cation. The team of assessors shall submit their recommendation upon validation to the regional director who will approve the Certificate. of Compliance for those health facilities that meet the certification standards.   3. Maternity Care Package (MCP)   The accreditation of BEmONC capable facilities shall be linked to the Maternity Care Package developed by the Philippine Health Insurance Corporation (PHIC) for District Hospitals (DH), Rural Health Units (RHUS) and Barangay Health Stations (BHS).   The Philippine Health Insurance Corporation (PHIC) shall grant accreditation upon application of the health facilities without the need for a pre-accreditation survey. It shall be subject to the health facility\u2019s compliance to requirements as prescribed jointly by the DOH and PHIC with the issuance of the following: (1) Certi\ufb01cate of Attendance to trainings conducted by the Department of Health for BEmONC skilled health professionals and (2) Certi\ufb01cate of Compliance by the DOH- Centers for Health Development (CHD) for complying with health facility standards for BEmONC.      VII. REPEALING CLAUSE   All other Orders and related issuances inconsistent with the provisions of this issuance is hereby repealed and rescinded.   VIII. EFFECTIVITY   This Order shall take effect immediately.  ", "  The Philippines has been certi\ufb01ed polio-free in October 2000 but surveillance for Acute Flaccid Paralysis (AFP) will continue until the whole world is certi\ufb01ed polio-free as envisioned by year 2005. In addition to AFP, there are two other diseases that have also been targeted for elimination - Neonatal Tetanus (NT) by 2005 and Measles by 2008. The same AFP Surveillance Network, which has been proven to be'effective, shall be used for Measles and NT surveillance.  As the target years for global polio-free certi\ufb01cation and Philippine measles and NT elimination are drawing near, further strengthening of the integration of surveillance of these Expanded Program on Immunization (EPI) diseases is very crucial. And as surveillance network for these diseases becomes more sensitive, the numbers of reported cases are expected to increase. Hence, a more ef\ufb01cient case identi\ufb01cation, prompt and proper specimen collection are top priorities. There is also the need to further clarify the \u201cwho,\" \u201cwhere,\" \u201cwhat,\" \u201cwhen,\" and \u201chow\" questions related to case investigation and specimen collection. In order to address these concerns, these guidelines are prescribed for reference and guidance of ALL reporting hospitals, rural health units and other health facilities.  I. ACUTE FLACCID PARALYSIS SURVEILLANCE  A. Acute Flaccid Paralysis (AFP) case de\ufb01nition -Sudden onset of \ufb02accid or \ufb02oppy muscle weakness/ paralysis in any child less than 15 years old.  A11 AFP cases admitted to the hospital should be investigated using the \u201cAFP Case Investigation Form\" (Refer to Annex A).  AFP cases must be investigated and collected with two (2) stool specimens even if the onset of paralysis is more than 14 days but still within two-month period at the time the case was identi\ufb01ed (late consultation).  B. Disease conditions that may manifest with Acute F laccid Paralysis (AFP)  1. Paralytic Polio 2. Transverse Myelltis 3. Traumatic Neuritis 4. Hypokalemia 5. Acute Gastroenteritis with dehydration 6. Hypokalemic Periodic Paralysis 7. Muscle Hypotonia 8. Pott\u2019s Disease 9. TB Meningitis 10. Encephalitis 11. Convulsion 12. CNS Infection (all forms) 13. Guillain-Barre Syndrome  Other diseases not mentioned above may also manifest Acute \ufb02accid paralysis. Therefore, regardless of diagnosis, all AFP cases should be reported, investigated and collected with adeguate stool specimens.  C. Guide on AFP stool specimen collection, storage and transport  Laboratory diagnosis of wild poliovirus is a key strategy in sustaining the country\u2019s polio-free status and in achieving the goal of global polio eradication. Isolation of the wild poliovirus or circulating Vaccine-derived poliovirus (cVDPV) is the diagnostic gold standard. Sustaining a high quality laboratory surveillance is crucial for maintenance of the Philippine \u201cpolio-free\" status.  Wild poliovirus may be isolated from infected persons within 72 hours after exposure. Viral shedding persists for 3 to 6 weeks or even longer, but is greatest during the \ufb01rst two weeks after the onset of paralysis.  Collection and labeling of stool specimen should be done immediately after admission of the patient. Transport should be done after collecting two (2) stool specimens (unless child dies or went home against medical advice before second specimen is collected).  Ensure adequate and timely specimen collection by following these procedures:  1. Immediately collect 2 stool specimens (with 24 - 48 hours interval) from all AFP cases regardless of diagnosis within 14 days from the onset of paralysis. 2. Give laxative if the patient cannot defecate. 3. Stool specimens should be as big as the size of an adult\u2019s thumb. For watery stools, \ufb01ll up 3A of the specimen container. 4. Place in a dry, clean, sealed and leak proof container. . 5. Label with the name of the patient, date of birth / age, date of collection and specimen number (# 1 or # 2) 6. Store in the refrigerator at a temperature of 4-8\u00b0C. Please DO NOT FREEZE the specimen. 7. Fill out completely appropriate laboratory request form (Refer to Annex B) 8. Ship the stool specimens by using provided stool specimen box or improvised vaccine carrier with four ice packs inside to maintain temperature. 9. Send specimens to the Research Institute for Tropical Medicine (RITM) through DHL (free of charge) or to any courier if DHL is not available (freight and handling to be charged to respective Centers for Health Development).  Arrange shipment of specimen in such a way that it will reach RITM on weekdays. Should it reach RITM weekends or holidays, advance notice shall be sent through the fastest mode of communication. (Telephone, FAX, or e-mail). Stool specimen should reach RITM within 7 days after collection and sent to:  Head, Virology Section Research Institute for Tropical Medicine Filinvest Compound Alabang, Muntinlupa City Telefax: 809-7120 E-mail: ritm@doh.gov.ph  Collecting two specimens 24 hours apart increases the chance of \ufb01nding the virus. Specimen collection is easiest done in the hospital. Ideally, the patient remains hospitalized until both stool specimens are collected.  II. MEASLES SURVEILLANCE  A. Measles case de\ufb01nitions  1. Suspect measles case  History of fever (38\u00b0C or more, or hot to touch) and generalized maculopapular (blotchy) rash of 3 or more days\u2019 duration and at least one of the following: cough, coryza and conjunctivitis.  2. Laboratory confirmed measles  - Suspect case that after complete investigation satis\ufb01es at least one of the following criteria: a. Measles IgM antibody positive and/or b. Epidemiologic linkage or direct contact, during the incubation period (7-18 days prior to onset of symptoms) of a suspect case, with an IgM antibody positive measles case.  3. Clinically confirmed measles  - Suspect measles case that, for any reason, is not completely investigated (e. g. death before investigation, no blood sample) or has equivocal IgM antibody test results.  4. Not Measles  \u2014 A suspect measles case that is Measles IgM antibody negative, and/or is con\ufb01rmed positive for other diseases, e. g. rubella or dengue fever is NOT a measles case.  All suspected measles cases admitted to the hospital should be investigated using the \u201cSuspect Measles Case Investigation Form\" (Refer to Annex C). Final outcome, diagnosis and laboratory results of all suspected measles cases must be followed up for proper Classi\ufb01cation.  B. Guide on measles serum specimen collection  Since clinical diagnosis is not suf\ufb01cient to con\ufb01rm measles infection, laboratory con\ufb01rmation is very important in measles elimination campaign. Measles infection may be con\ufb01rmed by documenting a measles-speci\ufb01c immune response in the patient and/or by culture and isolation of measles virus from clinical specimen. Blood samples are taken from at least 80% of admitted suspected measles cases in designated sentinel sites (Refer to Annex D). Hospitals should prioritize collecting blood from the \ufb01rst 3 - 5 index cases admitted from a given barangay/ municipality.  The most common technique in con\ufb01rming the measles diagnosis is to test for the presence of measles-speci\ufb01c IgM antibodies in the sera collected from patients. A single blood specimen obtained shortly after the onset of rash is suf\ufb01cient for laboratory examination.  Measles-specific IgM antibodies appear within the \ufb01rst few days of the rash and decline rapidly after one month. Thus, timeliness of collection is important. Laboratory form should be \ufb01lled out properly. Specimen and laboratory forms should be sent to the RITM [as contained in ANNEX C].  1. Blood extraction procedure  a. Make the patient comfortable with the arm accessible to the operator. b. Label the vacutainer tube with the patient\u2019s name, age/sex, and date of blood extraction. c. Collect 3cc blood from the patient. Keep blood at room temperature for 2 hours until a clot forms. d. Allow retracting in the re\ufb01'igerator (approximately 4\u00b0 to 8\u00b0C) or in transport box with 4 frozen ice packs. DO NOT FREEZE the specimen. e. Centrifuge at low speed (SOOXG for 5 minutes) to separate serum from the clot. Separate serum within the following 24 hours.  2. Processing and labeling  a. Decant the serum into a cryovial labeled with the patient's name, age/sex, and date of collection. Avoid mixing red blood cells with the serum as these hemolyze (i.e., the red blood-cells break down) during storage. b. Store cyrovial at \u00ab20\u00b0C. c. Fill out completely appropriate laboratory request form d. Keep the samples frozen until transport to RITM It should arrive within 48 hours after collection  3. Storage and transport of specimen  a. To ensure that specimens remain cold during transport to the laboratory, frozen ice packs and heavily insulated containers (e.g., vaccine carriers) are needed. They can be reused after thorough washing in water and/or Sodium hypochlorite solution (household bleach or any available disinfectant). b. Repeated freezing or thawing can have harmful effects on the stability of IgM antibodies. c. The serum sample should be placed in zip-locked or sealed plastic bag. d. The case investigation form should be sealed in a separate plastic bag and enclosed within the shipping box. e. Place the specimens in the transport box with no less \"than four pieces of frozen ice packs \ufb01tted around the specimens. f. Send the serum specimen also to the Virology Section of RITM. g. Shipment of specimens is chargeable against the respective Centers for Health Development.  III. NEONATAL TETANUS SURVEILLANCE  A. NT case de\ufb01nitions 1. Suspect case  - Any neonatal death between 3 and 28 days for which the cause of death is unknown or  - Any neonate reported as having suffered from NT between 3 and 28 days of age and not investigated.  2. Con\ufb01rmed Case  \u2014 Any newborn with normal ability to suck and cry during the \ufb01rst two days of life and who between 3 and 28 days cannot suck normally, and becomes stiff or has convulsions (i.e. jerking of the muscles or both).  All con\ufb01rmed or suspected Neonatal Tetanus cases admitted in the hospital should be investigated using the \u201cNeonatal Tetanus Case Investigation Form\" (Annex E).  B. Specimen collection for NT  Neonatal tetanus surveillance is purely based on clinical history and \ufb01ndings. There is no specimen collection involved. Hence, case identi\ufb01cation and investigation must be precisely based on WHO standard as de\ufb01ned above.  IV. IMPLEMENTING MECHANISM  A. Provision of specimen collection kits.  1. AFP surveillance \u2014 The Regional Surveillance and Epidemiology Units (RESUs), will provide free stool specimen collection kits to the hospital EPI Surveillance of\ufb01cer/contact person whenever an AFP case is identi\ufb01ed.  2. Measles surveillance - The RESUs will provide free blood specimen collection kits only to the designated sentinel sites [as contained in Annex D]. These are the only hospitals accredited to have the laboratory capacity for measles surveillance because they have a laboratory facility, trained medical technicians and centrifuge unit provided by RITM.  B. Processing of stool and blood specimen at the Research Institute for Tropical Medicine.  The RITM, as the National Reference Laboratory for AFP and Measles surveillance, processes all the stool and blood specimens for free. Therefore, all reporting hospitals and local health units must not charge the patients for the collection and processing of stool and blood specimens for AF P and measles surveillance respectively.  C. Hospital-based EPI surveillance reporting system    The diagram above is the recommended \ufb02ow of reporting for EPI disease surveillance. However, different RESUs may develop its own reporting system that is more suitable for its respective regional settings.  Although EPI surveillance is hospital\u2014based, cases seen/reported by RHUs, private clinics and other smaller health units (represented by broken lines) are also included, particularly in AFP surveillance. Close coordination with the national, regional and local EPI staff is encouraged since surveillance data can help the EPI staff in identifying possible areas with low immunization coverage.  D. Roles and functions of hospitals and LGUs in EPI Surveillance  1. Hospitals  a. Admission of AF P, Measles and Neonatal tetanus cases into the hospital.  b. Daily identi\ufb01cation of AFP, Measles and Neonatal tetanus cases among hospital admissions and OPD consultations as listed in relevant hospital logbooks and records.  c. Weekly counter checking of hospital records for any missed AF P, Measles and Neonatal tetanus cases  d. Clinical examination and initial investigation of AFP, Measles and Neonatal tetanus cases in coordination with RESU/ PESU/ CESU staff or designated regional EPI Surveillance Of\ufb01cer.  e. Reporting of identi\ufb01ed cases based on standard case de\ufb01nitions to Regional EPI Surveillance Of\ufb01cer (EPISO) or appropriate provincial/ city health personnel.   f. Safekeeping of unused specimen collection kit for AF P and Measles surveillance Collection, labeling and storage of stool/ blood specimens while waiting for transport. Done only in designated sentinel site as listed in Annex D.  g. Transport of stool and blood specimen to RITM via DHL or other available freight services. Either the RESU sta\ufb02 or hospital personnel will transport the stool specimen to nearest DHL of\ufb01ce, depending on what has been agreed   h. Referral of AFP patients for rehabilitation.  i. Allow the EPISO to have access to medical records of reported AF P, Measles and Neonatal tetanus cases  j. Provide photocopy of medical records of reported AFP cases, particularly those with inadequately collected stool specimen (one or both stools collected after 14 days from onset of paralysis)  k. When the \ufb01nal outcome of an AFP, Measles or Neonatal tetanus is not known because the patient went home against medical advice, hospitals should coordinate with the concerned PHO/ CHO or RHU for follow up of cases.  2. Local Government Units/ Rural Health Units  a. Referral of AFP and Neonatal tetanus cases detected at the RHU to nearest hospital reporting site for admission. Measles cases may also be referred to hospital for admission, particularly if there are complications.  b. If the AF P case detected at the RHU is not admitted to the hospital, RHU should facilitate collection of two stool specimens and immediately report the case to the EPI coordinator at the PHO/CHO or the EPISO or any RESU staff for case investigation.  c. If the provincial/ city EPI coordinator or the EPISO cannot respond immediately, a trained DOH representative shall be assigned to investigate the case.  d. Assist the EPISO, local EPI coordinator or DOH representative in determining \ufb01nal outcome of reported Measles and Neonatal tetanus cases, especially those who went home against medical advice.  e. Assist the EPISO, local EPI coordinator or DOH representative in conducting 60 days follow-up of all reported AFP cases (Refer to Annex F).  f. Provide EPISO, local EPI coordinator or DOH representative information about immunization history of AFP, Measles and Neonatal tetanus cases and FIC coverage in the areas where cases are clustering.  g. Assist the RESU/ PHO/ CESU in monitoring clustering of cases and during outbreak investigation.  E. Establishment of EPI Surveillance Team in the hospitals  To ensure that the above roles and functions shall be accomplished, each hospital, in collaboration with the respective RESUs, will establish its own EPI surveillance team. The composition of the team and speci\ufb01c tasks of each member and the RESU/PESU staff will be de\ufb01ned in a Memorandum of Agreement signed by the Chief of Hospital, EPI Surveillance Team Leader, Regional Epidemiologist or RESU Head and the Regional EPI Surveillance Of\ufb01cer.  Ideally, the team shall be composed of the hospital\u2019s neurologist, pediatrician, resident physician, pediatric and emergency ward nurses, laboratory staff, Admission Section staff and Records Section staff.  VI. REPEALING CLAUSE  Administrative issuances and other related orders inconsistent with this Order are hereby repealed.  VII. EFFECTIVITY  This order shall take effect immediately.       ", "  I. Background   The Philippines is signatory to the United Nations Millennium Declaration that de\ufb01ned 8 development goals 3 of which relates directly to health. The Millennium Development Goals (MDGs) are for countries of the world to accomplish in a span of 15 years to ensure the attainment of better quality of life for its people. In health, emphasis has been heavily placed on accelerating improvements in the attainment of MDGs 4 and 5 that aim to reduce under-\ufb01ve child and maternal mortality by 2015. Beyond 2015, the global target is an MMR of less than 70 by 2030; for the country the aim is to reduce maternal mortality ratio to 39.   To guide program implementers and service providers, the Department of Health, issued 2 administrative orders aimed at making pregnancy and delivery safer for both the mother and child: 1) AO 79, s. 2000 also known as the Safe Motherhood Policy issued in July 2000 and 2) AO 2008-0029 on Implementing Health Reforms to Rapidly Reduce Maternal and Neonatal Mortality in 9 September 2008. This is known as the MNCHN Policy. Both issuances target a reduction in maternal and newborn mortality.   Studies and experiences of other countries that have drastically reduced their maternal mortalities have shown that although women and the unborn need care, attention during delivery is most important to guarantee better survival of the mother and her newborn. In the Philippines 73% of births are attended by skilled health professionals and 61% occur at a health facility (NDHS 2013). But while there are improvements in maternal health outcomes, maternal mortality ratio remain high at 221/100,000 live births (FHS 2011) and 130/ 100,000 live births (UN Estimate, 2013). There is thus a need to further the delivery of basic emergency obstetrics and newborn care at the periphery. These services shall include among others the administration of life saving drugs by nurses and midwives in circumstances where a referral doctor or facility is not available.   II. Objective   This Guideline mandates the health sector to strengthen the capacity of nurses and midwives in maternal and newborn care to adequately and appropriately respond to pregnancy-related complications by ensuring that they are trained on Basic Emergency Obstetric and Newborn Care (BEmONC) and other related training courses and allowing them to perform all the BEmONC signal functions as de\ufb01ned by the Department of Health including the administration of life saving drugs as mandated by Republic Act 10354 (RPRH Act of 2012).   This AO likewise mandates every nurse and midwife practitioner to administer life-saving   drugs such as but not limited to oxytocin, anticonvulsants, corticosteroids, and antibiotics in emergency situations and where there are no available doctor and health facility.   III. Scope and Coverage   This Order shall apply to all heads of health facilities providing birthing services as well as registered nurses and midwives that provide skilled health professional maternal and newborn care services in both the public and private health sector.   IV. General Principles   To ensure safer pregnancy and delivery, the following principles shall guide every policy maker, program manager, local chief executive, health of\ufb01cer and health care provider in maternal and newborn health:   1. For better health outcomes, every pregnancy shall be planned and supported.   2. Health care providers shall perform the highest quality of care possible to ensure safety in every delivery  3. Gender and culture sensitivity shall be the norm in health service provision.   4. A three\u2014pronged approach that comprise the following shall be adopted:   a Birthing Centers upgraded to perform emergency obstetric and newborn care;  b. Health Professionals trained to pro\ufb01ciency in the performance of basic emergency obstetric and newborn care; and  c. Reproductive health services made universally accessible to persons of reproductive age.    5. Every woman shall be encouraged to give birth in a health facility.   6. System\u2014wide approach shall be implemented to ensure a wide reach.   7. Every client shall be accorded the right to make free and informed decisions in matters related to one\u2019s health.   V. De\ufb01nition of Terms   1. Basic Emergency Obstetric and Newborn Care (BEmONC) refers to lifesaving services for emergency maternal and newborn conditions/complications being provided by a health facility or professional to include the following services: administration of parenteral oxytocic drugs, administration of loading dose of parenteral anticonvulsants, administration of loading dose of parenteral antibiotics, antenatal administration of loading dose of steroids in threatened premature delivery, performance of assisted vaginal deliveries, removal of retained placental products, and manual removal of retained placenta. It also includes neonatal interventions which include at the minimum: newborn resuscitation, provision of warmth, referral and blood transfusion where possible.   2. Skilled Health Professional refers to a doctor, nurse and midwife who has been educated and trained in the skills needed to manage normal and complicated pregnancies, childbirth and the immediate postnatal period, and in the identi\ufb01cation, management and referral of complications in women and newborns.   -Midwife is a professional trained to provide services that require an understanding of the principles and application of procedures and techniques in the supervision and care of women during pregnancy, labor and puerperium, management of normal deliveries, including performance of internal examination during labor except when patient is with antenatal bleeding, carry out written order of the physician with regard to antenatal, intra\u2014natal and postnatal care of the normal pregnant including giving of immunization, oral and parenteral dispensing of oxytocic drug, suturing perineal laceration, give intravenous \ufb02uid during obstetrical emergencies provided she has been trained for that purpose and may inject vitamin K to newborns.  -Nurse is a duly registered professional who has successfully completed training in a formal nursing education program and has acquired knowledge and skills in health promotion and maintenance, disease prevention, physical and psychosocial assessment and management of health and illness for women throughout their life cycle. As a member of the BEmONC Team, the nurse provides independent and collaborative functions under the direct and indirect supervision of a physician in the provision of preventive care, episodic care, collaborative care and surgical care.   3. Life Saving Drugs are drugs such as oxytocin, magnesium sulfate, antenatal steroids, and antibiotics, among other medicines used to prevent and manage pregnancy\u2014related complications.   4. For purposes of this Administrative Order, Emergency shall be de\ufb01ned as a condition or state of a patient wherein based on the objective \ufb01ndings of a prudent medical of\ufb01cer, nurse or midwife on duty for the day there is immediate danger and where delay in initial support and treatment may cause loss of life or cause permanent disability to the patient.   VI. Implementing Guidelines   RA 10354 otherwise known as the Responsible Parenthood and Reproductive Health Act of 2012 mandates nurses and midwives who are tasked to provide maternal and newborn care services to administer life-saving drugs such as but not limited to oxytocin, steroids, antibiotics and magnesium sulfate in accordance with the following conditions:   1. The patient is suffering from a complication evaluated to be an emergency as de\ufb01ned in this Order and no physician and health facility is available to manage such condition.   2. Nurses shall have completed the 11-day basic emergency obstetric and newborn care (BEmONC) skills training course and certi\ufb01ed to perform the BEmONC signal functions required of nurses by a Training Center recognized by the Department of Health.   3. Midwives shall have completed the 11-day basic emergency obstetric and newborn care (BEmONC) skills training course or the 7-day BEmONC training for midwives and certi\ufb01ed to perform the BEmONC signal functions required of midwives by a Training Center recognized by the Department of Health.   4. The BEmONC Skills Training Course shall include the administration of life saving drugs. Thus a nurse or midwife certi\ufb01ed to perform the BEmONC signal functions as de\ufb01ned by the Department of Health is automatically certi\ufb01ed to administer life saving drugs. '   5. All emergency drugs to be administered by nurses and midwives shall be covered by a physician\u2019s order.   -In cases where a written order is impossible to obtain such as when the physician is not physically available, a verbal order shall be acquired through a call and appropriately recorded by the nurse or midwife. The verbal order shall be read to the physician before ending the call for con\ufb01rmation. As soon as the physician is physically available in the health facility, he or she shall be made to sign the verbal order made.   -In areas where geographic isolation brought about by calamities or armed con\ufb02ict are likely to occur any time and a written or verbal order is impossible to obtain, a clinical protocol duly signed by the physician shall be made available at the Birthing Center. Said protocol shall specify the following:   -Signs and symptoms of an emergency condition  -Drug to administer for such manifestations  -Timing and dosage of drug administration  -Route of drug administration  -Frequency of administration  -Signs and symptoms of an improving condition   6. The nurse or midwife shall inform the physician by all means about the administration of an emergency drug and apprise him or her of the patient\u2019s condition when or where possible. These actions shall be recorded in the Individual Treatment Chart/Patient\u2019s Chart.   7. All patients administered with an emergency drug shall be REFERRED IMMEDIATELY after the administration of the loading dose or as soon as the situation warrants, to the nearest facility providing comprehensive emergency obstetric and newborn care (CEmONC).   8. In the interest of saving patients\u2019 lives, nurses and midwives shall strictly observe the protocol for referral.   -Emergency transport shall be available to the patient either for free or for a fee.  -A health worker shall be available to accompany the patient to the referral hospital.  -Relevant Patient\u2019s record should be with the patient at the time of referral for endorsement to the referral hospital. .  -Referral note that speci\ufb01es reason for referral and speci\ufb01c actions and medical management received at the referring facility.  -While the patient is in transit, a call to the referral facility shall be made by the referring health worker to inform the receiving of\ufb01cer at the referral facility of such referral.   VII. Roles and Responsibilities   A. Training Centers offering BEmONC Skills course shall:   1. Manage the Training Program and conduct BEmONC Skills Training to service providers: doctors, nurses and midwives from the public and private sector as well as members of the academe, such as but not limited to the faculty members of schools of midwifery and colleges of nursing.   2. Conduct a Post Training Evaluation (PTE) as required by the BEmONC Skills Training design and certify the trainee\u2019s ability to perform the BEmONC signal functions required according to the de\ufb01nition of the Department of Health.  3. Issue a Certi\ufb01cate of Training to each trainee upon completion of the course requirements that include but are not limited to the following: pretest, passing the post test and return \u2014 demonstrations other related learning experiences (RLEs) and Certi\ufb01cate of Competency upon passing the Post Training Evaluation.   4. Ensure that the course is in compliance with the Standards of Nursing and Midwifery in the Philippines, certify that the Training Course is accredited by the Professional Regulation Commission (PRC) Board of Nursing and Board of Midwifery.   B. Local Government Units through the Provincial, City and Municipal Health Of\ufb01ces shall:   1. Ensure that the operation of their Birthing Centers in both the public and private sector comply with the DOH licensing requirements and the accreditation requirements of PhilHealth.  2. Ensure that life-saving drugs are available in all Birthing Centers including private birthing centers at all times in adequate number based on case load and experience.   3. Allow their staff to attend training programs such as but not limited to the BEmONC skills training course by providing paid time, cost of travel and the allowable per diem.   4. Sponsor or source out sponsors for their staff training.   5. Implement this Order by translating into local policy for optimal compliance by critical stakeholders.   6. Engage local chapters of professional groups such as: The Philippine Obstetrical and Gynecological Society (POGS), The Philippine Pediatric Society (PPS), The Philippine Society for Newborn Medicine (PSNbM), Philippine Nurses Association (PNA), The Philippine League of Government Nurses and the various Midwives Association to assist the Local Health Board in ensuring the effective implementation of this Order.   7. Ensure the setting-up of an operational public-private service delivery network that de\ufb01nes an ef\ufb01cient referral system within and outside geographical boundaries.   8. Ensure that each Birthing Center, including private birthing centers, has a stand by emergency transport, which is either a properly maintained government ambulance or privately owned public conveyance.   9. Conduct periodic monitoring and supervision of birthing centers to ensure health workers\u2019 compliance to the standards of BEmONC including the provision of life saving drugs and assess quality of care.   C. Department of Health through the Disease Prevention and Control Bureau, Women and Men\u2019s Health Development Division shall:   1. Provide over-all supervision of the BEmONC Skills Training Program being implemented in recognized Training Centers in the country.   2. Ensure that related training protocols including its technical contents are updated.   3. The National Safe Motherhood Program shall collaborate with the DOH Regional Of\ufb01ces on the conduct of periodic monitoring of the implementation of this order through such activities as monitoring of Program indicators that re\ufb02ect client and provider behavior change as well as quality of care.   4. Cause the expansion of Training Centers for BEmONC skills as necessary.   5. Allot funds for the sponsorship of trainees to the BEmONC skills course.    VIII. Monitoring and Evaluation   Monitoring and supervision of BEmONC teams as well as individually practicing professionals including nurses and midwives in the public and private health sector shall be conducted through a cooperative effort of the Provincial and City Health Of\ufb01ces and the DOH Regional Of\ufb01ces.    IX. Repealing Clause   The provision of previous Orders and other related Issuances that are inconsistent with this Administrative Order are hereby rescinded. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.   X. Effectivity   This Order shall take effect immediately.   ", " I. BACKGROUND and RATIONALE  The Philippines has been free of wild poliovirus for the past 12 years. The last indigenous wild poliovirus was isolated in Cebu last May 1993. Our country together with member countries of the Western Pacific Region (WPR) were certified as polio-free by an independent body, the Regional Certification Commission on Polio last October 2000 in Kyoto, Japan.  Sustaining and maintaining a polio-free status remains a challenge. Achieving a high population immunity (85% and above) against polio in all barangays, improve surveillance on Acute Flaccid Paralysis (AFP) and conduct of supplemental immunization activities (SIA) in targeted population are essential for polio eradication.  For the past 5 years, full immunization coverage among infants below 12 months never reached 95%, leaving an estimated half a million of children every year at risk of having any of the vaccine-preventable childhood illnesses. Likewise, low AFP surveillance, our geographic proximity to Indonesia, which as of morbidity week 31, has 205 cases of wild poliovirus cases, and the presence of port entries places the Philippines at risk of wild poliovirus importation. These significant findings prompted the Department of Health (DOH) to call for a SIA dubbed as \"PATAK KONTRA POLIO\" in selected identified areas nationwide.  This administrative order has been issued to guide all concerned health workers, and partners in the implementation of the campaign.  II. OBJECTIVES  A. General Objectives:  The campaign aims:  1) To increase population immunity against wild poliovirus to decrease the risk of imported wild poliovirus being transmitted into the Philippines  2) To consolidate the Polio Eradication Initiative in the Philippines during the post-certification stage up to the Global Certification  3) To protect children and mothers in high-risk areas against other vaccine-preventable diseases.  4) To develop a plan to ensure every child is reached in every barangay for immunization at least quarterly.  B. Specific Objectives  The door-to-door strategy adopted in the Philippines entails the movement of vaccination teams from door to door in urbanized areas and in strategically selected temporary fixed sites in rural barangays, streets, markets and other outdoor areas to:  1) Identify all children under 5 years of age 2) Vaccinate with one dose (two drop) of OPV all children identified for 2 rounds 3) Vaccinate all under-vaccinated children 4) Re-visit and vaccinate all absent eligible children  III. COVERAGE OF THE CAMPAIGN  The \"Patak Kontra Polio\" shall first be implemented regionwide in ARMM and all barangays in Zamboanga City on the following dates:  ROUND 1: August 29 - September 2, 2005 ROUND 2: September 26 - 30, 2005  IV. GENERAL GUIDELINES  A. Vaccination Strategies  1. Door-to-Door Vaccination  The strategy consists of door-to-door (OPV) immunization in urban, and poblacion; large numbers of unimmunized, or other locally determined reasons requiring door-to-door. Strategic temporary fixed sites in rural barangays, with meticulous micro planning and intensive supervision ensuring that all children from 0 to 59 months regardless of previous immunization status are reached in all selected areas.  Children in public areas such as streets, markets and parks, should also be targeted to ensure that all children are reached.  2. Polio Plus  To provide maximum protection to the children against the EPI diseases, other antigens and Vitamin A shall be provided. All under-immunized children under 12 months should receive BCG, unimmunized less than 24 months old should receive DPT; children between 9-59 months receive AMV to become fully vaccinated. Strongly consider vaccinating these children to 2 doses of AMV. Vitamin A for children ages 6 to 59 months shall also be given during the second round of PKP as part of Garantisadong Pambata, Round 2.  C. Organizational Management  The existing structures established in the conduct of mass immunizations shall be revitalized to provide directions, advice and recommendations to the successful implementation of the campaign.  The Secretary of Health shall be the over-all chairman with the National Immunization Committee (NIC) as the advisory body.  At the regional level/provincial/city/municipal levels, the head of office shall be the over-all responsible for the Operations.  D. Communication and Social Mobilization  Indonesia had a successful first immunization round. However, the second round was less successful. Community members attributed incidental deaths to the OPV. They identified the communication strategy as an area needing improvement. The Philippines has encountered similar situations, including the Tetanus Toxoid Controversy.  The success of this activity depends on the success of social mobilization activities. Social Mobilization before and during the campaign is essential because it (1) informs the target population about the importance of the campaign, the time & place immunization services will be offered; (2) informs the people who influence the target population such as the parents, informal opinion leaders, religious leaders, local chief executives, non-government organizations and special groups- nomadic groups, indigenous people and (3) clears up misconceptions about the campaign (4) Enables health workers and program planners to provide convenient services; to anticipate potential problems; and to arrive at viable solutions.  As in the previous mass vaccinations, multiple sectors and stakeholders will have to be mobilized. Provincial/City/Municipal and barangay level social mobilization activities are also expected to follow the same procedures and general pattern of networking. There are, however, many other innovations possible only at the community level. Below describes necessary steps.  Launchings, Ceremonial \"Patak\", sales conferences and orientations, press conference, local church announcements can be undertaken to inform the public about the campaign.  It is critical that religious and opinion leaders are advocates. This should take place through meetings with high-level leaders and subsequent meetings and orientations.  D. MOBILIZATION OF RESOURCES  These sections reiterate the functions of National/Regional (including DOH representatives), Provincial /City/Municipal Health Staff as well as the vaccination teams in the conduct of mass immunization campaigns such as this \"Patak Kontra Polio\" as follows:  1. Mobilize resources - human, financial, material, etc. - to ensure the successful implementation of the campaign. If necessary, they shall provide vaccinators teams from their own health staff. This shall also include full support for travel and communication of the vaccination and monitoring teams.  2. Prioritize vaccination efforts where unvaccinated children are likely to reside. Many implementers are placing undue energy to reach a few children who are most likely immunized while there are many more missed unvaccinated children who live in neighboring depressed and congested barangays.  3. Ensure that the field vaccination teams of the appropriate barangays utilize the list of children missed in school/day care center vaccinations as their guide when they do the community level vaccinations so that these children are vaccinated at home outside of school hours.  4. Coordinate more closely with pediatricians and other private practitioners so that they strongly encourage their clients to have their children vaccinated. Pediatricians may be allowed to vaccinate their own patients, if necessary.  5. Strengthen the command posts at all levels - region, province, city, municipality, barangay - by ensuring that they comply with all relevant guidelines and procedures and that they are fully provided with appropriate support systems and resources.  Other recommended activities and details to mobilize the provinces, cities, municipalities, barangays, communities and schools has been provided in the \"Ligtas Tigdas Field Guide 2004\" for details.  Information Dissemination:  IEC materials like posters, leaflets and streamers shall be posted in strategic areas. Leaflets with messages motivating the general public to have all children vaccinated shall be given to the parents. A streamer announcing the campaign shall be prominently displayed identified areas.  Information announcing and motivating mothers/child minders to bring their children for immunization shall be done by using the radio/TV/local newspaper, through the Church, through the local associations like PTA, schools and other agencies. This can be intensified during the 2 weeks preceding the date of the campaign.  Prototype promotional materials have been developed by the National Center for Health Promotion, Department of Health specific for the campaign to guide each LGUs. (Annex A Prototype Poster and Streamer)  V. IMPLEMENTING MECHANISMS  A. Pre-Patak Kontra Polio  A1. Perform Data Analysis  All planning should begin with data analysis. This will focus activities and resources to optimally reach every child. DPT3 unimmunized will be used as a proxy for the number of persons unimmunized against OPV because it is currently the most reliable data. Annex B Form 1 with the instructions shall be used specific for this activity.  A2. Determine Vaccine & Personnel Requirements  This activity will enable health workers to calculate vaccine needs for the SIA and number of staff needed.  A3. Develop a Detailed Community Map  Maps are critical to organize planning and visually show areas with unmet needs and how to reach all the infants and women in the area. Each LGU shall develop this map as follows:  \u2022 Obtain a detailed map of the area. These can usually be obtained from Urban Planning, municipal maps or other sources. Even a street map will suffice if it is large enough. For the purposes of this exercise, if a detailed map is unavailable now, draw an accurate map outlining your catchment areas.  \u2022 Demarcate on the map:^1  i. Boundaries of the catchment areas ii. Health facilities and sites used for health purposes iii. Roads iv. Geographical Landmarks  \u2022 Subdivide and demarcate on the map boundaries of areas with distinguished populations (e.g., for a barangay: urban slums areas, elite subdivisions, or middle class communities, for a region: cities and provinces).  \u2022 Indicate the estimated eligible population and number of households in each demarcated area.  \u2022 Color Code the areas on the map distinguishing in red highlight all known high-risk areas that were identified in Table 1.  \u2022 Health centers use the map to identify sites for setting up strategic temporary fixed posts in all barangays where door-to-door strategy will not be used. If in a far flung barangay, indicate route and means of transportation.  A4. Meeting With The Community  The community plays a vital role in achieving high immunization. Health center staff should meet with the barangay captains, religious leaders and other influential leaders to discuss the objectives of the campaign, identify ways and means on how they are of help in reaching all the children/mothers. Follow-up the agreements set during the initial meeting to ensure the full support and commitment for the activity.  Specific roles of the community to ensure 95% OPV coverage at the different phases of the campaign are highly recommended as follows:  1 This map should be reviewed with local medical and non-medical staff to ensure underserved populations are included.  Before the campaign:  Health staff will arrange with the Barangay Captain to hold a community meeting. They should do the following (in order):  \u2022 Elicit community concerns, perceived barriers and benefits, convenient time and place for the immunization activities; \u2022 Facilitate discussion around these points; \u2022 Address issues that have not come up, e.g., purpose, benefits, safety of the vaccine, coincidental problems; \u2022 Arrive at agreements of the community's roles in the activity, times and venues \u2022 Organize family leaders^2 to ensure family fully vaccinated  During the campaign:  To ensure high coverage, family leaders will remind parents the night before going house to house about the immunization activity. During the activity, at the appropriate time, they will mobilize the families to get vaccinated. They will inform the vaccination teams at once of any missed children or mothers while the vaccination team is present.  A5. Develop A Microplan  Review previous worksheets. identify how each of the following will be carried out  \u2022 Ensuring sufficient vaccines available at the right time and place. \u2022 Calculate other logistics needs using Table 4 for syringes/needles, safety collection box) \u2022 Ensure cold chain maintained (cold room, refrigerators, freezers, carriers, etc.) If not completed within the year, complete the Cold Chain and Logistics Assessment Worksheet. \u2022 Ensure Human Resources sufficient based on Table 2b. Consider if additional temporary manpower is required.  B. Actual Patak Kontra Polio  B1. Steps On The Conduct Of The Door-To-Door Vaccinations  B1.1 The Vaccination Team  The teams are composed of a vaccinator and a recorder. The teams will directly work with the family leaders. Vaccination teams must vaccinate all children under five they can find regardless of previous vaccination status, not only in households but also in the streets, markets, parks, everywhere.  2 A family leader is a community member who will represent the best interest of families within about 5-20 nearby households.  The vaccinator shall be the team leader and has the over-all supervision of the immunization activity in the assigned area. In areas with high under/unimmunized children or low immunization coverage, it is recommended that a midwife or a nurse shall be the vaccinator to provide the missed injectable vaccines. The vaccinator needs to organize and coordinate the vaccination site, the recorder and the family leaders for efficient crowd mobilization and control, flow of patients to ensure safe injection and disposal and information dissemination.  The recorder is responsible for filling up the form and document the team's progress and accomplishment. He or she is also responsible in making the child left's finger as well as marking of the house visited. The recorder will need to maintain the crowd control set up by the vaccinator and disseminate information on fever and reasons to seek help. The recorder will maintain the organization of the family leaders in terms of when to mobilize who and where.  \"Master-listing\" of children or any other type of nominal lists of children (such as \"enumeration lists\" or \"defaulters lists\") are no guarantee of completeness of coverage (all children) and should not be used as a \"tool\" for a high quality door-to-door immunization. There will almost always be some, and possibly many, target age children who are not included on these lists.  B1.2 Before starting the day's visit, each team should check the following:  \u2022 Coordinated with the barangay officials on the immunization sessions \u2022 Information on the expected results for the day \u2022 Route plan for the day, indicating houses, nursery schools and markets to be visited \u2022 Expected areas family leaders to cover at which time. \u2022 Expected number of houses, nursery schools and markets to be visited \u2022 Expected number of children under 5 years old to be immunized \u2022 Available supplies for the day's target  - A map (sketch) of the assigned area - Oral polio vaccine with vaccine vial monitor (VVM) and droppers - Other vaccines: BCG, DPT, MV, TT - Vitamin A capsules (100,000 IU & 200,000 IU) - Vaccine carrier: 1 per vaccination team, with 2 frozen icepacks - Tally sheets: 1 for each day - Chalk to mark the houses where immunization is completed - Markers or pens to mark the children - ECCD Cards  B1.3 Conducting The Visits Door To Door  a. Introduction on the Purpose of the Visit  On entering a house, the vaccinating team should:  \u2022 Introduce themselves as part of the \"PATAK KONTRA POLIO\" from the nearest health center. \u2022 Briefly explain the purpose of the visit: To protect all children under five years of age against polio and other EPI diseases. \u2022 Ask for all children under 5 years in the household to be presented to the team for vaccination.  b. Give the following vaccines:    Reminders for ensuring the quality of vaccines to be given to the children/mothers:  \u2022 It is important to keep the vaccine as cool as possible at all times. Open the vaccine carrier as little as possible, and keep the vaccine carrier in the shade if you can.  \u2022 The Vaccine Vial Monitor (VVM) indicates whether the vaccine can be used or not. Before giving vaccine, always check the VVM. If the VVM becomes as dark or darker in color than the indicator put it aside and DO NOT USE THE VACCINE.  c. Markings of a Vaccinated Infant/Child and Houses Visited:  \u2022 After giving vaccine, mark the nail and skin of the child's small left finger.  \u2022 Fill in the tally sheet - Vaccination Team Daily Accomplishment Report. Record all children immunized and count the house. Check the cell in form if the child was vaccinated in the household or in the street.  \u2022 For infants given first dose of any of the antigen, record in the ECCD card also.  \u2022 Place a circle (O) chalk mark on the house to identify it as 'completed' only if all children aged 0-59 months in it were vaccinated.  d. Markings On Closed Houses Or Missed Eligible Child/Children:  If the house is closed or the team doesn't immunize all of the 0-59 month old children  \u2022 For every missed child in the household, note down the name and address of the child at the back of the recording form. This record shall remind the vaccination team that a household needs to be revisited.  \u2022 Ask relatives or neighbours the most appropriate time to re-visit 'missed' house or children (should be in the end of the same day or next morning). At the end of the day, decide with your supervisor when to revisit these houses to finish the immunization.  \u2022 Place an (X) chalk mark on the house to indicate unvaccinated child/children and the house must be re-visited.  e. If there is a market, nursery school, hospital, factory or other building in the area or children in the street  \u2022 Inquire whether there are any 0-59 month old children and vaccinate them - the goal is to vaccinate all of the children wherever they are found  If the planned area is completed before the end of the day, the team should not stop but should continue immunizing in the next area.  f. At the end of the day the team should:  \u2022 Complete all the required information on the tally sheet, including number of vaccine vials returned, unused and partially used. \u2022 Report to the supervisor and review the day's activities: Were targets met? \u2022 Report on any difficulties encountered and children or houses missed \u2022 Decide on the re-visit for the (X) marked houses: Need to be re-visited in the evening or in the morning? \u2022 Plan the next day's activities in coordination with your supervisor.  Reminder:  Record the number of empty vaccine vials, partially used, or put aside because the WM changed on the tally sheet and turned in to the supervisor at the end of the day. Do not discard any vials of vaccine  B1.4 Injection Safety  Safe Injection: - Is one with a potent vaccine is administered in the correct dose using the correct procedure at the correct site; - Does not harm the recipient; - Does not expose the provider to any avoidable risk; and - Does not spread waste that is harmful to the community and health workers.  Unsafe injection practices put clients, health workers, and the community at risk of injection abscesses and blood-borne diseases.  Health workers should observe sterile procedures; guard against needle stick injuries; and place used syringes and needles into the designated safety boxes WITHOUT RECAPPING. Recapping of auto-destruct syringes should be avoided in order to prevent vaccinators from pricking themselves with used needles.  Always remember!  \u2022 Use one auto-disabled (AD) needle-syringe per child. \u2022 Apply the appropriate injection technique \u2022 Do not recap used needles \u2022 Handle used needles carefully to avoid wounds caused by needles \u2022 Dispose of used AD needles-syringes properly  a. Handling, Storage, Treatment & Collection of Empty Vaccine vials and other hazardous health care generated during the \"Patak Kontra Polio\"  In addition to the provisions on Injection Safety of the Guide to Ligtas Tigdas 2004, the following are procedures and guidelines in handling empty vials and other hazardous health care wastes.  \u2022 Empty vaccine vials and vials with residual liquid shall be stored in a leak proof container (e. g. hard container -plastic gallon) separate from the used needles and syringes from the other hazardous health care wastes.  \u2022 Empty vials shall be treated through chemical disinfections i.e. chlorine solutions or heating (boiling, solar disinfections) and other acceptable procedures. In areas where collection is not a problem, these stored wastes can be disposed off directly through concrete vault and other acceptable disposable methods.  The same procedures can be applied to other types of hazardous health care wastes generated during this activity.  \u2022 All waste shall be collected and transported into the designated disposal facility.  \u2022 Disposal may be through encapsulation and safe burial and shall be in accordance with the provisions of the DOI-I Health Care Waste Management Manual and Safety Injections of the Guide to Ligtas Tigdas 2004.  B1.5 Adverse Event Following Immunization (AEFI)  An adverse event following immunization or AEFI is a medical incident that happens after immunization that causes concern. Although the vaccines used in national immunization program are extremely safe and effective, adverse events can occur following vaccine administration. In addition to reactions to the vaccines themselves, the process of immunization is a potential source of adverse events.  All the vaccines given in the Expanded Program on Immunization (EPI) are safe and effective. However, just as no vaccine is perfectly effective, none is entirely without risk. Different children can react differently. Therefore, some adverse events following immunization (AEFI) may still happen.  The most common reactions are often mild, of short duration and are not due to the vaccine. They are often coincidental or an injection reaction such as anxiety over the pain caused by the injection.  Common minor reactions such as mild local reactions, fever, and other self-limiting systemic symptoms need not be reported. Therefore, it is important for health workers to advise the parent/caregiver at the time of immunization that these reactions are expected, and advise them how to manage these common minor reactions at home.  Health worker (physician/ nurse/midwife/ hospital stafD/concerned citizen/parent/teacher) reports to the Municipal/City/Provincial level any AEFI within 24-48 hours through the fastest available means. (Telephone, fax cell phone, text messages, etc.  A flow of the AEFI Report has been diagrammed in the \"Guide to Ligtas Tigdas\". The same flow of report shall be followed.  B1.6 Recording and Reporting  There are reporting forms that are to be used during this campaign and examples of each form are annexed to this guide. They are used and completed as follows:  Reporting Form A - Vaccination Team's Daily Accomplishment  This is a daily accomplishment form to be filled up by each vaccination team, specifically the recorder.  This records each child vaccinated with OPV in the household or street. This form consists of the following:  a) Table which represents the number of households visited by the vaccination team. Each cell corresponds to one household. Tick (/) each cell per vaccinated child if all eligible children in the household were vaccinated. Marked (X) if there were eligible children in the household that were missed. Missed children should be scheduled revisit. Write the addresses at the back of the form for houses that need to be revisited.  Write the total number of household visited at the box provided for in the form at the end of the vaccination day.  b) Tables that consists of cells on OPV coverage at the streets.  Same steps and procedures above are followed in filling up the cells as well as the total number of children given OPV.  c) A table on Logistics Daily Summary is the daily inventory of OPV.  Fill up the corresponding boxes on:  d.1 Total number of OPV received during the day, d.2 Total number of OPV spoiled d.3 Total number of OPV returned empty d.4 Total number of OPV returned unopened  Submit this form to the team supervisor at the end of every immunization day. Total for each vaccination team will be consolidated by the RHU or CHO using the Reporting Form B.  Reporting Form B1: Consolidated OPV Accomplishment Reports  This is a daily summary of OPV vaccination accomplishment to be filled up by each team supervisor. All spaces and columns should be filled up and the completed form should be submitted to the next higher level.  Reporting Form B2: Consolidated Polio Plus Accomplishment Reports  This is a daily summary of Polio Plus vaccination accomplishment to be filled up by each team supervisor. All spaces and columns should be filled up and the completed form should be submitted to the next higher level.  The following shall be the schedule of submission of the accomplishment reports.    C. Post-Patak Kontra Polio  C.1 Monitoring & Supervision  i. Composition  National, regional, provincial, city and municipal vaccination supervisors (if any) will be designated. It is recommended but is not limited to that the team supervisors are physicians and nurses.  The number of team supervisors should be as follows:  Urban Areas - At least 1 supervisor for 8 teams Rural Areas - At least 1 supervisor for 4 teams  ii. Roles of the Supervisors/Monitors.  Before the Campaign:  \u2022 Ensures the timely and adequate transport of supplies and staff to support all the necessary campaign activities is made available \u2022 Assists in the training of health workers and volunteers in all aspects of the campaign \u2022 Coordinates for additional vaccinators and volunteers \u2022 Coordinates with various partners in the campaign \u2022 Visit the community leaders e. g. the Barangay Captain, Kagawad or religious leader, schools and day care centers together with the team and orient them about the forthcoming activity \u2022 Coordinate with nearest hospital facility for possible referral of any AEFI \u2022 Identify hospital medical staff to manage serious AEFI  During the Campaign:  \u2022 Assures that the vaccination teams are moving from one house to the next, vaccinating children, giving Vitamin A, marking the vaccinated child, and marking the house and proper recording using Reporting Forms. \u2022 Provides special support to areas with lack of vaccination teams and supervisors \u2022 Discusses with the teams issues/concerns and lessons learned, particularly how to handle revisits \u2022 Reports daily accomplishment, issues/concerns and lessons learned to the CHO/MHO level \u2022 Collects the filled-up safety boxes from the vaccination teams and stores it in a safe place prior to pick up by the sanitary inspector for proper disposal \u2022 Monitors the safe collection and disposal of used syringes and needles \u2022 Assists in the referral of emergency cases and investigation of adverse events \u2022 Estimates and provides logistics to the vaccination teams \u2022 Supervises, monitors and assist the vaccination teams including the teams from the fixed sites \u2022 Accomplish and submit line list of AEFI to the City/Municipal Coordinator (Refer to Guide to Ligtas Tigdas 2004)  Immediate feedback to the persons supervised and the next higher levels of supervisors are important especially if there were problems found during the visits. The supervisor should know whom, when and how to call different persons involved so that immediate solutions to address the problem can be made using the fastest means. The use of mobile phones in the reporting of problems/issues before, during and after the campaign has proven to be advantageous resulting to immediate action as experienced in the past Polio Patak Campaign.  2. Rapid Coverage Assessment  The RCA shall be adopted to validate each child/mother were vaccinated.  Specifically this shall:  a. Compare assessment coverage with reported accomplishment; b. Identify areas where there are missed children and c. Take immediate actions to vaccinate missed children.  The duly designated and trained regional, provincial or city monitoring teams shall perform the validation procedures.  Validation shall be done at least once in all barangays in the cities, town proper and well-populated communities. In municipalities, all barangays in the poblacion and at least 2 barangays with highest and low accomplishment report must be covered.  Validation is usually barangay-wide, but can be done by sitio or by purok in big barangays.  At least one repeat validation shall be done in all areas that are found to have less than 95% coverage by the validation method.  The following shall be the procedure of validation:  1. Plan the validation. Assign validation/monitoring teams and schedule the validation based on the schedule of completion of vaccination in the barangay. Do not validate in areas that have not been fully covered by the vaccination teams.  2. Look at the Accomplishment Report of the City/Municipality/Barangay. Select areas with high and low reported OPV/measles immunization coverage for your sample. Ask for identified high risk areas especially populated/densely-populated areas.  3. Using the barangay spot map, identify four validation sites in each barangay to be validated: two (2) sites remote from general access (e.g. borders with other barangays, riverside, houses away from main roads) and two (2) central sites (e. g. slum areas around the market or railroad, houses along the main road or rail. Select all sites away from the health center.  4. Go to the selected sites one at a time and fill up the attached validation form (Rapid Assessment of Immunization Coverage using the Grab Sample and Door Sample Techniques).  Grab Sample: Grab at least 5 eligible children (0 to 59 months old) who are found in the streets in each selected sites. Determine their vaccination status by looking at their fingers and at their vaccination site. (The importance of immediate 1-2 days after validation is to ensure that at least the vaccination puncture is still visible). Make sure that there are 20 children in the grab sample.  Door Sample: Identify 5 doors (e.g. house, condominium, school, etc.) nearest to the selected site. If there is a variety, select at least two (2) doors of the hardest to reach doors (e.g. top floor or ones with complicated entry. Determine if the marking on the door correctly matches with vaccination status of all the children in the selected doors. Make sure that 20 doors are seen in sample sites.  5. Based on the summary of findings at the bottom of the validation form, determine the appropriate action for the barangay.  Action to be taken:  Findings A: If the findings show that all grabbed children have been vaccinated and that all doors are correctly labeled but there were still doors marked \"X\", the validation/monitoring team shall remind the vaccination team to revisit the \"X\" door immediately to vaccinate the missed children.  The validation/monitoring team shall also revisit these \"X\" doors to ensure that circles have been placed around the \"X\", corresponding to completion of vaccination of previously missed children. If the validation/monitoring team brought OPV/measles vaccines and other antigen/Vitamin A with them, they may instead vaccinate the missed children themselves, encircle the \"X\" on the door and submit the vaccination report to the appropriate vaccination team.  Findings B: If the findings show that there is at least one unmarked door or a door marked with a circle but with an unvaccinated eligible child, this means that, most probably, there are many more missed children in the area. The validation/monitoring team shall correct the labels on the doors (mark the doors \"X\") and immediately - the same day, if possible - discuss their findings with the appropriate vaccination team to elicit their commitment to revisit the barangay and do a door-to-door search for, and vaccinate, other children who might have been missed, and ensure 100% coverage.  As above, if the validation/monitoring team brought OPV/measles vaccines and other antigens/Vitamin A with them, they may also vaccinate the missed children themselves, appropriately marked the doors and submit the vaccination report to the appropriate vaccination team. The door-to-door search for additional missed children should still be conducted even if these missed children have already been vaccinated by the validation/monitoring teams.  The validation/monitoring team shall follow-up to check that the door-to-door search is actually conducted. They shall also, as much as possible, repeat the validation in these areas.  Continue the cycle of \"vaccination - validation - search for missed children - vaccination\" until there is not a single missed eligible child in any city, town proper or well-populated community.  3. Evaluation  A consultative meeting /workshop shall be conducted within 2 weeks after the province or city has declared completed immunization and validation has been completed for each round. It will provide an opportunity for replenishing or redistributing vaccines and other logistics where needed. It will serve as a forum for data analysis and planning for the next round and to improve routinely reaching these populations and improve surveillance.  VI. Repealing Clause  Any existing provision or issuance found inconsistent with this order should be repealed.  VII. Effectivity  This order shall take effect immediately. ", "    I. BACKGROUND AND RATIONALE   In 2005, the countries of the Western Pacific Region of the World Health Organization (WHO) adopted the goal of measles elimination. To achieve this, the WHO recommends that countries strengthen three areas of their Expanded Programme for Immunization. These areas are: 1) universal high population immunity through increased coverage; 2) high case\u2014based quality surveillance; and 3) adequate laboratory support for conformation of diagnosis.   World Health Organization guidelines in support of the goal of measles elimination state that any person satisfying the suspect case definition of measles shall be immediately reported, investigated and a blood specimen collected to conform whether the suspected case is indeed a case of measles. Effective surveillance for measles entails establishing case\u2014based surveillance that includes investigation and laboratory testing of specimens from all suspected cases. Such surveillance system will also identify rubella cases through laboratory conformation. As the country progresses towards measles elimination, reporting of rubella cases will be implemented and incorporated into the measles surveillance system.   The laboratory plays an important role in measles surveillance. In the elimination phase, it is well established that surveillance based on clinical recognition of cases is inaccurate and that laboratory conformation of all suspected cases is critical for effective surveillance and proper program planning. It is in this light that conformation of suspected measles cases through laboratory testing needs to be enhanced.   1. Monitoring and verifying virus transmission:   -Conformation of suspect cases/ outbreaks: confirm the clinical diagnosis, especially in the early stages of an outbreak   -Identification of measles and rubella virus . strains and genetic characteristics of viral isolates   -Differentiate endemic or imported cases: monitor circulation of wild genotypes to define pathways of transmission/importation '   2. Monitoring susceptibility pro\ufb01le of the population   -Determination of the age distribution of susceptibility to measles and rubella in order to assess population at risk and appropriate intervention to reduce risk.  -Evaluation of the impact of the immunization campaigns   Quality measles surveillance requires laboratory conformation of at least 80% of the reported suspected measles cases. However, during elimination phase, all suspected measles cases require laboratory conformation. This shall serve as the evidence of the country\u2019s achievement and maintenance of the elimination status.   11. OBJECTIVES A. General Objective:   To update the guidelines for strengthening laboratory conformation of suspect measles cases in support of the goal of measles elimination.   B. Speci\ufb01c Objectives:   To strengthen measles case-based surveillance To strengthen detection of rubella cases through measles surveillance and laboratory conformation   -To evaluate impact of the measles and rubella routine and supplemental immunization activities in interrupting measles transmission and achieving control of rubella through efficient laboratory conformation  -To establish the use of dried blood spot (DBS) as an alternative method of sample collection for serology  -To require the collection of nasopharyngeal swab (NPS) and orcpharyngeal swab (OPS) from all chains of measles transmission for virus isolation   -To implement standards for the collection, handling, storage and transport of DB8 and NPS/OPS samples   III. SCOPE AND COVERAGE   This issuance shall apply to the entire health sector, to include public and private health facilities both at the national and local government units involved in disease surveillance and response activities (refer to AO. No. 2007-0036: Guidelines on the Philippine Integrated Disease Surveillance and Response).   Moreover, this administrative issuance is an update to AO 2012-003 to provide the most recent guidelines for strengthening specimen collection from suspect measles cases in support of the goal of measles elimination.    IV. DEFINITION OF TERMS, ABBREVIATIONS & ACRONYMS   Case Investigation Form (CIF)  Refers to reporting form that allows collection of standard information to acquire epidemiological study of disease incidence and disease patterns   Cluster  De\ufb01ned as two or more persons presenting with manifestations of a>suspect measles case that are detected with onset of illness-within a period of 7 to 21 days and in the same geographical area and/or are epidemiologically linked   Contacts  Are all persons living in a household of other close quarters with the case during the infectious period (5 days before to 5 days after the onset of rash)  Disease Reporting Unit (DRU)  This includes all health facilities (rural health units, hospitals, laboratories, seaports and airport are considered DRUs)   Epidemiologically-Linked Measles Case  De\ufb01ned as a suspected measles case who was not discarded and who:   -had contact with a laboratory con\ufb01rmed case or another epidemiologically-linked case Within 7-21 days before rash onset and  -the other epidemiologically-linked or laboratory con\ufb01rmed case was infectious at the time of contact (i.e. contact was 5 days before and 5 days after rash onset)    Measles IgM  A measles-speci\ufb01c antibody that rises early in the infection: it  is used to con\ufb01rm suspect measles cases.   Provincial Epidemiology and Surveillance Unit (PESU)  Refers to the unit established in the Provincial Health Of\ufb01ces that provides services on public health surveillance and epidemiology   Philippine Integrated Disease Surveillance and Response (PIDSR)  Refers to the Philippines process of coordination, prioritizing, and streamlining of core surveillance activities (e.g., data collection, reporting, laboratory and epidemiological con\ufb01rmation, analysis and feedback), support functions (e.g., training, monitoring, \ufb01nancial and logistics) and response (e.g.. epidemic investigation) with the aim of making the system more ef\ufb01cient and effective in providing timely, accurate and relevant information for action    Regional Epidemiology and Surveillance Unit (RESU)  Refers to the unit established in the Centers for Health Development or the DOH regional of\ufb01ces that provide services on public health surveillance and epidemiology       Research Institute For Tropical Medicine (RITM)  It houses the Department of Virology which is the national measles reference laboratory   Rural Health Unit (RHU)   Refers to the unit established in the rural health units that provides services 7 on public health surveillance and epidemiology   Suspected Measles Case   Any individual, regardless of age, with history of fever (38\u00b0C . or more) or hot to touch, generalized non-vesicular rash of 3 or more days duration; and at least one of the following cough, coryza, or conjunctivitis   V. DECLARATION OF POLICIES   A. Global Immunization Vision Strategy (GIVS) proposed a new measles mortality reduction of 90% by 2010 with the following major challenges: (i) measles mortality reduction activities in several large countries with high measles burden, (ii) enhanced efforts are needed to improve immunization systems to ensure that at least 95% of infants are vaccinated with measles before their \ufb01rst birthday, (iii) continue conduct \u201cfollow-up\" SIAs every 3-4 years until their routine system are capable of providing two opportunities for measles immunization to >90% of every birth cohort, (iv) disease surveillance at district, provincial and national levels need to be strengthened to enable case-based surveillance with testing of clinical specimens from suspected cases in the laboratories. This was endorsed in the World Health Assembly 2005 -   B. In 1996, the Regional Office of the Western Pacific (WPRO) established a \u201cPlan of Action (POA) for Accelerated Measles Control\". By 2003, the region\u2019s vision had moved to elimination with the publication of the \u201cWestern Pacific Regional POA for Measles Elimination\", that covered the years 2003- 2005. The Regional Office published the Field Guidelines for Measles Elimination in 2004 and in 2005, a second Regional Committee (RC) resolution established 2012 as the target date for measles elimination   C. In light of the proven efficacy and safety of the Regional Advisory (RA) 27/3 bases rubella vaccine, WHO recommends its use in all countries where control or elimination of Congenital Rubella Syndrome (CRS) is considered a public health priority. Current efforts in global measles control shall be used as an opportunity to pursue control of rubella through the use of Measles Rubella (MR) and Measles Mumps Rubella (MMR) vaccines   D. WHO-UNICEF comprehensive strategy for reducing measles mortality among priority countries with the following goals: (1) achieving and maintaining high coverage (>90%) of the lSt dose of measles-containing vaccine (MCVl) among all children by the age of 12 months in every district through routine immunization services, (ii) ensuring that all children receive a second opportunity for measles immunization, (iii) enhancing measles surveillance with integration of epidemiological and laboratory information, and (iv) providing appropriate clinical management for measles cases     VI. IMPLEMENTING MECHANISM   The primary function of the laboratory in measles surveillance is confirming suspect measles cases, either through serology, molecular detection of the virus or virus isolation. The testing of serum specimen for the presence of anti- measles IgM antibodies remains the gold standard for laboratory conformation of suspect cases occurring both sporadically, in clusters or during outbreaks. Other means of conformation includes testing of DB8 for presence of anti-measles IgM antibodies and/or culture and isolation of measles virus from suspect or clinically confirmed measles cases.   In countries with measles elimination goal and implementing case-based surveillance, the recommendation is to collect either serum or DBS specimen within the \ufb01rst 28 days of rash onset from all suspect measles cases. While the collection of NPS/ OPS specimen for viral isolation must be within the \ufb01rst 7 days of rash onset. Viral isolation provides evidence of elimination of indigenous measles virus, including outbreak source and transmission pathways.   A. Laboratory Procedures for Case Conformation   1. Use of Serum Samples for Measles IgM testing   A single serum sample obtained at the \ufb01rst contact with the patient at am time within 28 days after rash onset shall be taken from ALL suspected measles ca_ses. Measles-speci\ufb01c IgM antibodies appear within the \ufb01rst few days of rash onset and decline rapidly after one month. Specimen shall be received at RITM within 72 hours after collection with the completely filled-up Measles Case Investigation Form (Annex A.).   Provided that the epidemiological linkage among cases has been established within a household, specimen shall be taken from the index case (\ufb01rst person that \ufb01t the case definition of suspected measles case).   In line with this, it is very important to identify accurate information regarding the exposure history of suspect measles case. The CIF shall contain basic epidemiological information on time, date, place and history of contact with a known measles case. This will help identify origin and path of measles virus transmission.   Patients admitted at hospital facilities and those DRUs (RHUlHealth Centers) that have the capacity to collect, store and transport shall have serum sample collected. Procedures for collection, storage and transport of sample are contained in the Annex B.   2. Use of alternative sample for Measles IgM detection (dried blood spot)   Dried blood spot samples shall ONLY be used as an alternative means of specimen collection where there is difficulty in extracting blood (e.g. very young infants, no medical technologist or certified phlebotomist), maintaining the specimen at 2\u20148\u00b0C during storage and transport (i.e. selected island barangays, municipalities or RHUs, and provinces, lack of specimen storage facilities and no local courier). Collection shall be done by medical, paramedical and other trained personnel (doctors, medical technologists, nurses, midwives, etc).   3. Use of Oropharyngeal and/or Nasopharyngeal swab for virus isolation   Aside from serum, it is also important to collect NPS/OPS for virus isolation from all clusters/outbreaks of suspected measles cases within 7 days from rash onset.   In collecting NPS/OPS, the response team shall consider the guide below in collecting samples of cases in a cluster/ outbreak:   3 cases - collect at least 1-2 samples   5 cases - collect a minimum of 3 samples   10 cases \u2014\u2014 collect a minimum cf 5 samples   >= 10 cases - collect a minimum of 10 samples   Virus isolation is significant to conform whether the transmissions of indigenous measles strains have been interrupted. This shall provide evidence that the country has achieved measles elimination goal.   B. Roles and Responsibilities   1. Research Institute for Tropical Medicine   a. Shall receive all specimens from the DRUs and other allied health units   b. Shall inform the RESU if specimen/s arrives at RITM in bad condition and if repeat collection is needed   c. Shall process/test the specimens   d. Shall send timely result including transmittal of individual results to the National Epidemiology Center (NEC), National Center for Disease and Prevention Control (NCDPC) and RESUs   e. Shall build and develop laboratory capacity and networking of laboratories at the national and local levels if needed   f. Shall collaborate with WHO to strengthen molecular surveillance and virus identification and share laboratory results (both serology and virus identification) on a monthly basis with WHO country office   2. National Epidemiology Center   a. Shall oversee the implementation of high quality measles surveillance in all regions, province and cities   b. Shall monitor and provide technical support to all regions, provinces and cities that are experiencing low surveillance performance   c. Shall facilitate the provision of logistics for specimen collection to all RESUs   d. Shall facilitate/ensure transport of specimens from the RESU/PESU and RHU   e. Shall ensure the adequacy & timeliness of specimen collection   f. Shall perform the overall coordination, feedback and data management    3. Center for Health Development   a. Shall coordinate and investigate suspect measles cases   b. Shall monitor and provide technical support to all provinces and cities that are experiencing low surveillance performance   c. Shall be responsible for regional level surveillance data management   d. Shall ensure the proper and timely collection, storage and transport of specimens to the National Measles Reference Laboratory (e. g. RITM)   e. Shall facilitate the provision of logistics to the hospitals and LGUs   f. Shall send laboratory results to concerned LGUs   4. PESU/PHO/RHU   a. Shall coordinate and facilitate the detection, reporting and investigation of suspect measles cases   b. Shall be responsible for provincial/city/municipality level surveillance data management   c. Shall ensure the proper and timely collection, storage and transport of specimens to the national reference laboratory, RITM and or CHD   d. Shall facilitate the provision of logistics to the hospitals and LGUs   e. Shall ensure that CIFs are completely filled up sealed in a separate plastic bag and enclosed in the shipping box   f. Shall send laboratory results to concerned LGUs   5. All Hospitals   a. Shall completely investigate with. proper documentation all suspected measles cases whether in-patient and outpatient wards   b. Shall collect blood specimen for all suspected measles cases at \ufb01rst contact or within 28 days from rash onset following the standard procedure in specimen collection   c. Shall properly label, store and/transport blood specimens to ESURITM   d. Shall ensure that CIFs are completely \ufb01lled up sealed in a separate plastic bag and enclosed in the shipping box   e. Shall keep specimen collection kits properly and check for the expiration date   f. Shall coordinate with CHD/ESU for the laboratory results   C. Funding Requirements   Budgetary requirements such as laboratory expenses, logistic support and other laboratory requirements for testing shall be charged against the Research Institute for Tropical Medicine through the support of Department of Health and World Health Organization. The freight and handling of specimen shall be charged against the different CHDs, subject to the usual accounting and auditing rules and regulations.   VII. REPEALING CLAUSE   The provisions of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing issuance which are not affected by this Order shall remain valid and in effect.   VIII. EFFECTIVITY   This order shall take effect immediately.   ", "  In line with the DOH to improve accessibility and expand availability of FP methods in the government health facilities, the Family Planning Service with support from Women\u2019s Health and Safe Motherhood Project will distribute IUD Kits to health facilities with trained service providers on IUD insertion. Attached is the guidelines for your reference.  For strict compliance.     ", "  I. RATIONALE:  Newborn screening was introduced more than 40 years ago in the United States. It is, now considered a standard of routine newborn care among developed countries. Newborn screening enables early detection and management of certain metabolic disorders, which if left untreated may lead to mental retardation and death. The early diagnosis and treatment of these disorders assures the child\u2019s right to live and safeguards him/her to reach his/her full potential.  In the Philippines, newborn screening was initiated in 1996 by the Newborn Screening Study Group consisting of pediatricians and obstetricians from 24 hospitals accredited by the Philippine Pediatric Society, Inc (PPS) and the Philippines Obstetrics and Gynecological Society, Inc (POGS).  Pilot studies on 272,547 newborns (NIH, June 2003) have shown the following incidences of disorders:    From these statistics, it is predicted that newborn screening for these disorders can save at least 33,000 newborns from mental retardation and death if all 1.5 million newborns born annually are screened. Cost bene\ufb01t analysis has demonstrated that a national newborn screening program vs a do-nothing alternative yield benefits of P600 million pesos annually (NIH, July 2003).  In line with the Vision of the Child 21 Framework that by the year 2025 it is crucial that newborn screening be integrated in the current health care delivery system. DOH recognizes that newborn screening will contribute in the objective of ensuring that all Filipino children have access to, and avail themselves of total quality care for their optimal growth and development to their full potential.  The Department has made efforts in implementing newborn screening in a limited scale. On January 2001, the Department of Health (DOH) issued Administrative Order No. l-A known as \u201cPolicies on the Nationwide Implementation of Newborn Screening\". This Order envisioned that by the year 2004, newborn screening shall be a part of standard newborn care and a formal national program would be in place. Since then, newborn screening has been pilot-tested and implemented in more than 250 hospitals and communities all over the country through the collaboration of DOH and the National Institutes of Health (NIH).  Considering that newborn screening is now an internationally accepted and was declared as medically necessary, full nationwide implementation is the next challenge for the program. With the end-view of strengthening the newborn screening program and making this more accessible among the general population, this Administrative Order aims provides the general guidelines for the national implementation of the NBS. This order also prescribes procedures for integrating newborn screening into various health efforts and activities at the national and local levels, including emphasis on community newborn screening implementation.  II. COVERAGE AND SCOPE  This Administrative Order shall apply to all government and private hospitals, clinics, and other health facilities.  III. GOALS AND OBJECTIVES  A. GOAL  All Filipino newborns are screened for the more common and life-threatening heritable disorders.  B. OBJECTIVES  The objectives of the National Newborn Screening System are:  1. To ensure that every newborn has access to newborn screening for certain heritable conditions that can result in mental retardation, serious health complications, or death if left undetected and untreated;  2. To establish and integrate a sustainable newborn screening system within the public health and hospital delivery system;  3. To ensure that all health practitioners are aware of the availability and advantages of newborn screening and of their respective responsibilities in offering parents of newborns the opportunity to take advantage of newborn screening;  4. To ensure that parents recognize their responsibility in promoting their child\u2019s right to health and full development, within the context of responsible parenthood, by protecting their child \ufb01om preventable causes of disability and death through newborn screening.  V. DEFINITION OF TERMS  1) Newborn Screening System means a system or an institutionalized process that includes, but is not limited to, education of relevant stakeholders; collection and biochemical screening of blood samples taken from newborns; tracking and confirmatory testing to ensure the accuracy of screening results; clinical evaluation and biomedical/medical con\ufb01rmation of test results; drugs and medical/surgical management and dietary supplementation to address the heritable conditions; and evaluation activities to assess long term outcome, treatment compliance and quality assurance.  2) Follow up means the monitoring of a newborn with a heritable condition for the purpose of ensuring that the medical or dietary prescriptions are \ufb01illy complied with.  3) Health facilities/institutions means hospitals, health in\ufb01rrnaries, health centers, lying-in centers or birthing homes or puericulture centers and other medical outpatient clinics with obstetrical and pediatric services, whether public or private.  4) Healthcare practitioner means physicians, nurses, midwives, nursing aides, traditional birth attendants and allied health professionals.  5) Heritable condition means any condition that can result in mental retardation, physical deformity or death if left undetected and untreated and which is usually inherited from the genes of either or both biological parents of the newborn.  6) Newborn Screening (NBS) means the process of collecting a few drops of blood from the newborn onto an appropriate collection card and performing biochemical testing for the purpose of determining if the newborn has a heritable condition,  7) Newborn Screening Center (NSC) means a facility equipped with a newborn screening laboratory that complies with the standards established by the NIH and provides all required laboratory tests and recall/follow-up programs for newborns with heritable conditions.  8) Newborn Screening Reference Center (NSRC) means the central facility at the National Institutes of Health (NIH) that defines testing and follow-up protocols, maintains an external laboratory proficiency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, oversees content of educational materials, and acts as the Secretariat of the Advisory Committee on Newborn Screening.  9) Parent education means the various means of providing parents or caregivers with information about newborn screening.  10) Recall means a procedure for locating a newborn with possible heritable condition for purposes of providing the newborn with access to appropriate laboratory testing to confirm the diagnosis and, as apprOpriate, provide treatment.  11) Treatment means the provision of prompt, appropriate, and adequate medicine, medical and surgical management, or dietary prescription to a newborn for purposes of treating or mitigating the adverse health consequences of the heritable condition.  GENERAL POLICY STATEMENTS  The DOH, together with the National Institutes of Health (NIH) which is the technical arm in the implementation of newborn screening and other concerned partners, adopts the following policies and principles in the nationwide implementation of newborn screening:  1. Newborn screening shall be an integral part of the child, adolescent, and maternal health programs and services.  2. It shall be a standard and routine procedure for newborns in public and private health and hospital facilities. Health practitioners shall fully inform their parents, legal guardians or other caregivers about the availability, nature, and bene\ufb01ts of newborn screening.  3. Newborn screening services available in all health facilities nationwide shall be supplemented with efforts necessary to increase the demand for these services.  4. Expenses for the newborn screening tests shall be borne by parents, and therefore \ufb01nancing mechanisms shall be explored to make newborn screening free or affordable. Hospital and local government or non-government organization are therefore highly encourage to develop a scheme providing partial or full subsidy depending on the \ufb01nancial capability of the parents. Newborn screening fees however, shall be regulated by the Newborn Screening Advisory Committee to prevent exorbitant overhead costs.  5. The DOH shall establish mechanisms to ensure that newborn screening is available in all Philippine Health Insurance Corporation (PHIC) accredited health facilities and accessible to all its members.  6. DOH shall ensure that a network of facilities for referral and management of all positive cases is established.  8. The DOH shall ensure inter-agency collaboration through inclusion of newborn screening in the agenda of existing committees on children\u2019s health and welfare. In such venues, the following agencies shall be represented: DOH, NIH, and DILG.  9. The DOH, the NCDPC, in partnership with NIH shall ensure quality and sustainability of newborn screening system through the establishment of NSRC as well as its attendant requisites:  VII. IMPLEMENTING MECHANISMS  A. NEWBORN SCREENlNG PROCEDURE  The following Standard Operating Procedures for Newborn Screening shall be observed by health facilities and/or NSC\u2019s.  1. It shall be the responsibility of the healthcare practitioner providing prenatal services or delivering the newborn to ensure that parents of the newborn are informed of the availability and advantages of newborn screening services.  A parent or legal guardian may refuse testing on the grounds of religious belief, but shall acknowledge in writing their understanding that refusal for testing places their newborns at risks for undiagnosed heritable conditions. A copy of this refusal documentation shall be made out of the newborn\u2019s medical record and refusal shall be indicated in the national newborn screening database.  2. Collection of a screening specimen shall occur after twenty four (24) hours of life but not later than three (3) days from complete delivery of the newborn. A newborn placed in intensive care may be exempted \ufb01om the 3\u2014day requirement but must be tested by seven (7) days of age.  3. Collected blood samples are transported to the accredited Newborn Screening Centers by courier or any available speedy mode of transport.  4. Testing of samples will be performed at accredited Newborn Screening Centers of the DOH-NIH network. Results, particularly those that are found positive of any of the disorder, are immediately released so that apprOpriate management can be instituted right away. Release of negative screens shall be released 7 working days after receipt in the NBS laboratory.  5. A newborn with positive screen is recalled or located as soon as possible to con\ufb01rm the diagnosis and appropriate treatment provided if necessary. This is primarily the responsibility of the newborn screening team of the health facility where sample was collected.  6. The newborn with positive heritable condition is referred to for treatment and management to a medical specialist or the attending physician in close coordination with a medical specialists.  7. Prompt management of newborns with positive screen is essential to prevent the debilitating consequences or death of the newborn.  8. All of the congenital metabolic disorders require lifetime management. Monitoring should be done regularly through the attending physicians or by direct inquiry from the parents.  B. ESTABLISHMENT OF NEWBORN SCREENING CENTERS (NSCs)  1. The DOH shall ensure access to the newborn screening procedure by establishing Newborn Screening Centers (NSC) that are strategically located to be accessible to the relevant public.  2. The establishmcnt of NSC shall be phased depending on the overall demand in the country. At the initial phase, two (2) NSC shall be established in Luzon, 2 in the Visayas and l in Mindanao.  3. The need to put up an additional NSC shall likewise be planned depending in the country\u2019s and the newborn screening system\u2019s evaluation by the National Technical Committee on Newborn Screening.  C. ESTABLISHMENT OF NEWBORN SCREENING REFERENCE CENTERS (NSRCS)  a. The NSRC shall be responsible for ensuring good laboratory practice standards for NSC, including the establishment of an external laboratory pro\ufb01ciency testing and certi\ufb01cation program. It shall also act as the principal repository of technical information relating to standards and practices and shall provide technical assistance to NSC as needed.  b. The NSRC shall be located at the National Institutes of Health, University of the Philippines Manila.  c. It shall provide the BHFS the technical assistance in accrediting NSC\u2019s which shall include, but not limited to, a minimum of 50, 000 samples a year.  d. It shall strictly observe the compliance of standard newborn screening procedures by health facilities and assurance of prompt submission of samples only to accredited NSC.  e. For the purpose of program evaluation and monitoring, the NSRC shall maintain a database of all patient tested and registry for each condition which will he submitted to DOH annually.  VIII. IMPLEMENTING STRUCTURES  1. National Center for Disease Prevention and Control, DOH  a. National Center for Disease Prevention and Control (NCDPC) shall serve as the lead of\ufb01ce for newborn screening and shall coordinate activities and programs in pursuit of the objectives of this order as shown in Annex A. It shall likewise spearhead the continuous organization of the National Technical Working Group on Newborn Screening (D.O # 29-C s 2000) until the said TWG has fully implemented and institutionalized all the necessary components of the Newborn Screening System.  b. It shall provide technical assistance to CHD\u2019s relative to newborn screening and shall establish coordination with other stakeholders in planning, materials development, monitoring and evaluation for newborn screening.  c. It shall provide avenues in developing innovative approaches and models of implementation in partnership with other cooperating agencies.  d. It shall advocate for the adeption of newborn screening among public and private institutions and practitioners  e. Monitor and evaluate the \ufb01eld implementation of newborn screening.  2. Role of the National Institutes of Health  1. Provide technical advice to the National Newborn Screening System.  2. Provide assistance to DOH in setting up the criteria in the Newborn Screening Centers  3. Formulate good laboratory practice standards for newborn screening facilities including the establishment of an external laboratory pro\ufb01ciency testing and certi\ufb01cation program.  4. Act as the principal repository of the technical information relating to newborn screening standards.  5. Establish the Newborn Screening Reference Center which will be responsible for the program review, laboratory pro\ufb01ciency, training and continuing education and research.  3. Technical Working Group on NBS  a. The Technical Working Committee on NBS shall be composed of the following:  i. representatives from the DOH of\ufb01ces namely: NCPDC, National Epidemiology Center (NEC), National Center for Health Facility Development (NCHFD), Bureau of Health Facilities and Services (BHFS), The National Center for Health Promotion (NCHP) involved in the implementation ii. representatives from the Center for Health and Development iii. representative form Philippine Society of Endocrinology iv. representative from NIH v. representatives from Department of Interior and Local Government vi. representative from any of the national organizations of pediatricians, obstetricians, family physicians, nurses and midwives  b. It shall have the following responsibilities and functions:  i. Develop/review policies, standards and guidelines on newborn screening for recommendations and approval of the management  ii. Recommend the conditions to be included in the newborn screening panel  iii. Review and recommend the newborn screening fee to be charged by the newborn screening centers  iv. Develop/review strategies and tools that will ensure effective and ef\ufb01cient implementation of the program at various levels  v. Formulate national program/project plan, proposals and collaborative studies on newborn screening  vi. Review the report of the Newborn Screening Reference Center on the performance of the Newborn Screening Centers and recommend corrective measures as deemed necessary  4. Bureau of Health Facilities and Services (BHFS)  The BHFS, in collaboration with NIH shall be responsible for regulating health facilities performing newborn screening procedures through:  1. Accreditation procedures and monitoring for compliance and quality assurance.  2. Development of needed rules and regulations pertaining to the regulation of the same.  3. Monitoring and evaluation of the newborn screening centers.  5 National Epidemiology Center (NBC)  The NEC in collaboration with the regional/ provincial epidemiology units shall be reaponsible for developing a surveillance system for heritable conditions. It shall establish registry of cases linked with the NIH as the central registry center, and the rural health units as the base registry units  6. National Center for Health Facility DeveIOpment (NCHFD)  The NCHFD shall participate in providing technical assistance and leadership for the continuous effective and ef\ufb01cient implementation of the Newborn Screening in hosPitals in coordination with the Center for Health and Development. It shall also encourage hospitals to participate in the monitoring and participation in the research and deveIOpment efforts that will be pursued and initiated by concerned stakeholders and the NIH.  7. National Center for Health Promotion (N CHP)  The NCHP shall act as the lead of\ufb01ce in the promotion of newborn screening and shall deve10p advocacy materials for dissemination to all partner agencies (LGUs. Academe, NGO\u2019s) and stakeholders. All IEC materials and collaterals shall be screened and reviewed by NCHP.  8. Center for Health Development (CHD)  The CHD\u2019s shall be responsible for the following:  a. Translate and implement newborn screening national policies and framework at the local and regional levels.  b. Provide technical and logistics assistance to LGUs, NGOs, Academic Institutions, and other stakeholders.  c. Advocate for the implementation of newborn screening at the regional level.  d. Reproduce newborn screening prototype materials for general distribution.  f. Conduct orientation and training on newborn screening.  g. Deve10p innovative approaches and models of implementation on newborn screening with local partners.  h. Establish a public and private sector collaborative partnerships to plan and manage the newborn screening implementation in the region.  i. Monitor and evaluate the implementation of newborn screening in the region.  9. DOH Retained Hospitals, Other government and private hospitals and lying\u2014ins  All DOH Retained Hospitals other government and private hospitals clinics and lying\u2014ins shall be responsible for the following:  1. Create an NBS team to ensure implementation of NBS and coordinate activities with DOH.  2. Ensure that adequate and sustained newborn screening services such as information, education, communication, screening, recall and management of identified cases are being provided in the hospital.  3. Establish an appropriate \ufb01nancial system that will ensure effective and ef\ufb01cient collection of fees and payment of laboratory services to the Newborn Screening Center  4. Conduct orientation and/or training of hospital staff on newborn Screening or clinic.  5. Monitor and evaluate the implementation of newborn screening within in the institution.  6. De\ufb01ne creative \ufb01nancial packages to make newborn screening accessible particularly among the economically deprived populace.  7. Establish a functional referral system with local as well as national agencies  10. Local Government Units (LGUs)  The LGUs through the Chief of Hospital and Municipal Health Of\ufb01cers shall be responsible for the following:  1. Ensure that adequate and sustained newborn screening services such as information, education, communication, screening, recall and follow-up are being provided in all LGU Health facilities (Rural Health Unit/ City Health Unit, Lying-ins, City/Municipal/ District/ Provincial Hospitals)  2. Establish a functional case management referral system with strategically accessible tertiary hospitals  3. Establish coordination and networking among concerned agencies in Newborn screening implementation  4. Monitor and evaluate the newborn implementation in their localities  5. Define creative \ufb01nancial packages to make newborn screening accessible particularly among the economically deprived populace.  VIII. RECORDS AND REPORTS  Proper recording of newborn screening data shall be instituted in all participating health facilities. Reports using the required format must be submitted to NSRC quarterly for documentation and analysis.  IX. MONITORING AND EVALUATION  Monitoring of newborn screening activities shall be incorporated in the routine monitoring activities.  Annual program reviews and periodic evaluation of the program shall be done every three years. Special studies may be conducted to address issues and problems that may surface.  X. FINANCING  All of\ufb01ces concerned shall allocate resources in support of the newborn screening system. External agencies are encouraged to provide funds for the implementation of newborn screening.  Funds for the program shall be derived from the \ufb01inds allocated for Child Health and Development. Supplemental funds and other resources shall be sourced out from extension services and other key stakeholders. LGU\u2019s shall be encouraged to provide funds for the implementation of newborn screening.  XI. REPEALING CLAUSE  Any existing issuance or provision thereof that is inconsistent with this Order is hereby repealed.  XII. EFFECTIVITY  This Order shall take effect immediately.    ", "  I. BACKGROUND/RATIONALE:   Rabies is a fatal disease in developing countries where animal immunization and control of dogs are inadequate. In view of the 100% case fatality of human rabies, the prevention of rabies infection after exposure is of utmost importance. The Department of Health, having committed itself to the prevention of human deaths due to rabies, provides vaccines for post exposure treatment through the Animal Bite Treatment Centers (ABTCs) to high risk exposed patients.   Over the last \ufb01ve years, many studies have been conducted by both local and foreign researchers focusing on changes in treatment modalities. The World Health Organization. ' has also issued new recommendations related to rabies exposure management or Post Exposure Prophylaxis (PEP). Based on the available information, the guideline on animal bite management is revised in order to provide more cost effective strategies for rabies prevention and control. The guidelines in the management of animal bite cases are being updated every \ufb01ve years to integrate updated global recommendations. The last guidelines was released in 2007 (AO 2007- 0029) and amended in 2009. A joint DOH- DA Administrative Order (AO 2011-002) was also issued in 2011.   Disease free zones initiative has been identi\ufb01ed as one of the strategies to reduce public health threats alongside with enhanced health promotion and surveillance. The initiatives aim to \u201cmop up\" diseases such as leprosy, schistosomiasis, \ufb01lariasis, rabies and malaria. This would entail doing strati\ufb01cation of areas according to burden of diseases, validation of status of potential disease-free areas, and identi\ufb01cation of appropriate interventions based on these strati\ufb01cation.    II. OBJECTIVE   To provide new policy guidelines and procedure to ensure an effective and ef\ufb01cient management for eventual reduction if not elimination of human rabies, and to increase voluntary pre-exposure coverage among high risk group such as animal handlers, \ufb01eld workers, health staff working in the rabies unit, rabies diagnostic laboratory staff, and children below 15 years old living in rabies endemic areas.   III. COVERAGE   All government health workers at all levels shall adopt these treatment guidelines to ensure standard and rational management of rabies exposures. Private practitioners in the country are strongly encouraged to adopt these treatment guidelines.   IV. DEFINITION OF TERMS    A. Active Immunization \u2014 refers to the administration of a vaccine to induce protective immune response.   B. Immunocompromised host \u2014 refers to patients receiving innnunosuppressive drugs such as systemic steroids (not topical or inhaled) and chemotherapeutic drugs for cancer, AIDS and HIV infected patients and patients with immune de\ufb01ciency. These patients are expected to have lower immune response to immunization.   C. Incubation Period \u2014 refers to the period from the time of exposure up to the appearance of \ufb01rst clinical symptoms of rabies. It is extremely variable ranging from 4 days to 7 years; but generally 20 to 90 days.   D. Observation Period \u2014 refers to animal observation for 14 days from the time of bite until the appearance of expected symptoms of rabies.   E. Passive Immunization \u2014 refers to the administration of pre-formed antibodies (immune globulins or passive immunization products) to provide immediate protection. These antibodies come from either human or animal source.   F.Post Exposure Prophylaxis (PEP) \u2014 formerly post exposure treatment (PET); refers to anti-rabies treatment administered after an exposure (such as bite, scratch, lick, etc.) to potentially rabid animals. It includes local wound care, administration of rabies vaccine with or without Rabies Immune Globulin (RIG) depending on category of exposure.   G. Pre exposure prophylaxis \u2014 refers to rabies vaccination administered before an exposure to potentially rabid animals. This is usually given to those who are at high risk of getting rabies such as veterinarians, animal handlers, staff in the rabies laboratory, hospitals handling rabies patients and school children from high risk areas, etc.   H. Prodromal Period \u2014 refers to the period lasting for 10 days with non-speci\ufb01c manifestations, which include fever, sorethroat, anorexia, nausea, vomiting, generalized body malaise, headache and abdominal pain. Parasthesia or pain at the site of the bite is due to viral multiplication at the spinal ganglion just before it enters the brain.   I. Rabid Animal \u2014 refers to biting animal with clinical manifestation of rabies and/or con\ufb01rmed laboratory \ufb01ndings      J. Suspected Rabid Animal \u2014\u2014 refers to biting animal with a potential to have rabies infection based on unusual behavior, living condition like stray dogs, endemicity of rabies in the area and no history of immunization.   K. Vaccine Potency \u2014 refers to the amount of acceptable active ingredients in a rabies vaccine which is expected to provide at least minimum protection.   V. GENERAL GUIDELINES   A. The Department of Health in collaboration with the Local Government Units (LGUs) shall be responsible for the management of animal bite victims including augmentation of human rabies vaccine.   B. Rabies Control Program shall be integrated to the regular health services provided by local health facilities of bite victims, as a measure.   C. Post exposure vaccination shall be shared and carried out by the Department of Health and LGUs.   D. Funding requirements needed for operational systems shall be secured prior to the implementation of this policy.   E. Advocacy through information dissemination and training of health workers shall be conducted at all levels.   F. Collaboration among government agencies, non\u2014government and private organizations to ensure successful implementation shall be strengthened.   VI. SPECIFIC GUIDELINES AND PROCEDURE   A. Management of Potential Rabies Exposure   1. Initiation of post-exposure prophylaxis (PEP) shall not be delayed for any reason regardless of interval between exposure and consultation as it increases the risk of rabies and it is associated with treatment failure.   2. There are no absolute contraindications to rabies PEP. Patients allergic to a speci\ufb01c vaccine/RIG or its components shall be given the alternative vaccine/RIG.   3. Table 1 shows the categories of exposure to a rabid animal or to an animal suspected to be rabid, with their corresponding management guidelines:     Table 1. Categories of Rabies Exposure with Corresponding Management         In case the biting animal is not available for observation or dies within the recommended fourteen (14) days observation period, all rabies exposures shall receive at least the Day 0, 3 and 7 doses. The decision to give the Day 28 dose and D14 for IM regimen,shall depend on the result of the laboratory examination (FAT) on the biting animal and whether the biting animal manifested signs and symptoms of rabies.   Table 1a. Management of patients with category II and III exposure where the biting animal cannot be observed or dies within the 14 days observation period.        B. Immunization   1. Active Immunization   a. Administration Vaccine is administered to induce antibody and T-cell production in order to neutralize the rabies virus in the body. It induces an active immune response in 7-10 days after vaccination, which may persist for years provided that primary immunization is completed.   b. Types of Rabies Vaccines and Dosage The National Rabies Prevention and Control Program (NRPCP) shall provide the following anti-rabies tissue culture vaccines (TCV): a) Puri\ufb01ed Vero Cell Rabies Vaccine (PVRV) m 0.5 ml/vial; and b) Puri\ufb01ed Chick Embryo Cell Vaccine (PCECV) - 1.0 ml/vial.   Table 2. List of TCV Provided by the NRPCP to Animal Bite Treatment Centers with Corresponding Preparation and Dose       c. Recommendations on the intradermal administration of anti-rabies vaccines:   The NRPCP introduced the intradermal (ID) use of rabies tissue culture vaccines in the country in 1997. The Philippines was among the \ufb01rst countries to adopt this regimen as recommended by the World Health Organization, in order to totally discontinue the use of nerve tissue vaccine (NTV) which was associated with vaccine induced encephalopathy. To mitigate the expected increase in the cost of PEP with the shift from NTV to TCV, the ID use of these vaccines was introduced. According to WHO, the ID use of tissue culture vaccines can decrease the cost of PEP by as much as 60- 80%.   However, only a limited number of commercially available rabies vaccines have been proven, to date, as safe and efficacious for PEP when administered by the ID route. Recently, local manufacturers in rabies-endemic countries have started to produce rabies vaccines. The ID use of these vaccines shall be based on adherence to WHO requirements for that route and approval by national health authorities as follows, \u201cNew vaccine manufacturers shall provide clinical evidence that their products are immunogenic and safe when used intradermally. Clinical evidence shall include clinical trials involving a vaccine of known immunogenicity and efficacy when used by this route as control, serological testing with rapid \ufb02uorescent focus inhibition test, and publication in internationally peer\u2014reviewed journals\".   To ensure compliance to these recommendations and guarantee that animal bite patients seeking treatment in government Animal Bite Treatment Centers receive only Tissue Culture Vaccines (TCVs) that have been proven to be safe and effective, the program shall utilize for its intradermal regimen only TCVs that satisfy the following criteria :   c.1. The vaccine is registered. with and approved by the Food and Drug Administration;   c.2. The vaccine is WHO prequali\ufb01ed (https://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/index.html);   c.3. The vaccine has been proven to be safe and ef\ufb01cacious for PEP when administered by the ID route using the schedule recommended by the World Health Organization. Having limited knowledge on and experience with the ID use of all available anti\u2014rabies vaccines in the country, the program shall utilize the WHO list of approved TCV for ID use OR in the case of vaccines not included in the WHO list for ID use, the vaccine must comply with WHO requirements for new rabies vaccines and must have gone through local clinical trials on safety and immunogenicity which are published in peer-reviewed journals;   c.4. The potency of vaccines for ID use shall be at least 0.5 IU/ID dose as evidenced by their lot release certificate. The potency of the vaccine batch shall be provided by the manufacturer; and   c.5. The product insert shall contain the vaccine\u2019s approved ID dose and consistent with its Certificate of Registration   2. Passive Immunization   Rabies immune globulins or RIG (also called passive immunization products) shall be given in combination with rabies vaccine to provide the immediate availability of neutralizing antibodies at the site of the exposure before it is physiologically possible for the patient to begin producing his or her own antibodies after vaccination. This is especially important for patients with Category III exposures. RIGs have a half-life of approximately 21 days.   a. Human Rabies Immune Globulin (HRIG) derived from plasma of human donors administered at 20 IU per kilogram body weight. Available preparation is 2 ml/vial; 150 IU/ml.   b. Highly purloined antibody antigen binding fragments [F(ab\u2019)2] produced from equine rabies immune globulin (ERIG) administered at 40 IU per kilogram body weight. Available preparation is 5 ml/vial; 200 IU/ml.   c. Equine Rabies Immune Globulin (ERIG) derived from purified, horse serum administered at 40 IU per kilogram body weight. Available preparation is 5 mI/vial; 200 IU/ml.   c.1. Types of Rabies Immune Globulins   Table 3. List of Rabies Immune Globulins provided by the NRPCP to Animal Bite Treatment Centers       c.2. Rabies Immune Globulin Criteria:   To ensure that only safe and efficacious RIG are provided by the National Rabies Prevention and Control Program to all ABTCs, the program shall be guided the by following criteria in procuring the RIG :   c.2.1. RIG must be registered and approved by FDA; c.2.2. RIG must be proven to be safe and effective when used together   c.2.3   with anti rabies vaccine as evidenced by publication on peer reviewed journals. These include studies on:   Safety;   - Non-interference when used with anti\u2014rabies vaccine;  -Animal survivorship, if any; and  -Post-marketing surveillance  -Results of RFFIT showing antibody content as claimed by the manufacturer.   c.3. Computation and Dosage of Rabies Immune Globulin   - HRIG at 20 IU/kg. body weight (150 IU/ml)  50 kg. patient x 20 IU/kg. = 1000 IU  10001U + 150 IU/ml = 6.7 ml.  - ERIG/ F(ab\u2019)2 at 40 IU/kg. body weight (200 IU/ml)   50 kg. patient x 40 IU/kg. = 2000 IU  2000 IU + 200 IU/ml = 10 ml.   c.4. Administration   c.4.1.   The total computed dose of RIG shall be infiltrated around and into the wound as much as anatomically feasible, even if the lesion has healed. In case some amount of the total computed dose of RIG is left after all wounds have been in\ufb01ltrated, it shall be administered deep IM at a site distant from the site of vaccine injection (preferably anterolateral thigh) using another needle. The total computed dose shall be administered as a single dose.    c.4.2. A gauge 23 or 24 needle, 1 inch length shall be used for in\ufb01ltration Multiple needle injections into the same wound shall be avoided.   c.4.3. A skin test shall be performed prior to ERIG administration using a gauge 26 needle. For skin testing, 0.02 ml of 1:10 dilution of solution is in\ufb01ltrated to raise a blob 3 mm and read after 15 minutes. A positive skin test is an in duration &gt 6 mm surrounded by a \ufb02are/erythema. If initial skin test is positive, repeat skin test on same arm; use distilled water as control on the other arm. The skin test shall be considered positive if the ERIG skin test is positive but the control is negative.   c.4.4. If a \ufb01nger or toe needs to be infiltrated, care shall be taken to ensure that blood circulation is not impaired. Injection of an excessive amount may lead to cyanosis, swelling and pain.   c.4.5. RIG shall not exceed the computed dose as it may reduce the efficacy of the vaccine. If the computed dose is insufficient to infiltrate all bite wounds, it may be diluted with sterile saline 2 or 3 fold for thorough infiltration of all wounds.   c.4.6. RIG shall always be given in combination with rabies vaccine. RIG shall be administered at the same time as the \ufb01rst dose of rabies vaccine (Day 0). In case RIG is unavailable on DAY 0, it may still be given until 7 days after the \ufb01rst dose of the vaccine. Beyond Day 7, regardless of whether day 3 and day 7 doses were received, RIG is not indicated because an active antibody response to the rabies CCV/EEV/TCV has already started and interference between active and passive immunization may occur.   c.4.7. In the event that RIG and vaccine cannot be given on the same day, the vaccine shall be given before RIG because the latter inhibits the level of neutralizing antibodies induced by immunization.   c.4.8. RIG shall be given only once during the same course of PEP.   c.4.9. Patients with Positive skin test to puri\ufb01ed ERIG shall be given HRIG.   c.4.10. Patient shall be observed for at least one hour after injection of ERIG for immediate allergic reactions. c.4.11. HRIG is preferred for the following:  -History of hypersensitivity to equine sera.  -Multiple severe exposures, especially where dog is sick or proven rabid.  -Symptomatic HIV infected patients.   c.5 Management of Adverse Reactions   Hypersensitivity to ERIG/F(ab\u2019)2 may not be predicted by a negative skin test. Adrenaline and antihistamines shall always be ready for treatment of hypersensitivity.    c.5.1 Anaphylaxis   -Give 0.1% adrenaline or epinephrine (1 : 1,000 or 1 mg/ml) underneath the skin or into the muscle. Adults - 0.5 ml  Children 0.01 ml/kg, maximum of 0.5 ml 0 Repeat epinephrine dose every 10-20 minutes for 3 doses.  -Give steroids after epinephrine.   c.5.2 Hypersensitivity reactions   -Give antihistamines, either as single drug or in combination.  -If status quo for 48 hrs despite combination of antihistamines, may give short course (5-7 days) of combined oral antihistamines plus steroids.  -If patient worsens and condition requires hospitalization or becomes life threatening, may give IV steroids in addition to antihistamines.   C. Treatment   1. Post\u2014 Exposure Prophylaxis   a. Local Wound Treatment   a.1. Wounds shall be immediately and vigorously washed and \ufb02ushed with soap or detergent, and water preferably for 10 minutes. If soap is not available, the wound shall be thoroughly and extensively washed with water.    a.2. Apply alcohol, povidone iodine or any antiseptic.   a.3. Suturing of wounds shall be avoided at all times since it may inoculate virus deeper into the wounds. Wounds may be coaptated using sterile adhesive strips. If suturing is unavoidable, it shall be delayed for at least 2 hours after administration of RIG to allow diffusion of the antibody to occur through the tissues.   a.4. Any ointment, cream or wound dressing shall not be applied to the bite site because it will favor the growth of bacteria and will occlude drainage of the wound, if any.    a.5. Anti-tetanus immunization shall be given, if indicated. History of tetanus immunization (TT/DPT/Td) shall be reviewed. Animal bites are considered tetanus prone wounds. Completion of the primary series of tetanus immunization is recommended.   Table 4. Guide to Tetanus Prophylaxis in Routine Wound Management        b. Routine Wound Management   b.1. The most common organism isolated from dog and cat bites is Pasteurellamultocida. Other organisms include S. aureus, Bacteroidessp, Fusobacterium and Capnocytophaga. Antimicrobials shall be recommended for the following conditions:   b.1.1. All frankly infected wounds  b.1.2. All category III cat bites  b.1.3. All other category III bites that are either deep, penetrating, multiple or extensive or located on the hand/ face/ genital area   b.2. Recommended antimicrobials for frankly infected wounds include:  b.2.1. Amoxicillin/clavulanic  -Adults - 500 mg p.o. TID  -Children - 30-45 mg/kg/day in 3 divided doses   b.2.2. Cloxacillin  -Adults - 500 mg p.o. QID  -Children - 10\u2014150\u2014100 mg/kg/day in 4 divided doses   b.2.3. Cefuroximeaxetil -Adults \u2014 500 mg p.o. BID  -Children - 10-15 mg/kg/day in 2 divided doses   b.2.4. For penicillin allergic patients  -Adults - Doxycycline  -Children \u2014 Erythromycin   b.2.5. For those instances where there are no obvious signs of infection, amoxycillin as prephylaxis may suf\ufb01ce  -Adults - 500 mg p.o. TID  -Children - 30-45 mg/kg/day in 3 divided doses   b.3 The public shall be educated in simple local wound treatment and warned not to use procedures that may further contaminate the wounds (e.g. tandok, bato, rubbing garlic on the wounds and other non\u2014traditional practices).   c. Vaccination   c.1. General Principles  c.1.1. Storage   c.1.1.1. Vaccines shall be stored at +2 to + 8 \u00b0C in a refrigerator, not freezer.   c.1.1.2. Once reconstituted, vaccines shall be kept in the refrigerator and used within 8 hours.   c.1.2. Administration Area   c.1.2.1. Injections shall be given on the deltoid area of each arm in adults or at the anterolateral aspect of the thigh in infants.   c.1.2.2. Vaccine shall never be injected in the gluteal area as absorption is unpredictable.     c.2. Treatment Regimen Schedule 0.2.1. Updated 2-Site Intradermal Schedule (2-2-2-0-2)   This regimen is a modi\ufb01cation of the original Thai Red Cross 2-site ID regimen where the day 90 dose has been transferred to day 28.   c.2.1.1. One dose for ID administration is equivalent to 0.1 ml for PCECV.   c.2.1.2. One dose shall be given on each deltoid on Days 0, 3, 7 and 28. (see table 5)   c.2.1.3. One intradermal dose shall have at least 0.5 IU vaccine  potency.   Table 5. Updated 2-Site Intradermal Schedule        c.2.1.4. The ID injection shall produce a minimum of 3 mm wheal. In the event that a dose of vaccine is inadvertently given subcutaneously or IM, the dose shall be repeated.   c.2.1.5. A one (1) ml syringe with gauge 27 needle, preferably auto\u2014 disposable syringe shall be used for ID injection.  c.2.1.6. The vaccination schedule shall be strictly followed to prevent treatment failure. In certain instances when patient fails to come on the scheduled date for his succeeding dose, the following rules shall apply:   Delay in second (i.e. day 3) dose:   &gt If delay is 1-2 days from day 3 schedule (i.e. day 4-5 from start of vaccination)\u2014 day 3 dose shall be given upon visit and follow the original schedule of day 7 and 28.   &gt If delay 1s 3 -4 days from day 3 schedule (i. e. days 6- 7 from start of vaccination)- day 3 dose shall be given upon visit, adjust succeeding doses (day 7 and 28) according to the prescribed interval.   &gt If delay is 4 days from day 3 schedule (i.e. beyond day 7 from start of vaccination) \u2014a new course shall be restarted.   Delay in third (i.e. day 7) dose   &gt If delay is &lt= 7 days from day 7 schedule (i.e. days 8\u201414 from start of vaccination) - day 7 dose shall be given upon visit, give day 28/ 30 dose as originally scheduled.   &gt If delay is &gt7 - 14 days from day 7 schedule (i.e. days 15 to 21 from start of vaccination)\u2014day 3 dose shall be repeated and revised according to the prescribed interval.   &gt If delay is &gt 14 days from day 7 schedule (i.e. beyond day 22 from start of vaccination) \u2014a new course shall be restarted.   Delay in fourth (i.e. day 28) dose:   &gt Give day 28 dose upon visit; this shall be considered as a booster. If RIG has already been administered, it shall not be given again.   c.2.2. Standard Intramuscular Schedule   c.2.2.1. Using the standard IM regimen, one dose is equivalent to 1 vial of 0.5 ml of PVRV or 1.0 ml of PCECV. One (1) dose is given intramuscularly (1M) on days 0, 3, 7, 14 and 28 (see table 6)   Table 6. Standard Intramuscular Schedule        c.2.2.2. Treatment schedule shall be strictly followed to prevent treatment failure. In certain instances when patient fails to come on the scheduled date for his succeeding dose, the following rules shall be followed:   Delay in second (i.e. day 3) dose:   &gt If delay is 1~2 days from day 3 schedule (i.e. day 4-5 from start of vaccination) \u2014 day 3 dose shall be given upon visit and follow the original schedule of day 7, l4 and 28/30.   &gt If delay is 3-4 days from day 3 schedule (i.e. days 67 from start of vaccination) \u2014 day 3 dose shall be given upon visit, adjust succeeding doses (day 7, 14 and 28/30) according to the prescribed interval.   &gt If delay is &gt 4 days (i.e. beyond day 7 from start of vaccination) \u2014 a new course shall be restarted.     Delay in third (i.e. day 7) dose:   &gt If delay is &lt= 7 days from day 7 schedule (i.e. days 8-14 from start of vaccination) - day 7 dose shall be given upon visit, give day 28 close as originally scheduled.   &gt If delay is &gt 7 - 14 days from day 7 schedule (i.e. days 15 to 21 from start of vaccination) \u2014 day 3 dose shall be given and revised according to the prescribed interval.   &gt If delay is &gt 14 days from day 7 schedule (i.e. beyond day 22 from start of vaccination) - a new course shall be restarted.   Delay in fourth (i.e. day 14) dose:   &gt Day 14 dose shall be given upon visit and give day 28 dose after two weeks.   Delay in \ufb01fth (i.e. day 28) dose:   &gt Day 28 dose shall be given upon visit.  f RIG has already been administered, it shall not be given again.   c.2.3. Alternative Intramuscular Regimen approved by WHO  c.2.3.1. Zagreb Regimen Schedule (2-1-1 Intramuscular   Table.7.Zagreb Schedule    c.2.3.2. Shortened Intramuscular Schedule (CDC)   An alternative for healthy, fully immunocompotent, exposed people who receive wound care plus high quality rabies immunoglobulin plus WHO-prequali\ufb01ed rabiesvaccines, shall be given a post\u2014exposure regimen consisting of 4 doses administered intramuscularly on days 0, 3, 7 and 14 (see table 8).    Table 8.Shortened Intramuscular Schedule (CDC)       d. Post-Exposure Prophylaxis under Special Conditions   d. 1. Pregnancy and infancy shall NOT be contraindications to treatment with puri\ufb01ed cell culture vaccines (PVRV, PCECV) and RIG.   d.2. Babies who are born of rabid mothers shall be given rabies vaccination as well as RIG as early as possible at birth.   d.3. Patients with hematologic conditions where IM injection is contraindicated shall receive rabies vaccine by ID route.   d.4. Patients with chronic liver disease and those taking chloroquine, and systemic steroids shall be given standard IM regimen as the response to ID regimen is not optimum for these conditions. Vaccination shall not be delayed in these circumstances as it increases the risk of rabies.   d.5. Immunocompromised individuals (such as those with HIV infection, cancer/transplant patients, patients on immunosuppressive therapy etc.) shall be given vaccine using standard IM regimen and RIG for both Category II and III exposures.   d.6. Exposed persons who present for evaluation or treatment weeks or months after the bite shall be treated as if exposure has occurred recently. However, if the biting animal has remained healthy and alive with no signs of rabies until 14 days after the bite, no treatment is needed.   d.7. Interchangeability of modern rabies vaccine brands or types shall not be recommended. However, in countries such as the Philippines, Thailand, Sri Lanka, France and Germany it has been practiced for many years without reported untoward events, each time circumstances made it inevitable to interchange vaccine used for administration. Shifting from one vaccine brand to another shall not be recommended but may be warranted in the following circumstances, provided that it is one of the WHO recommended cell culture vaccines:   d.7.1. Hypersensitivity reaction such as generalized rash, anaphylaxis, severe generalized pruritis, severe local reaction at injection site (swelling of entire upper arm).   d.7.2. Unavailability of the initial vaccine used.   d.8. Since no immunogenicity studies have been done regarding change inroute of vaccineadministration (i.e. shift from IM to ID or vice versa), shifting from one regimen to another shall NOT be recommended. As much as possible the initial regimen shall be completed. In extreme    d.9. circumstances that shifting has to be done from IM to ID regimen or vice versa, vaccination shall be restarted from day 0 using the new regimen. Bites by rodents, guinea pigs and rabbits do not require rabies post- exposure prophylaxis.   d.10. Bites by domestic animals (dog, cat) and livestock (cows, pigs, horses, goatsetc) as well as wild animals (bats, monkeys, etc) shall require PEP.   e. Post-Exposure Prephylaxis of Previously Immunized Animal Bite Patients   e.1. Local wound treatment shall always be carried out.   e.2. Persons with repeat exposure after having previously received complete primary immunization with Tissue Culture Vaccine (TCV) and persons who were exposed to rabies after completing the Pre-Exposure Prophylaxis against rabies with TCV shall be vaccinated as follows: (see Table 9)   Table 9. PEP schedule for previously immunized animal bite patients       e.3. The following patients are considered to have completed the primary   immunization:   e.3.1. Those who have received day 0, 7, 28 of pre-exposure prophylaxis.   e.3.2. Those who have received at least day 0, 3, 7 of post-exposure treatment.   e.4. Booster doses may be given ID (0.1 ml. for PVRV or PCECV) or IM (0.5 ml for PVRV or 1.0 ml for PCECV).  e.5. Patients who have previously received complete primary immunization with rabies vaccine have the advantage that booster doses will rapidly induce a large increase in antibody production (a \u201csecondary response\"). Therefore, there is no need to give RIG.   e.6. Patients who have not completed the primary immunization as described above shall receive full course including RIG if needed.   f. Management of Rabies Exposures from bites of animals vaccinated against rabies :   f.1. PEP shall not be recommended for all Category I exposures. f.2. PEP can be delayed for Category II Exposures provided that ALL of the following conditions are satisfied:   f.2.1. Dog/cat is healthy and available for observation for 14 days.   f.2.2. Dog/cat was vaccinated against rabies for the past 2 years:   f.2.2.1. Dog/cat shall be at least 1 year 6 months old and has updated vaccination certi\ufb01cate from a duly licensed veterinarian for the last 2 years.   f.2.2. The last vaccination must be within the past 12 months, the immunization status of the dog/cat shall not be considered updated if the animal is not vaccinated on the due date of the next vaccination.   f.3. PEP shall be given immediately for ANY of the following conditions:   f.3.1. The rabies exposure is category III;   f.3.2. The dog/cat is proven rabid/sick/ dead with no laboratory exam for rabies/not available before or during the consultation/dies within observation period.   f.3.3. The dog/cat is involved in at least 3 biting incidents within 24 hours or;   f.3.4. Dog/cat manifests the following behavior changes suggestive of rabies before, during or after the biting incident: (see Table 10)   Table 10. Clinical Signs of Animal Rabies      f.4. PEP shall not be required for bite/s of the following biting animals: rats, mouse, rabbits, snakes and other reptiles, birds and other avian, insects and \ufb01sh.   2. Pre-ExposureProphylaxis   a. Bene\ufb01ts  -The need for passive immunization product (RIG) is eliminated I PET vaccine regimen is reduced from \ufb01ve to two doses  -Protection against rabies is possible if PET is delayed  -Protection against inadvertent exposure to rabies is possible  -The cost of PEP is reduced    b. Target population  -Personnel in rabies diagnostic laboratories I Veterinarians and veterinary students  -Animal handlers  -Health care workersdirectly involved in care of rabies patients -Individuals directly involved in rabies control  -Field workers -It is recommended that children 2-10 years old shall also be immunized because of the increased risk and severity of animal bites in this age group   c. Regimen: (table 11)   -ID regimen \u2014 0.1 ml shall be at one site only for all vaccine types on days 0, 7 and 21/28  -IM regimen - 1 vial of 0.5 ml for PVRV or 1 ml of PCECV shall be given on days 0, 7 and 21/28   Table 11. Pre-exposure schedule       Table 12. Routine booster Schedule for individuals given Pre-Exposure     D. Management of the Biting Animal   1. The biting animal shall be observed for 14 days. Adequate animal care shall be 1 provided during the observation period.   2. It is advisable for patients to consult a veterinarian, whenever possible, 1 regarding biting animal management especially when any of the following is ' observed:   a) sudden change of behavior (from mild to vicious temperament or vice versa)   b) characteristic hoarse howl   c) watchful, apprehensive expression of the eyes, staring, blank gaze   d) drooling of saliva   e) paralysis or uncoordinated gait of hind legs   f) marked restlessness, pacing in cage   g) if at large runs aimlessly, biting anything in its way   h) depraved appetite, self mutilation   i) in some cases, lies quiescent, biting when provoked   j) snaps at imaginary objects   k) paralysis of lower jaw and tongue; inability to drink   l) sudden death without associated S/Sx   3. PEP may be discontinued if the biting animal remains healthy after the 14 days observation period.   4. If the animal dies or gets sick, the head shall be submitted to the nearest rabies diagnostic laboratory for testing.   E. Dispensing of Anti-Rabies Immunizing Agent 1. Patients needing PEP shall be referred to the nearest Animal Bite Treatment Center/Animal Bite Clinic where anti-rabies immunizing agents (vaccines and RIG) are administered.   2. The following procedures shall be observed when assessing animal bite patients and dispensing anti-rabies immunizing agents:   a) Assess the victim thoroughly and record in the Municipal/City/Hospital Rabies Surveillance Form (Facility-based form).   b) Decide whether or not to initiate treatment using the Revised Guidelines on   the Management of Animal Bite Patients as reference.   c) If the situation warrants immunization (Category II and Category III), the patient shall be given the intradermal regimen. The other approved regimens may be used if the ID regimen is not feasible.   d) If indicated, the patient shall be provided the required dose of passive immunization products/RIG, if available, preferably ERIG or F(ab 2.   e) Explain your decision to the patient with particular emphasis on adherence to treatment schedules, if immunization is indicated.   f) Observe courtesy and tactfulness when dealing with patients particularly among individuals who need not be immunized.   g) Give advice on the practice of Responsible Pet Ownership.   F. Priorities for Dispensing Vaccines   The following shall be the program\u2019s order of priority for dispensing vaccines:   1. Patients bitten by animals found to be positive by IFAT or for \u201cnegri bodies\" regardless of type of bite exposure.   2. Patients with Category III exposure.   3. Patients bitten by animals that are not available for observation (stray/ slaughtered).   4. Individuals exposed to human rabies patients through bite/non-bite exposure as de\ufb01ned in table 1.   5. Patients with Category 11 exposure.   G. Injection Safety: A safe injection is de\ufb01ned by the World Health Organization as an injection that:   -Does not harm the recipient  -Does not expose the health staff to any avoidable risks  -Does not result in waste that is dangerous to the community.   1. Injection Equipment   a. Auto-Disable (AD) Syringes\u2014 are disposable injection devices that are especially made to prevent re\u2014use and are therefore less likely than standard disposable syringes to cause person\u2014to\u2014person transmission of blood\u2014home diseases. The program recommends that health workers shall use AD syringe in their respective ABTC.   b. Conventional Syringes\u2014 are plastic syringes with steel needles that are provided usually by the manufacturer in sterile package. The needle may either be \ufb01xed to the syringe when it is produced or attached by the health staff just before use.   2. Management of Sharp Waste _ Used syringes and needles shall never be dumped in open areas where people might pick them up, step on them, or come in contact with them in any way.   The need to better manage used or contaminated sharps shall be through the use of safety boxes or sharp containers. These are puncture-resistant containers where used syringes and needles can be immediately and temporarily stored after use until its \ufb01nal disposal.   3. Waste Disposal Collector boxes \ufb01lled with used syringes and needles shall be immediately brought to its \ufb01nal disposal. The program recommends the following methods of disposal: 0 Use of septic vault o Pit burial; and 0 Waste treatment and \ufb01nal disposal to landfill    H. Roles and Responsibilities   1. Central Office The National Center for Disease Prevention and Control shall be responsible for procurement, allocation and distribution of vaccines and RIG and shall augment vaccine requirements for low \u2014 income municipalities with high incidence of rabies. All Centers for Health Development shall be given allocation every quarter subject to availability.   2. Centers for Health Development The Centers for Health Development through the Director and the Rabies Control Program Coordinator shall be responsible for distribution of vaccines to the Provincial/City Health Offices.   3. Local Government Units Encouraged to enact and strictly enforce ordinance relevant to rabies. The Provincial Rabies Control Coordinators shall distribute the augmented vaccines of the Department of Health to the established Animal Bite Treatment Centers where human anti-rabies immunizing agents (vaccines and RIG) are administered. The LGUs shall be encouraged to allocate funds for the procurement of syringes and anti rabies vaccines for bite victims.   VII. REPEALING CLAUSE   Provisions of Administrative Order No. 164 s. 2002 \u201cRevised Guidelines on Management of Animal Bite Patients\" and Administrative Order No. 2005-0022 \u201cAmendment to AD. 164 s. 2002, AO 2007- 0029 and AO 2009- 0027 and any other issuances inconsistent herewith are hereby rescinded.   VIII. EFFECTIVITY   This order shall take effect immediately.   ", "  The following Project Implementation Arrangements \ufb01or the Women\u2019s Health and Safe Motherhood Project are hereby issued to ensure effective implementation of the said project:   1. The Department of Health is responsible for the over-all direction for project implementation nationwide.  2. The Project Steering Committee (PSC) shall provide broad policy directions on project implementation.  3. The Project Management Office (PMO) shall provide over-all responsibility for project management and technical performance.  4. The Component Management composed of four (4) program managers shall be responsible for developing implementation guidelines and technical supervision  on their respective components  5. The DOH Integrated Regional Field Units Shall provide assistance to Local Government Units (LGUs), adopt project guidelines to regional conditions and undertake implementation of regionwide activities.  6. The Office for Management Services (Finance Service) ensures that Government of the Philippines\u2019 (GOP) rules and regulations are adhered to with respect to financial, budgetary, and accounting concerns of the project.   Attached are the organizational structures for  the over-all managerial and technical direction of the project for immediate reference.   This Order shall take effect immediately.            ", "  Every 3rd Wednesday of April and May from 1996-2000 are designated as KNOCK OUT POLIO DAYS targetted at eradicating the polio virus from the Philippines. On these days, only Oral Polio Vaccine will be given to all children between 0-59 months old. This is in contrast to the previous OPLAN ALIS DISEASE National Immunization Days.  The following guidelines are hereby promulgated to clarify the relation between routine EPI and the Knock Out Polio Days:  1. Schedule the routine immunization of children aged 1 month 6, 10 and 14 weeks and 9 months (BCG, DPT, OPV, hepatitis B or measles vaccines) on the week before the Knock Out Polio Days. On this scheduled day, give them all their scheduled routine vaccine doses, that is, including their OPV 1,2 or 3.  2. Ask the infants to be brought again the following week for their Knock Out Polio OPV dose.  Remember - Knock Out Polio doses are extra doses, that is, they are to be given in addition to the routine OPV doses. They are not to be considered as the equivalent of the routine OPV doses. The interval between doses does not matter at all.  3. If an infant comes during the Knock Out Polio Day and the parent requests for other routine vaccines to be given as scheduled, you have two options:  3.1. If you have the other antigens ready in the center, give these as requested. 3.2. If you do not have the other antigens at hand, ask the parent to bring the child the following scheduled immunization for the other antigens.  4. If an infant previously unreached by routine immunization comes during the Knock Out Polio Day, hand out an information leaflet on routine vaccination schedule for infants and give clear instructions on when and where to come for the other vaccines.  5. In hard-to-reach areas, the decision to include other antigens during visits to these areas will depend on the assessment of the vaccination team. The points to be considered in the decision should include the availability of the other antigens and the other supplies needed, such as needles and syringes; and the possibility of returning to the same area within the coming month or quarter.  If the vaccination team can return to the area within the same month or quarter, then it will really be easier for them to carry only OPV during the Knock Out Polio Day and return to the area for the routine vaccinations.  For immediate compliance.   ", " I. RATIONALE/BACKGROUND   Under Section 4 of the Republic Act (RA) 9288 or the Newborn Screening Act of 2004, one of the components of the National Comprehensive Newborn Screening System (NCNBSS) is the tracking and con\ufb01rmatory testing thereof to ensure the accuracy of screening results.   In accordance with this, Art. 4 Sec. 10\u20144 of RA 9288 mandates the Department of Health to \u201ccoordinate with the NIH Newborn Screening Reference Center for the accreditation of Newborn Screening Centers and preparation of de\ufb01ned testing protocols and quality assurance programs.\"   Subsequently, the NCNBSS has initiated steps to ensure accessibility of con\ufb01rmatory testing centers to the relevant public and to guarantee quality of con\ufb01rmatory results. The move has started with the Glucose-6-Phosphate Dehydrogenase (G6PD) de\ufb01ciency, one of the disorders included in the newborn screening panel. It is a condition where the body lacks the \"e\ufb01zyme called G6PD. Babies with this de\ufb01ciency may have hemolytic nemia resulting from exposure to oxidative substances found in drugs, foods and chemicals. Among the \ufb01ve congenital metabolic disorders being screened in the Philippines, G6PD De\ufb01ciency has the highest prevalence rate of one out of \ufb01fty\u2014\ufb01ve (1:55).   Since the start of the newborn screening program, almost 60,000 babies were initially found de\ufb01cient in G6PD, about 50% of which have not undergone con\ufb01rmatory test due to \ufb01nancial reasons and accessibility of the test. With the release of Department Memo No. 2008-0123 \u201cNewborn Screening Coverage\", the number of patients that need con\ufb01rmatory test for G6PD is expected to increase.   Some of the steps undertaken by the NCNBSS were the appointment of an Expert Committee on G6PD De\ufb01ciency which participates in the review of datasets and cutoffs of the disorder, treatment and management protocols among others; and the identi\ufb01cation of tertiary hospitals in the different regions of the country equipped and willing to integrate G6PD enzyme assay as one of their services.   The next step in the efforts to ensure the quality of the con\ufb01rmatory results of the disorders included in the newborn screening panel, is the establishment of the quality assurance program, initially for G6PD con\ufb01rmatory test in the country. NSRC being the central facility at the NIH that de\ufb01nes testing and follow-up protocols, maintains an external laboratory pro\ufb01ciency testing program is the ideal agency to manage the quality assurance program for the G6PD De\ufb01ciency Con\ufb01rmatory Testing.   II. OBJECTIVE   To designate the Newborn Screening Reference Center (N SRC) of the National Institutes of Health (NIH), University of the Philippines, Manila to oversee the quality assurance program for G6PD Con\ufb01rmatory test in the country.   III. SCOPE AND COVERAGE   This Order shall apply to the Newborn Screening Reference Center and other health facilities that shall run G6PD Con\ufb01rmatory Test.   IV. GUIDELINES   The NSRC is designated to oversee the quality assurance program for G6PD con\ufb01rmatory test. Facilities that shall provide G6PD Con\ufb01rmatory testing in their laboratories in country shall comply with the standards set by NSRC.   Roles and Responsibilities:   NSRC:  1. Provide technical assistance to laboratories offering G6PD con\ufb01rmatory test;  2. Ensure good laboratory practice in laboratories doing G6PD con\ufb01rmatory test by establishing external laboratory pro\ufb01ciency testing and certi\ufb01cation program in partnership with the International QA Program in Taiwan for G6PD. NSRC shall send Pro\ufb01ciency Testing Samples to G6PD testing Laboratories every two months and submit the results to the International QA Program in Taiwan; and  3. Report and make recommendations, if necessary, to the National Center for Disease Prevention and Control (N CDPC) semi\u2014annually.   G6PD Testing Laboratories:   1. Provide skilled medical technologists to extract blood from neonates and perform the G6PD con\ufb01rmatory testing services on a regular basis, at least once a week;  2. Provide immediate relay of G6PD con\ufb01rmatory results (whether con\ufb01rmed positive or negative) to the patient\u2019s family, attending physician and Newborn Screening Center\u2019s for their records;   3. Comply with the standard con\ufb01rmatory testing fee set by the Department of Health;  4. Comply with the standards set by NSRC to ensure good laboratory practice; and  5. Participate in the International QA program set by NSRC by running quality assurance samples and submit the result to NSRC.   Funding   Incidental costs for sending of quality assurance samples to G6PD Con\ufb01rmatory Testing Laboratories shall be shouldered by the NSRC.   V. REPEALING CLAUSE   This shall repeal and supersede all administrative issuances inconsistent thereof.   VI. EFFECTIVITY   This shall take effect \ufb01fteen (15) days after completion of its publication in the of\ufb01cial gazette or in a newspaper of general circulation.   This Order takes effect immediately ", " Provision of vaccines is important to prevent infectious diseases and its accompanying morbidity and mortality especially to immunocompromised individuals such as people living with HIV        (PLHIV). As such, provision of vaccines should be included to the existing administrative order on the guidelines on antiretroviral therapy in order to fully complement and complete the treatment, care and support package to PLHIV.    The following shall be added to the Administrative Order No. 2009-0006:  a. Addendum to Subject which states that:   SUBJECT: Guidelines on Antiretroviral Therapy among Adults and Adolescents with Human Imunodeficiencv Virus (HIV) Infection   The foregoing subject is hereby amended and read as follows:   SUBJECT: Guidelines on Antiretroviral Therapy and Provision of Vaccines among Adults and Adolescents with Human Immunode\ufb01ciency Virus (HIV) Infection   b. Addendum to Implementing Guidelines   The following provision shall be added to Section V Implementing Guidelines of the said Administrative Order:   K. Provision of Vaccines to Adults and Adolescents with HIV Infection   1. The following vaccines must be given to all PLHIV regardless of CD4 Cell Count:  a. Hepatitis B  b. In\ufb02uenza (Inactivated type)  c. Pneumococcal   2. The following vaccines may be given safely to PLHIV if indicated, regardless of CD4 Cell   Count:  a. Hepatitis  b. Cholera  c. Haemophilus In\ufb02uenza Type B  d. Japanese B Encephalitis  e. Meningococcal  f. Rabies  g. Td (Tetanus, Diphtheria)/ Tdap (Tetanus, Diphtheria, Pertussis) h. Inactivated Polio Vaccine  i. Typhoid vaccine (Vi capsular polysaccharide vaccine)  j. Human Papilloma Virus   3. The following vaccines may be given safely to PLHIV if indicated and if the CD4 Cell Count is more than 200 cu/mm3 :  a. Mumps, Measles and Rubella  b. Varicella  c. Yellow fever   4. The following vaccines should not be given to PLHIV regardless of the CD4 Cell   Count:  a. Oral Polio Vaccine  b. BCG  c. Typhoid Vaccine (Ty21a, live vaccine)  d. In\ufb02uenza (live attenuated in\ufb02uenza vaccine)  e. Herpes Zoster   All other provisions of Administrative Order No. 2009-0006 dated January 13, 2009, stand in effect.   This order shall take effect immediately.  ", " I. BACKGROUND AND RATIONALE   Despite previous efforts and improvement in general health status indicators, the rates of decline in maternal and neonatal mortality have decelerated in the past decade to a point where Philippine commitments to the Millennium Development Goals (MDGs) of lowering maternal mortality ratio (MMR) and infant mortality rate (IMR) may not be achieved.   However, with pregnancy and childbirth continuing to pose risks to Filipino mothers and their newborn, rapid reduction in these risks must be realized as quickly as possible while considering that variations in health outcomes and program performance across localities and population groups warrant targeted and locally\u2014 customized interventions in order to meet the rapid reduction goal.   The risk of maternal and neonatal deaths for a given population group is magni\ufb01ed with critical accumulation of the following four risks. First, is the risk of having mistimed, unplanned, unwanted and unsupported pregnancy. Secondly, having become pregnant exposes the mother and the fetus to the risk of not securing adequate care during the course of the pregnancy. Third, is the risk of delivering without being attended to by skilled birth attendants, namely: skilled midwives, nurses and physicians, and of not having access to emergency obstetric and neonatal care services. Lastly, there is the risk of not securing proper postpartum and postnatal care for the mother and neonate, respectively.   Long term control of mortality and morbidity and improvement in the equality of life require provision and use of a continuum of health services spanning each of the life cycle stages. Provision and use of these services would require informed decisions by mothers and their families (demand side), as well as a health system (supply side) that is responsive to their needs.   This Order applies the Fourmula One for Health (F1) approach for the local implementation of an integrated Maternal, Neonatal and Child Health and Nutrition (MNCHN) Strategy. It outlines speci\ufb01c policies and actions for local health systems to systematically address health risks that lead to maternal and, especially neonatal deaths, which comprise half of reported infant mortalities.   II. STATEMENT OF POLICY   An integrated MNCHN Strategy is hereby formulated and implemented pursuant to the priorities of F1 or Administrative Order No. 0023 series of 2005; the National Objectives for Health (NOH) 2005-2010; the Philippine commitments to the Millennium Development Goals (MDG) for 2015; the lessons obtained from various maternal and child health projects; National Health Sector Meeting Resolution No. 2008-01-02; DOH Executive Committee (Execom) resolution dated February 4, 2008 with a subsequent reiteration in DOH Execom resolution dated June 10, 2008 which was supplemented by DOH Execom resolutions dated July 21 and 30, 2008; as well as in compliance with the 1992 Philippine Midwifery Act or Republic Act (RA) 7392; (the Early Childhood Development Act (RA 8980) of year 2000; the Newborn Screening Law (RA 9288) of 2004; Executive Order 286 on the Bright Child Program, 2004; Executive Order 51 on the Milk Code, 1986; the Rooming-In and Breastfeeding Act (RA 7600) of 1992; and, other related laws.   This strategy shall guide the development, implementation and evaluation of various programs aimed at women, mothers and children, with the ultimate goal of rapidly reducing maternal and neonatal mortality in the country. It shall also serve as guide in the engagement, assistance and empowerment of local government units (LGUs) and other partners in rapidly achieving the maternal and neonatal mortality reduction goal.   iii. GENERAL PRINCIPLES   The goal of rapidly reducing maternal and neonatal mortality shall be achieved through effective population-wide provision and use of integrated MNCHN services as appropriate to any locality in the country.   Reforms, improvements and changes in local health systems shall, among other results, create the following intermediate results that can signi\ufb01cantly lower the risk of dying secondary to pregnancy and childbirth:   1. Every pregnancy is wanted, planned and supported;  2. Every pregnancy is adequately managed throughout its course;  3. Every delivery is facility-based and managed by skilled birth attendants; and  4. Every mother-and-newborn pair secures proper postpartum and postnatal care with smooth transitions to the women\u2019s health care package for the mother and child survival package for the newborn.    The above four intermediate results shall be achieved by:   1. Health Service Delivery\u2014Addressing the direct causes of mortality during childbirth by managing deliveries in either a basic emergency obstetric and newborn care (BEmONC) or comprehensive emergency obstetric and newborn care (CEmONC) facility. Moreover, public health services that reduce the risk of dying and improve the well-being of women, mothers and their children shall be made available. A core list of high priority interventions shall be promoted and supported by DOH for implementation by province-wide or city-wide health systems.   2. Health Regulation\u2014Enforcement of regulatory measures and guidelines related to the establishment and operations of health facilities, as well as the capacity building of an adequate health staff through competency-based standards that are linked with suitable performance\u2014based incentive mechanisms;   3. Health Financing\u2014Application of combined \ufb01nancing strategies using instruments available through DOH and LGU budgets, PhilHealth payments and other funding sources. These sources shall \ufb01nance the acquisition of additional capacities and maximize utilization of services particularly in areas or population groups where maternal and neonatal mortality is most severe; and   4. Governance for Health\u2014Establishment of governance mechanisms that secure the political commitment of local stakeholders and exact accountability for results. These mechanisms shall have broad-based participation, non-partisan leadership and sustained popular support to assure continued local effort regardless of different political, economic and socio-cultural conditions.   IV. GOAL AND OBJECTIVES   Goal Rapidly reduce maternal and neonatal mortality through local implementation of an integrated MNCHN strategy.   Objectives   1. Develop, adopt, promote, implement and evaluate an integrated MNCHN strategy for the rapid reduction of maternal and neonatal mortality;  2. Engage all province-wide or city-wide health systems to adopt and implement the integrated MNCHN strategy;  3. Provide targeted support to province-wide or city-wide health systems and specific population groups where the maternal and neonatal mortality problem is most severe; and   4. Achieve national MNCHN program targets for the following key indicators by 2010:  a. Increase modern contraceptive prevalence rate from 35.9% (Family Flaming Survey, 2006) to 60%;  b. Increase percentage of pregnant women having at least four antenatal care visits from 70% (National Demographic and Health Survey [NDHS], 2003) to 80%;  c. Increase percentage of skilled birth attendance and facility-based births from 40% (NDHS, 2003) to 80%; and  d. Increase percentage of fully immunized children from 70% (NDHS, 2003) to 95 percent.   V. DEFINITION OF TERMS   1. Basic Emergency Obstetric and Newborn Care (BEmONC) facilities are capable of performing six signal obstetric \ufb01lnctions, which include: (i) parenteral administration of oxytocin in the third stage of labor; (ii) parenteral administration of loading dose of anti- convulsants; (iii) parenteral administration of initial dose of antibiotics; (iv) performance of assisted deliveries; (v) removal of retained products of conception, and (vi) manual removal of retained placenta. BEmONC facilities are also capable of providing neonatal emergency interventions which include at the minimum: (i) newborn resuscitation, (ii) treatment of neonatal sepsis/infection; and (iii) oxygen support. It shall also be capable of providing blood transfusion services on top of its standard functions.   2. Community level providers refer primarily to Barangay Health Stations (BHS) and its health staff (e. g. midwife) and volunteer health workers (e. g. barangay health workers, traditional birth attendants) that typically comprise the Women\u2019s Health Team (or Barangay Health Team). These teams implement integrated MNCHN services identi\ufb01ed for the community level. Their functions include advocating for birth spacing and counseling on family planning services; the tracking and master listing of pregnant women; assisting pregnant women and their families in formulating a birthing plan; early detection and referral of high-risk pregnancies; and reporting maternal and infant deaths. The teams shall also facilitate discussions of relevant community health issues, particularly those affecting women and children.   3. Comprehensive Emergency Obstetric and Newborn Care (CEmONC) facilities can perform the six signal obstetric functions of a BEmONC and in addition, perform cesarean section and provide blood banking and transfusion services along with other highly specialized obstetric services. It is also capable of providing the following neonatal emergency interventions, which include at the minimum: (i) newborn resuscitation, (ii) treatment of neonatal sepsis/infection, (iii) oxygen support for neonates, and (iv) management of low birth weight or premature newborn, along with other specialized neonatal services.   4. MNCHN service delivery network refers to the network of facilities and providers within the province-wide or city-wide health system offering integrated MNCHN services in a coordinated manner. It also includes the communication and transportation system supporting this network. The facility, provider type and service standards for the network shall be described in the MNCHN Operations Manual.   5. Integrated MNCHN services refer to a package of services for women, mothers and children that cover the continuum of the following:   1. Known appropriate clinical case management services in preventing direct causes of maternal and neonatal deaths, and which are within the capacity of the health system to routinely provide, and;   2. Known cost-effective public health measures capable of reducing exposure to and the severity of risks for maternal and neonatal deaths, that are within the capacity of the health system to routinely provide.   6. Province-wide or city-wide health system refers to the default catchment area for delivering integrated MNCHN services. It consists of public and private providers organized into con\ufb01gurations such as interlocal health zones (ILHZ) or health districts for provinces and integrated urban health systems for highly-urbanized cities. Service arrangements with other LGUs may be considered if provision and use of integrated MNCHN services across provinces, municipalities and cities become necessary.   VI. SCOPE AND COVERAGE   This Order shall apply to the whole hierarchy of the DOH and its attached agencies, as well as LGUs, other public and private providers of health care and development partners implementing the MNCHN strategy. .   VII. GENERAL GUIDELINES   1. Recognize the province-wide or city-wide health system as the unit for planning, organizing and implementing the MNCHN strategy. The province-wide or city-wide health system shall be the basic unit for planning, organizing and implementing MNCHN activities. The DOH shall advocate and promote the standards of a stable and mature service delivery network to local stakeholders. It shall also ensure that the standards are \ufb02exible enough to adapt to local conditions, and are appropriate to the local area and population.   2. Engage local stakeholders and strengthen public-private partnerships to support the goal of rapidly reducing maternal and neonatal mortality. Local stakeholders shall be engaged to review the current functionality of their respective local service delivery network. Functionality includes, among other things, the level and quality of coordination across the various activities and functions of public and private providers. Based on this assessment, all local stakeholders shall be enjoined to take part in activities that address maternal and newborn health.   3. Mobilize the service delivery network to deliver the integrated MNCHN services as a continuum. Universal access to and utilization of integrated MNCHN services in its \ufb01ill continuum spanning the pre-pregnancy, pregnancy, delivery and postpartum/postnatal care phases shall be ensured in all localities, and shall be backed-up by pertinent laws and accessible operational resources. A core list of MNCHN services include those from the women\u2019s health and child survival packages developed by the DOH.   4. Pursue improvements in the delivery of various component services in the maternal and neonatal service package. In order to mount rapid response capacity in local health systems, the MNCHN strategy shall build on existing service capacities and utilization patterns. Targeted quality improvements in facilities and human resources, together with measures to facilitate utilization by clients, shall be carried out to achieve rapid mortality reduction with minimal effort and investment in the immediate and medium term. Over time, improvements in the current delivery system con\ufb01guration and services shall be introduced as standards improve, as demand increases, as local health'systems acquire additional capacity, as legal and resource constraints are addressed and as the nature of the maternal and neonatal mortality problem evolves.   5. Develop and support implementation of appropriate demand-sideinterventions.   The DOH shall develop schemes to support local health systems in designing, implementing and evaluating appropriate demand-side interventions to improve health seeking behavior and service utilization patterns in localities. Demand-side measures shall be given due emphasis  in local applications of the MNCHN strategy as life saving and cost saving interventions. These measures shall also be crafted and directed at speci\ufb01c target areas and populations (e.g. mothers, poor households) whichever is most appropriate and effective in a given locality.   6. Develop monitoring and evaluation systems for the MNCHN strategy. The DOH shall develop and support the establishment, operation and maintenance of monitoring and evaluation mechanisms for local implementation of the MNCHN strategy. Appropriate methodologies (e. g. maternal and perinatal death reviews) shall be employed to establish baseline, track progress and assess the impact of various interventions to improve the delivery of services in a local health system. The monitoring and evaluation system shall be developed incrementally and may begin with a limited set of readily available and veri\ufb01able indicators. It is also desired that these monitoring and evaluation mechaniSms are transparent, have established dissemination channels that feed into formal feedback mechanisms to policy and management that is sustainable given local constraints and conditions.   7. Provide national support to local planning and development in support of the MNCHN strategy. The DOH shall develop and apply various instruments to help localities develop customized MNCHN strategies, strengthen their service delivery networks, secure critical goods and commodities and improve monitoring and evaluation. These instruments shall include a mix of grant assistance schemes, policy issuances, technical assistance, institutionalized training, research and development, development of new standards, provision of specialized services, \ufb01nancing mechanisms through PhilHealth, and regulatory measures.   VIII. SPECIFIC GUIDELINES   The following are speci\ufb01c guidelines for implementing the general guidelines mentioned above:   1. The province-wide or city-wide health system shall be delineated by the politico- geographic jurisdictions of its component LGUs. Other providers and LGUs outside the catchment area may also be engaged within this health system should it be necessary for the effective provision and use of integrated MNCHN services. This may be recommended if the required service capacities are not accessible within the catchment area and/or if utilization patterns by constituents and neighboring populations overlap in these jurisdictions. To sustain operations, DOH shall also facilitate compliance of these facilities with DOH licensing and PhilHealth accreditation requirements.   2. The operations of the MNCHN service delivery network shall be organized as follows:   a. Third Tier\u2014CEmONCs are public or private facilities designated as the end- referral facility for integrated MNCHN services. The default CEmONC in a given locality shall be the provincial hospital or similarly capable DOH/LGU hospital or private hOSpital. Designation of the CEmON C facility shall be based primarily on its service capacity. However, other criteria such as pricing, service load, quality of care, location, topography, transport system, utilization patterns and other similar parameters may be used to determine the designation of a CEmONC facility. In case of multiple CEmONC facilities (as in large or highly-populated provinces or cities), the catchment area may be divided \ufb01thher into speci\ufb01c areas of responsibility for each facility, based on criteria mentioned above.   Ideally, the CEmONC facility shall be accessible within two hours travel from any residence/referring facility within the province/city. However, in anticipation of possible delays during referral, CEmONC facilities are recommended to be accessible within one-hour travel time. A CEmONC facility shall operate on a 24- hour basis with emergency standby capacity. At least one obstetrician] surgeon, a pediatrician, an anesthesiologist, six nurses, a medical technologist and six midwives staff the typical CEmONC.   b. Second Tier\u2014\u2014The default BEmONC facility shall consist of the core district hospital or similarly capable public or private facility assigned to serve an ILHZ or health district. In certain cases, such as in geographically isolated and disadvantaged areas or in densely-populated areas, rural health units (RHUs), health centers, BHS, lying-in clinics or birthing homes capable of performing the six signal obstetric functions and neonatal emergency care may also be designated as BEmONC facilties.   Designation of the BEmON C facility shall be based primarily on service capacity. However, other criteria such as pricing, service load, quality of care, location, topography, transport system, utilization patterns and other similar parameters may be used to determine to upgrade and designate a facility as a BEmONC facility. In case of multiple BEmONC facilities serving a particular ILHZ or health district the catchment area may be divided \ufb01lrther into speci\ufb01c areas of responsibility for each facility, based on criteria mentioned earlier.   Ideally, the BEmONC facility shall be accessible within one-hour travel from any residence/referring facility within the ILHZ, health district or city. However, in anticipation of possible delays during referral, BEmONC facilities are recommended to be accessible within 30 minutes of travel time. A BEmONC facility may have a minimum staff complement of at least one physician, a nurse and a midwife. The BEmONC facility shall operate on a 24-hour basis and shall have access to communication and transportation facilities to facilitate referrals.   Public and private clinics, lying-in clinics, birthing homes and other similar facilities currently managing deliveries but have no capacity to provide the six signal obstetric \ufb01mctions and neonatal emergency services may acquire new capacities to qualify and be designated as BEmONCs. Acquisition of these additional capacities shall be supported by DOH in terms of addressing legal and resource constraints, with resources focused mainly in areas where the maternal and neonatal mortality problems are most severe.   c. First Tier\u2014Community level service providers such as RHUs, health centers, BHS or similar private facilities shall have Women\u2019s Health Teams or Barangay Health Teams led by a nurse or a midwife organized to provide the identi\ufb01ed MNCHN services along with other \ufb01mctions deemed necessary in their communities. These teams shall vigorously campaign for proper birth spacing, complete required antenatal care visits, facilitate the shift from home deliveries to facility\u2014based births attended by skilled professionals, provide postpartum and postnatal care, and ensure smooth transitions to other health care packages for women and children.   The RHUs, health centers and private outpatient clinics in the network shall provide MNCHN services other than managing deliveries. These services shall include family planning, prenatal services and postpartum and postnatal care aside from other public health and clinical services deemed necessary in their localities, including organizing of outreach activities;   3. The province-wide or city-wide health system shall be supported by an adequate emergency communication and transportation system. This communication system shall facilitate consultation, referral and coordination \ufb01om and by peripheral facilities all the way up to the end referral facility level. LGUs are encouraged to invest in modern communication systems available in and suitable to their localities. The transportation system is intended to bring patients to and from facilities during referrals and transfers. This may be done through an organized ambulance network that services the whole breadth of the province-wide or city-wide health system or a mix of facility-based ambulances and locally available transportation with explicit arrangements for use and \ufb01nancing during referrals and transfers.   Appropriate measures shall be taken to facilitate the shift from home-based deliveries to facility-based births attended by skilled birth attendants. In order to facilitate the shift, schemes can be developed to provide traditional, non\u2014skilled attendants with incentives to refer deliveries to appropriate facilities. Aside from enjoining them to join barangay health teams, quali\ufb01ed TBAs may be provided educational assistance to become midwives.   4. The integrated MNCHN services shall consist of clinical and public health interventions for women and children that shall be delivered through a seamless continuum of care that shall include pre-pregnancy care, antenatal care, care during delivery and postpartum and postnatal care. The minimum standard services are:   a. Pre-Pregnancy Services      i. Provision of correct information and responsive counseling for fertility awareness, maternal nutrition, birth spacing and adolescent reproductive health;   ii. Active identi\ufb01cation and servicing of population segments with unmet needs for family planning and referral to alternative sources of services and supplies when these are not available in one\u2019s service outlet or facility;   iii. Assurance of a safety net of free family planning services and supplies for indigent potential users; and   iv. Provision of other basic and essential services for young females and women in the reproductive age.   b. Antenatal Care   i. Consistent coverage of all eight essential antenatal care functions (monitoring height and weight, taking blood pressure, blood testing, urine testing, iron and folate supplementation, tetanus toxoid immunization, malaria prophylaxis where appropriate and birth planning);   ii. Focused attention to individualized birth preparedness counseling about the place of delivery and transport arrangements to increase the mother\u2019s readiness to deliver in health facilities; and   iii. Discussion with household member/s and preparation for childbirth with partner support and involvement in care-seeking decisions.   c. Care during Delivery   i. Proper channeling of patient workloads with aggressive promotion of shifting from home-based deliveries to delivery in either a BEmONC or a CEmONC, especially for women with medical conditions and other special needs by classifying them as priority for transport and servicing by the appropriate delivery/birthing facility;   ii. Deliberate planning and special provisions for hard\u2014to-reach segments of the population within the province-Wide or city-wide system to promote facility-based deliveries;   iii. Active conversion and mobilization of traditional birth attendants into advocates and agents of facility-based deliveries; and   iv. Correct and updated monitoring and reporting of the number and preportion of facility-based births.   d. Postpartum and Postnatal Care   i. Provision of proper postpartum/postnatal care for mothers and neonates; and   ii. Provision of the whole range of women\u2019s health care services for mothers and of the child survival package for children.   5. The DOH shall support universal local implementation of the MNCHN strategy. However, local conditions and capacities shall be considered in the adoption of MNCHN services in the different LGUs. The DOH shall periodically determine the appropriateness and responsiveness of the comprehensive and core components of the integrated MNCI-IN package in order to adapt to the evolving nature of the maternal and neonatal mortality problem.   6. The assessment of coordination across the various MNCHN-related activities and functions within and outside the health service system shall be in accordance with speci\ufb01c criteria, and made part of a local monitoring and evaluation system. The assessment shall cover coordination within the province-wide or city-wide system, between public and private service providers, and between each tier of the 3-tier service delivery network.   IX. ROLES AND RESPONSIBILITIES   For purposes of this Order, the various DOH instrumentalities, partners and other stakeholders shall have the following roles and \ufb01inctions:   1. Office of the Undersecretary for Policy Standards and Development Team- Service Delivery a. Provide overall leadership in the implementation of the MNCHN strategy; b. Mobilize and coordinate resources for implementation of the MNCHN strategy; 0. Monitor overall progress of implementing the MNCHN strategy; and d. Regularly report progress of implementing the MNCHN strategy to the Secretary of Health, Execom and similar oversight bodies.   2. National Centers for Disease Prevention and Control (NCDPC)   a. Reorganize its systems and processes to ably support the delivery of the integrated MNCI-IN services;  b. Re-align relevant programs and services into the MNCHN framework and strategy;  c. Provide technical leadership and assistance in the delivery of integrated MNCHN services to CI-IDs, LGUs and other stakeholders;  d. Identify resources necessary to ef\ufb01ciently assist partners in their implementation of MNCHN; '  e. Develop service standards for MNCHN interventions; and,  f. Coordinate monitoring and evaluation of the implementation of the MNCHN strategy.   3. National Center for Health Facilities Development (NCHFD)  a. Assist designated facilities to comply with technical standards and requirements for providers in the service delivery network;  b. Deve10p facility standards for MNCHN providers and other facilities within the service delivery network;  c. Strengthen the MNCHN functions of hospitals and other facilities, including public health services; and,  d. Assist in monitoring the progress of implementation of the MNCHN strategy.   4. National Center for Health Promotion (NCHP)   a. Develop effective mechanisms to promote the MNCHN goals and strategies; Design and assess communication and health promotion schemes addressing various groups of stakeholders involved in MNCHN; and   b. Provide technical assistance to CI-IDs, LGUs and other stakeholders in developing locally-speci\ufb01c communication and heath promotion packages.   5. Health Human Resources Development Bureau (HHRDB)    a. Identify mechanisms to meet human resource requirements to operate province- wide or city- wide health systems;   b. Deve10p strategy and program to retool national and local personnel in order to facilitate delivery of integrated MNCHN services;   c. Facilitate integration and updating of existing training moduleson maternal\u2014 neonatal health and other related programs;   d. Develop training standards as part of civil service deployment and promotion criteria for local health officials.   6. Bureau of Local Health Development (BLHD)   a. Develop guide/criteria for designing the provincel-wide or city -wide health system providing integrated MNCHN services;   b. Assist CHDs in the engagement of LGUs;   c. Facilitate mainstreaming of the MNCHN strategy into the PIPH and AOPs of the F1 sites; and,   d. Assist in monitoring local implementation of the MNCHN strategy.   7. Health Policy Development and Planning Bureau (HPDPB)   a. Link MNCHN strategy implementation with DOH budget   b. Facilitate the review and updating of policies and plans for consistency with the MNCHN strategy;   c. Provide support in the enhancement of lawstRRs in support of the MNCHN strategy; and '   e. Institutionalize mechanisms for the use of accurate, timely and reliable evidence for policy decisions, strategic actions and prioritization of resources and efforts.   8. Bureau of International Health Cooperation (BIHC)   a. Manage external resources to support implementation of the MNCHN strategy;   b. In\ufb02uence the formulation by development partners of their country assistance package or assistance framework so that these are harmonized with the Philippine Health Sector Reform Program, in general, and the MNCHN strategy in particular; and   c. Facilitate access to information on international experience and best practices to enhance MNCHN as necessary.   9. National Epidemiology Center (NEC)   a. Provide accurate, timely and complete data as basis for policy decisions, strategic actions and prioritization of resources and efforts;   b. Enhance FHSIS as source for tracking maternal mortality and the other childhood health outcomes;   c. Design tools to improve data collection and skills of regional/local health managers/ staff, including development of compliance monitoring mechanisms; and,   d. Coordinate overall measurement of MDG-related goals on maternal-neonatal health including the conduct of national surveys and special studies.   10. Finance, Procurement and Materials Management Services   a. Assist in the development of guidelines for granting assistance to groups of stakeholders involved in the implementation of the strategy;   b. Facilitate process in transferring \ufb01nancial resources to the regions and LGUs as part of the overall grants approach to local health system deveIOpment; and   c. Enhancing procurement and supply chain management system of essential MNCHN logistics.   11. Office of Special Concerns, Field Implementation and Management Of\ufb01ce and Centers for Health and Development   a. Reorganize/ staff to support the delivery of the integrated MNCHN services, in the context of the health sector reform elements and goals;   b. Promote the adoption of the MNCHN Policy Framework and Strategy to their catchment LGUs;   c. Advocate for the participation of multi\u2014sectoral partners and work for the establishment of a coalition of advocates to reduce maternal and neonatal deaths in the region;   d. Promote the establishment of province-wide or city- wide health systems in the region;   e. Assist DOH-retained hospitals to qualify to serve as CEmONC facilities in their respective networks;   f. Assist LGUs in applying and qualifying for MNCHN and related grants;   g. Manage regional implementation of MNCHN and related grants facilities; and   h. Provide technical assistance to LGUs and providers implementing the MNNCHN strategy.    12. Local Government Units   a. Adopt and implement the MNCHN strategy;   b. Reorganize staff to deliver the integrated MNCI\u2014IN services, in the context of the health sector reform elements and goals;   c. Invest in the development of facilities and staff to improve implementation of MNCHN services;   d. Ensure adequate \ufb01nancing of MNCHN service inputs by allocating budgets and actively sourcing alternative \ufb01nancing sources such as grants;   e. Monitor and supervise local implementation of the MNCHN; and   f. Ensure sustainability of quality MCNHN services in the locality.    13. Philippine Health Insurance Corporation (PhilHealth)   a. Intensify enrollment campaigns in localities implementing the MNCHN strategy;   b. Facilitate the accreditation of facilities involved in the MNCHN service delivery network; .   c. Assist facilities in improving the management of claims, payments and reimbursements; and   d. Strengthen existing bene\ufb01t packages in support of the MNCHN strategy.    14. Commission on Population (PopCom)   a. Reorganize staff to support the delivery of the integrated MNCHN services, in the context of the health sector reform elements and goals;   b. Coordinate and intensify efforts at promoting family planning, especially natural family planning methods in localities implementing the MNCHN strategy; and   c. Mobilize local population workers including barangay population workers/volunteers (Bamagay Service Point Of\ufb01cers) and other community-based volunteers to support the MNCHN strategy in the localities.   15. National Nutrition Council (NNC)   a. Reorganize staff to support the delivery of the integrated MNCHN services, in the context of the health sector reform elements and goals;   b. Coordinate multisectoral efforts on nutrition in support of the MNCHN strategy (i.e. consolidating efforts targeted to mothers and children below two years old); and   c. Mobilize Barangay Nutrition Scholars to support MNCHN strategy in their localities   16. Philippine National AIDS Council (PNAC)   a. Coordinate multisectoral efforts on MV/AIDS and STI prevention in support of the MNCHN strategy; and   b. Mobilize Local HIV/AIDS Councils (LACS) to support MNCHN strategy in their localities.   17. Development Partners   a. Align country programs and support to facilitate the adoption and implementation of the MN CHN strategy, in the context of the health sector reform elements and goals; and   b. Provide technical assistance and other forms of support to LGUs in implementing the MN CHN strategy.   18. Professional Societies/Groups   a. Support the implementation and continuing development of the MNCHN strategy;   b. Assist in the review and updating of MNCHN facility and practice standards;   c. Assist in the development and implementation of compliance monitoring strategies for the MNCHN strategy; and I   d. Promote the adoption of the MNCHN strategy among members and component societies.   X. MANUAL OF OPERATIONS   The Undersecretary for Policy Standards and Development Team-Service Delivery shall organize and oversee the technical working group that shall draw up the Manual of Operations for the MNCHN Strategy, in consultation with maternal and child health experts and other sectoral and development partners. The Manual shall contain, among other necessary details, the following components of the MNCHN strategy:   a. Key indicators to measure progress in intermediate results  b. Integrated list of MNCHN services  c. Core list of MNCHN interventions  d. Budget execution guidelines for the MNCHN grants facility  e. Facility and service standards for the MNCHN network  f. Capacity building requirements for the MNCHN strategy  g. Coordination mechanisms within and with other province-wide or city\u2014wide health systems  h. Monitoring and evaluation systems and implementation guide  i. Reporting and documentation   XI. REPEALING CLAUSE   Provisions from previous issuances that are inconsistent or contrary to the provisions of this Order are hereby rescinded and modi\ufb01ed accordingly.   XII. SEPARABILITY CLAUSE   In the event that any provision or part of this Administrative Order be declared unauthorized or rendered invalid by any court of law or competent authority, those provisions not affected by such declaration shall remain valid and effective.   XIII. EFFECTIVITY   This Order shall take effect immediately.  ", "   I. Rationale   Efforts are continuously being done to achieve the goal of saving Filipino newborns for common life-threatening heritable disorders. To this end, the National Comprehensive Newborn Screening System is expanding the screening panel of disorders from six (6) to more than twenty (20) disorders. An expanded screening program will give opportunities to signi\ufb01cantly improve the quality of life for affected neWborns and will also identify babies whose condition may not become symptomatic until permanent damage or disability has occurred.   Review of data on Filipino newborns screened in the California newborn screening program from 2005 to 2011, showed that Filipino newborns con\ufb01rmed positive with several disorders in the newborn screening panel. The disorders were a mix of endocrinologic and metabolic conditions as well as hemoglobinopathies. (Padilla, 2012)   The data prompted a review and subsequently a formal recommendation of the expanded newborn screening program in the Philippines to the Advisory Committee on Newborn Screening.   In line with the implementation of the expanded newborn screening, a National Technical Working Group (NTWG) was created under the National Center for Disease Prevention and Control (NCDPC) composed of representatives of key of\ufb01ces at the Department of Health and of different concerned institutions. The NTWG was tasked to prepare the necessary guidelines for the implementation of expanded newborn screening in the country.   II. OBJECTIVE   This Administrative Order sets the guidelines for the implementation of the expanded newborn screening in the country.    III. SCOPE AND COVERAGE   Provisions of this Administrative Order shall apply to all Newborn Screening Centers, DOH-Regional Of\ufb01ces, DOH-ARMM, National Comprehensive Newborn Screening System \u2014 Treatment Network, health facilities and all other agencies and stakeholders concerned in the implementation Of the newborn screening program.   IV. DEFINITION OF TERMS   1. Con\ufb01rmatory Center refers to a facility identi\ufb01ed by the DOH to be part of the National Comprehensive Newborn Screening System Treatment Network. It is equipped to do con\ufb01rmatory testing to ensure the accuracy of screening results.   2. Newborn Screening Continuity Clinic refers to an ambulatory clinic based in a tertiary hospital identi\ufb01ed by the DOH to be part of the National Comprehensive Newborn Screening System Treatment Network. It is equipped to facilitate continuity of care of con\ufb01rmed patients in its area of coverage.   3. National Comprehensive Newborn Screening System Treatment Network refers to a network wherein total management of patient with con\ufb01rmed diagnosis shall be referred to. It follows the DOH-approved clinical protocol in the management of patients diagnosed in any of the disorders included in the newborn screening panel.   4. Newborn Screening Center (NSC) refers to a facility equipped with a newborn screening laboratory that complies with the standards established by the National Institutes of Health, and provides all required laboratory tests and recall/follow\u2014up programs for newborns with heritable conditions.   5. Newborn Screening Reference Center WSRC) refers to the central facility at the National Institutes of Health that de\ufb01nes testing and follow\u2014up protocols, maintains an external laboratory pro\ufb01ciency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, oversees content of educational materials and acts as the Secretariat of the Advisory Committee on Newborn Screening.   6. Republic Act 9288: Newborn Screening Act of 2004 refers to the act promulgating a comprehensive policy and a national system for ensuring newborn screening.   V. GENERAL GUIDELINES   1. The number of disorders in the newborn screening panel shall be increased from six (6) to twenty\u2014eight (28) falling under various types. of disorders namely: hemoglobinopathies, amino acid disorders, organic acidurias, disorders of fatty acid oxidation, disorders of carbohydrate metabolism, disorders of biotin metabolism, cystic \ufb01brosis, and endocrine disorders.   2. Site renovations/preparations, procurement of equipment and reagents, hiring and training Of personnel, upgrading of database, preparation of manuals and protocols, and implementation of other necessary program groundwork shall be undertaken prior to the implementation of the expanded newborn screening.   3. The necessary con\ufb01rmatory centers and network for referral, management and treatment of patients found positive under the expanded newborn screening shall likewise be established in strategic areas of the country.   4. Pilot-run of the Expanded Newborn Screening shall be undertaken at the. Newborn Screening Center-National Institutes of Health, prior to full implementation before 2015.   5. Newborn screening shall be offered to parents in all participating facilities with two Options:   a. Option 1: six (6) disorders (CH, CAH, GAL, PKU, G6PD, and MSUD) under the basic NBS panel; and   b. Option 2: twenty-eight (28) disorders under the expanded newborn screening panel.   6. Con\ufb01rmatory centers for the additional disorders shall be identi\ufb01ed.   7. A network of specialists shall be identi\ufb01ed for the management of the additional disorders.   8. A separate policy shall be issued in the identi\ufb01cation of expert panel.   9. Newborn Screening Continuity Clinics shall be set-up to facilitate long term care of patients con\ufb01rmed through newborn screening.   10. Information on the expanded screening and the disorders included shall be made available to health professionals, parents, and the general public at all NSCs, DOH- Regional Of\ufb01ces and Newborn Screening Facilities.   VI. SPECIFIC GUIDELINES/IMPLEMENTING MECHANISM   In terms of the different components of the newborn screening program, the following shall be considered in the implementation of the expanded screening:   A. Procedure   1. Implementing expanded newborn screening shall involve a series Of steps from motivation, screening, follow-up, diagnosis, management and evaluation.   2. As stated in Sec. 6 of the Implementing Rules and Regulations of RA 9288, any health practitioner who delivers, or assists in the delivery of a newborn in the Philippines shall, prior to delivery, inform parents or legal guardian of the newborn of the availability, nature and bene\ufb01ts of NBS. Health practitioners shall follow the DOH prescribed guidelines on noti\ufb01cation and education relative to the obligation to inform. The DOH, other government agencies, non-government agencies, professional societies and LGUs shall make available appropriate information materials and shall have a system Of its distribution. The health (4 practitioner shall maintain documentation in the patient\u2019s records that NBS information has been provided.   3. Refusal form shall be accomplished by parents refusing newborn screening.   4. The same screening protocol, which includes the proper timing and specimen collection, transport, laboratory testing, and reporting in compliance with the Implementing Rules and Regulation of Republic Act 9288 shall be followed.   B. Reporting and Monitoring Protocols   An evaluation plan shall be implemented that would clearly de\ufb01ne selected indicators, assign responsibility for monitoring, and outline the periodicity with which evaluations are to occur. The program evaluation shall encompass the detailed procedures, Operational arrangements and budget source.   C. Roles and Responsibilities   To ensure implementation of expanded NBS, the agencies/organization identi\ufb01ed below shall have the following responsibilities:   1. The Department of Health   a. The FHO shall be the lead agency in the implementation of expanded newborn screening. Its roles and responsibilities are stated in Section 13 of the Implementing Rules and Regulations of RA 9288.   b. The FHO, as the lead in the National Technical Working Group (NTWG) on Newborn Screening shall ensure that the expanded screening is integrated into the NTWG\u2019s various functions Of long-term or medium-term target setting and planning. This shall ensure that all policies, guidelines and standards of the expanded screening program adhere to over-all internationally accepted standards and ethical considerations. Speci\ufb01cally, expanded screening shall be included in the NTWG\u2019S functions of:   i. Developing/reviewing policies, standards and guidelines on Newborn Screening for recommendations to and approval of the Advisory Committee Of the Newborn Screening Program;   ii. Recommending the disorders to be included in the Newborn Screening panel;   iii. Reviewing and recommending the Newborn Screening fee to be charged by the Newborn Screening Centers;   iv. Developing/reviewing strategies and tools that ensure effective and ef\ufb01cient implementation of the Newborn Screening at various levels;   v. Formulating national program / project plan, proposals and collaborative studies on Newborn Screening; and   vi. Reviewing the report Of the Newborn Screening Reference Center on the performance Of the Newborn Screening Centers and recommended corrective measures as deemed necessary.   c. The Health Promotion and Communications Service (HPCS), in coordination with the NSRC, shall be responsible for advocacy and information dissemination on expanded screening to the communities throughout the country prior to and during the implementation of expanded screening.   2. Health Facilities   Health facilities, i.e. hospitals, birthing facilities, rural health units and health centers, shall ensure that the expanded newborn screening is Offered as an option. It shall be integrated in their Newborn Screening Services and provision of information, education, communication, screening, recall and management of identi\ufb01ed cases and other related services, as outlined in Section 14 of the IRR of RA 9288, shall be undertaken.   3. Newborn Screening Reference Center   NSRC shall de\ufb01ne the testing and follow\u2014up protocols for the additional disorders; maintains an external laboratory pro\ufb01ciency testing program, and integrating the additional disorders in its case registries and national testing database it oversees; assists in training activities in all aspects of the NBS program.   4. Newborn Screening Centers   NSCs shall ensure that laboratory space, equipment and supplies needed for the implementation of the expanded newborn screening are in place. It shall ensure that the mechanism for ordering and payment of expanded newborn screening service is in place. It shall ensure that patients identi\ufb01ed positive in any of the disorders are followed up and referred to specialists for initial management. All NSC\u2019s shall strictly follow the prescribed guidelines of good laboratory practices.   5. Newborn Screening Continuity Clinics   Newborn Screening Continuity Clinics shall facilitate continuous care of con\ufb01rmed positive patients. It shall provide long-term follow-up care activities related to improving care delivery, including engagement Of affected individuals and their families.   D. Budget Source   1. The NBS Fee   a. The cost of the tests shall be as follows (Per recommendation of the Advisory Committee on Newborn Screening on August 19, 2012):   Option 1 (6 disorders) - Php550.00  Option 2 (expanded newborn screening) - Php 1,500.00.   b. For PhilHealth members, P550 shall be covered by PhilHealth. For Option 1 (6 disorders), the total cost shall be covered.   For Option 2 (expanded NBS), only P550 shall be covered by PhilHealth and the balance shall be an out-of\u2014pocket expense of \ufb02ee family.     c. Both options 1 and 2 shall have an allowable charge of P50 for the collection a of thesample (DOH AO No. 2005\u2014005).   d. Overpricing of newborn screening fees shall be reported to the Department of Health. The following administrative \ufb01nes shall be imposed on health facilities that were found liable for collecting more than the maximum allowable NBS fees (DOHAO 2008~0026\u2014A):   First offense \u2014 Warning  Second offense - Administrative \ufb01ne of \ufb01fty thousand pesos (P50,000) Third offense - Administrative \ufb01ne of one hundred thousand pesos (P100,000)   2. Usage of the NBS Fee   As stated in Section 22 of the Implementing Rules and Regulations of RA 9288, the NBS fee shall be applied to, among others, testing costs, education, sample transport, follow-up and reasonable overhead expenses.   VII. REPEALING CLAUSE   Provisions of AO No. 121 s. 2003 and all other issuances that are inconsistent with the provisions of this Order are hereby repealed /rescinded.   VIII. SEPARABILITY   If any provision of this Order is declared invalid, the other provisions not affected thereby shall remain valid and subsisting.   IX. EFFECTIVITY   This Order shall take effect \ufb01fteen (15) days after its approval and publication in the Of\ufb01cial gazette or newspaper of general circulation.  ", " I. RATIONALE   The Philippines is one of the 42 countries accounting for 90% of all global deaths of under 5 year old children. Childhood death rates in the Philippines showed a downward trend from 1993 to 2003 with the decline slowing down in the last 10 years. The under live mortality rate (USMR), decreased to only 32 per 1000 livebirths in 2003 from 52 per 1,000 live births in 1988. The infant mortality and child death rates exhibited similar trend over the same period. Neonatal and post-neonatal deaths declined the slowest over the past 20 years with the reduction ofonly 9 percent and 7 percent. respectively, from 1988 to 2003.   Further analysis of the neonatal deaths shows that half occur during the first 2 days of life. Birth asphyxia (31%). complications of prematurity (30%) and severe infection (19%) account for the majority of newborn deaths. If newborn mortality is not reduced by at least half. the goal of reducing childhood mortality by two thirds (Millennium Development Goal #4) by 2015 would not be met.   An observational study of consecutive deliveries using a standardized assessment tool to document minute-by\u2014minute newborn care done in the \ufb01rst hour of life was undertaken in Si hospitals in 9 regions of the country in 2008. The study found that Philippine hospital practices prevented newborns from bene\ufb01tting from their mothers' natural protection in the first hour of life. Further, the performance and timing of evidence-based interventions in immediate newborn care are below WHO essential newborn care standards. Speci\ufb01cally:   - Only 3% of our study newborns were dried prior to or with cord cutting. and only 1 of26 with difficult breathing was dried first. Hypothermia can lead to infection. coagulation defects, acidosis, delayed fetal to newborn circulatory adjustment. hyaline membrane disease and brain hemorrhage.   - Unnecessary delays and restrictions on immediate and sustained skin-to-skin contact, early latching on, rooming in and full breastfeeding compromised the newborns\u2019 chance for maintenance of warmth and sustained breastfeeding. These earliest interventions contribute to hospital infection control as they directly reduce risk of neonatal sepsis.   - Almost no newborn bene\ufb01ted from the natural transfusion through non- immediate cord clamping. A Cochrane systematic review of 7 Randomized Controlled Trials (RCTs) showed that among infants less than 37 weeks of gestation, non-immediate cord clamping is associated with fewer transfusions due to anemia or low blood pressure and fewer intraventricular hemorrhages. Full-term neonates also bene\ufb01t by having lower incidence of anemia.   - Only 61.3% of newborns was initiated to breastfeeding within the \ufb01rst hour. However, newborns were given a median of only about two minutes to get colostrum, their \ufb01rst immunization. Furthermore, they were being forced to breastfeed at a median of 10 mins, long before the typical newborn would be ready.   - More than 80% was exposed to hypothermia during washing. The WHO recommends that initial bathing should be six hours after birth or longer. The vernix was washed off at a median of 8 minutes thereby removing a protective barrier to bacteria such as E. c01i and Group B Strep. Furthermore, washing removes the crawling re\ufb02ex.   - Virtually all healthy newborns were suctioned unnecessarily, 80% more than once - a practice WHO discourages.   Correct and appropriately-timed interventions given to the newborn during this period will bene\ufb01t both the newborn and the mother as these will avert approximately 70% of avoidable newborn deaths. A package of services for newborn that follow a prescribed sequence of interventions increases newborn care effectiveness. This means that time- bound interventions are routinely performed \ufb01rst, non-time bound interventions are performed after time-bound ones, and unnecessary procedures are not performed.   This Administrative Order (AO) outlines speci\ufb01c policies and principles for health care providers with regard the prescribed systematic implementation of interventions that address health risks known to lead to preventable neonatal deaths. This AD is consistent with A0 no. 2008-0029 on Implementing Health Reforms for Rapid Reduction of Maternal and Newborn Mortality and supports all DOH initiatives and programs for newborn and child health.   II. OBJECTIVES   In general, this policy aims to ensure the provision of globally accepted evidence-based essential newborn care focusing on the \ufb01rst week of life.  Speci\ufb01cally, it aims to:  (1) Guide health workers and medical practitioners in providing evidence-based essential newborn care  (2) De\ufb01ne the roles and responsibilities of the different DOH of\ufb01ces and other agencies in the implementation of the Newborn Protocol   III. SCOPE OF APPLICATION   This order shall apply to the whole hierarchy of the DOH and its attached agencies, other public and private providers of health care and development partners implementing the Maternal, Newborn and Child Health and Nutrition (MNCHN) strategy and to all health practitioners involved in maternal and newborn care.   IV. DEFINITION OF TERMS   1. Attachment \u2014 is the mode of contact between the baby\u2019s mouth and the mother\u2019s breaSt during the act of breastfeeding.   2. Kangaroo Mother Care \u2014 a universally available and biologically sound method of care for all newborns, but in particular for premature babies, with three components: a) skin\u2014to- skin contact, b) exclusive breastfeeding and c) support to the mother-infant dyad.   3. Newborn Resuscitation \u2014 a series of actions taken to establish normal breathing in a newborn with depressed vital signs   4. Positioning -\u2014 means how the mother holds her baby to ensure proper attachment to each other.   5. Positive pressure ventilation \u2014 is the most important aspect of newborn resuscitation for ensuring adequate ventilation of the lungs, oxygenation of vital organs such as heart and brain, and initiation of spontaneous breathing.   6. Pregnancy, Childbirth, Postpartum and Newborn Care (PCPNC): A Guide for Essential practice in Philippine setting \u2014 an Essential Care Practice Guideline adapted from the World Health Organization by the Department of Health. It provides evidence-based recommendations to guide healthcare professionals in the management of women during pregnancy, childbirth and postpartum, post-abortion, and newborns during their \ufb01rst week of life   7. Skin-to\u2014skin contact \u2014 is placing the naked newborn prone on the mother\u2019s bare chest. It is considered a critical component for successful breastfeeding initiation.   8. Small baby -\u2014 a newborn weighing from between 1,500 g to 2,499 g   V. GUIDING PRINCIPLES   1. Evidence-based interventions - Continuous update of policies and guidelines must be in accordance to recommended international standards proven effective and applicable to the country. Efforts will be exerted to generate information to guide the planning and implementation of Newborn Care programs and activities. Research \ufb01ndings will be used to focus interventions and approaches most responsive to the affected groups.   2. Integrated service delivery - Under the MNCHN framework of health services delivery, there shall be assurance of provision of integrated and functional service packages where the mother and the newborn are seen as a unit but with varying needs, to respond to the interrelated health needs of mothers and newborns and ensure provision of a more effective and ef\ufb01cient care using a similar approach.   3. Human Rights-based approach - The human rights-based approach recognizes the person as the key actor to his/her own development and not as passive recipients of services. It also recognizes that human rights are indivisible whether they are cultural, economic or social; they are inherent to the dignity of every human person. It emphasizes that soliciting the participation of your clients should both be a means and a goal.   4. Life\u2014cycle based intervention - The continuum of care framework aims to veer away from the traditional approach of utilizing single, disease-speci\ufb01c interventions. Critical to the success of this framework are the delivery of essential services and the implementation of improved practices at key points in the life cycle, linking mothers, newborns and their households and communities with quality basic health care and maternity services.   5. Multi-sectoral collaboration - Networking with stakeholders must be proactively pursued and sustained. The government agencies, non-government organizations, private volunteer groups, religious and civic organization and educational institutions can contribute to Newborn Care through their respective capabilities, expertise, resources and networks.   VI. SPECIFIC GUIDELINES   Standard essential newborn care practices guidelines are organized by time, beginning at the time of perineal bulging until one week of life. However for this Administrative Order, emphasis is given to care interventions that should be provided to the newborn from birth until the \ufb01rst 6 hours of life (please see Annex A). The care for the newborn after six (6) hours till the \ufb01rst week of life is mentioned brie\ufb02y but will be discussed in more detail in a Department Circular that is issued corollary to this A0.   A. Ensure Qualitv Provision of Time-Bound Interventions\u2014This is the aspect of newborn care in the Philippines that have not met international standards, and should therefore, be re- taught and re-learned by all health care providers.   1. Within the \ufb01rst 30 seconds   1.1. Objective: Dry and provide warmth to the newborn and prevent hypothermia  - Put on double gloves just before delivery.  - Use a clean, dry cloth to thoroughly dry the newborn by wiping the eyes, face, head, front and back, arms and legs.  - Remove the wet cloth.  - Do a quick check of newborn\u2019s breathing while drying (See page 9 on Newborn Resuscitation).  - Do not put the newborn on a cold or wet surface.  - Do not bathe the newborn earlier than 6 hours of life.  - If the newborn must be separated from his/her mother, put him/her on a warm surface, in a safe place close to the mother.   2. After thorough drying 2.1. Objective: Facilitate bonding between the mother and her newborn through skin-to-skin contact to reduce likelihood of infection and hypoglycemia  - Place the newborn prone on the mother\u2019s abdomen or chest, skin-to\u2014skin.  - Cover the newborn\u2019s back with a blanket and head with a bonnet.  - Place the identi\ufb01cation band on the ankle.  - Do not separate the newborn from the mother, as long as the newborn does not exhibit severe chest in-drawing, gasping or apnea and the mother does not need - urgent medical/ surgical stabilization e. g. emergency hysterectomy.  - Do not wipe off vernix if present.   Check for multiple births as soon as newborn is securely positioned on the mother. Palpate the mother\u2019s abdomen to check for a second baby or multiple births. If there is a second baby (or more), get help. Deliver the second newborn. Manage like the \ufb01rst baby.   3. While on skin\u2014to-skin contact (up to 3 minutes post-delivery)  3.1. Objective: Reduce the incidence of anemia in term newborns and intraventricular hemorrhage in pre-term newborns by delaying or non-immediate cord clamping  - Remove the \ufb01rst set of gloves immediately prior to cord clamping.  - Clamp and cut the cord after cord pulsations have stOpped (typically at 1 to 3 minutes). Do not milk the cord towards the newborn.   a. Put ties tightly around the-cord at 2 cm and 5 cm from the newborn's abdomen.  b. Cut between ties with sterile instrument.  c. Observe for oozing blood.   After cord clamping, ensure 10 IU Oxytocin IM is given to the mother. Follow other protocols per PCPNC.   4. Within 90 minutes of age 4.1 Objective: Facilitate the newborn's early initiation to breastfeeding and transfer of colostrum through support and initiation of breastfeeding  - Leave the newborn on the mother\u2019s chest in skin-to-skin contact. Health workers should not touch the newborn unless there is a medical indication.  - Observe the newborn. Advice the mother to start feeding the newborn once the newborn shows feeding cues (e. g. opening of mouth, tonguing, licking, rooting). Make verbal suggestions to the mother to encourage her newborn to move toward the breast e. g. nudging.  - Counsel on positioning and attachment. When the newborn is ready, advise the mother to position and attach her newborn.  - Advise the mother not to throw away the colostrum.  - If the attachment or suckling is not good, try again and reassess.  - A small amount of breast milk may be expressed before starting breastfeeding to soften the nipple area so that it is easier for the newborn to attach.   4.2 Objective: To prevent ophthalmia neonatorum through proper eye care  - Administer erythromycin or tetracycline ointment or 2.5% povidone\u2014iodine drops to both eyes after the newborn has located the breast.  - Do not wash away the eye antimicrobial.   B. Non-Immediate Interventions\u2014These interventions are usually given within 6 hours after birth, and should never be made to compete with the time-bound interventions.  1. Give Vitamin K prophylaxis  - Inject a single dose of Vitamin K 1 mg IM (if parents decline intramuscular injections, offer oral vitamin K as a 2nd line).   2. Inject Hepatitis B and BCG vaccinations  - Inject hepatitis B vaccine IM and BCG intraderrnally.   3. Examine the newborn. Check for birth injuries, malformations or defects.  - Weigh the newborn and record.  - Look for possible birth injury and/or malformations.  - Refer for special treatment and/or evaluation if available.  - If the newborn has feeding dif\ufb01culties because of the injury/malformation, help the mother to breastfeed. If not successful, teach her alternative feeding methods.   4. Cord Care  - Wash hands.  - Fold diaper below stump. Keep cord stump loosely covered with clean clothes.  - If stump is soiled, wash it with clean water and soap. Dry it thoroughly with clean cloth.  - Explain to the mother that she should seek care if the umbilicus is red or draining pus..  - Teach the mother to treat local umbilical infection three times a day;   C. Newborn Resuscitation   1. Start resuscitation if the newborn is not breathing or is gasping after 30 seconds of drying or before 30 seconds of drying if the newborn is completely \ufb02oppy and not breathing.   2. Clamp and cut the cord immediately.   3. Call for help.   4. Transfer the newborn to a dry, clean and warm surface. Keep the newborn wrapped or under a heat source if available.   5. Inform the mother that the newborn needs help to breathe   6. Refer to the Department Circular for the step-by-step newborn resuscitation guideline.   D. Additional Care for a small baby or twin -\u2014 if a newborn is preterm, 1-2 months early or weighing 1,500 \u2014 2,499 g (or visibly small where a scale is not available)   1. If the newborn is delivered 2 months earlier or weighs &lt 1500 g, refer to a specialized hospital.  2. For a visibly small newborn or a newborn born &gt 1 month early:  - Teach the mother how to keep the small newborn warm in skin\u2014to\u2014skin contact via Kangaroo Mother Care (KMC). Start kangaroo mother care when:  a. The newborn is able to breathe on its own (no apneic episodes b. The newborn is free of life-threatening disease or malformations Reminders:  - The ability to coordinate sucking and swallowing is not a pre-requisite to KMC. Other methods of feeding can be used until the newborn can breastfeed.  - KMC should last for as long as possible each day. If the mother needs to interrupt KMC for a short period, the father, a relative or friend should take over.  - Provide extra blankets for the mother and the newborn, plus bonnet, mittens and socks for the newborn. - If the mother cannot keep the newborn skin-to-skin because of complications, wrap the newborn in a clean, dry, warm cloth and place in a cot. Cover with a blanket. Use a radiant warmer if the room is not warm or the baby is small.  - Give special support for breastfeeding: Encourage the mother to breastfeed every 2 \u2014 3 hours. - Weigh the newborn daily. - When the mother and newborn are separated, or if the newborn is not sucking effectively, use alternative feeding methods.   3. Discharge Flaming  - Plan to discharge when:  1. Breastfeeding well and gaining weight adequately for 3 consecutive days.  2. Body temperature between 36.5 and 37.5 \u00b0 C for 3 consecutive days.  3. Mother able and con\ufb01dent in caring for the newborn.   E. Unnecessary Procedures \u2014 The following are procedures that were observed to have been routinely given in Philippine hospitals but, in fact, are not recommended for all neonates.   1. Routine suctioning - Suctioning has no bene\ufb01t if the amniotic \ufb02uid is clear and especially with newborns who cry or breathe immediately after birth. Moreover, a dirty bulb can become a source of infection. Routine suctioning has also been associated with cardiac arrhythmia. Suctioning is indicated only if the mouth/nose is blocked with secretions or other materials. -   2. Early bathing/washing - The WHO recommends bathing at least after 6 hours of the newborn\u2019s life. Bathing the newborn soon after birth causes a drop in the body\u2019s temperature leading to increased risk of developing infections, coagulation defects and brain hemorrhage. It also removes the vemix which is protective against bacteria that cause neonatal sepsis and removes the crawling re\ufb02ex.   3. Footprinting - Footprinting has proven to be an inadequate technique for newborn identi\ufb01cation purposes. Better identi\ufb01cation techniques, such as DNA genotyping and human leukocyte antigen tests can serve more this purpose according to the American Academy of Pediatrics (AAP) and the American College of Obstetricians and Gynecologists (ACOG).   4. Giving sugar water, formula or other prelacteals and the use of bottles or paci\ufb01ers Delaying initiation to breastfeeding has been linked to a 2.6 fold increase in the chances of newborn deaths due to infection. If the sugar water, formula or prelacteals are introduced using a bottle, the newborn may develop a learned preference for the bottle leading to nipple confusion and inef\ufb01cient suckling which can further lead to failure in breastfeeding. A paci\ufb01er likewise contributes to nipple confusion especially if these are used before the newborn is offered the mother 5 breast. This undermines the chances of successful breastfeeding by contributing to a vicious cycle of poor attaChment, sore nipples and lactational insuf\ufb01ciency.   5. Application of alcohol, medicine and other substances on the cord stump and bandaging the cord stump or abdomen - The umbilical stump is an entry point for systemic infections in the newborn. The devitalized tissue of the cord stump can be an excellent medium for bacterial growth, especially if the stump is kept moist and unclean substances are applied to it. Cleaning with alcohol and bandaging delays healing and falling off of the stump. The alcohol keeps the stump moist while bandaging prevents aeration which facilitates the drying process.   E. Discharge Instructions  1. Advise the mother to return or go to the hospital immediately if:  - Jaundice of the soles or any of the following are present  - Dif\ufb01culty of feeding  - Convulsions  - Movement only when stimulated  - Fast or slow or dif\ufb01cult breathing (e. g. severe chest in-drawing)  - Temperature &gt 37.5\u00b0C or &lt 35.5\u00b0C   * From Lancet 2008, new IMCI algorithm for Young Infant II Study   2. Advise the mother to bring her newborn to the health facility for routine check-up at the following prescribed schedule:  - Postnatal visit 1: at 48 \u2014 72 hours of life  - Postnatal visit 2: at 7 days of life  - Immunization visit 1: at 6 weeks of life   3. Advise additional follow-up visits appropriate to problems in the following:  - TWO days \u2014 if with breastfeeding dif\ufb01culty, Low Birth Weight in the \ufb01rst week of life, red umbilicus, skin infection, eye infection, thrush or other problems.  - Seven days \u2014 if Low Birth Weight discharged more than a week of age and not gaining weight adequately.   4. Advise for Newborn Screening   F. Implementing Mechanism   1. Governance The protocol will be implemented utilizing the current MNCHN service delivery network, referral system. The LGU capacity is envisioned to be operational with the organization of a network of Service Delivery Teams at various level of the Health Service Delivery System. The network shall consist of:   At the community level:   - Community/Women\u2019s Health Teams (C/WHT)   At the facility level:  - BEmONC and CEmONC Teams  - Itinerant Teams - Social Hygiene Clinic Teams   The Teams are strategically dispersed throughout the Province to ensure timely access to obstetric and newborn emergency care by mothers. The Teams shall provide the full maternal and newborn care, family planning, adolescent reproductive health and STI and HIV service packages to the general population as well child survival packages: Infant and Young Child Feeding (IYCF), Integrated Management of Childhood Illnesses (IMCI), Expanded Program on Immunization (EPI), etc.   2. Financing - The implementation of the new policies and protocol on newborn care as part of the enhanced Normal Spontaneous Deliveries (NSD) and Maternal Care Packages (MCP) of PhilHealth will be one of the drivers for health facilities to be accredited and, for individual professionals to qualify for in Philhealth bene\ufb01ts.   Funds from the national and local levels, private and public sectors will be mobilized to \ufb01nance the provision of the necessary equipment and supplies and conduct of capability- building activities.   3. Service Delivery\u2014Standards for the physical structure, equipment and human resource - for Implementing Health Reforms towards the Rapid Reduction of Maternal and Neonatal Mortality Manual of Operations shall be strictly followed. The newborn protocol has been integrated likewise with the BEmONC training module. This protocol shall serve as the reference document on Newborn Care during the conduct of the BEmONC and to\u2014be-developed CEmONC training programs.   Home care for the newborn shall be developed and integrated with the existing training course for Community/Women\u2019s Health Teams. Communication for Behavior Impact (COMBI) or Behavior Change Communication strategy shall be utilized targeting behaviors of all major stakeholders, from the mothers to the health workers to the policy makers.   4. Regulation \u2014 The PHIC Benchbook which is currently being reviewed and revised will be integrated with the key Essential Newborn Care protocol interventions. The Benchbook will enforce the standards of care described in this AO along with other auxiliary issuances from the Department of Health. The DOH will likewise advocate medical and paramedical societies and appropriate learning institutions to adopt the policies and protocol described herein.   VIII. ROLES AND RESPONSIBILITIES   A. Task Force on the Rapid Reduction of Maternal and Neonatal Mortality   1. Ensure that the EmONC Investment Plan includes Essential Newborn Care activities;  2. Ensure integration of the Essential Newborn Care protocol with the BEmONC and the to- be\u2014developed training curriculum for the Comprehensive EmONC training course;  3. Ensure that the B/CEmONC facility, equipment and human resource requirements adhere to the requirements as indicated in the ENC protocol;  4. Ensure dissemination of the Essential Newborn Care Protocol and related materials.   B. National Center for Disease Prevention and Control   1. Update policies and guidelines on Maternal and Newborn Care;   2. Initiate the creation of an Experts Panel (sub\u2014group of existing Experts Panel) for Maternal and Newborn Care;   3. Formulate the Maternal and Newborn Care Investment Plan (include EmONC);   4. In collaboration with the HHRDB, provide support for capacity development to ensure that Maternal and Newborn Care (incl. EmONC) trainers and implementers are updated on Maternal and Newborn Care; '   5. In collaboration with the National Center for Health Promotion, develop prototype IEC materials on Maternal and Newborn Care (inc. EmONC);   6. Mobilize national, local and international, community support for the implementation of the policy and other Maternal and Newborn Care initiatives (incl. EmONC);   7. Ensure the procurement of newborn resuscitation equipment and supplies;   8. Provide support through health systems strengthening for delivering an integrated package of services for the pregnant woman and her newborn;   9. Conduct performance audit to ensure quality assurance on Maternal and Newborn Care program implementation;   10. Monitor and evaluate the implementation of Maternal and Newborn care programs/ activities including this protocol.    C. National Center For Health Facility Development   1. Review the technical guidelines on the Integrated Hospital Information System and PHIC accreditation guidelines to ensure congruity and synergism;   2. Coordinate the training program/modules with the HHRDB on the management of the different service components of health care facilities.   3. Strengthen the implementation of the Mother-Baby-Friendly Initiative.   D. Dr. Jose Fabella Memorial Hospital   1. Serve as the lead training institution for the provision of the Basic Emergency Obstetric and Newborn Care (BEmONC) training courses;   2. Serve as the designated National Lactation Management Center providing trainings for all government and private health facilities providing newborn and maternity care services;   3. PromOte Kangaroo Mother Care for all newborns especially the premature infants to improve their survival.   E. National Center for Health Promotion   1. Formulate and implement an Advocacy Plan together with the development of IEC materials targeted for Local Chief Executives, health of\ufb01cers, communities and families to gain political commitment and community support for Maternal and Newborn Care;   2. Ensure integration and synergism with the EmONC and Essential Newborn Care protocol in other health promotion activities and materials.   F. Health Human Resource Development Bureau   1. Together with the NCDPC, develop and \ufb01nalize training programs \"relative to the propagation of Maternal and Newborn Care policies (incl. EmONC);   2. Engage the Commission on Higher Education and the Professional Regulatory Commission in the integration of the Maternal and Newborn Care policies (incl. EmONC and this protocol) in the curricula of the Medical, Nursing and Midwifery professions;   3. Develop the integrated approach in the enhancement of existing training programs catering to the needs of the newborn (including the Newborn Protocol);   4. Ensure the inclusion of the competency needs and requirements in the updating of the Human Resource Master Plan and the Health Human Resource Information System.   G. Bureau of Local Health Development   1. Provide technical assistance in the enhancement of the health referral system;   2. Assist the CHDS in mobilizing of support for the LGUs in the implementation of Maternal and Newborn Care policies and activities.   H. Health Policy Development and Planning Bureau   1. Assist in the development of evidence\u2014based policies on Maternal and Newborn Care;   2. Assist in the formulation the Maternal and Newborn Care Investment Plan;   3. Coordinate research activities relative to Maternal and Newborn Care.   I. Bureau of International Health Cooperation   1. Ensure the application of the Sector-Wide Approach in the mobilization and utilization of funds for Maternal and Newborn Care;   2. Facilitate the linkage of local initiatives with international initiatives on Maternal and Newborn Care;   3. Act as clearing house for program initiatives with international partners. '   J. National Epidemiology Center   1. Recommend ways/scheme in data collection and reporting based on the indicators identi\ufb01ed by the Newborn Care Program using the SMART criteria;   2. Facilitate the updating of the current DOH and LGU databases to ensure the inclusion of possible more Newborn Care data.   K. Field Implementation and Management Of\ufb01ce   1. In partnership with the NCDPC and the BLHD, develop monitoring and evaluation tools, technical assistance packages and training programs for CHDS, LGUs and other stakeholders; and   2. Monitor and evaluate the implementation of the Maternal and Newborn care policies and activities;   L. Bureau of Health Facilities and Services   1. Ensure that existing standards and technical requirements as mandated are complied with, to include relevant ENC needs and requirements; -   2. Promote and advocate DOH standards and requirements for the implementation of ENC and other MNCHN strategies during monitoring and QA activities of DOH regulated facilities and services,   M. Center for Health Development   1. Incorporate the Maternal and Newborn Care Plan targets and strategies in the Regional Plans;   2. Advise, assist in the local policy formulation, legislation and local execution of legislative issuance;   3. Conduct an inventory of relevant competencies and assessment of needs for resources as may be required in the implementation of the A0 at the local level in the provision of essential newborn care;   4. Develop the capacity of the provincial/municipal health workers to implement the protocol;   5. Provide technical assistance to the LGUs;   6. Formulate and implement Advocacy plans to gain political commitment and community support;   7. Reproduce prototype IEC materials for distribution to the LGUs;   8. Allocate drugs and IEC materials to augment the logistics of the LGUs;   9. Assist in the procurement of newborn resuscitation equipment and supplies;   10. Monitor and evaluate the implementation of Maternal and Newborn care activities including this protocol in health facilities including the DOH Retained Hospitals.    N. DOH Retained Hospitals    1. Adopt and implement the policy;   2. Include in the Investment Plan/Work and Financial Plan a substantial amount for Maternal and newborn care including implementation of this protocol;   3. Conduct orientation on the protocol for its personnel and lower level facilities;   4. Monitor and evaluate the implementation of Maternal and newborn care policies including this protocol.    O. Local Government Unit   1. Adopt and implement the policy;   2. Ensure the availability of budget support to Maternal and Newborn Care and related activities;   3. Conduct Orientationltrainings for private and public health workers on the implementation of the Maternal and Newborn Care policies including this Protocol;   4. Monitor and evaluate the implementation of Maternal and Newborn care activities including this protocol.   Facilities with Comprehensive/Basic Emergency and Obstetric and Newborn Care capabilities   1. Provide emergency obstetric and neonatal care interventions;   2. Adopt and implement the policy;   3. Include in the Investment Plan/Work and Financial Plan a substantial amount for Maternal and newborn care including implementation of this protocol;   4. Conduct orientation on the protocol for its personnel and lower level facilities;   5. Monitor and evaluate the implementation of Maternal and newborn care policies including this protocol.    P. PhilHealth   1. Ensure the congruence of this policy with existing PHIC policies e. g. Benchbook Clinical Pathway;   2. Develop a Maternal Care Package (MCP) Plus bene\ufb01t package that will support the strict implementation of Maternal and Newborn Care policies including this protocol;   3. Provide support for the promotion of and advocacy for the PHIC Maternal and Newborn Care packages.   4. Monitor and evaluate the implementation of Maternal and Newborn care activities including this protocol.    Q. National Drug Policy   1. Ensure that relevant maternal and newborn care (as stated in this protocol) drugs and supplies are included in the Philippine National Drug Formulary.   R. Development Partners   1. Support the implementation of Maternal and Newborn care policies and activities;   2. Coordinate and collaborate with the DOH and LGUS in the conduct of maternal and newborn care activities.   S. Professional Societies/Groups   1. Act as Resource Personlmember in the to-be-developed Experts Panel;   2. Ensure communication of the policy to all'members;   3. Conduct monitoring of implementation among its members;   4. Coordinate and collaborate with the DOH and LGUS in the conduct of Maternal and Newborn Care activities.    IX. REPEALING CLAUSE   All other previous related issuance found inconsistent with this issuance Shall be repealed.  X. EFFECTIVITY   This Order takes effect immediately upon posting and publication in the DOH intranet of fifteen (15) days upon \ufb01lingwith the\" UP Law Center. ", "  In view of the Ligtas Tigdas 2004 vaccination campaign per Executive Order 237 s. 2003, a rapid coverage assessment shall be conducted to measure performance. Speci\ufb01cally this shall:  a. compare assessment coverage with reported accomplishment; b. identify areas where there are missed children and c. take immediate actions to vaccinate missed children.  This Order is issued to detail out guidelines and speci\ufb01c procedures.   A. Rapid Immunization Coverage Assessment  The duly designated and trained regional, provincial or city monitoring teams shall perform the validation procedures.  Validation shall be done at least once in all barangays in the cities, town proper and well\u2014populated communities. In municipalities, all barangays in the poblaeion and at least 2 barangays with highest and low accomplishment report must be covered.  Validation is preferably barangay\u2014wide, but can be done by sitio or by purok in big barangays.  At least one repeat validation shall be done in all areas that are found to have less than 95% coverage by the validation method.  The following shall be the procedure of validation:  1. Plan the validation. Assign validation/monitoring teams and schedule the validation based on the schedule of completion of vaccination in the barangay. Do not validate in areas that have not been fully covered by the vaccination teams.  2. Look at the Accomplishment Report of the City/Municipality/Barangay. Select areas with high and low reported measles immunization coverage for your sample. Ask for identified high risk areas especially populated/densely populated areas.  3. Using the barangay spot map, identify four validation sites in each barangay to be validated: two (2) sites remote from general access (e.g. borders with other barangays, riverside, houses away from main roads) and two (2) central sites (e.g. slum areas around the market or railroad, houses along the main road or railroad). Select all sites away from the health center.  4. Go to the selected sites one at a time and fill up the attached validation form (Rapid Assessment of Immunization Coverage of the \u201c Ligtas Tigdas 2004\" using the Grab Sample and Door Sample Techniques).  Grab Sample: Grab at least 5 eligible children (9 months to &lt;8 years old) who are found in the streets in each selected sites. Determine their vaccination status by looking at their \ufb01ngers and at their vaccination site. (The importance of immediate 1-2 days after validation is to ensure that at least the vaccination puncture is still visible). Make sure that there are 20 children in the grab sample.  Door Sample: Identify 5 doors (e.g. house, condominium, school, etc.) nearest to the selected site. If there is a variety, select at least two (2) doors of the hardest to reach doors (e.g. top floor or ones with complicated entry. Determine if the marking on the door correctly matches with vaccination status of all the children in the selected doors. Make sure that 20 doors are seen in sample sites.  5. Based on the summary of \ufb01ndings at the bottom of the validation form, determine the appropriate action for the barangay.  Action to be taken:  Findings A: If the \ufb01ndings show that all grabbed children have been vaccinated and that all doors are correctly labeled but there were still doors marked \u201cX\", the validation/monitoring team shall remind the vaccination team to revisit the \u201cX\" door immediately to vaccinate the missed children.  The validation/monitoring team shall also revisit these \u201cX\" doors to ensure that circles have been placed around the \u201cX\", corresponding to completion of vaccination of previously missed children.  If the validation/monitoring team brought measles vaccines with them, they may instead vaccinate the missed children themselves, encircle the \u201cX\" on the door and submit the vaccination report to the appropriate vaccination team.  Findings B: if the findings show that there is at least one unmarked door or a door marked with a circle but with an unvaccinated eligible child, this means that, most probably, there are many more missed children in the area. The validation/monitoring team shall correct the labels on the doors (mark the doors \u201cX\") and immediately \u2014\u2014 the same day, if possible \u2014 discuss their findings with the appropriate vaccination team to elicit their commitment to revisit the barangay and do a door~to\u2014door search for, and vaccinate, other children who might have been missed, and ensure 100% coverage.  As above, if the validationtmonitoring team brought measles vaccines with them, they may also vaccinate the missed children themselves, appropriately marked the doors and submit the vaccination report to the appropriate vaccination team. The door-to-door search. for additional missed children should still be conducted even if these missed children have already been vaccinated by the validation/monitoring teams.  The validation/monitoring team shall follow-up to check that the door-to-door search is actually conducted. They shall also, as much as possible, repeat the validation in these areas.  Compile barangay validation \ufb01ndings for each municipality/city: Validation Summary Form.  Continue the cycle of \u201cvaccination - validation \u2014 search for missed children \u2014 vaccination\" until there is not a single missed eligible child in any city, town proper or well-populated community.  B. Reiteration of Functions of National/Regional, Provincial and City Health Staff  Pursuant to Sec. 9 of the Guide to Ligtas Tigdas 2004, the DOl-l National/ Regional staff (including DOH representatives) as well as the Ligtas Tigdas teams at the provincial city and municipal health of\ufb01ces shall do the following:  1. Ensure that the door\u2014to\u2014door strategy is strictly followed in ALL cities, town proper and well\u2014populated communities. This means that door\u2014to-door vaccination shall start immediately in the morning and shall be continued until the doors targeted for the day are completed. This is to ensure 100% immunization coverage.  To ensure the correctness of the door-to-door procedures, the above-named health staff shall monitor vaccination activities closely and institute immediate corrective measures whenever necessary.  2. Train and supervise validation/monitoring teams and conduct rapid assessment of immunization coverage according to the guidelines mentioned above, provide feedback and advocate to Local Chief Executives (LCEs) on ensuring 100% immunization coverage.  3. Mobilize resources \u2014 human, \ufb01nancial, material, etc. \u2014 to ensure the successful implementation of the campaign. If necessary, they shall provide vaccinators teams from their own health staff. This shall also include full support for travel and communication of the vaccination and monitoring teams.  4. Prioritize vaccination efforts where unvaccinated children are likely to reside. Many implementers are placing undue energy to reach a few children who are most likely immunized (e.g., with MMR) while there are many more missed unvaccinated children who live in neighboring depressed barangays.  5. Ensure that the \ufb01eld vaccination teams of the appropriate barangays utilize the list of children missed in school and day care center vaccinations as their guide when they do the community level vaccinations so that these children are vaccinated at home outside of school hours.  6. Coordinate more closely with pediatricians and other private practitioners so that they strongly encourage their clients to have their children vaccinated. Pediatricians may be allowed to vaccinate their own patients, if necessary.  7. Strengthen the command posts at all levels \u2014 region, province, city, municipality, barangay -\u2014 by ensuring that they comply with all relevant guidelines and procedures and that they are fully provided with apprOpriate support systems and resources.  Reporting of Performance:  Because of issues of overestimate/underestimate of population, the following are the supplemental guidelines on reporting Ligtas Tigdas 2004 performance:  1. The method of calculation of performance in the Ligtas Tigdas 2004 shall be as follows: In areas reporting number of children vaccinated exceeding the estimated target eligible children:  Vaccination Coverage = Number of eligible children vaccinated / (No. of eligible children vaccinated + missed children)  In areas reporting number of children vaccinated not exceeding the estimated target eligible children:  Vaccination Coverage = Number of eligible children vaccinated / (Number of eligible children vaccinated + missed children)  (if this denominator is higher than the estimated target of eligible children)  OR  Vaccination Coverage = Number of eligible children vaccinated / Number of target eligible children vaccinated  (If the estimate is higher than the total of vaccinated and missed children)  2. In addition to the information required in the Guide to Ligtas Tigdas 2004 Section 10 on Recording and Reporting, the following shall also be reported as agreed upon during the follow-up consultative meeting with the Regional EPI Coordinators to the DOH Regional \u201cLigtas Tigdas \u201c Command Post:  a. Daily \u2014 number of children immunized, children missed, children given vitamin A  b. Weekly summary of validation of coverage (by municipality/city)  3. In analyzing performance, information on whether proper door\u2014to-door procedures were done or not shall also be considered.  This Order takes effect immediately.   ", "   The Philippines is committed to sustain poliomyelitis eradication until global certi\ufb01cation is achieved in 2005. In the past, strategies such as the National Immunization Days (NIDs)/Knock-Out Polio (KOP) and the Subnational Immunization Days (SNIDs) as well as the establishment of the Acute Flaccid Paralysis (APP) Surveillance have resulted in the certi\ufb01cation of the Philippines as Polio-Free, together with the rest of the Western Paci\ufb01c Region (WPR) in October 2000.  However, three (3) cases of recombinant or mutant polio strain were detected in 2001 as a result of high quality AFP Surveillance System. This recombinant strain can behave like wild poliovirus, i.e., it can also cause outbreaks. Containing the spread of the virus is therefore a matter of national emergency. As an immediate response, mop-up operations have been conducted in the affected areas. To \ufb02ush out any remaining mutant polio strains across the country, two more rounds of polio immunization activities will be conducted as part of the Polio\u2014Free Maintenance Immunization Campaign, otherwise known as Batik Patak Kontra Polio, on February 2\u20148 (Round 1) and March 2\u20148, 2002 (Round 2).  The objective of the campaign is to immunize all children aged 0-59 months old with Oral Polio Vaccine (OPV), regardless of their immunization status. The attached \u201cImplementing Guidelines for the Polio\u2014Free Maintenance Immunization Campaign for Door-to-Door Patak and for Patak Centers\" is hereby adopted to govern polio eradication activities nationwide.  For immediate dissemination and compliance.    ", "  The bene\ufb01cial effect of Vitamin A supplementation to pregnant women should be continuously emphasized considering that 2 out of 10 pregnant women have low to de\ufb01cient levels of serum retinol levels. This is based on the National Nutrition Survey conducted in 1998 by the Food and Nutrition Research Institute which showed a Vitamin A De\ufb01ciency (VAD) prevalence among pregnant women of 22.2 % compared to 16.4% obtained in 1993.  Cognizant of this, Administrative Order No. 3-A s. 2000 on Vitamin A and Iron supplementation was issued on January 10, 2000. As stipulated in the said Order, pregnant women are priority targets for Vitamin A supplementation given the following schedule:  A. Preventive Supplementation for pregnant women without signs and symptoms of Vitamin A de\ufb01ciency:  Preparation of Vitamin A to be used : 10,000 LU. Dose : 1 tablet of soft gel capsule twice a week or a total of 20,000 LU. per week When to start : 4th month or 16 weeks of gestation or pregnancy Duration of supplementation : Until delivery  B. Therapeutic Supplementation for pregnant women with signs and symptomsof Vitamin A de\ufb01ciency like night blindness  Preparation of Vitamin A to be used : 10,000 I.U. Dose : 1 tablet daily for 4 weeks upon diagnosis regardless of age of gestation  Prenatal vitamins are normally prescribed to pregnant women during consultations with private physicians and even with RHU physicians. These multivitamin preparations taken daily contain 5,000 to 10,000 LU. of Vitamin A. In cases when pregnant women are already taking the prenatal vitamins or the multiple micronutrient tablets of UNICEF need not be given the 10,000 I.U. of Vitamin A. The multivitamin preparation will also be suf\ufb01cient to treat and prevent night blindness associated with Vitamin A de\ufb01ciency. Onthe other hand, ferrous sulfate/folio acid can be given together with Vitamin A.  This Order reiterates the routine use of Vitamin A as preventive supplementation particularly for pregnant women. All other provisions of A.O. No. 3-A, s. 2000 that are not affected by this supplemental guideline shall remain in full force and effect.  This order shall take effect immediately.   ", " The following rules and regulations are hereby promulgated to implement Republic Act (R.A.) No. 9709, otherwise known as the Universal Newborn Hearing Screening and Intervention Act of 2009, an act establishing a Universal Newborn Hearing Screening (UNHSP) Program for the prevention, early diagnosis, and intervention of hearing loss.   RULE 1 - POLICY AND APPLICATIONS   SECTION 1. Purpose \u2014 These Implementing Rules and Regulations shall provide the concerned national government agencies, local government units, non-governmental organizatiOns, people\u2019 5 organizations, other public and private institutions with guidelines for the implementation of a UNHSP to institutionalize measures for the prevention and early diagnosis of congenital hearing loss among newborns, the provision of referral, follow-up, recall, and early intervention services to infants with hearing loss, and counseling and other support services for families of newborns with hearing loss, to afford them all the opportunities to be productive members of the community.   SECTION 2. Declaration of Policy \u2014 It is the policy of the State to protect and promote the right to health of the people, including the rights of children to survival, full and healthy development as individuals, and a better quality of life. Recognizing the fact that newborns and children who are deaf or hard of hearing have unique language, learning and communication needs, the State shall formulate a comprehensive program for the prevention, early detection, and diagnosis of congenital hearing loss among newborns and infants based on applied research and consultations with the sectors concerned.   SECTION 3. Universal Newborn Hearing Screening Program  There is hereby established a Universal Newborn Hearing Screening Program (UNHSP) to institutionalize measures for the prevention and early diagnosis of congenital hearing loss among newborns, the provision of referral, follow up, recall and early interventiOn services to infants with hearing loss and counseling and other support services for families of newborns with hearing loss, to afford them all the opportunities to be productive members of the community.   The UNHSP shall refer to a program that includes but is not limited to the following:   a. Educating relevant stakeholders about the signi\ufb01cance of Newborn Hearing Screening (NHS);   b. Conducting hearing loss screening on infants born in the country;   c. Tracking patients with congenital hearing loss for further evaluation;   d. Providing medical intervention to patients before the age of seven years, and   e. Monitoring and evaluating the UNHSP.   SECTION 4. The objectives. of the UNHSP are:  a. To ensure that newborns have access to hearing loss screening and diagnostic services such as clinical, audiologic, radiologic, or other methods which have been shown effective through scienti\ufb01c studies; -   b. To promote and establish a UNHSP in the country through a nationwide network of government and non-government agencies and other stakeholders who shall commit to the effective and ef\ufb01cient implementation of the program through appropriate policies, cost\u2014effective procedures, regular monitoring and evaluation;   c. To provide continuing capacity building which includes training for healthcare practitioners, conducting applied research and other related activities to aid in the effective implementation of a universal newborn hearing screening program;   Speci\ufb01cally the following shall be done to attain this objective:   c. 1. To provide teaching, training, educational, and capacity building activities to healthcare practitioners to increase awareness and enhance their capabilities in diagnosing and Screening and providing counseling, and the necessary interventions for the hearing impaired newborn, and   c.2. To initiate, implement, monitor, and evaluate research activities related to the diagnosis and management of newborn hearing impairment and to disseminate the results of research activities that will aid in the effective implementation of the program.   d. To promote, integrate, and coordinate research activities related to newborn hearing screening and intervention;   e. To establish and maintain a newborn hearing screening database which can serve as the foundation for decision-making and regulatory policies of health institutions and other national health policy- making bodies;   f. To develop public policy in earlylhearing detection diagnosis and intervention that is based on research and recognition that infants, toddlers and children who are deaf or hard-of-'hearing have unique language, learning and communication needs. Consultation with pertinent public and private sector is encouraged;   g. To establish linkages and referral Systems with a nationwide network of Newborn Hearing Screening Centers (NHSC) which are committed to providing appropriate screening to newborns, delivering appropriate and early intervention and counseling, implementing recall and follow-up programs for infants with hearing 103s, giving other support services to infants with hearing loss, and contributing to the Newborn Hearing Screening database at the NHSRCs at the National Institutes of Health;   h. To formulate and implement quality standardsto ensure effective and efficient implementation of the UNHSP, and   i. To promote, discover, develop, and recommend alternative methods, procedures or instruments for newborn hearing screening and intervention that may be used in areas where technologically-dependent instruments and procedures are not available or accessiblelt shall provide a system to validate the results of the alternative hearing screening procedures and initiate early intervention measures.   SECTION 5. De\ufb01nition of terms \u2014 Under this Act, following terms shall mean the following:   a. Alternative methods, instruments, and procedures ~\u2014 shall refer to non-traditional, indigenous substitutes recommended technology-based and or evidence-based . methods, instruments or procedures;   b. Audiologic diagnostic evaluation \u2014 shall refer to a service related to diagnosis of . hearing loss administered by professionals or by NHSCs; '   c. Certi\ufb01cation \u2014 shall refer to a formal. certi\ufb01cation/accreditation issued by the Department of Health to newborn hearing screening centers;   d. Congenital hearing loss \u2014 shall refer to hearing impairment already present at birth;   e. DOH \u2014 refers to the Department of Health;   f. Follow-up - shall refer to the monitoring of an infant with possible hearing loss for the purpose of ensuring that the infant receives necessary diagnostic services and intervention or treatment;   g. Healthcare practitioner \u2014 shall refer to physicians, audiologists, nurses, midwives, nursing aides, traditional birth attendants, occupational therapists, speech therapists, and rehabilitation personnel;   h. Health institutions \u2014 shall refer to hospitals and other health facilities such as but not limited to, health centers, lying-in centers or puericulture centers with obstetrical and pediatric services, whether public or private; -   i. Infant\u2014 refers to babies less than 12 months old;   j. Intervention \u2014 shall refer to any service rendered to an infant diagnosed with hearing loss ranging from counseling, diagnosis, and providing hearing aids as well as medical procedures for the correction of hearing loss;   k. IRR refers to Implementing Rules and Regulation of RA. 9709;   i. Newborn hearing screening database shall refer to an organized body of information related to newborn hearing screening;   m. Newborn \u2014 shall refer to a baby from the time of complete delivery to twenty\u2014eight- days (28) old;   n. Newborn hearing screening (NHS) - shall refer to an objective, screening procedure performed on a newborn for the purpose of determining if the newborn has hearing impairment.   o. Newborn Hearing Screening Reference Center (NHSRC) shall refer to the central facility at the National Institutes of Health that defines testing and follow up protocols, maintains an external laboratory pro\ufb01ciency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, and oversees content of educational materials;   p. Newborn Hearing Screening Center (NHSC) \u2014\u2014 shall refer to a facility equipped with newborn hearing screening equipment that complies with the standards established by the NHSRC as recognized by the DOH. These centers also implement recall and follow\u2014up programs for newborns that fail the initial screening;   q. NIH \u2014- shall refer to the National Institutes of Health;   r. Recall \u2014 shall refer to a procedure of locating an infant with a possible hearing loss for purposes of diagnosis, intervention; and/or treatment;   s. Refer \u2014 shall indicate a newborn hearing screening result that the ear being tested did not pass the newborn hearing screening;   t. Referral \u2014 shall refer to an act of sending a patient to another service provider within the network for continuation of care;   u. Universal Newborn Hearing Screening Program (UNHSP) \u2014\u2014 shall refer to the- program developed to carry out hearing screening for all newborns 1n the Philippines and to provide adequateinterventions for infants with congenital hearing. loss;   RULE II - IMPLEMENTING MECHANISMS   SECTION 6. Obligation to inform \u2014 Any health practitioner who delivers or assists in the delivery of a newborn in the Philippines shall inform the parents or legal guardian of the newborn of the availability, nature, and bene\ufb01ts of newborn hearing screening among infants three months old and below which should be done during the prenatal period or prior to delivery.   The parent or guardian of newborns Who, after undergoing newborn hearing screening, are suspected to have hearing loss or with \u201crefer\" results shall be informed of the availability, nature, and bene\ufb01ts of further evaluation, intervention, treatment, and counseling.   The DOH shall, in coordination with the NHSRC and other stakeholders, undertake the preparation, production and dissemination of informational educational and communication materials on the. nature, benefits and available medical interventions for hearing loss.   SECTION 7. Performance of NHS   a. All infants born In hospitals in the Philippines shall be made to undergo NHS before discharge, unless the parents or legal guardians of the newborn object to the procedure subject to Section 11 of this Implementing Rules and Regulations.   b. Infants not screened prior to discharge because of unavailability of instruments may seek hearing screening within the \ufb01rst three months after birth in the nearest facility doing hearing screening. In cases where the newborn is born at home, or outside birthing facilities, the healthcare practitioner attending the birth of the newborn or the health worker assigned in the community where the newborn is residing shall refer the newborn to the nearest hearing screening center.   c. In areas where these facilities are not accessible, the healthcare practitioner shall perform an alternative hearing screening procedure and thereafter encourage parents to seek validation cf the test results within three months after birth in NHSCs whenever the results indicate a possible hearing loss.   d. NHS shall be performed by duly trained healthcare providers   e. Validation or con\ufb01rmation of the NHS test shall only be performed by DOH certi\ufb01ed NHSCs.   SECTION 8. Obligation to Perform NHS and Audiologic Evaluation   a. Compliance to NHS shall be the joint responsibility of the parent(s)/ legal guardian, health practitioner, or any other individual attending to the newborn.   b. An appropriate informational brochure, prepared by the DOH and NHSRC shall be made available and distributed to all healthcare facilities.   SECTION 9. Recall \u2014 Any infant who has a \u201crefer\" result in the screening shall be recalled I immediately for further evaluation to con\ufb01rm hearing loss and, as appropriate, to provide intervention. Parents of the affected child shall be informed of the availability, nature, and bene\ufb01ts of evaluation and treatment.   The local government units through their provincial/municipal/city health of\ufb01ces, district health of\ufb01ces and barangay health centers shall be actively involved in the recall process.   a. The NHSC shall immediately notify the participating health institutions about the results of the patient.\u201c   b. Participating health institutions shall locate and recall patients for immediate referral and management. To ensure that all newborns who fail screening are . recalled, the institution should designate a person, section, or department in the health facility responsible for the recall.   c. The attending health practitioner shall also actively participate in locating and recalling the newborns with a \u201crefer\" result. Prompt management should be initiated within three months after birth. -   d. Once located, newborns with \u201crefer\" results should be referred to the appropriate health care provider for further evaluation, management, and follow-up.   e. Parents with the assistance of the local government unit, shall have the responsibility to ensure that the newborns who had a \u201crefer\" result shall receive the appropriate intervention needed.     SECTION 10. Referral and Management of newborns who had \u201cre er\" results   a. A network of hospitals and health facilities shall be established for the referral and management of all patients who fail initial screening.   b. All referral hospitals shall follow a standard clinical protocol in the management of patients who fail initial screening. The protocol shall be developed by the DOH in consultation with the NHSRC.   SECTION 11. Refusal to be Tested -\u2014 A parent or legal guardian may refuse hearing screening on the grounds of religious and/or cultural beliefs but shall acknowledge 1n writing that they have been informed of the availability of said screening, and of the implications of not having the NHS done on the newborn   A cppy of this Waiver shall be made part of the newborn\u2019s medical record and shall be entered into the national newborn hearing screening database.   SECTION 12. Continuing Education, Re\u2014education and Training of Health Personnel   a. Continuing education, re- -education, and training programs shall be conducted for health care practitioners on the rationale, bene\ufb01ts and procedures involved In NHS   b. Informational materials on NHS shall be prepared, produced, and disseminated annually to all healthcare providers in the \ufb01eld of maternal and pediatric care.   c. Information about NHS shall be integrated in existing educational programs of the medical and paramedical professionals.   RULE III - IMPLEMENTING ARRANGEMENTS   SECTION 13, Lead Agency -\u2014 the DOH shall be the lead agency in implementing the provisions of this Act. For this purpose, the DOH shall perform the following functions:  a. Develop a comprehensive program for prevention and management of hearing loss of children;   b. Appropriate, leverage, and mObilize resources of various of\ufb01ces within the DOH, NIH, PHIC, and other health related facilities, other external resources to fully implement the Law;   c. Enjoin local government, stakeholders, concerned health personnel and workers at all levels to fully implement the UNHS; -   d. Coordinate with other national government agencies, Local government units, health professional organizations and societies, funding agencies, development partners, socio-civic organizations private sectors and others in the implementation of the UNHS;   e. Coordinate with the NIH and NHSRC for the following:   e.1. Certi\ufb01cation of NHSCs;   e.2. Preparation of de\ufb01ned testing protocols and quality assurance programs;   e.3. Maintenance and improvement of the NHS registry;   e.4. Development of alternative hearing screening methods, instruments, and procedures, and   e.5. De\ufb01nition of candidacy and the promulgation of selection criteria regarding appropriate treatment and/or rehabilitative interventions for the deaf or hearing-impaired child;   f. Preparation of advocacy campaign activities and dissemination of public information materials; ,   g. Formulate policies for the institutionalization of the program at all levels of implementation. Integrate the NHSP into the current health care delivery system. It should become part and parcel of a routine procedure for newborn in hOSpitals, public and private health institutions;   h. Ensure that a network for prompt recall of those with \u201crefer\" results is established in collaboration with the LGUs, government agencies, and other non\u2014government organizations;   i. Establish a network of hospitals, health facilities and diagnostic hearing centers for the referral and management of those newborns who had \u201crefer\" result and for con\ufb01rmatory test;   j. Coordinate with the following groups for their roles in the implementation of the UNHSP: -   j.l. Patients\u2019 support groups and service provider delivery groups involved in attending to the needs and concern of individuals who are deaf and hard- of\u2014hearing and their families;   j.2. Quali\ufb01ed professional personnel who are pro\ufb01cient in deaf or hard-of- hearing children\u2019s language and who possess the specialized knowledge, skills and attributes needed to serve deaf and hard-of\u2014hearing infants, . toddlers, children and their families -   j.3. Other health and education professionals and organizations   k. To monitor the extent to which hearing screening and evaluation are conducted in health institutions, and assist in the development of UNHSPs for hospitals, health institutions and diagnostic hearing centers. The DOH shall require these healthcare institutions to periodically submit data on newborns screened in their facility and include compliance to this function as a criterion for renewal of certi\ufb01cation.   SECTION 14. Major Stakeholders \u2014 To ensure the implementation of the UNHSP, the following organizations/agencies identi\ufb01ed below shall have the following responsibilities:  a. Healthcare institutions (hospitals, birthing facilities, rural health units and health centers) shall:  1. Integrate newborn hearing screening in the delivery of health services in the respective healthcare institutions;   2. Institutionalize NHS services in healthcare facilities by ensuring that information, education, communication, screening, recall, referral, and management of newborns who had a \u201crefer\" result are being provided in the healthcare facilities;   3. Ensure that all staff in the healthcare institutions is oriented about the bene\ufb01ts of NHS, the integration of the services in their current health services provided in the health facility and the roles and responsibilities of the staff in the institutionalization 'of the services;   4. Designate people who will be responsible for the following:  4.1. Educating expectant parents about the signi\ufb01cance of NHS;  4.2. Conducting hearing screening;  4.3. Recalling high risk patients in need of further management, and  4.4. Referring newborns for further audiologic examination and management;   5. Establish a \ufb01nancial system that will ensure the effective and ef\ufb01cient collection of fees and services for the duly-certi\ufb01ed Newborn Hearing Screening Center;   6. Monitor and evaluate the operations of Newborn Hearing Screening in the health facility, and   7. De\ufb01ne creative health \ufb01nancing packages to make NHS accessible, particularly to the economically deprived.   b. The Department of Interior Local Government (DILG) shall advocate and encourage the cooperation of LGUs to take active role in the implementation of RA 9709.Assist the DOH in the monitoring and evaluation of the program.   c. Local Government Units (LGUs) shall:   1. Develop the capabilities of health workers in the implementation of RA 9709. Public health physicians and other designated health workers should be trained to conduct hearing screening tests on all newborns in their locality;   2. Appropriate budget for the training of their public health workers on how to do newborn hearing screening; .   3. Issue local ordinances and resolutions that integrate Newborn Hearing Screening in the local health delivery system and the appropriation of budget such as, butnot limited to, the following:   3.1. Operation of RA. 9709;   3.2. Training of personnel on how to conduct hearing screening;   3.3. Establishment of a hearing screening center in the locality;   3.4. Purchase of the hearing screening equipment, and   3.5. Referral of a newborn detected with hearing loss to a referral center for further evaluation and treatment;   4. Ensure that adequate and sustained newborn hearing screening services such as information, education, communication, screening, recall, and follow-up are being provided In all LGU Health facilities (Rural Health Unit/ City Health Unit, Lying- in clinics, Citnyunicipal/District/Provincial Hospitals);   5. Establish a functional case management for the recall and referral system with a . strategically accessible NHS health facility referral center;   6. Establish coordination and networking among concerned agencies in the implementation of the law;   7. Monitor and evaluate the implementation of the law in their localities;   8. Explore/encourage creative health \ufb01nancing packages to make newborn hearing screening accessible particularly among the economically deprived populace, and   9. Perform other roles and responsibilities as deemed necessary for the implementation of this Act.   d. Academe, Health Professional Societies, National Organizations of Health Professionals shall:   1. Ensure that all its members are aware of the signi\ufb01cance of newborn hearing screening to their clients, their families and the society at large;   2. De\ufb01ne mechanisms that will ensure and monitor that its members are doing their moral and social obligations to inform parents about the signi\ufb01cance of Newborn Hearing Screening   3. Recommend the incluSion of NHS as part of the curricula of all allied health professions   e. Council for the Welfare of Children (CWC) shall:   1. Ensure NHS in the establishment of the system for early detection, prevention, referral and intervention of congenital hearing loss and disabilities In early ch\ufb02dhood;   2. Promote NHS as an integral part of the Early Childhood and Care Development (ECCD) programs implemented at the national, regional and local levels;   3. Provide avenues in developing innovative advocacy and cemmunication approaches and social mobilization in partnership with civil societies, non~ government organizations and other groups;   4. Include NHS-related indicators in the monitoring and evaluation system of child advocacy programs.   RULE IV - ADVISORY COMMITTEE ON NEWBORN HEARING SCREENING   SECTION 15. Advisory Committee on NHS \u2014 To ensure Sustainable inter-agency collaboration, the Advisory Committee on NHS shall be created and made an integral part of the Of\ufb01ce of the Secretary.   SECTION. 16. Composition of the Advisory Committee ~\u2014 The composition of the Advisory Committee on NHS created under Section 11 of Republic Act No, 9288, \u201cNewborn ScreeningAct of 2004\" shall be expanded to include the representatives from the Philippine Society Otorhinolaryngology-Head and Neck Surgery (PSO-HNS) and the Philippine Society of Audiology (PSA). The committee shall be composed of: '   1. Secretary of Health, who shall act as Chairperson;   2. Executive Director of the National Institutes-of Health Philippines, who shall act as Vice Chairperson;   3. Undersecretary of the DILG;   4. Executive Director of the Council for the Welfare of Children;   5. Director of the NSRC;   6. Executive Director of the NHSRC   7. Representative of the Philippine Society of Otolaryngology-Head and Neck Surgery   8. Representative of the Philippine Society of Audiology   9. Three (3) representatives appointed by the Secretary of Health who shall either be a pediatrician, obstetrician-gynecologist, endocrinologist, family physician, nurse or midwife, from either the public or private sector. The three (3) representatives shall be appointed for a term of three (3) years, subject to their being reappointed for additional three (3) year periods for each extension.   SECTION 17. Functions of the Advisory Committee on Newborn Hearing Screening   a. Review and recommend risk factors to be included in the NHS;   b. Review and recommend the standard NHS hearing screening fees to be charged by NHSC for each newborn, and -   c. Recommend corrective measures and strategic directions as deemed necessary. '   SECTION 18. Meetings \u2014 The ACNBS shall meet at least twice a year. The National Institutes of Health shall serve as the Secretariat of the Committee.    RULE IV - THE NEWBORN HEARING SCREENING REFERENCE CENTER '   SECTION 19. Establishment of a NHSRC   The NHSRC shall be established at the NIH Philippines. NIH shall be responsible for establishing the NHSRC. The NHSRC shall have the following functions:   a. Establish standards for certi\ufb01cation for newborn hearing screening centers;   b. De\ufb01ne the testing and follow-up protocols on hearing screening;   c. Maintain an external labOratory pro\ufb01ciency testing program;   d. Oversee the national testing database and case registries;   e. Assist in the training activities in all aspects of the program;   f. Oversee the content of all promotional and educational materials on newborn hearing Screening program, and   g. Report to DOH any non\u2014compliance committed by any NHSC or health facility 1n the . implementation of this Act.     SECTION 20. Data Management  a. NHSRC shall coordinate with NHSC for the consolidation of all patients database. NHSRC together with DOH shall ensure that all NHSC and health facilities shall submitperiodically copies of the results of the hearing screening test including a summarized tabulation of result to NHSRC. Compliance to these provisions shall be used as a criterion for renewal of certi\ufb01cation of the involved institutions.   b. The NHSRC shall submit reports annually to DOH on the status of and relevant health information derived from the database.   c. NHSRC shall maintain a national database of all children tested and a registry of all children diagnosed to have hearing loss   A plan for long-term outcome evaluation of hearing screening utilizing the case registries shall be developed within one (1) year from the effectiveness of this Act by the NIH in consultation with various stakeholders. This plan may be amended as the need arises. '   RULE V - NEWBORN HEARING SCREENING CENTERS   SECTION 21. Establishment of Newborn Hearing Screening Center \u2014 Newborn Screening Hearing Centers shall be established nationwide.   Established Newborn Screening Centers pursuant to Section 12 of Republic Act No, 9288 shall adopt and implement a program to develop its capacity to become a Newborn Hearing Screening Center in accordance with the standards formulated by DOH through collaboration with health institutions Capable of setting up a newborn hearing screening center.   Newborn Hearing Screening Centers duly certi\ufb01ed by the DOH after having complied with the standards formulated 1n collaboration with the NHSRC shall be established In strategic areas.   The DOH shall provide technical support to the establishment of Newborn Hearing Screening Centers other than those under the Newborn Screening Centers.   1. No NHSC shall ' be allowed to operate unless it shall be duly-certi\ufb01ed by DOH based on the standards and procedural guidelines approved by DOH.   2. All NHSC shall be subjected to a periodic announced and unannounced monitoring by DOH and shall make available their records to a monitoring team, including their \ufb01nancial books to determine compliance with fee structures and other certi\ufb01cation rules and regulations.   SECTION 22. Functions of NHSC   All NHSC shall Undertake the following functions:   a. Newborn hearing loss screening;   b. Initial evaluation of newborns at risk of congenital hearing loss;   c. Recall of babies with high risk of congenital hearing loss;   e. Follow up and referral programs and   e. Maintain and submit database of all newborn screened 1n their center.   SECTION 23. Certification   The DOH has the sole responsibility of approving or disapproving the certi\ufb01cation of NHS facilities. The NIH\u2014NHSRC will assist the DOH in formulating guidelines including good laboratory practices. Renewal of c\u00e9rti\ufb01cation shall be every three years.   SECTION 24. Applied Research on Newborn Hearing Screening   a. The Secretary of Health in collaboration with the NIH shall make awards of grants or cooperative agreements to provide technical assistance to agencies to complement an intramural program and to conduct applied research related to infant hearing detection, diagnosis and treatment/intervention.   b. Quali\ufb01cation requirements for this award will depend on the track record of the concerned agencies and evaluation of the proposal or plan of activities. The NIH will evaluate the proposal and will submit its recommendation to the DOH for \ufb01nal action.   c. Renewal for granting the award will depend on compliance to the terms of the award and outcome evaluation of previous activities.   The following activities shall be carried out;   a. Provide technical assistance on data collection and management;   b. Develop standardized procedures for data management to ensure quality monitoring of infant hearing loss detection, diagnosis and intervention program;   c. Study the cost and effectiveness of hearing detection conducted by programs in order to answer issues of importance to policymakers;   d. Identify the causes and risk factors for congenital hearing loss that might lead to the development of preventive interventions;   e. Study the effectiveness of early hearing detection, diagnosis and treatment/intervention programs by assessing the health, developmental, cognitive, and language status of these children at school age;   f. Promote the sharing of data regarding early hearing loss with birth defects and developmental disabilities monitoring program for the purpose of identifying previously unknown causes of hearing loss; and   g. Other areas of research or programs that may enhance the implementation and outcome of the Universal Newborn Hearing Screening Program.   SECTION 25. Government Intervention on Newborn Hearing Loss In the event that a newborn fails the initial screening, the following government interventions at the various levels should be done:    At the Local Government Unit:   a. The barangay health worker (BHW) with the assistance of the public health midwives (PHMs) shall accompany and refer the newborn detected with hearing loss to the nearest health facility offering Newborn Hearing Screening Services   b. The municipal or city health of\ufb01cers or their designated of\ufb01cers shall provide referral for validation of the hearing screening results and possible appropriate intervention to the identi\ufb01ed UNHS referral centers. For indigent patients, the local government unit should provide appropriate assistance for the referral.   c. If the validation of the hearing screening tests and/or the treatment/ intervention of congenital hearing less of the newborn are beyond the clinical capability of the provincial hospital, the latter shall provide referral for the treatment of the newborn to a DOH certi\ufb01ed referral centers.   d. The local government unit hospitals concerned Shall have the funds for the treatment/ intervention of newborn hearing loss from the internal revenue allotment of the local government unit concerned   SECTION 26. Newborn Hearing Screening Fees  a. The Philippine Health Insurance Corporation (PHIC or PhilHealth) shall include the cost of hearing loss screening in its bene\ufb01t package for newborn care. Such screening test may include among others testing costs, registry, follow-up and the reasonable overhead expenses.   b. For this purpose, the PhilHealth shall develop a prOgram for the gradual coverage of hearing screening, audiologic diagnostic evaluation, and intervention services subject to Section 10 of Republic Act NO. 7875, as amended by Republic Act No. 9241 , otherwise known as the \u201cNational Health Insurance of 1995\".   c. No screening fee shall be charged to a patient who availed of accredited behavioral-re\ufb02exive tests, such as the Tuning Fork test, Penlight Visual examination method and other indigenous methods.   d. Only methods approved by the DOH, upon recommendation by the NIH, shall be allowed as newborn hearing screening process.    SECTION 27. Funding \u2014 The amount necessary to effectively carry out the purposes of this Act shall be included in the annual General Appropriations Act.   SECTION 28. Separability Clause \u2014 If any provision of this Act shall be held unconstitutional or invalid, the other provisions hereof shall remain valid and continue to be in full force and effect.   SECTION 29. E\ufb02ectivity Clause \u2014 This Implementing Rules and Regulation shall take effect immediately after its publication in a newspaper of general circulation.  ", "  Pursuant to the Financing Agreement executed between the Republic Of the Philippines and the Kreditanstalt fur Wiederaufbau dated 02 November 1995, the Guidelines for Procurement and Distribution of all grant\u2014 in- aid from Germany is hereby laid down. Thus,   I. PROCUREMENT  All procurement procedures shall be done in Germany with 30% of goods originating from the New Federal Lender.   II. DISTRIBUTION Import duties, levies and other fees as well as all transportation costs from port of Manila to the WHSMP covered provinces shall be borne by the Department of Health as GOP counterpart to the Financing Agreement;  Delivery of medical equipment for Provincial Hospitals, District Hospitals, Rural Health Units and Barangay Health Stations shall be effected only where the construction under the ADB project.  Equipment/drugs shall be provided only to WHSMP-covered provinces with signed Project Implementation Agreement with DOH.    III. SPECIFIC GUIDELINES  The awarded German supplier will undertake the proper packing and labeling pursuant to the specific conditions of the Lender documents/contract for convenient delivery of goods to the destined local facilities.  The Philippine forwarders to be identified by Department of Health shall be responsible in undertaking the direct delivery of goods from the port of Manila to the destined provinces  within 15 days in Luzon and 30 days in Visayas and Mindanao.  Local Government Units (LGUs) shall be responsible for the distribution of goods and equipment to the selected District Hospitals, Rural Health Units and Barangay Health Stations and shall bear the costs of local distribution.  The Training\u2014related equipment such as kits for midwives, TBAs and first referral doctors shall be distributed in coordination with the Australian Aid and the Health Manpower Development and Training Service.  The Procurement and Logistics Services, the Finance Services, the PMO (WHSMP) and all  departments concerned shall be responsible for the smooth implementation of this distribution system in accordance with existing parallel distribution systems, rules and regulations. The appropriate forms and detailed procedures shall be designed and implemented by the concerned offices to safeguard the grant-in-kind from KFW. The PMO\u2014WHSMP shall particularly be responsible for the preparation and submission to PLS-DOH of the allocation list and grant/donation documents while the PLS-DOH shall be responsible for the preparation of the invoice receipt.   IV. EFFECTIVITY:  This Order shall take effect immediately.  For strict compliance of all concerned.  ", "  I. RATIONALE  Hepatitis B is a major public health problem in the Philippines with an estimated seven million people (approximately 10-12% of the total population) chronically infected with the virus. Twenty to 30% of these chronically infected people will develop chronic liver disease (cirrhosis of liver, liver cancer, etc) mostly between 30\u201450 years of age. Many will die from it as there is no effective and affordable drug treatment currently available for hepatitis B. Approximately 9000 people are estimated to die from chronic liver disease in Philippines annually\u2014a mortality rate comparable to that of tuberculosis. Majority of chronic carriers of infection acquire their infection either at birth (when the risk of becoming a chronic carrier is almost 90%) or in the early childhood by exposure to serous/blood eXudates from cuts/wounds/bites of other infected children (the risk of becoming chronic carrier is almost 30% if exposed between age 1 and 5 years, though gets reduced to 10% if infected after \ufb01ve years of age).  Based on current evidence, universal childhood immunization with three doses of hepatitis B vaccine including a birth dose - available since early 19803 - will enable the Philippines to reduce Hepatitis B prevalence from its current 10-12% to below 1%. For example, Taiwan saw a reduction from 20.3 percent to 4.4 percent in males and 14.3 percent to 2.4 percent in females born more than 6 years before the start of the national vaccination program (1991 \u2014 2001 Evaluation). From a later study in 2003, it further decreased to 0.7 percent. Hepatitis B vaccine is also effective in preventing infection, if given immediately after exposure to infection (post-exposure prophylaxis). Hence, in settings such as the Philippines where almost 10% of mothers may be chronic carriers of the virus, and at risk of transmitting the infection to their newborns at the time of birth (due to exposure of newborn to infected blood from mother), it is recommended to give the \ufb01rst dose of vaccine within 24 hours of birth to prevent mother to child transmission of infection. The baby of HBsAg and HBeAg positive mother has a 70-90% risk of infection. Immunization reduces the risk by 70-95% of the \ufb01rst dose is given soon after birth. In the absence of a birth dose, despite sustained high coverage with three doses of vaccine (e. g. when the immunization schedule starts at 6 wks rather than at birth), an estimated 3-5% of all infant will develop chronic liver infection as a result of mother to child transmission at birth resulting in overall poor hepatitis B control.  Hepatitis B vaccine has been introduced and available in the national EPI program since 1992, targeting 40% of the infants, with the aim of increasing coverage by an additional 10% of the population each year to reach 100% coverage by 1999 (Department Circular No. 242s.1990, \u201cImplementing Guidelines on the Integration of Hepatitis B into the Expanded Program, on Immunization \" dated December 10, 1990). However, insuf\ufb01cient allocation of fund to EPI limits the full implementation Of the Hepatitis B vaccination as planned earlier.  In addition, the hepatitis B vaccination schedule introduced in 1992 included \ufb01rst dose at 6 weeks of age rather than at birth and hence was not effective in preventing transmission of infection from infected mother to newborns.  Pursuant to Republic Act No. 7846 otherwise known as the Compulsory Hepatitis B immunization among infants and children less than 8 years old, Hepatitis B vaccination shall be routinely strengthened with the activities and plans of the Expanded Program on Immunization (EPI) to effectively control hepatitis B in the country by reducing the chronic infection rate of hepatitis B to less than 1% among future birth cohorts from the current levels of 10-12%. A legislative bill is currently being pushed entitled, \u201cBasic Immunization Services for Infants\",.to address this concern. This is envisioned to provide the administration of \ufb01rst dose of Hepatitis B vaccine as soon as possible after birth within 24 hours of birth to prevent mother to child (perinatal) transmission. Perinatal transmission is known to be a major source for maintaining a pool of chronic infection carriers who are at risk of developing long term complications of infection in their economically productive years, besides serving as source of infection for others. In support of this, Republic Act No. 2029 otherwise known as the \u201cLiver Cancer and Hepatitis B Awareness Month Act\" which declares the month of February as the liver cancer and hepatitis B awareness month throughout the Philippines was also passed.  To ensure an effective and ef\ufb01cient management of routine hepatitis B vaccination program for infants in all types of facilities including the hospitals, this guideline is hereby prescribed and established. Consultations with the EPI regional nurse and medical coordinators nationwide, WHO, UNICEF and presentations to the National Immunization Committee (NIC), an interagency advisory body of EPI was sought to ensure successful operations of Hepatitis B vaccination among infants.  II. SCOPE AND COVERAGE  This order shall apply to all DOH health facilities at all levels of health care including all public and private health facilities and other institutions providing immunization services for children nationwide.  III. PROGRAM GOAL  To reduce the chronic hepatitis B infection rate as measured by HBsAg prevalence to less than 1% among \ufb01ve\u2014year-old children born after routine Hepatitis B vaccination at birth started.  IV. OBJECTIVES  A. General  To improve effectiveness of management in the provision of three (3) doses of routine Hepatitis B vaccine among infants including a birth dose.  B. Specific  a. To provide new guidelines and procedures for Hepatitis B vaccination for infants at all types of health facilities, b. To provide instructions for administration of birth dose Hepatitis B vaccine according to the settings where the birth takes place.  V. DEFINITION OF TERMS  Perinatal transmission - refers to transmission from mother to child at the time of birth.  Seroprevalence \u2014 refers to percentage of a polulation whose sera are positive for a speci\ufb01c marker such as an antibody (e.g. anti\u2014HBs or anti-HBc) or an antigen (e. g. HBsAg or HBeAg)  HBs Ag - refers to Hepatitis B surface antigen. A protein from the virus\u2019 s coat. Its presence in the blood indicates current infection (acute or Chronic). The immune response to the HBsAg provides the basis for immunity against Hepatitis B virus.  HbeAg - refers to Hepatitis B \u201ce \" antigen, the presence of which implies active viral replication, thus making it a marker of greater infectivity in chronic infection.  Monovalent vaccine - refers to a vaccine containing antigen for protection against a single disease  VI. GENERAL GUIDELINES  1. DOH shall procure 75% of the hepatitis B vaccine needs for 2007 and 100% starting 2008 and onwards to provide all 0~11 months olds with three doses of hepatitis B vaccine in the \ufb01rst year of life free of charge in all health facilities and other institutions providing immunization services for children nationwide.  2. All newborns infants shall be given immunization against hepatitis B immediately Within 24 hours after birth.  3. Infants born outside of hospital, medical clinic or birthing facilities should be brought to any available healthcare facility so as to be immunized against Hepatitis B within 24 hours after birth but not later than 7 days.  4. The subsequent doses of Hepatitis B vaccination shall be completed according to the new recommended schedule of Hepatitis B immunization.  5. All health care practitioners or health care workers providing prenatal care shall educate all pregnant mothers on the importance of giving their infants the basic immunization services.  6. Every child shall be immunized through the Reach Every Barangay strategy.  7. Health education and information campaigns shall be intensi\ufb01ed at the ground level especially among the disadvantaged population to increase the proportion of mothers and caretakers practicing behaviors that promote child immunization.  8. The implementation of RA 7846, also known as Compulsory Hepatitis B immunization Among Infants and Children Less Than 8 Years Old and other laws and policies for the protection of infants shall be pursued.  VII. IMPLEMENTING GUIDELINES  A. New Immunization Schedule  The \ufb01rst dose of Hepatitis B vaccine shall be administered as soon as possible within 24 hours after birth. The subsequent two doses shall be given with the \ufb01rst and third dose of DPT and OPV to avoid the need for any additional visits. Table 1 indicates the recommended ages for the routine administration of the Hepatitis B vaccine. Any dose not administered at the recommended age should be administered at any subsequent visit when indicated and feasible. There is no need to restart vaccination series regardless of the time that has elapsed between doses.  Table 1 Schedule of Hep B, DPT and OPV Immunization    B. Vaccine Type, Routes and Sites of Administration  B.l Type of Vaccine  Recombinant or genetically engineered vaccines using HBsAg (10 mg dose) synthesized in yeast or mammalian cells into which the HBsAg gene has been inserted.  B.2 Formulations  Hepatitis B vaccines are available in monovalent formulations that protect only against Hepatitis B, and in combination formulations that protect against Hepatitis B and other diseases (DTP-HepB, DTP-HepB + Hib, Hib-HepB).  Only monovalent Hepatitis B vaccine MUST BE USED for the birth dose.  Combination vaccines that include Hepatitis B MUST NOT BE USED for the birth dose of Hepatitis B vaccine because DTP and Hib vaccines should not be administered at birth.  Either monovalent Hepatitis B vaccine or combination vaccines may be used for later doses in the hepatitis vaccine schedule. Combination vaccines can be given whenever all the antigens in the vaccines are indicated:  B.3 Presentation  Hepatitis B (HepB) vaccine is a liquid vaccine available as a single antigen formulation (monovalent) or in combination with other antigens (e.g. DPT-HepB or DPT-HepB\u2014Hib) as combination vaccine. Both monovalent and combination vaccine are available in single\u2014or multi-dose vials (2, 6 and 10 dose vials). Only monovalent HepB vaccine should be used for birth dose, as DPT contained in combination vaccines can cause adverse reaction and has reduced immunogencity if given less than 6 weeks of age. Combination vaccines may be used for subsequent doses.  Currently all the hepatitis B vaccine under the program is being supplied as 10-dose vials of monovalent vaccine.  B.4 Dosage  The standard pediatric dose is 0.5 ml.  B.5 Sites of Administration  The recommended series of 3 doses of Hepatitis B vaccine shall be given intramuscularly only in the anterolateral thigh muscle.  When hepatitis B vaccine is administered to infants at the same time as another injectable vaccine, the vaccine should be administered in different thighs. However, if more than one injection has to be given in the same limb the injection. sites should be 2.5 cm to Scm apart so that local reactions are unlikely to overlap.  The preferred injection device for Hepatitis B vaccine shall be a 0.5ml auto-disable (AD) injection syringe with any of the 25mm, 22-, or 23- gauge needle.  The following practices shall be avoided:  - Hepatitis B vaccine SHOULD NOT be given in the buttocks. There may be a risk of injury to the sciatic nerve.  - Hepatitis B SHOULD NOT be administered intradermally because this does not produce adequate antibody response to the children.  - Hepatitis B SHOULD NOT be mixed in the same syringe with other vaccines.  C. Vaccine Storage & Handling  Hepatitis B vaccine shall be transported, stored and handled similar to DPT and Tetanus Toxoid (TT) vaccines. It should be stored in refrigerators provided solely for vaccine storage at +2 to +8\u00b0C. ' It should be transported properly in ice\u2014packed containers with cold chain monitors or thermometers. Hepatitis B vaccine like DPT and TT should NEVER BE FROZEN or allowed to come into direct contact with ice because the vaccine will be inactivated and will no longer be potent. Twice daily temperature monitoring is critical. Speci\ufb01c vaccine storage requirements are described in detail in the Cold Chain and Logistics Manual. The \u201cShake test\" should be used to determine if the vaccine has been damaged by freezing.  All Hepatitis B vaccine supplied by DOH comes with attached \u201cVaccine Vial Monitor\" (VVM). VVM should be regularly read before using the vaccine to assess heat damage to the vaccine.  Since hepatitis B vaccine is also supplied with a preservative, \u201cMulti-dose Vial\" policy will also be applicable to Hepatitis B vaccine as is the case with DPT, OPV and TT. Multi-dose policy states that if one or more doses of OPV, DPT, TT and Hepatitis B vaccines have been removed during an'immunization sessions, this may be used in subsequent sessions for four weeks provided the following conditions are met:  - Expiry date has not passed; - Vaccines are stored under appropriate cold chain conditions; - Vaccine vial septum has not been submerged in water; - Aseptic technique has been used to withdraw all doses; - The Vaccine Vial Monitor, if attached, has not reached its discard point  D. Indications and Contraindications  There are no contraindications for the administration of Hepatitis B vaccine to a newborn within 24 hours of birth.  Low birth weight or premature delivery are not contraindications to Hepatitis B vaccination. If the birth weight is less than 2000 grams, a birth dose and three additional doses should be given.  E. Vaccine Side Effects and Adverse Reactions  Hepatitis B vaccine is one of the safest vaccines. Mild reactions include:  - Soreness. About 5% of children may develop tenderness, redness, or mild swelling at the injection site. - Fever. About 1% to 6% of those who receive the vaccine may develop a mild fever that lasts 1\u20142days after injection of the vaccine.  Anaphylaxis is the only known serious reaction to Hepatitis B vaccine. The risk of anaphylaxis is estimated at l per 600,000 doses. No fatal reaction has been reported.  F. Administration of Hepatitis B Vaccine Birth Dose  While the 2nd and 3rd dose of Hepatitis B vaccine shall be administered along with \ufb01rst and third dose of DPT and OPV, administration of the \ufb01rst dose within 24 hour of birth requires further instructions, which will vary depending on the place of birth. The following speci\ufb01c instructions/guidelines for administration of birth dose of Hepatitis B vaccine shall be implemented.  1) Hospitals & Lying-In Clinics  a. Supply of vaccine to hospitals/hing in clinics: All regions/provinces/cities/municipalities shall supply the Hepatitis B vaccine to different hospitals/clinics that provide in\u2014patient maternity health services on a quarterly/monthly basis based on the average number of births in that health facility. Regional/provincial/city/municipal cold chain manager must assess that proper cold chain equipment is available for storage of the vaccines.  All hospitals shall submit the quarterly number of deliveries and birth dose vaccines delivered to the region prior to receipt of the allocated vaccines.  b. The health facility shall store/handle the vaccine as per the recommendations listed above, near the labor/matemity room, where the staff assisting the child-birth can easily access the vaccine.  c. The staff responsible for providing birth dose shall be clearly designated in the health facility and shall provide the recommended dose of monovalent vaccine to the newborn as soon as possible within 24 hours of birth. No mother/child should be discharged; from the hospital without providing the birth dose of Hepatitis B vaccine to the newborn.  d. Provision of birth dose of Hepatitis B vaccine should be included as part of the standing orders for the routine care of medically stable infants weighing equal to or more than 2000 grams at birth.  e. The health facility shall submit a monthly report to the next higher level (municipality/city/province, etc.) on the total number of births in a health facility and total number of newborns given timely birth dose and those given vaccine after 24 hours of birth (with reasons).  f. Recording of the birth dose: The health facility shall record the date and time of the birth dose in the Early Childhood Care and Development (ECCD) card/Growth Monitoring Card (GMC)/Mother and Child Book/Immunization Card and give it to the mother/caretaker.  If no such cards are available in the health facility, the \"vaccinator shall give a referral note indicating that the vaccine was given including the date and time of administration, to the care-givers with the instructions for future vaccinations. An additional column will be added in the maternity register to record whether the birth dose was given. This information will be used to compile the monthly report to be sent to the higher level as mentioned previously.  g. All vaccinator shall inform the mother/caregiver on the common reactions of Hepatitis B immunization and the importance of the completion of the vaccination.  2) Health Centers/ and Barangay Health Stations  a. All health centers and BHS shall follow the revised schedule of Hepatitis B immunization among infants as provided in these guidelines.  b. Health staff and BHWs shall promote in every opportunity, especially during prenatal consultation the importance of providing the \ufb01rst dose of Hepatitis B vaccine as soon as possible within 24 hours of birth, so that the mother can ask/demand the vaccine from the providers at the time of childbirth. The mothers should also be educated about importance of getting complete series of hepatitis B and other immunizations.  c. All infants attended at bi1th by midwives from the health center/BHS shall be given the monovalent Hepatitis B vaccine within 24 hours after birth. The midwife shall carry with her a vaccine vial and a disposable syringe as part of midwifery kit while going to attend the birth.  d. Using the vaccine outside the cold chain: Since Hepatitis B vaccine is found to be relatively heat stable, it is recommended that midwife can carry the hepatitis B vaccine outside the vaccine carrier for birth dose purposes as long as the VVM is not past discard point. However, in the health center, the vaccine should be kept in the cold chain as far as possible. In the event, single dose vaccine vials are supplied under the program, the midwives will use single dose vials for Hepatitis B birth dose, and multiple dose vials for 2nd and 3rd dose. The MVDP shall be adopted in this situation as long as it is not taken out of cold chain.  3) Birth taking place outside health facilities attended by traditional birth attendants (TBAs) or other non-trained providers  Midwives in the BHS/health center should enquire about the place and provider of the birth services during prenatal consultations. In case, the pregnant woman decides to have her delivery attended by TBA, the TBA or the mother should be advised to inform the nearest health facility either by phone or by personal visit for the provision of the HepB and BCG or should bring the newborn to the health facility for vaccination or a midwife to give immunization during house visit within 7 days after delivery. The midwife at BHS/health center should provide the hepatitis B vaccine as soon as possible after getting the information along with other post-natal services.  G. Calculation of Hepatitis B Vaccine Needs  The following are the steps for calculating Hepatitis B requirement:  a. Identify the important data for computation:  - Eligible Population (EP) of Infants - EP = Total Population (TP) X 3% - Wastage Multiplier : 1.2  National: - Reserve Stock : 25% - Reserve stock Multiplier : . 1.25  Region/Province/City : - Reserve Stock : 12.5 % - Reserve stock Multiplier : 1.125  Municipality: - Reserve Stock F : 12.5 % - Reserve stock Multiplier : 1.1  b. Formula  Hep B requirements at national/provincial/city level = EP x Number of doses x wastage multiplier x reserve stock multiplier  c. Hep B requirements at lower level = EP x Number of doses x wastage multiplier x reserve stock multiplier  d. Example Computation  Given: Province A with a total population of 2,000,000 for 2006. Compute for the annual requirements for Hepatitis B.  d.1 Compute for the eligible population infants for Province A.  2,000,000 x 0.03 = 60,000 infants  d.2 Calculate for the annual needs (in doses) for Province A.  60,000 x 3 doses x 1.2 x 1.125 = 243,000 doses  d.3 Calculate for annual needs (in vials) for Province A.  243,000 doses + 10 doses per vial = 24,300 vials  In the event the single dose vials are made available for Hepatitis B, one-third of all requirements should be estimated for single dose and the rest in 10- dese vials.  H. Recording & Reporting  All vaccination given to infants shall be appropriately recorded in the Early Childhood Care and Development (ECCD) Card/Growth Monitoring Card (GMC)/Mother and Child Book/Immunization Card as well as in the Target Client List (TCL) by midwives or nurses in the facility where the infant is registered.  The Hepatitis B immunization series (Hep Bl, HepB2 & HepB3) shall be included in the de\ufb01nition of the fully immunized child (FIC). Thus, a fully immunized child shall be de\ufb01ned as an infant who received 1 dose of BCG, 3 doses each of DPT, OPV, Hepatitis B and anti-measles before reaching 12 months old.  While ideally a birth dose is, given 24 hours, full accounting of Hepatitis B doses administered regardless of site of delivery is required. Thus, the recording of the Hepatitis B is as follows:     I. Monitoring & Evaluation  The primary method of monitoring will be through routine Hepatitis B1-3 coverage reports and seroprevalence surveys. Birth dose and Hepatitis B3 shall be included in the standards for Sentrong Sigla Certi\ufb01cation.  Impact of the Hepatitis B immunization on Hepatitis B related mortality and morbidity will not be immediately visible as current immunization only protects the future generation with no impact on population already chronically infected. Hence, monitoring of hepatitis B vaccination especially in the short term will require special methods such as regular seroprevalence surveys of the children home after the start of vaccination program, and acute disease surveillance. However, considering the demonstrated ef\ufb01cacy of Hepatitis B vaccine, the vaccine coverage data can provide indirect evidence of program impact on Hepatitis B infection.  It is suggested that following indicators be regularly monitored at all levels (regional, provincial, municipality, city and district):  1) Percent of infant who are immunized with three doses of Hepatitis B vaccine (HepB3 %)  2) Percent of infants receiving \ufb01rst dose within 24 hours of birth (timely birth dose %) separately for the infants born at home and infants born in health facilities.  3) % Drop out rate from Hepatitis B1 to Hepatitis B3.  4) % Difference between DPT3 and Hepatitis B3.  The national level 'should undertake at least one serosurvey of HBsAg prevalence in vaccinated cohorts within 5 years of sustained high 3 doses Hepatitis B coverage and at least 50% of timely birth dose following the recommended WHO survey design.  J. Advocacy and Social Mobilization  The nature of Hepatitis B means that special advocacy and social mobilization efforts are needed as the disease burden is sometimes not recognized (considering the lag period between time of infection and manifestation of disease late in life) and vaccinating newborn infants may be dif\ufb01cult in some societies. The efforts need to include ensuring that health workers are fully informed as to the importance of hepatitis B immunization in preventing chronic liver disease and cancer.  VIII. IMPLEMENTING MECHANISMS  Roles and Responsibilities:  1. Department of Health  a. Central Office/National Center for Disease Prevention and Control  The EPI-National Center for Disease Prevention and Control (NCDPC) shall provide the standards, policies and guidelines on the Hepatitis B immunization program and ensures adequate and potent Hepatitis B vaccines are procured and delivered nationwide. Auto-disabled needles and syringes Shall also be procured for all the 5th and 6th class municipalities nationwide.  The DOH shall provide the monovalent recombinant Hepatitis B vaccines to all the health facilities  b. CHDs/Hospitals  The CHDs shall ensure that all the vaccines are potent, adequate and (timely delivered to their catchment areas, ensure the timely submission of the accomplishment reports, provide technical assistance to include supervisory/monitoring visits to the LGUs to ensure all infants receive 3 doses of Hepatitis B vaccines including Hepatitis B at birth. CHD shall ensure that all LGUS have suf\ufb01cient supply of needles and syringes. This shall entail monitoring, advocacy as well as augmentation of supplies.  Hospitals shall provide Hepatitis B birth dose and BCG to all newborns and all immunizations for infants, children and mothers during consultation and for in\u2014patients. All infants receiving birth dose in the hospitals shall be properly endorsed or referred to health centers/health stations for their succeeding doses. Accomplishment reports shall be submitted to the appropriate health facilities as agreed upon.  2. Local Government Unit  All local government units shall ensure that the vaccines are given to the targeted eligible population \u2014 the infants, reach all infants in every barangay, ensure those who received initial vaccination from the private sectors are fully vaccinated, follow\u2014up the missed and the under-immunized infants including transients, and submit accomplishment reports on time.  All LGUs shall provide funds for the procurement of the auto-disabled syringes forHepatitis B and other primary vaccinations series for infants; provide adequate funds for the traveling and incidental expenses for the health workers for them to conduct outreach activities. They must also ensure that regular immunization activity is being done at least once a week.  3. Private Sectors/Professional Organizations  All health practitioners shall ensure that every infant receives all vaccinations covered in the DOH policy. Professional organizations shall disseminate this policy to its members.  4. Partner Agencies  World Health Organization (WHO) and UNICEF shall provide technical assistance and assist in the procurement of quality and safe vaccines from certi\ufb01ed manufacturers.  5. Academe  The academe shall incorporate updated EPI policies and laws into its curriculum and continuing education. '  B. Funding  All expenses for the procurement and delivery of the vaccines from the national cold room to the regions and selected provinces and cities shall be charged against the funds Of the EPI subject to the accounting and auditing procedures.  The procurement of the annual needs for the needles and syringes, traveling expenses and other incidental expenses by the vaccinators shall be the counterpart of the Local Chief Executives.  IX. Repealing Clause  Any existing provision or issuance found inconsistent with this order shall be repealed.  X. Effectivity  The order shall take effect immediately.   ", "  The Philippine Measles Elimination-Campaign (PMEC) aims to reduce measles to zero by year 2008. To pursue this elimination goal, the guidelines as contained in the attached manuals are hereby adopted as official guidelines governing the Philippine Measles Elimination Campaign. These manuals namely: The Philippine Measles Elimination Campaign Planning Guide, Field Managers Guide, Guide for Field Implementors, and the School Information Guide ; all contain the plans and operations for the PMEC especially the component on \u201cLigtas Tigdas\" month to be conducted on September 16 to October 14, 1998  nationwide The Ligtas Tigdas Month aims to vaccinate all children ages 9 months to less than 15 years old with a dose of measles vaccine regardless of status of immunization and/or history of measles infection. The Ligtas Tigdas Month aims to reduce the number of measles susceptible children quickly and drastically.  The scope of each manual is outlined as follows:   A. Planning Guide  This is intended for the health managers and programme coordinators and contains the preparation of logistics and human resources requirements and other activities at the province/city/municipality/rural health unit and other health center levels prior to the \"Ligtas Tigdas\" month.   B. Field Managers Guide  This is intended for all health managers at the national, regional provincial/city, and municipal levels. It contains the following:  - general information - concepts and strategies - operations for the \u201cLigtas Tigdas\"month - target population to be vaccinated - vaccination tactics - organization of activities and plans for the \u201cLigtas Tigdas\" month in schools in the community - organization of regional/provincial/city/municipal subcommittees to effectively manage the implementation of the \u201cLigtas Tigdas\" month - organization of vaccination teams, tasks and schedules - organization of the flow of children and activities during vaccination sessions  - obtaining logistics requirement - surveillance - social mobilizatIon - monitoring, supervision and evaluation - reconstitution and administration of the measles vaccine - precautions to ensure safety of injections - monitoring and management of adverse reactions to measles vaccine  - other vaccines and health services to be provided during the \u201cLigtas Tigdas\" month - proper procedure for discarding used needles and syringes - incineration - performance and inventory information to be collected reported, and monitored - annexes (issuances, adverse effect following immunization, measles investIgatIve form, supervising form, directory of contact persons)   C. Guide for Field Implementors  This is a simplified \ufb01eld managers guide retaining only those relevant for health implementors such as:  - general information  - concepts and strategies - operations in Ligtas Tigdas month in schools and community - vaccination procedure - recording and reporting - annexes   D. School Information Guide  This manual is intended for school principals and teachers. It includes:  - general information on Measles and the \u201cLigtas Tigdas\" month - core messages on PMEC that teachers can communicate to students and parents about measles and the benefits of vaccination - role of teachers on \u201cLigtas Tigdas\" month - DECS memorandum - standard consent slip  This order is effective immediately.   ", "  1. Rationale   To ensure sustainability of the National Comprehensive Newborn Screening System and subsequently reach the vision of saving all Filipino newborns from mental retardation and death, provision was made in Section 16 of the Republic Act 9288, otherwise known as the \u201cNewborn Screening Act of 2004\", for the NBS fee to be divided and at least four percent (4%) be set aside for the DOH Centers for Health Development (CHDs) and Department of HealthAutonomous Region in Muslim Mindanao (DOH\u2014ARMM). The said fund shall be used solely for follow-up services, education and other activities directly related to the provision of newborn screening services.   Furthermore, in consonance with this vision of saving Filipino newborns, preparation for the expansion of the newborn screening panel from six (6)5 to more than twenty (20) disorders is underway.   As the expanded Newborn Screening will incur additional expenses, and since the newborn screening coverage remains below the 2010 national target of 85%, it was resolved, in the August 29, 2012 meeting of the Advisory Committee of the Newborn Screening (ACNBS) that the utilization of the 4% share of the DOH-CHDS and DOH\u2014 ARMM shall be reviewed and guidelines shall be set to ensure maximum and appropriate utilization of Newborn Screening Fund. In this light this Administrative Order is being issued.   II. Objective   To set the guidelines for the use of the 4% fund allotted to the DOH-CHDs and DOH- ARMM.   III. Coverage   Provisions of this Administrative Order shall apply to all DOH-CHDs, DOH-ARMM, and Newborn Screening Follow-up Clinics.     IV. Definition of Terms   Newborn Screening Follow -up Clinics refers to regional and provincial referral centers of all confirmed positive cases.   Newborn Screening Center W8C) refers to a facility equipped with a newborn screening laboratory that complies with the standards established by the National Institutes of Health, and provides all required laboratory tests and recall/follow-up programs for newborns with heritable conditions. -   Newborn Screening Reference Center (NSRC) refers to the central facility at the National Institutes of Health that defines testing and follow-up protocols, maintains an external laboratory proficiency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, oversees content of educational materials and acts as the Secretariat of the Advisory Committee on Newborn Screening.   RA 9288: Newborn Screening Act of 2004 refers to :the act promulgating a comprehensive policy and a national system for ensuring newborn screening   V. Policies and Procedures   A. General Guidelines   1. Memorandum of Agreement shall be executed between NSRC, NSCs and CHDstOH\u2014ARMM on the collection and transfer of 4% of NBS fees;   2. NSRC shall collect from NSCs the percentage of the NBS fees for CHDs/DOH- ARMM;   3. NSRC shall notify the CHDs/DOH-ARMM on the availability of 4% of NBS fees;   4. CHDstOH-ARMM shall request from NSRC the amount for transfer as indicated in the CHDs/DOH-ARMM Annual Internal Operating Budget (10B);   5. The earmarked amount to CHDs/DOH\u2014ARMM shall be for the purpose of implementing the newborn screening program and facilitating achievement of required outputs;   6. CHDs/DOH-ARMM shall: a) maintain a Trust Fund account for the 4% earmarked amount;   b) take charge of the overall management and disbursement of the transferred fund;   c) submit to DOH National Center for Disease Prevention and Control (NCDPC) the required accomplishment reports;   (1) prepare and submit to NSRC semi\u2014 annually the fund utilization report verified by the Commission on Audit (COA) Auditor which Shall form part of the attachment for succeeding request,   7. NSRC shall:   a) request funding and payment approval from UP Manila of the fund for transfer to CHDs/DOH-ARMM;   b) transfer earmarked funds to CHDs/DOH-ARMM 30 working days from date of receipt of requests;   8. NBS NurSe Coordinators shall be iii-charge in the monitoring of funds transferred to CHDs/DOH-ARMM;   9. Transfer of funds for Capital Outlay is subject to special budget;   10. All disbursement of funds shall be subject to existing accounting and auditing rules and regulations.   B. Speci\ufb01c Guidelines   The 4% share of the DOH and DOH ARMM shall be used for the following NBS- related activities:   1. Follow-up service of patients with positive screening result by personnel hired for the NBS unit based at CHDs/DOH-ARMM.   The line item budget shall be used for the following:   a) Salaries and Wages of Nurse and/or Medical Coordinator on contract of service;   b) Traveling expenses of monitoring visits;   c) Per diem of monitoring team; and   d) Other related expenses.   2. Follow\u2014up service of patients confirmed positive by personnel hired for the NBS unit based at Newborn Screening Follow\u2014up Clinics.   The line item budget shall be used for the following:   a) Salaries and Wages of Nurse/Genetic Counselor and/or Medical Coordinator on contract of service;   b) Traveling expenses of monitoring visits/attendance to trainings/conferences;   c) Per diem of monitoring team;   d) Confirmatory testing for indigent patients; and.   e) Other related expenses.   3. Education and other activities directly related to the provision of NBS services. The budget line item shall be used for the following:   a) Meetings with Newborn Screening Facilities\u2019 Coordinators;   b) Venue and food of participants during the conduct of lectures/trainings/orientation seminars;   c) Supplies and materials needed for the conduct of lectures/trainings/orientation seminars;   d) Honorarium of resource persons/facilitators;   e) Traveling expenses and per diem for the conduct of training/orientation seminars;   f) Printing and reproduction of advocacy and information materials; and   g) Other training/ seminar and campaign related expenses.   4. Incentives for RHU collecting health units AT LEASTQXQ of the money allocated to the CHDs/DOH\u2014ARMM.   Incentive may be in the form of:  a) \"NBS kits;  b) sponsorship to newborn screening -related meetings and conferences;  c) promotional materials/giveaways or  d) telecommunication expenses related to newborn screening activities    5. Staff development of the personnel of the NBS unit based at the CHD/DOH- ARMM.   The budget line item shall be used for the following:   a) Registration fees of trainings/seminars/conventions/official meetings;   b) Traveling and accommodation expenses;   c) Per diem of staff directly involved in the program; and   d) Attendance to international conferences approved by DOH-Screening & Evaluation Committee for Training & Development (SECTD). Approval shall be based on the following;   (1) an of\ufb01cial country representative involving a highly specialized \ufb01eld that is related in the program management of policy development; and  (2) the conference focus on newborn screening program management and policy development; and  (3) paper or poster presenter/s on newborn screening-related services/innovation; or  (4) oral presenter/invited resource person representing the country either in plenary or in parallel session.   6. Capital outlay   The budget line item shall be used for the following:   a) Purchase Of Office Equipment, Communication Equipment, IT Equipment and Software, Furniture and Fixtures;  b) Purchase of Motor Vehicle for NBS program;   7. Maintenance and operating expenses of the program   The budget line item shall be used for the following:   a) Telephone bills/Call Cards (Landline and mobile phones);   b) Office Supplies and Other Supplies Expenses;   c) Internet Expenses;   d) Representation Expenses;   e) Repairs and Maintenance of acquired Properties & Equipment; and   f) Other Administrative Overhead related expenses.   8. Cost of repeat samples due to insuf\ufb01cient and unsatisfactory samples of patients in their catchment area.   These guidelines shall be reviewed periodically by NatiOna] Center for Disease Prevention and Control for technical processes, and Newborn Screening Reference Center for usage of fund.   VI. Repealing Clause   All issuance that are inconsistent with the provisions of this Order are hereby repealed/rescinded.   VII. Effectivity   This Order shall take effect fifteen (15) days after its approval and publication in the official gazette or newspaper of general circulation.   ", "   The DOH implementing structures for the IFPMHP were outlined in Department Order No. 65-B s. 1995 dated Feb. 28. Department of Health personnel were assigned responsibility for the management of the project and its three components. This Administrative Order de\ufb01nes the roles, relationships and responsibilities of key Department of Health management personnel for the Integrated Family Planning and Maternal Health Project (IFPMHP). Also included to this Administrative Order are the responsibilities of the Project Steering Committee that will assist the Project Director, and the Advisory Committees that will assist the Component Managers.     I. Project Director: This position will be \ufb01lled by the Undersecretary for Public Health and will have the following responsibilities:  1. Provide policy direction and general management oversight for the project;  2. Brief the Secretary of Health and the Chief of Staff on project plans and activities;  3. Approve project-wide plans budgets and reports on behalf of DOH and endorse these plans to USAID;  4. Issue directives governing the project's organization and management and the creation of structural or ad hoc organizational units;  5. Conduct meetings at least quarterlv to monitor the progress made by the project toward achieving anticipated outputs;  6. Represent the project to DOH management and to the highest levels of the government;   7. Chair the project Steering Committee;  8. Supervise the Project Manager.    II. Project Manager: This position will be \ufb01lled by the Assistant to the Undersecretary of Public Health for Women's and Children\u2019s Health and will have the following responsibilities:  \u201cmissing text\"  toward achieving annual benchmarks and outputs; and approve benchmarks once they have been ful\ufb01lled;  3. Brief the Project Director on project plans, budgets, activities, outputs and any major issues facing the project;  4. Ensure the effective coordination of activities among the three project components;  5. Ensure the effective coordination between IFPMHP and related DOH programs and projects;  6. Approve all publications and media campaigns produced under IFPMHP;  7. Submit quarterly reports to the Project Director for endorsement to USAID;  8. Provide for project monitoring and evaluation;  9. Serve as the primary contact for the project on behalf of the government with USAID and other donors;  10. Serve as the primary spokesperson for the project in the media and other public fora;  11. Maintain \ufb01les of key project documents;  12. Supervise the Component Managers and the staff of the project management office.   Reports to: Project Director    III. Project Component Managers: IFPMHP has three components, each of which will have a Component Manager. The following DOH organizational mats and personnel have been designated as component managers:   Component 1, National Services, will he managed by the Officer in Charge, Family Planning Services. This component will include the following subcomponents:   a) Logistics b) IECM c) Training d) Operations Research e) Voluntary Surgical Contraception f) Policy Planning g) National Program Monitoring   Component 2, NGO Strengthening, will be managed. by the Service Director, Noncommunicable Diseases. This component will include the following subcomponents:  a) NGOs b) Social Marketing c) Industrial Sector   Compound 3, Performance\u2014Based Program, will be managed by the Of\ufb01cer in Charge, Maternal and Child Health Services.  The component managers will have the following responsibilities:  1. Formulate annual plans and budgets for the component in consultation with the collaborating agencies; recommend any proposed revisions to the plan and budget to the Project Manager;   2. Oversee the implementation of plans for the component and achieve the expected outrun;  3. Brief the Project Manager on project activities, progress toward outputs and any major issues facing the project component;  4. Submit quarterly and annual progress reports for the component and its subcomponents, in consultation with the collaborating agencies;   5. Conduct an annual performance evaluation of the collaborating agencies;   6. Ensure that subcomponent activities are well coordinated and that IFPMHP activities are coordinated with related programs and projects;   7. Ensure that project participants adhere to project-wide procedures for administration and coordination;   8. Approve activities, scopes of work, selection of consultants and travel plans;  9. Chair the Component Advisory Committee;   Report to: Project Manager   The Steering Committee will advise the Project Director on policy, management, and coordination issues with regard to IFPMHP, and will have the following responsibilities:  1. Advise the Project Director on policy matters;  2. Advise on the organization and management of the project;  3. Advise on the coordination of project components;  4. Advise on the integration of the project with other DOH programs and projects;  5. Ensure that project activities re\ufb02ect government wide and DOH policies and priorities;  6. Ensure that the project is regularly evaluated.    The Component Advisory Committees will advise the Component Managers on operational issues pertaining to their respective Components, and will have the following responsibilities:  1. Act on policy and operational issues with major implications for the project that could not be resolved at the component level;   2. Advise on the planning and implementation of component activities;  3. Advise on the organization and management of the component;  4. Provide guidance on the appropriateness and acceptability of project strategies and materials;  5. Ensure that project activities reflect the needs of consumers and other stakeholders;   6. Advise on the coordination of project subcomponents;  7. Advise on the integration of the project with other DOH programs and projects;  8. Advise on the monitoring and evaluation of the component.   This order shall take effect immediately.   ", " Pursuant to the provisions of Section 16 of P.D. 851 dated December 2, 1982, and in order to facilitate action on routine personnel matters that will enhance administrative efficiency at their level, authority is hereby granted to Provincial Health Officers or Officers in Charge of Integrated Provincial Health Offices to approve applications for maternity leave of absence of married women employees holding positions in the integrated health and medical units under their supervision, including computation of salary incident to such maternity leave, subject to the following conditions:  l. That when necessary, any initial application for maternity leave of absence to be approved with full pay under this authority shall be supported by a copy of the applicant's approved appointment or service record, particularly in the case of vertical programs integrated with the health office.  2. That, when applications for maternity leave of absence is approved with half pay, deductions shall be immediately effected in the payro11 of the Corresponding office. '  3. That leave applications to be approved under this Order shall bear the following phrase above that of the signing official:  \"By authority of the Minister of Health\"    This Order takes effect September 1, 1984. ", "  1. Purpose  These guidelines are issued for the following purposes and objectives:  (a) To expedite the release of funds to the Regional Health Of\ufb01ces (RHOs) and the replenishment and liquidation of the same;   (b) To enable the Project Management Office (PMO) to effectively monitor on time the actual utilization of funds.   2. Responsibilities of Concerned Units/Of\ufb01cials  2.1 Finance Service- DOH (Central Office)  (a) Release the loan proceeds requirement of the respective regional health offices out of the ADB Imprest Fund and World Bank Special Account, and GOP Counterpart upon submission of sub-allotment requests by the PMO. These sub allotments requested by the PMO shall be subject to compliance by the regions of the necessary reports by project components/subcomponents accordingly.  (b) Transfer Imprest Fund and Special Account on a bank-to\u2014bank mode.  (c) Consult and advise the PMO regarding the release of funds to the different regions.  (d) Prepare the consolidated Financial Statements i.e. Trial Balance, Income Statement (if applicable) for the Project as required by the Commission on Audit. These Financial Statements are consolidation of all financial transactions for the Project including those transactions done at the \ufb01eld level and at the Central Office.  (e) Maintain separate books of accounts for the Project.   2.2 Project Management Office (PMO) - DOH (Central Office)  (a) Prepare all withdrawal applications to the ADE/World Bank including liquidation and replenishments of Imprest Fund/Special Account.  (b) Consolidate the audited regional annual Statement of Sources and Applications of Funds (SSAF), including SOEs, and integrate these with project expenditures at the Central Office to form the overall for the project.  (c) Monitor the actual accomplishments and release of funds to the regions, and the submission of reports required by the Finance Service and the COA.  2.3 Regional Health Offices  (a) Maintain separate bank accounts for the Imprest Fund of the ADB or Special Account of the World Bank. GOP Counterpart fund could be maintained in existing bank account but should be properly accounted for. (b) Maintain separate books of accounts for ADB and World Bank loans. (c) Prepare on a monthly basis statement of expenditures (SOEs) and submit to the PMO - Women\u2019s Health and Safe Motherhood Project, Department of  Health, 3rd Floor, Building 12, san Lazaro Compound, Sta. Cruz, Manila, and to the Regional COA. The RHOs should maintain a one month lag time, meaning SOEs for the month of September should be submitted in the month of October (d) Prepare and submit monthly report of disbursements to the Finance Service, copy furnished the PMO.  (e) submit to the COA within three (3) months from the end of each year the project\u2019s annual Statement of sources and Application of Funds for audit. (f) Submit monthly accomplishment reports to the PMO.  3. Effectivity  This Order shall take effect on September 15, 1997.  ", "  I. RATIONALE  In response to the increasing number of women and children who consult the hospitals due to violence, rape, incest, and other related cases the Hospital Based Women\u2019s Desk Program known as Project Haven, an Non-Government Organization \u2014 Government Organization (NGO-GO) partnership between Women Crisis Center and East Avenue Medical Center was established in 1995 to address their medical and psychological needs. In 1996 a purely GO based Women's Desk was piloted in five other  government hospitals. There was a need to mainstream the vast experience of NGO\u2019s in providing gender\u2014sensitive services for women survivors of violence thus institutionalizing these services within the government health care delivery system was envisioned. Hence, the Hospital \u2014 Based Women\u2019s Desk was an initial step towards the institutionalization, sustainability, and replicability in other government hospitals as well as in private hospitals.  Violence against women is not merely a health concern and requires a whole range of medical, social and non\u2014medical interventions and services. To be effective, it needs to be integrated and holistic. There is a need to pool resources, logistics and human resources ( both government and non\u2014government) for a more concerted and systematized training program for care providers. The training program must be multidisciplinary and multilevel in its approach.  Pursuant to Department Circular NO. 47,s. 1997 in response to the Memorandum dated February 5, 1997 by the President of the Philippines on the subject, \u201c Call to Action  against Domestic Violence\" the President has directed all agencies to launch and maintain comprehensive campaign against all forms of violence. In view of all these, the Women\u2019s Desk Program later called the Women and Children Protection Program under the Office for Health Facilities, Standards and Regulations is institutionalizing the creation of a unit in DOH hospitals that will answer the medical and psychological needs of victims of violence and shall be known as the \u201cWOMEN AND CHILDREN PROTECTION UNIT\".   2. GOAL:  To provide a holistic, gender sensitive health care to women and children who are victims of violence.   3. OBJECTIVES:  GENERAL OBJECTIVE:  To institutionalize the establishment of a Women and Children Protection Unit in the DOH hospitals for victims/survivors of domestic violence, rape, incest, torture, sex trafficking, and other abusive and exploitative acts.  SPECIFIC OBJECTIVES:  3.1 To ensure that women and children who consult the DOH hospitals due to violence are treated with utmost care, concern and understanding. 3.2 To create and sustain a women sensitive and women friendly environment within the hospital setting.  3.3 To sensitize and reorient the staff and all sectors of the hospital to the issue of violence against women and children.  3.4 To provide training opportunities for the program staff as well as other individuals who may be interested in pursuing a career path relevant to the concern of violence against women and children. 3.5 To develop a systematic gender sensitive documentation and monitoring system.  3.6 To document experiences which will serve as inputs for policy research, formulation and program improvement. 3.7 To replicate the program concept and procedures in other government hospitals as well as in private hospitals. 3.8 To develop training modules evolved from the experiences of the program, which can be used in other government hospitals and institutions. 3.9 To coordinate with other government and non\u2014government institutions and organizations for a more organized approach to address other non\u2014medical needs of the victims/survivors.   4. KEY COMPONENTS:  Given the multi-faceted nature of the problem of violence against women and children it must be approached from many disciplines that act not in isolation but in collaboration with each other.  As such, the unit shall involve the following components, namely:  4.1 Medical/Surgical, Psychological and Health Services:  It will feature the following:  4.1.1 A 24 hour personalized care and service which includes identification of patients and families in crises, provision of therapeutic and supportive management and assurance of physical security, safety and confidentiality.  4.1.2 A :Women and Children Protection Unit\" as a holding and processing area for victims/survivors. This will be manned by a team headed by a women and children coordinator. Once victims are admitted in specific areas the team is also responsible for following up the victims until they are discharged, followed up and/or properly referred. Emphasis is made on the continuity of care to the victims.  4.1.3 A standard patients\u2019 \ufb02ow and clinical protocol in interviewing, physical examination and management.   4.1.4 A gender sensitive recording system which also ensures utmost confidentiality.   4.2 Networking Mechanism:  A holistic and integrated approach will be ensured through an efficient referral and networking system that will mobilize a wide network of GO\u2019s, NGO\u2019s and other institutions involved with violence against women and children   4.3 Training and Education:  A multi-disciplinary training program will address human resource development needs as well as the need to create and sustain a women sensitive and  friendly hospital environment. The Women and Children Protection Program in the central office will set directions and define a career path for medical and paramedical graduates who might be interested in professionally pursuing this line of work. However, this will be made available net only to hospital personnel but to the community and interested organizations who would like to avail of the training. Training areas may focus on the following:  4.3.1 For trainees to acquire/enhance attitudes necessary in the management of acute and chronic causes of crisis such as sensitivity, compassion, confidentiality and empathy.   4.3.2 For the trainees to develop/ strengthen their skills in early detection, screening, interviewing, physical examination, use of appropriate diagnostic procedures, management, counseling and referral.  4.3.4 For the trainees to have additional knowledge on understanding of conditions leading to crisis, recognition of early sign of crisis identification, analysis of aggravating/contributory factors including family factors/stresses, understanding of the impact of crisis on the individual the family and the community management of patients and their families networking, linkage development and referral.  4.4 Research:  This component shall be responsible for eliciting. and documenting experiences to serve as inputs for further studies, researches for policy and program improvement.   4.5 Information and Advocacy:   This will deal with the development of communication strategies for crisis mitigation prevention and control in the community; dissemination of information about the Women and Children Protection Unit and its activities and advocacy for empowerment of victims.    5. MANAGEMENT AND COORDINATING MECHANISM:  5.1 The Program   The Women and Children Protection Program shall be established under the Office for Health Facilities Standards and Regulations (OHFSR). The Program shall give advice and policy directions. It shall be handled by a Program Manager.   The Program shall coordinate with the Chiefs of Hospitals in the operation  and management of the Women and Children Protection Units. The Chiefs of  Hospital shall have administrative supervision over the coordinators of each unit while the Program Manager shall have technical supervision over the said coordinator.   5.2 The Women and Children Protection Unit:  5.2.1 The Unit shall be an integral part of the hospital. 5.2.2 A Women and Children Protection Unit shall be established and situated at the Emergency Room Complex ( or any room identified for that matter) 5.2.3 The Unit shall be under the Chief of Clinics and has the following  staff who shall be performing their duties in addition to their regular hospital assignment. a. Women and Children Protection Coordinator b. Nurse c. Social worker d. Psychiatrist/Psychologist (if available)  5.2.3 Each unit shall have the following core services a. Service b. Training c. Research  5.3 The Role of the Hospitals:  5.3.1 Budget: As a priority program of the government, the OHFSR together with the hospitals shall work for the inclusion of the Women and Children Protection Program/Units in the national budgetary allocation. All hospitals should include this in their work and financial plan.  5.3.2 Manpower: The hospital should designate the personnel necessary for this unit. In the event that there would be additional plantilla positions such manpower requirements should be included. 5.3.3 Support and encourage innovative activities of the program. 5.3.4 Link with other GO\u2019s, NGO\u2019s to enhance support with the WCPU.  5.3.5 Support the training of the trainers and require all personnel to undergo training on Gender Sensitivity. All personnel especialIlly residents shall have a briefing by the coordinator before rotation in the Emergency Room.  5.4 Responsibilities of the Women and Children Coordinator:  The Coordinator shall be responsible for:  5.4.1. Integrating all functions of the Women and Children Protection Unit.  5.4.2 Organizing a team within the hospital that would man the unit and take charge of all activities of the unit. The size of the team will depend on the size, type and needs of the hospital. She would likewise be responsible in coordinating with the different departments and offices within the hospital to facilitate in the implementation of the unit.  5.4.2. Coming up with the work and financial plan of the unit including the budget preparation.  5.4.3. Submission of quarterly reports to the Undersecretary of Health  Facilities, Standards and Regulation attention to the Program Manager of the Women and Children Protection Program.  The name of the designated Coordinator shall be submitted to the Office for Health Facilities Standards and Regulation and shall be issued out through a Department Order.  6. Effectivity: This order shall take effect on March 2, 1998.   ", "  I. Introduction:  The Department of Health (DOH) through the Maternal and Child Health Services (MCHS) is responsible for providing policies, standards, guidelines and services in the promotion of safe motherhood and child health. One of its main program is the Expanded Program on Immunization (EPI) with the aim of reducing vaccine preventable diseases such as Tuberculosis, Diphtheria, Pertussis, Tetanus, Poliomyelitis, Measles and hepatitis B, through complete immunization of children 0-12 months of age. Diphtheria-Pertussis-Tetanus and Hepatitis B (HB) vaccines are injectable vaccines given in 3 doses together with OPV. A quadrivalent DPT-HB vaccine has been developed and among its benefits are fewer injections, fewer syringes and needles, less storage, shipment and administrative cost. Smith Kline Beecham Research Limited has come up with such combination - the TRITANRIX-HB10.  SmithKline Beecham (SB) is donating about 100,000 doses of TRITANRIX-HB10 for trial use by the DOH in its immunization program for infants ages 6 weeks to 1 year. The MCHS in collaboration with SB conducted a project to document and evaluate the possible adverse reactions following the TRITANRIX-HB10 and its acceptability among the parents and the service providers.    II. Target Population:  A total 30,000 Filipino children ages 6 weeks to 1 year without previous DPT or Hepatitis B vaccine immunization shall be the primary targets for the 3 doses of TRITANRIX-HB10.    III. Characteristics of the Vaccine  TRITANRIX-HB10 contains diphtheria (D), tetanus (T) toxoid, inactivated pertussis bacteria (Pw) and the purified major surface antigen of the hepatitis B virus (HBV), adsorbed on aluminum salts.  Each 0.5 ml. dose of vaccine contains minimum 30 IU of adsorbed diphtheria and minimum 60IU of adsorbed tetanus toxoid, minimum 4 IU of adsorbed pertussis vaccine, of aluminum hydroxide and aluminum phosphate equivalent to 0.4 mg. of adjuvants and 0.025 mg. of sodium thimerfonate as preservative. The vaccine is presented as a whitish, turbid suspension.    IV. Dosage, Route and Site Administration  The recommended dose (0.5 ml.) for 3 doses of the Tritanrix HB10 shall be administered deep intramuscular (IM) on the left anterolateral part of the thigh and can start from the age of 6 weeks onwards. Subsequent doses of vaccine must be administered within an interval of at least 4 to 8 weeks. The longer the interval between subsequent closes, the higher the antibody titers.  It should not be administered intravenously because of risk of anaphylactic shock.        V. Immunization Schedule:   Tritanrix HB10 vaccination schedule shall follow the EPI schedule:      VI. Vaccine Storage and Handling:  Tritanrix HB10 shall be transported, stored and handled similar to DPT, TT and Hep B vaccines. It shall be Stored in refrigerators provided solely for vaccine storage at +2\u00b0C to +8\u00b0C. It shall be transported in properly ice-packed  containers with cold chain monitors. DO NOT FREEZE. Discard if the vaccine  has been frozen.  The vaccine is presented as a turbid-white suspension in a monodose glass vial and 10-dose glass vials. Upon storage, a white deposit and clear  supernatant can be observed.  PRIOR TO ADMINISTRATION, the vaccine should be well shaken in order to obtain a homogeneous turbid suspension and visually inspected for any  foreign particulate matter and/or variation of physical aspect. In the event of  either being observed, discard the vaccine.    VII. Adverse Reactions and How to Manage these:  Adverse reactions can be seen following immunization and it can be due  to the intrinsic characteristics of the vaccine or to the technique or handling oe the so\u2014called program-related cause. However, some reactions will occur  coincidentally after immunization which is not due to immunization and would happen had the child no been vaccinated.   The usual side effect of an injection such as inflammation and pain at the injection site should be managed in the same way as for the other vaccines. (with antipyretics and physical care)     VIII. Recording of Immunization Given:  The immunization of the child shall be recorded in the Growth Monitdoring Cards (GMC) and in the Target Client List (TCL) or masterlist.  If there are no GMCm any recording sheet can be used. However, these shall be replaced with GMC as soon as these are available.    IX. Reporting, Monitoring, Supervision and Evaluation:  The total number of children immunized with Tritanrix HB10 shall be reported in the FHSlS Form for the FIC Coverage.  All children vaccinated with the vaccine shall be regularly be monitored and supervised by the RHMS/RHNs with regards to development of adverse reactions and for follow-up for the succeeding doses.  This Administrative Order shall take effect immediately   ", "  I. RATIONALE  The coverage of the National Tuberculosis Control Program since it started in 1987 was to detect and cure tuberculosis cases among the 10 years old and above. Priority was given among this age group becauSe they'are highly communicable.  An adult in the immediate household Usually infects children. In the Philippines, in 77% of children admitted in the hospitals, the usual source of infection was either the mother or the father. In 13%, another family member was the source or infection. Therefore, abOut 90% of tuberculosis infections in children occurred in the family.  The National Prevalence Survey done in 1997 by Tupasi et al showed that the prevalence of infection in 0-4 years old is, 6.9% and 16% in ages 5-9.years-old. From these infections, only 5% will develop active TB. One can therefore esitimate that approximately 1,500,000 children (0-9 years) are infected and 40,000 of them develop the disease each year.  The risk of being infected as well as the risk of developing the disease depends on the number of factors: age of the occurrence of the primary infection, the nutritional status of the child and the intensity of the contact. Infants and very young children develop the disseminated hematogenous forms of tuberculosis more often than the older children or adults. The highest mortality rate occurs in children ages 0-4 years.  Tuberculosis in children is not easin diagnosed. This is because children with tuberculosis rarely produce bacteriologically positive specimen and do not present the physical signs and symptoms of the disease especially in the. initial stage. It is also in\ufb02uenced by the limited diagnostic tools.  Because of existing cases, the difficulty in the diagnosis and the presence of several groups (that are interested of the welfare of the children, the need to implement a tuberculosis control program among children, was realized.  These guidelines prescribe the management of TB in children employing the DOTS strategy. This strategy has proven to have dramatically improved the cure rate of TB patients to more than 85% in areas where it has been implemented; These guidelines, may be updated in accordance with the results of the evaluation of the implementation of tuberculosis in children in the pilot areas.  II. DEFINITION OF TERMS  1. Positive history of onnosnro\u2014 refers to a continued exposure of a child to an adult/adolescent TB case within the household and with either positive or negative  _ smear examlnatlon result and 1s presently undergoing treatment.  TB symptomatlc 'a child with any three (3) of the following signs and symptoms:  a. ocugh/wheezing of 2 Weeks or more '  b. unexplained fever. or 2 weeks or more .  0. loss of weight/failure to gain weight! weight faltering/loss of appetite  d failure to respond to. 2 weeks of appropriate antibiotic therapy for lower  ' respiratory tract infection i - e. failure to regain previous state of health 2 weeks after a viral infection or exanthem (e g. measles) ' .  Positive tuberculin test \u2014 an area (if induration of the skin with diameter of 8mms or '  more after 72 hours of lnjectlon of the tuberculin solution  Pulmonary TB case-- a classi\ufb01cation of a TB case based on location and is  characterized by one of the following  '.a A patient that has any three of the following criteria: - 1. Positive exposure to an adultl\u2019adolescent with active ITB disease 2 Positive tuberculin test. I - '3. Positive signs and symptoms suggestive of TB -4. Abnormal chest radlograph suggestive of TB .- 5. LabOratory findings suggestive or. indicative of TB (histological, cytological, biochemical, immunological and/or molecular) b. A patient who has at least _2. sputum Specimens positive for; Acid fast Bacilli (AFB) by mlcroscopy  'Extrapulmonary TB ease \u2014\u2014 a classr\ufb01catlon of a TB case characterized as one of the following. ' '  a. A patient with clinical and/or histological evidence consistent with active  tuberculosis outside the lungs and decision by a physician to treat the patient .- '  ' Iwith anti-tuberculosis chemotherapy or I b. A patient with one IIII(1) mycobacterlal Culture poSitive Specimen from a site outside the lungs ' . . .  New Case\u2014 a type of. TB patient who had never had .TB 111 the past, or a patient who has previously taken ant1-tuberculosrs drugs for less than (1) month , '  'Relapse\u2014 a type of TB patient who had Igood compliance and had successful treatment  with anti-TB drugs and was positive again in any one of the following i. Symptoms suggestive of tuberculosis - - __ _ ii. Progressive deterioration or. worsenlng of Chest Xjray \ufb01ndings or recurrence of .  I- . Chest X-ray \ufb01ndings I- - . 7  iii. Positive AFB smear or TB culture 3'  'IFailure \u2014 a type of TB patlent .that is Inew1y diagnosed and whose TB symptoms  persisted and has failed to gain weight after nine (9) months of treatment or an initially  ' - smear positive patient who remains or becomes smear positive on the 5th month of  I treatment.  ' a n n . , 2 . a * . .. r' _- . a b - _ ,1. . .y._ _. .I_.: - . . ,__ l. -- -. ' 5\"\" . -' . ;_ |. 'I: 12'-  '.. '. '?-'- ' \"SI-I}: ' .-,.'\u00bb ._\\ _. 5..\u201c . .- . ._ _ L I \" T-.'-- . \"~.a\u201c-':_\"*I':., \"--\u2014 d3-'.' ...2' ',' --.'-,'- _ . _-_'-_'n ._ r_ -'_ . a: _ - - . 1'. _ \ufb01ns\u201c: It's-1., \ufb02j' \u00ab4'45\u201c. Mk; ::;_;\u00a7,A.,.. 32:? _ my: 54:\u201c; \u201c.1 u .C'a _\u2014._:r' Ig)/'-.-'.I\u201c.-,, , .I\" . _- I/ . .\" .. F-r' v 2.1: .        9. Transfer-in a type of TB patient who has been transferred into the health center from another area with preper referral slip -  10. Return After Default -\u2014 a type of TB patient who has to start treatment again after interrupting treatrnent for more than have (2) months, has persistence of TB symptoms and with failure to gain weight .  11. Other \u2014 a type of TB patient who does not fit the de\ufb01nition of New, Relapse, Failure, Transfer-in or Return After Default.  III. COVERAGEAND SCOPE  These guidelines shall apply to all health facilities, agencies and organizations that will implement TuberculoSis control Program-1n children  IV. GENERAL GUIDELINES A. Management of children with TB  . 1. Prevention I  In accordanCe with 'the policies and procedures of the Expanded Program. on  Immunization, BCG'vaccination' shall be- given to all infants. The BCG vaccine is  ' moderately effective. It has a protective ef\ufb01cacy of 50% against any TB disease, 64% against TB meningitis and 71% against death from TB. _  _ 2. Casefinding  a- Cases of TB in children are reported and. identi\ufb01ed in two instances ' i. The patient sought censultation, was screened and was found to have signs and symptoms of TB. . The patient was reported to have been exposed to an adult TB patient.  ' b. '~All TB symptomatic children 0-9 years old, except the sputum positive child ' I shall be subjeoted to Tubereulin testing. ' 1. Only a trained Public Health Nurse or the main health center midwife _ trained as alternate shall do. tuberoulin testing and reading. - ' ii. Tuberculin testing and reading shall be conducted once a week either on- Monday or on Tuesday. Ten children 'shall be gathered for testing to avoid wastage. . _  c. A patient shall be suspected as having TB and Will be considered as a TB '1 symptomatic if With any three of the folloiving signs. and symptoms: i. Cough/wheezing of 2 Weeks or more ii. Unexplained fever of 2 Weeks or more  ' iii. .Loss of welgh\u2019rffailure to gain weight! weight faltering/loss of appetite ' - iv; Failure to respond to 2 weeks of. apprdpriate antibiotic therapy for lower . -. respiratory tract infection '  ' \" 'v,'IFa11ure to regain previOus state of health 2 weeks after a viral infection or  ' ._ exanthem (e. g. measles) ' '     d. 'A child shall be clinically diagnosed or con\ufb01rmed of having TB if he has any \"three cfthe following conditions: ' ' \u2019 \" i. Positive history of expos'ure to an adult/adolescent TB case- lii. Presence of signs andsymptoms suggestive of TB iii. Positive Tuberculin Test. \" _ \" - .' iv. Abnormal Chest x\u2014ray suggestive of TB v. Laboratory \ufb01ndings suggestive or indicative of TB  . However, biological demonstration of TB bacilli in the smear/culture makes a con\ufb01rmatory diagnosis of TB in children. Thus with this continuation alone, the child will be labeled as having TB disease and Tuberculin testing shall no lenger be performed. '  _ e. For Children with. positive exposure to TB  - i. A child who had exposure to'an adult TB patient (who is also registered in the NTP\" registry)'_ shall undergo physical examination and tuberculin testing. _ \"' '_ 5 t '- . ' \u2014 .  ' ii. A child wi .h-productive cough shall be referred for sputum examination. If  ' - found'positive, treatment shall be started immediately. tuberculin testing  shall no: longer be, performed. - . - . '  ~ f iii-Childrenwithout signs and symptoms of TB but with positive tuberculin . \"\ufb01rst, and thosewith- symptoms but with negative tuberculin test shall be ' referred-for chest x\u2014ray, examination. ' \" ' '  f._For.chi_ldren with signs and symptoms of TB  - - . - i. A child with symptoms and with either known or unknown exposure to a ' ' TB case shall' be referred for Tuberculin test. (Those with unknown exposure; the suspected adult. source shall be advised to undergo work-up '_. follctving the 'NTP guidelines for adults). 'ii.-' Children with known contact but with negative Tuberculin test and those with'unknown contact but-with positive Tuberculin test shall be referred for chest x-ray eXamination'.\u2019 .2. ' ' - -'  \" iii. For children with negative chest x-ray, Tuberculin test shall be repeated _ after three-months. ' __ - ' ' , . -_ ' iv. Chemoprophylaxis of __iNH__for three months shall be given to children less  than \ufb01ve years-oldgwith negative chest x\u2014ray; after which, tuberculin test shall be repeated. i-However, chemoprophy'laxis shall only be followed if  - ' .' adequate resources are available. - . ' ' -  3. Caseholding and Treatment ' ' a. CaseholdingMechanism _' ._ _ Directly observed treatment is; one element of the DOTS strategy of the WHO recommended policy package for TB: control. This element shall be the mechanism ' employed to provide support to_-TB patients solthat they will be motivated to regularly take their drugs daily: for 6 fro\u20148. months. .- ' Direct'observation-Ior treatment meansthat'a- treatment partner observes the patient  , ~ takes his drugs daily. ThisenSures that the patient takes the right drugs and in the right dose.  4     All. patients shall undergo supervised treatment. The treatment partner shall preferably be the health worker, or any member of the community such as the barangay health worker, local government of\ufb01cial or a former TB patient. Family members shall be the last priority as treatment partner's, ,  D. O. T. shall preferably he done at the health facility. If the patient lives far from the . health facility, the D. O .T. may be done at the house .of the volunteer health worker. The _ I health worker should be knowledgeable 1n managing adverse reactions to the drugs.  The treatment shall be done 1111-5111 months and the treatment partner shall ensure that the child 1s supervised daily for six months.  7 The following are the policies regarding treatment of children with tuberculosis  . '1;  Short course regimen with at least 3 anti-TB drugs fer 2 months during the intensive phase and 2 anti\u2014TB drugs for 4 months during the  maintenance phase shall be the mode of treatment for pulmonary TB  . cases. If there 1s no resolution of symptoms after six months of treatment, . the mainmnance phase shall be extended for 3 months. For extra-  '. pulmonary TB cases, e. g. TB meningitis, TB lymphadenopathy, TB \"~ ef\ufb01lsions- and spinal TB, treatment regimen is composed of 4 anti\u2014TB  _ . drugs for 2' months during the intensive phase and 2 anti\u2014TB drugs for 10  ii.  menths during the maintenance phase.'  Domiciliary treatment shall be the preferred mode of care.  _ iii; No patients shall be initiated into treatment unless the patient and health  worker has agreed upon a- case holding mechanism for treatment  ' - compliance.I  . iv..- and; the dose shall. be adjusted to the weight of the child. While on .  All diagnosed TB cases shall be treated based on the following regimen-  tr'eat'ment, the dose shall be adjusted based on the follow-up examination  ' weight 'of the. child.- .  ' b. Treatment Regimen - '              1-. Pulmonary TB- \u2014 . - \" I ' ' Drugs _ ' ' ' Daily Dose Duration \" ' - (mg/kg/body weight) * ' . ' Intensive Phase '_ _ 2 months \" Isoniazid ' - _ 1 . 10-15 mg/kg body weight ' ' Rifampicin -' - 10\u2014 15 rug/kg body weight Pyrazinamide - '_ 20-30-mg/kg3body weight Maintenance Phase . I _ '- 4 months IsoniaZid I' . \" \"10-15 rug/kg body weight              Rifampicin \" ' \"'-10- 15.111 m\ufb02g body weight     . I . . J .5 l .I- i . _ _ _ _ .. . ., '1. _ ..\\._...:. ,-r_. J-' ... _ -'.... .4.\u201c-. P. - ._..._ -.,..\\., .-l r . - 1'.\u00bb - '. _~ g..-_.-'. ,{r\u2019v'z '... \u2019.\"'\\~' ' -\u2019 -'1. ' -' ' _. _ _ :nka-H. \u2019.'_\u2019v_,' (5:311 .'.-.'-\\\u2014\"-1.'P'-\u2019 -.-'.',r._-' .'-. \".4- \u201c.'.' ' , K '1- .J-'( t.\"..','- '-\"-\"\" a . - .- '. . 1 - . _\\_-..-.-A_f.~.1c.-1..1-....,.1.rememfm..~:\u2014.m:c-.:-:.\u00a2..:.~\u00a3it'rr3.*-15.':x-1'..3\u00a3.1airfare..12Ln'.\u00b0.-.-1,-5:'..\u201c., - 'H\u2019 _ - - \u2014        2. Extra-pulmonary TB (e. g. TB meningitis, TB lymphadenopathy, TB effusions and spinal TB.                                Drugs I _' \" Daily Dose Duration [ * ' ' ' (mm/body weight) Intensive Phase I. 2 months- Iso'niazid I 10- 15 mg/kg body weight ' - Rifampicin- 10-15 mg/kg body weight Pyrazinamide _ 20\u201430 trig/kg body weight Plus ' _ . _ _- \u2014 ' Ethambutol or . 15-25 mg/kg body weight Streptomycin ' 20-30 'mg/kg body weight Maintenance Phase I' ' . . . - 10 months Isoniazid ' ' . 110-15 mg/kg body weight Rifampicin ' -. 10-15 m\ufb02g body weight  c. Management of adverse reactions to the drugs  I The following are the adveISe reaction to anti-TB drugs, usually occurring during the \ufb01rst two months of treatment.  .1. Minor side reaction to Speci\ufb01c drugs:  ISoniaIzid: II '-- Skin rash, neuritis 1 Rifampicin :' ' Flu-like syndrome, anorexia-vomiting, ' ' \" ' ' . \u2014. I abdominal pain, itchiness, skin rash Pyrazinamide -:, 1'. Arthralgia (joint pains) ii. Maj or adverse reactions to Speci\ufb01c drugs: Isoniazid ' : Jaundice, psychosis Rifampicin . .: - _ Jaundice, thrombocytOpenic purpura, shock _ ' ' ,- and renal failure or anuria Pyrazinamide :' . _Acute'gout(hyperuricemia)  iii. TB patients who show persistent minor side reactions in more than three days shall be referred to a medical of\ufb01cer. If signs of major adverse reactions are seen, the patient shall be referred to a medical of\ufb01cer immediately.  iv.IMonitoring_of response to treatment .  The child shall be subjected. to a monthly follow-up to check for improvement of  appetite and well- -being (more playml, more active), weight gain and persistence or  \u2014 disappearance of signs and symptoms. The skin, sclera are checked for jaundice and  the liver, Spleen and lymph nodes are palpated. For smear positive patients, sputum  follow\u2014up examination shall be done towards the end of the 2nd and 4th month and 1n the beginning of 62' Imonth of treatment  v. Otltcome of treatment . - - Treatment Success 11 a child who has completed treatment (six months for PTB and 12 months for extra-pulmonary TB) with at least 2 of the following \ufb01ndings within the last 2 months of treatment: II I  _ a. IAnyI weight gain liom the initial weight prior to start of therapy,  -. :...' '_ J'. . . . _,; . -. . '. '.\u00ab r , . . . . _ a . .__;_ . _..,n_,' .133,\u201c ,_-, ,., -, ._ _ _-_ . ' '_ - . '1. ' . \u2019 ' - 2\": _ -.'r -' -' \u201c ' tau-1 5 .1- ' . . ._._- .1 '5'; r _,1 . .I. .. v . .. d _ . _ . __ ,_ J_. .31 1.\u00a2,\\_.-_'\u00a2_. \"-\u2014\"\"*\"\"\\-hv-' ,x...'- '99.. . _- H.\"- 41 ._- .- . _ -, ,1 __;. ,1; 'ep, 1. .- t 9-1.1 ,\u2014 Vr ' . Jae-1' .-_ 512.: -w -r 1' 'ar' .-.- -\u201c-.'- -- r - . . . ~ ' 1.1.. ... \ufb01n-rgf-Mmm W... Mit1g$\u00a2ta-ni,\ufb01_:1-1-\"1'1gw'511. - \u201c3. . .-: ~.:\u2019,-.- _ . :1 . -' .. , _ 1 - -1 . . I . . .. . . ..        _ 1:), Clinical improvement based on the resolution of fever, cough or other signs and symptoms initially present prior to start of therapy and I , ' c. Improvement 1n the well-being of the child (more playful, more active)  'Cu___r__ed - a Sputum (+) child who has. completed treatment and has two (2) negative sputum follow-up results towards the end of treatment.  ' _ Treatment conipleted\u2014 a sputum (+) child who has completed treatment but does ' _ not meet the criteria to be classi\ufb01ed as cured or a child diagnosed through other - diagnostic criteria who has completed treat1n'ent but does not meet the criteria to be . classified as treatment success.  - Defaulter.-,-.a child who stoppedtreatment and remained unretrieved-for two months or more I ' . . ' ' ' ' -  - Transfer out a child who has been transferred to another health Ifacility with proper referral slip for continuation of treatment  Treatment Failure\u2014 a newly diagnosed child wthe symptoms persist and/or who has not gained weight nor has improved general well-being after 9 months of therapy.  Died \u2014 a child who died of whateverIcause-during the course of treatment  (1.- Breastfeeding Breastfeeding 13 not IdiSCoura'ged 111' mothers taking anti-TB drugs since low concentrations of the drugs 1n breastmilk do not produce toxicity in the nursing newborn. In addition, only minimal amounts of the drugs are ingested by the infant. I The American Family Phy'siCians (APP) recommends that lactaing mothers - should feed their infants before taking med1cat1ons  ' B. Recording and Reporting  . There are \ufb01ve recdrds to be maintained by the health workers at the health facility and two quarterly reports to be submitted to the Provincial/City health Of\ufb01ces, Center for Health Development and the Central Of\ufb01ce.-  The following records 111111111111 maintained at the health facility:- . 1.Masterlist of suspected Child with TB\u2014 This Is a listing of all children suspected of having tuberculosis identified through contact with adults or through consultation. This ' gives information regarding the presence of the \ufb01ve criteria for diagnosis or con\ufb01rmation of TB 1n children. -  2. NTP Diagnosis Form for Children \u2014 This shall be accomplished for every TB symptomatic child to determine if he has TB disease. It 13 completed by a physician who I I dec1des if the child has TB Disease. and needs to be treated. Once completed, this rs attached  _ to the NTP Treatment Card for Childrent '  3. NTP Treatment Card for Children \u2014 This shall be opened for each TB patient . admitted to treatment. It contains all pertinent information about the TB patient and records the daily drug intake, results of monthly follow-up examination and outcome of- treatment. This is kept at the health facility where the patient is receiving treatment but should be     _1 _. . returned to the main- health center after treannent- has been completed. This IS accomplished by the physician nurse and midwife. ' .  -.4 TB Identi\ufb01cation (ID) Card for Children\u2014 This 1s a handy source of information oh the patient\u2019s diagnosis, kind of drugs, follow-up examination results and monitoring of - drug intake. This is accomplished by the nurse and 1s given to the patient. The treatment partner will. af\ufb01x his signature in the column. for the drug monitoring each time the patient is ' observed to take his drugs. .  5. ITB Register for Children- ._This 1s a listing of all TB cases Iunder treatment. This  gives information on the type and classi\ufb01cation, treatment regimen, result of follow-up I.  - - I smear examinations and outcome of treatment.- It 1s maintained by the nurse assigned at the 1 main health center. .- I  - The- following are the reports to be submitted quarterly to the Provincial/City health ' 'I Of\ufb01ces, center for Health Development and the Central Of\ufb01ce. All of these reports are accomplished by the nurse. ' . - - 1. Quarterly Report on Gase\ufb01nding' of TB in Children\u2014 This summarizes the NTP ' . case\ufb01nding 1n children for pulmonary. and extra-pulmonary cases. It shall be used by the Regional / Central Coordinators to evaluate the easefinding of TB childhood cases.  _ 2. NTP Quarterly Retrospective Cohort Report for Children- This gives information  . on the outcome of treatment for a group of patients who were treated 12 15 months earlier. -  ' Like 1n adults, it is the most important report in the TB control program since it will provide ' information on the effectiveness of Chemotherapy and to evaluate the Cure / Success Rate.  C. Drugs. and other NTP supplies.  The. health centers shall have adequate supply of anti-TB drugs for children and other NTP _. * supplies to provide quality services. This includes tuberculin solution, tuberculin syringes, and recording/reporting forms. Buffer stocks shall be maintained at all levels to avoid stock-outs.  The central Of\ufb01ce shall. procure anti-TB drugs for children and laboratory supplies to be sent to the Centers for Health DeVeIOpmeInt who will 111 turn distribute to the provinces/cities. The -  provinces and cities will distribute the drugs and. supplies to the health centers. Quarterly request  1111111 be Ioarefully prepared by the lower level to avoid stock-oats and oversupply.  I V. IMPLEMENTING MECHANTSMS A Roles and responsibilities of Departrnent of Health and collaborating Agencies 1. Department of Health}- National Center for Disease Prevention and Control and Centers for Health Development. ' - - a) Formulate plans and policies b) Oversee program _implementation 1n coordination with LIGUs and Childhood I ' TB Task Force . - c) Provide the following logistics - , __(Il) Anti-TB drugs ' ' (2) Tuberculin solution (3) IEC materials - (4) Recording and reporting forms .d) Provide Technical Assistance - . ' I . e) Monitor and evaluate the program regularly 'I 2. Chlldhood 3TB. Task Force - '11) Provide technical support in program implementation     - b) Participate in monitoring and evaluation _  c) Finalize policies and guidelines fur national implementation  . Local Government Units - a) Provide health facility and manpower for the implementation of. the TB Control In  \" children pregram - 1 -'  'b)I Provide anti-TB drugs,\" recording and reporting forms ' 0) Implement the program according to agreed plan  d) Provide of\ufb01ce 'space for the project e) Prepare and submit reports  . . Non-govemrnent Agencies I .a) Provide technical. assistance - .b) Participate in training, monitoring and evaluation '  B Functions of LG U Health Personnel  1.  Physicians.- a) Examine and identify children suspected of having tuberculosis b) Inform and educate the mother about the child\u2019s disease. ' _ c) Refer the identi\ufb01ed tuberculous child to the nurse for further interview and  recording of data ' . (1) Perform follow\u2014up check-up of children every 28 days on treatment  and manage drug reactions. _ e) Identify and refer tuberculous children needing hospital care f) Supervise the. RHU and BHS health workers as to; ' '  - Maintenance, analysis and submission of quarterly report on cases admitted . and the quarterly cohort analysis - - - Requisition of NTP drugs and other supplies  . g) Assist' I111 the training of all categories of health workers involved 1n TB in children  ' .Ih) Organize planning and evaluation of the NTP activities on- TB in children  2. Public Health Nurses (PHN)  a) Interview and open treatment cards for identi\ufb01ed tuberculous children  .I J b) Perform tuberculin testing and reading to eligible children.  c) Give initial doses of medicines to the tuberculOus child - (1) Maintain NTP records such as the NTP treatment card, NTP TB Register for Children and quarterly reports .  ' e) Manage requisition and distribution of drugs.  t) Assist the medical of\ufb01cer 111 supervising the other health Workers of the RHU 1n the proper implementation of thepOliciesI and guidelines on TB in children g) Assist in the training of other health workerson tuberculin testing and-reading  3. Rural Health Midwives (RHM)  a) Identify and refer TB Symptomatic children to the medical of\ufb01cer for clinical evaluation and diagnosis .  b)' The RHM' of the Main Health Center shall be trained on tuberculin 'testing and reading as an alternate to the PHN.  II 1:) Implement good _casehoII'diIng by adopting DOTS  Ad) Supervise the activities of BHWs as treatrnent partners for tuberculous children ' e) Maintain and update NTP treatment cards - ' .  - __It) Refer children manifesting drug reactions: to the medical officer     . . .1 i - '::I:-III_.|. . -..- 1:3; - \"if?\u201c _ I_'.I__. \"c:- \"w. .__ _ _'( ,' __ v, .' \u2019.- . J I I _ .. . _ .- 'rv- \"' I'i -- , N {. ..-.';.'t\u00ab:\\'\u00a2t .\u00bb-'- nu. -... as\". , . - r\"._,-'.-.I -- .._- _|. . . q, 1' _ .-.- 1. .\"\" I'm-1...... . _ -.. .ca-J ._--.\u2014 2..) .. _ I). \u00abI. \"1.. r. ., r . .'.- '._ . .,_ - g I a - . s _ a . a: r . .' .- I 1. - - .}_ . .\"-\" . .I a... .- -. .. ~ . x\u2019M'.\"'-,1JI\" 73-1- fag/gas\u201c rspam-$3 a\ufb01-'N \ufb01gmqramte'\ufb01a\ufb02e',.},_:;.I.~I..':A.s 3. ,r ,w .3, .;-m ., .-. 1. .. e 1 . 1  r.  4. Treatment Partners '\u2014  a) Administer daily intake of antl-TB drugs _. . '  b) Record intake 0111111113 drugs 1n the NTP treatment card and NTP ID card c) Follow- -up. children who failed to report for treatment for two consecutive days d) Refer children with _'drug reactions to the Medical Of\ufb01cer '  e) Refer children for monthly check-up to Medical Of\ufb01cer  f) Ensure availability of drugs supply at all times  ' VI EFFECTIVITY  This Order shall take effect Immediately         MANUE_L M.' .,DAYRIT MD, ' Secretary of Health ", "  I. Rationale  The Philippine Expanded Program on Immunization (EPI) was launched in 1976 and has successfully vaccinated and protected millions of children from vaccine\u2014preventable diseases. The rapid acceleration of performance from 1987 onwards highlighted that such achievements are possible under good administration and management backed up by sound policies and clear guidelines.  The Department considered EPI as a priority public health program. While the previous years of EPI were focused on achievement of high immunization coverage, the current thrust now is to sustain this high coverage and focus on the control, elimination and eradication of major childhood diseases. There is a need to update the policies, standards and guidelines to concur with the current goals and immunization practices.  This Administrative Order is issued to prescribe guidelines for the national implementation of EPl and promote a common understanding among key stakeholders and implementers to ensure that quality immunization services are rendered to the eligible-population.   II. Coverage and Scope   Immunization shall be an essential health intervention for eligible children and women. This service shall be made available in all health facilities and institutions providing health services for women and children nationwide.  III. Policy Statement  Immunization is a basic right of the child and therefore-no child shall be deprived of this right._T he State regards children as one of the most important assets of the nation and therefore every effort should be exerted to promote their welfare'and full development of their potentials for a useful and quality life.  IV. Program Goals  A. Maintenance of at least 95% fully immunized child (FIC) coverage B. Maintenance of Polio Eradication C. Elimination of Measles D. Elimination of Maternal and Neonatal Tetanus E. Control of Diphtheria, Pertussis, Hepatitis B infection, Tuberculous Meningitis and other disseminated forms of TB.  V. General Guidelines and Procedures  A. Target age groups  1. All infants should receive one dose of BCG, three doses of DPT, three doses of OPV and one dose of measles vaccine before their first birthday. Three doses of Hepatitis B vaccine shall also be given if available.  2. All women of childbearing age (15\u201449 years old) shall receive five doses Of tetanus toxoid for their lifetime protection against tetanus and for prevention of neonatal tetanus among infants. Other age groups that may be determined for supplemental immunization activities  B. Immunization Activities  1. All immunization services rendered by the government health workers must be free of charge as prescribedby law. (Pres. Decree No. 996)  2. Wednesday is designated the national day for immunization in all government health facilities unless otherwise revised by local traditions, customs or regulations and other exceptions.  3. All government hospitals shall likewise provide immunization services at the outpatient department. Eligible children who are hospitalized should be immunized as soon as their general condition improve and at least before discharge from the hospital. Corresponding referral for subsequent doses should be done. Monthly reports of immunization coverage shall be submitted to the nearest City/ Municipal Health Office following guidelines on submission of reports.  4. Measles vaccine should preferably be given on admission in hospital because of the risk of nosocomial measles transmission.  5. Only health workers trained and skilled at giving injections are authorized by the DOH to give immunizations (except OPV which can be given by volunteers during National Immunization Days (NIDs) because it is orally administered and has no overdose and with very little or minor side effects).  6. Infants shall be vaccinated accOrdingto the Immunization Schedule prescribed in the EPI manual. Allthe EPI antigens are safe and effective when administered simultaneously, i.e. during the same immunization session but at different sites. It is NOT recommended, however, to mix different vaccines in One syringe before injection, or using a fluid vaccine for reconstitution of a freeze-dried vaccine.  7. Women of childbearing age (15\u201449 years-old) shall receive tetanus toxoid according to the fiVe\u2014dose schedule as provided for in the EPI manual.  8. It is justified to open one multi\u2014dose vial for one or two clients if the health worker feels that a client cannot come back for the scheduled immunization session. Parents and caregivers should be informed of the importance of immunization, the vaccine schedule and the need to complete the doses of vaccines.  9. Patients or clients or their guardians shall be informed of any side effects or adverse reactions of any of the EPI vaccines. The DOH shall not directly give monetary compensation for patients that may suffer any adverse reaction due to the administered vaccine. Instead, free treatment and services shall be available in all government hospitals.  10. Adverse events shall be monitored closely. Operational problems must be solved by appropriate legistical support, training and supervision.  11. Follow-up of dropouts and defaulters as well as supplemental immunization activities and. outreach services shall be regularly scheduled to catch up on \"missed\" children.  12. Extra efforts must be exerted to vaccmate children particularly in the underserved, hard-to-reach areas and tribal communities.  13. Special immunization strategies shall be conducted to respond to outbreaks of the EPI diseases. Separate guidelines on outbreak response strategies shall be formulated.  C. Contraindications to immunization  1. There are few absolute contraindications to the EPI vaccines. The only absolute contraindications to immunization are:  - DPT vaccine should NOT be given to Children over 5 years of age or to children who have suffered a severe reaction to a previous dose of this vaccine. - BCG vaccine should not be given to children who have signs and symptoms of AIDS or other immune deficiency diseases or those who are immunosuppressed due to malignant disease, therapy with immunosuppressive agents or irradiation.  2. Both measles vaccines and OPV can be given to children with HIV/AIDS.  3. False contraindications  - Children suffering from malnutrition should be immunized.  - Low-grade fever, mild respiratory infections and other minor illnesses should not be considered as contraindications to immunization. - Diarrhea should not be considered a contraindication to OPV.  D. Safe Injection Practices  1. Use only one Sterile syringe and needle per child or mother.  2. Auto\u2014disable (AD) syringes are the equipment of choice for administering vaCcines, both in routine immunization and mass campaigns. At present, however, standard-disposable syringes and needles may continue to be used for mass immunization campaigns nil/rile use of auto-disabled shall be encouraged until government budgets can be increased to cover the additional cost of AD syringes.  3. Disposable syringes and needles shall be discarded after single use in a puncture p1 oof container and shall be disposed of by burying or other impioved means of effective, safe and environmentally acceptable waste disposal.  4. Maximum efforts should be exerted to ensure rigorous procedures for injection safety. Aseptic techniques must be observed during immunization sessions.  E. Open Vial Policy  1. Multi-dose liquid vaccines, such as OPV, DPT, TT, and Hepatitis B from which one or more doses have been removed following standard sterile procedures, may be used in the next immunization sessions for up to a maximum of 4 weeks, provided that all the following conditions are met:  a. the expiry date has not passed; and b. the vaccine has not been contaminated (aseptic technique has been used to Withdraw all doses); and c. the vials have been stored under appropriate cold chain conditions, and d. the vaccine vial septum has not been submerged in water; and e. the vaccine vial monitor (VVM) on the vial, if attached, has not leached the discard point  2. Freeze-dried vaccines, such as AMV and BCG vaccines should be discarded six (6) hours after reconstitution or at the end of the immunization session, whichever comes sooner. Never ever reconstitute freeze-dried vaccines in anything other than the diluents supplied with them.  3. All opened vials of any vaccine must be diSCarded if sterile procedures have not been fol,lowed or there is evidence of contamination (such as floating particles in the vaccine), or there is just a suspicion that the vaCcine has been contaminated.  4. If the potency of the vaccine is questionable, the vial/s should be thrown away. Do not use these questionable vials for any immunization session. All vacicines should be verified before use to determine if vaccines have had too much heat exposures.  F. Cold Chain Management  1. All vaccine refrigerators or freezers shall be used exclusively for EPI vaccines. No food or drinks shall be stored in these to ensure the optimal temperature for vaccines.  2. Vaccines are stored according to the temperature requirement for each antigen (refer to EPI Manual). Maintain the correct temperature in the refrigerators, freezers, vaccine carriers, cold boxes and transport boxes at all times.  3. Regular temperature monitoring shall be done, charted, and posted on the door of the refrigerator or freezer.  4. A contingency plan for emergency measures should be available and known by all the staff of the facility.  N.B. Details on cold chain management, vaccine handling and storage and other operational guidelines can be found in the EPI manual.  G. Precurement of Vaccines and Other Supplies  1. Vaccine forecasting shall be done every five years, reviewed and adjusted yearly depending upon the calculated requirements for the year.  2. Vaccines shall be procured centrally through the Vaccine Independence Initiative (VII) agreement with UNICEF. or through procurement services with. UNICEF. Central procurement is more cost-efficient and ensures standard specifications for quality vaccines.  3. Procurement Shall follow the procurement schedule to ensure timely delivery of vaccines at the field level.  4. Syringes and needles and other EPI paraphernalia shall be the counterpart of the Local Government Units (LGUs). Supplemental syringes and needles shall be supplied by the DOH\u2014CHDS and shouldtherefore ensure availability of funds.  5. Calculation of requirements for vaccines and other supplies shall follow the formulae in the EPI Manual.  H. Recording and Reporting  1. The health worker providing the vaccination-shall record the given antigen in the. child\u2019s Early Childhood Care and Development Card (ECCD)/ Growth Monitoring Card (GMC)/ Baby Book / Mother and Baby Book, whichever is available.  2. Coverage accomplishment shall be reported as Fully Immunized Child (FIC) which is defined as an infant given one (1) dose of BCG, three (3) doses each of DPT and OPV and one (1) dose of anti-measles vaccine (AMV) before the infant reaches 12 months of age. Hepatitis B vaccine (HBV) and Tetanus toxoid2+ (TT2+) Shall be reported as separate accomplishment reports. Child protected at birth (CPAB) indicatOr shall be used as an indicator when optimum level (80 %+) of TT2+ coverage has been achieved.  3. EPI coverage reports (FIC and by antigen and by dose) shall be reported by all levels. Centers for Health Development (CHDs) shall collate all the reports from the provinces and cities and likewise report to the National level quarterly.  4. Vaccine utilization and stocks reports shall likewise be reported monthly at barangay and municipal level; quarterly at proVincial and city level using a Standard report form. CHDs shall collate provincial and city report and submitted quarterly to the National . level to monitor adequacy and utilization of vaccine supplies at all levels.  I. Surveillance  1. Surveillance of a suspect polio case or APP case, neonatal tetanus and measles cases is an integral part of EPI and a critical component of eradication and elimination activities and should therefore be strengthened and sustained.  2. Cases and deaths due to the seven (7) EPI diseases should be reported by age, sex, and immunization statusfrom the barangay up to the national level following the guidelines of reporting of notifiable diseases.  3. The criteria for diagnosis Of EPI diaeases shall be based on the WHO standard case definitions.  4. Case investigation and reporting shall be done in case of outbreaks and adverse events following immunization (AEFI) and appropriate measures shall be instituted.  5. Vigilance should be Strictly observed for any risk of importing vaccine\u2014preventable diseases, especially for poliovirus. Measures such as vaccination at pOints Of entry should be done if possible when there is a surge of migrants coming from countries where immunization policies are not strictly observed.  VI. Implementation Mechanisms  A. Management  1. The Department of Health (DOH). shall prepare and approve a National and Regional EPI Strategic Plan every five years. The National Plan shall be approved by the National Immunization; Committee (NIC) and subsequently endorsed by the Secretary of Health. The Center for Health Development (Cl-ID) Director shall likewise approve the regional plan. The Local Government Units (LGUs) shall be encouraged to also come up with an approved five-year EPI strategic plan.  2. The National Immunization Committee (NlC) shall continue to be the advisory and recommendatory body for all EPI initiatives. Its composition and responsibilities shall be reviewed regularly.  3. The National EPI team shall be formed and compose committees including but not limited to the following: Planning/ Management, Technical AsSistance, Monitoring . and Evaluation, Social Mobilization, Logistics and Surveillance.  4. The regional EPI team shall likewise be formed 7 and their composition, duties and responsibilities shall alSO be clearly defined based on DOH policies and guidelines.  5. Regional Epidemiology and Surveillance Units(RESUs) shall also be Continuously supported and strengthened as well as the Provincial / City Epidemiology Units. Establishments of these local surveillance units shall also be encouraged.  6. LGUs shall be advised to designate Provincial and city Coordinators or focal persons to coordinate EPI activities in their areas.  B. Supervision and Monitoring  1. There shall be a scheduled quarterly supervisory/ monitoring visits at all levels utilizing supervisory/ monitoring checklists and with corresponding feedback. Follow-up visits shall be programmed based on the findings during the previous visits. - '  2. Monthly accomplishments shall be analyzed-and indicated through graphic presentation (EPI monitoring Chart) at the field health units.  C. Evaluation  1. Annual program reviews shall be conducted at all levels to assess accomplishments.  2. Regular EPI coverage surveys at least every two years shall be done regionwide using the standard WHO coverage surveys  3. A ComprehensiVe Program Review shall be done every three years at national level  VII. Repealing Clause  Any existing provision or issuance found incOnsistent with this order should be repealed  VIII. Effectivity  This order shall take effect immediately.   ", " Newborn Screening (NBS) is an essential public health strategy that enables the early detection and management of several inborn errors of metabolism, which if left untreated, may lead to mental retardation and even death. In line with the mandate and thrust of ensuring quality life for all, promoting people\u2019s right to health, ensuring children\u2019s right for survival and full development, the Department of Health (DOH) issued policies Administrative Order No. 1-a s. 2000 and Administrative Order No. 121 s. 2003, pursuing the nationwide implementation of NBS. Consequently, Republic Act 9288 known as the Newborn Screening Act of 2004 was enacted in April 2004 which establishes the National Comprehensive Newborn Screening System (NCNBSS) to ensure that NBS is geographically accessible and affordable to every baby born in the Philippines. To ensure that the law is implemented at all levels, DOH issued the following:  a. Administrative Order 2005-0005 standardizing the NBS fee at P550.00 and setting the maximum allowable service fee at P50.00; and  b. Directives to Bureau of Health Facilities and Services and Philippine Health Insurance Corporation (PHIC) to include NBS in hospital licensing and PHIC accreditation to ensure that health facilities i.e. hospitals, birthing facilities, rural health units, shall ensure that adequate and sustained NBS services such as information, education, communication, screening, recall and management of identi\ufb01ed cases are provided in the hospital.  However, despite efforts to enforce the law, NBS coverage in the country remains at a dismal rate of 17% of the 1.5 million newborns as of December 2007 which is far below the targeted goal of screening all babies born in the country. Only 1,610 health facilities are enrolled as NBS facilities as of 2007. Of these health facilities 1,020 are hospitals, which is only 57.6% of the total 1,771 licensed hospitals. Out of the enrolled health facilities only 1,325 (82.3%) are active in the collection of newborn screening. Charging exorbitant fees way beyond the maximum allowed NBS fee of P600.00 are widely reported thus, defeating the purpose of making NBS accessible and affordable to all.  The following additional Rules and Regulations are hereby promulgated to fully implement Rule VII Sec. 24 Licensing and Accreditation of Republic Act 9288 otherwise known as \u201cNewborn Screening Act of 2004\":  x x x  d) The NBS coverage goal is eighty five percent (85%) in 2010. DOH and PHIC shall ensure that such target coverage will be attained by the hospitals and other birthing facilities.  e) The following administrative fines shall be imposed on health facilities that refuse to provide NBS services and collect more than the maximum allowed NBS fee:  First offense - warning Second offense - administrative fine of \ufb01fty thousand pesos (P50,000.00) Third offense - administrative \ufb01ne of one hundred thousand pesos (P100,000.00)  f) The DOH and PHIC shall formulate their respective guidelines on \ufb01ne imposition.  xxx ", "  National tetanus (NT) is said to have been eliminated if its incidence is below one (1) case per 1,000 livebirths (WHO definition or NT elimination). In 1990, the Philippines embarked on an NT elimination strategy. As a result, the national NT incidence based on surveillance data is now 0.17/100 livebirths, classifying the Philippines among those which have successfully eliminated neonatal tetanus. However, there are two remaining provinces (Cagayan and Maguindanao) which have reported more than one NT case per 1,000 livebirths in 1997. Furthermore, there may be NT cases which may not have been reported.  To further strengthen the NT elimination campaign, the attached Updated Guidelines on Neonatal Tetanus Elimination is hereby promulgated to guide field health personnel and local government executives. Our national goal is to have zero neonatal tetanus case in every municipality in the country. The nature of the disease tells us that there are selected areas and communities which are at higher risk of neonatal tetanus than others, most notably the tribal minorities. We must make sure the NT elimination services reach these communities.  Crucial to the attainment of the goals of NT Elimination is the use of the tetanus toxoid vaccines for pregnant women and women of child-bearing age. Please be assured that the tetanus toxoid currently used by the Department of Health has been proven to be pure and safe. Several laboratory tests were undertaken to con\ufb01rm the veracity of previous reports regarding tetanus toxoid efficacy and safety.   You are strongly enjoined to read these guidelines patiently and religiously. Your close adherence to these guidelines will prevent unnecessary confusion and controversy which only undermine the best of intentions. The bottomline is that health providers should carefully explain the objectives, intentions, and services provided in the NT Elimination campaign so that the target women and their families realize for themselves the value of the services being provided. This can be achieved only through adequate communication and social mobilization.  Let us once again communicate with each other and work together for the sake of our children.   This order takes effect immediately and rescinds A.O. No. 15 s.1995 dated 7 September 1995.   ", "  Because the target women beneficiaries of the tetanus toxoid vaccine being administered by the Department of Health have not been coming for immunization because of fear of abortion, there is a need to reinstitute the previous Tetanus Toxoid Immunization schedule to allay their fears.  Routine tetanus toxoid vaccination shall be given only to women who are already in their 5th or 6th month of pregnancy. The revised tetanus toxoid immunization schedule shall be as follows:     As much as possible, no mother should be given more than 5 Tetanus Toxoid doses in her lifetime.  Selected far flung areas with a high percentage of deliveries by untrained hilots and with high rates of neonatal tetanus cases shall be identified by the Maternal and Child Health Service as High Neonatal Tetanus Risk Areas. In these few areas, Tetanus Toxoid immunization may be given to non\u2014pregnant women to complete TT5 doses. However, to avoid being associated with abortion, tetanus toxoid even in these areas should be avoided during the first trimester of pregnancy.  This Order takes effect immediately.  For strict compliance.   ", "  The following guidelines are hereby issued to govern the \u201cMop Up Period\" after the main Ligtas Tigdas Campaign which ended last November 30, 1998.  In order to ensure that the remaining target children who have not yet been vaccinated against measles during the Ligtas Tigdas Campaign period are vaccinated before March 31, 1999, the following guidelines are hereby issued:  1. The \u201cMop-up\" period for the Philippine Measles Elimination Campaign (PMEC) started last December 1,1998 and will last until March 31, 1999. This is the period allotted for vaccination of children between 9 months to less than 15 years old who were missed during the Ligtas Tigdas Campaign held last September to November 1998.  2. Using the reported measles cases, identify areas where children may have been missed. Regional sentinel surveillance for November and December 1998 still show significant measles transmission especially among the children under 4 years old. Since preschool children may be home bound, this group is that most likely missed in masterlisting and mass vaccination campaigns. Improve the measles surveillance system by bringing the reporting down to the level of the municipality and barangay. Include also private hospitals and clinics. A Measles Surveillance Manual is being prepared detailing the procedures and plans for surveillance. This manual will be given to you as soon as it is finalized. Conduct mop-up vaccination of all children missed during the Ligtas Tigdas period.  3. Using the reported measles vaccination coverage based on \u201cestimated\" eligible children in the area, review the completeness of masterlisting in those areas reporting less than 95% coverage. You should do a spot check in one or two barangays by counterchecking children randomly to see if they are in the list. Especially good to check are children in the streets (\u201cstreet children\") in the cities and big towns. Areas found to have children not masterlisted should do a small campaign to capture the missed children. The defaulter\u2019s lists should also be counterchecked and house\u2014to\u2014house mop-up or small community\u2014based measles vaccinations can be conducted.  4. When staff are limited, start the search for missed children among preschoolers (9 months to less than 6 years old) since they are the ones most likely to still be unprotected from measles. Another group most likely to be missed are the out-of\u2014school youths.   5. Schools that have low initial coverage should be rescheduled for other vaccination rounds. Ensure good information campaign before the subsequent vaccination session.  6. During the mop-up period which will be until March 31, 1999, children who turn 9 months old should also be given their first measles vaccination.   The Ligtas Tigdas Campaign now lists a 96% coverage of target children and this is an excellent performance from everyone, as usual. The mop\u2014up period, however, is still necessary since the ultimate objective is 100% coverage. Measles will infect anyone who has not been immunized. Every child has the right to protection against diseases.  For compliance.   ", "  I. RATIONALE/BACKGROUND  Micronutrient malnutrition, particularly vitamin A, iron and iodine de\ufb01ciency disorders continue to be public health problems in the country. These de\ufb01ciencies lead to serious physical, mental, social and economic consequences, especially among children and women.  Micronutrient supplementation, food forti\ufb01cation and dietary diversi\ufb01cation are the strategies used in addressing micronutrient de\ufb01ciencies. Among these strategies micronutrient supplementation has been proven to be a cost-effective and cost\u2014bene\ufb01cial strategy to immediately correct the de\ufb01ciencies and prevent the adverse consequences attributed to each de\ufb01ciency. Food forti\ufb01cation however, is the least expensive and has long-term bene\ufb01ts.  During the past decade, the country made tremendous efforts on the passage of the \ufb01rst law on forti\ufb01cation which is the ASIN Law or Republic Act no. 8172 signed in 1995. The law mandates the universal iodination of salt both for human and animal consumption. Strict implementation of the law will eventually lead to the elimination of iodine de\ufb01ciency disorders. However, its implementation is not without dif\ufb01culties and current activities are still focused on continuous advocacy on the utilization of iodized salt to reach the goal of household utilization of 85-90 % by 2004.  The Food Forti\ufb01cation Law or the Republic Act no. 8976 signed in 2000 mandates the forti\ufb01cation of rice with iron, and sugar, oil with vitamin A and \ufb02our with vitamin A and iron. This law which will be implemented in 2004 will address the problem of iron de\ufb01ciency and iron de\ufb01ciency anemia ( IDA) and vitamin A de\ufb01ciency disorders (VADD).  Other efforts on food forti\ufb01cation include the Sangkap Pinoy Seal program which encourages food manufacturers to fortify their food products with 1/3 of the recommended daily allowance (RDA) of iron, vitamin A and iodine.  Food forti\ufb01cation offers an effective, inexpensive and sustainable strategy in the prevention and control of micronutrient de\ufb01ciencies. However, until such time that food fortification is in place, micronutrient supplementation will be pursued as the immediate or short term measure to address the immediate consequences of VADD, IDA and IDD.  Micronutrient supplementation will be provided to all priority women and children, and will be part of the routine services in all health centers nationwide. It will also be given universally during national campaigns. It shall likewise be provided in evacuation centers during emergencies, disasters and calamities. However, large doses of Vitamin A supplementation (100,000 IU and 200,000 IU) should not be given to pregnant women. This policy is being made to clarify questions on the administration of this supplement to pregnant women.  This Administrative Order is now being issued to update health workers in the provision of micronutrients . Multiple micronutrient supplementation is also brie\ufb02y described as one intervention that could be used to address multiple micronutrient deficiencies especially among pregnant and lactating women. Explanations on the prescriptions, administrations, and delivery of supplements as well as the safety of its ingestion are also provided to clarify issues and questions regarding side effects.  IV. GUIDELINES AND PROCEDURES FOR MICRONUTRIENT SUPPLEMENTATION  A. VITAMIN A  1. Targets and Doses  1.1. Universal supplementation of vitamin A  Universal supplementation of vitamin A involves the administration of supplemental doses every six months to all infants and children aged 6 months to 71 months. This is done during regular services in all health facilities including but not limited to the implementation of Integrated Management of Childhood Illnesses (IMCI) approach, Immunization activities, Growth Monitoring and Promotion and during national campaigns such as Garantisadong Pambata in April and October.  Table 1: High dose universal distribution schedule for the prevention of vitamin A de\ufb01ciency   1.2. Supplementation to High-risk children  Vitamin A supplementation is given to high-risk children because it helps re-establish body reserves drained by chronic or repeated infectious disease (e.g. diarrhea) and protects the children against severity of subsequent infections. It also reduces the complications of an existing measles infection and dramatically lowers measles morbidity and mortality.  Table 2: High dose prevention schedule for children at high-risk of Vitamin A   1.3. Supplementation to pregnant women and post-partum women.  Numerous studies have shown that pregnant women have an increased risk of VADD, particularly in pepulations where such deficiency is endemic. An increase in Vitamin A supplementation of the mother, results to an elevated Vit.A concentration of her breast milk as well as the vitamin A status of her breastfed child.  Table 3: Supplementation schedule for pregnant and postpartum women   1.4. Treatment of Xerophthalmia  Xerophthalmia is a serious consequence of vitamin A de\ufb01ciency that requires immediate treatment. It includes nightblindness, Bitot\u2019s spots, corneal xerosis, corneal ulceration and keratomalacia. Vitamin A must be administered immediately in the aforementioned cases, as prescribed in the table below.   Table 4: Treatment schedule for xerophthalmia for all age groups   Table 5: Treatment schedule for xerophthalmia for pregnant women   1.5. Vitamin A Supplementation During Emergencies  Vitamin A supplementation to children during emergencies is recommended.  Emergency situations include occurrences of natural calamities like \ufb02oods, typhoons and other situations that will require the use of evacuation centers. Refugees and others that are cut-off from their usual food sources or afflicted by famine constitute very\u2014high risk groups in special need of periodic supplementation. Their access to natural sources of vitamin A is extremely poor and their risk of infectious diseases and other complicating factors is high.  Thus, persons and special groups belonging to this classification are priority groups for supplementation. The same schedule should be followed as prescribed in table 1 (universal supplementation) and table 2 ( for high\u2014risk children)  2. Handling and storage  Vitamin A should be stored in dark colored bottles and kept in a cool, dry place away from heat and direct sunlight to maintain its maximum potency. The container should always be labeled to include the name of the drug, dosage and its expiry date.  3. Administration of Vitamin A  Vitamin A capsule is given orally. The nipple-like projection of the capsule is cut halfway and the content is squeezed into child\u2019s mouth. There are about 6 drops in each 200,000 I.U. capsule . In instances that the 100,000 LU .is not available, the 200,000 I.U. can be used and 3 dr0ps from the capsule will be equivalent to 100,0001.U. For bigger children and adults, the capsule is taken as is.  4. Safety of Vitamin A  Vitamin A is known to be safe and effective even for those who do not exhibit vitamin A deficiency. With high-dose capsule, some side effects may occur such as headache, nausea and vomiting. These are, however mild and transitory and would disappear within 24 hours even without treatment. Vitamin A in big doses is also safe even if given in an interval of 4 weeks.  Mothers of children who receive 200,000 I.U. and 100,000 I.U. of VAC should be especially advised on possible side effects.  Lower dose of vitamin A has been established safe for pregnant women. An added benefit to supplementing vitamin A in pregnant women is the improved utilization of iron.  B. IRON  1. Targets and Doses  Iron supplementation shall be provided to the following priority groups with corresponding doses:  1.1 Pregnant and lactating women  The high physiological requirement for iron in pregnancy is difficult to meet with most diets. Therefore, pregnant women must take iron supplements in almost all contexts. It is recommended that supplementation must start as soon as pregnancy is diagnosed. Intake of iron supplements should at least be for 6 months during the pregnancy period. Where the prevalence of anemia in pregnant women is high, supplementation should continue into the post partum period to enable women to acquire adequate iron reserves. Lactating women should take the supplements for 3 months after delivery.  Table B1: Iron supplementation to Pregnant and Lactating Women   1.2. Infants 6-11 Months of Age  Infants need a relatively high iron intake because they are growing very rapidly. Infants are normally born with plenty of iron. However, beyond six months of age, iron content of breastmilk is not sufficient to meet many infant\u2019s requirements and complementary foods are usually low in iron.  Low\u2014birth weight infants are born with fewer iron supply and are at high risk of iron deficiency even if exclusively breastfed. Supplementation starts at two (2) months of age. Iron requirements of low\u2014birth weight infants cannot be met from the iron in the breast milk because of rapid growth rate during this period.  It is therefore necessary for this group to have iron supplements.  Table B2: Iron supplementation to infant 6-11 months of age   1.3. Other Population Groups  Other population groups may also suffer its consequences and may benefit from iron supplementation programs. Anemic and underweight children should take iron supplements to correct existing anemia and prevent it from becoming severe.  Adolescents and older persons are both at risk of developing iron deficiency and iron deficiency anemia .. Supplementation to this age group is especially important particularly for adolescents where pregnancy could occur.  Table B3: Iron supplementation to preschool and school children   Table B4: Iron supplementation to other population groups   1.4. Complementary Parasite Control Measures  Iron deficiency is the direct cause of severe anemia. Other causes include parasitic infestations like hookworm, trichuris , malaria and schistosomiasis and other infections. Specific pepulation in these highly endemic areas should also be given iron supplementation together with environmental sanitation and personal hygiene control measures.  In areas where hookworm and trichuris are endemic, anthelminthic treatment to adults and children may be necessary to combine with iron supplementation.  Table B5: Iron supplementation to children and adults in Schistosomiasis and   2. Handling and Storage  Iron supplements should be in dark colored containers and stored in a cool dry place away from direct heat and sunlight and not within reach of children. When transferring iron tablets from the original container, make sure that the fingers do not touch the tablets to prevent the growth of molds. The container should also be labeled to include the name of the drug and its expiry date.  3. Safety  There is no risk of toxicity to iron/folate supplements when taken at the prescribed dose. Intake of iron also produces minor undesirable gastrointestinal side effects in some individuals such as epigastric discomfort, nausea, vomiting, constipation, and diarrhea. The frequency of these side effects is directly related to the dose of iron.  In cases of gastrointestinal intolerance, the dose of iron may be reduced and gradually increased until the full dose is reached and is well tolerated. It is also advised that the iron supplements be taken with or after meals and at bedtime.  C. IODINE  Iodine supplementation and salt iodization are the short and long term intervention measures respectively to correct the consequences of iodine deficiency disorders ..While salt iodization is the reason for eliminating IDD in some countries, there are instances that iodine supplementation is necessary because of the urgency of the situation that requires immediate intervention. In such situations, the following criteria have to be met for areas to qualify for supplementation :  Criteria for Areas to Qualify for Iodine Supplementation  a. Urinary Iodine Excretion (UTE) of less than 50ug/L in more than 20% of the population. b. Goiter prevalence among schoolchildren is greater than 5%. c. Prevalence of goiter among males.  1. Targets The following are the identified target population groups for iodine supplementation as prioritized:  1.1. Women of reproductive age  Women of reproductive age is the first priority for iodine supplementation. Among pregnant women, iodine deficiency may be associated with complications such as hypothyroidism, gestational abortion, increased first trimester abortions, abnormal fetal position and stillbirths. In addition, the hypothyroidism, infertility and fetal loss may have adverse effects on her quality of life and her role in the family and community. A child with mental and physical disorders, resulting from iodine deficiency may require long-term care taking away time and resources that could be used otherwise. Iodine supplementation is best if given before pregnancy. (IDD Newsletter, Feb. 2003, JTDunn & F. Delange, ICCIDD)  Pregnant women should also be given iodized oil especially in identified iodine-deficient areas. Pregnant women given iodized oil (average age of gestation was 28 weeks) have showed significant increase in birth weights and infant survival.  1.2. Children of school age  Children of school age are also a priority for iodine supplementation. These children have been shown to have increased demand for iodine because of growth spurts occurring during this period. There is also risk in developing hypothyroidism. It is also among this population group that the intake of iodine sources from food could be very poor. The reduction of intelligence quotients (IQ) points among iodine deficient is detrimental to the child\u2019s school performance.  1.3. Adult males  A population with high prevalence of goiter among adult males further indicates the severity of the problem of iodine deficiency in the community. Therefore, adult males with or without goiter should also be given iodine supplements.  Table C1 Iodine supplementation to speci\ufb01c population groups   2. Safety of Iodized Oil Capsule  There has been no report of side effects due to intake of oral iodized oil. However, there are clinical conditions that may worsen with the intake of iodized oil capsule. They are : (1) toxic goiter (2) untreated tuberculosis (3) recent hemorrhage. Hence, the iodized oil capsule should not be given to individuals with the above clinical conditions.  D. Multiple Micronutrients (Ref : Administrative Order No. 96, s, 2000 , April 3, 2002)  Multiple micronutrient supplementation is one strategy that can be used to address micronutrient deficiencies of women in developing countries. However, its cost effectiveness/efficiency needs further study because adding one nutrient is increasing the cost considering that women economically deprived are the micronutrient deficient. More studies could also be done comparing the multiple micronutrients vs. iron and vitamin A alone in improving maternal and morbidity rates and reducing the incidence of low birth weights.  1. Target  1.1. Pregnant women  The requirement for micronutrients increases substantially during pregnancy and lactation which cannot be met by diet alone. The average Filipino diet is generally short of the recommended daily allowances so that other micronutrients like Zinc, Selenium, etc may also be found de\ufb01cient, hence , multiple de\ufb01ciencies may occur.  Documented bene\ufb01ts ( foreign studies ) from taking micronutrients by pregnant women include: reduced incidence of low birth weights, reduced maternal mortality and mortality rates.  1.2. Lactating women  Taking of multiple micronutrients during lactation at least for 3 months post-delivery will improve the nutrient status of breast milk  Table C2 Multiple micronutrient supplementation to pregnant & lactating women    The micronutrient supplement has the following composition :   Literature review showed that the levels of nutrient contained in this multiple micronutrient preparation are the minimum daily recommended nutrient levels for women of reproductive age.  VI. IMPLEMENTING MECHANISM  Based on the provisions of the Local Government Code of 1991, the implementation of public health programs is now the responsibility of the LG Us. Therefore, together with the DOH Central Office and the Centers for Health Development, the procurement and distribution of vitamin A, iron and iodine to all barangays is the responsibility of PHOs and MHOs.  1. Procurement  The Central Of\ufb01ce of the Department of Health procures the 200,000 I.U vitamin A capsules for its twice-a\u2014year nationwide distribution campaign for the 12-71 months old. Iron tablets and iodized oil capsule are also procured when \ufb01rnds are available and when necessary. The DOH usually procures through UNICEF, subject to the usual procedure and requirements prescribed both by the government and UNICEF.  Because of logistic constraints, the Central Of\ufb01ce cannot procure the other vitamin A doses, iron tablets and syrup. Invoking the provisions of the LGC of 1991, the DOH therefore requires the Local Government Units to provide budget for the procurement of the said micronutrients including iodized oil capsules. This will augment the supply provided by the Department of Health and ensure the availability of the supplement in the delivery of regular services in all health centers.  Procurement can be made locally through local distributors provided that the specification of VAC prescribed by the Central Office are followed. LGUs are also encouraged to have procurement transactions with the following distributors provided at the appendix of this Order. (Appendix 1 )  2. Delivery and Distribution of micronutrients  All the necessary micronutrients should be available in all distribution points such as hospitals, main health centers, barangay health stations, and health and nutrition posts following the normal structure of health system . All RHUs and BHSs personnel are thus required to participate in this activity. The BHWs and other volunteers may give the supplements as long as they have been trained and supervised by a midwife, public health nurse or physician.  Clustering per purok of barangays and masterlisting of all target groups per barangay may be necessary to facilitate distribution.  B. How to procure vitamin A capsules , iron or iodized oil capsules preparation from UNICEF and other sources (For LGUS)  a. Compute for requirements (UNICEF requires a minimum order of commodities costing $ 4, 000. 00) b. Request for quotation from UNICEF Philippines. c. Upon receipt of quotation, confirm order d. Make advance payment in dollars to designated bank. UNICEF processes papers only upon receipt of payment. To be allowed advanced payment, request for exemption from Malacafrang, invoking PD 1445. e. The ordering LOU/Office is responsible for the delivery and distribution of the commodity to their areas.  Some projects provide 100% of the VAC requirement to all target groups in their areas of coverage like the ECD project in Region VI VII, and X, and the UNICEF Country Program for Children (CPC) V project which covers 21 provinces and 4 cities.  3 Speci\ufb01c Roles and Responsibilities  The following services/units shall be responsible in program implementation.  A. DOH Central Of\ufb01ce  1. Allocate funds for the procurement of vitamin A capsule for the universal supplementation.  2. Update policy directions and management guidelines in the implementation of micronutrient supplementation.  3. Advocate to LGUs to allocate \ufb01rnds to augment supply of the micronutrients and to ensure their availability at all times at health centers.  4. Assist LGUs in procuring supplements by providing a list of local suppliers accredited by the Central Office.  5. Develop/update prototype IEC materials for production  6. Monitor the micronutrient supplementation program, assess and evaluate accomplishment.  B. Center for Health and Development  1. Provide budgetary allocation for the procurement of micronutrients like vitamin A capsules, iron tablets/syrup/drops to ensure their availability in the delivery of health services.  2. Conduct proper orientation of health personnel on the micronutrient supplementation program and its policies for appropriate compliance and implementation.  3. Conduct and facilitate integrated nutrition education activities to its health personnel and LGUs.  4. Record and report and assess accomplishments particularly compliance, coverage and impact.  5. Submit accomplishment reports to CO.  C. Hospitals  1. Integrate this Administrative Order in their treatment protocol.  2. Provide budgetary allocations for the procurement of micronutrients like vitamin A, and iron.  3. Participate in nationwide campaigns like Vitamin A Day or Garantisadong Pambata (GP)  4. Conduct orientation of hospital personnel on the micronutrient supplementation program, its policies for appropriate compliance and implementation.  5. Conduct integrated nutrition education activities to its patients through the public health units.  6. Coordinate with the provincial or municipal health office especially for the referral of cases needing attention and follow\u2014up.  D. Local Health Of\ufb01ces  As the implementing agencies for health services by virtue of the LGC of 1991, Local Health Offices shall:  1. Appropriate the necessary funds in support of the advocacy , nutrition education activities, training of health personnel and actual provision of logistics for micronutrient supplementation.  2. Coordinate with other organizations and agencies in the area, e.g. local nutrition committee, for resource generation and mobilization  3. Maintain recording and reporting and assess accomplishments particularly compliance, coverage and impact.  4. Submit accomplishments and reports to the CHDs  5. Recording and Monitoring  A. The supplementation of vitamin A, iron and iodine to identified target groups should be properly recorded in all health centers in any one of the following:  1. Target Client List (TCL), found in all health centers. 2. Growth charts (i.e., ECCD card or UPC cards) during growth monitoring of all preschoolers 3. Home-Based Maternal Record (I-IBMR) for pregnant and post\u2014partum women 4. Patient\u2019s records for other targets  B. Masterlisting of all target groups and monthly updating of the master list are encourage to facilitate identification and follow\u2014up of recipient.  C. For iron supplementation, monitoring of compliance is important. This can be done by recording the intake of iron tablets and reported side effects.  VII. REPEALING CLAUSE AND EFFECTIVITY  This order shall supersede and repeal A.O. no. 3-A s 2000 : Implementing Guidelines on Micronutrient Supplementation. This shall take effect immediately.    ", "  The United states Agency for International Development (USAID) through the Primary Health Care Financing Project has financed the procurement of 15 utility vehicles and 100 motorcycles for the use of the Department of Health. This order provides guidelines on the allocation, distribution and use of these equipment as well as other pertinent matters regarding their disposition 1. Main Purpose Support for EPI These equipment are being provided primarily for the purpose of supporting the national expanded Program for Immunization (EPI). In all cases, the allocations, distribution, use and operation of these equipment shall be prioritized on the basis of the needs of EPI such as transport of vaccines and EPI supplies, conduct of immunization rounds, field supervision and monitoring for EPI, attendance in meetings and events related to EPI and other similar activities. Only cases of medical emergencies involving possible loss of lives supersede EPI activities in the use of these equipment. 2. Distribution of Vehicles Fourteen (14) vehicles shall be distributed on the basis of one vehicle per region, including NCR and CAR. The vehicle will be at the Regional Health Office, under the custody of the Regional Health Director who shall assign it specifically to the unit supervising EPI activities, except when it can be shown that EPI can be supported better if the vehicle shall be allocated to Maternal and Child Health Service. 3. Distribution of Motorcycles 3.1 Qualification of recipients: the following shall be required before being considered to be a recipient of a motorcycle under this scheme; A rural Health Midwife appointed to a permanent item in the DOH assigned to a Barangay Health Station. Non-midwives occupying midwife items or midwives not assigned to a BHS are not qualified under this scheme. 3.2 Prioritization on Criteria: Considering that more than 100 midwives are expected to qualify under 3.1 above, those that qualify shall be prioritized according to the following criteria supplied nationally:  a) qualified midwives with a total catchment population of at least 3,000 people, in an area with mostly third class roads not accessible via regular modes of transportation and with the farthest two points within the catchment of at least 5 kilometers. b) If there are more than 100 midwives complying with the above criteria, they shall be ranked on the basis of their EPI performance in terms of fully immunized coverage accomplished over eligible. The first 100 with the highest accomplishment shall be the priority recipients. 3.3 Procedure of Selection: All Regional Health Offices shall require their Provincial Health Offices to submit to the EPI Division, Maternal and Child Health Service (MCHS) the names and the corresponding fully immunized coverage performance in 1987 of those midwives in their respective areas that comply with Criteria 3.1 and 3.2 (a). This shall be submitted on or before January 31, 1989 4. Information on Distribution As soon as possible, the MCHS shall inform the Regional Offices about the selection and corresponding distribution of vehicles and motorcycles. 5. Documentation Requirements  5.1 Vehicles shall be covered by memorandum receipts. If the Regional Health Director intends to assume personal responsibility for the use of the vehicle in compliance with this order, he/she shall document it accordingly. If the vehicle shall be assigned to other RHO officials, the documentation should also reflect such assignment 5.2 Motorcycles shall be covered by memorandum receipts signed by the recipient midwife. 5.3 The Regional Immunization Officer shall render a report on the disposition or assignment of vehicles and motorcycles in his or her region. This report shall be submitted to EPI division, MCHS upon completion of the distribution and delivery  6. Other conditions 6.1 All vehicles and motorcycles shall be registered and insured for TPL and own Loss and Damage. The regional Health Director shall be responsible for the vehicle in the RHO while the Provincial Health Officer shall be responsible for motorcycles assigned to midwives in his/her province. Costs of registration and insurance shall be borne by the offices concerned. 6.2 Maintenance and repair costs shall be borne by the offices concerned. Negligent or abusive use may be corrected via administrative discipline or through the withdrawal of the unit from the recipient.  6.3 Gasoline shall be borne by the offices concerned. TEV of midwives assigned motorcycles shall not be reduced even as the PHO absorbs the costs of gasoline for such motorcycles. 6.4 Upon the retirement, transfer, resignation or death of the motorcycle recipient, the PHO shall arrange to transfer such motorcycle to another deserving midwife on the basis of criteria 3.1 and 3.2 above. Report of such transfer should be forwarded to MCHS as soon as possible. 6.5 Total loss or damage of these items should be reported immediately together with attendant details to MCHS. 6.6 MCHS and the Regional Immunization Officers shall be responsible for implementing this order and monitoring compliance by all concerned. ", "  I. INTRODUCTION  Micronutrient malnutrition, particularly vitamin A deficiency, iron deficiency anemia and incline deficiency disorders continue to persist in the country as a public health problem. Studies reveal that the above deficiencies result in learning disabilities, mental retardation, poor health, low work capacity, blindness and premature death among the population, especially children.  Cognizant of the problem, the Philippine Government has voluntarily signed the World Declaration on Nutrition and the Global Plan of Action for Nutrition adopted during the 1992 International Conference on Nutrition. The Philippine government has committed to virtually eliminate vitamin A deficiency and iodine deficiency disorders as well as significantly reduce iron deficiency anemia in the country by the year 2000. This commitment has been operationalized in the Medium-Term Philippine Food and Nutrition Plan 1993- 1998, otherwise called the Philippine Plan of Action for Nutrition (PPAN) coordinated by the National Nutrition Council in collaboration with other government and non-government agencies.  In line with this commitment, the Department of Health (DOH) through its Nutrition Service has implemented programs geared inwards the elimination or reduction of these deficiencies. In 1993, the DDH initiated the Universal Micronutrient Supplementation Program. This program primarily weeks in the provision of nutritional supplements to specific target population groups: Vitamin A capsules for 12\u201459 months old preschoolers, iron tablets for pregnant women and iodized oil capsules for child bearing age women. The Department of Health will continue to implement this program until 2004 when the effect of the Food Fortification project is expected to cause an impact on the Philippine population. Micronutrient supplementation has been proven to be one of the most cost-beneficial and cost-efficient strategies. It is considered a short-term intervention measure to immediately correct the existing deficiencies and prevent adverse consequences attributed with each micronutrient deficiency. Vitamin A deficiency, iron deficiency anemia and iodine deficiency disorders could waste as much as 5 percent of gross domestic product, but addressing them comprehensively would cost less than 0.3 percent of the Gross Domestic Product. (Enriching Lives, Overcoming Vitamin and Mineral Malnutrition in Developing Countries, 1994).  In line with the continuing efforts to provide clear policy direction in the prevention and control of micronutrient deficiencies, these policies and guidelines are being presented to provide a standard and uniform basis for implementation.   II. POLICY   The Philippine government is committed to virtually eliminate Vitamin A Deficiency and Iodine Deficiency disorders, and markedly reduce Iron Deficiency Anemia. Adopting this goal means improving the survival, growth, well being and development of children and their families. Hence, the Department of Health shall specifically seek to reduce morbidity and mortality associated with these micronutrient deficiencies. Preventive and control measures will be adopted including micronutrient supplementation program with supporting interventions such as feed fortification and dietary improvement through nutrition education.  Micronutrient supplementation shall be given during regular or routine services at the health facilities and during national campaigns such as the Garantisadong Pambata Week when universal supplementation is done. It shall likewise be provided in evacuation centers during emergencies, disasters and calamities.   III. IMPLEMENTATIDN GUIDELINES  1. VITAMIN A DEFICIENCY  1.1 RATIONALE   The Philippines is considered an endemic region for VAD. The 1993 National Nutrition Survey reveals that sub-clinical VAD (i.e. serum retinol level less than 0.7 umol/liter) continuous to be present in up to 35% of our pre-school children. The 1998 National Nutrition survey initial result reveals an even more alarming condition wherein the prevalence of maternal night blindness is 10.5% compared with the WHO cut-off point for public health significance of 1%.  Vitamin A is one of the most essential vitamins in child and maternal survival programs. It has an unquestionable rule in vision and eye health as well as in the immune system & also bone growth.  Vitamin A Deficiency (VAD) is a condition in which the body stores are depleted to the extent that physiological functions are impaired. Depletion of stored vitamin A occurs ever time when the diet contains too little in replace the amount used by tissues. Improving the vitamin A status of deficient children has been shown to improve resistance to diseases thus reducing chances of childhood mortality. With vitamin A supplementation, the risk from mortality from measles is reduced by about 50%, diarrhea by about 40% and over-all mortality of pre-school children by 23-35%.   Importance/ Uses of Vitamin A  * Maintenance of Normal Vision * Promotes the differentiation of the epithelial cells of the body\u2019s skin and linings of all tissues from invasive microorganisms and other harmful particles * Promotes growth * Promotes immunity by maintaining the integrity of the epithelial tissues * Influences the expression of over 300 genes  1.2 CLINICAL MANIFESTATION  Xeropthalmia constitute the principal clinical sign of Vitamin A deficiency and is the most widely employed definitive criterion for assessing whether Vitamin A poses a significant public health problem. Xeropthalmia includes all ocular manifestations of VAD, which are as follows:  * Nightblindness (XN): It is described as having difficulty in seeing in the dark and refuses to play after dusk; stumbles on furniture, gropes for food, ask questions at dusk like: is it already dark? Where is the door?  * Conjunctival Xerosis (X1A): The conjunctiva lesses its natural luster due to hyposecretion of the goblet cells which is variably conducive to dryness of the epithelium.  * Bilot\u2019s Spots (X1B): these are foamy, soapy whitish patches seen in the white part of the eye (Scleral conjunctiva). Frequently associated with nightblindness. It can be removed but may re-accumulate later. This is a result of longstanding lack of vitamin A.  * Corneal Xerosis (X2): cornea is cloudy and dry with an orange\u2014peel appearance. Some people call this fish scale over the eyes. Child\u2019s vision is diminished even at daytime.  * Corneal Ulcer/Keratomalacia (X3A): cornea becomes soft, bulges with large perforations or holes in the surface. Mast severe manifestation of VAD. Can lead to permanent blindness. Children with prolonged diarrhea and measles frequently develop this stage  * Corneal scar (XS): inactive VAD or healed corneal damage. Minimal scar slightly impairs vision but extensive scars at the pupil may cause total blindness.  1.3 PRIORITY TARGETS  First Priority:  * All active VAD cases * 6\u201459 month old high-risk groups (1st, 2nd, 3rd degree underweight children with measles, ARI, diarrhea) * post-partum/lactating mothers within one month after delivery  Second Priority:  * 60-72 month old high-risk pre-schoolers * pregnant women  Third Priority:  3rd, 2nd, 1st degree underweight school children (above 6-12 years old)  1.4 MECHANICS OF SUPPLEMENTATION  1.4.1 Vitamin A Preparations and Targets  The prescribed vitamin A supplements to be used in the Vitamin A program is shown below:     1.4.2. SCHEDULE OF SUPPLEMENTATION  1.4.2.1. THERAPEUTIC SUPPLEMENTATION   1.4.2.1. PREVENTIVE SUPPLEMENTATION   1.4.3. SAFETY  Vitamin A is known to be safe and effective even for persons who do not exhibit vitamin A deficiency. Some side effects may occur such as headache, nausea and vomiting. These are, however mild and transitory (disappear within 24 hours) and do not require specific treatment.  Mothers of children who receive 200,000 I.U. Vitamin A should be especially advised on possible side reactions.  1.9.4. DISTRIBUTION AND ADMINISTRATION  The distribution of Vitamin A supplements from the region to the barangay level is the responsibility of the Nutritionist\u2014Dietitians and RHU/BHS health workers.  Administration of Vitamin A  Administration of Vitamin A is the responsibility of the RHU/BHS personnel. Trained hilots or other health workers/volunteers may administer vitamin A supplements as long as he/she has been trained and are closely supervised by a midwife or other health personnel. Hospitals, health centers, clinics, weighing posts, Sangka/patak centers or even home visits shall be used as distribution points of the supplements.  Vitamin A capsule is administered be children by cutting the capsule\u2019s nipple or by pricking and then squeezing the content into their mouth. For bigger children and adults, the capsule may be taken as is.  Acceptance is expected to be high if health workers adequately advise mothers regarding benefits of supplementation versus the minimal side effects of a properly implemented high dose supplementation schedule.  1.4.5. HANDLING AND STORAGE OF VITAMIN A CAPSULES  Vitamin A should be stored in dark colored bottles and kept in a cool, dry place, away from heat and direct sunlight to maintain its maximum potency. The container should else be labeled to include the name of the drug, dosage and its expiry date.  1.4.6. MONITORING  A monitoring system should be developed and integrated into the existing health system to cover the following indicators.  * Masterlist of vitamin A capsule recipients by health workers * Information on the vitamin A comploiance * Information on observed signs and symptoms of vitamin A deficiency among recipients * Information on dose reactions and response  SUPPLEMENTATION WITH VITAMIN A SHOULD BE RECORDED IN THE TARGET CLIENT LIST AND ON THE GROWTH CHART FOR ALL PRE-SCHOOLERS, IN THE HOME-BASED MATERNAL RECDRD (HBMR) FOR PREGNANT AND LACTATING WOMEN, AND IN THE PATIENTS\u2019 RECORDS FOR OTHER TARGETS.  1.4.7 SUPPLY ESTIMATION PER TARGET    Local government units should see to it that adequate vitamin A supplements is made available all the time for the target groups. They can procure any available local preparations provided the recommended dosage is strictly followed.  1.4.8. EMERGENCIES, DISASTERS, CALAMITIES, AND OTHER CONDITIONS  During Calamities and other emergencies, when the risk of epidemic of infectious diseases is high especially when people are housed in evacuation centers, Universal Vitamin A Supplementation should be clean among RISK GROUPS as described above.  2. IRON DEFICIENCY ANEMIA  2.1. RATIONALE  Iron deficiency anemia is a problem of serious public health significance, given its impact on psychological and physical development, behavior, and work performance.  In the Philippines, the prevalence rate of anemia for all age groups is 30.6%. The most greatly affected groups are the infants (56.6%), pregnant women (50.3%), lactating women (45.7%), and the elderly (M-49.1%, F-39.2%) (FNRI\u2014NNS 1998)  Iron deficiency is by far the commonest nutritional cause of anemia. An iron deficiency occurs when an insufficient amount of iron is absorbed to meet the body\u2019 s requirements. This insufficiency may be due to inadequate iron intake, reduced bioavailability of dietary iron, increased needs for iron, or chronic blood loss. When prolonged, iron deficiency leads to anemia.  Anemia is caused by a deficiency of iron (or less often, of other nutrients) and other conditions. Malaria, hookworm disease (whether ancylostomiasis or necaturiasis), schistosomiasis and other infections play important role.  Infants, preschool children, adolescents and women of childbearing age, particularly pregnant women, are at greatest risk of developing iron deficiency anemia. However, adult males are also at risk, especially where there is inadequate food intake or frequent parasitic infestation.  The consequences of iron deficiency, and especially iron deficiency anemia, are many. They include the following:  In infants and children:  * Impaired meter development and coordination; * Impaired language development and scholastic achievement; * Psychological and behavioral effects (inattention, fatigue, insecurity, etc.}; * Decreased physical activity  In adults of both seizes:  * Decreased physical work and earning capacity; * Decreased resistance to fatigue  In pregnant women:  * Increased maternal morbidity and mortality * Increased fetal morbidity and mortality; * Increased risk of low birth weight  A number of interventions exist that may be used to prevent and correct iron deficiency anemia. These include dietary improvement, fortification of feeds with iron, iron supplementation and other public health measures like parasitic control. However, iron supplementation will always be a part of anemia control programs in almost all contests, and should be viewed as one of several tools in the battle against iron deficiency anemia.  2.2. PRIORITY TARGETS  First Priority:  - Pregnant women    \u2014 Low birth weight infants    \u2014 6\u201423 month old infants  Second Priority: - Lactating women    - 1-4 year old moderately and severely underweight  Third Priority:  - 6-11 year old anemic, moderate and severely underweight children    - adolescent girls    - older and other adults  2.3. MECHANICS OF SUPPLEMENTATION  2.3.1. Iron Preparation and Targets  The prescribed iron supplements to be used in the Iron supplementation program is shown below:   2.3.2. Schedule of Supplementation     2.3.3. Safety  It should be stressed that there is no risk of toxicity to iron/folate supplementation when taken at prescribed dose. Present evidence indicates only minor undesirable gastrointestinal side effects in some individuals such as epigastric discomfort, nausea, vomiting, constipation, and diarrhea. The frequency of these side-effects is directly related to the dose of iron.  In cases of gastrointestinal intolerance, it is vital not to discontinue therapy and risk treatment failure. Rather, the dose of iron should be reduced and then gradually increased again until the full dose is reached and is well tolerated.  Iron supplement is ideally taken with empty stomach for optimal absorption. However, the frequency of side\u2014effects can be reduced if the patient takes them with meals.  2.3.4 Distribution and Administration  The distribution of iron supplements is the responsibility of trained local health workers, i.e. midwives, other trained health or nutrition workers, including BHWs and BNS.  2.3.5. Handling and Storage  Iron supplements, particularly the iron folate tablet should be placed in dark colored containers and stored in a cool, dry place away from direct heat and sunlight. When transferring from its original container, make sure that the fingers do not touch the tablets to prevent the growth of molds. The container should also be labeled to include the name of the drug, and its expiry date.  2.3.3. Monitoring  A monitoring system should be developed and integrated into the existing health system to cover the following indicators.  * Master list of recipients of iron folate tablet/ferous sulfate drops and syrup by health workers * Information on compliance to supplementation * Information on observed signs and symptoms of Iron Deficiency Anemia among recipients * Information on dose reactions and response  RECEIPT OF IRON SUPPLEMENTS SHOULD BE RECORDED ON THE GROWTH CHART OF ALL PRESCHOOLERS GIVEN THE SUPPLEMENTS AND IN THE HOME BASED MATERNAL RECORD (HBMR) FOR PREGNANT AND LACTATING WOMEN.  2.3.2. Supply Estimation Per Target   Local government units should see to it that adequate supply of iron folate tablets/syrup and drops should be available at all level for the target population. They can procure any available local preparations provided the recommended dosage is strictly followed.  2.3.3 Emergencies, Disasters, Calamities and other Conditions  During calamities and other emergencies, when the risk of nutritional deficiencies is higher, iron supplementation may be given to all HIGH RISK GROUPS according to the prescribed dosage. High risk groups include pregnant women, low birth weight infants and infants 6 - 23 months.   IV. RULES AND RESPONSIBILITIES  The following services/units shall be responsible in program implementation.  A. DOH Central Office  1. Provide policy directions and management guidelines in the implementation of micronutrient supplementation 2. Advocate to LGU to allocate funds for routine supplementation. 3. Assists LGUs in resource generation 4. Formulate/develop IEC materials on micronutrient. 5. Monitor coverage of micronutrient supplementation/assess accomplishment and provide feedback to DOH management.  B. Regional Health Office/Local Government Unit  1. Provide budgetary allocations for the purchase of micronutrients especially Vitamin A,  iron and iodine to make the micronutrients available at all times. 2. Provide micronutrient in the delivery of routine health services at the health facilities, i.e. post partum supplementation with Vitamin A Capsule (200,000 I.U.); low dose Vitamin A tablets (10,000 I.U.) for pregnant women 2x a week. 3. Conduct of proper orientation of personnel on the micronutrient supplementation program and its policies for appropriate compliance and dissemination; 4. Conduct integrated nutrition education activities (use of IEC materials, lecturettes, and cassettes in wards/OPD). 5. Report, record and assess accomplishments particularly coverage and impact in the long run.  C. Hospitals  1. Provide budgetary allocations for the purchase of micronutrients especially Vitamin A, Iron and Iodine to make the micronutrients available at all times. 2. Integration of this Administrative Order in their treatment protocols. 3. Provide the micronutrients in the delivery of routine health services be it in the out patient department or in-hospital wards, i.e. post partum supplementation with Vitamin A Capsule (200,000 I.U.); low dose Vitamin A tablets (10,000 I.U.) for pregnant women 2x a week, etc. 4. Participate in nationwide programs for micronutrient supplementation like the Garantisadong Pambata Week. 5. Conduct of proper orientation of personnel on the micronutrient supplementation program and its policies for appropriate compliance and dissemination. 6. Conduct integrated nutrition education activities (use of IEC materials, lecturettes, and cassettes in wards/OPD). 7. Report, record and assess accomplishments particularly coverage and impact in the long run.   V. REPEALING CLAUSE  This order shall supercede and repeal all previous policies, guidelines and other related orders on micronutrient supplementation inconsistent herewith.  VI. EFFECTIVITY  This Order shall take effect immediately.   ", " I. BACKGROUND/RATIONALE   Rabies, present in all continents and endemic in most African and Asian countries, is a . ,. fatal zoonotic viral disease, transmitted to humans through contact with infected animals, both ., domestic and wild. Rabies is estimated to 'cause at least 55,000 deaths per year worldwide, about ' 56% of which occur in Asia and 43.6% in Africa, particularly in rural areas on both continents. In the Philippines, although rabies is not among the leading causes of morbidity and mortality, rabies is considered a signi\ufb01cant public health problem for two reasons: 1) it is one of the most acutely fatal infections and 2) it is responsible for the death of 200-300 Filipinos annually.   The Department of Health continues to be committed to the \ufb01ght against rabies and has set the goal of rabies elimination in 2020. An essential part of this strategy is the provision of post-exposure prophylaxis to bite victims and pre-exposure prophylaxis to high risk individuals as mandated by the Anti-Rabies Act of 2007. Pursuant thereto, guidelines for the appropriate as well as cost-effective management of animal bite patients have been issued.   Historically the management of animal bite cases had to be updated every \ufb01ve (5) years and the guidelines revised accordingly to incorporate new and better treatment modalities based on research results. The \ufb01rst revision was made in 1997, the second in 2002 and the 3rd in 2007.   Since the release of the latest guidelines in 2007, new recommendations related to rabies management have been released by the World Health Organization and the US Centers for Disease Control. The Anti-Rabies Act of 2007 and its Implementing Rules and Regulations provided for the provision of pre\u2014exposure prophylaxis among school children from high risk areas. These current guidelines are therefore amended to incorporate these crucial recommendations.   II. OBJECTIVE  To provide updated guidelines and procedures to ensure effective and ef\ufb01cient management of rabies exposures toward eventual reduction, if not elimination, of human rabies   III. AMENDMENTS IN A0 2007-0029  The following sections of A0 2007-0029 are hereby amended as follows:   1) Section III. COVERAGE (in page 2)   All government health workers at all levels shall adopt these treatment guidelines to ensure standardized and rational management of animal bite patients. Private practitioners in the country are strongly encouraged to adopt these treatment guidelines.   2) Section IV. DEFINITION OF TERMS (in page 2)   A. Post Exposure Prophylaxis (PEP) - formerly post exposure treatment (PET); refers to anti-rabies treatment administered after an exposure (such as bite, scratch, lick, etc.) to potentially rabid animals. It includes local wound care, administration of rabies vaccine with or without Rabies Immune Globulin (RIG) depending on category of exposure.   B. Pre exposure prophylaxis \u2014 refers to rabies vaccination administered before an exposure to potentially rabid animals. This is usually given to those who are at high risk of getting rabies such as veterinarians, animal handlers, staff in the rabies laboratory, hospitals handling rabies patients and school children from high risk areas, etc.   3) Section VI.A.3. Rabies exposure is stratified in three categories with corresponding management guidelines as shown in Table 1. (in page 4)   Table 1. Categories of Rabies Exposure with Corresponding Management         4) Section VI.B.l.l.2: Types of Rabies Vaccines and Dosage (in page 5)    The National Rabies Prevention and Control Program (NRPCP) provides the following anti-rabies tissue culture vaccines (TCV) a) Puri\ufb01ed Vero Cell Rabies Vaccine (PVRV) \u2014- 0.5 ml/vial and b) Puri\ufb01ed Chick Embryo Cell Vaccine (PCECV)- 1.0 ml/vial.   Table 2. List of TCV Provided by the NRPCP to Animal Bite Treatment Centers with Corresponding Preparation and Dose      Recommendations on the intradermal administration of anti\u2014rabies vaccines:   The NRPCP introduced the intradermal (ID) use of rabies tissue culture vaccines in the country in 1997. The Philippines was among the \ufb01rst countries to adopt this regimen as recommended by the World Health Organization, in order to totally discontinue the use of nerve tissue vaccine (NTV) which was associated with vaccine induced encephalopathy. To mitigate the expected increase in the cost of PEP with the shift from NTV to TCV, the ID use of these vaccines was introduced. According to WHO, the ID use of tissue culture vaccines can decrease the cost of PEP by as much as 60- 80%.   However, only a limited number of commercially available rabies vaccines have been proven, to date, as safe and ef\ufb01cacious for PEP when administered by the ID route. Recently, local manufacturers in rabies-endemic countries have started to produce rabies vaccines. The ID use of these vaccines should be based on adherence to WHO requirements for that route and approval by national health authorities as follows, \u201cNew vaccine manufacturers should provide clinical evidence that their products are immunogenic and safe when used intradermally. Clinical evidence should include clinical trials involving a vaccine of known immunogenicity and efficacy when used by this route as control, serological testing with rapid \ufb02uorescent focus inhibition test, and publication in internationally peer-reviewed journals\".   To ensure compliance to these recommendations and guarantee that animal bite patients seeking treatment in government Animal Bite Treatment Centers receive only TCV that have been proven to be safe and effective, the program shall utilize for its intradermal regimen only tissue culture vaccines that satisfy the following criteria :   1. The vaccine is registered with and approved by the Food and Drug Administration, formerly known as Bureau of Food and Drugs (BFAD);   2. The vaccine has been proven to be safe and ef\ufb01cacious for PEP when administered by the ID route using the schedule recommended by the World Health Organization. Having limited knowledge on and experience with the ID use of all available anti-rabies vaccines in the country, the program shall utilize the WHO list of approved TCV for ID use OR in the case of vaccines not included in the WHO list for ID use, the vaccine must comply with WHO requirements for new rabies vaccines and must have gone through local clinical trials on safety and immunogenicity which are published in peer-reviewed journals;   3. The potency of vaccines for ID use should be at least 0.5 IU/ID dose as evidenced by their lot release certi\ufb01cate. The potency of the vaccine batch should be provided by the manufacturer; AND   4. The product insert must contain the vaccine\u2019s approved ID dose and consistent with its Certi\ufb01cate of Registry (CPR) for Disease Control.   5) Section VI.B.2.a. Types of Rabies Immune Globulins (in page 6)   Table 3. List of Rabies Immune Globulins provided by the NRPCP to Animal Bite Treatment Centers      6) Section VI.B.2.d. Administration (in page 7)   1. The total computed dose of RIG should be in\ufb01ltrated around and into the wound as much as anatomically feasible, even if the lesion has healed. In case some amount of the total computed dose of RIG is left after all wounds have been in\ufb01ltrated, it should be administered deep [M at a site distant from the site of vaccine injection (preferably anterolateral thigh) using another needle. The total computed dose should be administered as a single dose.   2. A gauge 23 or 24 needle, 1 inch length should be used for in\ufb01ltration. Multiple needle injections into the same wound should be avoided.   3. A skin test must be performed prior to ERIG administration using a gauge 26 needle. For skin testing, 0.02 ml of 1:10 dilution of solution is in\ufb01ltrated to raise a blob 3 mm and read after 15 minutes. A positive skin test is an induration >6 mm surrounded by a \ufb02arelerythema. If initial skin test is positive, repeat skin test on same arm; use distilled water as control on the other arm. The skin test is considered positive if the ERIG skin test is positive but the control is negative.   4. If a \ufb01nger or toe needs to be in\ufb01ltrated, care must be taken not to impair blood circulation. Injection of an excessive amount may lead to cyanosis, swelling and pain.   5. RIG should not exceed the computed dose as it may reduce the ef\ufb01cacy of the vaccine. If the computed dose is insuf\ufb01cient to in\ufb01ltrate all bite wounds, it may be diluted with sterile saline 2 or 3 fold for thorough in\ufb01ltration of all wounds.   6. RIG should be administered at the same time as the \ufb01rst dose of vaccine (day 0). In case RIG is unavailable on day 0, it may still be given any time before the day 7 dose of the vaccine. However if the day 3 and/or day 7 doses of the vaccine have not been given, RIG may still be given anytime.   7. In the event that RIG and vaccine cannot be given on the same day, the vaccine should be given before RIG because the latter inhibits the level of neutralizing antibodies induced by immunization.   8. RIG is given only once during the same course of PEP.   9. Patients with Positive skin test to puri\ufb01ed BRIG should be given HRIG.   10. HRIG is preferred for the following:  a. History of hypersensitivity to equine sera  b. Multiple severe exposures (especially where dog is sick or suspected of being rabid) on head and neck area  c. Symptomatic HIV infected patients   11. Patient must be observed for at least one hour after injection of ERIG for immediate allergic reactions.   7) Section VI.D.1.l.l.e. (in page 9)   Table 4. Guide to Tetanus Prophylaxis in Routine Wound Management       The following provisions shall be added to section VI (page 23):   N. Injection Safety: A safe injection is de\ufb01ned by the World Health Organization as an injection that: 0 Does not harm the recipient 1\u00bb Does not expose the health staff to any avoidable risks 0 Does not result in waste that is dangerous to the community.   I. Injection Equipment   1. Auto-Disable (AD) Syringes~ are disposable injection devices that are especially made to prevent re\u2014use and are therefore less likely than standard disposable syringes to cause person-to\u2014person transmission of blood-bome diseases.   The program recommends that health workers use AD syringe in their respective ABTC.   2. Conventional Syringes~ are plastic syringes with steel needles that are provided usually by the manufacturer in sterile package. The needle may either be \ufb01xed to the syringe when it is produced or attached by the health staff just before use.   2. Management of Sharp Waste   Used syringes and needles should never be dumped in open areas where people might pick them up, step on them, or come in contact with them in any way.   The need to better manage used or contaminated sharps is through the use of safety boxes or sharp containers. These are puncture-resistant containers where used syringes and needles can be immediately and temporarily stored after use until its \ufb01nal disposal.   3. Waste Disposal   Collector boxes \ufb01lled with used syringes and needles should be immediately brought to its \ufb01nal disposal. The program recommends the following methods of disposal:   1. Use of septic vault  2. Pit burial; and  3. Waste treatment and \ufb01nal disposal to land\ufb01ll   III. REPEALING CLAUSE   Provisions of Administrative Order No. 2007-0029 dated September 21, 2007 \u201cRevised Guidelines on Management of Animal Bite Patients\" and Administrative Order No. 2005\u20140022 \u201cAmendment to A0. 1645. 2002 dated August 25, 2005 and any other issuances inconsistent herewith are hereby rescinded.   IV. EFFECTIVITY   This order shall take effect immediately.  ", " I. BACKGROUND AND RATIONALE   In 2010, the Department of Health (DOH) issued Administrative Order (A0) No. 2010- 0017 otherwise known as the \u201cGuidelines in Surveillance and Response to Adverse Events Following Immunization \" as part of its commitment to enhance its AEFI surveillance system and ensure delivery of safe and effective vaccine and iMunization services at all levels. The guideline was made and disseminated to guide the concerned stakeholders on the early detection, reporting, investigation and appropriate response to adverse events following immunization (AEFI). Since then, the Philippines had a' functional AEFI surveillance system. However, inadequate information and delayed investigation was still observed in most of the regions reporting serious AEFI cases. This significantly affected the quality of causality assessment during case review and classification.   In 2013, the World Health Organization \u2014 Western Pacific Regional Office (WPRO) issued a revised Immunization Safety Guidelines Manual which consists of additional information about vaccine safety, common/unusual event for old and new vaccines including its rate per million doses and a new algorithm for AEFI causality assessment. Hence, for further strengthening of the current AEFI surveillance, it is beneficial to adopt it.   In the same year, a group of consultants from WHO were invited to provide technical expertise and support improvement of the country\u2019s AEFI surveillance system and assist the country in aligning national guidelines with the WHO\u2019S revised immunization safety guidelines. Together with representatives from Epidemiology Bureau and partner offices, an Adverse Event Following Immunization (AEFI) Comprehensive National Assessment was then conducted.   Anchored on the learning and insights from the said AEFI surveillance strengthening activities in the country and the revised immunization safety surveillance manual, new protocols have been adopted and concomitant changes, to policies and guidelines are imminent for scale-up and full-implementation. This revision of A0 2010-0017 is hereby provided to guide implementers at all levels of health care delivery system.     II. OBJECTIVES   This AO is issued to provide guidelines for concerned stakeholders on the early detection, reporting, investigation and appropriate response to adverse events following immunization.   Further, this issuance aims to establish mechanisms for collaboration between and among Epidemiology Bureau, Food and Drug Administration, Family Health Office and other stakeholders involved in AEFI surveillance and response.   III. SCOPE AND COVERAGE   This issuance shall apply to health professionals who are providing all vaccines administered under the Expanded Program on Immunization (EPI) and other vaccines given by DOH nationwide. It shall also be applied in all DOH concerned offices and attached agencies, epidemiology and surveillance units, private and government health facilities treating AEFI cases, local government units and the community involved in the surveillance and management of AEFIs.   Private sectors and/or medical institutions handling immunization services and treating AEFI cases from non\u2014DOH vaccines are mandated to report to the Food and Drug Administration per existing rules and regulations.   IV. DEFINITION OF TERMS   a. Adverse Event - Any untoward medical occurrence which follows Following . immunization and which does not necessarily have a causal Immunization (AEFI) relationship with the usage of the vaccine. The adverse event may be any unfavorable or unintended sign, abnormal laboratory finding, symptom or disease.   b. Causality Assessment - A systematic review of data about an AEFI case to determine the likelihood of a causal association between the event and the vaccine(s) received.   c. Cluster - Two or more cases of the same or similar event related in time, geography, and/or vaccine administered.   d. Immunization Safety - The public health practices and policies dealing with the various aspects of the correct administration of vaccines, focusing on minimizing the risk of transmission of disease with vaccination and maximizing the effectiveness of the vaccine. The term encompasses the spectrum of events from proper manufacture to correct administration.   e. Minor AEFIs ' - These are AEFIs that are not included or categorized as serious AEFIs. These include local adverse events (such as pain, swelling, redness) and systemic reaction (fever) that are expected after immunization as part of the immune response of the vaccine recipient to induce immunity.   f. Pharmacovigilance - The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems.   g. Philippine Integrated - The Philippine Integrated Disease Surveillance and Disease Surveillance Response (PIDSR) in an integrated disease surveillance and Response system established in compliance to 2005 IHR for early detection and response to epidemics.   h. Safe injection practice - Those public health practices and policies which ensure that the process of injection carries the minimum of risk, regardless of the reason for the injection or the product injected.   i. Serious AEFI - An event that is causing a potential risk to the health/life of recipient leading to death, life-threatening conditions, congenital abnormalities/birth defects, disability/ incapacity or hospitalization.   j. Uppsala Monitoring - A WHO collaborating center for international drug/vaccine Center monitoring.   V. GENERAL GUIDELINES   1. AEFI Surveillance in the Epidemiology Bureau shall follow the basic principles for surveillance as stipulated in the implementing guidelines of the Philippine Integrated Surveillance and Response (PIDSR) system (A0 2007-0036). It shall be encouraged at all levels for early detection and execution of appropriate measures.   2. AEFI investigation shall follow the standard epidemiological investigation principles.   3. Reported AEFIs in the Epidemiology Bureau shall be submitted to the Food and Drug Administration for reporting to Uppsala Monitoring Center.   4. The National and Regional AEFI Committees shall be responsible in determining the final causality assessment of an AEFI case of cluster of AEFIs and will be based on the World Health Organization (WHO) Causality Assessment of an AEFI, User Manual for the Revised WHO Classification (March 2013).   5. Response and follow-up activities shall be based on findings of investigations, causality assessments and. recommendations by the investigation team and expert committees. Preliminary response shall be done at the LGU level and shall include medical treatment, risk communication and immunization safety interventions.   VI. IMPLEMENTING GUIDELINES A. Surveillance   1. Detection and Reporting   a. Responsibilitv of Reporting 1 The following shall be responsible for the detection and/or reporting of AEFIs:   i. All health professionals providing immunization services and clinical treatment of AEFIs.   ii. Individuals who received the vaccination can report AEFIs to any health professional. In cases of minors, parents or guardians can report the same.   iii. Researchers, sponsors, investigators and research laboratories involved in clinical studies or field trials that result to AEFIs.   iv. Vaccine manufacturers or distributors.   b. Timing and Flow of Reporting   i. All AEFI cases including minor AEFIs such as local reactions, fever and self\u2014limiting systemic symptoms shall be reported to the next higher epidemiology and surveillance unit (ESU) level on a weekly basis using the AEF I Case Report Form (Annex A).   ii. In cases of serious/ cluster of AEFI cases, notification shall be made to the epidemiology and surveillance unit of the next higher ESU level and the Epidemiology Bureau within 24-48 hours of case detection by the fastest means possible. Initial notification can be verbal using the telephone, text message or via facsimile or email. This is to notify the next higher level that an in-depth case investigation is warranted (Annex B).   2. Investigation   a. Once report has been received by the epidemiology and surveillance unit, an assessment shall be done to determine whether or not an investigation is needed.   b. Reported AEFIs shall be investigated if it is:  i. A Serious event of known or unknown cause, all hospitalizations  ii. A Cluster of minor AEFIs  iii. Events associated with newly introduced vaccine  iv. Suspected to be caused by immunization error  v. Appears on the list of events defined for AEFI surveillance (Annex C)  vi. Causing a significant parental or public concern  vii. All AEFIs suspected to be caused by the vaccine   c. AEFI investigations shall be conducted by a team composed of duly authorized representatives from the following and observe respective roles during investigation:  i. Epidemiology and Surveillance Unit (ESU) \u2014\u2014 conduct epidemiologic investigation  ii. EPI Coordinator/ Cold Chain Manager \u2014 observe safe injection practice, cold chain management  iii. FDA/ Food and Drug Regulation Officer (FDRO) _ observe, inspect and review compliance to cold chain management, review of vaccine lot/batch number including diluent. A review of the product file shall be conducted by the Center for Drug Regulation and Research when deemed necessary.  iv. Health Promotion Officer \u2014 shall lead in conducting risk communication activities during and after investigation   d. AEFI investigations shall be led by the Local Government Unit (City/Province). The regional office shall provide technical assistance as needed by the LGU.   e. Complete investigation and initial response activities shall be conducted within 48 hours upon reporting of a serious AEFI. The AEFI Case Investigation Form (Annex D) shall be used in the investigation of cases.  f. The investigators shall look directly at the suspected reaction as well as gather information from the patient/parent, health workers and supervisors, and community members. In addition, investigation of the vaccine(s), immunization techniques and procedures, and service in action shall be conducted.   g. The investigating team shall also be allowed to access medical records of the case and photocopy records as needed to support the investigation.   h. Laboratory testing of vaccines and/or human samples may be done only on a clear suspicion and not as routine and never before the working hypothesis.   i. In case of laboratory testing of suspected vaccines, the cost of the laboratory test(s) shall be borne by the FDA-Marketing Authorization Holder (MAH) or the DOH in case of WHO\u2014assisted purchased vaccines under the EPI and shall be paid' directly to the laboratory.   j. The completed -CIF together with all supporting documents shall be submitted within 48 hours or immediately after completion of investigation to the RESU for initial causality assessment by the Regional AEFI Committee (RAEFIC).   3. Data Management   a. Epidemiology Bureau shall consolidate all AEFI reports submitted (serious and minor) on a monthly basis and shall submit it to Food and Drug Administration (FDA).   b. The PIDSR system shall be utilized to maintain a database (paper-based or electronic) of AEFIs that is easily accessible to all reporting units.   c. Data analysis shall be carried out at different levels in the surveillance system. Epidemiology and Surveillance Units of the different levels shall lead the epidemiological analysis.   d. Corresponding EPI managers and FDA staff shall coordinate with the ESUs and provide additional information (e.g. number of children immunized, status of vaccine pro-qualification, international rates, etc.) that will make the analysis more comprehensive.   4. Feedback   a. There shall be a regular (at least quarterly) and timely feedback within and between all levels of the health delivery system (national, regional, province, city) including data on investigation results, classification of cases and data analysis among others.   B. Response   1. Case Management   a. Prompt treatment shall be the first response to an AEFI. Treatment may i vary depending on the signs and symptoms of the AEFI case.   b. If the AEFI is due to vaccine related\u2014reaction occurring at a higher reaction rate than expected from a specific vaccine or lot, the Secretary of Health or FDA Director General can suspend corresponding immunization activity and declare product recall and advisory.   c. If the AEFI is due to immunization errors, actions shall mainly focus in correcting the Case of the error and review at a later date that the immunization errors have been corrected.   d. If the AEFI is coincidental, the priority action shall focus on developing and implementing risk communication plan directed to the affected family and the general public.   2. Program Support   a. The EPI program managers in their corresponding levels shall take the lead to provide corrective actions and monitor outcomes of response interventions.   b. LGUs shall immediately implement corrective actions based on the preliminary investigation findings and causality assessment of the Regional AEFI committees and implement all other measures recommended by RAEFIC and/or NAEFIC.   C. Causality Assessment   1. A Regional AEFI Committee shall be established and suggested to be composed of the following:   a. 4 Clinical Experts (medicine/infectious disease/pediatrics)  b. Research specialist (academe), pharmaco-epidemiologist  c. Regional Director or Assistance Regional Director (observer)  d. Regional Food and Drug Authority (observers)  e. EPI Program Manager and cold chain manager (observer)  f. RESU head/staff (secretariat)   2. The Regional AEFI Committee shall conduct preliminary causality assessment as soon as possible upon receipt of the AEFI case investigation reports. The RAEFIC may require conduct of additional investigation.   3. The investigation team may offer a \u201cfirst opinion\" on the causality of a particular AEFI or cluster of AEFIs. The first opinion can be derived from the result of the investigation done by the team in collaboration with key stakeholders at the regional and sub\u2014regional levels.   4. AEFI investigations that have not reached conclusions and cases that are not classified by the RAEFIC shall be presented to the National AEFI Committee (NAEFIC) for final causality and provision of recommendations.   5. The minimum document requirement to facilitate an evidence\u00abbased causality assessment are as follows:   a. Completed Case Investigation Form (Annex C)   b. A \u201cvalid diagnosis\" for the unfavorable or unintended sign, abnormal - laboratory finding, symptom or disease in question   c. Hospital Records / Medical Charts / Laboratory Results   d. Preliminary Investigation Report / IMRAD   e. Death Certificate / Autopsy Report (for cases of deaths)   6. The expert committee may ask for additional supportng evidences as needed to provide a final causality assessment.   D. Assistance to AEFI cases   1. The LGU shall ensure that serious AEFI cases are provided with immediate assistance which may include hospitalization and transport to medical facility.   2. The LGU shall collaborate with the Regional Of\ufb01ces to discuss appropriate assistance to the patient. The LGU shall provide to the extent possible any immediate assistance to serious AEFI cases.   3. An autopsy shall be preferred and recommended following all deaths suspected to cause by vaccine / immunization. The DOH shall provide the necessary assistance to \ufb01nd or coordinate with an appropriate agency/facility for autopsy upon approval of consent.   4. Patients with serious AEFI shall be managed at a DOH retained and other government hospitals for free. If medical services, diagnostics or laboratory capacities needed by an AEFI case are not available in a public facility, the patient shall be referred to a private health facility. Hospital expenses incurred shall be shouldered by the LGU or the DOH. If the patient opts to be con\ufb01ned-at a private health facility, hospital expenses shall be shouldered by the patient themselves.   E. Assistance to health worker   1. Concerned public health professionals shall not be held liable for any AEFI as long as DOH standard operating procedures on immunization safety practices are complied and with proper assessment by National AEFI Committee.   2. DOH Legal Service shall collaborate with the Public Attorney\u2019s Of\ufb01ce (PAO)/Of\ufb01ce of the Solicitor General (OSG)/Integrated Bar of the Philippines (IBP) /Law Schools/volunteer lawyers in providing appropriate legal assistance to public health professionals as necessary if any case is \ufb01led against them for acts committed in the performance of their duty and in good faith.   3. Local police force may provide assistance to any health worker/s for any threats received.   4. In case of physical injury, the health worker shall be provided with free medical assistance in DOH-retained and other government hospitals. In case of referral to a private hospital is required, the expenses incurred shall be reimbursed by the ' LGU or DOH.   5. As mandated by ED. 663 and A0. No 2007-0028, the concerned health worker/s shall be given due process for any administrative, civil or criminal sanctions \ufb01led against him/her. In addition, assistance shall be given to the concerned health workers by LGU for any expenses incurred in the conduct of this activity.   F. Risk Communication   1. Risk communication for AEFI shall be the responsibility of the health sector at all levels particularly the health promotion of\ufb01cers.   2. Risk communication shall be comprehensive to cover the following target audiences: family, community, general public, media, and health workers.   3. All media coverage on AEFI shall be coursed through the OSEC-Media Relations Unit (MRU) at the national level and HEPO-PIO (Health Education Promotion Of\ufb01ce - Public Information Of\ufb01ce) at the regional level. The OSEC- MRU and the Regional HEPO-PIO shall refer those concerns to the appropriate of\ufb01ces.   4. Press releases shall be done when the AEFI incident has been publicized (by local, national or international media). Other AEFI incidents that had been investigated and resolved may not necessarily require press releases as determined by the MHO or Local Chief Executives (LCE).   5. At the city/provincial level, the LCE, or his duly designated official, shall be the spokesperson for inquiries related to AEFI. The MHO/CHO, in consultation with the regional AEFI committee, shall provide technical inputs to the LCE.   6. The health promotion officer, in coordination with the program coordinators shall formulate a health communication plan pertaining to AEFI and prepare key messages for advisories and press releases.   7. At the regional level, the Regional Director shall convene a meeting with the concerned LGU for synchronous press releases.   8. At the national level, the Secretary of Health or his duly designated of\ufb01cial shall act as the spokesperson for national matters related to AEFI.   9. The DOH through the Health Promotion and Communications Service (HPCS) in coordination with the Family Health Office (FHO), Epidemiology Bureau and Food and Drug Administration (FDA) shall prepare risk communication plan and key messages for advisories.   10. The MRU shall prepare and disseminate press releases and facilitate press conferences. _   11. Upon clearance by the Secretary of Health, the Epidemiology Bureau, being the International Health Regulation (IHR) focal point, shall notify the WHO and other concerned international organizations of the serious AEFI incidents and the response taken. Likewise, FDA as the National Regulatory Authority (NRA) shall notify international partners.   G. Post Incident Evaluation (PIE)   1. The Chair of the Regional AEFI Committee (RAEFIC) shall facilitate the conduct of post incident evaluation for all serious AEFIS. This shall be attended by the members of the regional AEFI committee, provincial, city/municipal EPI coordinators, PHO, MHO/CHO, surveillance staff, and DOH representatives.   2. The focus of the PIE shall include critical examination on the elements of the AEFI surveillance and response and come up with recommendations to improve AEFI surveillance and respOnse and the immunization program.   3. The National AEFI Committee and the LGU concerned shall be given feedback of the PIE results.   H. Monitoring and Evaluation   1. The role of monitoring is delegated to all government health units at all levels. It shall be done by person/s knowledgeable with AEFI surveillance and safe immunization practices who can easily track discrepancies and give immediate action to it. Hence, epidemiologist, DSO/DSCS, EPI coordinators and FDAlFDRO shall be responsible of the monitoring system. The surveillance system shall be monitored and evaluated regularly (at least annually) based on the following criteria:   a. The data reported by the AEFI surveillance system (reporting rate, number   of adverse reactions reported)  b. Timeliness, completeness and accuracy of AEFI reporting  c. Timeliness, completeness of investigations  d. Audit of corrective action   VII. ROLES AND RESPONSIBILITIES   A. National Immunization Committee (NIC) shall:   1. Provide direction and technical support on policies and plans pertaining to the immunization program as prescribed in Department Personnel Order No. 2007\u2014 0323.   B. Regional Adverse Events Following Immunization Committee (RAEFIC) shall:   1. Deliberate preliminary causality assessment upon receipt of complete AEFI case investigation reports from the provincial/regional investigating team. The committee should convene at least quarterly or as need arise.   2. Provide immediate written report regarding the deliberated preliminary assessment to EB and concerned LGU, copy furnish FHO and FDA.   3. Provide information of the final causality assessment and recommendations to the Regional OfficesIPHO/CHO and concerned LGU.   4. Monitor implementation of the recommendations by the responsible program/of\ufb01ces.   C. National Adverse Events Following Immunization Committee (NAEFIC) shall:   1. Review all reported serious and cluster of AEFI cases presented for expert opinion on a quarterly basis or as the need arise, and provide a final causality assessment of the AEFI cases as well as the cases that were not classified by the Regional AEFI Committee.   2. Ensure evidence-based causality assessment by recommending further investigation and data collection as needed.   3. Make final decisions on causality assessment of inconclusive investigations.   4. Ensure standard protocols for AEFI surveillance and investigation are correctly followed.   5. Engage with other national and international experts when requirements arise in establishing causality and vaccine quality issues.   6. Provide recommendations to the EPI Program, Epidemiology Bureau and National Cold Chain Manager on improving innnunization service delivery, compliance with injection safety and effective vaccine management, etc. based on lessons from the AEFI cases.   7. Serve as technical advisory group to the Secretary of Health and the FDA on vaccine and immunization safety-related issue of highest consideration such as immediate recall of vaccine from NIP and/or market or temporary/permanent withdrawal of a vaccine from the immunization program.   8. Serve as resource person in other AEFI related meetings, conferences or capacity building activities as requested.   D. Family Health Of\ufb01ce shall:   1. Modify EPI program policies and programs based on NAEFIC recommendations.   2. Coordinate with Epidemiology Bureau for any reported AEFI cases.   3. Provide the Epidemiology Bureau of the data necessary for analysis (i.e. vaccine doses administered/ doses used / doses distributed).   4. Provide technical assistance during ' AEFI investigation and immunization program reviews at all levels.   5. Provide technical assistance for corrective actions and improving quality of immunization service.   6. EPI program managers together with the FDA in their corresponding levels shall take the lead to provide corrective actions and monitor outcomes of response interventions.   E. Epidemiology Bureau (EB) shall:   1. Oversee the design and implementation of the National AEFI surveillance system.   2. Lead in the conduct of case investigation and comprehensive data analysis.   3. Provide technical assistance or training to develop/enhance capacity of regional/local AEFI surveillance.   4. Convene meetings of and serves as secretariat for the NAEFIC (quarterly).   5. Provide AEFI surveillance information to all stakeholders for policy and program use.   6. Coordinate AEFI surveillance activities with EPI and FDA both at the national and regional levels.   7. Maintain database of all reported AEFIs and submits database to FDA within the prescribed timeline.   F. Health Promotion and Communications Service (HPCS) shall:   1. Develop and oversee the implementation of the national AEFI risk communication plan.   2. Support sub -national levels in developing and implementing their respective risk communication plans including monitoring and evaluation tools.   3. Monitor and evaluate implementatibn of risk communication plan at all levels and provide feedback to all stakeholders.   G. Media Relations Unit (MRU) shall:   1. Coordinate with HPCS, Epidemiology Bureau, FDA and FHO in preparing and developing key messages for advisories and press statement.   2. Facilitate in the dissemination of press releases.   3. Facilitate in the preparation and conduct of press conference.   H. Food and Drug Administration (FDA) shall:   1. Communicate international vaccine safety signals and all serious AEFIs reported through the Pharmacovigilance Unit to Epidemiology Bureau, FHO and other stakeholders. -   2. Provide the Epidemiology Bureau, Epidemiology and Surveillance Unit counterparts and EPI Program of the datanecessary for analysis (i.e. status of vaccine pre-qualification, international rates, etc.).   3. Conduct collection of samples of implicated vaccine and facilitates laboratory testing by a WHO-recognized National Control Laboratory.   4. Implement regulatory action/s and issues timely advisory to the public on serious AEFI implicated vaccine.   5. Inspect warehouse and storage areas (cold chain facilities and equipments) of vaccines under EPI at all levels.   6. The FDA being the National Regulation Authority shall submit reports to the Uppsala Monitoring Centre.   I. Regional Of\ufb01ces shall:   1. Provide technical assistance (e. g. training, advocacy activities), logistics to local AEFI investigations and response.   2. Establish a functional Regional AEFI Committee (RAEFIC).   3. RESU shall organize an AEFI investigation team (s) when needed and take the lead in the investigation.   4. Regional EPI program managers in their corresponding levels together with the F-DRO shall be involved in the investigation and take the lead to provide corrective actions and monitor outcomes of response interventions.   5. Regional EPI program managers and FDRO shall provide the RESU of the data ' necessary for analysis (i.e. vaccine doses administered/ doses used / doses distributed, status of vaccine pro-quali\ufb01cation).   6. Develop, implement and monitor regional risk communication plan through the Regional HEPO/PIO, and provide technical assistance in the development of the LGU risk communication plan.   7. The regional of\ufb01ce shall track and monitor the compliance of public and private hospitals in the implementation of PIDSR and AEFI surveillance as part of the requirements for renewals of license to operate. The regional director shall issue a regional order to enforce compliance. The team shall inform the Regional Of\ufb01ces /PHOs/LGUs of activities taken against non\u2014complying hospital/institutions.   J. Provincial/ City/ Municipal Health Of\ufb01ces shall:   1. Provide timely feedback to the Local Chief Executives (governor/ city mayor).   2. Provide assistance to the health worker in the form of technical, legal, social, \ufb01nancial assistance among others.   3. Report hospitals and related facilities that fail to comply with the PIDSR reporting requirements to the Regional Of\ufb01ces.   4. Conduct investigation of reported serious and clusters of minor AEFIs within 48 hours and submits report to next higher level.   5. Designate representatives to AEFI investigation team or during RAEFIC case review.   6. Provide or coordinate with other agencies in the provision of assistance to patients with serious AEFIS.   7. Submit and maintain database of all reported AEFI cases.   8. Analyze, interpret and communicate AEFI data.   9. Develop and implement local risk communication plan and strategies.    K. Barangay shall:   1. Shall detect and report AEFIs to next higher level.   2. The midwife/nurse assigned in the area shall institute initial case management and refer to the MHO/CHO.   3. The barangay council shall provide support to the AEFI case including but not limited to transportation, medicines, hospital referral, communication to family and communities.   L. Hospitals shall:   1. Detect and report all AEFI cases to Epidemiology and Surveillance units.   2. Clinically manage AEFI cases.   3. Facilitate case investigation and specimen collection as needed.   4. Provide access of AEFI investigation teams to medical records of AEFI cases.   VIII. REPEALING CLAUSE   Provisions of AO 2010-0017 and other related issuances that are inconsistent or contrary to the provisions of this Order are hereby rescinded or modi\ufb01ed accordingly.   IX. EFFECTIVITY   This Order shall take effect immediately with a one year transition period.  ", "  I. BACKGROUND  The country has achieved considerable progress in improving health outcomes for women, particularly with respect to those outcomes associated With pregnancy and child bearing. This improvement is reflected in significant declines of one of the most important indicator of women\u2019s health, maternal mortality rate (MMR). National average MMR, which measures women's risks from dying at childbirth, has declined considerably from its high levels during the early period after Philippine independence to 209 maternal deaths per 100,000 live births in the 1987-1992 period, to 172 in the 1991-1997 period, to an estimated 138 in the most recent 19-98-2002 period.  Despite this improvement, however, there are still too many Filipino women who die during pregnancy or childbirth given available knowledge, means and services for their proper care. One out of every 100 Filipino women is likely to die from maternity-related causes over her lifetime, and maternal deaths comprise as much as 14% of all deaths of women of reproductive age (15 to 49 years old). As a reflection of society's desire to make pregnancy and childbearing safer for women, among the Philippines Millennium Development Goals (MDGs) is for MMR to decline to 112 maternal deaths per 100,000 live births by 2010 and lower still to 80 by 2015.  The Department of Health (DOH) has defined the package of essential health services that every Filipino woman should access and use in order to have a safe and healthy pregnancy and birth and therefore reduce the risk of maternal death. This package includes: (a) family planning counseling and provision of preferred method of child spacing; (b) antenatal care, tetanus toxoid immunization and micronutrient supplementation of pregnant women; (0) treatment of diseases and possible complications co-existing with pregnancies; (d) early detection and management of, complicated pregnancies; (e) safe delivery and support to breastfeeding. The country's main strategy for attaining its MDG on reducing risks of maternal deaths consists of making this package of essential services with adequate quality available, accessible and utilized according to the needs of every woman of reproductive age.  Available information regarding the actual population-wide coverage of each of these essential services suggests that there is ample room for further expansion in women\u2019s use of these health services as soon as possible. Contraceptive prevalence rates (portion of all married women of reproductive age using a family method of their preference) needs to increase to 80% from 48% for all methods in 2003, and to 60% from 33% for modern methods only. Portion of all pregnant women with at least 4 antenatal visits needs to increase to 80% from 72% in 2003, while portion of pregnantwomen- with at least two doses of tetanus toxoid immunization needs to increase even much more to 80% from 37% in 2003. Percentage of all deliveries with skilled attendance at birth also needs to increase to 70% from 54% in 2003. It is the judgment of public health experts that if the Philippines attains these targeted increases in population-wide coverage of these essential services as soon as possible, then the country should be able to achieve its 2010 and 2015 MDGs to reduce risks of maternal death, aside from contributing to securing other valuable benefits in terms of healthier newborns and children (reduced infant and child mortality) and reduced impoverishment due to illness or premature death (reduced poverty), among others.  The scale of improvement needed from present levels to targeted levels of increased population-wide coverage of various essential health services for women of reproductive age is indicated by the following priorities: nearly a tripling of current tetanus toxoid immunization of pregnant women;a doubling of present contraceptive prevalence rates; a 20% increase over present coverage of skilled attendance of all births; and a 10% increase in current use of adequate antenatal care of all pregnancies. This scale and scope of improvement is deemed attainable by the Philippines but it will not be attainable by the Philippine public sector alone. Fortunately, the Philippines has a large, vigorous and progressive private sector in health that can contribute to the attainment of improved population-wide coverage of essential health services for women.  Of total 85,000 hospital beds in the country, nearly 40,000 are private hospital beds. Private physicians, nurses, pharmacists, midwives and other professional health providers are ubiquitously practicing their professions and providing care in most Philippine communities and localities. The private pharmaceutical market from where women obtain many beneficial goods, products and drugs amounts to a massive P85\u201470 billion in sales annually (2004 data). A 2000 survey of households indicated that of the 77% of households that reported recent use of a health facility, half used public facilities and the other half used private health facilities (including a small portion of private traditional healers). These data suggest the tremendous capacity for providing care to the population that is available in a private sector consisting of practitioners, facilities, hospitals and a vital and large drugs and pharmaceuticals industry.  Given the country\u2019s desire to expand total population-wide coverage of essential health services for women of reproductive age as a key strategy to achieve its MDG on reduced risks of maternal death, and the large available private sector capacity that can contribute to this expansion, the DOH recognizes the need for a national policy on public-private collaboration in delivery of health services to women of reproductive age. As the prime national agency for the protection and promotion of the nation\u2019s health, the DOH hereby formulates, advocates and implements such a policy after conducting requisite technical studies, consultations with various stakeholders and preparations for proper implementation.  II. STATEMENT OF POLICY  It is the national policy to establish and sustain a supportive public and professional opinion climate, conducive regulatory regime, fair health financing system, and responsive operating and business environment in the health sector that promote efficient, effective and equitable collaboration between public and private sectors delivering services necessary for population-wide coverage of essential health services to women of reproductive age at levels sufficient to reduce risks of maternal deaths.  III. GOAL and OBJECTIVE  A. Goal  To improve and sustain reduction of Filipino women's risks from dying due to maternal causes as measured by following:  - Decline of the maternal mortality rate consistent with meeting the country's commitment to this specific MDG in 2010 (MMR not higher than 112) and 2015 (MMR not higher than 80).  - Decline of the maternal mortality rate consistent with meeting the country\u2019s commitment \"to this specific MDG in 2010 (MMR not higher than 112) and 2015 (MMR not higher than 80).  - Expansion of population-wide coverage of the following essential health services : _  > Family planning services: counseling and provision of preferred legal methods (contraceptive use of at least 60% for all modern methods)  > Maternal care services: antenatal care with tetanus toxoid immunization and micronutrient supplementation, plus early detection and management of complicated pregnancies (not less than 80% of all pregnancies), treatment of diseases and complications in pregnant women, safe delivery and support to breastfeeding (not less than 80% of births attended by professional health provider)  B. Objective  To provide policy direction for the public-private collaboration in the health sector within the context of increasing share of private sector provisions in total population-wide coverage of essential health services for women of reproductive age (i.e., private sector share of total contraceptive use, antenatal care and skilled attendance at birth).  IV. SCOPE and COVERAGE  The policy encompasses the operation of all agencies comprising the Department of Health, including its attached agencies like the Philippine Health Insurance Corporation (PHIC) and the Commission on Population (POPCOM) upon concurrence by these agencies\u2019 respective governing Boards, which the Secretary of Health chairs. It also covers the operation of government health agencies under the various national agencies and departments (DepED, DOLE, DND, among others) as well as those under the local governents at province, city and municipal levels in so far as these agencies\u2019 health services operations are governed by technical guidelines and standards mandated by the DOH. It further covers private entities (persons and enterprises) engaged in the provision of health goods and services in so far as this aspect of their operations are similarly governed by technical guidelines and standards mandated by the DOH.  V. DEFINITION OF TERMS  1. Health sector - refers to health system, including all institutions, organizations, enterprises and entities involved in actions that protect, promote or advance health status of individuals or populations; conceptually includes all aspects of society that influence health status but operationally focuses on those entities specifically organized to provide or govern the provision of health services and goods.  2. Public sector - refers to health providers (individual practitioners, health centers, hospitals, organizational units, agencies) operating within the rules and regulations of the government and all providers under the administration and control of the DOH, other national agencies (DepED, DOLE, DND, etc.) or of local governments (provincial, city or municipal governments).  3. Private sector - refers to health providers and facilities (individual practitioners, clinics, hospitals, facilities, drug outlets) licensed and regulated under existing laws but otherwise operating outside the ownership or management of the government; includes the drugs and pharmaceutical industry, non-government organizations as well as proprietary enterprises providing health services as part of their activities.  5. Public health authorities - refers to government entities that have technical responsibility for monitoring, maintaining, protecting and advancing general health status of the population (or public health) within given political jurisdictions such as Municipal or City Health Of\ufb01ce for a municipality or city, Provincial Health Office for a province, Center for Health Development (CHD) for a region, and the Department of Health for the whole nation. These entities - MHO, CHO, PHO, CHD and DOH - often have service provision and delivery activities'which are covered by their inclusion as public sector in health, and thus the emphasis in their being identified as public health authorities is in their technical governance- function in the health sector.  6. Essential health services for women of reproductive age - refers to family planning services (i.e., counseling and provision of preferred legal methods) and maternal care services (i.e., antenatal care with tetanus toxoid immunization and micro-nutrient supplementation, plus early detection and management of Complicated pregnancies, treatment of diseases and complications in pregnant women, safe delivery and support to breastfeeding) de\ufb01ned by the DOH as the package of essential health services for women aged 15-49 years old.  Inter-local health zone - refers to any form of institutional arrangement among different health providers and facilities serving a common population within a local geographic area under the jurisdiction of more than just one local government (e.g., multi-municipalities-province, municipal-ities\u2014city-province, multi-proyinces with component municipalities and cities), which meets theDOH's functional criteria on inter\u2014LGU coordination of health service delivery.  VI. GENERAL GUIDELINES  A. Supportive Climate for Public Private Collaboration  1. DOH shall raise the awareness of the general public and promote informed consensus within the community of health professionals in order: (a) to support commonly shared health goals and aspirations of the nation. and its component localities, and (b) to emphasize the vital necessity of wide, organized, and sustained cooperation and collaboration of everyone in the Successful pursuit of these goals and aspirations. The DOHshall advocate the concept of one health sector serving the collective health of one community and nation. The of\ufb01cial promulgation and wide dissemination of the National Objectives for Health, including the country\u2019s commitment to achieving the MDGs related to health, shall serve as a core foundation forthis central advocacy.  2. In support of attaining the specific MDG on reduced risks of. maternal deaths, the DOH shall in due course issue new national technical program standards for family planning and maternal care that: (a) apply to public and private sectors; (b) adjust service arrangements to the changing and diverse local environments in health care delivery, and; (c) adequately re\ufb02ect the increased importance of public-private collaboration in attainment of public health objectives.  In order to secure the widest possible support for thesenatiOnal technical program standards for family planning and maternal care and ensure willing compliance of the whole health sector, the DOH shall obtain the participation in, contribution to, and eventual endorsement of, these standards by the key national professional organizations of providers of these essential health services to women of reproductive age.  3. DOH entities that operate in various localities (such as Centers'for Health Development and DOH-owned/managed hospitals) as well as PHlC and POPCOM field units in the regions are hereby instructed to jointly establish'and maintain in their respective areas active forums and other social mechanisms for regular on\u2014going dialogues among public and private providers in the locality in order to promote the concept of one health sector serving the collective health of one community and nation. Thesis dialogues shall seek to improve sharing .of information, promote common understanding, address barriers to collaboration and enhance mutual trust and respect within the health sector of each locality.  4. DOH shall assist public providers to recognize the benefits to them from collaborating with private providers. Public providers shall be encouraged to recognize the potential benefits from: '(a) accessing specialized services available only in the private sector; (b) easing congestion-from excessive workloads by referring some patients to the private sector; (c) securing opportunities for adapting useful innovations and practices pioneered in the private sector; (d) obtaining politiCal support from the private sector in getting resources to meet their-budgetary and operational needs; (e) success in, securing availability of a complete range and package of services needed by the community using combined capabilities of both public and private sectors together.  5. DOH shall similarly assist private providers to also recognize the benefits for them from collaborating with the public sector. Private providers shall be encouraged to recognize the potential benefits from: (a) facilitating the referral to the public sector ofsome patients requiring subsidized care beyondtheir means to sustainably-support; (b) accessing from the public sector the numbers and types of patients necessary for an adequate clinical training and research program;(c) obtaining through active collaboration with the public sector more favorable public perceptions as a responsible publicservice enterprise; (d) participating through close cooperation with public sector in policy advocacy and information sharing for health sector priorities and goals.  B. Conducive Regulatory System  1. Within the limits and constraints of applicable laws, the DOH shall seek, in general and in an evolutionary manner, to eventually include explicit mandates for regulated providers to serve public (health (or \u201cpublic health mandates\") in future formulation and implementation of all regulations within the health sector. Such \"public health mandates\" may eventually require regulated entities to perform, as part of their social obligation, certain functions such as the following: (a) to report to public health authorities critical information essential to proper disease surveillance and prevention in the community; (b) to provide to their patients, clients or customers the correct information from public health authorities; (c) to observe technical and clinical practices deemed by public health authorities asessential to effective disease control in the population; ((1) to cooperate and participate in public service activities that protect or promote the general health of the community. As a matter of principle, the DOH shall seek to make the performance of certain tasks critical to the general advancement of the nation\u2019s collective health by collaborating with public health authorities an integral part of requirements that regulated professionals, organizations or enterprises must meet in order to operate within the health sector.  2. The regulation of professional practice in the \ufb01eld of .health (i.e., practice of medicine, nursing, pharmacy, midwifery, laboratory technology, physical therapy, among others) shall continue to be governed by existing laws, institutions, rules, regulations and procedures. The DOH shall coordinate with authorities involved in the regulation of health professions in order to include in future [standards and requirements in licensing such professionals their recognition and acceptance, regardless of sphere or area of practice of their inherent obligation to contribute to meeting the shared health goals of the country through their collaboration with public health authorities.  3. The regulation of drugs and pharmaceuticals, hospitals and other health facilities shall also continue to be governed by existing laws, institutions, rules regulations and procedures. The regulatory agencies that are part of the DOH are hereby instructed to pursue in their future regulatory standards and practices any and all opportunities to integrate, whenever legally or administratively feasible, the performance of appropriate and relevant \u201cpublic health mandates\" by regulated entities.  4. PHIC is hereby requested to adopt a policy that, in future improvements of provider accreditation standards under the National Health Insurance Program (NHIP) and within the limitsof applicable laws, it give due consideration to including explicit requirements for providers to demonstrate evidence of their organized collaboration with public health authorities in their catchment area in order to protect or promote the general health of the area's population.  C. Fair Health Financing System  1. As a general policy, the DOH shall seek to clearly distinguish, on one hand, the financing of public health authorities\u2019 functions (referring to the essential technical functions necessary for effective governance of the health sector at national, regional, provincial, city and municipal levels) from, on the other hand, the financing of health provision functions (referring to the public and private provider functions in delivering services and goods necessary for health).  Adequate financing of public health authorities' functions shall be mainly supported by a sufficient share in the annual tax-financed government budgets (portions of the DOH budget for functions at national and regional levels, of the provincial government budget for functions at the provincial level, and of the city or municipal government budgets for functions at the city or municipal levels) with supplementary financing from revenues through cost recovery fees and charges for some of these functions (such as regulatory and technical support services).  2. In the financing of health care provision, delivery and use, which accounts for the overwhelming bulk of health sector expenditures, DOH shall in general promote greater ef\ufb01ciency, effectiveness and equity through enhanced public-private collaboration.  3. With regards to the portion of the DOH budget, authorized by Congress to be used for health service delivery (such as operation of DOH hospitals, provision of goods and services as part of national health programs), the DOH shall progressively increase the share used to procure goods and services from the private sector, rather than itself produce such goods and services. The DOH via this policy can thus modestly contribute to increasing the assistance of the private sectorin the overall population-wide coverage of essential health services using national and regional level public funding to finance private sector services.  4. With regards to portions of LGU budgets, authorized by their respective local legislative councils to be used for health services delivery (such as operation of local hospitals, health centers, barangay health stations and other local health service activities and provision of goods), the DOH shall encourage those LGUs, through modeling, education, technical advise and advocacy, to explore and consider alternative and cost-effective means for using local public funds to increase population-wide coverage of essential health services via contracting or procurement of goods and services from the private sector. Should LGUs respond positively and strongly to this direction, LGU spending for health can be a major factor in increasing private sector contribution to population-wide coverage of essential health services.  5. With regards to health benefit payments of Philhealth under NHIP, the DOH supports the continued and prudent expansion of overall bene\ufb01t spending currently ongoing which equally cover costs of whichever public and private providers are used by Philhealth beneficiaries. lnthe future, when Philhealth shall have developed additional standards for accreditation that considers public-private collaboration, it might then be possible to reward through the benefit payment mechanism those providers that adopt the most efficient, effective and equitable public-private collaboration practices.  D. Responsive Operating And Business Environment  1. In order-to assure that women without the: means to pay for care (such as those with insufficient incOmes to pay out of pocket, and without Philhealth insurance coverage or without an employer-supported health benefit) are nonetheless able to access and use family planning and maternal care services essential for them to avoid increased risks of maternal mortality, the DOH shall seek to install nationwide a safety net level of free family planning and maternal care services available at each locality supported by an adequate level of public funding and provided either through services of the public sector or through publicly financed services of the private sector.  2. CHD shall arrange and assemble this safety net level of free (publicly funded) family planning and maternal care services at each locality by: (a) having the DOH budget and DOH hospitals cover part of the needed services; (b) securing provincial government support to cover another part through the provincial health budget; and (c) securingcity and municipal governments support to cover the final part through their respective city or municipal health budgets. This arrangement for safety net services in each locality should have speci\ufb01c quantitative target coverage, an agreed criteria for priority beneficiaries and preferred users, and explicit functional assignments among DOH, province, and city/municipality funding and providers for each essential health service included in the package for women of reproductive age.  3. CHD chiefs of DOH hospitals and PHIC area managers shall cooperate to determine the level of services needed beyond the scope of the safety net arrangements. The service needs for family planning and maternal care of other women of reproductive age that are beyond the scope of coverage of the safety net arrangement shall be principally met by the private sector, which shall be funded by Philhealth benefit payments for enrolled beneficiaries, supplemented by employer-supported benefits for those with employers, and by out of pocket payment for costs not covered by other sources. Private sector collaboration with the public sector shall be arranged to ensure that all women of reproductive age have continued access to essential health services within the safety net as well as beyond its coverage. A key policy at the local level will be the routine and smooth referral by the public sector to the private sector of any client or potential user that is beyond the scope of coverage of the safety net arrangements in place at the locality.  4. DOH shall work with LGUs to promote further expansion of private sources of services for family planning and maternal care in their respective localities. This shall inclUde both workplace-based, employer-supported providers as well as freestanding fee-for\u2014service providers in the community. DOH shall encourage LGUs to adopt local policies to officially encourage local private providers to meet service needs that LGUs cannot cover, to facilitate cross-referrals between public and priVate sectors, and to create a business-friendly environment for private health providers.  5. DOH shall implement these policies first in localities most likely to respond toopportunities and challenges. The most urgent geographic priorities where the safetynet coverage for family planning services needs to be arranged and also where rapid growth and business response by the private sector is most needed to meet existing demands are in those provinces and cities where donated condoms, pills and injectables being used by current users are scheduled to be phased out starting the last quarter of 2006. In these affected localities, increase in unmet needs for family planning should be prevented by insuring that: (a) the safety net arrangements are in place as soon as possible; .(b) alternative private sources of service are made available for those beyond the coverage of the safety net arrangement; and (c) public\u2014private collaboration functions well in meeting the needs of current and future new users of various family planning methods. The Centers of Health Development responsible for these provinces and cities are therefore correspondingly advised to give these affected localities utmost priority.  6. DOH shall encourage localities to make their inter-local health zones functional first in delivering: family planning and maternal care services to women of reproductive age. Such inter-local health zones should integrate both public and private providers in their organizational and service delivery arrangements. Publicly-funded and/or publicly provided services in the inter-local health zone should form core of the safety net arrangement and private providers as well as cost-recovery public provisions should meet whatever needs are beyond the safety net arrangement.  VII. ROLES and RESPONSIBILITIES  The roles and responsibilities of DOH, local government units and private partners relative to the establishment of public private collaboration in health are as follows:  A. Department Of Health  1. Central Of\ufb01ce a. Policy and Standards Development Team for Service Delivery  - Responsible for the overall development and management of implementing the public- private collaboration forwomen\u2019s health services; - Formulate strategic plans, programs, projects including mechanisms to operationalize the public-private collaboration;  - Conduct policy forums to advocate concepts and thrust, address concerns and share good practices on public-private collaboration; - Develop technical standards and guidelines on collaborative health service delivery that are appropriate for both public and private entities; and - Develop monitoring and evaluation tools and systems to track progress of collaboration efforts.  b. Policy and Standards Development Team for Financing  - Responsible for overseeing the development of fair health financing system for public-private collaboration thrust and efforts; - Develop financing schemes and models that will increase the contribution of public-private collaboration in the overall population wide coverage of essential health services; - Advocate to government authorities and private entities increase in budget shares or financing for purchase of goods and services in the population wide coverage provision of essential health services; and - Review and develop policies to expand PHIC benefit package for Family Planning and Maternal care.  c. Policy and Standards Development Team for Regulation  - Oversee the integration of \u201cpublic health mandates\" in the development of new regulatdry standards for drugs and pharmaceuticals, hospitals and other health facilities, - Coordinate with and advocate to public health authorities and other regulating agencies to include \u201cpublic health mandates\" in the regulations of professionals, organizations or enterprises operating within the health sector, and - Include explicit requirements of demonstrated evidence of collaboration with public health authorities in the development of new PHIC accreditation systems for providers.  d. Sectoral Management and Coordination Team  - Provide management support and coordinating function to the implementation of public-private collaboration in the health system; - Ensure linkage and adoption of public-private collaboration approach in the overall Fourmula One thrusts and efforts; and - Formulate policies and guidelines that will create responsive Operating and business environment for public-private collaboration.  2. Center for Health Development  - Formulate strategic plans to implement the public-private collaboration for women\u2019s health services in the region; - Conduct advocacy campaigns and forums on public-private collaboration among LGUs and private partners; - Provide technical assistance in setting up public-private collaboration in particular localities; - Arrange and assemble safety net level of free family planning and maternal care services at each locality In the region; - Provide resources for coordination and critical health service provision functions; and - Monitor and evaluate the development and implementation of the collaboration efforts.  B. Local Government Units (Province and City) and Autonomous Region for Muslim Mindanao (ARMM)  - Ensure that the package of essential health services for women are available to its constituents; - Establish coordination mechanism with private partners; - Develop and implement strategic plans and projects with partners on public-private collaboration; - Provide resources for coordination and other critical health service functions particularly for safety net level; - Formulate and issue local policies, ordinances and resolutions supportive of collaboration efforts ,and - Coordinate with CHD in ensuring safety net level of free family planning and maternal care services in their area. - Formulate and issue local policies, ordinances and resolutions supportive of collaboration efforts; and - Coordinate with CHD in ensuring safety net level of free family planning and maternal care services in their area. -  C. Private Sector  - Develop and strengthen poliCiesand programs on maternal care services and family planning services in their respective associations or organizations in line - With national health policies, standards and mandates; - Recommend policies, programs, standards and mechanisms to increase share of private sector provision in the total population-wide coverage of essential health services for women of reproductive age; - Participate in the development of technical standards, regulations and mechanisms related to the inclusion of public health mandates in regulated professionals, organizations or enterprises; - Coordinate with CHD, LGUs and other local public and private entities in the development and implementation of tasks related to the advancement of essential health services for women, public health mandates, in each locality;  - Supplement identified available resources and technical assistance needed; and - Ensure continued access to esSential health services for women of reproductive age.  VIII. REPEALING CLAUSE  The provisions of previous orders inconsistent or contrary with the provisions of this administrative order are hereby revoked, revised, modified accordingly, rescinded and/or repealed.  IX. EFFECTIVITY  This order shall take effect immediately.   ", " I. BACKGROUND/ RATIONALE   A child is a growing individual. Growth of children is an indicator of his/her health and nutrition status. It is sensitive to external factors such as nutrition and disease. Assessing the child\u2019s growth and nutritional status through growth monitoring and promotion (GMP) plays a vital role in identifying appropriate health and nutrition interventions. Hence, GMP is of great importance in child health and nutrition care.   In 2003, the Philippines adopted the National Center for Health Statistics (N CHS) International Reference Standards (IRS) for assessing the nutritional status of Filipino children. However, the NCHS\u2014IRS does not adequately represent early childhood growth at individual or population level assessment. In 2006, the World Health Organization (WHO), in cooperation with the United Nations Children\u2019s Fund (UNICEF), launched the Child Growth Standard (CGS) for children 0\u20145 years old.   The Department of Health (DOH), based on Resolution No. 23. \u201cAdopting the New WHO Child Growth Standards\" issued by the National Nutrition Council Governing Board, agreed to adopt the WHO\u2014CGS as the standards to use in assessing the nutritional status of 0\u20145 years old children and in the conduct of growth monitoring and promotion activities in the country. The reasons cited for the adoption of the WHO\u2014CGS are as follows:   1.) Will give deeper meaning to the achievement of the Millennium Development Goals (MDGs), speci\ufb01cally the target on the prevalence reduction of underweights among children 0\u20145 years old since the growth of Filipino Children will be benchmarked on the best possibility for their growth.   2.) Will allow comparison of the growth of Filipino Children against the single international standard that represents the best description of physiological growth for all children from birth to five years of age as opposed to describing growth against a reference.   3.) Will show that even a child in any part of the world regardless of ethnicity, has the potential to grow and develop as long as the child\u2019s basic needs are met.   4.) Will establish the breastfed infant as the normative model for growth and development, consistent with national and international guidelines that recognize breastfeeding as the best Source of nutrition for infants.   5.) Will detect malnutrition long before signs and symptoms of it become apparent and therefore, allows focus on preventive and promotive interventions rather than rehabilitative/curative measures and reaching more at\u2014risk children.   6.) Will include core development milestones that healthy children are expected to achieve during specified age ranges.   This Order is issued to adopt the WHO-CGS for the assessment of nutritional status of children 0\u20145 years old and in the conduct of growth monitoring and promotion (GMP) and Operation Timbang (OPT) activities, thereby repealing AO 25 s. 2003.   II. OBJECTIVE:   To promote optimum child growth and development through the enhanced implementation of GMP activities using the WHO\u2014CGS.   III.COVERAGE AND SCOPE   This order shall apply to all national, regional and local government units, public and private medical practitioners and health facilities and other agencies and stakeholders who are involved in assessing the nutritional status of children and in conducting GMP and OPT activities.   IV. GENERAL GUIDELINES   1. The growth and development Of children 0\u20145 years (0\u201471 months) old shall be assessed by measuring their weights and heights regularly.   a. For children 0\u2014less than 2 years (0\u201423 months) old, their weights and lengths shall be measured once a month   b. For children 2-5 years (24-71 months) old their weights and heights shall. be measured twice a year   c. The weight and height of a child shall also be measured every time they come in contact with the health care system e.g., when the child is sick and brought in for consultation.   d. The weights of children. 0-71 months taken during Operation Timbang (OPT) shall be done once a year (J anuary\u2014March) which would cover at least 16.2% of the total p0pulation. Underweight and overweight children identi\ufb01ed during OPT shall be referred to the health facility for regular growth monitoring and for institution of appropriate interventions.   2. WHO\u2014CGS shall be used as the standard in the assessment of child\u2019s nutritional status. Standard measurement indicators to measure child\u2019s growth are: weight for age for 0-71 months old; length for age for 0-23 months old or height for age for 24\u201471 months old; and weight for length for 0\u201423 months old or weight for height for 24\u201471 months old.   2.1 Weight-for-age indicator - reflects body weight relative to the child\u2019s age on a given day. This indicator provides a rough estimate of child\u2019s present nutritional status.   2.2 Length/height\u2014for\u2014age indicator \u2014 re\ufb02ects attained growth in length or height at the child\u2019s age at a given visit. Length/height combined with age will give a good indication of stunting which re\ufb02ects past and chronic malnutrition. Length and height are measured to children under two (2) years and children above 2 years, respectively.   2.3 Weight-for-length/height indicator - re\ufb02ects body weight in proportion to attained growth in length/height. This indicator can distinguish current malnutrition (acute) from past malnutrition (Chronic).   3. All newborns and children ages below 71 months old shall be given an ECCD card as the tool for growth monitoring and promotion. The ECCD card for boys and girls shall serve as the record of the essential services which a child shall receive from 0-71 months old. This card also contains a chart where the weights and heights of children shall be plotted to observe trends in growth and to detect growth faltering so that immediate measures/interventions shall be instituted. All newborns whose mothers have been issued a Mother and Child Book (MCB) shall use the ECCD card attached in the MCB.   4. Filling-up of ECCD Card and MCB shall be administered by a health professional e. g. doctors, nurses, midwives, nutritionist. Trained barangay health workers (BHWs) and barangay nutrition scholars (BNS) may also administer but under the supervision of the health professional.   5. The WHO-CGS Growth tables and charts, ECCD cards and equipments e.g. weighing sca1es/infantometer/microtoise/height/length board, etc. shall be used and made available in all Rural Health Units, public and private health and hospital facilities or in places where weight and height measurements will be taken. The reproduction of ECCD cards will be the responsibility of the LGU with augmentation from national agencies and other stakeholders, partners and donors   6. Assessing child\u2019s nutritional status/monitoring child\u2019s growth and development shall be integrated into the existing MNCHN service delivery channels and through other approaches that could reach children 0-71 months old children or in any contact point of visit of the child e.g Garantisadong Pambata, Operation Timbang, IMCI, EPI, etc.   7. Promotion to encourage mothers to bring their children for growth monitoring and availment of health and nutrition services shall be intensified.   8. Children needing immediate assistance shall be referred to the appropriate institution/health system.    V. ROLES AND RESPONSIBILITIES   A. Department of Health   1. National Center for Disease Prevention and Control   The DOH-NCDPC is primarily responsible in the overall execution and adoption of the revised policy and guidelines on Child Growth Standard and GMP. It will undertake the following tasks:   - Lead in the dissemination of the AO and advocate for its adoption and implementation among concerned stakeholders  - Provide technical inputs in the operationalization of the WHO-CGS and GMP  - Mobilize funds for the trainings of trainers and roll out trainings of WHO-CGS and GMP at the CHD/provincial levels and advocate for additional resources  - Monitor and evaluate the field implementation of the WHO-CGS and GMP  - Establish coordination and networking with FNRI, NNC and other stakeholders in planning, implementation, monitoring and evaluation of WHO-CGS adoption.   2. National Center for Health Promotion   - Develop prototype materials on WHO-CGS and GMP in coordination with DOH\u2014 NCDPC - Provide technical assistance to CHDs to help LGUs adopt and implement the WHO-CGS and GMP - Promote the adoption of WHO-CGS and GMP among concerned agencies and practitioners   3. National Nutrition Council   - Coordinate and facilitate the adoption of WHO\u2014CGS at local level  - Mobilize resources for the localization of the WHO\u2014CGS  - Evaluate progress of the CGS   4. Center for Health Development (CHD)   - Disseminate the revised AO on WHO-CGS and advocate for its adoption and implementation by LGU health systems within their respective regions - Provide technical assistance to LGUs, NGOs, academes and other stakeholders relative to WHO\u2014CGS adoption and GMP implementation - Generate additional resources to implement the WHO\u2014CGS and GMP - Conduct of orientation and training on WHO-CGS and GMP - Monitor the implementation of WHO-CGS and GMP in the region   5. Hospitals   - Ensure all growth tables and charts in the hospital are WHO-CGS based - Provide budgetary allocation for the procurement of ECCD cards and equipments for taking of weight and height measurements - Conduct orientation and/or training of hospital staff in using the WHO\u2014CGS and GMP - Monitor the implementation of WHO-CGS adoption and GMP implementationin the hospital   6. Local Government Units (LGUs)  - Ensure funding for the implementation of the WHO\u2014CGS and GMP - Ensure availability of weighing scales, microtoise, infantometers, height boards, ECCD cards, WHO-CGS tables and charts and other necessary supplies to be used for the assessment and recording of nutritional status - Ensure all growth charts and tables used in the LGU health facilities/day care centers are WHO-CGS based - Conduct orientation and training of field health workers including barangay health workers and barangay nutrition scholars in using WHO\u2014CGS and GMP - Monitor and evaluate the WHO\u2014CGS and GMP implementation in their localities - Establish coordination and networking among concerned agencies in WHO\u2014CGS and GMP implementation   7. Private Sector/Professional Groups   - Disseminate and promote the use of WHO\u2014CGS among private health practitioners  - Generate resources for the implementation of WHO\u2014CGS by private sector   VI. REPEALING CLAUSE   Administrative Order No. 25 s. 2003 and all other orders and related issuances found inconsistent with the provisions of this issuance are hereby rescinded.   VII. EFFECTIVITY   This Order shall take effect immediately.  ", "  1.0 BACKGROUND   1.1 The DOH Women\u2019s Health and Safe Motherhood Project (WHSMP) Maternal Care Component includes a Civil Works sub-component which will upgrade selected hospitals to enable them to provide 24\u2014hour obstetrical emergency care through improvement of ward, delivery and operating room, triage and laboratory facilities and essential furnishings; will renovate selected rural health units and barangay health stations to enable them to support the provision of prenatal and post-natal care, as well as safe deliveries; will construct maternity waiting homes as \u201chalf way\" houses for at risk obstetrical cases who live in very remote areas and lying-in clinics that provides normal delivery care on a 24-hour basis.    2.0 ORGANIZATION AND PRINCIPLES  2.1 The Civil Works sub\u2014component shall have four major phases of work. These are SITE AND FACILITIES INVESTIGATION (Assessment of Selected Health Facilities), PROJECT DEVELOPMENT (Preparation of Schematic and Design Development Plans), PROJECT DOCUMENTATION (Preparation of Detailed Architecture and Engineering Plans and Other Contract Documents) and PROJECT IMPLEMENTATION (Bidding and Awarding of Contracts and Construction).   2.2 The overall-all responsibility for management and administration of this particular sub- component shall rests upon the Project Management Office (PMO) of the WHSMP with technical assistance from the Health Infrastructure Service (INFRA), DOH.  2.3 The engineering units of the Regional Health Offices (RHOs), being the regional technical arm of the INFRA as far as health infrastructure projects are concerned, shall render technical assistance to the WHSMP by ensuring the proper implementation of project guidelines in their areas of jurisdiction.   2.4 The four major phases of work will be accomplished with the assistance of two consulting firms, the Philippine Center for Population and Development and the DCCD Engineering Corporation, hereinafter referred to as the Consultant.  2.5 The Local Government Units (LGUs), by virtue of a Project Implementation Agreement (PIA) executed with the WHSMP-DOH, shall support the conduct of the major phases of work by providing access to project sites, and needed data as well as monitoring and supervising the actual activities of these projects.    3.0 GUIDELINES FOR THE FOUR MAJOR PHASES OF WORK  3.1 SITE AND FACILITIES INVESTIGATION  3.1.1 This phase of work will include investigation of existing health facilities which were previously selected pursuant to provision no. 4 hereof and to include hospitals, rural health units and barangay health stations sites and structures to determine, among others, their architectural and structural integrity, the state of usefulness and availability of utility systems, and the prevailing environmental conditions.  3.1.2 The Consultant shall perform the above work for all selected hospitals, rural health units and barangay health stations. Space requirement analysis and soil foundation investigation when necessary shall be conducted in areas where lying-in clinics or maternity waiting homes will be constructed.  3.1.3 For each province, the Consultant shall prepare a Site Investigation Report on all health facilities visited which shall be submitted to WHSMP-DOH three (3) weeks after completion of the site investigation.   3.1.4 The INFRA Service shall assist the PMO in monitoring the work of the Consultant during the conduct of this phase of work.   3.1.5 The Regional Health Office WHSMP Coordinator and Engineer together with the Provincial and Municipal Engineer shall assist the Consultant in providing orientation on the scope of work of the civil work sub-component of the Project to the Provincial Governor, Municipal Mayor, Provincial Health Officer, Chiefs of Hospitals and Municipal Health Officers prior to the start of this phase of work.  3.1.6 The Regional Health Office WHSMP Coordinator and Engineer shall extend the appropriate assistance to the Consultant in data gathering and in the conduct of periodic visits by the PMO, INFRA Service and/or the Consultants to the selected health facilities.  3.2 PROJECT DEVELOPMENT  3.2.1 This phase of work will include the preparation and approval of schematic designs of the hospitals, rural health units and barangay health stations to be repaired/renovated and of the lying-in clinics and maternity waiting homes, to be constructed.  3.2.2 The Consultant shall perform the above work, subject to the review and evaluation of the PMO through INFRA Service for all selected health facilities.  3.2.3 The Consultant shall submit a Report consolidating all the approved schematic designs on a per province basis.  3.2.4 As a rule, the approved schematic designs will be forwarded to the end\u2014user (Chief of Hospital for selected hospitals and/or maternity waiting homes, and Municipal Health Officer for the selected rural health units and/or lying-in clinics and barangay health stations) for concurrence.  3.3 PROJECT DOCUMENTATION  3.3.1 This phase of work will focus on the preparation and approval of bid documents which include among others, Instruction to Bidders, Detailed Architectural and Engineering Plans, Technical Specification, General Conditions of Contract, Detailed Direct Cost Estimates with unit cost analysis for materials and labor and other related bidding documents like Bid Bulletin, etc.  3.3.2 The Bid Documents shall be prepared by the Consultant using the funding agency's Standard Bidding Documents for Procurement of Civil Works, Asian Development Bank (ADB) or International Bank for Reconstruction and Development (IBRD) as the case may be.  3.3.3 The Direct Cost Estimates of the Approved Agency Estimates (AAE) will be based on the Bill of Quantities submitted by the WHSMP Civil Works Consultant. In case the Regional Civil Engineer finds any difficulty in the preparation of the Direct Cost Estimates for the AAE resulting from budgetary constraints and existing local conditions such as local price indices of materials or differences in labor costs; he is authorized to make the necessary adjustments through deletion or downgrading of minor items provided that these adjustments are done with the knowledge of the Project Manager and the Consultants who prepared the Bill of Quantities.  3.3.4 The standard Contract Documents of the funding agency will be used.  3.4 PROJECT IMPLEMENTATION  3.4.1 This phase of work will include public bidding, awarding of contracts, construction period and final project acceptance and turnover.  3.4.2 The public bidding and awarding of contracts of projects partly or wholly financed from international institutions will be conducted using the guidelines stipulated by the funding agency. However, provisions of PD 1594 (Rules and Regulations for the Implementation of Government Infrastructure Projects) as amended and DOH A.O. 40s. 1996 shall apply in supplementary character.  3.4.3 The public bidding of projects will be done in the Regional Health Offices in order to tap the services and resources of the local industry. Accordingly, all regional health offices personnel involved in the bidding process shall temporarily be relieved of their regular functions during the entire process to facilitate contracting.  3.4.4 The Regional Infrastructure Prequalification, Bids, and Awards Committee (RIPBAC) shall submit to the DOH-WHSMP the bidding proposals of the first three lowest complying bidder including the Abstract of Bids, Minutes of the Pre\u2014bidding Conference and Bidding Proper, Bids Evaluation Report and Resolution to Award before any award shall be made. These documents shall be sent to the funding agency for concurrence.   3.4.5 As a general rule, contracts will be awarded at the Regional Health Office level and approved by the Regional Health Director.  3.4.6 The Regional Health Director shall be the contracting party in the Owner-Contractor Agreement.  3.4.7 The task of regular construction supervision of the projects will be the responsibility of the engineering units of the Office of the Governor for hospital projects and of the Office of the Mayor for RHU/BHS projects as provided for in the Project Implementation Agreement (PIA) between the DOH and the Local Government Units. They shall submit a Monthly Progress Report to the Regional Health Office not later than every 15th day of the succeeding month using the standard reporting form of the DOH-WHSMP.  3.4.8 The funding Agency guidelines shall be used in the contract implementation up to project acceptance and turn-over, however, PD 1594 provisions shall apply in supplementary character.  3.4.9 The Regional Health Office engineering units shall conduct periodic monitoring of construction work activities in their areas of jurisdiction. They shall prepare monthly status reports using the standard report for the DOH-WHSMP, copy furnished the INFRA Service.   3.4.10 As a general rule, the completed projects will be accepted by the Regional Health Director, and the WHSMP Project Manager upon the recommendation of the INFRA.  3.4.11 The completed projects will be turned over to the Local Government Units by the DOH.  4.0 SELECTION CRITERIA AND SCOPE OF WORK FOR CIVIL WORKS  4.1 Provincial and District Hospitals  The causes of maternal deaths are often directly related to the need for interventions beyond primary health care capabilities. The first referral level obstetric hospital is therefore needed to provide these services. The essential obstetric functions at the first referral level are:  (i) to perform caesarean sections (ii) to give anesthetics (iii) to give blood transfusions (iv) to carry out curettage for incomplete/septic abortions/miscarriages (v) to perform other minor surgical OB interventions such as voluntary surgical contraception (vi) to give neonatal special care  Selection Criteria for Provincial Hospital  The final selection of provincial hospitals will be based on the following criteria:  (i) located in a project province  (ii) facility to which the rural health midwives and rural health doctors can directly refer; (iii) requires upgrading of obstetric facilities (measured against a standard list of needs) to provide good quality, safe, and essential first-referral level facilities; (iv) if the provincial hospital is within 15 to 30 minutes of the regional medical center which can receive referrals direct from the rural health unit staff, then the provincial hospital should not be upgraded; (v) no facility will be upgraded to first referral level unless it already has the basic elements to provide emergency obstetric care already available or guaranteed by the provincial government (the package of needs is the minimum required and cannot be reduced or modified); and (vi) no facility will be upgraded for obstetrics care if the whole facility is in very poor condition and not planned for rehabilitation, or if a new facility is being planned, or if another financing source is planning improvements or upgrading.  Additional Selection Criteria for District Hospitals  In addition to the criteria outlined above, the following criteria will apply to district hospitals that are to be upgraded:   (i) 25-bed capacity or greater;  (ii) a facility to which the rural health midwives, and rural health doctors can directly refer, which is a maximum of 2 hours via local transportation for most of the rural population; (iii) the facility has staff available to support 24\u2014hour intensive nursing and emergency surgical care; and a minimum staff allocation of 4 doctors, 6 nurses and 8-12 trained midwives; and  (iv) LGU is committed to support the district hospital's operation and maintenance expenses.  Scope of Work   Each hospital will be upgraded to have:  (i) a fully operational obstetrics unit, including:  (a) a labor room (b) a delivery room (c) an operating room (d) a septic room  (e) an isolation room (f) an examination room (g) a nursery for intensive neonatal care  (h) a reception and triage area (i) a recovery room (j) a sterilizing room, and (k) adequate water, sanitation, and electricity infrastructure:  (ii) a laboratory capable of supporting blood bank and essential laboratory tests for emergency obstetrics.   The decision of whether to build annexes or not in the provincial hospital is to be made by the end user in coordination with the WHSM Project Management Office, based on utilization rates and human resource complement. If in case the above criteria can not be accommodated, the minimum requirements of the Bureau of Licensing and Regulations for provincial and district hospital shall be followed.   4.2 Rural Health Units (RHU)  The rural health unit is the closest full-time facility providing primary healthcare to a community. These facilities have a rural health midwife on call at all times. RHUs provide primary health care, minor surgery, (e.g., wound dressings, suturing) antenatal and postnatal care, family planning (pill and condom distribution, insertion and removal of intrauterine devices), nutrition, management of common infectious diseases, counseling and preventive intervention (e.g. immunization).   Issues that presently compromise the quality of these services provided at these facilities include lack of privacy for clients; poor management of sterile conditions poorly maintained facilities and equipment; lack of essential equipment, drugs, and supplies; lack of reliable and clean sources of water and power; poor sanitation facilities, especially needed for women undergoing internal examinations and for antenatal clients.  Selection Criteria  RHUs that are selected will:  (i) have a permanent or assigned rural health physician;  (ii) have a staff who is a resident of the catchment area where the RHU is being upgraded - where this staff can be called anytime from his/her residence to provide for emergency obstetrical care;  (iii) serve larger population catchment areas with easy access to the facility than other RHUs; (iv) be accessible to most communities and to the first referral level facility; (v) no RHU will be upgraded if the whole facility is in very poor conditions and not planned for rehabilitation, or if a new facility is being planned or if another financing source is planning improvements or upgrading; (vi) no RHU will be upgraded if the facility is less than 5 kilometers from any public health facilities; and (vii) have political and community will and support.  Scope of Work  The Project will upgrade the facility to increase its capacity to provide acceptable, safe and quality women's health service by:  i) repairing existing infrastructure such as root, ceiling, guttering, paintwork; ii) providing for connection to local electricity source if available; iii) improving water supply to the facility iv) improving sanitation facilities v) improving the capacity to provide privacy for clients for physical examinations and counseling by having a separate room for this purpose; (vi) improving the storage capacities for essential drugs and equipment; (vii) providing capacity for observation area for clients who may need observation i.e. prenatal/consultation room; and (viii) placing on the front door a board to notify visitors of the location of staff on call during weekends and nights.  4.3 Barangay Health Station (BHS)  The bararangay health station is the health post where the rural health midwife may base her work, and from where she may serve one to three barangays. The BHS should provide primary Health care; antenatal and postnatal care; family planning (pill and condom distribution); management of common infectious diseases; nutrition; preventive intervention (e.g. immunization) and counseling.  Issues that presently compromise the quality of services provided at these facilities include: lack of privacy for clients when requested; poor management of sterile conditions; poorly maintained facilities and equipment; lack of essential equipment, drugs, supplies; lack of reliable and clean sources of water and power; poor sanitation facilities, especially needed for women undergoing internal examinations and for antenatal clients.   Selection Criteria  (i) serve larger population catchment areas with easy access to the facility than other BHSs - eg. BHS that can centrally serve three to five barangays. (ii) located in the catchment area of an RHU that 15 being upgraded; (iii) accessibility to the communities (iv) no BHS will be upgraded if the facility is in very poor condition and not planned for rehabilitation, or if a new facility is being planned, or if another financing source is planning improvements or upgrading; (v) no BHS will be upgraded if the facility does not have a permanent assigned midwife; (vi) political and community will and support.  Scope of Work  To increase its capacity to provide an acceptable, safe, and quality women\u2019s health service, the Project will: (i) repair existing infrastructure such as roof, ceiling, guttering, paintwork; (ii) provide for connection to local electricity source if available; (iii) improve water supply to the facility; (iv) improve sanitation facilities; (v) improve the capacity to provide privacy for clients for physical examination and counseling by having a separate room for this purpose; and (vi) improve the storage capacities for essential drugs and equipment.  4.4 Lying-in Clinics (LC)  The lying\u2014in clinics offer services for safe deliveries; beds in which to rest for a few hours before returning home postpartum; and postdelivery counseling on mother and child care, family planning, and other aspects of women\u2019s health. They also provide an opportunity for the midwife to supervise deliveries by traditional birth attendants and in\u2014service training. They will serve as a point for stabilizing a women prior to transfer is she is suffering from an obstetrical complication.  The lying\u2014in clinic will be attached in the ground of an RHU.   Selection Criteria   The RHUs that will be upgraded to provide lying\u2014in clinic services will:   (i) already have staff to provide services for women on a 24\u2014hour basis, (ii) be located in areas that are easily reached by most of the population; (iii) be in the district with hospital that will be upgraded to first referral level obstetrical service capacities; and (iv) be near the main road.  Scope of Work  (i) a three-bed labor/post delivery room (ii) a delivery room (iii) a toilet and bathroom (iv) piped water (v) electricity (vi) three beds and bedside tables and (vii) equipment for RHU midwives.  4.5 Maternity Waiting Homes (MWH)  The maternity waiting homes provide pregnant women in hard to reach areas with a temporary residence where they can be observed prior to delivery. Women can treat it like a home, can be accompanied by a family member, and can prepare their food, etc.  While in residence, the pregnant women can be more closely monitored by the first referral level obstetric facility through provision of prenatal care and can be quickly admitted to the first referral level facility (i) at the onset of labor, (ii) at the first sign of any complications, or (iii) if an unanticipated complications arises. The facility addresses two problems regarding early management of obstetric complications.  (i) women who are identified as having high-risk pregnancies may not like to stay for long periods of time in a hospital-away from family members, in unfamiliar surroundings and where they believe sick people should be;  (ii) women who may need intervention can be quickly transferred to the hospital at the onset of labor or a problem.  Maternity waiting homes will be in the grounds of the selected provincial or district hospital.  Selection Criteria  The selected hospital that will be upgraded to provided maternity waiting home will:  (i) have a catchment area population that is hard to reach; (ii) have a facility with catchment area that have high levels of maternal deaths, perinatal mortality and morbidity; (iii) have adequate space to establish a maternity waiting home; (iv) have adequate manpower complement.  6cope of Work  (i) 2 three-bed room  (ii) a toilet and bathroom (iii) a kitchenette cum dining/receiving room (iv) piped water  (v) electricity  (vi) 6 beds and 3 bedside tables   5.0 UTILIZATION OF SAVINGS FOR VARIATION ORDER   Any amount of savings as a result of lower bids shall be used in the following prioritized item of works. Such savings shall be reprogrammed only within the province concerned.  5.1 Priority Item of Work  5.1.1 Water storage system 5.1.2 Repair or Replacement of Roofing 5.1.3 Flooring Finishes use vitrified unglazed tiles 5.1.4 Repainting of roofing, walls ceiling, doors 5.1.5 Repair/ Replacement glazed and unglazed tiles for toilets 5.1.6 Repair/ Replacement of windows, doors   6.0 EFEECTIVITY  All other orders and issuances inconsistent with this order are hereby rescinded.  This order shall take effect on February 16, 1998.    ", "  I. Rationale  Article XV, Section 3-A of the 1987 Constitution of the Republic of the Philippines emphasizes \u201cThe right of spouses to found a family in accordance with their religious convictions and the demands of responsible parenthood.\" While the government as a whole recognizes the demographic dimension of Family Planning (FP) initiatives, the Department of Health (DOH) as the lead agency, is concerned with PP and Natural Family Planning (NFP) solely for the health advantages that ought to be enjoyed by individual families.  The Philippine FP Program gives premium to the health needs of the population by providing clients with high quality care and by enhancing the efficiency and effectiveness of health service delivery. The DOH issued in January 1998 Administrative Order (A0) No. 1-A, Creation of Philippine Reproductive Health Program, which has FP as one of it\u2019s identified priority health care services. The DOH then issued AO No. 50-A s. 2001, National Family Planning Policy, to prescribe the key policies for FP services as element of reproductive health, focusing on seven (7) modern FP methods including NFP. AO No. 125, s. 2002 was issued defining the NFP Strategic Plan, 2002 \u2014 2006 which calls for the setting up of structures and activities necessary in the mainstreaming of NFP. This policy specifies the modern accepted methods of NFP, stressing the medical and sociological advantages of the approach, as well as its high efficacy of 96 \u2014 98% user effectiveness (International Journal on Fertility, 1986).  The government has the responsibility to provide information on medically-safe and socially-acceptable means towards enabling reproductive-age couples attain their respective family life aspirations. There is a policy directive for the DOH to anchor FP Programs on these four pillars: Responsible Parenthood, Birth Spacing, informed Choice, and Respect for Life.  To operationalize this directive and to better equip and inform couples, the DOH is providing a wider range of PP options covering all natural and existing modern artificial FP methods.Recognizing the challenge of reducing the 20.5% unmet need for FP and particularly increasing the 0.2% NFP current user (2002, NSO-FPS), the DOH shall be employing a two\u2014track strategy - one program to operationalize NFP and another program to run the existing FP. This order shall prescribe guidelines for the establishment of the NFP program for it to acquire a distinct, discrete personality all its own and as separate program from the existing FP program. Through the NFP program, the DOH envisions to work more closely with groups and partners which want to promote NFP exclusively and in the long run mainstream NFP in the Philippine Society.  II. Vision  Filipino families enjoying the benefits of responsible parenthood through the practice of safe, affordable, and efficacious methods of planning their families so they may attain their respective family life aspirations through means that are in consonance with their personal preferences and moral principles.  III. Mission  The DOH, in partnership with Local Government Units (LGUs), Non-Government Organizations, church groups and religious organizations, civic groups, and other interested organizations shall promote and teach modern methods of NFP to couples of reproductive age who prefer the approach over the use of artificial methods.  IV. Objectives  General  To make appropriate NFP advocacy and services available to Filipinos of reproductive age to enable them to truly exercise informed choice in attaining their desired family size according to their own family life aspirations, thereby attaining Responsible Parenthood.  Specific  1. To reduce the incidence of unplanned pregnancies among couples who have chosen to use natural means, but have been taught methods that ignores fertility awareness, or have found NFP difficult or perplexing;  2. To enable sub\u2014fertile couples achieve pregnancy when desired through the full application of their knowledge on fertility awareness and the various NFP methods available, minimizing the need for artificial reproductive technologies for this purpose; and  3. To reduce the incidence of unwanted and risk pregnancies, sexually-transmitted infections, and social problems associated with illicit sex practices through the values-orientation dimension of its training modules, and through the accompanying advocacy initiatives taken by both government and its partners.  V. Policy Statements  1. The general principles of NFP as provided for under AO No. 125 s. 2002 shall continue to be the primary basis of the NFP program.  2. The NFP Program shall recognize only the modern NFP methods that have been acknowledged by international authorities and NFP service providers, and subject to extensive testing to ascertain their efficacy and scientific validity. These include Cervical Mucus (Billings Ovulation) Method, Basal Body Temperature method, and the Sympto-Thermal Method which are all fertility awareness\u2014based methods of planning pregnancies, and the Lactational Amenorrhea Method which is a method used by breastfeeding mothers to delay the onset of subsequent ovulation so as to postpone subsequent pregnancy.  3. The Program shall no longer include methods that are not founded on fertility awareness on the part of the couple or of the woman whose ovulatory cycle is of concern.  4. The Standard Days Method (SDM), while regarded as an innovation, is, nevertheless, another calendar-based method wherein, through computer modeling using menstrual cycle data from large groups of women, a population-based fertile window is identified. These findings are translated into a necklace where the population-based fertile window is colored differently. A rubber is used to mark the days of the women\u2019s cycle. While this method is still under study, it should be used only as an adjunct with the other already established modern NFP methods and should not be preferred over the other NFP methods.  5. Fertility awareness orientation shall be the main mechanism of advocacy for NFP and may be targeted to the health providers, the general public aged 15-49 years, especially adolescents and young adults in various settlings such as the school, community and other venues of education and communication  VI. Implementing Mechanism  To expedite the implementation of this program on a nationwide basis, the following bodieslunits are created and/or mobilized:  A. DOH Natural Family Planning Management Committee (DOH\u2014NFPMC)  The DOH\u2014NFPMC shall report to the Director of the National Center for Disease Prevention and Control and coordinate with the National NFP Committee (NNFPC). This is an ad\u2014hoc group created under Department Order No. 288\u20140. 8.2002 and Department Order No. 2-J 8.2003, which is primarily tasked to provide advice to the Secretary of Health on the policy and implementation issues for NFP.  The DOH\u2014NFPMC shall function as follows:  1. Develop policies, plans and guidelines including investment plans for the strengthened implementation of the NFP Program and ensure that these are in line with the policies and goals of the DOH;  2. Ensure that NFP is mainstreamed in all relevant DOH programs as well as in all national and local activities;  3. Enhance harmonious networking and proper coordination among stakeholders;  4. Encourage the development of innovative projects and strategies in providing access to NFP services;  5. Ensure the full support of and sustained commitment for NFP activities from national agencies and local government units, non-government organizations and the private sector; and  6. Facilitate the accreditation of other agencies or institutions, whether government or non\u2014government, desirous of working in cooperation with the DOH in mainstreaming NFP.  B. Regional NFP Program Manager  The DOH NFP Program shall be implemented through all the CHDs. As such, NFP Program Managers shall be appointed in each of the CHDs.  The Regional NFP Program Manager shall be under the administrative supervision of the Regional Director and shall be under the technical supervision of the DOH-NFPMC. Helshe shall constantly communicate with the DOH-NFPMC at the DOH Central Office for instruction, guidance, updates, monitoring, and other forms of technical support and supervision.  The Regional NFP Program Manager shall function as follows:  1. Develop policies, plans, and guidelines including investment plans for the strengthened implementation of the NFP Program for the Region and ensure that these are in line with the policies, goals, and directives of the DOH central office;  2. Ensure that NFP is mainstreamed in all relevant DOH programs in the Region as well as in all activities conducted by the CHD, ascertaining that all health workers are aware of the program and its basic principles;  3. Organize and periodically convene the Regional NFP Committee composed of individuals from government or non\u2014government organizations that are already actively involved in providing NFP services using the modern methods;  4. Organize training of trainer sessions for selected health workers, community workers, and the like who would be subsequently tasked to provide NFP services in their respective locales;  5. Monitor the progress and quality of NFP service delivery at the local level;  6. Enhance harmonious networking and proper coordination among local stakeholders, including Church and religious groups visFa\u2014vis the NFP program;  7. Ensure the full support of and sustained commitment for NFP activities from local government units, non-government organizations, and the private sector;  8. Coordinate with the DOH-NFPMC for periodic instructions, advocacy materials, program directives, training, and monitoring; and  9. Submit monthly reports to the CHD Director, and the DOH-NFPMC on the accomplishments, status, and plans of the Regional NFP Program.  VIII. Funding  All expenses incurred during the meetings shall be charged to the National Center for Disease Prevention and Control Funds and l or Family Health and Primary Health Care Program Funds. Further, regional meetings and other related expenses shall be charged from the regional NFP budget allocation.  IX. Repealing Clause  This Order rescinds all other orders and circulars that are in inconsistent with the provisions of this issuance.  X. Effectivity  This Order shall take effect immediately.   ", "   To pursue the Philippine commitment towards Polio Eradication, we have requested the President to declare April 17 and May 15, 1996 and every third Wednesday of the year from 1996 - 2000 as Knock Out Polio Days. The attached \"Implementing Guidelines for the Knock Out Polio Campaign\u201c is hereby adopted to govern the activities during the series of national immunization rounds for the next 5 years.  Please be guided accordingly.   ", "    I. BACKGROUND AND RATIONALE   During the last quarter of 2013 and \ufb01rst quarter of 2014, the country observed high measles transmission in many provinces and cities resulting in increased measles incidence rates by the end of March 2014. Subsequently, the number of reported suspect measles cases increased and specimens submitted to the National Measles Reference Laboratory of the Research Institute for Tropical Medicine (NMRL/RITM) surpassed its capacity to conduct con\ufb01rmatory testing on all specimens. The above circumstances challenged the capacity of both the measles surveillance system and NMRL in providing timely epidemiologic data and laboratory results to con\ufb01rm the outbreak as well as local health workers to promptly implement appropriate response and control measures.   II. OBJECTIVES   1. Provide health workers guidance on responding to high transmission of measles in the community; and   2. Establish epidemiological linkage of new cases in barangays with laboratory con\ufb01rmed case(s) following the representative sampling method adopted by the NMRL   III. SCOPE AND COVERAGE   This issuance shall apply to the entire health sector, to include public and private health facilities both at the national and local government units involved in disease surveillance and response activities.    DEFINITION OF TERMS   1. Case Investigation Form (CIF)  Refers to reporting form that allows collection of standard information to acquire epidemiological study of disease incidence and disease patterns   2. Clinically-Measles Compatible Case  Any individual, regardless of age, with history of fever (38\u00b0C or more) or hot to touch, generalized non-vesicular rash of 3 or more days duration; and at least one of the following cough, coryza, or conjunctivitis    3. Laboratory\u2014 con\ufb01rmed Measles Case  A suspected measles case with a positive laboratory test result for measles-speci\ufb01c IgM antibodies or other approved laboratory test method   4. Laboratory- con\ufb01rmed Rubella Case  A suspect measles case with a positive laboratory test result for rubella\u2014speci\ufb01c IgM antibodies or other approved laboratory test method   5. Epidemiologically- Linked Measles Case   Cases with a credible mode of transmission from a laboratory-con\ufb01rmed case or another epidemiologically- con\ufb01rmed case 7 to 21 days prior to rash onset  6. Provincial Health Of\ufb01ce (PHO)  Refers to the unit established in the Provincial Health Of\ufb01ces that provides services on public health surveillance and epidemiology   7. Municipal Health Of\ufb01ce (MHO)  Refers to the unit established in the Municipal Health Of\ufb01ces that provides services on public health surveillance and epidemiology   8. City Health Of\ufb01ce (CHO)  Refers to the unit established in the City Health Of\ufb01ces that provides services on public health surveillance and epidemiology  9. Regional Health Of\ufb01ce (RHO)  Refers to the unit established in the Centers for Health Development or the DOH regional of\ufb01ces that provide services on public health surveillance and epidemiology   10. Rural Health Unit (RHU)  Refers to the unit established in the rural health units that provides services on public health surveillance and epidemiology  11. Disease Reporting Unit (DRU)  This includes all health facilities (rural health units, hospitals, laboratories, seaports and airport are considered DRUs)   12. Research Institute For Tropical Medicine (RITM)  It houses the Department of Virology which is the National Measles Reference Laboratory (NMRL)     V. IMPLEMENTING MECHANISM   OBJECTIVE 1. PROVIDE HEALTH WORKERS GUIDANCE ON RESPONDING TO HIGH TRANSMISSION OF MEASLES IN THE COMMUNITY   Health workers at all levels are encouraged to follow these basic steps in outbreak response:     -Investigate and isolate suspected measles case(s) in the household   -Obtain appropriate blood specimens for laboratory con\ufb01rmation   -Inform health authorities   -Assess immunization coverage in affected and surrounding barangays by conducting a rapid convenience survey   -Ensure appropriate case management, including Vitamin A administration in an age-appropriate dose   -Provide measles vaccine to unvaccinated household and community contacts Implement active case search in the community and nearby health facilities Alert surveillance focal points   -Monitor, analyze and prepare outbreak summary report    1.A ISOLATION INSTRUCTIONS   -At home, isolate the suspected measles case and limit contact with other household members whenever possible until \ufb01ve days after the rash appears.  -Suspected measles cases should not be hospitalized unless necessary (e.g. when complications develop such as pneumonia or severe diarrhea).  -In schools, suspected measles cases should be sent home and parents should be advised to keep the child at home for \ufb01ve days.  -At the hospital, isolate suspected measles cases in isolation ward/room from rash onset up to 5 days to prevent nosocomial spread.   INVESTIGATION INSTRUCTIONS    -All Disease Surveillance Of\ufb01cers and Coordinators should report cases based on the standard measles case de\ufb01nition (rash, fever and either cough, coryza or conjunctivitis).   -All disease reporting units, including private clinics and facilities and the community are encouraged to report suspected measles cases to the concerned regional, provincial or city epidemiology and surveillance unit.   -Each suspected measles case should be completely investigated using the standard measles-rubella CIF (Annex A).   -Collect serum/ dried blood spot (DBS) sample from ALL cases in a barangay with only 1-5 suspected measles cases. If the number of cases exceeds 5, collect at least 5 serum/DBS samples per barangay.   -Wen the number of cases exceeds the level where completing the CIF is operationally feasible due to limited resources, case investigators should collect at least the 10 core variables (information items) required to allow for meaningful epidemiological analysis to guide health workers in implementing appropriate measles outbreak response measures.   -Core variables/information to be collected from suspected measles cases in all barangays where measles transmission is observed, especially in barangays where high measles transmission is occurring:   - case identi\ufb01cation   \u2014 date of birth/age   - sex   - place of residence   - vaccination status or date of last vaccination   - date of rash onset   - date of noti\ufb01cation   - date of investigation   - date of blood specimen collection   - place of infection and travel history    -Collect information about the measles immunization status from all suspected measles cases, especially if the case is an under-\ufb01ve child. If the investigator failed to collect this data or the case is found to be unimmunized, the investigator(s) must immediately inform the local EPI coordinator and encourage to validate the information and to immunize the case as needed.   1.C. CROSS NOTIFICATION    -Health workers at all levels should immediately be oriented and involved in all aspects of the outbreak response.   -Health workers of neighboring barangays should be noti\ufb01ed so that they will begin implementing preventive actions as necessary.   -The public should be informed through the media about the outbreak and any protective measures that they can take.   -If a suspected case has traveled or has close contact with individuals from other barangays of the country 7-21 days before the onset of the illness, the D80 in those barangays should be noti\ufb01ed immediately.   1.D. MEASLES CASE MANAGEMENT   -All suspect cases with clinical manifestation of measles, e.g. maculopapular rash, high fever (238 C) accompanied by either cough, runny nose or red eyes, should receive recommended age-speci\ufb01c Vitamin A dosage.  -Administration of Vitamin A is the standard of care in measles case management.  -Vitamin A supplementation has been shown to reduce all-cause mortality by 23%-30%.  -Health workers are encouraged to include Vitamin A administration in the immunization response activity whenever possible if adequate supply is available.   1.E MEASLES VACCINATION   -Close contacts (persons living in the same household or other close quarters: classroom, dormitory, etc.) without evidence of measles immunity should immediately be vaccinated, regardless of age. They should also be instructed about the symptoms of measles and practice isolation as described above if symptoms appear.  -The immunization response for each scenario is dependent on the availability and timeliness of information about laboratory con\ufb01rmed measles cases.  -In the absence of a laboratory con\ufb01rmed measles case but with evidence of an increasing number of suspected measles cases, local health workers can adopt the recommended immunization response to a \u201cone con\ufb01rmed measles casein a barangay.\"  -Follow the recommended guidelines for an effective and ef\ufb01cient community outbreak response immunization. The guideline is only for using measles containing vaccine. Standard guidelines must be followed should local health workers decide to include other interventions (e.g. Vitamin A administration, OPV, etc.) in the response (Annex B).   1.F INTENSIFY MEASLES SURVEILLANCE    -Measles surveillance should be intensi\ufb01ed to search for additional suspected cases.   -For every chain (date of rash onset of cases fall within an interval of 7\u201421 days from each other) of con\ufb01rmed measles cases, at least 5 representative nasopharyngeal or oropharyngeal swab samples should be collected for laboratory measles viral isolation and allowing identi\ufb01cation of the circulating measles virus strain.   -Ideally the nasopharyngeal or oropharyngeal swabs should be collected from cases within seven days of rash onset. Whereas, serum IgM or DBS for measles-speci\ufb01c IgM is more likely to be positive if collected between 4-28 days after rash onset. Specimens for IgM testing and for virus isolation should be collected during the \ufb01rst contact. Specimens for virus isolation and for IgM testing do not need to be collected from the same cases during an outbreak investigation.   -All reporting units should be noti\ufb01ed once a measles outbreak is suspected and be alerted to be vigilant for additional cases.   -Health workers and public should be encouraged to report cases.   -The public should be informed where to report cases and where to get information for measles prevention and control.   1.G OUTBREAK MONITORING AND SUMMARY REPORTING   -All epidemiology and surveillance units should aim to update their measles database regularly. At least one staff in each unit should be assigned for this purpose.  -Surveillance data should be analyzed using the most updated information.  -Data should be analyzed for both suspected, clinically\u2014compatible, and con\ufb01rmed measles cases.  -Basic weekly analysis should include the following:   - Distribution of cases by case classi\ufb01cation. Epidemiologically-linked cases should be determined as soon as a laboratory con\ufb01rmed measles case is identi\ufb01ed.  - Distribution of cases by morbidity week and place  - Age distribution of cases and immunization status  - Patterns of transmission, including travel and exposure history  - Measles incidence and case fatality ratio  - Immunization response activities     -When no new case is reported during a three-week period, despite the presence of intensi\ufb01ed surveillance, the outbreak may be considered to be over.  -It is recommended for each epidemiology and surveillance unit with catchment barangays affected by the outbreaks to prepare and share a summary report to document the outbreak including lessons learned, best practices and recommendations that could be useful in improving the country\u2019s measles elimination strategies.   OBJECTIVE 2. ESTABLISH EPIDEMIOLOGICAL LINKAGE OF NEW CASES IN BARANGAYS WITH LABORATORY CONFIRMED CASEtS) FOLLOWING THE REPRESENTATIVE SAMPLING METHOD ADOPTED BY THE NMRL   The guidelines described in this section are temporary and applicable ONLY in the situation of widespread measles transmission. When faced with a high incidence of measles, strategic collection of blood samples is essential to conserve valuable staff time and lessen the overload of specimens in the laboratory. Once a reference sample has been con\ufb01rmed positive for either measles or rubella IgM, health care providers can redirect their time and effort in conducting a high-quality \ufb01eld investigation to search for other cases, epidemiologically-link other suspected cases to a known laboratory-con\ufb01rmed measles or rubella case and conduct an appropriate and timely outbreak and immunization response.   Once the measles transmission has been controlled and the number of suspected measles cases is signi\ufb01cantly reduced, it is important to follow the guidelines in AO. No. 2014\u20140003, which requires collection of serum/DBS samples from EVERY suspected measles case. This will facilitate con\ufb01rmation of the end of a measles outbreak. This approach also applies when sporadic measles cases are observed.   Please be reminded that once the country enters the measles elimination phase, it is highly recommended that ALL reported suspect measles cases are completely investigated and have blood specimens collected for laboratory con\ufb01rmation.   2.A. ESTABLISHING EPIDEMIOLOGICAL LINKAGE   A measles case con\ufb01rmed by epidemiological linkage to a laboratory- con\ufb01rrned case or epidemiologically\u2014linked case is a suspected measles case with a credible mode of transmission from a laboratory-con\ufb01rmed case or (in the event of a chain of transmission) to another epidemiologically-con\ufb01rmed case seven to 21 days prior to rash onset.   How should a \u201ccredible mode of transmission \" be understood?   Cases must be linked geographically and temporally, although the contact details may not always be proven and sometimes must be assumed. Measles virus spreads very rapidly and people may be completely unaware that they have been in contact with infected persons who have not yet developed a rash. The following situations are all credible and should be considered:    -A case in the same village or urban community;   -A case in a neighbouring community with contact occurring through schools, markets and social events;   -A case who has travelled to a country known to have measles circulating during the past seven to 21 days; and   -A case having visited a health facility where a con\ufb01rmed case is known to have occurred.   Who should perform epidemiological linking of measles cases?   - A barangay with no laboratory-con\ufb01rmed measles case:   - Depending on which unit is responsible for the barangay where the cases were reported, the provincial, municipal or city epidemiology and surveillance unit (MHO/PHO/CHO) shall be responsible for determining if the cases are epidemiologically-linked to con\ufb01rmed measles or other epidemiologically-linked measles cases from neighboring barangays or municipalities where laboratory-con\ufb01rmed cases are identi\ufb01ed.   - As the MHO/PHO/CHO has access to the measles database of the whole municipality, province or city, it has the ability to determine which of the newly reported cases are epidemiologically-linked to the laboratory-con\ufb01rmed measles cases from other areas by reviewing individual case\u2019s core information (e.g. date of onset, exposure and travel history).   - The MHO/PHO/CHO can also use maps to plot all the cases reported in their whole catchment area to determine patterns of transmission, population density and mobility, immunization data, etc., which could help identify outbreak risks and measles transmission chains.   - A barangay with at least one known laboratory-con\ufb01rmed measles case:   - If a barangay has at least one known laboratory-con\ufb01rmed measles case, the \ufb01eld investigation team or responsible disease surveillance of\ufb01cer should already determine if the new cases currently being investigated are epidemiologically\u2014linked to that case or other previously identi\ufb01ed epidemiologically-linked cases in the same barangay.   2.B. SELECTION OF REPRESENTATIVE SPECIMENS FOR LABORATORY CONFIRMATION OF MEASLES OUTBREAK/CASES   The NMRL is committed in providing timely laboratory results to guide planning for an effective and ef\ufb01cient outbreak immunization response with implementation of. appropriate control measures. However, due to the limited ELISA test kits and overwhelming number of. specimens being submitted for con\ufb01rmatory testing, the NMRL has suggested a plan for prioritizing samples to be tested using a simple method of selection. The selected samples represent certain barangays and would allow ef\ufb01cient epidemiological linking of suspected measles cases without specimens.   2.C. CLASSIFYING SUSPECTED MEASLES CASES WITH UNTESTED SPECIMEN   Having a reference laboratory-con\ufb01rmed measles case is necessary to facilitate epidemiological linkage. Therefore, while the laboratory test results of the selected specimen for priority testing are still pending, it is recommended that suspected measles cases with serum/DBS samples will be temporarily classi\ufb01ed as clinically-measles compatible cases if they belong to a barangay where representative samples were selected for priority testing. Once the test results of the representative samples are available, these cases will be reviewed and reclassi\ufb01ed as follows:   - Epidemiologically-linked cases \u2014 if the representative samples are positive for measles IgM and the criteria for epidemiologically-linked case is met.   - Clinically-Measles Compatible eases \u2014 this will be the \ufb01nal classi\ufb01cation if the representative samples are negative for measles and rubella IgM even if the criteria for epidemiological linkage are met. These cases will not be discarded as non-measles/non-rubella due to epidemiological linkage to a case that tested negative for measles/ rubella IgM.   Following standard protocol, all reported cases with negative measles IgM test results shall be re-tested by the NMRL for presence of rubella IgM. Based on the results, cases will be classi\ufb01ed as either con\ufb01rmed rubella or discarded non- measles/non-rubella. The same standard protocol applies to reported cases whose specimens were prioritized but tested negative for measles IgM.   2.D. STRATEGIC APPROACH TO SERUlVI/DBS COLLECTION DURING HIGH MEASLES TRANSMISSION   In line with the above mentioned strategy, it is recommended that specimen collection be done strategically to facilitate the process of epidemiological linkage of measles cases, particularly in provinces and cities with high measles transmission (e.g. multiple barangays with more than one laboratory-con\ufb01rmed measles case in several municipalities, provinces and/or cities) without overwhelming the NMRL's capacity to test specimens and provide timely test results. Please refer to the table below for the supplemental guidelines that apply ONLY during a period of high and widespread measles transmission.             The details of recent travels and contact tracing will be very important in establishing epidemiological linkage and probable source of infection. Integration of strong epidemiological information is achieved through conducting a high-quality \ufb01eld investigation.   In barangays where the surveillance system is inadequate to promptly identify and investigate cases, or when specimen collection is not possible, epidemiological linking may be done at the municipal or city level provided a laboratory-con\ufb01rmed case(s) exists in a neighboring barangay and there is suf\ufb01cient evidence of epidemiological linkage among cases. Oftentimes, plotting cases in a map and tracking transmission chains are helpful to support this process.   Furthermore, ensuring the collection of the 10 core variables/information from every suspected measles case will support proper case classi\ufb01cation and data analysis to help decision makers in planning for appropriate immunization response.   2.E. ROLES AND RESPONSIBILITIES   As previously mentioned, this issuance is developed to provide guidance to health workers at different levels to timely and effectively carry out interventions to contain an outbreak and prevent further transmission. Some items contained in this guideline apply only during a high level of measles transmission in the community (Annex C). As signi\ufb01cant reduction in measles transmission is expected after the conduct of a nationwide measles-rubella mass immunization (that will also include administration of OPV) in September 2014, health workers are encouraged to exercise tact in deciding which activities are to be carried out based on the local situation.   Once a low measles transmission is achieved, the country will shift to recommended measles elimination strategies where each case is required to be completely investigated and collected with appropriate specimen for measles con\ufb01rmation and genotyping. Likewise, during an elimination phase, one laboratory con\ufb01rmed case is considered an outbreak and appropriate measures must be carried out to prevent further spread of measles in the community. A.O. No. 2014-0003 provides guidance on laboratory con\ufb01rmation of measles case' during measles elimination phase.   VI. REPEALING CLAUSE The provisions of previous Orders and other related issuances inconsistent or contrary with the provisions of this Administrative Order are hereby revised, modi\ufb01ed, repealed or rescinded accordingly. All other provisions of existing issuances which are not affected by this Order shall remain valid and in effect.   VII. EFFECTIVITY   This order shall take effect immediately.  ", "  Ministry Circular No. 9-A s. 1983 institutionalized rooming in in all government hospitals but no clear standard have been set. After 9 years of implementation, it has been noted that rooming in is practiced widely in all government hospitals but there are certain routine procedures and practices during delivery and immediate newborn care which cause undue delays in rooming-in and interfere with the normal initiation and establishment of breastfeeding.        In May 1990, selected Pediatricians and Obstetricians trained on Lactation Management from selected hospitals were convened in a workshop to discuss these problems and propose the best standard procedures to overcome these difficulties.             These guidelines incorporate outputs of the workshop and the experiences and improvements made in the past two years on the practice of rooming-in. It covers standard procedures for mother and child care starting at the prenatal period up to at least 6 months postpartum.         Every facility providing maternity services and care for newborn infants is expected to follow these guidelines which should be translated into clearly stated breastfeeding policies of the hospital. Policies should be routinely communicated to all core staff. The salient features of this policy should he visibly posted in all areas which serve mothers, infants and children particularly in the Maternity Wards, Pediatric Wards, Infant Special Care Units and the Antenatal Care Services.           GUIDELINES ON ROOMING-IN, BREASTFEEDING  AND BREASTMILK FEEDING  1. At the Antenatal Services 1.1 From the first antenatal visit, carefully assess the attitudes, beliefs, knowledge and experiences of the mother and her family in relation to infant feeding. 1.2 Examine the breast for any anatomical malformation that would interfere with breastfeeding for example inverted nipples. Give clear advice on possibility of breastfeeding in spite of malformation. 1.3 Provide the parents with adequate information on infant feeding including the benefits of breastfeeding the proper management of lactation and the importance of an adequate diet during pregnancy. 2. During and Immediately After Delivery:  2.1 Immediate Bonding:  After a normal spontaneous vaginal delivery:  Place the baby on the mother\u2019s chest or abdomen immediately after delivery, after cleaning its airways, so that they can have skin-to-skin and eye contact. Assist the baby to latch onto the breast if it is crying. Leave them to bond together for at least 30 minutes keeping an eye on their comfort and congratulating the mother for a successful pregnancy and delivery.  After delivery by Caesarian Section:  Give the baby to the mother to hold and caress for at least, 30 minutes as soon as the mother wakes from the anesthesia which can be within 2-4 hours after delivery. This may be done even while the mother is still in the Recovery Room.          2.2 Rooming-In: (See Annex 1 for definition of terms) a. All well babies delivered vaginally without complications shall be roomed-in within 1 hour after delivery. b. All well babies delivered by caesarian section without complications shall be roomed-in within 4-6 hours after delivery. c. All roomed-in babies must be breast-fed or given breast milk. d. For complicated births (sick baby, sick mother or both are sick), babies shall be roomed0in as soon as medical conditions permit. While the baby is not yet roomed-in, deliver breast milk by other methods (see 3.1).  2.3 Support to the Mother: a. Teach mothers how to correctly position and attach the infant to the breast. Correct positioning prevents sore nipples. b. Convince mothers to breastfeed exclusively on demand up to 6 months and teach them how to empty the breast by manual expression to increase their milk supply. Mothers who know manual breast milk expression are more likely to continue breastfeeding even when they have to go back to work. c. Teach parents and relatives not to bring feeding bottles into the hospital and not to give the baby any water or other juices.  Do not forget to congratulate them every time they respond well to instructions and counseling.  3. Routine Procedures for Feeding the Neonate 3.1 Breast milk especially colostrum, must be given to all neonates who can tolerate oral feeding. Breast milk can be given by direct breastfeeding or in certain conditions, by orogastric or nasogastric tube, by cup or by dropper.    Do not use feeding bottles because these cause \"nipple confusion\u201c (see Annex 1). 3.2 Do not give prelacteal feeds to newborns such as sterile water and glucose water; neither should milk formula be introduced. 3.3 In rare cases necessitating complementary feeding, food can he provided by teaspoon dropper or small cup, never by feeding bottles. 3.4 Other foods or fluids may be given in addition to, or in place of, breast milk only for the following medical indications: a. Special milk formula for infants with inborn errors of metabolism, i.e., galactosemia, phenylketonuria and maple-syrup urine disease. b. Water for infants with increased insensible water loss, for example during phototherapy for jaundice when increased breastfeeding fails to provide adequate hydration. c. Specific supplements for infants with very low birth weight (&lt 1000 gms) or who are preterm (&lt 32 weeks gestation age at birth): \u2022 Multivitamin supplementation specifically vitamins A, D, C and possible E; may be given in the first week of life. \u2022 Iron supplementation: recommended only after 2 months of infant life. d. Specific fluids for infants with severe dysmaturity with potentially severe hypoglycemia or who require therapy for hypoglycemia and who do not improve through increased breastfeeding or by being given breast milk. e. Milk formula for infants whose mothers are undergoing drug therapy when a drug is known to be very harmful to the breastfed infant such as anticancer drugs (see 5.4 and Annex 2). 3.5 The infant should be permitted to suck freely at the breast, frequently and without any fixed timetable. Mothers should wake their babies for breastfeeding of they sleep more than 3 hours. 3.6 No artificial teats nor pacifiers (also called dummies or soothers) should be given to breastfeeding infants.  4. Special Procedures for Neonates in the Neonatal Intensive Care Unit (NICU): Colostrum is very valuable in the immediate care of these sick neonates because of its high content of much needed antibodies. Furthermore, being a biologic liquid, it is non-irritating, easily absorbed and well tolerated. Therefore, colostrum must be given to babies.  4.1 Preterms &lt 32-34 weeks gestation can be tube-fed almost immediately with a small amount of colostrum (1-2 ml Every 1-2 hrs). a. Give colostrum feeding using 5 ml/kg/day as early as 4 hours of life (generally at 8 hours). Orogastric tube is preferred to nasogastric tube. b. With stabilization of vital signs and/or attainment of gestational age 32-34 weeks in preterms, initiate breast milk by cup or breastfeeding. 4.2 Asphyxiated infants generally cannot be fed for 24-96 hours because of other complications as aspiration, or cerebral hypoxic-ischemic encephalopathy. They should receive intravenous nutrition during the critical period.   As soon as they can tolerate it, feed colostrum. It can be protective against necrotizing enterocolitis, Institute oral feeding after the critical period. 4.3 Hyperbilirubinemia a. Continue EBM feeding by tube or cup at NICU or breastfeed during feeding time at the NICU. b.  Phototherapy may be given in the rooming-in section. c.  Discourage water or dextrose water as much as possible. Avoid formula supplements. 4.4 Infants who have self-limited acute illnesses such as fever, upper respiratory infections, diarrhea or Contagious diseases like chickenpox should continue to breastfeed.  4.5 A Mother and Child Room (MFR) should be set-up near the NICU to enable the mother To breastfed her sick baby at any time. The room should be comfortable and attractive for mothers.  5. Breastfeeding During Maternal Illness and/or in Special Conditions. 5.1 Common breast problems, such as engorgement, sore nipples, mastitis:  a. Engorgement: \u2022 Avoid breast engorgement by immediate breastfeeding on demand and complete emptying of the breast by manual expression. \u2022 Relieve engorgement by manual emptying of the breast. b. Sore Nipples: \u2022 This is usually due to bad breastfeeding position. \u2022 Correct the breastfeeding position, that is, see to it that: the baby has all of the areola into its mouth, his mouth and chin are close to the breast; and the baby is taking slow deep sucks. \u2022 Continue breastfeeding on the sore nipple. Absence or greatly reduced pain on the sore nipple is a good sign that the breastfeeding position has been properly corrected. \u2022 Do not put creams, ointments or other medications on the nipples. c. Mastitis: \u2022 Continue breastfeeding on the affected breast. \u2022 The suppression of lactation (ablactation) by giving Bromocriptine (parlodel) to relieve engorgement and mastitis is no longer practiced. \u2022 If the mother does not want the baby to suck from the breast, show her how to express milk manually. \u2022 Select antibiotics which will not interfere with breastfeeding, such as: penicillin, erythromycin or trimethoprim. 5.2 For mothers with mild to moderate medical problems such as malaria, STD, diabetes, congestive heart disease (CHD) class T-III or TB sputum (-) or doubtful infectivity:  Follow routine procedures like other mothers and treat illness without stopping breastfeeding. a. Immediately bond at the delivery room b. Room-in and breastfeed immediately during feeding time at mother\u2019s bed or give EBM by cup as necessary. 5.3 For mothers who are severely ill such as those with eclampsia, CHD class IV, severe infections or severe diabetes:   Give EBM by cup. Eclamptic mothers can breastfeed 12 hours after the last seizure.  5.4 Drug Therapy: a. Avoid drugs that may interfere with initiation and establishment of breastfeeding (see Annex 2). b. Select drugs and other medications which are not contraindicated during breastfeeding. c. Any unnecessary medication during pregnancy and lactation should be avoided. Indiscriminate excessive use of sedatives, analgesics and anesthetics should be avoided as this may prevent the mother from establishing close contact with her infant immediately after delivery and may diminish the newborn infant\u2019s abilities to suckle. d. General advice regarding the use of drugs: \u2022 The mother should take the medication during or immediately after breastfeeding. \u2022 Whenever possible, long-acting drugs should not be used. \u2022 Choose the medication which is secreted in the smallest amount in milk. \u2022 Always watch the baby for changes in sleeping habits and feeding patterns as well as for fussiness and skin rashes.  6. Manual Expression of Breast milk and Mini-Milk Banking (see definition of terms) 6.1 The staff should be able to teach all mothers the technique of manual expression of breast milk especially if her infant is unable to breastfeed directly or if there is a need to maintain lactation should she be separated from her baby some time. 6.2 Each hospital must be required to have adequate facilities for banking expressed breast milk (EBM). 6.3 EBM should be stored in individual containers (not pooled), labeled properly with the name of the donor, the date and the time of collection. The EBM shall be preferably used by the donor\u2019s own child.   7. Discharge and Postpartum Care 7.1 General Advice for the Mother: a. Advice mothers on how to care for her breast and maintain lactation through exclusive breastfeeding on demand. b. Inform mothers about follow-up care provided by the hospital or refer them to any breastfeeding support groups. c. No \u201cdischarge packs\" containing items that may interfere with establishment of breastfeeding such as feeding bottles should be given. d. Appointments should be made for follow-up visits. e. Advise mothers on nutritional requirements during lactation  8. Information, Education, Communication and Training 8.1 The hospital staff must undergo training on lactation management and neonatal care and shall develop an in-service lactation management training program of at least 18 hours with 3 hours clinical practice tor the continuing education of the staff. 8.2 A parent education plan with the attached standard breastfeeding messages (Annex 3), starting at the antenatal services up to the follow-up care hi the mothers should be available and implemented. 8.3 Special counseling sessions must be scheduled by the best staff available for mothers most likely to stop breastfeeding and have breastfeeding problems such as primigravidas, mothers who previously bottle-fed, Working mothers, or mothers who have problems with breastfeeding. 8.4 The Department of Health shall provide breastfeeding education materials for dissemination to hospitals. Hospitals however, should also develop their own educational materials. 8.5 The hospital should be able to provide follow-up support for maintaining breastfeeding such as lactation brigades, hotlines, and volunteer groups. 8.6 The hospital should establish a network with the surrounding communities, health centers and private hospitals and clinics for the promotion, protection and maintenance of breastfeeding.  9. Prohibitions/ Regulations 9.1 No milk formula shall be kept on stock in the hospital, especially in the pharmacy; any necessary formula must be purchased by the patient outside the hospital or if really needed, can be purchased by the hospital as an emergency purchase. 9.2 All milk formula shall be by prescription only. No formula prescription shall be made without the approval of the Chief of Pediatrics or his/her designate based on the medical indication for the neonates. She/he shall be responsible for ensuring that the indications far formula prescriptions are medically acceptable.   9.3 No feeding bottles, artificial teats. And pacifiers Shall he allowed into the hospital newborn section in the nursery, pharmacy. etc.), Parents and relatives must be clearly informed about this and the hospital security must be mobilized to enforce this. 9.4 Sale of infant formula and other breast milk substitutes, feeding bottles, artificial teats and pacifiers shall not be allowed in the hospital pharmacy and in other newborn sections. 9.5 No medical representatives shall be permitted in hospital wards. 9.6 No posters, gifts, samples from milk companies, donations or supplies of infant formula shall be allowed anywhere in the hospital with or without brand or company names or other logos or labels which directly or indirectly relate to a product. 9.7 The use of \"professional service\" representatives, \"mother craft nurses\" or similar personnel for teaching parents or staff, provided or paid for by manufacturers or distributors, shall not be permitted. (E.O. 51, Sec 7 (d)). 9.8 No continuing education activities like training, workshops, conferences and similar activities shall be conducted without clearance from DOH through the regional Health Directors. No research projects, clinical trials and fellowships sponsored/assisted by manufacturers and distributors of products covered by the Milk Code shall be conducted without prior approval by DOH through the Undersecretary for Public Health Services, Technical or financial assistance shall be continuously monitored and documented.  Please be guided accordingly.      DEFINITION OF TERMS  1. Well Babies: Babies with Apgar score 7-10, usually term and older than 34 weeks gestational age, with no respiratory distress, asphyxia, severe congenital malformation, or other severe clinical problems. 2. Sick Babies: Babies with Apgar score below 7, usually preemies, younger than 34 weeks gestational age, lighter than 2,000 grams and with severe medical problem such as respiratory distress, asphyxia, severe or life threatening congenital anomaly, etc. 3. Neonates needing temporary formula supplements added to breast milk: These are neonates which fail to gain weight for at least 4 weeks. They are often also premature or low birth weight babies (LWB) but not all preterm or LBW babies need special formula supplements. Special supplementation is only until neonate reaches 2.5 kilograms. Do not forget to maintain good breast milk production. 4. Expressed Breast milk (EBM): Milk expressed from a lactating woman, either manually or with the aid of breast pumps. EBM given to a neonate may be from its own mother or from another mother. 5. \u201cLatching On\": when a baby takes enough of the nipple and the areola into his mouth to from a \u201cteat\". 6. Second Stage of Labor: stage of labor from full dilation of the cervix to expulsion of the baby. 7. Exclusive breastfeeding: giving only breast milk and no other extra fluid during the first 4-6 months of life. 8. Pre-lacteal or Starter Formula: a formula feed which is given to a newborn soon after birth or before putting the newborn to the breast. Normally pre-lacteal foods are sugar-water, tea or other traditional beverage given before any meal of milk. 9. Wet Nursing: feeding a newborn from another mother\u2019s breast when its own mother cannot breastfeed, for a short period or longer. 10. Mini-milk Banking (Philippine style): Facilitates for milk collection, storage, distribution and utilization. 11. Low Birth Weight (LWB): Babies with birth weight 2,500 grams. a. Preterm \u2013 babies delivered after 37 completed weeks of gestation. b. Term \u2013 babies delivered after 38-42 weeks of gestation. 12. Very Low Birth Weight: Infants with birth weight & lt 1500 grams. 13. Extremely Low Birth Weight: Infants with birth weight &lt 1000 grams. 14. Small for Gestational Age: Infant\u2019s weight is below 2 SD below mean for gestational age or below the 10th percentile. a. Symmetric SGA \u2013 proportionally growth retarded b. Asymmetric SGA \u2013 more profound loss in weight as compared to other body measurements. 15. Large for Gestational Age: Infants with birth weight above 2 SD or above 90th percentile for gestational age or &gt 4000 grams. 16. Post Term: infants born after 42 weeks of gestation. 17. Rooming-In: Refers to the practice of placing the newborn in the same room as the mother right after delivery up to discharge to facilitate mother-infant bonding and to initiate breastfeeding; the infant may either share the mother\u2019s bed or be placed in a crib beside the mother. 18. Ablactation: or \u201cStopping lactation\": It was a frequent practice two decades ago to suppress lactation by taking hormones (estrogen-testosterone combination) as management for breast engorgement or mastitis. 19. Mother and Child Room (MCR): A separate room located beside the nursery but considered part of the nursery unit where the mother can breastfeed her baby. 20. Nipple Confusion: Difficulty in feeding from a breast after using a feeding bottle. Sucking through a rubber teat is easier since it is long and does not have to be pulled-out while if sucking from the breast the baby needs to stretch the nipple out and take enough of the areola into his mouth.                        LIST OF DRUGS THAT SHOULD NOT BE TAKEN BY NURSING MOTHERS  1. Amiodarone 2. Amethopterin 3. Bromocriptine 4. Cimetidine 5. Chloramphenicol 6. Chlorthiazides 7. Clemastine 8. Clofibrate 9. Cyclophosphamide 10. Corticosteroids \u2013 Cortisone, Dexamethasone, Hydrodocortisone, Methylprednisolone, Triamcinolone 11. Dextroprpoxyphene 12. Ergotamine \u2013 Ergot and derivatives, Methysergide 13. Gold salts 14. Ethosoximide 15. Gamma Benzene Hexachloride 16. Hypnosedatives \u2013 Chlorosepate, Diazepam, Nitrazepam 17. Indomethacin 18. Iodine 19. Methimazole 20. Laxatives \u2013 Cascara, Danthron, Phenolphthalein 21. Lithium 22. Maprotiline 23. Phenindione 24. Phenylbutazone 25. Badiopharmaceuticals \u2013 Radioiodine 26. Thiouracil 27. Reserpine 28. Sulphonamides 29. Tinidazole 30. Sex hormones \u2013 Ethinylestradiol, Mestranol, Estradiol, Stilbestrol  For Mothers with G6PD Deficient Infants: 1. Co-trimoxazole 2. Fava beans 3. Nalidixic Acid 4. Nitrofurantoin 5. Sulphonamides 6. Sulphasalazine    STANDARD BREASTFEEDING MESSAGES  Advice at the antenatal period: 1. Breast milk alone is the best possible food and drink for your baby in the first 6 months of life. Other milks do not contain as much nutrients in the right amounts and in the proper form for easiest digestibility 2. Breastfeeding has the following benefits for both mother and baby: a. It contains all the essential nutrients needed for the adequate nutrition and growth of the baby. b. Breast milk especially colostrum protects child against many childhood diseases like diarrhea and respiratory infections. c. Breastfeeding fosters a closer mother-child relationship d. Breastfeeding helps mother prevent post-delivery hemorrhage, delays pregnancy and protects mother against cancer of the breast. 3. The first milk called \u201ccolostrum\" is thick and yellowish because it is full of protection against common infections. Give it to your baby. 4. Babies should start to breastfeed as soon as possible after birth. 5. Frequent sucking is needed to produce enough breast milk for the baby\u2019s needs. 6. Bottlefeeding can lead to serious illness and death. 7. The size and shape of the breasts do not matter. Small breasts and large breasts both produce perfect milk in sufficient quality.  Advice during and immediately after delivery: 1. It takes a few days for the milk to come in. The breast may feel empty but it does not mean that there is no milk. 2. Colostrum is exactly what a baby needs for the first few days. Do not throw it away. 3. The baby does not need milk supplements, glucose, water or anything else. 4. Frequent sucking at the breasts helps the milk to come in and it is the best way to build up your milk supply. 5. Let the baby suck as often as he wants and as long as he wants. 6. Let the baby finish the first breast before offering him the second. Start on one side for one feed and the other side for the next feed. 7. It is not necessary to wash the breast before every feed. 8. Sucking at night helps to keep up the milk supply. Advice before discharge: 1. Continue breastfeeding at home. 2. More sucking makes more milk. 3. For any breastfeeding problem, return to the hospital, or go to a nearby health center or any available breastfeeding support group. 4. Give expressed breast milk to your baby if returning to work.  Advice for the following weeks: 1. Continue with exclusive breastfeeding until the baby is at least 6 months old. 2. Do not give early supplements \u2013 they can cause diarrhea and interfere with breastfeeding. 3. Breastfed babies may not pass a stool every day. This means he is using up all the nutrients in milk.  ", " I. RATIONALE   Several developments have taken place since the current version of the Micronutrient Supplementation (MS) Guideline was formulated \ufb01ve years ago. New preparations of micronutrient supplements that could lead to control of the de\ufb01ciencies have been developed and are now available in the country. In 2007, zinc supplementation was introduced as an essential adjunct to oral rehydration therapy (ORT) in the management of diarrhea among children. New scienti\ufb01c evidence on the ef\ufb01cacy of speci\ufb01c MS, changes in the nutrient adequacy levels of the population and both national prevalence surveys require that a review and updating of the current policy on targeting and prioritization of MS be undertaken. It is necessary that the target populations for micronutrient supplementation identi\ufb01ed in the past be updated given the new data on the prevalence of micronutrient de\ufb01ciencies.   MS alongside with diet diversi\ufb01cation and food forti\ufb01cation comprise the three\u2014pronged strategy identi\ufb01ed by the government to combat micronutrient de\ufb01ciency problems in the country. The MS Program is dependent on the progress of diet diversi\ufb01cation, food forti\ufb01cation efforts, and the level of public health signi\ufb01cance of the prevailing micronutrient de\ufb01ciencies. Diet diversi\ufb01cation which aims to provide essential micronutrients needed by the body through diet enhancement remains the cornerstone of this strategy. The use of forti\ufb01ed foods on the other hand remains uneven among the general population. Since both interventions have yet to generate the desired level of micronutrient adequacy among the general population, there is a need to further strengthen the micronutrient supplementation with the aim of contributing to the overall improvement of nutritional status of Filipinos. In that light, the DOH\u2019s current policies and guidelines pertinent to its MS Program need to be updated.   II. DECLARATION OF POLICY   This issuance reiterates the provisions of AO No. 2007\u20140045 Zinc Supplementation and Reformulated Oral Rehydration Salt in the Management of Diarrhea and complements the provisions of DOH AO No. 2008-0029 on the Health Reforms for Rapid Reduction of Maternal and Neonatal Mortality. It also supersedes AO No. 119 s. 2003 on the Updated MS Guide issued in December 2003.   III. GUIDING PRINCIPLES , The updated MS Policy and Guidelines is governed by the following principles:   A. \ufb02ights-Based Approach. MS in the country is anchored on our respect of the rights of children and women as stipulated in our Philippine Constitution, the Convention on the Rights of the Child and the Convention on the Elimination of All Forms of Discrimination Against Women.   B. Systems Approach. Sustained MS provision is contingent on the adoption of a systems approach that institutes fundamental reforms in health service delivery, governance, \ufb01nancing and regulations.   C. Life-Cycle Based Intervention. The MS policy must be aligned with the requirements and conditions of individual clients at various stages of the life-cycle.   D. Equity Population groups with the least capacity to access MS and those most vulnerable to the de\ufb01ciency must be given top priority in MS assistance.   E. Complementation of Interventions. MS yields maximum results if complements other parallel but integrated interventions like deworrning, environmental sanitation, healthy lifestyle promotion, immunization and other relevant measures.   F. Evidence-Based Interventions and Approaches. Policies and guidelines shall be developed based on recent data gathered through prevalence surveys, ef\ufb01cacy studies and other research \ufb01ndings done locally and globally. Recommendations from international organizations will also be utilized but in consideration of the appropriateness with the local context.   G. Integrated Service Delivery. Service integration in MS delivery'must be observed in four tracks. First is the alignment of MS with the other existing public health program packages cascading from the national to local level. Second is the conscious and purposive integration of MS at each service delivery point and interface between the health care provider and client both in public and private facilities. Third is the continuity in provision of MS through appropriate referrals and follow-up of clients especially those that require extended period of supplementation over time. Fourth is for MS provision to take place in the health and non\u2014health sector settings, particularly in schools, workplaces, malls, etc.    IV. OBJECTIVES   In general, this policy and guide aims to ensure the appropriate provision of quality MS in the country. Speci\ufb01cally, it aims to:   (1) Guide health workers and providers in administering micronutrient supplements to identi\ufb01ed population groups and client needs,   (2) Promote the compliance and adherence among DOH of\ufb01ces, the LGUS and private sector to the revised policy and guidelines, and   (3) Generate the support of other stakeholders in implementing the MS policy and guide throughout the country.    V. SCOPE OF APPLICATION   This order shall apply to all national, regional and local government of\ufb01ces, public and private health facilities, NGOs, development partners and other stakeholders whose functions and activities contribute to the delivery and provision of MS nationwide.   VI. DEFINITION OF TERMS   1. Diet Diversi\ufb01cation - It is the changing of dietary practices that affect young children, pregnant and lactating mothers, toward consumption of foods adequate in energy and rich in micronutrients, especially those in short supply in the current diet carried out through nutrition information and education.   2. Emergency - It is an extraordinary situation wherein people are unable to meet their basic survival needs, due to serious and immediate threats to human life. These usually result from disaster, environmental degradation, among others.   3. Elderly - These are persons who are more than 60 years old as de\ufb01ned by the Senior Citizen\u2019s Act in the Philippines.   4.Food Forti\ufb01cation - It is one of the interventions to reduce micronutrient de\ufb01ciencies. It is the \u201cprocess whereby nutrients are added to foods to maintain or improve the quality of the diet of a group, a community or a population. Examples are \ufb02our forti\ufb01ed with Vitamin A and iron, sugar and oil with Vitamin A, rice with iron, and salt with iodine.   5. Health providers - Refers to individual health staff or any health care facilities (BHS, RHU/health center, private clinics, hospitals, lying-in/birthing clinics, school clinics, corporate clinics, etc.) that provides MS.   6. Iodine De\ufb01ciency Disorders - Refers to the ill-effects of iodine de\ufb01ciency in a population that can be prevented by ensuring that the population has adequate intake of iodine. It is the most common cause of preventable mental retardation. It also affects the mother\u2019s reproductive functions and impedes children\u2019s learning ability.   7. Iron De\ufb01ciency Anemia - It is a disorder resulting from the decrease in the number of red blood cells due to lack of iron. It is the most common nutritional de\ufb01ciency in the world and occurs if the amount of iron absorbed is too little to meet the body\u2019s needs.   8. Micronutrient - A dietary element essential only in small quantities.   9. Micronutrient Supplement - Vitamin and mineral supplements are sources in concentrated forms of those nutrients alone or in combinations, marketed in forms such as capsules, tablets, powders, solutions, etc. that are designed to be taken in measured small\u2014unit quantities but are not in a conventional food form and whose purpose is to supplement the intake of vitamins and/or minerals from the normal diet.   10. Micronutrient Supplementation - It is a short term intervention intended to correct high levels of micronutrient de\ufb01ciencies by providing large doses of micronutrients immediately until more sustainable food\u2014based approaches (e.g. food forti\ufb01cation and diet diversi\ufb01cation) are put in place and become effective.   11. Public Health Importance  - Refers to the cut-off points recommended by WHO where a micronutrient de\ufb01ciency is to be considered a public health concern necessitating the state or country to intervene.     12. Vitamin A De\ufb01ciency - A level of depletion of total body stores .of retinol and its active metabolites such that normal physiologic function is impaired.   13. Xeropthalmia - A term used to include all signs and symptoms affecting the eye that can be attributed to Vitamin A De\ufb01ciency.    VII. GENERAL GUIDELINES   A. Micronutrient supplementation shall be adopted as an intervention to address micronutrient de\ufb01ciency given the following conditions:   - population groups with micronutrient de\ufb01ciency prevalence that is at a level of public health importance,  - micronutrient needs of population groups cannot be met through regular diet and use of forti\ufb01ed foods,  - use of MS is proven ef\ufb01cacious and safe, and  - administration of MS has signi\ufb01cant effects on health and welfare at each stage in the life cycle and on the next generation.   B. Micronutrient supplementation is recommended for the following priority age and physiological groups:   - 0\u201459 months old children - pregnant and lactating women  - non-pregnant and non-lactating women of reproductive age (15-49 years old)   C. A package of micronutrient supplements in the right dosage, timing, frequency and duration shall be provided to the above priority groups according to their needs at various stages of their life cycle.   D. Priority shall also be given to population groups and individuals in special situations or with particular conditions:   - during emergencies  - those residing in areas endemic with malaria and schistosomiasis  - individuals who are clinically diagnosed with micronutrient de\ufb01ciencies e. g. xeropthalmia   E. Therapeutic dosage may be given to individuals with established de\ufb01ciencies even if micronutrient supplementation is not recommended for the following age groups,:   - 5-9 years old children  - adults, 50-60 years old  - elderly, > 60 years old   F. Delivery of the MS Packages shall be integrated into the existing Maternal, Newborn and Child Health and Nutrition (MNCHN) service delivery channels and through other avenues that could best reach the targeted clients. These may include non-traditional service settings such as the schools, the workplaces, etc. to widen reach and coverage.   G. LGU\u2019s capacity to provide quality MS to priority population groups shall be enhanced particularly in the area of MS program management, diagnosis and MS administration, counseling and information, and systems design and establishment for client referral, recording and reporting, follow-up and tracking.   H. Financing of essential MS must be sustained and secured.   I. MS information management shall be strengthened for better planning and implementation.   J. Promotion of MS shall be intensi\ufb01ed to generate the desired behaviors of targeted clients and other groups of stakeholders. Promotion efforts shall be focused towards improving the targeted clients\u2019 awareness and appreciation of MS bene\ufb01ts and its negative consequences if de\ufb01ciencies remained uncorrected, wider adoption by LGUs of the recommended MS packages.   K. Continuous availability of MS supply shall be ascertained at the local level.   L. Monitoring and evaluation of the MS program must be improved by expanding the coverage of scope to be tracked, integrating MS as part of the regular supervision visits at the local level, and inclusion of the review of the MS intervention in the regular Program Implementation Review (PIR).   A Manual of Operations on Micronutrient Supplementation shall be developed to detail the standards and protocols to operationalize the above policies and guidelines.   VIII. ROLES AND RESPONSIBILITIES   A. Department of Health at the National Level   1. National Center for Disease Prevention and Control (NCDPQ   The DOH-NCDPC is primarily responsible in the overall execution of the revised policy and guidelines on Micronutrient Supplementation. It will undertake the following tasks:   1.1 Lead in the dissemination of the Revised MS Policy and Guide and advocate for its adoption and implementation among concerned stakeholders;   1.2 Coordinate and provide technical inputs in the design, installation and operationalization of management systems (e.g. staff training, logistics management, recording/reporting system, referral, etc.) and other MS initiatives (e.g. Garantisadong Pambata, health promotion for MS);   1.3 Allocate funds for micronutrient supplement requirements based on National Objectives for Health (NOH) targets that should be interpreted yearly and on the Medium Term Expenditure Framework (MTEF);   1.4 Include micronutrient package in its procurement plan and submit the necessary documents (annual procurement plan (APP), allocation list, among others) in a timely manner to the DOH-Procurement Service to ensure timely procurement, allocation and delivery of MS.to CHDs;   1.5 Coordinate with FDA, pharmaceutical industry and other concerned agencies to facilitate the availability and accessibility of affordable and quality MS nationwide;   1.6 Monitor LGU compliance to the revised MS Policy and Guide together with CHDs;   1.7 Review and revise MS Policy and Guide based on body of technical evidences;   1.8 Organize panel of MS experts and other relevant multi-sectoral body to provide support in reviewing and updating policies, directions and technical guides on MS.   2. National Center for Health Promotion   2.1 Develop prototype materials on MS in coordination with DOH\u2014NCDPC;   2.2 Provide technical assistance to CHDs to help LGUs adopt and implement behavioral change measures towards desired MS behaviors;   3. Procurement Service/Material Management Division   3.1 Ensure timely procurement of micronutrient supplements;   3.2 Ensure proper storage, timely distribution and delivery of commodities to all CHDs.   4. Food and Drug Administration   4.1 Facilitate registration of MS products as deemed appropriate;   5. PhilHealth   5.1 Review the use of MS provision as a quality parameter during the assessment of renewal of the health facilities\" accreditation to Outpatient Bene\ufb01t Package (OPB);   5.2 Intensify promotion for LGUs\u2019 enrolment to PhilHealth, and to buy\u2014in to the accreditation for various bene\ufb01t packages;   5.3 Promote accreditation of all Rural Health Units for Mother and Child Package and Out Patient Bene\ufb01t packages;   5.4 Intensify enrollment campaign for sponsored program and individually\u2014paying program   6. National Nutrition Council />/   6.1 Mobilize resources in support to MS;   6.2 Coordinate nutrition activities as these impact on the MS program and vice versa;   6.3 Evaluate progress of the MS Policy and Guide implementation as part of Monitoring and Evaluation of Local Level Plan Implementation (MELLPI);   B. Food and Nutrition Research Institute   1. Undertake Research and Development (R and D) and Science and technology (S and T) activities related to micronutrient de\ufb01ciencies;   2. Generate resources to conduct national nutrition surveys and other R and D and S and T activities/studies;   3. Disseminate results of R and D and S and T activities to all concerned partners as basis for development planning;   4. Participate in the review and update of the MS Policy and Guide.   C. Centers for Health Development (CHD)   1. Disseminate the revised Policy and Guidelines on Micronutrient Supplementation and advocate for its adoption and implementation by LGU health systems in the different localities within their respective regions;   2. Ensure availability of micronutrient supplements in coordination with the DOH- NCDPC and LGUs by: (i) facilitating the distribution of supplements according to the allocation requirements; (ii) quarterly monitoring of supplement stocks and utilization; and (iii) maintaining stock of micronutrients for emergency situations;   3. Provide technical assistance to LGUs in organizing MS activities and developing relevant technical references and IEC materials;   4. Generate additional resources to strengthen the implementation of the revised policy and guidelines;   5. Formulate and implement advocacy plans to generate stakeholders\u2019 support, particularly the local of\ufb01cials; .   6. Monitor the implementation of the revised policy and guide in both public and private hospitals, and in different localities in their respective regions;   7. Undertake regular review with LGUs on the progress of the MS policy and guide.   D. Local Government Units   1. Provincial/City Health Of\ufb01ce (P/CHQ   1.1 Orient/train private and public health workers on the revised MS policy/ guide;   1.2 Advocate with municipalities/cities and other concerned agencies and stakeholders to adopt and implement the revised policy and guidelines;   1.3 Generate and allocate resources in support to MS provision (e. g. counterpart funds for training, procurement of additional MS, etc.);   1.4 Ensure proper storage, regular inventory of stocks, allocation and timely distribution of MS hospitals and municipalities/cities;   1.5 Ensure hospitals to include MS guides in the hospitals treatment/care protocols;   1.6 Ensure timely reporting of utilization and coverage; .   2. Rural Health Units/Health Centers   2.1 Prepare/update masterlist of targeted clients;   2.2 Screen and identify clients to be given micronutrient supplementation;   2.3 Provide the necessary micronutrient supplements according to protocol;   2.4 Identify other service channels where MS provision can be integrated;   2.5 Organize health staff and mobilize all concerned to participate in GP;   2.6 Forecast MS requirements of identi\ufb01ed targets and develop a plan for meeting the MS requirements, and incorporate into the annual operational plan;   2.7 Advocate among LCEs and other local of\ufb01cials to allocate budget for MS;   2.8 Segment if necessary clients to be fully subsidized from those who could pay;   2.9 Ensure proper storage of MS supply and do regular inventory of stocks; \ufb02   2.10 Train health staff and community volunteers on MS;   2.11 Ensure proper recording of MS provision and utilization and the timely submission of reports to appropriate levels;   2.12 Disseminate essential information on MS to clients and community members.  2.13 Monitor and supervise provision, utilization and coverage of MS   E. Regional, Provincial and District Hospitals   1. Integrate the updated MS policy and guide into their treatment protocols;   2. Provide budgetary allocation for the procurement of MS;   3. Participate in the nationwide campaign \u2014 Garantisadong Pambata;   4. Conduct orientation/training of hospital staff on the MS policy and guide; Conduct integrated nutrition education activities to patients;   5. Coordinate with PHO/RHUS on referral and follow up of clients.    F. Development Partners iprofessional societies, donors, NGOs, civic organizations, academe, private partners, etc.)   1. Participate in the review and revision of the MS Policy and Guide;   2. Help promote PIPH process at the local level as basis for determining LGUs\u2019 requirements for MS assistance;   3. Mobilize or provide resources to augment MS supply at the local level;   4. Assist in the review and update of training programs on MS;   5. Participate in monitoring the utilization and coverage of MS;   6. Support the national MS campaigns like GP;    VIII. REPEALING CLAUSE   Administrative Order 19 3.2003 and all other orders and related issuances inconsistent with the provisions of this issuance are hereby rescinded.   IX. EFFECTIVITY   This order takes effect immediately.  ", " There are well known toxic effects of tetracyclines especially during childhood up to the age of 8 years. Tetracyclines are deposited in calcifying areas in bones, in deciduous teeth and in nails. The risk of staining developing teeth is greater when given to neonates and babies prior to first dentition. Pigmentation of the permanent dentition may develop if the drug is given between the ages of 2 months and 5 years, when the teeth are being calcified. Tetracyclines when given in therapeutic doses to young infants or to women during the later stage of pregnancy are deposited in the skeleton of the human fetus and young child causing rarefaction of the bones. Tetracyclines may cause increased intracranial pressure and tense bulging of the fontanels (pseudotumor cerebri) in young infants, even when it given in the usual therapeutic dose.  In the interest of consumer protection and as a guidance to pharmaceutical manufacturer, distributor and retail outlets, the following orders are hereby promulgated:  ORDERS  1. Pharmaceutical preparations containing Chlortetracycline, Oxytetracycline, Tetracycline, Demeclocycline, Rolitetracycline, Methacycline, Doxycycline, Hinocycline and other tetracycline derivatives in the form of syrup (mixture or suspension) or drops particularly intended for pediatric it use are no longer certifiable.  2. Henceforth, the registration of the above\u2014mentioned pharmaceutical preparations are hereby recalled and cancelled.  3. For the orderly phasing out of stock which have been distributed to retail outlet prior to the issuance of this Order all stocks should have been recalled and withdrawn by the manufacturer or distributor before June 30, 1978. ", "   I. Rationale   Pursuant to Section 13 of the Implementing Rules and Regulation of Republic Act 9288, otherwise known as the Newborn Screening Act of 2004, the DOH being the lead agency shall ensure that a network of facilities for referral and management of all positive cases is established. In addition, it shall develop referral centers and identify referral teams in strategic areas for referral and management of patients with any of the disorders.   Recognizing this need and of the mandate to. develop referral centers, the Department of Health and the National Institutes of Health are setting\u2014up Newborn Screening (NBS) Continuity Clinics in the country to strengthen the National Comprehensive Newborn Screening System Treatment Network and ensure the early treatment and appropriate management of identi\ufb01ed positive-cases.   Initially, one Newborn Screening Continuity Clinic and Birth Defects Continuity Clinic per region shall be set-up. Subsequently, provincial continuity clinics shall be established.   II. Objective   To provide policies and guidelines for the setting-up and implementation of NBS Continuity Clinics and Birth Defects Continuity Clinics for referral and management of all screened-positive newborns.   III. Scope and Coverage   This Order shall apply to all Newborn Screening Centers, DOH \u2014 Regional Of\ufb01ces (DOH\u2014ROS), National Comprehensive Newborn Screening System Treatment Network and all other agencies and stakeholders concerned in the implementation of the newborn screening program.   IV. De\ufb01nition of Terms   National Comprehensive Newborn Screening System Treatment Network refers to a network wherein total management of patient with con\ufb01rmed diagnosis shall be referred to. It follows the DOH-approved clinical protocol in the management of patients diagnosed in any of the disorders included in the newborn screening panel.   National Institutes of Health \u2014 Institute of Human Genetics (NIH-IHG) refers to the unit at the National Institutes of Health that provides comprehensive clinical evaluation of families or individuals with or at iisk for'heritable conditions; it provides support for remote, real-time referral (the Telegenetics Referral System) and Birth Defects Surveillance System in the country. It also offers laboratory and diagnostic services pertinent to the management of heritable conditions.   Newborn Screening Panel of Disorders refers to the list of disorders tested under the Philippine Newborn Screening Program. The panel includes newborn screening for the following disorders: Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, Phenylketonuria, Galactosemia, G6PD De\ufb01ciency and Maple Syrup Urine Disease. By mid-2014, an expanded newborn screening panel shall be offered as an option increasing the number of disorders from six (6) to twenty-eight (28) falling under various types of disorders namely: hemoglobinopathies, amino acid disorders, organic acid disorders, disorders of fatty acid oxidation, disorders of carbohydrate metabolism, disorders of biotin metabolism, cystic \ufb01brosis and endocrine disorders.   Newborn Screening Reference Center (NSRC) refers to the central facility at the National Institutes of Health that de\ufb01nes testing and follow-up protocols, maintains an external laboratory pro\ufb01ciency testing program, oversees the national testing database and case registries, assists in training activities in all aspects of the program, oversees content of educational materials and acts as the Secretariat of the Advisory Committee on Newborn Screening.   Newborn Screening Center W8C) refers to a facility equipped with a newborn screening laboratory that complies with the standards established by the National Institutes of Health, and provides required laboratory tests and recall/follow-up programs for newborns with heritable conditions.   Newborn Screening Continuity Clinic refers to an ambulatory clinic based in a tertiary hospital identi\ufb01ed by the DOH to be part of the National Comprehensive Newborn Screening System Treatment Network. It is equipped to facilitate continuity of care of con\ufb01rmed patients in its area of coverage.   Birth De\ufb01ects Continuity Clinic refers to an ambulatory clinic based in regional and provincial referral centers identi\ufb01ed by the DOH. It speci\ufb01cally caters to patients with birth defects for the purpose of diagnosis and management.   Telegenetics Referral System refers to provision of remote genetic clinical consults to physicians in the provinces for their patients over a computer network.   V. General Guidelines   A. The NBS Continuity Clinics shall be established, initially in every region, equipped to facilitate continuity of care of con\ufb01rmed patients in its area of coverage. Subsequently, the NBS Continuity Clinics shall be established in the provincial level.   B. The Birth Defects Continuity Clinics shall be integrated in the National Comprehensive Newborn Screening System. The Birth Defects Continuity Clinics will share the same infrastructure and personnel of the Newborn Screening Continuity Clinics.   C. The Telegenetics Referral System shall be utilized by the NBS Continuity Clinics and Birth Defects Continuity Clinics where subspecialists are not available in the hospital.   D. Memoranda of Agreement shall be executed between NSRC, NSC, DOH-RO, Host Facility, and IHG for every regional/provincial Continuity Clinic.    VI. Speci\ufb01c Guidelines   A. Patient Care   In terms of the different components of NBS patient care, the following shall be considered in the implementation of the NBS Continuity Clinics and Birth Defects Continuity Clinics:   1. Diagnosis and Initial Management   a. In coordination with the DOH-ROS, the NSCs shall be responsible for the tracking of newborns with out\u2014of\u2014range screening results to ensure repeat specimen collection, repeat screening and/or con\ufb01rmatory testing from the NBS laboratories or con\ufb01rmatory Centers.   b. The NSCs shall facilitate the con\ufb01rmatory testing for newborns with out\u2014of\u2014 range screening results and initiate medical management for patients with con\ufb01rmed diagnosis.   2. Long-term Management (including counseling, treatment, monitoring and follow-up).   a. The NSCs shall refer all newborns who are con\ufb01rmed positive with heritable disorders to NBS Continuity Clinic for long-term follow-up care.   b. In coordination with the DOH-ROS, every effort shall be made by the personnel of the continuity clinics to contact and schedule patients referred from NSCs so that the necessary treatment and long\u2014term follow-up care shall be given, as well as timely monitoring shall be undertaken.   The continuity clinics shall facilitate referral of patients needing consults to available subspecialists in their facility or region. In cases wherein subspecialists are not available, the continuity clinics shall utilize the Telegenetics Referral System.   B. Operations of NBS Continuity Clinics   In terms of the different components of the newborn screening program, the following shall be considered in the implementation of the NBS Continuity Clinics and Birth Defects Continuity Clinics:   1. Selection, Recruitment and Hiring of Personnel   a. The continuity clinics shall be manned by a part-time Medical Specialist and a full\u2014time Nurse or Genetic Counselor.   b. The Department of Pediatrics of every host facility shall be responsible for overseeing the recruitment and selection of personnel for the continuity clinic in their facility. -   c. The host facility shall make the necessary recommendations for the hiring of their personnel.   2. Funding   The operational expenses of these clinics, including, but not limited to communication and travel expenses, as well as \ufb01nancial support for indigent families, shall be shared responsibilities of NSRC, NSCs, DOH-ROS and host facilities.   C. Capacity Building   Long-term management of patients, require enhancement of skills and competencies and will be supported with a capacity building program organized by the DOH in partnership with NSRC.   D. Information Education and Communication   1. Information on the establishment of the continuity clinics and the Telegenetics Referral System, shall be disseminated to all agencies concerned;   2. Information on the long-term follow\u2014up treatment and management of the disorders included in the NBS pane] shall be made available to health professionals, parents, and the general public at all continuity clinics, NSCs and DOH-ROS.   E. Monitoring and Evaluation   A monitoring and evaluation plan shall be developed to provide the mechanism for monitoring and evaluation of the continuity clinics implementation and the key indicators for impact monitoring.   F. Roles and Responsibilities   1. Department of Health   The DOH shall be the lead agency in the implementation of expanded newborn screening. Its roles and responsibilities are stated in Section 13 of the Implementing Rules and Regulations of RA 9288.   a. Family Health Of\ufb01ce shall:   1. Review and update guidelines on the operations of the NBS Continuity Clinics and Birth Defects Continuity Clinics.   2. Formulate and issue a monitoring and evaluation tool pursuant to the operations of these clinics.   b. Regional Of\ufb01ces shall:   1. Establish a mechanism for recall of con\ufb01rmed patients for referral to experts for management and follow-up care;   2. On the basis of availability of funds, provide indigency support for con\ufb01rmatory testing of patients with signi\ufb01cantly elevated laboratory results and for treatment and long-term management of con\ufb01rmed patients in the region.   2. Newborn Screening Reference Center shall:   a. Oversee the implementation of activities of NBS Continuity Clinics and Birth Defects Continuity Clinics;   b. Secure monthly, quarterly and yearly reports from participating units and ensures their timely dissemination to various program stakeholders;   c. Participate in consultation and evaluation activities initiated by the DOH in relation to the NSRC and the NBS Continuity Clinics\" and Birth Defects Continuity Clinics\u2019 performance and in improving of rules and regulations;   d. Assist in the training activities of the program;   e. Oversee and review content of educational materials as well as the production of the materials.   3. Newborn Screening Centers shall:   a. Give diagnosis, make proper referral and initiate management for all con\ufb01rmed NBS patients;   b. Provide roster of con\ufb01rmed patients, including their protocols for management and list of follow-up laboratory procedures, to the NBS Continuity Clinic.   4. Host Facilities of NBS Continuity Clinics shall:   a. Set-up NBS Continuity Clinic and Birth Defects Continuity Clinic;   b. Provide a clinic space for patient consultation and a work station for the follow-up nurse and/or genetic counselor.   c. Oversee the selection and hiring of personnel for the NBS Continuity Clinic in their facility;   d. Integrate NBS continuity clinic to the current services of the host facility;   e. Ensure the sustained operation of NBS Continuity Clinic and Birth Defects Continuity Clinic according to the Operational Guidelines set by the Department of Health and the Newborn Screening Reference Center for these clinics.   5. Institute of Human Genetics shall:   a. Strengthen the surveillance program for newborns with birth defects in the country;   b. Establish systems for the referral of patients with birth defects from BDS health facility to Birth Defects Continuity Clinics;   c. Provide support in the operations of Telegenetics Referral System;   d. Establish an ef\ufb01cient system in the procurement and availability of medicines, medical food and other medical requisites needed in the management of patients with birth defects and con\ufb01rmed patients detected through newborn screening.   VII. Repealing Clause   All orders and issuances, rules and regulations 0r parts thereof inconsistent with the provisions of this Order are hereby amended, modi\ufb01ed or repealed accordingly.   VIII. Separability Clause   If any provision of this Order is declared invalid, the other provisions not affected thereby shall remain valid and subsisting.   IX. Effectivity   This Order shall take effect \ufb01fteen (15) days after its approval and publication in the of\ufb01cial gazette or newspaper of general circulation.    ", "  1. INTRODUCTION  Prompt and effective treatment of Reproductive Tract Infections / Sexually Transmitted Diseases is an essential component in the control of these diseases. In patient with symptoms of RTI/STD ,case management through a syndromic approach had already been recommended by the Department of Health as contained in Administrative Order No.2s.17. This approach is simple, cheap, effective, treats unrecognized concurrent infection. Furthermore, it does not require expensive laboratory facilities which are usually available only in reference centers, allows treatment at the time of the first visit and the skills can easily be acquired by all health care workers.  However, it is probable that majority of these STD in women are asymptomatic or have minimal symptoms which are perceived as \u201cnormal\". In fact it is estimated that up to 90% of women infected with gonorrhea and / or with chlamydial infection, do not have sufficient symptoms to seek medical advice unless complications arise. For this reason serious complications  such as PID, ectopic pregnancy, adverse effects of pregnancy and neonatal infections are common as are late sequelae such as infertility and neoplastic changes.  Asymptomatic women may not be identified by using the syndromic approach to STD case management. Provision of guidelines on STD case finding among asymptomatic women is a public health priority.  Pursuant to Administrative Order no. 2 dated 20 February 1997 which provides National Policy Guidelines for the Prevention and Management of Sexually Transmitted Diseases, these policies were formulated to form the basis for the prevention and management of the STD  nationwide.    2. PURPOSE These guidelines are prescribed to improve case finding and management of asymptomatic women with RTI / STD.   3. OBJECTIVE  3.1. To provide directions on early case finding of asymptomatic women with RTI / STD in order to provide early treatment and prevent RTI / STD complications.  3.2. To establish standards for risk assessment, training, referral for managing asymptomatic women with RTI / STD.   4. DEFINITION OF TERMS  4.1. Sexually Transmitted Disease (STD): Infections transmitted sexually which includes the acute disease process which results, complications which may occur and the longer term permanent sequelae which may result. e. g. sexually transmitted infectious, gonorrhea, results in a disease, cervicitis, which may lead to a complication salphingitis, permanently impaired fertility would be a sequelae.  4.2. Reproductive Tract Infections (RTI): These are infections affecting the lower and the upper reproductive tracts of males and females. These includes STD, endogenous infections , which are acquired through an overgrowth of  microorganisms that are present in a healthy women's genital tract and iatrogenic infections that are acquired through medical and surgical procedures such as unsafe abortions, unsterile insertions of IUDs.  4.3. Asymptomatic Women with RTI / STD: A woman infected with RTI / STD with no obvious symptoms and signs presented or with minimal symptOms perceived as normal.  4.4. Syndromic Approach to STD Case Management : Management of STD patients based on the identification of consistent groups of symptoms and easily recognized signs and the provision of treatment that will deal with the majority of organism responsible for producing the syndrome.  4.5. Risk assessment : An assessment made by a health care worker as to whether a woman is likely to have a sexually acquired infection causing cervical infection by asking a set of questions on demographic, behavioral and related factors.   5. GENERAL GUIDELINES  5.1. All health care facilities such as hospitals, rural health units, OPDs and family planning clinics should routinely assess for RTI/STD in women.  5.2. All women attendees of the health care system should undergo a thorough \u201crisk assessment\" to identify those with asymptomatic RTI/STD.  5.3. All pregnant women should be routinely tested for syphilis.  5.4. Health care workers in public health programs and other specialties should be routinely assess for indications of RTI / STD while doing routine history taking and physical examination.  5.5. Health care workers in public health programs and other specialties should be trained in RTI / STD case finding.  5.6. RTI / STD casefinding through laboratory diagnosis should be made available and accessible especially in groups at increased risk of RTI / STD.  5.7. Regular, effective and acceptable RTI / STD services should be provided to all groups practicing high risk behaviors.  5.8. Effective and acceptable RTI / STD services should be accessible to different community groups.   5.9. Privacy of clients and confidentiality of information and services should be assured at all times.   5.l0. Appropriate referral system should be developed to ensure access of different community groups to STD services.  5.11. Every effort should be made to persuade all STD patients to notify their partner (s) and to encourage them to seek counseling and treatment.  5.12. Early health seeking behavior should be promoted through educating women on self risk assessment and recognizing symptoms indicative of STD.    6. RESPONSIBILITY AND NATURE OF ASSISTANCE  6.1 DOH (Central Office/Regional Health Office) 6.1.1. Technical assistance in training of health care workers. 6.1.2. Develop appropriate tools on risk assessment. 6.1.3. Develop prototype IEC materials on RTI / STD that can be adapted in the local health units. 6.1.4. Support for monitoring and operations research. 6.1.5. Augment logistic needs of the local health units. 6.1.6. Legislative support to include review of existing laws, drafting of laws and advocacy for the enactment of laws.  6.1.7. Develop methodologies and procedures for referral.  6.2. Local Government Unit  6.2.1. Implementation of these guidelines.  6.2.2. Provide adequate resources and environment for the provision of STD services. 6.2.3. Ensure that effective acceptable STD services are available at the local health unit. 6.2.4. Legislative support to include the review ,amendment and enactment of ordinances that will improve casefinding of asymptomatic women, one that is in accordance with the Department of Health guidelines.    This order shall take effect on September, 1997.  ", " I. BACKGROUND / RATIONALE  Schistosomiasis is an infection caused by Schistosoma japonicum a blood fluke endemic in the Philippines. It is the second most prevalent disease in the world after Malaria and remains to be a leading cause of morbidity in many parts of the world. Manifestation of the disease depends on the species a person is infected with, and the intensity of infection. Schistosoma japonicum species, which is found to be endemic in the Philippines, China and Indonesia, accounts for most of the transmission among the three major schistosome species, and one of the most difficult to control, due to its zoonotic nature. It has been controlled in some parts of the country such as Bohol, Zamboanga del Sur, Sultan Kudarat and Surigao del Sur and efforts have significantly reduced the transmission of the disease.  Recent environmental changes, closely linked to water resources development and increase in population densities, have led to the spread of the disease to previously low or non-endemic areas. With the approval of Republic Act No. 8435, otherwise known as the Agricultural Fisheries and Modernization Act of 1997, communal and national irrigation systems have emerged especially in the Mindanao Mainland, almost all provinces of which are all endemic of the disease.  Mass treatment strategy was first implemented in the Garage region to arrest dramatically high disease prevalence in the area due to constant flooding and heavy rainfall. This was implemented through Administrative Order No. 20-A, 3.1999, where mass treatment for schistosomiasis in endemic areas in Caraga Region was carried out in June 1999 and has successfully reduced the disease prevalence from 18% to 3%. Hence, Mass treatment as a strategy was promoted through Administrative Order No. 55-A s. 2000. In addition to the huge logistical requirements, achieving and sustaining high  coverage rates are major challenges. The community response is dependent on the intensity of advocacy and promotion prior to the actual conduct of mass treatment activity.  Despite the progress achieved, schistosomiasis remains endemic in eleven (11) regions covering 28 provinces, 189 municipalities and 2,222 barangays of the country. Two additional municipalities of Gonzaga, Cagayan (Region 2) and Calatrava, Negros Occidental (Region 6) were positively confirmed in CY-2004 and CY- 2006 as endemic for schistosomiasis with the presence of indigenous cases, infected Oncomelania hupensis quadrasi snail vector. Existing active transmission was shown by positive cases at 10% disease prevalence for Cagayan (2004) and 69% disease prevalence for Calatrava, Negros Occidental (May 2006) during the conduct of epidemiological surveys.  The total affected population approximates to 12 million and about 2.5 million among children from 5 to 15 years of age and the national mean prevalence for the past five years is 4.5 in 1997, which was programmed to be reduced to 1% by the end of CY-2010.  The Fourmula One for Health intervention in service delivery aims to improve the accessibility and availability of basic and essential health care for all, particularly the poor. In line with this, efforts should be made to reduce public health threats by undertaking disease free zones initiatives, implementing intensified disease prevention and control strategies and enhancement of health promotion and disease surveillance. Pursuant to the Local Government Code of 1991, Section 17-Subsection c & d, the DOH is granted authority to determine standards and guidelines for the prevention and management of diseases. The involvement of the LGUs, NGOs and private health facilities in the prevention and control of schistosomiasis necessitates the issuance of an updated and evidence based protocol in the diagnosis, treatment, and prevention of schistosomiasis to sustain the efforts of stakeholders and to strengthen the public health system.  With the recent evidence unfolding, there is a need to revise the existing guideline previously issued to determine the standards and guidelines for the prevention and management of schistosomiasis to include hospital management.  II. OBJECTIVE  This guideline aims to establish a standard in the screening & diagnosis, treatment, prevention and control of schistosomiasis for all public & private health facilities and other stakeholders.  III. COVERAGE  This order shall apply to all public and private health workers, LGUs, NGOs, academe and other stakeholders involved in the prevention and control of schistosomiasis.  IV. DEFINITION OF TERMS  A. History of Exposure ( Hx E ) - refers to actual water contact in natural or man-made waterways or bodies of water, contiguous or non-contiguous, in an endemic area.  B. Schistosoma japonicum case (Sj)  B.1 Suspected Case - With Clinical signs and with history of exposure to endemic area.  B.2 Confirmed Case - Positive stool exam by Kato Katz or any diagnostic method.  B.2.1. Complicated case - refers to manifestation of a seizure or signs of portal hypertension (edema, hepatosplenomegaly or ascites) or heart disease or complication of renal disease  B.2.2. Uncomplicated case - refers to cases w/o complications.  C. Prevalence Rate - Number of cases detected divided by the total number of persons examined multiplied by 100.  C.1. Low Prevalence - Prevalence rate of 2% and below.  C.2. Moderate Prevalence - Prevalence rate of 2.1% - 9.9%  C.3. High Prevalence - Prevalence rate 10% and above  D. Population - Number of residents living in a particular locality based on NSO survey.  D.1. Exposed/ Endemic - Total number of persons residing in an endemic area.  D.2. Eligible/ Target - Selected proportion of the endemic or exposed population.  E. Global Positioning Satellite System - Device that uses measurements from an overhead satellite to plot the exact coordinates of a geographical area.  V. GUIDELINES AND PROCEDURES  A. Screening and Diagnosis  1. Take clinical history & conduct physical examination by filling up the Individual Patient Record that includes past history of exposure to an endemic area, signs & symptoms ( Refer to Annex-A- Individual Patient Record).  2. Do Clinical Rapid Assessment (CRAss) with the following criteria / indications for Schistosoma japonicum case:  2.1 A history of exposure to endemic areas and any one (1) of the following signs/ symptoms (S/ S) with or without hepatomegaly:  i) Headache ii) Weakness iii) Pallor iv) Seizure v) Bloody stool vi) dizziness vii) abdominal pain / epigastric pain  3. Walk in patients with history of exposure to an endemic area who manifests any one of the above cited signs/symptoms maybe subjected to a laboratory confirmatory test; (Refer to Annex-B-Algorithm on Screening and Diagnosis).  B. Laboratory Work-Up: For Out-Patient.  1. Two stool examination using the Kato Katz technique; (Refer to Annex C - Procedure For Kato Katz Modified Thick Smear Technique). If first stool exam is negative, repeat the stool exam using another sample on another day within a week.  a. Require the patient to submit adult-thumb size formed stool sample, preferably taken from the last portion or tail end of the stool. Place the specimen in a clean, leak proof container.  b. Perform stool examination using two (2) aliquots per slide and determine Egg Per Gram (EPG). (See Annex D- EPG Index for Categorizing Intensity of Infection)  c. Because persons with inactive infection (treated w/in 14 days) may continue to shed dead eggs into stool for months, tests for egg viability such as egg hatching or microscopic examination of eggs for movement of flame cells should be performed.  2. Consider the following ancillary procedures, if negative for ova after two Kato-Katz thick smear, in patients with high index of suspicion: COPT, Rectal imprint/biopsy and Ultrasound (UTZ).  3. In areas without laboratory facilities and medical technologists, and if patient clinically manifests the signs and symptoms of schistosomiasis as evidenced by the patients history and physical examination, the patient Should be treated, using the CRAss (See Section A,2.2.1- Screening and Diagnosis). Record all S. japonicum cases identified on the basis of S/S,  C. Therapeutic Management  1. Management Guidelines  a. Primary Health Facilities for Outpatients  a.1 Selective Treatment (Passive or Active Surveillance)  Selective treatment is supported by a laboratory examination result positive for Schistosoma japonicum ova by stool exam and or rectal imprint.  \u2022 Drug of choice is Praziquantel 600mg/tab.  Dosage: Refer to Annex-E- Guideline on dose calculation.  \u25a0 60mg/kg body weight for one day \u25a0 Taken in two (2) divided doses at 4 to 6 hours interval with full stomach \u25a0 Observe patients for possible adverse reactions 1 to 3 hours such as headache, dizziness, abdominal discomfort, and less commonly, nausea, vomiting, diarrhea, fever and urticaria. Then instruct the patient to watch out for these reactions for 24 hours.  \u2022 Supportive drugs maybe given to cases with adverse reactions as appropriate. \u2022 Follow up Repeat treatment of confirmed cases 2 months later because praziquantel does not kill developing worms. \u2022 Indications for hospital referral - such as presence of complications such as periportal fibrosis, splenomegaly with hypersplenism, development of portosystemic collateral blood vessels, cor pulmonale, glomerulonephritis, CNS schistosomiasis (patient with seizures, focal neurologic deficit), such as signs of increased intracranial pressure, diffuse encephalitis.  a.2 Mass Treatment  1. A trained health worker should supervise the conduct of mass treatment. Use the Master-list of the population in the barangay to determine the treatment target coverage.  2. Praziquantel : Single dosage of 40mg/kg should be given with a full stomach; ( Refer to Annex-E, Guideline on the total dose calculation of Praziquantel, 600 mgs.)  3. Observe adverse events and give symptomatic treatment as may be necessary. An existing referral system must be in place before the conduct of mass treatment.  4. Ensure the availability of drugs for adverse reactions prior to the mass treatment.  Treatment of Adverse Events  Manage the adverse events of Praziquantel through symptomatic treatment: anti-spasmodics, anti-pyretics, analgesics, anti-histamines, antacids and anti-emetics. Adverse events should be recorded for purposes of determining drug supply for its management; (Refer to Annex-F Guide in the Management of Adverse Reactions)  Severe adverse events must be managed in the hospital  b. Secondary and Tertiary Health Facilities for Inpatients  b.1 Criteria and Indications for Admission  \u00a7 Jaundice \u00a7 Bleeding/ Anemia \u00a7 Large Ascites \u00a7 Grade 2 and above Pedal Edema \u00a7 Co-Morbid Conditions: CHF, CRF Etc. \u00a7 Cerebral Cases \u00a7 Hepato-splenomegaly (by UTZ) \u00a7 Liver Fibrosis (By liver biopsy)  Grading Severity of Chronic Schistosomiasis with Portal Hypertension.    Child's Class A: Score of 5-6 Child's Class B: Score of 7-9 Child's Class C: Score of &gt;10  b.2 Laboratory Procedures  Routine Examinations  \u25a0 CBC \u25a0 Stool Exam using Kato Katz \u25a0 Urinalysis \u25a0 Liver Function Tests (total protein, serum albumin, PT) \u25a0 Partial thromboplastin time (PTT)  Ancillary Examinations:  \u25a0 BUN \u25a0 Creatinine \u25a0 Blood Chemistry \u25a0 Hepatitis Markers - (HbsAg, Anti-HCV) \u25a0 Blood CS  Other Exams conditional on case at hand  \u25a0 Rectal biopsy / imprint / proctoscopic snip test \u25a0 COPT; ELISA \u25a0 EEG \u25a0 CT Scan; MRI \u25a0 UTZ \u25a0 X-ray \u25a0 Cerebrospinal fluid test  b.3. Case Definition for Final Diagnosis:  Definitive Diagnosis: A case with a (+) laboratory result from any of the following:  \u25a0 Schistosoma egg in stool \u25a0 Rectal Biopsy/Imprint / Proctoscopic Snip Test with actual demonstration of viable egg or miracidial shadow \u25a0 Serologic Test: COPT if no previous history of a positive test result \u25a0 Immunodiagnostic Test : ELISA \u25a0 Ultrasound of HBT showing pipe-stem fibrosis \u25a0 EEG ; CT SCAN; MRI with exposure history to schistosomiasis  b.4 Treatment  b.4.1 Hepato-intestinal cases of schistosomiasis and/ or pulmonary cases of schistosomiasis  Praziquantel dose of 60 mg/kg given in 2-3 divided doses on the same day, preferably after a meal.  Symptomatic/Supportive Treatment  Laxative: Lactulose 30 - 60 cc TID (Adult dose) to make 4 -5 BMs/day or do fleet enema if still without bowel movement.  Diuretics:  \u25a0 If with pedal edema: Furosemide (adult dose) 40 mg OD/BID PO or 20 mg IV every 8 hours; Pedia dose: oral 2 mg/kg/dose q 6-8 hours pm; 1 mg/kg/dose q 8- 121M, IV  \u25a0 If with ascites: Spirinolactone 50 mg BID/QID P.O. up to a maximum of 400mg/day;  \u25a0 Furosemide & Spironolactone (ratio of 100:40 to maintain normokalemia; maximum doses: 160/400)  INDICATIONS TO STOP DIURETICS  \u00a7 Encephalopathy \u00a7 Serum Sodium &lt; 120 mml/L despite fluid restriction \u00a7 Serum Creatinine &gt; 2.0 mg/dL \u00a7 Hyperkalemia & metabolic acidosis (Spironolactone usage)  \u2022 Therapeutic Paracentesis: Small Volume (up to 1 liter/tap) Large Volume (up to 4-6 l/tap): Albumin infusion is recommended For Refractory ascites: Intermittent large volume paracentesis (up to a total of 10L) with Sodium restriction and IV colloid replacement, preferably albumin.  \u25a0 Portal hypertension : Propranolol (adult dose) 10 mg TID or ISDN 20 mg BID; Pedia: 0.5- 1 mg/kg/24 hours divided into q 6-12 hours with a maximum of 2 mg/kg/24 hours.  \u25a0 Bleeding Esophageal Varices: \u00a7 Sclerotherapy \u00a7 Rubber Band Ligation \u00a7 Trans-jugular Intra-hepatic Shunt (TIPS)  \u25a0 Bleeding due to decrease in clotting factors: give 4-5 units of fresh frozen plasma or a pediatric dose of 10 cc/kg/dose plus 1-2 doses Vitamin K1 (phytomenadione or aquamephytone) at 10mg/ml amp. Q8Hrs; media dose of Vitamin K1 is 1-2 mg/dose IV once or 2-5 mg/24 ours, orally and PO.  \u25a0 Epigastric Discomfort: Proton Pump Inhibitors for adult patients OD or BID ; Pediatric dose: 0.5 ml/kg/dose or 40 mg/kg/dose p.o.; Ranitidine: p.o. 2-4 mg/kg/24 hours divided into q 12 hours. IV  \u25a0 Gastrointestinal bleeding: * IV Proton Pump Inhibitors BID \u25a0 H2-blockers: Ranitidine IV/IM 50 mg every 8 hours or \u00a7 Nasogastric tube insertion  \u25a0 Renal Failure: Cautious fluid management with CVP insertion and monitoring and refer to Intensive Care Unit.  \u25a0 Hypoglycemia: Hypertonic Glucose D50-50 IV (adult dose); Pediatric dose: 1 gm/kg glucose IV  \u25a0 Nutritional Therapy:  Multivitamins Fluid: restricted to 1- 1.5 liters / day if with hyponatremia (Na&lt;l 30) Dietary Recommendations:  \u00a7 Full High Fiber Diet \u00a7 Sodium restriction for ascitic cases \u00a7 Protein restriction for renal compromise Egg whites may be used instead for dietary protein supplement.  \u2022 Pediatric computation: formula for energy requirements for catch-up growth:    * Weight-age is age at which patient's current weight would be in the 50th percentile.  \u25a0 Antispasmodic for abdominal pain: Hyoscine-N-butyl bromide 1 amp IV q 8 hrs PRN (adult dose) Pediatric dose: 0.3-0.6 mg/kg body weight by slow IV, IM OR SC several times daily up to a maximum of 1.5 mg/kg body weight/day  \u25a0 Contraindicated drugs if liver is severely compromised: hepatotoxic drugs, diazepam, phenytoin  \u25a0 Fluid Replacement  Mild DHN - Oresol Moderate DHN - Oresol Severe DHN - Plain NSS and D5NSS  \u25a0 Fever -Paracetamol  \u25a0 Antihistamine for allergy: Chlorpheniramine Pediatric dose: 2-6 years old: 1mg/dose p.o. q 4-6 hours prn; maximum of 4 mg/24 hours; 6-12 years old: 2 mg/dose p.o. q 4-6 hours maximum of 12 mg/24 hours; Diphenhydramine Pediatric dose: 5 mg/kg/24 hours divided into q 6 hours p.o./IM/IV (maximum of 300 mg/24 hours)  b.4.2 CNS Involvement in Schistosomiasis  Pathogenesis:  Symptomatic Cerebral Schistosomiasis occur in approximately 2-4% of individuals infected with S. Japonicum. In Symptomatic NS, the eggs reach the CNS through retrograde venous flow into the Batson Vertebral-epidural venous plexus which connects the portal venous flow and the vena cava to the spinal cord and cerebral veins.  Cerebral NS often presents as a slow expanding intracranial lesion. The clinical presentations are variable and depend mainly on the site of the lesion and on the increase in the intracranial pressure caused by the mass effect. Headaches, seizures, papilledema, visual abnormalities, speech disturbances, sensory impairment, hemiparesis, nystagmus and ataxia are common presentation with the symptoms varying from a few weeks to more than a year.  \u25a0 Anti-convulsant Phenytoin (Dilantin) should be given as follows:  \u00a7 Loading dose of 18 - 20 mg /kg; do EEG after 6 months, if normal, taper the dose every 2 weeks;Adult dose: 5 mg/kg/24 hours divided into OD or q 12 hours p.o./IV; Pediatric dose: 6 months to 3 years: 8-10 mg/kg/24 hours; 4-9 years old: 7-8 mg/kg/24 hours; 10-16 years old: 6-7 mg/kg/24 hours. Doses are divided into q 8-12 hours.  PHENOBARBITAL: Loading: 15-20mg/kg slow IV at &lt; or = 50mg/min  Maintenance: 3-5mg/kg/day  Watch out for signs of respiratory Depression.  Phenytoin Dosage as per Neurology suggestion: Loading Dose: Also 18-20mg/kg slow IV at &lt; or =50mg/min  Maintenance: 3-5mg/kg/day  With Hypotension & cardiac arrhythmia precaution  Diazepam: 0.3-0.5mg for pediatric patients w/ frank seizures. For adult cases, 5mg IV( not to exceed 30mg/day)  \u00a7 If no EEG is available, the recommendation is to taper the dose after 2 years of being seizure free. \u00a7 Request EEG at 6 months of anti-convulsant treatment:  Normal EEG: Taper the dose of the anti-convulsant every 1-2 weeks then discontinue. Abnormal EEG: Continue anti-convulsant treatment and repeat EEG another 6 mos. Then advise regular OPD follow-up for seizure monitoring.  Note: Other anti-convulsant may be used at the discretion of the attending physician.  \u25a0 Praziquantel Dosage :  Dosage for NS caused by S. japonicum is 60mg/kg divided BID-TID for 3 days. Pediatric Dose: Less than 4 years is not established. For 4 years and older, treat as adult. Dosage for S. mansoni & S. haematobium has a range of 40-60mg/kg divided BID-TID for 3 days  \u25a0 Corticosteroids  PREDNISONE: 1.5-2.0mg/kg/d administered in 3 daily doses.  METHYLPREDNISOLONE: 500mg every 12 hours for 5 days followed by Prednisone as described above.  NOTE: This high dose prednisone is maintained for about 3- 4 weeks followed by tapering over several weeks.  SURGICAL APPROACH: Due to the risk of additional damage to the involved nervous tissue, this approach should be reserved for specific cases such as A) Those w/ evidence of medullary compression. B) Those who deteriorate despite adequate medical treatment, and C) When there is considerable uncertainty in diagnosis.  b.4.3 SURGICAL APPROACH: To relieve Portal Hypertension and Symptoms of bleeding Esophageal Varices  Around 70% of patients with liver cirrhosis who had an initial variceal hemorrhage will rebleed (1). The risk of rebleeding is lower in patients with presinusoidal obstruction (e.g. portal vein thrombosis or schistosomiasis) and in patients with compensated cirrhosis (Child A) as compared to patients with decompensated cirrhosis (Child B and C) (2). Furthermore it strongly depends on the portal pressure and the variceal pressure (3), Mortality of rebleeding mainly depends on liver function (2,4). It varies between 15 and 50% (4) Concomitant infection is an important risk factor of failure to control bleeding (5) and early rebleeding (4) and therefore worsens prognosis. See Annex \u00abI- Algorithm for Rebleeding Prophylaxis and Annex J- Therapeutic Options for Prevention of Rebleeding.  NOTE: good surgical candidate for above procedures are Child's A to Child's B.  b.5 Precautions in giving Praziquantel  \u2022 Administration of Praziquantel is not recommended during the first trimester of pregnancy, to those with severe HPN and /or those with on going TB. Can praziquantel be given to very young children (i.e what is the youngest age group that the drug can be given?  \u2022 Precautions in giving praziquantel to those undergoing chemotherapy, severely ill, patients with liver or kidney disease, malnourished, hypersensitivity to the drug and elderly patients and if possible with clearance from an internist.  \u2022 Praziquantel may be given to lactating mothers but breastfeeding should be withheld 48 hours after the intake of praziquantel.  \u2022 Ocular Cysticercosis is a contraindication to giving praziquantel due to the destruction of parasites within the eye can cause irreparable lesions.  \u2022 Praziquantel, likewise, minimally increases the liver enzymes.(Alanine Aminotransferase or ALT) and if possible monitoring of the level of enzymes should be conducted.  b.6 Criteria for Patients Discharge  Improvement of clinical condition : Afebrile for 72 hours; Resolution of signs and symptoms; and at least 50% improvement in values of monitored laboratory parameters.  b.7 Follow up advice upon discharge - Patients are advised to follow-up after 6 months at the OPD or RHU  V. Program Strategies  1. Case Finding  \u2022 Case finding should be done (service coverage - active surveillance done in moderate to high endemic areas & priority barangays in low endemic areas) among individuals one year old and above in endemic barangays covering at least 85 % of eligible population. Perform two stool examinations using two (2) aliquots per slide done in different days within a week and determine Egg per Gram using Kato Katz Technique. Compute the total EPG, arithmetic and geometric mean EPG of the total population examined for program evaluation. Fill up the Master-list of Stool Examination.  \u2022 Alternatively, when case finding is not feasible, covering less than 85% of the exposed population, the following can be done:  a. Passive case detection or parasitologic exam of walk-in patients in all Government health facilities, and ensure the availability of Praziquantel and lab supplies.  b. Use of a Clinical Rapid Assessment (CRAss) as follows:  b.1 Elicit a history of exposure, defined as water contact or contact with water possibly contaminated with cercaria;  b.2 Review of signs / symptomatology as follows:  \u25a0 Headache \u25a0 Weakness \u25a0 Pallor \u25a0 Seizure \u25a0 Bloody Stool \u25a0 Abdominal / Epigastric Pain \u25a0 Dizziness  b.3 Criteria for treatment after doing P.E.:  \u2022 Exposure history and S/S \u2022 This criteria (HxE and S/S) can be enhanced by a finding of hepatosplenomegaly.  2. Treatment  a. Selective Treatment  \u25a0 In areas with a prevalence rate less than 10%, that is, in moderate prevalence rate (2.1 -9.9%) and low (&lt;2%) prevalence rate areas, conduct selective treatment only in positive cases.  b. Mass Treatment  \u25a0 Treat with Praziquantel (40mg/kg as single dose with full stomach) all 5-65 years of age in a highly endemic barangay (PR&gt;10%) without the benefit of a stool exam.  \u25a0 Conduct mass treatment (at least 85% coverage) in high prevalence barangays (PR&gt;10%) for three (3) consecutive years after which evaluation should be done using the following parasitologic & process indicators (See Annex N-List of Parasitological & Process-Indicators)  \u25a0 Observable adverse events after intake of Praziquantel should be treated symptomatically.  3. Environmental Sanitation  Promote good sanitation and hygiene practices in endemic communities and encourage the people to reduce environmental health risks, including the safe disposal and hygienic management of human & animal excreta, refuse and waste water.  Specifically, campaign the following:  \u2022 Use of sanitary toilets and avoid defecation in the rice fields, rivers, streams-or elsewhere; promote the construction of sanitary toilets in all endemic barangays and monitor the toilet utilization.  \u2022 Use water obtained from safe sources for bathing, laundering, cleaning; and drinking;  \u2022 Control all the stray and domesticated animals (also agents of disease transmission) to prevent them from wading or polluting the bodies of  water inhabited by snail vectors. Prevent the working animals like the carabaos from bathing/swimming or crossing in infested streams & rivers;  \u2022 Use of footbridges or construction of wooden or cemented footbridges as waterway crossings in irrigation canals, dams, rivers, streams and creeks infested with schistosome snail vectors.  4. Snail mapping & control  \u2022 Conduct a time searched semi-quantitative survey to map out all disease transmission sites or potential disease transmission sites in all the endemic areas using malacological survey tools including GPS.  \u2022 Snail population can be reduced through:  \u25a0 Physical snail control by engineering of hydraulic infrastructures such as the concrete lining of canals, ensuring high water velocity, weed control, periodic flushing and emptying of canals.  \u25a0 Environmental modification methods such as clearing the vegetation in swampy areas to expose the vector snails to sunlight; construction of fish ponds when water cannot be drained; practice of scientific farming that promotes improved rice culture (e.g. constant plowing & periodic weeding of the fields).  \u2022 Chemical Control through Molluscicides  The use of chemicals to control snails is only recommended in areas with low prevalence(&lt;1%) as a final phase of elimination. A comprehensive mapping of snail colonies in the area should be done prior to such measure.  The use of molluscicides for snail control is restricted due to acute inhalation toxicity, aquatic organism toxicity and ground water contamination. Evidences on the health hazards to chemical applicators, death of aquatic organisms, contamination of food chain & ground water have been documented in other countries.  5. Health Promotion  \u2022 Prevention and control is optimal when it is part of the general health care \"system and when the Primary Health Care System performs specific control tasks for:  \u25a0 Social Mobilization & Advocacy \u25a0 Linkage & Networking \u25a0 Formation of Task Forces  \u2022 The Department of Education school curriculum is encouraged to integrate health education among children on disease infection, transmission, prevention and control of endemic parasitic diseases.  \u2022 Community organizations and peoples participation are enjoined in combating the disease to effect change in the attitudes and practices of the people who are exposed and at risk to schistosomiasis infection  \u2022 The use of tri-media is recommended as an effective tool to create awareness, to advocate, promote and educate the people on disease transmission, diagnosis, treatment, prevention & control of schistosomiasis.  6. Health Impact Assessment:  Health Impact Assessment should be carried out in close association with, but distinct from, environmental assessment, because it considers changes in both environmental and social determinants of health  \u2022 Schistosomiasis is a multifaceted problem that approaches to control must be multisectoral; the involvement of DepEd, DA-BAI & NIA, DPWH, DENR, DILG-LGUS, PIA, Academe, International Aid Organizations, NGOs, Professional Organizations and all stakeholders will strengthen & enhance the efforts of disease control & elimination.  7. Surveillance and Monitoring  \u2022 The DOH shall provide technical assistance in the conduct of Surveillance & Monitoring of Schistosomiasis in partnership with the LGUs and other stakeholders.  \u2022 Areas with large population coverage (&gt;120,000 population / province) may select Index barangay schools as sentinel sites. for surveillance of human cases. The selection shall follow the areas of snail sentinel sites.  \u2022 Human cases will be monitored using a sentinel group of public school children, grades 1-3. Annual Parasitologic examination should be done on these children and will be used for purposes of determining trends in human infection, using the Kato Katz technique. The EPG will be likewise obtained in parasitologic examinations.  \u2022 Conduct rapid epidemiological surveys in response to suspected new areas.  \u2022 Monitor households in the endemic areas as to the existing sanitary toilets facilities, safe water supply facilities and the utilization of these facilities.  \u2022 Conduct a prevalence survey every 5 years to determine the status of prevalence per endemic barangay / municipality / province for program evaluation. A random selection (multi-stage sampling) of endemic barangays shall be done.  \u2022 Sentinel surveillance (snail vectors) of disease transmission sites (at least 3-5 municipalities per province) should be done to determine the snail density and snail infection rate in areas of low prevalence.  8. Quality Control (QC):  \u2022 Ten percent of the total slides examined randomly, should be subjected to a blind validation by a Certified Validator for Schistosomiasis, other Helminths & Protozoans from another province ; ( see Algorithm in Annex-G, Quality Control for Validation ). This random validation shall be done in all slides examined.  \u2022 Slides examined by the RHUs and other health facilities shall be validated by a certified provincial validator. Refer to Algorithm for QC of RHUs in Annex-L.  \u2022 A discordance of 15% of the total slides validated shall be sent to Central Office for inter validation by UPM-CPH or RITM.  \u2022 Proficiency training or retraining of Med Techs shall be based. on the result of inter validation.  9. Networking and Linkages  A multi-sectoral approach is encouraged in. the implementation of schistosomiaSis project initiatives with. the involvement of all stakeholders, collaborating Institutions, and. local community organizations.  VII. IMPLEMENTING - GUIDELINES  A. Phased Implementation  a. The CHDs should provide technical assistance to LGUs to build its capacity for implementation.  b. Piloting / Operationalization of Sentinel Surveillance for human disease and snail vector.  Year 2007-2010  \u2022 Development of Surveillance System in coordination with National Epidemiology Center \u2022 Pilot implementation of different sites for sentinel surveillance \u2022 Operationalization of Surveillance system \u2022 Training and Human Resource development of CHDs/ LGUs / RHUs/ government & private hospitals. \u2022 Resource Generation / Sharing \u2022 Joint Program Implementation Review (PIR) and Planning with the Local Government  c. Reporting  \u2022 Forms to be used with the narrative summary are Annex D , L & M . Form. L. with narrative-summary should be submitted  \u2022 Observe reporting flow as follows: From RHU to PHO monthly: From PHO to CHD quarterly, From CHD to CO quarterly.  All stakeholders should develop strategies for schistosomiasis control including early and prompt treatment. Integration with other health care services provided by the different levels of care in endemic areas should be done.  B. Roles and Responsibilities  1. Department of Health ( DOH )  a. National Center For Disease Prevention and Control (NCDPC)  \u2022 Formulation of the Schistosomiasis Program Investment Plan. \u2022 Formulates evidence based policies to improve/enhance the program implementation \u2022 Conduct Training of Trainers and provision of support for capacity development at all levels of health care. \u2022 Put in place a \"system\" for Health Human Resource Development, Logistics Management , Reporting and Surveillance Systems. \u2022 Conduct regular Monitoring and Evaluation activities. \u2022 Provide technical assistance in research development & implementation \u2022 Augment the requirement for schistosomicide drug PRAZIQUANTEL \u2022 Generate external resources through Project's development & Public investment packages to support program implementation.  b. Center For Health Development ( CHD )  \u2022 Incorporate Schistosomiasis Plan Targets and Strategies in the Regional Plans. \u2022 Include in the Investment Plan] Annual Work & Financial Plan, a substantial amount for the control, prevention and treatment of schistosomiasis. (See Annex H - Guidelines For Operations Costing) \u2022 Develop the capacity of health providers to implement the Revised Guidelines in the Management and Prevention of Schistosomiasis at the Provincial/Municipal/Barangay levels. \u2022 Conduct of Inventory of Relevant Competencies and Assessment of Needs for Resources as may be required in the implementation on the Revised Guidelines in the Management and Prevention of Schistosomiasis. \u2022 Formulate and implement Advocacy Plans to gain political commitment and community support. \u2022 Implement \"systems\" on Health Human Resource Development, Logistics Management, Reporting and Surveillance Systems. \u2022 Allocate drugs, laboratory supplies and IEC materials to augment the logistics of the LGUs \u2022 Establish Quality Assurance and Control System. \u2022 Collect, analyze and submit report to NCDPC. & FICO \u2022 Provide technical assistance to other LG-Us, NGAs and other stakeholders in determining the health impact during the planning stage of the construction and/or rehabilitation of irrigation structures, dams or any water development projects. \u2022 Monitor activities related to schistosomiasis control and prevention. \u2022 Advocate the Schistosomiasis Control Program to the Local Health Board through the DOH Representatives for funding requirements, human resource needs and inclusion in the local development plan \u2022 Advise/assist in the Policy formulation, legislation and local execution of legislative issuances. \u2022 Recommend to the DOH Central Office the technical assistance requested and identified by the LGUs  2. Local Government Units (LGUs)  a. Provincial Health Office (PHO)  \u2022 Conduct Orientation/Training for private and public health workers on the implementation of the Revised Guidelines in the Management and Prevention of Schistosomiasis. \u2022 Provide funding support for training, drugs and laboratory supplies. \u2022 Collaborate with other LGUs and other stakeholders in the implementation of the Revised Guideline in the Management and  Prevention of Schistosomiasis. \u2022 Monitor implementation of the revised guidelines in the Rural Health Units and Hospitals (private and government). \u2022 Ensure the effective implementation of the systems on Health Human Resource Development, Logistics Management and Reporting and Surveillance System. \u2022 Collect, analyze and submit report to CHD \u2022 Include in the Investment Plan/ Annual Work & Financial Plan, a substantial amount for the control, prevention and treatment of schistosomiasis. (See Annex H - Guidelines For Operations Costing) \u2022 Secure/initiate drafting of local legislations necessary to eliminate schistosomiasis in their area.  b. Rural Health Unit (RHU)  \u2022 Implement the Revised Guideline in the Management and Prevention of Schistosomiasis \u2022 Provide Praziquantel & anti-reaction drugs for schistosomiasis treatment. \u2022 Provide laboratory services and supplies in the diagnosis of schistosomiasis \u2022 Conduct orientation for BHWs and volunteers on the Revised Guideline in the Management and Prevention of Schistosomiasis. \u2022 Conduct advocacy to ensure awareness and active community participation \u2022 Supervise and monitor activities in the control & prevention of schistosomiasis. \u2022 Collect, analyze and submit reports to the PHO. \u2022 Include in the Investment Plan/Annual Work & Financial Plan, a substantial amount for the prevention and control of schistosomiasis. (See Annex H - Guidelines For Operations Costing) \u2022 Conduct regular surveillance, monitoring and evaluation. \u2022 Submit regular accomplishment report to the PHO and CHD.  3. NGO/NGA/GO, International Aid Organizations & Other Stakeholders  \u2022 Support the implementation of The Revised Guidelines in the Management and Prevention of Schistosomiasis. \u2022 Coordinate and collaborate with the DOH and LGUs specially in planning of water resources development, irrigation structure, construction or rehabilitation to determine / assess its impact on health prior to implementation.  VIII. REPEALING CLAUSE  Provisions of Administrative Order 55 s 2000, Guidelines in the Implementation of Mass Treatment Strategy for Schistosomiasis Control Elimination still in effect. All other previous related issuances found inconsistent with this issuance shall be repealed.  IX. EFFECTIVITY  This Order takes effect immediately upon posting and publication in the DOH intranet or fifteen days upon filing with UP Law Center. ", "  I. Rationale:  Women in developing countries often have inadequate levels of micronutrients because of limited intake of animal products, fruits , vegetables and forti\ufb01ed foods. The Recommended Dietary Allowance ( RDA) including those for micronutrients increases substantially especially during pregnancy and lactation which is dif\ufb01cult to meet by diet alone. Studies reveal that micronutrient de\ufb01ciencies result in learning disabilities, mental retardation, poor health, low work capacity, blindness and premature death among women and children.  The Philippines is currently addressing the problem of iron de\ufb01ciency anemia which affects 5 out of 10 pregnant women and 2 out of 10 of thesame women has nightblindness or suffering from vitamin A de\ufb01ciency. Iodine de\ufb01ciency is likewise a public health problem ( 1998 NNS FNRI\u2014DOST) . The average Filipino diet is generally short of recommended daily allowances so that other micronutrients like Zn, Se, etc would also be found de\ufb01cient or inadequate hence, multiple de\ufb01ciencies may exist.  The consequences of micronutrient de\ufb01ciencies are many and could be permanent. They contribute to increase in morbidity and mortality of the pregnant women, increase incidence of low birth weights, and congenital malformations i.e, folate de\ufb01ciency cause neural tube defects.  The Department of Health cognizant of the need to improve the health status of pregnant women have. designed programs like the iron/folate supplementation and vitamin A supplementationto post\u2014partum mothers. ( AO no 3,s. 2000) However, limited coverage and compliance and \ufb01nancial limitations to provide the total requirements and sustain the availability of the micronutrients are the reasons ,Why it is dif\ufb01cult to make a dent in the prevalence of iron de\ufb01ciency and iron de\ufb01ciency anemia and vitamin A de\ufb01ciency. Added to this is the poor economic conditions which make it dif\ufb01cult to consume good food sources of the vitamins and minerals as they could be more expensive.  Multiple micronutrients supplementation have been found bene\ufb01cial based on a number of studies. It improves the micronutrient status of pregnant and lactating women and it could be one component of a strategy to address micronutrient de\ufb01ciencies of women in developing countries. One major issue however , is what level of nutrient standards to be used. The Philippines have RDA (l989-FNRI) which could be followed for the country, however it is not complete and needs to be updated. On the other hand, the WHO have recommended values for women of reproductive age in developing countries which could be used for reference.  This guideline is issued to serve as reference for health workers in the use of the multiple micronutrient in UNICEF CPC V areas.  II. Objectives  1.To improve the nutritional status of pregnant women.  2. To reduce morbidity/mortality associated with micronutrient de\ufb01ciencies among pregnant women.  3. To improve the health and nutritional status of breastfed infants.  III. Coverage  The use of multiple micronutrients is being recommended by the international communities on health and nutrition and to be considered as a strategy addressing micronutrient de\ufb01ciencies among pregnant women.  United Nations Childrens' Fund (UNICEF ) is introducing the use of multiple micronutrient supplement in the country as part of the micronutrient supplementation program in CPC V areas. The supplement has passed Bureau of Food and Drugs (BFAD) and was approved as a food supplement.  The UNICEF CPC V areas are :    The micronutrient supplement has the following composition :    Literature review showed that the levels of nutrient that are contained in this multiple micronutrient preparation are the minimum daily recommended nutrient levels for women of reproductive age.  Documented Benefits    IV. Guideline /procedure for Supplementation:  Target : Pregnant women Dose : One tablet per day When to start : First trimester of pregnancy until delivery  Precautionary Measures/ Reminders:  Pregnant mothers who are receiving the multiple micronutrient will not be given the preventive supplementation of vitamin A 10,000 I.U which is given 1 capsule of 10,000 I.U . 2x a week from the 4th month of pregnancy until delivery.  Monitoring and Recording  Pregnant mothers taking the multiple micronutrient should be properly recorded and monitored in the target client list which records pre\u2014natal visits and services rendered .  Evaluation  Evaluation shall be done to document impact of multiple micronutrient supplementation i.e., improved nutritional status of pregnant women during the period of gestation, decrease in maternal and child morbidity and mortality, decrease in low birth weights and pregnancy complications. Results of evaluation shall be the basis for future policy recommendations.  V. Implementing Mechanism Roles and Responsibilities of the CHDs and Local Government Units 1. Oversee the delivery of multiple micronutrients in health facilities 2. Conduct proper orientation of health personnel on implementing guidelines for multiple micronutrient supplementation 3. Record, report and assess accomplishments particularly coverage, and compliance.  VI. Effectivity  This order shall take effect upon its approval.   ", "  The National Drug Committee and the Bureau of Food and Drugs recommended the banning of loperamide hydrochloride liquid preparations for children because - -   (1) \"children are more sensitive to its (loperamide) adverse CNS (central nervous system) effects,  (2) \"its (loperamide) safety and efficacy in children are not yet established\".         This recommendation is supported by the December 21-28, 1990 issue of the weekly Epidemiological Record from WHO- (P. 398).         FINDING the foregoing recommendation in the] interest of safety and consumer\u2019s protection, loperamide hydrochloride liquid preparation for children is hereby banned.         This preparation shall no longer be registered for distribution in the market.         The BFAD shall ensure that no loperamide liquid preparation is introduced henceforth in the market.         This Order shall be effective fifteen (15) days from its publication in a newspaper of general circulation.    ", "  SUBJECT:   Administrative Order No. 21-A s. 1996 includes the Guidelines for the Development and implementation of the DOH Women's Health and Safe Motherhood Project Maternal Care Delivery Civil Works Sub-component.  To obviate confusion on Project Development and Implementation, provisions. Nos.3.3.1; 3.3.2; 3.3.3; 3.3.4; 3.3.5; 3.4.2; 3.4.3.1; 3.4.4.1; 3.4.5 and 3.4.6 thereof are hereby modified to read:  3.3 PROJECT DOCUMENTATION  3.3.1 This phase of work will focus on the preparation and approval of bid documents which include among others, Instruction to Bidders, Detailed Architectural and Engineering Plans, Technical Specification, General Conditions, Detailed Direct Cost Estimates with unit cost analysis for materials and labor and other related bidding documents like Bid Bulletin, etc.  3.3.2 The Bid Documents shall be prepared by the CONSULTANT using the funding agency's Standard Bidding Documents for Procurement of Civil Works, Asian Development Bank or international Bank for Reconstruction and Development as the case may be.  3.3.3 The Approved Agency Estimate (AAE) shalt be jointly prepared by the Regional Civil Engineer in coordination with the Provincial and or Municipal Engineer accordingly using the submitted Approved Direct Cost Estimates of the Consultant and to be approved by the Regional Health Director at least 2 days prior to the bidding date.  3.3.4 The DOH\u2014INFRA shall assist the PMO in the review, evaluation and final approval of the Bidding Documents.  3.3.5 As a rule the Bidding Documents will be approved following the order set forth in item 3.2.5 (a).   3.4 PROJECT IMPLEMENTATION   3.4.1 X X X  3.4.2 The public bidding and awarding of contracts of projects partly or wholly financed from international institutions will be conducted using the guidelines stipulated by the lending agency. However, provisions of PD 1594 (Rules and Regulations for the Implementation of Government Infrastructure Projects) as amended and DOH A.O. 40 s. 1996 shall apply in supplementary character.  3.4.3 X X X  3.4.3.1 The RIPBAC shall submit to the DOH\u2014WHSMP the bidding documents of the first three lowest complying bidder including the Abstract of Bids, Minutes of the Pre- bidding Conference and Bidding Proper, Bids Evaluation Report and Resolution to Award before any award shall be made. These documents shall be sent to the funding agency for concurrence.   3.4.4 X X X  3.4.4.1 The Regional Health Director shall be the contracting party in the Owner-Contractor Agreement and approved by the WHSMP Project Director.   3.4.5 The regular construction supervision of the projects will be the responsibility of the engineering units of the Office of the Governor and Mayor concerned as provided for in the Project Implementation Agreement (PIA) between the DOH and the Local Government Units. They shall submit a Monthly Progress Report to the Regional Health Office not later than every 10th day of the succeeding month using the standard report of the DOH-WHSMP.  3.4.6 The funding Agency guidelines shall be used in the contract implementation up to project acceptance and turn-over, however, PD 1594 provisions shall be used in the absence of the funding agency guidelines.  4.0 SELECTION CRITERIA AND SCOPE OF WORK FOR CIVIL WORKS   Anent the purpose of physically preparing health facilities to be upgraded under WHSMP, it is deemed necessary to include in Administrative Order No. 21 s. 1996 the selection criteria and the scope of civil works. Thus:   A. First Referral-Level Hospitals (Provincial and District)  The causes of maternal deaths are often directly related to the need for interventions beyond primary health care capabilities. The first referral level obstetric hospital is therefore needed to provide these services. The essential obstetric functions at the first referral level are:  (i) to perform caesarean sections (ii) to give anaesthetic (iii) to give blood transfusions  (iv) to carry out curettage for incomplete/septic abortions/miscarriages  (v) to perform other minor surgical OB intervention such as voluntary surgical contraception  (vi) to give neonatal special care  First referral facilities are de\ufb01ned as hospitals able to provide emergency obstetric procedures at any time.  Selection Criteria for Provincial Hospital  The final selection of provincial hospitals will be based on the following criteria:  (i) facility to which the rural health midwives, and rural health doctors can directly refer; (ii) requires upgrading of obstetric facilities (measured against a standard list of needs) to provide good quality, safe, and essential first-referral level facilities;  (iii) if the provincial hospital is within 15 to 30 minutes of the regional medical center which can receive referrals direct from the rural health unit staff then the provincial hospital should not be upgraded;  (iv) no facility will be upgraded to first referral level unless it already has the basic elements to provide emergency obstetric care already available or guaranteed by the provincial government (the package of needs is the minimum required and cannot be reduced or modi\ufb01ed); and  (v) no facility will be upgraded for obstetrics care if the whole facility is in very poor condition and not planned for rehabilitation, or if a new facility is being planned, or if another financing source is planning improvements or upgrading.  Additional Selection Criteria for District Hospitals  In addition to the criteria outlined above, the following criteria will apply to district hospitals that are to be upgraded:   (i) 25-bed capacity or greater; (ii) a facility to which the rural health midwives, and rural health doctors can directly refer, which is a maximum of 2 hours via local transportation for most of the rural population;  (iii) the facility has staff available to support 24 hour intensive nursing and emergency surgical care; and a minimum staff allocation of 4 doctors, 6 nurses and 8-12 trained midwives; and (iv) LGU is committed to support the district hospital's operation and maintenance expenses.   Scope of Work ,  Each first referral hospital will be upgraded to have a fully operational obstetrics unit including:  (a) a labor room, (b) a delivery room, (c) an operating room, (d) a septic room, (e) an isolation room, (f) an examination room, (g) a nursery for intensive neonatal care, (h) a reception and triage area, (i) a recovery room, (j) a sterilizing room, and (k) adequate water, sanitation, and electricity infrastructure;  The decision of whether to build annexes or not in the provincial hospital is to be made by the end user in coordination with the WHSM-Project Management Office, based on utilization rates and human resource complement. If in case the above criteria can not be accommodated, the minimum requirements of the Bureau of Licensing and Regulations, Department of Health for provincial and district hospitals shall be followed.  B. Rural Health Units (RHU)  The rural health unit is the closest full~time staff facility providing primary health care to a community. These facilities have a rural health midwife on call at all times. RHUs provide primary health care minor surgery, (e.g., wound dressings, suturing) antenatal and postnatal care, family planning (pill and condom distribution insertion and removal of intrauterine devices), nutrition, management of common infectious diseases, counseling and preventive intervention (e.g. immunization)   Issues that presently compromise the quality of these services provided at these facilities include lack of privacy for clients; poor management of sterile conditions; poorly maintained facilities and equipment; lack of essential equipment, drugs, and supplies; lack of reliable and clean sources of water and power; poor sanitation facilities, especially needed for women undergoing internal examinations and for antenatal clients.   Selection Criteria   RHUs that are selected should:  (i) have a permanent or assigned rural health physician; (ii) have a staff who is a resident of the catchment area where the RHU is being upgraded where this staff can be called anytime from his / her residence to provide for emergency obstetrical care; (iii) serve larger population catchment areas with easy access to the facility than other RHUs;  (iv) be accessible to most communities and to the first referral level facility; (v) no RHU will be upgraded if the whole facility is in very poor conditions and not planned for rehabilitation, or if a new facility is being planned, or if another financing source is planning improvements or upgrading;  (vi) no RHU will be upgraded if the facility is less than 5 kilometers from any public health facilities; and (vii) have political and community will and support.  Scope of Work  The Project will upgrade the facility to increase its capacity to provide acceptable, safe; and quality women's health service by:  (i) repairing existing infrastructure such as roof, ceiling, guttering, paintwork;  (ii) providing for connection to local electricity source if available; (iii) improving water supply to the facility; (iv) improving sanitation facilities; (v) improving the capacity to provide privacy for clients for physical eXaminations and counseling by having a separate room for this purpose;  (vi) improving the storage capacities for essential drugs and equipment; (vii) providing capacity for observation area for clients who may need observation i.e. prenatal/consultation room; and  (viii) placing on the front door a board to notify visitors of the location of staff on call during weekends and nights.  Barangay Health Stations (BHS)  The barangay health station is the health post where the rural health midwife may base her work, and from where she may serve one to three barangays. The BHS should provide primary health care; antenatal and postnatal care; family planning (pill and condom distribution); management of common infectious diseases; nutrition; preventive intervention  (e.g. immunization) and counseling.  Issues that presently compromise the quality of services provided at these facilities include lack of privacy for clients when requested; poor management of sterile conditions; poorly maintained facilities and equipment; lack of essential equipment, drugs, and supplies; lack of reliable and clean sources of water and power; poor sanitation facilities, especially needed for women undergoing internal examinations and for antenatal clients.  Selection Criteria  (i) serve larger population catchment areas with easy access to the facility than other BHSs - eg. BHS that can centrally serve three to five barangays;  (ii) in situation that catchment area of an RHU that is being upgraded; (iii) accessibility to the communities  (iv) no BHS will be upgraded if the facility is in very poor condition and not planned for rehabilitation, or if a new facility is being planned, or if another financing source is planning improvements or upgrading. (v) no BHS will be upgraded if the facility does not have a permanent assigned midwife; (vi) political and community will and support.  Scope of Work  To increase its capacity to provide an acceptable, safe, and quality women's health service, the Project will:  (i) repair existing infrastructure such as roof, ceiling, guttering, paintwork; (ii) provide for connection to local electricity source if available; (iii) improve water supply to the facility; (iv) improve sanitation facilities; (v) improve the capacity to provide privacy for clients by having separate room for this purpose; and (vi) improve the storage capacities for essential drugs and equipment.  D. Lying-in Clinics  The lying-in clinics offer services for safe deliveries; beds in which to rest for a few hours before returning home postpartum; and postdelivery counseling on mother and child care, family planning, and other aspects of women's health. They also provide an opportunity for the midwife to supervise deliveries by traditional birth attendants and in-service training. They will serve as a point for stabilizing a women prior to transfer if she is suffering from an obstetrical complication.  The lying-in clinic will be attached/in the grounds of an RHU.  Selection Criteria  The RHUs that will be upgraded to provide lying-in clinic services will:  (i) already have staff to provide services for women on a 24-hour basis; (ii) be located to areas that are easily reached by most of the population; (iii) be in the district with hospital that will be upgraded to first referral level obstetrical service capacities; and (iv) be near the main road.  Scope of Work  (i) a three-bed labor/post delivery room, (ii) a delivery room, (iii) a toilet and bathroom, (iv) piped water, (v) electricity, (vi) three beds and bedside tables, and (vii) equipment for RHU midwives.  E. Maternity Waiting Homes  The maternity waiting home provide pregnant women in hard to reach areas with a temporary residence where they can be observed prior to delivery. This facility has a space where food can be prepared (kitchen), laundry done, etc. Women should treat it like a home, and should accompanied by a family member. While in the residence, the pregnant woman can be more closely monitored by the first referral level obstetric facility through provision of prenatal care and can be quickly admitted to the first referral level facility (i) at the onset of labor, (ii) at the first sign of any complications, or (iii) if an unanticipated complication arises. The facility addresses two problems regarding early management of obstetric complications.   (i) Women who are identified as having high-risk pregnancies may not like to stay for long periods of time in a hospital away from family members, in unfamiliar surroundings and where they believe sick people should be.  (ii) Women who may need intervention can be quickly transferable to the hospital at the onset of labor or a problem.  Maternity waiting homes will be in the grounds of the selected provincial hospital.  Selection Criteria  The selected provincial hospital that will be upgraded to provide maternity waiting home will:  (i) have a catchment area population that is hard to reach; (ii) have a facility with catchment area that have high levels of maternal deaths, perinatal mortality and morbidity; (iii) have adequate space to establish a maternity waiting home; (iv) have adequate human resource complement.  Hard to reach area for this purpose means that a referral facility can only be reached by hiking for 2 hours or more or referral facility can only be reached seasonally.   Scope of Work (i) 2 three\u2014bed room, (ii) toilet and bathroom, (iii) a kitchenette cum dining/receiving room, (iv) piped water, (v) electricity, (vi) 6 beds and 3 bedside tables  F. Utilization of Savings for Variation Order  Any amount of savings as a result of lower bids shall be used in the following prioritized item of works. Such savings shall be reprogrammed only within the province concerned.  Priority Item of Work  1. Repair or Replacement of Roofing  2. Flooring Finishes (except toilet) - use Vinyl Tiles 1.5 mm thick  3. Repainting of rooting, walls ceiling, doors  4. Repair / Replacement glazed and unglazed tiles for toilets 5. Repair / Replacement of windows.  All other provisions of AO 21\u2014A s. 1996 shall remain in effect.  "]}}; }
buildViz(1000,undefined,null,null,true,false,false,false,false,true,false,false,true,0.1,false,undefined,undefined);
</script>

